PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Song, QT; Wu, ZG; Fan, YY; Song, WR; Zhang, PR; Wang, L; Wang, FX; Xu, YY; Wang, PG; Cheng, JS				Song, Qitao; Wu, Zhigang; Fan, Yueyuan; Song, Woran; Zhang, Peiru; Wang, Li; Wang, Faxing; Xu, Yangyang; Wang, Peng G.; Cheng, Jiansong			Production of homogeneous glycoprotein with multisite modifications by an engineered N-glycosyltransferase mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycosyltransferase; N-linked glycosylation; post-translational modification (PTM); protein engineering	O-GLCNAC TRANSFERASE; PROTEIN DATA-BANK; ACTINOBACILLUS-PLEUROPNEUMONIAE; LINKED GLYCOSYLATION; STRUCTURAL INSIGHTS; CHEMICAL-SYNTHESIS; ESCHERICHIA-COLI; CARBOHYDRATE; SPECIFICITY; MECHANISM	Naturally occurring N-glycoproteins exhibit glycoform heterogeneity with respect to N-glycan sequon occupancy (macroheterogeneity) and glycan structure (microheterogeneity). However, access to well-defined glycoproteins is always important for both basic research and therapeutic purposes. As a result, there has been a substantial effort to identify and understand the catalytic properties of N-glycosyltransferases, enzymes that install the first glycan on the protein chain. In this study we found that ApNGT, a newly discovered cytoplasmic N-glycosyltransferase from Actinobacillus pleuropneumoniae, has strict selectivity toward the residues around the Asn of N-glycosylation sequon by screening a small library of synthetic peptides. The inherent stringency was subsequently demonstrated to be closely associated with a critical residue (Gln-469) of ApNGT which we propose hinders the access of bulky residues surrounding the occupied Asn into the active site. Site-saturated mutagenesis revealed that the introduction of small hydrophobic residues at the site cannot only weaken the stringency of ApNGT but can also contribute to enormous improvement of glycosylation efficiency against both short peptides and proteins. We then employed the most efficient mutant (Q469A) other than the wild-type ApNGT to produce a homogeneous glycoprotein carrying multiple (up to 10) N-glycans, demonstrating that this construct is a promising biocatalyst for potentially addressing the issue of macroheterogeneity in glycoprotein preparation.	[Song, Qitao; Fan, Yueyuan; Song, Woran; Zhang, Peiru; Wang, Li; Wang, Faxing; Xu, Yangyang; Wang, Peng G.; Cheng, Jiansong] Nankai Univ, State Key Lab Med Chem Biol, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China; [Song, Qitao; Fan, Yueyuan; Song, Woran; Zhang, Peiru; Wang, Li; Wang, Faxing; Xu, Yangyang; Wang, Peng G.; Cheng, Jiansong] Nankai Univ, Coll Pharm, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China; [Wu, Zhigang] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	Nankai University; Nankai University; University System of Georgia; Georgia State University	Wang, PG; Cheng, JS (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.; Wang, PG; Cheng, JS (corresponding author), Nankai Univ, Coll Pharm, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.	pwang@nankai.edu.cn; jiansongcheng@nankai.edu.cn	WANG, Peng/GSN-5263-2022	Wu, Zhigang/0000-0001-5117-8480	Natural Science Foundation [21372130, 81302682]	Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation Grants 21372130 and 81302682.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207; BEAVIS RC, 1990, ANAL CHEM, V62, P1836, DOI 10.1021/ac00216a020; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Doerr A, 2015, NAT METHODS, V12, P14, DOI 10.1038/nmeth.3246; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Grogan MJ, 2002, ANNU REV BIOCHEM, V71, P593, DOI 10.1146/annurev.biochem.71.110601.135334; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lomino JV, 2013, BIOORGAN MED CHEM, V21, P2262, DOI 10.1016/j.bmc.2013.02.007; Lutteke T, 2004, CARBOHYD RES, V339, P1015, DOI 10.1016/j.carres.2003.09.038; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mazola Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002285; McCann JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003977; Muthana MM, 2012, CHEM COMMUN, V48, P2728, DOI 10.1039/c2cc17577k; Naegeli A, 2014, J BIOL CHEM, V289, P24521, DOI 10.1074/jbc.M114.579326; Naegeli A, 2014, J BIOL CHEM, V289, P2170, DOI 10.1074/jbc.M113.524462; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Spahn PN, 2014, CURR OPIN BIOTECH, V30, P218, DOI 10.1016/j.copbio.2014.08.004; Wang P, 2013, SCIENCE, V342, P1357, DOI 10.1126/science.1245095; Wu ZG, 2016, BIOCONJUGATE CHEM, V27, P1972, DOI 10.1021/acs.bioconjchem.6b00385; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280	40	25	25	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8856	8863		10.1074/jbc.M117.777383	http://dx.doi.org/10.1074/jbc.M117.777383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381551	hybrid, Green Published			2022-12-28	WOS:000402153900039
J	Schreiber, G				Schreiber, Gideon			The molecular basis for differential type I interferon signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cell signaling; interferon; protein-protein interaction; receptor structure-function; STAT transcription factor	ALPHA-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; IFN-BETA; GENE-TRANSCRIPTION; ANTIVIRAL RESPONSE; RECEPTOR-BINDING; LIGAND-BINDING; CANCER-CELLS; STAT2; EXPRESSION	Type I interferons (IFN-1) are cytokines that affect the expression of thousands of genes, resulting in profound cellular changes. IFN-1 activates the cell by dimerizing its two-receptor chains, IFNAR1 and IFNAR2, which are expressed on all nucleated cells. Despite a similar mode of binding, the different IFN-1s activate a spectrum of activities. The causes for differential activation may stem from differences in IFN-1-binding affinity, duration of binding, number of surface receptors, induction of feedbacks, and cell type-specific variations. All together these will alter the signal that is transmitted from the extracellular domain inward. The intracellular domain binds, directly or indirectly, different effector proteins that transmit signals. The composition of effector molecules deviates between different cell types and tissues, inserting an additional level of complexity to the system. Moreover, IFN-1s do not act on their own, and clearly there is much cross-talk between the activated effector molecules by IFN-1 and other cytokines. The outcome generated by all of these factors (processing step) is an observed phenotype, which can be the transformation of the cell to an antiviral state, differentiation of the cell to a specific immune cell, senescence, apoptosis, and many more. IFN-1 activities can be divided into robust and tunable. Antiviral activity, which is stimulated by minute amounts of IFN-1 and is common to all cells, is termed robust. The other activities, which we term tunable, are cell type-specific and often require more stringent modes of activation. In this review, I summarize the current knowledge on the mode of activation and processing that is initiated by IFN-1, in perspective of the resulting phenotypes.	[Schreiber, Gideon] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il			United States-Israel Binational Science Foundation (BSF) [2011093]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]	United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This research was funded by the United States-Israel Binational Science Foundation (BSF) Grant 2011093 and the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation Grant 1775/12. The author declares that he has no conflicts of interest with the contents of this article.	Akabayov SR, 2010, BIOCHEMISTRY-US, V49, P687, DOI 10.1021/bi901313x; Apelbaum A, 2013, MOL CELL BIOL, V33, P800, DOI 10.1128/MCB.01430-12; Arimoto K, 2017, NAT STRUCT MOL BIOL, V24, P279, DOI 10.1038/nsmb.3378; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Bhattacharya S, 2013, ONCOGENE, V32, P4214, DOI 10.1038/onc.2012.439; Bhattacharya S, 2014, EMBO MOL MED, V6, P384, DOI 10.1002/emmm.201303236; Blaszczyk K, 2016, CYTOKINE GROWTH F R, V29, P71, DOI 10.1016/j.cytogfr.2016.02.010; Blaszczyk K, 2015, BIOCHEM J, V466, P511, DOI 10.1042/BJ20140644; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Booy S, 2014, J CELL MOL MED, V18, P492, DOI 10.1111/jcmm.12200; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chiantore MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036909; Chill JH, 2003, STRUCTURE, V11, P791, DOI 10.1016/S0969-2126(03)00120-5; Chmiest D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13476; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Crow MK, 2015, TRANSL RES, V165, P296, DOI 10.1016/j.trsl.2014.10.005; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Fish EN, 1999, J BIOL CHEM, V274, P571, DOI 10.1074/jbc.274.2.571; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; George CX, 2008, VIROLOGY, V380, P338, DOI 10.1016/j.virol.2008.07.029; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Gui J, 2016, J INVEST DERMATOL, V136, P1990, DOI 10.1016/j.jid.2016.06.608; Gupta S, 1999, J IMMUNOL, V163, P3834; Harari D, 2014, J BIOL CHEM, V289, P29014, DOI 10.1074/jbc.M114.602474; Harari D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084259; Hjortsberg L, 2007, EXP CELL RES, V313, P404, DOI 10.1016/j.yexcr.2006.10.022; Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117; Hsu YA, 2016, CANCER LETT, V375, P303, DOI 10.1016/j.canlet.2016.02.047; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaitin DA, 2007, J INTERF CYTOK RES, V27, P653, DOI 10.1089/jir.2006.0162; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Katlinskaya YV, 2016, CELL REP, V15, P171, DOI 10.1016/j.celrep.2016.03.006; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kraus TA, 2003, J BIOL CHEM, V278, P13033, DOI 10.1074/jbc.M212972200; Krause CD, 2015, CYTOKINE, V76, P480, DOI 10.1016/j.cyto.2015.07.019; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Linossi EM, 2015, IMMUNOL REV, V266, P123, DOI 10.1111/imr.12305; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Lochte S, 2014, J CELL BIOL, V207, P407, DOI 10.1083/jcb.201406032; Majoros A, 2016, EMBO REP, V17, P367, DOI 10.15252/embr.201540726; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Oon S, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.26; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297; Picaud S, 2002, J INTERF CYTOK RES, V22, P457, DOI 10.1089/10799900252952244; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Romero-Weaver AL, 2010, MOL CANCER RES, V8, P80, DOI 10.1158/1541-7786.MCR-08-0344; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sandling JK, 2011, EUR J HUM GENET, V19, P479, DOI 10.1038/ejhg.2010.197; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; SENDA T, 1992, EMBO J, V11, P3193, DOI 10.1002/j.1460-2075.1992.tb05396.x; Sharma N, 2016, J BIOL CHEM, V291, P3371, DOI 10.1074/jbc.M115.686071; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; Speer SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11496; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Teijaro JR, 2016, P NATL ACAD SCI USA, V113, P1351, DOI 10.1073/pnas.1525356113; Testoni B, 2011, J BIOL CHEM, V286, P20217, DOI 10.1074/jbc.M111.231068; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tyler DR, 2007, MOL IMMUNOL, V44, P1864, DOI 10.1016/j.molimm.2006.10.006; Uddin S, 2003, BIOCHEM BIOPH RES CO, V308, P325, DOI 10.1016/S0006-291X(03)01382-2; Urin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130797; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Wagner TC, 2004, INT J CANCER, V111, P32, DOI 10.1002/ijc.20236; Waichman S, 2010, ANAL CHEM, V82, P1478, DOI 10.1021/ac902608a; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Zhang KJ, 2017, CLIN CANCER RES, V23, P2038, DOI 10.1158/1078-0432.CCR-16-1386; Zhao LJ, 2016, CYTOKINE, V80, P48, DOI 10.1016/j.cyto.2015.08.264	100	117	124	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7285	7294		10.1074/jbc.R116.774562	http://dx.doi.org/10.1074/jbc.R116.774562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28289098	hybrid, Green Published			2022-12-28	WOS:000400761300001
J	Stolzenberg, S; Li, Z; Quick, M; Malinauskaite, L; Nissen, P; Weinstein, H; Javitch, JA; Shi, L				Stolzenberg, Sebastian; Li, Zheng; Quick, Matthias; Malinauskaite, Lina; Nissen, Poul; Weinstein, Harel; Javitch, Jonathan A.; Shi, Lei			The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; conformational change; metal ion-protein interaction; molecular dynamics; neurotransmitter transport; transporter	X-RAY STRUCTURES; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; SODIUM SYMPORTER; BINDING-SITE; MECHANISM; LEUT; SUBSTRATE	Neurotransmitter:sodium symporters (NSSs) terminate neurotransmission by the reuptake of released neurotransmitters. This active accumulation of substrate against its concentration gradient is driven by the transmembrane Na+ gradient and requires that the transporter traverses several conformational states. LeuT, a prokaryotic NSS homolog, has been crystallized in outward-open, outward-occluded, and inward-open states. Two crystal structures of another prokaryotic NSS homolog, the multihydrophobic amino acid transporter (MhsT) from Bacillus halodurans, have been resolved in novel inward-occluded states, with the extracellular vestibule closed and the intracellular portion of transmembrane segment 5 (TM5i) in either an unwound or a helical conformation. We have investigated the potential involvement of TM5i in binding and unbinding of Na2, i.e. the Na+ bound in the Na2 site, by carrying out comparative molecular dynamics simulations of the models derived from the two MhsT structures. We find that the helical TM5i conformation is associated with a higher propensity for Na2 release, which leads to the repositioning of the N terminus and transition to an inward-open state. By using comparative interaction network analysis, we also identify allosteric pathways connecting TM5i and the Na2 binding site to the extracellular and intracellular regions. Based on our combined computational and mutagenesis studies of MhsT and LeuT, we propose that TM5i plays a key role in Na2 binding and release associated with the conformational transition toward the inward-open state, a role that is likely to be shared across the NSS family.	[Stolzenberg, Sebastian] Free Univ Berlin, Inst Math, Computat Mol Biol Grp, D-74195 Berlin, Germany; [Stolzenberg, Sebastian; Li, Zheng; Weinstein, Harel; Shi, Lei] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Weinstein, Harel; Shi, Lei] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Stolzenberg, Sebastian] Cornell Univ, Dept Phys, Ithaca, NY 14850 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Malinauskaite, Lina; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, Nord EMBL Partnership Mol Med, Danish Res Inst Translat Neurosci DANDRITE, DK-8000 Aarhus C, Denmark; [Shi, Lei] NIDA, Computat Chem & Mol Biophys Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Free University of Berlin; Cornell University; Cornell University; Cornell University; Columbia University; Columbia University; New York State Psychiatry Institute; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shi, L (corresponding author), 333 Cassell Dr,Rm 1121, Baltimore, MD 21224 USA.	lei.shi2@nih.gov	WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020	WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Nissen, Poul/0000-0003-0948-6628; Javitch, Jonathan/0000-0001-7395-2967; Malinauskaite, Lina/0000-0003-3232-0415	National Institutes of Health [DA023694, DA012408, U54GM087519, DA022413, DA17293]; National Institute on Drug Abuse Intramural Research Program; Dahlem Research School (DRS)/Marie Curie Post-Doctoral Postdoc International (POINT) Fellowship at Freie Universitat Berlin; Lundbeck Foundation [R126-2012-12576] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023694, K05DA022413, P01DA012408, R01DA017293, ZIADA000606, K99DA023694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Dahlem Research School (DRS)/Marie Curie Post-Doctoral Postdoc International (POINT) Fellowship at Freie Universitat Berlin; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA023694 (to L. S.), DA012408 and U54GM087519 (to H. W.), and DA022413, DA17293, and U54GM087519 (to J. A. J.). This work was also supported in part by the National Institute on Drug Abuse Intramural Research Program (to L. S.) and a Dahlem Research School (DRS)/Marie Curie Post-Doctoral Postdoc International (POINT) Fellowship at Freie Universitat Berlin (to S. S.). This work utilized the computational resources of the National Institutes of Health High-Performance Computing (HPC) Biowulf cluster. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Billesbolle CB, 2015, J BIOL CHEM, V290, P26725, DOI 10.1074/jbc.M115.677658; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hummer G, 1996, J PHYS CHEM-US, V100, P1206, DOI 10.1021/jp951011v; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Ku H. H., 1969, Precision Measurement & Calibration , N.B.S. papers on on statistical concepts and procedures, P331; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; R Development Core Team, 2016, R LANG ENV STAT COMP; Razavi AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40076; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2011, COMPREHENSIVE BIOPHYSICS, VOL 9: SIMULATION AND MODELLING, P105, DOI 10.1016/B978-0-12-374920-8.00910-3; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Stolzenberg S, 2016, BBA-BIOMEMBRANES, V1858, P1652, DOI 10.1016/j.bbamem.2016.01.010; Stolzenberg S, 2015, J BIOL CHEM, V290, P13992, DOI 10.1074/jbc.M114.625343; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2016, P NATL ACAD SCI USA, V113, pE2776, DOI 10.1073/pnas.1603282113; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	42	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7372	7384		10.1074/jbc.M116.757153	http://dx.doi.org/10.1074/jbc.M116.757153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28320858	Green Published, hybrid			2022-12-28	WOS:000400761300009
J	Comino, N; Cifuente, JO; Marina, A; Orrantia, A; Eguskiza, A; Guerin, ME				Comino, Natalia; Cifuente, Javier O.; Marina, Alberto; Orrantia, Ane; Eguskiza, Ander; Guerin, Marcelo E.			Mechanistic insights into the allosteric regulation of bacterial ADP-glucose pyrophosphorylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-DIPHOSPHATE GLUCOSE; ESCHERICHIA-COLI; GLYCOGEN-SYNTHASE; CRYSTAL-STRUCTURE; AGROBACTERIUM-TUMEFACIENS; STRUCTURAL BASIS; CONFORMATIONAL PLASTICITY; LACTATE-DEHYDROGENASE; CATALYTIC MECHANISM; STARCH METABOLISM	ADP-glucose pyrophosphorylase (AGPase) controls bacterial glycogen and plant starch biosynthetic pathways, the most common carbon storage polysaccharides in nature. AGPase activity is allosterically regulated by a series of metabolites in the energetic flux within the cell. Very recently, we reported the first crystal structures of the paradigmatic AGPase from Escherichia coli (EcAGPase) in complex with its preferred physiological negative and positive allosteric regulators, adenosine 5 ' -mono-phosphate (AMP) and fructose 1,6-bisphosphate (FBP), respectively. However, understanding the molecular mechanism by which AMP and FBP allosterically modulates EcAGPase enzymatic activity still remains enigmatic. Here we found that single point mutations of key residues in the AMP-binding site decrease its inhibitory effect but also clearly abolish the overall AMP-mediated stabilization effect in wild-type EcAGPase. Single point mutations of key residues for FBP binding did not revert the AMP-mediated stabilization. Strikingly, an EcAG-Pase- R130A mutant displayed a dramatic increase in activity when compared with wild-type EcAGPase, and this increase correlated with a significant increment of glycogen content in vivo. The crystal structure of EcAGPase-R130A revealed unprecedented conformational changes in structural elements involved in the allosteric signal transmission. Altogether, we propose a model in which the positive and negative energy reporters regulate AGPase catalytic activity via intra-and inter-protomer cross-talk, with a "sensory motif" and two loops, RL1 and RL2, flanking the ATP-binding site playing a significant role. The information reported herein provides exciting possibilities for industrial/biotechnological applications.	[Comino, Natalia; Cifuente, Javier O.; Marina, Alberto; Orrantia, Ane; Eguskiza, Ander; Guerin, Marcelo E.] CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio 48160, Spain; [Guerin, Marcelo E.] Univ Pais Vasco Euskal Herriko Unibertsitatea CSI, UPV EHU, CSIC, Unidad Biofis,Ctr Mixto, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain; [Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa 48940, Bizkaia, Spain; [Guerin, Marcelo E.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science	Guerin, ME (corresponding author), CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio 48160, Spain.	mrcguerin@cicbiogune.es	Cifuente, Javier O./AAC-5127-2019; Guerin, Marcelo M/N-7245-2016; Cifuente, Javier/F-3874-2016; Marina, Alberto/Z-5252-2019	Cifuente, Javier O./0000-0001-5420-121X; Guerin, Marcelo M/0000-0001-9524-3184; Cifuente, Javier/0000-0001-5420-121X; Marina, Alberto/0000-0001-7822-0503; Comino, Natalia/0000-0001-8924-8819; Orrantia Robles, Ane/0000-0002-9016-3799	European Commission [HEALTH-F32011-260872]; Spanish Ministry of Economy and Competitiveness [BIO2013-49022-C2-2-R]; Basque Government	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government)	This work was supported by European Commission Contract HEALTH-F32011-260872, Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R, and the Basque Government (toM.E.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albesa-Jove D, 2016, CURR OPIN STRUC BIOL, V40, P23, DOI 10.1016/j.sbi.2016.07.007; Albesa-Jove D, 2014, GLYCOBIOLOGY, V24, P108, DOI 10.1093/glycob/cwt101; ARCHIBALD A, 1961, J CHEM SOC, P1183, DOI 10.1039/jr9610001183; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cifuente JO, 2016, STRUCTURE, V24, P1613, DOI 10.1016/j.str.2016.06.023; CLARKE AR, 1987, BIOCHIM BIOPHYS ACTA, V913, P72, DOI 10.1016/0167-4838(87)90234-2; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; Diaz A, 2012, IUBMB LIFE, V64, P649, DOI 10.1002/iub.1048; Diaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109; Duetz WA, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P99; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng L, 2015, BIOCHEMISTRY-US, V54, P6207, DOI 10.1021/acs.biochem.5b00228; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; Fuhring J, 2013, ACS CATAL, V3, P2976, DOI 10.1021/cs4007777; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; Fushinobu S, 1996, J BIOL CHEM, V271, P25611, DOI 10.1074/jbc.271.41.25611; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; GENTNER N, 1967, BIOCHEM BIOPH RES CO, V27, P417, DOI 10.1016/S0006-291X(67)80116-5; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Guerin ME, 2003, ACTA CRYSTALLOGR D, V59, P526, DOI 10.1107/S0907444902023119; HILL MA, 1991, J BIOL CHEM, V266, P12455; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Ikehara Y, 2014, J BIOL CHEM, V289, P31550, DOI 10.1074/jbc.M114.599092; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kornberg A., 1962, HORIZONS BIOCH, P251; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983; Laskowski Roman A, 2003, Methods Biochem Anal, V44, P273; LELOIR LF, 1957, J AM CHEM SOC, V79, P6340, DOI 10.1021/ja01580a061; LODEIRO AR, 1994, BIOCHEM EDUC, V22, P213; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer CR, 1998, ARCH BIOCHEM BIOPHYS, V352, P247, DOI 10.1006/abbi.1998.0593; Moller MS, 2016, CELL MOL LIFE SCI, V73, P2619, DOI 10.1007/s00018-016-2241-y; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ormo M, 1998, BIOCHEMISTRY-US, V37, P16565, DOI 10.1021/bi981616s; PAULE MR, 1971, J BIOL CHEM, V246, P4602; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PREISS J, 1975, J BIOL CHEM, V250, P7631; PREISS J, 1983, MOL CELL BIOCHEM, V57, P61; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; PREISS J, 1965, BIOCHEM BIOPH RES CO, V18, P180, DOI 10.1016/0006-291X(65)90737-0; Preiss J, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P317; PREISS J, 1989, ADV MICROB PHYSIOL, V30, P183; Preiss J, 2014, ECOSAL, V6, P1, DOI [10.1128/ecosalplus.ESP-0015-2014, DOI 10.1128/ECOSALPLUS.ESP-0015-2014]; RECONDO E, 1961, BIOCHEM BIOPH RES CO, V6, P85, DOI 10.1016/0006-291X(61)90389-8; RIBEREAUGAYON G, 1971, ARCH BIOCHEM BIOPHYS, V142, P675, DOI 10.1016/0003-9861(71)90534-0; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Sweetlove LJ, 1996, BIOCHEM J, V320, P493, DOI 10.1042/bj3200493; Swift RV, 2012, BIOCHEMISTRY-US, V51, P10236, DOI 10.1021/bi301224b; Tuncel A, 2013, PLANT SCI, V211, P52, DOI 10.1016/j.plantsci.2013.06.009; Ugalde JE, 1998, J BACTERIOL, V180, P6557, DOI 10.1128/JB.180.24.6557-6564.1998; Ugalde JE, 2003, P NATL ACAD SCI USA, V100, P10659, DOI 10.1073/pnas.1534787100; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Vithani N, 2014, ACTA CRYSTALLOGR F, V70, P703, DOI 10.1107/S2053230X14008279; Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111	82	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6255	6268		10.1074/jbc.M116.773408	http://dx.doi.org/10.1074/jbc.M116.773408			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223362	hybrid, Green Published			2022-12-28	WOS:000399538700020
J	Augustine, T; Chaudhary, P; Gupta, K; Islam, S; Ghosh, P; Santra, MK; Mitra, D				Augustine, Tracy; Chaudhary, Priyanka; Gupta, Kailash; Islam, Sehbanul; Ghosh, Payel; Santra, Manas Kumar; Mitra, Debashis			Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITION; CELL-CYCLE; ANTIVIRAL ACTIVITY; DEPENDENT MANNER; ENZYME APOBEC3G; IN-VITRO; REPLICATION; EXPRESSION; NEF	Cyclin F protein, also known as FBXO1, is the largest among all cyclins and oscillates in the cell cycle like other cyclins. Apart from being a G(2)/M cyclin, cyclin F functions as the substratebinding subunit of SCFcyclin F E3 ubiquitin ligase. In a gene expression analysis performed to identify novel gene modulations associated with cell cycle dysregulation during HIV-1 infection in CD4(+) T cells, we observed down-regulation of the cyclin F gene (CCNF). Later, using gene overexpression and knockdown studies, we identified cyclin F as negatively influencing HIV-1 viral infectivity without any significant impact on virus production. Subsequently, we found that cyclin F negatively regulates the expression of viral protein Vif (viral infectivity factor) at the protein level. We also identified a novel hostpathogen interaction between cyclin F and Vif protein in T cells during HIV-1 infection. Mutational analysis of a cyclin F-specific amino acid motif in the C-terminal region of Vif indicated rescue of the protein from cyclin F-mediated down-regulation. Subsequently, we showed that Vif is a novel substrate of the SCFcyclin F E3 ligase, where cyclin F mediates the ubiquitination and proteasomal degradation of Vif through physical interaction. Finally, we showed that cyclin F augments APOBEC3G expression through degradation of Vif to regulate infectivity of progeny virions. Taken together, our results demonstrate that cyclin F is a novel F-box protein that functions as an intrinsic cellular regulator of HIV-1 Vif and has a negative regulatory effect on the maintenance of viral infectivity by restoring APOBEC3G expression.	[Augustine, Tracy; Chaudhary, Priyanka; Gupta, Kailash; Islam, Sehbanul; Santra, Manas Kumar; Mitra, Debashis] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Ghosh, Payel] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Mitra, D (corresponding author), Natl Ctr Cell Sci, Lab HIV Res, Pune 411007, Maharashtra, India.	dmitra@nccs.res.in		Islam, Sehbanul/0000-0003-2686-2787	National Centre for Cell Science, Pune, India; Indian Council of Medical Research (ICMR); University Grant Commission (UGC) research fellowship; DBT research fellowship; Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India	National Centre for Cell Science, Pune, India; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grant Commission (UGC) research fellowship(University Grants Commission, India); DBT research fellowship; Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, in the form of a Tata Innovation Fellowship (to D. M.) and by intramural support from the National Centre for Cell Science, Pune, India. This work also was supported by a research fellowship (to T. A.) from the Indian Council of Medical Research (ICMR), a University Grant Commission (UGC) research fellowship (to K. G.), and a DBT research fellowship (to S. I.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aiken C, 2011, NATURE, V472, P305, DOI 10.1038/472305a; Anderson BD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500296; Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bogerd HP, 2015, P NATL ACAD SCI USA, V112, pE7249, DOI 10.1073/pnas.1516305112; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Charrasse S, 1999, CELL GROWTH DIFFER, V10, P611; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; COATES K, 1995, J GEN VIROL, V76, P837, DOI 10.1099/0022-1317-76-4-837; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; CULLEN BR, 1990, VIROLOGY, V178, P1, DOI 10.1016/0042-6822(90)90373-Y; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Dussart S, 2004, BIOCHEM BIOPH RES CO, V315, P66, DOI 10.1016/j.bbrc.2004.01.023; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Farrow MA, 2005, AIDS RES HUM RETROV, V21, P565, DOI 10.1089/aid.2005.21.565; Fujita M, 2004, MICROBES INFECT, V6, P791, DOI 10.1016/j.micinf.2004.04.011; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Goff SP, 2003, CELL, V114, P281, DOI 10.1016/S0092-8674(03)00602-0; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Imai K, 2009, FEBS J, V276, P7124, DOI 10.1111/j.1742-4658.2009.07424.x; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Khan SZ, 2011, J BIOL CHEM, V286, P22943, DOI 10.1074/jbc.M110.201194; Klein DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6800; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyei GB, 2015, CELL HOST MICROBE, V17, P98, DOI 10.1016/j.chom.2014.11.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng J, 2014, CELL HOST MICROBE, V15, P717, DOI 10.1016/j.chom.2014.05.011; Madani N, 2000, J VIROL, V74, P5982, DOI 10.1128/JVI.74.13.5982-5987.2000; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Miyakawa K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7945; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ran XZ, 2016, CURR HIV RES, V14, P217, DOI 10.2174/1570162X14999160224100541; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Valera MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0181-5; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walter D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10530; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Yang ZY, 2014, NAT MED, V20, P808, DOI 10.1038/nm.3657; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zuo T, 2012, J VIROL, V86, P5497, DOI 10.1128/JVI.06957-11	72	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5349	5363		10.1074/jbc.M116.765842	http://dx.doi.org/10.1074/jbc.M116.765842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28184007	hybrid, Green Published			2022-12-28	WOS:000397875500017
J	Sharma, V; Roy, S; Sekler, I; O'Halloran, DM				Sharma, Vishal; Roy, Soumitra; Sekler, Israel; O'Halloran, Damien M.			The NCLX-type Na+/Ca2+ Exchanger NCX-9 Is Required for Patterning of Neural Circuits in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON GUIDANCE; CALCIUM EXCHANGE; PIONEER AXONS; SODIUM; UNC-5; MIGRATIONS; NEURONS; CELLS; CONE	NCLX is a Na+/Ca2+ exchanger that uses energy stored in the transmembrane sodium gradient to facilitate the exchange of sodium ions for ionic calcium. Mammals have a single NCLX, which has been shown to function primarily at the mitochondrion and is an important regulator of neuronal physiology by contributing to neurotransmission and synaptic plasticity. The role of NCLX in developmental cell patterning (e.g. in neural circuits) is largely unknown. Here we describe a novel role for the Caenorhabditis elegans NCLX- type protein, NCX- 9, in neural circuit formation. NCX-9 functions in hypodermal seam cells that secrete the axon guidance cue UNC-129/ BMP, and our data revealed that ncx-9(-/-) mutant animals exhibit development defects in stereotyped left/right axon guidance choices within the GABAergic motor neuron circuit. Our data also implicate NCX-9 in a LON-2/heparan sulfate and UNC-6/netrin-mediated, RAC-dependent signaling pathway to guide left/ right patterning within this circuit. Finally, we also provide in vitro physiology data supporting the role for NCX-9 in handling calcium exchange at the mitochondrion. Taken together, our work reveals the specificity by which the handling by NCLX of calcium exchange can map to neural circuit patterning and axon guidance decisions during development.	[Sharma, Vishal; O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA; [Sharma, Vishal; O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA; [Roy, Soumitra; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-8499000 Beer Sheva, Israel	George Washington University; George Washington University; Ben Gurion University	O'Halloran, DM (corresponding author), George Washington Univ, Dept Biol Sci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA.; O'Halloran, DM (corresponding author), George Washington Univ, Inst Neurosci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA.	damienoh@gwu.edu		Sekler, Israel/0000-0002-7550-1550	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Anthony LaMantia and members of the O'Halloran laboratory for critical reading of the manuscript. We also thank David Sherwood, Piali Sengupta, Oliver Hobert, Sally Moody, Mary Ann Stepp, and John Hawdon for support and advice at various stages of the project. We thank Theresa Stiernagle and Aric Daul (Caenorhabditis Genetics Center (CGC), supported by National Institutes of Health Office of Research Infrastructure Programs Grant P40 OD010440) for the strains used. We also thank Eric Lundquist and Eric Struckhoff for kindly supplying mutant strains. We thank Anastas Popratiloff for imaging advice.	Ackley BD, 2014, DEV NEUROBIOL, V74, P781, DOI 10.1002/dneu.22146; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Blanchette CR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006525; Blanchette CR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002183; Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; BRENNER S, 1974, GENETICS, V77, P71; Broadbent ID, 2002, CURR BIOL, V12, P59, DOI 10.1016/S0960-9822(01)00624-8; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Canitano A, 2002, ANN NY ACAD SCI, V976, P394; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Firnhaber C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003921; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Gysi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074908; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Huang X, 2003, DEVELOPMENT, V130, P3147, DOI 10.1242/dev.00518; Hutter H, 2005, DEV BIOL, V284, P260, DOI 10.1016/j.ydbio.2005.05.025; LI ZP, 1994, J BIOL CHEM, V269, P17434; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; Mei D, 2004, EXP CELL RES, V301, P84, DOI 10.1016/j.yexcr.2004.08.017; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Norris AD, 2014, DEVELOPMENT, V141, P4395, DOI 10.1242/dev.110437; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Sharma V, 2013, GENETICS, V195, P611, DOI 10.1534/genetics.113.153106; Sheng JZ, 2000, BIOPHYS J, V79, P1945, DOI 10.1016/S0006-3495(00)76443-5; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	34	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5364	5377		10.1074/jbc.M116.758953	http://dx.doi.org/10.1074/jbc.M116.758953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196860	Green Published, hybrid			2022-12-28	WOS:000397875500018
J	Cashmore, TJ; Klatt, S; Yamaryo-Botte, Y; Brammananth, R; Rainczuk, AK; McConville, MJ; Crellin, PK; Coppel, RL				Cashmore, Tamaryn J.; Klatt, Stephan; Yamaryo-Botte, Yoshiki; Brammananth, Rajini; Rainczuk, Arek K.; McConville, Malcolm J.; Crellin, Paul K.; Coppel, Ross L.			Identification of a Membrane Protein Required for Lipomannan Maturation and Lipoarabinomannan Synthesis in Corynebacterineae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL ARABINAN BIOSYNTHESIS; MYCOBACTERIAL CELL-WALL; PHOSPHATIDYLINOSITOL MANNOSIDES; DEFICIENT MUTANT; LEISHMANIA-MAJOR; CLONING VECTORS; MYCOLIC ACIDS; TUBERCULOSIS; GLUTAMICUM; ARABINOFURANOSYLTRANSFERASE	Mycobacterium tuberculosis and related Corynebacterineae synthesize a family of lipomannans (LM) and lipoarabinomann-ans (LAM) that are abundant components of the multilaminate cell wall and essential virulence factors in pathogenic species. Here we describe a new membrane protein, highly conserved in all Corynebacterineae, that is required for synthesis of full-length LM and LAM. Deletion of the Corynebacterium glutamicum NCgl2760 gene resulted in a complete loss of mature LM/LAM and the appearance of a truncated LM (t-LM). Complementation of the mutant with the NCgl2760 gene fully restored LM/LAM synthesis. Structural studies, including monosaccharide analysis, methylation linkage analysis, and mass spectrometry of native LM species, indicated that the Delta NCgl2760 t-LM comprised a series of short LM species (8-27 residues long) containing an alpha 1-6-linked mannose backbone with greatly reduced alpha 1-2-mannose side chains and no arabinose caps. The structure of the Delta NCgl2760 t-LM was similar to that of the t-LM produced by a C.glutamicum mutant lacking the mptA gene, encoding a membrane alpha 1-6-mannosyltransferase involved in extending the alpha 1-6-mannan backbone of LM intermediates. Interestingly, NCgl2760 lacks any motifs or homology to other proteins of known function. Attempts to delete the NCgl2760 orthologue in Mycobacterium smegmatis were unsuccessful, consistent with previous studies indicating that the M. tuberculosis orthologue, Rv0227c, is an essential gene. Together, these data suggest that NCgl2760/Rv0227c plays a critical role in the elongation of the mannan backbone of mycobacterial and corynebacterial LM, further highlighting the complexity of lipoglycan pathways of Corynebacterineae.	[Cashmore, Tamaryn J.; Brammananth, Rajini; Rainczuk, Arek K.; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Cashmore, Tamaryn J.; Brammananth, Rajini; Rainczuk, Arek K.; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Klatt, Stephan; Yamaryo-Botte, Yoshiki; McConville, Malcolm J.] Univ Melbourne, Bio21 Inst Mol Sci & Biotechnol, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Monash University; Monash University; University of Melbourne	Crellin, PK (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu		Crellin, Paul K/0000-0002-2017-4935; Klatt, Stephan/0000-0003-0064-3367; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411; Coppel, Ross/0000-0002-4476-9124	National Health and Medical Research Council of Australia (NHMRC) [1064466]; Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics [COE562063]; ARC Discovery [140101244]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); ARC Discovery(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1064466, Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics Grant COE562063, and ARC Discovery Grant 140101244. The authors declare that they have no conflicts of interest with the contents of this article.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belardinelli JM, 2016, ACS INFECT DIS, V2, P702, DOI 10.1021/acsinfecdis.6b00095; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Maeda N, 2003, J BIOL CHEM, V278, P5513, DOI 10.1074/jbc.C200586200; Rodriguez DM, 2012, PEPTIDES, V38, P208, DOI 10.1016/j.peptides.2012.08.023; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Rainczuk AK, 2012, J BIOL CHEM, V287, P42726, DOI 10.1074/jbc.M112.373415; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; Skovierova H, 2009, GLYCOBIOLOGY, V19, P1235, DOI 10.1093/glycob/cwp116; Stoop EJM, 2013, CELL MICROBIOL, V15, P2093, DOI 10.1111/cmi.12175; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	51	14	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4976	4986		10.1074/jbc.M116.772202	http://dx.doi.org/10.1074/jbc.M116.772202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28167532	hybrid, Green Published			2022-12-28	WOS:000397590400019
J	Dagbay, KB; Bolik-Coulon, N; Savinov, SN; Hardy, JA				Dagbay, Kevin B.; Bolik-Coulon, Nicolas; Savinov, Sergey N.; Hardy, Jeanne A.			Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; AMYLOID PRECURSOR PROTEIN; C-TERMINAL CLEAVAGE; ALZHEIMERS-DISEASE; MUTANT HUNTINGTIN; AXONAL DEGENERATION; CRYSTAL-STRUCTURES; HYDROGEN-EXCHANGE; TRANSGENIC MICE; SELF-ACTIVATION	Caspases are cysteine aspartate proteases that are major players in key cellular processes, including apoptosis and inflammation. Specifically, caspase-6 has also been implicated in playing a unique and critical role in neurodegeneration; however, structural similarities between caspase-6 and other caspase active sites have hampered precise targeting of caspase-6. All caspases can exist in a canonical conformation, in which the substrate binds atop a beta-strand platform in the 130' s region. This caspase-6 region can also adopt a helical conformation that has not been seen in any other caspases. Understanding the dynamics and interconversion between the helical and strand conformations in caspase-6 is critical to fully assess its unique function and regulation. Here, hydrogen/deuterium exchange mass spec-trometry indicated that caspase-6 is inherently and dramatically more conformationally dynamic than closely related caspase-7. In contrast to caspase-7, which rests constitutively in the strand conformation before and after substrate binding, the hydrogen/deuterium exchange data in the L2 ' and 130' s regions suggested that before substrate binding, caspase-6 exists in a dynamic equilibrium between the helix and strand conformations. Caspase-6 transitions exclusively to the canonical strand conformation only upon substrate binding. Glu-135, which showed noticeably different calculated pK(a) values in the helix and strand conformations, appears to play a key role in the interconversion between the helix and strand conformations. Because caspase-6 has roles in several neurodegenerative diseases, exploiting the unique structural features and conformational changes identified here may provide new avenues for regulating specific caspase-6 functions for therapeutic purposes.	[Dagbay, Kevin B.; Bolik-Coulon, Nicolas; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, 745A Lederle Grad Res Tower,710 N Pleasant, Amherst, MA 01003 USA; [Savinov, Sergey N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 745A Lederle Grad Res Tower,710 N Pleasant, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Bolik-Coulon, Nicolas/0000-0002-2759-5767; Kevin, Dagbay/0000-0001-7002-7207; Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM080532]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080532. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Aharony I, 2015, HUM MOL GENET, V24, P2604, DOI 10.1093/hmg/ddv023; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Cao Q, 2014, ACTA CRYSTALLOGR D, V70, P58, DOI 10.1107/S1399004713024218; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Ding ZM, 2012, INT J MOL SCI, V13, P6089, DOI 10.3390/ijms13056089; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Galvan V, 2002, J NEUROCHEM, V82, P283, DOI 10.1046/j.1471-4159.2002.00970.x; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hill ME, 2016, ACS CHEM BIOL, V11, P1603, DOI 10.1021/acschembio.5b00971; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Landgraf RR, 2013, STRUCTURE, V21, P1942, DOI 10.1016/j.str.2013.08.023; LeBlanc AC, 2013, EUR J NEUROSCI, V37, P2005, DOI 10.1111/ejn.12250; Liao SY, 2013, PROTEIN SCI, V22, P1623, DOI 10.1002/pro.2368; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024227; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Majdi A, 2016, J NEUROSCI RES, V94, P879, DOI 10.1002/jnr.23757; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; Muller I, 2011, BIOORG MED CHEM LETT, V21, P5244, DOI 10.1016/j.bmcl.2011.07.041; Muller I, 2011, J MOL BIOL, V410, P307, DOI 10.1016/j.jmb.2011.05.020; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan LY, 2014, ANAL CHEM, V86, P2657, DOI 10.1021/ac404003q; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Pirrone GF, 2015, ANAL CHEM, V87, P99, DOI 10.1021/ac5040242; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Riechers SP, 2016, HUM MOL GENET, V25, P1600, DOI 10.1093/hmg/ddw036; Saganich MJ, 2006, J NEUROSCI, V26, P13428, DOI 10.1523/JNEUROSCI.4180-06.2006; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Snijder J, 2014, J MOL BIOL, V426, P1971, DOI 10.1016/j.jmb.2014.02.022; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Strajbl M, 2001, J PHYS CHEM B, V105, P4471, DOI 10.1021/jp010279l; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Vaidya S, 2011, BIOCHEMISTRY-US, V50, P3282, DOI 10.1021/bi2001664; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Witkowski WA, 2011, PROTEIN SCI, V20, P1421, DOI 10.1002/pro.673; Wong BKY, 2015, NEUROBIOL DIS, V76, P24, DOI 10.1016/j.nbd.2014.12.030; Yassine W, 2009, BBA-BIOMEMBRANES, V1788, P1722, DOI 10.1016/j.bbamem.2009.05.014; Zhao H, 2014, CELL MOL NEUROBIOL, V34, P369, DOI 10.1007/s10571-013-0021-x; Zhao M, 2003, NEUROBIOL DIS, V14, P391, DOI 10.1016/j.nbd.2003.07.006	80	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4885	4897		10.1074/jbc.M116.773499	http://dx.doi.org/10.1074/jbc.M116.773499			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28154009	Green Published, hybrid			2022-12-28	WOS:000397590400012
J	Mast, N; Anderson, KW; Lin, JB; Li, Y; Turko, IV; Tatsuoka, C; Bjorkhem, I; Pikuleva, IA				Mast, Natalia; Anderson, Kyle W.; Lin, Joseph B.; Li, Yong; Turko, Illarion V.; Tatsuoka, Curtis; Bjorkhem, Ingemar; Pikuleva, Irina A.			Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BIOSYNTHETIC ENZYME; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL HOMEOSTASIS; ESCHERICHIA-COLI; LIVER-MITOCHONDRIA; DIRECT EXPRESSION; MOUSE RETINA; MICE; MECHANISM; 27-HYDROXYLASE	Cytochrome P450 27A1 (CYP27A1 or sterol 27-hydroxylase) is a ubiquitous, multifunctional enzyme catalyzing regio-and stereospecific hydroxylation of different sterols. In humans, complete CYP27A1 deficiency leads to cerebrotendinous xanthomatosis or nodule formation in tendons and brain (preferentially in the cerebellum) rich in cholesterol and cholestanol, the 5 alpha-saturated analog of cholesterol. In Cyp27a1(-/-) mice, xanthomas are not formed, despite a significant cholestanol increase in the brain and cerebellum. The mechanism behind cholestanol production has been clarified, yet little is known about its metabolism, except that CYP27A1 might metabolize cholestanol. It also is unclear why CYP27A1 deficiency results in preferential cholestanol accumulation in the cerebellum. We hypothesized that cholestanol might be metabolized by CYP46A1, the principal cholesterol 24-hydroxylase in the brain. We quantified sterols along with CYP27A1 and CYP46A1 in mouse models (Cyp27a1(-/-), Cyp46a1(-/-), Cyp27a1(-/-,) Cyp46a1(-/-), and two wild type strains) and human brain specimens. In vitro experiments with purified P450s were conducted as well. We demonstrate that CYP46A1 is involved in cholestanol removal from the brain and that several factors contribute to the preferential increase in cholestanol in the cerebellum arising from CYP27A1 deficiency. These factors include (i) low cerebellar abundance of CYP46A1 and high cerebellar abundance of CYP27A1, the lack of which probably selectively increases the cerebellar cholestanol production; (ii) spatial separation in the cerebellum of cholesterol/ cholestanol-metabolizing P450s from a pool of metabolically available cholestanol; and (iii) weak cerebellar regulation of cholesterol biosynthesis. We identified a new physiological role of CYP46A1, an important brain enzyme and cytochrome P450 that could be activated pharmacologically.	[Mast, Natalia; Lin, Joseph B.; Li, Yong; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA; [Tatsuoka, Curtis] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Anderson, Kyle W.; Turko, Illarion V.] Natl Inst Stand & Technol, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Bjorkhem, Ingemar] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14186 Huddinge, Sweden	Case Western Reserve University; Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA; Karolinska Institutet	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	iap8@case.edu		Lin, Joseph/0000-0001-6667-9018; Anderson, Kyle/0000-0002-2808-3026; Bjorkhem, Ingemar/0000-0002-0575-9425; Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health [GM62882, P30, EY011373]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM62882 ( to I. A. P) and P30 Core Grant EY011373. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Certain commercial materials, instruments, and equipment are identified in this manuscript in order to specify the experimental procedure as completely as possible. In no case does such identification imply a recommendation or endorsement by the National Institute of Standards and Technology nor does it imply that the materials, instruments, or equipment identified are necessarily the best available for the purpose.	Anderson KW, 2016, J BIOL CHEM, V291, P11876, DOI 10.1074/jbc.M116.723577; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Bavner A, 2010, J LIPID RES, V51, P2722, DOI 10.1194/jlr.M008326; Bhattacharyya AK, 2007, J LIPID RES, V48, P185, DOI 10.1194/jlr.M600113-JLR200; BJORKHEM I, 1992, J BIOL CHEM, V267, P19872; BJORKHEM I, 1987, HEPATOLOGY, V7, P266, DOI 10.1002/hep.1840070210; BJORKHEM I, 1974, BIOCHIM BIOPHYS ACTA, V337, P129, DOI 10.1016/0005-2760(74)90046-0; Bjorkhem I, 2013, CURR OPIN LIPIDOL, V24, P283, DOI 10.1097/MOL.0b013e328362df13; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; Bogaert L. v., 1937, ANN MED, V42, P69; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BUCHMANN MS, 1987, BIOCHIM BIOPHYS ACTA, V922, P111, DOI 10.1016/0005-2760(87)90144-5; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Dubrac S, 2005, J LIPID RES, V46, P76, DOI 10.1194/jlr.M400219-JLR200; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Honda A, 2001, J LIPID RES, V42, P291; Jack CR, 2015, JAMA NEUROL, V72, P511, DOI 10.1001/jamaneurol.2014.4821; Liao WL, 2008, ANAL BIOCHEM, V377, P55, DOI 10.1016/j.ab.2008.03.016; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mast N, 2006, BIOCHEMISTRY-US, V45, P4396, DOI 10.1021/bi052654w; Mast N, 2004, ARCH BIOCHEM BIOPHYS, V428, P99, DOI 10.1016/j.abb.2004.05.012; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; MASUMOTO O, 1988, J BIOL CHEM, V263, P14256; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; Mignarri A, 2016, J INHERIT METAB DIS, V39, P75, DOI 10.1007/s10545-015-9873-1; OFTEBRO H, 1980, J CLIN INVEST, V65, P1418, DOI 10.1172/JCI109806; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Panzenboeck U, 2007, J LIPID RES, V48, P1167, DOI 10.1194/jlr.M700027-JLR200; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Saadane A, 2014, AM J PATHOL, V184, P2403, DOI 10.1016/j.ajpath.2014.05.024; SAGARA Y, 1992, FEBS LETT, V300, P208, DOI 10.1016/0014-5793(92)80847-A; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; Seyama Yousuke, 2003, Journal of Medicinal Food, V6, P217, DOI 10.1089/10966200360716634; SKREDE S, 1985, SCAND J CLIN LAB INV, V45, P15; SKREDE S, 1985, J BIOL CHEM, V260, P77; SKREDE S, 1988, J LIPID RES, V29, P157; SKREDE S, 1985, J CLIN INVEST, V75, P448, DOI 10.1172/JCI111719; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; VOGEL MW, 1989, J NEUROSCI, V9, P3454; von Bahr S, 2002, ARTERIOSCL THROM VAS, V22, P1129, DOI 10.1161/01.ATV.0000022600.61391.A5; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046; WIKVALL K, 1984, J BIOL CHEM, V259, P3800; Zheng WC, 2015, J LIPID RES, V56, P81, DOI 10.1194/jlr.M053439	55	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4913	4924		10.1074/jbc.M116.774760	http://dx.doi.org/10.1074/jbc.M116.774760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28190002	hybrid, Green Published			2022-12-28	WOS:000397590400014
J	Wang, L; Chakravarthy, S; Verdine, GL				Wang, Lan; Chakravarthy, Srinivas; Verdine, Gregory L.			Structural Basis for the Lesion-scanning Mechanism of the MutY DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; REPAIR; EXCISION; 8-OXOGUANINE; RECOGNITION; SPECIFICITY; PROTEINS; VALIDATION; MUTATIONS; REMOVAL	The highly mutagenic A: 8-oxoguanine (oxoG) base pair is generated mainly by misreplication of the C: oxoG base pair, the oxidation product of the C: G base pair. The A: oxoG base pair is particularly insidious because neither base in it carries faithful information to direct the repair of the other. The bacterial MutY (MUTYHin humans) adenine DNA glycosylase is able to initiate the repair of A: oxoG by selectively cleaving the A base from the A: oxoG base pair. The difference between faithful repair and wreaking mutagenic havoc on the genome lies in the accurate discrimination between two structurally similar base pairs: A: oxoG and A:T. Here we present two crystal structures of the MutY N-terminal domain in complex with either undamaged DNA or DNA containing an intrahelical lesion. These structures have captured for the first time a DNA glycosylase scanning the genome for a damaged base in the very first stage of lesion recognition and the base extrusion pathway. The mode of interaction observed here has suggested a common lesion-scanning mechanism across the entire helix-hairpin-helix superfamily to which MutY belongs. In addition, small angle X-ray scattering studies together with accompanying biochemical assays have suggested a possible role played by the C-terminal oxoG-recognition domain of MutY in lesion scanning.	[Wang, Lan; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Med Sch, 12 Oxford St, Cambridge, MA 02138 USA; [Chakravarthy, Srinivas] Argonne Natl Lab, Biophys Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA	Harvard University; Harvard University; Harvard University; United States Department of Energy (DOE); Argonne National Laboratory	Verdine, GL (corresponding author), Harvard Med Sch, 12 Oxford St, Cambridge, MA 02138 USA.; Verdine, GL (corresponding author), Harvard Univ, 12 Oxford St, Cambridge, MA 02138 USA.	Gregory_verdine@harvard.edu			National Institutes of Health [CA100742, P41 GM103622, 1S10OD018090-01]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants CA100742,P41 GM103622 (to BioCAT), and 1S10OD018090-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2010, J BIOL CHEM, V285, P35783, DOI 10.1074/jbc.M110.155663; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106; Li XH, 2000, J BIOL CHEM, V275, P8448, DOI 10.1074/jbc.275.12.8448; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lipton L, 2003, CANCER RES, V63, P7595; LU AL, 1995, J BIOL CHEM, V270, P23582, DOI 10.1074/jbc.270.40.23582; Manuel RC, 1997, BIOCHEMISTRY-US, V36, P11140, DOI 10.1021/bi9709708; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Volk DE, 2000, BIOCHEMISTRY-US, V39, P7331, DOI 10.1021/bi000416p; Wang L, 2015, J BIOL CHEM, V290, P17096, DOI 10.1074/jbc.M115.657866; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	42	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5007	5017		10.1074/jbc.M116.757039	http://dx.doi.org/10.1074/jbc.M116.757039			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28130451	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000397590400022
J	Honda-Ogawa, M; Sumitomo, T; Mori, Y; Hamd, DT; Ogawa, T; Yamaguchi, M; Nakata, M; Kawabata, S				Honda-Ogawa, Mariko; Sumitomo, Tomoko; Mori, Yasushi; Hamd, Dalia Talat; Ogawa, Taiji; Yamaguchi, Masaya; Nakata, Masanobu; Kawabata, Shigetada			Streptococcus pyogenes Endopeptidase O Contributes to Evasion from Complement-mediated Bacteriolysis via Binding to Human Complement Factor C1q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; INNATE IMMUNITY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALPHA-ENOLASE; M-PROTEIN; PNEUMONIAE; SYSTEM; FIBRONECTIN; PLASMINOGEN; ACTIVATION	Streptococcus pyogenes secretes various virulence factors for evasion from complement-mediated bacteriolysis. However, full understanding of the molecules possessed by this organism that interact with complement C1q, an initiator of the classical complement pathway, remains elusive. In this study, we identified an endopeptidase of S. pyogenes, PepO, as an interacting molecule, and investigated its effects on complement immunity and pathogenesis. Enzyme-linked immunosorbent assay and surface plasmon resonance analysis findings revealed that S. pyogenes recombinant PepO bound to human C1q in a con-centration-dependent manner under physiological conditions. Sites of inflammation are known to have decreased pH levels, thus the effects of PepO on bacterial evasion from complement immunity was analyzed in a low pH condition. Notably, under low pH conditions, PepO exhibited a higher affinity for C1q as compared with IgG, and PepO inhibited the binding of IgG to C1q. In addition, pepO deletion rendered S. pyogenes more susceptible to the bacteriocidal activity of human serum. Also, observations of the morphological features of the pepO mutant strain (Delta pepO) showed damaged irregular surfaces as compared with the wild-type strain (WT). WT-infected tissues exhibited greater severity and lower complement activity as compared with those infected by Delta pepO in a mouse skin infection model. Furthermore, WT infection resulted in a larger accumulation of C1q than that with Delta pepO. Our results suggest that interaction of S. pyogenes PepO with C1q interferes with the complement pathway, which enables S. pyogenes to evade complement-mediated bacteriolysis under acidic conditions, such as seen in inflammatory sites.	[Honda-Ogawa, Mariko; Sumitomo, Tomoko; Mori, Yasushi; Hamd, Dalia Talat; Yamaguchi, Masaya; Nakata, Masanobu; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Mori, Yasushi] Osaka Univ, Dent Hosp, Div Special Care Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Ogawa, Taiji] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science (JSPS) [A15H06380]; Naito Foundation;  [A15H05012];  [A16H058470];  [T266708000]; Grants-in-Aid for Scientific Research [26463112, 16K15787, 15H05012, 26462780] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) A15H05012, Grant-in-aid for Scientific Research (B) A16H058470, Grant-in-Aid for challenging Exploratory Research T266708000, and Grant-in-Aid for Young Scientists (Start-up) A15H06380 from the Japan Society for the Promotion of Science (JSPS), and the Naito Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castelli R, 2013, IMMUNOPHARM IMMUNOT, V35, P181, DOI 10.3109/08923973.2012.726627; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Emeis M, 1998, MEDIAT INFLAMM, V7, P417, DOI 10.1080/09629359890802; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; FISHELSON Z, 1987, J IMMUNOL, V138, P3392; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; HAANES EJ, 1989, J BACTERIOL, V171, P6397, DOI 10.1128/jb.171.12.6397-6408.1989; HANSKI E, 1992, INFECT IMMUN, V60, P5119, DOI 10.1128/IAI.60.12.5119-5125.1992; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Igonin AA, 2012, CRIT CARE MED, V40, P770, DOI 10.1097/CCM.0b013e318236edb8; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Kaul M, 1997, J BIOL CHEM, V272, P33234, DOI 10.1074/jbc.272.52.33234; Kawabata S, 1999, MICROB PATHOGENESIS, V27, P71, DOI 10.1006/mpat.1999.0283; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Koroleva IV, 1998, FEMS IMMUNOL MED MIC, V20, P11, DOI 10.1016/S0928-8244(97)00101-6; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; LIN TY, 1978, IMMUNOCHEMISTRY, V15, P107; Liu D, 2007, J IMMUNOL, V179, P3966, DOI 10.4049/jimmunol.179.6.3966; MENKIN V, 1956, SCIENCE, V123, P527, DOI 10.1126/science.123.3196.527; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Mori Y, 2012, J BIOL CHEM, V287, P10472, DOI 10.1074/jbc.M111.280321; Murakami J, 2002, EPIDEMIOL INFECT, V128, P397, DOI 10.1017/S0950268802006854; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Oetjen J, 2001, INFECT IMMUN, V69, P58, DOI 10.1128/IAI.69.1.58-64.2001; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Sakamoto M, 1998, NUTRITION, V14, P391, DOI 10.1016/S0899-9007(97)00473-5; SJOHOLM AG, 1991, APMIS, V99, P1120; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Sonntag J, 1998, MEDIAT INFLAMM, V7, P49, DOI 10.1080/09629359891388; STEEN KH, 1995, J NEUROSCI, V15, P3982; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sumitomo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20069; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; THERN A, 1995, J IMMUNOL, V154, P375; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112; Zhang H, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00023	60	15	15	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4244	4254		10.1074/jbc.M116.749275	http://dx.doi.org/10.1074/jbc.M116.749275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154192	hybrid, Green Published			2022-12-28	WOS:000395837100022
J	Canver, MC; Bauer, DE; Dass, A; Yien, YY; Chung, J; Masuda, T; Maeda, T; Paw, BH; Orkin, SH				Canver, Matthew C.; Bauer, Daniel E.; Dass, Abhishek; Yien, Yvette Y.; Chung, Jacky; Masuda, Takeshi; Maeda, Takahiro; Paw, Barry H.; Orkin, Stuart H.			Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells (vol 289, pg 21312, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625	1	16	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2556	2556		10.1074/jbc.A114.564625	http://dx.doi.org/10.1074/jbc.A114.564625			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28188222	Green Published, hybrid			2022-12-28	WOS:000395530300041
J	Horie, T; Kawamata, T; Matsunami, M; Ohsumi, Y				Horie, Tetsuro; Kawamata, Tomoko; Matsunami, Miou; Ohsumi, Yoshinori			Recycling of iron via autophagy is critical for the transition from glycolytic to respiratory growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; VACUOLAR MEMBRANE; RNA DEGRADATION; DIAUXIC SHIFT; YEAST GENES; DEFICIENT; OXIDASE; PCR; MITOCHONDRIA	Autophagy is a bulk degradation process conserved from yeast to mammals. To examine the roles of autophagy in cellular metabolism, we generated autophagy-defective (atg) mutants in the X2180-1B strain background. We compared the growth of wild-type (WT) and atg cells in minimal (synthetic dextrose, SD) and rich (yeast extract/peptone/dextrose, YEPD) medium, and we found that mutations in the core autophagy machinery result in defects in the diauxic shift, the transition from fermentation to respiratory growth upon glucose depletion, specifically in SD. Furthermore, we confirmed that autophagy was induced prior to the diauxic shift, implying that it plays a role in this process. In YEPD, atg mutants grew normally, so we assumed that the insufficiency of certain nutrients in SD was responsible for the defects. We ultimately identified iron, which is a necessary cofactor for respiratory activity, as the nutrient required for the diauxic shift in atg mutants. Indeed, atg mutants exhibited defects in respiration, which was rescued by supplementation with iron. Based on these data, we hypothesized that autophagy is involved in iron recycling during the diauxic shift. smf3 Delta fet5 Delta or smf3 Delta ftr1 Delta cells, which are unable to export iron from the vacuole, also exhibit defects in the diauxic shift, so iron released from the vacuole is important for the shift in SD medium. Finally, we observed that smf3 Delta fet5 Delta cells accumulated nearly twice as much vacuolar iron as smf3 Delta fet5 Delta atg2 Delta cells, suggesting that autophagy is involved in iron recycling by the vacuolar transport and degradation of iron-containing cargos.	[Horie, Tetsuro; Kawamata, Tomoko; Matsunami, Miou; Ohsumi, Yoshinori] Tokyo Inst Technol, Inst Innovat Res, Res Unit Cell Biol, Yokohama, Kanagawa 2268503, Japan; [Horie, Tetsuro] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Res Ctr Odontol, Chiyoda Ku, Tokyo 1028159, Japan; [Kawamata, Tomoko] Japan Soc Promot Sci, Tokyo, Japan	Tokyo Institute of Technology; Nippon Dental University; Japan Society for the Promotion of Science	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Res Unit Cell Biol, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; , 堀江哲郎/AAV-2371-2020; Kawamata-HORIE, Tomoko/B-1699-2017	Ohsumi, Yoshinori/0000-0003-2384-2166; , 堀江哲郎/0000-0002-6713-6725; Kawamata-HORIE, Tomoko/0000-0002-3990-1194	Ministry of Education, Culture, Sports, Science and Technology of Japan [23000015, 16H06375]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research 23000015 (to Y. O.) and 16H06375 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Research Fellowship from the Japan Society for the Promotion of Science.	Alhebshi A, 2012, MOL BIOL CELL, V23, P3582, DOI 10.1091/mbc.E12-05-0413; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Cockrell AL, 2011, BIOCHEMISTRY-US, V50, P10275, DOI 10.1021/bi2014954; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Holmes-Hampton GP, 2013, BIOCHEMISTRY-US, V52, P105, DOI 10.1021/bi3015339; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kruckeberg AL, 2004, METABOLISM MOL PHYSL, P42; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li LT, 2003, BIOCHEM J, V375, P793, DOI 10.1042/BJ20030866; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Murphy JP, 2015, MOL CELL PROTEOMICS, V14, P2454, DOI 10.1074/mcp.M114.045849; Nakamura N, 1997, J BIOCHEM, V121, P338; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Piggott N, 2011, G3-GENES GENOM GENET, V1, P353, DOI 10.1534/g3.111.000836; Pringle JR, 1981, MOL CELLULAR BIOL YE, P97; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; WICKERHAM LJ, 1948, J BACTERIOL, V56, P363, DOI 10.1128/JB.56.3.363-371.1948; WICKERHAM LJ, 1946, J BACTERIOL, V51, P6; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Zampar GG, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.11; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zimbro M.J., 2009, DIFCO AND BBL MANUAL	46	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8533	8543		10.1074/jbc.M116.762963	http://dx.doi.org/10.1074/jbc.M116.762963			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28320861	hybrid, Green Published			2022-12-28	WOS:000401788600036
J	Matsuda, M; Hirata, M				Matsuda, Miho; Hirata, Masato			Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INS(1,4,5)P-3 BINDING-PROTEIN; LUTEINIZING-HORMONE RECEPTOR; GRANULOSA-CELLS; GABA(A) RECEPTOR; POLYCYSTIC OVARIES; MEDICAL PROGRESS; IN-VITRO; PRIP; INSULIN; P130	Phospholipase C-related but catalytically inactive proteins PRIP-1 and -2 are inositol-1,4,5-trisphosphate binding proteins that are encoded by independent genes. Ablation of the Prip genes in mice impairs female fertility, which is manifested by fewer pregnancies, a decreased number of pups, and the decreased and increased secretion of gonadal steroids and gonadotropins, respectively. We investigated the involvement of the PRIPs in fertility, focusing on the ovaries of Prip-1 and -2 double-knock-out (DKO) mice. Multiple cystic follicles were observed in DKO ovaries, and a superovulation assay showed a markedly decreased number of ovulated oocytes. Cumulusoocyte complexes showed normal expansion, and artificial gonadotropin stimulation regulated the ovulation-related genes in a normal fashion, suggesting that the ovulation itself was probably normal. Ahistological analysis showed atresia in fewer follicles of the DKO ovaries, particularly in the secondary follicle stages. The expression of luteinizing hormone receptor (LHR) was aberrantly higher in developing follicles, and the phosphorylation of extracellular signal-regulated protein kinase, a downstream target of LH-LHR signaling, was higher in DKO granulosa cells. This suggests that the up-regulation of LH-LHR signaling is the cause of impaired follicle development. The serum estradiol level was lower, but estradiol production was unchanged in the DKO ovaries. These results suggest that PRIPs are positively involved in the development of follicles via their regulation of LH-LHR signaling and estradiol secretion. Female DKO mice had higher serum levels of insulin, testosterone, and uncarboxylatedosteocalcin, which, togetherwithreducedfertility, are reminiscent of polycystic ovary syndrome in humans.	[Matsuda, Miho] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Hirata, Masato] Fukuoka Dent Coll, Fukuoka 8140193, Japan	Kyushu University; Fukuoka Dental College (FDC)	Matsuda, M (corresponding author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	natural@dent.kyushu-u.ac.jp			KAKENHI Grants [24229009, 24592804]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [17H01595] Funding Source: KAKEN	KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research, KAKENHI Grants: 24229009 (to M.H.) and 24592804 (to M.M.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Asano S, 2014, BIOL OPEN, V3, P463, DOI 10.1242/bio.20147591; Caldwell JD, 2014, STEROIDS, V81, P13, DOI 10.1016/j.steroids.2013.11.010; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chang RJ, 2013, MOL CELL ENDOCRINOL, V373, P51, DOI 10.1016/j.mce.2012.07.011; DAVOREN JB, 1986, ENDOCRINOLOGY, V119, P2155, DOI 10.1210/endo-119-5-2155; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Donadeu FX, 2011, ENDOCRINOLOGY, V152, P2857, DOI 10.1210/en.2010-1298; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Eppig JJ, 1998, BIOL REPROD, V59, P1445, DOI 10.1095/biolreprod59.6.1445; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Feng Y, 2013, AM J TRANSL RES, V5, P15; Foong SC, 2006, J CLIN ENDOCR METAB, V91, P2327, DOI 10.1210/jc.2005-2142; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Jakimiuk AJ, 2001, J CLIN ENDOCR METAB, V86, P1318, DOI 10.1210/jc.86.3.1318; Kanamarlapudi V, 2016, REPROD BIOMED ONLINE, V32, P635, DOI 10.1016/j.rbmo.2016.03.003; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kotani M, 2015, J CELL BIOCHEM, V116, P2814, DOI 10.1002/jcb.25228; Lan CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14994; Makker A, 2014, J MOL ENDOCRINOL, V53, pR103, DOI 10.1530/JME-14-0220; Maman E, 2012, FERTIL STERIL, V97, P592, DOI 10.1016/j.fertnstert.2011.12.027; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Menon KMJ, 2004, BIOL REPROD, V70, P861, DOI 10.1095/biolreprod.103.024471; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Murakami A, 2017, J BIOL CHEM, V292, P7994, DOI [10.1074/jbc.M117.784777, 10.1074/jbc.M117.801936]; Orisaka M, 2013, ENDOCRINOLOGY, V154, P2870, DOI 10.1210/en.2012-2173; Oue K, 2016, J BIOL CHEM, V291, P4185, DOI 10.1074/jbc.M115.705723; Pepene CE, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-4; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Shelling AN, 2010, REPRODUCTION, V140, P633, DOI 10.1530/REP-09-0567; Sugiyama Goro, 2013, Advances in Biological Regulation, V53, P331, DOI 10.1016/j.jbior.2013.07.001; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; TSAFRIRI A, 1995, ADV EXP MED BIOL, V377, P121; Tsutsumi K, 2011, J BIOL CHEM, V286, P31032, DOI 10.1074/jbc.M111.235903; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Webber LJ, 2007, J CLIN ENDOCR METAB, V92, P1975, DOI 10.1210/jc.2006-1422; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Yung Y, 2014, MOL HUM REPROD, V20, P844, DOI 10.1093/molehr/gau041; Zhang ZH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/408012	54	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8369	8380		10.1074/jbc.M116.759928	http://dx.doi.org/10.1074/jbc.M116.759928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360101	hybrid, Green Published			2022-12-28	WOS:000401788600021
J	Hutchings, ML; Alpha-Cobb, CJ; Hiller, DA; Berro, J; Strobel, SA				Hutchings, Michelle L.; Alpha-Cobb, Cambria J.; Hiller, David A.; Berro, Julien; Strobel, Scott A.			Mycofumigation through production of the volatile DNA-methylating agent N-methyl-N-nitrosoisobutyramide by fungi in the genus Muscodor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; DNA methylation; fungi; gas chromatography-mass spectrometry (GC-MS); mycotoxin; toxicity; N-nitroso compounds; endophyte; mycofumigation; volatile organic compounds	ANTIBIOTIC-PRODUCING FUNGUS; DOUBLE-STRANDED DNA; ESCHERICHIA-COLI; ENDOPHYTIC FUNGUS; ORGANIC-COMPOUNDS; SECONDARY METABOLITES; NORTHEASTERN HIMALAYAS; ADAPTIVE RESPONSE; ALBUS; DAMAGE	Antagonistic microorganisms produce antimicrobials to inhibit the growth of competitors. Although water-soluble antimicrobials are limited to proximal interactions via aqueous diffusion, volatile antimicrobials are able to act at a distance and diffuse through heterogeneous environments. Here, we identify the mechanism of action of Muscodor albus, an endophytic fungus known for its volatile antimicrobial activity toward a wide range of human and plant pathogens and its potential use in mycofumigation. Proposed uses of the Muscodor species include protecting crops, produce, and building materials from undesired fungal or bacterial growth. By analyzing a collection of Muscodor isolates with varying toxicity, we demonstrate that the volatile mycotoxin, N-methyl-N-nitrosoisobutyramide, is the dominant factor in Muscodor toxicity and acts primarily through DNA methylation. Additionally, Muscodor isolates exhibit higher resistance to DNA methylation compared with other fungi. This work contributes to the evaluation of Muscodor isolates as potential mycofumigants, provides insight into chemical strategies that organisms use to manipulate their environment, and provokes questions regarding the mechanisms of resistance used to tolerate constitutive, long-term exposure to DNA methylation.	[Hutchings, Michelle L.] Yale Univ, Inst Chem Biol, Dept Chem, West Haven, CT 06516 USA; [Alpha-Cobb, Cambria J.; Hiller, David A.; Strobel, Scott A.] Yale Univ, Inst Chem Biol, Dept Mol Biophys & Biochem, 600 West Campus Dr,Mol Innovat Ctr Rm 214A, West Haven, CT 06516 USA; [Berro, Julien] Yale Univ, Nanobiol Inst, Dept Mol Biophys & Biochem, West Haven, CT 06516 USA	Yale University; Yale University; Yale University	Strobel, SA (corresponding author), Yale Univ, Inst Chem Biol, Dept Mol Biophys & Biochem, 600 West Campus Dr,Mol Innovat Ctr Rm 214A, West Haven, CT 06516 USA.	scott.strobel@yale.edu		Berro, Julien/0000-0002-9560-8646	Office of Assistant Secretary of Defense for Research and Engineering; National Security Science and Engineering Faculty Fellowship [N0024-09-1-0070]; Environmental Protection Agency Science to Achieve Results Graduate Fellowship [FP91761001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	Office of Assistant Secretary of Defense for Research and Engineering; National Security Science and Engineering Faculty Fellowship; Environmental Protection Agency Science to Achieve Results Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Assistant Secretary of Defense for Research and Engineering, National Security Science and Engineering Faculty Fellowship Grant N0024-09-1-0070 (to S. A. S.) and Environmental Protection Agency Science to Achieve Results Graduate Fellowship FP91761001 (to M. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpha CJ, 2015, APPL ENVIRON MICROB, V81, P1147, DOI 10.1128/AEM.03294-14; Atmosukarto I, 2005, PLANT SCI, V169, P854, DOI 10.1016/j.plantsci.2005.06.002; Banerjee D., 2010, Mycology - An International Journal on Fungal Biology, V1, P179, DOI 10.1080/21501203.2010.506204; Banerjee D, 2014, INDIAN J MICROBIOL, V54, P27, DOI 10.1007/s12088-013-0400-5; Bascom-Slack CA, 2012, SCIENCE, V338, P485, DOI 10.1126/science.1215227; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; Bolzan AD, 2002, MUTAT RES-REV MUTAT, V512, P121, DOI 10.1016/S1383-5742(02)00044-3; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Corcuff R, 2011, FUNGAL BIOL-UK, V115, P220, DOI 10.1016/j.funbio.2010.12.005; Cotsonas King A., 2009, CURR PROTOC PHARM; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; DENNIS C, 1971, T BRIT MYCOL SOC, V57, P41, DOI 10.1016/S0007-1536(71)80078-5; DOLAN ME, 1988, CARCINOGENESIS, V9, P2139, DOI 10.1093/carcin/9.11.2139; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Fernando WGD, 2005, SOIL BIOL BIOCHEM, V37, P955, DOI 10.1016/j.soilbio.2004.10.021; Fialho MB, 2010, WORLD J MICROB BIOT, V26, P925, DOI 10.1007/s11274-009-0255-4; Goates BJ, 2011, EUR J PLANT PATHOL, V131, P403, DOI 10.1007/s10658-011-9817-z; Gonzalez MC, 2009, MYCOTAXON, V110, P363, DOI 10.5248/110.363; Grzesiuk E, 2001, MUTAT RES-FUND MOL M, V480, P77, DOI 10.1016/S0027-5107(01)00171-3; Hebels DGAJ, 2010, TOXICOL SCI, V116, P194, DOI 10.1093/toxsci/kfq121; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; Humphris SN, 2002, FEMS MICROBIOL LETT, V210, P215, DOI 10.1016/S0378-1097(02)00604-3; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Jimenez J. I., 2012, US Patent, Patent No. 20120058058; Karran P., 1988, NUCL ACIDS MOL BIOL, P188; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Krajaejun T, 2012, SE ASIAN J TROP MED, V43, P1474; Kudalkar P, 2012, MYCOSCIENCE, V53, P319, DOI 10.1007/s10267-011-0165-9; Lacey LA, 2009, J ECON ENTOMOL, V102, P43, DOI 10.1603/029.102.0107; Lijinsky W., 1992, CHEM BIOL N NITROSO; Masoud W, 2005, YEAST, V22, P1133, DOI 10.1002/yea.1304; Mercier J, 2005, BIOL CONTROL, V32, P401, DOI 10.1016/j.biocontrol.2004.12.002; Mercier J, 2007, CAN J MICROBIOL, V53, P404, DOI 10.1139/W06-124; Mercier J, 2009, BIOCONTROL, V54, P797, DOI 10.1007/s10526-009-9223-z; Meshram V, 2014, MYCOTAXON, V128, P93, DOI 10.5248/128.93; Meshram Vineet, 2013, Mycology, V4, P196, DOI 10.1080/21501203.2013.877990; Mitchell AM, 2008, FUNGAL DIVERS, V31, P37; Mitchell AM, 2010, MICROBIOL-SGM, V156, P270, DOI 10.1099/mic.0.032540-0; MONTESANO R, 1980, J TOXICOL ENV HEALTH, V6, P1001, DOI 10.1080/15287398009529922; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; O'Hanlon KA, 2012, NUCLEIC ACIDS RES, V40, P7806, DOI 10.1093/nar/gks522; Pletsa V, 1999, CANCER LETT, V135, P21; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Saxena S, 2015, ANN MICROBIOL, V65, P47, DOI 10.1007/s13213-014-0834-y; Saxena S, 2014, SYDOWIA, V66, P55; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Shaw JJ, 2015, APPL MICROBIOL BIOT, V99, P3715, DOI 10.1007/s00253-014-6206-5; SINGARAM S, 1979, J ANTIBIOT, V32, P379, DOI 10.7164/antibiotics.32.379; Siri-udom S, 2016, ANN MICROBIOL, V66, P437, DOI 10.1007/s13213-015-1126-x; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2011, PHYTOCHEM REV, V10, P165, DOI 10.1007/s11101-010-9163-3; Strobel GA, 2007, MICROBIOL-SGM, V153, P2613, DOI 10.1099/mic.0.2007/008912-0; Suwannarach N, 2015, BIOL CONTROL, V90, P25, DOI 10.1016/j.biocontrol.2015.05.008; Suwannarach N, 2013, ANN MICROBIOL, V63, P1341, DOI 10.1007/s13213-012-0593-6; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; TAKAHASHI K, 1987, BIOCHEM BIOPH RES CO, V144, P447, DOI 10.1016/S0006-291X(87)80530-2; Tyc O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00567; United Nations Environment Programme, 2014, ENV EFF OZ DEPL ITS, DOI [10.1002/9780470670590.wbeog931, DOI 10.1002/9780470670590.WBEOG931]; Wheatley RE, 2002, ANTON LEEUW INT J G, V81, P357, DOI 10.1023/A:1020592802234; Wu YP, 2013, ANAL CHEM, V85, P6908, DOI 10.1021/ac401346x; WURDEMAN RL, 1993, NUCLEIC ACIDS RES, V21, P4975, DOI 10.1093/nar/21.21.4975; Yuan J, 2012, APPL ENVIRON MICROB, V78, P5942, DOI 10.1128/AEM.01357-12; Zhang CL, 2010, FUNGAL BIOL-UK, V114, P797, DOI 10.1016/j.funbio.2010.07.006	73	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7358	7371		10.1074/jbc.M117.779009	http://dx.doi.org/10.1074/jbc.M117.779009			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28283571	Green Published, hybrid			2022-12-28	WOS:000400761300008
J	Olivier-Van Stichelen, S; Wang, P; Comly, M; Love, DC; Hanover, JA				Olivier-Van Stichelen, Stephanie; Wang, Peng; Comly, Marcy; Love, Dona C.; Hanover, John A.			Nutrient-driven O-linked N-acetylglucosamine (O-GlcNAc) cycling impacts neurodevelopmental timing and metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT NEUROGENESIS; BRAIN-DEVELOPMENT; GENE-EXPRESSION; CELL-FUNCTION; X-CHROMOSOME; BIRTH-WEIGHT; HIGH-FAT; GLCNACYLATION; TRANSCRIPTION; SURVIVAL	Nutrient-driven O-GlcNAcylation is strikingly abundant in the brain and has been linked to development and neurodegen-erative disease. We selectively targeted the O-GlcNAcase (Oga) gene in the mouse brain to define the role of O-GlcNAc cycling in the central nervous system. Brain knockout animals exhibited dramatically increased brainO-GlcNAc levels and pleiotropic phenotypes, including early-onset obesity, growth defects, and metabolic dysregulation. Anatomical defects in the Oga knockout included delayed brain differentiation and neurogenesis as well as abnormal proliferation accompanying a developmental delay. The molecular basis for these defects included transcriptional changes accompanying differentiating embryonic stem cells. In Oga KO mouse ES cells, we observed pronounced changes in expression of pluripotency markers, including Sox2, Nanog, and Otx2. These findings link the O-GlcNAc modification to mammalian neurogenesis and highlight the role of this nutrient-sensing pathway in developmental plasticity and metabolic homeostasis.	[Olivier-Van Stichelen, Stephanie; Wang, Peng; Comly, Marcy; Love, Dona C.; Hanover, John A.] NIDDK, Lab Cell & Mol Biol, NIH, Bldg 8,Rm B127,8 Ctr Dr,MSC 0850 NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, Lab Cell & Mol Biol, NIH, Bldg 8,Rm B127,8 Ctr Dr,MSC 0850 NIH, Bethesda, MD 20892 USA.	jah@helix.nih.gov	olivier-van stichelen, Stephanie/AAH-9328-2021	olivier-van stichelen, Stephanie/0000-0002-2033-5241; Hanover, John/0000-0002-3154-9878	Intramural Research Program of the NIDDK; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ars Charlotte L, 2019, Br J Nutr, V122, pS1, DOI 10.1017/S0007114515002081; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hogan B, 1994, MANIPULATING MOUSE E; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Li SY, 2005, DIABETES OBES METAB, V7, P448, DOI 10.1111/j.1463-1326.2004.00387.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Mauras N, 2015, DIABETES, V64, P1770, DOI 10.2337/db14-1445; Maury JJP, 2013, STEM CELL RES, V11, P926, DOI 10.1016/j.scr.2013.06.004; Medford HM, 2012, LIFE SCI, V90, P883, DOI 10.1016/j.lfs.2012.04.030; Miura T, 2016, BIOCHEM BIOPH RES CO, V480, P655, DOI 10.1016/j.bbrc.2016.10.111; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Myers SA, 2016, ELIFE, V5, DOI 10.7554/eLife.10647; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Speakman CM, 2014, STEM CELLS, V32, P2605, DOI 10.1002/stem.1761; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	43	40	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6076	6085		10.1074/jbc.M116.774042	http://dx.doi.org/10.1074/jbc.M116.774042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28246173	Green Published, hybrid			2022-12-28	WOS:000399538700005
J	Li, L; Ng, NKL; Koon, AC; Chan, HYE				Li, Li; Ng, Nelson Ka Lam; Koon, Alex Chun; Chan, Ho Yin Edwin			Expanded polyalanine tracts function as nuclear export signals and promote protein mislocalization via eEF1A1 factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila genetics; gene transcription; genetic disease; protein export; protein-protein interaction; eEF1A	CENTRAL HYPOVENTILATION SYNDROME; OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; GREEN FLUORESCENT PROTEIN; LINKED MENTAL-RETARDATION; ELONGATION-FACTOR 1A; TRANSCRIPTION FACTOR; TRANSFER-RNA; FRAMESHIFT MUTATIONS; EXPANSION MUTATIONS; CELL-DEATH	Polyalanine (poly(A)) diseases are caused by the expansion of translated GCN triplet nucleotide sequences encoding poly(A) tracts in proteins. To date, nine human disorders have been found to be associated with poly(A) tract expansions, including congenital central hypoventilation syndrome and oculopharyngeal muscular dystrophy. Previous studies have demonstrated that unexpanded wild-type poly(A)-containing proteins localize to the cell nucleus, whereas expanded poly(A)-containing proteins primarily localize to the cytoplasm. Because most of these poly(A) disease proteins are transcription factors, this mislocalization causes cellular transcriptional dysregulation leading to cellular dysfunction. Correcting this faulty localization could potentially point to strategies to treat the aforementioned disorders, so there is a pressing need to identify the mechanisms underlying the mislocalization of expanded poly(A) protein. Here, we performed a glutathione S-transferase pulldown assay followed by mass spectrometry and identified eukaryotic translation elongation factor 1 1 (eEF1A1) as an interacting partner with expanded poly(A)-containing proteins. Strikingly, knockdown of eEF1A1 expression partially corrected the mislocalization of the expanded poly(A) proteins in the cytoplasm and restored their functions in the nucleus. We further demonstrated that the expanded poly(A) domain itself can serve as a nuclear export signal. Taken together, this study demonstrates that eEF1A1 regulates the subcellular location of expanded poly(A) proteins and is therefore a potential therapeutic target for combating the pathogenesis of poly(A) diseases.	[Li, Li; Ng, Nelson Ka Lam; Koon, Alex Chun; Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Lab Drosophila Res, Shatin, Hong Kong, Peoples R China; [Li, Li; Ng, Nelson Ka Lam; Koon, Alex Chun; Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Biochem Program, Shatin, Hong Kong, Peoples R China; [Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Cell & Mol Biol Program, Shatin, Hong Kong, Peoples R China; [Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Mol Biotechnol Program, Sch Life Sci, Fac Sci, Shatin, Hong Kong, Peoples R China; [Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Gerald Choa Neurosci Ctr, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, HYE (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	hyechan@cuhk.edu.hk	Chan, Edwin/A-9478-2011	Chan, Edwin/0000-0003-4307-474X; Koon, Alex/0000-0002-4274-7052	Hong Kong Research Grants Council [461013]; CUHK Gerald Choa Neuroscience Centre Grant [7105306]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); CUHK Gerald Choa Neuroscience Centre Grant	This work was supported by General Research Fund of the Hong Kong Research Grants Council Grant 461013 and CUHK Gerald Choa Neuroscience Centre Grant 7105306. The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; Alatzoglou KS, 2011, J CLIN ENDOCR METAB, V96, pE685, DOI 10.1210/jc.2010-1239; Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Bachetti T, 2005, HUM MOL GENET, V14, P1815, DOI 10.1093/hmg/ddi188; Bao YP, 2002, J BIOL CHEM, V277, P12263, DOI 10.1074/jbc.M109633200; Berger Z, 2006, HUM MOL GENET, V15, P453, DOI 10.1093/hmg/ddi460; Brown L, 2005, HUM MOL GENET, V14, P411, DOI 10.1093/hmg/ddi037; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Buescher M, 2002, DEVELOPMENT, V129, P4193; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2003, AM J HUM GENET, V72, P478, DOI 10.1086/346118; Di Lascio S, 2016, J BIOL CHEM, V291, P13375, DOI 10.1074/jbc.M115.679027; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fullston T, 2011, CLIN GENET, V80, P510, DOI 10.1111/j.1399-0004.2011.01685.x; Girard F, 2006, DEV BIOL, V299, P530, DOI 10.1016/j.ydbio.2006.08.014; Grespin ME, 2008, J BIOL CHEM, V283, P25576, DOI 10.1074/jbc.M710482200; Grosshans H, 2000, GENE DEV, V14, P830; Hatters D. M., 2013, TANDEM REPEATS GENES; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hughes James N, 2013, Methods Mol Biol, V1017, P135, DOI 10.1007/978-1-62703-438-8_10; Kanno Y, 2005, BBA-MOL CELL RES, V1745, P215, DOI 10.1016/j.bbamcr.2005.06.012; Kanno Y, 2007, BBA-MOL CELL RES, V1773, P934, DOI 10.1016/j.bbamcr.2007.03.020; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; LAUGHON A, 1984, MOL CELL BIOL, V4, P268, DOI 10.1128/MCB.4.2.268; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Mingot JM, 2013, CELL REP, V5, P727, DOI 10.1016/j.celrep.2013.09.030; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; McGuire AT, 2007, EMBO J, V26, P288, DOI 10.1038/sj.emboj.7601493; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Munshi R, 2001, GENETICS, V157, P1425; Murthi A, 2010, MOL BIOL CELL, V21, P639, DOI 10.1091/mbc.E09-07-0551; Nasrallah IM, 2004, J CELL BIOL, V167, P411, DOI 10.1083/jcb.200408091; Oma Y, 2007, PROTEIN SCI, V16, P2195, DOI 10.1110/ps.072955307; Overton PM, 2002, DEVELOPMENT, V129, P4219; Patterson GH, 2004, METHODS, V32, P445, DOI 10.1016/j.ymeth.2003.10.006; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Rankin J, 2000, BIOCHEM J, V348, P15, DOI 10.1042/0264-6021:3480015; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Solomon NM, 2004, J MED GENET, V41, P669, DOI 10.1136/jmg.2003.016949; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Tsoi H, 2014, BIOCHEM J, V464, P439, DOI 10.1042/BJ20131461; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; Wong J, 2007, FRONT BIOSCI, V12, P2085, DOI 10.2741/2213; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	63	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5784	5800		10.1074/jbc.M116.763599	http://dx.doi.org/10.1074/jbc.M116.763599			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28246169	Green Published, hybrid			2022-12-28	WOS:000398813200016
J	Shi, J; Chen, WF; Zhang, B; Fan, SH; Ai, X; Liu, NN; Rety, S; Xi, XG				Shi, Jing; Chen, Wei-Fei; Zhang, Bo; Fan, San-Hong; Ai, Xia; Liu, Na-Nv; Rety, Stephane; Xi, Xu-Guang			A helical bundle in the N-terminal domain of the BLM helicase mediates dimer and potentially hexamer formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; enzyme kinetics; genetic disease; protein self-assembly; X-ray crystallography; dimerization helical bundle; small angle X-ray scattering	BLOOMS-SYNDROME HELICASE; HUMAN RECQ HELICASES; DNA HELICASE; INSIGHTS; COMPLEX; RECOMBINATION; VISUALIZATION; MECHANISMS; DEFICIENT; PROTEINS	Helicases play a critical role in processes such as replication or recombination by unwinding double-stranded DNA; mutations of these genes can therefore have devastating biological consequences. In humans, mutations in genes of three members of the RecQ family helicases (blm, wrn, and recq4) give rise to three strikingly distinctive clinical phenotypes: Bloom syndrome, Werner syndrome, and Rothmund-Thomson syndrome, respectively. However, the molecular basis for these varying phenotypic outcomes is unclear, in part because a full mechanistic description of helicase activity is lacking. Because the helicase core domains are highly conserved, it has been postulated that functional differences among family members might be explained by significant differences in the N-terminal domains, but these domains are poorly characterized. To help fill this gap, we now describe bioinformatics, biochemical, and structural data for three vertebrate BLM proteins. We pair high resolution crystal structures with SAXS analysis to describe an internal, highly conserved sequence we term the dimerization helical bundle in N-terminal domain (DHBN). We show that, despite the N-terminal domain being loosely structured and potentially lacking a defined three-dimensional structure in general, the DHBN exists as a dimeric structure required for higher order oligomer assembly. Interestingly, the unwinding amplitude and rate decrease as BLM is assembled from dimer into hexamer, and also, the stable DHBN dimer can be dissociated upon ATP hydrolysis. Thus, the structural and biochemical characterizations of N-terminal domains will provide new insights into how the N-terminal domain affects the structural and functional organization of the full BLM molecule.	[Shi, Jing; Chen, Wei-Fei; Zhang, Bo; Fan, San-Hong; Ai, Xia; Liu, Na-Nv; Xi, Xu-Guang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Rety, Stephane] CNRS, UMR 5086, Inst Biochim & Chim Prot, F-69367 Lyon, France; [Xi, Xu-Guang] Univ Paris Saclay, ENS Cachan, CNRS, Lab Biol & Pharmacol Appl, 61 Ave President Wilson, F-94235 Cachan, France	Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Xi, XG (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.; Rety, S (corresponding author), CNRS, UMR 5086, Inst Biochim & Chim Prot, F-69367 Lyon, France.; Xi, XG (corresponding author), Univ Paris Saclay, ENS Cachan, CNRS, Lab Biol & Pharmacol Appl, 61 Ave President Wilson, F-94235 Cachan, France.	stephane.rety@ibcp.fr; xxi01@ens-cachan.fr	Rety, Stephane/L-9870-2019; Xi, Xu Guang/AAK-4511-2020	Rety, Stephane/0000-0002-2089-6727; Zhang, Bo/0000-0002-5011-1505	National Natural Science Foundation of China [11574252, 31370798]; Northwest AF University [Z101021102, Z111021103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest AF University	This work was supported by National Natural Science Foundation of China Grants 11574252 and 31370798 and Northwest A&F University Startup Funding for Xu-Guang Xi (Grants Z101021102 and Z111021103). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelhaleem M, 2010, METHODS MOL BIOL, V587, P1, DOI 10.1007/978-1-60327-355-8_1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arora H, 2014, INT J DERMATOL, V53, P798, DOI 10.1111/ijd.12408; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Ben Salah G, 2014, MOL BIOL REP, V41, P7373, DOI 10.1007/s11033-014-3624-5; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bohm S, 2014, DNA REPAIR, V22, P123, DOI 10.1016/j.dnarep.2014.07.007; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evrard G, 2011, J APPL CRYSTALLOGR, V44, P1264, DOI 10.1107/S0021889811035758; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gyimesi M, 2013, FASEB J, V27, P4954, DOI 10.1096/fj.13-234088; Harrigan JA, 2003, BIOCHIMIE, V85, P1185, DOI 10.1016/j.biochi.2003.10.006; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kitano K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00366; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; NICOTERA TM, 1991, CANCER GENET CYTOGEN, V53, P1, DOI 10.1016/0165-4608(91)90109-8; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pike ACW, 2015, P NATL ACAD SCI USA, V112, P4286, DOI 10.1073/pnas.1417594112; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Rezazadeh S, 2012, MOL BIOL REP, V39, P4527, DOI 10.1007/s11033-011-1243-y; RODERMUND OE, 1978, FORTSCHR MED, V96, P1852; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Swan MK, 2014, ACTA CRYSTALLOGR D, V70, P1465, DOI 10.1107/S139900471400501X; Vindigni A, 2010, BIOPHYS CHEM, V149, P67, DOI 10.1016/j.bpc.2010.03.012; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; Wang Y, 2000, GENE DEV, V14, P927; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Xu YN, 2012, NUCLEIC ACIDS RES, V40, P9802, DOI 10.1093/nar/gks728; Xue Y, 2002, BIOCHEMISTRY-US, V41, P2901, DOI 10.1021/bi0157161; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576	54	11	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5909	5920		10.1074/jbc.M116.761510	http://dx.doi.org/10.1074/jbc.M116.761510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28228481	hybrid, Green Published			2022-12-28	WOS:000398813200025
J	Mercer, SW; Wang, JB; Burke, R				Mercer, Stephen W.; Wang, Jianbin; Burke, Richard			In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer's Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE GENE; MOLECULAR-BASIS; ATPASE ATP7B; MUTANT ATP7B; PROTEIN; LOCALIZATION; TRAFFICKING; DROSOPHILA; HOMEOSTASIS; ROLES	Copper is an essential biometal, and several inherited diseases are directly associated with a disruption to normal copper homeostasis. The best characterized are the copper deficiency and toxicity disorders Menkes and Wilson diseases caused by mutations in the p-type Cu-ATPase genes ATP7A and ATP7B, respectively. Missense mutations in the C-terminal portion of ATP7A have also been shown to cause distal motor neuropathy, whereas polymorphisms inATP7Bare associated with increased risk of Alzheimer's disease. We have generated a single, in vivo model for studying multiple pathogenic mutations inATP7proteins using Drosophila melanogaster, which has a single orthologue of ATP7A and ATP7B. Four pathogenic ATP7A mutations and two ATP7B mutations were introduced into a genomic ATP7 rescue construct containing an in-frame C-terminal GFP tag. Analysis of the wild type ATP7-GFP transgene confirmed that ATP7 is expressed at the basolateral membrane of larval midgut copper cells and that the transgene can rescue a normally early lethal ATP7 deletion allele to adulthood. Analysis of the gATP7-GFP transgenes containing pathogenic mutations showed that the function of ATP7 was affected, to varying degrees, by all six of the mutations investigated in this study. Of particular interest, the ATP7B(K832R) Alzheimer's disease susceptibility allele was found, for the first time, to be a loss of function allele. This in vivo system allows us to assess the severity of individual ATP7A/ B mutations in an invariant genetic background and has the potential to be used to screen for therapeutic compounds able to restore function to faulty copper transport proteins.	[Mercer, Stephen W.; Wang, Jianbin; Burke, Richard] Monash Univ, Sch Biol Sci, Wellington Rd, Clayton, Vic 3800, Australia	Monash University	Burke, R (corresponding author), Monash Univ, Sch Biol Sci, Wellington Rd, Clayton, Vic 3800, Australia.	richard.burke@monash.edu		Burke, Richard/0000-0003-0086-0767	Australian National Health and Medical Research Council Project [RB 606609]	Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council Project Grant RB 606609. The authors declare that they have no conflicts of interest with the contents of this article.	Ambrosini L, 1999, HUM MOL GENET, V8, P1547, DOI 10.1093/hmg/8.8.1547; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; Bucossi S, 2012, J ALZHEIMERS DIS, V29, P913, DOI 10.3233/JAD-2012-111997; Burke R, 2008, INT J BIOCHEM CELL B, V40, P1850, DOI 10.1016/j.biocel.2008.01.021; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Forbes JR, 2000, HUM MOL GENET, V9, P1927, DOI 10.1093/hmg/9.13.1927; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Gromadzka G, 2006, MOVEMENT DISORD, V21, P245, DOI 10.1002/mds.20671; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Jones MWM, 2015, J BIOL INORG CHEM, V20, P979, DOI 10.1007/s00775-015-1281-3; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; La Fontaine S, 2010, INT J BIOCHEM CELL B, V42, P206, DOI 10.1016/j.biocel.2009.11.007; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; Lutsenko S, 2002, J BIOENERG BIOMEMBR, V34, P351, DOI 10.1023/A:1021297919034; Menkes J H, 1999, Eur J Paediatr Neurol, V3, P245, DOI 10.1016/S1090-3798(99)90979-0; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Moller LB, 2005, HUM MUTAT, V26, P84, DOI 10.1002/humu.20190; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; Southon A, 2010, BIOMETALS, V23, P681, DOI 10.1007/s10534-010-9332-2; Squitti R, 2014, BIOMETALS, V27, P53, DOI 10.1007/s10534-013-9686-3; Squitti R, 2013, REJUV RES, V16, P3, DOI 10.1089/rej.2012.1357; Tang JR, 2008, MOL GENET METAB, V95, P174, DOI 10.1016/j.ymgme.2008.06.015; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WACHNIK A, 1988, NAHRUNG, V32, P755, DOI 10.1002/food.19880320811; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; Yi L, 2012, HUM MOL GENET, V21, P1794, DOI 10.1093/hmg/ddr612	45	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4113	4122		10.1074/jbc.M116.756163	http://dx.doi.org/10.1074/jbc.M116.756163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28119449	Green Published, hybrid			2022-12-28	WOS:000395837100013
J	Hu, BC; Wang, X; Hu, SF; Ying, XM; Wang, P; Zhang, XM; Wang, J; Wang, HY; Wang, Y				Hu, Baocheng; Wang, Xiang; Hu, Shuofeng; Ying, Xiaomin; Wang, Ping; Zhang, Xiangming; Wang, Jian; Wang, Hongyan; Wang, Ya			RETRACTED: miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks (Retracted article. See vol. 295, pg. 6250, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						cellular regulation; DNA repair; DNA-dependent serine; threonine protein kinase (DNA-PK); microRNA (miRNA); radiation biology; miR-21; ionizing radiation; DNA double strand breaks; GSK3; non-homologous end-joining; homologous recombination repair	HOMOLOGOUS RECOMBINATION; CYCLIN D1; LUNG TUMORIGENESIS; DAMAGE RESPONSE; PROTEIN-KINASE; CELL-CYCLE; PATHWAY; MICRORNA-21; CANCER; GENE	miR-21, as an oncogene that overexpresses in most human tumors, is involved in radioresistance; however, the mechanism remains unclear. Here, we demonstrate that miR-21-mediated radioresistance occurs through promoting repair of DNA double strand breaks, which includes facilitating both non-homologous end-joining (NHEJ) and homologous recombination repair (HRR). The miR-21-promoted NHEJ occurs through targeting GSK3B (a novel target of miR-21), which affects the CRY2/PP5 pathway and in turn increases DNA-PKcs activity. The miR-21-promoted HRR occurs through targeting both GSK3B and CDC25A (a known target of miR-21), which neutralizes the effects of targeting GSK3B-induced CDC25A increase because GSK3B promotes degradation of both CDC25A and cyclin D1, but CDC25A and cyclin D1 have an opposite effect on HRR. A negative correlation of expression levels between miR-21 and GSK3 exists in a subset of human tumors. Our results not only elucidate miR-21-mediated radioresistance, but also provide potential new targets for improving radiotherapy.	[Hu, Baocheng; Wang, Xiang; Wang, Ping; Zhang, Xiangming; Wang, Jian; Wang, Hongyan; Wang, Ya] Emory Univ, Sch Med, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Hu, Shuofeng; Ying, Xiaomin] Beijing Inst Basic Med Sci, Beijing 100850, Peoples R China	Emory University; Academy of Military Medical Sciences - China	Wang, Y (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, 1365 Clifton Rd NE, Atlanta, GA 30322 USA.	ywang94@emory.edu			National Institutes of Health [P30CA138292]; NATIONAL CANCER INSTITUTE [R21CA185882, P30CA138292, R01CA186129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Eric Olson, James Woodgett, Chenguang Wang, Maria Jasin, Eric Hendrickson, Tej Pandita, John Mina, and Jiri Bartek for providing reagents; members of the Wang laboratory for helpful discussion; and Doreen Theune for editing the manuscript. The Winship Cancer Institute of Emory University was supported by National Institutes of Health Grant P30CA138292.	Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Croce CM, 2011, NAT MED, V17, P935, DOI 10.1038/nm0811-935; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Elledge SJ, 2015, JAMA-J AM MED ASSOC, V314, P1111, DOI 10.1001/jama.2015.10387; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hu BC, 2014, CANCER RES, V74, P2283, DOI 10.1158/0008-5472.CAN-13-3279; Hu BC, 2005, CANCER RES, V65, P8613, DOI 10.1158/0008-5472.CAN-05-1966; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Liu BL, 2015, NUCLEIC ACIDS RES, V43, P1626, DOI 10.1093/nar/gku1368; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Ma YF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/617868; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang HY, 2010, NUCLEIC ACIDS RES, V38, P3245, DOI 10.1093/nar/gkq069; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wang J, 2016, LIFE SCI SPACE RES, V9, P48, DOI 10.1016/j.lssr.2016.04.002; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wang X, 2003, J BIOL CHEM, V278, P30869, DOI 10.1074/jbc.M301876200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Yang ES, 2011, NEURO-ONCOLOGY, V13, P459, DOI 10.1093/neuonc/nor016; Yang ES, 2009, J CLIN INVEST, V119, P1124, DOI 10.1172/JCI34051; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhao SY, 1997, PHOTOCHEM PHOTOBIOL, V66, P727, DOI 10.1111/j.1751-1097.1997.tb03214.x; Zheng ZM, 2012, CANCER RES, V72, P1221, DOI 10.1158/0008-5472.CAN-11-2785; Zhou LL, 2015, HEMATOLOGY, V20, P343, DOI 10.1179/1607845414Y.0000000201; Zhu Y, 2010, INT J CLIN EXP MED, V3, P211	54	24	25	0	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3531	3540		10.1074/jbc.M116.772392	http://dx.doi.org/10.1074/jbc.M116.772392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28096467	hybrid, Green Published			2022-12-28	WOS:000395538800040
J	Guo, HT; Mi, ZY; Kuo, PC				Guo, Hongtao; Mi, Zhiyong; Kuo, Paul C.			RETRACTION: Characterization of short range DNA looping in endotoxin-mediated transcription of the murine inducible nitric-oxide synthase (iNOS) gene (Retraction of Vol 283, Pg 25209, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200	1	0	0	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1144	1144		10.1074/jbc.A116.804062	http://dx.doi.org/10.1074/jbc.A116.804062			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	28108616	Green Published, hybrid			2022-12-28	WOS:000392318700034
J	Chen, L; Paquette, N; Mamoor, S; Rus, F; Nandy, A; Leszyk, J; Shaffer, SA; Silverman, N				Chen, Li; Paquette, Nicholas; Mamoor, Shahan; Rus, Florentina; Nandy, Anubhab; Leszyk, John; Shaffer, Scott A.; Silverman, Neal			Innate immune signaling in Drosophila is regulated by transforming growth factor beta (TGF beta)-activated kinase (Tak1)-triggered ubiquitin editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); Drosophila; mass spectrometry (MS); NF-B (NF-B); phosphorylation; ubiquitylation (ubiquitination); Imd; Tak1; ubiquitin editing	NF-KAPPA-B; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; IMD-PATHWAY; PGRP-LC; ACTIVATION; PEPTIDOGLYCAN; E2; BINDING; TAK1	Coordinated regulation of innate immune responses is necessary in all metazoans. In Drosophila the Imd pathway detects Gram-negative bacterial infections through recognition of diaminopimelic acid (DAP)-type peptidoglycan and activation of the NF-kappa B precursor Relish, which drives robust antimicrobial peptide gene expression. Imd is a receptor-proximal adaptor protein homologous to mammalian RIP1 that is regulated by proteolytic cleavage and Lys-63-polyubiquitination. However, the precise events and molecular mechanisms that control the post-translational modification of Imd remain unclear. Here, we demonstrate that Imd is rapidly Lys-63-polyubiquitinated at lysine residues 137 and 153 by the sequential action of two E2 enzymes, Ubc5 and Ubc13-Uev1a, in conjunction with the E3 ligase Diap2. Lys-63-ubiquitination activates the TGF beta-activated kinase (Tak1), which feeds back to phosphorylate Imd, triggering the removal of Lys-63 chains and the addition of Lys-48 polyubiquitin. This ubiquitin-editing process results in the proteasomal degradation of Imd, which we propose functions to restore homeostasis to the Drosophila immune response.	[Chen, Li; Paquette, Nicholas; Mamoor, Shahan; Rus, Florentina; Nandy, Anubhab; Silverman, Neal] Univ Massachusetts, Med Sch, Div Infect Dis, Dept Med, 364 Plantat St, Worcester, MA 01605 USA; [Leszyk, John; Shaffer, Scott A.] Univ Massachusetts, Med Sch, Prote & Mass Spectrometry Facil, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), Univ Massachusetts, Med Sch, Div Infect Dis, Dept Med, 364 Plantat St, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu		Mamoor, Shahan/0000-0003-4150-0936	National Institutes of Health [AI060025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025, T32AI095213, R56AI060025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant AI060025 (to N. S.).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Bergmann A, 2010, CELL DEATH DIFFER, V17, P61, DOI 10.1038/cdd.2009.70; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guntermann S, 2009, DEV COMP IMMUNOL, V33, P127, DOI 10.1016/j.dci.2008.07.021; Jones D, 2002, GENOME BIOL, V3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; Kim CH, 2014, J BIOL CHEM, V289, P20092, DOI 10.1074/jbc.M113.544841; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Wooff J, 2004, FEBS LETT, V566, P229, DOI 10.1016/j.febslet.2004.04.038; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhuang ZH, 2006, CELL SIGNAL, V18, P964, DOI 10.1016/j.cellsig.2005.08.020	47	20	22	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8738	8749		10.1074/jbc.M117.788158	http://dx.doi.org/10.1074/jbc.M117.788158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377500	Green Published, hybrid			2022-12-28	WOS:000402153900020
J	Sato, Y; Tsuyama, T; Sato, C; Karim, MF; Yoshizawa, T; Inoue, M; Yamagata, K				Sato, Yoshifumi; Tsuyama, Tomonori; Sato, Chinami; Karim, Md. Fazlul; Yoshizawa, Tatsuya; Inoue, Masahiro; Yamagata, Kazuya			Hypoxia reduces HNF4 alpha/MODY1 protein expression in pancreatic beta-cells by activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); -cell (B-cell); hepatocyte nuclear factor 4 (HNF-4); hypoxia; transcription factor	HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; INSULIN-SECRETION; OXYGEN-CONSUMPTION; ALPHA-GENE; TARGET; YOUNG; DEGRADATION; DYSFUNCTION; METABOLISM; MUTATIONS	Hypoxia plays a role in the deterioration of beta-cell function. Hepatocyte nuclear factor 4 (HNF4 alpha) has an important role in pancreatic beta-cells, and mutations of the human HNF4A gene cause a type of maturity-onset diabetes of the young (MODY1). However, it remains unclear whether hypoxia affects the expression of HNF4 alpha in beta-cells. Here, we report that hypoxia reduces HNF4 alpha protein expression in beta-cells. Hypoxia-inducible factor was not involved in the down-regulation of HNF4 alpha under hypoxic conditions. The down-regulation of HNF4 alpha was dependent on the activation of AMP-activated protein kinase (AMPK), and the reduction of HNF4 alpha protein expression by metformin, an AMPK activator, and hypoxia was inhibited by the overexpression of a kinase-dead (KD) form of AMPK alpha 2. In addition, hypoxia decreased the stability of the HNF4 alpha protein, and the down-regulation of HNF4 alpha was sensitive to proteasome inhibitors. Adenovirus-mediated overexpression of KD-AMPK alpha 2 improved insulin secretion in metformin-treated islets, hypoxic islets, and ob/ob mouse islets. These results suggest that down-regulation of HNF4 alpha could be of importance in beta-cell dysfunction by hypoxia.	[Sato, Yoshifumi; Tsuyama, Tomonori; Sato, Chinami; Karim, Md. Fazlul; Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Dept Med Biochem, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, 1-3-3 Nakamichi, Tokyo 5378511, Japan	Kumamoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Yamagata, K (corresponding author), Kumamoto Univ, Dept Med Biochem, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	k-yamaga@kumamoto-u.ac.jp	Sato, Yoshifumi/GYQ-7230-2022	Yoshizawa, Tatsuya/0000-0002-5728-1996; Sato, Yoshifumi/0000-0003-0697-1476	Uehara Memorial Foundation; Japan Diabetes Foundation; Naito Foundation	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Diabetes Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported by a Grant-in-Aid for Young Scientists (B) (to Y. S.), a islets (Fig. 1D). Hypoxia reduces the expression of Hnf3b/Foxa2 Grant-in-Aid for Scientific Research (B) (to K. Y.), a grant from the Uehara Memorial Foundation (to K. Y.), a grant from the Japan Diabetes Foundation (to K. Y.), and a grant from the Naito Foundation (to K. Y.).	Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nammo T, 2008, GENE EXPR PATTERNS, V8, P96, DOI 10.1016/j.modgep.2007.09.006; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Sato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114868; Sato Y, 2012, J BIOL CHEM, V287, P23236, DOI 10.1074/jbc.M112.368779; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Stoner M, 2002, MOL ENDOCRINOL, V16, P2231, DOI 10.1210/me.2001-0347; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wang WJ, 2005, J ENDOCRINOL, V185, P445, DOI 10.1677/joe.1.06092; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8; Yang Q, 2000, DIABETOLOGIA, V43, P520, DOI 10.1007/s001250051338; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	42	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8716	8728		10.1074/jbc.M116.767574	http://dx.doi.org/10.1074/jbc.M116.767574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28364040	Green Published, hybrid			2022-12-28	WOS:000402153900018
J	Palivec, V; Viola, CM; Kozak, M; Ganderton, TR; Krizkova, K; Turkenburg, JP; Haluskova, P; Zakova, L; Jiracek, J; Jungwirth, P; Brzozowski, AM				Palivec, Vladimir; Viola, Cristina M.; Kozak, Mateusz; Ganderton, Timothy R.; Krizkova, Kvetoslava; Turkenburg, Johan P.; Haluskova, Petra; Zakova, Lenka; Jiracek, Jiri; Jungwirth, Pavel; Brzozowski, Andrzej M.			Computational and structural evidence for neurotransmitter-mediated modulation of the oligomeric states of human insulin in storage granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; MECHANICAL CALCULATIONS; ALLOSTERIC TRANSITION; LIGAND INTERACTIONS; ALZHEIMERS-DISEASE; PANCREATIC-ISLETS; BINDING-SITE; HEXAMER; ZINC	Human insulin is a pivotal protein hormone controlling metabolism, growth, and aging and whose malfunctioning underlies diabetes, some cancers, and neurodegeneration. Despite its central position in human physiology, the in vivo oligomeric state and conformation of insulin in its storage granules in the pancreas are not known. In contrast, many in vitro structures of hexamers of this hormone are available and fall into three conformational states: T-6, T3R3f, and R-6. As there is strong evidence for accumulation of neurotransmitters, such as serotonin and dopamine, in insulin storage granules in pancreatic beta-cells, we probed by molecular dynamics (MD) and protein crystallography (PC) if these endogenous ligands affect and stabilize insulin oligomers. Parallel studies independently converged on the observation that serotonin binds well within the insulin hexamer (site I), stabilizing it in the T3R3 conformation. Both methods indicated serotonin binding on the hexamer surface (site III) as well. MD, but not PC, indicated that dopamine was also a good site III ligand. Some of the PC studies also included arginine, which may be abundant in insulin granules upon processing of pro-insulin, and stable T3R3 hexamers loaded with both serotonin and arginine were obtained. The MD and PC results were supported further by in solution spectroscopic studies with R-state-specific chromophore. Our results indicate that the T3R3 oligomer is a plausible insulin pancreatic storage form, resulting from its complex interplay with neurotransmitters, and pro-insulin processing products. These findings may have implications for clinical insulin formulations.	[Viola, Cristina M.; Kozak, Mateusz; Ganderton, Timothy R.; Turkenburg, Johan P.; Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Palivec, Vladimir; Krizkova, Kvetoslava; Haluskova, Petra; Zakova, Lenka; Jiracek, Jiri; Jungwirth, Pavel] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic; [Kozak, Mateusz] Univ Geneva, Dept Biochem, Quai Ernest Ansermet 30, CH-1205 Geneva, Switzerland	University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Geneva	Brzozowski, AM (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.; Jiracek, J; Jungwirth, P (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	jiracek@uochb.cas.cz; pavel.jungwirth@uochb.cas.cz; marek.brzozowski@york.ac.uk	Jungwirth, Pavel/D-9290-2011; Jiracek, Jiri/Y-6703-2019; Jiracek, Jiri/A-7124-2008; Mlčochová, Květoslava/L-6979-2017; Zakova, Lenka/Y-6234-2019; Zakova, Lenka/A-7119-2008	Jungwirth, Pavel/0000-0002-6892-3288; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; Mlčochová, Květoslava/0000-0002-6226-8067; Zakova, Lenka/0000-0001-6439-2574; Turkenburg, Johan/0000-0001-6992-6838; Kozak, Mateusz/0000-0002-1354-693X; Ganderton, Timothy Richard/0000-0002-3949-4795	Research Project of the Czech Academy of Sciences [RVO:61388963]; Medical Research Council Grant [MR/K000179/1]; Czech Science Foundation [16-01074S]; Medical Research Council [MR/K000179/1] Funding Source: researchfish; MRC [MR/K000179/1] Funding Source: UKRI	Research Project of the Czech Academy of Sciences; Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Czech Science Foundation(Grant Agency of the Czech Republic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was also supported by the Research Project of the Czech Academy of Sciences RVO:61388963 (to the Institute of Organic Chemistry and Biochemistry). This work was also supported by Medical Research Council Grant MR/K000179/1 (to A.M.B.), and Supported by Czech Science Foundation Grant 16-01074S (to P.J.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arrieta-Cruz I, 2016, REV INVEST CLIN, V68, P53; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BENTLEY G, 1978, J MOL BIOL, V126, P871, DOI 10.1016/0022-2836(78)90026-8; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bloom CR, 1998, BIOCHEMISTRY-US, V37, P10937, DOI 10.1021/bi980071z; BRADER ML, 1991, BIOCHEMISTRY-US, V30, P6636, DOI 10.1021/bi00241a002; BRYANT C, 1993, BIOCHEMISTRY-US, V32, P8075, DOI 10.1021/bi00083a004; BRZOVIC PS, 1994, BIOCHEMISTRY-US, V33, P13057, DOI 10.1021/bi00248a015; Case D.A., 2022, AMBER; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; CHOI WE, 1993, BIOCHEMISTRY-US, V32, P11638, DOI 10.1021/bi00094a021; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FALCK B, 1963, EXPERIENTIA, V19, P139, DOI 10.1007/BF02171596; Fava E, 2012, DIABETOLOGIA, V55, P1013, DOI 10.1007/s00125-011-2438-4; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; Frisch M. J., 2009, GAUSSION 09 REVISION; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; HAGEDORS H. C., 1936, Journal of the American Medical Association, V106, P177; Huang ST, 1997, BIOCHEMISTRY-US, V36, P9878, DOI 10.1021/bi9701639; HUTTON JC, 1982, BIOCHEM J, V204, P171, DOI 10.1042/bj2040171; Huus K, 2006, BIOCHEMISTRY-US, V45, P4014, DOI 10.1021/bi0524520; Ishikawa T, 2008, BIOCHEM BIOPH RES CO, V376, P32, DOI 10.1016/j.bbrc.2008.08.071; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Kohagen M, 2016, J PHYS CHEM B, V120, P1454, DOI 10.1021/acs.jpcb.5b05221; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leontyev I, 2011, PHYS CHEM CHEM PHYS, V13, P2613, DOI 10.1039/c0cp01971b; Leontyev IV, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4884276; Leontyev IV, 2012, J CHEM THEORY COMPUT, V8, P3207, DOI 10.1021/ct300011h; Lisi GP, 2014, BIOCHEMISTRY-US, V53, P3576, DOI 10.1021/bi401678n; LUNDQUIST I, 1971, DIABETOLOGIA, V7, P414, DOI 10.1007/BF01212056; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Norrman M, 2007, EUR J PHARM SCI, V30, P414, DOI 10.1016/j.ejps.2007.01.003; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SEYDOUX J, 1974, EXPERIENTIA, V30, P683; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; Smith GD, 1998, J MOL STRUCT, V470, P71, DOI 10.1016/S0022-2860(98)00471-2; Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806; SMITH GD, 1994, P NATL ACAD SCI USA, V91, P8851, DOI 10.1073/pnas.91.19.8851; SMITH GD, 1984, P NATL ACAD SCI-BIOL, V81, P7093, DOI 10.1073/pnas.81.22.7093; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Smith GD, 2001, ACTA CRYSTALLOGR D, V57, P1091, DOI 10.1107/S0907444901007685; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Steensgaard DB, 2013, BIOCHEMISTRY-US, V52, P295, DOI 10.1021/bi3008609; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; TURNER RC, 1995, DIABETES, V44, P1, DOI 10.2337/diabetes.44.1.1; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wagner A, 2009, PROTEINS, V74, P1018, DOI 10.1002/prot.22213; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Ward Colin W, 2011, Front Endocrinol (Lausanne), V2, P76, DOI 10.3389/fendo.2011.00076; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; WHITTINGHAM JL, 1995, BIOCHEMISTRY-US, V34, P15553, DOI 10.1021/bi00047a022; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	85	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8342	8355		10.1074/jbc.M117.775924	http://dx.doi.org/10.1074/jbc.M117.775924			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348075	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000401788600019
J	Suber, T; Wei, JX; Jacko, AM; Nikolli, I; Zhao, YT; Zhao, J; Mallampalli, RK				Suber, Tomeka; Wei, Jianxin; Jacko, Anastasia M.; Nikolli, Ina; Zhao, Yutong; Zhao, Jing; Mallampalli, Rama K.			SCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3 beta in lung epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; inflammation; lung; lung injury; ubiquitin	F-BOX PROTEINS; TUMOR-NECROSIS-FACTOR; CYTOKINE PRODUCTION; UBIQUITIN LIGASES; 3-BETA; CANCER; GSK3; PHOSPHORYLATION; INHIBITION; DIVERSITY	Glycogen synthase kinase-3 (GSK3) has diverse biological roles including effects on cellular differentiation, migration, and inflammation. GSK3 phosphorylates proteins to generate phosphodegrons necessary for recognition by Skp1/Cullin-1/F-box (SCF) E3 ubiquitin ligases leading to subsequent proteasomal degradation of these substrates. However, little is known regarding how GSK3 protein stability itself is regulated and how its stability may influence inflammation. Here we show that GSK3 is degraded by the ubiquitin-proteasome pathway in murine lung epithelial cells through lysine 183 as an acceptor site for K48 polyubiquitination. We have identified FBXO17 as an F-box protein subunit that recognizes and mediates GSK3 polyubiquitination. Both endogenous and ectopically expressed FBXO17 associate with GSK3, and its overexpression leads to decreased protein levels of GSK3. Silencing FBXO17 gene expression increased the half-life of GSK3 in cells. Furthermore, overexpression of FBXO17 inhibits agonist-induced release of keratinocyte-derived cytokine (KC) and interleukin-6 (IL-6) production by cells. Thus, the SCFFBXO17 E3 ubiquitin ligase complex negatively regulates inflammation by targeting GSK3 in lung epithelia.	[Suber, Tomeka; Wei, Jianxin; Jacko, Anastasia M.; Nikolli, Ina; Zhao, Yutong; Zhao, Jing; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol Physiol & Bioengn, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Dept Med, UPMC Montefiore, Pulm Allergy & Crit Care Med, NW 628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; Flight Attendant Medical Research Institute; National Institutes of Health R01 Grants [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01HL114453, R01 HL131665, R01 GM115389]; American Heart Association GIA award; American Lung Association [BRG RG350146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL137248, P01HL114453, R01HL098174, T32HL007563, R01HL096376, R01HL112791, R01HL131665, R01HL081784, UH2HL123502, R01HL097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); Flight Attendant Medical Research Institute; National Institutes of Health R01 Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association GIA award(American Heart Association); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, a Merit Review Award from the United States Department of Veterans Affairs, the Flight Attendant Medical Research Institute, and National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01HL114453 (to R. K. M.), R01 HL131665 (to Y. Z.), R01 GM115389 (to J. Z), an American Heart Association GIA award (to Y. Z), and American Lung Association Grant BRG RG350146 (to J. Z). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs.	Alper S, 2016, GENETICS, V204, P327, DOI 10.1534/genetics.115.185314; Balch WE, 2014, AM J RESP CRIT CARE, V189, P96, DOI 10.1164/rccm.201306-1164WS; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen BB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.271; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Ko R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7765; Liao XB, 2003, MOL CANCER THER, V2, P1215; Liu ZY, 2015, MOL MED, V21, P937, DOI 10.2119/molmed.2015.00198; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mialki RK, 2013, J BIOL CHEM, V288, P15437, DOI 10.1074/jbc.C112.446682; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Peng D, 2017, J IMMUNOL, V198, P808, DOI 10.4049/jimmunol.1601009; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reichard EL, 2016, J BIOL CHEM, V291, P18547, DOI 10.1074/jbc.M116.720151; Ren F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.56; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Teixeira FR, 2016, BIOCHEM J, V473, P3563, DOI 10.1042/BCJ20160387; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Wang HZ, 2014, TRENDS MICROBIOL, V22, P208, DOI 10.1016/j.tim.2014.01.009; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Weathington NM, 2013, CELL SIGNAL, V25, P1792, DOI 10.1016/j.cellsig.2013.05.003; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhang H., 2014, MEDIATORS INFLAMM; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341	50	24	27	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7452	7461		10.1074/jbc.M116.771667	http://dx.doi.org/10.1074/jbc.M116.771667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28298444	Green Published, hybrid			2022-12-28	WOS:000400761300015
J	Wang, J; Sun, LF; Cui, WW; Zhao, WS; Ma, XF; Li, B; Liu, Y; Yang, Y; Hu, YM; Huang, LD; Cheng, XY; Li, LY; Lu, XY; Tian, Y; Yu, Y				Wang, Jin; Sun, Liang-Fei; Cui, Wen-Wen; Zhao, Wen-Shan; Ma, Xue-Fei; Li, Bin; Liu, Yan; Yang, Yang; Hu, You-Min; Huang, Li-Dong; Cheng, Xiao-Yang; Li, Lingyong; Lu, Xiang-Yang; Tian, Yun; Yu, Ye			Intersubunit physical couplings fostered by the left flipper domain facilitate channel opening of P2X4 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; gating; ion channel; protein domain; receptor structure-function; P2X receptors; molecular simulations; physical couplings; single channel recording	SENSING ION CHANNELS; SALT BRIDGE STABILIZES; ATP-BINDING; CONFORMATIONAL-CHANGES; TRANSMEMBRANE HELICES; OPTICAL CONTROL; OPEN STATE; ACTIVATION; MECHANISM; GATE	P2X receptors are ATP-gated trimeric channels with important roles in diverse pathophysiological functions. A detailed understanding of the mechanism underlying the gating process of these receptors is thus fundamentally important and may open new therapeutic avenues. The left flipper (LF) domain of the P2X receptors is a flexible loop structure, and its coordinated motions together with the dorsal fin (DF) domain are crucial for the channel gating of the P2X receptors. However, the mechanism underlying the crucial role of the LF domain in the channel gating remains obscure. Here, we propose that the ATP-induced allosteric changes of the LF domain enable it to foster intersubunit physical couplings among the DF and two lower body domains, which are pivotal for the channel gating of P2X4 receptors. Metadynamics analysis indicated that these newly established intersubunit couplings correlate well with the ATP-bound open state of the receptors. Moreover, weakening or strengthening these physical interactions with engineered intersubunit metal bridges remarkably decreased or increased the open probability of the receptors, respectively. Further disulfide cross-linking and covalent modification confirmed that the intersubunit physical couplings among the DF and two lower body domains fostered by the LF domain at the open state act as an integrated structural element that is stringently required for the channel gating of P2X4 receptors. Our observations provide new mechanistic insights into P2X receptor activation and will stimulate development of new allosteric modulators of P2X receptors.	[Wang, Jin; Sun, Liang-Fei; Cui, Wen-Wen; Zhao, Wen-Shan; Ma, Xue-Fei; Li, Bin; Liu, Yan; Yang, Yang; Hu, You-Min; Huang, Li-Dong; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China; [Wang, Jin; Sun, Liang-Fei; Cui, Wen-Wen; Zhao, Wen-Shan; Ma, Xue-Fei; Li, Bin; Liu, Yan; Yang, Yang; Hu, You-Min; Huang, Li-Dong; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China; [Ma, Xue-Fei; Li, Bin; Lu, Xiang-Yang; Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Li, Lingyong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hunan Agricultural University; University of Texas System; UTMD Anderson Cancer Center	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China.; Tian, Y; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	tianyun79616@163.com; yuye@shsmu.edu.cn	Cheng, Xiaoyang/N-9970-2019; Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Wang, Jin/0000-0001-8337-0434; Zhao, Wenshan/0000-0002-8018-5978; Yu, Ye/0000-0002-4054-8543	National Natural Science Foundation of China [31570832, 31170787, 31400707]; National Program on Key Basic Research Project of China [2014CB910302]; National Excellent Young Scientist Foundation of China [31222018]; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant [13XJ10042]; Opening Project of State Key Laboratory of Drug Research Grant [SIMM1601KF-02]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine Grant [BXJ201405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project of China(National Basic Research Program of China); National Excellent Young Scientist Foundation of China; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant; Opening Project of State Key Laboratory of Drug Research Grant; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine Grant	This work was supported by National Natural Science Foundation of China Grants 31570832, 31170787, and 31400707, National Program on Key Basic Research Project of China Grant 2014CB910302, National Excellent Young Scientist Foundation of China Grant 31222018, Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant 13XJ10042, the Opening Project of State Key Laboratory of Drug Research Grant SIMM1601KF-02, and Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine Grant BXJ201405. The authors declare that they have no conflicts of interest with the contents of this article.	Aboul-Enein HY, 2003, PREP BIOCHEM BIOTECH, V33, P173, DOI 10.1081/PB-120022986; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Beamer E, 2016, NEUROPHARMACOLOGY, V104, P94, DOI 10.1016/j.neuropharm.2015.09.019; Browne LE, 2014, P NATL ACAD SCI USA, V111, P521, DOI 10.1073/pnas.1318582111; Burnstock G, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0422; Burnstock G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00204; Chataigneau T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00273; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cremlyn R. J., 1996, INTRO ORGANOSULFUR C, P7; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; Evans RJ, 1996, NEUROSCI LETT, V212, P212, DOI 10.1016/0304-3940(96)12804-4; Fryatt AG, 2014, MOL PHARMACOL, V86, P707, DOI 10.1124/mol.114.095307; Habermacher C, 2016, ELIFE, V5, DOI 10.7554/eLife.11050; Habermacher C, 2016, NEUROPHARMACOLOGY, V104, P18, DOI 10.1016/j.neuropharm.2015.07.032; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jie YL, 2014, NEUROSCI LETT, V582, P1, DOI 10.1016/j.neulet.2014.08.038; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Kasuya G, 2016, CELL REP, V14, P932, DOI 10.1016/j.celrep.2015.12.087; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kellenberger S, 2015, J MOL BIOL, V427, P54, DOI 10.1016/j.jmb.2014.06.004; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Kowalski M, 2014, BRIT J PHARMACOL, V171, P5093, DOI 10.1111/bph.12830; Kuan YH, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0240-4; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lemoine D, 2013, P NATL ACAD SCI USA, V110, P20813, DOI 10.1073/pnas.1318715110; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Minato Y, 2016, P NATL ACAD SCI USA, V113, P4741, DOI 10.1073/pnas.1600519113; Negulyaev YA, 2000, NEUROSCI LETT, V279, P165, DOI 10.1016/S0304-3940(99)00976-3; North RA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0427; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Pippel A, 2017, P NATL ACAD SCI USA, V114, pE2156, DOI 10.1073/pnas.1610414114; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Rokic MB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; SATAV JG, 1977, EUR J BIOCHEM, V73, P287, DOI 10.1111/j.1432-1033.1977.tb11318.x; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Wang J, 2016, ACTA PHARMACOL SIN, V37, P44, DOI 10.1038/aps.2015.127; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhao WS, 2016, J BIOL CHEM, V291, P7990, DOI 10.1074/jbc.M115.711127; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	63	15	15	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7619	7635		10.1074/jbc.M116.771121	http://dx.doi.org/10.1074/jbc.M116.771121			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302727	hybrid, Green Published			2022-12-28	WOS:000400761300029
J	Thaker, YR; Recino, A; Raab, M; Jabeen, A; Wallberg, M; Fernandez, N; Rudd, CE				Thaker, Youg R.; Recino, Asha; Raab, Monika; Jabeen, Asma; Wallberg, Maja; Fernandez, Nelson; Rudd, Christopher E.			Activated Cdc42-associated kinase 1 (ACK1) binds the sterile alpha motif (SAM) domain of the adaptor SLP-76 and phosphorylates proximal tyrosines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; CONTAINING LEUKOCYTE PHOSPHOPROTEIN; SIGNAL-TRANSDUCTION; PROTEIN SLP-76; CD4 RECEPTOR; COMPLEX; TCR; MICROCLUSTERS; TRANSCRIPTION; P56LCK	The adaptor protein Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76) plays a crucial role in T cell activation by linking antigen receptor (T cell receptor, TCR) signals to downstream pathways. At its N terminus, SLP-76 has three key tyrosines (Tyr-113, Tyr-128, and Tyr-145, "3Y") as well as a sterile alpha motif (SAM) domain whose function is unclear. We showed previously that the SAM domain has two binding regions that mediate dimer and oligomer formation. In this study, we have identified SAM domain-carrying non-receptor tyrosine kinase, activated Cdc42-associated tyrosine kinase 1 (ACK1; also known as Tnk2, tyrosine kinase non-receptor 2) as a novel binding partner of SLP-76. Co-precipitation, laser-scanning confocal microscopy, and in situ proximity analysis confirmed the binding of ACK1 to SLP-76. Further, the interaction was induced in response to the anti-TCR ligation and abrogated by the deletion of SLP-76 SAM domain (Delta SAM) or mutation of Tyr-113, Tyr-128, and Tyr-145 to phenylalanine (3Y3F). ACK1 induced phosphorylation of the SLP-76 N-terminal tyrosines (3Y) dependent on the SAM domain. Further, ACK1 promoted calcium flux and NFAT-AP1 promoter activity and decreased the motility of murine CD4(+) primary T cells on ICAM-1-coated plates, an event reversed by a small molecule inhibitor of ACK1 (AIM-100). These findings identify ACK1 as a novel SLP-76-associated protein-tyrosine kinase that modulates early activation events in T cells.	[Thaker, Youg R.; Recino, Asha; Wallberg, Maja; Rudd, Christopher E.] Univ Cambridge, Cell Signaling Sect, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Raab, Monika] Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynecol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Jabeen, Asma; Fernandez, Nelson] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Rudd, Christopher E.] Maisonneuve Rosemont Hosp, Oncol Res Ctr, Div Immunol, Montreal, PQ H1T 2M4, Canada; [Rudd, Christopher E.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Cambridge; Goethe University Frankfurt; University of Essex; Universite de Montreal; Universite de Montreal	Thaker, YR (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02151 USA.	youg_thaker@hms.harvard.edu	Rudd, Christopher E/ABF-7259-2021; Thaker, Youg/K-6083-2016; Rudd, Christopher E/GOH-2021-2022	Thaker, Youg/0000-0002-6496-1017; Rudd, Christopher E/0000-0001-5295-9019	Wellcome Trust [092627/Z/10/Z]; National Centre for the Replacement [NC/M001083/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement	This work was supported by Wellcome Trust Grant 092627/Z/10/Z (to E. R.).	Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bubeck W. J., 1996, J BIOL CHEM, V271, P19641; BURGESS KE, 1991, EUR J IMMUNOL, V21, P1663, DOI 10.1002/eji.1830210712; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; daSilva AJ, 1997, BIOCHEM SOC T, V25, P361, DOI 10.1042/bst0250361; Fang N, 1996, J IMMUNOL, V157, P3769; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Jabeen A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111963; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Johnson PE, 2006, NAT STRUCT MOL BIOL, V13, P177, DOI 10.1038/nsmb1039; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Liu HB, 2015, MOL CELL, V59, P840, DOI 10.1016/j.molcel.2015.07.015; Liu HB, 2013, J BIOL CHEM, V288, P29539, DOI 10.1074/jbc.M112.424846; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Mahajan K, 2015, ONCOGENE, V34, P4162, DOI 10.1038/onc.2014.350; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Prieto-Echagile V., 2011, J SIGNAL TRANSDUCT, V2011; Prieto-Echague V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-42; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rasband W., 2006, IMAGEJ; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Rudd CE, 1998, CURR BIOL, V8, pR805, DOI 10.1016/S0960-9822(07)00505-2; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Samelson LE, 1999, COLD SPRING HARB SYM, V64, P259, DOI 10.1101/sqb.1999.64.259; Schneider H, 2000, J BIOL CHEM, V275, P3835, DOI 10.1074/jbc.275.6.3835; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Shen SD, 2009, BLOOD, V114, P74, DOI 10.1182/blood-2008-09-177832; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stubbington MJT, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0045-x; Thaker YR, 2015, IMMUNOL LETT, V163, P113, DOI 10.1016/j.imlet.2014.10.020; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Xie BH, 2015, INT J ONCOL, V46, P2057, DOI 10.3892/ijo.2015.2910; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	52	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6281	6290		10.1074/jbc.M116.759555	http://dx.doi.org/10.1074/jbc.M116.759555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28188290	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000399538700022
J	Cannan, WJ; Rashid, I; Tomkinson, AE; Wallace, SS; Pederson, DS				Cannan, Wendy J.; Rashid, Ishtiaque; Tomkinson, Alan E.; Wallace, Susan S.; Pederson, David S.			The Human Ligase III alpha-XRCC1 Protein Complex Performs DNA Nick Repair after Transient Unwrapping of Nucleosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; SINGLE-STRAND BREAK; RNA-POLYMERASE-II; CORE PARTICLE; RECOMBINANT HISTONES; MAMMALIAN-CELLS; IN-VITRO; CHROMATIN; BINDING; GENE	Reactive oxygen species generate potentially cytotoxic and mutagenic lesions in DNA, both between and within the nucleosomes that package DNA in chromatin. The vast majority of these lesions are subject to base excision repair (BER). Enzymes that catalyze the first three steps in BER can act at many sites in nucleosomes without the aid of chromatin-remodeling agents and without irreversibly disrupting the host nucleosome. Here we show that the same is true for a protein complex comprising DNA ligase III alpha and the scaffolding protein X-ray repair cross-complementing protein 1 (XRCC1), which completes the fourth and final step in (short-patch) BER. Using in vitro assembled nucleosomes containing discretely positioned DNA nicks, our evidence indicates that the ligase III alpha-XRCC1 complex binds to DNA nicks in nucleosomes only when they are exposed by periodic, spontaneous partial unwrapping of DNA from the histone octamer; that the scaffolding protein XRCC1 enhances the ligation; that the ligation occurs within a complex that ligase III alpha-XRCC1 forms with the host nucleosome; and that the ligase III alpha-XRCC1-nucleosome complex decays when ligation is complete, allowing the host nucleosome to return to its native configuration. Taken together, our results illustrate ways in which dynamic properties intrinsic to nucleosomes may contribute to the discovery and efficient repair of base damage in chromatin.	[Cannan, Wendy J.; Wallace, Susan S.; Pederson, David S.] Univ Vermont, Dept Microbiol & Mol Genet, Rm 220,Stafford Bldg,95 Carrigan Dr, Burlington, VT 05405 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of Vermont; University of New Mexico; University of New Mexico; University of New Mexico	Pederson, DS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Rm 220,Stafford Bldg,95 Carrigan Dr, Burlington, VT 05405 USA.	david.pederson@uvm.edu	Classen, Scott/AAY-8176-2020; Cannan, Wendy J/L-6359-2016	Cannan, Wendy J/0000-0002-7629-8611; Wallace, Susan S./0000-0002-3906-0321	NCI, National Institutes of Health [P01CA098993, CA92584]; NIEHS, National Institutes of Health [ES012512]; NATIONAL CANCER INSTITUTE [P01CA092584, P01CA098993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NCI, National Institutes of Health Grants P01CA098993 (to S.S.W.) and CA92584 (to A.E.T.) and NIEHS, National Institutes of Health Grant ES012512 (to A.E.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Arakawa H, 2015, GENES-BASEL, V6, P385, DOI 10.3390/genes6020385; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Campalans A, 2013, NUCLEIC ACIDS RES, V41, P3115, DOI 10.1093/nar/gkt025; Cannan WJ, 2014, J BIOL CHEM, V289, P19881, DOI 10.1074/jbc.M114.571588; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Czaja W, 2014, DNA REPAIR, V16, P35, DOI 10.1016/j.dnarep.2014.01.002; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; Duclos S, 2012, ISSUES TOXICOL, V13, P115, DOI 10.1039/9781849732925-00115; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friedberg E. C., 2005, DNA REPAIR MUTAGENES, P9; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; Nakanishi S, 2007, NUCLEIC ACIDS RES, V35, P4313, DOI 10.1093/nar/gkm436; Odell ID, 2013, J CELL PHYSIOL, V228, P258, DOI 10.1002/jcp.24134; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Odell ID, 2010, DNA REPAIR, V9, P134, DOI 10.1016/j.dnarep.2009.11.005; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PEDERSON DS, 1986, P NATL ACAD SCI USA, V83, P7206, DOI 10.1073/pnas.83.19.7206; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287; Ye Y, 2012, BIOCHEMISTRY-US, V51, P6028, DOI 10.1021/bi3006412	62	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5227	5238		10.1074/jbc.M116.736728	http://dx.doi.org/10.1074/jbc.M116.736728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28184006	Green Published, hybrid			2022-12-28	WOS:000397875500007
J	Garfoot, AL; Dearing, KL; VanSchoiack, AD; Wysocki, VH; Rappleye, CA				Garfoot, Andrew L.; Dearing, Kacey L.; VanSchoiack, Andrew D.; Wysocki, Vicki H.; Rappleye, Chad A.			Eng1 and Exg8 Are the Major beta-Glucanases Secreted by the Fungal Pathogen Histoplasma capsulatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE RECOGNITION; CELL-SEPARATION; IDENTIFICATION; BINDING; HEAT-SHOCK-PROTEIN-60; MACROPHAGES; DECTIN-1; ALPHA-(1,3)-GLUCAN; BETA-1,3-GLUCANASE; REQUIREMENT	Fungal cell walls contain beta-glucan polysaccharides that stimulate immune responses when recognized by host immune cells. The fungal pathogen Histoplasma capsulatum minimizes detection of beta-glucan by host cells through at least two mechanisms: concealment of beta-glucans beneath beta-glucans and enzymatic removal of any exposed beta-glucan polysaccharides by the secreted glucanase Eng1. Histoplasma yeasts also secrete the putative glucanase Exg8, which may serve a similar role as Eng1 in removing exposed beta-glucans from the yeast cell surface. Here, we characterize the enzymatic specificity of the Eng1 and Exg8 proteins and show that Exg8 is an exo-beta 1,3-glucanase and Eng1 is an endo-beta 1,3-glucanase. Together, Eng1 and Exg8 account for nearly all of the total secreted glucanase activity of Histoplasma yeasts. Both Eng1 and Exg8 proteins are secreted through a conventional secretion signal and are modified posttranslationally by O-linked glycosylation. Both glucanases have near maximal activity at temperature and pH conditions experienced during infection of host cells, supporting roles in Histoplasma pathogenesis. Exg8 has a higher specific activity than Eng1 for beta 1,3-glucans; yet despite this, Exg8 does not reduce detection of yeasts by the host beta-glucan receptor Dectin-1. Exg8 is largely dispensable for virulence in vivo, in contrast to Eng1. These results show that Histoplasma yeasts secrete two beta 1,3glucanases and that Eng1 endoglucanase activity is the predominant factor responsible for removal of exposed cell wall beta-glucans to minimize host detection of Histoplasma yeasts.	[Garfoot, Andrew L.; Dearing, Kacey L.; Rappleye, Chad A.] Ohio State Univ, Dept Microbiol Microbial Infect & Immun, Columbus, OH 43210 USA; [VanSchoiack, Andrew D.; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rappleye, CA (corresponding author), 484 W 12th Ave,540 Biol Sci Bldg, Columbus, OH 43210 USA.	rappleye.1@osu.edu		Wysocki, Vicki/0000-0003-0495-2538; Rappleye, Chad/0000-0001-7880-5958	National Institutes of Health from NIAID [R21-AI117122]; National Institutes of Health Predoctoral Fellowship [T32AI112542]; National Institutes of Health NRSA; National Institutes of Health [R33AI085563]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117122, T32AI112542, R01AI083335] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Award R21-AI117122 from NIAID (to C. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Predoctoral Fellowship T32AI112542 and National Institutes of Health NRSA training grant administered by the Center for Microbial Interface Biology (CMIB) at Ohio State University.; Both authors were supported by National Institutes of Health Grant R33AI085563 (to Marta Feldmesser).	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BULLOCK WE, 1987, J EXP MED, V165, P195, DOI 10.1084/jem.165.1.195; Edwards JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-695; Edwards JA, 2013, ANTIMICROB AGENTS CH, V57, P4349, DOI 10.1128/AAC.00459-13; Edwards JA, 2011, EUKARYOT CELL, V10, P87, DOI 10.1128/EC.00214-10; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Esteban PF, 2005, CURR MICROBIOL, V51, P385, DOI 10.1007/s00284-005-0066-2; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Fernandez-Alvarez A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002563; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garfoot AL, 2016, MBIO, V7, DOI 10.1128/mBio.01388-15; Garfoot AL, 2016, FEBS J, V283, P619, DOI 10.1111/febs.13389; Goughenour KD, 2015, J CLIN MICROBIOL, V53, P3286, DOI 10.1128/JCM.00795-15; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Habich C, 2006, FEBS LETT, V580, P115, DOI 10.1016/j.febslet.2005.11.060; Holbrook ED, 2011, J PROTEOME RES, V10, P1929, DOI 10.1021/pr1011697; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Kemski MM, 2013, FUNGAL BIOL-UK, V117, P41, DOI 10.1016/j.funbio.2012.11.004; Lin J., 2010, SYNTHESIS LECT HUMAN, V3, P1, DOI [DOI 10.2200/S00274ED1V01Y201006HLT007, 10.2200/S00274ED1V01Y201006HLT007]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long KH, 2003, J IMMUNOL, V170, P487, DOI 10.4049/jimmunol.170.1.487; Martin-Cuadrado AB, 2008, FUNGAL GENET BIOL, V45, P542, DOI 10.1016/j.fgb.2007.09.001; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mouyna I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00081; NEWMAN SL, 1990, J CLIN INVEST, V85, P223, DOI 10.1172/JCI114416; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Ramada MHS, 2010, J MICROBIOL METH, V81, P6, DOI 10.1016/j.mimet.2010.01.010; Strasser JE, 1999, J IMMUNOL, V162, P6148; TAYLOR ML, 1989, CLIN EXP IMMUNOL, V75, P466; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; WORSHAM PL, 1988, J MED VET MYCOL, V26, P137; Youseff Brian H, 2012, Methods Mol Biol, V845, P151, DOI 10.1007/978-1-61779-539-8_10; Zemska Olga, 2012, Methods Mol Biol, V845, P51, DOI 10.1007/978-1-61779-539-8_4	39	24	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4801	4810		10.1074/jbc.M116.762104	http://dx.doi.org/10.1074/jbc.M116.762104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28154008	Green Published, hybrid			2022-12-28	WOS:000397590400005
J	Bui-Nguyen, TM; Pakala, SB; Sirigiri, DR; Martin, E; Murad, F; Kumar, R				Bui-Nguyen, Tri M.; Pakala, Suresh B.; Sirigiri, Divijendranatha Reddy; Martin, Emil; Murad, Ferid; Kumar, Rakesh			Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein-HBx requires MTA1 coregulator (Withdrawal of Vol 285, Pg 6980, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal													Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803				Bui-Nguyen TM, 2010, J BIOL CHEM, V285, P6980, DOI 10.1074/jbc.M109.065987	1	1	1	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4765	4765		10.1074/jbc.A117.065987	http://dx.doi.org/10.1074/jbc.A117.065987			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28314778	hybrid, Green Published			2022-12-28	WOS:000397585100033
J	Oakes, E; Anderson, A; Cohen-Gadol, A; Hundley, HA				Oakes, Eimile; Anderson, Ashley; Cohen-Gadol, Aaron; Hundley, Heather A.			Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; GLUR-B; Q/R SITE; SELECTIVE ADENOSINE; MAMMALIAN BRAIN; AMPA RECEPTORS; NEURONAL DEATH; DSRNA-BINDING; HUMAN-DISEASE; ENZYME ADAR2	RNA editing is a cellular process that precisely alters nucleotide sequences, thus regulating gene expression and generating protein diversity. Over 60% of human transcripts undergo adenosine to inosine RNA editing, and editing is required for normal development and proper neuronal function of animals. Editing of one adenosine in the transcript encoding the glutamate receptor subunit B, glutamate receptor ionotropic AMPA 2 (GRIA2), modifies a codon, replacing the genomically encoded glutamine (Q) with arginine (R); thus this editing site is referred to as the Q/R site. Editing at the Q/R site of GRIA2 is essential, and reduced editing of GRIA2 transcripts has been observed in patients suffering from glioblastoma. In glioblastoma, incorporation of unedited GRIA2 subunits leads to a calcium-permeable glutamate receptor, which can promote cell migration and tumor invasion. In this study, we identify adenosine deaminase that acts on RNA 3 (ADAR3) as an important regulator of Q/R site editing, investigate its mode of action, and detect elevated ADAR3 expression in glioblastoma tumors compared with adjacent brain tissue. Overexpression of ADAR3 in astrocyte and astrocytoma cell lines inhibits RNA editing at the Q/R site of GRIA2. Furthermore, the double-stranded RNA binding domains of ADAR3 are required for repression of RNA editing. As the Q/R site of GRIA2 is specifically edited by ADAR2, we suggest that ADAR3 directly competes with ADAR2 for binding to GRIA2 transcript, inhibiting RNA editing, as evidenced by the direct binding of ADAR3 to the GRIA2 pre-mRNA. Finally, we provide evidence that both ADAR2 and ADAR3 expression contributes to the relative level of GRIA2 editing in tumors from patients suffering from glioblastoma.	[Oakes, Eimile] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Anderson, Ashley; Hundley, Heather A.] Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; [Cohen-Gadol, Aaron] Dept Neurol Surg, Goodman Campbell Brain & Spine, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Goodman Campbell Brain & Spine	Hundley, HA (corresponding author), Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA.	hahundle@indiana.edu	Hundley, Heather/AAV-2808-2020		American Cancer Society Institutional Research Grant [IRG-84-002-28]; American Cancer Society Research Scholar Award [RSG-15-051-RMC]	American Cancer Society Institutional Research Grant(American Cancer Society); American Cancer Society Research Scholar Award(American Cancer Society)	This work was supported by American Cancer Society Institutional Research Grant IRG-84-002-28 (to H.A.H.) and American Cancer Society Research Scholar Award RSG-15-051-RMC (to H.A.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Barbon A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P882, DOI 10.1134/S0006297911080037; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Behm M, 2016, TRENDS GENET, V32, P165, DOI 10.1016/j.tig.2015.12.005; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Gleghorn ML, 2013, NAT STRUCT MOL BIOL, V20, P515, DOI 10.1038/nsmb.2528; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Hong HQ, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140190; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Kawahara Y, 2003, EUR J NEUROSCI, V18, P23, DOI 10.1046/j.1460-9568.2003.02718.x; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Kwak S, 2010, NEUROPATHOLOGY, V30, P182, DOI 10.1111/j.1440-1789.2009.01090.x; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Licht K, 2016, NUCLEIC ACIDS RES, V44, P6398, DOI 10.1093/nar/gkw325; Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041; Liu Y, 1996, J VIROL, V70, P1961, DOI 10.1128/JVI.70.3.1961-1968.1996; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Maas S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004225; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Ohlson J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni169; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pachernegg S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00069; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Rieder LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3232; Rosenthal JJC, 2015, J EXP BIOL, V218, P1812, DOI 10.1242/jeb.119065; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; SCHUMACHER JM, 1995, BIOL REPROD, V52, P1274, DOI 10.1095/biolreprod52.6.1274; Shtrichman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041576; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Sonoda Y, 2001, CANCER RES, V61, P4956; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Tariq A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00099; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Washburn MC, 2016, RNA, V22, P722, DOI 10.1261/rna.055079.115; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Wright A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00034; Yamashita T, 2012, NEUROSCI RES, V73, P42, DOI 10.1016/j.neures.2012.02.002; Yang JH, 1997, P NATL ACAD SCI USA, V94, P4354, DOI 10.1073/pnas.94.9.4354; Yang Y, 2013, SCI CHINA LIFE SCI, V56, P944, DOI 10.1007/s11427-013-4546-5; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	82	94	101	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4326	4335		10.1074/jbc.M117.779868	http://dx.doi.org/10.1074/jbc.M117.779868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28167531	hybrid, Green Published			2022-12-28	WOS:000395837100029
J	Hicks, KC; Patel, TB				Hicks, Kristin C.; Patel, Tarun B.			Sprouty2 protein regulates hypoxia-inducible factor-alpha (HIF alpha) protein levels and transcription of HIF alpha-responsive genes (vol 291, pg 16787, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Hicks KC, 2016, J BIOL CHEM, V291, P16787, DOI 10.1074/jbc.M116.714139	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3060	3060		10.1074/jbc.A116.714139	http://dx.doi.org/10.1074/jbc.A116.714139			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28213533	Green Published, hybrid			2022-12-28	WOS:000395535100044
J	Ho, CH; Tsai, SF				Ho, Ching-Huang; Tsai, Shih-Feng			Functional and biochemical characterization of a T cell-associated anti-apoptotic protein, GIMAP6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; P-TYPE ATPASES; GTPASE ACTIVITIES; HUMAN ORTHOLOG; ATP-BINDING; IAN FAMILY; ACTIVATION; EXPRESSION; DEATH; DIFFERENTIATION	GTPases of immunity-associated proteins (GIMAPs) are expressed in lymphocytes and regulate survival/death signaling and cell development within the immune system. We found that human GIMAP6 is expressed primarily in T cell lines. By sorting human peripheral blood mononuclear cells and performing quantitative RT-PCR, GIMAP6 was found to be expressed in CD3+ cells. In Jurkat cells that had been knocked down for GIMAP6, treatment with hydrogen peroxide, FasL, or okadaic acid significantly increased cell death/apoptosis. Exogenous expression of GMAP6 protected Huh-7 cells from apoptosis, suggesting that GIMAP6 is an anti-apoptotic protein. Furthermore, knockdown of GIMAP6 not only rendered Jurkat cells sensitive to apoptosis but also accelerated T cell activation under phorbol 12-myristate 13-acetate/ionomycin treatment conditions. Using this experimental system, we also observed a down-regulation of p65 phosphorylation (Ser-536) in GIMAP6 knockdown cells, indicating that GIMAP6 might display antiapoptotic function through NF-kappa B activation. The conclusion from the study on cultured T cells was corroborated by the analysis of primary CD3+ T cells, showing that specific knockdown of GIMAP6 led to enhancement of phorbol 12-myristate 13-acetate/ionomycin-mediated activation signals. To characterize the biochemical properties of GIMAP6, we purified the recombinant GIMAP6 to homogeneity and revealed that GIMAP6 had ATPase as well as GTPase activity. We further demonstrated that the hydrolysis activity of GIMAP6 was not essential for its anti-apoptotic function inHuh-7cells. Combining the expression data, biochemical properties, and cellular features, we conclude that GIMAP6 plays a role in modulating immune function and that it does this by controlling cell death and the activation of T cells.	[Ho, Ching-Huang; Tsai, Shih-Feng] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Ho, Ching-Huang; Tsai, Shih-Feng] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli 350, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Tsai, SF (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.; Tsai, SF (corresponding author), Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan.; Tsai, SF (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli 350, Taiwan.	petsai@nhri.org.tw			Intramural Grant of the National Health Research Institutes, Taiwan [MG-105-PP-01]; Taiwan's Ministry of Health and Welfare [106-0324-01-10-05, 106-0324-01-10-07]	Intramural Grant of the National Health Research Institutes, Taiwan; Taiwan's Ministry of Health and Welfare	This work was supported by Intramural Grant MG-105-PP-01 of the National Health Research Institutes, Taiwan, and two extramural grants from Taiwan's Ministry of Health and Welfare (106-0324-01-10-05 and Advance Medical Plan 106-0324-01-10-07). The authors declare that they have no conflicts of interest with the contents of this article.	Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; BREITMAN TR, 1980, EXP CELL RES, V126, P494, DOI 10.1016/0014-4827(80)90296-7; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Cambot M, 2002, BLOOD, V99, P3293, DOI 10.1182/blood.V99.9.3293; Datta P, 2017, EUR J IMMUNOL, V47, P84, DOI 10.1002/eji.201646599; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Filen JJ, 2009, MOL CELL PROTEOMICS, V8, P32, DOI 10.1074/mcp.M800139-MCP200; GALLAGHER R, 1979, BLOOD, V54, P713; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Heinonen MT, 2015, IMMUNOL CELL BIOL, V93, P158, DOI 10.1038/icb.2014.86; Hildeman DA, 2003, P NATL ACAD SCI USA, V100, P15035, DOI 10.1073/pnas.1936213100; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Kadare G, 1996, J VIROL, V70, P8169; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Krucken J, 2005, J CELL BIOCHEM, V96, P339, DOI 10.1002/jcb.20552; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kuhlbrandt W, 1998, CURR OPIN STRUC BIOL, V8, P510, DOI 10.1016/S0959-440X(98)80130-9; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Moore-Carrasco R, 2009, ANTICANCER RES, V29, P1315; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Park J, 2001, J MOL BIOL, V307, P929, DOI 10.1006/jmbi.2001.4526; Pascall JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077782; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; RAYCHAUDHURI D, 1994, J BIOL CHEM, V269, P22941; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SATISHCHANDRAN C, 1992, BIOCHEMISTRY-US, V31, P11684, DOI 10.1021/bi00162a003; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Schmitz I, 2003, J IMMUNOL, V171, P2930, DOI 10.4049/jimmunol.171.6.2930; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Shiao YM, 2008, LUNG CANCER, V62, P287, DOI 10.1016/j.lungcan.2008.03.021; Stamm O, 2002, GENE, V282, P159, DOI 10.1016/S0378-1119(01)00837-X; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Sugimoto K, 1998, BLOOD, V91, P1407, DOI 10.1182/blood.V91.4.1407; Uno T, 2010, BIOL LETTERS, V6, P379, DOI 10.1098/rsbl.2009.0878; URITANI M, 1988, J BIOCHEM-TOKYO, V103, P522, DOI 10.1093/oxfordjournals.jbchem.a122302; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webb LMC, 2016, J IMMUNOL, V196, P207, DOI 10.4049/jimmunol.1501582; Weiss Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-400; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200; Zenz T, 2004, GENES IMMUN, V5, P109, DOI 10.1038/sj.gene.6364044	55	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9305	9319		10.1074/jbc.M116.768689	http://dx.doi.org/10.1074/jbc.M116.768689			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28381553	hybrid, Green Published			2022-12-28	WOS:000402538900025
J	Stopa, JD; Baker, KM; Grover, SP; Flaumenhaft, R; Furie, B				Stopa, Jack D.; Baker, Katherine M.; Grover, Steven P.; Flaumenhaft, Robert; Furie, Bruce			Kinetic-based trapping by intervening sequence variants of the active sites of protein-disulfide isomerase identifies platelet protein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; THROMBUS FORMATION; BOND FORMATION; CATHEPSIN-G; CATALYSIS; PEPTIDE; DOMAINS; FAMILY; RIBONUCLEASE; RESIDUES	Thiol isomerases such as protein-disulfide isomerase (PDI) direct disulfide rearrangements required for proper folding of nascent proteins synthesized in the endoplasmic reticulum. Identifying PDI substrates is challenging because PDI catalyzes conformational changes that cannot be easily monitored (e.g. compared with proteolytic cleavage or amino acid phosphorylation); PDI has multiple substrates; and it can catalyze either oxidation, reduction, or isomerization of substrates. Kinetic-based substrate trapping wherein the active site motif CGHC is modified to CGHA to stabilize a PDI-substrate intermediate is effective in identifying some substrates. A limitation of this approach, however, is that it captures only substrates that are reduced by PDI, whereas many substrates are oxidized by PDI. By manipulating the highly conserved-GH-residues in the CGHC active site of PDI, we created PDI variants with a slowed reaction rate toward substrates. The prolonged intermediate state allowed us to identify protein substrates that have biased affinities for either oxidation or reduction by PDI. Because extracellular PDI is critical for thrombus formation but its extracellular substrates are not known, we evaluated the ability of these bidirectional trapping PDI variants to trap proteins released from platelets and on the platelet surface. Trapped proteins were identified by mass spectroscopy. Of the trapped substrate proteins identified by mass spectroscopy, five proteins, cathepsin G, glutaredoxin-1, thioredoxin, GP1b, and fibrinogen, showed a bias for oxidation, whereas annexin V, heparanase, ERp57, kallekrein-14, serpin B6, tetranectin, and collagen VI showed a bias for reduction. These bidirectional trapping variants will enable more comprehensive identification of thiol isomerase substrates and better elucidation of their cellular functions.	Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Furie, B (corresponding author), Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Ctr Life Sci, CLS924,3 Blackfan Circle, Boston, MA 02215 USA.	bfurie@bidmc.harvard.edu		Grover, Steven/0000-0001-8709-8394	National Institutes of Health [U54HL112302, T32HL07917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135775, T32HL007917, R01HL136394, U54HL112302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants U54HL112302 and T32HL07917. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; CREIGHTON TE, 1993, CURR BIOL, V3, P790, DOI 10.1016/0960-9822(93)90034-L; DARBY NJ, 1994, BIOCHEMISTRY-US, V33, P7937, DOI 10.1021/bi00191a022; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, CURR BIOL, V8, pR468, DOI 10.1016/S0960-9822(98)70295-7; Furie B, 2014, CIRC RES, V114, P1162, DOI 10.1161/CIRCRESAHA.114.301808; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; GLEASON FK, 1992, PROTEIN SCI, V1, P609, DOI 10.1002/pro.5560010507; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hotchkiss KA, 1996, BIOCHEMISTRY-US, V35, P9761, DOI 10.1021/bi9603938; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; JOELSON T, 1990, J BIOL CHEM, V265, P3183; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; OHBA H, 1981, J BIOCHEM, V89, P889, DOI 10.1093/oxfordjournals.jbchem.a133272; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535	38	26	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9063	9074		10.1074/jbc.M116.771832	http://dx.doi.org/10.1074/jbc.M116.771832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28364042	hybrid, Green Published			2022-12-28	WOS:000402538900006
J	Singaravelu, P; Lee, WL; Wee, S; Ghoshdastider, U; Ding, K; Gunaratne, J; Grimes, JM; Swaminathan, K; Robinson, RC				Singaravelu, Pavithra; Lee, Wei Lin; Wee, Sheena; Ghoshdastider, Umesh; Ding, Ke; Gunaratne, Jayantha; Grimes, Jonathan M.; Swaminathan, Kunchithapadam; Robinson, Robert C.			Yersinia effector protein (YopO)-mediated phosphorylation of host gelsolin causes calcium-independent activation leading to disruption of actin dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; KINASE; YOPO; EVOLUTIONARY; MODULATION; MECHANISMS; NUCLEATION; FRAGMENT; COMPLEX; BINDING	Pathogenic Yersinia bacteria cause a range of human diseases. To modulate and evade host immune systems, these yersiniae inject effector proteins into host macrophages. One such protein, the serine/threonine kinase YopO (YpkA in Yersinia pestis), uses monomeric actin as bait to recruit and phosphorylate host actin polymerization-regulating proteins, including the actin-severing protein gelsolin, to disrupt actin filaments and thus impair phagocytosis. However, the YopO phosphorylation sites on gelsolin and the consequences of YopO-mediated phosphorylation on actin remodeling have yet to be established. Here we determined the effects of YopO-mediated phosphorylation on gelsolin and identified its phosphorylation sites by mass spectrometry. YopO phosphorylated gelsolin in the linker region between gelsolin homology domains G3 and G4, which, in the absence of calcium, are compacted but adopt an open conformation in the presence of calcium, enabling actin binding and severing. Using phosphomimetic and phospho-deletion gelsolin mutants, we found that YopO-mediated phosphorylation partially mimics calcium-dependent activation of gelsolin, potentially contributing to a reduction in filamentous actin and altered actin dynamics in phagocytic cells. In summary, this work represents the first report of the functional outcome of serine/threonine phosphorylation in gelsolin regulation and provides critical insight into how YopO disrupts normal gelsolin function to alter host actin dynamics and thus cripple phagocytosis.	[Singaravelu, Pavithra; Lee, Wei Lin; Wee, Sheena; Ghoshdastider, Umesh; Ding, Ke; Gunaratne, Jayantha; Grimes, Jonathan M.; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Grimes, Jonathan M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Grimes, Jonathan M.] Diamond Light Source Ltd, Diamond House,Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Singaravelu, Pavithra; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source; National University of Singapore	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Lee, WL (corresponding author), Singapore MIT Alliance Res & Technol, Singapore, Singapore.	dbsks@nus.edu.sg; weilin@smart.mit.edu	Ghoshdastider, Umesh/O-5327-2015; robinson, robert/G-9702-2011	Lee, Wei Lin/0000-0003-1048-7556; Grimes, Jonathan Mark/0000-0001-9698-0389; Ghoshdastider, Umesh/0000-0003-4471-9394; Wee, Sheena/0000-0003-2536-3433; Singaravelu, Pavithra/0000-0002-4799-807X; robinson, robert/0000-0001-6367-6903	Nanyang Technological University; Wellcome Trust [090532/Z/09/Z]	Nanyang Technological University(Nanyang Technological University); Wellcome Trust(Wellcome TrustEuropean Commission)	We acknowledge the Joint Centre for Structural Biology, Singapore, which is supported by Nanyang Technological University and the Biomedical Research Council of A*STAR, for providing research facilities. Wellcome Trust Centre for Human Genetics is supported by the Wellcome Trust Core award (090532/Z/09/Z).	Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Corte V, 1999, PROTEIN SCI, V8, P234; DeLano W.L, PYMOL MOL GRAPHICS S; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Heroven AK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00146; HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x; Huang BH, 2016, ONCOTARGET, V7, P25391, DOI 10.18632/oncotarget.8603; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lee WL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39998; Lee WL, 2015, NAT STRUCT MOL BIOL, V22, P248, DOI 10.1038/nsmb.2964; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Martin P, 2010, J BIOL CHEM, V285, P18918, DOI 10.1074/jbc.M109.056028; MAURY CPJ, 1991, J CLIN INVEST, V87, P1195, DOI 10.1172/JCI115118; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; Takiguchi K, 2000, CELL STRUCT FUNCT, V25, P57, DOI 10.1247/csf.25.57; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112	40	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8092	8100		10.1074/jbc.M116.757971	http://dx.doi.org/10.1074/jbc.M116.757971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28280241	hybrid, Green Published			2022-12-28	WOS:000401154100033
J	De Franceschi, G; Fecchio, C; Sharon, R; Schapira, AHV; Proukakis, C; Bellotti, V; de Laureto, PP				De Franceschi, Giorgia; Fecchio, Chiara; Sharon, Ronit; Schapira, Anthony H. V.; Proukakis, Christos; Bellotti, Vittorio; de laureto, Patrizia Polverino			alpha-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; PARKINSONS-DISEASE; METHIONINE OXIDATION; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; MEMBRANE-BINDING; IN-VITRO; MUTATION; MECHANISMS; PHOSPHOLIPIDS	alpha-Synuclein (aS) is a protein abundant in presynaptic nerve terminals in Parkinson disease (PD) and is a major component of intracellular Lewy bodies, the pathological hallmark of neurodegenerative disorders such as PD. Accordingly, the relationships between aS structure, its interaction with lipids, and its involvement in neurodegeneration have attracted great interest. Previously, we reported on the interaction of aS with brain polyunsaturated fatty acids, in particular docosahexaenoic acid (DHA). aS acquires an alpha-helical secondary structure in the presence of DHA and, in turn, affects DHA structural and aggregative properties. Moreover, aS forms a covalent adduct with DHA. Here, we provide evidence that His-50 is the main site of this covalent modification. To better understand the role of His-50, we analyzed the effect of DHA on aS-derived species: a naturally occurring variant, H50Q; an oxidized aS in which all methionines are sulfoxides (aS4ox); a fully lysine-alkylated aS (acetyl-aS); and aS fibrils, testing their ability to be chemically modified by DHA. We show, by mass spectrometry and spectroscopic techniques, that H50Q and aS4ox are modified by DHA, whereas acetyl-aS is not. We correlated this modification with aS structural features, and we suggest a possible functional role of aS in sequestering the early peroxidation products of fatty acids, thereby reducing the level of highly reactive lipid species. Finally, we show that fibrillar aS loses almost 80% of its scavenging activity, thus lacking a potentially protective function. Our findings linking aS scavenging activity with brain lipid composition suggest a possible etiological mechanism in some neurodegenerative disorders.	[De Franceschi, Giorgia; Fecchio, Chiara; de laureto, Patrizia Polverino] Univ Padua, Dept Pharmaceut Sci, CRIBI, Biotechnol Ctr, I-35121 Padua, Italy; [Sharon, Ronit] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, IMRIC, IL-9112102 Jerusalem, Israel; [Schapira, Anthony H. V.; Proukakis, Christos] UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England; [Bellotti, Vittorio] UCL, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, Div Med, London, England; [Bellotti, Vittorio] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy	University of Padua; Hebrew University of Jerusalem; University of London; University College London; University of London; University College London; University of Pavia	de Laureto, PP (corresponding author), Viale G Colombo 3, I-35131 Padua, Italy.	patrizia.polverinodelaureto@unipd.it	proukakis, christos/ABE-3447-2020; Schapira, Anthony H V/A-1245-2010; Bellotti, Vittorio/A-6201-2014	proukakis, christos/0000-0001-6423-6539; Schapira, Anthony H V/0000-0002-3018-3966; Bellotti, Vittorio/0000-0001-8678-662X	Progetti di Ateneo-University of Padova Grant [CPDA125928/12]; Cariplo Foundation [2013-0964]; United Kingdom Medical Research Council [MR/M006646/1]; NeuroMET; MRC [MR/M006646/1, MR/K000187/1] Funding Source: UKRI; Medical Research Council [MR/K000187/1, MR/M006646/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10237] Funding Source: researchfish	Progetti di Ateneo-University of Padova Grant; Cariplo Foundation(Fondazione Cariplo); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NeuroMET; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Progetti di Ateneo-University of Padova Grant CPDA125928/12, Cariplo Foundation Project 2013-0964, United Kingdom Medical Research Council Grant MR/M006646/1, and NeuroMET (to V.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Bae EJ, 2013, ANTIOXID REDOX SIGN, V18, P770, DOI 10.1089/ars.2011.4429; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Binolfi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10251; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chavarria C, 2013, ARCH BIOCHEM BIOPHYS, V533, P25, DOI 10.1016/j.abb.2013.02.009; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G., 2014, J CHROMATOGRAPH SEPA, V5, P219; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; Derogis PBMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077561; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fecchio C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082732; FRANKEL EN, 1984, PROG LIPID RES, V23, P197, DOI 10.1016/0163-7827(84)90011-0; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Galasko D, 2010, BIOMARK MED, V4, P27, DOI 10.2217/BMM.09.89; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; Means G. E., 1971, CHEM MODIFICATION PR, V2; Miyashita K, 2014, EUR J LIPID SCI TECH, V116, P1268, DOI 10.1002/ejlt.201400114; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Perez-De La Cruz V, 2009, BEHAV BRAIN RES, V199, P210, DOI 10.1016/j.bbr.2008.11.037; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porcari R, 2015, J BIOL CHEM, V290, P2395, DOI 10.1074/jbc.M114.610527; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; SUBCZYNSKI WK, 1983, BIOPHYS J, V41, P283, DOI 10.1016/S0006-3495(83)84439-7; Trostchansky A, 2006, BIOCHEM J, V393, P343, DOI 10.1042/BJ20051277; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Xiang W, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0004-0; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zarbiv Y, 2014, NEUROBIOL DIS, V70, P90, DOI 10.1016/j.nbd.2014.05.031; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2006, BIOCHEMISTRY-US, V45, P8135, DOI 10.1021/bi052584t	63	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6927	6937		10.1074/jbc.M116.765149	http://dx.doi.org/10.1074/jbc.M116.765149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28232489	Green Published, hybrid			2022-12-28	WOS:000400478300006
J	Jacobsen, SE; Ammendrup-Johnsen, I; Jansen, AM; Gether, U; Madsen, KL; Brauner-Osborne, H				Jacobsen, Stine Engesgaard; Ammendrup-Johnsen, Ina; Jansen, Anna Mai; Gether, Ulrik; Madsen, Kenneth Lindegaard; Brauner-Osborne, Hans			The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; CALCIUM-SENSING RECEPTOR; AMINO-ACID RECEPTOR; ALLOSTERIC ANTAGONISTS; LYSOSOMAL DEGRADATION; PEPTIDE-1 RECEPTOR; GABA(B) RECEPTORS; PLASMA-MEMBRANE; BETA-ARRESTINS	The class C G protein-coupled receptor GPRC6A is a putative nutrient-sensing receptor and represents a possible new drug target in metabolic disorders. However, the specific physiological role of this receptor has yet to be identified, and the mechanisms regulating its activity and cell surface availability also remain enigmatic. In the present study, we investigated the trafficking properties of GPRC6A by use of both a classical antibody feeding internalization assay in which cells were visualized using confocal microscopy and a novel internalization assay that is based on real-time measurements of fluorescence resonance energy transfer. Both assays revealed that GPRC6A predominantly undergoes constitutive internalization, whereas the agonist-induced effects were imperceptible. Moreover, postendocytic sorting was investigated by assessing the co-localization of internalized GPRC6A with selected Rab protein markers. Internalized GPRC6A was mainly co-localized with the early endosome marker Rab5 and the long loop recycling endosome marker Rab11 and to a much lesser extent with the late endosome marker Rab7. This suggests that upon agonist-independent internalization, GPRC6A is recycled via the Rab11-positive slow recycling pathway, which may be responsible for ensuring a persistent pool of GPRC6A receptors at the cell surface despite chronic agonist exposure. Distinct trafficking pathways have been reported for several of the class C receptors, and our results thus substantiate that non-canonical trafficking mechanisms are a common feature for the nutrient-sensing class C family that ensure functional receptors in the cell membrane despite prolonged agonist exposure.	[Jacobsen, Stine Engesgaard; Brauner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Ammendrup-Johnsen, Ina; Jansen, Anna Mai; Gether, Ulrik; Madsen, Kenneth Lindegaard] Univ Copenhagen, Fac Hlth & Med Sci, Lundbeck Fdn Ctr Biomembranes Nanomed, Mol Neuropharmacol Lab,Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark	University of Copenhagen; Lundbeckfonden; University of Copenhagen	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	hbo@sund.ku.dk	Madsen, Kenneth/C-7778-2012; Brauner-Osborne, Hans/D-7260-2011	Madsen, Kenneth/0000-0001-9274-6691; Gether, Ulrik/0000-0002-0020-3807; Brauner-Osborne, Hans/0000-0001-9495-7388	Lundbeck Foundation; Danish Council for Independent Research\Medical Sciences; Lundbeck Foundation [R126-2012-12484] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research\Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation and the Danish Council for Independent Research vertical bar Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Clemmensen C, 2013, PHYSIOL BEHAV, V118, P144, DOI 10.1016/j.physbeh.2013.05.015; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Gloriam DE, 2011, CHEM BIOL, V18, P1489, DOI 10.1016/j.chembiol.2011.09.012; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Johansson H, 2015, J MED CHEM, V58, P8938, DOI 10.1021/acs.jmedchem.5b01254; Jorgensen S, 2017, J BIOL CHEM, V292, P1524, DOI 10.1074/jbc.M116.756577; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Norskov-Lauritsen L, 2015, FEBS LETT, V589, P588, DOI 10.1016/j.febslet.2015.01.019; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2005, MOL ENDOCRINOL, V19, P1078, DOI 10.1210/me.2004-0450; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; Roed SN, 2015, J BIOL CHEM, V290, P1233, DOI 10.1074/jbc.M114.592436; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Rueda P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146846; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; THOMSEN C, 1994, J NEUROCHEM, V63, P2038; Tilakaratne N, 2005, CLIN EXP PHARMACOL P, V32, P979, DOI 10.1111/j.1440-1681.2005.04295.x; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Xiong XF, 2016, NAT CHEM, V8, P1035, DOI [10.1038/NCHEM.2577, 10.1038/nchem.2577]; Yao Y, 2003, J NEUROCHEM, V86, P947, DOI 10.1046/j.1471-4159.2003.01906.x; Zhang C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600241; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200; Zhuang XL, 2012, J BIOL CHEM, V287, P4165, DOI 10.1074/jbc.M111.271528	56	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6910	6926		10.1074/jbc.M116.762385	http://dx.doi.org/10.1074/jbc.M116.762385			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28280242	hybrid, Green Published			2022-12-28	WOS:000400478300005
J	Sengupta, S; Naz, S; Das, I; Ahad, A; Padhi, A; Naik, SK; Ganguli, G; Pattanaik, KP; Raghav, SK; Nandicoori, VK; Sonawane, A				Sengupta, Srabasti; Naz, Saba; Das, Ishani; Ahad, Abdul; Padhi, Avinash; Naik, Sumanta Kumar; Ganguli, Geetanjali; Pattanaik, Kali Prasad; Raghav, Sunil Kumar; Nandicoori, Vinay Kumar; Sonawane, Avinash			RETRACTED: Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages (Retracted article. See vol. 294, pg. 1632, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NITRIC-OXIDE; HISTONE MODIFICATIONS; ALVEOLAR MACROPHAGES; 19-KDA LIPOPROTEIN; BACILLARY SURVIVAL; OXIDATIVE STRESS; INTERFERON-GAMMA; GENE-EXPRESSION; DENDRITIC CELLS; REACTIVE OXYGEN	Mycobacterium tuberculosis is known to modulate the host immune responses to facilitate its persistence inside the host cells. One of the key mechanisms includes repression of class-II transactivator (CIITA) and MHC-II expression in infected macrophages. However, the precise mechanism of CIITA and MHC-II down-regulation is not well studied. M. tuberculosis 6-kDa early secretory antigenic target (ESAT-6) is a known potent virulence and antigenic determinant. The M. tuberculosis genome encodes 23 such ESAT-6 family proteins. We herein report that M. tuberculosis and M. bovis bacillus Calmette-Guerin infection down-regulated the expression of CIITA/MHC-II by inducing hypermethylation in histone H3 lysine 9 (H3K9me2/3). Further, we showed that M. tuberculosis ESAT-6 family protein EsxL, encoded by Rv1198, is responsible for the down-regulation of CIITA/MHC-II by inducing H3K9me2/3. We further report that M. tuberculosis esxL induced the expression of nitric-oxide synthase, NO production, and p38 MAPK pathway, which in turn was responsible for the increased H3K9me2/3 in CIITA via up-regulation of euchromatic histone-lysine N-methyltransferase 2 (G9a). In contrast, inhibition of nitric-oxide synthase, p38 MAPK, and G9a abrogated H3K9me2/3, resulting in increased CIITA expression. A chromatin immunoprecipitation assay confirmed that hypermethylation at the promoter IV region of CIITA is mainly responsible for CIITA down-regulation and subsequent antigen presentation. We found that co-culture of macrophages infected with esxL-expressing M. smegmatis and mouse splenocytes led to down-regulation of IL-2, a key cytokine involved in T-cell proliferation. In summary, we demonstrate that M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promoter, thereby repressing its expression through NO and p38 MAPK activation.	[Sengupta, Srabasti; Das, Ishani; Padhi, Avinash; Naik, Sumanta Kumar; Ganguli, Geetanjali; Pattanaik, Kali Prasad; Sonawane, Avinash] KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar 751024, Orissa, India; [Naz, Saba; Nandicoori, Vinay Kumar] Natl Inst Immunol, Delhi 110067, India; [Ahad, Abdul; Raghav, Sunil Kumar] Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India	Kalinga Institute of Industrial Technology (KIIT); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Sonawane, A (corresponding author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar 751024, Orissa, India.	asonawane@kiitbiotech.ac.in	Sonawane, Avinash/S-9889-2019; Raghav, Sunil/AAL-1121-2021	Nandicoori, Vinay/0000-0002-5682-4178	Indian Council of Medical Research (ICMR) [AMR/44/2011-ECD-I]; Department of Biotechnology, Government of India [BT/PR5790/MED/29/602/2012]; Department of Science and Technology, Government of India, DST-INSPIRE Fellowship [IF150081]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, DST-INSPIRE Fellowship	This work was supported by Indian Council of Medical Research (ICMR) Grant AMR/44/2011-ECD-I and Department of Biotechnology, Government of India, Grant BT/PR5790/MED/29/602/2012 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Department of Science and Technology, Government of India, DST-INSPIRE Fellowship IF150081.	Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393; Barros SP, 2014, PERIODONTOL 2000, V64, P95, DOI 10.1111/prd.12000; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bose M, 1999, INT J IMMUNOPATH PH, V12, P69; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Chumduri C, 2013, CELL HOST MICROBE, V13, P746, DOI 10.1016/j.chom.2013.05.010; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Esterhuyse MM, 2012, TRENDS MICROBIOL, V20, P220, DOI 10.1016/j.tim.2012.03.002; Firmani MA, 2002, J CLIN MICROBIOL, V40, P3162, DOI 10.1128/JCM.40.9.3162-3166.2002; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Geluk A, 2002, INFECT IMMUN, V70, P2544, DOI 10.1128/IAI.70.5.2544-2548.2002; Ghorpade DS, 2013, J BIOL CHEM, V288, P20592, DOI 10.1074/jbc.M113.472183; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kanangat S, 1999, INFECT IMMUN, V67, P2834, DOI 10.1128/IAI.67.6.2834-2840.1999; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Kumar P, 2012, IMMUNOL CELL BIOL, V90, P411, DOI 10.1038/icb.2011.54; Lamichhane G, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00176; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Marongiu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075684; Mohanty S, 2016, TUBERCULOSIS, V96, P44, DOI 10.1016/j.tube.2015.11.006; Mohanty S, 2015, J BIOL CHEM, V290, P13321, DOI 10.1074/jbc.M114.598482; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Padhi A, 2016, MICROBES INFECT, V18, P224, DOI 10.1016/j.micinf.2015.11.007; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pandey H, 2017, BBA-GEN SUBJECTS, V1861, P396, DOI 10.1016/j.bbagen.2016.10.013; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Rahman MA, 2015, J BIOL CHEM, V290, P14407, DOI 10.1074/jbc.M115.653600; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saini NK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-200; Schmeck B, 2005, J IMMUNOL, V175, P2843, DOI 10.4049/jimmunol.175.5.2843; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sethi D, 2016, J BIOL CHEM, V291, P2938, DOI 10.1074/jbc.M115.662593; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Siddle KJ, 2014, GENOME RES, V24, P850, DOI 10.1101/gr.161471.113; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh G, 2005, IMMUNOL LETT, V98, P180, DOI 10.1016/j.imlet.2004.11.011; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tiwari BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051686; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687; World Health Organisation, 2014, TUBERCULOSIS; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yaseen I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9922; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	78	12	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6855	6868		10.1074/jbc.M117.775205	http://dx.doi.org/10.1074/jbc.M117.775205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28209712	Green Published, hybrid			2022-12-28	WOS:000400478300001
J	Majkowska, I; Shitomi, Y; Ito, N; Gray, NS; Itoh, Y				Majkowska, Iwona; Shitomi, Yasuyuki; Ito, Noriko; Gray, Nathanael S.; Itoh, Yoshifumi			Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-A ACTIVATION; RHEUMATOID-ARTHRITIS; IMATINIB MESYLATE; MT1-MMP MMP-14; CELL-SURFACE; EXPRESSION; INHIBITION; MECHANISM; DDR2; METASTASIS	Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a membrane-bound MMP that is highly expressed in cells with invading capacity, including fibroblasts and invasive cancer cells. However, pathways of MT1-MMP up-regulation are not clearly understood. Apotential physiological stimulus for MT1MMPexpression is fibrillar collagen, and it has been shown that it up-regulates both MT1-MMP gene and functions in various cell types. However, the mechanisms of collagen-mediated MT1-MMP activation and its physiological relevance are not known. In this study, we identified discoidin domain receptor 2 (DDR2) as a crucial receptor that mediates this process in human fibroblasts. Knocking down DDR2, but not the 1 integrin subunit, a common subunit for all collagen-binding integrins, inhibited the collagen-induced MT1-MMP-dependent activation of pro-MMP-2 and up-regulation of MT1-MMP at the gene and protein levels. Interestingly, DDR2 knockdown or pharmacological inhibition of DDR2 also inhibited the MT1MMP- dependent cellular degradation of collagen film, suggesting that cell-surface collagen degradation by MT1-MMP involves DDR2-mediated collagen signaling. This DDR2-mediated mechanism is only present in non-transformed mesenchymal cells as collagen-induced MT1-MMP activation in HT1080 fibrosarcoma cells and MT1-MMP function in MDA-MB231 breast cancer cells were not affected by DDR kinase inhibition. DDR2activation was found to be noticeably more effective when cells were stimulated by collagen without the non-helical telopeptide region compared with intact collagen fibrils. Furthermore, DDR2-dependent MT1-MMP activation by cartilage was found to be more efficient when the tissue was partially damaged. These data suggest that DDR2 is a microenvironment sensor that regulates fibroblast migration in a collagen-rich environment.	[Majkowska, Iwona; Shitomi, Yasuyuki; Ito, Noriko; Itoh, Yoshifumi] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England; [Gray, Nathanael S.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02215 USA	University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Itoh, Y (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	yoshi.itoh@kennedy.ox.ac.uk		Itoh, Yoshifumi/0000-0002-2128-2823	Arthritis Research UK Program [19797]; Arthritis Research UK Centre for Osteoarthritis Pathogenesis [20205]; National Institutes of Health P01 Grant [CA154303-04]; Kennedy Trust for Rheumatology Research; MRC [G0802007] Funding Source: UKRI; Medical Research Council [G0802007] Funding Source: researchfish; Versus Arthritis [19797] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA154303] Funding Source: NIH RePORTER	Arthritis Research UK Program(Versus Arthritis); Arthritis Research UK Centre for Osteoarthritis Pathogenesis(Versus Arthritis); National Institutes of Health P01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kennedy Trust for Rheumatology Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Arthritis Research UK Program Grant 19797 (to Y. I.), Arthritis Research UK Centre for Osteoarthritis Pathogenesis Grant 20205 (Y. I.), National Institutes of Health P01 Grant CA154303-04 (to N. S. G.), and a Ph.D. studentship from the Kennedy Trust for Rheumatology Research (to I. M. and Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akashi N, 2011, MOD RHEUMATOL, V21, P267, DOI 10.1007/s10165-010-0392-5; Ando W, 2006, J BONE MINER METAB, V24, P274, DOI 10.1007/s00774-006-0684-1; AZZAM HS, 1992, CANCER RES, V52, P4540; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Evans Richard D., 2007, V135, P239; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Honda S, 2001, CLIN EXP IMMUNOL, V126, P131, DOI 10.1046/j.1365-2249.2001.01624.x; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Juin A, 2014, J CELL BIOL, V207, P517, DOI 10.1083/jcb.201404079; Kadono Y, 1998, BIOCHEM BIOPH RES CO, V251, P681, DOI 10.1006/bbrc.1998.9531; Kaneko K, 2016, ARTHRITIS RHEUMATOL, V68, P521, DOI 10.1002/art.39414; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Lafleur MA, 2006, J BIOL CHEM, V281, P6826, DOI 10.1074/jbc.M513084200; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765; Manning HB, 2013, MATRIX BIOL, V32, P32, DOI 10.1016/j.matbio.2012.11.012; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Morris EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08389; Nagase H., 2014, PROTEASES STRUCTURE, P433; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; Palmisano R, 2010, METHODS MOL BIOL, V622, P379, DOI 10.1007/978-1-60327-299-5_23; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Petrow PK, 2002, ANN RHEUM DIS, V61, P391, DOI 10.1136/ard.61.5.391; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2010, J IMMUNOL, V184, P6396, DOI 10.4049/jimmunol.0904068; Saby C, 2016, ONCOTARGET, V7, P24908, DOI 10.18632/oncotarget.8795; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200; Stanton H, 1998, J CELL SCI, V111, P2789; Swanson CD, 2009, NAT REV RHEUMATOL, V5, P317, DOI 10.1038/nrrheum.2009.82; Tomasek JJ, 1997, J BIOL CHEM, V272, P7482, DOI 10.1074/jbc.272.11.7482; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	50	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6633	6643		10.1074/jbc.M116.770057	http://dx.doi.org/10.1074/jbc.M116.770057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28270508	Green Published, hybrid			2022-12-28	WOS:000399813400016
J	Buchanan, PC; Boylan, KLM; Walcheck, B; Heinze, R; Geller, MA; Argenta, PA; Skubitz, APN				Buchanan, Petra C.; Boylan, Kristin L. M.; Walcheck, Bruce; Heinze, Rachel; Geller, Melissa A.; Argenta, Peter A.; Skubitz, Amy P. N.			Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERITONEAL MESOTHELIAL CELLS; GROWTH-FACTOR-RECEPTOR; FACTOR-ALPHA; LYSOPHOSPHATIDIC ACID; TNF-ALPHA; L-SELECTIN; EXPRESSION; CARCINOMA; FAMILY; MIGRATION	We previously showed that the cell adhesion molecule Nectin-4 is overexpressed in ovarian cancer tumors, and its cleaved extracellular domain can be detected in the serum of ovarian cancer patients. The ADAM ((a) under bar (d) under bar isintegrin (a) under bar nd (m) under bar etalloproteinase) proteases are involved in ectodomain cleavage of transmembrane proteins, and ADAM17 is known to cleave Nectin-4 in breast cancer. However, the mechanism of Nectin-4 cleavage in ovarian cancer has not yet been determined. Analysis of ovarian cancer gene microarray data showed that higher expression of Nectin-4, ADAM10, and ADAM17 is associated with significantly decreased progression-free survival. We quantified Nectin-4 shedding from the surface of ovarian cancer cells after stimulation with lysophosphatidic acid. We report that ADAM17 and ADAM10 cleave Nectin-4 and release soluble Nectin-4 (sN4). Small molecule inhibitors and siRNA knockdown of both ADAM proteases confirmed these results. In matched samples from 11 high-grade serous ovarian cancer patients, we detected 2-20-fold more sN4 in ascites fluid than serum. Co-incubation of ovarian cancer cells with ascites fluid significantly increased sN4 shedding, which could be blocked using a dual inhibitor of ADAM10 and ADAM17. Furthermore, we detected RNA for Nectin-4, ADAM10, and ADAM17 in primary ovarian carcinoma tumors, secondary omental metastases, and ascites cells isolated from serous ovarian cancer patients. In a signaling pathway screen, lysophosphatidic acid increased phosphorylation of AKT, EGF receptor, ERK1/2, JNK1/2/3, and c-Jun. Understanding the function of Nectin-4 shedding in ovarian cancer progression is critical to facilitate its development as both a serum biomarker and a therapeutic target for ovarian cancer.	[Buchanan, Petra C.; Boylan, Kristin L. M.; Walcheck, Bruce; Heinze, Rachel; Skubitz, Amy P. N.] Univ Minnesota, Dept Lab Med & Pathol, MMC 395,420 Delaware St,SE, Minneapolis, MN 55455 USA; [Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA; [Geller, Melissa A.; Argenta, Peter A.] Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Skubitz, APN (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, MMC 395,420 Delaware St,SE, Minneapolis, MN 55455 USA.	skubi002@umn.edu		Skubitz, Amy/0000-0003-4672-3450	Minnesota Ovarian Cancer Alliance; National Institutes of Health [R01 CA203348, P30 CA77598]; NATIONAL CANCER INSTITUTE [R01CA203348, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	Minnesota Ovarian Cancer Alliance; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funds from the Minnesota Ovarian Cancer Alliance (to A.P.N.S.), by National Institutes of Health Grant R01 CA203348 (to B.W.), and in part by National Institutes of Health Grant P30 CA77598 for use of the University of Minnesota Masonic Cancer Center's Flow Cytometry Shared Resource. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Boylan KLM, 2017, ONCOTARGET, V8, P9717, DOI 10.18632/oncotarget.14206; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cao LY, 2015, J OBSTET GYNAECOL RE, V41, P1951, DOI 10.1111/jog.12806; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Challita-Eid PM, 2016, CANCER RES, V76, P3003, DOI 10.1158/0008-5472.CAN-15-1313; DeRycke MS, 2010, AM J CLIN PATHOL, V134, P835, DOI 10.1309/AJCPGXK0FR4MHIHB; Dinh P, 2008, CRIT REV ONCOL HEMAT, V67, P103, DOI 10.1016/j.critrevonc.2008.01.012; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Georgiadis D, 2008, BIOORGAN MED CHEM, V16, P8781, DOI 10.1016/j.bmc.2008.08.058; Glaysher S, 2013, BRIT J CANCER, V109, P1786, DOI 10.1038/bjc.2013.529; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Haley J, 2016, ONCOTARGET, V7, P32810, DOI 10.18632/oncotarget.9053; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen Christian, 2003, Blood, V102, P1186; Hurst LA, 2012, NEUROSCI LETT, V521, P52, DOI 10.1016/j.neulet.2012.05.057; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jing YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121788; Kurita S, 2011, J BIOL CHEM, V286, P36297, DOI 10.1074/jbc.M111.261768; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lattanzio R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.32; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Matte I, 2015, INT J CANCER, V137, P289, DOI 10.1002/ijc.29385; McGowan PM, 2008, ANN ONCOL, V19, P1075, DOI 10.1093/annonc/mdm609; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Mishra HK, 2015, J LEUKOCYTE BIOL, V97, P447, DOI 10.1189/jlb.3HI0714-340R; Mullooly M, 2016, CANCER BIOL THER, V17, P870, DOI 10.1080/15384047.2016.1177684; Mullooly M, 2015, BRIT J CANCER, V113, P945, DOI 10.1038/bjc.2015.288; Nabih ES, 2014, BIOMARKERS, V19, P498, DOI 10.3109/1354750X.2014.940503; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nishiwada S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0144-7; Ogita H, 2008, INT REV CYTOL, V265, P1, DOI 10.1016/S0074-7696(07)65001-3; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Ott GR, 2008, BIOORG MED CHEM LETT, V18, P1577, DOI 10.1016/j.bmcl.2008.01.075; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Perets R, 2016, CANCER RES, V76, P10, DOI 10.1158/0008-5472.CAN-15-1382; Poersch A, 2016, J PROTEOMICS, V145, P226, DOI 10.1016/j.jprot.2016.05.005; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Pruessmeyer J, 2014, BLOOD, V123, P4077, DOI 10.1182/blood-2013-09-511543; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Sheppard GS, 1998, BIOORG MED CHEM LETT, V8, P3251, DOI 10.1016/S0960-894X(98)00597-6; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Takano A, 2009, CANCER RES, V69, P6694, DOI 10.1158/0008-5472.CAN-09-0016; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Wang Y, 2013, BBA-MOL CELL RES, V1833, P680, DOI 10.1016/j.bbamcr.2012.11.027; Wang Y, 2011, J BIOL CHEM, V286, P38980, DOI 10.1074/jbc.M111.277087; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Yuan S, 2013, ONCOL REP, V30, P1715, DOI 10.3892/or.2013.2650; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	68	36	36	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6339	6351		10.1074/jbc.M116.746859	http://dx.doi.org/10.1074/jbc.M116.746859			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28232483	Green Published, hybrid			2022-12-28	WOS:000399538700027
J	Sinha, I; Poonia, P; Sawhney, S; Natarajan, K				Sinha, Ishani; Poonia, Poonam; Sawhney, Sonal; Natarajan, Krishnamurthy			Functional specialization of two paralogous TAF12 variants by their selective association with SAGA and TFIID transcriptional regulatory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; PROTEIN-ASSOCIATED FACTORS; HISTONE-FOLD; ACTIVATION DOMAIN; COACTIVATOR; YEAST; BINDING; GENE; INTERACTS; EVOLUTION	TATA box-binding protein (TBP)-associated factors (TAFs), evolutionarily conserved from yeast to humans, play a central role during transcription initiation. A subset of TAF proteins is shared in transcription factor II D(TFIID) and SAGA transcription regulatory complexes. Although higher eukaryotes contain multiple TAF variants that specify tissue-and developmental stage-specific organization of TFIID or SAGA complexes, in unicellular genomes, however, each TAF is encoded by a single gene. Surprisingly, we found that the genome of Candida albicans, the predominant human fungal pathogen, contains two paralogous TAF12 genes, CaTAF12L and CaTAF12, encoding H2B-like histone- fold domain-containing variants. Of the available fungal genome sequences, only seven other closely related diploid pathogenic Candida genomes encode the two TAF12 paralogs. Using affinity purifications from C. albicans cell extracts, we demonstrate that CaTAF12L uniquely associates with the SAGA complex and CaTAF12 associates with the TFIID complex. We further show that CaTAF12, but not CaTAF12L, is essential for C. albicans growth. Conditional depletion of the two TAF12 variant proteins caused distinct cellular and colony phenotypes. Together our results define a specialized organization of the TAF12 variants and non-redundant roles for the two TAF12 variants in the unicellular C. albicans genome.	[Sinha, Ishani; Poonia, Poonam; Sawhney, Sonal; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Lab Eukaryot Gene Regulat, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Lab Eukaryot Gene Regulat, Sch Life Sci, New Delhi 110067, India.	nat0200@mail.jnu.ac.in	Kumar, Shambhu/O-7598-2017	Kumar, Shambhu/0000-0003-0567-3346; Kumar, Shambhu/0000-0003-1225-1790	Department of Biotechnology; DST-PURSE; UPE2; DST-FIST; UGC-NRC; Council of Scientific and Industrial Research, New Delhi; Indian Council for Medical Research, New Delhi	Department of Biotechnology; DST-PURSE; UPE2; DST-FIST(Department of Science & Technology (India)); UGC-NRC; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research, New Delhi(Indian Council of Agricultural Research (ICAR)Indian Council of Medical Research (ICMR))	This work was partially supported by a grant from the Department of Biotechnology and through the DST-PURSE and UPE2 grants, and departmental funding under DST-FIST and UGC-NRC grants. This work was also supported by junior and senior research fellowships from the Council of Scientific and Industrial Research, New Delhi (to I. S. and P. P.) and by a senior research fellowship from the Indian Council for Medical Research, New Delhi (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Apone LM, 1998, NATURE, V393, P114, DOI 10.1038/30097; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Lago C, 2004, GENE, V342, P231, DOI 10.1016/j.gene.2004.08.023; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Maguire SL, 2013, MOL BIOL EVOL, V30, P1281, DOI 10.1093/molbev/mst042; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mitsuzawa H, 2002, NUCLEIC ACIDS RES, V30, P1952, DOI 10.1093/nar/30.9.1952; Mitsuzawa H, 2001, J BIOL CHEM, V276, P17117, DOI 10.1074/jbc.M100248200; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Natarajan K, 1998, MOL CELL, V2, P683, DOI 10.1016/S1097-2765(00)80166-5; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Roberts SM, 1997, GENETICS, V147, P451; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wang PJ, 2002, HUM MOL GENET, V11, P2341, DOI 10.1093/hmg/11.19.2341; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weake VM, 2009, GENE DEV, V23, P2818, DOI 10.1101/gad.1846409; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005	56	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6047	6055		10.1074/jbc.C116.768549	http://dx.doi.org/10.1074/jbc.C116.768549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28275052	Green Published, hybrid			2022-12-28	WOS:000399538700003
J	Liu, YY; Han, X; Yuan, JT; Geng, TY; Chen, SH; Hu, XM; Cui, IH; Cui, HM				Liu, Yangyang; Han, Xiao; Yuan, Junting; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Isabelle H.; Cui, Hengmi			Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; gene knockout; gene silencing; long non-coding RNA (long ncRNA; lncRNA); polyadenylation	HUMAN GENOME; LOCUS; LNCRNA; CELLS; MICE; CAS9; DNA	The type II bacterial CRISPR/Cas9 system is a simple, convenient, and powerful tool for targeted gene editing. Here, we describe a CRISPR/Cas9-based approach for inserting a poly(A) transcriptional terminator into both alleles of a targeted gene to silence protein-coding and non-protein-coding genes, which often play key roles in gene regulation but are difficult to silence via insertion or deletion of short DNA fragments. The integration of 225 bp of bovine growth hormone poly(A) signals into either the first intron or the first exon or behind the promoter of target genes caused efficient termination of expression of PPP1R12C, NSUN2 (protein-coding genes), and MALAT1 (non-protein-coding gene). Both NeoR and PuroR were used as markers in the selection of clonal cell lines with biallelic integration of a poly(A) signal. Genotyping analysis indicated that the cell lines displayed the desired biallelic silencing after a brief selection period. These combined results indicate that this CRISPR/Cas9-based approach offers an easy, convenient, and efficient novel technique for gene silencing in cell lines, especially for those in which gene integration is difficult because of a low efficiency of homology-directed repair.	[Liu, Yangyang; Han, Xiao; Yuan, Junting; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Hengmi] Yangzhou Univ, Inst Epigenet & Epigen, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Yangyang; Han, Xiao; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Hengmi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Yuan, Junting] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Hengmi] Yangzhou Univ, Inst Comparat Med, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Hengmi] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Isabelle H.] New York Presbyterian Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Cui, HM (corresponding author), Yangzhou Univ, Inst Epigenet & Epigen, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China.	hmcui@yzu.edu.cn			National Key Research and Development Program in China [2016YFC1303604]; National Natural Science Foundation of China [81171965, 81372237, 91540117]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine)	National Key Research and Development Program in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine)	This work was supported by National Key Research and Development Program in China Grant 2016YFC1303604, National Natural Science Foundation of China Grants 81171965, 81372237, and 91540117, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine). The authors declare that they have no conflicts of interest with the contents of this article.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BATT DB, 1994, NUCLEIC ACIDS RES, V22, P2811, DOI 10.1093/nar/22.14.2811; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Jiang Q, 2014, RNA BIOL, V11, P1243, DOI 10.1080/15476286.2014.996067; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Ling H, 2015, ONCOGENE, V34, P5003, DOI 10.1038/onc.2014.456; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhuang CL, 2015, ONCOTARGET, V6, P41194, DOI 10.18632/oncotarget.5880	21	27	28	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5624	5633		10.1074/jbc.M116.769034	http://dx.doi.org/10.1074/jbc.M116.769034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196870	hybrid, Green Published			2022-12-28	WOS:000398813200001
J	Webb, S; Nagy, T; Moseley, H; Fried, M; Dutch, R				Webb, Stacy; Nagy, Tamas; Moseley, Hunter; Fried, Michael; Dutch, Rebecca			Hendra virus fusion protein transmembrane domain contributes to pre-fusion protein stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; fusion protein; membrane fusion; transmembrane domain; virus; paramyxovirus; pre-fusion conformation	MEMBRANE-SPANNING DOMAIN; PARAMYXOVIRUS-F PROTEIN; MOLECULAR-DYNAMICS; INFLUENZA-VIRUS; HELIX PACKING; CELL-FUSION; HIV-1; GP41; HEMAGGLUTININ; GLYCOPROTEIN	Enveloped viruses utilize fusion (F) proteins studding the surface of the virus to facilitate membrane fusion with a target cell membrane. Fusion of the viral envelope with a cellular membrane is required for release of viral genomic material, so the virus can ultimately reproduce and spread. To drive fusion, the F protein undergoes an irreversible conformational change, transitioning from a metastable pre-fusion conformation to a more thermodynamically stable post-fusion structure. Understanding the elements that control stability of the pre-fusion state and triggering to the post-fusion conformation is important for understanding F protein function. Mutations in F protein transmembrane (TM) domains implicated the TM domain in the fusion process, but the structural and molecular details in fusion remain unclear. Previously, analytical ultracentrifugation was utilized to demonstrate that isolated TM domains of Hendra virus F protein associate in a monomer-trimer equilibrium (Smith, E. C., Smith, S. E., Carter, J. R., Webb, S. R., Gibson, K. M., Hellman, L. M., Fried, M. G., and Dutch, R. E. (2013) J. Biol. Chem. 288, 35726-35735). To determine factors driving this association, 140 paramyxovirus F protein TM domain sequences were analyzed. A heptad repeat of -branched residues was found, and analysis of the Hendra virus F TM domain revealed a heptad repeat leucine-isoleucine zipper motif (LIZ). Replacement of the LIZ with alanine resulted in dramatically reduced TM-TM association. Mutation of the LIZ in the whole protein resulted in decreased protein stability, including pre-fusion conformation stability. Together, our data suggest that the heptad repeat LIZ contributed to TM-TM association and is important for F protein function and pre-fusion stability.	[Webb, Stacy; Nagy, Tamas; Moseley, Hunter; Fried, Michael; Dutch, Rebecca] Univ Kentucky, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA	University of Kentucky	Dutch, R (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	rdutc2@uky.edu		Moseley, Hunter/0000-0003-3995-5368; Fried, Michael/0000-0002-5393-2640	National Institutes of Health [R01 AI051517, F31AI120653, P30GM110787]; Direct For Biological Sciences [1419282] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI120653, R01AI051517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI051517, F31AI120653, and P30GM110787. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Aller P, 2006, J BIOMOL STRUCT DYN, V24, P209, DOI 10.1080/07391102.2006.10507114; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; Bublil EM, 2016, BIOCHEMISTRY-US, V55, P5520, DOI 10.1021/acs.biochem.6b00450; Carter JR, 2005, J VIROL, V79, P7922, DOI 10.1128/JVI.79.12.7922-7925.2005; Chan YP, 2012, J VIROL, V86, P11457, DOI 10.1128/JVI.01318-12; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Decock M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00107; Dev J, 2016, SCIENCE, V353, P172, DOI 10.1126/science.aaf7066; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farzan SF, 2011, J BIOL CHEM, V286, P37945, DOI 10.1074/jbc.M111.256248; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Gao GF, 2013, J BIOL CHEM, V288, P234, DOI 10.1074/jbc.M112.424432; Gravel KA, 2011, J VIROL, V85, P3486, DOI 10.1128/JVI.02308-10; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; Kajanajmudeen A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3138jc6; KEMBLE GW, 1993, J CELL BIOL, V122, P1253, DOI 10.1083/jcb.122.6.1253; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kim JH, 2009, BBA-BIOMEMBRANES, V1788, P1804, DOI 10.1016/j.bbamem.2009.06.011; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Miyauchi K, 2006, JPN J INFECT DIS, V59, P77; Miyauchi K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-95; Muhlebach MD, 2008, J VIROL, V82, P11437, DOI 10.1128/JVI.00779-08; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; PATERSON RG, 1984, P NATL ACAD SCI-BIOL, V81, P6706, DOI 10.1073/pnas.81.21.6706; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Popa A, 2012, J VIROL, V86, P3014, DOI 10.1128/JVI.05826-11; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Ruan WM, 2004, PROTEIN SCI, V13, P555, DOI 10.1110/ps.03357404; Sergel TA, 2000, J VIROL, V74, P5101, DOI 10.1128/JVI.74.11.5101-5107.2000; Smith EC, 2013, J BIOL CHEM, V288, P35726, DOI 10.1074/jbc.M113.514554; Smith EC, 2012, J VIROL, V86, P3003, DOI 10.1128/JVI.05762-11; Smith EC, 2010, J VIROL, V84, P10928, DOI 10.1128/JVI.01108-10; Victor BL, 2012, J CHEM INF MODEL, V52, P3001, DOI 10.1021/ci3003396; Vitu E, 2013, J MOL BIOL, V425, P2056, DOI 10.1016/j.jmb.2013.03.001; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Wong JJW, 2016, P NATL ACAD SCI USA, V113, P1056, DOI 10.1073/pnas.1523303113; Xu K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005322; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	53	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5685	5694		10.1074/jbc.M117.777235	http://dx.doi.org/10.1074/jbc.M117.777235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213515	Green Published, hybrid			2022-12-28	WOS:000398813200007
J	Wofford, JD; Chakrabarti, M; Lindahl, PA				Wofford, Joshua D.; Chakrabarti, Mrinmoy; Lindahl, Paul A.			Mossbauer Spectra of Mouse Hearts Reveal Age-dependent Changes in Mitochondrial and Ferritin Iron Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALASSEMIA HEMOGLOBIN-E; HUMAN JURKAT CELLS; FRIEDREICHS-ATAXIA; BETA-THALASSEMIA; ENERGY-METABOLISM; MODEL; MICE; CARDIOMYOPATHY; PROTEINS; OVERLOAD	Cardiac function requires continuous high levels of energy, and so iron, a critical player in mitochondrial respiration, is an important component of the heart. Hearts from Fe-57-enriched mice were evaluated by Mossbauer spectroscopy. Spectra consisted of a sextet and two quadrupole doublets. One doublet was due to residual blood, whereas the other was due to [Fe4S4](2+) clusters and low-spin FeII hemes, most of which were associated with mitochondrial respiration. The sextet was due to ferritin; there was no evidence of hemosiderin, a ferritin decomposition product. Iron from ferritin was nearly absent in young hearts, but increased steadily with age. EPR spectra exhibited signals similar to those of brain, liver, and human cells. No age-dependent EPR trends were apparent. Hearts from HFE-/- mice with hemochromatosis contained slightly more iron overall than controls, including more ferritin and less mitochondrial iron; these differences typify slightly older hearts, perhaps reflecting the burden due to this disease. HFE-/- livers were overloaded with ferritin but had low mitochondrial iron levels. IRP2(-/-) hearts contained less ferritin than controls but normal levels of mitochondrial iron. Hearts of young mice born to an iron-deficient mother contained normal levels of mitochondrial iron and no ferritin; the heart from the mother contained low ferritin and normal levels of mitochondrial iron. High-spin FeII ions were nearly undetectable in heart samples; these were evident in brains, livers, and human cells. Previous Mossbauer spectra of unenriched diseased human hearts lacked mitochondrial and blood doublets and included hemosiderin features. This suggests degradation of iron-containing species during sample preparation.	[Wofford, Joshua D.; Chakrabarti, Mrinmoy; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chakrabarti, Mrinmoy] 221st River St, Hoboken, NJ 07030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Lindahl, PA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu			National Institutes of Health [GM084266]; Robert A. Welch Foundation [A1170]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084266 (for the non-vertebrate animal portion) and Robert A. Welch Foundation Grant A1170. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad S, 2013, INT J CLIN EXP PATHO, V6, P622; BELL SH, 1984, BIOCHIM BIOPHYS ACTA, V787, P227, DOI 10.1016/0167-4838(84)90313-3; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; Chakrabarti M., 2014, IRON SULFUR CLUSTERS, P49; Chakrabarti M, 2015, J BIOL CHEM, V290, P520, DOI 10.1074/jbc.M114.606731; Chakrabarti M, 2015, METALLOMICS, V7, P88, DOI 10.1039/c4mt00215f; Chua-anusorn W, 2000, INORG CHIM ACTA, V300, P932, DOI 10.1016/S0020-1693(00)00006-2; CHUAANUSORN W, 1994, HYPERFINE INTERACT, V91, P905, DOI 10.1007/BF02064626; Elas M, 2008, FREE RADICAL BIO MED, V45, P321, DOI 10.1016/j.freeradbiomed.2008.04.016; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gutierrez L, 2009, BBA-MOL BASIS DIS, V1792, P541, DOI 10.1016/j.bbadis.2009.03.007; Holmes-Hampton GP, 2012, METALLOMICS, V4, P761, DOI 10.1039/c2mt20086d; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Jhurry ND, 2013, BIOCHEMISTRY-US, V52, P7926, DOI 10.1021/bi401015t; Jhurry ND, 2012, BIOCHEMISTRY-US, V51, P5276, DOI 10.1021/bi300382d; KAUFMAN KS, 1980, BIOCHIM BIOPHYS ACTA, V629, P522, DOI 10.1016/0304-4165(80)90157-9; Kistler M, 2014, EXP HEMATOL, V42, P59, DOI 10.1016/j.exphem.2013.08.007; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Neves JV, 2010, AM J PHYSIOL-GASTR L, V298, pG525, DOI 10.1152/ajpgi.00449.2009; Omiya S, 2009, J MOL CELL CARDIOL, V46, P59, DOI 10.1016/j.yjmcc.2008.09.714; Payne RM, 2011, PROG PEDIATR CARDIOL, V31, P103, DOI 10.1016/j.ppedcard.2011.02.007; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Sanchis-Gomar F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.33; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; STPIERRE TG, 1992, HYPERFINE INTERACT, V71, P1279, DOI 10.1007/BF02397317; STPIERRE TG, 1991, BIOL MET, V4, P162, DOI 10.1007/BF01141308; Subramaniam VN, 2012, AM J PATHOL, V181, P1173, DOI 10.1016/j.ajpath.2012.06.025; Sutak R, 2008, PROTEOMICS, V8, P1731, DOI 10.1002/pmic.200701049; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Webb J, 1999, COORDIN CHEM REV, V190, P1199, DOI 10.1016/S0010-8545(99)00176-9; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124; Zhao N, 2010, CELL PHYSIOL BIOCHEM, V25, P587, DOI 10.1159/000315077; Zumbrennen-Bullough KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098072	43	16	16	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5546	5554		10.1074/jbc.M117.777201	http://dx.doi.org/10.1074/jbc.M117.777201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202542	hybrid, Green Published			2022-12-28	WOS:000397875500033
J	Bender, KW; Blackburn, RK; Monaghan, J; Derbyshire, P; Menke, FLH; Zipfel, C; Goshe, MB; Zielinski, RE; Huber, SC				Bender, Kyle W.; Blackburn, R. Kevin; Monaghan, Jacqueline; Derbyshire, Paul; Menke, Frank L. H.; Zipfel, Cyril; Goshe, Michael B.; Zielinski, Raymond E.; Huber, Steven C.			Autophosphorylation-based Calcium (Ca2(+)) Sensitivity Priming and Ca2(+)/Calmodulin Inhibition of Arabidopsis thaliana Ca2(+)-dependent Protein Kinase 28 (CPK28)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; RECEPTOR-LIKE KINASE; SIGNALING NETWORK; BINDING; CDPK; ACTIVATION; CA2+; SPECIFICITY; PROVIDES; BIK1	Plant calcium (Ca2(+))-dependent protein kinases (CPKs) represent the primary Ca2(+) -dependent protein kinase activities in plant systems. CPKs are composed of a dual specificity (Ser/Thr and Tyr) kinase domain tethered to a calmodulin-like domain (CLD) via an autoinhibitory junction (J). Although regulation of CPKs by Ca2(+)has been extensively studied, the contribution of autophosphorylation in controlling CPK activity is less well understood. Furthermore, whether calmodulin (CaM) contributes to CPK regulation, as is the case for Ca2(+) /CaM-dependent protein kinases outside the plant lineage, remains an open question. We therefore screened a subset of plant CPKs for CaM binding and found that CPK28 is a high affinity Ca2(+)/CaM-binding protein. Using synthetic peptides and native gel electrophoresis, we coarsely mapped the CaM-binding domain to a site within the CPK28 J domain that overlaps with the known site of intramolecular interaction between the J domain and the CLD. Peptide kinase activity of fully dephosphorylated CPK28 was Ca2(+)-responsive and was inhibited by Ca2(+)/CaM. Using in situ autophosphorylated protein, we expand on the known set of CPK28 autophosphorylation sites, and we demonstrate that, unexpectedly, autophosphorylated CPK28 had enhanced kinase activity at physiological concentrations of Ca2(+)compared with the dephosphorylated protein, suggesting that autophosphorylation functions to prime CPK28 for Ca2(+) activation and might also allow CPK28 to remain active when Ca2(+) levels are low. Furthermore, CPK28 autophosphorylation substantially reduced sensitivity of the kinase to Ca2(+) /CaM inhibition. Overall, our analyses uncover new complexities in the control of CPK28 and provide mechanistic support for Ca2(+) signaling specificity through Ca2(+) sensor priming.	[Bender, Kyle W.; Zielinski, Raymond E.; Huber, Steven C.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Blackburn, R. Kevin; Goshe, Michael B.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Monaghan, Jacqueline; Derbyshire, Paul; Menke, Frank L. H.; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Huber, Steven C.] Agr Res Serv, United States Dept Agr Agr, Urbana, IL 61801 USA; [Monaghan, Jacqueline] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; North Carolina State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA); Queens University - Canada	Bender, KW; Zielinski, RE (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	kwbender@illinois.edu; rez@illinois.edu	Bender, Kyle W/V-4678-2017; ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021; Bender, Kyle/AAJ-5993-2020; Menke, Frank/F-2739-2014	Bender, Kyle W/0000-0002-1805-8097; ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583; Bender, Kyle/0000-0002-1805-8097; Menke, Frank/0000-0003-2490-4824; Zielinski, Ray/0000-0003-0324-7407	National Science Foundation-IOS Grant [1354094]; National Science Foundation Grant [DBI-1126244]; North Carolina Agricultural Research Service; European Molecular Biology Organization and Anniversary Future Leader Fellowship from the United Kingdom Biotechnology and Biological Sciences Research Council [BB/M013499]; Gatsby Charitable Foundation; European Research Council Grant "PHOSPHinnATE"; United States Department of Agriculture-Agricultural Research Service; Direct For Biological Sciences [1354094] Funding Source: National Science Foundation; BBSRC [BBS/E/J/000PR9796, BB/M013499/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9796, BB/M013499/1] Funding Source: researchfish	National Science Foundation-IOS Grant; National Science Foundation Grant(National Science Foundation (NSF)); North Carolina Agricultural Research Service; European Molecular Biology Organization and Anniversary Future Leader Fellowship from the United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; European Research Council Grant "PHOSPHinnATE"; United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Science Foundation-IOS Grant 1354094 (to S.C.H. and R.E.Z.), National Science Foundation Grant DBI-1126244, the North Carolina Agricultural Research Service (to M.B.G. and R.K.B.), European Molecular Biology Organization and Anniversary Future Leader Fellowship BB/M013499 from the United Kingdom Biotechnology and Biological Sciences Research Council (to J.M.), the Gatsby Charitable Foundation (to C.Z. and F.L.H.M.), European Research Council Grant "PHOSPHinnATE") (to C.Z.), and the United States Department of Agriculture-Agricultural Research Service (to S.C.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Bender KW, 2015, BIOCHEM J, V467, P399, DOI 10.1042/BJ20141403; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Boudsocq M, 2012, BIOCHEM J, V447, P291, DOI 10.1042/BJ20112072; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Charpenteau M, 2004, BIOCHEM J, V379, P841, DOI 10.1042/BJ20031045; Chaudhuri S, 1999, PLANT PHYSIOL, V120, P859, DOI 10.1104/pp.120.3.859; Chehab EW, 2004, PLANT PHYSIOL, V135, P1430, DOI 10.1104/pp.103.035238; Chen ZH, 2010, PLANT J, V61, P816, DOI 10.1111/j.1365-313X.2009.04108.x; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, FEBS LETT, V584, P4717, DOI 10.1016/j.febslet.2010.10.059; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Ingram JR, 2015, P NATL ACAD SCI USA, V112, pE4975, DOI 10.1073/pnas.1505914112; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Ito T, 2010, PLANT CELL, V22, P1592, DOI 10.1105/tpc.109.073577; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kim HS, 2009, FEBS LETT, V583, P36, DOI 10.1016/j.febslet.2008.11.046; Laanemets K, 2013, PLANT PHYSIOL, V163, P504, DOI 10.1104/pp.113.220343; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Matschi S, 2013, PLANT J, V73, P883, DOI 10.1111/tpj.12090; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Monaghan J, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1018497; Monaghan J, 2014, CELL HOST MICROBE, V16, P605, DOI 10.1016/j.chom.2014.10.007; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Oh MH, 2012, BIOCHEM J, V443, P515, DOI 10.1042/BJ20111871; ONEIL KT, 1987, SCIENCE, V236, P1454, DOI 10.1126/science.3589665; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; SAHA P, 1995, BIOCHEM J, V305, P205, DOI 10.1042/bj3050205; Swatek KN, 2014, BIOCHEM J, V459, P15, DOI 10.1042/BJ20130035; Tse JKY, 2007, BIOCHEMISTRY-US, V46, P4017, DOI 10.1021/bi700013y; Wang Y, 2004, BIOCHEM J, V383, P73, DOI 10.1042/BJ20031907; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Zhang XRS, 2001, J MOL EVOL, V53, P214, DOI 10.1007/s002390010211; Zielinski Raymond E, 2002, Methods Mol Biol, V172, P143; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	46	28	28	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3988	4002		10.1074/jbc.M116.763243	http://dx.doi.org/10.1074/jbc.M116.763243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154194	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000395837100004
J	Salehi-Najafabadi, Z; Li, B; Valentino, V; Ng, C; Martin, H; Yu, Y; Wang, ZF; Kashyap, P; Yu, Y				Salehi-Najafabadi, Zahra; Li, Bin; Valentino, Victoria; Ng, Courtney; Martin, Hannah; Yu, Yang; Wang, Zhifei; Kashyap, Parul; Yu, Yong			Extracellular Loops Are Essential for the Assembly and Function of Polycystin Receptor-Ion Channel Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; TRANSIENT RECEPTOR; DOMAIN; IDENTIFICATION; PKD2L1; PKD1L3; GENE; PROTEIN; OLIGOMERIZATION; LOCALIZATION	Polycystin complexes, or TRPP-PKD complexes, made of transient receptor potential channel polycystin (TRPP) and polycystic kidney disease (PKD) proteins, play key roles in coupling extracellular stimuli with intracellular Ca2+ signals. For example, the TRPP2-PKD1 complex has a crucial function in renal physiology, with mutations in either protein causing autosomal dominant polycystic kidney disease. In contrast, the TRPP3-PKD1L3 complex responds to lowpHand was proposed to be a sour taste receptor candidate. It has been shown previously that the protein partners interact via association of the C-terminal or transmembrane segments, with consequences for the assembly, surface expression, and function of the polycystin complexes. However, the roles of extracellular components, especially the loops that connect the transmembrane segments, in the assembly and function of the polycystin complex are largely unknown. Here, with an immunoprecipitation method, we found that extracellular loops between the first and second transmembrane segments of TRPP2 and TRPP3 associate with the extracellular loops between the sixth and seventh transmembrane segments ofPKD1and PKD1L3, respectively. Immunofluorescence and electrophysiology data further confirm that the associations between these loops are essential for the trafficking and function of the complexes. Interestingly, most of the extracellular loops are also found to be involved in homomeric assembly. Furthermore, autosomal dominant polycystic kidney disease-associated TRPP2 mutant T448K significantly weakened TRPP2 homomeric assembly but had no obvious effect on TRPP2-PKD1 heteromeric assembly. Our results demonstrate a crucial role of these functionally underexplored extracellular loops in the assembly and function of the polycystin complexes.	[Salehi-Najafabadi, Zahra; Li, Bin; Valentino, Victoria; Ng, Courtney; Martin, Hannah; Yu, Yang; Wang, Zhifei; Kashyap, Parul; Yu, Yong] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA	Saint John's University	Yu, Y (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	yuy2@stjohns.edu	Wang, Zhifei/AAN-2553-2021; Salehi Najafabadi, Zahra/C-6795-2017	Yu, Yong/0000-0002-1849-0779; Salehi Najafabadi, Zahra/0000-0002-0658-9966; Martin, Hannah/0000-0003-2028-5798	National Institutes of Health Grant [DK102092]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK102092] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK102092 (to Yong Yu). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cai YQ, 2014, J CLIN INVEST, V124, P5129, DOI 10.1172/JCI67273; Chapin HC, 2010, MOL BIOL CELL, V21, P4338, DOI 10.1091/mbc.E10-05-0407; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Grieben M, 2017, NAT STRUCT MOL BIOL, V24, P114, DOI 10.1038/nsmb.3343; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lam C, 2014, METHODS MOL BIOL, V1172, P193, DOI 10.1007/978-1-4939-0928-5_17; Li AR, 2003, GENOMICS, V81, P596, DOI 10.1016/S0888-7543(03)00048-X; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Molland KL, 2012, BBA-PROTEINS PROTEOM, V1824, P413, DOI 10.1016/j.bbapap.2011.12.002; Molland KL, 2010, BIOCHEM J, V429, P171, DOI 10.1042/BJ20091843; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Oatley P, 2012, BIOCHEMISTRY-US, V51, P2879, DOI 10.1021/bi300134b; Pavel MA, 2016, P NATL ACAD SCI USA, V113, pE2363, DOI 10.1073/pnas.1517066113; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Semmo M, 2014, HANDB EXP PHARMACOL, V222, P675, DOI 10.1007/978-3-642-54215-2_27; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Veldhuisen B, 1999, EUR J HUM GENET, V7, P860, DOI 10.1038/sj.ejhg.5200383; Wilkes M, 2017, NAT STRUCT MOL BIOL, V24, P123, DOI 10.1038/nsmb.3357; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Yang YF, 2015, J BIOL CHEM, V290, P10544, DOI 10.1074/jbc.M115.641803; Yu Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2257; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zheng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09460; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Zhu J, 2011, P NATL ACAD SCI USA, V108, P10133, DOI 10.1073/pnas.1017669108	49	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4210	4221		10.1074/jbc.M116.767897	http://dx.doi.org/10.1074/jbc.M116.767897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154010	Green Published, hybrid			2022-12-28	WOS:000395837100019
J	Sundermeier, TR; Sakami, S; Sahu, B; Howell, SJ; Gao, SQ; Dong, ZQ; Golczak, M; Maeda, A; Palczewski, K				Sundermeier, Thomas R.; Sakami, Sanae; Sahu, Bhubanananda; Howell, Scott J.; Gao, Songqi; Dong, Zhiqian; Golczak, Marcin; Maeda, Akiko; Palczewski, Krzysztof			MicroRNA-processing Enzymes Are Essential for Survival and Function of Mature Retinal Pigmented Epithelial Cells in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eye; retina; retinal degeneration; retinal metabolism; vision; ret; retina; retina metabolism	MACULAR DEGENERATION; NLRP3 INFLAMMASOME; ALU RNA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MOUSE MODEL; C-ELEGANS; MIRNAS; ROD; PHOTORECEPTORS	Age-related macular degeneration (AMD) is a major cause of irreversible vision loss. The neovascular or wet form of AMD can be treated to varying degrees with anti-angiogenic drugs, but geographic atrophy (GA) is an advanced stage of the more prevalent dry form of AMD for which there is no effective treatment. Development of GA has been linked to loss of the microRNA (miRNA)-processing enzyme DICER1 in the mature retinal pigmented epithelium (RPE). This loss results in the accumulation of toxic transcripts of Alu transposable elements, which activate the NLRP3 inflammasome and additional downstream pathways that compromise the integrity and function of the RPE. However, it remains unclear whether the loss of miRNA processing and subsequent gene regulation in the RPE due to DICER1 deficiency also contributes to RPE cell death. To clarify the role of miRNAs in RPE cells, we used two different mature RPE cell-specific Cre recombinase drivers to inactivate either Dicer1 or DiGeorge syndrome critical region 8 (Dgcr8), thus removing RPE miRNA regulatory activity in mice by disrupting two independent and essential steps of miRNA biogenesis. In contrast with prior studies, we found that the loss of each factor independently led to strikingly similar defects in the survival and function of the RPE and retina. These results suggest that the loss of miRNAs also contributes to RPE cell death and loss of visual function and could affect the pathology of dry AMD.	[Sundermeier, Thomas R.; Sakami, Sanae; Gao, Songqi; Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Sahu, Bhubanananda; Howell, Scott J.; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Dong, Zhiqian] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu		Imanishi, Sanae/0000-0001-9884-2123; DONG, ZHIQIAN/0000-0002-8748-4532	National Institutes of Health [EY022326, EY R24024864, EY022658, EY023948, P30EY011373]; Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY023948, P30EY011373, R01EY022326, R01EY022658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by National Institutes of Health Grants EY022326 and EY R24024864 (to K.P.), EY022658 (to A. M.), EY023948 (to M. G.), and P30EY011373 (from the VSRC CORE grant). This work was also supported by the Arnold and Mabel Beckman Foundation and the Foundation Fighting Blindness. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Cheung LK, 2013, PHARMACOTHERAPY, V33, P838, DOI 10.1002/phar.1264; Dai XD, 2015, PIGM CELL MELANOMA R, V28, P217, DOI 10.1111/pcmr.12334; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dynoodt P, 2013, J INVEST DERMATOL, V133, P201, DOI 10.1038/jid.2012.266; Emde A, 2014, EMBO J, V33, P1428, DOI 10.15252/embj.201488142; Fabian MR, 2010, PROG MOL SUBCELL BIO, V50, P1, DOI 10.1007/978-3-642-03103-8_1; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Gelfand BD, 2015, CELL REP, V11, P1686, DOI 10.1016/j.celrep.2015.05.023; Golczak M, 2010, METHODS MOL BIOL, V652, P229, DOI 10.1007/978-1-60327-325-1_13; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Jian Q, 2014, MOL CELL BIOL, V34, P3407, DOI 10.1128/MCB.00106-14; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Kleinman ME, 2016, DEV OPHTHALMOL, V55, P46, DOI 10.1159/000431141; Krol J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8305; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Mione M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12346; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Ohana R, 2015, DEVELOPMENT, V142, P2487, DOI 10.1242/dev.121533; Peden MC, 2015, OPHTHALMOLOGY, V122, P803, DOI 10.1016/j.ophtha.2014.11.018; Pelaez N, 2012, CURR TOP DEV BIOL, V99, P237, DOI 10.1016/B978-0-12-387038-4.00009-4; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; ROBISON WG, 1977, INVEST OPHTH VIS SCI, V16, P1110; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sethna Saumil, 2013, Methods Mol Biol, V935, P245, DOI 10.1007/978-1-62703-080-9_17; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sundermeier TR, 2016, FASEB J, V30, P23, DOI 10.1096/fj.15-279745; Sundermeier TR, 2014, FASEB J, V28, P3780, DOI 10.1096/fj.14-254292; Tajaddod M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1083-0; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yaqoob Zahid, 2005, Biotechniques, V39, pS6, DOI 10.2144/000112090; Yazdi MH, 2015, EXPERT OPIN BIOL TH, V15, P1349, DOI 10.1517/14712598.2015.1057565; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028	56	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3366	3378		10.1074/jbc.M116.770024	http://dx.doi.org/10.1074/jbc.M116.770024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28104803	Green Published, hybrid			2022-12-28	WOS:000395538800026
J	Lin, QH; Parker, MJ; Taguchi, AT; Ravichandran, K; Kim, A; Kang, G; Shao, JM; Drennan, CL; Stubbe, J				Lin, Qinghui; Parker, Mackenzie J.; Taguchi, Alexander T.; Ravichandran, Kanchana; Kim, Albert; Kang, Gyunghoon; Shao, Jimin; Drennan, Catherine L.; Stubbe, JoAnne			Glutamate 52-beta at the alpha/beta subunit interface of Escherichia coli class Ia ribonucleotide reductase is essential for conformational gating of radical transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; SITE-SPECIFIC INCORPORATION; 2-AZIDO-2-DEOXYURIDINE 5-DIPHOSPHATE; DIPHOSPHATE REDUCTASE; PROPAGATION PATHWAY; CATALYTIC-ACTIVITY; KINETIC-ANALYSIS; PROTEIN; INTERMEDIATE; INHIBITION	Ribonucleotide reductases (RNRs) catalyze the conversion of nucleoside diphosphate substrates (S) to deoxynucleotides with allosteric effectors (e) controlling their relative ratios and amounts, crucial for fidelity of DNA replication and repair. Escherichia coli class Ia RNR is composed of alpha and beta subunits that form a transient, active alpha 2 beta 2 complex. The E. coli RNR is rate- limited by S/e- dependent conformational change(s) that trigger the radical initiation step through a pathway of 35 angstrom across the subunit (alpha/beta) interface. The weak subunit affinity and complex nucleotide- dependent quaternary structures have precluded a molecular understanding of the kinetic gating mechanism( s) of the RNR machinery. Using a docking model of alpha 2 beta 2 created from X- ray structures of alpha and beta and conserved residues from a new subclassification of the E. coli Ia RNR (Iag), we identified and investigated four residues at the alpha/beta interface (Glu(350) and Glu(52) in beta 2 and Arg(329) and Arg(639) in alpha 2) of potential interest in kinetic gating. Mutation of each residue resulted in loss of activity and with the exception of E52Q-beta 2, weakened subunit affinity. An RNR mutant with 2,3,5- trifluorotyrosine radical (F3Y122 center dot) replacing the stable Tyr122(center dot) in WT-beta 2, a mutation that partly overcomes conformational gating, was placed in the E52Q background. Incubation of this double mutant with His(6)-alpha 2/S/e resulted in anRNRcapable of catalyzing pathway- radical formation (Tyr(356 center dot) -beta 2), 0.5 eq of dCDP/F3Y122 center dot, and formation of an alpha 2 beta 2 complex that is isolable in pulldown assays over 2 h. Negative stainEMimages with S/e (GDP/TTP) revealed the uniformity of the alpha 2 beta 2 complex formed.	[Lin, Qinghui; Shao, Jimin] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Parker, Mackenzie J.; Taguchi, Alexander T.; Ravichandran, Kanchana; Kim, Albert; Kang, Gyunghoon; Drennan, Catherine L.; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.; Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Zhejiang University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Stubbe, J (corresponding author), 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu; stubbe@mit.edu			National Institutes of Health [GM29595]; National Natural Science Foundation of China [81372138]; Foundation of Zhejiang University for International Cooperation and Exchanges; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Zhejiang University for International Cooperation and Exchanges; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29595 (to J.S.), National Natural Science Foundation of China Grant 81372138 and Foundation of Zhejiang University for International Cooperation and Exchanges (to J.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando N, 2016, BIOCHEMISTRY-US, V55, P373, DOI 10.1021/acs.biochem.5b01207; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; CLIMENT I, 1991, BIOCHEMISTRY-US, V30, P5164, DOI 10.1021/bi00235a008; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; DOBELN UV, 1976, J BIOL CHEM, V251, P3616; Ekberg M, 1998, J BIOL CHEM, V273, P21003, DOI 10.1074/jbc.273.33.21003; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Hassan AQ, 2008, BIOORG MED CHEM LETT, V18, P5923, DOI 10.1016/j.bmcl.2008.08.048; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110; Minnihan EC, 2011, J AM CHEM SOC, V133, P15942, DOI 10.1021/ja207719f; Minnihan EC, 2011, J AM CHEM SOC, V133, P9430, DOI 10.1021/ja201640n; Nick TU, 2015, J AM CHEM SOC, V137, P289, DOI 10.1021/ja510513z; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Persson AL, 1997, J BIOL CHEM, V272, P31533, DOI 10.1074/jbc.272.50.31533; Ravichandran K. R., 2016, THESIS; Ravichandran K, 2017, BIOCHEMISTRY-US, V56, P856, DOI 10.1021/acs.biochem.6b01145; Ravichandran KR, 2017, J AM CHEM SOC, V139, P2994, DOI 10.1021/jacs.6b11011; Ravichandran KR, 2016, J AM CHEM SOC, V138, P13706, DOI 10.1021/jacs.6b08200; Ravichandran KR, 2015, J AM CHEM SOC, V137, P14387, DOI 10.1021/jacs.5b09189; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; SALOWE S, 1993, BIOCHEMISTRY-US, V32, P12749, DOI 10.1021/bi00210a026; SALOWE SP, 1987, BIOCHEMISTRY-US, V26, P3408, DOI 10.1021/bi00386a024; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15748, DOI 10.1021/ja076459b; Seyedsayamdost MR, 2007, NAT PROTOC, V2, P1225, DOI 10.1038/nprot.2007.159; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15060, DOI 10.1021/ja076043y; Seyedsayamdost MR, 2009, METHOD ENZYMOL, V462, P45, DOI 10.1016/S0076-6879(09)62003-6; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, P NATL ACAD SCI USA, V95, P2723, DOI 10.1073/pnas.95.6.2723; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; VANDERDONK WA, 1995, J AM CHEM SOC, V117, P8908, DOI 10.1021/ja00140a003; Worsdorfer B, 2013, J AM CHEM SOC, V135, P8585, DOI 10.1021/ja401342s; Yokoyama K, 2011, J AM CHEM SOC, V133, P18420, DOI 10.1021/ja207455k; Yokoyama K, 2010, J AM CHEM SOC, V132, P15368, DOI 10.1021/ja1069344; Yokoyama K, 2010, J AM CHEM SOC, V132, P8385, DOI 10.1021/ja101097p; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141	50	23	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9229	9239		10.1074/jbc.M117.783092	http://dx.doi.org/10.1074/jbc.M117.783092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28377505	hybrid, Green Published			2022-12-28	WOS:000402538900018
J	Martinez-Sernandez, V; Mezo, M; Gonzalez-Warleta, M; Perteguer, MJ; Garate, T; Romaris, F; Ubeira, FM				Martinez-Sernandez, Victoria; Mezo, Mercedes; Gonzalez-Warleta, Marta; Perteguer, Maria J.; Garate, Teresa; Romaris, Fernanda; Ubeira, Florencio M.			Delineating distinct heme-scavenging and -binding functions of domains in MF6p/helminth defense molecule (HDM) proteins from parasitic flatworms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-penetrating peptide (CPP); heme; homeostasis; oligomerization; parasite; Fasciola; fluke; MF6p; FhHDM-1; MF6p; HDM; trematode	CELL-PENETRATING PEPTIDES; FASCIOLA-HEPATICA; PORPHYRIN; AGGREGATION; TRAFFICKING; HEMOGLOBIN; COMPLEX; SURFACE; GLOBIN; CATTLE	MF6p/FhHDM-1 is a small protein secreted by the parasitic flatworm (trematode) Fasciola hepatica that belongs to a broad family of heme-binding proteins (MF6p/helminth defense molecules (HDMs)). MF6p/HDMs are of interest for understanding heme homeostasis in trematodes and as potential targets for the development of new flukicides. Moreover, interest in these molecules has also increased because of their immunomodulatory properties. Here we have extended our previous findings on the mechanism of MF6p/HDM-heme interactions and mapped the protein regions required for heme binding and for other biological functions. Our data revealed that MF6p/FhHDM-1 forms high-molecular-weight complexes when associated with heme and that these complexes are reorganized by a stacking procedure to form fibril-like and granular nanostructures. Furthermore, we showed that MF6p/FhHDM-1 is a transitory heme-binding protein as protein.heme complexes can be disrupted by contact with an apoprotein (e.g. apomyoglobin) with higher affinity for heme. We also demonstrated that (i) the heme-binding region is located in the MF6p/FhHDM-1 C-terminal moiety, which also inhibits the peroxidase-like activity of heme, and (ii) MF6p/HDMs from other trematodes, such as Opisthorchis viverrini and Paragonimus westermani, also bind heme. Finally, we observed that the N-terminal, but not the C-terminal, moiety of MF6p/HDMs has a predicted structural analogy with cell-penetrating peptides and that both the entire protein and the peptide corresponding to the N-terminal moiety of MF6p/FhHDM-1 interact in vitro with cell membranes in hemin-preconditioned erythrocytes. Our findings suggest that MF6p/HDMs can transport heme in trematodes and thereby shield the parasite from the harmful effects of heme.	[Martinez-Sernandez, Victoria; Romaris, Fernanda; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela 15782, Spain; [Mezo, Mercedes; Gonzalez-Warleta, Marta] Inst Galego Calidade Alimentaria INGACAL, Ctr Invest Agr Mabegondo, Lab Parasitol, Abegondo 15318, A Coruna, Spain; [Perteguer, Maria J.; Garate, Teresa] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28220, Spain	Universidade de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela 15782, Spain.	fm.ubeira@usc.es	PERTEGUER, MARIA J/T-1266-2018; Mezo, Mercedes/R-4703-2019; González-Warleta, Marta/R-5124-2019	PERTEGUER, MARIA J/0000-0002-7533-5134; Mezo, Mercedes/0000-0001-8819-453X; González-Warleta, Marta/0000-0003-3315-5757; Ubeira, Florencio/0000-0001-7312-2752; Romaris Martinez, Fernanda/0000-0002-0633-674X	Ministerio de Ciencia e Innovacion (Spain) [AGL2011-30563-C03]; Xunta de Galicia (Spain) [GPC2014/058]; Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural [PI14CIII/00076]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Ministerio de Ciencia e Innovacion (Spain) [AGL2011-30563-C03]; Xunta de Galicia (Spain) [GPC2014/058]; Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural [PI14CIII/00076]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (Spain)(Xunta de Galicia); Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural; European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (Spain)(Xunta de Galicia); Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural; European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	This work was supported in part by Ministerio de Ciencia e Innovacion (Spain) Grant AGL2011-30563-C03, Xunta de Galicia (Spain) Grant GPC2014/058, Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural Grant PI14CIII/00076, and the European Fund for Regional Development (FEDER).r Holds a predoctoral fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario).	Ashrafi K, 2014, TRAVEL MED INFECT DI, V12, P636, DOI 10.1016/j.tmaid.2014.09.006; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Burrows ND, 2013, MICROSC MICROANAL, V19, P1542, DOI 10.1017/S1431927613013354; Cao XD, 2016, J PROTEOMICS, V130, P221, DOI 10.1016/j.jprot.2015.10.001; CARR C, 1985, INFECT IMMUN, V49, P84, DOI 10.1128/IAI.49.1.84-89.1985; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Flint A, 2015, J BACTERIOL, V197, P1002, DOI 10.1128/JB.02346-14; Fry HC, 2012, J AM CHEM SOC, V134, P14646, DOI 10.1021/ja304674d; FUHRHOP JH, 1993, J AM CHEM SOC, V115, P11036, DOI 10.1021/ja00076a090; GALLAGHER WA, 1967, BIOCHEM J, V105, P461, DOI 10.1042/bj1050461; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; GE Healthcare Life Science, 2000, USITC PUBL; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Giovannetti R., 2012, MACRONANOSPECTROSCOP, P87, DOI [DOI 10.5772/38797, 10.5772/38797]; Giovannetti R, 2010, J PHOTOCH PHOTOBIO A, V211, P108, DOI 10.1016/j.jphotochem.2010.02.003; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GREGG BA, 1989, J PHYS CHEM-US, V93, P4227, DOI 10.1021/j100347a065; Hacariz O, 2012, J PROTEOME RES, V11, P3592, DOI 10.1021/pr300015p; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010; Holton TA, 2013, BIOINFORMATICS, V29, P3094, DOI 10.1093/bioinformatics/btt518; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; KACA W, 1994, J BIOL CHEM, V269, P25078; KAWAMURAKONISHI Y, 1985, J BIOCHEM-TOKYO, V98, P1181, DOI 10.1093/oxfordjournals.jbchem.a135384; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Lee KS, 2007, J BIOL CHEM, V282, P36525, DOI 10.1074/jbc.M705620200; Lengyel Jeffrey, 2014, Journal of Structural and Functional Genomics, V15, P117, DOI 10.1007/s10969-014-9179-9; Li BL, 2009, ANAL CHIM ACTA, V651, P234, DOI 10.1016/j.aca.2009.09.009; Liu XL, 2016, J MED CHEM, V59, P5238, DOI 10.1021/acs.jmedchem.5b02016; Maiti NC, 1998, J PHYS CHEM B, V102, P1528, DOI 10.1021/jp9723372; Martinez-Sernandez V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156530; Martinez-Sernandez V, 2014, J BIOL CHEM, V289, P1441, DOI 10.1074/jbc.M113.499517; MCGONIGLE S, 1995, PARASITOLOGY, V111, P209, DOI 10.1017/S0031182000064969; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2003, J PARASITOL, V89, P843, DOI 10.1645/GE-74RI.1; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Mulvenna J, 2010, PROTEOMICS, V10, P1063, DOI 10.1002/pmic.200900393; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P1753, DOI 10.1021/bi00277a002; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rai J, 2007, J PEPT SCI, V13, P406, DOI 10.1002/psc.862; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; SOLAR I, 1991, BIOCHIM BIOPHYS ACTA, V1062, P51, DOI 10.1016/0005-2736(91)90334-5; SRINIVAS V, 1990, BIOCHEM INT, V21, P849; Thivierge K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002307; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Verma S, 2012, J PHYS CHEM LETT, V3, P1877, DOI 10.1021/jz300639q; von Berlepsch H, 2015, J PHYS CHEM B, V119, P11900, DOI 10.1021/acs.jpcb.5b05576; Wang F, 2006, BIOCHEM PHARMACOL, V71, P799, DOI 10.1016/j.bcp.2005.12.002; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	59	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8667	8682		10.1074/jbc.M116.771675	http://dx.doi.org/10.1074/jbc.M116.771675			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28348084	Green Published, hybrid			2022-12-28	WOS:000402153900014
J	Darwiche, R; Mene-Saffrane, L; Gfeller, D; Asojo, OA; Schneiter, R				Darwiche, Rabih; Mene-Saffrane, Laurent; Gfeller, David; Asojo, Oluwatoyin A.; Schneiter, Roger			The pathogen-related yeast protein Pry1, a member of the CAP protein superfamily, is a fatty acid-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; VENOM ALLERGEN; DOMAIN; GENE; INHIBITOR; MECHANISM; REVEALS; EXPORT; MOTIF	Members of the CAP superfamily (cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins), also known as SCP superfamily (sperm-coating proteins), have been implicated in many physiological processes, including immune defenses, venom toxicity, and sperm maturation. Their mode of action, however, remains poorly understood. Three proteins of the CAP superfamily, Pry1, -2, and -3 (pathogen related in yeast), are encoded in the Saccharomyces cerevisiae genome. We have shown previously that Pry1 binds cholesterol in vitro and that Pry function is required for sterol secretion in yeast cells, indicating that members of this superfamily may generally bind sterols or related small hydrophobic compounds. On the other hand, tablysin-15, aCAPprotein from the horsefly Tabanus yao, has been shown to bind leukotrienes and free fatty acids in vitro. Therefore, here we assessed whether the yeast Pry1 protein binds fatty acids. Computational modeling and site-directed mutagenesis indicated that the mode of fatty acid binding is conserved between tablysin-15 and Pry1. Pry1 bound fatty acids with micromolar affinity in vitro, and its function was essential for fatty acid export in cells lacking the acyl-CoA synthetases Faa1 and Faa4. Fatty acid binding of Pry1 is independent of its capacity to bind sterols, and the two sterol-and fatty acid-binding sites are nonoverlapping. These results indicate that some CAP family members, such as Pry1, can bind different lipids, particularly sterols and fatty acids, at distinct binding sites, suggesting that the CAP domain may serve as a stable, secreted protein domain that can accommodate multiple ligand-binding sites.	[Darwiche, Rabih; Mene-Saffrane, Laurent; Schneiter, Roger] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Gfeller, David] Univ Lausanne, Ludwig Ctr Canc Res, Biopole 3, CH-1066 Epalinges, Switzerland; [Gfeller, David] SIB, CH-1015 Lausanne, Switzerland; [Asojo, Oluwatoyin A.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA	University of Fribourg; University of Lausanne; Swiss Institute of Bioinformatics; Baylor College of Medicine	Schneiter, R (corresponding author), Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	roger.schneiter@unifr.ch	Asojo, Oluwatoyin/H-1324-2019; Gfeller, David/A-6493-2019; Mène-Saffrané, Laurent/A-7440-2013	Asojo, Oluwatoyin/0000-0002-4043-2700; Gfeller, David/0000-0002-3952-0930; Mène-Saffrané, Laurent/0000-0002-1763-7871; Schneiter, Roger/0000-0002-9102-8396	Swiss National Science Foundation [31003A_153416]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, 31003A_153416. The authors declare that they have no conflict of interest with the contents of this article.	Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Choudhary V, 2014, J LIPID RES, V55, P883, DOI 10.1194/jlr.M047126; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Darwiche R., 2016, J STEROIDS HORM SCI, V7, P172; Darwiche R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28838; Eberle HB, 2002, J CELL SCI, V115, P827; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gamir J, 2017, PLANT J, V89, P502, DOI 10.1111/tpj.13398; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; Kelleher A, 2014, ACTA CRYSTALLOGR D, V70, P2186, DOI 10.1107/S1399004714013315; Ma DY, 2010, TOXICON, V55, P45, DOI 10.1016/j.toxicon.2009.06.038; Michinaka Y, 2003, J BIOSCI BIOENG, V95, P435, DOI 10.1016/S1389-1723(03)80041-5; MIOSGA T, 1995, YEAST, V11, P681, DOI 10.1002/yea.320110709; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Omura S, 1981, Methods Enzymol, V72, P520; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Thompson TC, 2010, YONSEI MED J, V51, P479, DOI 10.3349/ymj.2010.51.4.479; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; Xu XQ, 2012, J BIOL CHEM, V287, P10967, DOI 10.1074/jbc.M112.340471	32	28	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8304	8314		10.1074/jbc.M117.781880	http://dx.doi.org/10.1074/jbc.M117.781880			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28365570	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000401788600016
J	Shibata, T; Shimizu, K; Hirano, K; Nakashima, F; Kikuchi, R; Matsushita, T; Uchida, K				Shibata, Takahiro; Shimizu, Kazuma; Hirano, Keita; Nakashima, Fumie; Kikuchi, Ryosuke; Matsushita, Tadashi; Uchida, Koji			Adductome-based identification of biomarkers for lipid peroxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FATTY-ACID-COMPOSITION; INDUCED DNA-ADDUCTS; OXIDIZED LDL; ATHEROSCLEROTIC LESIONS; OXIDATIVE MODIFICATION; APOLIPOPROTEIN-B; ALDEHYDES; PRODUCTS; PROTEINS	Lipid peroxidation is an endogenous source of aldehydes that gives rise to covalent modification of proteins in various pathophysiological states. In this study, a strategy for the comprehensive detection and comparison of adducts was applied to find a biomarker for lipid peroxidation-modified proteins in vivo. This adductome approach utilized liquid chromatography with electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) methods designed to detect the specific product ions from positively ionized adducts in a selected reaction monitoring mode. Using this procedure, we comprehensively analyzed lysine and histidine adducts generated in the in vitro oxidized low-density lipoproteins (LDL) and observed a prominent increase in several adducts, including a major lysine adduct. Based on the high resolution ESI-MS of the adduct and on the LC-ESI-MS/MS analysis of the synthetic adduct candidates, the major lysine adduct detected in the oxidized LDL was identified as N-is an element of-(8-carboxyoctanyl) lysine (COL). Strikingly, a significantly higher amount of COL was detected in the sera from atherosclerosis-prone mice and from patients with hyperlipidemia compared with the controls. These data not only offer structural insights into protein modification by lipid peroxidation products but also provide a platform for the discovery of biomarkers for human diseases.	[Shibata, Takahiro; Shimizu, Kazuma; Hirano, Keita; Nakashima, Fumie; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Takahiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kikuchi, Ryosuke] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi 4668560, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab & Blood Transfus, Nagoya, Aichi 4668560, Japan; [Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; University of Tokyo	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	a-uchida@mail.ecc.u-tokyo.ac.jp	Kikuchi, Ryosuke/AAX-4971-2021; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Japan Science and Technology Agency PRESTO program of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [JPMJPR1334];  [26252018];  [26111011]	Japan Science and Technology Agency PRESTO program of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; ; 	This work was supported in part by Grant-in-aid for Scientific Research (A) 26252018 (to K. U.), Grant-in-aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 (to K. U.), and the Japan Science and Technology Agency PRESTO program (JPMJPR1334 to T. S.) of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Albertini R., 2002, Current Molecular Medicine (Hilversum), V2, P579, DOI 10.2174/1566524023362177; Alwaili K, 2009, CURR OPIN ENDOCRINOL, V16, P132, DOI 10.1097/MED.0b013e328329135a; Baggio B, 1996, J AM SOC NEPHROL, V7, P613; Chou PH, 2010, CHEM RES TOXICOL, V23, P1442, DOI 10.1021/tx100047d; DALCANALE E, 1986, J ORG CHEM, V51, P567, DOI 10.1021/jo00354a037; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fujiwara M., 2013, Asian Journal of Animal and Veterinary Advances, V8, P639; Gillotte KL, 2000, J LIPID RES, V41, P824; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hoppe G, 1997, J LIPID RES, V38, P1347; ITABE H, 1994, J BIOL CHEM, V269, P15274; JURGENS G, 1986, BIOCHIM BIOPHYS ACTA, V875, P103, DOI 10.1016/0005-2760(86)90016-0; Kanaly RA, 2007, MUTAT RES-FUND MOL M, V625, P83, DOI 10.1016/j.mrfmmm.2007.05.006; Kanaly RA, 2006, ANTIOXID REDOX SIGN, V8, P993, DOI 10.1089/ars.2006.8.993; Kawai Y, 2003, J BIOL CHEM, V278, P21040, DOI 10.1074/jbc.M212426200; Kumano-Kuramochi M, 2012, BIOCHEM J, V442, P171, DOI 10.1042/BJ20111029; LaRosa JC, 2001, CIRCULATION, V104, P1688, DOI 10.1161/hc3901.096665; Matsuda T, 2013, CARCINOGENESIS, V34, P121, DOI 10.1093/carcin/bgs327; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Shimozu Y, 2011, J BIOL CHEM, V286, P29313, DOI 10.1074/jbc.M111.255737; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; TERTOV VV, 1995, BIOCHEM BIOPH RES CO, V214, P608, DOI 10.1006/bbrc.1995.2329; Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016	27	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8223	8235		10.1074/jbc.M116.762609	http://dx.doi.org/10.1074/jbc.M116.762609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28341743	Green Published, hybrid			2022-12-28	WOS:000401788600009
J	Palomino, R; Lee, HW; Millhauser, GL				Palomino, Rafael; Lee, Hsiau-Wei; Millhauser, Glenn L.			The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); glycosaminoglycan; heparan sulfate; heparin-binding protein; neuropeptide; AgRP; mc4r; syndecan	INVERSE AGONIST; NMR STRUCTURE; PROTEIN; AGRP; SYNDECAN-3; ACTIVATION; OBESITY; STATES	Syndecans potently modulate agouti-related peptide (AgRP) signaling in the central melanocortin system. Through heparan sulfate moieties, syndecans are thought to anchor AgRP near its receptor, enhancing its orexigenic effects. Original work proposed that the N-terminal domain of AgRP facilitates this interaction. However, this is not compatible with evidence that this domain is posttranslationally cleaved. Addressing this long-standing incongruity, we used calorimetry and magnetic resonance to probe interactions of AgRP peptides with glycosaminoglycans, including heparan sulfate. We show that mature, cleaved, C-terminal AgRP, not the N-terminal domain, binds heparan sulfate. NMR shows that the binding site consists of regions distinct from the melanocortin receptor-binding site. Using a library of designed AgRP variants, we find that the strength of the syndecan interaction perfectly tracks orexigenic action. Our data provide compelling evidence that AgRP is a heparan sulfate-binding protein and localizes critical regions in the AgRP structure required for this interaction.	[Palomino, Rafael; Lee, Hsiau-Wei; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	glennm@ucsc.edu		Lee, Hsiau-Wei/0000-0002-6060-6341	National Institutes of Health [F31 DK102343, DK064265, DK110403, S10OD018455]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110403, R01DK064265, F31DK102343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058903] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Fellowship F31 DK102343 (to R. P.) and National Institutes of Health Grants DK064265 and DK110403 (to G. L. M.). The 800-MHz NMR spectrometer was funded by National Institutes of Health Grant S10OD018455.The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Denis RGP, 2015, CELL METAB, V22, P646, DOI 10.1016/j.cmet.2015.07.011; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; FALLER B, 1992, BIOCHEMISTRY-US, V31, P8285, DOI 10.1021/bi00150a023; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Hagan MM, 2001, ENDOCRINOLOGY, V142, P1050, DOI 10.1210/en.142.3.1050; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; Hoggard N, 2004, CLIN ENDOCRINOL, V61, P31, DOI 10.1111/j.1365-2265.2004.02056.x; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Jackson PJ, 2002, BIOCHEMISTRY-US, V41, P7565, DOI 10.1021/bi012000x; Karlsson-Lindahl L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034313; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krasnow Stephanie M, 2010, Curr Opin Support Palliat Care, V4, P266, DOI 10.1097/SPC.0b013e32833e48e7; Liu TM, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00200; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; Madonna ME, 2012, ACS CHEM BIOL, V7, P394, DOI 10.1021/cb2003412; McNulty JC, 2001, BIOCHEMISTRY-US, V40, P15520, DOI 10.1021/bi0117192; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Reizes O, 2006, PEPTIDES, V27, P274, DOI 10.1016/j.peptides.2005.02.030; Reizes O, 2003, ANN NY ACAD SCI, V994, P66, DOI 10.1111/j.1749-6632.2003.tb03163.x; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Shen CP, 2002, J NEUROENDOCRINOL, V14, P607, DOI 10.1046/j.1365-2826.2002.00825.x; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zheng Q, 2010, NEUROSCIENCE, V171, P1032, DOI 10.1016/j.neuroscience.2010.09.060	36	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7651	7661		10.1074/jbc.M116.772822	http://dx.doi.org/10.1074/jbc.M116.772822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28264929	hybrid, Green Published			2022-12-28	WOS:000400761300031
J	Morais, MAB; Giuseppe, PO; Souza, TACB; Castro, H; Honorato, RV; Oliveira, PSL; Netto, LES; Tomas, AM; Murakami, MT				Morais, Mariana A. B.; Giuseppe, Priscila O.; Souza, Tatiana A. C. B.; Castro, Helena; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Netto, Luis E. S.; Tomas, Ana M.; Murakami, Mario T.			Calcium and magnesium ions modulate the oligomeric state and function of mitochondrial 2-Cys peroxiredoxins in Leishmania parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPAREDOXIN PEROXIDASE; ANTIOXIDANT PROTEIN; DECAMER; AHPC; CA2+; CRYSTALLIZATION; INTERCONVERSION; COORDINATION; STIMULATION; RESOLUTION	Leishmania parasites have evolved a number of strategies to cope with the harsh environmental changes during mammalian infection. One of these mechanisms involves the functional gain that allows mitochondrial 2-Cys peroxiredoxins to act as molecular chaperones when forming decamers. This function is critical for parasite infectivity in mammals, and its activation has been considered to be controlled exclusively by the enzyme redox state under physiological conditions. Herein, we have revealed that magnesium and calcium ions play a major role in modulating the ability of these enzymes to act as molecular chaperones, surpassing the redox effect. These ions are directly involved in mitochondrial metabolism and participate in a novel mechanism to stabilize the decameric form of 2-Cys peroxiredoxins in Leishmania mitochondria. Moreover, we have demonstrated that a constitutively dimeric Prx1m mutant impairs the survival of Leishmania under heat stress, supporting the central role of the chaperone function of Prx1m for Leishmania parasites during the transition from insect to mammalian hosts.	[Morais, Mariana A. B.; Giuseppe, Priscila O.; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Murakami, Mario T.] Natl Ctr Res Energy & Mat, Biosci Natl Lab, Rua Giuseppe Maximo Scolfaro 10000, BR-13083100 Campinas, SP, Brazil; [Souza, Tatiana A. C. B.] Fiocruz MS, Carlos Chagas Inst, Prote & Prot Engn Lab, Rua Prof Algacyr Munhoz Mader 2135, BR-81310020 Curitiba, PR, Brazil; [Castro, Helena; Tomas, Ana M.] Univ Porto, I3S Inst Invest & Innovat Hlth, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Castro, Helena; Tomas, Ana M.] Univ Porto, Inst Mol & Cell Biol IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Netto, Luis E. S.] Univ State Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Rua Matao 14, BR-05508090 Sao Paulo, SP, Brazil; [Tomas, Ana M.] Univ Porto, Abel Salazar Biomed Sci Inst, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal	Fundacao Oswaldo Cruz; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade Estadual Paulista; Universidade do Porto	Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Biosci Natl Lab, Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Oliveira de Giuseppe, Priscila/GLR-1319-2022; Castro, Helena/J-4794-2013; Oliveira, Paulo S/K-5588-2013; Honorato, Rodrigo Vargas/AAY-9375-2020; Netto, Luis/A-3783-2008; Murakami, Mario T/F-5640-2016; Tomas, Ana/J-9919-2013	Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Castro, Helena/0000-0002-6021-9210; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Netto, Luis/0000-0002-4250-9177; Murakami, Mario T/0000-0002-0405-8010; Morais, Mariana Abrahao Bueno de/0000-0003-1012-1394; Tomas, Ana/0000-0002-0781-9567	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/51730-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Norte Portugal Regional Operational Programme (NORTE) under the Quadro de Referencia Estrategico Nacional through the European Regional Development Fund (ERDF); Portuguese Foundation for Science and Technology; NORTE under the PORTUGAL Partnership Agreement through ERDF); FAPESP [2011/10248-4, 2012/24134-3, 2015/05851-4]; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) through the "Investigador FCT" programme;  ["NORTE-07-0124-FEDER-000002"];  ["NORTE-01-0145-FEDER-000012"]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Norte Portugal Regional Operational Programme (NORTE) under the Quadro de Referencia Estrategico Nacional through the European Regional Development Fund (ERDF); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NORTE under the PORTUGAL Partnership Agreement through ERDF); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) through the "Investigador FCT" programme; ; 	This work was supported by Grant 2010/51730-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to M. T. M.). This work was also supported by grants from Project "NORTE-07-0124-FEDER-000002" (co-funded by the Norte Portugal Regional Operational Programme (NORTE 2020) under the Quadro de Referencia Estrategico Nacional through the European Regional Development Fund (ERDF) and by the the Portuguese Foundation for Science and Technology) and from Project "NORTE-01-0145-FEDER-000012" (supported by NORTE 2020 under the PORTUGAL 2020 Partnership Agreement through ERDF) (to A. M. T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FAPESP Fellowships 2011/10248-4, 2012/24134-3, and 2015/05851-4.; Supported by the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) through the "Investigador FCT" programme.	Andreini C, 2012, BIOINFORMATICS, V28, P1658, DOI 10.1093/bioinformatics/bts246; Angelucci F, 2016, MOL BIOCHEM PARASIT, V206, P2, DOI 10.1016/j.molbiopara.2016.03.005; Barranco-Medina S, 2008, BIOCHEMISTRY-US, V47, P7196, DOI 10.1021/bi8002956; BENAIM G, 1990, MOL BIOCHEM PARASIT, V39, P61, DOI 10.1016/0166-6851(90)90008-A; Bernier-Villamor L, 2004, J EXP BOT, V55, P2191, DOI 10.1093/jxb/erh238; Beverley S M, 1993, Methods Mol Biol, V21, P333; de Morais MAB, 2013, ACTA CRYSTALLOGR F, V69, P408, DOI 10.1107/S1744309113003989; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Castro H, 2004, MOL BIOCHEM PARASIT, V136, P137, DOI 10.1016/j.molbiopara.2004.02.015; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Castro H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002325; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; de Oliveira MA, 2007, ACTA CRYSTALLOGR F, V63, P665, DOI 10.1107/S1744309107031557; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; LETILLY V, 1993, BIOCHEMISTRY-US, V32, P7753, DOI 10.1021/bi00081a021; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Morais MAB, 2015, J BIOL CHEM, V290, P8582, DOI 10.1074/jbc.M114.619205; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pearson R. D., 1989, Parasitic infections in the compromised host., P31; Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Prasad A, 2001, MOL CELL BIOCHEM, V224, P39, DOI 10.1023/A:1011965109446; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; RUTTER GA, 1990, BIOCHEM J, V271, P627, DOI 10.1042/bj2710627; Sarkar AR, 2016, CHEM SCI, V7, P766, DOI 10.1039/c5sc03708e; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Sousa AF, 2014, FREE RADICAL BIO MED, V73, P229, DOI 10.1016/j.freeradbiomed.2014.05.007; Suzuki N, 2005, J MOL BIOL, V353, P80, DOI 10.1016/j.jmb.2005.08.018; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Teixeira F, 2015, P NATL ACAD SCI USA, V112, pE616, DOI 10.1073/pnas.1419682112; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhao Q, 2015, CHEM SCI, V6, P4124, DOI 10.1039/c5sc00633c	52	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7023	7039		10.1074/jbc.M116.762039	http://dx.doi.org/10.1074/jbc.M116.762039			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28292930	Green Published, hybrid			2022-12-28	WOS:000400478300014
J	Jiang, YL; Jin, H; Yang, HB; Zhao, RL; Wang, SL; Chen, YX; Zhou, CZ				Jiang, Yong-Liang; Jin, Hua; Yang, Hong-Bo; Zhao, Rong-Li; Wang, Shiliang; Chen, Yuxing; Zhou, Cong-Zhao			Defining the enzymatic pathway for polymorphic O-glycosylation of the pneumococcal serine-rich repeat protein PsrP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-GORDONII; BINDING; INSIGHTS; COMPLEX; SYSTEM; DOMAIN; SUGAR; GLYCOSYLTRANSFERASES; IDENTIFICATION; PURIFICATION	Protein O-glycosylation is an important post-translational modification in all organisms, but deciphering the specific functions of these glycans is difficult due to their structural complexity. Understanding the glycosylation of mucin-like proteins presents a particular challenge as they are modified numerous times with both the enzymes involved and the glycosylation patterns being poorly understood. Here we systematically explored the O-glycosylation pathway of a mucin-like serine-rich repeat protein PsrP from the human pathogen Streptococcus pneumoniae TIGR4. Previous works have assigned the function of 3 of the 10 glycosyltransferases thought to modify PsrP, GtfA/B, and Gtf3 as catalyzing the first two reactions to form a unified disaccharide core structure. We now use in vivo and in vitro glycosylation assays combined with hydrolytic activity assays to identify the glycosyltransferases capable of decorating this core structure in the third and fourth steps of glycosylation. Specifically, the full-length GlyE and GlyG proteins and the GlyD DUF1792 domain participate in both steps, whereas full-length GlyA and the GlyD GT8 domain catalyze only the fourth step. Incorporation of different sugars to the disaccharide core structure at multiple sites along the serine-rich repeats results in a highly polymorphic product. Furthermore, crystal structures of apo- and UDP-complexed GlyE combined with structural analyses reveal a novel Rossmann-fold "add-on" domain that we speculate to function as a universal module shared by GlyD, GlyE, and GlyA to forward the peptide acceptor from one enzyme to another. These findings define the complete glycosylation pathway of a bacterial glycoprotein and offer a testable hypothesis of how glycosyltransferase coordination facilitates glycan assembly.	[Jiang, Yong-Liang; Jin, Hua; Yang, Hong-Bo; Zhao, Rong-Li; Wang, Shiliang; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Jiang, Yong-Liang; Jin, Hua; Yang, Hong-Bo; Zhao, Rong-Li; Wang, Shiliang; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Jiang, Yong-Liang; Jin, Hua; Yang, Hong-Bo; Zhao, Rong-Li; Chen, Yuxing; Zhou, Cong-Zhao] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Chen, YX; Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Chen, YX; Zhou, CZ (corresponding author), Chinese Acad Sci, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China.	cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Yang, Hong-Bo/0000-0002-9639-7166; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2015CB910100, 2013CB835300, 2014CB910100]; National Natural Science Foundation of China [31270781, 31570728, 31400628]; Innovation Center for Cell Signaling Network	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Center for Cell Signaling Network	This work was supported by Ministry of Science and Technology of China Grants 2015CB910100, 2013CB835300, and 2014CB910100, National Natural Science Foundation of China Grants 31270781, 31570728, and 31400628, and by the Innovation Center for Cell Signaling Network. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2008, ACTA CRYSTALLOGR D, V64, P1, DOI 10.1107/S0907444907051554; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hanuszkiewicz A, 2014, J BIOL CHEM, V289, P19231, DOI 10.1074/jbc.M114.562603; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; King NP, 2011, MICROBIOL-SGM, V157, P1161, DOI 10.1099/mic.0.047639-0; Kukita K, 2013, INFECT IMMUN, V81, P1870, DOI 10.1128/IAI.00011-13; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Lu QH, 2015, TRENDS MICROBIOL, V23, P630, DOI 10.1016/j.tim.2015.07.003; Munoz-Almagro C, 2010, CLIN VACCINE IMMUNOL, V17, P1672, DOI 10.1128/CVI.00271-10; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Schulte T, 2016, SCI REP-UK, V6, DOI 10.1038/srep32371; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi WW, 2014, J BIOL CHEM, V289, P20898, DOI 10.1074/jbc.M114.581934; Shibayama K, 1998, J BACTERIOL, V180, P5313, DOI 10.1128/JB.180.20.5313-5318.1998; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; Tan FYY, 2015, TRENDS BIOCHEM SCI, V40, P342, DOI 10.1016/j.tibs.2015.03.016; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yu HJ, 2015, NAT CHEM BIOL, V11, P847, DOI 10.1038/nchembio.1927; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhang H, 2016, J BIOL CHEM, V291, P22106, DOI 10.1074/jbc.M116.731695; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629	64	17	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6213	6224		10.1074/jbc.M116.770446	http://dx.doi.org/10.1074/jbc.M116.770446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28246170	hybrid, Green Published			2022-12-28	WOS:000399538700017
J	Chen, YD; Porter, K; Osawa, M; Augustus, AM; Milam, SL; Joshi, C; Osteryoung, KW; Erickson, HP				Chen, Yaodong; Porter, Katie; Osawa, Masaki; Augustus, Anne Marie; Milam, Sara L.; Joshi, Chandra; Osteryoung, Katherine W.; Erickson, Harold P.			The Chloroplast Tubulin Homologs FtsZA and FtsZB from the Red Alga Galdieria sulphuraria Co-assemble into Dynamic Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL-DIVISION; PLASTID DIVISION; IN-VITRO; ESCHERICHIA-COLI; HIGHER-PLANTS; EVOLUTION; RINGS; REORGANIZATION; POLYMERIZATION	FtsZ is a homolog of eukaryotic tubulin and is present in almost all bacteria and many archaea, where it is the major cytoskeletal protein in the Z ring, required for cell division. Unlike some other cell organelles of prokaryotic origin, chloroplasts have retained FtsZ as an essential component of the division machinery. However, chloroplast FtsZs have been challenging to study because they are difficult to express and purify. To this end, we have used a FATT tag expression system to produce as soluble proteins the two chloroplast FtsZs from Galdieria sulphuraria, a thermophilic red alga. GsFtsZA and GsFtsZB assembled individually in the presence of GTP, forming large bundles of protofilaments. GsFtsZA also assembled in the presence of GDP, the first member of the FtsZ/tubulin superfamily to do so. Mixtures of GsFtsZA and GsFtsZB assembled protofilament bundles and hydrolyzed GTP at a rate approximately equal to the sum of their individual rates, suggesting a random co-assembly. GsFtsZA assembly by itself in limiting GTP gave polymers that remained stable for a prolonged time. However, when GsFtsZB was added, the co-polymers disassembled with enhanced kinetics, suggesting that the GsFtsZB regulates and enhances disassembly dynamics. GsFtsZA-mts (where mts is a membrane-targeting amphipathic helix) formed Z ring-like helices when expressed in Escherichia coli. Co-expression of GsFtsZB (without an mts) gave co-assembly of both into similar helices. In summary, we provide biochemical evidence that GsFtsZA assembles as the primary scaffold of the chloroplast Z ring and that GsFtsZB co-assembly enhances polymer disassembly and dynamics.	[Chen, Yaodong] Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Chen, Yaodong; Osawa, Masaki; Augustus, Anne Marie; Milam, Sara L.; Joshi, Chandra; Erickson, Harold P.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Porter, Katie; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Joshi, Chandra] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Northwest University Xi'an; Duke University; Michigan State University; Cornell University	Erickson, HP (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu	Chen, Yaodong/X-8923-2019	Chen, Yaodong/0000-0002-3751-0923	National Science Foundation [1121943]; National Institutes of Health [GM66014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant 1121943 (to K. W. O. and H. P. E.) and National Institutes of Health Grant GM66014 (to H. P. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; El-Kafafi ES, 2005, BIOCHEM J, V387, P669, DOI 10.1042/BJ20041281; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Kiefel BR, 2006, INT REV CYTOL, V254, P151, DOI 10.1016/S0074-7696(06)54004-5; Kiefel BR, 2004, PROTIST, V155, P105, DOI 10.1078/1434461000168; Lawlor D. W., 2001, PHOTOSYNTHESIS MOL P; Leger MM, 2015, P NATL ACAD SCI USA, V112, P10239, DOI 10.1073/pnas.1421392112; Lohse S, 2006, PLANT CELL PHYSIOL, V47, P1124, DOI 10.1093/pcp/pcj083; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Miyagishima S, 2010, CURR OPIN MICROBIOL, V13, P738, DOI 10.1016/j.mib.2010.10.004; Miyagishima SY, 2004, J MOL EVOL, V58, P291, DOI 10.1007/s00239-003-2551-1; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Sangawa T, 2013, PROTEIN SCI, V22, P840, DOI 10.1002/pro.2254; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Sato M, 2007, PLANTA, V227, P177, DOI 10.1007/s00425-007-0605-0; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Takahara M, 1999, PLANT CELL PHYSIOL, V40, P784, DOI 10.1093/oxfordjournals.pcp.a029606; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	46	11	12	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5207	5215		10.1074/jbc.M116.767715	http://dx.doi.org/10.1074/jbc.M116.767715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28174299	Green Published, hybrid			2022-12-28	WOS:000397875500005
J	Rujas, E; Caaveiro, JMM; Insausti, S; Garca-Porras, M; Tsumoto, K; Nieva, JL				Rujas, Edurne; Caaveiro, Jose M. M.; Insausti, Sara; Garca-Porras, Miguel; Tsumoto, Kouhei; Nieva, Jose L.			Peripheral Membrane Interactions Boost the Engagement by an Anti-HIV-1 Broadly Neutralizing Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL EXTERNAL REGION; HIV-1 GP41; MONOCLONAL-ANTIBODIES; TRANSMEMBRANE DOMAIN; EPITOPE RECOGNITION; AROMATIC RESIDUES; PERFRINGOLYSIN-O; ANTI-GP41 2F5; 4E10; BINDING	The 4E10 antibody displays an extreme breadth of HIV-1 neutralization and therefore constitutes a suitable model system for structure-guided vaccine design and immunotherapeutics against AIDS. In this regard, the relevance of autoreactivity with membrane lipids for the biological function of this antibody is still a subject of controversy. To address this dispute, herein we have compared the membrane partitioning ability of the 4E10 antibody and several of its variants, which were mutated at the region of the paratope surface in contact with the membrane interface. We first employed a physical separation approach (vesicle flotation) and subsequently carried out quantitative fluorescence measurements in an intact system (spectroscopic titration), using 4E10 Fab labeled with a polarity-sensitive fluorescent probe. Moreover, recognition of epitope peptide in membrane was demonstrated by photo-cross-linking assays using a Fab that incorporated the genetically encoded unnatural amino acid p-benzoylphenylalanine. The experimental data ruled out that the proposed stereospecific recognition of viral lipids was necessary for the function of the antibody. In contrast, our data suggest that nonspecific electrostatic interactions between basic residues of 4E10 and acidic phospholipids in the membranes contribute to the observed biological function. Moreover, the energetics of membrane partitioning indicated that 4E10 behaves as a peripheral membrane protein, tightening the binding to the ligand epitope inserted in the viral membrane. The implications of these findings for the natural production and biological function of this antibody are discussed.	[Rujas, Edurne; Insausti, Sara; Garca-Porras, Miguel; Nieva, Jose L.] Univ Basque Country, UPV EHU, Biofisika Inst, Consejo Super Invest Cientif, Bilbao 48080, Spain; [Rujas, Edurne; Insausti, Sara; Garca-Porras, Miguel; Nieva, Jose L.] Univ Basque Country, UPV EHU, Dept Biochem & Mol Biol, POB 644, Bilbao 48080, Spain; [Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Phar maceut Sci, Lab Global Healthcare, Fukuoka 8128582, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Tokyo; Kyushu University	Nieva, JL (corresponding author), Univ Basque Country, UPV EHU, Dept Biochem & Mol Biol, POB 644, Bilbao 48080, Spain.; Tsumoto, K (corresponding author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.	tsumoto@k.u-tokyo.ac.jp; gbpniesj@lg.ehu.es	Nieva, Jose L/Q-2063-2019; Rujas, Edurne/P-1969-2018; Caaveiro, Jose/J-2790-2013; Rujas, Edurne/AGV-1475-2022; Rujas, Edurne/GXG-7368-2022	Nieva, Jose L/0000-0001-6446-5649; Caaveiro, Jose/0000-0001-5568-2369; Insausti, Sara/0000-0003-0871-1344; Rujas, Edurne/0000-0002-4465-5071	National Institutes of Health; Basque Government [AI097051, IT838-13]; Japanese Society for the Promotion of Science (JSPS) KAKENHI-A [25249115, 16H02420]; Platform for Drug Discovery, Informatics and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI-C [15K06962]; Basque Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basque Government(Basque Government); Japanese Society for the Promotion of Science (JSPS) KAKENHI-A; Platform for Drug Discovery, Informatics and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI-C(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Basque Government(Basque Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health and Basque Government Grants AI097051 and IT838-13 (to J. L. N.). Work in the Tsumoto laboratory was supported by Japanese Society for the Promotion of Science (JSPS) KAKENHI-A Grants 25249115 and 16H02420 (to K. T.), by the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by JSPS KAKENHI-C Grant 15K06962 (to J. M. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a predoctoral fellowship from the Basque Government.	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alving CR, 2008, AIDS, V22, P649, DOI 10.1097/QAD.0b013e3282f51922; Apellaniz B, 2015, J BIOL CHEM, V290, P12999, DOI 10.1074/jbc.M115.644351; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Arbuzova A, 1997, J BIOL CHEM, V272, P27167, DOI 10.1074/jbc.272.43.27167; Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Finton KAK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003639; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Huarte N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34190; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; Jacob RA, 2015, J VIROL, V89, P5264, DOI 10.1128/JVI.00129-15; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Kim AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004271; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwon YD, 2016, J VIROL, V90, P5899, DOI 10.1128/JVI.03246-15; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P205; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Rujas E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38177; Rujas E, 2016, J VIROL, V90, P3276, DOI 10.1128/JVI.02970-15; Rujas E, 2015, J VIROL, V89, P11975, DOI 10.1128/JVI.01793-15; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sanchez-Martinez S, 2006, FEBS LETT, V580, P2395, DOI 10.1016/j.febslet.2006.03.067; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Serrano S, 2014, J BIOL CHEM, V289, P6565, DOI 10.1074/jbc.M113.527747; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Verkoczy L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004073; White SH, 1998, METHOD ENZYMOL, V295, P62; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	59	7	7	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5571	5583		10.1074/jbc.M117.775429	http://dx.doi.org/10.1074/jbc.M117.775429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213514	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000397875500035
J	Lindahl, E; Nyman, U; Zaman, F; Palmberg, C; Cascante, A; Shafqat, J; Takigawa, M; Saevendahl, L; Joernvall, H; Joseph, B				Lindahl, Emma; Nyman, Ulrika; Zaman, Farasat; Palmberg, Carina; Cascante, Anna; Shafqat, Jawed; Takigawa, Masaharu; Saevendahl, Lars; Joernvall, Hans; Joseph, Bertrand			Proinsulin C-peptide regulates ribosomal RNA expression (vol 292, pg 3467, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Lindahl, Emma/HHM-4459-2022; Zaman, Farasat/AAE-1144-2020					Lindahl E, 2017, J BIOL CHEM, V292, P4382, DOI 10.1074/jbc.A109.053587	1	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4382	4382		10.1074/jbc.A109.053587	http://dx.doi.org/10.1074/jbc.A109.053587			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28283590	hybrid, Green Published			2022-12-28	WOS:000395837100037
J	Zhang, YX; Li, XF; Yuan, GQ; Hu, H; Song, XY; Li, JY; Miao, XK; Zhou, TX; Yang, WL; Zhang, XW; Mou, LY; Wang, R				Zhang, Yi-Xin; Li, Xiao-Fang; Yuan, Guo-Qiang; Hu, Hui; Song, Xiao-Yun; Li, Jing-Yi; Miao, Xiao-Kang; Zhou, Tian-Xiong; Yang, Wen-Le; Zhang, Xiao-Wei; Mou, Ling-Yun; Wang, Rui			beta-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G(2)/M phase transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; cell cycle; cell proliferation; cyclin-dependent kinase (CDK); glioblastoma; neurokinin-1 receptor	ACTIVATED PROTEIN-KINASE; SUBSTANCE-P; ERK1/2 ACTIVATION; ASTROCYTOMA-CELLS; CYCLIN B1; SIGNAL-TRANSDUCTION; DEPENDENT PATHWAYS; NK-1 RECEPTOR; NK1 RECEPTORS; TUMOR-GROWTH	Glioblastoma is the most common malignant brain tumor and has a poor prognosis. Tachykinin receptor neurokinin-1 (NK1R) is a promising target in glioblastoma therapy because of its overexpression in human glioblastoma. NK1R agonists promote glioblastoma cell growth, whereas NK1R antagonists efficiently inhibit cell growth both in vitro and in vivo. However, the molecular mechanisms involved in these effects are incompletely understood. beta-Arrestins (ARRBs) serve as scaffold proteins and adapters to mediate intracellular signal transduction. Here we show that the ARRB1-mediated signaling pathway is essential for NK1-mediated glioblastoma cell proliferation. ARRB1 knockdown significantly inhibited NK1-mediated glioblastoma cell proliferation and induced G(2)/M phase cell cycle arrest. ARRB1 knockdown cells showed remarkable down-regulation of CDC25C/CDK1/cyclin B1 activity. We also demonstrated that ARRB1 mediated prolonged phosphorylation of ERK1/2 and Akt in glioblastoma cells induced by NK1R activation. ERK1/2 and Akt phosphorylation are involved in regulating CDC25C/CDK1/cyclin B1 activity. The lack of long-term ERK1/2 and Akt activation in ARRB1 knockdown cells was at least partly responsible for the delayed cell cycle progression and proliferation. Moreover, we found that ARRB1-mediated ERK1/2 and Akt phosphorylation regulated the transcriptional activity of both NF-kappa B and AP-1, which were involved in cyclin B1 expression. ARRB1 deficiency increased the sensitivity of glioblastoma cells to the treatment of NK1R antagonists. Taken together, our results suggest that ARRB1 plays an essential role in NK1R-mediated cell proliferation and G(2)/M transition in glioblastoma cells. Interference with ARRB1-mediated signaling via NK1R may have potential significance for therapeutic strategies targeting glioblastoma.	[Zhang, Yi-Xin; Li, Xiao-Fang; Hu, Hui; Song, Xiao-Yun; Li, Jing-Yi; Miao, Xiao-Kang; Zhou, Tian-Xiong; Yang, Wen-Le; Zhang, Xiao-Wei; Mou, Ling-Yun; Wang, Rui] Lanzhou Univ, Inst Biochem & Mol Biol, Sch Life Sci, 222 Tian Shui South Rd, Lanzhou 730000, Peoples R China; [Zhang, Yi-Xin; Li, Xiao-Fang; Yuan, Guo-Qiang; Hu, Hui; Song, Xiao-Yun; Li, Jing-Yi; Miao, Xiao-Kang; Zhou, Tian-Xiong; Yang, Wen-Le; Zhang, Xiao-Wei; Mou, Ling-Yun; Wang, Rui] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Yuan, Guo-Qiang] Lanzhou Univ, Affiliated Hosp 2, Dept Neurosurg, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Mou, LY; Wang, R (corresponding author), Lanzhou Univ, Inst Biochem & Mol Biol, Sch Life Sci, 222 Tian Shui South Rd, Lanzhou 730000, Peoples R China.	muly@lzu.edu.cn; wangrui@lzu.edu.cn			National Nature Science Foundation of China [81302798, 81473095, 21432003]; Project of Healthy and Family Planning Commission of Gansu [GSWSKY-2014-31/2015-58]; Doctoral Research Fund of Lanzhou University Second Hospital [ynbskyjj2015-1-02]; Fundamental Research Funds for the Central Universities [lzujbky-2015-154, lzujbky-2016-ct01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Healthy and Family Planning Commission of Gansu; Doctoral Research Fund of Lanzhou University Second Hospital; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Nature Science Foundation of China (Grants 81302798, 81473095, and 21432003), the Project of Healthy and Family Planning Commission of Gansu (Grant GSWSKY-2014-31/2015-58), the Doctoral Research Fund of Lanzhou University Second Hospital (Grant ynbskyjj2015-1-02), and Fundamental Research Funds for the Central Universities (Grants lzujbky-2015-154 and lzujbky-2016-ct01). The authors declare that they have no conflicts of interest with the contents of this article.	Adamson DC, 2011, CANCER BIOMARK, V9, P193, DOI 10.3233/CBM-2011-0177; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Akazawa T, 2009, J NEUROCHEM, V109, P1079, DOI 10.1111/j.1471-4159.2009.06032.x; American Cancer Society, 2015, CANC FACTS FIG 2015; Backman LJ, 2013, J CELL MOL MED, V17, P723, DOI 10.1111/jcmm.12059; Bavi P, 2011, AM J PATHOL, V178, P2109, DOI 10.1016/j.ajpath.2011.01.034; Berger A, 2005, J NEUROIMMUNOL, V164, P48, DOI 10.1016/j.jneuroim.2005.03.016; Berges C, 2009, MOL IMMUNOL, V46, P2892, DOI 10.1016/j.molimm.2009.07.004; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cheng C, 2016, MOL MED REP, V13, P3763, DOI 10.3892/mmr.2016.5037; Chun KS, 2010, J BIOL CHEM, V285, P39672, DOI 10.1074/jbc.M110.117689; Cianfrocca R, 2014, LIFE SCI, V118, P179, DOI 10.1016/j.lfs.2014.01.078; Cordier D, 2010, EUR J NUCL MED MOL I, V37, P1335, DOI 10.1007/s00259-010-1385-5; Cordier D, 2010, J NEURO-ONCOL, V100, P129, DOI 10.1007/s11060-010-0153-5; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; HENNIG IM, 1995, INT J CANCER, V61, P786, DOI 10.1002/ijc.2910610608; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Jean-Charles PY, 2016, J CELL PHYSIOL, V231, P2071, DOI 10.1002/jcp.25317; Kendall RT, 2014, J BIOL CHEM, V289, P26155, DOI 10.1074/jbc.M114.595728; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Lazarczyk M, 2007, FOLIA NEUROPATHOL, V45, P99; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Luo WH, 1996, CANCER RES, V56, P4983; Mandell JW, 2009, J NEUROPATH EXP NEUR, V68, P535, DOI 10.1097/NEN.0b013e3181a2b8F4-9; Mou LY, 2013, J BIOL CHEM, V288, P306, DOI 10.1074/jbc.M112.389783; Mou LY, 2011, BIOCHEM PHARMACOL, V81, P661, DOI 10.1016/j.bcp.2010.12.007; Munoz M, 2011, CURR MED CHEM, V18, P1820, DOI 10.2174/092986711795496746; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Ogo H, 1996, J NEUROCHEM, V67, P1813; Palma C, 1999, BRIT J CANCER, V79, P236, DOI 10.1038/sj.bjc.6690039; Palma C, 2000, BRIT J CANCER, V82, P480; Palma C, 2000, LIFE SCI, V67, P985, DOI 10.1016/S0024-3205(00)00692-5; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Parathath SR, 2010, CELL CYCLE, V9, P4013, DOI 10.4161/cc.9.19.13325; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt Enrique, 1999, Current Opinion in Oncology, V11, P116; Sagan S, 1996, J PHARMACOL EXP THER, V276, P1039; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schulte G, 2011, P NATL ACAD SCI USA, V108, P19839, DOI 10.1073/pnas.1117444108; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Talbot J, 2012, MOL CELL ENDOCRINOL, V364, P65, DOI 10.1016/j.mce.2012.08.010; Trembley JH, 2000, GENE, V255, P93, DOI 10.1016/S0378-1119(00)00319-X; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; Walsh S, 2003, MOL CANCER RES, V1, P280; Warfel NA, 2015, PHARMACOL THERAPEUT, V151, P41, DOI 10.1016/j.pharmthera.2015.03.001; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamaguchi Keisuke, 2005, Brain Tumor Pathol, V22, P1, DOI 10.1007/s10014-005-0178-1; Yamaguchi R, 2016, BLOOD CELL MOL DIS, V57, P85, DOI 10.1016/j.bcmd.2016.01.006; Yin DL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32167; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757	65	29	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8933	8947		10.1074/jbc.M116.770420	http://dx.doi.org/10.1074/jbc.M116.770420			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28341744	hybrid, Green Published			2022-12-28	WOS:000402153900045
J	Arndt, S; Baeza-Garza, CD; Logan, A; Rosa, T; Wedmann, R; Prime, TA; Martin, JL; Saeb-Parsy, K; Krieg, T; Filipovic, MR; Hartley, RC; Murphy, MP				Arndt, Sabine; Baeza-Garza, Carlos D.; Logan, Angela; Rosa, Tiziana; Wedmann, Rudolf; Prime, Tracy A.; Martin, Jack L.; Saeb-Parsy, Kourosh; Krieg, Thomas; Filipovic, Milos R.; Hartley, Richard C.; Murphy, Michael P.			Assessment of H2S in vivo using the newly developed mitochondria-targeted mass spectrometry probe MitoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE-GAMMA-LYASE; HYDROGEN-SULFIDE; FLUORESCENT-PROBES; NITRIC-OXIDE; LIVING DROSOPHILA; ANTIOXIDANT MITOQ; HEART-FAILURE; CELLS; MICE	Hydrogen sulfide (H2S) is produced endogenously in vivo and has multiple effects on signaling pathways and cell function. Mitochondria can be both an H2S source and sink, and many of the biological effects of H2S relate to its interactions with mitochondria. However, the significance of mitochondrial H2S is uncertain, in part due to the difficulty of assessing changes in its concentration in vivo. Although a number of fluorescent H2S probes have been developed these are best suited to cells in culture and cannot be used in vivo. To address this unmet need we have developed a mitochondria-targeted H2S probe, MitoA, which can be used to assess relative changes in mitochondrial H2S levels in vivo. MitoA comprises a lipophilic triphenylphosphonium (TPP) cation coupled to an aryl azide. The TPP cation leads to the accumulation of MitoA inside mitochondria within tissues in vivo. There, the aryl azido group reacts with H2S to form an aryl amine (MitoN). The extent of conversion of MitoA to MitoN thus gives an indication of the levels of mitochondrial H2S in vivo. Both compounds can be detected sensitively by liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis of the tissues, and quantified relative to deuterated internal standards. Here we describe the synthesis and characterization of MitoA and show that it can be used to assess changes in mitochondrial H2S levels in vivo. As a proof of principle we used MitoA to show that H2S levels increase in vivo during myocardial ischemia.	[Arndt, Sabine; Logan, Angela; Prime, Tracy A.; Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Baeza-Garza, Carlos D.; Hartley, Richard C.] Univ Glasgow, WestCHEM Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Rosa, Tiziana; Krieg, Thomas] Univ Cambridge, Dept Med, Biomed Campus, Cambridge CB2 2QQ, England; [Wedmann, Rudolf; Filipovic, Milos R.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Chem & Pharm, Egerlandstr 1, D-91058 Erlangen, Germany; [Filipovic, Milos R.] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France; [Martin, Jack L.; Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Biomed Campus, Cambridge CB2 2QQ, England; [Martin, Jack L.; Saeb-Parsy, Kourosh] Univ Cambridge, Cambridge NIHR Biomed Res Ctr, Biomed Campus, Cambridge CB2 2QQ, England	University of Cambridge; University of Glasgow; University of Cambridge; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; University of Cambridge	Murphy, MP (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.; Hartley, RC (corresponding author), Univ Glasgow, WestCHEM Sch Chem, Glasgow G12 8QQ, Lanark, Scotland.	Richard.Hartley@glasgow.ac.uk; mpm@mrc-mbu.cam.ac.uk	Hartley, Richard/AAT-7834-2020; Hartley, Richard/E-3489-2010; Murphy, Michael/C-2120-2009	Hartley, Richard/0000-0003-1033-5405; Hartley, Richard/0000-0003-1033-5405; Krieg, Thomas/0000-0002-5192-580X; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Arndt, Sabine/0000-0002-6728-0479; Murphy, Michael/0000-0003-1115-9618	Medical Research Council UK [MC_U105663142]; Wellcome Trust Investigator award [110159/Z/15/Z, 110158/Z/15/Z]; Biotechnology and Biological Sciences Research Council [BB/I012826/1]; Consejo Nacional de Ciencia y Technologia studentship; CNRS/INSERM Atip-Avenir grant; BBSRC [BB/I012826/1] Funding Source: UKRI; MRC [MR/L017520/1, MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142, MR/L017520/1] Funding Source: researchfish; Wellcome Trust [110158/Z/15/Z] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator award(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Consejo Nacional de Ciencia y Technologia studentship; CNRS/INSERM Atip-Avenir grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Medical Research Council UK Grant MC_U105663142, Wellcome Trust Investigator award 110159/Z/15/Z (to M. P. M.), Biotechnology and Biological Sciences Research Council Grant BB/I012826/1, Wellcome Trust Investigator award 110158/Z/15/Z (to R. C. H.), and a Consejo Nacional de Ciencia y Technologia studentship (to C. B.-G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a CNRS/INSERM Atip-Avenir grant.	Abe K, 1996, J NEUROSCI, V16, P1066; Artaud I, 2014, CHEMBIOCHEM, V15, P2361, DOI 10.1002/cbic.201402312; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Barca E, 2016, J NEUROPATH EXP NEUR, V75, P663, DOI 10.1093/jnen/nlw037; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Chen W, 2016, ANGEW CHEM INT EDIT, V55, P9993, DOI 10.1002/anie.201604892; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cocheme HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Dare AJ, 2015, REDOX BIOL, V5, P163, DOI 10.1016/j.redox.2015.04.008; Dare AJ, 2015, J HEART LUNG TRANSPL, V34, P1471, DOI 10.1016/j.healun.2015.05.007; Denekamp C, 1999, INT J MASS SPECTROM, V188, P163, DOI 10.1016/S1387-3806(99)00020-2; Derwall M, 2011, CRIT CARE, V15, DOI 10.1186/cc10016; Drabek T, 2011, SHOCK, V35, P67, DOI 10.1097/SHK.0b013e3181e86f49; Dufton N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00499; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Filipovic MR, 2012, J AM CHEM SOC, V134, P12016, DOI 10.1021/ja3009693; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hartle MD, 2016, ANGEW CHEM INT EDIT, V55, P11480, DOI 10.1002/anie.201605757; Hartle MD, 2016, DALTON T, V45, P4843, DOI 10.1039/c5dt04563k; Henthorn HA, 2015, J AM CHEM SOC, V137, P15330, DOI 10.1021/jacs.5b10675; Hughes M. N., 1968, J AM CHEM SOC, V1968, P450; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kamoun P, 2003, AM J MED GENET A, V116A, P310, DOI 10.1002/ajmg.a.10847; Kang JM, 2016, J AM CHEM SOC, V138, P6336, DOI 10.1021/jacs.6b01373; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; King AL, 2011, EXP PHYSIOL, V96, P840, DOI 10.1113/expphysiol.2011.059725; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Lin VS, 2015, CHEM SOC REV, V44, P4596, DOI 10.1039/c4cs00298a; Lin VS, 2013, P NATL ACAD SCI USA, V110, P7131, DOI 10.1073/pnas.1302193110; Lippert AR, 2011, J AM CHEM SOC, V133, P10078, DOI 10.1021/ja203661j; Logan A, 2014, BBA-GEN SUBJECTS, V1840, P923, DOI 10.1016/j.bbagen.2013.05.026; Lord SJ, 2008, J AM CHEM SOC, V130, P9204, DOI 10.1021/ja802883k; Manna P, 2014, J BIOL CHEM, V289, P11767, DOI 10.1074/jbc.M113.524645; Miljkovic JL, 2013, ANGEW CHEM INT EDIT, V52, P12061, DOI 10.1002/anie.201305669; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Montoya LA, 2012, CHEM COMMUN, V48, P4767, DOI 10.1039/c2cc30730h; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Nicholls P, 2013, BIOCHEM SOC T, V41, P1312, DOI 10.1042/BST20130070; ONO H, 1984, J BIOCHEM-TOKYO, V95, P345, DOI 10.1093/oxfordjournals.jbchem.a134614; Porteous CM, 2013, BBA-GEN SUBJECTS, V1830, P3458, DOI 10.1016/j.bbagen.2013.02.005; Porteous CM, 2010, BBA-GEN SUBJECTS, V1800, P1009, DOI 10.1016/j.bbagen.2010.06.001; Pun PBL, 2014, FREE RADICAL BIO MED, V67, P437, DOI 10.1016/j.freeradbiomed.2013.11.025; Qian Y, 2012, CHEM SCI, V3, P2920, DOI 10.1039/c2sc20537h; Schmidt B, 2010, CIRC-ARRHYTHMIA ELEC, V3, P481, DOI 10.1161/CIRCEP.110.954149; Shimamoto K, 2015, NITRIC OXIDE-BIOL CH, V46, P72, DOI 10.1016/j.niox.2014.11.008; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Szabo C, 2014, BRIT J PHARMACOL, V171, P2099, DOI 10.1111/bph.12369; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Wang XL, 2011, BIOSCIENCE REP, V31, P87, DOI 10.1042/BSR20100003; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	68	25	25	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7761	7773		10.1074/jbc.M117.784678	http://dx.doi.org/10.1074/jbc.M117.784678			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28320864	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000401154100007
J	Meijer, BM; Jang, SM; Guerrera, IC; Chhuon, C; Lipecka, J; Reisacher, C; Baleux, F; Sansonetti, PJ; Muchardt, C; Arbibe, L				Meijer, Benoit M.; Jang, Suk Min; Guerrera, Ida C.; Chhuon, Cerina; Lipecka, Joanna; Reisacher, Caroline; Baleux, Francoise; Sansonetti, Philippe J.; Muchardt, Christian; Arbibe, Laurence			Threonine eliminylation by bacterial phosphothreonine lyases rapidly causes cross-linking of mitogen-activated protein kinase (MAPK) in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATARACTOUS HUMAN LENSES; EFFECTOR; SECRETION; IDENTIFICATION; ELIMINATION; PHOSPHATE; REPORTER	Old long-lived proteins contain dehydroalanine (Dha) and dehydrobutyrine (Dhb), two amino acids engendered by dehydration of serines and threonines, respectively. Although these residues have a suspected role in protein cross-linking and aggregation, their direct implication has yet to be determined. Here, we have taken advantage of the ability of the enteropathogen Shigella to convert the phosphothreonine residue of the pT-X-pY consensus sequence of ERK and p38 into Dhb and followed the impact of dehydration on the fate of the two MAPKs. To that end, we have generated the first antibodies recognizing Dhb-modified proteins and allowing tracing them as they form. We showed that Dhb modifications accumulate in a long-lasting manner in Shigella-infected cells, causing subsequent formation of covalent cross-links of MAPKs. Moreover, the Dhb signal correlates precisely with the activation of the Shigella type III secretion apparatus, thus evidencing injectisome activity. This observation is the first to document a causal link between Dhb formation and protein cross-linking in live cells. Detection of eliminylation is a new avenue to phosphoproteome regulation in eukaryotes that will be instrumental for the development of type III secretion inhibitors.	[Meijer, Benoit M.; Reisacher, Caroline; Arbibe, Laurence] CNRS UMR 8253, Dept Immunol Infectiol & Hematol, Team Genom Plast & Infect, Inst Necker Enfants Malad,INSERM U1151, F-75993 Paris 14, France; [Arbibe, Laurence] Univ Paris 05, F-75270 Paris 06, France; [Meijer, Benoit M.] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur UPMC, F-75724 Paris, France; [Jang, Suk Min; Muchardt, Christian] Inst Pasteur, Dept Biol Dev & Cellules Souches, Unite Regulat Epigenet, F-75724 Paris 15, France; [Jang, Suk Min; Muchardt, Christian] UMR3738 CNRS, F-75732 Paris 15, France; [Guerrera, Ida C.; Chhuon, Cerina; Lipecka, Joanna] Struct Federat Rech SFR Necker US24, PPN 3P5, Prote Platform Necker, F-75015 Paris, France; [Lipecka, Joanna] UMR INSERM 894, Ctr Psychiat & Neurosci, CPN Prote Facil 3P5, F-75014 Paris, France; [Baleux, Francoise] Inst Pasteur, Unite Chim Biomol, F-75015 Paris, France; [Sansonetti, Philippe J.] Inst Pasteur, Unite INSERM U1202, Unite Pathogenie Microbienne Mol, F-75015 Paris, France; [Jang, Suk Min] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Arbibe, L (corresponding author), CNRS UMR 8253, Dept Immunol Infectiol & Hematol, Team Genom Plast & Infect, Inst Necker Enfants Malad,INSERM U1151, F-75993 Paris 14, France.; Arbibe, L (corresponding author), Univ Paris 05, F-75270 Paris 06, France.	laurence.arbibe@inserm.fr	GUERRERA, Ida Chiara/GOJ-9151-2022	GUERRERA, Ida Chiara/0000-0002-4832-6793; Reisacher, Caroline/0000-0002-8390-2872; Arbibe, Laurence/0000-0001-7102-346X	Agence National de la Recherche; INSERM; Ministere de l'Enseignement Superieur et de la Recherche; ENS Cachan	Agence National de la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); ENS Cachan	This work was supported by grants from the Agence National de la Recherche and INSERM and by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche and ENS Cachan (to B. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrzejewska Z, 2016, J AM SOC NEPHROL, V27, P1678, DOI 10.1681/ASN.2014090937; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; BESSEMS GJH, 1987, EXP EYE RES, V44, P691, DOI 10.1016/S0014-4835(87)80139-2; Campbell-Valois FX, 2014, CELL HOST MICROBE, V15, P177, DOI 10.1016/j.chom.2014.01.005; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cloos PAC, 2000, BIOGERONTOLOGY, V1, P341, DOI 10.1023/A:1026534400435; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Goswami S, 2009, BIODEGRADATION, V20, P199, DOI 10.1007/s10532-008-9213-3; Konradt C, 2011, CELL HOST MICROBE, V9, P263, DOI 10.1016/j.chom.2011.03.010; LeGouy E, 1998, DEV DYNAM, V212, P38, DOI 10.1002/(SICI)1097-0177(199805)212:1<38::AID-AJA4>3.0.CO;2-3; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Linetsky M, 2004, EXP EYE RES, V79, P499, DOI 10.1016/j.exer.2004.06.026; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mattila K, 2005, ORG BIOMOL CHEM, V3, P3039, DOI 10.1039/b505573c; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; SAMUEL D, 1963, J CHEM SOC, P289, DOI 10.1039/jr9630000289; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Srivastava K, 2008, EXP EYE RES, V87, P356, DOI 10.1016/j.exer.2008.07.001; Wang Z, 2014, AGING CELL, V13, P226, DOI 10.1111/acel.12164; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006	22	3	3	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7784	7794		10.1074/jbc.M117.775940	http://dx.doi.org/10.1074/jbc.M117.775940			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325837	Green Published, hybrid			2022-12-28	WOS:000401154100009
J	van Haaften-Visser, DY; Harakalova, M; Mocholi, E; van Montfrans, JM; Elkadri, A; Rieter, E; Fiedler, K; van Hasselt, PM; Triffaux, EMM; van Haelst, MM; Nijman, IJ; Kloosterman, WP; Nieuwenhuis, EES; Muise, AM; Cuppen, E; Houwen, RHJ; Coffer, PJ				van Haaften-Visser, Desiree Y.; Harakalova, Magdalena; Mocholi, Enric; van Montfrans, Joris M.; Elkadri, Abdul; Rieter, Ester; Fiedler, Karoline; van Hasselt, Peter M.; Triffaux, Emily M. M.; van Haelst, Mieke M.; Nijman, Isaac J.; Kloosterman, Wigard P.; Nieuwenhuis, Edward E. S.; Muise, Aleixo M.; Cuppen, Edwin; Houwen, Roderick H. J.; Coffer, Paul J.			Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; ULCERATIVE-COLITIS; CROHNS-DISEASE; MODIFIER GENES; PATHOGENESIS; PROTEIN; STABILIZATION; RECEPTOR; CELLS	Infantile-onset inflammatory bowel disease (IO IBD) is an invalidating illness with an onset before 2 years of age and has a complex pathophysiology in which genetic factors are important. Homozygosity mapping and whole-exome sequencing in an IO IBD patient and subsequent sequencing of the candidate gene in 12 additional IO IBD patients revealed two patients with two mutated ankyrin repeat and zinc-finger domain-containing 1 (ANKZF1) alleles (homozygous ANKZF1 R585Q mutation and compound heterozygous ANKZF1 E152K and V32_Q87del mutations, respectively) and two patients with one mutated ANKZF1 allele. Although the function of ANKZF1 in mammals had not been previously evaluated, we show that ANKZF1 has an indispensable role in the mitochondrial response to cellular stress. ANKZF1 is located diffusely in the cytoplasm and translocates to the mitochondria upon cellular stress. ANKZF1 depletion reduces mitochondrial integrity and mitochondrial respiration under conditions of cellular stress. The ANKZF1 mutations identified in IO IBD patients with two mutated ANKZF1 alleles result in dysfunctional ANKZF1, as shown by an increased level of apoptosis in patients' lymphocytes, a decrease in mitochondrial respiration in patient fibroblasts with a homozygous ANKZF1 R585Q mutation, and an inability of ANKZF1 R585Q and E152K to rescue the phenotype of yeast deficient in Vms1, the yeast homologue of ANKZF1. These data indicate that loss-of-function mutations in ANKZF1 result in deregulation of mitochondrial integrity, and this may play a pathogenic role in the development of IO IBD.	[van Haaften-Visser, Desiree Y.; van Montfrans, Joris M.; van Hasselt, Peter M.; Nieuwenhuis, Edward E. S.; Houwen, Roderick H. J.; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, NL-3584 CT Utrecht, Netherlands; [van Haaften-Visser, Desiree Y.; Mocholi, Enric; Rieter, Ester; Triffaux, Emily M. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Regenerat Med Ctr, Uppsalalaan 6, NL-3584 CT Utrecht, Netherlands; [van Haaften-Visser, Desiree Y.; Mocholi, Enric; Rieter, Ester; Triffaux, Emily M. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CT Utrecht, Netherlands; [Harakalova, Magdalena; van Haelst, Mieke M.; Nijman, Isaac J.; Kloosterman, Wigard P.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CT Utrecht, Netherlands; [Elkadri, Abdul; Fiedler, Karoline; Muise, Aleixo M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Elkadri, Abdul; Fiedler, Karoline; Muise, Aleixo M.] Hosp Sick Children, SickKids Inflammatory Bowel Dis Ctr, Toronto, ON M5G 1X8, Canada; [Elkadri, Abdul; Fiedler, Karoline; Muise, Aleixo M.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Cuppen, Edwin] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Regenerat Med Ctr, Uppsalalaan 6, NL-3584 CT Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Coffer, Paul/AAF-7970-2020; Mocholi, Enric/ABH-5275-2020; Elkadri, Abdul/CAJ-1902-2022	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Mocholi Gimeno, Enric/0000-0002-6614-3173	Dutch Rheumatology Foundation (ReumaFonds) [2016-1-003]; Marie Curie Initial Training Network grant: European Translational tRaining for Autoimmunity and Immune manipulation Network (EU-TRAIN) [R2409]	Dutch Rheumatology Foundation (ReumaFonds); Marie Curie Initial Training Network grant: European Translational tRaining for Autoimmunity and Immune manipulation Network (EU-TRAIN)	Supported by Dutch Rheumatology Foundation (ReumaFonds) Grant 2016-1-003.r Supported by a Marie Curie Initial Training Network grant: European Translational tRaining for Autoimmunity and Immune manipulation Network (EU-TRAIN) Grant R2409.	Adolph TE, 2012, DIGEST DIS, V30, P341, DOI 10.1159/000338121; Avitzur Y, 2014, GASTROENTEROLOGY, V146, P1028, DOI 10.1053/j.gastro.2014.01.015; Beltran B, 2010, INFLAMM BOWEL DIS, V16, P76, DOI 10.1002/ibd.21027; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, CURR OPIN GASTROEN, V26, P318, DOI 10.1097/MOG.0b013e32833a9ff1; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Paul T, 2006, J CLIN GASTROENTEROL, V40, P583, DOI 10.1097/00004836-200608000-00004; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santhanam S, 2012, INFLAMM BOWEL DIS, V18, P2158, DOI 10.1002/ibd.22926; Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	35	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7904	7920		10.1074/jbc.M116.772038	http://dx.doi.org/10.1074/jbc.M116.772038			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302725	Green Published, hybrid			2022-12-28	WOS:000401154100018
J	Malonis, RJ; Fu, WX; Jelcic, MJ; Thompson, M; Canter, BS; Tsikitis, M; Esteva, FJ; Sanchez, I				Malonis, Ryan J.; Fu, Wenxiang; Jelcic, Mark J.; Thompson, Marae; Canter, Brian S.; Tsikitis, Mary; Esteva, Francisco J.; Sanchez, Irma			RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; E3 ubiquitin ligase; endosome; transforming growth factor beta (TGF-B); ubiquitylation (ubiquitination)	FINGER PROTEIN 11; TGF-BETA RECEPTOR; UBIQUITIN LIGASE; BREAST-CANCER; I RECEPTOR; DOMAIN; DEGRADATION; METASTASIS; INTERACTS; PATHWAYS	The activity of the E3 ligase, SMURF2, is antagonized by an intramolecular, autoinhibitory interaction between its C2 and Hect domains. Relief of SMURF2 autoinhibition is induced by TGF and is mediated by the inhibitory SMAD, SMAD7. In a proteomic screen for endomembrane interactants of the RING-domain E3 ligase, RNF11, we identified SMURF2, among a cohort of Hect E3 ligases previously implicated in TGF signaling. Reconstitution of the SMURF2<bold>RNF</bold>11 complex in vitro unexpectedly revealed robust SMURF2 E3 ligase activity, with biochemical properties previously restricted to the SMURF2<bold>SMAD</bold>7 complex. Using in vitro binding assays, we find that RNF11 can directly compete with SMAD7 for SMURF2 and that binding is mutually exclusive and dependent on a proline-rich domain. Moreover, we found that co-expression of RNF11 and SMURF2 dramatically reduced SMURF2 ubiquitylation in the cell. This effect is strictly dependent on complex formation and sorting determinants that regulate the association of RNF11 with membranes. RNF11 is overexpressed in certain tumors, and, importantly, we found that depletion of this protein down-regulated gene expression of several TGF-responsive genes, dampened cell proliferation, and dramatically reduced cell migration in response to TGF. Our data suggest for the first time that the choice of binding partners for SMURF2 can sustain or repress TGF signaling, and RNF11 may promote TGF-induced cell migration.	[Malonis, Ryan J.; Fu, Wenxiang; Jelcic, Mark J.; Thompson, Marae; Canter, Brian S.; Tsikitis, Mary; Esteva, Francisco J.; Sanchez, Irma] NYU Langone, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Malonis, Ryan J.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Fu, Wenxiang] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Jelcic, Mark J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Canter, Brian S.] Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Tsikitis, Mary] Acad Athens, Div Cell Biol, Athens 11527, Greece	NYU Langone Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Basel; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Academy of Athens	Sanchez, I (corresponding author), NYU Langone, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	Irma.Sanchez@nyumc.org		Esteva, Francisco J./0000-0003-2437-3920; Canter, Brian/0000-0002-4496-3293	Center to Reduce Cancer Health Disparities (CRCHD) of NCI, National Institutes of Health [R21CA153179, R21CA15317902-S1, R21CA15317902-S2]; Department of Pathology at the NYU School of Medicine; NATIONAL CANCER INSTITUTE [R21CA153179] Funding Source: NIH RePORTER	Center to Reduce Cancer Health Disparities (CRCHD) of NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology at the NYU School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Center to Reduce Cancer Health Disparities (CRCHD) of NCI, National Institutes of Health, Grants R21CA153179, R21CA15317902-S1, and R21CA15317902-S2 (to I. S.) and bridging funds from the Department of Pathology at the NYU School of Medicine. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Anderson L. B., 2007, THESIS; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duffy MJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0428-4; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fu WX, 2016, CELL REP, V17, P1505, DOI 10.1016/j.celrep.2016.10.018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.bbadis.2003.07.001; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kostaras E, 2013, ONCOGENE, V32, P5220, DOI 10.1038/onc.2012.554; Krstic J, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/521754; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lallemand F, 2005, J BIOL CHEM, V280, P27645, DOI 10.1074/jbc.M500188200; Mazzoccoli G, 2012, J CANCER RES CLIN, V138, P501, DOI 10.1007/s00432-011-1126-6; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Santonico E, 2015, ONCOGENE, V34, P3377, DOI 10.1038/onc.2014.256; Santonico E, 2010, ONCOGENE, V29, P5604, DOI 10.1038/onc.2010.294; Seki N, 1999, BBA-GENE STRUCT EXPR, V1489, P421, DOI 10.1016/S0167-4781(99)00190-6; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; Wang L, 2015, AM J TRANSL RES, V7, P1629; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050	31	20	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7435	7451		10.1074/jbc.M117.783662	http://dx.doi.org/10.1074/jbc.M117.783662			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28292929	Green Published, hybrid			2022-12-28	WOS:000400761300014
J	Aksnes, H; Goris, M; Stromland, O; Drazic, A; Waheed, Q; Reuter, N; Arnesen, T				Aksnes, Henriette; Goris, Marianne; Stromland, Oyvind; Drazic, Adrian; Waheed, Qaiser; Reuter, Nathalie; Arnesen, Thomas			Molecular determinants of the N-terminal acetyltransferase Naa60 anchoring to the Golgi membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; ALPHA-ACETYLTRANSFERASE; CELLULAR-PROTEINS; GTPASE ARL3P; FORCE-FIELD; ACETYLATION; DYNAMICS; YEAST; CHARMM; REVEALS	N alpha-Acetyltransferase 60 (Naa60 or NatF) was recently identified as an unconventional N-terminal acetyltransferase (NAT) because it localizes to organelles, in particular the Golgi apparatus, and has a preference for acetylating N termini of the transmembrane proteins. This knowledge challenged the prevailing view of N-terminal acetylation as a co-translational ribosomeassociated process and suggested a new mechanistic functioning for the enzymes responsible for this increasingly recognized protein modification. Crystallography studies on Naa60 were unable to resolve the C-terminal tail of Naa60, which is responsible for the organellar localization. Here, we combined modeling, in vitro assays, and cellular localization studies to investigate the secondary structure and membrane interacting capacity of Naa60. The results show that Naa60 is a peripheral membrane protein. Two amphipathic helices within the Naa60 C terminus bind the membrane directly in a parallel position relative to the lipid bilayer via hydrophobic and electrostatic interactions. A peptide corresponding to the C terminus was unstructured in solution and only folded into an alpha-helical conformation in the presence of liposomes. Computational modeling and cellular mutational analysis revealed the hydrophobic face of two alpha-helices to be critical for membranous localization. Furthermore, we found a strong and specific binding preference of Naa60 toward membranes containing the phosphatidylinositol PI(4) P, thus possibly explaining the primary residency of Naa60 at the PI(4) P-rich Golgi. In conclusion, we have defined the mode of cytosolic Naa60 anchoring to the Golgi apparatus, most likely occurring post-translationally and specifically facilitating post-translational N-terminal acetylation of many transmembrane proteins.	[Aksnes, Henriette; Goris, Marianne; Stromland, Oyvind; Drazic, Adrian; Waheed, Qaiser; Reuter, Nathalie; Arnesen, Thomas] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Waheed, Qaiser; Reuter, Nathalie] Univ Bergen, Dept Informat, Computat Biol Unit, N-5020 Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Arnesen, T (corresponding author), Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway.; Arnesen, T (corresponding author), Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway.	thomas.arnesen@uib.no	Reuter, Nathalie/G-2037-2012; Arnesen, Thomas/J-7139-2017; Arnesen, Thomas/Q-8117-2019; Aksnes, Henriette/AAD-6290-2020; Drazic, Adrian/AAC-6120-2019	Reuter, Nathalie/0000-0002-3649-7675; Arnesen, Thomas/0000-0002-3005-147X; Arnesen, Thomas/0000-0002-3005-147X; Aksnes, Henriette/0000-0003-4968-2324; Drazic, Adrian/0000-0001-9263-5502; Goris, Marianne/0000-0003-0175-3082; Waheed, Qaiser/0000-0002-7566-2506	Research Council of Norway [230865, 249843]; Norwegian Cancer Society; Bergen Research Foundation BFS; Deutsche Forschungsgemeinschaft [DR 998/2-1]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Bergen Research Foundation BFS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Research Council of Norway Grants 230865 and 249843 (to T. A.), grants from the Norwegian Cancer Society (to T. A.), the Bergen Research Foundation BFS (to T. A.), and fellowship Grant DR 998/2-1 from the Deutsche Forschungsgemeinschaft (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Aksnes H, 2015, TRENDS BIOCHEM SCI, V40, P422, DOI 10.1016/j.tibs.2015.05.003; Aksnes H, 2015, CELL REP, V10, P1362, DOI 10.1016/j.celrep.2015.01.053; Aksnes H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061012; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bienvenut WV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015131; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carney Joanne, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1912s45; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Chen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31425; Chon NL, 2015, BIOCHEMISTRY-US, V54, P5696, DOI 10.1021/acs.biochem.5b00422; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; Dinh TV, 2015, PROTEOMICS, V15, P2426, DOI 10.1002/pmic.201500025; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Fritzsching KJ, 2013, BBA-BIOMEMBRANES, V1828, P1889, DOI 10.1016/j.bbamem.2013.03.028; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Guixa-Gonzalez R, 2014, BIOINFORMATICS, V30, P1478, DOI 10.1093/bioinformatics/btu037; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Holmes WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5383; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Izaguirre JA, 1999, J CHEM PHYS, V110, P9853, DOI 10.1063/1.478995; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miller MB, 2015, J BIOL CHEM, V290, P13541, DOI 10.1074/jbc.M115.636746; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Myklebust LM, 2015, HUM MOL GENET, V24, P1956, DOI 10.1093/hmg/ddu611; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Rathore OS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21304; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Saunier C, 2016, HUM MUTAT, V37, P755, DOI 10.1002/humu.23001; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Sodt AJ, 2015, BIOPHYS J, V109, P948, DOI 10.1016/j.bpj.2015.07.036; Stove SI, 2016, STRUCTURE, V24, P1044, DOI 10.1016/j.str.2016.04.020; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233	58	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6821	6837		10.1074/jbc.M116.770362	http://dx.doi.org/10.1074/jbc.M116.770362			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28196861	Green Published, hybrid			2022-12-28	WOS:000399813400032
J	Groves, JA; Maduka, AO; O'Meally, RN; Cole, RN; Zachara, NE				Groves, Jennifer A.; Maduka, Austin O.; O'Meally, Robert N.; Cole, Robert N.; Zachara, Natasha E.			Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMISCUOUS PROTEIN BIOTINYLATION; BETA-N-ACETYLGLUCOSAMINIDASE; ISCHEMIA-REPERFUSION INJURY; NEONATAL CARDIOMYOCYTES; CYTOSOLIC PROTEINS; TRAUMA-HEMORRHAGE; IMPROVES SURVIVAL; DATA SUBMISSION; PRIDE DATABASE; X-CHROMOSOME	The dynamic post-translational modification O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates thousands of nuclear, cytoplasmic, and mitochondrial proteins. Cellular stress, including oxidative stress, results in increased O-GlcNAcylation of numerous proteins, and this increase is thought to promote cell survival. The mechanisms by which the O-GlcNAc transferase (OGT) and the O-GlcNAcase (OGA), the enzymes that add and remove O-GlcNAc, respectively, are regulated during oxidative stress to alter O-GlcNAcylation are not fully characterized. Here, we demonstrate that oxidative stress leads to elevated O-GlcNAc levels in U2OS cells but has little impact on the activity of OGT. In contrast, the expression and activity of OGA are enhanced. Wehypothesized that this seeming paradox could be explained by proteins that bind to and control the local activity or substrate targeting of OGA, thereby resulting in the observed stress-induced elevations of O-GlcNAc. To identify potential protein partners, we utilized BioID proximity biotinylation in combination with stable isotopic labeling of amino acids in cell culture (SILAC). This analysis revealed 90 OGA-interacting partners, many of which exhibited increased binding to OGA upon stress. The associations of OGA with fatty acid synthase (FAS), filamin-A, heat shock cognate 70-kDa protein, and OGT were confirmed by co-immunoprecipitation. The pool of OGA bound to FAS demonstrated a substantial (similar to 85%) reduction in specific activity, suggesting that FAS inhibits OGA. Consistent with this observation, FAS overexpression augmented stress-induced O-GlcNAcylation. Although the mechanism by which FAS sequesters OGA remains unknown, these data suggest that FAS fine-tunes the cell's response to stress and injury by remodeling cellular O-GlcNAcylation.	[Groves, Jennifer A.; Maduka, Austin O.; O'Meally, Robert N.; Cole, Robert N.; Zachara, Natasha E.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA; [Maduka, Austin O.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA; [O'Meally, Robert N.; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore County; Johns Hopkins University	Zachara, NE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	nzachara@jhmi.edu			National Institutes of Health [P01HL107153, S10RR024550]; National Institutes of Health Grant from NCI [P30CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Antibodies for OGA (345) and O-GlcNAc (CTD110.6), as well as pcDNA3.1 His<INF>6</INF>-OGA, were kind gifts from the laboratory of Gerald Hart (Department of Biological Chemistry, The Johns Hopkins University School of Medicine Core C4, supported by National Institutes of Health Grant P01HL107153). We thank Michael Wolfgang (Department of Biological Chemistry, The Johns Hopkins University School of Medicine) for providing pCMV-SPORT6 FAS and Kyle Roux (Sanford Research) for providing pcDNA3.1 Myc-mBirA-MCS and pcDNA3.1 MCS-mBirA-HA via Addgene. Confocal microscopy was performed at The Johns Hopkins University School of Medicine Microscope Facility (supported by National Institutes of Health Grant S10RR024550; Research Resources). Mass spectrometry sample preparation, data acquisition, and database searching was performed by The Johns Hopkins University School of Medicine Mass Spectrometry and Proteomics Facility (supported by National Institutes of Health Grant P30CA006973 from NCI).	AbdAlla Said, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P190; Amanchy Ramars, 2005, Sci STKE, V2005, ppl2, DOI 10.1126/stke.2672005pl2; Baldini SF, 2016, J MOL BIOL, V428, P3295, DOI 10.1016/j.jmb.2016.04.035; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Boulon S, 2010, MOL CELL PROTEOMICS, V9, P861, DOI 10.1074/mcp.M900517-MCP200; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Cote RG, 2012, MOL CELL PROTEOMICS, V11, P1682, DOI 10.1074/mcp.O112.021543; Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Greig KT, 2007, MOL CELL BIOL, V27, P5849, DOI 10.1128/MCB.00802-07; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hamada S, 2014, JPN J CLIN ONCOL, V44, P486, DOI 10.1093/jjco/hyu020; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hwang SY, 2010, GLIA, V58, P1881, DOI 10.1002/glia.21058; Ito T, 2014, ONCOL LETT, V7, P616, DOI 10.3892/ol.2014.1793; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Jensen RV, 2013, SCAND CARDIOVASC J, V47, P168, DOI 10.3109/14017431.2012.756984; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Lee A, 2016, J PROTEOME RES, V15, P4318, DOI 10.1021/acs.jproteome.6b00369; Lee JS, 2009, BIOL PHARM BULL, V32, P1427, DOI 10.1248/bpb.32.1427; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Mehta Virja, 2016, F1000Res, V5, DOI 10.12688/f1000research.7629.1; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; MOSS J, 1971, ADV ENZYMOL RAMB, V35, P321; Mullen GE, 2015, BIOORG MED CHEM LETT, V25, P4363, DOI 10.1016/j.bmcl.2015.08.087; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Neilson Karlie A, 2013, Methods Mol Biol, V1002, P205, DOI 10.1007/978-1-62703-360-2_17; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Not LG, 2007, SHOCK, V28, P345, DOI 10.1097/shk.0b013e3180487ebb; Not LG, 2010, CRIT CARE MED, V38, P562, DOI 10.1097/CCM.0b013e3181cb10b3; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Perez-Riverol Y, 2016, MOL CELL PROTEOMICS, V15, P305, DOI 10.1074/mcp.O115.050229; Pizer ES, 1996, CANCER RES, V56, P1189; Razani B, 2011, J BIOL CHEM, V286, P30949, DOI 10.1074/jbc.M111.230508; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Ryu IH, 2011, BIOCHEM BIOPH RES CO, V408, P52, DOI 10.1016/j.bbrc.2011.03.115; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Seither P, 1998, J MOL BIOL, V275, P43, DOI 10.1006/jmbi.1997.1434; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Srikanth B, 2010, J BIOL CHEM, V285, P34062, DOI 10.1074/jbc.M109.098996; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Varnaite R, 2016, PROTEOMICS, V16, P2503, DOI 10.1002/pmic.201600123; Veigel D, 2015, INT J CANCER, V136, P2078, DOI 10.1002/ijc.29261; Ventura R, 2015, EBIOMEDICINE, V2, P808, DOI 10.1016/j.ebiom.2015.06.020; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wakamiya T, 2014, NEUROPATHOLOGY, V34, P465, DOI 10.1111/neup.12132; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Yang SL, 2006, SHOCK, V25, P600, DOI 10.1097/01.shk.0000209563.07693.db; Yang Y., 2012, ADV MULTIMEDIA, V2012, P11, DOI DOI 10.1016/j.jep.2012.11.041; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2011, AMINO ACIDS, V40, P793, DOI 10.1007/s00726-010-0695-z; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang Z, 2016, J BIOL CHEM, V291, P15628, DOI 10.1074/jbc.M116.721928; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339; Zhou WB, 2003, CANCER RES, V63, P7330; Zou LY, 2007, SHOCK, V27, P402, DOI 10.1097/01.shk.0000245031.31859.29	92	36	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6493	6511		10.1074/jbc.M116.760785	http://dx.doi.org/10.1074/jbc.M116.760785			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28232487	Green Published, hybrid			2022-12-28	WOS:000399813400007
J	Inoue, M; Ando, D; Kamada, H; Taki, S; Niiyama, M; Mukai, Y; Tadokoro, T; Maenaka, K; Nakayama, T; Kado, Y; Inoue, T; Tsutsumi, Y; Tsunoda, S				Inoue, Masaki; Ando, Daisuke; Kamada, Haruhiko; Taki, Shintaro; Niiyama, Mayumi; Mukai, Yohei; Tadokoro, Takashi; Maenaka, Katsumi; Nakayama, Taisuke; Kado, Yuji; Inoue, Tsuyoshi; Tsutsumi, Yasuo; Tsunoda, Shin-ichi			A trimeric structural fusion of an antagonistic tumor necrosis factor-alpha mutant enhances molecular stability and enables facile modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PEGYLATION; T-REGULATORY-CELLS; SINGLE-CHAIN TNF; TRANSMEMBRANE-TNF; TRANSGENIC MICE; ARTHRITIS; THERAPY; DEMYELINATION; INFECTION; EXPANSION	Tumor necrosis factor-alpha (TNF) exerts its biological effect through two types of receptors, p55 TNF receptor (TNFR1) and p75 TNF receptor (TNFR2). An inflammatory response is known to be induced mainly by TNFR1, whereas an anti-inflammatory reaction is thought to be mediated by TNFR2 in some autoimmune diseases. We have been investigating the use of an antagonistic TNF mutant (TNFR1-selective antagonistic TNF mutant (R1antTNF)) to reveal the pharmacological effect of TNFR1-selective inhibition as a new therapeutic modality. Here, we aimed to further improve and optimize the activity and behavior of this mutant protein both in vitro and in vivo. Specifically, we examined a trimeric structural fusion of R1antTNF, formed via the introduction of short peptide linkers, as a strategy to enhance bioactivity and molecular stability. By comparative analysis with R1antTNF, the trimeric fusion, referred to as single-chain R1antTNF (scR1antTNF), was found to retain in vitro molecular properties of receptor selectivity and antagonistic activity but displayed a marked increase in thermal stability. The residence time of scR1antTNF in vivo was also significantly prolonged. Furthermore, molecular modification using polyethylene glycol (PEG) was easily controlled by limiting the number of reactive sites. Taken together, our findings show that scR1antTNF displays enhanced molecular stability while maintaining biological activity compared with R1antTNF.	[Inoue, Masaki; Ando, Daisuke; Kamada, Haruhiko; Taki, Shintaro; Niiyama, Mayumi; Mukai, Yohei; Nakayama, Taisuke; Kado, Yuji; Inoue, Tsuyoshi; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, 7-6-8 Saito Asagi, Osaka 5670085, Japan; [Inoue, Masaki; Kamada, Haruhiko; Mukai, Yohei; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, 7-6-8 Saito Asagi, Osaka 5670085, Japan; [Inoue, Masaki; Tsunoda, Shin-ichi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Cellular & Mol Physiol, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan; [Ando, Daisuke; Taki, Shintaro; Tsunoda, Shin-ichi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biomed Innovat, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan; [Tsutsumi, Yasuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Toxicol & Safety Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan; [Kamada, Haruhiko; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Global Ctr Med Engn & Informat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Ctr Res & Educ Drug Discovery, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Nakayama, Taisuke; Kado, Yuji; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Div Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan	Kobe Gakuin University; Osaka University; Osaka University; Osaka University; Hokkaido University; Osaka University	Kamada, H (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, 7-6-8 Saito Asagi, Osaka 5670085, Japan.; Tsunoda, S (corresponding author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Cellular & Mol Physiol, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	kamada@nibiohn.go.jp; tsunoda@pharm.kobegakuin.ac.jp			Japan Society for the Promotion of Science KAKENHI; Hoansya Foundation; Takeda Science Foundation; Project for Cancer Research and Therapeutic Evolution (P-CREATE); Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hoansya Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Project for Cancer Research and Therapeutic Evolution (P-CREATE); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Society for the Promotion of Science KAKENHI, Hoansya Foundation, Takeda Science Foundation, Project for Cancer Research and Therapeutic Evolution (P-CREATE), and the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2008, J IMMUNOL METHODS, V335, P71, DOI 10.1016/j.jim.2008.02.019; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Ban Liqin, 2015, Mol Cell Ther, V3, P7, DOI 10.1186/s40591-015-0044-4; Boschert V, 2010, CELL SIGNAL, V22, P1088, DOI 10.1016/j.cellsig.2010.02.011; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Butler DM, 1997, J IMMUNOL, V159, P2867; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2011, IMMUNOLOGY, V133, P426, DOI 10.1111/j.1365-2567.2011.03460.x; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Kamada H, 1999, BIOCHEM BIOPH RES CO, V257, P448, DOI 10.1006/bbrc.1999.0353; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Krippner-Heidenreich A, 2008, J IMMUNOL, V180, P8176, DOI 10.4049/jimmunol.180.12.8176; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; Lubel JS, 2007, INTERN MED J, V37, P705, DOI 10.1111/j.1445-5994.2007.01479.x; Mercieca C, 2012, MOD RHEUMATOL, V22, P303, DOI 10.1007/s10165-011-0498-4; Mori L, 1996, J IMMUNOL, V157, P3178; Morishige T, 2010, BIOCHEM BIOPH RES CO, V393, P888, DOI 10.1016/j.bbrc.2010.02.119; Nomura T, 2011, J CONTROL RELEASE, V149, P8, DOI 10.1016/j.jconrel.2009.12.015; Okubo Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03153; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Rouached H, 2005, J BIOL CHEM, V280, P15976, DOI 10.1074/jbc.M501635200; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Shibata H, 2004, CLIN CANCER RES, V10, P8293, DOI 10.1158/1078-0432.CCR-04-0770; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Shibata H, 2009, BIOMATERIALS, V30, P6638, DOI 10.1016/j.biomaterials.2009.08.041; Talpaz M, 2001, BLOOD, V98, P1708, DOI 10.1182/blood.V98.6.1708; Thalayasingam N, 2011, BEST PRACT RES CL RH, V25, P549, DOI 10.1016/j.berh.2011.10.004; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; Yoshioka Y, 2004, BIOCHEM BIOPH RES CO, V315, P808, DOI 10.1016/j.bbrc.2004.01.125	34	8	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6438	6451		10.1074/jbc.M117.779686	http://dx.doi.org/10.1074/jbc.M117.779686			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28235800	hybrid, Green Published			2022-12-28	WOS:000399813400002
J	Lee, HJ; Lee, DY; Mariappan, MM; Feliers, D; Ghosh-Choudhury, G; Abboud, HE; Gorin, Y; Kasinath, BS				Lee, Hak Joo; Lee, Doug Yoon; Mariappan, Meenalakshmi M.; Feliers, Denis; Ghosh-Choudhury, Goutam; Abboud, Hanna E.; Gorin, Yves; Kasinath, Balakuntalam S.			Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetic nephropathy; laminin; oxidative stress; reactive oxygen species (ROS)	ACTIVATED PROTEIN-KINASE; DIABETIC-NEPHROPATHY; FIBRONECTIN EXPRESSION; SODIUM HYDROSULFIDE; OXIDATIVE STRESS; ANGIOTENSIN-II; MOUSE MODEL; TGF-BETA; NOX4; RENOPROTECTION	High-glucose increases NADPH oxidase 4 (NOX4) expression, reactive oxygen species generation, and matrix protein synthesis by inhibiting AMP-activated protein kinase (AMPK) in renal cells. Because hydrogen sulfide (H2S) inhibits high glucose-induced matrix protein increase by activating AMPK in renal cells, we examined whether H2S inhibits high glucose-induced expression of NOX4 and matrix protein and whether H2S and NO pathways are integrated. High glucose increased NOX4 expression and activity at 24 h in renal proximal tubular epithelial cells, which was inhibited by sodium hydrosulfide (NaHS), a source of H2S. High glucose decreased AMPK phosphorylation and activity, which was restored by NaHS. Compound C, an AMPK inhibitor, prevented NaHS inhibition of high glucose-induced NOX4 expression. NaHS inhibition of high glucose-induced NOX4 expression was abrogated by N()-nitro-l-arginine methyl ester, an inhibitor of NOS. NaHS unexpectedly augmented the expression of inducible NOS (iNOS) but not endothelial NOS. iNOS siRNA and 1400W, a selective iNOS inhibitor, abolished the ameliorative effects of NaHS on high glucose-induced NOX4 expression, reactive oxygen species generation, and, matrix laminin expression. Thus, H2S recruits iNOS to generate NO to inhibit high glucose-induced NOX4 expression, oxidative stress, and matrix protein accumulation in renal epithelial cells; the two gasotransmitters H2S and NO and their interaction may serve as therapeutic targets in diabetic kidney disease.	[Lee, Hak Joo; Lee, Doug Yoon; Mariappan, Meenalakshmi M.; Feliers, Denis; Ghosh-Choudhury, Goutam; Abboud, Hanna E.; Gorin, Yves; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, MC7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Lee, Hak Joo; Mariappan, Meenalakshmi M.; Feliers, Denis; Ghosh-Choudhury, Goutam; Abboud, Hanna E.; Kasinath, Balakuntalam S.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, MC7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Kasinath@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	University of Texas Health Science Center at San Antonio (UTHSCSA); NCI, National Institutes of Health [P30 CA54174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R29DK050190, R37DK033665, R01DK050190, R01DK033665, R01DK079996] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001340, I01BX000926] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio (UTHSCSA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Images were generated in the Core Optical Imaging Facility, which is supported by University of Texas Health Science Center at San Antonio (UTHSCSA) and NCI, National Institutes of Health Grant P30 CA54174 (Cancer Therapy & Research Center (CTRC) at UTHSCSA).	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Eid AA, 2013, MOL CELL BIOL, V33, P3439, DOI 10.1128/MCB.00217-13; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Fang L, 2013, NEPHROL DIAL TRANSPL, V28, P1751, DOI 10.1093/ndt/gfs391; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2015, AM J PHYSIOL-RENAL, V308, pF1276, DOI 10.1152/ajprenal.00396.2014; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Han WH, 2011, ANTIOXID REDOX SIGN, V15, P2121, DOI 10.1089/ars.2010.3821; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097315; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Jha JC, 2016, DIABETOLOGIA, V59, P379, DOI 10.1007/s00125-015-3796-0; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Kamat PK, 2015, J CELL PHYSIOL, V230, P378, DOI 10.1002/jcp.24722; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kasinath B. S., 2003, CONT DIABETES DIABET, P97; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Lee HJ, 2015, J BIOL CHEM, V290, P12014, DOI 10.1074/jbc.M114.615377; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Poon BY, 2003, CIRCULATION, V108, P1107, DOI 10.1161/01.CIR.0000086321.04702.AC; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Scheele W, 2016, J AM SOC NEPHROL, V27, P3459, DOI 10.1681/ASN.2015050473; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Si JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107832; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Thallas-Bonke V, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12192; Tonolo G, 2014, INT J NEPHROL RENOV, V7, P107, DOI 10.2147/IJNRD.S37883; Trachtman H, 2002, PEDIATR NEPHROL, V17, P20, DOI 10.1007/s004670200004; Wang R, 2014, TRENDS BIOCHEM SCI, V39, P227, DOI 10.1016/j.tibs.2014.03.003; Wang R, 2012, P NATL ACAD SCI USA, V109, P8801, DOI 10.1073/pnas.1206646109; Wang YW, 2015, MOL CELL BIOCHEM, V399, P189, DOI 10.1007/s11010-014-2245-6; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; You YH, 2016, J AM SOC NEPHROL, V27, P466, DOI 10.1681/ASN.2015030302; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593	55	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5665	5675		10.1074/jbc.M116.766758	http://dx.doi.org/10.1074/jbc.M116.766758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28188286	Green Published, hybrid			2022-12-28	WOS:000398813200005
J	Li, W; Hofer, MJ; Songkhunawej, P; Jung, SR; Hancock, D; Denyer, G; Campbell, IL				Li, Wen; Hofer, Markus J.; Songkhunawej, Pattama; Jung, So Ri; Hancock, Dale; Denyer, Gareth; Campbell, Iain L.			Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; glial cell; interferon; interferon regulatory factor (IRF); signal transducers and activators of transcription 1 (STAT1)	CENTRAL-NERVOUS-SYSTEM; IFN-ALPHA; UNPHOSPHORYLATED STAT1; TARGETED DISRUPTION; MEDIATED DISEASE; IMMUNE-SYSTEM; MICE; PATHWAYS; GAMMA; INFECTION	Type I interferons (IFN-I) are critical in antimicrobial and antitumor defense. Although IFN-I signal via the interferon-stimulated gene factor 3 (ISGF3) complex consisting of STAT1, STAT2, and IRF9, IFN-I can mediate significant biological effects via ISGF3-independent pathways. For example, the absence of STAT1, STAT2, or IRF9 exacerbates neurological disease in transgenic mice with CNS production of IFN-I. Here we determined the role of IFN-I-driven, ISGF3-independent signaling in regulating global gene expression in STAT1-, STAT2-, or IRF9-deficient murine mixed glial cell cultures (MGCs). Compared with WT, the expression of IFN--stimulated genes (ISGs) was reduced in number and magnitude in MGCs that lacked STAT1, STAT2, or IRF9. There were significantly fewer ISGs in the absence of STAT1 or STAT2 versus in the absence of IRF9. The majority of ISGs regulated in the STAT1-, STAT2-, or IRF9-deficient MGCs individually were shared with WT. However, only a minor number of ISGs were common to WT and STAT1-, STAT2-, and IRF9-deficient MGCs. Whereas signal pathway activation in response to IFN- was rapid and transient in WT MGCs, this was delayed and prolonged and correlated with increased numbers of ISGs expressed at 12 h versus 4 h of IFN- exposure in all three IFN-I signaling-deficient MGCs. In conclusion, 1) IFN-I can mediate ISG expression in MGCs via ISGF3-independent signaling pathways but with reduced efficiency, with delayed and prolonged kinetics, and is more dependent on STAT1 and STAT2 than IRF9; and 2) signaling pathways not involving STAT1, STAT2, or IRF9 play a minor role only in mediating ISG expression in MGCs.	[Li, Wen; Hofer, Markus J.; Songkhunawej, Pattama; Jung, So Ri; Hancock, Dale; Denyer, Gareth; Campbell, Iain L.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Hofer, Markus J.; Campbell, Iain L.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Hofer, Markus J.; Campbell, Iain L.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Campbell, IL (corresponding author), Mol Biosci Bldg,G08, Sydney, NSW 2006, Australia.	iain.campbell@sydney.edu.au	Hofer, Markus J/C-3688-2013	Hofer, Markus J/0000-0001-5111-3978; Campbell, Iain/0000-0001-8681-1100; Jung, David/0000-0003-1611-7644	National Health and Medical Research Council of Australia [512407]; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 512407 (to I. L. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Australian Postgraduate Award.	Abdul-Sater AA, 2015, J IMMUNOL, V195, P210, DOI 10.4049/jimmunol.1401139; Akwa Y, 1998, J IMMUNOL, V161, P5016; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Blaszczyk K, 2015, BIOCHEM J, V466, P511, DOI 10.1042/BJ20140644; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Carter SL, 2007, GLIA, V55, P1728, DOI 10.1002/glia.20587; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ghislain JJ, 1996, J BIOL CHEM, V271, P12408, DOI 10.1074/jbc.271.21.12408; Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Gupta S, 1999, J IMMUNOL, V163, P3834; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; Hofer MJ, 2012, J VIROL, V86, P6932, DOI 10.1128/JVI.07147-11; Hofer MJ, 2010, J NEUROSCI, V30, P1149, DOI 10.1523/JNEUROSCI.3711-09.2010; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Li W, 2014, J VIROL, V88, P7578, DOI 10.1128/JVI.03117-13; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Maier J, 2002, AM J PATHOL, V160, P271, DOI 10.1016/S0002-9440(10)64371-4; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mulligan C, 2002, J BIOL CHEM, V277, P42480, DOI 10.1074/jbc.M206206200; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Ousman SS, 2005, METH MOLEC MED, V116, P115; Ousman SS, 2005, J VIROL, V79, P7514, DOI 10.1128/JVI.79.12.7514-7527.2005; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Plumlee CR, 2009, J BIOL CHEM, V284, P30058, DOI 10.1074/jbc.M109.018283; Rani MRS, 2005, J INTERF CYTOK RES, V25, P788, DOI 10.1089/jir.2005.25.788; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Santoni FA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001008; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Testoni B, 2011, J BIOL CHEM, V286, P20217, DOI 10.1074/jbc.M111.231068; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wang JP, 2002, P NATL ACAD SCI USA, V99, P16209, DOI 10.1073/pnas.252454799; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463; Zimmerman MA, 2012, CANCER RES, V72, P4724, DOI 10.1158/0008-5472.CAN-12-1347	63	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5845	5859		10.1074/jbc.M116.756510	http://dx.doi.org/10.1074/jbc.M116.756510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213522	Green Published, hybrid			2022-12-28	WOS:000398813200020
J	Vashi, N; Andrabi, SBA; Ghanwat, S; Suar, M; Kumar, D				Vashi, Nimi; Andrabi, Syed Bilal Ahmad; Ghanwat, Swapnil; Suar, Mrutyunjay; Kumar, Dhiraj			Ca2+-dependent Focal Exocytosis of Golgi-derived Vesicles Helps Phagocytic Uptake in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; ADP-RIBOSYLATION FACTOR-1; NEURONAL CALCIUM SENSOR-1; PLASMA-MEMBRANE REPAIR; MYCOBACTERIUM-TUBERCULOSIS; NEUROTRANSMITTER RELEASE; INTRACELLULAR CA2+; MAMMALIAN-CELLS; ARF FAMILY	The role of Golgi apparatus during phagocytic uptake by macrophages has been ruled out in the past. Notably, all such reports were limited to Fc gamma receptor-mediated phagocytosis. Here, we unravel a highly devolved mechanism for recruitment of Golgi-derived secretory vesicles during phagosome biogenesis, which was important for uptake of most cargos, except the IgG-coated ones. We report recruitment of mannosidase-IIpositive Golgi-derived vesicles during uptake of diverse targets, including latex beads, Escherichia coli, Salmonella typhimurium, and Mycobacterium tuberculosis in human and mouse macrophages. The recruitment of mannosidase-II vesicles was an early event mediated by focal exocytosis and coincided with the recruitment of transferrin receptor, VAMP3, and dynamin-2. Brefeldin A treatment inhibited mannosidase-II recruitment and phagocytic uptake of serum-coated or-uncoated latex beads and E. coli. However, consistent with previous studies, brefeldin A treatment did not affect uptake of IgG-coated latex beads. Mechanistically, recruitment of mannosidase- II vesicles during phagocytic uptake required Ca2+ from both extra-and intracellular sources apart from PI3K, microtubules, and dynamin-2. Extracellular Ca2+ via voltagegated Ca2+ channels established a Ca2+-dependent local phosphatidylinositol 1,4,5-trisphosphate gradient, which guides the focal movement of Golgi-derived vesicles to the site of uptake. We confirmed Golgi-derived vesicles recruited during phagocytosis were secretory vesicles as their recruitment was sensitive to depletion of VAMP2 or NCS1, whereas recruitment of the recycling endosome marker VAMP3 was unaffected. Depletion of both VAMP2 and NCS1 individually resulted in the reduced uptake by macrophages. Together, the study provides a previously unprecedented role of Golgi-derived secretory vesicles in phagocytic uptake, the key innate defense function.	[Vashi, Nimi; Andrabi, Syed Bilal Ahmad; Ghanwat, Swapnil; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Suar, Mrutyunjay] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Kalinga Institute of Industrial Technology (KIIT)	Kumar, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	dhiraj@icgeb.res.in	Vashi, Nimi K/AFS-1039-2022	Vashi, Nimi K/0000-0002-1930-9206; Andrabi, Syed Bilal Ahmad/0000-0003-3009-0425; Suar, Mrutyunjay/0000-0003-4815-5477	Department of Biotechnology	Department of Biotechnology	The work related to M. tuberculosis infections was carried out at Department of Biotechnology-funded Tuberculosis Aerosol Challenge Facility at International Centre for Genetic Engineering and Biotechnology. We thank Prof. Sarman Singh for access to the flow cytometer at All India Institute of Medical Sciences and Purnima Kumar for help in the confocal microscopy. We thank C-CAMP, National Center for Biological Sciences, Bangalore, India, for the mass spectrometry facility.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BAINTON DF, 1989, AM J PATHOL, V134, P15; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Braun V, 2006, BIOL CELL, V98, P195, DOI 10.1042/BC20050021; Braun V, 2007, MOL BIOL CELL, V18, P4921, DOI 10.1091/mbc.E07-04-0392; Caceres PS, 2014, J BIOL CHEM, V289, P23951, DOI 10.1074/jbc.M114.589333; CANNON GJ, 1992, J CELL SCI, V101, P907; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHURCH J, 1994, MOL PHARMACOL, V45, P747; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Dai SP, 2007, TRAFFIC, V8, P1365, DOI 10.1111/j.1600-0854.2007.00613.x; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Faundez V, 1997, J CELL BIOL, V138, P505, DOI 10.1083/jcb.138.3.505; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gillingham AK, 2016, TRENDS CELL BIOL, V26, P399, DOI 10.1016/j.tcb.2016.02.005; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Kochegarov AA, 2003, CELL CALCIUM, V33, P145, DOI 10.1016/S0143-4160(02)00239-7; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li SK, 2014, DIABETOLOGIA, V57, P809, DOI 10.1007/s00125-013-3143-2; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu YW, 2011, TRAFFIC, V12, P1620, DOI 10.1111/j.1600-0854.2011.01250.x; Lundqvist-Gustafsson H, 2000, CELL CALCIUM, V27, P353, DOI 10.1054/ceca.2000.0130; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Mosser D M, 1994, Immunol Ser, V60, P99; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Scalettar BA, 2002, J CELL SCI, V115, P2399; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; STENDAHL O, 1994, SCIENCE, V265, P1439, DOI 10.1126/science.8073285; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Togo T, 1999, J CELL SCI, V112, P719; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VICKER MG, 1977, EXP CELL RES, V109, P127, DOI 10.1016/0014-4827(77)90052-0; Vinet AF, 2008, J IMMUNOL, V181, P5289, DOI 10.4049/jimmunol.181.8.5289; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	76	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5144	5165		10.1074/jbc.M116.743047	http://dx.doi.org/10.1074/jbc.M116.743047			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28174296	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000397875500001
J	Mine, S; Watanabe, M; Kamachi, S; Abe, Y; Ueda, T				Mine, Shouhei; Watanabe, Masahiro; Kamachi, Saori; Abe, Yoshito; Ueda, Tadashi			The Structure of an Archaeal beta-Glucosaminidase Provides Insight into Glycoside Hydrolase Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BASED CLASSIFICATION; CHITIN-BINDING DOMAIN; HYPERTHERMOPHILIC CHITINASE; ENZYME PROMISCUITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GALACTOSIDASE; RECOGNITION; MECHANISMS; EXPRESSION	The archaeal exo-beta-D-glucosaminidase (GlmA) is a dimeric enzyme that hydrolyzes chitosan oligosaccharides into monomer glucosamines. GlmA is a member of the glycosidase hydrolase (GH)-A superfamily-subfamily 35 and is a novel enzyme in terms of its primary structure. Here, we present the crystal structure of GlmA in complex with glucosamine at 1.27 angstrom resolution. The structure reveals that a monomeric form of GlmA shares structural homology with GH42 beta-galactosidases, whereas most of the spatial positions of the active site residues are identical to those of GH35 beta-galactosidases. We found that upon dimerization, the active site of GlmA changes shape, enhancing its ability to hydrolyze the smaller substrate in a manner similar to that of homotrimeric GH42 beta-galactosidase. However, GlmA can differentiate glucosamine from galactose based on one charged residue while using the "evolutionary heritage residue" it shares with GH35 beta-galactosidase. Our study suggests that GH35 and GH42 beta-galactosidases evolved by exploiting the structural features of GlmA.	[Mine, Shouhei] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst BMD, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan; [Watanabe, Masahiro; Kamachi, Saori] AIST, Res Inst Sustainable Chem ISC, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan; [Abe, Yoshito; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Prot Struct Funct & Design, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Kyushu University	Mine, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst BMD, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.; Watanabe, M (corresponding author), AIST, Res Inst Sustainable Chem ISC, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	s-mine@aist.go.jp; masa-watanabe@aist.go.jp	Mine, Shouhei/M-1640-2018; Abe, Yoshito/AAH-6141-2021; Abe, Yoshito/D-8370-2012	Mine, Shouhei/0000-0003-2031-4552; Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Watanabe, Masahiro/0000-0001-5211-1333	Japan Society for the Promotion of Science [25450143]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research 25450143 from the Japan Society for the Promotion of Science (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beecher CN, 2015, ANAL CHEM, V87, P6842, DOI 10.1021/acs.analchem.5b01181; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng W, 2012, J BIOL CHEM, V287, P22910, DOI 10.1074/jbc.M112.367128; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Juers DH, 1999, PROTEIN SCI, V8, P122; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu B, 2006, BIOTECHNOL LETT, V28, P1655, DOI 10.1007/s10529-006-9137-0; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mine S, 2014, FEBS J, V281, P2584, DOI 10.1111/febs.12805; Mine S, 2014, J BIOCHEM, V155, P115, DOI 10.1093/jb/mvt104; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Nakamura T, 2007, ACTA CRYSTALLOGR F, V63, P7, DOI 10.1107/S1744309106051773; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Richard JP, 1996, BIOCHEMISTRY-US, V35, P12387, DOI 10.1021/bi961029b; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Schwarz A, 2007, BIOCHEM J, V403, P441, DOI 10.1042/BJ20070042; Solomon HV, 2015, ACTA CRYSTALLOGR D, V71, P2433, DOI 10.1107/S1399004715018672; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Tanaka T, 2004, J BIOL CHEM, V279, P30021, DOI 10.1074/jbc.M314187200; Tanaka T, 2003, J BACTERIOL, V185, P5175, DOI 10.1128/JB.185.17.5175-5181.2003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Bueren AL, 2009, J MOL BIOL, V385, P131, DOI 10.1016/j.jmb.2008.10.031; Viborg AH, 2014, MOL MICROBIOL, V94, P1024, DOI 10.1111/mmi.12815; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zheng B, 2012, J INEQUAL APPL, DOI 10.1186/1029-242X-2012-201	42	6	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4996	5006		10.1074/jbc.M116.766535	http://dx.doi.org/10.1074/jbc.M116.766535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28130448	hybrid, Green Published			2022-12-28	WOS:000397590400021
J	Dwane, L; Gallagher, WM; Chonghaile, TN; O'Connor, DP				Dwane, Lisa; Gallagher, William M.; Chonghaile, Triona Ni; O'Connor, Darran P.			The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer; deubiquitylation (deubiquitination); polyubiquitin chain; signal transduction; ubiquitylation (ubiquitination); monoubiquitination; non-degradative pathways; therapeutic intervention; ubiquitination; deubiquitination	NF-KAPPA-B; REGULATES AKT UBIQUITINATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; FANCONI-ANEMIA PATHWAY; POLYUBIQUITIN CHAINS; TUMOR-SUPPRESSOR; CANCER CELLS; MULTIPLE-MYELOMA; LUNG-CANCER; HISTONE H2B	The addition of ubiquitin to a target protein has long been implicated in the process of degradation and is the primary mediator of protein turnover in the cell. Recently, however, many non-proteolytic functions of ubiquitination have emerged as key regulators of cellular homeostasis. In this review, we will describe the various non-traditional functions of ubiquitination, with particular focus on how they can be used as signaling entities in cancer formation and progression. Elaboration of this topic can lead to a better understanding of oncogenic mechanisms, as well as the discovery of novel druggable proteins within the ubiquitin pathway.	[Dwane, Lisa; O'Connor, Darran P.] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, 123 St Stephens Green, Dublin 2, Ireland; [Chonghaile, Triona Ni] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Gallagher, William M.] Univ Coll Dublin, Canc Biol & Therapeut Lab, UCD Sch Biomol & Biomed Sci, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; University College Dublin	O'Connor, DP (corresponding author), Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, 123 St Stephens Green, Dublin 2, Ireland.	darranoconnor@rcsi.ie	; Ni Chonghaile, Triona/L-9418-2015	Gallagher, William/0000-0002-4307-5999; Ni Chonghaile, Triona/0000-0002-3041-4031; O'Connor, Darran/0000-0002-8835-1547	BREAST-PREDICT, The Irish Cancer Society's Collaborative Cancer Research Centre [CCRC13GAL]; Science Foundation Ireland; OPTi-PREDICT project under the Investigator Programme [15/IA/3104]	BREAST-PREDICT, The Irish Cancer Society's Collaborative Cancer Research Centre; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); OPTi-PREDICT project under the Investigator Programme	This work was supported by BREAST-PREDICT, The Irish Cancer Society's Collaborative Cancer Research Centre (Grant CCRC13GAL), and Science Foundation Ireland, in particular the OPTi-PREDICT project, which was funded under the Investigator Programme (Grant 15/IA/3104). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Bold R, 2004, CANCER INVEST, V22, P328, DOI 10.1081/CNV-120030223; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cao J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00026; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chan CH, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-59; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chervona Y, 2012, AM J CANCER RES, V2, P589; Choi YB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004458; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Chun MJ, 2016, ONCOTARGET, V7, P53642, DOI 10.18632/oncotarget.10686; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cole AJ, 2015, ENDOCR-RELAT CANCER, V22, pT19, DOI 10.1530/ERC-14-0185; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; Dai T, 2015, J PATHOL, V235, P490, DOI 10.1002/path.4479; Ding FB, 2015, INT J MOL SCI, V16, P307, DOI 10.3390/ijms16010307; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Farshi P, 2015, EXPERT OPIN THER PAT, V25, P1191, DOI 10.1517/13543776.2015.1056737; Fostier K, 2012, ONCOTARGETS THER, V5, P237, DOI 10.2147/OTT.S28911; Gallo LH, 2014, CELL CYCLE, V13, P3964, DOI 10.4161/15384101.2014.988026; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gregory RC, 2003, SEMIN CANCER BIOL, V13, P77, DOI 10.1016/S1044-579X(02)00102-5; Haas AL, 1997, FASEB J, V11, P1257; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hahn MA, 2012, HUM MOL GENET, V21, P559, DOI 10.1093/hmg/ddr490; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hayakawa M, 2012, J BIOCHEM, V151, P115, DOI 10.1093/jb/mvr139; He ZY, 2016, ONCOL REP, V35, P1933, DOI 10.3892/or.2016.4602; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jo U, 2015, MOL CELLS, V38, P669, DOI 10.14348/molcells.2015.0175; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kim M, 2016, FEBS LETT, V590, P340, DOI 10.1002/1873-3468.12060; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kushwaha D, 2015, CANCER BIOL THER, V16, P392, DOI 10.1080/15384047.2014.1002358; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lavorgna A, 2014, VIRUSES-BASEL, V6, P3925, DOI 10.3390/v6103925; Li ZY, 2015, J CLIN INVEST, V125, P1081, DOI 10.1172/JCI75821; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; McCarthy EE, 2003, MOL CELL BIOL, V23, P5056, DOI 10.1128/MCB.23.14.5056-5063.2003; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moreau P, 2016, NEW ENGL J MED, V374, P1621, DOI 10.1056/NEJMoa1516282; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oosterkamp HM, 2014, CANCER RES, V74, P3810, DOI 10.1158/0008-5472.CAN-13-1960; Pellom Samuel Troy Jr, 2012, J Clin Cell Immunol, VS5, P5; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Raghunandan M, 2015, CELL CYCLE, V14, P342, DOI 10.4161/15384101.2014.987614; Renaudin X, 2016, MUTAT RES-REV MUTAT, V769, P36, DOI 10.1016/j.mrrev.2016.06.004; Rickman KA, 2015, CELL REP, V12, P35, DOI 10.1016/j.celrep.2015.06.014; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shen RR, 2015, ONCOGENE, V34, P209, DOI 10.1038/onc.2013.543; Silva GM, 2015, NAT STRUCT MOL BIOL, V22, P116, DOI 10.1038/nsmb.2955; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Su YT, 2013, MOL CELL BIOL, V33, P1546, DOI 10.1128/MCB.01146-12; Sun H, 2014, INT J BIOCHEM CELL B, V53, P195, DOI 10.1016/j.biocel.2014.04.010; Suresh B, 2015, BIOCHEM BIOPH RES CO, V466, P180, DOI 10.1016/j.bbrc.2015.08.127; Suryadinata Randy, 2014, Cells, V3, P674, DOI 10.3390/cells3030674; Tang B, 2015, ONCOTARGET, V6, P12654, DOI 10.18632/oncotarget.3705; Tarcic O, 2016, CELL REP, V14, P1462, DOI 10.1016/j.celrep.2016.01.020; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang GC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00005; Wang YC, 2014, CELL RES, V24, P143, DOI 10.1038/cr.2013.151; Wang ZJ, 2015, HUM PATHOL, V46, P1006, DOI 10.1016/j.humpath.2015.04.001; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133444; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhang H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-5	91	38	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3543	3551		10.1074/jbc.R116.755694	http://dx.doi.org/10.1074/jbc.R116.755694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28154183	Green Published, hybrid			2022-12-28	WOS:000395542500001
J	Kim, SY; Lee, JH; Merrins, MJ; Gavrilova, O; Bisteau, X; Kaldis, P; Satin, LS; Rane, SG				Kim, So Yoon; Lee, Ji-Hyeon; Merrins, Matthew J.; Gavrilova, Oksana; Bisteau, Xavier; Kaldis, Philipp; Satin, Leslie S.; Rane, Sushil G.			Loss of Cyclin-dependent Kinase 2 in the Pancreas Links Primary -Cell Dysfunction to Progressive Depletion of -Cell Mass and Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cell cycle; cyclin-dependent kinase (CDK); diabetes; FOXO; beta cell function; beta cell mass; CDK2; foxo1	SCALE ASSOCIATION ANALYSIS; ISLET BETA-CELL; EXPRESSION; FAILURE; PROGENITORS; GLUCOSE; MOUSE; FOXO1; MICE; CDK4	The failure of pancreatic islet -cells is a major contributor to the etiology of type 2 diabetes. -Cell dysfunction and declining -cell mass are two mechanisms that contribute to this failure, although it is unclear whether they are molecularly linked. Here, we show that the cell cycle regulator, cyclin-dependent kinase 2 (CDK2), couples primary -cell dysfunction to the progressive deterioration of -cell mass in diabetes. Mice with pancreas-specific deletion of Cdk2 are glucose-intolerant, primarily due to defects in glucose-stimulated insulin secretion. Accompanying this loss of secretion are defects in -cell metabolism and perturbed mitochondrial structure. Persistent insulin secretion defects culminate in progressive deficits in -cell proliferation, reduced -cell mass, and diabetes. These outcomes may be mediated directly by the loss of CDK2, which binds to and phosphorylates the transcription factor FOXO1 in a glucose-dependent manner. Further, we identified a requirement for CDK2 in the compensatory increases in -cell mass that occur in response to age- and diet-induced stress. Thus, CDK2 serves as an important nexus linking primary -cell dysfunction to progressive -cell mass deterioration in diabetes.	[Kim, So Yoon; Lee, Ji-Hyeon; Rane, Sushil G.] NIDDK, Cell Growth & Metab Sect, Diabet Endocrinol & Obes Branch, NIH,Clin Res Ctr, 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Clin Res Ctr, Bethesda, MD 20892 USA; [Merrins, Matthew J.] Univ Wisconsin, Dept Med, Div Endocrinol Diabet & Metab, Madison, WI 53705 USA; [Bisteau, Xavier; Kaldis, Philipp] ASTAR, IMCB, 61 Biopolis Dr,Proteos 3-09, Singapore 138673, Singapore; [Bisteau, Xavier; Kaldis, Philipp] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Satin, Leslie S.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Satin, Leslie S.] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI 48105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rane, SG (corresponding author), NIDDK, Cell Growth & Metab Sect, Diabet Endocrinol & Obes Branch, NIH,Clin Res Ctr, 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Bisteau, Xavier/Q-7239-2018; Bisteau, Xavier/AAH-6744-2021; Kaldis, Philipp/G-2714-2010	Bisteau, Xavier/0000-0002-8896-5098; Kaldis, Philipp/0000-0002-7247-7591	National Institutes of Health (NIH) [R01-DK46409]; NIH [K01-DK101683, R21-AG050135]; American Diabetes Association [1-16-IBS-212]; Biomedical Research Council of A*STAR (Agency for Science, Technology, and Research), Singapore; NIH Intramural Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055105, ZIADK075073, P30DK020572, ZICDK070002, R01DK046409, K01DK101683, ZIADK055107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050135] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Biomedical Research Council of A*STAR (Agency for Science, Technology, and Research), Singapore(Agency for Science Technology & Research (A*STAR)); NIH Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) Grant R01-DK46409 (to L. S. S.); NIH Grants K01-DK101683 and R21-AG050135 and American Diabetes Association Grant 1-16-IBS-212 (to M. J. M.); the Biomedical Research Council of A*STAR (Agency for Science, Technology, and Research), Singapore (to P. K.); and the NIH Intramural Program (to S. G. R.). The authors declare that they have no conflicts with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Calbo J, 2004, CELL DEATH DIFFER, V11, P1055, DOI 10.1038/sj.cdd.4401481; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Honig G, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-82; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Ishii H, 2011, ENDOCR J, V58, P519, DOI 10.1507/endocrj.EJ11-0064; Jayapal SR, 2015, HAEMATOLOGICA, V100, P434, DOI 10.3324/haematol.2014.106468; Jiang H, 1998, MOL CELL BIOL, V18, P5284, DOI 10.1128/MCB.18.9.5284; Kim SY, 2011, DEVELOPMENT, V138, P1903, DOI 10.1242/dev.061481; Kim YC, 2011, EMBO J, V30, P1563, DOI 10.1038/emboj.2011.57; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lane ME, 2001, CANCER RES, V61, P6170; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008653; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624	46	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3841	3853		10.1074/jbc.M116.754077	http://dx.doi.org/10.1074/jbc.M116.754077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100774	hybrid, Green Published			2022-12-28	WOS:000395542500025
J	Guo, HB; Zhang, B; Nairn, AV; Nagy, T; Moremen, KW; Buckhaults, P; Pierce, M				Guo, Huabei; Zhang, Bing; Nairn, Alison V.; Nagy, Tamas; Moremen, Kelley W.; Buckhaults, Phillip; Pierce, Michael			O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO PROPAGATION; A-MYB; DNA METHYLATION; GENE-EXPRESSION; TRANSFERASE OGT; HYPERMETHYLATION PROFILE; 3'-UNTRANSLATED REGION; UP-REGULATION; C-MYC	To study the regulation of colorectal adenocarcinoma progression by O-GlcNAc, we have focused on the O-GlcNAcmediated epigenetic regulation of human colon cancer stem cells (CCSC). Xenograft tumors from colon tumor cells with O-linked N-acetylglucosamine transferase (OGT) knockdown grew significantly slower than those formed from control cells, indicating a reduced proliferation of tumor cells due to inhibition ofOGTexpression. Significant reduction of the CCSC population was observed in the tumor cells after OGT knockdown, whereas tumor cells treated with the O-GlcNAcase inhibitor showed an increased CCSC population, indicating that O-GlcNAc levels regulated the CCSC compartment. When grown in suspension, tumor cells withOGTknockdown showed a reduced ability to form tumorspheres, indicating a reduced self-renewal of CCSC due to reduced levels of O-GlcNAc. ChIP-sequencing experiments using an anti-O-GlcNAc antibody revealed significant chromatin enrichment of O-GlcNAcmodified proteins at the promoter of the transcription factor MYBL1, which was also characterized by the presence of H3K27me3. RNA-sequencing analysis showed an increased expression of MYBL1 in tumor cells with OGT knockdown. Forced overexpression of MYBL1 led to a reduced population of CCSC and tumor growth in vivo, similar to the effects of OGT silencing. Moreover, two CpG islands near the transcription start site of MYBL1 were identified, and O-GlcNAc levels regulated their methylation status. These results strongly argue that O-GlcNAc epigenetically regulates MYBL1, functioning similarly to H3K27me3. The aberrant CCSC compartment observed after modulatingO-GlcNAc levels is therefore likely to result, at least in part, from the epigenetic regulation of MYBL1 expression by O-GlcNAc, thereby significantly affecting tumor progression.	[Guo, Huabei; Nairn, Alison V.; Moremen, Kelley W.; Pierce, Michael] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Zhang, Bing] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Buckhaults, Phillip] Univ South Carolina, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Zhang, Bing] Jiaotong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Harvard University; Boston Children's Hospital; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Shanghai Jiao Tong University	Pierce, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	hawkeye@uga.edu	Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593	National Institutes of Health [U01CA128454, P41-GM103490]; NATIONAL CANCER INSTITUTE [U01CA128454, U01CA158428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01CA128454 and P41-GM103490 (to M.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137640; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arsura M, 2000, BLOOD, V96, P1013, DOI 10.1182/blood.V96.3.1013.015k06_1013_1020; Baysan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094045; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen CL, 2003, EUR J CANCER, V39, P517, DOI 10.1016/S0959-8049(02)00175-2; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Esteller M, 2001, CANCER RES, V61, P3225; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fujii S, 2016, ONCOTARGET, V7, P81571, DOI 10.18632/oncotarget.13147; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; George OL, 2014, CANCERS, V6, P2049, DOI 10.3390/cancers6042049; Ghiaur G, 2012, STEM CELLS, V30, P89, DOI 10.1002/stem.769; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GOLAY J, 1994, ONCOGENE, V9, P2469; Golay J, 1998, J IMMUNOL, V160, P2786; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guo HB, 2014, J BIOL CHEM, V289, P31534, DOI 10.1074/jbc.M114.602680; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hammoud SS, 2013, CURR OPIN CELL BIOL, V25, P177, DOI 10.1016/j.ceb.2013.01.007; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Hou ZJ, 2015, ONCOTARGET, V6, P6326, DOI 10.18632/oncotarget.3436; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishiwata T, 2016, PATHOL INT, V66, P601, DOI 10.1111/pin.12447; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jeon JH, 2014, STEM CELLS DEV, V23, P2067, DOI 10.1089/scd.2013.0583; Jones MF, 2015, P NATL ACAD SCI USA, V112, pE1550, DOI 10.1073/pnas.1503370112; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kassis JA, 2010, MOL CELL BIOL, V30, P2581, DOI 10.1128/MCB.00231-10; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kriegl L, 2012, ONCOTARGET, V3, P1182; Krzeslak A, 2010, INT J MOL MED, V25, P643, DOI 10.3892/ijmm_00000387; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Malaterre J, 2016, ONCOGENE, V35, P2475, DOI 10.1038/onc.2015.305; Malumbres M, 1999, ONCOGENE, V18, P385, DOI 10.1038/sj.onc.1202299; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Maussion G, 2014, EPIGENETICS-US, V9, P1061, DOI 10.4161/epi.29068; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mitani Y, 2016, CLIN CANCER RES, V22, P725, DOI 10.1158/1078-0432.CCR-15-2867-T; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; Ng JMK, 2015, INT J MOL SCI, V16, P2472, DOI 10.3390/ijms16022472; Oh IH, 1997, J BIOL CHEM, V272, P21432, DOI 10.1074/jbc.272.34.21432; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Onodera Y, 2014, J CLIN INVEST, V124, P367, DOI 10.1172/JCI63146; Paz MF, 2003, CANCER RES, V63, P1114; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramkissoon LA, 2013, P NATL ACAD SCI USA, V110, P8188, DOI 10.1073/pnas.1300252110; RAMSAY RG, 1992, CELL GROWTH DIFFER, V3, P723; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sato R, 2016, STEM CELLS, V34, P1997, DOI 10.1002/stem.2406; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Weige CC, 2014, MOL CANCER RES, V12, P1029, DOI 10.1158/1541-7786.MCR-13-0286-T; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu YA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041001; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yang YR, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.24; Yang YR, 2015, ONCOTARGET, V6, P12529, DOI 10.18632/oncotarget.3725; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang XL, 2015, MOL CELL BIOCHEM, V410, P101, DOI 10.1007/s11010-015-2542-8; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zhao ST, 2016, CANCER MED-US, V5, P837, DOI 10.1002/cam4.650; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	103	35	35	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4123	4137		10.1074/jbc.M116.763201	http://dx.doi.org/10.1074/jbc.M116.763201			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28096468	hybrid, Green Published			2022-12-28	WOS:000395837100014
J	Patil, AV; Hsieh, TS				Patil, Ajay Vitthal; Hsieh, Tao-Shih			Ribosomal Protein S3 Negatively Regulates Unwinding Activity of RecQ-like Helicase 4 through Their Physical Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; DNA-REPAIR ACTIVITIES; BASE EXCISION-REPAIR; BIOCHEMICAL-CHARACTERIZATION; GENOTOXIC STRESS; DAMAGE; RPS3; REPLICATION; BINDING; DOMAIN	Human RecQ-like helicase 4 (RECQL4) plays crucial roles in replication initiation and DNA repair; however, the contextual regulation of its unwinding activity is not fully described. Mutations in RECQL4 have been linked to three diseases including Rothmund-Thomson syndrome, which is characterized by osteoskeletal deformities, photosensitivity, and increased osteosarcoma susceptibility. Understanding regulation of RECQL4 helicase activity by interaction partners will allow deciphering its role as an enzyme and a signaling cofactor in different cellular contexts. We became interested in studying the interaction of RECQL4 with ribosomal protein S3 (RPS3) because previous studies have shown that RPS3 activity is sometimes associated with phenotypes mimicking those of mutated RECQL4. RPS3 is a small ribosomal protein that also has extraribosomal functions, including apurnic-apyrimi-dinic endonuclease-like activity suggested to be important during DNA repair. Here, we report a functional and physical interaction between RPS3 and RECQL4 and show that this interaction may be enhanced during cellular stress. We show that RPS3 inhibits ATPase, DNA binding, and helicase activities of RECQL4 through their direct interaction. Further domain analysis shows that N-terminal 1-320 amino acids of RECQL4 directly interact with the C-terminal 94-244 amino acids of RPS3 (C-RPS3). Biochemical analysis of C-RPS3 revealed that it comprises a standalone apurnic-apyrimidinic endonuclease-like domain. We used U2OS cells to show that oxidative stress and UV exposure could enhance the interaction between nuclear RPS3 and RECQL4. Regulation of RECQL4 biochemical activities by RPS3 along with nuclear interaction during UV and oxidative stress may serve to modulate active DNA repair.	[Patil, Ajay Vitthal; Hsieh, Tao-Shih] Acad Sinica, Taiwan Int Grad Program, Mol & Cell Biol, Taipei 115, Taiwan; [Patil, Ajay Vitthal; Hsieh, Tao-Shih] Acad Sinica, Inst Cellular & Organism Biol, 128,Acad Rd,Sec 2, Taipei 11529, Taiwan; [Patil, Ajay Vitthal; Hsieh, Tao-Shih] Grad Inst Life Sci, Natl Def Med Ctr, Taipei 114, Taiwan; [Hsieh, Tao-Shih] Duke Univ Med Ctr, Dept Biochem, Durham, NC 27710 USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center; Duke University	Patil, AV (corresponding author), Acad Sinica, Taiwan Int Grad Program, Mol & Cell Biol, Taipei 115, Taiwan.; Patil, AV (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128,Acad Rd,Sec 2, Taipei 11529, Taiwan.; Patil, AV (corresponding author), Grad Inst Life Sci, Natl Def Med Ctr, Taipei 114, Taiwan.	ajaypatil@gate.sinica.edu.tw			Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan	Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	We are grateful to Dr. Ting-Fang Wang and Dr. Meng-Chao Yao (Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan) for suggestions and support. We thank Wen-Hsiang Tsai for technical assistance. We thank John O'Brien and Marcus J. Calkins (Academia Sinica) for suggestions on the manuscript as native English speakers.	Ahn B, 2004, J BIOL CHEM, V279, P53465, DOI 10.1074/jbc.M409624200; Capp C, 2010, CRIT REV BIOCHEM MOL, V45, P233, DOI 10.3109/10409231003786086; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; Croteau DL, 2012, TRENDS GENET, V28, P624, DOI 10.1016/j.tig.2012.08.003; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Ghosh AK, 2012, J BIOL CHEM, V287, P196, DOI 10.1074/jbc.M111.295063; Hegde V, 2001, J BIOL CHEM, V276, P27591, DOI 10.1074/jbc.M101213200; Hegde V, 2007, DNA REPAIR, V6, P94, DOI 10.1016/j.dnarep.2006.09.004; Heyde V, 2006, DNA REPAIR, V5, P810, DOI 10.1016/j.dnarep.2006.04.001; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; Keller H, 2014, NUCLEIC ACIDS RES, V42, P12614, DOI 10.1093/nar/gku993; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; Lachapelle S, 2011, J PROTEOME RES, V10, P1216, DOI 10.1021/pr100990s; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; Lee SB, 2010, J BIOL CHEM, V285, P29457, DOI 10.1074/jbc.M110.131367; Lu H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.168; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Marino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21501; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Nagao-Kitamoto H, 2015, CANCER LETT, V356, P855, DOI 10.1016/j.canlet.2014.10.042; Ng AJM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005160; Ohlenschlager O, 2012, NUCLEIC ACIDS RES, V40, P8309, DOI 10.1093/nar/gks591; Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291; Seong KM, 2012, FEBS LETT, V586, P356, DOI 10.1016/j.febslet.2011.12.030; Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x; Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074; Tian Y, 2015, ONCOTARGET, V6, P29614, DOI 10.18632/oncotarget.4868; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yacoub A, 1996, EMBO J, V15, P2306, DOI 10.1002/j.1460-2075.1996.tb00584.x; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003	42	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4313	4325		10.1074/jbc.M116.764324	http://dx.doi.org/10.1074/jbc.M116.764324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28159839	Green Published, hybrid			2022-12-28	WOS:000395837100028
J	Xu, JK; Jaiswal, AK				Xu, Junkang; Jaiswal, Anil K.			RETRACTION: NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBP leading to its stabilization and protection against radiation-induced myeloproliferative disease (Retraction of Vol 287, Pg 41608, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Xu JK, 2012, J BIOL CHEM, V287, P41608, DOI 10.1074/jbc.M112.387738	1	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2047	2047		10.1074/jbc.A117.387738	http://dx.doi.org/10.1074/jbc.A117.387738			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159760	Green Published, hybrid			2022-12-28	WOS:000395515600042
J	Guo, HT; Mi, ZY; Bowles, DE; Bhattacharya, SD; Kuo, PC				Guo, Hongtao; Mi, Zhiyong; Bowles, Dawn E.; Bhattacharya, Syamal D.; Kuo, Paul C.			Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages (vol 285, pg 37787, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Guo HT, 2010, J BIOL CHEM, V285, P37787, DOI 10.1074/jbc.M110.161869	1	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1142	1142		10.1074/jbc.A110.161869	http://dx.doi.org/10.1074/jbc.A110.161869			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	28108614	Green Published, hybrid			2022-12-28	WOS:000392318700032
J	Cao, Q; Yang, YM; Zhong, XZ; Dong, XP				Cao, Qi; Yang, Yiming; Zhong, Xi Zoe; Dong, Xian-Ping			The lysosomal Ca2+ release channel TRPML1 regulates lysosome size by activating calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-PORE CHANNELS; ION-CHANNEL; STORAGE DISEASES; CALCIUM-RELEASE; MEMBRANE-FUSION; LUMINAL PH; NAADP; MUCOLIPIDOSIS; TRAFFICKING; PATHWAY	Intracellular lysosomal membrane trafficking, including fusion and fission, is crucial for cellular homeostasis and normal cell function. Both fusion and fission of lysosomal membrane are accompanied by lysosomal Ca2+ release. We recently have demonstrated that the lysosomal Ca2+ release channel P2X4 regulates lysosome fusion through a calmodulin (CaM)-dependent mechanism. However, the molecular mechanism underlying lysosome fission remains uncertain. In this study, we report that enlarged lysosomes/vacuoles induced by either vacuolin-1 or P2X4 activation are suppressed by up-regulating the lysosomal Ca2+ release channel transient receptor potential mucolipin 1 (TRPML1) but not the lysosomal Na+ release channel two-pore channel 2 (TPC2). Activation of TRPML1 facilitated the recovery of enlarged lysosomes/vacuoles. Moreover, the effects of TRPML1 on lysosome/vacuole size regulation were eliminated by Ca2+ chelation, suggesting a requirement for TRPML1-mediated Ca2+ release. We further demonstrate that the prototypical Ca2+ sensor CaM is required for the regulation of lysosome/vacuole size by TRPML1, suggesting that TRPML1 may promote lysosome fission by activating CaM. Given that lysosome fission is implicated in both lysosome biogenesis and reformation, our findings suggest that TRPML1 may function as a key lysosomal Ca2+ channel controlling both lysosome biogenesis and reformation.	[Cao, Qi; Yang, Yiming; Zhong, Xi Zoe; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada	Dalhousie University	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca	Yang, Yiming/X-3444-2019	Yang, Yiming/0000-0002-6716-8014; Dong, Xianping/0000-0002-4496-7104	Department of Physiology and Biophysics; Dalhousie University; Dalhousie Medical Research Foundation (DMRF) Equipment Grant; DMRF new investigator award; Canadian Institutes of Health Research Grant [MOP-119349]; Canadian Institutes of Health Research New Investigator Award [201109MSH261462-208625]; Nova Scotia Health Research Foundation (NSHRF) Establishment Grant [MED-PRO-2011-7485]; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund for Research Infrastructure Grant [29291]	Department of Physiology and Biophysics; Dalhousie University; Dalhousie Medical Research Foundation (DMRF) Equipment Grant; DMRF new investigator award; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation (NSHRF) Establishment Grant; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund for Research Infrastructure Grant	This work was supported by start-up funds ( to X.-P. D.) from the Department of Physiology and Biophysics, Dalhousie University, Dalhousie Medical Research Foundation (DMRF) Equipment Grant, DMRF new investigator award, Canadian Institutes of Health Research Grant MOP-119349, Canadian Institutes of Health Research New Investigator Award 201109MSH261462-208625, Nova Scotia Health Research Foundation (NSHRF) Establishment Grant MED-PRO-2011-7485, and Canada Foundation for Innovation (CFI) Leaders Opportunity Fund for Research Infrastructure Grant 29291. The authors declare that they have no conflicts of interest with the contents of this article.	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bakker AC, 1997, J CELL SCI, V110, P2227; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cao Q, 2015, J CELL BIOL, V209, P879, DOI 10.1083/jcb.201409071; Cao Q, 2015, DEV CELL, V33, P427, DOI 10.1016/j.devcel.2015.04.010; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Christensen KA, 2002, J CELL SCI, V115, P599; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dayam RM, 2015, TRAFFIC, V16, P1010, DOI 10.1111/tra.12303; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Evans EL, 2010, BIOCHEM SOC T, V38, P1458, DOI 10.1042/BST0381458; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Kilpatrick BS, 2016, J CELL SCI, V129, P3859, DOI 10.1242/jcs.190322; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee JH, 2015, TISSUE ENG REGEN MED, V12, P90, DOI 10.1007/s13770-015-0102-7; Li RJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19360; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Lu YY, 2014, AUTOPHAGY, V10, P1895, DOI 10.4161/auto.32200; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Miller A, 2015, TRAFFIC, V16, P284, DOI 10.1111/tra.12249; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Pitt SJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004854; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Shen DB, 2011, BIOESSAYS, V33, P448, DOI 10.1002/bies.201000152; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Venkatachalam K, 2015, CELL CALCIUM, V58, P48, DOI 10.1016/j.ceca.2014.10.008; Vergarajauregui S, 2009, J BIOL CHEM, V284, P36357, DOI 10.1074/jbc.M109.047241; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu M, 2013, AM J PHYSIOL-CELL PH, V304, pC458, DOI 10.1152/ajpcell.00342.2012; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109	73	56	57	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8424	8435		10.1074/jbc.M116.772160	http://dx.doi.org/10.1074/jbc.M116.772160			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360104	Green Published, hybrid			2022-12-28	WOS:000401788600026
J	Rubaiy, HN; Ludlow, MJ; Henrot, M; Gaunt, HJ; Miteva, K; Cheung, SY; Tanahashi, Y; Hamzah, N; Musialowski, KE; Blythe, NM; Appleby, HL; Bailey, MA; McKeown, L; Taylor, R; Foster, R; Waldmann, H; Nussbaumer, P; Christmann, M; Bon, RS; Muraki, K; Beech, DJ				Rubaiy, Hussein N.; Ludlow, Melanie J.; Henrot, Matthias; Gaunt, Hannah J.; Miteva, Katarina; Cheung, Sin Ying; Tanahashi, Yasuyuki; Hamzah, Nurasyikin; Musialowski, Katie E.; Blythe, Nicola M.; Appleby, Hollie L.; Bailey, Marc A.; McKeown, Lynn; Taylor, Roger; Foster, Richard; Waldmann, Herbert; Nussbaumer, Peter; Christmann, Mathias; Bon, Robin S.; Muraki, Katsuhiko; Beech, David J.			Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRPC5 CATIONIC CHANNELS; CALCIUM-CHANNELS; ION-CHANNEL; TRANSIENT; IDENTIFICATION; ACTIVATION; BEHAVIOR; POTENT; PAIN; (-)-ENGLERIN	The concentration of free cytosolic Ca2+ and the voltage across the plasma membrane are major determinants of cell function. Ca2+-permeable non-selective cationic channels are known to regulate these parameters, but understanding of these channels remains inadequate. Here we focus on transient receptor potential canonical 4 and 5 proteins (TRPC4 and TRPC5), which assemble as homomers or heteromerize with TRPC1 to form Ca2+-permeable non-selective cationic channels in many mammalian cell types. Multiple roles have been suggested, including in epilepsy, innate fear, pain, and cardiac remodeling, but limitations in tools to probe these channels have restricted progress. A key question is whether we can overcome these limitations and develop tools that are high-quality, reliable, easy to use, and readily accessible for all investigators. Here, through chemical synthesis and studies of native and overexpressed channels by Ca2+ and patch-clamp assays, we describe compound 31, a remarkable small-molecule inhibitor of TRPC1/4/5 channels. Its potency ranged from 9 to 1300 pM, depending on the TRPC1/4/5 subtype and activation mechanism. Other channel types investigated were unaffected, including TRPC3, TRPC6, TRPV1, TRPV4, TRPA1, TRPM2, TRPM8, and store-operated Ca2+ entry mediated by Orai1. These findings suggest identification of an important experimental tool compound, which has much higher potency for inhibiting TRPC1/4/5 channels than previously reported agents, impressive specificity, and graded subtype selectivity within the TRPC1/4/5 channel family. The compound should greatly facilitate future studies of these ion channels. We suggest naming this TRPC1/4/5-inhibitory compound Pico145.	[Rubaiy, Hussein N.; Ludlow, Melanie J.; Gaunt, Hannah J.; Miteva, Katarina; Cheung, Sin Ying; Tanahashi, Yasuyuki; Musialowski, Katie E.; Blythe, Nicola M.; Appleby, Hollie L.; Bailey, Marc A.; McKeown, Lynn; Bon, Robin S.; Beech, David J.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Hamzah, Nurasyikin; Taylor, Roger; Foster, Richard] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Henrot, Matthias; Christmann, Mathias] Free Univ Berlin, Inst Chem & Biochem, Takustr 3, D-14195 Berlin, Germany; [Tanahashi, Yasuyuki] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan; [Waldmann, Herbert] Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany; [Nussbaumer, Peter] Lead Discovery Ctr GmbH, Otto Hahn Str 15, D-44227 Dortmund, Germany; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan	University of Leeds; University of Leeds; Free University of Berlin; Kyoto Sangyo University; Max Planck Society; Lead Discovery Center GmbH (LDC); Aichi Gakuin University	Muraki, K (corresponding author), Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.; Beech, DJ (corresponding author), Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, LIGHT Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	kmuraki@dpc.aichi-gakuin.ac.jp; d.j.beech@leeds.ac.uk	- The Truth, HNR/AAO-2514-2020; McKeown, Lynn/AAC-6037-2020; Christmann, Mathias/C-9648-2010; Rubaiy, Hussein N./ABG-5191-2021; hamzah, nurasyikin/AAP-6689-2020	McKeown, Lynn/0000-0003-2326-7595; Christmann, Mathias/0000-0001-9313-2392; Rubaiy, Hussein N./0000-0002-1489-5576; hamzah, nurasyikin/0000-0002-5115-227X; Bon, Robin/0000-0003-1733-3680; Beech, David/0000-0002-7683-9422; Bailey, Marc/0000-0001-5038-1970; Ludlow, Melanie/0000-0002-0720-5581; Foster, Richard/0000-0002-2361-3884; Miteva, Katarina/0000-0001-5657-4191	University of Leeds; LTHT Charitable Foundation; Wellcome Trust; BHF Ph.D. studentship; British Heart Foundation [FS/13/23/30122, FS/14/22/30734] Funding Source: researchfish	University of Leeds; LTHT Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); BHF Ph.D. studentship; British Heart Foundation(British Heart Foundation)	This work was supported by the University of Leeds, the LTHT Charitable Foundation, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a BHF Ph.D. studentship.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Al-Shawaf E, 2011, CELL CALCIUM, V50, P343, DOI 10.1016/j.ceca.2011.06.003; Alawi KM, 2017, ANN RHEUM DIS, V76, P252, DOI 10.1136/annrheumdis-2015-208886; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Bon RS, 2013, BRIT J PHARMACOL, V170, P459, DOI 10.1111/bph.12274; Carson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127498; Chenard BL, 2014, WO Patent, Patent No. [2014/143799, 2014143799]; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gaunt HJ, 2016, EUR BIOPHYS J BIOPHY, V45, P611, DOI 10.1007/s00249-016-1142-1; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jairaman A, 2013, CHANNELS, V7, P402, DOI 10.4161/chan.25292; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Lau OC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11947; Londono JEC, 2015, EUR HEART J, V36, P2257, DOI 10.1093/eurheartj/ehv250; Ludlow MJ, 2017, J BIOL CHEM, V292, P723, DOI 10.1074/jbc.M116.755678; Majeed Y, 2011, MOL PHARMACOL, V79, P1023, DOI 10.1124/mol.110.069922; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Naylor J, 2016, BRIT J PHARMACOL, V173, P562, DOI 10.1111/bph.13387; Phelan KD, 2013, MOL PHARMACOL, V83, P429, DOI 10.1124/mol.112.082271; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Richter JM, 2014, MOL PHARMACOL, V86, P514, DOI 10.1124/mol.114.093229; Richter JM, 2014, BRIT J PHARMACOL, V171, P158, DOI 10.1111/bph.12436; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Sukumar P, 2010, BIOCHEM BIOPH RES CO, V393, P50, DOI 10.1016/j.bbrc.2010.01.074; Wei H, 2015, NEUROSCI LETT, V608, P12, DOI 10.1016/j.neulet.2015.09.033; Wei ZL, 2015, BIOORG MED CHEM LETT, V25, P4011, DOI 10.1016/j.bmcl.2015.06.098; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Westlund KN, 2014, NEUROSCIENCE, V262, P165, DOI 10.1016/j.neuroscience.2013.12.043; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zheng F, 2014, CELLS-BASEL, V3, P288, DOI 10.3390/cells3020288; Zhu YM, 2015, BRIT J PHARMACOL, V172, P3495, DOI 10.1111/bph.13140	46	64	67	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8158	8173		10.1074/jbc.M116.773556	http://dx.doi.org/10.1074/jbc.M116.773556			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28325835	Green Accepted, hybrid, Green Published, Green Submitted			2022-12-28	WOS:000401788600004
J	Son, YO; Pratheeshkumar, P; Divya, SP; Zhang, Z; Shi, XL				Son, Young-Ok; Pratheeshkumar, Poyil; Divya, Sasidharan Padmaja; Zhang, Zhuo; Shi, Xianglin			RETRACTED: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells (Retracted article. See vol. 293, pg. 15457, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ROS-DEPENDENT ACTIVATION; OXIDATIVE STRESS; CANCER-CELLS; NRF2; PROTEIN; RESISTANCE; MECHANISM; BCL-2; KEAP1; RADIORESISTANCE	Nickel-containing compounds are widely used in industry. Nickel is a known human carcinogen that primarily affects the lungs. Proposed mechanisms of nickel-induced carcinogenesis include disruption of cellular iron homeostasis, generation of reactive oxygen species (ROS), and induction of hypoxia signaling. However, the precise molecular mechanisms of nickel-induced malignant transformation and tumor development remain unclear. This study shows that the transcription factor Nrf2 is highly expressed in lung tumor tissue and in nickel-transformed human lung bronchial epithelial BEAS-2B cells (NiT cells). Additionally, constitutively high levels of Nrf2 play a critical role in apoptosis resistance in NiT cells. Basal ROS levels were extremely low in NiT cells and were correlated with elevated expression levels of both antioxidant enzymes (e.g. catalase and superoxide dismutases) and antiapoptotic proteins (e.g. Bcl-2 and Bcl-xL). These processes are tightly controlled by Nrf2. Autophagy inhibition, induced pharmacologically or genetically, enhanced Ni2+-induced apoptosis, indicating that the induction of autophagy is the cause of apoptosis resistance in NiT cells. Using similar approaches, we show that in NiT cells the inhibition of apoptosis decreases autophagy. Wehave shown that Stat3, which is up-regulated by Nrf2, controls autophagy induction in NiT cells. Colony formation and tumor growth were significantly attenuated by knockdown of Nrf2 or Bcl-2. Taken together, this study demonstrates that in NiT cells constitutively high Nrf2 expression inhibits apoptosis by up-regulating antioxidant enzymes and antiapoptotic proteins to increase autophagy via Stat3 signaling. These findings indicate that the Nrf2-mediated suppression of apoptosis and promotion of autophagy contribute to nickel-induced transformation and tumorigenesis.	[Son, Young-Ok; Pratheeshkumar, Poyil; Shi, Xianglin] Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA; [Son, Young-Ok; Pratheeshkumar, Poyil; Divya, Sasidharan Padmaja; Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Son, Young-Ok] Gwangju Inst Sci & Technol, Natl Creat Res Initiat Ctr Osteoarthritis Pathoge, Gwangju 61005, South Korea; [Son, Young-Ok] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea	University of Kentucky; University of Kentucky; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA.; Shi, XL (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.; Son, YO (corresponding author), Gwangju Inst Sci & Technol, Natl Creat Res Initiat Ctr Osteoarthritis Pathoge, Gwangju 61005, South Korea.; Son, YO (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea.	sounagi@gist.ac.kr; xshi5@email.uky.edu		Son, Youngok/0000-0003-0154-4061	National Institutes of Health [R01 ES015518, R01 CA119028, R01 ES015375, R01 CA116697]; Biospecimen and Tissue Procurement Shared Resource Facility; Cytometry and Cell Sorting Core Facility of the University of Kentucky Markey Cancer Center [P30CA177558]; Basic Science Research Program through the National Research Foundation of Korea [2016R1D1A1B03930327]; NATIONAL CANCER INSTITUTE [P30CA177558, R01CA116697, R01CA119028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015518, R01ES015375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biospecimen and Tissue Procurement Shared Resource Facility; Cytometry and Cell Sorting Core Facility of the University of Kentucky Markey Cancer Center; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants R01 ES015518, R01 CA119028, R01 ES015375, and R01 CA116697, the Biospecimen and Tissue Procurement Shared Resource Facility, and Cytometry and Cell Sorting Core Facility of the University of Kentucky Markey Cancer Center Grant P30CA177558. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Basic Science Research Program through the National Research Foundation of Korea Grant 2016R1D1A1B03930327. To whom correspondence may be addressed: National Creative Research Initiatives Center for Osteoarthritis Pathogenesis and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, South Korea. Tel.: 82-62-715-2545; Fax: 82-62-715-2516; E-mail: sounagi@gist.ac.kr.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen X, 2016, FREE RADICAL RES, V50, P744, DOI 10.3109/10715762.2016.1173689; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; COSTA M, 1991, ANNU REV PHARMACOL, V31, P321; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76; Edwards MR, 2014, CELL REP, V6, P1017, DOI 10.1016/j.celrep.2014.01.043; Ellen TP, 2009, BIOCHEMISTRY-US, V48, P4626, DOI 10.1021/bi900246h; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; INT AGCY RES CANC, 1990, IARC MONOG EVAL CARC, V49, P257; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu CW, 2016, FREE RADICAL BIO MED, V95, P180, DOI 10.1016/j.freeradbiomed.2016.03.019; Luwor RB, 2013, J CLIN NEUROSCI, V20, P907, DOI 10.1016/j.jocn.2013.03.006; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Oller AR, 1997, TOXICOL APPL PHARM, V143, P152, DOI 10.1006/taap.1996.8075; Orrenius S, 2013, ANNU REV PHARMACOL, V53, P275, DOI 10.1146/annurev-pharmtox-011112-140210; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pan JJ, 2011, INT J ONCOL, V39, P1285, DOI 10.3892/ijo.2011.1157; Pan JJ, 2010, CHEM RES TOXICOL, V23, P568, DOI 10.1021/tx9003193; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; REDDEL RR, 1988, CANCER RES, V48, P1904; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Son YO, 2015, J BIOL CHEM, V290, P27090, DOI 10.1074/jbc.M115.675371; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Son YO, 2011, TOXICOL APPL PHARM, V255, P287, DOI 10.1016/j.taap.2011.06.024; Son YO, 2011, TOXICOL SCI, V119, P335, DOI 10.1093/toxsci/kfq335; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang Y, 2016, CLIN SCI, V130, P801, DOI 10.1042/CS20150617; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xue H, 2016, AUTOPHAGY, V12, P1129, DOI 10.1080/15548627.2016.1178446; Yang XH, 2016, NEUROSCI LETT, V626, P6, DOI 10.1016/j.neulet.2016.05.012; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhang ZD, 2016, GENE, V584, P75, DOI 10.1016/j.gene.2016.03.012	67	18	19	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8315	8330		10.1074/jbc.M116.773986	http://dx.doi.org/10.1074/jbc.M116.773986			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28330870	Green Published, hybrid			2022-12-28	WOS:000401788600017
J	Murphy, G				Murphy, Gillian			Riding the metalloproteinase roller coaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN FIBROBLAST COLLAGENASE; MATRIX METALLOPROTEINASES; RABBIT BONE; TUMOR MICROENVIRONMENT; TADPOLE COLLAGENASE; TISSUE INHIBITORS; RAT UTERUS; IN-VIVO; PURIFICATION; FAMILY	To many of us in the field, working on matrix metalloproteinases (MMPs) has felt like riding a roller coaster, traveling through times of both excitement and despair. I was fortunate to join the ride when it was a mere carousel of three activities thought to target the proteins that comprise the extracellular matrix (ECM). Newtechnologies brought the thrills of discovery as we uncovered specific proteinase genes and defined specialized activities in different cellular processes. The MMPs and the sister families of "a disintegrin and metalloproteinase" (ADAMs), ADAMs with thrombospondin domains (ADAM-TS), and Astacins are now recognized as key signaling "scissors" that drive rapid changes in a plethora of cellular pathways. My many excellent colleagues and collaborators and I were enthused to contribute to the early development of the field and continue to be amazed at its growth and sophistication. In contrast, the hype and failure of early inhibitor discovery have dogged our standing with the pharmaceutical industry and grant-giving bodies. However, the true believers have kept going, and knowledge of particular functions of MMPs and their contributions to disease progression has progressed. Recognition of the strategic importance of proteinase function should inspire more work harnessing new technologies such as imaging, proteomics, and gene editing to generate a more precise understanding of individual situations. New approaches to inhibitor design and assessment are possible, and the consequent ability to precisely abrogate specific MMP activity could contribute to the fight against a number of pathologies with unmet needs. What a ride it could be!	[Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Murphy, G (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England.	gm290@cam.ac.uk			Medical Research Council, UK; Wellcome Trust; Arthritis Research UK; Cancer Research UK; European Union Framework Programmes	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); Cancer Research UK(Cancer Research UK); European Union Framework Programmes	I am exceedingly grateful to my colleagues and students for working so hard and sharing the thrill of discovery with me. I am also grateful to all in the MMP community across the world for sharing the excitements and disappointments of research in this field and for such valuable collaborations. I thank the Medical Research Council, UK, the Wellcome Trust, Arthritis Research UK, Cancer Research UK and the European Union Framework Programmes for supporting our research from 1975 to 2014. Thanks to Hideaki Nagase for critical comments on the manuscript.	Aiken A, 2010, BBA-MOL CELL RES, V1803, P121, DOI 10.1016/j.bbamcr.2009.07.002; Amar S, 2015, EXPERT REV PROTEOMIC, V12, P445, DOI 10.1586/14789450.2015.1069190; Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Basu B, 2012, INT J BIOCHEM CELL B, V44, P393, DOI 10.1016/j.biocel.2011.11.015; Botkjaer KA, 2016, ONCOTARGET, V7, P16773, DOI 10.18632/oncotarget.7780; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brown PD, 1995, ANN ONCOL, V6, P967, DOI 10.1093/oxfordjournals.annonc.a059091; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; CAWSTON TE, 1981, BIOCHEM J, V195, P159, DOI 10.1042/bj1950159; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EISEN AZ, 1968, BIOCHIM BIOPHYS ACTA, V151, P637, DOI 10.1016/0005-2744(68)90010-7; EVERSON JM, 1967, SCIENCE, V158, P499, DOI 10.1126/science.158.3800.499; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hall LA, 1996, MED HIST, V40, P231, DOI 10.1017/S0025727300061020; HARPER E, 1971, BIOCHEMISTRY-US, V10, P3035, DOI 10.1021/bi00792a008; Iyer RP, 2012, AM J PHYSIOL-HEART C, V303, pH919, DOI 10.1152/ajpheart.00577.2012; JEFFREY JJ, 1970, BIOCHEMISTRY-US, V9, P268, DOI 10.1021/bi00804a012; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Matusiak N, 2013, CURR PHARM DESIGN, V19, P4647, DOI 10.2174/1381612811319250011; Murphy G, 2003, BIOCHEM SOC SYMP, V70, P65, DOI 10.1042/bss0700065; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; NAGAI Y, 1966, BIOCHEMISTRY-US, V5, P3123, DOI 10.1021/bi00874a007; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; OKADA Y, 1986, J BIOL CHEM, V261, P14245; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Schlage P, 2015, MATRIX BIOL, V44-46, P232, DOI 10.1016/j.matbio.2015.01.003; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; SELLERS A, 1978, BIOCHEM J, V171, P493, DOI 10.1042/bj1710493; SELLERS A, 1977, BIOCHEM J, V167, P353, DOI 10.1042/bj1670353; SELLERS A, 1977, BIOCHEM J, V163, P303, DOI 10.1042/bj1630303; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; STRICKLIN GP, 1983, J BIOL CHEM, V258, P2252; STRICKLIN GP, 1978, BIOCHEMISTRY-US, V17, P2331, DOI 10.1021/bi00605a012; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Waschkau B, 2013, CONTRAST MEDIA MOL I, V8, P1, DOI 10.1002/cmmi.1486; Watson SA, 1996, BRIT J CANCER, V74, P1354, DOI 10.1038/bjc.1996.549; WOESSNER JF, 1962, BIOCHEM J, V83, P304, DOI 10.1042/bj0830304; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	53	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7708	7717		10.1074/jbc.X117.785295	http://dx.doi.org/10.1074/jbc.X117.785295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28298437	Green Published, hybrid			2022-12-28	WOS:000401154100001
J	Ogino, H; Ishino, S; Kohda, D; Ishino, Y				Ogino, Hiromi; Ishino, Sonoko; Kohda, Daisuke; Ishino, Yoshizumi			The RecJ2 protein in the thermophilic archaeon Thermoplasma acidophilum is a 3 '-5 ' exonuclease that associates with a DNA replication complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINS COMPLEX; MCM HELICASE; PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; CDC45; REPAIR; ACTIVATION; RECOMBINATION; SUGGESTS; FORK	RecJ/cell division cycle 45 (Cdc45) proteins are widely conserved in the three domains of life, i. e. in bacteria, Eukarya, and Archaea. Bacterial RecJ is a 5'-3' exonuclease and functions in DNA repair pathways by using its 5'-3' exonuclease activity. Eukaryotic Cdc45 has no identified enzymatic activity but participates in theCMGcomplex, so named because it is composed of Cdc45, minichromosome maintenance protein complex (MCM) proteins 2-7, and GINS complex proteins (Sld5, Psf113). Eukaryotic Cdc45 and bacterial/archaeal RecJ share similar amino acid sequences and are considered functional counterparts. In Archaea, a RecJ homolog in Thermococcus kodakarensis was shown to associate with GINS and accelerate its nuclease activity and was, therefore, designated GAN (GINS-associated nuclease); however, to date, no archaeal RecJ.MCM.GINS complex has been isolated. The thermophilic archaeon Thermoplasma acidophilum has two RecJ-like proteins, designated TaRecJ1 and TaRecJ2. TaRecJ1 exhibited DNA-specific 5'-3' exonuclease activity, whereas TaRecJ2 had 3'-5' exonuclease activity and preferred RNA over DNA. TaRecJ2, but not TaRecJ1, formed a stable complex with TaGINS in a 2: 1 molar ratio. Furthermore, the TaRecJ2.TaGINS complex stimulated activity of TaMCM (T. acidophilum MCM) helicase in vitro, and the TaRecJ2.TaMCM.TaGINS complex was also observed in vivo. However, TaRecJ2 did not interact with TaMCM directly and was not required for the helicase activation in vitro. These findings suggest that the function of archaeal RecJ in DNA replication evolved divergently from Cdc45 despite conservation of the CMG-like complex formation between Archaea and Eukarya.	[Ogino, Hiromi; Ishino, Sonoko; Ishino, Yoshizumi] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Kohda, Daisuke; Ishino, Yoshizumi] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Ogino, Hiromi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu, Gifu 5011193, Japan; [Ishino, Yoshizumi] Univ Illinois, Inst Univ Biol, Urbana, IL 61801 USA; [Ishino, Yoshizumi] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA	Kyushu University; Kyushu University; Gifu University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ishino, Y (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.; Ishino, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.; Ishino, Y (corresponding author), Univ Illinois, Inst Univ Biol, Urbana, IL 61801 USA.; Ishino, Y (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	ishino@agr.kyushu-u.ac.jp	Kohda, Daisuke/I-4990-2019	Kohda, Daisuke/0000-0001-8234-3776; Ishino, Yoshizumi/0000-0001-9419-0826; Ishino, Sonoko/0000-0002-1833-1735	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26242075]; Institute for Fermentation, Osaka (IFO); JSPS (Japan Society for the Promotion of Science) bilateral program	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO)); JSPS (Japan Society for the Promotion of Science) bilateral program	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant 26242075 (to Y. I.) and in part by the Institute for Fermentation, Osaka (IFO). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a JSPS (Japan Society for the Promotion of Science) bilateral program. Member of affiliated faculty at the Institute for Universal Biology and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois. To whom correspondence should be addressed. Tel.: 81-92-642-4218; Fax: 81-92-642-3051; E-mail: ishino@agr.kyushu-u.ac.jp.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Ciaramella M, 2005, TRENDS MICROBIOL, V13, P49, DOI 10.1016/j.tim.2004.12.001; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; Fujikane R, 2006, GENES CELLS, V11, P99, DOI 10.1111/j.1365-2443.2006.00925.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giroux Xavier, 2015, Methods Mol Biol, V1300, P187, DOI 10.1007/978-1-4939-2596-4_13; Goswami K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09057; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishino S, 2011, GENES CELLS, V16, P1176, DOI 10.1111/j.1365-2443.2011.01562.x; Ishino Y, 2012, SCI CHINA LIFE SCI, V55, P386, DOI 10.1007/s11427-012-4324-9; Krastanova I, 2012, J BIOL CHEM, V287, P4121, DOI 10.1074/jbc.M111.285395; Lang SW, 2015, J BACTERIOL, V197, P3409, DOI 10.1128/JB.00496-15; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Morimatsu K, 2014, P NATL ACAD SCI USA, V111, pE5133, DOI 10.1073/pnas.1420009111; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ogino H, 2015, BIOSCI BIOTECH BIOCH, V79, P432, DOI 10.1080/09168451.2014.982503; Ogino H, 2014, EXTREMOPHILES, V18, P915, DOI 10.1007/s00792-014-0673-6; Ogino H, 2011, EXTREMOPHILES, V15, P529, DOI 10.1007/s00792-011-0383-2; Oyama T, 2016, NUCLEIC ACIDS RES, V44, P9505, DOI 10.1093/nar/gkw789; Perez-Arnaiz P, 2016, NUCLEIC ACIDS RES, V44, P315, DOI 10.1093/nar/gkv1260; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; SEARCY DG, 1976, BIOCHIM BIOPHYS ACTA, V451, P278, DOI 10.1016/0304-4165(76)90278-6; Simon AC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11638; Sutera VA, 1999, J BACTERIOL, V181, P6098, DOI 10.1128/JB.181.19.6098-6102.1999; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Xia YS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01247; Xu Y, 2016, P NATL ACAD SCI USA, V113, P13390, DOI 10.1073/pnas.1613825113; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; YASUDA M, 1995, APPL ENVIRON MICROB, V61, P3482, DOI 10.1128/AEM.61.9.3482-3485.1995; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; Yuan H, 2013, NUCLEIC ACIDS RES, V41, P5817, DOI 10.1093/nar/gkt275; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170	42	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7921	7931		10.1074/jbc.M116.767921	http://dx.doi.org/10.1074/jbc.M116.767921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302716	hybrid, Green Published			2022-12-28	WOS:000401154100019
J	Kacprzak, S; Njimona, I; Renz, A; Feng, J; Reijerse, E; Lubitz, W; Krauss, N; Scheerer, P; Nagano, S; Lamparter, T; Weber, S				Kacprzak, Sylwia; Njimona, Ibrahim; Renz, Anja; Feng, Juan; Reijerse, Edward; Lubitz, Wolfgang; Krauss, Norbert; Scheerer, Patrick; Nagano, Soshichiro; Lamparter, Tilman; Weber, Stefan			Intersubunit distances in full-length, dimeric, bacterial phytochrome Agp1, as measured by pulsed electron-electron double resonance (PELDOR) between different spin label positions, remain unchanged upon photoconversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; dimerization; electron paramagnetic resonance (EPR); histidine kinase; photoreceptor; spectroscopy; PELDOR; SDSL; biliprotein; phytochrome	INDUCED CONFORMATIONAL-CHANGES; HISTIDINE-KINASE; CRYSTAL-STRUCTURE; SENSORY MODULE; CHROMOPHORE; CYANOBACTERIAL; REVEALS; BIOMACROMOLECULES; REARRANGEMENTS; PROTEIN	Bacterial phytochromes are dimeric light-regulated histidine kinases that convert red light into signaling events. Light absorption by the N-terminal photosensory core module (PCM) causes the proteins to switch between two spectrally distinct forms, Pr and Pfr, thus resulting in a conformational change that modulates the C-terminal histidine kinase region. To provide further insights into structural details of photoactivation, we investigated the full-length Agp1 bacteriophytochrome from the soil bacterium Agrobacterium fabrum using a combined spectroscopic and modeling approach. We generated seven mutants suitable for spin labeling to enable application of pulsed EPR techniques. The distances between attached spin labels were measured using pulsed electron-electron double resonance spectroscopy to probe the arrangement of the subunits within the dimer. We found very good agreement of experimental and calculated distances for the histidine-kinase region when both subunits are in a parallel orientation. However, experimental distance distributions surprisingly showed only limited agreement with either parallel- or antiparallel-arranged dimer structures when spin labels were placed into the PCM region. This observation indicates that the arrangements of the PCM subunits in the full-length protein dimer in solution differ significantly from that in the PCM crystals. The pulsed electron-electron double resonance data presented here revealed either no or only minor changes of distance distributions upon Pr-to-Pfr photoconversion.	[Kacprzak, Sylwia; Renz, Anja; Weber, Stefan] Albert Ludwigs Univ Freiburg, Inst Phys Chem, Albertstr 21, D-79104 Freiburg, Germany; [Njimona, Ibrahim; Feng, Juan; Krauss, Norbert; Lamparter, Tilman] Karlsruhe Inst Technol, Bot Inst 1, D-76131 Karlsruhe, Germany; [Reijerse, Edward; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Scheerer, Patrick] Charite Univ Med Berlin, Grp Prot Xray Crystallog & Signal Transduct, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Nagano, Soshichiro] Justus Liebig Univ Giessen, Inst Pflanzenphysiol, D-35390 Giessen, Germany; [Njimona, Ibrahim] Bamenda Univ Sci & Technol, POB 277, Nkwen, Bamenda, Cameroon; [Renz, Anja] Friedrich Schiller Univ Jena, Jena Univ Hosp, Single Mol Microscopy Grp, Nonnenplan 2-4, D-07743 Jena, Germany; [Feng, Juan] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Friedrich Schiller University of Jena; University of Electronic Science & Technology of China	Kacprzak, S (corresponding author), Albert Ludwigs Univ Freiburg, Inst Phys Chem, Albertstr 21, D-79104 Freiburg, Germany.	Sylwia.Kacprzak@physchem.uni-freiburg.de	Weber, Stefan/G-6164-2010; Lamparter, Tilman/E-4421-2013	Scheerer, Patrick/0000-0001-5028-2075; Lamparter, Tilman/0000-0003-4327-9737; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft [WE 2376/3-1, LA 799/11-1, SFB740-B6, SFB1078-B6, INST 39/928-1FUGG]; Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field Grant [D3/E3-1]; Struktur- und Innovationsfond fur die Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field Grant(German Research Foundation (DFG)); Struktur- und Innovationsfond fur die Forschung	This work was supported by Deutsche Forschungsgemeinschaft Grants WE 2376/3-1 and LA 799/11-1 and by the Max Planck Gesellschaft. This work was also supported in part by Deutsche Forschungsgemeinschaft Grants SFB740-B6 and SFB1078-B6 (to P. S.), by Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field Grant D3/E3-1 (to P. S.), by Struktur- und Innovationsfond fur die Forschung (to S. W. and S. K.), and by Deutsche Forschungsgemeinschaft Grant INST 39/928-1FUGG(to S. W. and S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Borbat PP, 2014, STRUCT BOND, V152, P1, DOI 10.1007/430_2012_82; Borucki B, 2009, J BIOL CHEM, V284, P26005, DOI 10.1074/jbc.M109.049056; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Heyes DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052418; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Nagano S, 2016, J BIOL CHEM, V291, P20674, DOI 10.1074/jbc.M116.739136; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Noack S, 2007, METHOD ENZYMOL, V423, P203, DOI 10.1016/S0076-6879(07)23009-5; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Song PS, 1999, J BIOCHEM MOL BIOL, V32, P215; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yamada S, 2006, J MOL BIOL, V362, P123, DOI 10.1016/j.jmb.2006.07.012; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106	34	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7598	7606		10.1074/jbc.M116.761882	http://dx.doi.org/10.1074/jbc.M116.761882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28289094	Green Published, hybrid			2022-12-28	WOS:000400761300027
J	Gunn, LH; Valegard, K; Andersson, I				Gunn, Laura H.; Valegard, Karin; Andersson, Inger			A unique structural domain in Methanococcoides burtonii ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) acts as a small subunit mimic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; CRYSTAL-STRUCTURE; ARCHAEAL RUBISCO; 1,5-BISPHOSPHATE CARBOXYLASE; PSI-BLAST; PROTEIN; EVOLUTION; OXYGENASE; COMPLEX; PHOTOSYNTHESIS	The catalytic inefficiencies of the CO2-fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) often limit plant productivity. Strategies to engineer more efficient plant Rubiscos have been hampered by evolutionary constraints, prompting interest in Rubisco isoforms from non-photosynthetic organisms. The methanogenic archaeon Methanococcoides burtonii contains a Rubisco isoform that functions to scavenge the ribulose-1,5-bisphosphate (RuBP) by-product of purine/pyrimidine metabolism. The crystal structure of M. burtonii Rubisco (MbR) presented here at 2.6A degrees resolution is composed of catalytic large subunits (LSu) assembled into pentamers of dimers, (L-2)(5), and differs from Rubiscos from higher plants where LSus are glued together by small subunits (SSu) into hexadecameric L8S8 enzymes. MbRcontains a unique 29-amino acid insertion near the C terminus, which folds as a separate domain in the structure. This domain, which is visualized for the first time in this study, is located in a similar position to SSus in L8S8 enzymes between LSus of adjacent L-2 dimers, where negatively charged residues coordinate around a Mg2+ ion in a fashion that suggests this domain may be important for the assembly process. The Rubisco assembly domain is thus an inbuilt SSu mimic that concentrates L-2 dimers. MbRassembly is ligand-stimulated, and we show that only 6-carbon molecules with a particular stereochemistry at the C-3 carbon can induce oligomerization. Based on MbR structure, subunit arrangement, sequence, phylogenetic distribution, and function, MbRand a subset of Rubiscos from the Methanosarcinales order are proposed to belong to a new Rubisco subgroup, named form IIIB.	[Gunn, Laura H.; Valegard, Karin; Andersson, Inger] Uppsala Univ, Dept Cell & Mol Biol, Husargatan 3,Box 596, S-75124 Uppsala, Sweden	Uppsala University	Gunn, LH (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Husargatan 3,Box 596, S-75124 Uppsala, Sweden.	laura.gunn@icm.uu.se		Andersson, Inger/0000-0002-2729-0787	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bricogne G., 2011, BUSTER VERSION 2 10; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Danson MJ, 1996, PROTEIN ENG, V9, P629, DOI 10.1093/protein/9.8.629; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Hanson MR, 2016, PLANT J, V87, P38, DOI 10.1111/tpj.13139; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; LEE EH, 1993, J BIOL CHEM, V268, P26583; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; Mackinder LCM, 2016, P NATL ACAD SCI USA, V113, P5958, DOI 10.1073/pnas.1522866113; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller-Cajar O, 2007, BIOESSAYS, V29, P722, DOI 10.1002/bies.20616; Nei M., 2000, MOL EVOLUTION PHYLOG, p[33, 99]; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Saito Y, 2009, J BIOL CHEM, V284, P13256, DOI 10.1074/jbc.M807095200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHNEIDER G, 1990, EMBO J, V9, P2045, DOI 10.1002/j.1460-2075.1990.tb07371.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Smrcka A. V., 1990, THESIS; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor TC, 1996, J BIOL CHEM, V271, P32894, DOI 10.1074/jbc.271.51.32894; Taylor TC, 1997, BIOCHEMISTRY-US, V36, P4041, DOI 10.1021/bi962818w; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Wilson RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22284; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte B. H., 2012, THESIS; Wommack KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/sigs.2945050; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172; ZHU GH, 1990, PLANT PHYSIOL, V93, P244, DOI 10.1104/pp.93.1.244; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354	69	12	12	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6838	6850		10.1074/jbc.M116.767145	http://dx.doi.org/10.1074/jbc.M116.767145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28154188	Green Published, hybrid			2022-12-28	WOS:000399813400033
J	Bukiya, AN; Durdagi, S; Noskov, S; Rosenhouse-Dantsker, A				Bukiya, Anna N.; Durdagi, Serdar; Noskov, Sergei; Rosenhouse-Dantsker, Avia			Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; K-ACH CHANNEL; MEMBRANE CHOLESTEROL; LARGE-CONDUCTANCE; HYPERCHOLESTEROLEMIA; IDENTIFICATION; RECTIFIER; RECEPTORS; SENSITIVITY; MECHANISMS	Hypercholesterolemia is a well known risk factor for the development of neurodegenerative disease. However, the underlying mechanisms are mostly unknown. In recent years, it has become increasingly evident that cholesterol-driven effects on physiology and pathophysiology derive from its ability to alter the function of a variety of membrane proteins including ion channels. Yet, the effect of cholesterol on G protein-gated inwardly rectifying potassium (GIRK) channels expressed in the brain is unknown. GIRK channels mediate the actions of inhibitory brain neurotransmitters. As a result, loss of GIRK function can enhance neuron excitability, whereas gain of GIRK function can reduce neuronal activity. Here we show that in rats on a high-cholesterol diet, cholesterol levels in hippocampal neurons are increased. We also demonstrate that cholesterol plays a critical role in modulating neuronal GIRK currents. Specifically, cholesterol enrichment of rat hippocampal neurons resulted in enhanced channel activity. In accordance, elevated currents upon cholesterol enrichment were also observed in Xenopus oocytes expressing GIRK2 channels, the primary GIRK subunit expressed in the brain. Furthermore, using planar lipid bilayers, we show that although cholesterol did not affect the unitary conductance of GIRK2, it significantly enhanced the frequency of channel openings. Last, combining computational and functional approaches, we identified two putative cholesterol-binding sites in the transmembrane domain of GIRK2. These findings establish that cholesterol plays a critical role in modulating GIRK activity in the brain. Because up-regulation of GIRK function can reduce neuronal activity, our findings may lead to novel approaches for prevention and therapy of cholesterol-driven neurodegenerative disease.	[Rosenhouse-Dantsker, Avia] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Bukiya, Anna N.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38103 USA; [Durdagi, Serdar; Noskov, Sergei] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Durdagi, Serdar; Noskov, Sergei] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Durdagi, Serdar] Bahcesehir Univ, Dept Biophys, Sch Med, TR-34353 Istanbul, Turkey	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Calgary; University of Calgary; Bahcesehir University	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.	dantsker@uic.edu	Bukiya, Anna/N-5361-2019; Durdagi, Serdar/J-1904-2018	Durdagi, Serdar/0000-0002-0426-0905; Noskov, Sergei/0000-0001-7769-335X	Scientist Development Grant from the American Heart Association [11SDG5190025]; National Sciences and Engineering Research Council (NSERC) [RGPIN-315019]; Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation	Scientist Development Grant from the American Heart Association(American Heart Association); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation	This work was supported in part by Scientist Development Grant 11SDG5190025 from the American Heart Association (to A. R.-D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the National Sciences and Engineering Research Council (NSERC) Discovery Grants RGPIN-315019 (to S. N.) and the Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation.	Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254; Aleksandrov A, 1996, BIOPHYS J, V70, P2680, DOI 10.1016/S0006-3495(96)79837-5; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; Awayda MS, 2011, J BIOL CHEM, V286, P1683, DOI 10.1074/jbc.M110.159194; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Bajic D, 2002, P NATL ACAD SCI USA, V99, P14494, DOI 10.1073/pnas.222379999; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; BOND CT, 1995, FEBS LETT, V367, P61, DOI 10.1016/0014-5793(95)00497-W; Bukiya A. N., 2015, HYPERCHOLESTEROLEMIA, P95; Bukiya A, 2014, ALCOHOL CLIN EXP RES, V38, P1216, DOI 10.1111/acer.12373; Bukiya AN, 2015, BBA-BIOMEMBRANES, V1848, P2406, DOI 10.1016/j.bbamem.2015.07.007; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Christian AE, 1997, J LIPID RES, V38, P2264; Chubinskiy-Nadezhdin VI, 2011, BIOCHEM BIOPH RES CO, V412, P80, DOI 10.1016/j.bbrc.2011.07.046; Clayton PT, 1998, ARCH DIS CHILD, V78, P185, DOI 10.1136/adc.78.2.185; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; Deng W, 2012, J BIOL CHEM, V287, P4925, DOI 10.1074/jbc.M111.306134; Dias IHK, 2014, BIOCHEM SOC T, V42, P1001, DOI 10.1042/BST20140164; Dopico AM, 2012, PHARMACOL THERAPEUT, V135, P133, DOI 10.1016/j.pharmthera.2012.05.002; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Grigg JJ, 1996, J NEUROPHYSIOL, V75, P318, DOI 10.1152/jn.1996.75.1.318; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Ho YS, 2012, CURR PHARM DESIGN, V18, P15, DOI 10.2174/138161212798919039; Jones PJH, 1996, ARTERIOSCL THROM VAS, V16, P1222, DOI 10.1161/01.ATV.16.10.1222; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; Kawano T, 2004, NEUROSCI LETT, V358, P63, DOI 10.1016/j.neulet.2003.12.104; Kitamura H, 2000, J PHARMACOL EXP THER, V293, P196; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kruth Howard S., 2001, Current Molecular Medicine (Hilversum), V1, P633, DOI 10.2174/1566524013363212; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Michaeli A, 2010, NEUROSCIENCE, V165, P1159, DOI 10.1016/j.neuroscience.2009.11.045; MIYAKE M, 1989, P NATL ACAD SCI USA, V86, P3419, DOI 10.1073/pnas.86.9.3419; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nelson CS, 1997, MOL BRAIN RES, V46, P185, DOI 10.1016/S0169-328X(96)00301-4; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Rosenhouse-Dantsker A, 2013, J BIOL CHEM, V288, P31154, DOI 10.1074/jbc.M113.496117; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Singh A. K., 2012, J ENV SCI TOXICOL FO, V1, P1, DOI DOI 10.1016/J.BMC.2011.09.022; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Surmeier DJ, 1996, P NATL ACAD SCI USA, V93, P11191, DOI 10.1073/pnas.93.20.11191; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vaithianathan T, 2010, AM J PHYSIOL-CELL PH, V299, pC264, DOI 10.1152/ajpcell.00318.2009; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; VELIMIROVIC BM, 1995, P NATL ACAD SCI USA, V92, P1590, DOI 10.1073/pnas.92.5.1590; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Witkowski G, 2008, NEUROSCIENCE, V155, P53, DOI 10.1016/j.neuroscience.2008.05.021; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	91	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6135	6147		10.1074/jbc.M116.753350	http://dx.doi.org/10.1074/jbc.M116.753350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28213520	hybrid, Green Published			2022-12-28	WOS:000399538700011
J	Liu, F; Qin, YY; Yu, SS; Soares, DC; Yang, LF; Weng, J; Li, C; Gao, M; Lu, ZJ; Hu, XB; Liu, XL; Jiang, T; Liu, JY; Shu, XH; Tang, ZH; Liu, MG				Liu, Fei; Qin, Yayun; Yu, Shanshan; Soares, Dinesh C.; Yang, Lifang; Weng, Jun; Li, Chang; Gao, Meng; Lu, Zhaojing; Hu, Xuebin; Liu, Xiliang; Jiang, Tao; Liu, Jing Yu; Shu, Xinhua; Tang, Zhaohui; Liu, Mugen			Pathogenic mutations in retinitis pigmentosa 2 predominantly result in loss of RP2 protein stability in humans and zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORTH-AMERICAN COHORT; RETINITIS-PIGMENTOSA-2 PROTEIN; PHOTORECEPTOR DEGENERATION; GENE; FAMILIES; RPGR; IDENTIFICATION; PHENOTYPE; TRAFFICKING; INTERACTS	Mutations in retinitis pigmentosa 2 (RP2) account for 10-20% of X-linked retinitis pigmentosa (RP) cases. The encoded RP2 protein is implicated in ciliary trafficking of myristoylated and prenylated proteins in photoreceptor cells. To date > 70 mutations in RP2 have been identified. How these mutations disrupt the function of RP2 is not fully understood. Here we report a novel in-frame 12-bp deletion (c. 357_ 368del, p. Pro120_ Gly123del) in zebrafish rp2. The mutant zebrafish shows reduced rod phototransduction proteins and progressive retinal degeneration. Interestingly, the protein level of mutant Rp2 is almost undetectable, whereas itsmRNAlevel is near normal, indicating a possible post-translational effect of the mutation. Consistent with this hypothesis, the equivalent 12-bp deletion in human RP2 markedly impairs RP2 protein stability and reduces its protein level. Furthermore, we found that a majority of the RP2 pathogenic mutations (including missense, single-residue deletion, and C-terminal truncation mutations) severely destabilize the RP2 protein. The destabilized RP2 mutant proteins are degraded via the proteasome pathway, resulting in dramatically decreased protein levels. The remaining non-destabilizing mutations T87I, R118H/R118G/R118L/R118C, E138G, and R211H/R211L are suggested to impair the interaction between RP2 and its protein partners (such as ARL3) or with as yet unknown partners. By utilizing a combination of in silico, in vitro, and in vivo approaches, our work comprehensively indicates that loss of RP2 protein structural stability is the predominating pathogenic consequence for most RP2 mutations. Our study also reveals a role of the C-terminal domain of RP2 in maintaining the overall protein stability.	[Liu, Fei; Qin, Yayun; Yu, Shanshan; Yang, Lifang; Weng, Jun; Li, Chang; Gao, Meng; Lu, Zhaojing; Hu, Xuebin; Liu, Xiliang; Jiang, Tao; Liu, Jing Yu; Tang, Zhaohui; Liu, Mugen] Huazhong Univ Sci & Technol, Dept Genet & Dev Biol, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Soares, Dinesh C.] Univ Edinburgh, MRC Human Genet Unit, Ctr Genom & Expt Med, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Shu, Xinhua] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland	Huazhong University of Science & Technology; University of Edinburgh; Glasgow Caledonian University	Liu, MG (corresponding author), Huazhong Univ Sci & Technol, Dept Genet & Dev Biol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	lium@hust.edu.cn	Liu, Fei/AAR-6464-2021; Soares, Dinesh/A-4425-2012	Liu, Fei/0000-0002-0310-1072; Soares, Dinesh/0000-0001-7557-0495	National Natural Science Foundation of China [81670890, 31601026, 81500762, 31571303, 31471194, 81371064]; China Postdoctoral Science Foundation [2015M582216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81670890, 31601026, 81500762, 31571303, 31471194, and 81371064) and the China Postdoctoral Science Foundation (2015M582216). The authors declare that they have no conflicts of interest with the contents of this article.	Alibes A, 2010, NUCLEIC ACIDS RES, V38, P7422, DOI 10.1093/nar/gkq683; Bader I, 2003, INVEST OPHTH VIS SCI, V44, P1458, DOI 10.1167/iovs.02-0605; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Chapple JP, 2000, HUM MOL GENET, V9, P1919, DOI 10.1093/hmg/9.13.1919; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Dandekar SS, 2004, BRIT J OPHTHALMOL, V88, P528, DOI 10.1136/bjo.2003.027979; Evans RJ, 2006, EXP EYE RES, V82, P543, DOI 10.1016/j.exer.2005.10.023; Grayson C, 2002, J MED GENET, V39, P62, DOI 10.1136/jmg.39.1.62; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Li C, 2014, BBA-MOL BASIS DIS, V1842, P1121, DOI 10.1016/j.bbadis.2014.04.009; Li LJ, 2015, CYTOSKELETON, V72, P447, DOI 10.1002/cm.21255; Li LJ, 2013, INVEST OPHTH VIS SCI, V54, P4503, DOI 10.1167/iovs.13-12140; Liu F, 2015, HUM MOL GENET, V24, P4648, DOI 10.1093/hmg/ddv197; Mears AJ, 1999, AM J HUM GENET, V64, P897, DOI 10.1086/302298; Miano MG, 2001, HUM MUTAT, V18, P109, DOI 10.1002/humu.1160; Neidhardt J, 2008, MOL VIS, V14, P1081; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Patil SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021379; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Pomares E, 2009, INVEST OPHTH VIS SCI, V50, P5107, DOI 10.1167/iovs.08-3208; Prokisch H, 2007, INVEST OPHTH VIS SCI, V48, P4012, DOI 10.1167/iovs.07-0071; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Schwahn U, 2001, HUM MOL GENET, V10, P1177, DOI 10.1093/hmg/10.11.1177; Schwarz N, 2012, HUM MOL GENET, V21, P863, DOI 10.1093/hmg/ddr520; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Thiselton D L, 2000, Hum Mutat, V15, P580, DOI 10.1002/1098-1004(200006)15:6<580::AID-HUMU15>3.0.CO;2-3; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Villaverde-Montero Cristina, 2007, Hum Genet, V121, P289; Wada Y, 2000, INVEST OPHTH VIS SCI, V41, P290; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Wright ZC, 2016, HUM MOL GENET, V25, P2031, DOI 10.1093/hmg/ddw077; Yoon JH, 2006, EXP CELL RES, V312, P1323, DOI 10.1016/j.yexcr.2005.12.026; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915	50	14	14	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6225	6239		10.1074/jbc.M116.760314	http://dx.doi.org/10.1074/jbc.M116.760314			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28209709	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000399538700018
J	Gu, CF; Nguyen, HN; Hofer, A; Jessen, HJ; Dai, XM; Wang, HC; Shears, SB				Gu, Chunfang; Nguyen, Hoai-Nghia; Hofer, Alexandre; Jessen, Henning J.; Dai, Xuming; Wang, Huanchen; Shears, Stephen B.			The Significance of the Bifunctional Kinase/Phosphatase Activities of Diphosphoinositol Pentakisphosphate Kinases (PPIP5Ks) for Coupling Inositol Pyrophosphate Cell Signaling to Cellular Phosphate Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED FAMILY; HEXAKISPHOSPHATE; ROBUSTNESS; IDENTIFICATION; CYCLES; DOMAIN; ROLES; SERUM	Proteins responsible for Pi homeostasis are critical for all life. In Saccharomyces cerevisiae, extracellular [P-1] is "sensed" by the inositol-hexakisphosphate kinase (IP6K) that synthesizes the intracellular inositol pyrophosphate 5-diphosphoinositol 1,2,3,4,6-pentakisphosphate (5-InsP(7)) as follows: during a period of Pi starvation, there is a decline in cellular [ATP]; the unusually low affinity of IP6Ks for ATP compels 5-InsP(7) levels to fall in parallel (Azevedo, C.,and Saiardi, A. (2017) Trends. Biochem. Sci. 42, 219-231. Hitherto, such P-1 sensing has not been documented in metazoans. Here, using a human intestinal epithelial cell line (HCT116), we show that levels of both 5-InsP(7) and ATP decrease upon [P-1] starvation and subsequently recover during Pi replenishment. However, a separate inositol pyrophosphate, 1,5-bisdiphosphoinositol 2,3,4,6-tetrakisphosphate (InsP(8)), reacts more dramatically (i.e. with a wider dynamic range and greater sensitivity). To understand this novel InsP(8) response, we characterized kinetic properties of the bifunctional 5-InsP(7) kinase/InsP(8) phosphatase activities of full-length diphosphoinositol pentakisphosphate kinases (PPIP5Ks). These data fulfil previously published criteria for any bifunctional kinase/phosphatase to exhibit concentration robustness, permitting levels of the kinase product (InsP(8) in this case) to fluctuate independently of varying precursor (i.e. 5-InsP(7)) pool size. Moreover, we report that InsP(8) phosphatase activities of PPIP5Ks are strongly inhibited by P-1 (40-90% within the 0-1 mM range). For PPIP5K2, P-1 sensing by InsP(8) is amplified by a 2-fold activation of 5-InsP(7) kinase activity by P-1 within the 0-5 mM range. Overall, our data reveal mechanisms that can contribute to specificity in inositol pyrophosphate sig-naling, regulating InsP(8) turnover independently of 5-InsP(7), in response to fluctuations in extracellular supply of a key nutrient.	[Gu, Chunfang; Nguyen, Hoai-Nghia; Wang, Huanchen; Shears, Stephen B.] NIEHS, Natl Inst Hlth, Lab Signal Transduct, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Hofer, Alexandre] Univ Zurich, Dept Chem, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland; [Jessen, Henning J.] Albert Ludwigs Univ, Inst Organ Chem, Albertstrasse 21, D-79104 Freiburg, Germany; [Dai, Xuming] Univ N Carolina, McAllister Heart Inst, Div Cardiol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Zurich; University of Freiburg; University of North Carolina; University of North Carolina Chapel Hill	Shears, SB (corresponding author), NIEHS, Natl Inst Hlth, Lab Signal Transduct, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	shears@niehs.nih.gov	Hofer, Alexandre/L-9975-2017; Jessen, Henning/O-1157-2019; Jessen, Henning/F-5108-2014; Shears, Stephen B/C-6335-2019; Hofer, Alexandre/Y-9852-2019	Hofer, Alexandre/0000-0001-6396-3689; Jessen, Henning/0000-0002-1025-9484; Jessen, Henning/0000-0002-1025-9484; Shears, Stephen B/0000-0001-7309-8916; Hofer, Alexandre/0000-0001-6396-3689; Wang, Huanchen/0000-0003-2701-7155	Intramural Research Program of the NIEHS, National Institutes of Health; National Science Foundation [PP00P2_157607]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Swiss National Science Foundation Grant PP00P2_157607.; Partially supported by National Center for Advancing Translational Sciences, National Institutes of Health Grant UL1TR001111.	Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Dasgupta T, 2014, J BIOL CHEM, V289, P13010, DOI 10.1074/jbc.M113.546515; Dexter JP, 2015, INTEGR BIOL-UK, V7, P883, DOI 10.1039/c5ib00009b; DICK CF, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/103980; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gu CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165286; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Ingram SW, 2003, BIOCHEM J, V369, P519, DOI 10.1042/BJ20020733; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Komaba H, 2016, KIDNEY INT, V90, P753, DOI 10.1016/j.kint.2016.03.039; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Levine J, 2007, BIOPHYS J, V92, P4473, DOI 10.1529/biophysj.106.088856; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; MacDonald JA, 2005, FEBS J, V272, P120, DOI 10.1111/j.1432-1033.2004.04388.x; Machkalyan G, 2016, CELL SIGNAL, V28, P401, DOI 10.1016/j.cellsig.2016.02.002; Marks J, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12281; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; NEWSHOLME EA, 1983, BIOCHEM SOC T, V11, P52, DOI 10.1042/bst0110052; Otto JC, 2007, P NATL ACAD SCI USA, V104, P15653, DOI 10.1073/pnas.0705729104; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Pavlovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10622; Pohlmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004586; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A., 2012, SUBCELL BIOCH, V59, P413; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; Shears Stephen B, 2015, Adv Biol Regul, V57, P203, DOI 10.1016/j.jbior.2014.09.015; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; SOBOLL S, 1978, EUR J BIOCHEM, V87, P377, DOI 10.1111/j.1432-1033.1978.tb12387.x; Straube R, 2013, BIOPHYS J, V105, P1925, DOI 10.1016/j.bpj.2013.09.010; Thota SG, 2015, J BIOSCIENCES, V40, P593, DOI 10.1007/s12038-015-9549-x; Tobey SL, 2003, ORG LETT, V5, P2029, DOI 10.1021/ol034427x; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; WANG H., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1016/J.TPLANTS.2015.04.003; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Weaver JD, 2013, BIOSCIENCE REP, V33, P229, DOI 10.1042/BSR20120115; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Wu MX, 2016, P NATL ACAD SCI USA, V113, pE6757, DOI 10.1073/pnas.1606853113; Wundenberg T, 2012, BIOL CHEM, V393, P979, DOI 10.1515/hsz-2012-0133	49	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4544	4555		10.1074/jbc.M116.765743	http://dx.doi.org/10.1074/jbc.M116.765743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28126903	Green Published, hybrid			2022-12-28	WOS:000397585100013
J	Harding, CM; Pulido, MR; Di Venanzio, G; Kinsella, RL; Webb, AI; Scott, NE; Pachon, J; Feldman, MF				Harding, Christian M.; Pulido, Marina R.; Di Venanzio, Gisela; Kinsella, Rachel L.; Webb, Andrew I.; Scott, Nichollas E.; Pachon, Jeronimo; Feldman, Mario F.			Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; BIOFILM FORMATION; VI SECRETION; SP NOV.; BAUMANNII; IDENTIFICATION; GROWTH; EFFLUX; MEMBER; OVEREXPRESSION	Pathogenic Acinetobacter species, including Acinetobacter baumannii and Acinetobacter nosocomialis, are opportunistic human pathogens of increasing relevance worldwide. Although their mechanisms of drug resistance are well studied, the virulence factors that govern Acinetobacter pathogenesis are incompletely characterized. Here we define the complete secretome of A. nosocomialis strain M2 in minimal medium and demonstrate that pathogenic Acinetobacter species produce both a functional type I secretion system (T1SS) and a contact-dependent inhibition (CDI) system. Using bioinformatics, quantitative proteomics, and mutational analyses, we show that Acinetobacter uses its T1SS for exporting two putative T1SS effectors, an Repeatsin-Toxin (RTX)-serralysin-like toxin, and the biofilm-associated protein (Bap). Moreover, we found that mutation of any component of the T1SS system abrogated type VI secretion activity under nutrient-limited conditions, indicating a previously unrecognized cross-talk between these two systems. We also demonstrate that the Acinetobacter T1SS is required for biofilm formation. Last, we show that both A. nosocomialis and A. baumannii produce functioning CDI systems that mediate growth inhibition of sister cells lacking the cognate immunity protein. The Acinetobacter CDI systems are widely distributed across pathogenic Acinetobacter species, with many A. bauman-nii isolates harboring two distinct CDI systems. Collectively, these data demonstrate the power of differential, quantitative proteomics approaches to study secreted proteins, define the role of previously uncharacterized protein export systems, and observe cross-talk between secretion systems in the pathobiology of medically relevant Acinetobacter species.	[Harding, Christian M.; Pulido, Marina R.; Di Venanzio, Gisela; Kinsella, Rachel L.; Feldman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Pulido, Marina R.; Pachon, Jeronimo] Univ Seville, Unit Infect Dis Microbiol & Prevent Med, Seville 41004, Spain; [Pulido, Marina R.; Pachon, Jeronimo] Univ Seville, Biomed Inst Seville, Univ Hosp Virgen Rocio, CSIC, Seville 41004, Spain; [Kinsella, Rachel L.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada; [Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Scott, Nichollas E.] Univ Melbourne, Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	Washington University (WUSTL); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Alberta; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Feldman, MF (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	mariofeldman@wustl.edu	Di Venanzio, Gisela/GYV-3910-2022; Pachon, Jeronimo/M-4337-2014; Pulido, Marina/J-3176-2018	Pachon, Jeronimo/0000-0002-8166-5308; Pulido, Marina Rosa/0000-0003-1633-4294; Scott, Nichollas/0000-0003-2556-8316	Subprograma Sara Borrell from the Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Economia y Competitividad of Spain [CD14/00014]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Health and Medical Research Council of Australia (NHMRC) Overseas (Biomedical) Fellowship [APP1037373]; NHMRC [APP1100164]; University of Melbourne Early Career Researcher Grant Scheme [603107]	Subprograma Sara Borrell from the Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Economia y Competitividad of Spain; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Health and Medical Research Council of Australia (NHMRC) Overseas (Biomedical) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Early Career Researcher Grant Scheme(University of Melbourne)	Supported by the Subprograma Sara Borrell from the Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Economia y Competitividad of Spain (CD14/00014).; Funded by Natural Sciences and Engineering Research Council of Canada (NSERC).; Supported by a National Health and Medical Research Council of Australia (NHMRC) Overseas (Biomedical) Fellowship APP1037373, NHMRC Project Grant APP1100164, and the University of Melbourne Early Career Researcher Grant Scheme (Proposal 603107).	Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Balakrishnan L, 2001, J MOL BIOL, V313, P501, DOI 10.1006/jmbi.2001.5038; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; Brossard KA, 2012, INFECT IMMUN, V80, P228, DOI 10.1128/IAI.05913-11; Carruthers MD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00906-13; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; CDC, 2013, ANTIBIOTIC RESISTANC; Cosgaya C, 2016, INT J SYST EVOL MICR, V66, P4105, DOI 10.1099/ijsem.0.001318; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; De Gregorio E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2136-6; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Garcia EC, 2016, P NATL ACAD SCI USA, V113, P8296, DOI 10.1073/pnas.1606323113; Garcia EC, 2013, MOL MICROBIOL, V89, P1213, DOI 10.1111/mmi.12339; Garcia-Bayona L, 2017, ELIFE, V6, DOI 10.7554/eLife.24869; Giammanco A, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00310-16; Goh HMS, 2013, APPL ENVIRON MICROB, V79, P6535, DOI 10.1128/AEM.01402-13; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Holland I. B., 2016, ECOSAL PLUS, V7; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jamet A, 2015, MBIO, V6, DOI 10.1128/mBio.00285-15; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Kodori M, 2017, LETT APPL MICROBIOL, V64, P304, DOI 10.1111/lam.12717; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Liu CC, 2014, GENOMICS, V104, P215, DOI 10.1016/j.ygeno.2014.07.011; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Luo TL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00182; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Mari-Almirall M., 2016, CLIN MICROBIOL INFEC, V23; Mercy C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147435; Nemec A, 2015, INT J SYST EVOL MICR, V65, P934, DOI 10.1099/ijs.0.000043; Parker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011096; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Schaab C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014068; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Sun GW, 2010, MOL MICROBIOL, V76, P677, DOI 10.1111/j.1365-2958.2010.07124.x; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; WANG RC, 1991, J MOL BIOL, V217, P441, DOI 10.1016/0022-2836(91)90748-U; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Yoon EJ, 2013, ANTIMICROB AGENTS CH, V57, P2989, DOI 10.1128/AAC.02556-12; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036	62	35	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9075	9087		10.1074/jbc.M117.781575	http://dx.doi.org/10.1074/jbc.M117.781575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28373284	Green Published, hybrid			2022-12-28	WOS:000402538900007
J	Brito-Moreira, J; Lourenco, MV; Oliveira, MM; Ribeiro, FC; Ledo, JH; Diniz, LP; Vital, JFS; Magdesian, MH; Melo, HM; Barros-Aragao, F; de Souza, JM; Alves-Leon, SV; Gomes, FCA; Clarke, JR; Figueiredo, CP; De Felice, FG; Ferreira, ST				Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Diniz, Luan P.; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; Barros-Aragao, Fernanda; de Souza, Jorge M.; Alves-Leon, Soniza V.; Gomes, Flavia C. A.; Clarke, Julia R.; Figueiredo, Claudia P.; De Felice, Fernanda G.; Ferreira, Sergio T.			Interaction of amyloid- (A) oligomers with neurexin 2 and neuroligin 1 mediates synapse damage and memory loss in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid (A); brain; neuron; synapse; amyloid oligomers; memory; neurexin; neuroligin	A-BETA OLIGOMERS; DEPRESSIVE-LIKE BEHAVIOR; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; BRAIN; RECOGNITION; INHIBITION; ADHESION; DYSFUNCTION	Brain accumulation of the amyloid- protein (A) and synapse loss are neuropathological hallmarks of Alzheimer disease (AD). A oligomers (AOs) are synaptotoxins that build up in the brains of patients and are thought to contribute to memory impairment in AD. Thus, identification of novel synaptic components that are targeted by AOs may contribute to the elucidation of disease-relevant mechanisms. Trans-synaptic interactions between neurexins (Nrxs) and neuroligins (NLs) are essential for synapse structure, stability, and function, and reduced NL levels have been associated recently with AD. Here we investigated whether the interaction of AOs with Nrxs or NLs mediates synapse damage and cognitive impairment in AD models. We found that AOs interact with different isoforms of Nrx and NL, including Nrx2 and NL1. Anti-Nrx2 and anti-NL1 antibodies reduced AO binding to hippocampal neurons and prevented AO-induced neuronal oxidative stress and synapse loss. Anti-Nrx2 and anti-NL1 antibodies further blocked memory impairment induced by AOs in mice. The results indicate that Nrx2 and NL1 are targets of AOs and that prevention of this interaction reduces the deleterious impact of AOs on synapses and cognition. Identification of Nrx2 and NL1 as synaptic components that interact with AOs may pave the way for development of novel approaches aimed at halting synapse failure and cognitive loss in AD.	[Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil; [Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil; [Diniz, Luan P.; Barros-Aragao, Fernanda; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21947902 Rio De Janeiro, RJ, Brazil; [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil; [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurol, Epilepsy Program, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil; [Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21947902 Rio De Janeiro, RJ, Brazil; [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Queens University - Canada	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.	ferreira@bioqmed.ufrj.br	Lourenco, Mychael/G-2614-2014; Gomes, Flavia/AAX-6354-2021; Leon, Soniza V Alves/J-7786-2012; Ferreira, Sergio/AAZ-1576-2020; Figueiredo, Claudia P/F-8424-2012; Ribeiro, Felipe Campos/W-9758-2019; Clarke, Julia/AAF-9434-2019; De Felice, Fernanda G/M-1074-2017; Gomes, Flavia/C-5383-2013	Lourenco, Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866; Ribeiro, Felipe Campos/0000-0003-3028-3307; Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; Gomes, Flavia/0000-0003-2966-0638; Figueiredo, Claudia/0000-0001-9467-9891	National Institute for Translational Neuroscience (INNT/Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Human Frontiers Science Program; CNPq; FAPERJ; CAPES (Brazil)	National Institute for Translational Neuroscience (INNT/Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Human Frontiers Science Program(Human Frontier Science Program); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from National Institute for Translational Neuroscience (INNT/Brazil) (to S. T. F.), the Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and the Human Frontiers Science Program (to F. G. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by predoctoral fellowships from CNPq, FAPERJ, or CAPES (Brazil).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bemben MA, 2015, TRENDS NEUROSCI, V38, P496, DOI 10.1016/j.tins.2015.06.004; Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dachtler J, 2015, BEHAV NEUROSCI, V129, P765, DOI 10.1037/bne0000108; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107; Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu A, 2016, J CELL BIOL, V212, P449, DOI 10.1083/jcb.201509023; Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nery AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067194; Nunomura A, 1999, J NEUROSCI, V19, P1959; Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304; SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010	64	58	60	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7327	7337		10.1074/jbc.M116.761189	http://dx.doi.org/10.1074/jbc.M116.761189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28283575	hybrid, Green Published			2022-12-28	WOS:000400761300005
J	Das, S; Pawale, VS; Dadireddy, V; Singh, AK; Ramakumar, S; Roy, RP				Das, Sreetama; Pawale, Vijaykumar S.; Dadireddy, Venkatareddy; Singh, Avinash Kumar; Ramakumar, Suryanarayanarao; Roy, Rajendra P.			Structure and specificity of a new class of Ca2+-independent housekeeping sortase from Streptomyces avermitilis provide insights into its non-canonical substrate preference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; TRANSPEPTIDASE-SRTA; CRYSTAL-STRUCTURES; BIOFILM FORMATION; IN-VITRO; LIGATION; ENZYME	Surface proteins in Gram-positive bacteria are incorporated into the cell wall through a peptide ligation reaction catalyzed by transpeptidase sortase. Six main classes (A-F) of sortase have been identified of which class A sortase is meant for housekeeping functions. The prototypic housekeeping sortase A (SaSrtA) from Staphylococcus aureus cleaves LPXTG-containing proteins at the scissile T-G peptide bond and ligates protein-LPXT to the terminal Gly residue of the nascent cross-bridge of peptidoglycan lipid II precursor. Sortase-mediated ligation ("sortagging") of LPXTG-containing substrates and Gly-terminated nucleophiles occurs in vitro as well as in cellulo in the presence of Ca2+ and has been applied extensively for protein conjugations. Although the majority of applications emanate from SaSrtA, low catalytic efficiency, LPXTG specificity restriction, and Ca2+ requirement (particularly for in cellulo applications) remain a drawback. Given that Gram-positive bacteria genomes encode a variety of sortases, natural sortase mining can be a viable complementary approach akin to engineering of wildtype SaSrtA. Here, we describe the structure and specificity of a new class E sortase (SavSrtE) annotated to perform housekeeping roles in Streptomyces avermitilis. Biochemical experiments define the attributes of an optimum peptide substrate, demonstrate Ca2+-independent activity, and provide insights about contrasting functional characteristics of SavSrtE and SaSrtA. Crystal structure, substrate docking, and mutagenesis experiments have identified a critical residue that dictates the preference for a non-canonical LAXTG recognition motif over LPXTG. These results have implications for rational tailoring of substrate tolerance in sortases. Besides, Ca2+-independent orthogonal specificity of SavSrtE is likely to expand the sortagging toolkit.	[Das, Sreetama; Dadireddy, Venkatareddy; Ramakumar, Suryanarayanarao] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Pawale, Vijaykumar S.; Singh, Avinash Kumar; Roy, Rajendra P.] Natl Inst Immunol, Delhi 110067, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Ramakumar, S (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.; Roy, RP (corresponding author), Natl Inst Immunol, Delhi 110067, India.	ramak@physics.iisc.ernet.in; rproy@nii.ac.in		Das, Sreetama/0000-0002-4523-8915; Singh, Avinash/0000-0002-1841-395X	Department of Biotechnology (Government of India)	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India)	We thank Dr. S. Kumaran for helpful discussions and Sushma Nagpal for technical help with peptide synthesis. The National Institute of Immunology was supported by core grants from the Department of Biotechnology (Government of India).	Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Biswas T, 2014, BIOCHEMISTRY-US, V53, P2515, DOI 10.1021/bi4016023; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Chambers CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09449; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; Dasgupta S, 2011, J BIOL CHEM, V286, P23996, DOI 10.1074/jbc.M111.247650; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Duong A, 2012, MOL MICROBIOL, V83, P992, DOI 10.1111/j.1365-2958.2012.07983.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kattke MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167763; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levesque CM, 2005, INFECT IMMUN, V73, P3773, DOI 10.1128/IAI.73.6.3773-3777.2005; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mashiach E, 2010, NUCLEIC ACIDS RES, V38, pW457, DOI 10.1093/nar/gkq373; Matsumoto T, 2012, BIOTECHNOL J, V7, P642, DOI 10.1002/biot.201100213; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Novick RP, 2000, TRENDS MICROBIOL, V8, P148, DOI 10.1016/S0966-842X(00)01741-8; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strijbis K, 2012, TRAFFIC, V13, P780, DOI 10.1111/j.1600-0854.2012.01345.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zhang J, 2013, J BIOSCI BIOENG, V116, P298, DOI 10.1016/j.jbiosc.2013.03.006; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	64	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7244	7257		10.1074/jbc.M117.782037	http://dx.doi.org/10.1074/jbc.M117.782037			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28270507	Green Published, hybrid			2022-12-28	WOS:000400478300034
J	Kim, SK; Barron, L; Hinck, CS; Petrunak, EM; Cano, KE; Thangirala, A; Iskra, B; Brothers, M; Vonberg, M; Leal, B; Richter, B; Kodali, R; Taylor, AB; Du, SC; Barnes, CO; Sulea, T; Calero, G; Hart, PJ; Hart, MJ; Demeler, B; Hinck, AP				Kim, Sun Kyung; Barron, Lindsey; Hinck, Cynthia S.; Petrunak, Elyse M.; Cano, Kristin E.; Thangirala, Avinash; Iskra, Brian; Brothers, Molly; Vonberg, Machell; Leal, Belinda; Richter, Blair; Kodali, Ravindra; Taylor, Alexander B.; Du, Shoucheng; Barnes, Christopher O.; Sulea, Traian; Calero, Guillermo; Hart, P. John; Hart, Matthew J.; Demeler, Borries; Hinck, Andrew P.			An engineered transforming growth factor beta (TGF-beta) monomer that functions as a dominant negative to block TGF-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IN-VITRO; BIOLOGICAL-ACTIVITY; NMR-SPECTROSCOPY; TERNARY COMPLEX; II RECEPTOR; CANCER; GROWTH-FACTOR-BETA-1; METASTASIS; PROTEINS	The transforming growth factor beta isoforms, TGF-beta 1, -beta 2, and -beta 3, are small secreted homodimeric signaling proteins with essential roles in regulating the adaptive immune system and maintaining the extracellular matrix. However, dysregulation of the TGF-beta pathway is responsible for promoting the progression of several human diseases, including cancer and fibrosis. Despite the known importance of TGF-beta s in promoting disease progression, no inhibitors have been approved for use in humans. Herein, we describe an engineered TGF-beta monomer, lacking the heel helix, a structural motif essential for binding the TGF-beta type I receptor (T beta RI) but dispensable for binding the other receptor required for TGF-beta signaling, the TGF-beta type II receptor (T beta RII), as an alternative therapeutic modality for blocking TGF-beta signaling in humans. As shown through binding studies and crystallography, the engineered monomer retained the same overall structure of native TGF-beta monomers and bound T beta RII in an identical manner. Cell-based luciferase assays showed that the engineered monomer functioned as a dominant negative to inhibit TGF-beta signaling with a K-i of 20-70 nM. Investigation of the mechanism showed that the high affinity of the engineered monomer for T beta RII, coupled with its reduced ability to non-covalently dimerize and its inability to bind and recruit T beta RI, enabled it to bind endogenous T beta RII but prevented it from binding and recruiting T beta RI to form a signaling complex. Such engineered monomers provide a new avenue to probe and manipulate TGF-beta signaling and may inform similar modifications of other TGF-beta family members.	[Hinck, Cynthia S.; Petrunak, Elyse M.; Kodali, Ravindra; Du, Shoucheng; Barnes, Christopher O.; Calero, Guillermo; Hinck, Andrew P.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Biomedical Sci Tower 3,Rm 1035,3501 Fifth Ave, Pittsburgh, PA 15260 USA; [Kim, Sun Kyung; Cano, Kristin E.; Thangirala, Avinash; Iskra, Brian; Brothers, Molly; Vonberg, Machell; Leal, Belinda; Richter, Blair; Taylor, Alexander B.; Hart, P. John; Demeler, Borries] Univ Texas San Antonio, Hlth Sci Ctr, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Barron, Lindsey] Univ Texas San Antonio, Hlth Sci Ctr, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Hart, Matthew J.] Univ Texas San Antonio, Hlth Sci Ctr, Ctr Innovat Drug Discovery, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Sulea, Traian] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Montreal, PQ H4P 2R2, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; National Research Council Canada	Hinck, AP (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Biomedical Sci Tower 3,Rm 1035,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	ahinck@pitt.edu		Hart, Matthew/0000-0002-2683-480X; Demeler, Borries/0000-0002-2414-9518; Hinck, Andrew/0000-0003-3320-8054; Taylor, Alexander/0000-0003-3517-6033	National Institutes of Health [GM120600]; National Science Foundation [ACI-1339649]; Extreme Science and Engineering Discovery Environment (XSEDE) Community Allocation Grant [MCB070039]; NATIONAL CANCER INSTITUTE [R01CA172886, P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058670, R01GM112686, R01GM120600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Extreme Science and Engineering Discovery Environment (XSEDE) Community Allocation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Peter Sun, NIAID, National Institutes of Health, for providing the stably transected CHO cell line over-expressing TGF-beta 1; Dr. William Furey for guidance on the refinement of the mmTGF-beta 2-7M and mmTGF-beta 2-7M center dot T beta RII structures; Doowon Lee for assistance with the X-ray instrumentation; Mike Delk for assistance with the NMR instrumentation; and Liping Wang for technical assistance with the analytical ultracentrifugation measurements. UltraScan software development was supported by National Institutes of Health Grant GM120600 (to B. D.) and National Science Foundation Grant ACI-1339649 (to B. D.). The calculations at San Diego Supercomputer Center (SDSC) were supported by Extreme Science and Engineering Discovery Environment (XSEDE) Community Allocation Grant MCB070039 (to B. D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMATAYAKULCHANTLER S, 1994, J BIOL CHEM, V269, P27687; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Boesen CC, 2002, STRUCTURE, V10, P913, DOI 10.1016/S0969-2126(02)00780-3; Cao WM, 2008, BIOPHYS J, V95, P54, DOI 10.1529/biophysj.107.123950; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Connolly EC, 2011, CANCER RES, V71, P2339, DOI 10.1158/0008-5472.CAN-10-2941; Cull MG, 2000, METHOD ENZYMOL, V326, P430; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler Borries, 2010, Curr Protoc Protein Sci, VChapter 7, DOI 10.1002/0471140864.ps0713s60; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Ge RR, 2004, BIOCHEM PHARMACOL, V68, P41, DOI 10.1016/j.bcp.2004.03.011; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Hinck A. P., 2016, COLD SPRING HARB PER, V8, DOI [10.1101/cshperspect.a022103, DOI 10.1101/CSHPERSPECT.A022103]; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Hinck AP, 2000, J BIOMOL NMR, V18, P369, DOI 10.1023/A:1026775321886; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Huang T, 2016, METHODS MOL BIOL, V1344, P63, DOI 10.1007/978-1-4939-2966-5_4; Huang T, 2011, EMBO J, V30, P1263, DOI 10.1038/emboj.2011.54; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; LAIHO M, 1991, J BIOL CHEM, V266, P9108; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Loeys BL, 2013, PEDIATR ENDOCR REV P, V10, P417; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lonning S, 2011, CURR PHARM BIOTECHNO, V12, P2176, DOI 10.2174/138920111798808392; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meibohm B., 2008, PHARM BIOTECHNOLOGY, P95; Meibohm B, 2012, THERAPEUTIC PROTEINS, P23; Miao ZF, 2014, TUMOR BIOL, V35, P3575, DOI 10.1007/s13277-013-1472-x; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Singh J, 2004, CURR OPIN DRUG DISC, V7, P437; Thies RS, 2001, GROWTH FACTORS, V18, P251; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamada M, 2007, J CLIN PATHOL, V60, P916, DOI 10.1136/jcp.2006.039396; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Ying JF, 2017, J BIOMOL NMR, V68, P101, DOI 10.1007/s10858-016-0072-7; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zou ZC, 2004, PROTEIN EXPRES PURIF, V37, P265, DOI 10.1016/j.pep.2003.06.001; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014	68	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7173	7188		10.1074/jbc.M116.768754	http://dx.doi.org/10.1074/jbc.M116.768754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28228478	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000400478300029
J	Hargrove, TY; Friggeri, L; Wawrzak, Z; Qi, AD; Hoekstra, WJ; Schotzinger, RJ; York, JD; Guengerich, FP; Lepesheva, GI				Hargrove, Tatiana Y.; Friggeri, Laura; Wawrzak, Zdzislaw; Qi, Aidong; Hoekstra, William J.; Schotzinger, Robert J.; York, John D.; Guengerich, F. Peter; Lepesheva, Galina I.			Structural analyses of Candida albicans sterol 14 alpha-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTIOUS-DISEASES SOCIETY; TRYPANOSOMA-CRUZI; CHAGAS-DISEASE; FLUCONAZOLE RESISTANCE; SUBSTRATE PREFERENCES; ANTIFUNGAL AGENTS; MURINE MODEL; AMINO-ACID; CYP51; TARGET	With some advances in modern medicine (such as cancer chemotherapy, broad exposure to antibiotics, and immunosuppression), the incidence of opportunistic fungal pathogens such as Candida albicans has increased. Cases of drug resistance among these pathogens have become more frequent, requiring the development of new drugs and a better understanding of the targeted enzymes. Sterol 14 alpha-demethylase (CYP51) is a cytochrome P450 enzyme required for biosynthesis of sterols in eukaryotic cells and is the major target of clinical drugs for managing fungal pathogens, but some of the CYP51 key features important for rational drug design have remained obscure. We report the catalytic properties, ligand-binding profiles, and inhibition of enzymatic activity of C. albicans CYP51 by clinical antifungal drugs that are used systemically (fluconazole, voriconazole, ketoconazole, itraconazole, and posaconazole) and topically (miconazole and clotrimazole) and by a tetrazolebased drug candidate, VT-1161 (oteseconazole: (R)-2-(2,4difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-(4(2,2,2-trifluoroethoxy)phenyl)pyridin-2-yl) propan-2-ol). Among the compounds tested, the first-line drug fluconazole was the weakest inhibitor, whereas posaconazole and VT-1161 were the strongest CYP51 inhibitors. We determined the X-ray structures of C. albicans CYP51 complexes with posaconazole and VT-1161, providing a molecular mechanism for the potencies of these drugs, including the activity of VT-1161 against Candida krusei and Candida glabrata, pathogens that are intrinsically resistant to fluconazole. Our comparative structural analysis outlines phylum-specific CYP51 features that could direct future rational development of more efficient broadspectrum antifungals.	[Hargrove, Tatiana Y.; Friggeri, Laura; Qi, Aidong; York, John D.; Guengerich, F. Peter; Lepesheva, Galina I.] Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Hoekstra, William J.; Schotzinger, Robert J.] Viamet Pharmaceut, Durham, NC 27703 USA; [Lepesheva, Galina I.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Northwestern University; Vanderbilt University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source (Argonne, IL). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Andriani G, 2013, J MED CHEM, V56, P2556, DOI 10.1021/jm400012e; Antinori S, 2016, EUR J INTERN MED, V34, P21, DOI 10.1016/j.ejim.2016.06.029; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cherkesova TS, 2014, FEBS LETT, V588, P3878, DOI 10.1016/j.febslet.2014.08.030; Correia MA., 2005, CYTOCHROME P450 STRU, P246; Dantas AD, 2016, CURR OPIN MICROBIOL, V34, P111, DOI 10.1016/j.mib.2016.08.006; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Desai JV, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0005-2014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Friggeri L, 2014, J MED CHEM, V57, P6704, DOI 10.1021/jm500739f; Garvey EP, 2015, ANTIMICROB AGENTS CH, V59, P5567, DOI 10.1128/AAC.00185-15; GOTOH O, 1992, J BIOL CHEM, V267, P83; Hargrove TY, 2016, J LIPID RES, V57, P1552, DOI 10.1194/jlr.M069229; Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310; Hargrove TY, 2013, J BIOL CHEM, V288, P31602, DOI 10.1074/jbc.M113.497990; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hoekstra WJ, 2016, ANTIMICROB AGENTS CH, V60, P1058, DOI 10.1128/AAC.02287-15; Hoekstra WJ, 2014, BIOORG MED CHEM LETT, V24, P3455, DOI 10.1016/j.bmcl.2014.05.068; Jampilek J, 2016, FUTURE MED CHEM, V8, P1393, DOI 10.4155/fmc-2016-0124; Jeong W, 2016, J ANTIMICROB CHEMOTH, V71, P3540, DOI 10.1093/jac/dkw322; JOHNSON EM, 1983, J ANTIMICROB CHEMOTH, V12, P303, DOI 10.1093/jac/12.4.303; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lass-Florl C, 2011, DRUGS, V71, P2405, DOI 10.2165/11596540-000000000-00000; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2015, J INFECT DIS, V212, P1439, DOI 10.1093/infdis/jiv228; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mane A, 2016, MYCOSES, V59, P93, DOI 10.1111/myc.12439; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Morschhauser J, 2016, J MICROBIOL, V54, P192, DOI 10.1007/s12275-016-5628-4; Noble SM, 2017, NAT REV MICROBIOL, V15, P96, DOI 10.1038/nrmicro.2016.157; Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; SAAG MS, 1988, ANTIMICROB AGENTS CH, V32, P1, DOI 10.1128/AAC.32.1.1; Schell WA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01817-16, 10.1128/aac.01817-16]; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Vanden Bossche H, 1988, STEROL BIOSYNTHESIS, V79-119, P79; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wilson DT, 2016, THER CLIN RISK MANAG, V12, P1197, DOI 10.2147/TCRM.S90335; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	56	155	159	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6728	6743		10.1074/jbc.M117.778308	http://dx.doi.org/10.1074/jbc.M117.778308			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258218	Green Published, hybrid			2022-12-28	WOS:000399813400024
J	Dajnowicz, S; Parks, JM; Hu, XC; Gesler, K; Kovalevsky, AY; Mueser, TC				Dajnowicz, Steven; Parks, Jerry M.; Hu, Xiche; Gesler, Korie; Kovalevsky, Andrey Y.; Mueser, Timothy C.			Direct evidence that an extended hydrogen-bonding network influences activation of pyridoxal 5-phosphate in aspartate aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; hydrogen bond; pyridoxal phosphate; quantum chemistry; X-ray crystallography	CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; INTERNAL ALDIMINE; NMR-SPECTROSCOPY; MODEL SYSTEMS; ACTIVE-SITE; LOW-BARRIER; BASIS-SETS; ACID-BASE; 5'-PHOSPHATE	Pyridoxal 5-phosphate (PLP) is a fundamental, multifunctional enzyme cofactor used to catalyze a wide variety of chemical reactions involved in amino acid metabolism. PLP-dependent enzymes optimize specific chemical reactions by modulating the electronic states of PLP through distinct active site environments. In aspartate aminotransferase (AAT), an extended hydrogen bond network is coupled to the pyridinyl nitrogen of the PLP, influencing the electrophilicity of the cofactor. This network, which involves residues Asp-222, His-143, Thr-139, His-189, and structural waters, is located at the edge of PLP opposite the reactive Schiff base. We demonstrate that this hydrogen bond network directly influences the protonation state of the pyridine nitrogen of PLP, which affects the rates of catalysis. We analyzed perturbations caused by single- and double-mutant variants using steady-state kinetics, high resolution X-ray crystallography, and quantum chemical calculations. Protonation of the pyridinyl nitrogen to form a pyridinium cation induces electronic delocalization in the PLP, which correlates with the enhancement in catalytic rate in AAT. Thus, PLP activation is controlled by the proximity of the pyridinyl nitrogen to the hydrogen bond microenvironment. Quantum chemical calculations indicate that Asp-222, which is directly coupled to the pyridinyl nitrogen, increases the pK(a) of the pyridine nitrogen and stabilizes the pyridinium cation. His-143 and His-189 also increase the pK(a) of the pyridine nitrogen but, more significantly, influence the position of the proton that resides between Asp-222 and the pyridinyl nitrogen. These findings indicate that the second shell residues directly enhance the rate of catalysis in AAT.	[Dajnowicz, Steven; Hu, Xiche; Gesler, Korie; Mueser, Timothy C.] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA; [Dajnowicz, Steven; Kovalevsky, Andrey Y.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Parks, Jerry M.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Biosci Div, Oak Ridge, TN 37831 USA	University System of Ohio; University of Toledo; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Mueser, TC (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	timothy.mueser@utoledo.edu	Parks, Jerry M./B-7488-2009	Parks, Jerry M./0000-0002-3103-9333; Kovalevsky, Andrey/0000-0003-4459-9142	DOE Office of Science [DE-AC02-06CH11357]; United States Department of Energy [DE-AC05-00OR22725]	DOE Office of Science(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	This research used resources from the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This research also used resources from the Compute and Data Environment for Science (CADES) at Oak Ridge National Laboratory, which is managed by UT-Battelle, LLC, for the United States Department of Energy under Contract No. DE-AC05-00OR22725.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMADOR E, 1962, CLIN CHEM, V8, P343; Banik SD, 2014, J PHYS CHEM B, V118, P11077, DOI 10.1021/jp506196m; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Casasnovas R, 2009, CHEM PHYS, V355, P149, DOI 10.1016/j.chemphys.2008.12.006; Chan-Huot M, 2013, J AM CHEM SOC, V135, P18160, DOI 10.1021/ja408988z; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch M. J. T, 2010, GAUSSIAN 09 REV E 01; Goldberg JM, 1996, BIOCHEMISTRY-US, V35, P5280, DOI 10.1021/bi952138d; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Griswold WR, 2011, J AM CHEM SOC, V133, P14823, DOI 10.1021/ja2061006; Griswold WR, 2011, BIOCHEMISTRY-US, V50, P5918, DOI 10.1021/bi200436y; Hayashi H, 1997, BIOCHEMISTRY-US, V36, P13558, DOI 10.1021/bi971638z; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; KINTANAR A, 1991, J BIOL CHEM, V266, P17222; Lankau T, 2007, PHYS CHEM CHEM PHYS, V9, P299, DOI 10.1039/b612945e; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Limbach HH, 2011, BBA-PROTEINS PROTEOM, V1814, P1426, DOI 10.1016/j.bbapap.2011.06.004; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Metzler C M, 1979, Methods Enzymol, V62, P551; METZLER DE, 1994, J BIOL CHEM, V269, P28017; Mollova ET, 1997, BIOCHEMISTRY-US, V36, P615, DOI 10.1021/bi9615811; Oliveira EF, 2011, J AM CHEM SOC, V133, P15496, DOI 10.1021/ja204229m; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; PAN QW, 1993, J BIOL CHEM, V268, P24758; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Richard JP, 2009, CURR OPIN CHEM BIOL, V13, P475, DOI 10.1016/j.cbpa.2009.06.023; Sharif S, 2007, J AM CHEM SOC, V129, P9558, DOI 10.1021/ja0728223; Sharif S, 2007, J AM CHEM SOC, V129, P6313, DOI 10.1021/ja070296+; Sharif S, 2007, J AM CHEM SOC, V129, P4440, DOI 10.1021/ja066240h; Sharif S, 2007, J PHYS CHEM B, V111, P3869, DOI 10.1021/jp067334g; Siegbahn PEM, 2011, WIRES COMPUT MOL SCI, V1, P323, DOI 10.1002/wcms.13; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Toney MD, 2014, ARCH BIOCHEM BIOPHYS, V544, P119, DOI 10.1016/j.abb.2013.10.002; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YANO T, 1992, BIOCHEMISTRY-US, V31, P5878, DOI 10.1021/bi00140a025; YANO T, 1991, J BIOL CHEM, V266, P6079	44	26	27	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5970	5980		10.1074/jbc.M116.774588	http://dx.doi.org/10.1074/jbc.M116.774588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28232482	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000398813200030
J	Hsu, MH; Baer, BR; Rettie, AE; Johnson, EF				Hsu, Mei-Hui; Baer, Brian R.; Rettie, Allan E.; Johnson, Eric F.			The Crystal Structure of Cytochrome P450 4B1 (CYP4B1) Monooxygenase Complexed with Octane Discloses Several Structural Adaptations for omega-Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT HEME-BINDING; CHAIN FATTY-ACIDS; SUBSTRATE-BINDING; 20-HYDROXYEICOSATETRAENOIC ACID; GENETIC-VARIATION; ESCHERICHIA-COLI; RABBIT CYP4B1; OXIDATION; ENZYMES; P450	P450 family 4 fatty acid omega-hydroxylases preferentially oxygenate primary C-H bonds over adjacent, energetically favored secondary C-H bonds, but the mechanism explaining this intriguing preference is unclear. To this end, the structure of rabbit P450 4B1 complexed with its substrate octane was determined by X-ray crystallography to define features of the active site that contribute to a preference for omega-hydroxylation. The structure indicated that octane is bound in a narrow active-site cavity that limits access of the secondary C-H bond to the reactive intermediate. A highly conserved sequence motif on helix I contributes to positioning the terminal carbon of octane for omega-hydroxylation. Glu-310 of this motif auto-catalytically forms an ester bond with the heme 5-methyl, and the immobilized Glu-310 contributes to substrate positioning. The preference for omega-hydroxylation was decreased in an E310A mutant having a shorter side chain, but the overall rates of metabolism were retained. E310D and E310Q substitutions having longer side chains exhibit lower overall rates, likely due to higher conformational entropy for these residues, but they retained high preferences for octane omega-hydroxylation. Sequence comparisons indicated that active-site residues constraining octane for omega-hydroxylation are conserved in family 4 P450s. Moreover, the heme 7-propionate is positioned in the active site and provides additional restraints on substrate binding. In conclusion, P450 4B1 exhibits structural adaptations for omega-hydroxylation that include changes in the conformation of the heme and changes in a highly conserved helix I motif that is associated with selective oxygenation of unactivated primary C-H bonds.	[Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Baer, Brian R.; Rettie, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Scripps Research Institute; University of Washington; University of Washington Seattle	Johnson, EF (corresponding author), Scripps Res Inst tute, MEM 255, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, R01GM031001, R01GM049054, P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, NIGMS Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baer BR, 2005, BIOCHEMISTRY-US, V44, P13914, DOI 10.1021/bi051267j; Baer BR, 2007, BIOCHEMISTRY-US, V46, P11598, DOI 10.1021/bi701064b; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; BJORKHEM I, 1978, J LIPID RES, V19, P585; Borbulevych OY, 2014, ACTA CRYSTALLOGR D, V70, P1233, DOI 10.1107/S1399004714002260; Cheesman MJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P17, DOI 10.1016/S0003-9861(03)00278-9; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; de Montellano PRO, 2016, RSC METALLOBIO SER, V4, P3; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Denisov IG, 2012, J INORG BIOCHEM, V108, P150, DOI 10.1016/j.jinorgbio.2011.11.026; Edson KZ, 2013, CURR TOP MED CHEM, V13, P1429; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fisher MB, 1998, BIOCHEM BIOPH RES CO, V248, P352, DOI 10.1006/bbrc.1998.8842; GASSER R, 1989, MOL PHARMACOL, V35, P617; GOTOH O, 1992, J BIOL CHEM, V267, P83; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Jefcoate C R, 1978, Methods Enzymol, V52, P258; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAM W, 1978, J LIPID RES, V19, P591; KORZEKWA KR, 1990, J AM CHEM SOC, V112, P7042, DOI 10.1021/ja00175a040; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Laffer CL, 2014, J AM SOC HYPERTENS, V8, P475, DOI 10.1016/j.jash.2014.04.011; LeBrun LA, 2002, BIOCHEMISTRY-US, V41, P5931, DOI 10.1021/bi025527y; LeBrun LA, 2002, J BIOL CHEM, V277, P12755, DOI 10.1074/jbc.M112155200; Lockhart CM, 2014, INVEST OPHTH VIS SCI, V55, P5572, DOI 10.1167/iovs.13-13717; Mak PJ, 2008, BIOPOLYMERS, V89, P1045, DOI 10.1002/bip.21058; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V666, P394, DOI 10.1016/0005-2760(81)90298-8; Nakano M, 2012, MOL PHARMACOL, V82, P679, DOI 10.1124/mol.112.080085; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Olsen L, 2006, J MED CHEM, V49, P6489, DOI 10.1021/jm060551l; PALMER CNA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P161, DOI 10.1016/0167-4781(93)90285-L; Roberts BR, 2005, PROTEIN SCI, V14, P2414, DOI 10.1110/ps.051459705; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Stark K, 2005, ARCH BIOCHEM BIOPHYS, V441, P174, DOI 10.1016/j.abb.2005.07.003; Stark K, 2008, FEBS J, V275, P3706, DOI 10.1111/j.1742-4658.2008.06518.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WOLF CR, 1982, MOL PHARMACOL, V22, P738; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Zheng YM, 2003, BIOCHEMISTRY-US, V42, P4601, DOI 10.1021/bi020667t; Zollner A, 2009, BIOL CHEM, V390, P313, DOI 10.1515/BC.2009.030	60	30	32	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5610	5621		10.1074/jbc.M117.775494	http://dx.doi.org/10.1074/jbc.M117.775494			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28167536	Green Published, hybrid			2022-12-28	WOS:000397875500040
J	King, C; Raicu, V; Hristova, K				King, Christopher; Raicu, Valerica; Hristova, Kalina			Understanding the FRET Signatures of Interacting Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; DIMERIZATION; DOMAIN; COMPLEXES; CHANNEL; STOICHIOMETRY; ACTIVATION; EFFICIENCY; DIMERS; CELLS	FRET is an indispensable experimental tool for studying membrane proteins. Currently, two models are available for researchers to determine the oligomerization state of membrane proteins in a static quenching FRET experiment: the model of Veatch and Stryer, derived in 1977, and the kinetic theory- based model for intraoligomeric FRET, derived in 2007. Because of confinement in two dimensions, a substantial amount of FRET is generated by energy transfer between fluorophores located in separate oligomers in the two-dimensional bilayer. This interoligomeric FRET (also known as stochastic, bystander, or proximity FRET) is not accounted for in either model. Here, we use the kinetic theory formalism to describe the dependence of the FRET efficiency measured in an experiment (i.e. the "total apparentFRETefficiency") on the interoligomeric FRET due to random proximity within the bilayer and the intraoligomeric FRET resulting from protein-protein interactions. We find that data analysis with both models without consideration of the proximity FRET leads to incorrect conclusions about the oligomeric state of the protein. We show that knowledge of the total surface densities of fluorophore-labeled membrane proteins is essential for correctly interpreting the measured total apparent FRET efficiency. We also find that bulk, two-color, static quenching FRET experiments are best suited for the study of monomeric, dimerizing, or dimeric proteins but have limitations in discerning the order of larger oligomers. The theory and methodology described in this work will allow researchers to extract meaningful parameters from static quenching FRET measurements in biological membranes.	[Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [King, Christopher; Hristova, Kalina] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Raicu, Valerica] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA	Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Milwaukee	Hristova, K (corresponding author), Dept Mat Sci & Engn, 3400 N Charles St, Baltimore, MD 21212 USA.	kh@jhu.edu		King, Christopher/0000-0002-2400-5717	National Science Foundation (NSF) [MCB 1157687]; National Institutes of Health [GM068619]; NSF Graduate Research Fellowship [DGE-1232825]; NSF [PFI-1114305, PHY-1058470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) Grant MCB 1157687 and National Institutes of Health Grant GM068619 (to K. H.), NSF Graduate Research Fellowship DGE-1232825 (to C. K.), and NSF Grants PFI-1114305 and PHY-1058470 (to V. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Bohme I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-16; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Mathiasen S, 2014, NAT METHODS, V11, P931, DOI [10.1038/nmeth.3062, 10.1038/NMETH.3062]; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; Patowary S, 2015, BIOPHYS J, V108, P1613, DOI 10.1016/j.bpj.2015.02.021; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Press W, 1989, NUMERICAL RECIPES AR; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Raicu V, 2010, NANOSCOPY AND MULTIDIMENSIONAL OPTICAL FLUORESCENCE MICROSCOPY; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2016, BBA-GEN SUBJECTS, V1860, P1922, DOI 10.1016/j.bbagen.2016.06.004; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; SNYDER B, 1982, BIOPHYS J, V40, P137, DOI 10.1016/S0006-3495(82)84468-8; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wang X.F, 1996, FLUORESCENCE IMAGING; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1	46	39	39	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5291	5310		10.1074/jbc.M116.764282	http://dx.doi.org/10.1074/jbc.M116.764282			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188294	hybrid, Green Published			2022-12-28	WOS:000397875500013
J	Fan, Y; Mok, CKP; Chan, MCW; Zhang, Y; Nal, B; Kien, F; Bruzzone, R; Sanyal, S				Fan, Ying; Mok, Chris Ka-Pun; Chan, Michael Chi Wai; Zhang, Yang; Nal, Beatrice; Kien, Francois; Bruzzone, Roberto; Sanyal, Sumana			Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G1 PHASE PROGRESSION; A VIRUS; M2 PROTEIN; RETINOBLASTOMA PROTEIN; POLYMERASE COMPLEX; CYTOPLASMIC TAIL; ION-CHANNEL; HIV-1 INFECTION; M1 PROTEIN; KINASE	To identify new host factors that modulate the replication of influenza A virus, we performed a yeast two-hybrid screen using the cytoplasmic tail of matrix protein 2 from the highly pathogenic H5N1 strain. The screen revealed a high-score interaction with cyclin D3, a key regulator of cell cycle early G(1) phase. M2-cyclin D3 interaction was validated through GST pull-down and recapitulated in influenza A/WSN/33-infected cells. Knockdown of Ccnd3 by small interfering RNA significantly enhanced virus progeny titers in cell culture supernatants. Interestingly, the increase in virus production was due to cyclin D3 deficiency per se and not merely a consequence of cell cycle deregulation. A combined knockdown of Ccnd3 and Rb1, which rescued cell cycle progression into S phase, failed to normalize virus production. Infection by influenza A virus triggered redistribution of cyclin D3 from the nucleus to the cytoplasm, followed by its proteasomal degradation. When overexpressed in HEK 293T cells, cyclin D3 impaired binding of M2 with M1, which is essential for proper assembly of progeny virions, lending further support to its role as a putative restriction factor. Our study describes the identification and characterization of cyclin D3 as a novel interactor of influenza A virus M2 protein. We hypothesize that competitive inhibition of M1-M2 interaction by cyclin D3 impairs infectious virion formation and results in attenuated virus production. In addition, we provide mechanistic insights into the dynamic interplay of influenza virus with the host cell cycle machinery during infection.	[Fan, Ying; Mok, Chris Ka-Pun; Zhang, Yang; Nal, Beatrice; Kien, Francois; Bruzzone, Roberto; Sanyal, Sumana] Univ Hong Kong, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China; [Fan, Ying; Mok, Chris Ka-Pun; Chan, Michael Chi Wai; Zhang, Yang; Nal, Beatrice; Kien, Francois; Bruzzone, Roberto; Sanyal, Sumana] Univ Hong Kong, Influenza Res Ctr, Sch Publ Hlth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Fan, Ying] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 4HN, Scotland; [Zhang, Yang] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Nal, Beatrice] Brunel Univ London, Coll Hlth & Life Sci, Div Biosci, London UB8 3PH, England; [Kien, Francois] French German Adv Translat Ctr, Ksilink, F-67000 Strasbourg, France; [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, F-75015 Paris, France	University of Hong Kong; University of Hong Kong; University of Dundee; Harbin Institute of Technology; University Town of Shenzhen; Brunel University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bruzzone, R; Sanyal, S (corresponding author), Univ Hong Kong, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China.; Bruzzone, R; Sanyal, S (corresponding author), Univ Hong Kong, Influenza Res Ctr, Sch Publ Hlth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	bruzzone@hku.hk; sanyal@hku.hk	Mok, Chris Ka Pun/ABD-2667-2021; NAL, Beatrice/GYU-8888-2022; Sanyal, Sumana/AAF-5155-2020; Bruzzone, Roberto/G-9355-2017; Zhang, Yang/AAK-8021-2021; Chan, Michael Chi Wai/C-4212-2009; Sanyal, Sumana/I-7975-2013	Bruzzone, Roberto/0000-0003-4373-1447; Zhang, Yang/0000-0002-3503-5161; Chan, Michael Chi Wai/0000-0001-8174-8405; Sanyal, Sumana/0000-0002-6230-5366; Nal, Beatrice/0000-0003-3452-7524	Research Fund for the Control of Infectious Diseases [RFCID 11101332]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Hong Kong Special Administrative Region, China [T11-705/14N, 17113915]	Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grants Committee; Hong Kong Special Administrative Region, China	This work was supported by Research Fund for the Control of Infectious Diseases Grant RFCID 11101332 and Area of Excellence Scheme of the University Grants Committee Grant AoE/M-12/06 and also supported in part by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Projects T11-705/14N and 17113915). The authors declare that they have no conflicts of interest with the contents of this article.	AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; Balasubramaniam VRMT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-196; BARTKOVA J, 1994, J PATHOL, V172, P237, DOI 10.1002/path.1711720303; Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Dove BK, 2012, PROTEOMICS, V12, P1431, DOI 10.1002/pmic.201100470; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; Eward KL, 2004, CELL CYCLE, V3, P1057; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Faussillon M, 2005, CANCER LETT, V221, P67, DOI 10.1016/j.canlet.2004.08.010; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guan ZH, 2010, PROTEIN CELL, V1, P944, DOI 10.1007/s13238-010-0115-x; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Henkel JR, 1998, J BIOL CHEM, V273, P6518, DOI 10.1074/jbc.273.11.6518; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; INABA T, 1992, GENOMICS, V13, P565, DOI 10.1016/0888-7543(92)90126-D; Iwatsuki-Horimoto K, 2006, J VIROL, V80, P5233, DOI 10.1128/JVI.00049-06; Jiang W, 2013, J VIROL, V87, P3039, DOI 10.1128/JVI.03176-12; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; KEYOMARSI K, 1994, CANCER RES, V54, P380; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; KOBAYASHI H, 1992, MOL BIOL CELL, V3, P1279, DOI 10.1091/mbc.3.11.1279; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; LUKAS J, 1995, ONCOGENE, V10, P2125; Le L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022970; Ma H., 2012, ADV PHYS CHEM, V2012, DOI DOI 10.1100/2012/541786; Mahony D, 1998, ONCOGENE, V16, P603, DOI 10.1038/sj.onc.1201570; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mi SF, 2010, SCI CHINA LIFE SCI, V53, P1098, DOI 10.1007/s11427-010-4048-7; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; NUGENT JHA, 1991, J CELL SCI, V99, P669; PALMERO I, 1993, ONCOGENE, V8, P1049; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Planz O, 2003, J VIROL, V77, P11186, DOI 10.1128/JVI.77.20.11186-11192.2003; Pokrovskaja K, 1996, CELL GROWTH DIFFER, V7, P1723; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shoemaker JE, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-117; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Sorrell DA, 1999, PLANT PHYSIOL, V119, P343, DOI 10.1104/pp.119.1.343; STOOF JC, 1992, EUR J PHARMACOL, V213, P439, DOI 10.1016/0014-2999(92)90634-G; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thomas JM, 1998, VIROLOGY, V252, P54, DOI 10.1006/viro.1998.9384; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wallensten A, 2009, EUROSURVEILLANCE, V14, P6; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; World Health Organization, 2016, FACT SHEET SOL STAR; Xie ZJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P153, DOI 10.1006/abbi.1996.0237; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	86	26	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5070	5088		10.1074/jbc.M117.776112	http://dx.doi.org/10.1074/jbc.M117.776112			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28130444	hybrid, Green Published			2022-12-28	WOS:000397590400027
J	Kroczynska, B; Blyth, GT; Rafidi, RL; Majchrzak-Kita, B; Xu, L; Saleiro, D; Kosciuczuk, EM; Jemielity, J; Su, B; Altman, JK; Eklund, EA; Fish, EN; Platanias, LC				Kroczynska, Barbara; Blyth, Gavin T.; Rafidi, Robert L.; Majchrzak-Kita, Beata; Xu, Lucy; Saleiro, Diana; Kosciuczuk, Ewa M.; Jemielity, Jacek; Su, Bing; Altman, Jessica K.; Eklund, Elizabeth A.; Fish, Eleanor N.; Platanias, Leonidas C.			Central Regulatory Role for SIN1 in Interferon gamma (IFN gamma) Signaling and Generation of Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-INHIBITORY RESPONSES; MESSENGER-RNA TRANSLATION; RICTOR-MTOR COMPLEX; I INTERFERONS; MAMMALIAN TARGET; APLASTIC-ANEMIA; PHOSPHORYLATION; PATHWAY; AKT	The precise signaling mechanisms by which type II IFN receptors control expression of unique genes to induce biological responses remain to be established. We provide evidence that Sin1, a known element of the mammalian target of rapamycin complex 2 (mTORC2), is required for IFN gamma-induced phosphorylation and activation of AKT and that such activation mediates downstream regulation of mTORC1 and its effectors. These events play important roles in the assembly of the eukaryotic translation initiation factor 4F (eIF4F) andmRNAtranslation of IFN-stimulated genes. Interestingly, IFN gamma-induced tyrosine phosphorylation of STAT1 is reduced in cells with targeted disruption of Sin1, leading to decreased transcription of several IFN gamma-inducible genes in an mTORC2-independent manner. Additionally, our studies establish that Sin1 is essential for generation of type II IFN-dependent antiviral effects and antiproliferative responses in normal and malignant hematopoiesis. Together, our findings establish an important role for Sin1 in both transcription and translation of IFN-stimulated genes and type II IFN-mediated biological responses, involving both mTORC2-dependent and -independent functions.	[Kroczynska, Barbara; Blyth, Gavin T.; Rafidi, Robert L.; Xu, Lucy; Saleiro, Diana; Kosciuczuk, Ewa M.; Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kroczynska, Barbara; Blyth, Gavin T.; Rafidi, Robert L.; Xu, Lucy; Saleiro, Diana; Kosciuczuk, Ewa M.; Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kroczynska, Barbara] Northwestern Univ, Dept Radiat Oncol, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Kosciuczuk, Ewa M.; Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Jemielity, Jacek] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland; [Su, Bing] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Su, Bing] Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200000, Peoples R China; [Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200000, Peoples R China	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Warsaw; Yale University; Yale University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super Ave,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Jemielity, Jacek/E-2635-2013; Kosciuczuk, Ewa Maria/AAD-2815-2022	Jemielity, Jacek/0000-0001-7633-788X; 	National Institutes of Health [CA155566, CA161796, CA77816, CA121192, T32 CA080621]; Department of Veterans Affairs [I01CX000916]; NCI; National Science Centre (Poland) [UMO-2013/09/B/ ST5/01341]; National Natural Science Foundation of China [31470845, 81430033]; Shanghai Science and Technology Commission [13JC1404700]; NATIONAL CANCER INSTITUTE [T32CA080621, R01CA077816, P30CA060553, R01CA161796, R01CA121192, R01CA155566] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Centre (Poland); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants CA155566, CA161796, CA77816, and CA121192 and by Department of Veterans Affairs Grant I01CX000916. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NCI, National Institutes of Health, Grant T32 CA080621; Supported by National Science Centre (Poland) Grant UMO-2013/09/B/ ST5/01341; Supported by National Natural Science Foundation of China Grants 31470845 and 81430033 and Shanghai Science and Technology Commission Grant 13JC1404700	Aimbetov R, 2012, ONCOGENE, V31, P2115, DOI 10.1038/onc.2011.404; Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jemielity J, 2012, ORG BIOMOL CHEM, V10, P8570, DOI 10.1039/c2ob26060c; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; Kroczynska B, 2016, J BIOL CHEM, V291, P2389, DOI 10.1074/jbc.M115.664995; Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148; Kroczynska B, 2011, J BIOL CHEM, V286, P1147, DOI 10.1074/jbc.M110.183566; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Larsen TS, 2013, LEUKEMIA RES, V37, P1041, DOI 10.1016/j.leukres.2013.06.012; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li C, 2014, BIOCHEM BIOPH RES CO, V450, P646, DOI 10.1016/j.bbrc.2014.06.030; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mehrotra S, 2013, J BIOL CHEM, V288, P23814, DOI 10.1074/jbc.M113.476192; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saleiro D, 2016, CYTOKINE GROWTH F R, V29, P17, DOI 10.1016/j.cytogfr.2016.03.008; Saleiro D, 2015, TRENDS IMMUNOL, V36, P21, DOI 10.1016/j.it.2014.10.006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sassano A, 2015, MOL CELL BIOL, V35, P2684, DOI 10.1128/MCB.00019-15; Shiloh R, 2014, APOPTOSIS, V19, P286, DOI 10.1007/s10495-013-0924-5; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Wang SZ, 2004, ENDOCRINOLOGY, V145, P5820, DOI 10.1210/en.2004-0991; Warminski M, 2015, EUR J ORG CHEM, V2015, P6153, DOI 10.1002/ejoc.201500672; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	65	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4743	4752		10.1074/jbc.M116.757666	http://dx.doi.org/10.1074/jbc.M116.757666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28174303	hybrid, Green Published			2022-12-28	WOS:000397585100029
J	Hudson, DM; Weis, M; Rai, J; Joeng, KS; Dimori, M; Lee, BH; Morello, R; Eyre, DR				Hudson, David M.; Weis, MaryAnn; Rai, Jyoti; Joeng, Kyu Sang; Dimori, Milena; Lee, Brendan H.; Morello, Roy; Eyre, David R.			P3h3-null and Sc65-null Mice Phenocopy the Collagen Lysine Under-hydroxylation and Cross-linking Abnormality of Ehlers-Danlos Syndrome Type VIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; collagen; endoplasmic reticulum (ER); mass spectrometry (MS); post-translational modification (PTM); skin; cross-links	OSTEOGENESIS IMPERFECTA; I COLLAGEN; PROLYL 3-HYDROXYLATION; BRUCK-SYNDROME; CYCLOPHILIN-B; BONE-COLLAGEN; NULL MICE; MUTATIONS; PYRIDINOLINE; LEPREL1	Tandem mass spectrometry was applied to tissues from targeted mutant mouse models to explore the collagen substrate specificities of individual members of the prolyl 3-hydroxylase (P3H) gene family. Previous studies revealed that P3h1 preferentially 3-hydroxylates proline at a single site in collagen type I chains, whereas P3h2 is responsible for 3-hydroxylating multiple proline sites in collagen types I, II, IV, and V. In screening for collagen substrate sites for the remaining members of the vertebrate P3H family, P3h3 and Sc65 knock-out mice revealed a common lysine under-hydroxylation effect at helical domain cross-linking sites in skin, bone, tendon, aorta, and cornea. No effect on prolyl 3-hydroxylation was evident on screening the spectrum of known 3-hydroxyproline sites from all major tissue collagen types. However, collagen type I extracted from both Sc65(-/-) and P3h3(-/-) skin revealed the same abnormal chain pattern on SDS-PAGE with an overabundance of a (112) cross-linked trimer. The latter proved to be from native molecules that had intramolecular aldol cross-links at each end. The lysine under-hydroxylation was shown to alter the divalent aldimine cross-link chemistry of mutant skin collagen. Furthermore, the ratio of mature HP/LP cross-links in bone of both P3h3(-/-) and Sc65(-/-) mice was reversed compared with wild type, consistent with the level of lysine under-hydroxylation seen in individual chains at cross-linking sites. The effect on cross-linking lysines was quantitatively very similar to that previously observed in EDS VIA human and Plod1(-/-) mouse tissues, suggesting that P3H3 and/or SC65 mutations may cause as yet undefined EDS variants.	[Hudson, David M.; Weis, MaryAnn; Rai, Jyoti; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Joeng, Kyu Sang; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dimori, Milena; Morello, Roy] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Arkansas System; University of Arkansas Medical Sciences	Hudson, DM (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	dmhudson@uw.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases and Eunice Kennedy Shriver NICHD; National Institutes of Health NIAMS [AR037318, AR036794, AR060823]; NICHD [HD070394]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R01AR060823, R01AR037318, R37AR036794] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases and Eunice Kennedy Shriver NICHD; National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and Eunice Kennedy Shriver NICHD, National Institutes of Health NIAMS Grants AR037318 (to D. E.), AR036794 (to D. E.), AR060823 (to R. M.), and NICHD Grant HD070394 (to B. L. and D. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnes AM, 2012, HUM MUTAT, V33, P1589, DOI 10.1002/humu.22139; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Bella J, 2016, BIOCHEM J, V473, P1001, DOI 10.1042/BJ20151169; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cavazzini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048845; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Gjaltema RAF, 2016, P NATL ACAD SCI USA, V113, P7142, DOI 10.1073/pnas.1600074113; Gruenwald K, 2014, J BONE MINER RES, V29, P666, DOI 10.1002/jbmr.2075; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Homan EP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004121; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Khan AO, 2015, OPHTHALMIC GENET, V36, P58, DOI 10.3109/13816810.2014.985847; Lietman CD, 2014, HUM MOL GENET, V23, P4822, DOI 10.1093/hmg/ddu197; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Matsui Y, 2003, MATRIX BIOL, V22, P123, DOI 10.1016/S0945-053X(02)00102-6; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; ROBINS SP, 1973, BIOCHEM J, V135, P657, DOI 10.1042/bj1350657; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2003, CONNECTIVE TISSUE IT, P431; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; TANZER ML, 1973, J BIOL CHEM, V248, P393; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI DOI 10.1042/BSE0520113; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850	43	16	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3877	3887		10.1074/jbc.M116.762245	http://dx.doi.org/10.1074/jbc.M116.762245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28115524	Green Published, hybrid			2022-12-28	WOS:000395542500028
J	Vitale, S; Partida-Hanon, A; Serrano, S; Martinez-del-Pozo, A; Di Pietro, A; Turra, D; Bruix, M				Vitale, Stefania; Partida-Hanon, Angelica; Serrano, Soraya; Martinez-del-Pozo, Alvaro; Di Pietro, Antonio; Turra, David; Bruix, Marta			Structure-Activity Relationship of Mating Pheromone from the Fungal Pathogen Fusarium oxysporum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; fungi; G protein-coupled receptor (GPCR); peptides; pheromone; Fusarium oxysporum; chemotropism; hyphal growth inhibition	NMR CHEMICAL-SHIFTS; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; ALPHA-FACTOR; YEAST-CELLS; PROTEIN; RECEPTOR; GENE; PEPTIDES; IDENTIFICATION	During sexual development ascomycete fungi produce two types of peptide pheromones termed a and . The pheromone from the budding yeast Saccharomyces cerevisiae, a 13-residue peptide that elicits cell cycle arrest and chemotropic growth, has served as paradigm for the interaction of small peptides with their cognate G protein-coupled receptors. However, no structural information is currently available for pheromones from filamentous ascomycetes, which are significantly shorter and share almost no sequence similarity with the S. cerevisiae homolog. High resolution structure of synthetic -pheromone from the plant pathogenic ascomycete Fusarium oxysporum revealed the presence of a central -turn resembling that of its yeast counterpart. Disruption of the-fold by d-alanine substitution of the conserved central Gly(6)-Gln(7) residues or by random sequence scrambling demonstrated a crucial role for this structural determinant in chemoattractant activity. Unexpectedly, the growth inhibitory effect of F. oxysporum -pheromone was independent of the cognate G protein-coupled receptors Ste2 and of the central -turn but instead required two conserved Trp(1)-Cys(2) residues at the N terminus. These results indicate that, despite their reduced size, fungal -pheromones contain discrete functional regions with a defined secondary structure that regulate diverse biological processes such as polarity reorientation and cell division.	[Vitale, Stefania; Di Pietro, Antonio; Turra, David] Univ Cordoba, Dept Genet, Campus Excelencia Int Agroalimentario CeiA3, E-14071 Cordoba, Spain; [Partida-Hanon, Angelica; Serrano, Soraya; Bruix, Marta] CSIC, Inst Phys Chem Rocasolano, Dept Biol Phys Chem, Serrano 119, Madrid 28006, Spain; [Martinez-del-Pozo, Alvaro] Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Complutense University of Madrid	Turra, D (corresponding author), Univ Cordoba, Dept Genet, Campus Excelencia Int Agroalimentario CeiA3, E-14071 Cordoba, Spain.; Bruix, M (corresponding author), CSIC, Inst Phys Chem Rocasolano, Dept Biol Phys Chem, Serrano 119, Madrid 28006, Spain.	ge3tutud@uco.es; mbruix@iqfr.csic.es	Di Pietro, Antonio/K-9220-2014; Vitale, Stefania/AAO-1929-2021; Bruix, Marta/H-4161-2011; Turra, David/AAC-9453-2020; Martinez-del-Pozo, Alvaro/L-8556-2014; Turrà, David/G-1193-2016	Di Pietro, Antonio/0000-0001-5930-5763; Bruix, Marta/0000-0002-0096-3558; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Turrà, David/0000-0002-0687-6754; Vitale, Stefania/0000-0002-3580-2885; Partida-Hanon, Angelica/0000-0003-4367-2117	Spanish Ministerio de Economia y Competitividad (MINECO) [CTQ2014-52633-P, BFU2012-32404, BIO2013-47870-R]; Marie Curie ITN FUNGIBRAIN from the European Commission [FP7-PEOPLE-ITN-607963]; CONACYT (Consejo Nacional de Ciencia y Tecnologia) [579971]	Spanish Ministerio de Economia y Competitividad (MINECO); Marie Curie ITN FUNGIBRAIN from the European Commission; CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO) through projects CTQ2014-52633-P, BFU2012-32404, and BIO2013-47870-R. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Marie Curie ITN FUNGIBRAIN (FP7-PEOPLE-ITN-607963) from the European Commission.; Recipient of a predoctoral fellowship 579971 from CONACYT (Consejo Nacional de Ciencia y Tecnologia).	Alby K, 2011, P NATL ACAD SCI USA, V108, P2510, DOI 10.1073/pnas.1017234108; Arkowitz RA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001958; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; BUCKINGTHROM E, 1973, EXP CELL RES, V76, P99, DOI 10.1016/0014-4827(73)90424-2; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; CHOU PY, 1979, BIOPHYS J, V26, P367, DOI 10.1016/S0006-3495(79)85259-5; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Antonio C, 2000, PROTEINS, V41, P350, DOI 10.1002/1097-0134(20001115)41:3<350::AID-PROT70>3.0.CO;2-V; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Gelin-Licht R, 2012, CELL REP, V1, P483, DOI 10.1016/j.celrep.2012.03.004; Goddard T. D., 2005, SPARKY, P3; GRATHWOHL C, 1976, BIOPOLYMERS, V15, P2043, DOI 10.1002/bip.1976.360151013; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; Guntert Peter, 2004, Methods Mol Biol, V278, P353; JIMENEZ MA, 1993, EUR J BIOCHEM, V211, P569, DOI 10.1111/j.1432-1033.1993.tb17584.x; Jones SK, 2015, MBIO, V6, DOI 10.1128/mBio.01604-15; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; Lee BK, 2001, J BIOL CHEM, V276, P37950; Lin CH, 2011, MOL BIOL CELL, V22, P4918, DOI 10.1091/mbc.E11-09-0749; MANNEY TR, 1983, J BACTERIOL, V155, P291, DOI 10.1128/JB.155.1.291-301.1983; Markley JL, 1998, EUR J BIOCHEM, V256, P1, DOI 10.1046/j.1432-1327.1998.2560001.x; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; Naider F, 2004, PEPTIDES, V25, P1441, DOI 10.1016/j.peptides.2003.11.028; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Panwar SL, 2003, EUKARYOT CELL, V2, P1350, DOI 10.1128/EC.2.6.1350-1360.2003; PERKINS SJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P409, DOI 10.1016/0005-2795(79)90416-1; Poggeler S., 2011, EVOLUTION FUNGI FUNG, P73; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHENBAGAMURTHI P, 1985, BIOCHEMISTRY-US, V24, P7070, DOI 10.1021/bi00346a008; Turra D, 2016, SEMIN CELL DEV BIOL, V57, P69, DOI 10.1016/j.semcdb.2016.04.020; Turra D, 2015, NATURE, V527, P521, DOI 10.1038/nature15516; Turra D, 2015, CURR OPIN PLANT BIOL, V26, P135, DOI 10.1016/j.pbi.2015.07.004; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wirth J, 1997, ARCH BIOCHEM BIOPHYS, V343, P188, DOI 10.1006/abbi.1997.0175; WISHART DS, 1995, J BIOMOL NMR, V5, P332, DOI 10.1007/BF00211764; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC	52	6	6	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3591	3602		10.1074/jbc.M116.766311	http://dx.doi.org/10.1074/jbc.M116.766311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100777	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000395542500005
J	Furukawa, M; Ohkawara, H; Ogawa, K; Ikeda, K; Ueda, K; Shichishima-Nakamura, A; Ito, E; Imai, JI; Yanagisawa, Y; Honma, R; Watanabe, S; Waguri, S; Ikezoe, T; Takeishi, Y				Furukawa, Miki; Ohkawara, Hiroshi; Ogawa, Kazuei; Ikeda, Kazuhiko; Ueda, Koki; Shichishima-Nakamura, Akiko; Ito, Emi; Imai, Jun-Ichi; Yanagisawa, Yuka; Honma, Reiko; Watanabe, Shinya; Waguri, Satoshi; Ikezoe, Takayuki; Takeishi, Yasuchika			Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RECEPTOR TYROSINE KINASE; PROTEIN-S; EXPRESSION; GAS6; AXL; PROLIFERATION; INHIBITION; AXIS; MICROENVIRONMENT	The pathogenesis of multiple myeloma (MM) has not yet been fully elucidated. Our microarray analysis and immunohistochemistry revealed significant up-regulation of growth arrest-specific gene 6 (Gas6), a vitamin K-dependent protein with a structural homology with protein S, in bone marrow (BM) cells of MM patients. ELISA showed that the serum levels of soluble Gas6 were significantly increased in the MM patients when compared with healthy controls. Gas6 was overexpressed in the human CD138-positive MM cell line RPMI-8226. Exogenous Gas6 suppressed apoptosis induced by serum deprivation and enhanced cell proliferation of the MM cells. The conditional medium from the human BM stromal cell line HS-5 induced cell proliferation and anti-apoptosis of the MM cells with extracellular signal-regulated kinase, Akt, and nuclear factor-kappa B phosphorylation, which were reversed by the neutralizing antibody to Gas6 or IL-6. The TAM family receptor Mer, which has been identified as a Gas6 receptor, was overexpressed in BM cells of MM patients. The knockdown of Mer by siRNA inhibited cell proliferation, anti-apoptosis, and up-regulation of intercellular cell adhesion molecule-1 (ICAM-1) in MM cells stimulated by an HS-5 cell-conditioned medium. Furthermore, the Gas6-neutralizing antibody reduced the up-regulation of IL-6 and ICAM-1 induced by a HS-5 cell-conditioned medium in MM cells. The present study provides new evidence that autocrine and paracrine stimulation of Gas6 in concert with IL-6 contributes to the pathogenesis of MM, suggesting that Gas6-Mer-related signaling pathways may be a promising novel target for treating MM.	[Furukawa, Miki; Ohkawara, Hiroshi; Ogawa, Kazuei; Ikeda, Kazuhiko; Ueda, Koki; Shichishima-Nakamura, Akiko; Ikezoe, Takayuki] Fukushima Med Univ, Dept Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan; [Ikeda, Kazuhiko] Fukushima Med Univ, Blood Transfus & Transplantat Immunol, Fukushima 9601295, Japan; [Takeishi, Yasuchika] Fukushima Med Univ, Cardiovasc Med, Fukushima 9601295, Japan; [Ito, Emi; Imai, Jun-Ichi; Yanagisawa, Yuka; Watanabe, Shinya; Waguri, Satoshi] Fukushima Med Univ, Translat Res Ctr, Fukushima, Japan; [Honma, Reiko] NIPPON GENE Co Ltd, Tokyo 1010054, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Ohkawara, H (corresponding author), Fukushima Med Univ, Dept Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	ohkawara@fmu.ac.jp		Ohkawara, Hiroshi/0000-0002-3129-1977	Fukushima Medical University Research Project; Japan Society for the Promotion of Science [16K19583, 2479080]	Fukushima Medical University Research Project; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Fukushima Medical University Research Project and Grants-in-Aid for Scientific Research 2479080 and 16K19583 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Avanzi GC, 1997, EXP HEMATOL, V25, P1219; Ben-Batalla I, 2013, BLOOD, V122, P2443, DOI 10.1182/blood-2013-03-491431; CALIGARISCAPPIO F, 1991, BLOOD, V77, P2688; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Dirks W, 1999, LEUKEMIA RES, V23, P643, DOI 10.1016/S0145-2126(99)00075-2; Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779; Faid L, 1996, EUR J HAEMATOL, V57, P349; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hansson M, 2015, CLIN CANCER RES, V21, P2730, DOI 10.1158/1078-0432.CCR-14-3090; Harada-Shirado K, 2015, BRIT J HAEMATOL, V168, P338, DOI 10.1111/bjh.13129; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2001, SEMIN ONCOL, V28, P607, DOI 10.1053/sonc.2001.28608; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jiang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133940; Katagiri M, 2001, J BIOL CHEM, V276, P7376, DOI 10.1074/jbc.M007393200; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KLEIN B, 1989, BLOOD, V73, P517; Klein B, 1992, Curr Top Microbiol Immunol, V182, P237; Lee-Sherick AB, 2013, ONCOGENE, V32, P5359, DOI 10.1038/onc.2013.40; Leow CCY, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.1; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu Q, 2016, J BIOL CHEM, V291, P4779, DOI 10.1074/jbc.M115.683052; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Markovina S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-176; Mc Cormack O, 2008, BRIT J CANCER, V98, P1141, DOI 10.1038/sj.bjc.6604260; Mitsiades CS, 2011, J CLIN ONCOL, V29, P1916, DOI 10.1200/JCO.2010.34.0760; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Miura A, 2006, FEBS LETT, V580, P6871, DOI 10.1016/j.febslet.2006.11.041; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Munoz X, 2004, HUM MUTAT, V23, P506, DOI 10.1002/humu.20025; Murray MY, 2015, CELL CYCLE, V14, P2367, DOI 10.1080/15384101.2014.998067; NEUBAUER A, 1994, BLOOD, V84, P1931; Noll JE, 2014, HAEMATOLOGICA, V99, P163, DOI 10.3324/haematol.2013.090977; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Ohkawara H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105697; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Ramakrishnan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050005; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Shiozawa Y, 2010, EXP HEMATOL, V38, P132, DOI 10.1016/j.exphem.2009.11.002; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waizenegger JS, 2015, LEUKEMIA, V29, P696, DOI 10.1038/leu.2014.236; Wallace SR, 2001, CANCER-AM CANCER SOC, V91, P1219, DOI 10.1002/1097-0142(20010401)91:7<1219::AID-CNCR1122>3.0.CO;2-1; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; Whitman SP, 2014, LEUKEMIA, V28, P1252, DOI 10.1038/leu.2013.371; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141	56	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4280	4292		10.1074/jbc.M116.733030	http://dx.doi.org/10.1074/jbc.M116.733030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154173	hybrid, Green Published			2022-12-28	WOS:000395837100025
J	Tang, LY; Heller, M; Meng, Z; Yu, LR; Tang, Y; Zhou, M; Zhang, YE				Tang, Liu-Ya; Heller, Mary; Meng, Zhaojing; Yu, Li-Rong; Tang, Yi; Zhou, Ming; Zhang, Ying E.			Transforming Growth Factor-beta (TGF-beta) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STELLATE CELLS; JUNB PROMOTER; STAT3; EXPRESSION; IL-6; PHOSPHORYLATION; HEPATOCYTES; TRANSDUCERS; APOPTOSIS; ELEMENT	Transforming growth factor-beta (TGF-beta) signals through both SMAD and non-SMAD pathways to elicit a wide array of biological effects. Existing data have shown the association and coordination between STATs and SMAD sin mediating TGF-beta functions in hepatic cells, but it is not clear how STATs are activated under these circumstances. Here, we report that JAK1 is a constitutive TGF beta RI binding protein and is absolutely required for phosphorylation of STATs in a SMAD-independent manner within minutes of TGF-beta stimulation. Following the activation of SMADs, TGF-beta also induces a second phase of STAT phosphorylation that requires SMADs, de novo protein synthesis, and contribution from JAK1. Our global gene expression profiling indicates that the non-SMAD JAK1/STAT pathway is essential for the expression of a subset of TGF-beta target genes in hepatic stellate cells, and the cooperation between the JAK1STAT3 and SMAD pathways is critical to the roles of TGF-beta in liver fibrosis.	[Tang, Liu-Ya; Heller, Mary; Tang, Yi; Zhang, Ying E.] Natl Inst Hlth, Lab Cellular & Mol Biol, Ctr Canc Res, NCI, Bethesda, MD 20892 USA; [Meng, Zhaojing; Yu, Li-Rong; Zhou, Ming] Frederick Natl Lab Canc Res, Prot Characterizat Lab, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Yu, Li-Rong] Div System Biol, Biomarkers & Alternat Models Branch, Food & Drug Adm, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Zhang, YE (corresponding author), Natl Inst Hlth, Lab Cellular & Mol Biol, Ctr Canc Res, NCI, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Yu, Li-Rong/0000-0001-6084-991X	National Institutes of Health; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the National Institutes of Health, NCI, Center for Cancer Research (to Y.E.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; COFFER P, 1995, ONCOGENE, V10, P985; Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Harrison DA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011205; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Inagaki-Ohara Kyoko, 2013, JAKSTAT, V2, pe24053, DOI 10.4161/jkst.24053; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kojima H, 1996, ONCOGENE, V12, P547; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Kusaba M, 2007, J HEPATOL, V47, P546, DOI 10.1016/j.jhep.2007.04.017; Liu Y, 2004, GENESIS, V40, P118, DOI 10.1002/gene.20072; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Wang G, 2016, ONCOGENE, V35, P4388, DOI 10.1038/onc.2015.446; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Xu MY, 2014, BBA-MOL BASIS DIS, V1842, P2237, DOI 10.1016/j.bbadis.2014.07.025; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Yang YA, 2006, CANCER CELL, V9, P445, DOI 10.1016/j.ccr.2006.04.025; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang Y. E., 2016, COLD SPRING HARB PER, V9	36	142	148	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4302	4312		10.1074/jbc.M116.773085	http://dx.doi.org/10.1074/jbc.M116.773085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154170	hybrid, Green Published			2022-12-28	WOS:000395837100027
J	Jain, AK; Bloom, DA; Jaiswal, AK				Jain, Abhinav K.; Bloom, David A.; Jaiswal, Anil K.			Nuclear import and export signals in control of Nrf2 (vol 280, pg 29158, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200	1	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2052	2052		10.1074/jbc.A117.502083	http://dx.doi.org/10.1074/jbc.A117.502083			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159765	Green Published, hybrid			2022-12-28	WOS:000395515600047
J	Manzar, GS; Kim, EM; Zavazava, N				Manzar, Gohar S.; Kim, Eun-Mi; Zavazava, Nicholas			Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; induced pluripotent stem cell; iPS cell; iPSC; insulin secretion; pancreatic islet; type 1 diabetes; 3D differentiation; beta cell; insulin producing cells; diabetes	INSULIN-PRODUCING CELLS; ORGAN BUD TRANSPLANT; HUMAN IPS CELLS; BETA-CELLS; IN-VITRO; SECRETING CELLS; ENDOCRINE-CELLS; HUMAN LIVER; GENERATION; ENDODERM	Type 1 diabetes (T1D) can be managed by transplanting either the whole pancreas or isolated pancreatic islets. However, cadaveric pancreas is scarcely available for clinical use, limiting this approach. As such, there is a great need to identify alternative sources of clinically usable pancreatic tissues. Here, we used induced pluripotent stem (iPS) cells derived from patients with T1D to generate glucose-responsive, insulin-producing cells (IPCs) via 3D culture. Initially, T1D iPS cells were resistant to differentiation, but transient demethylation treatment significantly enhanced IPC yield. The cells responded to high-glucose stimulation by secreting insulin in vitro. The shape, size, and number of their granules, as observed by transmission electron microscopy, were identical to those found in cadaveric cells. When the IPCs were transplanted into immunodeficient mice that had developed streptozotocin-induced diabetes, they promoted a dramatic decrease in hyperglycemia, causing the mice to become normoglycemic within 28 days. None of the mice died or developed teratomas. Because the cells are derived from self, immunosuppression is not required, providing a much safer and reliable treatment option for T1D patients. Moreover, these cells can be used for drug screening, thereby accelerating drug discovery. In conclusion, our approach eliminates the need for cadaveric pancreatic tissue.	[Manzar, Gohar S.; Kim, Eun-Mi; Zavazava, Nicholas] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Manzar, Gohar S.; Zavazava, Nicholas] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Manzar, Gohar S.; Kim, Eun-Mi; Zavazava, Nicholas] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Manzar, Gohar S.] Mayo Clin, Coll Med, Rochester, MN USA; [Kim, Eun-Mi] Korea Inst Toxicol, Predict Model Res Ctr, Daejeon 34114, South Korea	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Mayo Clinic; Korea Institute of Toxicology	Zavazava, N (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Immunol, C429-1 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	nicholas-zavazava@uiowa.edu		Manzar, Gohar/0000-0003-0331-7102	Veterans Affairs Merit Award; NHLBI, National Institutes of Health [5R01HL073015-08]; ReproCELL Inc.; AHA Career Development Award [14SDG18690008]; AAI Careers in Immunology Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	Veterans Affairs Merit Award(US Department of Veterans Affairs); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ReproCELL Inc.; AHA Career Development Award; AAI Careers in Immunology Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was made possible by support from a Veterans Affairs Merit Award and by NHLBI, National Institutes of Health, Grant 5R01HL073015-08, as well as by funding from ReproCELL Inc. This work was also supported by AHA Career Development Award 14SDG18690008 (to E.-M. K.) and an AAI Careers in Immunology Fellowship Award (to G. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bose B, 2012, CELL BIOL INT, V36, P1013, DOI 10.1042/CBI20120210; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Chen AE, 2013, DEVELOPMENT, V140, P675, DOI 10.1242/dev.085431; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Greggio C, 2013, DEVELOPMENT, V140, P4452, DOI 10.1242/dev.096628; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Kim EM, 2013, BLOOD, V121, P5167, DOI 10.1182/blood-2012-11-467753; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Leroux C, 2014, CAN J DIABETES, V38, P62, DOI 10.1016/j.jcjd.2013.08.268; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Manzar GS, 2014, IMMUNOL RES, V59, P279, DOI 10.1007/s12026-014-8546-8; Mfopou JK, 2010, DIABETES, V59, P2094, DOI 10.2337/db10-0439; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Norris DO, 2013, VERTEBRATE ENDOCRINOLOGY, FIFTH EDITION, P443, DOI 10.1016/B978-0-12-394815-1.00012-4; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Raikwar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116582; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Shahjalal HM, 2014, J MOL CELL BIOL, V6, P394, DOI 10.1093/jmcb/mju029; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Thatava T, 2011, GENE THER, V18, P283, DOI 10.1038/gt.2010.145; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Ye DZ, 2006, DIABETES, V55, P742, DOI 10.2337/diabetes.55.03.06.db05-0653; Yechoor V, 2010, MOL ENDOCRINOL, V24, P1501, DOI 10.1210/me.2009-0311; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	48	27	29	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14066	14079		10.1074/jbc.M117.784280	http://dx.doi.org/10.1074/jbc.M117.784280			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28360105	Green Published, hybrid			2022-12-28	WOS:000408439800014
J	Nonaka, S; Ando, Y; Kanetani, T; Hoshi, C; Nakai, Y; Nainu, F; Nagaosa, K; Shiratsuchi, A; Nakanishi, Y				Nonaka, Saori; Ando, Yuki; Kanetani, Takuto; Hoshi, Chiharu; Nakai, Yuji; Nainu, Firzan; Nagaosa, Kaz; Shiratsuchi, Akiko; Nakanishi, Yoshinobu			Signaling pathway for phagocyte priming upon encounter with apoptotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR TAILLESS; DROSOPHILA BLOOD-CELLS; CAENORHABDITIS-ELEGANS; C-ELEGANS; CORPSE ENGULFMENT; DORSAL CLOSURE; MYOBLAST CITY; CLEARANCE; GENES; DEATH	The phagocytic elimination of cells undergoing apoptosis is an evolutionarily conserved innate immune mechanism for eliminating unnecessary cells. Previous studies showed an increase in the level of engulfment receptors in phagocytes after the phagocytosis of apoptotic cells, which leads to the enhancement of their phagocytic activity. However, precise mechanisms underlying this phenomenon require further clarification. We found that the pre-incubation of a Drosophila phagocyte cell line with the fragments of apoptotic cells enhanced the subsequent phagocytosis of apoptotic cells, accompanied by an augmented expression of the engulfment receptors Draper and integrin alpha PS3. The DNA-binding activity of the transcription repressor Tailless was transiently raised in those phagocytes, depending on two partially overlapping signal-transduction pathways for the induction of phagocytosis as well as the occurrence of engulfment. The RNAi knockdown of tailless in phagocytes abrogated the enhancement of both phagocytosis and engulfment receptor expression. Furthermore, the hemocyte-specific RNAi of tailless reduced apoptotic cell clearance in Drosophila embryos. Taken together, we propose the following mechanism for the activation of Drosophila phagocytes after an encounter with apoptotic cells: two partially overlapping signal-transduction pathways for phagocytosis are initiated; transcription repressor Tailless is activated; expression of engulfment receptors is stimulated; and phagocytic activity is enhanced. This phenomenon most likely ensures the phagocytic elimination of apoptotic cells by stimulated phagocytes and is thus considered as a mechanism to prime phagocytes in innate immunity.	[Nonaka, Saori; Ando, Yuki; Kanetani, Takuto; Nainu, Firzan; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Hoshi, Chiharu; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan; [Nakai, Yuji; Nagaosa, Kaz] Hirosaki Univ, Inst Food Sci, Aomori, Aomori 0380012, Japan; [Nainu, Firzan] Hasanuddin Univ, Fac Pharm, Makassar 90245, South Sulawesi, Indonesia	Kanazawa University; Kanazawa University; Hirosaki University; Universitas Hasanuddin	Nakanishi, Y (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nakanaka@p.kanazawa-u.ac.jp	NAKAI, Yuji/G-3433-2014; Nainu, Firzan/U-3442-2019; Nainu, Firzan/E-2447-2017; Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015; Nonaka, Saori/L-4092-2015	NAKAI, Yuji/0000-0002-2458-3875; Nainu, Firzan/0000-0003-0989-4023; Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409; Ando, Yukio/0000-0001-7115-9105; Nonaka, Saori/0000-0003-2672-3082	Japan Society for the Promotion of Science KAKENHI [740101, JP16H04762]; Directorate General of Higher Education scholarship from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia;  [26-6163]; Grants-in-Aid for Scientific Research [16H04762] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Directorate General of Higher Education scholarship from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Japan Society for the Promotion of Science Fellows 26-6163 (to S. N.) and Japan Society for the Promotion of Science KAKENHI Grants 740101 (to K. N.) and JP16H04762 (to Y. Nakanishi). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Directorate General of Higher Education scholarship from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Baanannou A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003581; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Escudero LM, 2005, DEVELOPMENT, V132, P1211, DOI 10.1242/dev.01691; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Gui HX, 2011, DEV NEUROSCI-BASEL, V33, P1, DOI 10.1159/000321585; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Issigonis M, 2012, DEV BIOL, V368, P181, DOI 10.1016/j.ydbio.2012.04.034; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2010, APOPTOSIS, V15, P998, DOI 10.1007/s10495-010-0509-5; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kuhnlein RP, 1998, MECH DEVELOP, V79, P161, DOI 10.1016/S0925-4773(98)00183-X; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Meehan TL, 2015, DIS MODEL MECH, V8, P1603, DOI 10.1242/dmm.021998; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Moran E, 2006, MOL CELL BIOL, V26, P3446, DOI 10.1128/MCB.26.9.3446-3454.2006; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Nonaka S, 2013, J BIOL CHEM, V288, P10374, DOI 10.1074/jbc.M113.451427; Okada R, 2012, J BIOL CHEM, V287, P3138, DOI 10.1074/jbc.M111.277921; Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376; PIGNONI F, 1990, CELL, V62, P151, DOI 10.1016/0092-8674(90)90249-E; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; SANTALA P, 1991, J BIOL CHEM, V266, P23505; Sarang Z, 2014, J IMMUNOL, V192, P5730, DOI 10.4049/jimmunol.1400284; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Savill J, 1997, BRIT MED BULL, V53, P491; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; STRECKER TR, 1986, DEV BIOL, V113, P64, DOI 10.1016/0012-1606(86)90108-9; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Team RC., 2022, LANG ENV STAT COMP; Tung TT, 2013, J BIOCHEM, V153, P483, DOI 10.1093/jb/mvt014; Vlisidou I, 2015, FEBS J, V282, P1368, DOI 10.1111/febs.13235; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Wang XC, 2016, CELL MOL LIFE SCI, V73, P2221, DOI 10.1007/s00018-016-2196-z; Wang Y, 2013, MECH DEVELOP, V130, P388, DOI 10.1016/j.mod.2013.02.001; Weavers H, 2016, CELL, V165, P1658, DOI 10.1016/j.cell.2016.04.049; Wood W, 2017, DEV CELL, V40, P221, DOI 10.1016/j.devcel.2017.01.001; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zhou Z, 2008, TRENDS CELL BIOL, V18, P474, DOI 10.1016/j.tcb.2008.08.002	76	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8059	8072		10.1074/jbc.M116.769745	http://dx.doi.org/10.1074/jbc.M116.769745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325838	Green Published, hybrid			2022-12-28	WOS:000401154100030
J	Abe, K; Nakajima, M; Yamashita, T; Matsunaga, H; Kamisuki, S; Nihira, T; Takahashi, Y; Sugimoto, N; Miyanaga, A; Nakai, H; Arakawa, T; Fushinobu, S; Taguchi, H				Abe, Koichi; Nakajima, Masahiro; Yamashita, Tetsuro; Matsunaga, Hiroki; Kamisuki, Shinji; Nihira, Takanori; Takahashi, Yuta; Sugimoto, Naohisa; Miyanaga, Akimasa; Nakai, Hiroyuki; Arakawa, Takatoshi; Fushinobu, Shinya; Taguchi, Hayao			Biochemical and structural analyses of a bacterial endo-beta-1,2-glucanase reveal a new glycoside hydrolase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; glycosidase; Gram-negative bacteria; oligosaccharide; polysaccharide; -1; 2-glucan; Chitinophaga pinensis; endo--1; 2-glucanase; novel glycoside hydrolase family; sophorooligosaccharide	SEQUENCE-BASED CLASSIFICATION; CYCLIC-BETA-GLUCANS; STRUCTURE VALIDATION; PERIPLASMIC GLUCANS; ALGINATE LYASE; ACTIVE-SITE; BETA-1,2-GLUCAN; PURIFICATION; EVOLUTIONARY; ADAPTATION	-1,2-Glucan is an extracellular cyclic or linear polysaccharide from Gram-negative bacteria, with important roles in infection and symbiosis. Despite -1,2-glucan's importance in bacterial persistence and pathogenesis, only a few reports exist on enzymes acting on both cyclic and linear -1,2-glucan. To this end, we purified an endo--1,2-glucanase to homogeneity from cell extracts of the environmental species Chitinophaga arvensicola, and an endo--1,2-glucanase candidate gene (Cpin_6279) was cloned from the related species Chitinophaga pinensis. The Cpin_6279 protein specifically hydrolyzed linear -1,2-glucan with polymerization degrees of 5 and a cyclic counterpart, indicating that Cpin_6279 is an endo--1,2-glucananase. Stereochemical analysis demonstrated that the Cpin_6279-catalyzed reaction proceeds via an inverting mechanism. Cpin_6279 exhibited no significant sequence similarity with known glycoside hydrolases (GHs), and thus the enzyme defines a novel GH family, GH144. The crystal structures of the ligand-free and complex forms of Cpin_6279 with glucose (Glc) and sophorotriose (Glc--1,2-Glc--1,2-Glc) determined up to 1.7 angstrom revealed that it has a large cavity appropriate for polysaccharide degradation and adopts an (/)(6)-fold slightly similar to that of GH family 15 and 8 enzymes. Mutational analysis indicated that some of the highly conserved acidic residues in the active site are important for catalysis, and the Cpin_6279 active-site architecture provided insights into the substrate recognition by the enzyme. The biochemical characterization and crystal structure of this novel GH may enable discovery of other -1,2-glucanases and represent a critical advance toward elucidating structure-function relationships of GH enzymes.	[Abe, Koichi; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Abe, Koichi; Nakajima, Masahiro; Matsunaga, Hiroki; Kamisuki, Shinji; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan; [Yamashita, Tetsuro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Kamisuki, Shinji] Azabu Univ, Sch Vet Med, Chuoh Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2298501, Japan; [Nihira, Takanori; Takahashi, Yuta; Sugimoto, Naohisa; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	University of Tokyo; Tokyo University of Science; Iwate University; Azabu University; Niigata University; Tokyo Institute of Technology	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	m-nakajima@rs.tus.ac.jp	Miyanaga, Akimasa/C-1472-2015; Nakajima, Masahiro/J-3566-2019; Fushinobu, Shinya/E-4987-2011; Arakawa, Takatoshi/K-9739-2013	Miyanaga, Akimasa/0000-0003-2219-6051; Nakajima, Masahiro/0000-0002-3182-0859; Fushinobu, Shinya/0000-0003-1346-6435; Arakawa, Takatoshi/0000-0001-6496-5440; Kamisuki, Shinji/0000-0001-8773-3909; Taguchi, Hayao/0000-0001-5270-581X	Noda Institute for Scientific Research	Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported in part by a Noda Institute for Scientific Research Grant (2013 Young Investigator Research Grant). The authors declare that they have no conflicts of interest with the contents of this article.	Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; AMEMURA A, 1985, J GEN MICROBIOL, V131, P301; AMEMURA A, 1986, J GEN MICROBIOL, V132, P2443; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; Hemsworth GR, 2016, BIOCHEM SOC T, V44, P94, DOI 10.1042/BST20150180; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HISAMATSU M, 1982, J GEN MICROBIOL, V128, P1873; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Liu JL, 2013, J PHYS CHEM B, V117, P10080, DOI 10.1021/jp402110j; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; McKee LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139932; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MENDOZA NS, 1983, J FERMENT TECHNOL, V61, P473; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakajima M, 2012, APPL MICROBIOL BIOT, V93, P1989, DOI 10.1007/s00253-011-3538-2; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; NELSON TE, 1970, J BIOL CHEM, V245, P869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; REESE ET, 1971, CARBOHYD RES, V18, P381, DOI 10.1016/S0008-6215(00)80274-8; REESE ET, 1961, CAN J MICROBIOL, V7, P309, DOI 10.1139/m61-038; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008; Sova VV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P529, DOI 10.1023/A:1023951525250; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	58	26	28	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7487	7506		10.1074/jbc.M116.762724	http://dx.doi.org/10.1074/jbc.M116.762724			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28270506	Green Published, hybrid			2022-12-28	WOS:000400761300018
J	Alam, MM; Okazaki, K; Nguyen, LTT; Ota, N; Kitamura, H; Murakami, S; Shima, H; Igarashi, K; Sekine, H; Motohashi, H				Alam, Md. Morshedul; Okazaki, Keito; Nguyen, Linh Thi Thao; Ota, Nao; Kitamura, Hiroshi; Murakami, Shohei; Shima, Hiroki; Igarashi, Kazuhiko; Sekine, Hiroki; Motohashi, Hozumi			Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; glucocorticoid receptor; histone acetylation; Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); oxidative stress; electrophile	SMALL MAF PROTEINS; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; B-CELLS; DOMAIN; ELEMENTS; BINDING; GENES; KEAP1; MICE	NRF2 (nuclear factor erythroid 2-related factor 2) is a key transcriptional activator that mediates the inducible expression of antioxidant genes. NRF2 is normally ubiquitinated by KEAP1 (Kelch-like ECH-associated protein 1) and subsequently degraded by proteasomes. Inactivation of KEAP1 by oxidative stress or electrophilic chemicals allows NRF2 to activate transcription through binding to antioxidant response elements (AREs) and recruiting histone acetyltransferase CBP (CREB-binding protein). Whereas KEAP1-dependent regulation is a major determinant of NRF2 activity, NRF2-mediated transcriptional activation varies from context to context, suggesting that other intracellular signaling cascades may impact NRF2 function. To identify a signaling pathway that modifies NRF2 activity, we immunoprecipitated endogenous NRF2 and its interacting proteins from mouse liver and identified glucocorticoid receptor (GR) as a novel NRF2-binding partner. We found that glucocorticoids, dexamethasone and betamethasone, antagonize diethyl maleate-induced activation of NRF2 target genes in a GR-dependent manner. Dexamethasone treatment enhanced GR recruitment to AREs without affecting chromatin binding of NRF2, resulting in the inhibition of CBP recruitment and histone acetylation at AREs. This repressive effect was canceled by the addition of histone deacetylase inhibitors. Thus, GR signaling decreases NRF2 transcriptional activation through reducing the NRF2-dependent histone acetylation. Consistent with these observations, GR signaling blocked NRF2-mediated cytoprotection from oxidative stress. This study suggests that an impaired antioxidant response by NRF2 and a resulting decrease in cellular antioxidant capacity account for the side effects of glucocorticoids, providing a novel viewpoint for the pathogenesis of hypercorticosteroidism.	[Alam, Md. Morshedul; Okazaki, Keito; Nguyen, Linh Thi Thao; Ota, Nao; Kitamura, Hiroshi; Murakami, Shohei; Sekine, Hiroki; Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Shima, Hiroki; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Shima, Hiroki; Igarashi, Kazuhiko] AMED, CREST, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Sekine, H; Motohashi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	sekine@med.tohoku.ac.jp; hozumim@med.tohoku.ac.jp	Murakami, Shohei/GPW-9730-2022; Alam, Morshedul/K-1158-2019; Motohashi, Hozumi/AAZ-2628-2020	Murakami, Shohei/0000-0002-2555-1568; Alam, Morshedul/0000-0003-1564-969X; Igarashi, Kazuhiko/0000-0002-2470-2475; Sekine, Hiroki/0000-0002-0929-6456	JSPS KAKENHI [15H04692, 16K15228]; Uehara Memorial Foundation; Mitsubishi Foundation; Naito Foundation; Gonryo Medical Foundation; AMED; Princess Takamatsu Cancer Research Fund [15-24728]; Grants-in-Aid for Scientific Research [15H04692, 15H02506] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Naito Foundation(Naito Memorial Foundation); Gonryo Medical Foundation; AMED(Japan Agency for Medical Research and Development (AMED)); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 15H04692 (to H. M.) and 16K15228 (to H. M.), the Uehara Memorial Foundation (to H. M.), the Mitsubishi Foundation (to H. M.), the Naito Foundation (to H. M.), the Gonryo Medical Foundation (to H. S.), the Core Research for Evolutional Science and Technology from the AMED (to K. I.), and the Princess Takamatsu Cancer Research Fund 15-24728 (to H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ando R, 2016, J BIOL CHEM, V291, P1826, DOI 10.1074/jbc.M115.661702; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Goto M, 2015, GENES CELLS, V20, P464, DOI 10.1111/gtc.12237; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Ki SH, 2005, MOL CELL BIOL, V25, P4150, DOI 10.1128/MCB.25.10.4150-4165.2005; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kratschmar DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036774; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Maruyama A, 2008, ARCH BIOCHEM BIOPHYS, V477, P139, DOI 10.1016/j.abb.2008.06.004; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Rockall AG, 2003, EUR J ENDOCRINOL, V149, P543, DOI 10.1530/eje.0.1490543; Sakamuri SSVP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050216; Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200; Sekine H, 2016, MOL CELL BIOL, V36, P407, DOI 10.1128/MCB.00785-15; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Shirasaki K, 2014, HEPATOLOGY, V59, P2371, DOI 10.1002/hep.27020; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stefan N, 2014, LANCET DIABETES ENDO, V2, P406, DOI 10.1016/S2213-8587(13)70170-0; Sugimoto H, 2010, AM J PHYSIOL-GASTR L, V298, pG283, DOI 10.1152/ajpgi.00296.2009; Taguchi K, 2014, MOL CELL BIOL, V34, P900, DOI 10.1128/MCB.01384-13; Tanaka H, 2016, J BIOL CHEM, V291, P6316, DOI 10.1074/jbc.M116.713842; Wakabayashi N, 2014, MOL CELL BIOL, V34, P653, DOI 10.1128/MCB.01408-13; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Woods CP, 2015, J CLIN ENDOCR METAB, V100, P1434, DOI 10.1210/jc.2014-4120; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang YKJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059122; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016	46	59	63	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7519	7530		10.1074/jbc.M116.773960	http://dx.doi.org/10.1074/jbc.M116.773960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28314773	Green Published, hybrid			2022-12-28	WOS:000400761300020
J	Bikkavilli, RK; Zerayesus, SA; Van Scoyk, M; Wilson, L; Wu, PY; Baskaran, A; Tang, K; Raheem, S; Samuelson, BA; Reddy, NM; Reddy, SP; Cool, CD; Kosmider, B; Avasarala, S; Winn, RA				Bikkavilli, Rama Kamesh; Zerayesus, Sereke Adam; Van Scoyk, Michelle; Wilson, Lora; Wu, Pei-Ying; Baskaran, Abhinaya; Tang, Ke; Raheem, Syed; Samuelson, Blain A.; Reddy, Narsa M.; Reddy, Sekhar P.; Cool, Carlyne D.; Kosmider, Beata; Avasarala, Sreedevi; Winn, Robert A.			K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell migration; mRNA decay; post-transcriptional regulation; RNA-binding protein; KSRP; NSCLC; Spry4	MESSENGER-RNA DECAY; AU-RICH ELEMENT; BINDING PROTEIN; EXPRESSION; CATENIN; COMPLEX; GROWTH; IDENTIFICATION; STABILIZATION; INVOLVEMENT	AU-rich element-binding proteins (ARE-BPs) offer post-transcriptional regulation of gene expression via physical interaction and recruitment of RNA decay machinery to the AU-rich elements within the 3-UTR of the target transcripts. However, the role of ARE-BPs in lung cancer remains poorly understood. In this study, we have identified that K-homology splicing regulatory protein (KSRP), an ARE-BP, is robustly up-regulated in human lung cancer. Importantly, Kaplan-Meier survival analysis indicated that elevated KSRP expression was correlated with poor overall survival of lung cancer patients. Furthermore, cigarette smoke, a leading risk factor for lung cancer, was also identified to be an important contributor to increased KSRP expression. Remarkably, silencing of KSRP decreased cell proliferation, reversed anchorage-independent growth, and reduced migration/invasion, suggesting an oncogenic role for KSRP in lung cancer. Finally, we provide mechanistic evidence that KSRP promotes the down-regulation of Spry4 by a previously unidentified mechanism, i.e. post-transcriptional mRNA regulation.	[Bikkavilli, Rama Kamesh; Zerayesus, Sereke Adam; Van Scoyk, Michelle; Wu, Pei-Ying; Baskaran, Abhinaya; Tang, Ke; Raheem, Syed; Samuelson, Blain A.; Avasarala, Sreedevi; Winn, Robert A.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Rm 5160,Coll Med Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA; [Reddy, Narsa M.; Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Div Dev Biol & Basic Res, Chicago, IL 60612 USA; [Wilson, Lora; Cool, Carlyne D.] Univ Colorado Anschutz Med Campus, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Wilson, Lora; Cool, Carlyne D.] Univ Colorado Anschutz Med Campus, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Kosmider, Beata] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kosmider, Beata] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med, Philadelphia, PA 19140 USA; [Kosmider, Beata] Temple Univ, Lewis Katz Sch Med, Dept Surg, Philadelphia, PA 19140 USA; [Kosmider, Beata] Temple Univ, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19140 USA; [Kosmider, Beata] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Winn, Robert A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Jewish Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Rm 5160,Coll Med Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA.	rwinn@uic.edu	Reddy, Narsa/AHE-5604-2022		National Institutes of Health [R01 CA138528, R01 HL118171]; NATIONAL CANCER INSTITUTE [U54CA203000, U54CA202997, U54CA202995, R01CA138528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 CA138528 (to R. A. W.) and R01 HL118171 (to B. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Bikkavilli RK, 2010, J CELL SCI, V123, P1352, DOI 10.1242/jcs.056176; Bird CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079255; Bollmann F, 2014, NUCLEIC ACIDS RES, V42, P12555, DOI 10.1093/nar/gku1033; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Cammas A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5190; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Chou CF, 2015, J LIPID RES, V56, P227, DOI 10.1194/jlr.M050724; Chou CF, 2014, DIABETES, V63, P2949, DOI 10.2337/db13-1901; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2014, SEMIN CELL DEV BIOL, V34, P2, DOI 10.1016/j.semcdb.2014.05.004; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Giovarelli M, 2013, BBA-GENE REGUL MECH, V1829, P469, DOI 10.1016/j.bbagrm.2013.02.008; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Khabar K. S., 2016, WILEY INTERDISCIP RE, V8, pe1368; King PH, 2014, J INTERF CYTOK RES, V34, P267, DOI 10.1089/jir.2013.0143; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Liu Y, 2011, MOL CELL, V41, P367, DOI 10.1016/j.molcel.2011.01.027; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Nechama M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-70; Nicastro G, 2012, NAT STRUCT MOL BIOL, V19, P1282, DOI 10.1038/nsmb.2427; Pasero M, 2012, CELL REP, V2, P1159, DOI 10.1016/j.celrep.2012.10.020; Reddy NM, 2012, AM J PATHOL, V180, P562, DOI 10.1016/j.ajpath.2011.10.029; Repetto E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002823; Ruggiero T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-28; Sechler M, 2015, J BIOL CHEM, V290, P15610, DOI 10.1074/jbc.M114.631820; Seok H, 2002, PROTEIN PEPTIDE LETT, V9, P511, DOI 10.2174/0929866023408454; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Tennis MA, 2010, MOL CANCER RES, V8, P833, DOI 10.1158/1541-7786.MCR-09-0400; Trabucchi M, 2010, ADV EXP MED BIOL, V700, P36, DOI 10.1007/978-1-4419-7823-3_4; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zhang Kun, 2015, Zhongguo Fei Ai Za Zhi, V18, P219, DOI 10.3779/j.issn.1009-3419.2015.04.02	45	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7423	7434		10.1074/jbc.M116.757906	http://dx.doi.org/10.1074/jbc.M116.757906			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28275056	hybrid, Green Published			2022-12-28	WOS:000400761300013
J	Japaridze, A; Renevey, S; Sobetzko, P; Stoliar, L; Nasser, W; Dietler, G; Muskhelishvili, G				Japaridze, Aleksandre; Renevey, Sylvain; Sobetzko, Patrick; Stoliar, Liubov; Nasser, William; Dietler, Giovanni; Muskhelishvili, Georgi			Spatial organization of DNA sequences directs the assembly of bacterial chromatin by a nucleoid-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); bacterial genetics; DNA binding protein; DNA topology; protein-DNA interaction; DNA binding sites; bacterial chromatin; nucleoid-associated protein H-NS; nucleoprotein filaments	VIRULENCE GENE-EXPRESSION; H-NS; CHROMOSOME ORGANIZATION; ARCHITECTURAL ROLE; FORCE MICROSCOPY; CURVED DNA; FIS; TRANSCRIPTION; BINDING; SHIGELLA	Structural differentiation of bacterial chromatin depends on cooperative binding of abundant nucleoid-associated proteins at numerous genomic DNA sites and stabilization of distinct long-range nucleoprotein structures. Histone-like nucleoid-structuring protein (H-NS) is an abundant DNA-bridging, nucleoid-associated protein that binds to an AT-rich conserved DNA sequence motif and regulates both the shape and the genetic expression of the bacterial chromosome. Although there is ample evidence that the mode of H-NS binding depends on environmental conditions, the role of the spatial organization of H-NS-binding sequences in the assembly of long-range nucleoprotein structures remains unknown. In this study, by using high-resolution atomic force microscopy combined with biochemical assays, we explored the formation of H-NS nucleoprotein complexes on circular DNA molecules having different arrangements of identical sequences containing high-affinity H-NS-binding sites. We provide the first experimental evidence that variable sequence arrangements result in various three-dimensional nucleoprotein structures that differ in their shape and the capacity to constrain supercoils and compact the DNA. We believe that the DNA sequence-directed versatile assembly of periodic higher-order structures reveals a general organizational principle that can be exploited for knowledge-based design of long-range nucleoprotein complexes and purposeful manipulation of the bacterial chromatin architecture.	[Japaridze, Aleksandre; Renevey, Sylvain; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, CE-3316 Lausanne, Switzerland; [Sobetzko, Patrick; Stoliar, Liubov; Muskhelishvili, Georgi] Jacobs Univ, Campus Ring 1, D-28759 Bremen, Germany; [Nasser, William] Univ Lyon, INSA Lyon, CNRS INSA UCB UMR5240, F-69003 Villeurbanne, France; [Muskhelishvili, Georgi] Agr Univ Georgia, 240 David Aghmashenebeli Alley, GE-0159 Tbilisi, Georgia; [Japaridze, Aleksandre] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Maasweg 9, NL-2629 HZ Delft, Netherlands; [Sobetzko, Patrick] Philipps Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35037 Marburg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Jacobs University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Delft University of Technology; Philipps University Marburg	Dietler, G (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Living Matter, CE-3316 Lausanne, Switzerland.; Muskhelishvili, G (corresponding author), Jacobs Univ, Campus Ring 1, D-28759 Bremen, Germany.	giovanni.dietler@epfl.ch; g.muskhelishvili@jacobs-university.de	Japaridze, Aleksandre/AAK-5062-2020; NASSER, William/C-9611-2019; Renevey, Sylvain/AAB-5136-2021	Japaridze, Aleksandre/0000-0002-9581-9128; NASSER, William/0000-0001-9848-3597; Renevey, Sylvain/0000-0001-7279-5488	Swiss National Science Foundation [P2ELP2_168554]; Deutsche Forschungsgemeinschaft [MU1549/11-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Swiss National Science Foundation Grant P2ELP2_168554. Present address: Dept. of Bionanoscience, Kavli Institute of Nanoscience, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, The Netherlands.; Supported by Deutsche Forschungsgemeinschaft (MU1549/11-1). To whom correspondence may be addressed: Jacobs University Bremen, Campus Ring 1, D-28759 Bremen, Germany. E-mail: g.muskhelishvili@jacobs-university.de.	Afflerbach H, 1999, J MOL BIOL, V286, P339, DOI 10.1006/jmbi.1998.2494; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bladel I, 2013, FEMS MICROBIOL LETT, V340, P41, DOI 10.1111/1574-6968.12073; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Cerreta A, 2013, EUR POLYM J, V49, P1916, DOI 10.1016/j.eurpolymj.2013.03.026; Colby R.H., 2003, POLYM PHYS; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2013, BIOCHEM SOC T, V41, P542, DOI 10.1042/BST20120222; DORMAN CJ, 1990, NATURE, V344, P789, DOI 10.1038/344789a0; Duprey A, 2016, BBA-GENE REGUL MECH, V1859, P1470, DOI 10.1016/j.bbagrm.2016.08.001; DURRENBERGER M, 1991, RES MICROBIOL, V142, P373, DOI 10.1016/0923-2508(91)90106-K; Eijkelkamp BA, 2013, INFECT IMMUN, V81, P2574, DOI 10.1128/IAI.00065-13; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Japaridze A, 2016, MACROMOLECULES, V49, P643, DOI 10.1021/acs.macromol.5b01827; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kotlajich MV, 2015, ELIFE, V4, DOI 10.7554/eLife.04970; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; LAZARUS LR, 1993, EMBO J, V12, P2483, DOI 10.1002/j.1460-2075.1993.tb05903.x; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; LYUBCHENKO Y, 1993, P NATL ACAD SCI USA, V90, P2137, DOI 10.1073/pnas.90.6.2137; Madrid C, 2002, J BACTERIOL, V184, P5058, DOI 10.1128/JB.184.18.5058-5066.2002; Maurer S, 2009, J MOL BIOL, V387, P1261, DOI 10.1016/j.jmb.2009.02.050; Mikhaylov A., 2013, J ADV MICROSC RES, V8, P241, DOI [10.1166/jamr.2013.1164, DOI 10.1166/JAMR.2013.1164]; Mou XY, 2013, INFECT IMMUN, V81, P3566, DOI 10.1128/IAI.00506-13; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; OBYRNE CP, 1994, FEMS MICROBIOL LETT, V121, P99, DOI 10.1016/0378-1097(94)90152-X; Ouafa ZA, 2012, NUCLEIC ACIDS RES, V40, P4306, DOI 10.1093/nar/gks014; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; PORTER ME, 1994, J BACTERIOL, V176, P4187, DOI 10.1128/JB.176.13.4187-4191.1994; Reverchon S, 2013, ENV MICROBIOL REP, V5, P622, DOI 10.1111/1758-2229.12073; Rimsky S, 2001, MOL MICROBIOL, V42, P1311, DOI 10.1046/j.1365-2958.2001.02706.x; Rimsky S, 2011, CURR OPIN MICROBIOL, V14, P136, DOI 10.1016/j.mib.2011.01.003; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider R, 1997, MOL MICROBIOL, V26, P519, DOI 10.1046/j.1365-2958.1997.5951971.x; Schneider R, 2001, NUCLEIC ACIDS RES, V29, P5107, DOI 10.1093/nar/29.24.5107; Shin M, 2012, MOL MICROBIOL, V86, P707, DOI 10.1111/mmi.12012; Singh SS, 2014, GENE DEV, V28, P214, DOI 10.1101/gad.234336.113; SPURIO R, 1992, MOL GEN GENET, V231, P201, DOI 10.1007/BF00279792; Srinivasan R, 2013, MOL BIOSYST, V9, P2021, DOI 10.1039/c3mb70035f; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Travers AA, 2013, BIOCHEM SOC T, V41, P548, DOI 10.1042/BST20120334; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; van der Maarel JRC, 2016, SOFT MATTER, V12, P3636, DOI 10.1039/c5sm03076e; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Zhang C, 2013, SOFT MATTER, V9, P9593, DOI 10.1039/c3sm51214b; ZUBER F, 1994, MOL MICROBIOL, V12, P231, DOI 10.1111/j.1365-2958.1994.tb01012.x; Zwir I, 2014, MBIO, V5, DOI 10.1128/mBio.01485-14	56	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7607	7618		10.1074/jbc.M117.780239	http://dx.doi.org/10.1074/jbc.M117.780239			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28316324	Green Published, hybrid			2022-12-28	WOS:000400761300028
J	Jacobs, BL; McNally, RM; Kim, KJ; Blanco, R; Privett, RE; You, JS; Hornberger, TA				Jacobs, Brittany L.; McNally, Rachel M.; Kim, Kook-Joo; Blanco, Rocky; Privett, Rachel E.; You, Jae-Sung; Hornberger, Troy A.			Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE HYPERTROPHY; MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; ECCENTRIC CONTRACTIONS; PHOSPHATIDIC-ACID; TSC1-TSC2 COMPLEX; SCLEROSIS COMPLEX; 14-3-3 PROTEINS; GENE-PRODUCT; OLDER-ADULTS	Mechanistic target of rapamycin (mTOR) signaling is necessary to generate a mechanically induced increase in skeletal muscle mass, but the mechanism(s) through which mechanical stimuli regulate mTOR signaling remain poorly defined. Recent studies have suggested that Ras homologue enriched in brain (Rheb), a direct activator of mTOR, and its inhibitor, the GTPase-activating protein tuberin (TSC2), may play a role in this pathway. To address this possibility, we generated inducible and skeletal muscle-specific knock-out mice for Rheb (iRhebKO) and TSC2 (iTSC2KO) and mechanically stimulated muscles from these mice with eccentric contractions (EC). As expected, the knock-out of TSC2 led to an elevation in the basal level of mTOR signaling. Moreover, we found that the magnitude of the EC-induced activation of mTOR signaling was significantly blunted in muscles from both inducible and skeletal muscle-specific knock-out mice for Rheb and iTSC2KO mice. Using mass spectrometry, we identified six sites on TSC2 whose phosphorylation was significantly altered by the EC treatment. Employing a transient transfection-based approach to rescue TSC2 function in muscles of the iTSC2KO mice, we demonstrated that these phosphorylation sites are required for the role that TSC2 plays in the EC-induced activation of mTOR signaling. Importantly, however, these phosphorylation sites were not required for an insulin-induced activation of mTOR signaling. As such, our results not only establish a critical role for Rheb and TSC2 in the mechanical activation of mTOR signaling, but they also expose the existence of a previously unknown branch of signaling events that can regulate the TSC2/mTOR pathway.	[Jacobs, Brittany L.; McNally, Rachel M.; Kim, Kook-Joo; Blanco, Rocky; Privett, Rachel E.; You, Jae-Sung; Hornberger, Troy A.] Univ Wisconsin Madison, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA; [Jacobs, Brittany L.; McNally, Rachel M.; Kim, Kook-Joo; Blanco, Rocky; Privett, Rachel E.; You, Jae-Sung; Hornberger, Troy A.] Univ Wisconsin Madison, Sch Vet Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hornberger, TA (corresponding author), Univ Wisconsin Madison, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	troy.hornberger@wisc.edu	You, Jae-Sung/ABF-6763-2020	You, Jae-Sung/0000-0001-7791-8563	NIAMS; National Institutes of Health [AR057347]; Department of Defense [W81XWH-14-1-0105]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grant AR057347 and Department of Defense Grant W81XWH-14-1-0105 (to T. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apro W, 2015, FASEB J, V29, P4358, DOI 10.1096/fj.15-273474; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Frey JW, 2014, CELL SIGNAL, V26, P313, DOI 10.1016/j.cellsig.2013.11.009; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Hall MN, 2013, BIOCHEM SOC T, V41, P887, DOI 10.1042/BST20130092; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jacobs BL, 2014, J MUSCLE RES CELL M, V35, P11, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Langlais P, 2010, J AM SOC MASS SPECTR, V21, P1490, DOI 10.1016/j.jasms.2010.05.009; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Miyazaki M, 2010, FEBS J, V277, P2180, DOI 10.1111/j.1742-4658.2010.07635.x; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Pahor M, 1998, J Nutr Health Aging, V2, P97; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; You JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047258; You JS, 2014, J BIOL CHEM, V289, P1551, DOI 10.1074/jbc.M113.531392; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhang YJ, 2015, EBIOMEDICINE, V2, P1944, DOI 10.1016/j.ebiom.2015.11.031; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	61	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6987	6997		10.1074/jbc.M117.777805	http://dx.doi.org/10.1074/jbc.M117.777805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28289099	hybrid, Green Published			2022-12-28	WOS:000400478300011
J	Gillissen, B; Richter, A; Richter, A; Preissner, R; Schulze-Osthoff, K; Essmann, F; Daniel, PT				Gillissen, Bernhard; Richter, Anja; Richter, Antje; Preissner, Robert; Schulze-Osthoff, Klaus; Essmann, Frank; Daniel, Peter T.			Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-MEDIATED APOPTOSIS; HEPATOCELLULAR-CARCINOMA; BCL-2 FAMILY; CANCER-CELLS; CASPASE ACTIVATION; IN-VITRO; DEATH; PROTEIN; INHIBITION; RECEPTOR	Renal cell carcinoma (RCC) is polyresistant to chemo-and radiotherapy and biologicals, including TNF-related apoptosisinducing ligand (TRAIL). Sorafenib, a multikinase inhibitor approved for the treatment of RCC, has been shown to sensitize cancer cells to TRAIL-induced apoptosis, in particular by downregulation of the Bak-inhibitory Bcl-2 family protein Mcl-1. Here we demonstrate that sorafenib overcomes TRAIL resistance in RCC by a mechanism that does not rely on Mcl-1 downregulation. Instead, sorafenib induces rapid dissipation of the mitochondrial membrane potential (Delta psi m) that is accompanied by the accumulation of reactive oxygen species (ROS). Loss of Delta psi m and ROS production induced by sorafenib are independent of caspase activities and do not depend on the presence of the proapoptotic Bcl-2 family proteins Bax or Bak, indicating that both events are functionally upstream of the mitochondrial apoptosis signaling cascade. More intriguingly, we find that it is sorafenib-induced ROS accumulation that enables TRAIL to activate caspase-8 in RCC. This leads to apoptosis that involves activation of an amplification loop via the mitochondrial apoptosis pathway. Thus, our mechanistic data indicate that sorafenib bypasses central resistance mechanisms through a direct induction of Delta psi m breakdown and ROS production. Activation of this pathway might represent a useful strategy to overcome the cell-inherent resistance to cancer therapeutics, including TRAIL, in multiresistant cancers such as RCC.	[Gillissen, Bernhard; Richter, Anja; Richter, Antje; Daniel, Peter T.] Humboldt Univ, Univ Med Ctr Charite, Dept Hematol Oncol & Tumor Immunol, Campus Berlin Buch, Berlin, Germany; [Gillissen, Bernhard; Richter, Anja; Schulze-Osthoff, Klaus; Essmann, Frank; Daniel, Peter T.] German Canc Consortium, D-69120 Heidelberg, Germany; [Gillissen, Bernhard; Richter, Anja; Schulze-Osthoff, Klaus; Essmann, Frank; Daniel, Peter T.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Daniel, Peter T.] Max Delbruck Ctr Mol Med, Clin & Mol Oncol, D-13125 Berlin, Germany; [Schulze-Osthoff, Klaus; Essmann, Frank] Univ Tubingen, Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany; [Preissner, Robert] Univ Med Ctr Charite, Inst Physiol, D-13125 Berlin, Germany; [Preissner, Robert] Univ Med Ctr Charite, Expt Clin Res Ctr, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daniel, PT (corresponding author), Univ Med Ctr Charite, Clin & Mol Oncol, Lindenberger Weg 80, D-13125 Berlin, Germany.; Daniel, PT (corresponding author), Max Delbruck Ctr Mol Med, Lindenberger Weg 80, D-13125 Berlin, Germany.	pdaniel@mdc-berlin.de	Essmann, Frank/ABG-7409-2020; Schulze-Osthoff, Klaus/N-9025-2013	Essmann, Frank/0000-0003-4369-8456; Schulze-Osthoff, Klaus/0000-0003-1443-2720; preissner, robert/0000-0002-2407-1087; Gillissen, Bernhard/0000-0002-1815-2091	Stiftung Urologische Forschung Berlin; Deutsche Krebshilfe; Deutsches Konsortium fur Translationale Krebsforschung (DKTK) - Deutsches Krebsforschungszentrum	Stiftung Urologische Forschung Berlin; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Konsortium fur Translationale Krebsforschung (DKTK) - Deutsches Krebsforschungszentrum	This work was supported by the Stiftung Urologische Forschung Berlin, Deutsche Krebshilfe, and Deutsches Konsortium fur Translationale Krebsforschung (DKTK) - Deutsches Krebsforschungszentrum. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulghani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075414; Bender T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011106; Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Bracarda S, 2007, ANN ONCOL, V18, P22, DOI 10.1093/annonc/mdm219; Brooks AD, 2010, MOL CANCER RES, V8, P729, DOI 10.1158/1541-7786.MCR-10-0022; Bull VH, 2012, J PROTEOME RES, V11, P1609, DOI 10.1021/pr200790e; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen KF, 2013, BRIT J PHARMACOL, V168, P658, DOI 10.1111/j.1476-5381.2012.02212.x; Chen KF, 2010, CLIN CANCER RES, V16, P5189, DOI 10.1158/1078-0432.CCR-09-3389; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Coriat R, 2012, MOL CANCER THER, V11, P2284, DOI 10.1158/1535-7163.MCT-12-0093; Daniel PT, 2003, ESSAYS BIOCHEM, V39, P73, DOI 10.1042/bse0390073; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; Gillissen B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.67; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hemmati PG, 2010, J MOL MED, V88, P609, DOI 10.1007/s00109-010-0606-5; Hoffmann JC, 2009, MOL CELL BIOL, V29, P4431, DOI 10.1128/MCB.02261-07; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Keane MM, 2000, BREAST CANCER RES TR, V64, P211, DOI 10.1023/A:1006458407515; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuo YC, 2012, BIOMED PHARMACOTHER, V66, P12, DOI 10.1016/j.biopha.2011.09.011; Laukens B, 2011, NEOPLASIA, V13, P971, DOI 10.1593/neo.11610; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marini P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-5; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; Nojiri K, 2013, INT J ONCOL, V42, P101, DOI 10.3892/ijo.2012.1676; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Park GB, 2014, INT J ONCOL, V44, P977, DOI 10.3892/ijo.2014.2252; Perez-Cruz I, 2007, APOPTOSIS, V12, P225, DOI 10.1007/s10495-006-0475-0; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schenk B, 2015, ONCOGENE, V34, P5796, DOI 10.1038/onc.2015.35; Schmelz K, 2004, ONCOGENE, V23, P6743, DOI 10.1038/sj.onc.1207848; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wang C, 2012, COMMUN ASSOC INF SYS, V31, P105; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Yamada H, 1999, BIOCHEM BIOPH RES CO, V265, P130, DOI 10.1006/bbrc.1999.1641; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	57	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6478	6492		10.1074/jbc.M116.754184	http://dx.doi.org/10.1074/jbc.M116.754184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28154184	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000399813400006
J	Liang, T; Dolai, S; Xie, L; Winter, E; Orabi, AI; Karimian, N; Cosen-Binker, LI; Huang, YC; Thorn, P; Cattral, MS; Gaisano, HY				Liang, Tao; Dolai, Subhankar; Xie, Li; Winter, Erin; Orabi, Abrahim I.; Karimian, Negar; Cosen-Binker, Laura I.; Huang, Ya-Chi; Thorn, Peter; Cattral, Mark S.; Gaisano, Herbert Y.			Ex vivo human pancreatic slice preparations offer a valuable model for studying pancreatic exocrine biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; confocal microscopy; exocytosis; pancreas; receptor; CCK-8; CCK-A; B Receptor; carbachol; human exocrine pancreas	ACINAR-CELLS; BASOLATERAL EXOCYTOSIS; ALPHA-CELLS; IN-VITRO; CHOLECYSTOKININ; TRYPSINOGEN; ACTIVATION; RECEPTORS; SECRETION; EXPRESSION	A genuine understanding of human exocrine pancreas biology and pathobiology has been hampered by a lack of suitable preparations and reliance on rodent models employing dispersed acini preparations. We have developed an organotypic slice preparation of the normal portions of human pancreas obtained from cancer resections. The preparation was assessed for physiologic and pathologic responses to the cholinergic agonist carbachol (Cch) and cholecystokinin (CCK-8), including 1) amylase secretion, 2) exocytosis, 3) intracellular Ca2+ responses, 4) cytoplasmic autophagic vacuole formation, and 5) protease activation. Cch and CCK-8 both dose-dependently stimulated secretory responses from human pancreas slices similar to those previously observed in dispersed rodent acini. Confocal microscopy imaging showed that these responses were accounted for by efficient apical exocytosis at physiologic doses of both agonists and by apical blockade and redirection of exocytosis to the basolateral plasma membrane at supramaximal doses. The secretory responses and exocytotic events evoked by CCK-8 were mediated by CCK-A and not CCK-B receptors. Physiologic agonist doses evoked oscillatory Ca2+ increases across the acini. Supraphysiologic doses induced formation of cytoplasmic autophagic vacuoles and activation of proteases (trypsin, chymotrypsin). Maximal atropine pretreatment that completely blocked all the Cch-evoked responses did not affect any of the CCK-8-evoked responses, indicating that rather than acting on the nerves within the pancreas slice, CCK cellular actions directly affected human acinar cells. Human pancreas slices represent excellent preparations to examine pancreatic cell biology and pathobiology and could help screen for potential treatments for human pancreatitis.	[Liang, Tao; Dolai, Subhankar; Xie, Li; Karimian, Negar; Cosen-Binker, Laura I.; Huang, Ya-Chi; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Med Sci Bldg,Rm 7368,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Winter, Erin; Cattral, Mark S.] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2N2, Canada; [Orabi, Abrahim I.] Childrens Hosp Pittsburgh UPMC, Rangos Res Ctr, Pittsburgh, PA 15224 USA; [Thorn, Peter] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2050, Australia	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, Med Sci Bldg,Rm 7368,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca	Thorn, peter/F-7030-2010	Thorn, peter/0000-0002-3228-770X; Huang, Ya-Chi/0000-0001-5168-1174	Canadian Institute of Health Research Grant [MOP119352]; Canadian Foundation for Innovation and Ontario Research Fund [19442]	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation and Ontario Research Fund	This work was supported by Canadian Institute of Health Research Grant MOP119352 and an equipment grant to the 3D Centre from the Canadian Foundation for Innovation and Ontario Research Fund #19442. The authors declare that they have no conflicts of interest with the contents of this article.	AMSTERDA.A, 1974, J CELL BIOL, V63, P1037, DOI 10.1083/jcb.63.3.1037; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Cosen-Binker LI, 2007, GASTROENTEROLOGY, V132, P1527, DOI 10.1053/j.gastro.2007.01.042; Dolai S, 2012, GASTROENTEROLOGY, V143, P832, DOI 10.1053/j.gastro.2012.06.011; El-Kouhen K, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/875167; El-Kouhen K, 2010, PANCREAS, V39, P127, DOI 10.1097/MPA.0b013e3181bea475; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Gaisano HY, 2001, J CLIN INVEST, V108, P1597; Galindo J, 2005, PANCREAS, V31, P325, DOI 10.1097/01.mpa.0000181487.50269.dc; Gonzalez-Puga C, 2005, J PINEAL RES, V39, P243, DOI 10.1111/j.1600-079X.2005.00239.x; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hartwig W, 1999, GASTROENTEROLOGY, V117, P717, DOI 10.1016/S0016-5085(99)70466-X; Huang YC, 2013, DIABETES, V62, P519, DOI 10.2337/db11-0786; Huang YC, 2011, ISLETS, V3, P139, DOI 10.4161/isl.3.4.16166; Huang YC, 2011, J PHYSIOL-LONDON, V589, P395, DOI 10.1113/jphysiol.2010.200345; Ji B, 2001, GASTROENTEROLOGY, V121, P1380, DOI 10.1053/gast.2001.29557; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Low JT, 2010, J CELL SCI, V123, P3201, DOI 10.1242/jcs.071225; Marciniak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078706; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Miyasaka K, 2002, PANCREAS, V25, P161, DOI 10.1097/00006676-200208000-00008; Morisset J, 2003, J HISTOCHEM CYTOCHEM, V51, P1501, DOI 10.1177/002215540305101110; Murphy JA, 2008, GASTROENTEROLOGY, V135, P632, DOI 10.1053/j.gastro.2008.05.026; NIEDERAU C, 1988, J CLIN INVEST, V81, P229, DOI 10.1172/JCI113300; Nishimori I, 1999, PANCREAS, V19, P109, DOI 10.1097/00006676-199908000-00001; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; Phillips PA, 2010, P NATL ACAD SCI USA, V107, P17397, DOI 10.1073/pnas.1000359107; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Saluja A, 2008, GASTROENTEROLOGY, V135, P357, DOI 10.1053/j.gastro.2008.06.066; Saluja AK, 2013, GASTROENTEROLOGY, V144, P1194, DOI 10.1053/j.gastro.2013.01.070; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Shin DM, 2001, J BIOL CHEM, V276, P44146, DOI 10.1074/jbc.M105203200; Susini C, 1986, Pancreas, V1, P124; Tang CW, 1996, GASTROENTEROLOGY, V111, P1621, DOI 10.1016/S0016-5085(96)70025-2; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c	37	35	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5957	5969		10.1074/jbc.M117.777433	http://dx.doi.org/10.1074/jbc.M117.777433			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28242761	Green Published, hybrid			2022-12-28	WOS:000398813200029
J	Bas-Orth, C; Tan, YW; Lau, D; Bading, H				Bas-Orth, Carlos; Tan, Yan-Wei; Lau, David; Bading, Hilmar			Synaptic Activity Drives a Genomic Program That Promotes a Neuronal Warburg Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; AEROBIC GLYCOLYSIS; GENE-EXPRESSION; BRAIN-FUNCTION; CANCER-CELLS; METABOLISM; CALCIUM; DEATH; GLUCOSE; PHOSPHORYLATION	Synaptic activity drives changes in gene expression to promote long lasting adaptations of neuronal structure and function. One example of such an adaptive response is the buildup of acquired neuroprotection, a synaptic activity-and gene transcription-mediated increase in the resistance of neurons against harmful conditions. A hallmark of acquired neuroprotection is the stabilization of mitochondrial structure and function. We therefore re-examined previously identified sets of synaptic activity-regulated genes to identify genes that are directly linked to mitochondrial function. In mouse and rat primary hippocampal cultures, synaptic activity caused an up-regulation of glycolytic genes and a concomitant down-regulation of genes required for oxidative phosphorylation, mitochondrial biogenesis, and maintenance. Changes in metabolic gene expression were induced by action potential bursting, but not by glutamate bath application activating extrasynaptic NMDA receptors. The specific and coordinate pattern of gene expression changes suggested that synaptic activity promotes a shift of neuronal energy metabolism from oxidative phosphorylation toward aerobic glycolysis, also known as the Warburg effect. The ability of neurons to up-regulate glycolysis has, however, been debated. We therefore used FACS sorting to show that, in mixed neuron glia co-cultures, activity-dependent regulation of metabolic gene expression occurred in neurons. Changes in gene expression were accompanied by changes in the phosphorylation-dependent regulation of the key metabolic enzyme, pyruvate dehydrogenase. Finally, increased synaptic activity caused an increase in the ratio of L-lactate production to oxygen consumption in primary hippocampal cultures. Based on these data we suggest the existence of a synaptic activity-mediated neuronal Warburg effect that may promote mitochondrial homeostasis and neuroprotection.	[Bas-Orth, Carlos; Tan, Yan-Wei; Lau, David; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany; [Tan, Yan-Wei] Univ Basel, Dept Biomed, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	Ruprecht Karls University Heidelberg; University of Basel	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Bading@nbio.uni-heidelberg.de		Bas Orth, Carlos/0000-0002-6037-8350	ERC Advanced Grant; German Ministry of Education and Research [1134, 01GQ1003A]; German-Israeli Project Cooperation Grant [SE 2372/1-1]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology of Heidelberg University	ERC Advanced Grant; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German-Israeli Project Cooperation Grant; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology of Heidelberg University	This work was supported by an ERC Advanced Grant (to H.B.), Sonderforschungsbereich Grant 1134, German Ministry of Education and Research Grant 01GQ1003A, German-Israeli Project Cooperation Grant SE 2372/1-1, and funds from the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology of Heidelberg University. The authors declare that they have no conflicts of interest with the contents of this article.	BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Banker G., 1998, CULTURING NERVE CELL, P357; Bas-Orth C, 2013, MECH DEVELOP, V130, P396, DOI 10.1016/j.mod.2012.09.008; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Dienel GA, 2016, J NEUROCHEM, V138, P14, DOI 10.1111/jnc.13630; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Galow Lukas V, 2014, Front Neurosci, V8, P398, DOI 10.3389/fnins.2014.00398; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hai T, 1999, GENE EXPRESSION, V7, P321; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; Magistretti PJ, 2016, P NATL ACAD SCI USA, V113, P7015, DOI 10.1073/pnas.1607423113; Mangia S, 2011, J CEREBR BLOOD F MET, V31, P1346, DOI 10.1038/jcbfm.2011.29; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195; Newington JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019191; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Sun JH, 2016, J ETHNOPHARMACOL, V187, P249, DOI 10.1016/j.jep.2016.04.034; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tadi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141568; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	47	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5183	5194		10.1074/jbc.M116.761106	http://dx.doi.org/10.1074/jbc.M116.761106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196867	hybrid, Green Published			2022-12-28	WOS:000397875500003
J	Glasser, NR; Wang, BX; Hoy, JA; Newman, DK				Glasser, Nathaniel R.; Wang, Benjamin X.; Hoy, Julie A.; Newman, Dianne K.			The Pyruvate and alpha-Ketoglutarate Dehydrogenase Complexes of Pseudomonas aeruginosa Catalyze Pyocyanin and Phenazine-1-carboxylic Acid Reduction via the Subunit Dihydrolipoamide Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOAMIDE DEHYDROGENASE; SECONDARY METABOLISM; ANAEROBIC SURVIVAL; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; REDOX; BIOSYNTHESIS; FLUORESCENS; EXPRESSION; GLUTATHIONE	Phenazines are a class of redox-active molecules produced by diverse bacteria and archaea. Many of the biological functions of phenazines, such as mediating signaling, iron acquisition, and redox homeostasis, derive from their redox activity. Although prior studies have focused on extracellular phenazine oxidation by oxygen and iron, here we report a search for reductants and catalysts of intracellular phenazine reduction in Pseudomonas aeruginosa. Enzymatic assays in cell-free lysate, together with crude fractionation and chemical inhibition, indicate that P. aeruginosa contains multiple enzymes that catalyze the reduction of the endogenous phenazines pyocyanin and phenazine-1-carboxylic acid in both cytosolic and membrane fractions. We used chemical inhibitors to target general enzyme classes and found that an inhibitor of flavoproteins and heme-containing proteins, diphenyleneiodonium, effectively inhibited phenazine reduction in vitro, suggesting that most phenazine reduction derives from these enzymes. Using natively purified proteins, we demonstrate that the pyruvate and pi-ketoglutarate dehydrogenase complexes directly catalyze phenazine reduction with pyruvate or alpha-ketoglutarate as electron donors. Both complexes transfer electrons to phenazines through the common subunit dihydrolipoamide dehydrogenase, a flavoprotein encoded by the gene lpdG. Although we were unable to co-crystallize LpdG with an endogenous phenazine, we report its X-ray crystal structure in the apo-form (refined to 1.35 angstrom), bound to NAD(+) (1.45 angstrom), and bound to NADH(1.79 angstrom). In contrast to the notion that phenazines support intracellular redox homeostasis by oxidizing NADH, our work suggests that phenazines may substitute for NAD(+) in LpdG and other enzymes, achieving the same end by a different mechanism.	[Glasser, Nathaniel R.; Wang, Benjamin X.; Hoy, Julie A.; Newman, Dianne K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Newman, DK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu		Wang, Benjamin/0000-0002-5270-6043	Howard Hughes Medical Institute; National Institutes of Health [5R01HL117328-03]; National Science Foundation [1144469]; Amgen Scholars Program; National Science Foundation Graduate Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117328] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Amgen Scholars Program(Amgen); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Howard Hughes Medical Institute, National Institutes of Health Grant 5R01HL117328-03, National Science Foundation Grant 1144469, and the Amgen Scholars Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a National Science Foundation Graduate Research Fellowship.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ARMSTRONG AV, 1971, J MED MICROBIOL, V4, P263, DOI 10.1099/00222615-4-2-263; Babin BM, 2016, P NATL ACAD SCI USA, V113, pE597, DOI 10.1073/pnas.1514412113; Berkholz DS, 2008, J MOL BIOL, V382, P371, DOI 10.1016/j.jmb.2008.06.083; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; BURNS G, 1989, J BACTERIOL, V171, P665, DOI 10.1128/jb.171.2.665-668.1989; Carter DE, 2003, TOXICOL APPL PHARM, V193, P309, DOI 10.1016/j.taap.2003.07.009; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Corran HS, 1939, BIOCHEM J, V33, P793, DOI 10.1042/bj0330793; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; Das T., 2016, MICROB BIOFILMS IMPO, V13, P23, DOI [10.5772/63497, DOI 10.5772/63497]; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Elema B, 1931, RECL TRAV CHIM PAY-B, V50, P807; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Friedheim E, 1931, J BIOL CHEM, V91, P355; Friedheim EAH, 1934, BIOCHEM J, V28, P173, DOI 10.1042/bj0280173; FRIEDHEIM ERNST A. H., 1931, JOUR EXP MED, V54, P207, DOI 10.1084/jem.54.2.207; Gessard C., 1882, THESIS; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; GRUYS KJ, 1989, BIOCHEMISTRY-US, V28, P9071, DOI 10.1021/bi00449a018; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; HERBERT RB, 1969, J CHEM SOC C, P2517, DOI 10.1039/j39690002517; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; HOLLIMAN FG, 1969, J CHEM SOC C, P2514, DOI 10.1039/j39690002514; HOLLSTEIN U, 1971, BIOCHEMISTRY-US, V10, P497, DOI 10.1021/bi00779a023; Huang JF, 2012, APPL ENVIRON MICROB, V78, P5016, DOI 10.1128/AEM.00026-12; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; JEYASEELAN K, 1980, J GEN MICROBIOL, V120, P393; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kasozi DM, 2011, REDOX REP, V16, P154, DOI 10.1179/174329211X13049558293678; Kern S. E., 2013, THESIS; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MATTEVI A, 1992, PROTEINS, V13, P336, DOI 10.1002/prot.340130406; MATTEVI A, 1993, J MOL BIOL, V230, P1200, DOI 10.1006/jmbi.1993.1236; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald M, 2001, J AM CHEM SOC, V123, P9459, DOI 10.1021/ja011243+; Michaelis L, 1931, J BIOL CHEM, V92, P211; Morales DK, 2010, MOL MICROBIOL, V78, P1379, DOI 10.1111/j.1365-2958.2010.07414.x; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; PATEL MS, 1995, METHOD ENZYMOL, V252, P186; Petrova OE, 2012, MOL MICROBIOL, V86, P819, DOI 10.1111/mmi.12018; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A. M., 2009, THESIS; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; SAHLMAN L, 1989, J BIOL CHEM, V264, P8039; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sullivan NL, 2011, ACS CHEM BIOL, V6, P893, DOI 10.1021/cb200094w; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227	72	14	14	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5593	5607		10.1074/jbc.M116.772848	http://dx.doi.org/10.1074/jbc.M116.772848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28174304	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000397875500037
J	Lu, JH; Guo, SY; Xue, XL; Chen, Q; Ge, J; Zhuo, YJ; Zhong, HQ; Chen, BX; Zhao, MM; Han, W; Suzuki, T; Zhu, MJ; Xia, L; Schneider, C; Blackwell, TS; Porter, NA; Zheng, LM; Tsimikas, S; Yin, HY				Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Ge, Jing; Zhuo, Yujuan; Zhong, Huiqin; Chen, Buxing; Zhao, Mingming; Han, Wei; Suzuki, Takashi; Zhu, Mingjiang; Xia, Lin; Schneider, Claus; Blackwell, Timothy S.; Porter, Ned A.; Zheng, Lemin; Tsimikas, Sotirios; Yin, Huiyong			Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; OXIDIZED PHOSPHOLIPIDS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); STRUCTURAL IDENTIFICATION; MASS-SPECTROMETRY; MACROPHAGES; PATHWAY; INFLAMMATION; GENERATION	Oxidative stress and inflammation are two major contributing factors to atherosclerosis, a leading cause of cardiovascular disease. Oxidation of phospholipids on the surface of low density lipoprotein (LDL) particles generated under oxidative stress has been associated with the progression of atherosclerosis, but the underlying molecular mechanisms remain poorly defined. We identified a novel series of oxidation products containing the cyclopentenone moiety, termed deoxy-A(2)/J(2)-isoprostanesphosphocholine, from 1-palmitoyl-2-arachidonoyl-sn-glycero3- phosphocholine in vivo using mass spectrometry and by comparison to a chemically synthesized standard. Transcriptomic analysis (RNA-seq) demonstrated that these compounds affected > 200 genes in bone marrow-derived macrophages, and genes associated with inflammatory and anti-oxidative responses are among the top 5 differentially expressed. To further investigate the biological relevance of these novel oxidized phospholipids in atherosclerosis, we chemically synthesized a representative compound 1-palmitoyl-2-15-deoxy-delta-12,14prostaglandin J(2)-sn-glycero-3-phosphocholine (15d-PGJ(2)-PC) and found that it induced anti-inflammatory and anti-oxidant responses in macrophages through modulation of NF-kappa B, peroxisome proliferator-activated receptor gamma (PPAR gamma), and Nrf2 pathways; this compound also showed potent anti-inflammatory properties in a mice model of LPS-induced systematic inflammatory response syndrome. Additionally, 15d-PGJ(2)-PC inhibited macrophage foam cell formation, suggesting a beneficial role against atherosclerosis. These properties were consistent with decreased levels of these compounds in the plasma of patients with coronary heart disease compared with control subjects. Our findings uncovered a novel molecular mechanism for the negative regulation of inflammation and positive enhancement of anti-oxidative responses in macrophages by these oxidized phospholipids in LDL in the context of atherosclerosis.	[Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Zhuo, Yujuan; Zhong, Huiqin; Zhu, Mingjiang; Xia, Lin; Yin, Huiyong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China; [Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Zhuo, Yujuan; Zhong, Huiqin; Yin, Huiyong] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Zhuo, Yujuan; Zhong, Huiqin; Zhu, Mingjiang; Xia, Lin; Yin, Huiyong] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100000, Peoples R China; [Guo, Shuyuan; Zhuo, Yujuan; Yin, Huiyong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Ge, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Chen, Buxing] Capital Med Univ, Beijing Tiantan Hosp, Dept Cardiol, Beijing 100050, Peoples R China; [Zhao, Mingming; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Beijing 100191, Peoples R China; [Zhao, Mingming; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Sch Basic Med Sci,Key Lab Mol Cardiovasc Sci,Mini, Beijing 100191, Peoples R China; [Han, Wei; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Suzuki, Takashi; Schneider, Claus] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Dept Vet Affairs, Nashville, TN 37232 USA; [Porter, Ned A.] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Tsimikas, Sotirios] Univ Calif San Diego, Sulpizio Cardiovasc Ctr, Dept Med, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Capital Medical University; Peking University; Peking University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Yin, HY (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Rm 1826,New Life Sci Bldg,320 Yueyang Rd, Shanghai 200031, Peoples R China.	hyyin@sibs.ac.cn		yin, hui yong/0000-0001-7049-1560	National Natural Science Foundation of China [31470831, 91439103, 91539127, 21402221, 31170809, 31671231]; Ministry of Science and Technology of China [2016YFC0903403, 2016YFD0400205, 2012CB524905]; Hundred Talents Program from the Chinese Academy of Sciences [2012OHTP07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hundred Talents Program from the Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Natural Science Foundation of China (31470831, 91439103, 91539127, 21402221, 31170809, and 31671231), Ministry of Science and Technology of China (2016YFC0903403, 2016YFD0400205, and 2012CB524905), and Hundred Talents Program from the Chinese Academy of Sciences (2012OHTP07). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Bochkov VN, 2007, THROMB HAEMOSTASIS, V97, P348, DOI 10.1160/TH06-08-0474; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bretscher P, 2015, EMBO MOL MED, V7, P593, DOI 10.15252/emmm.201404702; Brown HA, 2011, CHEM REV, V111, P5817, DOI 10.1021/cr200363s; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen B, 2016, VASC PHARMACOL, V85, P1, DOI 10.1016/j.vph.2015.08.012; Davies SS, 2004, CHEM PHYS LIPIDS, V128, P85, DOI 10.1016/j.chemphyslip.2003.10.007; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hardy KD, 2011, J LIPID RES, V52, P113, DOI 10.1194/jlr.M010264; Harmon GS, 2011, CHEM REV, V111, P6321, DOI 10.1021/cr2001355; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Lin CS, 2012, CARDIOVASC RES, V95, P346, DOI 10.1093/cvr/cvs189; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Mendis S, 2015, STROKE, V46, pE121, DOI 10.1161/STROKEAHA.115.008097; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Ravandi A, 2004, LIPIDS, V39, P97, DOI 10.1007/s11745-004-1207-5; Ravandi A, 2014, J AM COLL CARDIOL, V63, P1961, DOI 10.1016/j.jacc.2014.01.055; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Salomon RG, 2012, CIRC RES, V111, P930, DOI 10.1161/CIRCRESAHA.112.275388; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Seno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025541; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yin HY, 2013, MITOCHONDRION, V13, P209, DOI 10.1016/j.mito.2012.10.003; Yin HY, 2009, J MASS SPECTROM, V44, P672, DOI 10.1002/jms.1542; Yin HY, 2005, ANTIOXID REDOX SIGN, V7, P170, DOI 10.1089/ars.2005.7.170; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006; Yu ZY, 2007, LIPIDS, V42, P491, DOI 10.1007/s11745-007-3054-4	47	25	28	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5378	5391		10.1074/jbc.M116.751909	http://dx.doi.org/10.1074/jbc.M116.751909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202546	Green Published, hybrid			2022-12-28	WOS:000397875500019
J	Gatla, HR; Zou, Y; Uddin, MM; Singha, B; Bu, PL; Vancura, A; Vancurova, I				Gatla, Himavanth R.; Zou, Yue; Uddin, Mohammad M.; Singha, Bipradeb; Bu, Pengli; Vancura, Ales; Vancurova, Ivana			Histone Deacetylase (HDAC) Inhibition Induces IkB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; SMALL INTERFERING RNA; EPITHELIAL OVARIAN; GROWTH-FACTOR; UP-REGULATION; APOPTOSIS; RECEPTOR; ACETYLATION; INCREASES	Overexpression of the pro-angiogenic chemokine IL-8 (CXCL8) is associated with a poor prognosis in several solid tumors, including epithelial ovarian cancer (EOC). Even though histone deacetylase (HDAC) inhibition has shown remarkable antitumor activity in hematological malignancies, it has been less effective in solid tumors, including EOC. Here we report results that may explain the decreased efficiency of HDAC inhibition in EOC, based on our data demonstrating that HDAC inhibition specifically induces expression of IL-8/CXCL8 in SKOV3, CAOV3, andOVCAR3cells. Suppression or neutralization of vorinostat-induced IL-8/CXCL8 potentiates the vorinostat inhibitory effect on cell viability and proliferation. The IL-8/CXCL8 expression induced by vorinostat in EOC cells is dependent on IkB kinase (IKK) activity and associated with a gene-specific recruitment of IKK beta and IKK-dependent recruitment of p65 NFkB to the IL-8/CXCL8 promoter. In addition, HDACinhibition induces acetylation of p65 and histone H3 and their IL-8/CXCL8 promoter occupancy. In vivo results demonstrate that combining vorinostat and the IKK inhibitor Bay 117085 significantly reduces tumor growth in nude mice compared with control untreated mice or either drug alone. Mice in the combination group had the lowest IL-8/CXCL8 tumor levels and the lowest tumor expression of the murine neutrophil [7/4] antigen, indicating reduced neutrophil infiltration. Together, our results demonstrate that HDAC inhibition specifically induces IL-8/CXCL8 expression in EOC cells and that the mechanism involves IKK, suggesting that using IKK inhibitors may increase the effectiveness of HDAC inhibitors when treating ovarian cancer and other solid tumors characterized by increased IL-8/CXCL8 expression.	[Gatla, Himavanth R.; Zou, Yue; Uddin, Mohammad M.; Bu, Pengli; Vancura, Ales; Vancurova, Ivana] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA; [Singha, Bipradeb] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Saint John's University; The Wistar Institute	Vancurova, I (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	vancuroi@stjohns.edu	Gatla, Himavanth/AAP-7955-2021; Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; zou, yue/0000-0002-6999-8329; Vancura, Ales/0000-0002-5895-1218	St.John's University; National Institutes of Health [CA173452, CA202775]; NATIONAL CANCER INSTITUTE [R15CA173452, R15CA202775] Funding Source: NIH RePORTER	St.John's University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by St. John's University and by National Institutes of Health Grants CA173452 and CA202775 (to I. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Campbell LM, 2013, PHARMACEUTICALS, V6, P929, DOI 10.3390/ph6080929; CERRETTI DP, 1993, GENOMICS, V18, P410, DOI 10.1006/geno.1993.1486; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Galdieri L, 2016, J BIOL CHEM, V291, P25154, DOI 10.1074/jbc.M116.742247; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; Grassadonia Antonino, 2013, Cancers (Basel), V5, P919, DOI 10.3390/cancers5030919; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang S, 2000, CANCER RES, V60, P5334; Ivarsson K, 2000, ACTA OBSTET GYN SCAN, V79, P777, DOI 10.1034/j.1600-0412.2000.079009777.x; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Khabele D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00111; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matulonis U, 2015, CANCER CHEMOTH PHARM, V76, P417, DOI 10.1007/s00280-015-2813-9; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Natoli G, 2012, IMMUNOL REV, V246, P183, DOI 10.1111/j.1600-065X.2012.01103.x; Nomiyama H, 2010, CYTOKINE GROWTH F R, V21, P253, DOI 10.1016/j.cytogfr.2010.03.004; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Randall BK, 2004, SURGERY, V136, P416, DOI 10.1016/j.surg.2004.05.018; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Sanacora S, 2015, BIOCHEM BIOPH RES CO, V460, P375, DOI 10.1016/j.bbrc.2015.03.041; Singha B, 2015, ONCOTARGET, V6, P26347, DOI [10.18632/oncotarget.4713, 10.18632/oncotarget.4613]; Singha B, 2015, BIOMOLECULES, V5, P223, DOI 10.3390/biom5010223; Singha B, 2014, J BIOL CHEM, V289, P2687, DOI 10.1074/jbc.M113.502641; Sonnemann J, 2008, ONCOL REP, V20, P219; Strait KA, 2005, MOL CANCER THER, V4, P603, DOI 10.1158/1535-7163.MCT-04-0107; Stronach EA, 2015, ONCOTARGET, V6, P31593, DOI 10.18632/oncotarget.3415; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Takai N, 2010, J ONCOL, V2010, DOI 10.1155/2010/458431; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang Y, 2005, CELL MOL IMMUNOL, V2, P365; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wilson AJ, 2011, CANCER BIOL THER, V12, P484, DOI 10.4161/cbt.12.6.15956; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x	61	29	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5043	5054		10.1074/jbc.M116.771014	http://dx.doi.org/10.1074/jbc.M116.771014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28167529	Green Published, hybrid			2022-12-28	WOS:000397590400025
J	Carman, G; Taylor, A				Carman, George; Taylor, Alexandra			Masochistic Enzymology: Dennis Vance's Work on Phosphatidylcholine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Carman, George] Rutgers State Univ, New Brunswick, NJ USA; [Taylor, Alexandra] Johns Hopkins Univ, Sci & Med Writing, Baltimore, MD 21218 USA	Rutgers State University New Brunswick; Johns Hopkins University	Taylor, A (corresponding author), Johns Hopkins Univ, Sci & Med Writing, Baltimore, MD 21218 USA.	alexandraataylor@gmail.com			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM028140] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4753	4754		10.1074/jbc.O117.000002	http://dx.doi.org/10.1074/jbc.O117.000002			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28314776	hybrid, Green Published			2022-12-28	WOS:000397585100030
J	Goth, CK; Tuhkanen, HE; Khan, H; Lackman, JJ; Wang, SJ; Narimatsu, Y; Hansen, LH; Overall, CM; Clausen, H; Schjoldager, KT; Petaja-Repo, UE				Goth, Christoffer K.; Tuhkanen, Hanna E.; Khan, Hamayun; Lackman, Jarkko J.; Wang, Shengjun; Narimatsu, Yoshiki; Hansen, Lasse H.; Overall, Christopher M.; Clausen, Henrik; Schjoldager, Katrine T.; Petaja-Repo, Ulla E.			Site-specific O-Glycosylation by Polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates beta(1)- Adrenergic Receptor N-terminal Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA(1)-ADRENERGIC RECEPTOR; SUBSTRATE SPECIFICITIES; ENDOPLASMIC-RETICULUM; LINKED GLYCOSYLATION; QUALITY-CONTROL; IN-VIVO; IDENTIFICATION; ECTODOMAIN; BINDING; METALLOPROTEINASES	The beta(1)-adrenergic receptor (beta(1)AR) is a G protein-coupled receptor (GPCR) and the predominant adrenergic receptor subtype in the heart, where it mediates cardiac contractility and the force of contraction. Although it is the most important target for beta(1)-adrenergic antagonists, such as beta(1)-blockers, relatively little is yet known about its regulation. We have shown previously that beta(1)AR undergoes constitutive and regulated N-terminal cleavage participating in receptor down-regulation and, moreover, that the receptor is modified by O-glycosylation. Here we demonstrate that the polypeptide GalNAc-transferase 2 (GalNAcT2) specifically O-glycosylates beta(1)AR at five residues in the extracellular N terminus, including the Ser-49 residue at the location of the common S49G single-nucleotide polymorphism. Using in vitro O-glycosylation and proteolytic cleavage assays, a cell line deficient in O-glycosylation, GalNAc-T-edited cell line model systems, and a GalNAc-T2 knock-out rat model, we show that GalNAc-T2 co-regulates the metalloproteinase-mediated limited proteolysis of beta(1)AR. Furthermore, we demonstrate that impaired O-glycosylation and enhanced proteolysis lead to attenuated receptor signaling, because the maximal response elicited by the beta(1)AR agonist isoproterenol and its potency in a cAMPaccumulation assay were decreased in HEK293 cells lacking GalNAc-T2. Our findings reveal, for the first time, aGPCRas a target for co-regulatory functions of site-specific O-glycosylation mediated by a unique GalNAc-T isoform. The results provide a new level of beta(1)AR regulation that may open up possibilities for new therapeutic strategies for cardiovascular diseases.	[Goth, Christoffer K.; Wang, Shengjun; Narimatsu, Yoshiki; Clausen, Henrik; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Tuhkanen, Hanna E.; Khan, Hamayun; Lackman, Jarkko J.; Petaja-Repo, Ulla E.] Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, POB 5000, FI-90014 Oulu, Finland; [Hansen, Lasse H.] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, DK-2100 Copenhagen O, Denmark; [Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Copenhagen; University of Oulu; Rigshospitalet; University of Copenhagen; University of British Columbia; University of British Columbia	Schjoldager, KT (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.; Petaja-Repo, UE (corresponding author), Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, POB 5000, FI-90014 Oulu, Finland.	Schjoldager@sund.ku.dk; ulla.petaja-repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021; clausen, henrik/AAD-8016-2021; Khan, Hamayun/GNO-9295-2022; Narimatsu, Yoshiki/G-8388-2019	Khan, Hamayun/0000-0001-6325-6255; Hansen, Lasse Holst/0000-0001-6517-0412; Clausen, Henrik/0000-0002-0915-5055; Goth, Christoffer/0000-0002-5766-1411; Lackman, Jarkko/0000-0002-0422-5157; Narimatsu, Yoshiki/0000-0003-1428-5695	Danish Research Councils; University of Copenhagen; Novo Nordisk Foundation; Danish National Research Foundation [DNRF107]; Neye Foundation; MRC Oulu and Magnus Ehrnrooth Foundation	Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); Neye Foundation; MRC Oulu and Magnus Ehrnrooth Foundation	This work was supported by the Danish Research Councils (including a Sapere Aude Research Talent Grant to K.T.S.), a program of excellence grant from the University of Copenhagen, the Novo Nordisk Foundation, Danish National Research Foundation Grant DNRF107 (to H.C.), the Neye Foundation (to C.G.), and the MRC Oulu and Magnus Ehrnrooth Foundation (to U.E.P.-R.).	Ahles A, 2014, PHARMACOL REV, V66, P598, DOI 10.1124/pr.113.008219; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Coleman JLJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1089; Couet J, 1996, J BIOL CHEM, V271, P4545; Dorn GW, 2009, MOL PHARMACOL, V76, P466, DOI 10.1124/mol.109.056572; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Halim A, 2013, J PROTEOME RES, V12, P573, DOI 10.1021/pr300963h; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Klenk C, 2010, J BIOL CHEM, V285, P8665, DOI 10.1074/jbc.M109.058685; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Lackman JJ, 2014, J BIOL CHEM, V289, P17830, DOI 10.1074/jbc.M114.566273; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Magrane J, 1999, FEBS LETT, V451, P56, DOI 10.1016/S0014-5793(99)00494-9; Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Mattila SO, 2016, J CELL SCI, V129, P1366, DOI 10.1242/jcs.176115; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Osuala K, 2012, PHYSIOL GENOMICS, V44, P934, DOI 10.1152/physiolgenomics.00180.2011; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Rathz DA, 2002, J CARDIOVASC PHARM, V39, P155, DOI 10.1097/00005344-200202000-00001; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sadeghi H, 1999, GLYCOBIOLOGY, V9, P731, DOI 10.1093/glycob/9.7.731; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Schlage P, 2015, MATRIX BIOL, V44-46, P232, DOI 10.1016/j.matbio.2015.01.003; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; van den Berg CW, 2012, IMMUNOBIOLOGY, V217, P935, DOI 10.1016/j.imbio.2012.01.005; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280	60	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4714	4726		10.1074/jbc.M116.730614	http://dx.doi.org/10.1074/jbc.M116.730614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28167537	hybrid, Green Published			2022-12-28	WOS:000397585100027
J	Ballmer, BA; Moos, R; Liberali, P; Pelkmans, L; Hornemann, S; Aguzzi, A				Ballmer, Boris A.; Moos, Rita; Liberali, Prisca; Pelkmans, Lucas; Hornemann, Simone; Aguzzi, Adriano			Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CELL-SURFACE; TRAFFICKING; RECEPTOR; ANTIBODIES; BIOLOGY; RAB5; PRPC; INTERNALIZATION; CHOLESTEROL	The cellular prion protein, PrPC, is attached by a glycosyl-phosphatidylinositol anchor to the outer leaflet of the plasma membrane. Its misfolded isoform PrPSc is the causative agent of prion diseases. Conversion of PrPC into PrPSc is thought to take place at the cell surface or in endolysosomal organelles. Understanding the intracellular trafficking of PrPC may, therefore, help elucidate the conversion process. Here we describe a time-resolved fluorescence energy transfer (FRET) assay reporting membrane expression and real-time internalization rates of PrPC. The assay is suitable for high-throughput genetic and pharmaceutical screens for modulators of PrPC trafficking. Simultaneous administration of FRET donor and acceptor anti-PrPC antibodies to living cells yielded a measure of PrPC surface density, whereas sequential addition of each antibody visualized the internalization rate of PrPC (Z' factor > 0.5). RNA interference assays showed that suppression of AP2M1 (AP-2 adaptor protein), RAB5A, VPS35 (vacuolar protein sorting 35 homolog), and M6PR (mannose 6-phosphate receptor) blocked (PrC)-C-P internalization, whereas down-regulation of GIT2 and VPS28 increased PrPC internalization. PrPC cell-surface expression was reduced by down-regulation of RAB5A, VPS28, and VPS35 and enhanced by silencing EHD1. These data identify a network of proteins implicated in PrPC trafficking and demonstrate the power of this assay for identifying modulators of PrPC trafficking.	[Ballmer, Boris A.; Moos, Rita; Hornemann, Simone; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland; [Liberali, Prisca; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8091 Zurich, Switzerland; [Liberali, Prisca] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Zurich; University of Zurich; Friedrich Miescher Institute for Biomedical Research	Hornemann, S; Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	simone.hornemann@usz.ch; adriano.aguzzi@usz.ch		Hornemann, Simone/0000-0002-2674-9891; Aguzzi, Adriano/0000-0002-0344-6708; Pelkmans, Lucas/0000-0002-6754-9730; Liberali, Prisca/0000-0003-0695-6081	Swiss National Science Foundation [PP00P3_157531]; Swiss National Science Foundation; University of Zurich Research Priority Program in Systems Biology; Swiss Initiative in Systems Biology, SystemsX.ch (LipidX, PrionX); Swiss Initiative in Systems Biology, SystemsX.ch (SynucleiX); commission innovations of the University Hospital of Zurich; European Research Council; European Union Framework 7 Grant (NEURINOX); Swiss National Foundation; Clinical Research Priority Program "Small RNAs"; Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Gelu Foundation; Clinical Research Priority Program "Human Hemato-Lymphatic Diseases"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich Research Priority Program in Systems Biology; Swiss Initiative in Systems Biology, SystemsX.ch (LipidX, PrionX); Swiss Initiative in Systems Biology, SystemsX.ch (SynucleiX); commission innovations of the University Hospital of Zurich; European Research Council(European Research Council (ERC)European Commission); European Union Framework 7 Grant (NEURINOX); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Clinical Research Priority Program "Small RNAs"; Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Gelu Foundation; Clinical Research Priority Program "Human Hemato-Lymphatic Diseases"	Recipient of the Swiss National Science Foundation (PP00P3_157531).; Recipient of a Consolidator Grant of the Swiss National Science Foundation, the University of Zurich Research Priority Program in Systems Biology, and the Swiss Initiative in Systems Biology, SystemsX.ch (LipidX, PrionX).; Recipient of the Swiss Initiative in Systems Biology, SystemsX.ch (SynucleiX) and the commission innovations of the University Hospital of Zurich. To whom correspondence may be addressed: University of Zurich, Institute of Neuropathology, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland. Tel.: 41-44-255-21-07; Fax: 41-44-255-44-02; E-mail: simone.hornemann@usz.ch.; Recipient of an Advanced Grant of the European Research Council, a European Union Framework 7 Grant (NEURINOX), the Swiss National Foundation, the Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases," the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX), and the Gelu Foundation. To whom correspondence may be addressed: University of Zurich, Institute of Neuropathology, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland. Tel.: 41-44255-21-07; Fax: 41-44-255-44-02; E-mail: adriano.aguzzi@usz.ch.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Karapetyan YE, 2013, P NATL ACAD SCI USA, V110, P7044, DOI 10.1073/pnas.1303510110; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; LeBorgne R, 1997, J CELL BIOL, V137, P335; Luo K, 2010, BIOCHEM BIOPH RES CO, V394, P493, DOI 10.1016/j.bbrc.2010.02.159; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; MORRISON LE, 1988, ANAL BIOCHEM, V174, P101, DOI 10.1016/0003-2697(88)90524-6; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Prusiner S. B., 2004, Prion biology and diseases; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sakudo A, 2007, MICROBIOL IMMUNOL, V51, P1, DOI 10.1111/j.1574-695X.2007.00284.x; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Triantaphyllidou IE, 2006, ANAL BIOCHEM, V359, P176, DOI 10.1016/j.ab.2006.10.002; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	50	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8356	8368		10.1074/jbc.M116.773283	http://dx.doi.org/10.1074/jbc.M116.773283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28341739	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000401788600020
J	Kupke, T; Malsam, J; Schiebel, E				Kupke, Thomas; Malsam, Joerg; Schiebel, Elmar			A ternary membrane protein complex anchors the spindle pole body in the nuclear envelope in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEXES; CELL-CYCLE; COMPONENT; NDC1P; CURVATURE; MPS3; DUPLICATION; INTERACTS; INSERTION; BODIES	In budding yeast (Saccharomyces cerevisiae) the multilayered spindle pole body (SPB) is embedded in the nuclear envelope (NE) at fusion sites of the inner and outer nuclear membrane. The SPB is built from 18 different proteins, including the three integral membrane proteins Mps3, Ndc1, and Mps2. These membrane proteins play an essential role in the insertion of the new SPB into the NE. How the huge core structure of the SPB is anchored in the NE has not been investigated thoroughly until now. The present model suggests that the NE protein Mps2 interacts via Bbp1 with Spc29, one of the coiled-coil proteins forming the central plaque of the SPB. To test this model, we purified and reconstituted the Mps2-Bbp1 complex from yeast and incorporated the complex into liposomes. We also demonstrated that Mps2-Bbp1 directly interacts with Mps3 and Ndc1. We then purified Spc29 and reconstituted the ternary Mps2-Bbp1-Spc29 complex, proving that Bbp1 can simultaneously interact with Mps2 and Spc29 and in this way link the central plaque of the SPB to the nuclear envelope. Interestingly, Bbp1 induced oligomerization of Spc29, which may represent an early step in SPB duplication. Together, this analysis provides important insights into the interaction network that inserts the new SPB into the NE and indicates that the Mps2-Bbp1 complex is the central unit of the SPB membrane anchor.	[Kupke, Thomas; Schiebel, Elmar] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Kupke, Thomas; Malsam, Joerg] Univ Heidelberg BZH, Biochem Zentrum, Neuenheimer Feld 328, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schiebel, E (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de		Kupke, Thomas/0000-0003-2341-1710; schiebel, Elmar/0000-0002-3683-247X	Deutsche Forschungsgemeinschaft [SFB638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This was supported by a grant from the Deutsche Forschungsgemeinschaft (Collaborative Research Centre SFB638; to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Antonin W, 2005, NAT CELL BIOL, V7, P10, DOI 10.1038/ncb0105-10; Antonin W, 2009, CURR BIOL, V19, pR410, DOI 10.1016/j.cub.2009.03.053; Araki Y, 2006, MOL BIOL CELL, V17, P1959, DOI 10.1091/mbc.E05-07-0668; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Burns S, 2015, ELIFE, V4, DOI 10.7554/eLife.08586; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; Chen JJ, 2014, J CELL BIOL, V204, P523, DOI 10.1083/jcb.201307043; Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gardner JM, 2011, J CELL BIOL, V193, P489, DOI 10.1083/jcb.201011017; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jaspersen SL, 2006, J CELL BIOL, V174, P665, DOI 10.1083/jcb.200601062; Jaspersen SL, 2012, NUCLEUS-PHILA, V3, P226, DOI 10.4161/nucl.20148; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kupke T, 2011, EMBO J, V30, P3337, DOI 10.1038/emboj.2011.242; Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Madrid AS, 2006, J CELL BIOL, V173, P361, DOI 10.1083/jcb.200506199; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Meseroll RA, 2016, J CELL PHYSIOL, V231, P2353, DOI 10.1002/jcp.25355; Munoz-Centeno MD, 1999, MOL BIOL CELL, V10, P2393, DOI 10.1091/mbc.10.7.2393; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Park CJ, 2004, MOL BIOL CELL, V15, P1711, DOI 10.1091/mbc.E03-07-0461; Ruthnick D, 2016, MOL CELL BIOL, V36, P1324, DOI 10.1128/MCB.00048-16; Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519; Schramm C, 2000, EMBO J, V19, P421, DOI 10.1093/emboj/19.3.421; Seybold C, 2013, CURR BIOL, V23, pR858, DOI 10.1016/j.cub.2013.07.024; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; WINEY M, 1993, J CELL BIOL, V122, P743, DOI 10.1083/jcb.122.4.743; Zizlsperger N, 2008, BIOCHEMISTRY-US, V47, P11858, DOI 10.1021/bi801378z; Zizlsperger N, 2010, J STRUCT BIOL, V170, P246, DOI 10.1016/j.jsb.2010.01.022	43	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8447	8458		10.1074/jbc.M117.780601	http://dx.doi.org/10.1074/jbc.M117.780601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28356353	Green Published, hybrid			2022-12-28	WOS:000401788600028
J	Tripathi, A; Mandon, EC; Gilmore, R; Rapoport, TA				Tripathi, Arati; Mandon, Elisabet C.; Gilmore, Reid; Rapoport, Tom A.			Two alternative binding mechanisms connect the protein translocation Sec71-Sec72 complex with heat shock proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPRO-ALPHA-FACTOR; ENDOPLASMIC-RETICULUM; SEC PROTEINS; HSP70; YEAST; RECOGNITION; CHAPERONES; TRANSPORT; DOMAINS; SYSTEM	The biosynthesis of many eukaryotic proteins requires accurate targeting to and translocation across the endoplasmic reticulum membrane. Post-translational protein translocation in yeast requires both the Sec61 translocation channel, and a complex of four additional proteins: Sec63, Sec62, Sec71, and Sec72. The structure and function of these proteins are largely unknown. This pathway also requires the cytosolic Hsp70 protein Ssa1, but whether Ssa1 associates with the translocation machinery to target protein substrates to the membrane is unclear. Here, we use a combined structural and biochemical approach to explore the role of Sec71-Sec72 subcomplex in post-translational protein translocation. To this end, we report a crystal structure of the Sec71-Sec72 complex, which revealed that Sec72 contains a tetratricopeptide repeat (TPR) domain that is anchored to the endoplasmic reticulum membrane by Sec71. We also determined the crystal structure of this TPR domain with a C-terminal peptide derived from Ssa1, which suggests how Sec72 interacts with full-length Ssa1. Surprisingly, Ssb1, a cytoplasmic Hsp70 that binds ribosome-associated nascent polypeptide chains, also binds to the TPR domain of Sec72, even though it lacks the TPR-binding C-terminal residues of Ssa1. We demonstrate that Ssb1 binds through its ATPase domain to the TPR domain, an interaction that leads to inhibition of nucleotide exchange. Taken together, our results suggest that translocation substrates can be recruited to the Sec71-Sec72 complex either post-translationally through Ssa1 or co-translationally through Ssb1.	[Tripathi, Arati; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tripathi, Arati; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Mandon, Elisabet C.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Tripathi, A; Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Tripathi, A; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	arati_tripathi@hms.harvard.edu; tom_rapoport@hms.harvard.edu			National Institutes of Health [RO1 GM35687, RO1 GM 052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687, R01GM052586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM35687 (to R. G.) and RO1 GM 052586 (to T. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Becker J, 1996, MOL CELL BIOL, V16, P4378; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DeLano W.L, PYMOL MOL GRAPHICS S; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HANSEN W, 1988, J CELL BIOL, V106, P1075, DOI 10.1083/jcb.106.4.1075; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Panigrahi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083461; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; ROTHBLATT JA, 1986, EMBO J, V5, P1031; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	50	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8007	8018		10.1074/jbc.M116.761122	http://dx.doi.org/10.1074/jbc.M116.761122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28286332	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000401154100026
J	Piacente, F; De Castro, C; Jeudy, S; Gaglianone, M; Laugieri, ME; Notaro, A; Salis, A; Damonte, G; Abergel, C; Tonetti, MG				Piacente, Francesco; De Castro, Cristina; Jeudy, Sandra; Gaglianone, Matteo; Laugieri, Maria Elena; Notaro, Anna; Salis, Annalisa; Damonte, Gianluca; Abergel, Chantal; Tonetti, Michela G.			The rare sugar N-acetylated viosamine is a major component of Mimivirus fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); glycosylation; mass spectrometry (MS); nuclear magnetic resonance (NMR); virus; Mimivirus; viosamine	LARGE DNA VIRUSES; BIOCHEMICAL-CHARACTERIZATION; BIOSYNTHETIC-PATHWAY; CATALYTIC MECHANISM; MASS-SPECTROMETRY; O-ANTIGEN; GLYCOSYLATION; ACETYLTRANSFERASE; ENCODES; GENOME	The giant virus Mimivirus encodes an autonomous glycosylation system that is thought to be responsible for the formation of complex and unusual glycans composing the fibers surrounding its icosahedral capsid, including the dideoxyhexose viosamine. Previous studies have identified a gene cluster in the virus genome, encoding enzymes involved in nucleotide-sugar production and glycan formation, but the functional characterization of these enzymes and the full identification of the glycans found in viral fibers remain incomplete. Because viosamine is typically found in acylated forms, we suspected that one of the genes might encode an acyltransferase, providing directions to our functional annotations. Bioinformatic analyses indicated that the L142 protein contains an N-terminal acyltransferase domain and a predicted C-terminal glycosyltransferase. Sequence analysis of the structural model of the L142 N-terminal domain indicated significant homology with some characterized sugar acetyltransferases that modify the C-4 amino group in the bacillosamine or perosamine biosynthetic pathways. Using mass spectrometry and NMR analyses, we confirmed that the L142 N-terminal domain is a sugar acetyltransferase, catalyzing the transfer of an acetyl moiety from acetyl-CoA to the C-4 amino group of UDP-d-viosamine. The presence of acetylated viosamine in vivo has also been confirmed on the glycosylated viral fibers, using GC-MS and NMR. This study represents the first report of a virally encoded sugar acetyltransferase.	[Piacente, Francesco; Gaglianone, Matteo; Laugieri, Maria Elena; Salis, Annalisa; Damonte, Gianluca; Tonetti, Michela G.] Univ Genoa, Dept Expt Med, Viale Benedetto 15, I-16126 Genoa, Italy; [Piacente, Francesco; Gaglianone, Matteo; Laugieri, Maria Elena; Salis, Annalisa; Damonte, Gianluca; Tonetti, Michela G.] Univ Genoa, Ctr Excellence Biomed Res, I-16126 Genoa, Italy; [De Castro, Cristina] Univ Napoli, Dept Agr Sci, I-80138 Naples, Italy; [Notaro, Anna] Univ Napoli, Dept Chem Sci, I-80138 Naples, Italy; [Jeudy, Sandra; Notaro, Anna; Abergel, Chantal] Aix Marseille Univ, CNRS, Informat Genom & Struct, UMR 7256,IMM FR3479, F-13288 Marseille 9, France	University of Genoa; University of Genoa; University of Naples Federico II; University of Naples Federico II; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Tonetti, MG (corresponding author), Univ Genoa, Dept Expt Med, Viale Benedetto 15, I-16126 Genoa, Italy.	tonetti@unige.it	Piacente, Francesco/J-8295-2016; Tonetti, Michela/F-3039-2018; De Castro, Cristina/I-5899-2012; TONETTI, MICHELA/AAF-3404-2021; Salis, Annalisa/R-9241-2018	Piacente, Francesco/0000-0001-5470-5987; De Castro, Cristina/0000-0002-5147-1756; TONETTI, MICHELA/0000-0002-8829-7173; Notaro, Anna/0000-0002-7224-8641; Gaglianone, Matteo/0000-0002-0490-8062; Salis, Annalisa/0000-0002-3082-2908; jeudy, sandra/0000-0002-5297-0135; Abergel, Chantal/0000-0003-1875-4049	Fondo per la Ricerca di Ateneo, University of Genova; French National Research Agency [ANR-14-CE14-0023-01]; UIF Vinci program Ph.D. Fellowship [C3_90]	Fondo per la Ricerca di Ateneo, University of Genova; French National Research Agency(French National Research Agency (ANR)); UIF Vinci program Ph.D. Fellowship	This work was supported in part by the Fondo per la Ricerca di Ateneo, University of Genova, and French National Research Agency Grant ANR-14-CE14-0023-01. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a UIF Vinci program 2015 Ph.D. Fellowship C3_90.	Arbatsky NP, 2010, ORG BIOMOL CHEM, V8, P3571, DOI 10.1039/c004090h; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Chantigian DP, 2013, BIOCHEMISTRY-US, V52, P8374, DOI 10.1021/bi401170t; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; De Castro C, 2016, ANGEW CHEM INT EDIT, V55, P654, DOI 10.1002/anie.201509150; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; Dong SL, 2010, J BACTERIOL, V192, P5053, DOI 10.1128/JB.00568-10; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hulsmeier AJ, 2014, GLYCOBIOLOGY, V24, P703, DOI 10.1093/glycob/cwu034; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klose T, 2015, STRUCTURE, V23, P1058, DOI 10.1016/j.str.2015.03.023; Kondakova AN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1034, DOI 10.1023/B:BIRY.0000043546.46903.32; Kondakova AN, 2011, CARBOHYD RES, V346, P1951, DOI 10.1016/j.carres.2011.05.019; Kubiak RL, 2012, BIOCHEMISTRY-US, V51, P867, DOI 10.1021/bi201650c; Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99; Liu B, 2012, GLYCOBIOLOGY, V22, P1236, DOI 10.1093/glycob/cws089; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luther KB, 2011, J BIOL CHEM, V286, P43701, DOI 10.1074/jbc.M111.309096; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Morrison MJ, 2013, J BIOL CHEM, V288, P32248, DOI 10.1074/jbc.M113.510560; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Ovchinnikova OG, 2013, CARBOHYD RES, V375, P73, DOI 10.1016/j.carres.2013.04.016; Perepelov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P406, DOI 10.1134/S0006297908040044; Piacente F, 2015, INT J MOL SCI, V16, P29315, DOI 10.3390/ijms161226169; Piacente F, 2014, J BIOL CHEM, V289, P24428, DOI 10.1074/jbc.M114.588947; Piacente F, 2014, GLYCOBIOLOGY, V24, P51, DOI 10.1093/glycob/cwt089; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Rommel AJ, 2016, BIOCHEM J, V473, P3451, DOI 10.1042/BCJ20160280; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Thoden JB, 2012, BIOCHEMISTRY-US, V51, P3433, DOI 10.1021/bi300197h; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P2699, DOI 10.1021/bi802313n; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; Vinogradov E, 2005, CARBOHYD RES, V340, P1750, DOI 10.1016/j.carres.2005.04.009; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Yamamoto M, 2011, GENES-BASEL, V2, P788, DOI 10.3390/genes2040788	43	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7385	7394		10.1074/jbc.M117.783217	http://dx.doi.org/10.1074/jbc.M117.783217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28314774	Green Published, hybrid			2022-12-28	WOS:000400761300010
J	Koole, C; Reynolds, CA; Mobarec, JC; Hick, C; Sexton, PM; Sakmar, TP				Koole, Cassandra; Reynolds, Christopher A.; Mobarec, Juan C.; Hick, Caroline; Sexton, Patrick M.; Sakmar, Thomas P.			Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; PHOTOREACTIVE AMINO-ACID; CLASS-B GPCRS; EXTRACELLULAR DOMAIN; MAMMALIAN-CELLS; CROSS-LINKERS; TRP-CAGE; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE	The glucagon-like peptide-1 receptor (GLP-1R) is a key therapeutic target in the management of type II diabetes mellitus, with actions including regulation of insulin biosynthesis and secretion, promotion of satiety, and preservation of beta-cell mass. Like most class B G protein-coupled receptors (GPCRs), there is limited knowledge linking biological activity of the GLP-1R with the molecular structure of an intact, full-length, and functional receptor.ligand complex. In this study, we have utilized genetic code expansion to site-specifically incorporate the photoactive amino acid p-azido-L-phenylalanine (azF) into N-terminal residues of a full-length functional human GLP-1R in mammalian cells. UV-mediated photolysis of azF was then carried out to induce targeted photocross-linking to determine the proximity of the azido group in the mutant receptor with the peptide exendin-4. Cross-linking data were compared directly with the crystal structure of the isolated N-terminal extracellular domain of the GLP-1R in complex with exendin(9-39), revealing both similarities as well as distinct differences in the mode of interaction. Generation of a molecular model to accommodate the photo-cross-linking constraints highlights the potential influence of environmental conditions on the conformation of the receptor center dot peptide complex, including folding dynamics of the peptide and formation of dimeric and higher order oligomeric receptor multimers. These data demonstrate that crystal structures of isolated receptor regions may not give a complete reflection of peptide/receptor interactions and should be combined with additional experimental constraints to reveal peptide/receptor interactions occurring in the dynamic, native, and full-length receptor state.	[Koole, Cassandra; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA; [Koole, Cassandra; Hick, Caroline; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Reynolds, Christopher A.; Mobarec, Juan C.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England	Rockefeller University; Monash University; University of Essex	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA.	sakmar@mail.rockefeller.edu	Sexton, Patrick M/B-1319-2008; Sakmar, Thomas P/D-1833-2015; Reynolds, Christopher/G-1036-2010	Sexton, Patrick M/0000-0001-8902-2473; Sakmar, Thomas P/0000-0002-2836-8953; Mobarec, Juan Carlos/0000-0001-9482-4294; Reynolds, Christopher/0000-0001-9267-5141	Rockefeller University; National Health and Medical Research Council of Australia [1061044, 1055134]; Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/M006883/1]; BBSRC [BB/M007529/1, BB/M006883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M007529/1, BB/M006883/1] Funding Source: researchfish	Rockefeller University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by institutional funds from The Rockefeller University, National Health and Medical Research Council of Australia Grants 1061044 and 1055134 (to P. M. S.) and Biotechnology and Biological Sciences Research Council of the United Kingdom Project Grant BB/M006883/1 (to C. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P11803, DOI 10.1073/pnas.1309584110; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Coin I, 2011, ANGEW CHEM INT EDIT, V50, P8077, DOI 10.1002/anie.201102646; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Culik RM, 2011, ANGEW CHEM INT EDIT, V50, P10884, DOI 10.1002/anie.201104085; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Dong M, 2014, BRIT J PHARMACOL, V171, P1085, DOI 10.1111/bph.12293; ENG J, 1992, J BIOL CHEM, V267, P7402; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Koole C, 2013, BIOCHEM SOC T, V41, P172, DOI 10.1042/BST20120236; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Linhananta A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1874812; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Meuzelaar H, 2013, J PHYS CHEM B, V117, P11490, DOI 10.1021/jp404714c; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Rannversson H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11261; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Valentin-Hansen L, 2014, J BIOL CHEM, V289, P18045, DOI 10.1074/jbc.M113.527085; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Wang WJ, 2014, ACS CHEM BIOL, V9, P2165, DOI 10.1021/cb500351s; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Wootten D, 2016, BIOCHEM PHARMACOL, V118, P68, DOI 10.1016/j.bcp.2016.08.015; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42	61	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7131	7144		10.1074/jbc.M117.779496	http://dx.doi.org/10.1074/jbc.M117.779496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283573	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000400478300023
J	Dai, Y; Haque, MM; Stuehr, DJ				Dai, Yue; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.			Restricting the conformational freedom of the neuronal nitric-oxide synthase flavoprotein domain reveals impact on electron transfer and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 OXIDOREDUCTASE; REDUCTASE DOMAIN; NO SYNTHASE; DIFLAVIN REDUCTASE; STRUCTURAL BASIS; CALMODULIN; FMN; MECHANISM; DYNAMICS; MOTIONS	The signaling molecule nitric oxide (NO) is synthesized in animals by structurally related NO synthases (NOSs), which contain NADPH/FAD-and FMN-binding domains. During catalysis, NADPH-derived electrons transfer into FAD and then distribute into the FMN domain for further transfer to internal or external heme groups. Conformational freedom of the FMN domain is thought to be essential for the electron transfer (ET) reactions in NOSs. To directly examine this concept, we utilized a " Cys-lite" neuronal NOS flavoprotein domain and substituted Cys for two residues (Glu-816 and Arg-1229) forming a salt bridge between theNADPH/FADandFMNdomains in the conformationally closed structure to allow cross-domain disulfide bond formation or cross-linking by bismaleimides of various lengths. The disulfide bond cross-link caused a > 95% loss of cytochrome c reductase activity that was reversible with DTT treatment, whereas graded cross-link lengthening gradually increased activity, thus defining the conformational constraints in the catalytic process. We used spectroscopic and stoppedflow techniques to further investigate how the changes in FMN domain conformational freedom impact the following: (i) the NADPH interaction; (ii) kinetics of electron loading (flavin reduction); (iii) stabilization of open versus closed conformational forms in two different flavin redox states; (iv) reactivity of the reduced FMN domain toward cytochrome c; (v) response to calmodulin binding; and (vi) the rates of interflavin ET and the FMN domain conformational dynamics. Together, our findings help explain how the spatial and temporal behaviors of the FMN domain impact catalysis by the NOS flavoprotein domain and how these behaviors are governed to enable electron flow through the enzyme.	[Dai, Yue; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA; [Dai, Yue] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Dai, Yue/AAD-9906-2019	Dai, Yue/0000-0001-9368-7769; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM51491, HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM51491 and HL081064 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Arnett DC, 2015, FEBS LETT, V589, P1173, DOI 10.1016/j.febslet.2015.03.035; Astashkin AV, 2014, J PHYS CHEM A, V118, P6864, DOI 10.1021/jp503547w; Baird EJ, 2003, BIOCHEMISTRY-US, V42, P12739, DOI 10.1021/bi034884l; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frances O, 2015, BIOPHYS J, V108, P1527, DOI 10.1016/j.bpj.2015.01.032; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2012, FEBS J, V279, P1306, DOI 10.1111/j.1742-4658.2012.08525.x; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2014, FEBS J, V281, P5325, DOI 10.1111/febs.13073; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2016, J BIOL CHEM, V291, P23047, DOI 10.1074/jbc.M116.737361; Haque MM, 2013, BIOCHEM J, V450, P607, DOI 10.1042/BJ20121488; He YF, 2015, P NATL ACAD SCI USA, V112, P11835, DOI 10.1073/pnas.1508829112; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Iyanagi T, 2005, BIOCHEM BIOPH RES CO, V338, P520, DOI 10.1016/j.bbrc.2005.08.043; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; Leferink NGH, 2015, FEBS J, V282, P3016, DOI 10.1111/febs.13171; Leferink NGH, 2012, FEBS LETT, V586, P578, DOI 10.1016/j.febslet.2011.07.003; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Panda K, 2004, J BIOL CHEM, V279, P18323, DOI 10.1074/jbc.M310391200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pudney CR, 2012, FEBS J, V279, P1534, DOI 10.1111/j.1742-4658.2011.08442.x; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532	44	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6753	6764		10.1074/jbc.M117.777219	http://dx.doi.org/10.1074/jbc.M117.777219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28232486	Green Published, hybrid			2022-12-28	WOS:000399813400026
J	Stavenuiter, F; Ebberink, EHTM; Mertens, K; Meijer, AB				Stavenuiter, Fabian; Ebberink, Eduard H. T. M.; Mertens, Koen; Meijer, Alexander B.			Role of glycine 221 in catalytic activity of hyaluronan-binding protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VII-ACTIVATING PROTEASE; GROWTH-FACTOR ACTIVATOR; MARBURG-I POLYMORPHISM; SERINE-PROTEASE; NA+ SITE; THERMODYNAMIC LINKAGE; CRYSTAL-STRUCTURE; AUTOLYSIS LOOP; FACTOR IXA; CA2+ SITE	HABP2 (hyaluronan-binding protein 2) is a Ca2+ -dependent serine protease with putative roles in blood coagulation and fibrinolysis. A G221E substitution, known as the Marburg I polymorphism, reportedly affects HABP2 function and has been associated with increased risk for cardiovascular disease. How-ever, the importance of Gly-221 for HABP2 activity is unclear. Here, we used G221E, G221A, and G221S mutants to assess the role of Gly-221 in HABP2 catalysis. The G221E variant failed to activate the single-chain urokinase-type plasminogen activator, and the G221A and G221S variants displayed moderately reduced single-chain urokinase-type plasminogen activator activation. Activity toward the peptide substrate S-2288 was markedly decreased in all HABP2 variants, with G221E being the most defective and G221A being the least defective. In the absence of Ca2+, S-2288 cleavage by wild-type HABP2 was Na+ -dependent, with K-m decreasing from 3.0 to 0.6 mM upon titration from 0 to 0.3 M Na+. In the presence of 5 mM Ca2+, K-m was further reduced to 0.05 mM, but without an appreciable contribution of Na+. At physiological concentrations of Na+ and Ca2+, the three HABP2 variants, and particularly G221E, displayed a major K-m increase for S-2288. Chemical footprinting revealed that Ile-16 is significantly less protected from chemical modification in G221E than in wild-type HABP2, suggesting impaired insertion of the N terminus into the G221E protease domain, with a concomitant impact on catalytic activity. Homology modeling suggested that the Glu-221 side chain could sterically hinder insertion of the N terminus into the HABP2 protease domain, helping to explain the detrimental effects of Glu-221 substitution on HABP2 activity.	[Stavenuiter, Fabian; Ebberink, Eduard H. T. M.; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3584 CG Utrecht, Netherlands	Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl						Azim-Zadeh O, 2007, J BIOL CHEM, V282, P21609, DOI 10.1074/jbc.M610921200; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P140, DOI 10.1248/bpb.24.140; ChoiMiura NH, 1996, J BIOCHEM, V119, P1157; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Etscheid M, 2012, THROMB RES, V130, P935, DOI 10.1016/j.thromres.2012.07.023; Gabant G, 2008, J MASS SPECTROM, V43, P360, DOI 10.1002/jms.1328; HAMAGUCHI N, 1993, BIOCHEMISTRY-US, V32, P6324, DOI 10.1021/bi00076a004; Hunfeld A, 1999, FEBS LETT, V456, P290, DOI 10.1016/S0014-5793(99)00959-X; Ireland H, 2004, THROMB HAEMOSTASIS, V92, P986, DOI 10.1160/TH04-05-0275; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Kannemeier C, 2001, EUR J BIOCHEM, V268, P3789, DOI 10.1046/j.1432-1327.2001.02285.x; Kanse SM, 2012, ARTERIOSCL THROM VAS, V32, P427, DOI 10.1161/ATVBAHA.111.238394; Mathur A, 1997, J BIOL CHEM, V272, P23418, DOI 10.1074/jbc.272.37.23418; MIYATA T, 1994, THROMB HAEMOSTASIS, V71, P32; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Romisch J, 1999, HAEMOSTASIS, V29, P292; Rouy S, 2006, BRIT J HAEMATOL, V132, P770, DOI 10.1111/j.1365-2141.2005.05920.x; Sabharwal AK, 1997, J BIOL CHEM, V272, P22037, DOI 10.1074/jbc.272.35.22037; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharer K, 2005, ANGEW CHEM INT EDIT, V44, P4400, DOI 10.1002/anie.200500883; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; Schmidt AE, 2002, J BIOL CHEM, V277, P28987, DOI 10.1074/jbc.M201892200; Segel I. H., 1975, ENZYME KINETICS, P25; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Stavenuiter F, 2012, J THROMB HAEMOST, V10, P859, DOI 10.1111/j.1538-7836.2012.04619.x; Subramaniam S, 2015, THROMB HAEMOSTASIS, V113, P870, DOI 10.1160/TH14-06-0519; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Weisbach V, 2007, THROMB HAEMOSTASIS, V97, P870, DOI 10.1160/TH06-12-0739	32	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6381	6388		10.1074/jbc.M116.757849	http://dx.doi.org/10.1074/jbc.M116.757849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28246168	hybrid, Green Published			2022-12-28	WOS:000399538700030
J	Stevens, RL; McNeil, HP; Wensing, LA; Shin, K; Wong, GW; Hansbro, PM; Krilis, SA				Stevens, Richard L.; McNeil, H. Patrick; Wensing, Lislaine A.; Shin, Kichul; Wong, G. William; Hansbro, Philip M.; Krilis, Steven A.			Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY ARTHRITIS; TRICHINELLA-SPIRALIS; NEUTRAL PROTEASES; HUMAN CHYMASE; RHEUMATOID-ARTHRITIS; CARBOXYPEPTIDASE-A; GRANULE PROTEASES; MOLECULAR-CLONING; TRYPTASE MMCP-6; SYNOVIAL-FLUID	The constitutive heparin(+) (HP) mast cells (MCs) in mice express mouseMCprotease (mMCP)-5 and carboxypeptidaseA (mMC-CPA). The amino acid sequence ofmMCP-5is most similar to that of human chymase-1, as are the nucleotide sequences of their genes and transcripts. Using a homologous recombination approach, a C57BL/6 mouse line was created that possessed a disrupted mMCP-5 gene. The resulting mice were fertile and had no obvious developmental abnormality. Lack of mMCP-5 protein did not alter the granulation of the IL-3/IL-9-dependent mMCP-2(+) MCs in the jejunal mucosa of Trichinella spiralisinfected mice. In contrast, the constitutive HP+ MCs in the tongues of mMCP-5-null mice were poorly granulated and lacked mMC-CPA protein. Bone marrow-derived MCs were readily developed from the transgenic mice using IL-3. Although these MCs contained high levels of mMC-CPA mRNA, they also lacked the latter exopeptidase. mMCP-5 protein is therefore needed to target translated mMC-CPA to the secretory granule along with HP-containing serglycin proteoglycans. Alternately, mMCP-5 is needed to protect mMC-CPA from autolysis in the cell's granules. Fibronectin was identified as a target of mMCP-5, and the exocytosis ofmMCP-5from theMCs in the mouse's peritoneal cavity resulted in the expression of metalloproteinase protease-9, which has been implicated in arthritis. In support of the latter finding, experimental arthritis was markedly reduced in mMCP-5-null mice relative to wildtype mice in two disease models.	[Stevens, Richard L.; Wensing, Lislaine A.; Krilis, Steven A.] Univ New South Wales, Dept Infect Dis Immunol & Sexual Hlth, St George Hosp, Sydney, NSW 2217, Australia; [Stevens, Richard L.; Wensing, Lislaine A.; Krilis, Steven A.] Univ New South Wales, Fac Med, St George & Sutherland Clin Sch, Sydney, NSW 2217, Australia; [Stevens, Richard L.; Krilis, Steven A.] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Newcastle, NSW 2308, Australia; [McNeil, H. Patrick] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia; [Wensing, Lislaine A.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Shin, Kichul] SNU, SMG, Div Rheumatol, Boramae Med Ctr, Seoul 07061, South Korea; [Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Hansbro, Philip M.] Hunter Med Res Inst, Newcastle, NSW 2308, Australia	St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; University of Newcastle; Macquarie University; Universidade de Sao Paulo; Seoul National University (SNU); Seoul National University Hospital; Johns Hopkins University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Stevens, RL (corresponding author), St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Res & Educ Ctr, Level 3,4-10 South St, Sydney, NSW 2217, Australia.	rstevens@richardstevensphd.org	Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Wong, G. William/0000-0002-5286-6506; McNeil, Hugh Patrick/0000-0003-4336-2960	St. George and Sutherland Medical Research Foundation; Harvard Club of Australia Foundation; Australian Research Council; University of Newcastle; National Institutes of Health [DK084171, AI059746]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	St. George and Sutherland Medical Research Foundation; Harvard Club of Australia Foundation; Australian Research Council(Australian Research Council); University of Newcastle; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by funds from the St. George and Sutherland Medical Research Foundation (to R. L. S. and S. K.), the Harvard Club of Australia Foundation (to R. L. S., S. K., and P. M. H.), the Australian Research Council (to P. M. H. and R. L. S.), and the University of Newcastle (to R. L. S.); National Institutes of Health Grants DK084171 (to G. W. W.) and AI059746 (to R. L. S.); a fellowship from the National Health and Medical Research Council of Australia (to P. M. H.); the Brawn Fellowship from the University of Newcastle (to P. M. H.); and a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (to L. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abonia JP, 2005, J IMMUNOL, V174, P7285, DOI 10.4049/jimmunol.174.11.7285; Buckley MG, 1997, CLIN SCI, V93, P363, DOI 10.1042/cs0930363; CAUGHEY GH, 1991, J BIOL CHEM, V266, P12956; DAYTON ET, 1989, J IMMUNOL, V142, P4307; DUBUSKE L, 1984, J IMMUNOL, V133, P1535; EKLUND KK, 1993, J IMMUNOL, V151, P4266; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 1998, J IMMUNOL, V160, P5537; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; GODFREY HP, 1984, ARTHRITIS RHEUM, V27, P852, DOI 10.1002/art.1780270803; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Gotis-Graham I, 1998, ANN RHEUM DIS, V57, P664, DOI 10.1136/ard.57.11.664; HALPERN BN, 1963, BRIT J PHARM CHEMOTH, V20, P389, DOI 10.1111/j.1476-5381.1963.tb01477.x; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; IRANI AMA, 1991, J IMMUNOL, V147, P247; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; KATZ HR, 1986, J IMMUNOL, V136, P3819; KOOLWIJK P, 1995, J RHEUMATOL, V22, P385; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Lazaar AL, 2002, J IMMUNOL, V169, P1014, DOI 10.4049/jimmunol.169.2.1014; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEES M, 1994, EUR J BIOCHEM, V223, P171, DOI 10.1111/j.1432-1033.1994.tb18980.x; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; McGrath ME, 1997, BIOCHEMISTRY-US, V36, P14318, DOI 10.1021/bi971403n; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Okumura K, 2004, CLIN CHIM ACTA, V347, P223, DOI 10.1016/j.cccn.2004.04.019; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Peschke K, 2015, METHODS MOL BIOL, V1220, P403, DOI 10.1007/978-1-4939-1568-2_25; Prieto-Garcia A, 2012, J BIOL CHEM, V287, P7834, DOI 10.1074/jbc.M111.325712; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; SALI A, 1993, J BIOL CHEM, V268, P9023; Semaan W, 2015, BIOCHEM PHARMACOL, V94, P91, DOI 10.1016/j.bcp.2015.02.001; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Stevens R. L., 2000, PROTEOGLYCANS STRUCT, P177; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; STEVENS RL, 1982, J BIOL CHEM, V257, P253; Tchougounova E, 2001, J BIOL CHEM, V276, P3772, DOI 10.1074/jbc.M008434200; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; URATA H, 1991, J BIOL CHEM, V266, P17173; URATA H, 1990, J BIOL CHEM, V265, P22348; Wang YF, 2001, ARTERIOSCL THROM VAS, V21, P1928, DOI 10.1161/hq1201.100227; Xia ZN, 1996, J BIOL CHEM, V271, P8747, DOI 10.1074/jbc.271.15.8747; XIE DL, 1992, J RHEUMATOL, V19, P1448; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803	64	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5392	5404		10.1074/jbc.M116.773416	http://dx.doi.org/10.1074/jbc.M116.773416			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193842	Green Published, hybrid			2022-12-28	WOS:000397875500020
J	Huang, JY; Zhou, QL; Huang, CH; Song, Y; Sharma, AG; Liao, ZP; Zhu, K; Massidda, MW; Jamieson, RR; Zhang, JY; Tenen, DG; Jiang, ZY				Huang, Jun-Yuan; Zhou, Qiong Lin; Huang, Chun-Hong; Song, Ye; Sharma, Andria G.; Liao, Zhangping; Zhu, Kavin; Massidda, Miles W.; Jamieson, Ryan R.; Zhang, Jun-Yuan; Tenen, Daniel G.; Jiang, Zhen Y.			Neutrophil Elastase Regulates Emergency Myelopoiesis Preceding Systemic Inflammation in Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; C/EBP-ALPHA; SELF-RENEWAL; EXPRESSION; GFI-1; DIFFERENTIATION; PROLIFERATION	Inflammation plays a significant role in the development of obesity-related complications, but the molecular events that initiate and propagate such inflammation remain unclear. Here, we report that mice fed a high fat diet (HFD) for as little as 1-3 days show increased differentiation of myeloid progenitors into neutrophils and monocytes but reduced B lymphocyte production in the bone marrow. Levels of neutrophil elastase (NE) and the nuclear factors CCAAT/ enhancer-binding protein alpha (C/ EBP alpha) and growth factor-independent 1 (GFI-1) are elevated in hematopoietic stem and progenitor cells from HFD-fed mice, but mice lacking either NE or C/EBP alpha are resistant to HFDinduced myelopoiesis. NE deletion increases expression of the inhibitory isoform of p30 C/EBP alpha, impairs the transcriptional activity of p42 C/EBP alpha, and reduces expression of the C/EBP alpha target gene GFI-1 in hematopoietic stem and progenitor cells, suggesting a mechanism by which NE regulates myelopoiesis. Furthermore, NE deletion prevents HFD-induced vascular leakage. Thus, HFD feeding rapidly activates bone marrow myelo-poiesis through the NE-dependent C/EBP alpha-GFI-1 pathway preceding vascular damage and systemic inflammation.	[Huang, Jun-Yuan; Zhou, Qiong Lin; Huang, Chun-Hong; Song, Ye; Sharma, Andria G.; Liao, Zhangping; Zhu, Kavin; Massidda, Miles W.; Jamieson, Ryan R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Huang, Jun-Yuan; Zhou, Qiong Lin; Huang, Chun-Hong; Song, Ye; Sharma, Andria G.; Liao, Zhangping; Zhu, Kavin; Massidda, Miles W.; Jamieson, Ryan R.; Jiang, Zhen Y.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 700 Albany St, Boston, MA 02118 USA; [Zhang, Jun-Yuan; Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Huang, Chun-Hong; Liao, Zhangping] Nanchang Univ, Med Ctr, Nanchang 330006, Jiangxi, Peoples R China; [Song, Ye] Southern Med Univ, Nanfang Hosp, Guangzhou 510000, Guangdong, Peoples R China	Boston University; Boston University; Harvard University; National University of Singapore; Nanchang University; Southern Medical University - China	Jiang, ZY (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 700 Albany St, Boston, MA 02118 USA.	zyjiang@bu.edu		Massidda, Miles/0000-0001-7704-9273	American Diabetes Association [1-16-IBS146]; National Institutes of Health [R01DK094025]; Boston University Clinical & Translational Science Institute (CTSI) [1UL1TR001430]; National Research Foundation Singapore; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR); China Scholarship Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094025] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Clinical & Translational Science Institute (CTSI); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR)(Ministry of Health-SingaporeNational Medical Research Council, Singapore); China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association Grant 1-16-IBS146 and National Institutes of Health Grant R01DK094025 (to Z.Y.J.), a Boston University Clinical & Translational Science Institute (CTSI) Pilot Grant 1UL1TR001430 (to Q.L.Z.), a grant from the National Research Foundation Singapore and the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (to D.G.T.), and visiting scholarships from the China Scholarship Council ( to C.H.,Y.S., and Z.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Flach RJR, 2013, J BIOL CHEM, V288, P2882, DOI 10.1074/jbc.M112.412346; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Lidonnici MR, 2010, CANCER RES, V70, P7949, DOI 10.1158/0008-5472.CAN-10-1667; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu X, 2015, INT J OBESITY, V39, P26, DOI 10.1038/ijo.2014.194; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	23	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4770	4776		10.1074/jbc.C116.758748	http://dx.doi.org/10.1074/jbc.C116.758748			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28202548	hybrid, Green Published			2022-12-28	WOS:000397590400002
J	Britain, CM; Dorsett, KA; Bellis, SL				Britain, Colleen M.; Dorsett, Kaitlyn A.; Bellis, Susan L.			The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIALYLATION; GLYCOSYLATION; RECEPTOR; AKT; EXPRESSION; APOPTOSIS; ADHESION; ACTIVATION; RESISTANCE	A hallmark of cancer cells is the ability to survive and proliferate when challenged with stressors such as growth factor insufficiency. In this study, we report a novel glycosylation-dependent mechanism that protects tumor cells from serum growth factor withdrawal. Our results suggest that the beta-galactoside alpha-2,6-sialyltransferase 1 (ST6Gal-I) sialyltransferase, which is up-regulated in numerous cancers, promotes the survival of serum-starved cells. Using ovarian and pancreatic cancer cell models with ST6Gal-I overexpression or knockdown, we find that serum-starved cells with high ST6Gal-I levels exhibit increased activation of prosurvival signaling molecules, including pAkt, p-p70S6K, and pNF kappa B. Correspondingly, ST6Gal-I activity augments the expression of tumor-promoting pNF kappa B transcriptional targets such as IL-6, IL-8, and the apoptosis inhibitor cIAP2. ST6Gal-I also potentiates expression of the cell cycle regulator cyclin D2, leading to increased phosphorylation and inactivation of the cell cycle inhibitor pRb. Consistent with these results, serum-starved cells with high ST6Gal-I expression maintain a greater number of S phase cells compared with low ST6Gal-I expressors, reflecting enhanced proliferation. Finally, selective enrichment in clonal variants with high ST6Gal-I expression is observed upon prolonged serum deprivation, supporting the concept that ST6Gal-I confers a survival advantage. Collectively, these results implicate a functional role for ST6Gal-I in fostering tumor cell survival within the serum-depleted tumor microenvironment.	[Britain, Colleen M.; Dorsett, Kaitlyn A.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982A McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982A McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@uab.edu			National Institutes of Health [P30AR048311, P30AI027767]; NATIONAL CANCER INSTITUTE [R21CA192629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111093, T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the UAB Flow Cytometry Core Facility for assistance (supported by National Institutes of Health Grants P30AR048311 and P30AI027767).	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Clark AS, 2002, MOL CANCER THER, V1, P707; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Fukumori T, 2003, CANCER RES, V63, P8302; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hussain AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039945; Ip CKM, 2014, ONCOTARGET, V5, P9133; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takahashi M, 2016, MOL ASPECTS MED, V51, P56, DOI 10.1016/j.mam.2016.04.008; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	49	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4663	4673		10.1074/jbc.M116.763862	http://dx.doi.org/10.1074/jbc.M116.763862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154177	hybrid, Green Published			2022-12-28	WOS:000397585100023
J	Li, ZG; Zhang, YH; Hedman, AC; Ames, JB; Sacks, DB				Li, Zhigang; Zhang, Yonghong; Hedman, Andrew C.; Ames, James B.; Sacks, David B.			Calmodulin Lobes Facilitate Dimerization and Activation of Estrogen Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; TRANSCRIPTIONAL ACTIVITY; ANTIESTROGENS; INHIBITION; HADDOCK; IQGAP1; CA2+/CALMODULIN; ANTAGONIST; STABILITY; TAMOXIFEN	Estrogen receptor alpha (ER-alpha) is a nuclear hormone receptor that controls selected genes, thereby regulating proliferation and differentiation of target tissues, such as breast. Gene expression controlled by ER-alpha is modulated by Ca2+ via calmodulin (CaM). Here we present the NMR structure of Ca2+ - CaM bound to two molecules of ER-alpha (residues 287-305). The two lobes of CaM bind to the same site on two separate ER-alpha molecules (residues 292, 296, 299, 302, and 303), which explains why CaM binds two molecules of ER-alpha in a 1: 2 complex and stabilizes ER-alpha dimerization. Exposed glutamate residues in CaM (Glu-11, Glu-14, Glu-84, and Glu-87) form salt bridges with key lysine residues in ER-alpha (Lys-299, Lys-302, and Lys-303), which is likely to prevent ubiquitination at these sites and inhibit degradation of ER-alpha. Transfection of cells with full-length CaM slightly increased the ability of estrogen to enhance transcriptional activation by ER-alpha of endogenous estrogen-responsive genes. By contrast, expression of either the N- or C-lobe of CaM abrogated estrogen-stimulated transcription of the estrogen responsive genes pS2 and progesterone receptor. These data suggest that CaM-induced dimerization of ER-alpha is required for estrogen-stimulated transcriptional activation by the receptor. In light of the critical role of ER-alpha in breast carcinoma, our data suggest that small molecules that selectively disrupt the interaction of ER-alpha with CaM may be useful in the therapy of breast carcinoma.	[Li, Zhigang; Hedman, Andrew C.; Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Zhang, Yonghong] Univ Texas Rio Grande Valley, Dept Chem, Edinburg, TX 78539 USA; [Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Rio Grande Valley; University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.; Sacks, DB (corresponding author), 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	jbames@ucdavis.edu; david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	Intramural Research Program of the National Institutes of Health; National Institutes of Health [EY012347]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); CLINICAL CENTER	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health ( to Z. L., A. C. H., and D. B. S.) and an extramural grant from the National Institutes of Health (EY012347) (to J. B. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biswas DK, 1998, J BIOL CHEM, V273, P33817, DOI 10.1074/jbc.273.50.33817; BOUHOUTE A, 1992, BIOCHEM BIOPH RES CO, V184, P1432, DOI 10.1016/S0006-291X(05)80043-9; Carlier L, 2012, BIOCHEM BIOPH RES CO, V419, P356, DOI 10.1016/j.bbrc.2012.02.028; CASTORIA G, 1988, MOL ENDOCRINOL, V2, P167, DOI 10.1210/mend-2-2-167; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; FRANKFURT OS, 1995, CANCER LETT, V97, P149, DOI 10.1016/0304-3835(95)03970-8; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; GULINO A, 1986, CANCER RES, V46, P6274; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Liu R, 2010, J PHARM SCI-US, V99, P3266, DOI 10.1002/jps.22082; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Newton CJ, 2000, J STEROID BIOCHEM, V73, P29, DOI 10.1016/S0960-0760(00)00047-9; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; Pedrero JMG, 2002, MOL ENDOCRINOL, V16, P947; SACKS DB, 1989, BIOCHEM J, V263, P803, DOI 10.1042/bj2630803; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schulltz-Norton JR, 2011, TRENDS ENDOCRIN MET, V22, P124, DOI 10.1016/j.tem.2010.11.005; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; WEI JW, 1983, CANCER CHEMOTH PHARM, V11, P86; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zhang YH, 2014, EMBO J, V33, P1341, DOI 10.1002/embj.201488126; Zhang YH, 2012, J BIOL CHEM, V287, P9336, DOI 10.1074/jbc.M111.334797; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069	39	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4614	4622		10.1074/jbc.M116.754804	http://dx.doi.org/10.1074/jbc.M116.754804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28174300	hybrid, Green Published			2022-12-28	WOS:000397585100019
J	Yasin, B; Kohn, E; Peters, M; Zaguri, R; Weiss, S; Schopf, K; Katz, B; Huber, A; Minke, B				Yasin, Bushra; Kohn, Elkana; Peters, Maximilian; Zaguri, Rachel; Weiss, Shirley; Schopf, Krystina; Katz, Ben; Huber, Armin; Minke, Baruch			Ectopic Expression of Mouse Melanopsin in Drosophila Photoreceptors Reveals Fast Response Kinetics and Persistent Dark Excitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; electrophysiology; gene expression; photoreceptor; rhodopsin; Opn4; Early Receptor Potential; single photon response	RETINAL GANGLION-CELLS; IN-VIVO; VISUAL PIGMENT; PHOSPHOLIPASE-C; G-PROTEIN; PHOTOTRANSDUCTION CASCADE; HETEROLOGOUS EXPRESSION; GENETIC DISSECTION; LIGHT RESPONSE; RHODOPSIN	The intrinsically photosensitive M1 retinal ganglion cells (ipRGC) initiate non-image-forming light-dependent activities and express the melanopsin (OPN4) photopigment. Several features of ipRGC photosensitivity are characteristic of fly photoreceptors. However, the light response kinetics of ipRGC is much slower due to unknown reasons. Here we used transgenic Drosophila, in which the mouse OPN4 replaced the native Rh1 photopigment of Drosophila R1-6 photoreceptors, resulting in deformed rhabdomeric structure. Immunocytochemistry revealed OPN4 expression at the base of the rhabdomeres, mainly at the rhabdomeral stalk. Measurements of the early receptor current, a linear manifestation of photopigment activation, indicated large expression of OPN4 in the plasma membrane. Comparing the early receptor current amplitude and action spectra between WT and the Opn4-expressing Drosophila further indicated that large quantities of a blue absorbing photopigment were expressed, having a dark stable blue intermediate state. Strikingly, the light-induced current of the Opn4-expressing fly photoreceptors was approximate to 40-fold faster than that of ipRGC. Furthermore, an intense white flash induced a small amplitude prolonged dark current composed of discrete unitary currents similar to the Drosophila single photon responses. The induction of prolonged dark currents by intense blue light could be suppressed by a following intense green light, suggesting induction and suppression of prolonged depolarizing afterpotential. This is the first demonstration of heterologous functional expression of mammalian OPN4 in the genetically emendable Drosophila photoreceptors. Moreover, the fast OPN4-activated ionic current of Drosophila photoreceptors relative to that of mouse ipRGC, indicates that the slow light response of ipRGC does not arise from an intrinsic property of melanopsin.	[Yasin, Bushra; Kohn, Elkana; Peters, Maximilian; Zaguri, Rachel; Weiss, Shirley; Katz, Ben; Minke, Baruch] Hebrew Univ Jerusalem, Dept Med Neurobiol, IMRIC, Fac Med, IL-91120 Jerusalem, Israel; [Yasin, Bushra; Kohn, Elkana; Peters, Maximilian; Zaguri, Rachel; Weiss, Shirley; Katz, Ben; Minke, Baruch] Hebrew Univ Jerusalem, Fac Med, Edmond & Lily Safra Ctr Brain Sci ELSC, IL-91120 Jerusalem, Israel; [Schopf, Krystina; Huber, Armin] Univ Hohenheim, Inst Physiol, Dept Biosensor, D-70599 Stuttgart, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University Hohenheim	Minke, B (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, IL-91120 Jerusalem, Israel.	baruchm@ekmd.huji.ac.il	Huber, Armin/GYU-6322-2022; Peters, Maximilian/AAA-3509-2020	Wagner, Krystina/0000-0001-8840-3805	Israel Science Foundation (ISF); Deutsch-Israelische Projektkooperation (DIP); US-Israel Binational Science Foundation (BSF)	Israel Science Foundation (ISF)(Israel Science Foundation); Deutsch-Israelische Projektkooperation (DIP); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	This work was supported by grants from the Israel Science Foundation (ISF), the Deutsch-Israelische Projektkooperation (DIP), and the US-Israel Binational Science Foundation (BSF). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad ST, 2006, INVEST OPHTH VIS SCI, V47, P3722, DOI 10.1167/iovs.06-0281; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borges R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052413; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Cerny AC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005578; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; CONE RA, 1964, NATURE, V204, P736, DOI 10.1038/204736a0; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Ferrer C, 2012, J NEUROSCI, V32, P17977, DOI 10.1523/JNEUROSCI.3069-12.2012; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HILLMAN P, 1973, J GEN PHYSIOL, V62, P77, DOI 10.1085/jgp.62.1.77; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; HOCHSTEIN S, 1973, J GEN PHYSIOL, V62, P105, DOI 10.1085/jgp.62.1.105; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; Katz B, 2012, J NEUROSCI, V32, P2722, DOI 10.1523/JNEUROSCI.5221-11.2012; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; Knox BE, 2003, J BIOL CHEM, V278, P40493, DOI 10.1074/jbc.M304567200; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MINKE B, 1973, J GEN PHYSIOL, V62, P87, DOI 10.1085/jgp.62.1.87; MINKE B, 1974, BIOPHYS J, V14, P490, DOI 10.1016/S0006-3495(74)85929-1; Minke B., 1992, SENSORY TRANSDUCTION, P202; Minke B, 2012, J NEUROGENET, V26, P106, DOI 10.3109/01677063.2012.666299; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2016, NEURON, V90, P1016, DOI 10.1016/j.neuron.2016.04.016; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; PAK WL, 1974, J GEN PHYSIOL, V63, P740, DOI 10.1085/jgp.63.6.740; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; Pinal N, 2011, J CELL SCI, V124, P1564, DOI 10.1242/jcs.082115; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Rinaldi S, 2014, P NATL ACAD SCI USA, V111, P1714, DOI 10.1073/pnas.1309508111; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sekharan S, 2011, J AM CHEM SOC, V133, P19052, DOI 10.1021/ja208789h; SELINGER Z, 1993, BIOCHIM BIOPHYS ACTA, V1179, P283, DOI 10.1016/0167-4889(93)90084-3; Sexton TJ, 2012, J BIOL CHEM, V287, P20888, DOI 10.1074/jbc.M111.325969; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Spoida K, 2016, CURR BIOL, V26, P1206, DOI 10.1016/j.cub.2016.03.007; Tsukamoto H, 2015, J BIOL CHEM, V290, P27176, DOI 10.1074/jbc.M115.666305; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang T, 2005, J NEUROSCI, V25, P5187, DOI 10.1523/JNEUROSCI.0995-05.2005; Wang XY, 2010, CURR BIOL, V20, P93, DOI 10.1016/j.cub.2009.12.022; Weiss S, 2012, J NEUROSCI, V32, P14696, DOI 10.1523/JNEUROSCI.2456-12.2012; Xue HH, 2000, J BIOCHEM, V128, P329, DOI 10.1093/oxfordjournals.jbchem.a022757; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	67	4	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3624	3636		10.1074/jbc.M116.754770	http://dx.doi.org/10.1074/jbc.M116.754770			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28119450	hybrid, Green Published			2022-12-28	WOS:000395542500008
J	Beydoun, R; Hamood, MA; Zubieta, DMG; Kondapalli, KC				Beydoun, Rami; Hamood, Mohamed A.; Zubieta, Daniela M. Gomez; Kondapalli, Kalyan C.			Na+/H+ Exchanger 9 Regulates Iron Mobilization at the Blood-Brain Barrier in Response to Iron Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; RESTLESS LEGS SYNDROME; NEURODEGENERATIVE DISORDERS; GENE-EXPRESSION; RAT-BRAIN; MODEL; COCULTURE; TRANSPORT; ACCUMULATION; PERMEABILITY	Iron is essential for brain function, with loss of iron homeo-stasis in the brain linked to neurological diseases ranging from rare syndromes to more common disorders, such as Parkinson's and Alzheimer's diseases. Iron entry into the brain is regulated by the blood-brain barrier (BBB). Molecular mechanisms regulating this transport are poorly understood. Using an in vitro model of the BBB, we identify NHE9, an endosomal cation/proton exchanger, as a novel regulator of this system. Human brain microvascular endothelial cells (hBMVECs) that constitute the BBB receive brain iron status information via paracrine signals from ensheathing astrocytes. In hBMVECs, we show that NHE9 expression is up-regulated very early in a physiological response invoked by paracrine signals from iron-starved astrocytes. Ectopic expression of NHE9 in hBMVECs without external cues induced up-regulation of the transferrin receptor (TfR) and down-regulation of ferritin, leading to an increase in iron uptake. Mechanistically, we demonstrate that NHE9 localizes to recycling endosomes in hBMVECs where it raises the endosomal pH. The ensuing alkalization of the endosomal lumen increased translocation of TfRs to the hBMVEC membrane. TfRs on the membrane were previously shown to facilitate both recycling-dependent and -independent iron uptake. We propose that NHE9 regulates TfR-dependent, recycling-independent iron uptake in hBMVECs by fine-tuning the endosomal pH in response to paracrine signals and is therefore an important regulator in iron mobilization pathway at the BBB.	[Zubieta, Daniela M. Gomez; Kondapalli, Kalyan C.] Univ Michigan Dearborn, Dept Nat Sci, 4901 Evergreen Rd,ASC 207, Dearborn, MI 48128 USA	University of Michigan System; University of Michigan Dearborn	Kondapalli, KC (corresponding author), Univ Michigan Dearborn, Dept Nat Sci, 4901 Evergreen Rd,ASC 207, Dearborn, MI 48128 USA.	kondap@umich.edu	Kondapalli, Kalyan C/N-8097-2019		Office of Research and Sponsored Programs, University of Michigan-Dearborn; Department of Natural Sciences	Office of Research and Sponsored Programs, University of Michigan-Dearborn; Department of Natural Sciences	This work was supported by funds provided to Kalyan C. Kondapalli by the Department of Natural Sciences and Office of Research and Sponsored Programs, University of Michigan-Dearborn. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Allen Institute for Brain Science, 2010, ALL HUM BRAIN ATL; Allen RP, 2001, NEUROLOGY, V56, P263, DOI 10.1212/WNL.56.2.263; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Boveri M, 2005, GLIA, V51, P187, DOI 10.1002/glia.20189; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Cabantchik ZI, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00045; Cardon M, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000062; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Coelho L., 2010, INT J SOFTWARE SCI C, DOI [10.1109/COGINF, DOI 10.1109/COGINF.2009.5250695]; Connor JR, 2011, BRAIN, V134, P959, DOI 10.1093/brain/awr012; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Demeuse P, 2002, J NEUROSCI METH, V121, P21, DOI 10.1016/S0165-0270(02)00225-X; Diaz-Coranguez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060655; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; DSa C, 1996, MOL BRAIN RES, V41, P105, DOI 10.1016/0169-328X(96)00073-3; Du F, 2015, MOL NEUROBIOL, V52, P101, DOI 10.1007/s12035-014-8847-x; Duck KA, 2016, BIOMETALS, V29, P573, DOI 10.1007/s10534-016-9952-2; Easton AS, 2002, BRAIN RES, V953, P157, DOI 10.1016/S0006-8993(02)03281-X; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hurst RD, 1996, J CELL PHYSIOL, V167, P81, DOI 10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.3.CO;2-F; Kondapalli KC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7289; Kondapalli KC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00172; Kondapalli KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3510; Levy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092165; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Martinelli-Boneschi F, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.008; McCarthy RC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00031; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Patak J, 2017, AUTISM RES, V10, P414, DOI 10.1002/aur.1670; Perez-Palma E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095413; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simpson IA, 2015, J CEREBR BLOOD F MET, V35, P48, DOI 10.1038/jcbfm.2014.168; THEIL EC, 1990, J BIOL CHEM, V265, P4771; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Yang LN, 2016, AM J MED GENET B, V171, P363, DOI 10.1002/ajmg.b.32415; Youdim M. B., 1988, BRAIN IRON NEUROCHEM, P25; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang-James Y, 2012, DEV NEUROSCI-BASEL, V34, P218, DOI 10.1159/000338813; Zhang-James Y, 2011, AM J MED GENET B, V156B, P835, DOI 10.1002/ajmg.b.31229; Zhao HS, 2016, PROG NEUROBIOL, V138, P19, DOI 10.1016/j.pneurobio.2016.02.002	57	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4293	4301		10.1074/jbc.M116.769240	http://dx.doi.org/10.1074/jbc.M116.769240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130443	Green Published, hybrid			2022-12-28	WOS:000395837100026
J	Liu, XY; Chen, M; Li, L; Gong, LY; Zhou, H; Gao, DM				Liu, Xiangyuan; Chen, Min; Li, Long; Gong, Liyan; Zhou, Hu; Gao, Daming			Extracellular Signal-regulated Kinases (ERKs) Phosphorylate Lin28a Protein to Modulate P19 Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; STEM-CELLS; NEURONAL DIFFERENTIATION; SELF-RENEWAL; CYCLIN D1; PLURIPOTENCY; METABOLISM; EXPRESSION; NEUROGENESIS; URIDYLATION	Lin28a, originally discovered in the nematode Caenorhabditis elegans and highly conserved across species, is a well characterized regulator of let-7 microRNA (miRNA) and is implicated in cell proliferation and pluripotency control. However, little is known about how Lin28a function is modulated at the posttranslational level and thereby responds to major signaling pathways. Here we show that Lin28a is directly phosphorylated by ERK1/2 kinases at Ser-200. By editing lin28a gene with the CRISPR/Cas9-based method, we generated P19 mouse embryonic carcinoma stem cells expressing Lin28a-S200A (phosphodeficient) and Lin28a-S200D (phospho-mimetic) mutants, respectively, to study the functional impact of Ser-200 phosphorylation. Lin28a-S200D-expressing cells, but not Lin28a-S200A-expressing or control P19 embryonic carcinoma cells, displayed impaired inhibition of let-7 miRNA and resulted in decreased cyclin D1, whereas Lin28a-S200-A knock-in cells expressed less let-7 miRNA, proliferated faster, and exhibited differentiation defect upon retinoic acid induction. Therefore our results support that ERK kinase-mediated Lin28a phosphorylation may be an important mechanism for pluripotent cells to facilitate the escape from the self-renewal cycle and start the differentiation process.	[Liu, Xiangyuan; Chen, Min; Li, Long; Gong, Liyan; Zhou, Hu; Gao, Daming] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Key Lab Sys, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, 320 Yueyang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Gao, DM (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Key Lab Sys, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	dgao@sibcb.ac.cn		Gao, Daming/0000-0003-4374-1055	Ministry of Science and Technology of China [2015CB964502]; National Science Foundation of China Grant [81372602, 81422033]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China Grant; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grant 2015CB964502, National Science Foundation of China Grants 81372602 and 81422033, and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000) (to D.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Choudhury NR, 2014, CELL REP, V9, P1265, DOI 10.1016/j.celrep.2014.10.017; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Leontieva OV, 2013, CELL DEATH DIFFER, V20, P1241, DOI 10.1038/cdd.2013.86; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Meloche S, 2004, CELL CYCLE, V3, P241; Nowak JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4687; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tsanov KM, 2017, NAT CELL BIOL, V19, P60, DOI 10.1038/ncb3453; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	42	8	8	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3970	3976		10.1074/jbc.C117.775122	http://dx.doi.org/10.1074/jbc.C117.775122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28179426	Green Published, hybrid			2022-12-28	WOS:000395837100002
J	Singh, SK; Thirumalai, A; Pathak, A; Ngwa, DN; Agrawal, A				Singh, Sanjay K.; Thirumalai, Avinash; Pathak, Asmita; Ngwa, Donald N.; Agrawal, Alok			Functional Transformation of C-reactive Protein by Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host defense; immunology; inflammation; innate immunity; ligand-binding protein	LOW-DENSITY-LIPOPROTEIN; MODULATES COMPLEMENT ACTIVATION; SITE-DIRECTED MUTAGENESIS; INFLAMMATION IN-VIVO; AMYLOID P COMPONENT; OXIDATIVE STRESS; ATHEROSCLEROTIC LESIONS; PNEUMOCOCCAL INFECTION; ENDOTHELIAL-CELLS; INDUCED ARTHRITIS	C-reactive protein (CRP) is present at sites of inflammation including amyloid plaques, atherosclerotic lesions, and arthritic joints. CRP, in its native pentameric structural conformation, binds to cells and molecules that have exposed phosphocholine (PCh) groups. CRP, in its non-native pentameric structural conformation, binds to a variety of deposited, denatured, and aggregated proteins, in addition to binding to PCh-containing substances. In this study, we investigated the effects of H2O2, a prototypical reactive oxygen species that is also present at sites of inflammation, on the ligand recognition function of CRP. Controlled H2O2 treatment of native CRP did not monomerize CRP and did not affect the PCh binding activity of CRP. In solid phase ELISA-based ligand binding assays, purified pentameric H2O2-treated CRP bound to a number of immobilized proteins including oxidized LDL, IgG, amyloid peptide 1-42, C4b-binding protein, and factor H, in a CRP concentration- and ligand concentration-dependent manner. Using oxidized LDL as a representative protein ligand for H2O2-treated CRP, we found that the binding occurred in a Ca2+-independent manner and did not involve the PCh-binding site of CRP. We conclude that H2O2 is a biological modifier of the structure and ligand recognition function of CRP. Overall, the data suggest that the ligand recognition function of CRP is dependent on the presence of an inflammatory microenvironment. We hypothesize that one of the functions of CRP at sites of inflammation is to sense the inflammatory microenvironment, change its own structure in response but remain pentameric, and then bind to pathogenic proteins deposited at those sites.	[Singh, Sanjay K.; Thirumalai, Avinash; Pathak, Asmita; Ngwa, Donald N.; Agrawal, Alok] East Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Agrawal, A (corresponding author), East Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, Johnson City, TN 37614 USA.	agrawal@etsu.edu		Thirumalai, Avinash/0000-0002-7722-7479	National Institutes of Health [AR068787, AI117730]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI117730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR068787 (to A. A.) and AI117730 (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGRAWAL A, 1994, J IMMUNOL, V152, P5404; Agrawal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/319215; Agrawal Alok, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P235; Ahmed UK, 2016, J BIOL CHEM, V291, P11939, DOI 10.1074/jbc.M115.702746; Asztalos BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109238; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Boguslawski G, 2007, J HEART LUNG TRANSPL, V26, P705, DOI 10.1016/j.healun.2007.04.006; Boncler M, 2011, PHARMACOL REP, V63, P464, DOI 10.1016/S1734-1140(11)70513-8; Braig D, 2014, INT IMMUNOL, V26, P467, DOI 10.1093/intimm/dxu056; Chang MK, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-42; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Csincsi AI, 2015, J IMMUNOL, V194, P4963, DOI 10.4049/jimmunol.1403121; Danielsen B, 1997, BBA-PROTEIN STRUCT M, V1339, P73, DOI 10.1016/S0167-4838(96)00218-X; de Oliveira S, 2014, J IMMUNOL, V192, P5710, DOI 10.4049/jimmunol.1302902; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Dimitrov JD, 2013, MOL IMMUNOL, V55, P195, DOI 10.1016/j.molimm.2013.03.009; Doni A, 2015, J EXP MED, V212, P905, DOI 10.1084/jem.20141268; Dorta-Estremera S. M., 2015, J CLIN CELL IMMUNOL, V6, P332; DUCLOS TW, 1981, CLIN EXP IMMUNOL, V43, P565; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Fu T, 2002, BIOCHEM J, V366, P195, DOI 10.1042/BJ20020045; Gang TB, 2015, INFECT IMMUN, V83, P1845, DOI 10.1128/IAI.03058-14; GITLIN JD, 1977, ARTHRITIS RHEUM, V20, P1491, DOI 10.1002/art.1780200808; Guillon C, 2015, PROTEIN PEPTIDE LETT, V22, P248, DOI 10.2174/0929866522666141231111226; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; JIANG H, 1991, IMMUNOLOGY, V74, P725; Jiang S, 2006, SCAND J RHEUMATOL, V35, P351, DOI 10.1080/03009740600757963; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; KOTTGEN E, 1992, J IMMUNOL, V149, P445; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li HY, 2016, J BIOL CHEM, V291, P8795, DOI 10.1074/jbc.M115.695023; Millonig G, 2012, J BIOL CHEM, V287, P37472, DOI 10.1074/jbc.M112.358911; MIYAZAWA K, 1988, J IMMUNOL, V141, P570; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Motie M, 1996, J IMMUNOL, V156, P4435; Nayeri H, 2010, ARYA ATHEROSCLER, V6, P85; Okahashi N, 2016, INFECT IMMUN, V84, P2042, DOI 10.1128/IAI.00134-16; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Ottaviano FG, 2008, CIRC J, V72, P1, DOI 10.1253/circj.72.1; Ozawa D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29077; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Reifenberg K, 2005, ARTERIOSCL THROM VAS, V25, P1641, DOI 10.1161/01.ATV.0000171983.95612.90; ROWE IF, 1985, J PATHOL, V145, P241, DOI 10.1002/path.1711450305; Rufail ML, 2006, FEBS LETT, V580, P5155, DOI 10.1016/j.febslet.2006.08.045; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; Sato A, 2014, EUR J PHARMACOL, V745, P46, DOI 10.1016/j.ejphar.2014.10.020; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Schwedler SB, 2009, CLIN CHEM, V55, P1728, DOI 10.1373/clinchem.2009.125732; Shi P, 2014, ACTA BIOL HUNG, V65, P265, DOI 10.1556/ABiol.65.2014.3.3; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Simons JP, 2014, IMMUNOLOGY, V142, P414, DOI 10.1111/imm.12266; Singh SK, 2008, J IMMUNOL, V180, P4316, DOI 10.4049/jimmunol.180.6.4316; Singh SK, 2012, J BIOL CHEM, V287, P3550, DOI 10.1074/jbc.M111.310011; Singh SK, 2009, CLIN CHIM ACTA, V409, P143, DOI 10.1016/j.cca.2009.08.013; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Sun HJ, 2005, AM J PATHOL, V167, P1139, DOI 10.1016/S0002-9440(10)61202-3; Suresh MV, 2004, J BIOL CHEM, V279, P52552, DOI 10.1074/jbc.M409054200; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; Thiele M, 2015, J IMMUNOL, V195, P2343, DOI 10.4049/jimmunol.1500572; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; TSUJIMOTO M, 1983, J BIOCHEM, V94, P1367, DOI 10.1093/oxfordjournals.jbchem.a134483; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; VOLANAKIS JE, 1979, NATURE, V281, P155, DOI 10.1038/281155a0; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Zhang J, 2011, BIOCHIMIE, V93, P1710, DOI 10.1016/j.biochi.2011.06.003; Zhang R, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-42	85	19	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3129	3136		10.1074/jbc.M116.773176	http://dx.doi.org/10.1074/jbc.M116.773176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28096464	Green Published, hybrid			2022-12-28	WOS:000395538800006
J	Luo, JH; Warmlander, SKTS; Graslund, A; Abrahams, JP				Luo, Jinghui; Warmlander, Sebastian K. T. S.; Graslund, Astrid; Abrahams, Jan Pieter			Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins. A FURTHER ASPECT OF THE AMYLOID CASCADE HYPOTHESIS (vol 291, pg 16488, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Abrahams, Jan Pieter/AAE-4319-2020	Abrahams, Jan Pieter/0000-0001-8216-1868				Luo JH, 2017, J BIOL CHEM, V292, P2046, DOI 10.1074/jbc.A116.714576	1	8	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2046	2046		10.1074/jbc.A116.714576	http://dx.doi.org/10.1074/jbc.A116.714576			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159759	hybrid, Green Published			2022-12-28	WOS:000395515600041
J	Guo, HT; Cai, CQ; Kuo, PC				Guo, Hongtao; Cai, Charles Q.; Kuo, Paul C.			RETRACTION: Hepatocyte nuclear factor-4 alpha mediates redox sensitivity of inducible nitric-oxide synthase gene transcription (Retraction of Vol 277, Pg 5054, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Guo HT, 2002, J BIOL CHEM, V277, P5054, DOI 10.1074/jbc.M109017200	1	0	0	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1143	1143		10.1074/jbc.A116.109017	http://dx.doi.org/10.1074/jbc.A116.109017			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	28108615	Green Published, hybrid			2022-12-28	WOS:000392318700033
J	Vaidyanathan, K; Niranjan, T; Selvan, N; Teo, CF; May, M; Patel, S; Weatherly, B; Skinner, C; Opitz, J; Carey, J; Viskochil, D; Gecz, J; Shaw, M; Peng, YH; Alexov, E; Wang, T; Schwartz, C; Wells, L				Vaidyanathan, Krithika; Niranjan, Tejasvi; Selvan, Nithya; Teo, Chin Fen; May, Melanie; Patel, Sneha; Weatherly, Brent; Skinner, Cindy; Opitz, John; Carey, John; Viskochil, David; Gecz, Jozef; Shaw, Marie; Peng, Yunhui; Alexov, Emil; Wang, Tao; Schwartz, Charles; Wells, Lance			Identification and characterization of a missense mutation in the O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase gene that segregates with X-linked intellectual disability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; NUCLEOCYTOPLASMIC PROTEINS; CHROMOSOME INACTIVATION; SUBSTRATE-SPECIFICITY; INSULIN-RESISTANCE; FRAGILE-X; GLYCOSYLATION; NUCLEAR	O-GlcNAc is a regulatory post-translational modification of nucleocytoplasmic proteins that has been implicated in multiple biological processes, including transcription. In humans, single genes encode enzymes for its attachment (O-GlcNAc transferase (OGT)) and removal (O-GlcNAcase (OGA)). An X-chromosome exome screen identified a missense mutation, which encodes an amino acid in the tetratricopeptide repeat, in OGT (759G>T (p.L254F)) that segregates with X-linked intellectual disability (XLID) in an affected family. A decrease in steady-state OGT protein levels was observed in isolated lymphoblastoid cell lines from affected individuals, consistent with molecular modeling experiments. Recombinant expression of L254F-OGT demonstrated that the enzyme is active as both a glycosyltransferase and an HCF-1 protease. Despite the reduction in OGT levels seen in the L254F-OGT individual cells, we observed that steady-state global O-GlcNAc levels remained grossly unaltered. Surprisingly, lymphoblastoids from affected individuals displayed a marked decrease in steady-state OGA protein and mRNA levels. We observed an enrichment of the OGT-containing transcriptional repressor complex mSin3A-HDAC1 at the proximal promoter region of OGA and correspondingly decreased OGA promoter activity in affected cells. Global transcriptome analysis of L254F-OGT lymphoblastoids compared with controls revealed a small subset of genes that are differentially expressed. Thus, we have begun to unravel the molecular consequences of the 759G>T (p.L254F) mutation in OGT that uncovered a compensation mechanism, albeit imperfect, given the phenotype of affected individuals, to maintain steady-state O-GlcNAc levels. Thus, a single amino acid substitution in the regulatory domain (the tetratricopeptide repeat domain) of OGT, which catalyzes the O-GlcNAc post-translational modification of nuclear and cytosolic proteins, appears causal for XLID.	[Vaidyanathan, Krithika; Selvan, Nithya; Teo, Chin Fen; Patel, Sneha; Weatherly, Brent; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA; [Niranjan, Tejasvi; Wang, Tao] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [May, Melanie; Skinner, Cindy; Schwartz, Charles] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Opitz, John; Carey, John; Viskochil, David] Univ Utah, Sch Med, Pediat Med Genet Pediat Pathol Human Genet Obstet, Salt Lake City, UT 84132 USA; [Gecz, Jozef; Shaw, Marie] Univ Adelaide, Dept Paediat, Adelaide, SA 5006, Australia; [Gecz, Jozef; Shaw, Marie] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5006, Australia; [Peng, Yunhui; Alexov, Emil] Clemson Univ, Dept Computat Biophys & Bioinformat, Clemson, SC 29634 USA	University System of Georgia; University of Georgia; Johns Hopkins University; Greenwood Genetic Center; Utah System of Higher Education; University of Utah; University of Adelaide; Robinson Research Institute; University of Adelaide; Clemson University	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA.; Schwartz, C (corresponding author), Greenwood Genet Ctr, Greenwood, SC 29646 USA.	ceschwartz@ggc.org; lwells@ccrc.uga.edu	Peng, Yunhui/AAA-3393-2021; Niranjan, Tejasvi/ABD-2892-2020; Vaidyanathan, Krithika/AAN-4574-2020; Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861; Wells, Lance/0000-0003-4956-5363	W.M. Keck Foundation; NIGMS, National Institutes of Health (NIH) [P41GM103490]; NINDS, NIH [RO1NS073854]; South Carolina Department of Disabilities and Special Needs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073854] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); South Carolina Department of Disabilities and Special Needs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a grant from the W.M. Keck Foundation (to L. W.); NIGMS, National Institutes of Health (NIH) Grant P41GM103490 (to L. W.); NINDS, NIH, Grant RO1NS073854 (to C. E. S. and T. W.); and a grant from the South Carolina Department of Disabilities and Special Needs (to C. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; [Anonymous], 2010, R LANG ENV STAT COMP; ANTECOL MH, 1986, CANCER RES, V46, P1867; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekanayake D, 2011, EUKARYOT CELL, V10, P1465, DOI 10.1128/EC.05185-11; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HART GW, 1989, CIBA F SYMP, V145, P102; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Huq A., 2015, AM SOC HUM GEN ANN M, p2297T; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Janetzko J, 2016, NAT CHEM BIOL, V12, P899, DOI [10.1038/NCHEMBIO.2173, 10.1038/nchembio.2173]; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lisik MZ, 2008, MED SCI MONITOR, V14, pRA221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Otte Christine, 2013, Praxis (Bern 1994), V102, P1467, DOI 10.1024/1661-8157/a001488; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Raymond FL, 2006, J MED GENET, V43, P193, DOI 10.1136/jmg.2005.033043; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Salvador-Carulla L, 2008, PSYCHOPATHOLOGY, V41, P10, DOI 10.1159/000109950; Selvan N, 2015, J BIOL CHEM, V290, P11969, DOI 10.1074/jbc.M114.628750; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaidyanathan K, 2014, CRIT REV BIOCHEM MOL, V49, P140, DOI 10.3109/10409238.2014.884535; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	73	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8948	8963		10.1074/jbc.M116.771030	http://dx.doi.org/10.1074/jbc.M116.771030			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28302723	hybrid, Green Published			2022-12-28	WOS:000402153900046
J	Peters, D; Radine, C; Reese, A; Budach, W; Sohn, D; Janicke, RU				Peters, Dominik; Radine, Claudia; Reese, Alina; Budach, Wilfried; Sohn, Dennis; Jaenicke, Reiner U.			The DEAD-box RNA helicase DDX41 is a novel repressor of p21(WAF1/CIP1) mRNA translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRRADIATION-INDUCED APOPTOSIS; BINDING PROTEIN; P21 EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; MULTIPLE FUNCTIONS; EMERGING ROLES; CELL-CYCLE; P53; INHIBITOR; TARGET	The cyclin-dependent kinase inhibitor p21 is an important player in stress pathways exhibiting both tumor-suppressive and oncogenic functions. Thus, expression of p21 has to be tightly controlled, which is achieved by numerous mechanisms at the transcriptional, translational, and posttranslational level. Performing immunoprecipitation of bromouridine-labeled p21 mRNAs that had been incubated before with cytoplasmic extracts of untreated HCT116 colon carcinoma cells, we identified the DEAD-box RNA helicase DDX41 as a novel regulator of p21 expression. DDX41 specifically precipitates with the 3'UTR, but not with the 5'UTR, of p21 mRNA. Knockdown of DDX41 increases basal and gamma irradiation-induced p21 protein levels without affecting p21 mRNA expression. Conversely, overexpression of DDX41 strongly inhibits expression of a FLAG-p21 and a luciferase construct, but only in the presence of the p21 3'UTR. Together, these data suggest that this helicase regulates p21 expression at the translational level independent of the transcriptional activity of p53. However, knockdown of DDX41 completely fails to increase p21 protein levels in p53-deficient HCT116 cells. Moreover, posttranslational up-regulation of p21 achieved in both p53(+/+) and p53(-/-) HCT116 cells in response to pharmaceutical inhibition of the proteasome (by MG-132) or p90 ribosomal S6 kinases (by BI-D1870) is further increased by knockdown of DDX41 only in p53-proficient but not in p53-deficient cells. Although our data demonstrate that DDX41 suppresses p21 translation without disturbing the function of p53 to directly induce p21 mRNA expression, this process indirectly requires p53, perhaps in the form of another p53 target gene or as a still undefined posttranscriptional function of p53.	[Peters, Dominik; Radine, Claudia; Reese, Alina; Budach, Wilfried; Sohn, Dennis; Jaenicke, Reiner U.] Heinrich Heine Univ, Med Fac, Clin Radiat Therapy & Radiooncol, Lab Mol Radiooncol, Univ Str 1, D-40255 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Janicke, RU (corresponding author), Heinrich Heine Univ, Med Fac, Clin Radiat Therapy & Radiooncol, Lab Mol Radiooncol, Univ Str 1, D-40255 Dusseldorf, Germany.	janicke@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft Grants [JA 1060/3-1, JA 1060/5-1, SO 881/5-1]	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants JA 1060/3-1 and JA 1060/5-1 (to R.U.J.) and SO 881/5-1 (to D.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abdelhaleem M, 2004, ANTICANCER RES, V24, P3951; Abdul-Ghani M, 2005, J CELL PHYSIOL, V204, P210, DOI 10.1002/jcp.20285; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Germann S, 2012, ONCOGENE, V31, P4536, DOI 10.1038/onc.2011.618; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Irion U, 2004, CURR BIOL, V14, P138, DOI 10.1016/j.cub.2004.01.002; Irion U, 1999, CURR BIOL, V9, P1373, DOI 10.1016/S0960-9822(00)80082-2; Janicke RU, 2007, CELL CYCLE, V6, P407; Jiang Y, 2017, PROTEIN CELL, V8, P83, DOI 10.1007/s13238-016-0303-4; Jiang YQ, 2014, J BIOL CHEM, V289, P3164, DOI 10.1074/jbc.M113.524413; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lewinsohn M, 2016, BLOOD, V127, P1017, DOI 10.1182/blood-2015-10-676098; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Linder P, 2013, BBA-GENE REGUL MECH, V1829, P750, DOI 10.1016/j.bbagrm.2013.03.007; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marcel V, 2015, ONCOGENE, V34, P5513, DOI 10.1038/onc.2015.25; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Neise D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.386; Nicol SM, 2013, ONCOGENE, V32, P3461, DOI 10.1038/onc.2012.426; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schmucker D, 2000, MECH DEVELOP, V91, P189, DOI 10.1016/S0925-4773(99)00298-1; Scott DD, 2016, BIOCHEM CELL BIOL, V94, P419, DOI 10.1139/bcb-2016-0068; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Sohn D, 2016, ONCOTARGET, V7, P15915, DOI 10.18632/oncotarget.7432; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zaccara S, 2014, CELL DEATH DIFFER, V21, P1522, DOI 10.1038/cdd.2014.79; Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	58	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8331	8341		10.1074/jbc.M116.772327	http://dx.doi.org/10.1074/jbc.M116.772327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348086	Green Published, hybrid			2022-12-28	WOS:000401788600018
J	Sens, C; Huck, K; Pettera, S; Uebel, S; Wabnitz, G; Moser, M; Nakchbandi, IA				Sens, Carla; Huck, Katrin; Pettera, Stefan; Uebel, Stephan; Wabnitz, Guido; Moser, Markus; Nakchbandi, Inaam A.			Fibronectins containing extradomain A or B enhance osteoblast differentiation via distinct integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED EDA SEGMENT; CELL-ADHESION; IN-VITRO; BONE-FORMATION; MICE LACKING; MATRIX; ALPHA-V-BETA-3; EXPRESSION; BINDING; OSTEOCLASTS	Fibronectin is a multidomain protein secreted by various cell types. It forms a network of fibers within the extracellular matrix and impacts intracellular processes by binding to various molecules, primarily integrin receptors on the cells. Both the presence of several isoforms and the ability of the various domains and isoforms to bind to a variety of integrins result in a wide range of effects. In vivo findings suggest that fibronectin isoforms produced by the osteoblasts enhance their differentiation. Here we report that the isoform characterized by the presence of extradomain A activates alpha 4 beta 1 integrin and augments osteoblast differentiation. In addition, the isoform containing extradomain B enhances the binding of fibronectin through the RGD sequence to beta 3-containing integrin, resulting in increased mineralization by and differentiation of osteoblasts. Our study thus reveals novel functions for two fibronectin isoforms and the mediating receptors in osteoblast differentiation.	[Sens, Carla; Huck, Katrin; Pettera, Stefan; Uebel, Stephan; Moser, Markus; Nakchbandi, Inaam A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Sens, Carla; Huck, Katrin; Wabnitz, Guido; Nakchbandi, Inaam A.] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Nakchbandi, IA (corresponding author), Heidelberg Univ, Max Planck Inst Biochem, Neuenheimer Feld 305,2-OG, D-69120 Heidelberg, Germany.	inaam.nakchbandi@immu.uni-heidelberg.de		Wabnitz, Guido/0000-0001-5101-9885	Max-Planck Society; German Science Foundation (DFG)	Max-Planck Society(Max Planck Society); German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Max-Planck Society and the German Science Foundation (DFG). The authors declare that they have no conflicts of interest with the contents of this article.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Astrof S, 2004, MOL CELL BIOL, V24, P8662, DOI 10.1128/MCB.24.19.8662-8670.2004; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277; CLOVER J, 1992, J CELL SCI, V103, P267; Cseh B, 2010, J CELL SCI, V123, P3989, DOI 10.1242/jcs.073346; Fukuda T, 2002, CANCER RES, V62, P5603; Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Hackl NJ, 2010, SCAND J GASTROENTERO, V45, P349, DOI 10.3109/00365520903490606; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hoepner R, 2014, J CENT NERV SYST DIS, V6, P41, DOI [10.4137/JCNSD.S14049, 10.4137/JCnsD.s14049]; HUGHES DE, 1993, J BONE MINER RES, V8, P527; HULTENBY K, 1993, EUR J CELL BIOL, V62, P86; Hynes R.O., 1990, FIBRONECTINS, P113, DOI DOI 10.1007/978-1-4612-3264-3_6; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Jung YK, 2012, J BONE MINER RES, V27, P2024, DOI 10.1002/jbmr.1632; Kawelke N, 2008, J BONE MINER RES, V23, P1278, DOI 10.1359/JBMR.080313; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Kohan M, 2010, FASEB J, V24, P4503, DOI 10.1096/fj.10-154435; Kraft S, 2016, J MOL MED, V94, P567, DOI 10.1007/s00109-015-1373-0; Kumar CC, 1997, J PHARMACOL EXP THER, V283, P843; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Leone DR, 2003, J PHARMACOL EXP THER, V305, P1150, DOI 10.1124/jpet.102.047332; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; MAKAREM R, 1991, Biochemical Society Transactions, V19, p380S; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Moursi AM, 1997, J CELL SCI, V110, P2187; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Nakamura I, 1999, J CELL SCI, V112, P3985; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Palumbo A, 2011, BRIT J CANCER, V104, P1106, DOI 10.1038/bjc.2011.78; Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062; POSTIGO AA, 1993, J IMMUNOL, V151, P2471; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rossnagl S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002562; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Saruta M, 2014, GASTROENTEROL CLIN N, V43, P581, DOI 10.1016/j.gtc.2014.05.012; SATO M, 1990, J CELL BIOL, V111, P1713, DOI 10.1083/jcb.111.4.1713; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; SCHWARZBAUER JE, 1989, J CELL BIOL, V109, P3445, DOI 10.1083/jcb.109.6.3445; Sens C, 2017, J BONE MINER RES, V32, P70, DOI 10.1002/jbmr.2916; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Su XL, 2016, AM J TRANSL RES, V8, P1447; Trachsel E, 2007, J INVEST DERMATOL, V127, P881, DOI 10.1038/sj.jid.5700653; Yamamoto M, 1998, ENDOCRINOLOGY, V139, P1411, DOI 10.1210/en.139.3.1411; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zou W, 2015, J CELL BIOL, V208, P125, DOI 10.1083/jcb.201410123	56	27	28	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7745	7760		10.1074/jbc.M116.739987	http://dx.doi.org/10.1074/jbc.M116.739987			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325836	Green Published, hybrid			2022-12-28	WOS:000401154100006
J	Lavall, D; Schuster, P; Jacobs, N; Kazakov, A; Bohm, M; Laufs, U				Lavall, Daniel; Schuster, Pia; Jacobs, Nadine; Kazakov, Andrey; Boehm, Michael; Laufs, Ulrich			Rac1 GTPase regulates 11 beta hydroxysteroid dehydrogenase type 2 and fibrotic remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aldosterone; connective tissue growth factor (CTGF); fibrosis; mineralocorticoid receptor; Rac (Rac GTPase); 11 hydroxysteroid dehydrogenase type 2; Rac1	MINERALOCORTICOID RECEPTOR ACTIVATION; CARDIAC FIBROSIS; ATRIAL-FIBRILLATION; HEART-FAILURE; HYPERTENSION; ALDOSTERONE; ASSOCIATION; MECHANISMS; SURVIVAL; INJURY	The aim of the study was to characterize the role of Rac1 GTPase for the mineralocorticoid receptor (MR)-mediated pro-fibrotic remodeling. Transgenic mice with cardiac overexpression of constitutively active Rac1 (RacET) develop an age-dependent phenotype with atrial dilatation, fibrosis, and atrial fibrillation. Expression of MR was similar in RacET and WT mice. The expression of 11 hydroxysteroid dehydrogenase type 2 (11-HSD2) was age-dependently up-regulated in the atria and the left ventricles of RacET mice on mRNA and protein levels. Statin treatment inhibiting Rac1 geranylgeranylation reduced 11-HSD2 up-regulation. Samples of human left atrial myocardium showed a positive correlation between Rac1 activity and 11-HSD2 expression (r = 0.7169). Immunoprecipitation showed enhanced Rac1-bound 11-HSD2 relative to Rac1 expression in RacET mice that was diminished with statin treatment. Both basal and phorbol 12-myristate 13-acetate (PMA)-induced NADPH oxidase activity were increased in RacET and correlated positively with 11-HSD2 expression (r = 0.788 and r = 0.843, respectively). In cultured H9c2 cardiomyocytes, Rac1 activation with l-buthionine sulfoximine increased; Rac1 inhibition with NSC23766 decreased 11-HSD2 mRNA and protein expression. Connective tissue growth factor (CTGF) up-regulation induced by aldosterone was prevented with NSC23766. Cardiomyocyte transfection with 11-HSD2 siRNA abolished the aldosterone-induced CTGF up-regulation. Aldosterone-stimulated MR nuclear translocation was blocked by the 11-HSD2 inhibitor carbenoxolone. In cardiac fibroblasts, nuclear MR translocation induced by aldosterone was inhibited with NSC23766 and spironolactone. NSC23766 prevented the aldosterone-induced proliferation and migration of cardiac fibroblasts and the up-regulation of CTGF and fibronectin. In conclusion, Rac1 GTPase regulates 11-HSD2 expression, MR activation, and MR-mediated pro-fibrotic signaling.	[Lavall, Daniel; Schuster, Pia; Jacobs, Nadine; Kazakov, Andrey; Boehm, Michael; Laufs, Ulrich] Univ Saarland, Klin Innere Med Kardiol Angiol & Internist Intens, Univ Klinikum Saarlandes, D-66421 Homburg, Germany	Saarland University; Universitatsklinikum des Saarlandes	Lavall, D (corresponding author), Kirrberger Str, D-66421 Homburg, Germany.	daniel.lavall@uks.eu	Böhm, Michael/C-3638-2011	Lavall, Daniel/0000-0002-7932-212X	Universitat des Saarlandes; Deutsche Forschungsgemeinschaft [DFG KA 4024/3-1]	Universitat des Saarlandes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Universitat des Saarlandes and by the Deutsche Forschungsgemeinschaft (DFG KA 4024/3-1). The authors declare that they have no conflicts of interest with the contents of this article.	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; Ayuzawa N, 2016, HYPERTENSION, V67, P99, DOI 10.1161/HYPERTENSIONAHA.115.06054; Bauersachs J, 2015, HYPERTENSION, V65, P257, DOI 10.1161/HYPERTENSIONAHA.114.04488; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Funder JW, 2006, ENDOCRINOLOGY, V147, P5564, DOI 10.1210/en.2006-0826; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Kawarazaki H, 2012, J HYPERTENS, V30, P1977, DOI 10.1097/HJH.0b013e3283576904; Kimura S, 2011, HYPERTENS RES, V34, P584, DOI 10.1038/hr.2010.277; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Lavall D, 2014, J BIOL CHEM, V289, P6656, DOI 10.1074/jbc.M113.519256; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Mummidi S, 2016, J MOL CELL CARDIOL, V98, P95, DOI 10.1016/j.yjmcc.2016.07.006; Nagase M, 2012, HYPERTENSION, V59, P500, DOI 10.1161/HYPERTENSIONAHA.111.185520; Odermatt A, 2001, J BIOL CHEM, V276, P28484, DOI 10.1074/jbc.M100374200; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Swedberg K, 2012, J AM COLL CARDIOL, V59, P1598, DOI 10.1016/j.jacc.2011.11.063; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Young MJ, 2008, CURR OPIN NEPHROL HY, V17, P174, DOI 10.1097/MNH.0b013e3282f56854; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zheng Z, 2016, NEW ENGL J MED, V374, P1744, DOI 10.1056/NEJMoa1507750	31	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7542	7553		10.1074/jbc.M116.764449	http://dx.doi.org/10.1074/jbc.M116.764449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28320863	hybrid, Green Published			2022-12-28	WOS:000400761300022
J	McCoy, JM; Stewart, RJ; Uboldi, AD; Li, DD; Schroder, J; Scott, NE; Papenfuss, AT; Lehane, AM; Foster, LJ; Tonkin, CJ				McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.; Li, Dongdi; Schroder, Jan; Scott, Nicollas E.; Papenfuss, Anthony T.; Lehane, Adele M.; Foster, Leonard J.; Tonkin, Christopher J.			A forward genetic screen identifies a negative regulator of rapid Ca2+-dependent cell egress (MS1) in the intracellular parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular genetics; parasite; proteomics; signaling; Toxoplasma gondii; Ca2+ signalling; apicomplexa; forward genetic screen; host cell egress	DEPENDENT PROTEIN-KINASE; MICRONEME SECRETION; CALCIUM; EXPRESSION; INHIBITORS	Toxoplasma gondii, like all apicomplexan parasites, uses Ca2+ signaling pathways to activate gliding motility to power tissue dissemination and host cell invasion and egress. A group of plant-like Ca2+-dependent protein kinases (CDPKs) transduces cytosolic Ca2+ flux into enzymatic activity, but how they function is poorly understood. To investigate how Ca2+ signaling activates egress through CDPKs, we performed a forward genetic screen to isolate gain-of-function mutants from an egress-deficient cdpk3 knockout strain. We recovered mutants that regained the ability to egress from host cells that harbored mutations in the gene Suppressor of Ca2+-dependent Egress 1 (SCE1). Global phosphoproteomic analysis showed that SCE1 deletion restored many cdpk3-dependent phosphorylation events to near wild-type levels. We also show that CDPK3-dependent SCE1 phosphorylation is required to relieve its suppressive activity to potentiate egress. In summary, our work has uncovered a novel component and suppressor of Ca2+-dependent cell egress during Toxoplasma lytic growth.	[McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.; Schroder, Jan; Papenfuss, Anthony T.; Tonkin, Christopher J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.; Schroder, Jan; Papenfuss, Anthony T.; Tonkin, Christopher J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic 3010, Australia; [Li, Dongdi; Lehane, Adele M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Schroder, Jan; Papenfuss, Anthony T.] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; [Scott, Nicollas E.; Foster, Leonard J.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Australian National University; Peter Maccallum Cancer Center; University of British Columbia	Tonkin, CJ (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tonkin@wehi.edu.au	Lehane, Adele M/B-4127-2012; Tonkin, Christopher/K-6534-2019; Papenfuss, Anthony T/C-6297-2008	Lehane, Adele M/0000-0002-0050-9101; Tonkin, Christopher/0000-0002-7036-6222; Papenfuss, Anthony T/0000-0002-1102-8506; SCHROEDER, JAN/0000-0001-5270-0605; Scott, Nichollas/0000-0003-2556-8316				Asano T, 2011, PLANT MOL BIOL, V75, P179, DOI 10.1007/s11103-010-9717-1; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Borges-Pereira L, 2015, J BIOL CHEM, V290, P26914, DOI 10.1074/jbc.M115.652511; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Bullen HE, 2016, CELL HOST MICROBE, V19, P349, DOI 10.1016/j.chom.2016.02.006; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Coleman BI, 2012, JOVE-J VIS EXP, DOI 10.3791/3807; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Gaji RY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005268; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Howard BL, 2015, ACS CHEM BIOL, V10, P1145, DOI 10.1021/cb501004q; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Lourido S, 2013, ACS CHEM BIOL, V8, P1155, DOI 10.1021/cb400115y; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Sidik SM, 2016, J BIOL CHEM, V291, P9566, DOI 10.1074/jbc.M115.703546; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Soldati D, 1995, MOL BIOCHEM PARASIT, V74, P87, DOI 10.1016/0166-6851(95)02487-5; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Stewart RJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12685; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tham WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005343; Treeck M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004197; Uboldi AD, 2015, CELL HOST MICROBE, V18, P670, DOI 10.1016/j.chom.2015.11.004; Wang JL, 2016, PARASITOL RES, V115, P697, DOI 10.1007/s00436-015-4791-6	42	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7662	7674		10.1074/jbc.M117.775114	http://dx.doi.org/10.1074/jbc.M117.775114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28258212	Green Published, hybrid			2022-12-28	WOS:000400761300032
J	Kang, H; Bang, I; Jin, KS; Lee, B; Lee, J; Shao, XQ; Heier, JA; Kwiatkowski, AV; Nelson, WJ; Hardin, J; Weis, WI; Choi, HJ				Kang, Hyunook; Bang, Injin; Jin, Kyeong Sik; Lee, Boyun; Lee, Junho; Shao, Xiangqiang; Heier, Jonathon A.; Kwiatkowski, Adam V.; Nelson, W. James; Hardin, Jeff; Weis, William I.; Choi, Hee-Jung			Structural and functional characterization of Caenorhabditis elegans alpha-catenin reveals constitutive binding to beta-catenin and F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; ADHERENS JUNCTIONS; IN-VITRO; CADHERIN; COMPLEX; VINCULIN; SWITCH; TENSION; SYSTEM; DOMAIN	Intercellular epithelial junctions formed by classical cadherins, beta-catenin, and the actin-binding protein alpha-catenin link the actin cytoskeletons of adjacent cells into a structural continuum. These assemblies transmit forces through the tissue and respond to intracellular and extracellular signals. However, the mechanisms of junctional assembly and regulation are poorly understood. Studies of cadherin-catenin assembly in a number of metazoans have revealed both similarities and unexpected differences in the biochemical properties of the cadherin center dot catenin complex that likely reflect the developmental and environmental requirements of different tissues and organisms. Here, we report the structural and biochemical characterization of HMP-1, the Caenorhabditis elegans alpha-catenin homolog, and compare it with mammalian alpha-catenin. HMP-1 shares overall similarity in structure and actin-binding properties, but displayed differences in conformational flexibility and allosteric regulation from mammalian alpha-catenin. HMP-1 bound filamentous actin with an affinity in the single micromolar range, even when complexed with the beta-catenin homolog HMP-2 or when present in a complex of HMP-2 and the cadherin homolog HMR-1, indicating that HMP-1 binding to F-actin is not allosterically regulated by the HMP-2.HMR-1 complex. The middle (i.e. M) domain of HMP-1 appeared to be less conformationally flexible than mammalian alpha-catenin, which may underlie the dampened effect of HMP-2 binding on HMP-1 actin-binding activity compared with that of the mammalian homolog. In conclusion, our data indicate that HMP-1 constitutively binds beta-catenin and F-actin, and although the overall structure and function of HMP-1 and related alpha-catenins are similar, the vertebrate proteins appear to be under more complex conformational regulation.	[Kang, Hyunook; Bang, Injin; Lee, Junho; Choi, Hee-Jung] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Jin, Kyeong Sik] Pohang Accelerator Lab, Pohang 37673, Gyeongbuk, South Korea; [Lee, Boyun; Lee, Junho] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 08826, South Korea; [Lee, Junho] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 08826, South Korea; [Shao, Xiangqiang; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Shao, Xiangqiang; Hardin, Jeff] Univ Wisconsin, Program Genet, Madison, WI 53706 USA; [Heier, Jonathon A.; Kwiatkowski, Adam V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Sch Med, Stanford, CA 94305 USA; [Nelson, W. James; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Stanford University; Stanford University	Choi, HJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	choihj@snu.ac.kr	; Weis, William/G-1437-2011	Choi, Hee-Jung/0000-0002-1167-1526; Bang, Injin/0000-0003-0247-6056; Kang, Hyunook/0000-0002-7017-4597; Weis, William/0000-0002-5583-6150; Shao, Xiangqiang/0000-0002-8789-2333	TJ Park Science Fellowship; Basic Research Laboratory Grant from the National Research Foundation of Korea [NRF-2014R1A4A10052590]; National Institutes of Health [GM094663, GM114462, GM058038, HL127711]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058038, P41GM103393, P50GM107615, U01GM094663, R35GM118064, R01GM114462] Funding Source: NIH RePORTER	TJ Park Science Fellowship; Basic Research Laboratory Grant from the National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a TJ Park Science Fellowship (to H. J. C.), Basic Research Laboratory Grant NRF-2014R1A4A10052590 from the National Research Foundation of Korea (to H. J. C. and J. L.), and National Institutes of Health Grants GM094663 (to W. J. N. and W. I. W.), GM114462 (to W. I. W.), GM058038 (to J. H.), and HL127711 (to A. V. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Callaci S, 2015, BIOCHEM J, V472, P339, DOI 10.1042/BJ20150410; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 2015, DEV CELL, V33, P82, DOI 10.1016/j.devcel.2015.02.005; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; DeLano W.L, PYMOL MOL GRAPHICS S; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Kang H, 2016, ACTA CRYSTALLOGR F, V72, P234, DOI 10.1107/S2053230X16001862; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Ladoux B, 2015, INTEGR BIOL-UK, V7, P1109, DOI 10.1039/c5ib00070j; Li J, 2015, J BIOL CHEM, V290, P18890, DOI 10.1074/jbc.M115.647941; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Miller PW, 2013, CURR TOP MEMBR, V72, P267, DOI 10.1016/B978-0-12-417027-8.00008-8; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shibahara T, 2015, FEBS LETT, V589, P1754, DOI 10.1016/j.febslet.2015.05.053; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wickline ED, 2016, J BIOL CHEM, V291, P15687, DOI 10.1074/jbc.M116.735423; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	34	12	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7077	7086		10.1074/jbc.M116.769778	http://dx.doi.org/10.1074/jbc.M116.769778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298447	hybrid, Green Published			2022-12-28	WOS:000400478300018
J	Snyder, JC; Rochelle, LK; Ray, C; Pack, TF; Bock, CB; Lubkov, V; Lyerly, HK; Waggoner, AS; Barak, LS; Caron, MG				Snyder, Joshua C.; Rochelle, Lauren K.; Ray, Caroline; Pack, Thomas F.; Bock, Cheryl B.; Lubkov, Veronica; Lyerly, H. Kim; Waggoner, Alan S.; Barak, Larry S.; Caron, Marc G.			Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; V-ATPASE; WNT/BETA-CATENIN; PLASMA-MEMBRANE; WNT RECEPTORS; NATURAL-PRODUCTS; BREAST-CANCER; BETA-ARRESTIN; LGR5; EXPRESSION	The leucine-rich G protein-coupled receptor-5 (LGR5) is expressed in adult tissue stem cells of many epithelia, and its overexpression is negatively correlated with cancer prognosis. LGR5 potentiates WNT/beta-catenin signaling through its unique constitutive internalization property that clears negative regulators of the WNT-receptor complex from the membrane. However, both the mechanism and physiological relevance of LGR5 internalization are unclear. Therefore, a natural product library was screened to discover LGR5 internalization inhibitors and gain mechanistic insight into LGR5 internalization. The plant lignan justicidin B blocked the constitutive internalization of LGR5. Justicidin B is structurally similar to more potent vacuolar-type H+-ATPase inhibitors, which all inhibited LGR5 internalization by blocking clathrin-mediated endocytosis. We then tested the physiological relevance of LGR5 internalization blockade in vivo. A LGR5-rainbow (LBOW) mouse line was engineered to express three different LGR5 isoforms along with unique fluorescent protein lineage reporters in the same mouse. In this manner, the effects of each isoform on cell fate can be simultaneously assessed through simple fluorescent imaging for each lineage reporter. LBOW mice express three different forms of LGR5, a wild-type form that constitutively internalizes and two mutant forms whose internalization properties have been compromised by genetic perturbations within the carboxyl-terminal tail. LBOW was activated in the intestinal epithelium, and a year-long lineage-tracing course revealed that genetic blockade of LGR5 internalization diminished cell fitness. Together these data provide proof-of-concept genetic evidence that blocking the clathrin-mediated endocytosis of LGR5 could be used to pharmacologically control cell behavior.	[Snyder, Joshua C.; Rochelle, Lauren K.; Ray, Caroline; Barak, Larry S.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27712 USA; [Snyder, Joshua C.; Lubkov, Veronica; Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27712 USA; [Pack, Thomas F.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27712 USA; [Bock, Cheryl B.] Duke Univ, Med Ctr, Duke Canc Inst Transgen Core, Durham, NC 27712 USA; [Waggoner, Alan S.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Waggoner, Alan S.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA	Duke University; Duke University; Duke University; Duke University; Carnegie Mellon University; Carnegie Mellon University	Snyder, JC; Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	joshua.snyder@duke.edu; marc.caron@duke.edu	Lyerly, Herbert Kim/AAX-4925-2020; Lyerly, Herbert K/B-6528-2014	Lyerly, Herbert Kim/0000-0002-0063-4770; Lyerly, Herbert K/0000-0002-0063-4770; Pack, Thomas/0000-0002-1240-8324; Snyder, Joshua/0000-0002-9787-3371; Lubkov, Veronica/0000-0002-5264-7549	NCI, National Institutes of Health [5P30CA014236-42]; NATIONAL CANCER INSTITUTE [P30CA014236, R21CA173245, K12CA100639, R33CA191198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA041160, P30DA029925] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Yushi Bai for management of our small molecular libraries and robotic pipetting systems. We also thank Dr. Harvey McMahon for the gift of the plasmid encoding the AP-180 carboxyl-terminal fragment. We are grateful to Dr. Michael Forgac for helpful advice and discussion of this manuscript. Dr. P. J. Nicholls provided image acquisition and analysis consultations. The Duke Transgenic Core was supported by NCI, National Institutes of Health Grant 5P30CA014236-42.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen HW, 2013, ANTIVIR RES, V99, P371, DOI 10.1016/j.antiviral.2013.06.014; Coma I, 2009, J BIOMOL SCREEN, V14, P66, DOI 10.1177/1087057108326664; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Cotter K, 2016, ONCOTARGET, V7, P46142, DOI 10.18632/oncotarget.10063; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Di Gregorio A, 2016, DEV CELL, V38, P621, DOI 10.1016/j.devcel.2016.08.012; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Greathouse GA, 1940, PLANT PHYSIOL, V15, P563, DOI 10.1104/pp.15.3.563; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hemmati S, 2016, MOLECULES, V21, DOI 10.3390/molecules21070820; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jiang YY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-015-1986-2; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Perez-Vilar J, 1997, J BIOL CHEM, V272, P33410, DOI 10.1074/jbc.272.52.33410; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ruiz A, 2014, J AGR FOOD CHEM, V62, P12407, DOI 10.1021/jf502929z; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snyder JC, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0216-3; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Snyder JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084476; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Weissman Tamily A, 2011, Cold Spring Harb Protoc, V2011, P851, DOI 10.1101/pdb.prot5632; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhao XH, 2001, J CELL SCI, V114, P353; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	63	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7208	7222		10.1074/jbc.M116.756635	http://dx.doi.org/10.1074/jbc.M116.756635			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28275053	hybrid, Green Published			2022-12-28	WOS:000400478300031
J	Li, KT; Cheng, XX; Tilevik, A; Davis, SJ; Zhu, C				Li, Kaitao; Cheng, Xiaoxiao; Tilevik, Andreas; Davis, Simon J.; Zhu, Cheng			In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; CRYSTAL-STRUCTURE; BINDING-KINETICS; TCR; EXPRESSION; AFFINITY; ADHESION; COMPLEX; FRAMEWORK; SURFACES	Programmed cell death-1 (PD-1) is an inhibitory receptor with an essential role in maintaining peripheral tolerance and is among the most promising immunotherapeutic targets for treating cancer, autoimmunity, and infectious diseases. A complete understanding of the consequences of PD-1 engagement by its ligands, PD-L1 and PD-L2, and of PD-L1 binding to B7-1 requires quantitative analysis of their interactions at the cell surface. We present here the first complete in situ kinetic analysis of the PD-1/PD-ligands/B7-1 system. Consistent with previous solution measurements, we observed higher in situ affinities for human (h) than murine (m) PD-1 interactions, stronger binding of hPD-1 to hPD-L2 than hPD-L1, and comparable binding of mPD-1 to both ligands. However, in contrast to the relatively weak solution affinities, the in situ affinities of PD-1 are as high as those of the T cell receptor for agonist pMHC and of LFA-1 (lymphocyte function-associated antigen 1) for ICAM-1 (intercellular adhesion molecule 1) but significantly lower than that of the B7-1/CTLA-4 interaction, suggesting a distinct basis for PD-1-versus CTLA-4-mediated inhibition. Notably, the in situ interactions of PD-1 are much stronger than that of B7-1 with PD-L1. Overall, the in situ affinity ranking greatly depends on the on-rate instead of the off-rate. In silico simulations predict that PD-1/PD-L1 interactions dominate at interfaces between activated T cells and mature dendritic cells and that these interactions will be highly sensitive to the dynamics of PD-L1 and PD-L2 expression. Our results provide a kinetic framework for better understanding inhibitory PD-1 activity in health and disease.	[Li, Kaitao; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA; [Cheng, Xiaoxiao; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England; [Cheng, Xiaoxiao; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DU, England; [Tilevik, Andreas] Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Box 408, Skovde, Sweden; [Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Oxford; University of Oxford; University of Skovde; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu		Zhu, Cheng/0000-0002-1718-565X	National Institutes of Health [R01AI044902]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902] Funding Source: NIH RePORTER; MRC [MC_UU_12010/4, MC_UU_00008/4] Funding Source: UKRI; Medical Research Council [MC_UU_12010/4, MC_UU_00008/4] Funding Source: researchfish; Wellcome Trust [207547/Z/17/Z] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by National Institutes of Health Grant R01AI044902 (to C. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Hong JS, 2015, J IMMUNOL, V195, P3557, DOI 10.4049/jimmunol.1501407; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; Jin HT, 2011, CURR TOP MICROBIOL, V350, P17, DOI 10.1007/82_2010_116; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Liu BY, 2015, EUR J IMMUNOL, V45, P2099, DOI 10.1002/eji.201445358; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Park HJ, 2015, J IMMUNOL, V194, P5801, DOI 10.4049/jimmunol.1401936; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Seo YJ, 2016, IMMUNITY, V45, P988, DOI 10.1016/j.immuni.2016.10.024; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang L. F., 2008, WATER SAV IRRIG, V2008, P1, DOI DOI 10.1038/NATURE07065; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g	55	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6799	6809		10.1074/jbc.M116.763888	http://dx.doi.org/10.1074/jbc.M116.763888			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28270509	hybrid, Green Published			2022-12-28	WOS:000399813400030
J	Guo, Z; Black, S; Hu, Y; McMonagle, P; Ingravallo, P; Chase, R; Curry, S; Asante-Appiah, E				Guo, Zhuyan; Black, Stuart; Hu, Yuan; McMonagle, Patricia; Ingravallo, Paul; Chase, Robert; Curry, Stephanie; Asante-Appiah, Ernest			Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELBASVIR MK-8742; REPLICATION; INFECTION; RIBAVIRIN; MK-5172; PLUS; RNA; SIMEPREVIR; INHIBITOR; EFFICACY	Grazoprevir is a potent pan-genotype and macrocyclic inhibitor of hepatitis C virus (HCV) NS3/4A protease and was developed for treating chronicHCVinfection. InHCVgenotype (GT) 1a, grazoprevir maintains potent activity against a majority of NS3 resistance-associated amino acid substitutions, including the highly prevalent and naturally occurring Q80K polymorphism that impacts simeprevir, another NS3/4A protease inhibitor. The basis for an unexpected difference in the clinical impact of some NS3 substitutions was investigated. Phenotypic analysis of resistance-associated substitutions identified in NS3 from GT1a-infected patients who failed therapy with grazoprevir (in combination with elbasvir, an inhibitor of HCV NS5A protein) showed that positions 56, 156, and 168 in NS3 were most impactful because they diminished protein-inhibitor interactions. Although an amino acid substitution from aspartic acid to alanine at position 168 (D168A) reduced the potency of grazoprevir, its combination with R155K unexpectedly nullified this effect. Molecular dynamics and free-energy surface studies indicated that Asp-168 is important in anchoring Arg-155 for ligand binding but is not critical for Lys-155 because of the inherent flexibility of its side chain. Moreover, modeling studies supported a strong direct cation-heterocycle interaction between the Lys-155 side chain of the double substitution, R155K/D168A, and the lone pair on the quinoxaline in grazoprevir. This unique interaction provides a structural basis for grazoprevir's higher potency than simeprevir, an inhibitor to which the double substitution confers a significant reduction in potency. Our findings are consistent with the detection of R155K/D168A in NS3 from virologic failures treated with simeprevir but not grazoprevir.	[Guo, Zhuyan; Hu, Yuan] Merck Res Labs, Dept Chem Modeling & Informat, Kenilworth, NJ 07033 USA; [Black, Stuart; McMonagle, Patricia; Ingravallo, Paul; Chase, Robert; Curry, Stephanie; Asante-Appiah, Ernest] Merck Res Labs, Dept Infect Dis, Kenilworth, NJ 07033 USA; [Guo, Zhuyan; Black, Stuart; Hu, Yuan; McMonagle, Patricia; Ingravallo, Paul; Chase, Robert; Curry, Stephanie; Asante-Appiah, Ernest] Merck Sharp & Dohme Corp, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company	Asante-Appiah, E (corresponding author), 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	Ernest_asanteappiah@merck.com		Curry, Stephanie/0000-0002-2180-0264; Hu, Yuan/0000-0002-1014-6594				Bae A, 2010, ANTIMICROB AGENTS CH, V54, P5288, DOI 10.1128/AAC.00777-10; Black S, 2015, J HEPATOL, V62, pS677, DOI 10.1016/S0168-8278(15)31094-1; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Case D. A., 2016, AMBER 2016 VERSION 1; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Green MR, 2012, MOL CLONING LAB MANU, V1; Harper S, 2012, ACS MED CHEM LETT, V3, P332, DOI 10.1021/ml300017p; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Liverton NJ, 2008, J AM CHEM SOC, V130, P4607, DOI 10.1021/ja711120r; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Mao SS, 2008, ANAL BIOCHEM, V373, P1, DOI 10.1016/j.ab.2007.10.041; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Romano KP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002832; Rosenquist A, 2014, J MED CHEM, V57, P1673, DOI 10.1021/jm401507s; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; WHO, 2016, MYANM NATL SIMPL TRE; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004	28	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6202	6212		10.1074/jbc.M116.772996	http://dx.doi.org/10.1074/jbc.M116.772996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28228479	hybrid, Green Published			2022-12-28	WOS:000399538700016
J	Karam, JA; Parikh, RY; Nayak, D; Rosenkranz, D; Gangaraju, VK				Karam, Joseph A.; Parikh, Rasesh Y.; Nayak, Dhananjaya; Rosenkranz, David; Gangaraju, Vamsi K.			Co-chaperone Hsp70/Hsp90-organizing protein (Hop) is required for transposon silencing and Piwi-interacting RNA (piRNA) biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; PHENOTYPIC VARIATION; MAMMALIAN OOCYTES; EARLY EMBRYOS; STEM-CELLS; GERM-LINE; ZUCCHINI; PATHWAY; HSP90	Piwi-interacting RNAs (piRNAs) are 26-30-nucleotide germ line-specific small non-coding RNAs that have evolutionarily conserved function in mobile genetic element (transposons) silencing and maintenance of genome integrity. Drosophila Hsp70/90-organizing protein homolog (Hop), a co-chaperone, interacts with piRNA-binding protein Piwi and mediates silencing of phenotypic variations. However, it is not known whether Hop has a direct role in piRNA biogenesis and transposon silencing. Here, we show that knockdown of Hop in the germ line nurse cells (GLKD) of Drosophila ovaries leads to activation of transposons. Hop GLKD females can lay eggs at the same rate as wild-type counterparts, but the eggs do not hatch into larvae. Hop GLKD leads to the accumulation of gamma-H2Av foci in the germ line, indicating increased DNA damage in the ovary. We also show that Hop GLKD-induced transposon up-regulation is due to inefficient piRNA biogenesis. Based on these results, we conclude that Hop is a critical component of the piRNA pathway and that it maintains genome integrity by silencing transposons.	[Karam, Joseph A.; Parikh, Rasesh Y.; Nayak, Dhananjaya; Gangaraju, Vamsi K.] Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Karam, Joseph A.; Parikh, Rasesh Y.; Nayak, Dhananjaya; Gangaraju, Vamsi K.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Rosenkranz, David] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolutionary Biol, D-55122 Mainz, Germany	Medical University of South Carolina; Medical University of South Carolina; Johannes Gutenberg University of Mainz	Gangaraju, VK (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	gangaraj@musc.edu		Karam, Joseph/0000-0002-4536-7362	Genomics/shRNA Shared Resource; National Institutes of Health Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021736] Funding Source: NIH RePORTER	Genomics/shRNA Shared Resource; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Mikiko Siomi and Haifan Lin for antibodies, members of the Gangaraju lab for critical reading of the manuscript, Robert Wilson and Jennifer Schulte for preparing mRNA and small RNA sequencing libraries, and Philip Zamore and Bo Han for answering our queries during installation and execution of piPipes. We acknowledge support of the Genomics/shRNA Shared Resource and National Institutes of Health Grant P30 CA138313 to Cell & Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina.	Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; Feltzin VL, 2015, AGING CELL, V14, P443, DOI 10.1111/acel.12323; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Hayashi R, 2016, NATURE, V539, P588, DOI 10.1038/nature20162; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hu YH, 2013, GENETICS, V195, P37, DOI 10.1534/genetics.113.151340; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Iwasaki S, 2015, NATURE, V521, P533, DOI 10.1038/nature14254; Izumi N, 2013, RNA, V19, P896, DOI 10.1261/rna.037200.112; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Olivieri D, 2012, MOL CELL, V47, P954, DOI 10.1016/j.molcel.2012.07.021; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Preall JB, 2012, RNA, V18, P1446, DOI 10.1261/rna.034405.112; Qi H, 2011, J BIOL CHEM, V286, P3789, DOI 10.1074/jbc.M110.193888; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Rosenkranz D, 2015, GENOM DATA, V5, P309, DOI 10.1016/j.gdata.2015.06.026; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schisa JA, 2014, WIRES RNA, V5, P231, DOI 10.1002/wrna.1204; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Wickersheim ML, 2013, BIOTECHNIQUES, V55, P271, DOI 10.2144/000114102; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Yamamoto S, 2014, J BIOL CHEM, V289, P9880, DOI 10.1074/jbc.M114.553255; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	62	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6039	6046		10.1074/jbc.C117.777730	http://dx.doi.org/10.1074/jbc.C117.777730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28193840	Green Published, hybrid			2022-12-28	WOS:000399538700002
J	Menon, D; Salloum, D; Bernfeld, E; Gorodetsky, E; Akselrod, A; Frias, MA; Sudderth, J; Chen, PH; DeBerardinis, R; Foster, DA				Menon, Deepak; Salloum, Darin; Bernfeld, Elyssa; Gorodetsky, Elizabeth; Akselrod, Alla; Frias, Maria A.; Sudderth, Jessica; Chen, Pei-Hsuan; DeBerardinis, Ralph; Foster, David A.			Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; RAS-TRANSFORMED CELLS; ENDOPLASMIC-RETICULUM; LYSOPHOSPHATIDIC ACID; CANCER-CELLS; ACYLTRANSFERASE-BETA; MAMMALIAN-CELLS; TGF-BETA; RAPAMYCIN; TARGET	mTOR, the mammalian target of rapamycin, integrates growth factor and nutrient signals to promote a transformation from catabolic to anabolic metabolism, cell growth, and cell cycle progression. Phosphatidic acid (PA) interacts with the FK506-binding protein-12-rapamycin-binding (FRB) domain of mTOR, which stabilizes both mTOR complexes: mTORC1 and mTORC2. We report here that mTORC1 and mTORC2 are activated in response to exogenously supplied fatty acids via the de novo synthesis of PA, a central metabolite for membrane phospholipid biosynthesis. We examined the impact of exogenously supplied fatty acids on mTOR in KRas-driven cancer cells, which are programmed to utilize exogenous lipids. The induction of mTOR by oleic acid was dependent upon the enzymes responsible for de novo synthesis of PA. Suppression of the de novo synthesis of PA resulted in G(1) cell cycle arrest. Although it has long been appreciated that mTOR is a sensor of amino acids and glucose, this study reveals that mTOR also senses the presence of lipids via production of PA.	[Menon, Deepak; Salloum, Darin; Bernfeld, Elyssa; Gorodetsky, Elizabeth; Akselrod, Alla; Frias, Maria A.; Foster, David A.] CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Menon, Deepak; Bernfeld, Elyssa; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Salloum, Darin; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Sudderth, Jessica; Chen, Pei-Hsuan; DeBerardinis, Ralph] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Foster, DA (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Frias, Maria A/0000-0001-7753-6290; Lehman, Elyssa/0000-0002-9869-1588	National Institutes of Health [R01-CA046677, R01-CA179542, R01-CA157996]; Research Centers in Minority Institutions of the National Center for Research Resources of the National Institutes of Health [RP-03037]; Robert A. Welch Foundation [I-1733]; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions of the National Center for Research Resources of the National Institutes of Health; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01-CA046677 and R01-CA179542 (to D. A. F.) and Pilot Project Award RP-03037 from the Research Centers in Minority Institutions of the National Center for Research Resources of the National Institutes of Health. Ralph DeBerardinis is on the Scientific Advisory Board of Agios Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant R01-CA157996 and Robert A. Welch Foundation Award I-1733.	Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Chatterjee A, 2015, CANCER LETT, V360, P134, DOI 10.1016/j.canlet.2015.01.043; Chun SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-293; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	43	71	71	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6303	6311		10.1074/jbc.M116.772988	http://dx.doi.org/10.1074/jbc.M116.772988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223357	Green Published, hybrid			2022-12-28	WOS:000399538700024
J	Minkoff, BB; Makino, SI; Haruta, M; Beebe, ET; Wrobel, RL; Fox, BG; Sussman, MR				Minkoff, Benjamin B.; Makino, Shin-ichi; Haruta, Miyoshi; Beebe, Emily T.; Wrobel, Russell L.; Fox, Brian G.; Sussman, Michael R.			A cell-free method for expressing and reconstituting membrane proteins enables functional characterization of the plant receptor-like protein kinase FERONIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mutation; lipid bilayer; membrane protein; mutagenesis in vitro; receptor protein serine; threonine kinase; FERONIA; cell-free translation; nanodiscs; plant protein kinase	SIGNAL-TRANSDUCTION; SYNTHESIS SYSTEM; PLASMA-MEMBRANE; GENE FAMILY; ACTIVATION; COMPLEX; GROWTH; BRI1; BAK1; PHOSPHORYLATION	There are more than 600 receptor-like kinases (RLKs) in Arabidopsis, but due to challenges associated with the characterization of membrane proteins, only a few have known biological functions. The plant RLK FERONIA is a peptide receptor and has been implicated in plant growth regulation, but little is known about its molecular mechanism of action. To investigate the properties of this enzyme, we used a cell-free wheat germ-based expression system in which mRNA encoding FERONIA was co-expressed with mRNA encoding the membrane scaffold protein variant MSP1D1. With the addition of the lipid cardiolipin, assembly of these proteins into nanodiscs was initiated. FERONIA protein kinase activity in nanodiscs was higher than that of soluble protein and comparable with other heterologously expressed protein kinases. Truncation experiments revealed that the cytoplasmic juxtamembrane domain is necessary for maximal FERONIA activity, whereas the transmembrane domain is inhibitory. An ATP analogue that reacts with lysine residues inhibited catalytic activity and labeled four lysines; mutagenesis demonstrated that two of these, Lys-565 and Lys-663, coordinate ATP in the active site. Mass spectrometric phosphoproteomic measurements further identified phosphorylation sites that were examined using phosphomimetic mutagenesis. The results of these experiments are consistent with a model in which kinase-mediated phosphorylation within the C-terminal region is inhibitory and regulates catalytic activity. These data represent a step further toward understanding the molecular basis for the protein kinase catalytic activity of FERONIA and show promise for future characterization of eukaryotic membrane proteins.	[Minkoff, Benjamin B.; Makino, Shin-ichi; Haruta, Miyoshi; Beebe, Emily T.; Wrobel, Russell L.; Fox, Brian G.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, 425 Henry Mall, Madison, WI 53706 USA; [Minkoff, Benjamin B.; Haruta, Miyoshi; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, 425 Henry Mall, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sussman, MR (corresponding author), Univ Wisconsin, Ctr Biotechnol, 425 Henry Mall, Madison, WI 53706 USA.	msussman@wisc.edu			National Science Foundation Molecular and Cellular Biosciences (MCB) [0929395]; NIGMS (National Institutes of Health) Protein Structure Initiative [U54 GM094584]; National Human Genome Research Institute-University of Wisconsin Genomic Sciences Training Program (NIH) [5T32HG002760]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094584] Funding Source: NIH RePORTER	National Science Foundation Molecular and Cellular Biosciences (MCB); NIGMS (National Institutes of Health) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute-University of Wisconsin Genomic Sciences Training Program (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Molecular and Cellular Biosciences (MCB) Grant 0929395 (to M.R.S.), NIGMS (National Institutes of Health) Protein Structure Initiative Grant U54 GM094584 (to B. G. F.), and the National Human Genome Research Institute-University of Wisconsin Genomic Sciences Training Program (NIH Grant 5T32HG002760) (to B. B. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Du CQ, 2016, P NATL ACAD SCI USA, V113, pE8326, DOI 10.1073/pnas.1609626113; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gogol EP, 2013, PROTEIN SCI, V22, P586, DOI 10.1002/pro.2241; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; He K, 2013, J INTEGR PLANT BIOL, V55, P1264, DOI 10.1111/jipb.12122; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Kessler SA, 2015, EMBO REP, V16, P107, DOI 10.15252/embr.201438801; Kovacs E, 2015, MOL CELL BIOL, V35, P3083, DOI 10.1128/MCB.00248-15; Li B, 2016, PROTEIN EXPRES PURIF, V126, P33, DOI 10.1016/j.pep.2016.04.016; Li C, 2016, PLANT PHYSIOL, V171, P2379, DOI 10.1104/pp.16.00667; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Madono M, 2011, NEW BIOTECHNOL, V28, P211, DOI 10.1016/j.nbt.2010.08.009; Makino SI, 2014, METHODS MOL BIOL, V1091, P161, DOI 10.1007/978-1-62703-691-7_11; Mayank P, 2012, PLANT J, V72, P89, DOI 10.1111/j.1365-313X.2012.05061.x; McCormick S, 2007, SCIENCE, V317, P606, DOI 10.1126/science.1146655; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Mueller BK, 2014, P NATL ACAD SCI USA, V111, pE888, DOI 10.1073/pnas.1319944111; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oh MH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00562; Peck SC, 2006, PLANT J, V45, P512, DOI 10.1111/j.1365-313X.2005.02613.x; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shih HW, 2014, CURR BIOL, V24, P1887, DOI 10.1016/j.cub.2014.06.064; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Vaid N, 2013, MOL PLANT, V6, P1405, DOI 10.1093/mp/sst033; Villamor JG, 2013, MOL CELL PROTEOMICS, V12, P2481, DOI 10.1074/mcp.M112.026278; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597	49	10	10	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5932	5942		10.1074/jbc.M116.761981	http://dx.doi.org/10.1074/jbc.M116.761981			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28235802	Green Published, hybrid			2022-12-28	WOS:000398813200027
J	Yi, Y; Chen, DS; Ao, J; Sun, SN; Wu, M; Li, XR; Bergholz, J; Zhang, YJ; Xiao, ZX				Yi, Yong; Chen, Deshi; Ao, Juan; Sun, Shengnan; Wu, Min; Li, Xiaorong; Bergholz, Johann; Zhang, Yujun; Xiao, Zhi-Xiong			Metformin Promotes AMP-activated Protein Kinase-independent Suppression of Delta Np63 alpha Protein Expression and Inhibits Cancer Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P63; METASTASIS; APOPTOSIS; SURVIVAL; GROWTH; 2-DEOXYGLUCOSE; METABOLISM; STABILITY; CARCINOMA; MECHANISM	The blood glucose modifier metformin is used to treat type II diabetes and has also been shown to possess anticancer activities. Recent studies indicate that glucose deprivation can greatly enhance metformin-mediated inhibition of cell viability, but the molecular mechanism involved in this inhibition is unclear. In this study, we report that, under glucose deprivation, metformin inhibited expression of Delta Np63 alpha, a p53 family member involved in cell adhesion pathways, resulting in disruption of cell matrix adhesion and subsequent apoptosis in human squamous carcinoma cells. We further show that metformin promoted Delta Np63 alpha protein instability independent of AMP-activated protein kinase and that WWP1, an E3 ligase of Delta Np63 alpha, was involved in metformin-mediated down-regulation of Delta Np63 alpha levels. In addition, we demonstrate that a combination of metformin and the glycolysis inhibitor 2-deoxy-D-glucose significantly inhibited Delta Np63 alpha expression and also suppressed xenographic tumor growth in vivo. In summary, this study reveals a new mechanism for metformin-mediated anticancer activity and suggests a new strategy for treating human squamous cell carcinoma.	[Yi, Yong; Chen, Deshi; Ao, Juan; Sun, Shengnan; Wu, Min; Li, Xiaorong; Bergholz, Johann; Zhang, Yujun; Xiao, Zhi-Xiong] Sichuan Univ, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm, Minist Educ,Coll Life Sci, Chengdu 610064, Peoples R China; [Bergholz, Johann] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA	Sichuan University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Xiao, ZX (corresponding author), Sichuan Univ, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm, Minist Educ,Coll Life Sci, Chengdu 610064, Peoples R China.	jimzx@scu.edu.cn		Yi, Yong/0000-0003-4664-9692	National Natural Science Foundation of China [81330054, 81520108020]; Ministry of Science and Technology of China [2012CB910700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 81330054 and 81520108020 and Ministry of Science and Technology of China Grant 2012CB910700 (to Z.X.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Bergholz J, 2012, CANCER MICROENVIRON, V5, P311, DOI 10.1007/s12307-012-0116-9; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Menendez JA, 2011, AGING-US, V3, P1063, DOI 10.18632/aging.100407; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ogawa T, 2016, P NATL ACAD SCI USA, V113, P11913, DOI 10.1073/pnas.1604047113; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Verma S, 2000, J HYPERTENS, V18, P1445, DOI 10.1097/00004872-200018100-00012; WICK AN, 1957, J BIOL CHEM, V224, P963; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	41	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5253	5261		10.1074/jbc.M116.769141	http://dx.doi.org/10.1074/jbc.M116.769141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193839	Green Published, hybrid			2022-12-28	WOS:000397875500009
J	ElAzzouny, M; Tom, CTMB; Evans, CR; Olson, LL; Tanga, MJ; Gallagher, KA; Martin, BR; Burant, CF				ElAzzouny, Mahmoud; Tom, Christopher T. M. B.; Evans, Charles R.; Olson, Lori L.; Tanga, Mary J.; Gallagher, Katherine A.; Martin, Brent R.; Burant, Charles F.			Dimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINATE-DEHYDROGENASE; INFLAMMATORY MACROPHAGES; INSULIN-SECRETION; GLUCOSE; ACID; METABOLOMICS; IMMUNITY; GENE-1; CELLS; GPR91	Itaconic acid is an important metabolite produced by macrophages after stimulation with LPS. The role of itaconate in the inflammatory cascade is unclear. Here we used [C-13] itaconate and dimethyl [C-13] itaconate ( DMI) to probe itaconate metabolism, and find that [C-13] DMI is not metabolized to itaconate. [C-13] Itaconate in the cell culture medium leads to elevated intracellular levels of unlabeled succinate, with no evidence of intracellular uptake. The goal of this study is to encourage the development of effective pro-drug strategies to increase the intracellular levels of itaconate, which will enable more conclusive analysis of its action on macrophages and other cell and tissue types.	[ElAzzouny, Mahmoud; Evans, Charles R.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA; [Tom, Christopher T. M. B.; Martin, Brent R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Gallagher, Katherine A.] Univ Michigan, Dept Surg, Ann Arbor, MI 48105 USA; [Olson, Lori L.; Tanga, Mary J.] SRI Int, Menlo Pk, CA 94025 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; SRI International	ElAzzouny, M (corresponding author), 6309 Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	mazzouny@umich.edu	Burant, Charles/GPC-5690-2022; Martin, Brent/B-4370-2012	Burant, Charles/0000-0001-9189-5003; Martin, Brent/0000-0002-7136-2397	National Institutes of Health [P30DK089503, P30DK020572, U24DK097153]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB019320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, K08DK102357, P30DK020572, U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Amrita Joshi for macrophage isolation and Hashim Motiwala for helpful discussions (University of Michigan). The Michigan Nutrition Obesity Research Center is funded by National Institutes of Health Grant P30DK089503, the Michigan Diabetes Research Center is funded by National Institutes of Health Grant P30DK020572, and the Michigan Regional Comprehensive Metabolomics Resource Core is supported by National Institutes of Health Grant U24DK097153.	Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; El Azzouny M, 2016, MOL METAB, V5, P980, DOI 10.1016/j.molmet.2016.07.011; El-Azzouny M, 2014, J BIOL CHEM, V289, P13575, DOI 10.1074/jbc.M113.531970; ElAzzouny MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129029; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P400, DOI 10.1016/0003-9861(89)90123-9; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Sud M, 2016, NUCLEIC ACIDS RES, V44, pD463, DOI 10.1093/nar/gkv1042; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	17	49	52	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4766	4769		10.1074/jbc.C117.775270	http://dx.doi.org/10.1074/jbc.C117.775270			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28188288	Green Published, hybrid			2022-12-28	WOS:000397590400001
J	Torres, A; Gubbiotti, MA; Iozzo, RV				Torres, Annabel; Gubbiotti, Maria A.; Iozzo, Renato V.			Decorin-inducible Peg3 Evokes Beclin 1-mediated Autophagy and Thrombospondin 1-mediated Angiostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; IMPRINTED GENE PEG3; HUMAN ENDOTHELIAL-CELLS; RECEPTOR 2; ALPHA-2-BETA-1 INTEGRIN; P53-MEDIATED APOPTOSIS; SIGNAL-TRANSDUCTION; MAMMALIAN AUTOPHAGY; MATERNAL-BEHAVIOR; CANCER GROWTH	We previously discovered that systemic delivery of decorin for treatment of breast carcinoma xenografts induces paternally expressed gene 3 ( Peg3), an imprinted gene encoding a zinc finger transcription factor postulated to function as a tumor suppressor. Here we found that de novo expression of Peg3 increased Beclin 1 promoter activity and protein expression. This process required the full-length Peg3 as truncated mutants lacking either the N-terminal SCAN domain or the zinc fingers failed to translocate to the nucleus and promote Beclin 1 transcription. Importantly, overexpression of Peg3 in endothelial cells stimulated autophagy and concurrently inhibited endothelial cell migration and evasion from a 3D matrix. Mechanistically, we found that Peg3 induced the secretion of the powerful angiostatic glycoprotein Thrombospondin 1 independently of Beclin 1 transcriptional induction. Thus, we provide a new mechanism whereby Peg3 can simultaneously evoke autophagy in endothelial cells and attenuate angiogenesis.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 JAH, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 JAH, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020		National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA164462, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Champagne FA, 2009, BEHAV NEUROSCI, V123, P469, DOI 10.1037/a0015060; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Custer SK, 2014, MOL CELL NEUROSCI, V61, P133, DOI 10.1016/j.mcn.2014.06.006; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Dunkman AA, 2014, MATRIX BIOL, V35, P232, DOI 10.1016/j.matbio.2013.10.008; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gaffney J, 2015, MATRIX BIOL, V44-46, P191, DOI 10.1016/j.matbio.2015.01.012; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Grumati Paolo, 2012, Cells, V1, P325, DOI 10.3390/cells1030325; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Horvath Z, 2014, MATRIX BIOL, V35, P194, DOI 10.1016/j.matbio.2013.11.004; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Kalas W, 2013, ANTICANCER RES, V33, P1429; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Koren I, 2012, SCIENCE, V338, P889, DOI 10.1126/science.1230577; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee SJ, 2011, AUTOPHAGY, V7, P829, DOI 10.4161/auto.7.8.15598; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145531; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lu YC, 2006, J BIOL CHEM, V281, P39081, DOI 10.1074/jbc.M606687200; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Morcavallo A, 2014, MATRIX BIOL, V35, P82, DOI 10.1016/j.matbio.2013.12.010; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Neill T, 2016, ADV DRUG DELIVER REV, V97, P174, DOI 10.1016/j.addr.2015.10.016; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2013, FEBS J, V280, P2353, DOI 10.1111/febs.12148; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; Nikolovska K, 2014, MATRIX BIOL, V35, P91, DOI 10.1016/j.matbio.2014.01.003; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; O'Doherty AM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00156; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Robinson PS, 2004, J BIOMECH ENG-T ASME, V126, P252, DOI 10.1115/1.1695570; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Skandalis SS, 2014, MATRIX BIOL, V35, P182, DOI 10.1016/j.matbio.2013.09.002; Song J, 2008, BBA-GENE REGUL MECH, V1779, P134, DOI 10.1016/j.bbagrm.2007.11.002; Soto-Pantoja DR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01038; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Stenina-Adognravi O, 2014, MATRIX BIOL, V37, P69, DOI 10.1016/j.matbio.2014.02.001; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wu Z, 2014, MATRIX BIOL, V35, P266, DOI 10.1016/j.matbio.2013.12.006; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yao T, 2016, FEBS OPEN BIO, V6, P707, DOI 10.1002/2211-5463.12076; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhou QY, 2011, ANIM REPROD SCI, V123, P70, DOI 10.1016/j.anireprosci.2010.11.012; Zoeller JJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-7; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	123	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5055	5069		10.1074/jbc.M116.753632	http://dx.doi.org/10.1074/jbc.M116.753632			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28174297	hybrid, Green Published			2022-12-28	WOS:000397590400026
J	Verma, K; Datta, S				Verma, Kuldeep; Datta, Sunando			The Monomeric GTPase Rab35 Regulates Phagocytic Cup Formation and Phagosomal Maturation in Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-R; ENDOPLASMIC-RETICULUM; MYOSIN IB; PARASITE; MEMBRANE; COMPLEX; PROTEINS; CYTOSKELETON; RECRUITMENT; BIOGENESIS	One of the hallmarks of amoebic colitis is the detection of Entamoeba histolytica (Eh) trophozoites with ingested erythrocytes. Therefore, erythrophagocytosis is traditionally considered as one of the most important criteria to identify the pathogenic behavior of the amoebic trophozoites. Phagocytosis is an essential process for the proliferation and virulence of this parasite. Phagocytic cargo, upon internalization, follows a defined trafficking route to amoebic lysosomal degradation machinery. Here, we demonstrated the role of EhRab35 in the early and late phases of erythrophagocytosis by the amoeba. EhRab35 showed large vacuolar as well as punctate vesicular localization. The spatiotemporal dynamics of vacuolar EhRab35 and its exchange with soluble cytosolic pool were monitored by fluorescence recovery after photobleaching experiments. Using extensive microscopy and biochemical methods, we demonstrated that upon incubation with RBCs EhRab35 is recruited to the site of phagocytic cups as well as to the nascent phagosomes that har-bor Gal/GalNAc lectin and actin. Overexpression of a dominant negative mutant of EhRab35 reduced phagocytic cup formation and thereby reducedRBCinternalization, suggesting a potential role of the Rab GTPase in the cup formation. Furthermore, we also performed a phagosomal maturation assay and observed that the activated form of EhRab35 significantly increased the rate of RBC degradation. Interestingly, this mutant also significantly enhanced the number of acidic compartments in the trophozoites. Taken together, our results suggest that EhRab35 is involved in the initial stage of phagocytosis as well as in the phagolysosomal biogenesis in E. histolytica and thus contributes to the pathogenicity of the parasite.	[Verma, Kuldeep; Datta, Sunando] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal Bypass Rd, Bhauri 462030, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Datta, S (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal Bypass Rd, Bhauri 462030, Madhya Pradesh, India.	sunando@iiserb.ac.in		Verma, Kuldeep/0000-0002-8912-3781	Max Planck Gesellschaft, Germany; Department of Biotechnology, New Delhi, India; Department of Science and Technology, India [IGSTC/MPG/PG(SD)/2011]	Max Planck Gesellschaft, Germany(Max Planck Society); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported in part by Max Planck Gesellschaft, Germany and Department of Science and Technology, India partner group funding (Grant IGSTC/MPG/PG(SD)/2011, December 19, 2011). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Department of Biotechnology, New Delhi, India DBT-IISc postdoctoral fellowship.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; [Anonymous], 1997, Epidemiol Bull, V18, P13; Aslam S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003055; Babuta M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005310; BAILEY GB, 1985, J EXP MED, V162, P546, DOI 10.1084/jem.162.2.546; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Bracha Rivka, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020048; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CARDELLI JA, 1989, J BIOL CHEM, V264, P3454; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Chen CS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-21; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Coppolino MG, 2001, J CELL SCI, V114, P4307; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dikshit N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005083; Duclos S, 2000, J CELL SCI, V113, P3531; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Emmanuel M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004666; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Foret L, 2012, CURR BIOL, V22, P1381, DOI 10.1016/j.cub.2012.06.021; GONZALEZRUIZ A, 1994, J CLIN PATHOL, V47, P236, DOI 10.1136/jcp.47.3.236; Gunther J, 2011, AM J TROP MED HYG, V85, P1038, DOI 10.4269/ajtmh.2011.11-0288; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Hanadate Y, 2016, CELL MICROBIOL, V18, P1358, DOI 10.1111/cmi.12570; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hernandes-Alejandro M, 2013, PARASITOL RES, V112, P1631, DOI 10.1007/s00436-013-3318-2; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Labruyere E, 2003, J CELL SCI, V116, P61, DOI 10.1242/jcs.00190; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Mansuri MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004411; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Olivos-Garcia A, 2004, EXP MOL PATHOL, V77, P66, DOI 10.1016/j.yexmp.2003.09.003; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramalho JS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-26; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RODRIGUEZ MA, 1986, J INFECT DIS, V154, P27, DOI 10.1093/infdis/154.1.27; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Saito-Nakano Y, 2005, EXP PARASITOL, V110, P244, DOI 10.1016/j.exppara.2005.02.021; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Talamas-Lara D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/626259; Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TRISSL D, 1978, J EXP MED, V148, P1137, DOI 10.1084/jem.148.5.1137; Verma K, 2016, MOL MICROBIOL, V102, P1043, DOI 10.1111/mmi.13533; Verma K, 2015, CELL MICROBIOL, V17, P1779, DOI 10.1111/cmi.12470; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Voigt H, 1999, J CELL SCI, V112, P1191; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Wheeler DB, 2015, SCIENCE, V350, P211, DOI 10.1126/science.aaa4903; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	82	16	16	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4960	4975		10.1074/jbc.M117.775007	http://dx.doi.org/10.1074/jbc.M117.775007			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28126902	Green Published, hybrid			2022-12-28	WOS:000397590400018
J	Pakala, SB; Bui-Nguyen, TM; Reddy, SDN; Li, DQ; Peng, SH; Rayala, SK; Behringer, RR; Kumar, R				Pakala, Suresh B.; Bui-Nguyen, Tri M.; Reddy, Sirigiri Divijendra Natha; Li, Da-Qiang; Peng, Shaohua; Rayala, Suresh K.; Behringer, Richard R.; Kumar, Rakesh			Regulation of NF-kappa B circuitry by a component of the nucleosome remodeling and deacetylase complex controls inflammatory response homeostasis (Withdrawal of Vol 285, Pg 23590, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal													Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Rayala, Suresh/0000-0003-4394-4450				Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469	1	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4764	4764		10.1074/jbc.A117.139469	http://dx.doi.org/10.1074/jbc.A117.139469			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28314777	Green Published, hybrid			2022-12-28	WOS:000397585100032
J	Dahmene, M; Berard, M; Oueslati, A				Dahmene, Manel; Berard, Morgan; Oueslati, Abid			Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated -Synuclein-selective Autophagic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein (a-synuclein); protein degradation; protein kinase; protein phosphorylation; ubiquitin	UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; IN-VIVO; NEURODEGENERATIVE DISEASES; MAMMALIAN-CELLS; NERVOUS-SYSTEM; CULTURED-CELLS; BODY FORMATION; LEWY BODIES	Increasing lines of evidence support the causal link between -synuclein (-syn) accumulation in the brain and Parkinson's disease (PD) pathogenesis. Therefore, lowering -syn protein levels may represent a viable therapeutic strategy for the treatment of PD and related disorders. We recently described a novel selective -syn degradation pathway, catalyzed by the activity of the Polo-like kinase 2 (PLK2), capable of reducing -syn protein expression and suppressing its toxicity in vivo. However, the exact molecular mechanisms underlying this degradation route remain elusive. In the present study we report that among PLK family members, PLK3 is also able to catalyze -syn phosphorylation and degradation in living cells. Using pharmacological and genetic approaches, we confirmed the implication of the macroautophagy on PLK2-mediated -syn turnover, and our observations suggest a concomitant co-degradation of these two proteins. Moreover, we showed that the N-terminal region of -syn is important for PLK2-mediated -syn phosphorylation and degradation and is implicated in the physical interaction between the two proteins. We also demonstrated that PLK2 polyubiquitination is important for PLK2-syn protein complex degradation, and we hypothesize that this post-translational modification may act as a signal for the selective recognition by the macroautophagy machinery. Finally, we observed that the PD-linked mutation E46K enhances PLK2-mediated -syn degradation, suggesting that this mutated form is a bona fide substrate of this degradation pathway. In conclusion, our study provides a detailed description of the new degradation route of -syn and offers new opportunities for the development of therapeutic strategies aiming to reduce -syn protein accumulation and toxicity.	[Oueslati, Abid] Univ Laval, CHU Quebec Res Ctr, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Oueslati, A (corresponding author), Univ Laval, CHU Quebec Res Ctr, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada.	Abid.Oueslati@crchudequebec.ulaval.ca	Oueslati, Abid/ABG-8116-2020	Oueslati, Abid/0000-0003-1122-7086	Natural Sciences and Engineering Research Council of Canada (NSERC); CHU de Quebec Foundation; CHU de Quebec Research Center-Universite Laval	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CHU de Quebec Foundation; CHU de Quebec Research Center-Universite Laval	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the CHU de Quebec Foundation, and CHU de Quebec Research Center-Universite Laval. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Burre J, 2015, J PARKINSON DIS, V5, P699, DOI 10.3233/JPD-150642; Carroll B, 2013, ESSAYS BIOCHEM, V55, P119, DOI [10.1042/bse0550119, 10.1042/BSE0550119]; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Guan HC, 2012, J VIROL, V86, P5594, DOI 10.1128/JVI.06811-11; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Janda E, 2012, MOL NEUROBIOL, V46, P639, DOI 10.1007/s12035-012-8318-1; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; Kim E, 2014, BIOCHEM BIOPH RES CO, V449, P399, DOI 10.1016/j.bbrc.2014.05.063; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kleppe R, 2014, MOL CELL PROTEOMICS, V13, P2017, DOI 10.1074/mcp.M113.035709; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lindner JM, 2013, MOL CELL BIOL, V33, P4628, DOI 10.1128/MCB.01590-12; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Mbefo MK, 2015, J BIOL CHEM, V290, P9412, DOI 10.1074/jbc.M114.610774; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oueslati Abid, 2014, Exp Neurobiol, V23, P324, DOI 10.5607/en.2014.23.4.324; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pandey N, 2006, EXP NEUROL, V197, P515, DOI 10.1016/j.expneurol.2005.10.019; Rozeboom AM, 2012, NEUROSCIENCE, V202, P147, DOI 10.1016/j.neuroscience.2011.11.003; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Wang H, 2015, INT J BIOCHEM CELL B, V62, P24, DOI 10.1016/j.biocel.2015.02.011; Wang SX, 2012, P NATL ACAD SCI USA, V109, P16119, DOI 10.1073/pnas.1206286109; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yogosawa S, 2005, J BIOL CHEM, V280, P41619, DOI 10.1074/jbc.M508397200	52	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3919	3928		10.1074/jbc.M116.759373	http://dx.doi.org/10.1074/jbc.M116.759373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28154193	Green Published, hybrid			2022-12-28	WOS:000395542500032
J	Lord, MS; Cheng, B; Farrugia, BL; McCarthy, S; Whitelock, JM				Lord, Megan S.; Cheng, Bill; Farrugia, Brooke L.; McCarthy, Simon; Whitelock, John M.			Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-IV; SERGLYCIN PROTEOGLYCAN; ENDOTHELIAL-CELLS; IN-VITRO; HEPARIN; PERLECAN; ANGIOGENESIS; RECEPTOR; ENDOREPELLIN; INHIBITION	Platelet factor 4 (PF4) is produced by platelets with roles in both inflammation and wound healing. PF4 is stored in platelet alpha-granules bound to the glycosaminoglycan (GAG) chains of serglycin. This study revealed that platelet serglycin is decorated with chondroitin/dermatan sulfate and that PF4 binds to these GAG chains. Additionally, PF4 had a higher affinity for endo-thelial- derived perlecan heparan sulfate chains than serglycin GAG chains. The binding of PF4 to perlecan was found to inhibit both FGF2 signaling and platelet activation. This study revealed additional insight into the ways in which PF4 interacts with components of the vasculature to modulate cellular events.	[Lord, Megan S.; Cheng, Bill; Farrugia, Brooke L.; Whitelock, John M.] Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [McCarthy, Simon] Tricol Biomed, Portland, OR 97205 USA; [Cheng, Bill] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	University of New South Wales Sydney; Academia Sinica - Taiwan	Lord, MS (corresponding author), Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.	m.lord@unsw.edu.au	Lord, Megan/D-4673-2013; Farrugia, Brooke/J-1292-2012	Lord, Megan/0000-0002-0506-9811; Farrugia, Brooke/0000-0003-1303-4165; Whitelock, John/0000-0003-1835-802X; Cheng, Bill/0000-0002-0692-4349	Australian Research Council Linkage Project [LP0776293]	Australian Research Council Linkage Project(Australian Research Council)	This work was supported by Australian Research Council Linkage Project LP0776293. The authors declare that they have no conflicts of interest with the contents of this article.	Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; Baroletti SA, 2006, CIRCULATION, V114, pE355, DOI 10.1161/CIRCULATIONAHA.106.632653; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9; DAWES J, 1982, THROMB RES, V27, P65, DOI 10.1016/0049-3848(82)90279-1; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; GOLDBERG ID, 1980, SCIENCE, V209, P611, DOI 10.1126/science.6994228; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; HANSELL P, 1995, AM J PHYSIOL-HEART C, V269, pH829, DOI 10.1152/ajpheart.1995.269.3.H829; IBEL K, 1986, BIOCHIM BIOPHYS ACTA, V870, P58, DOI 10.1016/0167-4838(86)90008-7; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Knox S, 2001, PROTEOMICS, V1, P1534, DOI 10.1002/1615-9861(200111)1:12<1534::AID-PROT1534>3.0.CO;2-A; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Lord MS, 2016, METAB ENG, V38, P105, DOI 10.1016/j.ymben.2016.07.006; Lord MS, 2011, BIOMATERIALS, V32, P6655, DOI 10.1016/j.biomaterials.2011.05.062; Lord MS, 2009, BIOMATERIALS, V30, P4898, DOI 10.1016/j.biomaterials.2009.05.063; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; Melrose J, 2001, Methods Mol Biol, V171, P53; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; SATO Y, 1990, BIOCHEM BIOPH RES CO, V172, P595, DOI 10.1016/0006-291X(90)90715-Y; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	40	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4054	4063		10.1074/jbc.M116.760660	http://dx.doi.org/10.1074/jbc.M116.760660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28115521	Green Published, hybrid			2022-12-28	WOS:000395837100009
J	Jain, AK; Mahajan, S; Jaiswal, AK				Jain, Abhinav K.; Mahajan, Shilpi; Jaiswal, Anil K.			RETRACTION: Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2. A NOVEL MECHANISM IN NRF2 ACTIVATION (Retraction of Vol 283, Pg 17712, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Jain AK, 2008, J BIOL CHEM, V283, P17712, DOI 10.1074/jbc.M709854200	1	0	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2050	2050		10.1074/jbc.A117.709854	http://dx.doi.org/10.1074/jbc.A117.709854			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159763	Green Published, hybrid			2022-12-28	WOS:000395515600045
J	Song, ZY; Xiaoli, AM; Zhang, QW; Zhang, Y; Yang, EST; Wang, S; Chang, R; Zhang, ZDD; Yang, GS; Strich, R; Pessin, JE; Yang, FJ				Song, Ziyi; Xiaoli, Alus M.; Zhang, Quanwei; Zhang, Yi; Yang, Ellen S. T.; Wang, Sven; Chang, Rui; Zhang, Zhengdong D.; Yang, Gongshe; Strich, Randy; Pessin, Jeffrey E.; Yang, Fajun			Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipogenesis; cell differentiation; gene expression; transcription coregulator; C; EBP; cyclin C; PPAR; brown adipocyte; Mediator complex	BROWN ADIPOSE-TISSUE; RNA-POLYMERASE-II; PROLIFERATOR-ACTIVATED RECEPTOR; ADIPOCYTE DIFFERENTIATION; MEDIATOR COMPLEX; PPAR-GAMMA; COACTIVATOR COMPLEX; MITOCHONDRIAL FISSION; NUCLEAR RECEPTORS; GENE-EXPRESSION	Brown adipose tissue is important for maintaining energy homeostasis and adaptive thermogenesis in rodents and humans. As disorders arising from dysregulated energy metabolism, such as obesity and metabolic diseases, have increased, so has interest in the molecular mechanisms of adipocyte biology. Using a functional screen, we identified cyclin C (CycC), a conserved subunit of the Mediator complex, as a novel regulator for brown adipocyte formation. siRNA-mediated CycC knockdown (KD) in brown preadipocytes impaired the early transcriptional program of differentiation, and genetic KO of CycC completely blocked the differentiation process. RNA sequencing analyses of CycC-KD revealed a critical role of CycC in activating genes co-regulated by peroxisome proliferator activated receptor gamma (PPAR alpha) and CCAAT/enhancer-binding protein alpha (C/EBP alpha). Overexpression of PPAR gamma(2) or addition of the PPAR gamma ligand rosiglitazone rescued the defects in CycC-KO brown preadipocytes and efficiently activated the PPAR gamma-responsive promoters in both WT and CycC-KO cells, suggesting that CycC is not essential for PPAR gamma transcriptional activity. In contrast, CycC-KO significantly reduced C/EBP alpha-dependent gene expression. Unlike for PPAR gamma, overexpression of C/EBP alpha could not induce C/EBP alpha target gene expression in CycC-KO cells or rescue the CycC-KO defects in brown adipogenesis, suggesting that CycC is essential for C/EBP alpha-mediated gene activation. CycC physically interacted with C/EBP, and this interaction was required for C/EBP alpha transactivation domain activity. Consistent with the role of C/EBP alpha in white adipogenesis, CycC-KD also inhibited differentiation of 3T3-L1 cells into white adipocytes. Together, these data indicate that CycC activates adipogenesis in part by stimulating the transcriptional activity of C/EBP alpha.	[Song, Ziyi; Yang, Gongshe] Northwest A&F Univ, Dept Anim Sci, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China; [Song, Ziyi; Xiaoli, Alus M.; Zhang, Yi; Yang, Ellen S. T.; Pessin, Jeffrey E.; Yang, Fajun] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA; [Song, Ziyi; Xiaoli, Alus M.; Zhang, Yi; Yang, Ellen S. T.; Pessin, Jeffrey E.; Yang, Fajun] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Xiaoli, Alus M.; Zhang, Yi; Yang, Ellen S. T.; Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhang, Quanwei; Zhang, Zhengdong D.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Wang, Sven; Chang, Rui] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Strich, Randy] Rowan Univ, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08055 USA	Northwest A&F University - China; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Rowan University; Rowan University School of Osteopathic Medicine	Yang, GS (corresponding author), Northwest A&F Univ, Dept Anim Sci, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	gsyang999@hotmail.com; fajun.yang@einstein.yu.edu		Yang, Gongshe/0000-0003-2003-979X; SONG, ZIYI/0000-0003-4306-4648	National Science and Technology Major Project of China [2016ZX08006003]; National Institutes of Health [P30 DK020541, R01 DK093623, DK098439, DK110063]; China Scholarship Council; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK093623, R01DK110063, R01DK098439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475] Funding Source: NIH RePORTER	National Science and Technology Major Project of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Science and Technology Major Project of China Grant 2016ZX08006003 (to G. Y.) and the National Institutes of Health Grants P30 DK020541, R01 DK093623, DK098439, and DK110063. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a scholarship from the China Scholarship Council.	Abdulla A, 2014, J BIOL CHEM, V289, P29937, DOI 10.1074/jbc.M114.573659; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cooper KF, 2014, DEV CELL, V28, P161, DOI 10.1016/j.devcel.2013.12.009; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daniels D., 2013, J PROTEOM BIOINFORM, V2, P004, DOI DOI 10.4172/JPB.S2-004; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feng DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126240; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Grontved L, 2010, MOL CELL BIOL, V30, P2155, DOI 10.1128/MCB.01238-09; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Iida S, 2015, GENE DEV, V29, P308, DOI 10.1101/gad.252809.114; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li H, 2008, J BIOL CHEM, V283, P13077, DOI 10.1074/jbc.M800604200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nanbu-Wakao R, 2002, MOL ENDOCRINOL, V16, P1565, DOI 10.1210/me.16.7.1565; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Wang K, 2015, MOL BIOL CELL, V26, P1030, DOI 10.1091/mbc.E14-08-1315; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Yin JW, 2012, GENE DEV, V26, P2192, DOI 10.1101/gad.192666.112; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhao XP, 2014, DIABETES, V63, P2464, DOI 10.2337/db13-0835; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	63	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8918	8932		10.1074/jbc.M117.776229	http://dx.doi.org/10.1074/jbc.M117.776229			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28351837	Green Published, hybrid			2022-12-28	WOS:000402153900044
J	Yoshimura, Y; Holmberg, MA; Kukic, P; Andersen, CB; Mata-Cabana, A; Falsone, SF; Vendruscolo, M; Nollen, EAA; Mulder, FAA				Yoshimura, Yuichi; Holmberg, Mats A.; Kukic, Predrag; Andersen, Camilla B.; Mata-Cabana, Alejandro; Falsone, S. Fabio; Vendruscolo, Michele; Nollen, Ellen A. A.; Mulder, Frans A. A.			MOAG-4 promotes the aggregation of alpha-synuclein by competing with self-protective electrostatic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; FIBRIL FORMATION; AMYLOID FIBRILS; CHEMICAL-SHIFTS; NMR EXPERIMENTS; PROTEIN; KINETICS; N-15; ASSIGNMENTS; RELAXATION	Aberrant protein aggregation underlies a variety of age-related neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Little is known, however, about the molecular mechanisms that modulate the aggregation process in the cellular environment. Recently, MOAG-4/SERF has been identified as a class of evolutionarily conserved proteins that positively regulates aggregate formation. Here, by using nuclear magnetic resonance (NMR) spectroscopy, we examine the mechanism of action of MOAG-4 by characterizing its interaction with alpha-synuclein (alpha-Syn). NMR chemical shift perturbations demonstrate that a positively charged segment of MOAG-4 forms a transiently populated alpha-helix that interacts with the negatively charged C terminus of alpha-Syn. This process interferes with the intramolecular interactions between the Nand C-terminal regions of alpha-Syn, resulting in the protein populating less compact forms and aggregating more readily. These results provide a compelling example of the complex competition between molecular and cellular factors that protect against protein aggregation and those that promote it.	[Yoshimura, Yuichi; Andersen, Camilla B.; Mulder, Frans A. A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Yoshimura, Yuichi; Mulder, Frans A. A.] Aarhus Univ, Dept Chem, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Holmberg, Mats A.; Mata-Cabana, Alejandro; Nollen, Ellen A. A.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Aging, NL-9700 AD Groningen, Netherlands; [Kukic, Predrag; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Andersen, Camilla B.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Falsone, S. Fabio] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Schubertstr 1, A-8010 Graz, Austria; [Yoshimura, Yuichi] Hiroshima Univ, Grad Sch Sci, Res Ctr Math Chromatin Live Dynam RcMcD, Kagamiyama 1-3-1, Higashihiroshima, Hiroshima 7398526, Japan; [Yoshimura, Yuichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Kagamiyama 1-3-1, Higashihiroshima, Hiroshima 7398526, Japan	Aarhus University; Aarhus University; University of Groningen; University of Cambridge; Aarhus University; University of Graz; Hiroshima University; Hiroshima University	Mulder, FAA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.; Mulder, FAA (corresponding author), Aarhus Univ, Dept Chem, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	fmulder@chem.au.dk	Yoshimura, Yuichi/G-8924-2019; Cabana, Alejandro Mata/U-8388-2019; Vendruscolo, Michele/F-5901-2012; Mulder, Frans AA/C-7158-2017; Andersen, Camilla Bertel/AAN-8607-2020	Yoshimura, Yuichi/0000-0002-9905-453X; Cabana, Alejandro Mata/0000-0002-0179-2746; Vendruscolo, Michele/0000-0002-3616-1610; Mulder, Frans AA/0000-0001-9427-8406; Andersen, Camilla Bertel/0000-0003-1298-0598; Falsone, Salvatore Fabio/0000-0002-3724-5824	European Molecular Biology Organization Long-term Fellowship [ALTF 687-2013]; Marie Curie Actions Fellowship; European Research Council	European Molecular Biology Organization Long-term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions Fellowship; European Research Council(European Research Council (ERC)European Commission)	Supported by European Molecular Biology Organization Long-term Fellowship ALTF 687-2013.; Supported by Marie Curie Actions Fellowship FP7-MC-IEF.; Supported by a European Research Council starting grant.	Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Allison JR, 2009, J AM CHEM SOC, V131, P18314, DOI 10.1021/ja904716h; Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bai J, 2016, J PHYS CHEM B, V120, P3140, DOI 10.1021/acs.jpcb.6b01225; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Buell AK, 2013, BIOPHYS J, V104, P1116, DOI 10.1016/j.bpj.2013.01.031; Camilloni C, 2013, J CHEM THEORY COMPUT, V9, P5610, DOI 10.1021/ct4006272; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cho MK, 2009, PROTEIN SCI, V18, P1840, DOI 10.1002/pro.194; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Falsone SF, 2012, CELL REP, V2, P358, DOI 10.1016/j.celrep.2012.06.012; Felli IC, 2009, J BIOMOL NMR, V43, P187, DOI 10.1007/s10858-009-9302-6; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Grzesiek S, 1997, J BIOMOL NMR, V9, P207, DOI 10.1023/A:1018614505948; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lescop E, 2010, J MAGN RESON, V203, P190, DOI 10.1016/j.jmr.2009.12.001; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liu AZ, 2000, J BIOMOL NMR, V16, P127, DOI 10.1023/A:1008305022907; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marek PJ, 2012, BIOCHEMISTRY-US, V51, P8478, DOI 10.1021/bi300574r; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Morel B, 2010, BIOPHYS J, V99, P3801, DOI 10.1016/j.bpj.2010.10.039; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nielsen JT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00004; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen MS, 2001, J BIOL CHEM, V276, P22680, DOI 10.1074/jbc.M101181200; Oktaviani NA, 2015, J BIOMOL NMR, V62, P129, DOI 10.1007/s10858-015-9925-8; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Sin O, 2015, CELL MOL LIFE SCI, V72, P4027, DOI 10.1007/s00018-015-1985-0; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Theillet FX, 2011, J BIOMOL NMR, V51, P487, DOI 10.1007/s10858-011-9577-2; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; WANG AC, 1993, J BIOMOL NMR, V3, P715; Wang CY, 2003, MAGN RESON CHEM, V41, P866, DOI 10.1002/mrc.1262; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yoshimura Y, 2015, J BIOMOL NMR, V61, P109, DOI 10.1007/s10858-014-9890-7; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Yuwen T, 2014, J MAGN RESON, V241, P155, DOI 10.1016/j.jmr.2013.08.008	76	23	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8269	8278		10.1074/jbc.M116.764886	http://dx.doi.org/10.1074/jbc.M116.764886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28336532	Green Published, hybrid			2022-12-28	WOS:000401788600013
J	Rutsdottir, G; Harmark, J; Weide, Y; Hebert, H; Rasmussen, MI; Wernersson, S; Respondek, M; Akke, M; Hojrup, P; Koeck, PJB; Soderberg, CAG; Emanuelsson, C				Rutsdottir, Gudrun; Harmark, Johan; Weide, Yoran; Hebert, Hans; Rasmussen, Morten I.; Wernersson, Sven; Respondek, Michal; Akke, Mikael; Hojrup, Peter; Koeck, Philip J. B.; Soderberg, Christopher A. G.; Emanuelsson, Cecilia			Structural model of dodecameric heat-shock protein Hsp21: Flexible N-terminal arms interact with client proteins while C-terminal tails maintain the dodecamer and chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; ALPHA-B-CRYSTALLIN; MASS-SPECTROMETRY; SUBUNIT EXCHANGE; EVOLUTION; SOFTWARE; DYNAMICS; SYSTEM; SUITE; MACROMOLECULES	Small heat-shock proteins (sHsps) prevent aggregation of thermosensitive client proteins in a first line of defense against cellular stress. The mechanisms by which they perform this function have been hard to define due to limited structural information; currently, there is only one high-resolution structure of a plant sHsp published, that of the cytosolic Hsp16.9. We took interest in Hsp21, a chloroplast-localized sHsp crucial for plant stress resistance, which has even longer N-terminal arms than Hsp16.9, with a functionally important and conserved methionine-rich motif. To provide a framework for investigating structure-function relationships of Hsp21 and understanding these sequence variations, we developed a structural model of Hsp21 based on homology modeling, cryo-EM, cross-linking mass spectrometry, NMR, and small-angle X-ray scattering. Our data suggest a dodecameric arrangement of two trimer-of-dimer discs stabilized by the C-terminal tails, possibly through tail-to-tail interactions between the discs, mediated through extended IXVXI motifs. Our model further suggests that six N-terminal arms are located on the outside of the dodecamer, accessible for interaction with client proteins, and distinct from previous undefined or inwardly facing arms. To test the importance of the IXVXI motif, we created the point mutant V181A, which, as expected, disrupts the Hsp21 dodecamer and decreases chaperone activity. Finally, our data emphasize that sHsp chaperone efficiency depends on oligomerization and that client interactions can occur both with and without oligomer dissociation. These results provide a generalizable workflow to explore sHsps, expand our understanding of sHsp structural motifs, and provide a testable Hsp21 structure model to inform future investigations.	[Rutsdottir, Gudrun; Weide, Yoran; Emanuelsson, Cecilia] Lund Univ, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Wernersson, Sven; Respondek, Michal; Akke, Mikael] Lund Univ, Dept Biophys Chem, SE-22100 Lund, Sweden; [Soderberg, Christopher A. G.] Lund Univ, MAX IV Lab, POB 118, SE-22100 Lund, Sweden; [Harmark, Johan; Hebert, Hans; Koeck, Philip J. B.] Karolinska Inst, KTH Royal Inst Technol, Sch Technol & Hlth, SE-17177 Stockholm, Sweden; [Harmark, Johan; Hebert, Hans; Koeck, Philip J. B.] Karolinska Inst, Dept Biosci & Nutr, SE-17177 Stockholm, Sweden; [Rasmussen, Morten I.; Hojrup, Peter] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Lund University; Lund University; Lund University; Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet; University of Southern Denmark	Soderberg, CAG (corresponding author), Lund Univ, MAX IV Lab, POB 118, SE-22100 Lund, Sweden.; Emanuelsson, C (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, POB 124, SE-22100 Lund, Sweden.	soderberg@maxiv.lu.se; cecilia.emanuelsson@biochemistry.lu.se	Højrup, Peter/ABG-8477-2020; Koeck, Philip/AAG-5333-2020	Akke, Mikael/0000-0002-2395-825X; Hojrup, Peter/0000-0002-7838-6180	Carl Tryggers Foundation; Crafoord Foundation; Danish Council for Independent Research, Natural Sciences [0602- 02380B]; Villum Fonden [00007292] Funding Source: researchfish	Carl Tryggers Foundation; Crafoord Foundation; Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This work was supported by the Carl Tryggers Foundation and the Crafoord Foundation (to C. E.); by Danish Council for Independent Research, Natural Sciences, Grant 0602- 02380B (to P. H.); and by the Center for Innovative Medicine (CIMED), Karolinska Institutet (to H. H.), in support of the EM infrastructure. The authors declare that they have no conflicts of interest with the contents of this article.	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Ahrman E, 2007, PROTEIN SCI, V16, P1464, DOI 10.1110/ps.072831607; Akerfeldt KS, 1996, BIOCHEMISTRY-US, V35, P3662, DOI 10.1021/bi9527956; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Bammes BE, 2013, MICROSC MICROANAL, V19, P1320; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boelt SG, 2015, ANAL BIOCHEM, V481, P33, DOI 10.1016/j.ab.2015.04.016; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Carver JA, 1999, PROG RETIN EYE RES, V18, P431, DOI 10.1016/S1350-9462(98)00027-5; CHEN Q, 1991, MOL GEN GENET, V226, P425, DOI 10.1007/BF00260655; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ecroyd H., 2015, BIG BOOK SMALL HEAT, P179, DOI [10.1007/978-3-319-16077-1_7, DOI 10.1007/978-3-319-16077-1_7]; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Groitl B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10357; Gustavsson N, 2002, PLANT J, V29, P545, DOI 10.1046/j.1365-313X.2002.029005545.x; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Hanazono Y, 2012, J MOL BIOL, V422, P100, DOI 10.1016/j.jmb.2012.05.017; Harndahl U, 1998, PROTEIN EXPRES PURIF, V14, P87, DOI 10.1006/prep.1998.0921; Harndahl U, 2001, BBA-PROTEIN STRUCT M, V1545, P227, DOI 10.1016/S0167-4838(00)00280-6; Haslbeck M., 2015, BIG BOOK SMALL HEAT, P155, DOI [10.1007/978-3-319-16077-1_6, DOI 10.1007/978-3-319-16077-1_6]; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hilario E, 2011, J MOL BIOL, V408, P74, DOI 10.1016/j.jmb.2011.02.004; Jackson SE, 2013, TOP CURR CHEM, V328, P69, DOI 10.1007/128_2012_324; Jaspard E, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0820-6; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Koldewey P, 2016, CELL, V166, P369, DOI 10.1016/j.cell.2016.05.054; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Labrador A, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/7/072019; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert W, 2013, CELL STRESS CHAPERON, V18, P75, DOI 10.1007/s12192-012-0360-4; Lambert W, 2011, PROTEIN SCI, V20, P291, DOI 10.1002/pro.560; Leitner A, 2016, TRENDS BIOCHEM SCI, V41, P20, DOI 10.1016/j.tibs.2015.10.008; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Magliery TJ, 2015, CURR OPIN STRUC BIOL, V33, P161, DOI 10.1016/j.sbi.2015.09.002; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; McLoughlin F, 2016, PLANT PHYSIOL, V172, P1221, DOI 10.1104/pp.16.00536; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rasmussen MI, 2011, J PROTEOMICS, V74, P1871, DOI 10.1016/j.jprot.2011.04.019; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Soderberg CAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038927; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Treweek TM, 2010, EXP EYE RES, V91, P691, DOI 10.1016/j.exer.2010.08.015; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Waters ER, 1999, P NATL ACAD SCI USA, V96, P14394, DOI 10.1073/pnas.96.25.14394; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	81	16	18	0	175	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8103	8121		10.1074/jbc.M116.766816	http://dx.doi.org/10.1074/jbc.M116.766816			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325834	Green Published, hybrid			2022-12-28	WOS:000401154100035
J	Haneklaus, M; O'Neil, JD; Clark, AR; Masters, SL; O'Neill, LAJ				Haneklaus, Moritz; O'Neil, John D.; Clark, Andrew R.; Masters, Seth L.; O'Neill, Luke A. J.			The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; TNF-ALPHA; ALTERNATIVE POLYADENYLATION; KAPPA-B; ACTIVATION; STABILITY; KINASE; INTERLEUKIN-1-BETA; EXPRESSION	The NLRP3 inflammasome is a central regulator of inflammation in many common diseases, including atherosclerosis and type 2 diabetes, driving the production of pro-inflammatory mediators such as IL-1 beta and IL-18. Due to its function as an inflammatory gatekeeper, expression and activation of NLRP3 need to be tightly regulated. In this study, we highlight novel post-transcriptional mechanisms that can modulate NLRP3 expression. We have identified the RNA-binding protein Tristetraprolin (TTP) as a negative regulator of NLRP3 in human macrophages. TTP targets AU-rich elements in the NLRP3 3'-untranslated region (UTR) and represses NLRP3 expression. Knocking down TTP in primary macrophages leads to an increased induction of NLRP3 by LPS, which is also accompanied by increased Caspase-1 and IL-1 beta cleavage upon NLRP3, but not AIM2 or NLRC4 inflammasome activation. Furthermore, we found that human NLRP3 can be alternatively polyadenylated, producing a short 3'-UTR isoform that excludes regulatory elements, including the TTP- and miRNA-223-binding sites. Because TTP also represses IL-1 beta expression, it is a dual inhibitor of the IL-1 beta system, regulating expression of the cytokine and the upstream controller NLRP3.	[Haneklaus, Moritz; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [O'Neil, John D.; Clark, Andrew R.] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England; [Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic 3052, Australia	Trinity College Dublin; University of Birmingham; Walter & Eliza Hall Institute	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Haneklaus, Moritz/AAE-4728-2020; Masters, Seth L/N-2886-2013; Clark, Andrew/AAN-4043-2021	Masters, Seth L/0000-0003-4763-576X; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; European Research Council; Medical Research Council [G0800207] Funding Source: researchfish; Versus Arthritis [19614] Funding Source: researchfish; MRC [G0800207] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Science Foundation Ireland and the European Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chang JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8218; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark AR, 2016, BIOCHEM SOC T, V44, P1321, DOI 10.1042/BST20160166; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elkon R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r59; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Filardy AA, 2016, MUCOSAL IMMUNOL, V9, P850, DOI 10.1038/mi.2015.109; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Gaba A, 2012, J IMMUNOL, V189, P2089, DOI 10.4049/jimmunol.1201126; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Greenhill CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0419-y; Gurung P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14488; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Joe Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088776; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kang JG, 2011, J IMMUNOL, V187, P2696, DOI 10.4049/jimmunol.1101149; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lacey D, 2015, P NATL ACAD SCI USA, V112, P9698, DOI 10.1073/pnas.1508399112; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Patial S, 2016, P NATL ACAD SCI USA, V113, P1865, DOI 10.1073/pnas.1519906113; Qi MY, 2012, MOL CELL BIOL, V32, P913, DOI 10.1128/MCB.05340-11; Ross EA, 2017, ANN RHEUM DIS, V76, P612, DOI 10.1136/annrheumdis-2016-209424; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Sedlyarov V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156628; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Tao XZ, 2015, MOL CELL BIOL, V35, P3921, DOI 10.1128/MCB.00845-15; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yao Y, 2015, J IMMUNOL, V195, P488, DOI 10.4049/jimmunol.1403225; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang J, 2014, MUCOSAL IMMUNOL, V7, P1139, DOI 10.1038/mi.2014.1	82	38	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6869	6881		10.1074/jbc.M116.772947	http://dx.doi.org/10.1074/jbc.M116.772947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28302726	hybrid, Green Published			2022-12-28	WOS:000400478300002
J	Kong, PF; Ufermann, CM; Zimmermann, DLM; Yin, Q; Suo, X; Helms, JB; Brouwers, JF; Gupta, N				Kong, Pengfei; Ufermann, Christoph-Martin; Zimmermann, Diana L. M.; Yin, Qing; Suo, Xun; Helms, J. Bernd; Brouwers, Jos F.; Gupta, Nishith			Two phylogenetically and compartmentally distinct CDP-diacylglycerol synthases cooperate for lipid biogenesis in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; APICOMPLEXAN PARASITES; ENDOPLASMIC-RETICULUM; ORGANELLE BIOGENESIS; TRYPANOSOMA-BRUCEI; PROTOZOAN PARASITE; SELECTABLE MARKER; ALGAL ORIGIN; APICOPLAST; GENE	Toxoplasma gondii is among the most prevalent protozoan parasites, which infects a wide range of organisms, including one-third of the human population. Its rapid intracellular replication within a vacuole requires efficient synthesis of glycerophospholipids. Cytidine diphosphate-diacylglycerol (CDP-DAG) serves as a major precursor for phospholipid synthesis. Given the peculiarities of lipid biogenesis, understanding the mechanism and physiological importance of CDP-DAG synthesis is particularly relevant in T. gondii. Here, we report the occurrence of two phylogenetically divergent CDP-DAG synthase (CDS) enzymes in the parasite. The eukaryotic-type TgCDS1 and the prokaryotic-type TgCDS2 reside in the endoplasmic reticulum and apicoplast, respectively. Conditional knockdown of TgCDS1 severely attenuated the parasite growth and resulted in a nearly complete loss of virulence in a mouse model. Moreover, mice infected with the TgCDS1 mutant became fully resistant to challenge infection with a hyper-virulent strain of T. gondii. The residual growth of the TgCDS1 mutant was abolished by consecutive deletion of TgCDS2. Lipidomic analyses of the two mutants revealed significant and specific declines in phosphatidylinositol and phosphatidylglycerol levels upon repression of TgCDS1 and after deletion of TgCDS2, respectively. Our data suggest a "division of labor" model of lipid biogenesis in T. gondii in which two discrete CDP-DAG pools produced in the endoplasmic reticulum and apicoplast are subsequently used for the synthesis of phosphatidylinositol in the Golgi bodies and phosphatidylglycerol in the mitochondria. The essential and divergent nature of CDP-DAG synthesis in the parasite apicoplast offers a potential drug target to inhibit the asexual reproduction of T. gondii.	[Kong, Pengfei; Ufermann, Christoph-Martin; Zimmermann, Diana L. M.; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10115 Berlin, Germany; [Yin, Qing; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [Yin, Qing; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Helms, J. Bernd; Brouwers, Jos F.] Univ Utrecht, Inst Biomembranes, Dept Biochem & Cell Biol, NL-3584 CM Utrecht, Netherlands	Humboldt University of Berlin; China Agricultural University; China Agricultural University; Utrecht University	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de	Brouwers, Jos F/AAH-1444-2019	Brouwers, Jos F/0000-0003-2924-3279; Gupta, Nishith/0000-0003-1452-5126; Kong, Pengfei/0000-0003-2944-5874; Ufermann, Christoph-Martin/0000-0002-4779-5424	German Research Foundation (DFG) [GU1100/3-1, GU1100/4-1]; Heisenberg program award	German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg program award	This work was supported by German Research Foundation (DFG) Grants GU1100/3-1 and GU1100/4-1 and a Heisenberg program award (to N. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Amiar S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005765; Arroyo-Olarte RD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002288; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouchut A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112096; Brouwers JF, 2013, PROTEOMICS, V13, P1660, DOI 10.1002/pmic.201200348; Cilingir G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036598; D'Souza K, 2014, BIOCHEMISTRY-US, V53, P7358, DOI 10.1021/bi501250m; Daher W, 2015, CELL MICROBIOL, V17, P559, DOI 10.1111/cmi.12383; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; DeRocher A, 2005, J CELL SCI, V118, P565, DOI 10.1242/jcs.01627; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Halford S, 1998, GENOMICS, V54, P140, DOI 10.1006/geno.1998.5547; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Heiny SR, 2014, TRAFFIC, V15, P1290, DOI 10.1111/tra.12226; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Inglis-Broadgate SL, 2005, GENE, V356, P19, DOI 10.1016/j.gene.2005.04.037; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lilley AC, 2014, MOL MICROBIOL, V92, P453, DOI 10.1111/mmi.12553; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; Martin D, 2000, MOL BIOCHEM PARASIT, V110, P93, DOI 10.1016/S0166-6851(00)00260-7; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nitzsche R, 2016, J BIOL CHEM, V291, P126, DOI 10.1074/jbc.M114.624619; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Sampels V, 2012, J BIOL CHEM, V287, P16289, DOI 10.1074/jbc.M112.347138; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shastri S, 2010, INT J PARASITOL, V40, P1257, DOI 10.1016/j.ijpara.2010.03.006; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stewart RJ, 2016, TRAFFIC, V17, P102, DOI 10.1111/tra.12348; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tomova C, 2009, TRAFFIC, V10, P1471, DOI 10.1111/j.1600-0854.2009.00954.x; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; Wichroski MJ, 2003, EUKARYOT CELL, V2, P1132, DOI 10.1128/EC.2.5.1132-1136.2003; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Zhou YH, 2013, PLANT J, V75, P867, DOI 10.1111/tpj.12248	57	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7145	7159		10.1074/jbc.M116.765487	http://dx.doi.org/10.1074/jbc.M116.765487			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28314772	hybrid, Green Published			2022-12-28	WOS:000400478300024
J	Gkekas, S; Singh, RK; Shkumatov, AV; Messens, J; Fauvart, M; Verstraeten, N; Michiels, J; Versees, W				Gkekas, Sotirios; Singh, Ranjan Kumar; Shkumatov, Alexander V.; Messens, Joris; Fauvart, Maarten; Verstraeten, Natalie; Michiels, Jan; Versees, Wim			Structural and biochemical analysis of Escherichia coli ObgE, a central regulator of bacterial persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; crystal structure; enzyme kinetics; enzyme structure; GTPase; X-ray crystallography; X-ray scattering	50S RIBOSOMAL-SUBUNIT; G-PROTEINS; STRINGENT RESPONSE; BACILLUS-SUBTILIS; GTPASE REACTION; G-DOMAIN; BINDING; DIMERIZATION; MODEL; MACROMOLECULES	The Obg protein family belongs to the TRAFAC (translation factor) class of P-loop GTPases and is conserved from bacteria to eukaryotes. Essential roles in many different cellular processes have been suggested for the Obg protein from Escherichia coli (ObgE), and we recently showed that it is a central regulator of bacterial persistence. Here, we report the first crystal structure of ObgE at 1.85- resolution in the GDP-bound state, showing the characteristic N-terminal domain and a central G domain that are common to all Obg proteins. ObgE also contains an intrinsically disordered C-terminal domain, and we show here that this domain specifically contributed to GTP binding, whereas it did not influence GDP binding or GTP hydrolysis. Biophysical analysis, using small angle X-ray scattering and multi-angle light scattering experiments, revealed that ObgE is a monomer in solution, regardless of the bound nucleotide. In contrast to recent suggestions, our biochemical analyses further indicate that ObgE is neither activated by K+ ions nor by homodimerization. However, the ObgE GTPase activity was stimulated upon binding to the ribosome, confirming the ribosome-dependent GTPase activity of the Obg family. Combined, our data represent an important step toward further unraveling the detailed molecular mechanism of ObgE, which might pave the way to further studies into how this GTPase regulates bacterial physiology, including persistence.	[Gkekas, Sotirios; Singh, Ranjan Kumar; Shkumatov, Alexander V.; Messens, Joris; Versees, Wim] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Gkekas, Sotirios; Singh, Ranjan Kumar; Shkumatov, Alexander V.; Messens, Joris; Versees, Wim] VIB VUB Ctr Struct Biol, B-1050 Brussels, Belgium; [Fauvart, Maarten; Verstraeten, Natalie; Michiels, Jan] Univ Leuven, KU Leuven, Ctr Microbial & Plant Genet, B-3001 Leuven, Belgium; [Fauvart, Maarten] IMEC, Dept Life Sci Technol, Smart Syst & Emerging Technol Unit, B-3001 Leuven, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; IMEC	Versees, W (corresponding author), Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium.	wim.versees@vib-vub.be	Verstraeten, Natalie/AAH-3963-2019; Messens, Joris/AAH-3008-2020; Fauvart, Maarten/B-1612-2010; Michiels, Jan/F-1601-2010; Verstraeten, Natalie/AAJ-1464-2021; SINGH, RANJAN/Q-2752-2017	Verstraeten, Natalie/0000-0002-9548-4647; Messens, Joris/0000-0002-2128-8264; Fauvart, Maarten/0000-0002-6256-9193; Michiels, Jan/0000-0001-5829-0897; Verstraeten, Natalie/0000-0002-9548-4647; SINGH, RANJAN/0000-0002-6929-0670; Versees, Wim/0000-0002-4695-696X	Fonds voor Wetenschappelijk Onderzoek [G0471.12N, G0B2515N]; Hercules Foundation; BioStruct-X by the European Community's Seventh Framework Programme; VUB [SRP34]; Interuniversity Attraction Poles Program; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT); Belgian Science Policy Office	Fonds voor Wetenschappelijk Onderzoek(FWO); Hercules Foundation; BioStruct-X by the European Community's Seventh Framework Programme; VUB; Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy Office(Belgian Federal Science Policy Office)	This work was supported in part by Fonds voor Wetenschappelijk Onderzoek Grants G0471.12N and G0B2515N, the Hercules Foundation, BioStruct-X by the European Community's Seventh Framework Programme, a Strategic Research Program (SRP34) from the VUB, and the Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT).	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2012, FEBS LETT, V586, P2218, DOI 10.1016/j.febslet.2012.06.030; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; Bang WY, 2009, PLANT MOL BIOL, V71, P379, DOI 10.1007/s11103-009-9529-3; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Chatterjee A, 2015, BIOCHEM BIOPH RES CO, V461, P636, DOI 10.1016/j.bbrc.2015.04.079; Cheung MY, 2016, P NATL ACAD SCI USA, V113, P2648, DOI 10.1073/pnas.1522966113; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Fislage M, 2016, BIOPOLYMERS, V105, P568, DOI 10.1002/bip.22813; Fislage M, 2014, NUCLEIC ACIDS RES, V42, P5978, DOI 10.1093/nar/gku213; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Foucher AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046795; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hirano Y, 2006, GENES CELLS, V11, P1295, DOI 10.1111/j.1365-2443.2006.01017.x; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kint C, 2014, CRIT REV MICROBIOL, V40, P207, DOI 10.3109/1040841X.2013.776510; Kint CI, 2012, FEBS J, V279, P3692, DOI 10.1111/j.1742-4658.2012.08731.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Maracci C, 2016, BIOPOLYMERS, V105, P463, DOI 10.1002/bip.22832; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Mishra AK, 2016, BIOPOLYMERS, V105, P431, DOI 10.1002/bip.22833; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rafay A, 2012, FEBS OPEN BIO, V2, P173, DOI 10.1016/j.fob.2012.07.008; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004	68	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5871	5883		10.1074/jbc.M116.761809	http://dx.doi.org/10.1074/jbc.M116.761809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223358	Green Published, hybrid			2022-12-28	WOS:000398813200022
J	Wills, MKB; Chahi, AK; Lau, HR; Tilak, M; Guild, BD; New, LA; Lu, PH; Jacquet, K; Meakin, SO; Bisson, N; Jones, N				Wills, Melanie K. B.; Chahi, Ava Keyvani; Lau, Hayley R.; Tilak, Manali; Guild, Brianna D.; New, Laura A.; Lu, Peihua; Jacquet, Kevin; Meakin, Susan O.; Bisson, Nicolas; Jones, Nina			Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular signal-regulated kinase (ERK); growth factor receptor-bound protein 2 (GRB2); neurotrophin; signal transduction; TRK1-transforming tyrosine kinase protein (Trk-A); RaLP; ShcD; Shp2; TrkB; phosphotyrosine adaptor	NEGATIVE REGULATOR; DOCKING PROTEIN; ACTIVATION; GROWTH; EXPRESSION; FAMILY; BINDING; NEUROBLASTOMA; MECHANISM; PATHWAY	Proteins of the Src homology and collagen (Shc) family are typically involved in signal transduction events involving Ras/MAPK and PI3K/Akt pathways. In the nervous system, they function proximal to the neurotrophic factors that regulate cell survival, differentiation, and neuron-specific characteristics. The least characterized homolog, ShcD, is robustly expressed in the developing and mature nervous system, but its contributions to neural cell circuitry are largely uncharted. We now report that ShcD binds to active Ret, TrkA, and TrkB neurotrophic factor receptors predominantly via its phosphotyrosine-binding (PTB) domain. However, in contrast to the conventional Shc adaptors, ShcD suppresses distal phosphorylation of the Erk MAPK. Accordingly, genetic knock-out of mouse ShcD enhances Erk phosphorylation in the brain. In cultured cells, this capacity is tightly aligned to phosphorylation of ShcD CH1 region tyrosine motifs, which serve as docking platforms for signal transducers, such as Grb2. Erk suppression is relieved through independent mutagenesis of the PTB domain and the CH1 tyrosine residues, and successive substitution of these tyrosines breaks the interaction between ShcD and Grb2, thereby promoting TrkB-Grb2 association. Erk phosphorylation can also be restored in the presence of wild type ShcD through Grb2 overexpression. Conversely, mutation of the ShcD SH2 domain results in enhanced repression of Erk. Although the SH2 domain is a less common binding interface in Shc proteins, we demonstrate that it associates with the Ptpn11 (Shp2) phosphatase, which in turn regulates ShcD tyrosine phosphorylation. We therefore propose a model whereby ShcD competes with neurotrophic receptors for Grb2 binding and opposes activation of the MAPK cascade.	[Wills, Melanie K. B.; Chahi, Ava Keyvani; Lau, Hayley R.; Tilak, Manali; Guild, Brianna D.; New, Laura A.; Lu, Peihua; Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Jacquet, Kevin; Bisson, Nicolas] Univ Laval, Canc Res Ctr, Quebec Network Res Prot Funct Engn & Applicat PRO, Quebec City, PQ G1R 2J6, Canada; [Jacquet, Kevin; Bisson, Nicolas] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ G1R 2J6, Canada; [Meakin, Susan O.] Western Univ, Dept Biochem, London, ON N6A 5B7, Canada	University of Guelph; Laval University; Laval University; Western University (University of Western Ontario)	Jones, N (corresponding author), Univ Guelph, Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	jonesmcb@uoguelph.ca		Wills, Melanie/0000-0002-7448-8657; Bisson, Nicolas/0000-0001-7752-9517	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; Canada Research Chair awards; Canadian Institutes of Health Research Vanier Scholarship; University of Guelph Brock Doctoral Scholarship; NSERC Alexander Graham Bell Canada graduate scholarship; Canadian Imperial Bank of Commerce Health and Science studentship; University of Guelph College of Biological Sciences studentship; NSERC; PROTEO scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair awards(Canada Research Chairs); Canadian Institutes of Health Research Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); University of Guelph Brock Doctoral Scholarship; NSERC Alexander Graham Bell Canada graduate scholarship; Canadian Imperial Bank of Commerce Health and Science studentship; University of Guelph College of Biological Sciences studentship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); PROTEO scholarship	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (to N. J.) and Tier 2 Canada Research Chair awards (to N. J. and N. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canadian Institutes of Health Research Vanier Scholarship, the University of Guelph Brock Doctoral Scholarship, and an NSERC Alexander Graham Bell Canada graduate scholarship (M.Sc.).; Held a Canadian Imperial Bank of Commerce Health and Science studentship.; Received a University of Guelph College of Biological Sciences studentship.; Recipient of an NSERC undergraduate student research award.; Supported by a PROTEO scholarship.	Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Aoudjit Lamine, 2011, J Signal Transduct, V2011, P376543, DOI 10.1155/2011/376543; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Beigbeder A, 2016, METHODS MOL BIOL, V1458, P339, DOI 10.1007/978-1-4939-3801-8_23; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Conti L, 2001, NAT NEUROSCI, V4, P579, DOI 10.1038/88395; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Ferro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029899; George R, 2008, J MOL BIOL, V377, P740, DOI 10.1016/j.jmb.2007.12.040; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hawley SP, 2011, DEV DYNAM, V240, P221, DOI 10.1002/dvdy.22506; Jones N, 2007, MOL CELL BIOL, V27, P4759, DOI 10.1128/MCB.00184-07; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Kumamaru E, 2011, FEBS LETT, V585, P3224, DOI 10.1016/j.febslet.2011.09.010; Lai KMV, 2000, GENE DEV, V14, P1132; Ledda F, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00199; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; MacDonald JIS, 2000, J BIOL CHEM, V275, P18225, DOI 10.1074/jbc.M001862200; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Miyake I, 2009, ONCOGENE, V28, P662, DOI 10.1038/onc.2008.413; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelicci G, 2002, MOL CELL BIOL, V22, P7351, DOI 10.1128/MCB.22.20.7351-7363.2002; Ponti G, 2005, NEUROSCIENCE, V133, P105, DOI 10.1016/j.neuroscience.2005.02.014; Ponti G, 2010, NEUROSCIENCE, V168, P314, DOI 10.1016/j.neuroscience.2010.03.008; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Savino MT, 2009, J IMMUNOL, V182, P301, DOI 10.4049/jimmunol.182.1.301; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Suen KM, 2013, NAT STRUCT MOL BIOL, V20, P620, DOI 10.1038/nsmb.2557; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Terui E, 2005, CLIN CANCER RES, V11, P3280, DOI 10.1158/1078-0432.CCR-04-1681; Villanacci V, 2008, NEUROGASTROENT MOTIL, V20, P206, DOI 10.1111/j.1365-2982.2007.01017.x; Wills MKB, 2014, MOL BIOL CELL, V25, P739, DOI 10.1091/mbc.E13-08-0434; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; You YG, 2010, BMB REP, V43, P485, DOI 10.5483/BMBRep.2010.43.7.485	43	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5748	5759		10.1074/jbc.M116.770511	http://dx.doi.org/10.1074/jbc.M116.770511			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213521	Green Published, hybrid			2022-12-28	WOS:000398813200013
J	Cheng, Q; Arner, ESJ				Cheng, Qing; Arner, Elias S. J.			Selenocysteine Insertion at a Predefined UAG Codon in a Release Factor 1 (RF1)-depleted Escherichia coli Host Strain Bypasses Species Barriers in Recombinant Selenoprotein Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; SECIS ELEMENTS; GENETIC-CODE; IN-VIVO; EXPRESSION; SELENIUM; RNA; PROTEINS; PURIFICATION; EFFICIENCY	Selenoproteins contain the amino acid selenocysteine (Sec), co-translationally inserted at a predefined UGA opal codon by means of Sec-specific translation machineries. In Escherichia coli, this process is dependent upon binding of the Sec-dedicated elongation factor SelB to a Sec insertion sequence (SECIS) element in the selenoprotein-encoding mRNA and competes with UGA-directed translational termination. Here, we found that Sec can also be efficiently incorporated at a predefined UAG amber codon, thereby competing with RF1 rather than RF2. Subsequently, utilizing the RF1-depleted E. coli strain C321. Delta A, we could produce mammalian selenoprotein thioredoxin reductases with unsurpassed purity and yield. We also found that a SECIS element was no longer absolutely required in such a system. Human glutathione peroxidase 1 could thereby also be produced, and we could confirm a previously proposed catalytic tetrad in this selenoprotein. We believe that the versatility of this new UAG-directed production methodology should enable many further studies of diverse selenoproteins.	[Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	elias.arner@ki.se	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114	Swedish Research Council; Swedish Cancer Society; Knut Foundation; Alice Wallenberg Foundation; Karolinska Institutet; NATIONAL INSTITUTE ON AGING [R21AG055022] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut Foundation; Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Swedish Research Council, the Swedish Cancer Society, The Knut and Alice Wallenberg Foundations, and Karolinska Institutet. The authors declare that they have no conflicts of interest with the contents of this article.	Aldag C, 2013, ANGEW CHEM INT EDIT, V52, P1441, DOI 10.1002/anie.201207567; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; ARNER ESJ, 2000, CURRENT PROTOCOLS TO; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brocker MJ, 2014, ANGEW CHEM INT EDIT, V53, P319, DOI 10.1002/anie.201308584; Casi G, 2008, CHEMBIOCHEM, V9, P1623, DOI 10.1002/cbic.200700745; Castellano S, 2008, NUCLEIC ACIDS RES, V36, pD332, DOI 10.1093/nar/gkm731; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; Esworthy RS, 2001, CURR PROTOC TOXICOL; Fletcher JE, 2001, RNA, V7, P1442; George S, 2016, FEBS LETT, V590, P1530, DOI 10.1002/1873-3468.12182; Hondal RJ, 2009, BBA-GEN SUBJECTS, V1790, P1501, DOI 10.1016/j.bbagen.2009.04.015; Jiang ZH, 2004, BIOCHEM BIOPH RES CO, V321, P94, DOI 10.1016/j.bbrc.2004.06.110; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2004, EMBO REP, V5, P538, DOI 10.1038/sj.embor.7400126; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Metanis N, 2014, CURR OPIN CHEM BIOL, V22, P27, DOI 10.1016/j.cbpa.2014.09.010; Miller C, 2015, FEBS LETT, V589, P2194, DOI 10.1016/j.febslet.2015.06.039; Mukai T, 2016, ANGEW CHEM INT EDIT, V55, P5337, DOI 10.1002/anie.201511657; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nilsson M, 2003, BBA-GENE STRUCT EXPR, V1627, P1, DOI 10.1016/S0167-4781(03)00050-2; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Reich HJ, 2016, ACS CHEM BIOL, V11, P821, DOI 10.1021/acschembio.6b00031; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rengby O, 2007, APPL ENVIRON MICROB, V73, P432, DOI 10.1128/AEM.02019-06; Rengby O, 2009, FREE RADICAL BIO MED, V46, P893, DOI 10.1016/j.freeradbiomed.2008.12.017; Rother M, 2001, MOL MICROBIOL, V40, P900, DOI 10.1046/j.1365-2958.2001.02433.x; SAWERS G, 1991, J BACTERIOL, V173, P4983, DOI 10.1128/jb.173.16.4983-4993.1991; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Thanbichler M, 2002, EMBO J, V21, P6925, DOI 10.1093/emboj/cdf673; Thyer R, 2015, J AM CHEM SOC, V137, P46, DOI 10.1021/ja510695g; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Xu JQ, 2013, NUCLEIC ACIDS RES, V41, P9800, DOI 10.1093/nar/gkt764; Zhang Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r37; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000095; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660	53	35	35	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5476	5487		10.1074/jbc.M117.776310	http://dx.doi.org/10.1074/jbc.M117.776310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193838	Green Published, hybrid			2022-12-28	WOS:000397875500027
J	Vitvitsky, V; Yadav, PK; An, S; Seravalli, J; Cho, US; Banerjee, R				Vitvitsky, Victor; Yadav, Pramod K.; An, Sojin; Seravalli, Javier; Cho, Uhn-Soo; Banerjee, Ruma			Structural and Mechanistic Insights into Hemoglobin-catalyzed Hydrogen Sulfide Oxidation and the Fate of Polysulfide Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PECTINATA BACTERIA SYMBIOSIS; CYSTEINE PERSULFIDES; MIGRATION; KINETICS; THIOSULFATE; UNDERSTAND; SYNTHASE; MODEL; O-2	Hydrogen sulfide is a cardioprotective signaling molecule but is toxic at elevated concentrations. Red blood cells can synthesize H2S but, lacking organelles, cannot dispose of H2S via the mitochondrial sulfide oxidation pathway. We have recently shown that at high sulfide concentrations, ferric hemoglobin oxidizes H2S to a mixture of thiosulfate and iron-bound polysulfides in which the latter species predominates. Here, we report the crystal structure of human hemoglobin containing low spin ferric sulfide, the first intermediate in heme-catalyzed sulfide oxidation. The structure provides molecular insights into why sulfide is susceptible to oxidation in human hemoglobin but is stabilized against it in HbI, a specialized sulfide-carrying hemoglobin from a mollusk adapted to life in a sulfide-rich environment. We have also captured a second sulfide bound at a postulated ligand entry/exit site in the alpha-subunit of hemoglobin, which, to the best of our knowledge, represents the first direct evidence for this site being used to access the heme iron. Hydrodisulfide, a postulated intermediate at the junction between thiosulfate and polysulfide formation, coordinates ferric hemoglobin and, in the presence of air, generated thiosulfate. At low sulfide/heme iron ratios, the product distribution between thiosulfate and iron-bound polysulfides was approximately equal. The iron-bound polysulfides were unstable at physiological glutathione concentrations and were reduced with concomitant formation of glutathione persulfide, glutathione disulfide, and H2S. Hence, although polysulfides are unlikely to be stable in the reducing intracellular milieu, glutathione persulfide could serve as a persulfide donor for protein persulfidation, a posttranslational modification by which H2S is postulated to signal.	[Vitvitsky, Victor; Yadav, Pramod K.; An, Sojin; Cho, Uhn-Soo; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [GM112455, DK111465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM112455 (to R. B.) and DK111465 (to U.-S. C). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAGARINAO T, 1992, J COMP PHYSIOL B, V162, P614, DOI 10.1007/BF00296642; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; Cumnock K, 2013, BIOCONJUGATE CHEM, V24, P1154, DOI 10.1021/bc4000299; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Lucas MF, 2012, BIOPHYS J, V102, P887, DOI 10.1016/j.bpj.2012.01.011; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; HYLIN JW, 1959, J BIOL CHEM, V234, P2141; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P347, DOI 10.1089/ars.2014.6082; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagy P, 2010, CHEM RES TOXICOL, V23, P1541, DOI 10.1021/tx100266a; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Savino C, 2009, BIOPOLYMERS, V91, P1097, DOI 10.1002/bip.21201; Shadrina MS, 2015, BIOCHEMISTRY-US, V54, P5279, DOI 10.1021/acs.biochem.5b00369; Shadrina MS, 2015, BIOCHEMISTRY-US, V54, P5268, DOI 10.1021/acs.biochem.5b00368; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2015, METHOD ENZYMOL, V554, P111, DOI 10.1016/bs.mie.2014.11.013; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Yi J, 2008, BIOCHEMISTRY-US, V47, P8247, DOI 10.1021/bi801015c	36	39	39	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5584	5592		10.1074/jbc.M117.774943	http://dx.doi.org/10.1074/jbc.M117.774943			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213526	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000397875500036
J	Nakano, N; Tsuchiya, Y; Kako, K; Umezaki, K; Sano, K; Ikeno, S; Otsuka, E; Shigeta, M; Nakagawa, A; Sakata, N; Itoh, F; Nakano, Y; Iemura, S; van Dinther, M; Natsume, T; ten Dijke, P; Itoh, S				Nakano, Naoko; Tsuchiya, Yuki; Kako, Kenro; Umezaki, Kenryu; Sano, Keigo; Ikeno, Souichi; Otsuka, Eri; Shigeta, Masashi; Nakagawa, Ai; Sakata, Nobuo; Itoh, Fumiko; Nakano, Yota; Iemura, Shun-ichiro; van Dinther, Maarten; Natsume, Tohru; ten Dijke, Peter; Itoh, Susumu			TMED10 Protein Interferes with Transforming Growth Factor (TGF)-beta Signaling by Disrupting TGF-beta Receptor Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD PROTEINS; I RECEPTORS; NEGATIVE REGULATION; FAMILY; CELLS; TMP21; ACTIVATION; TRAFFICKING; PATHWAYS; DISEASE	The intensity and duration of TGF-beta signaling determine the cellular biological response. How this is negatively regulated is not well understood. Here, we identified a novel negative regulator of TGF-beta signaling, transmembrane p24-trafficking protein 10 (TMED10). TMED10 disrupts the complex formation between TGF-beta type I (also termed ALK5) and type II receptors (T beta RII). Misexpression studies revealed that TMED10 attenuated TGF-beta-mediated signaling. A 20-amino acid-long region from Thr(91) to Glu(110) within the extracellular region of TMED10 was found to be crucial for TMED 10 interaction with both ALK5 and T beta RII. Synthetic peptides corresponding to this region inhibit both TGF-beta-induced Smad2 phosphorylation and Smad-dependent transcriptional reporter activity. In a xenograft cancer model, where previously TGF-beta was shown to elicit tumor-promoting effects, gain-of-function and loss-of-function studies for TMED10 revealed a decrease and increase in the tumor size, respectively. Thus, we determined herein that TMED10 expression levels are the key determinant for efficiency of TGF-beta receptor complex formation and signaling.	[Nakano, Naoko; Tsuchiya, Yuki; Kako, Kenro; Umezaki, Kenryu; Sano, Keigo; Ikeno, Souichi; Otsuka, Eri; Shigeta, Masashi; Nakagawa, Ai; Sakata, Nobuo; Nakano, Yota; Itoh, Susumu] Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan; [Iemura, Shun-ichiro] Fukushima Med Univ, Translat Res Ctr, 11-25 Sakaemachi, Fukushima, Fukushima 9608031, Japan; [van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Med Ctr, Canc Genom Ctr Netherlands, Dept Mol Cell Biol, S-1-P, NL-2300 RC Leiden, Netherlands; [Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan; [ten Dijke, Peter] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, SE-75124 Uppsala, Sweden	Showa Pharmaceutical University; Tokyo University of Pharmacy & Life Sciences; Fukushima Medical University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institute of Advanced Industrial Science & Technology (AIST); Ludwig Institute for Cancer Research; Uppsala University	Itoh, S (corresponding author), Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	sitoh@ac.shoyaku.ac.jp	Dijke, Peter ten/AAG-4660-2021; Natsume, Tohru/M-7627-2018; Sakata, Nobuo/L-9753-2015	Dijke, Peter ten/0000-0002-7234-342X; Natsume, Tohru/0000-0002-1510-2582; Sakata, Nobuo/0000-0001-9967-8409; Itoh, Fumiko/0000-0002-6134-5331; Itoh, Susumu/0000-0002-7967-0730	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Vehicle Racing Commemorative Foundation; MEXT; Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science;  [15K18866]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Vehicle Racing Commemorative Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This research was supported by Grant-in-aid for Young Scientists (B) 15K18866 (to N.N.); the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. Itoh); the Takeda Science Foundation (to S. Itoh); the Smoking Research Foundation (to S. Itoh); the Daiichi-Sankyo Foundation of Life Science (to S. Itoh); the Naito Foundation (to S. Itoh); the Vehicle Racing Commemorative Foundation (to S. Itoh); Grant 2013-2017 from the MEXT-supported Program for the Strategic Research Foundation at Private Universities (to N. N. and S. Itoh); and a Grant-in-aid for Young Scientists from Showa Pharmaceutical University (to N. N.). This research also was supported by the Joint Usage/Research Program of the Medical Research Institute, Tokyo Medical and Dental University, and the Japan Society for the Promotion of Science Core-to-Core Program, "Cooperative International Framework in TGF-beta Family Signaling." The authors declare that they have no conflicts of interest with the contents of this article.	ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blum R, 1999, J CELL SCI, V112, P537; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Blum R, 2008, TRAFFIC, V9, P1530, DOI 10.1111/j.1600-0854.2008.00784.x; Bromley-Brits K, 2012, CURR ALZHEIMER RES, V9, P411, DOI 10.2174/156720512800492521; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Derynck Rik, 2008, P29; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Jin W, 2005, P NATL ACAD SCI USA, V102, P16239, DOI 10.1073/pnas.0503137102; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Jun Y, 2011, BMB REP, V44, P369, DOI 10.5483/BMBRep.2011.44.6.369; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakano N, 2014, J BIOL CHEM, V289, P12680, DOI 10.1074/jbc.M114.558981; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P28634, DOI 10.1074/jbc.M109.059345; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu XB, 2015, INT J CLIN EXP PATHO, V8, P10824; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao B, 2014, SCI CAIRO, V2014; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	68	13	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	10					4099	4112		10.1074/jbc.M116.769109	http://dx.doi.org/10.1074/jbc.M116.769109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ4GV	28115518	Green Published, hybrid			2022-12-28	WOS:000404672500001
J	Zhao, Y; Wang, CL; Li, RM; Hui, TQ; Su, YY; Yuan, Q; Zhou, XD; Ye, L				Zhao, Yuan; Wang, Chen-Lin; Li, Rui-Min; Hui, Tian-Qian; Su, Ying-Ying; Yuan, Quan; Zhou, Xue-Dong; Ye, Ling			Wnt5a promotes inflammatory responses via nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells (vol 289, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													yuan, quan/GZM-5597-2022		National Natural Science Foundation of China [81322013, 813220170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	There was an error in the grant information. The grant number for one of the grants from the National Natural Science Foundation of China should be 81322013 instead of 813220170.	Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523	1	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4358	4358		10.1074/jbc.A113.546523	http://dx.doi.org/10.1074/jbc.A113.546523			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28283587	hybrid, Green Published			2022-12-28	WOS:000395837100032
J	Chang, H; Smallwood, PM; Williams, J; Nathans, J				Chang, Hao; Smallwood, Philip M.; Williams, John; Nathans, Jeremy			Intramembrane Proteolysis of Astrotactins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intramembrane proteolysis; membrane protein; protein processing; protein sequence; transmembrane domain	SIGNAL PEPTIDE PEPTIDASE; NEURONAL MIGRATION; INVARIANT CHAIN; 3 SPPL3; B-CELL; PROTEASE SPPL2A; RECEPTOR; GLYCOSYLATION; CLEAVAGE; DOMAIN	Astrotactins are vertebrate-specific membrane proteins implicated in neuron-glia interactions during central nervous system development and in hair follicle polarity during skin development. By studying epitope-tagged derivatives of mouse astrotactin-2 (Astn2) produced in transfected cells, we determined that the amino and carboxyl termini reside in the extracellular space and are initially linked by two transmembrane segments and a single cytoplasmic domain. We further show that Astn2 undergoes proteolytic cleavage in the second transmembrane domain (TM2) and that a disulfide bond holds the resulting two fragments together. Recombinant Astn1 also undergoes TM2 cleavage, as does Astn2 isolated from mouse cerebellum. Astn2 intramembrane proteolysis is insensitive to replacement of TM2 by the transmembrane domain of CD74 or by 21 alanines. However, replacement of TM2 by the transmembrane domain of CD4, the asialoglycoprotein receptor, or the transferrin receptor eliminates intramembrane proteolysis, as does leucine substitution of residues that overlap or are immediately upstream of the cleavage site. Replacement of the transmembrane domain of CD74 or the asialoglycoprotein receptor with Astn2 TM2 leads to the appearance of a carboxyl-terminal fragment consistent with intramembrane proteolysis. These experiments define a highly unusual transmembrane topology for the astrotactins, reveal intramembrane proteolysis as a feature of astrotactin maturation, and constrain the substrate sequences that are permissive for cleavage of one type 2 transmembrane segment.	[Chang, Hao; Smallwood, Philip M.; Williams, John; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Chang, Hao] Univ Wisconsin Madison, Dept Dermatol, 1300 Univ Ave, Madison, WI 53706 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, 805 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Adams NC, 2002, DEVELOPMENT, V129, P965; ALARCON C, 1994, BIOCHEM J, V301, P257, DOI 10.1042/bj3010257; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chang H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005532; Chen G, 2010, PROTEIN SCI, V19, P2015, DOI 10.1002/pro.496; DRICKAMER K, 1987, KIDNEY INT, V32, pS167; FISHELL G, 1991, DEVELOPMENT, V113, P755; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; HEDO JA, 1983, J BIOL CHEM, V258, P20; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Huttl S, 2016, BIOCHEM J, V473, P1405, DOI 10.1042/BCJ20160156; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lionel AC, 2014, HUM MOL GENET, V23, P2752, DOI 10.1093/hmg/ddt669; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Ni T, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160053; PARNES JR, 1987, IMMUNOL REV, V100, P109, DOI 10.1111/j.1600-065X.1987.tb00529.x; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176; ZERIAL M, 1986, EMBO J, V5, P1543, DOI 10.1002/j.1460-2075.1986.tb04395.x; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	44	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3506	3516		10.1074/jbc.M116.768077	http://dx.doi.org/10.1074/jbc.M116.768077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28100779	Green Published, hybrid			2022-12-28	WOS:000395538800038
J	DeSantis, MC; Kim, JH; Song, H; Klasse, PJ; Cheng, W				DeSantis, Michael C.; Kim, Jin H.; Song, Hanna; Klasse, Per Johan; Cheng, Wei			Quantitative correlation between infectivity and Gp120 density on HIV-1 virions revealed by optical trapping virometry (vol 291, pg 13088, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X				DeSantis MC, 2016, J BIOL CHEM, V291, P13088, DOI 10.1074/jbc.M116.729210	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3061	3061		10.1074/jbc.A116.729210	http://dx.doi.org/10.1074/jbc.A116.729210			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28213534	hybrid, Green Published			2022-12-28	WOS:000395535100045
J	Kalyanaraman, H; Zhuang, SH; Pilz, RB; Casteel, DE				Kalyanaraman, Hema; Zhuang, Shunhui; Pilz, Renate B.; Casteel, Darren E.			The activity of cGMP-dependent protein kinase I alpha is not directly regulated by oxidation-induced disulfide formation at cysteine 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDANT-INDUCED ACTIVATION; PKG I; BETA; PHOSPHORYLATION; BINDING; SITE; HYPERTENSION; MUTAGENESIS; MIGRATION; DYNAMICS	The type I cGMP-dependent protein kinases (PKGs) are key regulators of smooth muscle tone, cardiac hypertrophy, and other physiological processes. The two isoforms PKGI alpha and PKGI beta are thought to have unique functions because of their tissue-specific expression, different cGMP affinities, and isoform-specific protein-protein interactions. Recently, a non-canonical pathway of PKGI alpha activation has been proposed, in which PKGI alpha is activated in a cGMP-independent fashion via oxidation of Cys(43), resulting in disulfide formation within the PKGI alpha N-terminal dimerization domain. A "redox-dead" knock-in mouse containing a C43S mutation exhibits phenotypes consistent with decreased PKGI alpha signaling, but the detailed mechanism of oxidation-induced PKGI alpha activation is unknown. Therefore, we examined oxidation-induced activation of PKGI alpha, and in contrast to previous findings, we observed that disulfide formation at Cys(43) does not directly activate PKGI alpha in vitro or in intact cells. In transfected cells, phosphorylation of Ras homolog gene family member A(RhoA) and vasodilator-stimulated phosphoprotein was increased in response to 8-CPT-cGMP treatment, but not when disulfide formation in PKGI alpha was induced by H2O2. Using purified enzymes, we found that the Cys(43) oxidation had no effect on basal kinase activity or K-m and V-max values; however, PKGI alpha containing the C43S mutation was less responsive to cGMP-induced activation. This reduction in cGMP affinity may in part explain the PKGI alpha loss-of-function phenotype of the C43S knock-in mouse. In conclusion, disulfide formation at Cys(43) does not directly activate PKGI alpha, and the C43S-mutant PKGI alpha has a higher K-a for cGMP. Our results highlight that mutant enzymes should be carefully biochemically characterized before making in vivo inferences.	[Kalyanaraman, Hema; Zhuang, Shunhui; Pilz, Renate B.; Casteel, Darren E.] Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Casteel, DE (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcasteel@ucsd.edu			National Institutes of Health [RO1-HL132141]; University of California, San Diego, Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego, Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant RO1-HL132141 (to R. B. P.) and the University of California, San Diego, Department of Medicine ( to D. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Burgoyne JR, 2013, METHOD ENZYMOL, V528, P111, DOI 10.1016/B978-0-12-405881-1.00007-0; Casteel DE, 2008, CELL SIGNAL, V20, P1392, DOI 10.1016/j.cellsig.2008.03.009; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; GLASS DB, 1982, J BIOL CHEM, V257, P1196; GLASS DB, 1979, J BIOL CHEM, V254, P9728; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann LS, 2014, N-S ARCH PHARMACOL, V387, P707, DOI 10.1007/s00210-014-0999-8; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Huang YPJ, 2005, NATURE, V438, P36, DOI 10.1038/438036a; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Lee JH, 2011, INT J MASS SPECTROM, V302, P44, DOI 10.1016/j.ijms.2010.07.021; Lorenz JE, 2014, ANTIOXID REDOX SIGN, V21, P1504, DOI 10.1089/ars.2013.5585; Nakamura T, 2015, J CLIN INVEST, V125, P2468, DOI 10.1172/JCI80275; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Prysyazhna O, 2016, J BIOL CHEM, V291, P17427, DOI 10.1074/jbc.M116.724070; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rudyk O, 2013, P NATL ACAD SCI USA, V110, P9909, DOI 10.1073/pnas.1301026110; Rudyk O, 2012, CIRCULATION, V126, P287, DOI 10.1161/CIRCULATIONAHA.112.101287; Ruth P, 1999, PHARMACOL THERAPEUT, V82, P355, DOI 10.1016/S0163-7258(98)00067-9; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200	37	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8262	8268		10.1074/jbc.C117.787358	http://dx.doi.org/10.1074/jbc.C117.787358			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360102	Green Published, hybrid			2022-12-28	WOS:000401788600012
J	Portnoff, AD; Gao, CH; Borrok, MJ; Gao, XZ; Gao, CS; Rainey, GJ				Portnoff, Alyse D.; Gao, Cuihua; Borrok, M. Jack; Gao, Xizhe; Gao, Changshou; Rainey, G. Jonah			An antidote approach to reduce risk and broaden utility of antibody-based therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL FC-RECEPTOR; HALF-LIFE; MONOCLONAL-ANTIBODIES; AMINO-ACID; HUMAN IGG1; IMMUNOGLOBULIN-G; CLICK CHEMISTRY; LIVING CELLS; COPPER-FREE; PROTEIN	Antibody therapeutics offer effective treatment options for a broad range of diseases. One of the greatest benefits of antibody therapeutics is their extraordinarily long serum half-life, allowing infrequent dosing with long-lasting effects. A characteristic of antibodies that drives long half-life is the ability to interact with the recycling receptor, FcRn, in a pH-dependent manner. The benefit of long half-life, however, carries with it liabilities. Although the positive effects of antibody therapeutics are long-lasting, any acute adverse events or chronic negative impacts, such as immunosuppression in the face of an infection, are also long-lasting. Therefore, we sought to develop antibodies with a chemical handle that alone would enjoy the long half-life of normal antibodies but, upon addition of a small-molecule antidote, would interact with the chemical handle and inhibit the antibody recycling mechanism, thus leading to rapid degradation and shortened half-life in vivo. Here we present a proof of concept study where we identify sites to incorporate a non-natural amino acid that can be chemically modified to modulate FcRn interaction in vitro and antibody half-life in vivo. This is an important first step in developing safer therapeutics, and the next step will be development of technology that can perform the modifying chemistry in vivo.	[Portnoff, Alyse D.; Gao, Cuihua; Borrok, M. Jack; Gao, Changshou; Rainey, G. Jonah] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Gao, Xizhe] MedImmune, Dept Translat Sci, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Gao, CS (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.; Rainey, GJ (corresponding author), MabVax Therapeut Holdings Inc, San Diego, CA 92121 USA.	gaoc@medimmune.com; jrainey@mabvax.com						Borrok MJ, 2015, J BIOL CHEM, V290, P4282, DOI 10.1074/jbc.M114.603712; Brennan FR, 2010, MABS-AUSTIN, V2, P233, DOI 10.4161/mabs.2.3.11782; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Deis LN, 2015, P NATL ACAD SCI USA, V112, P9028, DOI 10.1073/pnas.1424724112; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Giamberardino MA, 2016, INTERN EMERG MED, V11, P1045, DOI 10.1007/s11739-016-1489-4; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; KIM JK, 1994, EUR J IMMUNOL, V24, P542, DOI 10.1002/eji.1830240308; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li J, 2014, NAT CHEM BIOL, V10, P1003, DOI 10.1038/nchembio.1656; Murrey HE, 2015, J AM CHEM SOC, V137, P11461, DOI 10.1021/jacs.5b06847; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Novarra S, 2016, MABS-AUSTIN, V8, P1118, DOI 10.1080/19420862.2016.1186321; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Reichert JM, 2016, MABS-AUSTIN, V8, P197, DOI 10.1080/19420862.2015.1125583; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rossin R, 2013, BIOCONJUGATE CHEM, V24, P1210, DOI 10.1021/bc400153y; Salvana EMT, 2009, CLIN MICROBIOL REV, V22, P274, DOI 10.1128/CMR.00040-08; Sonzini S, 2016, ANGEW CHEM INT EDIT, V55, P14000, DOI 10.1002/anie.201606763; Stefan N, 2014, BIOCONJUGATE CHEM, V25, P2144, DOI 10.1021/bc500468s; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; VanBrunt MP, 2015, BIOCONJUGATE CHEM, V26, P2249, DOI 10.1021/acs.bioconjchem.5b00359; Wan W, 2014, BBA-PROTEINS PROTEOM, V1844, P1059, DOI 10.1016/j.bbapap.2014.03.002; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	42	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8498	8506		10.1074/jbc.M117.775528	http://dx.doi.org/10.1074/jbc.M117.775528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28258216	Green Published, hybrid			2022-12-28	WOS:000401788600032
J	Wang, SY; Cao, ZY; Xue, JH; Li, H; Jiang, W; Cheng, YN; Li, G; Zhang, XW				Wang, Shuya; Cao, Zhengyi; Xue, Junhui; Li, Hui; Jiang, Wei; Cheng, Yuning; Li, Gang; Zhang, Xiaowei			A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELL SENESCENCE; PROTEIN; PHOSPHORYLATION; HETEROZYGOSITY; REPRESSION; CARCINOMAS; PATHWAY; CANCER; GENE	Oxidative stress can induce cell dysfunction and lead to a broad range of degenerative alterations, including carcinogenesis, aging, and other oxidative stress-related conditions. To avoid undergoing carcinogenesis in response to oxidative stress, cells trigger a succession of checkpoint responses, including premature senescence and apoptosis. Increasing evidence indicates that H2O2, an important cause of oxidative stress, functions as an important physiological regulator of intracellular signaling pathways that participate in regulation of cell premature senescence and apoptosis. However, the precise mechanisms underlying this process remain to be studied extensively. In this study, we describe the importance of Pim-1 kinase in this checkpoint response to oxidative stress. Pim-1 binds to and phosphorylates the transcription factor high mobility group box transcription factor 1 (HBP1), activating it. H2O2 enhances the interaction between Pim-1 and HBP1 and promotes HBP1 accumulation. In turn, HBP1 rapidly and selectively up-regulates Pim-1 expression in H2O2-stimulated cells, thereby creating a Pim-1-HBP1 positive feedback loop that regulates H2O2-induced premature senescence and apoptosis. Furthermore, the Pim-1-HBP1 positive feedback loop exerts its effect by regulating the senescence markers DNMT1 and p16 and the apoptosis marker Bax. The Pim-1-HBP1 axis thus constitutes a novel checkpoint pathway critical for the inhibition of tumorigenesis.	[Wang, Shuya; Cao, Zhengyi; Xue, Junhui; Li, Hui; Jiang, Wei; Cheng, Yuning; Li, Gang; Zhang, Xiaowei] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol,Sch Basic Med Sci, Beijing 100191, Peoples R China	Peking University	Zhang, XW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Xueyuan Rd 38, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn	Cheng, Yuning/GSE-2360-2022	Cheng, Yuning/0000-0002-8171-8748	National Natural Science Foundation of China [81672717, 31471292, 81572705]; Beijing Natural Science Foundation [5162013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81672717, 31471292, and 81572705 and Beijing Natural Science Foundation Grant 5162013. The authors declare that they have no conflicts of interest with the contents of this article.	Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Chen YF, 2016, J BIOL CHEM, V291, P12688, DOI 10.1074/jbc.M116.714147; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Driouch K, 1998, CANCER RES, V58, P2081; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jin B, 2014, AGING CELL, V13, P879, DOI 10.1111/acel.12249; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Li HS, 2010, CHIN CONT DECIS CONF, P1, DOI 10.1109/CCDC.2010.5499147; Li ZY, 2014, J BIOL CHEM, V289, P26872, DOI 10.1074/jbc.M114.586651; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pan KW, 2013, MOL CELL BIOL, V33, P887, DOI 10.1128/MCB.00637-12; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Samse K, 2015, J BIOL CHEM, V290, P13935, DOI 10.1074/jbc.M114.617431; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Valencia A, 2004, FREE RADICAL BIO MED, V36, P1112, DOI 10.1016/j.freeradbiomed.2004.02.013; Wang W, 2014, INT CONF INSTR MEAS, P1, DOI [10.1109/IMCCC.2014.9, 10.1109/SNW.2014.7348528]; Wang Z, 2001, J Vet Sci, V2, P167; Warnecke-Eberz U, 2008, ONCOL REP, V20, P619, DOI 10.3892/or_00000050; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Yang JL, 2013, CANCER RES, V73, P4898, DOI 10.1158/0008-5472.CAN-12-4277; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yee Amy S., 1998, Frontiers in Bioscience, V3, pD532; Yin XY, 2016, ONCOTARGET, V7, P66512, DOI 10.18632/oncotarget.11614; Zemskova M, 2010, MOL CANCER RES, V8, P1126, DOI 10.1158/1541-7786.MCR-10-0174; Zemskova MY, 2015, CELL SIGNAL, V27, P135, DOI 10.1016/j.cellsig.2014.10.010; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	53	14	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8207	8222		10.1074/jbc.M116.768101	http://dx.doi.org/10.1074/jbc.M116.768101			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348080	Green Published, hybrid			2022-12-28	WOS:000401788600008
J	Zhang, M; Zhu, HP; Ding, Y; Liu, ZY; Cai, ZJ; Zou, MH				Zhang, Miao; Zhu, Huaiping; Ding, Ye; Liu, Zhaoyu; Cai, Zhejun; Zou, Ming-Hui			AMP-activated protein kinase alpha 1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; SMOOTH-MUSCLE-CELLS; GENETICALLY HETEROGENEOUS MICE; EXTENDS LIFE-SPAN; IN-VIVO; APOLIPOPROTEIN-E; ATHEROSCLEROTIC PLAQUES; TRANSCRIPTION FACTOR; KNOCKOUT MICE; LDL RECEPTOR	Monocyte-to-macrophage differentiation, which can be initiated by physiological or atherogenic factors, is a pivotal process in atherogenesis, a disorder in which monocytes adhere to endothelial cells and subsequently migrate into the subendothelial spaces, where they differentiate into macrophages and macrophage- derived foam cells and cause atherosclerotic lesions. However, the monocyte-differentiation signaling pathways that are activated by atherogenic factors are poorly defined. Here we report that the AMP-activated protein kinase alpha 1 (AMPK alpha 1) in monocytes promotes atherosclerosis by increasing monocyte differentiation and survival. Exposure of monocytes to oxidized low-density lipoprotein, 7-ketocholesterol, phorbol 12-myristate 13-acetate, or macrophage colony-stimulated factor (M-CSF) significantly activated AMPK and promoted monocyte-tomacrophage differentiation. M-CSF-activated AMPK is via M-CSFreceptor-dependent reactive oxygen species production. Consistently, genetic deletion of AMPK alpha 1 or pharmacological inhibition of AMPK blunted monocyte-to-macrophage differentiation and promoted monocyte/ macrophage apoptosis. Compared with apolipoprotein E knock-out (ApoE(-/-)) mice, which show impaired clearing of plasma lipoproteins and spontaneously develop atherosclerosis, ApoE(-/-) / AMPKK alpha 1(-/-) mice showed reduced sizes of atherosclerotic lesions and lesser numbers of macrophages in the lesions. Furthermore, aortic lesions were decreased in ApoE(-/-) mice transplanted with ApoE(-/-) / AMPKK alpha 1(-/-) bone marrow and in myeloid-specific AMPKK alpha 1deficient ApoE(-/-) mice. Finally, rapamycin treatment, which abolished delayed monocyte differentiation in ApoE(-/-) / AMPKK alpha 1(-/-) mice, lost its atherosclerosis-lowering effects in these mice. Mechanistically, we found that AMPKK alpha 1 regulates FoxO3-dependent expression of both LC3 and ULK1, which are two important autophagy-related markers. Rapamycin treatment increased FoxO3 activity as well as LC3 and ULK1 expressions in macrophages from AMPKK alpha 1(-/-) mice. Our results reveal that AMPKK alpha 1 deficiency impairs autophagy-mediated monocyte differentiation and decreases monocyte/ macrophage survival, which attenuates atherosclerosis in ApoE(-/-) mice in vivo.	[Zhang, Miao] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zhu, Huaiping; Ding, Ye; Liu, Zhaoyu; Cai, Zhejun; Zou, Ming-Hui] Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30302 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; Georgia State University	Zou, MH (corresponding author), Georgia State Univ, Ctr Mol & Translat Med, Petit Sci Ctr, Rm 588,100 Piedmont Ave SE, Atlanta, GA 30302 USA.	mzou@gsu.edu	Cai, Zhejun/J-5205-2019; liu, zhao/GXV-6141-2022	Cai, Zhejun/0000-0002-7645-3714; 	NHLBI, National Institutes of Health [HL079584, HL080499, HL089920, HL110488, HL128014, HL132500, HL137371]; NCI, National Institutes of Health [CA213022]; NIA, National Institutes of Health [AG047776]; NATIONAL CANCER INSTITUTE [R01CA213022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL128014, R01HL079584, R01HL137371, R01HL132500, R01HL110488, R01HL080499, R01HL105157, R01HL074399, R01HL096032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NHLBI, National Institutes of Health Grants HL079584, HL080499, HL089920, HL110488, HL128014, HL132500, and HL137371; NCI, National Institutes of Health Grant CA213022; and NIA, National Institutes of Health Grant AG047776 (to M.-H.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Bhatt NY, 2002, J IMMUNOL, V169, P6427, DOI 10.4049/jimmunol.169.11.6427; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; Cao Q, 2016, DIABETES, V65, P1565, DOI 10.2337/db15-0917; Castro C, 2004, ATHEROSCLEROSIS, V172, P31, DOI 10.1016/j.atherosclerosis.2003.09.003; Chen WQ, 2009, BRIT J PHARMACOL, V156, P941, DOI 10.1111/j.1476-5381.2008.00102.x; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Fuhrman B, 2008, ATHEROSCLEROSIS, V196, P598, DOI 10.1016/j.atherosclerosis.2007.06.026; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Hayden JM, 2002, J LIPID RES, V43, P26; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jacquel A, 2012, BLOOD, V119, P4527, DOI 10.1182/blood-2011-11-392167; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lei ZB, 2002, CARDIOVASC RES, V53, P524, DOI 10.1016/S0008-6363(01)00491-6; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Ma KL, 2007, AM J PHYSIOL-HEART C, V292, pH2721, DOI 10.1152/ajpheart.01174.2006; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MANGAN DF, 1991, J IMMUNOL, V147, P3408; Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Mathis AS, 2007, J PHARM SCI-US, V96, P209, DOI 10.1002/jps.20751; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Pakala R, 2005, J CARDIOVASC PHARM, V46, P481, DOI 10.1097/01.fjc.0000177985.14305.15; Qiao JH, 1997, AM J PATHOL, V150, P1687; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Veniant MM, 2001, ARTERIOSCL THROM VAS, V21, P1567, DOI 10.1161/hq1001.097780; Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915; Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383; Zhao L, 2009, BRIT J PHARMACOL, V156, P774, DOI 10.1111/j.1476-5381.2008.00080.x; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	53	42	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7888	7903		10.1074/jbc.M117.779447	http://dx.doi.org/10.1074/jbc.M117.779447			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28330873	Green Published, hybrid			2022-12-28	WOS:000401154100017
J	Nagao, R; Yamaguchi, M; Nakamura, S; Ueoka-Nakanishi, H; Noguchi, T				Nagao, Ryo; Yamaguchi, Motoki; Nakamura, Shin; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi			Genetically introduced hydrogen bond interactions reveal an asymmetric charge distribution on the radical cation of the special-pair chlorophyll P680	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chlorophyll; cyanobacteria; hydrogen bond; photosynthesis; photosystem II; site-directed mutagenesis; FTIR; quantum chemical calculation; special pair; thermoluminescence	TRANSFORM INFRARED DIFFERENCE; PRIMARY ELECTRON-DONOR; II CORE COMPLEXES; TYROSINE Y-Z; PHOTOSYSTEM-II; REACTION CENTERS; FTIR DIFFERENCE; PLASTOQUINONE Q(A); MN4CAO5 CLUSTER; WATER OXIDATION	The special-pair chlorophyll (Chl) P680 in photosystem II has an extremely high redox potential (E-m) to enable water oxidation in photosynthesis. Significant positive-charge localization on one of the Chl constituents, P-D1 or P-D2, in P680(+) has been proposed to contribute to this high E-m. To identify the Chl molecule on which the charge is mainly localized, we genetically introduced a hydrogen bond to the 13(1)-keto C=O group of P-D1 and P-D2 by changing the nearby D1-Val-157 and D2-Val-156 residues to His, respectively. Successful hydrogen bond formation at P-D1 and P-D2 in the obtained D1-V157H and D2-V156H mutants, respectively, was monitored by detecting 13(1)-keto C=O vibrations in Fourier transfer infrared (FTIR) difference spectra upon oxidation of P680 and the symmetrically located redox-active tyrosines Y-Z and Y-D, and they were simulated by quantum-chemical calculations. Analysis of the P680(+)/P680 FTIR difference spectra of D1-V157H and D2-V156H showed that upon P680(+) formation, the 13(1)-keto C=O frequency upshifts by a much larger extent in P-D1 (23 cm(-1)) than in P-D2 (<9 cm(-1)). In addition, thermoluminescence measurements revealed that the D1-V157H mutation increased the E-m of P680 to a larger extent than did the D2-V156H mutation. These results, together with the previous results for the mutants of the His ligands of P-D1 and P-D2, lead to a definite conclusion that a charge is mainly localized to P-D1 in P680(+).	[Nagao, Ryo; Yamaguchi, Motoki; Nakamura, Shin; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University	Nagao, R; Noguchi, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	nagao@bio.phys.nagoya-u.ac.jp; tnoguchi@bio.phys.nagoya-u.ac.jp	NAGAO, Ryo/D-4117-2012; Noguchi, Takumi/I-7105-2014	NAGAO, Ryo/0000-0001-8212-3001; zhong xi, hua dai/0000-0001-8619-9513	Japan Society for the Promotion of Science [15J10320, 26840091, 24000018, 24107003]; Grants-in-Aid for Scientific Research [17K07442] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Japan Society for the Promotion of Science Fellows 15J10320 (to S. N.) and Scientific Research from Japan Society for the Promotion of Science 26840091 (to R. N.) and 24000018 and 24107003 (to T. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Azai C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19878; BALLSCHMITER K, 1969, J AM CHEM SOC, V91, P2661, DOI 10.1021/ja01038a044; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; BUSER CA, 1990, BIOCHEMISTRY-US, V29, P8977, DOI 10.1021/bi00490a014; Case DA, 2012, AMBER 12; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEGROOTH BG, 1981, BIOCHIM BIOPHYS ACTA, V635, P445, DOI 10.1016/0005-2728(81)90104-3; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; Faller P, 2001, P NATL ACAD SCI USA, V98, P14368, DOI 10.1073/pnas.251382598; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hasegawa K, 2005, BIOCHEMISTRY-US, V44, P8865, DOI 10.1021/bi050273c; HEALD RL, 1990, J PHYS CHEM-US, V94, P3968, DOI 10.1021/j100373a019; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; Hienerwadel R, 1996, BIOCHEMISTRY-US, V35, P15447, DOI 10.1021/bi961952d; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P4118, DOI 10.1021/bi047922p; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ito H, 2011, P NATL ACAD SCI USA, V108, P18014, DOI 10.1073/pnas.1107590108; Ivancich A, 1998, BIOCHEMISTRY-US, V37, P11812, DOI 10.1021/bi9806908; Kato Y, 2016, BIOMED SPECTROSC IMA, V5, P269, DOI 10.3233/BSI-160146; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; Kitajima Y, 2006, BIOCHEMISTRY-US, V45, P1938, DOI 10.1021/bi052346y; KLIMOV VV, 1979, DOKL AKAD NAUK SSSR+, V249, P227; KRAWCZYK S, 1989, BIOCHIM BIOPHYS ACTA, V976, P140, DOI 10.1016/S0005-2728(89)80223-3; LIN X, 1994, P NATL ACAD SCI USA, V91, P10265, DOI 10.1073/pnas.91.22.10265; Lutz M., 1991, CHLOROPHYLLS, P855; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2011, RSC ENERGY ENVIRON S, P163; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; NABEDRYK E, 1990, BIOCHEMISTRY-US, V29, P3242, DOI 10.1021/bi00465a015; NABEDRYK E, 1993, BIOCHEMISTRY-US, V32, P13879, DOI 10.1021/bi00213a017; Nakamura S, 2016, P NATL ACAD SCI USA, V113, P12727, DOI 10.1073/pnas.1607897113; Nakamura S, 2016, BIOCHEMISTRY-US, V55, P597, DOI 10.1021/acs.biochem.5b01120; Nakamura S, 2015, BIOCHEMISTRY-US, V54, P5045, DOI 10.1021/acs.biochem.5b00568; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; Narzi D, 2016, J AM CHEM SOC, V138, P257, DOI 10.1021/jacs.5b10523; Noguchi T, 1998, BIOCHEMISTRY-US, V37, P13614, DOI 10.1021/bi9812975; Noguchi T, 2005, ADV PHOTO RESPIRAT, V22, P367; Noguchi T, 2002, SPECTROSC-INT J, V16, P89, DOI 10.1155/2002/960232; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Noguchi T, 2015, BBA-BIOENERGETICS, V1847, P35, DOI 10.1016/j.bbabio.2014.06.009; Okubo T, 2007, BIOCHEMISTRY-US, V46, P4390, DOI 10.1021/bi700157n; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Rappaport F, 2005, BIOPHYS J, V88, P1948, DOI 10.1529/biophysj.104.050237; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Rappaport F, 2009, J AM CHEM SOC, V131, P4425, DOI 10.1021/ja808604h; Raszewski G, 2005, BIOPHYS J, V88, P986, DOI 10.1529/biophysj.104.050294; Raszewski G, 2008, BIOPHYS J, V95, P105, DOI 10.1529/biophysj.107.123935; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Renger T, 2011, J PHOTOCH PHOTOBIO B, V104, P126, DOI 10.1016/j.jphotobiol.2011.03.016; RIGBY SEJ, 1994, BIOCHEMISTRY-US, V33, P10043, DOI 10.1021/bi00199a031; Rutherford AW, 2003, PHILOS T R SOC B, V358, P245, DOI 10.1098/rstb.2002.1186; Saito K, 2013, P NATL ACAD SCI USA, V110, P7690, DOI 10.1073/pnas.1300817110; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Saito K, 2011, J AM CHEM SOC, V133, P14379, DOI 10.1021/ja203947k; Sakurai I, 2007, PLANT PHYSIOL, V144, P1336, DOI 10.1104/pp.107.098731; SETIF P, 1980, ARCH BIOCHEM BIOPHYS, V204, P477, DOI 10.1016/0003-9861(80)90059-4; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Styring S, 2012, BBA-BIOENERGETICS, V1817, P76, DOI 10.1016/j.bbabio.2011.03.016; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2016, BBA-BIOENERGETICS, V1857, P1943, DOI 10.1016/j.bbabio.2016.09.012; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Takahashi R, 2008, BIOCHEMISTRY-US, V47, P6289, DOI 10.1021/bi8007998; Takahashi R, 2007, J PHYS CHEM B, V111, P13833, DOI 10.1021/jp0760556; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P14245, DOI 10.1021/bi701752d; TANG XS, 1993, BIOCHEMISTRY-US, V32, P13742, DOI 10.1021/bi00212a045; Tomo T, 2007, P NATL ACAD SCI USA, V104, P7283, DOI 10.1073/pnas.0701847104; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANMIEGHEM FJE, 1989, BIOCHIM BIOPHYS ACTA, V977, P207, DOI 10.1016/S0005-2728(89)80073-8; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Zhang HM, 1997, BIOCHEMISTRY-US, V36, P11762, DOI 10.1021/bi970815t	87	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7474	7486		10.1074/jbc.M117.781062	http://dx.doi.org/10.1074/jbc.M117.781062			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302724	Green Published, hybrid			2022-12-28	WOS:000400761300017
J	Chehboun, S; Labrecque-Carbonneau, J; Pasquin, S; Meliani, Y; Meddah, B; Ferlin, W; Sharma, M; Tormo, A; Masson, JF; Gauchat, JF				Chehboun, Salma; Labrecque-Carbonneau, Jeremie; Pasquin, Sarah; Meliani, Yasmine; Meddah, Bouchra; Ferlin, Walter; Sharma, Mukut; Tormo, Aurelie; Masson, Jean-Francois; Gauchat, Jean-Francois			Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESIGNER CYTOKINE; SOLUBLE IL-6; FACTOR CNTF; IN-VIVO; RECEPTOR; EXPRESSION; SUBUNIT; INDUCTION; PROTEIN; CELLS	Epstein-Barr virus-induced gene 3 (EBI3) is a subunit of the composite cytokines IL-27 and IL-35. Both have beneficial functions or effects in models of infectious and autoimmune diseases. This suggests that administration of EBI3 could be therapeutically useful by binding free p28 and p35 to generate IL-27 and IL-35. IL-27-and IL-35-independent functions of EBI3 could compromise its therapeutic uses. We therefore assessed the effects of EBI3 on cytokine receptor-expressing cells. We observed that EBI3 activates STAT3 and induces the proliferation of the IL-6-dependent B9 mouse plasmacytoma cell line. Analyses using blocking mAbs and Ba/F3 transfectants expressing gp130 indicate that EBI3 activity was linked to its capacity to mediate IL-6 trans-signaling, albeit less efficiently than soluble IL-6R alpha. In line with this interpretation, co-immunoprecipitation and SPR experiments indicated that EBI3 binds IL-6. An important pro-inflammatory function of IL-6 trans-signaling is to activate blood vessel endothelial cells. Weobserved that EBI3 in combination with IL-6 could induce the expression of chemokines by human venal endothelial cells. Our results indicate that EBI3 can promote pro-inflammatory IL-6 functions by mediating trans-signaling. These unexpected observations suggest that use of EBI3 as a therapeutic biologic for autoimmune diseases will likely require co-administration of soluble gp130 to prevent the side effects associated with IL-6 trans-signaling. Together with previous studies that demonstrated activation of IL-6R by p28 (IL-30), new findings further suggest a complex interrelation between IL-27 and IL-6.	[Chehboun, Salma; Pasquin, Sarah; Meliani, Yasmine; Tormo, Aurelie; Gauchat, Jean-Francois] Univ Montreal, Dept Pharmacol, Pavillon Roger Gaudry S455-N424, Montreal, PQ H3T 1J4, Canada; [Labrecque-Carbonneau, Jeremie; Masson, Jean-Francois] Univ Montreal, Dept Chim, Montreal, PQ H3T 1J4, Canada; [Meddah, Bouchra] Univ Mohammed 5, Fac Med & Pharm, Lab Pharmacol & Toxicol, Rabat, Morocco; [Ferlin, Walter] NovImmune, CH-1228 Plan Les Ouates, Switzerland; [Sharma, Mukut] Kansas City Vet Affairs Med Ctr, Res Serv, Kansas City, MO 64128 USA; [Sharma, Mukut] Midwest Biomed Res Fdn, Kansas City, MO 64128 USA	Universite de Montreal; Universite de Montreal; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Gauchat, JF (corresponding author), Univ Montreal, Dept Pharmacol, Pavillon Roger Gaudry S455-N424, Montreal, PQ H3T 1J4, Canada.	jf.gauchat@umontreal.ca	Masson, Jean-Francois/C-4893-2008; Labrecque-Carbonneau, Jeremie/AAR-7732-2020	chehboun, Salma/0000-0002-9509-6185	Canadian Institutes of Health Research Grant [MOP-57832]; Natural Science and Engineering Research Council of Canada Grant [412305-2011]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grant MOP-57832 (to J.-F. G.) and Natural Science and Engineering Research Council of Canada Grant 412305-2011 (to J.-F. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; Brahmachari S, 2008, Minerva Med, V99, P105; Chiesa C, 2015, CYTOKINE, V76, P1, DOI 10.1016/j.cyto.2015.03.015; Chung YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003628; Cognet I, 2004, EUR CYTOKINE NETW, V15, P255; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; DIAMANT M, 1994, J IMMUNOL METHODS, V173, P229, DOI 10.1016/0022-1759(94)90301-8; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Hill M, 2011, AM J TRANSPLANT, V11, P2036, DOI 10.1111/j.1600-6143.2011.03651.x; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Jana M, 2009, GLIA, V57, P1553, DOI 10.1002/glia.20869; Jones LL, 2012, MOL IMMUNOL, V51, P234, DOI 10.1016/j.molimm.2012.03.025; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Lacroix M, 2015, J BIOL CHEM, V290, P26943, DOI 10.1074/jbc.M115.682138; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Liu JQ, 2012, J IMMUNOL, V188, P3099, DOI 10.4049/jimmunol.1100106; Liu ZZ, 2013, AM J TRANSL RES, V5, P470; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Peters M, 1998, J IMMUNOL, V161, P3575; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Ratel M, 2013, ANAL CHEM, V85, P5770, DOI 10.1021/ac400386z; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Rousseau F, 2010, P NATL ACAD SCI USA, V107, P19420, DOI 10.1073/pnas.1005793107; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thibault V, 1997, FEBS LETT, V408, P182, DOI 10.1016/S0014-5793(97)00417-1; Tormo AJ, 2013, J IMMUNOL, V191, P1657, DOI 10.4049/jimmunol.1201595; Tormo AJ, 2013, J IMMUNOL, V190, P2931, DOI 10.4049/jimmunol.1201460; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Zhao SS, 2015, BIOSENS BIOELECTRON, V64, P664, DOI 10.1016/j.bios.2014.09.082	52	29	31	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6644	6656		10.1074/jbc.M116.762021	http://dx.doi.org/10.1074/jbc.M116.762021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28280243	hybrid, Green Published			2022-12-28	WOS:000399813400017
J	Miropolskaya, N; Esyunina, D; Kulbachinskiy, A				Miropolskaya, Nataliya; Esyunina, Daria; Kulbachinskiy, Andrey			Conserved functions of the trigger loop and Gre factors in RNA cleavage by bacterial RNA polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPT CLEAVAGE; ACTIVE-CENTER; ESCHERICHIA-COLI; STRUCTURAL BASIS; NASCENT-RNA; F LOOP; FIDELITY; MECHANISM; CATALYSIS; INTERPLAY	RNA cleavage by RNA polymerase (RNAP) is the central step in co-transcriptional RNA proofreading. Bacterial RNAPs were proposed to rely on the same mobile element of the active site, the trigger loop (TL), for both nucleotide addition and RNA cleavage. RNA cleavage can also be stimulated by universal Gre factors, which should replace the TL to get access to the RNAP active site. The contributions of the TL and Gre factors to RNA cleavage reportedly vary between RNAPs from different bacterial species and, probably, different types of transcription complexes. Here, by comparing RNAPs from Escherichia coli, Deinococcus radiodurans, and Thermus aquaticus, we show that the functions of the TL and Gre factors in RNA cleavage are conserved in various species, with important variations that may be related to extremophilic adaptation. Deletions of the TL strongly impair intrinsic RNA cleavage by all three RNAPs and eliminate the interspecies differences in the reaction rates. GreA factors activate RNA cleavage by wild-type RNAPs to similar levels. The rates of GreA-dependent cleavage are lower for Delta TL RNAP variants, suggesting that the TL contributes to the Gre function. Finally, neither the TL nor GreA can efficiently activate RNA cleavage in certain types of backtracked transcription complexes, suggesting that these complexes adopt a catalytically inactive conformation probably important for transcription regulation.	[Miropolskaya, Nataliya; Esyunina, Daria; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Kurchatov Sq 2, Moscow 123182, Russia	Russian Academy of Sciences	Kulbachinskiy, A (corresponding author), Russian Acad Sci, Inst Mol Genet, Kurchatov Sq 2, Moscow 123182, Russia.	akulb@img.ras.ru	Esyunina, Daria/L-7604-2018; Kulbachinskiy, Andrey/P-5401-2016	Kulbachinskiy, Andrey/0000-0002-2292-6424; Esyunina, Daria/0000-0002-3706-4425	Russian Science Foundation [14-14-01074]; Russian Federation for Young Scientists [MK 8983.2016.4]; Russian Foundation for Basic Research [16-34-60237]; Russian Academy of Sciences Presidium Programme on Molecular and Cellular Biology	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Federation for Young Scientists; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Programme on Molecular and Cellular Biology	This work was supported by the Russian Science Foundation (14-14-01074; to A. K.), a grant from the President of Russian Federation for Young Scientists (MK 8983.2016.4; to N. M.), Russian Foundation for Basic Research (16-34-60237; to D. E.), and the Russian Academy of Sciences Presidium Programme on Molecular and Cellular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Bae B, 2015, P NATL ACAD SCI USA, V112, pE4178, DOI 10.1073/pnas.1502368112; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Cabart P, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28869; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Esyunina DM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1271, DOI 10.1134/S0006297915100077; Esyunina D, 2016, NUCLEIC ACIDS RES, V44, P1298, DOI 10.1093/nar/gkv1521; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Fouqueau T, 2013, NUCLEIC ACIDS RES, V41, P7048, DOI 10.1093/nar/gkt433; GUO HL, 1993, J BIOL CHEM, V268, P18762; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulbachinskiy A, 2004, J BACTERIOL, V186, P7818, DOI 10.1128/JB.186.22.7818-7820.2004; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Miropolskaya N, 2014, NUCLEIC ACIDS RES, V42, P544, DOI 10.1093/nar/gkt877; Miropolskaya N, 2009, P NATL ACAD SCI USA, V106, P18942, DOI 10.1073/pnas.0905402106; Nayak D, 2013, MOL CELL, V50, P882, DOI 10.1016/j.molcel.2013.05.015; Nielsen S, 2013, TRANSCR-AUSTIN, V4, P209, DOI 10.4161/trns.27062; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Petushkov I, 2015, NUCLEIC ACIDS RES, V43, P5798, DOI 10.1093/nar/gkv504; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; Sekine S, 2015, MOL CELL, V57, P408, DOI 10.1016/j.molcel.2014.12.014; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Sosunova E, 2013, J BIOL CHEM, V288, P6688, DOI 10.1074/jbc.M112.424002; Svetlov Vladimir, 2015, Methods Mol Biol, V1276, P13, DOI 10.1007/978-1-4939-2392-2_2; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Yuzenkova Y, 2010, P NATL ACAD SCI USA, V107, P10878, DOI 10.1073/pnas.0914424107; Yuzenkova Y, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-54; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zenkin N, 2014, MICROBIOL-SGM, V160, P1316, DOI 10.1099/mic.0.079020-0; Zhang JW, 2016, TRENDS BIOCHEM SCI, V41, P293, DOI 10.1016/j.tibs.2015.12.009; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732	46	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6744	6752		10.1074/jbc.M116.766592	http://dx.doi.org/10.1074/jbc.M116.766592			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28242762	hybrid, Green Published			2022-12-28	WOS:000399813400025
J	Morales, C; Li, ZH				Morales, Crystal; Li, Zihai			Drosophila canopy b is a cochaperone of glycoprotein 93	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; CELL-SURFACE EXPRESSION; SHOCK-PROTEIN GP96; MASTER CHAPERONE; INTEGRIN SUBUNIT; PRAT4A; MELANOGASTER; MORPHOGENESIS; REGULATOR; ORTHOLOG	Drosophila gp93 was identified as the ortholog of the mammalian endoplasmic reticulum-resident chaperone gp96. gp93 was found capable of rescuing gp96 client proteins, such as Tolllike receptors ( TLRs) and integrins, in a gp96-deficient murine cell line. Mammalian gp96 was further found to require the cochaperone canopy 3 ( CNPY3) for proper folding and expression of TLRs, but not integrins. In Drosophila, two possible CNPY family members have been identified but have not yet been characterized. Therefore, we sought to determine the role of Drosophila CNPYa and CNPYb in gp93 biology. Because of higher similarities between CNPY3 and CNPYb, we postulated that CNPYb would be a TLR-specific cochaperone of gp93. Indeed, CNPYb addition in gp93-expressing cells improved TLR expression. CNPYb and gp93 were further found to physically interact. Mutational analysis of cysteine residues in CNPYb identified differential dependence of these cysteines in chaperone function. Our study is the first to characterize Drosophila CNPY molecules. We further uncover more gp93 biology by identifying CNPYb as a cochaperone. A better understanding of this simpler Drosophila system will enable application to the mammalian system, such as has been done with Escherichia coli, yeast, and mammalian HSP90.	[Morales, Crystal; Li, Zihai] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Morales, Crystal] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA	Medical University of South Carolina; University of Connecticut	Li, ZH (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [R01AI070603]; NATIONAL CANCER INSTITUTE [P30CA138313, P01CA186866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01AI070603. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hart BE, 2012, J BIOL CHEM, V287, P16550, DOI 10.1074/jbc.M112.342717; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Kiyokawa T, 2008, INT IMMUNOL, V20, P1407, DOI 10.1093/intimm/dxn098; Konno K, 2006, BIOCHEM BIOPH RES CO, V339, P1076, DOI 10.1016/j.bbrc.2005.11.123; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Shibata T, 2012, INT IMMUNOL, V24, P613, DOI 10.1093/intimm/dxs068; Stark KA, 1997, DEVELOPMENT, V124, P4583; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Takada Y., 2007, BIOL, V8, P215, DOI DOI 10.1186/GB-2007-8-5-215; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; WEHRLI M, 1993, MECH DEVELOP, V43, P21, DOI 10.1016/0925-4773(93)90020-X; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; YEE GH, 1993, DEVELOPMENT, V118, P845	23	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6657	6666		10.1074/jbc.M116.755538	http://dx.doi.org/10.1074/jbc.M116.755538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28275054	Green Published, hybrid			2022-12-28	WOS:000399813400018
J	Qiu, YJ; Gilmour, DS				Qiu, Yijun; Gilmour, David S.			Identification of Regions in the Spt5 Subunit of DRB Sensitivity-inducing Factor (DSIF) That Are Involved in Promoter-proximal Pausing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NEGATIVE ELONGATION-FACTOR; TERMINAL DOMAIN CTD; HEAT-SHOCK GENES; TRANSCRIPTION ELONGATION; IN-VIVO; P-TEFB; FISSION YEAST; DROSOPHILA; COMPLEX	DRB sensitivity-inducing factor (DSIF or Spt4/5) is a conserved transcription elongation factor that both inhibits and stimulates transcription elongation in metazoans. In Drosophila and vertebrates, DSIF together with negative elongation factor (NELF) associates with RNA polymerase II during early elongation and causes RNA polymerase II to pause in the promoterproximal region of genes. The mechanism of how DSIF establishes pausing is not known. We constructed Spt5 mutant forms of DSIF and tested their capacity to restore promoter-proximal pausing to DSIF-depleted Drosophila nuclear extracts. The C-terminal repeat region of Spt5, which has been implicated in both inhibition and stimulation of elongation, is dispensable for promoter-proximal pausing. A region encompassing KOW4 and KOW5 of Spt5 is essential for pausing, and mutations in KOW5 specifically shift the location of the pause. RNA crosslinking analysis reveals that KOW5 directly contacts the nascent transcript, and deletion of KOW5 disrupts this interaction. Our results suggest that KOW5 is involved in promoter-proximal pausing through contact with the nascent RNA.	[Qiu, Yijun; Gilmour, David S.] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gilmour, DS (corresponding author), Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dsg11@psu.edu			TRiP at Harvard Medical School (National Institutes of Health (NIH)/NIGMS) [R01-GM084947]; Bloomington Drosophila Stock Center (NIH) [P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM047477] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	TRiP at Harvard Medical School (National Institutes of Health (NIH)/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloomington Drosophila Stock Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Song Tan for providing the polycistronic expression vector, Mitzi Kuroda for providing the MSL-2 antibody, and the TRiP at Harvard Medical School (National Institutes of Health (NIH)/NIGMS Grant R01-GM084947) for providing the transgenic RNAi stock. Stocks obtained from the Bloomington Drosophila Stock Center (NIH Grant P40OD018537) were used in this study. We thank Joseph Reese for critiquing the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Booth GT, 2016, GENOME RES, V26, P799, DOI 10.1101/gr.204578.116; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHAMPLIN DT, 1991, GENE DEV, V5, P1611, DOI 10.1101/gad.5.9.1611; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crickard JB, 2016, J BIOL CHEM, V291, P9853, DOI 10.1074/jbc.M116.716001; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Ghosh SKB, 2011, MOL CELL BIOL, V31, P4232, DOI 10.1128/MCB.05930-11; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hartzog GA, 2013, BBA-GENE REGUL MECH, V1829, P105, DOI 10.1016/j.bbagrm.2012.08.007; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jennings BH, 2004, CURR BIOL, V14, P1680, DOI 10.1016/j.cub.2004.08.066; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Li WT, 2014, NUCLEIC ACIDS RES, V42, P7069, DOI 10.1093/nar/gku333; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mayer A, 2012, MOL CELL BIOL, V32, P1321, DOI 10.1128/MCB.06310-11; Meyer PA, 2015, MOL CELL BIOL, V35, P3354, DOI 10.1128/MCB.00520-15; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Schulz S, 2016, P NATL ACAD SCI USA, V113, pE1816, DOI 10.1073/pnas.1515817113; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang ZQ, 2004, J BIOL CHEM, V279, P23223, DOI 10.1074/jbc.M402956200	60	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5555	5570		10.1074/jbc.M116.760751	http://dx.doi.org/10.1074/jbc.M116.760751			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213523	Green Published, hybrid			2022-12-28	WOS:000397875500034
J	Singh, AK; Rastogi, S; Shukla, H; Asalam, M; Rath, SK; Akhtar, MS				Singh, Amit Kumar; Rastogi, Shivangi; Shukla, Harish; Asalam, Mohd.; Rath, Srikanta Kumar; Akhtar, Md. Sohail			Cdc15 Phosphorylates the C-terminal Domain of RNA Polymerase II for Transcription during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; MITOTIC REPRESSION; GENE; TFIIH; CTD; CHROMATIN; PHOSPHATASE; INHIBITION; ACTIVATION	In eukaryotes, the basal transcription in interphase is orchestrated through the regulation by kinases (Kin28, Bur1, and Ctk1) and phosphatases (Ssu72, Rtr1, and Fcp1), which act through the post-translational modification of the C-terminal domain (CTD) of the largest subunit of RNA polymerase II. The CTD comprises the repeated Tyr-Ser-Pro-Thr-Ser-Pro-Ser motif with potential epigenetic modification sites. Despite the observation of transcription and periodic expression of genes during mitosis with entailing CTD phosphorylation and dephosphorylation, the associated CTD specific kinase(s) and its role in transcription remains unknown. Here we have identified Cdc15 as a potential kinase phosphorylating Ser-2 and Ser-5 of CTD for transcription during mitosis in the budding yeast. The phosphorylation of CTD by Cdc15 is independent of any prior Ser phosphorylation(s). The inactivation of Cdc15 causes reduction of global CTD phosphorylation during mitosis and affects the expression of genes whose transcript levels peak during mitosis. Cdc15 also influences the complete transcription of clb2 gene and phosphorylates Ser-5 at the promoter and Ser-2 toward the 3' end of the gene. The observation that Cdc15 could phosphorylate Ser-5, as well as Ser-2, during transcription in mitosis is in contrast to the phosphorylation marks put by the kinases in interphase (G(1), S, and G(2)), where Cdck7/Kin28 phosphorylates Ser-5 at promoter and Bur1/Ctk1 phosphorylates Ser-2 at the 3' end of the genes.	[Singh, Amit Kumar; Shukla, Harish; Asalam, Mohd.; Akhtar, Md. Sohail] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Rastogi, Shivangi] Cent Drug Res Inst, CSIR, Div Microbiol, Lucknow 226031, Uttar Pradesh, India; [Rath, Srikanta Kumar] Cent Drug Res Inst, CSIR, Div Toxicol, Lucknow 226031, Uttar Pradesh, India; [Rath, Srikanta Kumar; Akhtar, Md. Sohail] Acad Sci & Innovat Res, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Akhtar, MS (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India.; Akhtar, MS (corresponding author), Acad Sci & Innovat Res, New Delhi 110025, India.	sohail@cdri.res.in	Singh, Amit/AAB-8820-2022; Rastogi, Shivangi/AAV-5521-2021; Shukla, Harish/O-6453-2018	Singh, Amit/0000-0002-5564-3236; Rastogi, Shivangi/0000-0002-0046-0045; Shukla, Harish/0000-0002-5919-6808	Science and Engineering Research Board (SERB) [EMR/2016/002167, BSC-0118, BSC-0103]; CSIR; University Grants Commission (UGC); Department of Biotechnology (DBT), India	Science and Engineering Research Board (SERB); CSIR(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported in part by Science and Engineering Research Board (SERB) Grants EMR/2016/002167 and BSC-0118 (EpiHed) (to M. S. A.) and BSC-0103 (UNDO) (to S. K. R.) and by funds from CSIR (to A. K. S. and H. S.), University Grants Commission (UGC) (to S. R.), and Department of Biotechnology (DBT), India (to M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Bharati AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31294; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chymkowitch P, 2012, P NATL ACAD SCI USA, V109, P10450, DOI 10.1073/pnas.1200067109; Clemente-Blanco A, 2011, NAT CELL BIOL, V13, P1450, DOI 10.1038/ncb2365; Corden JL, 2013, CHEM REV, V113, P8423, DOI 10.1021/cr400158h; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kao L, 2014, MOL CELL PROTEOMICS, V13, P594, DOI 10.1074/mcp.M113.032680; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Liang KW, 2015, MOL CELL, V60, P435, DOI 10.1016/j.molcel.2015.09.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Rock JM, 2011, GENE DEV, V25, P1943, DOI 10.1101/gad.17257711; Rodriguez-Molina JB, 2016, MOL CELL, V63, P433, DOI 10.1016/j.molcel.2016.06.036; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; SCHWEITZER B, 1991, YEAST, V7, P265, DOI 10.1002/yea.320070308; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Veis J, 2007, MOL CELL BIOL, V27, P8364, DOI 10.1128/MCB.01253-07; Yellman CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128604; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214	37	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5507	5518		10.1074/jbc.M116.761056	http://dx.doi.org/10.1074/jbc.M116.761056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202544	Green Published, hybrid			2022-12-28	WOS:000397875500030
J	Li, W; Reeb, AN; Lin, BY; Subramanian, P; Fey, EE; Knoverek, CR; French, RL; Bigio, EH; Ayala, YM				Li, Wen; Reeb, Ashley N.; Lin, Binyan; Subramanian, Praveen; Fey, Erin E.; Knoverek, Catherine R.; French, Rachel L.; Bigio, Eileen H.; Ayala, Yuna M.			Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; HEXANUCLEOTIDE REPEAT; CFTR EXON-9; ANTISENSE TRANSCRIPTS; ALZHEIMER-DISEASE; STRESS GRANULES; RNA FOCI; IN-VIVO	TAR DNA-binding protein (TDP-43) is a highly conserved and essential DNA-and RNA-binding protein that controls gene expression through RNA processing, in particular, regulation of splicing. Intracellular aggregation of TDP-43 is a hallmark of amyotrophic lateral sclerosis and ubiquitin-positive frontotemporal lobar degeneration. This TDP-43 pathology is also present in other types of neurodegeneration including Alzheimer's disease. We report here that TDP-43 is a substrate of MEK, a central kinase in the MAPK/ERK signaling pathway. TDP-43 dual phosphorylation by MEK, at threonine 153 and tyrosine 155 ( p-T153/Y155), was dramatically increased by the heat shock response (HSR) in human cells. HSR promotes cell survival under proteotoxic conditions by maintaining protein homeostasis and preventing protein misfolding. MEK is activated by HSR and contributes to the regulation of proteome stability. Phosphorylated TDP-43 was not associated with TDP-43 aggregation, and p-T153/Y155 remained soluble under conditions that promote protein misfolding. We found that active MEK significantly alters TDP-43-regulated splicing and that phosphomimetic substitutions at these two residues reduce binding to GU-rich RNA. Cellular imaging using a phospho-specific p-T153/Y155 antibody showed that phosphorylated TDP-43 was specifically recruited to the nucleoli, suggesting that p-T153/Y155 regulates a previously unappreciated function of TDP-43 in the processing of nucleolarassociated RNA. These findings highlight a new mechanism that regulates TDP-43 function and homeostasis through phosphorylation and, therefore, may contribute to the development of strategies to prevent TDP-43 aggregation and to uncover previously unexplored roles of TDP-43 in cell metabolism.	[Li, Wen; Reeb, Ashley N.; Lin, Binyan; Subramanian, Praveen; Fey, Erin E.; Knoverek, Catherine R.; French, Rachel L.; Ayala, Yuna M.] St Louis Univ, Sch Med, Edward Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Subramanian, Praveen] AT Still Univ Kirksville, Coll Osteopath Med, Kirksville, MO 63501 USA; [Fey, Erin E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Knoverek, Catherine R.] Washington Univ, Dept Computat & Mol Biophys, St Louis, MO 63110 USA	Saint Louis University; Northwestern University; Feinberg School of Medicine; A.T. Still University of Health Sciences; Vanderbilt University; Washington University (WUSTL)	Ayala, YM (corresponding author), St Louis Univ, Sch Med, Edward Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	yayala@slu.edu			National Institutes of Health, NINDS [K01 NS082391]; St. Louis University Presidential Research Fund [230175]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS082391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013854] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); St. Louis University Presidential Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health, NINDS Grant K01 NS082391 and St. Louis University Presidential Research Fund Grant 230175. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bigio EH, 2010, ACTA NEUROPATHOL, V120, P43, DOI 10.1007/s00401-010-0681-2; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Butch ER, 1996, J BIOL CHEM, V271, P4230; Chen HJ, 2016, BRAIN, V139, P1417, DOI 10.1093/brain/aww028; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kalmar B, 2014, PHARMACOL THERAPEUT, V141, P40, DOI 10.1016/j.pharmthera.2013.08.003; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin PY, 2016, J NEUROSCI RES, V94, P671, DOI 10.1002/jnr.23725; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shalgi R, 2014, CELL REP, V7, P1362, DOI 10.1016/j.celrep.2014.04.044; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Udan-Johns M, 2014, HUM MOL GENET, V23, P157, DOI 10.1093/hmg/ddt408; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	55	33	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5089	5100		10.1074/jbc.M116.753913	http://dx.doi.org/10.1074/jbc.M116.753913			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28167528	Green Published, hybrid			2022-12-28	WOS:000397590400028
J	Mourer, T; Normant, V; Labbe, S				Mourer, Thierry; Normant, Vincent; Labbe, Simon			Heme Assimilation in Schizosaccharomyces pombe Requires Cell-surface-anchored Protein Shu1 and Vacuolar Transporter Abc3.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON ACQUISITION; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; REGULATORY MOTIF; CRYPTOCOCCUS-NEOFORMANS; COPPER TRANSPORTER; MEMBRANE-PROTEINS; ZINC STORAGE; HEMOGLOBIN; YEAST	The Schizosaccharomyces pombe shu1(+) gene encodes a cell-surface protein required for assimilation of exogenous heme. In this study, shaving experiments showed that Shu1 is released from membrane preparations when spheroplast lysates are incubated with phosphoinositide-specific phospholipase C (PI-PLC). Shu1 cleavability by PI-PLC and its predicted hydropathy profile strongly suggested that Shu1 is a glycosylphosphatidyli-nositol-anchored protein. When heme biosynthesis is selec-tively blocked in hem1 Delta mutant cells, the heme analog zinc mesoporphyrin IX (ZnMP) first accumulates into vacuoles and then subsequently, within the cytoplasm in a rapid and Shu1-de-pendent manner. An HA(4)-tagged shu1(+) allele that retained wild-type function localizes to the cell surface in response to low hemin concentrations, but under high hemin concentrations, Shu1-HA(4) re-localizes to the vacuolar membrane. Inactivation of abc3(+), encoding a vacuolar membrane transporter, results in hem1 Delta abc3 Delta mutant cells being unable to grow in the presence of hemin as the sole iron source. In hem1 Delta abc3 Delta cells, ZnMP accumulates primarily in vacuoles and does not sequentially accumulate in the cytosol. Consistent with a role for Abc3 as vacuolar hemin exporter, results with hemin-agarose pulldown assays showed that Abc3 binds to hemin. In contrast, an Abc3 mutant in which an inverted Cys-Pro motif had been replaced with Ala residues fails to bind hemin with high affinity. Taken together, these results show that Shu1 undergoes rapid hemininduced internalization from the cell surface to the vacuolar membrane and that the transporter Abc3 participates in the mobilization of stored heme from the vacuole to the cytosol.	[Mourer, Thierry; Normant, Vincent; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci La Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci La Sante, 3201,Pavillon Z-8,Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Mourer, Thierry/0000-0003-1651-6768	Natural Sciences and Engineering Research of Canada (NSERC) [RGPIN-2015/2020-04878]	Natural Sciences and Engineering Research of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research "helical basket"-fold that consists of six-helices(15). Based on Council of Canada (NSERC) Grant RGPIN-2015/2020-04878 (to S.L.). The authors declare that they have no conflict of interest with the content of this article.	Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Cadieux B, 2013, J INFECT DIS, V207, P1339, DOI 10.1093/infdis/jit029; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Christ L, 2017, TRENDS BIOCHEM SCI, V42, P42, DOI 10.1016/j.tibs.2016.08.016; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Duffy SP, 2010, MOL CELL BIOL, V30, P5318, DOI 10.1128/MCB.00690-10; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu GG, 2015, MOL MICROBIOL, V96, P973, DOI 10.1111/mmi.12985; Hu GG, 2013, INFECT IMMUN, V81, P292, DOI 10.1128/IAI.01037-12; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Liu XM, 2015, MOL CELL, V59, P1035, DOI 10.1016/j.molcel.2015.07.034; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Mizushima N, 2015, MOL CELL, V59, P887, DOI 10.1016/j.molcel.2015.09.004; Mourer T, 2015, J BIOL CHEM, V290, P10176, DOI 10.1074/jbc.M115.642058; Nasser L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.156, 10.1038/nmicrobiol.2016.156]; Nichols B, 2009, J CELL BIOL, V186, P457, DOI 10.1083/jcb.200907119; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pendrak ML, 2004, J BIOL CHEM, V279, P3426, DOI 10.1074/jbc.M311550200; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x; Schubert E, 2015, J INORG BIOCHEM, V148, P49, DOI 10.1016/j.jinorgbio.2015.05.008; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang ZW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008066	60	19	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4898	4912		10.1074/jbc.M117.776807	http://dx.doi.org/10.1074/jbc.M117.776807			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28193844	hybrid, Green Published			2022-12-28	WOS:000397590400013
J	Heffernan, C; Jain, MR; Liu, T; Kim, H; Barretto, K; Li, H; Maurel, P				Heffernan, Corey; Jain, Mohit R.; Liu, Tong; Kim, Hyosung; Barretto, Kevin; Li, Hong; Maurel, Patrice			Nectin-like 4 Complexes with Choline Transporter-like Protein-1 and Regulates Schwann Cell Choline Homeostasis and Lipid Biogenesis in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; SPHINGOMYELIN SYNTHASE; STATISTICAL-MODEL; MAMMALIAN-CELLS; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; NEUROPATHY; SYSTEM	Nectin-like 4 (NECL4, CADM4) is a Schwann cell-specific cell adhesion molecule that promotes axo-glial interactions. In vitro and in vivo studies have shown that NECL4 is necessary for proper peripheral nerve myelination. However, the molecular mechanisms that are regulated by NECL4 and affect peripheral myelination currently remain unclear. We used an in vitro approach to begin identifying some of the mechanisms that could explain NECL4 function. Using mass spectrometry and Western blotting techniques, we have identified choline transporter-like 1 (CTL1) as a putative complexing partner with NECL4. We show that intracellular choline levels are significantly elevated in NECL4-deficient Schwann cells. The analysis of extracellular d(9)-choline uptake revealed a deficit in the amount of d(9)-choline found inside NECL4-deficient Schwann cells, suggestive of either reduced transport capabilities or increased metabolization of transported choline. An extensive lipidomic screen of choline derivatives showed that total phosphatidylcholine and phosphatidylinositol (but not diacylglycerol or sphingomyelin) are significantly elevated in NECL4deficient Schwann cells, particularly specific subspecies of phosphatidylcholine carrying very long polyunsaturated fatty acid chains. Finally, CTL1-deficient Schwann cells are significantly impaired in their ability to myelinate neurites in vitro. To our knowledge, this is the first demonstration of a bona fide cell adhesion molecule, NECL4, regulating choline homeostasis and lipid biogenesis. Phosphatidylcholines are major myelin phospholipids, and several phosphorylated phosphatidylinositol species are known to regulate key aspects of peripheral myelination. Furthermore, the biophysical properties imparted to plasma membranes are regulated by fatty acid chain profiles. Therefore, it will be important to translate these in vitro observations to in vivo studies of NECL4 and CTL1-deficient mice.	[Heffernan, Corey; Kim, Hyosung; Barretto, Kevin; Maurel, Patrice] Rutgers State Univ, Dept Biol Sci, Boyden Hall,Rm 206,195 Univ Ave, Newark, NJ 07102 USA; [Jain, Mohit R.; Liu, Tong; Li, Hong] Univ Med & Dent New Jersey, Ctr Adv Prote Res, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Maurel, P (corresponding author), Rutgers State Univ, Dept Biol Sci, Boyden Hall,Rm 206,195 Univ Ave, Newark, NJ 07102 USA.	maurep01@andromeda.rutgers.edu	Maurel, Patrice/E-9559-2017	Li, Hong/0000-0001-5731-5335	National Institutes of Health from NINDS [P30 NS046593]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593, R21NS090305, R01NS065218] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Haesun Kim for helpful discussion. We thank Dr. Baichen Zhang at LipoSpectrum Inc. for lipidomic mass spectrometry and Drs. Haiyan Zheng and Caifeng Zhao (Rutgers University) for help with MALDI-TOF mass spectrometry. Operation of the Center for Advanced Proteomics was supported by National Institutes of Health Grant P30 NS046593 from NINDS (to H. L.).	Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Baykal AT, 2008, METABOLOMICS, V4, P347, DOI 10.1007/s11306-008-0125-3; Bazalakova MH, 2006, HANDB EXP PHARM, V175, P525; Berger P, 2011, J CELL MOL MED, V15, P307, DOI 10.1111/j.1582-4934.2009.00967.x; BLUSZTAJN JK, 1985, BIOCHEM J, V232, P505, DOI 10.1042/bj2320505; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; BREMER J, 1961, BIOCHIM BIOPHYS ACTA, V46, P205, DOI 10.1016/0006-3002(61)90745-4; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Campagnoni A.T., 2004, MYELIN BIOL DISORDER, P387, DOI DOI 10.1016/B978-012439510-7/50068-1; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Cui Z, 1996, J BIOL CHEM, V271, P2839, DOI 10.1074/jbc.271.5.2839; Dangata YY, 1996, J ANAT, V189, P117; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Estrada V, 2006, METABOLISM, V55, P940, DOI 10.1016/j.metabol.2006.02.024; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fujita E, 2007, AM J PATHOL, V171, P1800, DOI 10.2353/ajpath.2007.070261; Goebbels S, 2012, EMBO MOL MED, V4, P486, DOI 10.1002/emmm.201200227; Golan N, 2013, J NEUROSCI, V33, P10950, DOI 10.1523/JNEUROSCI.0571-13.2013; GOULD RM, 1977, J CELL BIOL, V75, P326, DOI 10.1083/jcb.75.2.326; Ho C S, 2003, Clin Biochem Rev, V24, P3; Hudson L. D., 2004, MYELIN BIOL DISORDER; Jang WH, 2014, BIOSCI BIOTECH BIOCH, V78, P644, DOI 10.1080/09168451.2014.890031; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim HA, 2010, SPRINGER PROTOC HAND, P253, DOI 10.1007/978-1-60761-292-6_15; Kim T, 1999, J NEUROCYTOL, V28, P281, DOI 10.1023/A:1007001427597; Kirschner D. A., 2004, MYELIN BIOL DISORDER, V1, P523; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LASSEGUE B, 1993, BIOCHEM J, V292, P509, DOI 10.1042/bj2920509; MACALA LJ, 1983, J LIPID RES, V24, P1243; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; McGrath C, 2016, CLIN ANAT, V29, P547, DOI 10.1002/ca.22653; Meunier FM, 2002, NEUROREPORT, V13, P1617, DOI 10.1097/00001756-200209160-00009; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Musse AA, 2008, BIOCHEMISTRY-US, V47, P10372, DOI 10.1021/bi801302b; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nawaz S, 2009, J NEUROSCI, V29, P4794, DOI 10.1523/JNEUROSCI.3955-08.2009; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; OWENS GC, 1990, GLIA, V3, P118, DOI 10.1002/glia.440030205; Pertusa M, 2007, J BIOL CHEM, V282, P28768, DOI 10.1074/jbc.M701878200; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Szule JA, 2002, BIOPHYS J, V83, P977, DOI 10.1016/S0006-3495(02)75223-5; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Talbot WA, 1997, BIOCHEMISTRY-US, V36, P5827, DOI 10.1021/bi962437i; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; TASHIRO S-I, 1983, Tohoku Journal of Experimental Medicine, V141, P485; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Traiffort E, 2005, J NEUROCHEM, V92, P1116, DOI 10.1111/j.1471-4159.2004.02962.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaccari I, 2015, HUM MOL GENET, V24, P383, DOI 10.1093/hmg/ddu451; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Verheijen MHG, 2009, P NATL ACAD SCI USA, V106, P21383, DOI 10.1073/pnas.0905633106; Verkade P, 1997, HISTOCHEM CELL BIOL, V108, P211, DOI 10.1007/s004180050161; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; Yageta M, 2002, CANCER RES, V62, P5129; Yuan ZF, 2006, PHYSIOL GENOMICS, V26, P76, DOI 10.1152/physiolgenomics.00107.2005; Zacchetti D, 1995, FEBS LETT, V377, P465, DOI 10.1016/0014-5793(95)01396-2; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	74	9	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4484	4498		10.1074/jbc.M116.747816	http://dx.doi.org/10.1074/jbc.M116.747816			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28119456	Green Published, hybrid			2022-12-28	WOS:000397585100009
J	Alexaki, A; Clarke, BA; Gavrilova, O; Ma, YY; Zhu, HL; Ma, XR; Xu, LY; Tuymetova, G; Larman, BC; Allende, ML; Dunn, TM; Proia, RL				Alexaki, Aikaterini; Clarke, Benjamin A.; Gavrilova, Oksana; Ma, Yinyan; Zhu, Hongling; Ma, Xinran; Xu, Lingyan; Tuymetova, Galina; Larman, Bridget C.; Allende, Maria L.; Dunn, Teresa M.; Proia, Richard L.			De Novo Sphingolipid Biosynthesis Is Required for Adipocyte Survival and Metabolic Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; inflammation; lipodystrophy; serine palmitoyltransferase; sphingolipid	HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESITY; CERAMIDE; MICE; INFLAMMATION; DYSFUNCTION; FAT; DEFICIENCY; EXPRESSION	Sphingolipids are a diverse class of essential cellular lipids that function as structural membrane components and as signaling molecules. Cells acquire sphingolipids by both de novo biosynthesis and recycling of exogenous sphingolipids. The individual importance of these pathways for the generation of essential sphingolipids in differentiated cells is not well understood. To investigate the requirement for de novo sphingolipid biosynthesis in adipocytes, a cell type with highly regulated lipid metabolism, we generated mice with an adipocyte-specific deletion of Sptlc1. Sptlc1 is an obligate subunit of serine palmitoyltransferase, the enzyme responsible for the first and rate-limiting step of de novo sphingolipid biosynthesis. These mice, which initially developed adipose tissue, exhibited a striking age-dependent loss of adipose tissue accompanied by evidence of adipocyte death, increased macrophage infiltration, and tissue fibrosis. Adipocyte differentiation was not affected by the Sptlc1 deletion. The mice also had elevated fasting blood glucose, fatty liver, and insulin resistance. Collectively, these data indicate that de novo sphingolipid biosynthesis is required for adipocyte cell viability and normal metabolic function and that reduced de novo sphingolipid biosynthesis within adipocytes is associated with adipocyte death, adipose tissue remodeling, and metabolic dysfunction.	[Alexaki, Aikaterini; Clarke, Benjamin A.; Zhu, Hongling; Ma, Xinran; Xu, Lingyan; Tuymetova, Galina; Larman, Bridget C.; Allende, Maria L.; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana; Ma, Yinyan] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA; [Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20184 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr,MSC 1821, Bethesda, MD 20892 USA.	proia@nih.gov	Proia, Richard L/A-7908-2012	Zhu, Hongling/0000-0003-0612-009X; Proia, Richard/0000-0003-0456-1270; Alexaki, Aikaterini/0000-0003-2511-8569	National Institutes of Health [P30CA138313, P20RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056014, ZICDK070002, ZIADK056015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Linda Raab for editorial assistance. The Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina, was the recipient of National Institutes of Health Grants P30CA138313 and P20RR017677.	Alexaki A, 2014, J LIPID RES, V55, P2521, DOI 10.1194/jlr.M051862; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Blachnio-Zabielska AU, 2012, OBESITY, V20, P2341, DOI 10.1038/oby.2012.126; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Camell CD, 2015, J BIOL CHEM, V290, P29402, DOI 10.1074/jbc.M115.680199; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen M, 2010, CELL METAB, V11, P320, DOI 10.1016/j.cmet.2010.02.013; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kolak M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-115; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061380; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	36	28	29	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3929	3939		10.1074/jbc.M116.756460	http://dx.doi.org/10.1074/jbc.M116.756460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100772	Green Published, hybrid			2022-12-28	WOS:000395542500033
J	DeBalsi, KL; Longley, MJ; Hoff, KE; Copeland, WC				DeBalsi, Karen L.; Longley, Matthew J.; Hoff, Kirsten E.; Copeland, William C.			Synergistic Effects of the in cis T251I and P587L Mitochondrial DNA Polymerase gamma Disease Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG MUTATIONS; PATHOGENIC MUTATIONS; EXONUCLEASE ACTIVITY; BIOCHEMICAL-ANALYSIS; AUTOSOMAL-DOMINANT; ACCESSORY SUBUNIT; REPLICATION; DISORDERS; TOXICITY	Human mitochondrial DNA (mtDNA) polymerase gamma (Pol gamma) is the only polymerase known to replicate the mitochondrial genome. The Pol gamma holoenzyme consists of the p140 catalytic subunit (POLG) and the p55 homodimeric accessory subunit (POLG2), which enhances binding of Pol gamma to DNA and promotes processivity of the holoenzyme. Mutations within POLG impede maintenance of mtDNA and cause mitochondrial diseases. Two common POLG mutations usually found in cis in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions. To determine whether T251I or P587L is the primary pathogenic allele or whether both substitutions are required to cause disease, we overproduced and purified WT, T251I, P587L, and T251I + P587L double variant forms of recombinant Pol gamma. Biochemical characterization of these variants revealed impaired DNA binding affinity, reduced thermostability, diminished exonuclease activity, defective catalytic activity, and compromisedDNAprocessivity, even in the presence of the p55 accessory subunit. However, physical association with p55 was unperturbed, suggesting intersubunit affinities similar to WT. Notably, although the single mutants were similarly impaired, a dramatic synergistic effect was found for the double mutant across all parameters. In conclusion, our analyses suggest that individually both T251I and P587L substitutions functionally impair Pol gamma, with greater pathogenicity predicted for the single P587L variant. Combining T251I and P587L induces extreme thermal lability and leads to synergistic nucleotide and DNA binding defects, which severely impair catalytic activity and correlate with presentation of disease in patients.	[DeBalsi, Karen L.; Longley, Matthew J.; Hoff, Kirsten E.; Copeland, William C.] NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	Intramural Research Program of the NIEHS, National Institutes of Health [ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065078, ZIAES065078] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIEHS, National Institutes of Health, Grant ES 065078. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C; Al-Zubeidi D, 2014, PEDIATR NEUROL, V51, P448, DOI 10.1016/j.pediatrneurol.2014.04.006; Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150; Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686; Caito SW, 2015, ANTIOXID REDOX SIGN, V23, P578, DOI 10.1089/ars.2015.6289; Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409; Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008; Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006; Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279; Gonzalez-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802; Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940; Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341; Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702; Lucas P, 1997, CR ACAD SCI III-VIE, V320, P299, DOI 10.1016/S0764-4469(97)82771-0; Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303; McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171; Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105; Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004; Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180; Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891; Stumpf JD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004748; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x; Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002; Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240; Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209	67	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4198	4209		10.1074/jbc.M116.773341	http://dx.doi.org/10.1074/jbc.M116.773341			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154168	Green Published, hybrid			2022-12-28	WOS:000395837100018
J	Mukherjee, A; Wang, ZJ; Kinlough, CL; Poland, PA; Marciszyn, AL; Montalbetti, N; Carattino, MD; Butterworth, MB; Kleyman, TR; Hughey, RP				Mukherjee, Anindit; Wang, Zhijian; Kinlough, Carol L.; Poland, Paul A.; Marciszyn, Allison L.; Montalbetti, Nicolas; Carattino, Marcelo D.; Butterworth, Michael B.; Kleyman, Thomas R.; Hughey, Rebecca P.			Specific Palmitoyltransferases Associate with and Activate the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; PROTEIN PALMITOYLATION; BETA-SUBUNIT; MEDIATED PALMITOYLATION; ALPHA-SUBUNIT; VACUOLAR H+; ENAC; 2-BROMOPALMITATE; LOCALIZATION; RESIDUES	The epithelial sodium channel (ENaC) has an important role in regulating extracellular fluid volume and blood pressure, as well as airway surface liquid volume and mucociliary clearance. ENaC is a trimer of three homologous subunits (alpha, beta, and gamma). We previously reported that cytoplasmic residues on the beta (beta Cys-43 and beta Cys-557) and gamma (gamma Cys-33 and gamma Cys-41) subunits are palmitoylated. Mutation of Cys that blocked ENaC palmitoylation also reduced channel open probability. Furthermore, gamma subunit palmitoylation had a dominant role over beta subunit palmitoylation in regulating ENaC. To determine which palmitoyltransferases (termed DHHCs) regulate the channel, mouse ENaCs were co-expressed in Xenopus oocytes with each of the 23 mouse DHHCs. ENaC activity was significantly increased by DHHCs 1, 2, 3, 7, and 14. ENaC activation by DHHCs was lost when gamma subunit palmitoylation sites were mutated, whereas DHHCs 1, 2, and 14 still activated ENaC lacking beta subunit palmitoylation sites. beta subunit palmitoylation was increased by ENaC co-expression withDHHC7. Both wild type ENaC and channels lacking beta and gamma palmitoylation sites co-immunoprecipitated with the five activating DHHCs, suggesting that ENaC forms a complex with multiple DHHCs. RT-PCR revealed that transcripts for the five activatingDHHCswere present in culturedmCCD(cl1) cells, and DHHC 3 was expressed in aquaporin 2-positive principal cells of mouse aldosterone-sensitive distal nephron where ENaC is localized. Treatment of polarized mCCD(cl1) cells with a general inhibitor of palmitoylation reduced ENaC-mediated Na+ currents within minutes. Our results indicate that specific DHHCs have a role in regulating ENaC.	[Mukherjee, Anindit; Wang, Zhijian; Kinlough, Carol L.; Poland, Paul A.; Marciszyn, Allison L.; Montalbetti, Nicolas; Carattino, Marcelo D.; Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Butterworth, Michael B.; Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Elect Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Yang, Wei/HIA-0360-2022; Montalbetti, Nicolas/T-4212-2019	Montalbetti, Nicolas/0000-0003-2897-9540	National Institutes of Health [R01 DK065161, R37 DK051391, R01 DK102843, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102843, R37DK051391, P30DK079307, R01DK065161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK065161 (to T. R. K. and R. P. H.), R37 DK051391 (to T. R. K.), R01 DK102843 (to M. B. B.), and P30 DK079307 (to T. R. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-bataineh MM, 2014, AM J PHYSIOL-RENAL, V306, pF981, DOI 10.1152/ajprenal.00362.2013; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; Gorleku OA, 2011, J BIOL CHEM, V286, P39573, DOI 10.1074/jbc.M111.272369; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Heidrich E, 2015, J BIOL CHEM, V290, P11569, DOI 10.1074/jbc.M115.640763; Heiler S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0105-y; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Locke D, 2006, FASEB J, V20, P1221, DOI 10.1096/fj.05-5309fje; Ma HP, 2007, PFLUG ARCH EUR J PHY, V455, P169, DOI 10.1007/s00424-007-0294-3; Mueller GM, 2012, AM J PHYSIOL-RENAL, V303, pF220, DOI 10.1152/ajprenal.00493.2011; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pedro MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075232; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Ronzaud C, 2014, PHYSIOLOGY, V29, P16, DOI 10.1152/physiol.00021.2013; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SCHMIDT MFG, 1979, P NATL ACAD SCI USA, V76, P1687, DOI 10.1073/pnas.76.4.1687; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Szkudelski T, 2011, LIFE SCI, V89, P450, DOI 10.1016/j.lfs.2011.07.010; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004	68	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4152	4163		10.1074/jbc.M117.776146	http://dx.doi.org/10.1074/jbc.M117.776146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154191	Green Published, hybrid			2022-12-28	WOS:000395837100015
J	Horiuchi, T; Sakata, N; Narumi, Y; Kimura, T; Hayashi, T; Nagano, K; Liu, KY; Nishibori, M; Tsukita, S; Yamada, T; Katagiri, H; Shirakawa, R; Horiuchi, H				Horiuchi, Takahiro; Sakata, Natsumi; Narumi, Yoshihiro; Kimura, Tomohiro; Hayashi, Takashi; Nagano, Keisuke; Liu, Keyue; Nishibori, Masahiro; Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki; Shirakawa, Ryutaro; Horiuchi, Hisanori			Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP BOX-1; CYTOKINE ACTIVITY; PROTEIN; INFLAMMATION; INJURY; HEPATOTOXICITY; CELLS	Metformin is the first-line drug in the treatment of type 2 diabetes. In addition to its hypoglycemic effect, metformin has an anti-inflammatory function, but the precise mechanism promoting this activity remains unclear. High mobility group box 1 (HMGB1) is an alarmin that is released from necrotic cells and induces inflammatory responses by its cytokine-like activity and is, therefore, a target of anti-inflammatory therapies. Here we identified HMGB1 as a novel metformin-binding protein by affinity purification using a biotinylated metformin analogue. Metformin directly bound to the C-terminal acidic tail of HMGB1. Both in vitro and in vivo, metformin inhibited inflammatory responses induced by full-length HMGB1 but not by HMGB1 lacking the acidic tail. In an acetaminophen-induced acute liver injury model in which HMGB1 released from injured cells exacerbates the initial injury, metformin effectively reduced liver injury and had no additional inhibitory effects when the extracellular HMGB1 was blocked by anti-HMGB1-neutralizing antibody. In summary, we report for the first time that metformin suppresses inflammation by inhibiting the extracellular activity of HMGB1. Because HMGB1 plays a major role in inflammation, our results suggest possible new ways to manage HMGB1-induced inflammation.	[Horiuchi, Takahiro; Sakata, Natsumi; Narumi, Yoshihiro; Kimura, Tomohiro; Shirakawa, Ryutaro; Horiuchi, Hisanori] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Hayashi, Takashi] Otsuka Pharmaceut Co Ltd, Biomed Technol Res Ctr, Tokushima Res Inst, 463-10 Kagasuno, Kawaguchi, Tokushima 7710192, Japan; [Nagano, Keisuke] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, 463-10 Kagasuno, Kawaguchi, Tokushima 7710192, Japan; [Liu, Keyue; Nishibori, Masahiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacol, Okayama 7008558, Japan; [Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Dept Metab & Diabet, Sendai, Miyagi 9808575, Japan	Tohoku University; Otsuka Pharmaceutical; Otsuka Pharmaceutical; Okayama University; Tohoku University	Shirakawa, R; Horiuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ryutaro.shirakawa.b1@tohoku.ac.jp; hisanori.horiuchi.e8@tohoku.ac.jp		Horiuchi, Takahiro/0000-0002-1907-2042; Sakata, Natsumi/0000-0001-5420-957X	Japan Society for the Promotion of Science KAKENHI Grant [15K19000]; Smart Aging Research Center, Tohoku University; Good Practice (GP) Program, "Nurturing MD researchers competitive in the world arena, Tohoku University School of Medicine" by the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Otsuka Pharmaceutical Co, Ltd.; Otsuka Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [16K15486, 15K19000] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smart Aging Research Center, Tohoku University; Good Practice (GP) Program, "Nurturing MD researchers competitive in the world arena, Tohoku University School of Medicine" by the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Otsuka Pharmaceutical Co, Ltd.(Otsuka Pharmaceutical); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work supported in part by a Japan Society for the Promotion of Science KAKENHI Grant 15K19000 (to T. K.), the Smart Aging Research Center, Tohoku University, and a research fund from Otsuka Pharmaceutical Co., Ltd. It was also supported by the Good Practice (GP) Program, "Nurturing MD researchers competitive in the world arena, Tohoku University School of Medicine" by the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to T. Ho., N. S., and Y. N.). T. Hayashi and K. Nagano are employees of Otsuka Pharmaceutical Co., Ltd. H. Horiuchi received a research fund from Otsuka Pharmaceutical Co, Ltd.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Gronich N, 2013, NAT REV CLIN ONCOL, V10, P625, DOI 10.1038/nrclinonc.2013.169; Hadi NR, 2012, J PHARMACOL PHARMACO, V3, P248, DOI 10.4103/0976-500X.99426; Hattori Y, 2015, DIABETES, V64, P1907, DOI 10.2337/db15-0090; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Hyun Bobae, 2013, Immune Netw, V13, P123, DOI 10.4110/in.2013.13.4.123; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kim J, 2014, J BIOL CHEM, V289, P23246, DOI 10.1074/jbc.M114.577908; Kim YH, 2015, J HEPATOL, V63, P75, DOI [10.1016/j.jhep.2015.02.050, 10.1016/j.jhep.2015.02.008]; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lotze Michael T, 2003, Curr Opin Investig Drugs, V4, P1405; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Poon MKT, 2003, J PHARMACOL SCI, V93, P501, DOI 10.1254/jphs.93.501; Ramstein J, 1999, EUR J BIOCHEM, V260, P692, DOI 10.1046/j.1432-1327.1999.00185.x; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang RK, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-66	48	60	63	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8436	8446		10.1074/jbc.M116.769380	http://dx.doi.org/10.1074/jbc.M116.769380			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28373282	Green Published, hybrid			2022-12-28	WOS:000401788600027
J	Fukuda, S; Kita, S; Obata, Y; Fujishima, Y; Nagao, H; Masuda, S; Tanaka, Y; Nishizawa, H; Funahashi, T; Takagi, J; Maeda, N; Shimomura, I				Fukuda, Shiro; Kita, Shunbun; Obata, Yoshinari; Fujishima, Yuya; Nagao, Hirofumi; Masuda, Shigeki; Tanaka, Yoshimitsu; Nishizawa, Hitoshi; Funahashi, Tohru; Takagi, Junichi; Maeda, Norikazu; Shimomura, Iichiro			The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; MOLECULAR-WEIGHT ADIPONECTIN; METABOLIC SYNDROME; INSULIN-RESISTANCE; CDH13; PLASMA; ACRP30/ADIPONECTIN; GENE; MICE; SPECIFICITY	Adiponectin, an adipocyte-derived circulating protein, accumulates in the heart, vascular endothelium, and skeletal muscles through an interaction with T-cadherin (T-cad), a unique glycosylphosphatidylinositol-anchored cadherin. Recent studies have suggested that this interaction is essential for adiponectin-mediated cardiovascular protection. However, the precise protein-protein interaction between adiponectin and T-cad remains poorly characterized. Using ELISA-based and surface plasmon analyses, we report here that T-cad fused with IgG Fc as a fusion tag by replacing its glycosylphosphatidylinositol-anchor specifically bound both hexameric and larger multimeric adiponectin with a dissociation constant of similar to 1.0 nM and without any contribution from other cellular or serum factors. The extracellular T-cad repeats 1 and 2 were critical for the observed adiponectin binding, which is required for classical cadherin-mediated cell-to-cell adhesion. Moreover, the 130-kDa prodomain-bearing T-cad, uniquely expressed on the cell surface among members of the cadherin family and predominantly increased by adiponectin, contributed significantly to adiponectin binding. Inhibition of prodomain-processing by a prohormone convertase inhibitor increased 130-kDa T-cad levels and also enhanced adiponectin binding to endothelial cells both by more preferential cell-surface localization and by higher adiponectin-binding affinity of 130-kDa T-cad relative to 100-kDa T-cad. The preferential cell-surface localization of 130-kDa T-cad relative to 100-kDa T-cad was also observed in normal mice aorta in vivo. In conclusion, our study shows that a unique key feature of the T-cad prodomain is its involvement in binding of the T-cad repeats 1 and 2 to adiponectin and also demonstrates that adiponectin positively regulates T-cad abundance.	[Fukuda, Shiro; Kita, Shunbun; Obata, Yoshinari; Fujishima, Yuya; Nagao, Hirofumi; Masuda, Shigeki; Tanaka, Yoshimitsu; Nishizawa, Hitoshi; Funahashi, Tohru; Maeda, Norikazu; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Suita, Suita, Osaka 5650871, Japan; [Kita, Shunbun; Funahashi, Tohru; Maeda, Norikazu] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan; [Takagi, Junichi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kita, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Suita, Suita, Osaka 5650871, Japan.	shunkita@endmet.med.osaka-u.ac.jp			Takeda Science Foundation [16K09802, 16K09801, 15H04853]; Japan Foundation for Applied Enzymology; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by Grant-in-aid for Scientific Research (C) 16K09802 (to S. K.), Grant-in-aid for Scientific Research (C) 16K09801 (to N. M.) and Grant-in-aid for Scientific Research (B) 15H04853 (to I. S.) and, grants from Takeda Science Foundation (to N. M.), Japan Foundation for Applied Enzymology (to Y. F.), Core Research for Evolutional Science and Technology (CREST), and Japan Science and Technology Agency (JST) (to I. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bassaganas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098595; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Ciatto C, 2010, NAT STRUCT MOL BIOL, V17, P339, DOI 10.1038/nsmb.1781; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Inoue T, 2007, AM J CARDIOL, V100, P569, DOI 10.1016/j.amjcard.2007.03.062; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Joshi MB, 2009, FASEB J, V23, P4011, DOI 10.1096/fj.09-133611; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuda K, 2015, ENDOCRINOLOGY, V156, P934, DOI 10.1210/en.2014-1618; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; TODA KI, 1990, CANCER RES, V50, P5526; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423	29	35	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7840	7849		10.1074/jbc.M117.780734	http://dx.doi.org/10.1074/jbc.M117.780734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325833	hybrid, Green Published			2022-12-28	WOS:000401154100014
J	Geillon, F; Gondcaille, C; Raas, Q; Dias, AMM; Pecqueur, D; Truntzer, C; Lucchi, G; Ducoroy, P; Falson, P; Savary, S; Trompier, D				Geillon, Flore; Gondcaille, Catherine; Raas, Quentin; Dias, Alexandre M. M.; Pecqueur, Delphine; Truntzer, Caroline; Lucchi, Geraldine; Ducoroy, Patrick; Falson, Pierre; Savary, Stephane; Trompier, Doriane			Peroxisomal ATP-binding cassette transporters form mainly tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; PROTEIN-PROTEIN INTERACTIONS; ACID AMIDE HYDROLASE; CHAIN FATTY-ACIDS; ABC TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; PLASMA-MEMBRANE; PMP70 ABCD3; CELL-LINES	ABCD1 and its homolog ABCD2 are peroxisomal ATP-binding cassette (ABC) half-transporters of fatty acyl-CoAs with both distinct and overlapping substrate specificities. Although it is established that ABC half-transporters have at least to dimerize to generate a functional unit, functional equivalents of tetramers (i.e. dimers of full-length transporters) have also been reported. However, oligomerization of peroxisomal ABCD transporters is incompletely understood but is of potential significance because more complex oligomerization might lead to differences in substrate specificity. In this work, we have characterized the quaternary structure of the ABCD1 and ABCD2 proteins in the peroxisomal membrane. Using various biochemical approaches, we clearly demonstrate that both transporters exist as both homo-and heterotetramers, with a predominance of homotetramers. In addition to tetramers, some larger molecular ABCD assemblies were also found but represented only a minor fraction. By using quantitative co-immunoprecipitation assays coupled with tandem mass spectrometry, we identified potential binding partners of ABCD2 involved in polyunsaturated fatty-acid metabolism. Interestingly, we identified calcium ATPases as ABCD2-binding partners, suggesting a role of ABCD2 in calcium signaling. In conclusion, we have shown here that ABCD1 and its homolog ABCD2 exist mainly as homotetramers in the peroxisomal membrane.	[Geillon, Flore; Gondcaille, Catherine; Raas, Quentin; Dias, Alexandre M. M.; Savary, Stephane; Trompier, Doriane] Univ Bourgogne Franche Comte, Lab BioperoxIL EA7270, 6 Bd Gabriel, F-21000 Dijon, France; [Pecqueur, Delphine; Truntzer, Caroline; Lucchi, Geraldine; Ducoroy, Patrick] Univ Bourgogne Franche Comte, CLIPP ICMUB, 6 Bd Gabriel, F-21000 Dijon, France; [Falson, Pierre] Univ Lyon 1, CNRS UMR5086, Drug Resistance & Membrane Prot Team, Mol Microbiol & Struct Biochem Lab,IBCP, 7 Passage Vercors, F-69367 Lyon, France	Universite de Bourgogne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Trompier, D (corresponding author), Univ Bourgogne Franche Comte, Lab BioperoxIL EA7270, 6 Bd Gabriel, F-21000 Dijon, France.	doriane.trompier@u-bourgogne.fr	Savary, Stephane/C-8137-2011	Savary, Stephane/0000-0002-9237-1727; Lucchi, Geraldine/0000-0003-2103-486X; Falson, Pierre/0000-0002-9760-4577; Truntzer, Caroline/0000-0003-0895-4813; Trompier, Doriane/0000-0002-0746-1753	regional council of Burgundy; University of Burgundy	regional council of Burgundy(Region Bourgogne-Franche-Comte); University of Burgundy	This work was supported by grants from the regional council of Burgundy and from the University of Burgundy. The authors declare that they have no conflicts of interest with the contents of this article.	Abel S, 2011, J PHYS CHEM B, V115, P487, DOI 10.1021/jp109545v; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Brown I, 2010, CARCINOGENESIS, V31, P1584, DOI 10.1093/carcin/bgq151; Clough T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S6; Costello JL, 2017, J CELL BIOL, V216, P331, DOI 10.1083/jcb.201607055; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ferdinandusse S, 2015, HUM MOL GENET, V24, P361, DOI 10.1093/hmg/ddu448; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Frixel S, 2016, INT J MOL MED, V38, P558, DOI 10.3892/ijmm.2016.2650; Geillon F, 2014, J BIOL CHEM, V289, P24511, DOI 10.1074/jbc.M114.575506; Genin EC, 2011, J BIOL CHEM, V286, P8075, DOI 10.1074/jbc.M110.211912; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gueugnon F, 2006, BIOCHEM BIOPH RES CO, V341, P150, DOI 10.1016/j.bbrc.2005.12.152; Guimaraes CP, 2005, J HUM GENET, V50, P99, DOI 10.1007/s10038-004-0226-4; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Hillebrand M, 2012, J BIOL CHEM, V287, P210, DOI 10.1074/jbc.M111.272732; Hua R, 2017, J CELL BIOL, V216, P367, DOI 10.1083/jcb.201608128; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kruska N, 2015, BBA-MOL BASIS DIS, V1852, P925, DOI 10.1016/j.bbadis.2015.01.005; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; Liu XX, 2015, BIOCHEM BIOPH RES CO, V456, P129, DOI 10.1016/j.bbrc.2014.11.046; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Madsen L, 1998, J LIPID RES, V39, P583; Makkar RS, 2006, ARCH BIOCHEM BIOPHYS, V451, P128, DOI 10.1016/j.abb.2006.05.003; Matar-Merheb R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018036; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Nury T, 2017, J STEROID BIOCHEM, V169, P123, DOI 10.1016/j.jsbmb.2016.03.037; PETER GF, 1991, J BIOL CHEM, V266, P16745; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Schrader Michael, 2013, Subcell Biochem, V69, P1, DOI 10.1007/978-94-007-6889-5_1; Shani N, 1996, ANN NY ACAD SCI, V804, P770, DOI 10.1111/j.1749-6632.1996.tb18697.x; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Trompier D., 2013, MORGAN CLAYPOOL LIFE, DOI [10.4199/C00075ED1V01Y201303GBD004, DOI 10.4199/C00075ED1V01Y201303GBD004]; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Trompier D, 2014, BIOCHEM BIOPH RES CO, V446, P651, DOI 10.1016/j.bbrc.2014.01.025; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Wong K, 2016, BBA-MOL CELL RES, V1863, P19, DOI 10.1016/j.bbamcr.2015.10.002; Woudenberg J, 2010, HEPATOLOGY, V52, P623, DOI 10.1002/hep.23684; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200	61	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6965	6977		10.1074/jbc.M116.772806	http://dx.doi.org/10.1074/jbc.M116.772806			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28258215	Green Published, hybrid			2022-12-28	WOS:000400478300009
J	Sharma, AK; Birrane, G; Anklin, C; Rigby, AC; Alper, SL				Sharma, Alok K.; Birrane, Gabriel; Anklin, Clemens; Rigby, Alan C.; Alper, Seth L.			NMR insight into myosin-binding subunit coiled-coil structure reveals binding interface with protein kinase G-I alpha leucine zipper in vascular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; SMOOTH-MUSCLE RELAXATION; BACKBONE DYNAMICS; PKGI-ALPHA; SPECTROSCOPY; DOMAINS; ELECTROSTATICS; ASSIGNMENT; ISOFORMS; PIPELINE	Nitrovasodilators relax vascular smooth-muscle cells in part by modulating the interaction of the C-terminal coiled-coil domain (CC) and/or the leucine zipper (LZ) domain of the myosin light-chain phosphatase component, myosin-binding subunit (MBS), with the N-terminal LZ domain of protein kinase G (PKG)-I alpha. Despite the importance of vasodilation in cardiovascular homeostasis and therapy, our structural understanding of the MBS CC interaction with LZ PKG-1 alpha has remained limited. Here, we report the 3D NMR solution structure of homodimeric CC MBS in which amino acids 932-967 form a coiled-coil of two monomeric alpha-helices in parallel orientation. We found that the structure is stabilized by non-covalent interactions, with dominant contributions from hydrophobic residues at a and d heptad positions. Using NMR chemical-shift perturbation (CSP) analysis, we identified a subset of hydrophobic and charged residues of CC MBS (localized within and adjacent to the C-terminal region) contributing to the dimer-dimer interaction interface between homodimeric CC MBS and homodimeric LZ PKG-I alpha. N-15 backbone relaxation NMR revealed the dynamic features of the CC MBS interface residues identified by NMR CSP. Paramagnetic relaxation enhancement-and CSP-NMR-guided HADDOCK modeling of the dimer-dimer interface of the heterotetrameric complex exhibits the involvement of non-covalent intermolecular interactions that are localized within and adjacent to the C-terminal regions of each homodimer. These results deepen our understanding of the binding restraints of this CC MBS.LZ PKG-I alpha low-affinity heterotetrameric complex and allow reevaluation of the role(s) of myosin light-chain phosphatase partner polypeptides in regulation of vascular smooth-muscle cell contractility.	[Sharma, Alok K.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Sharma, Alok K.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA 02215 USA; [Birrane, Gabriel] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA; [Birrane, Gabriel; Alper, Seth L.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Anklin, Clemens] Bruker Biospin Corp, Billerica, MA 01821 USA; [Rigby, Alan C.] Warp Drive Bio Inc, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Bruker Corporation; Bruker BioSpin GmbH	Sharma, AK (corresponding author), Beth Israel Deaconess Med Ctr, 99 Brookline Ave,RN386, Boston, MA 02215 USA.; Alper, SL (corresponding author), Beth Israel Deaconess Med Ctr, 99 Brookline Ave,RN380F, Boston, MA 02215 USA.	aksharma@bidmc.harvard.edu; salper@bidmc.harvard.edu	Anklin, Clemens/P-6469-2019	Anklin, Clemens/0000-0002-3421-8951; Birrane, Gabriel/0000-0002-1759-5499	Atorvastatin research award	Atorvastatin research award	This work was supported by an Atorvastatin research award (to A. C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo YR, 2015, J BIOL CHEM, V290, P7707, DOI 10.1074/jbc.M114.632786; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Hubbard S. J., 1993, NACCESS; IKEBE M, 1985, EXPERIENTIA, V41, P1006, DOI 10.1007/BF01952122; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mackay JP, 1996, BIOCHEMISTRY-US, V35, P4867, DOI 10.1021/bi952761y; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rathinavelan T, 2011, J BIOL CHEM, V286, P4922, DOI 10.1074/jbc.M110.159434; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Sharma AK, 2014, PROTEIN PEPTIDE LETT, V21, P639, DOI 10.2174/0929866521666140328112426; Sharma AK, 2012, PROTEIN EXPRES PURIF, V81, P126, DOI 10.1016/j.pep.2011.09.013; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Takahashi N, 1997, GENOMICS, V44, P150, DOI 10.1006/geno.1997.4859; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	57	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7052	7065		10.1074/jbc.M117.781260	http://dx.doi.org/10.1074/jbc.M117.781260			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28280239	hybrid, Green Published			2022-12-28	WOS:000400478300016
J	Glinton, K; Beck, J; Liang, Z; Qiu, CJ; Lee, SW; Ploplis, VA; Castellino, FJ				Glinton, Kristofor; Beck, Julia; Liang, Zhong; Qiu, Cunjia; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.			Variable region in streptococcal M-proteins provides stable binding with host fibrinogen for plasminogen-mediated bacterial invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; GENOME SEQUENCE; MOLECULAR-INTERACTIONS; CRYSTAL-STRUCTURE; PYOGENES; STRAIN; STREPTOKINASE; PATTERN; ACTIVATION; PHAGOCYTOSIS	Dimeric M-proteins (M-Prt) in group A Streptococcus pyogenes (GAS) are surface-expressed virulence factors implicated in processes that contribute to the pathogenicity of infection. Sequence analyses of various GAS M-Prts have shown that they contain a highly conserved sortase A-dependent cell wall-anchored C terminus, whereas the surface-exposed N terminus is highly variable, a feature used for identification and serotyping of various GAS strains. This variability also allows for strainspecific responses that suppress host defenses. Previous studies have indeed identified the N-terminal M-Prt B-domain as the site interacting with antiphagocytotic human-host fibrinogen (hFg). Herein, we show that hFg strongly interacts with M-Prts containing highly variable B-domains. We further demonstrate that specific GAS clinical isolates display high affinity for the D-domain of hFg, and this interaction allowed for subsequent surface binding of human-host plasminogen (hPg) to the E-domain of hFg. This GAS surface-bound hPg is then activated by GAS-secreted streptokinase, leading to the generation of an invasive proteolytic bacterial surface. Our results underscore the importance of the human fibrinolytic system in host-pathogen interactions in invasive GAS infections.	[Glinton, Kristofor; Beck, Julia; Liang, Zhong; Qiu, Cunjia; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Glinton, Kristofor; Beck, Julia; Qiu, Cunjia; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.; Castellino, FJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Glinton, Kristofor/0000-0001-9301-7132	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013423, R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL013423. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrahari G, 2016, J BIOL CHEM, V291, P9181, DOI 10.1074/jbc.M115.704221; Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Bao YJ, 2016, J BACTERIOL, V198, P1712, DOI 10.1128/JB.01019-15; Bao YJ, 2014, J BACTERIOL, V196, P4089, DOI 10.1128/JB.02131-14; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; BERGE A, 1993, J BIOL CHEM, V268, P25417; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bhattacharya S, 2014, J BIOL CHEM, V289, P21684, DOI 10.1074/jbc.M114.570218; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chandrahas V, 2015, J BIOL CHEM, V290, P18833, DOI 10.1074/jbc.M115.655365; Cole Jason N., 2008, V425, P295, DOI 10.1007/978-1-60327-210-0_24; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Figuera-Losada M, 2010, BBA-PROTEINS PROTEOM, V1804, P1342, DOI 10.1016/j.bbapap.2010.01.019; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Flores AR, 2013, INFECT IMMUN, V81, P4128, DOI 10.1128/IAI.00405-13; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hess JL, 2006, PROTEOMICS, V6, P375, DOI 10.1002/pmic.200500189; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Johnson DR, 2006, J MED MICROBIOL, V55, P157, DOI 10.1099/jmm.0.46224-0; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Lannergard J, 2015, MICROBIOLOGYOPEN, V4, P774, DOI 10.1002/mbo3.278; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Lijnen HR, 2000, FIBRINOLYSIS PROTEOL, V14, P175, DOI 10.1054/fipr.2000.0065; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Pahlman LI, 2008, CELL MICROBIOL, V10, P404, DOI 10.1111/j.1462-5822.2007.01053.x; Pietrocola G, 2016, J BIOL CHEM, V291, P18148, DOI 10.1074/jbc.M116.731125; Port GC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00725-15; Ringdahl U, 2000, METHODS, V21, P143, DOI 10.1006/meth.2000.0985; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; STRICKLAND DK, 1982, BIOCHEMISTRY-US, V21, P721, DOI 10.1021/bi00533a021; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	57	11	13	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6775	6785		10.1074/jbc.M116.768937	http://dx.doi.org/10.1074/jbc.M116.768937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28280245	hybrid, Green Published			2022-12-28	WOS:000399813400028
J	Obeid, S; Wankell, M; Charrez, B; Sternberg, J; Kreuter, R; Esmaili, S; Ramezani-Moghadam, M; Devine, C; Read, S; Bhathal, P; Lopata, A; Ahlensteil, G; Qiao, L; George, J; Hebbard, L				Obeid, Stephanie; Wankell, Miriam; Charrez, Berenice; Sternberg, Jade; Kreuter, Roxane; Esmaili, Saeed; Ramezani-Moghadam, Mehdi; Devine, Carol; Read, Scott; Bhathal, Prithi; Lopata, Andreas; Ahlensteil, Golo; Qiao, Liang; George, Jacob; Hebbard, Lionel			Adiponectin confers protection from acute colitis and restricts a B cell immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; INTESTINAL EPITHELIAL-CELLS; MICE LACKING ADIPONECTIN; INDUCED COLON-CANCER; BODY-MASS INDEX; CROHNS-DISEASE; ULCERATIVE-COLITIS; INSULIN-RESISTANCE; DEFICIENCY ROLE	Adiponectin demonstrates beneficial effects in various metabolic diseases, including diabetes, and in bowel cancer. Recent data also suggest a protective role in colitis. However, the precise molecular mechanisms by which adiponectin and its receptors modulate colitis and the nature of the adaptive immune response in murine models are yet to be elucidated. Adiponectin knock-out mice were orally administered dextran sulfate sodium for 7 days and were compared with wild-type mice. The severity of disease was analyzed histopathologically and through cytokine profiling. HCT116 colonic epithelial cells were employed to analyze the in vitro effects of adiponectin and AdipoR1 interactions in colonic injury following dextran sulfate sodium treatment. Adiponectin knock-out mice receiving dextran sulfate sodium exhibited severe colitis, had greater inflammatory cell infiltration, and an increased presence of activated B cells compared with controls. This was accompanied by an exaggerated proinflammatory cytokine profile and increased STAT3 signaling. Adiponectin knock-out mouse colons had markedly reduced proliferation and increased epithelial apoptosis and cellular stress. In vitro, adiponectin reduced apoptotic, antiproliferative, and stress signals and restored STAT3 signaling. Following the abrogation of AdipoR1 in vitro, these protective effects of adiponectin were abolished. In summary, adiponectin maintains intestinal homeostasis and protects against murine colitis through interactions with its receptor AdipoR1 and by modulating adaptive immunity.	[Obeid, Stephanie; Esmaili, Saeed; Ramezani-Moghadam, Mehdi; Devine, Carol; Read, Scott; Ahlensteil, Golo; Qiao, Liang; George, Jacob; Hebbard, Lionel] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW 2145, Australia; [Obeid, Stephanie; Esmaili, Saeed; Ramezani-Moghadam, Mehdi; Devine, Carol; Read, Scott; Ahlensteil, Golo; Qiao, Liang; George, Jacob; Hebbard, Lionel] Univ Sydney, Sydney, NSW 2145, Australia; [Bhathal, Prithi] Univ Melbourne, Melbourne, Vic 3010, Australia; [Wankell, Miriam; Charrez, Berenice; Sternberg, Jade; Kreuter, Roxane; Lopata, Andreas; Hebbard, Lionel] James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld 4811, Australia; [Hebbard, Lionel] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Melbourne; James Cook University; James Cook University	Hebbard, L (corresponding author), Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW 2145, Australia.; Hebbard, L (corresponding author), Univ Sydney, Sydney, NSW 2145, Australia.; Hebbard, L (corresponding author), James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld 4811, Australia.; Hebbard, L (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia.	lionel.hebbard@jcu.edu.au	Ahlenstiel, Golo/U-1990-2017; Lopata, Andreas L/O-2143-2017; Hebbard, Lionel/O-1489-2017; Read, Scott/K-6462-2019; Hebbard, Lionel/W-4057-2019	Ahlenstiel, Golo/0000-0003-0026-1457; Lopata, Andreas L/0000-0002-2940-9235; Hebbard, Lionel/0000-0002-7094-9065; Read, Scott/0000-0001-6775-2061; Esmaili, Saeed/0000-0002-2843-7277	Robert W. Storr Bequest; National Health and Medical Research Council of Australia (NHMRC) Program [APP1053206]; NHMRC [1047417, 1087297]; Cancer Council NSW Project [1070076, 1069733]; Cancer Council Queensland Project Grant [1123436]; James Cook Development Grant	Robert W. Storr Bequest; National Health and Medical Research Council of Australia (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW Project(Cancer Council New South Wales); Cancer Council Queensland Project Grant(Cancer Council Queensland); James Cook Development Grant	This work was supported by The Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Program Grant APP1053206, NHMRC project Grants 1047417 (to L. Q.) and 1087297 (to J. G. and L. H.), Cancer Council NSW Project Grants 1070076 (to L. Q.) and 1069733 (to L. H.), Cancer Council Queensland Project Grant 1123436 (to L. H., J. G., and L. Q.), and James Cook Development Grant 2016 (to L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Alexander KL, 2014, IMMUNOL REV, V260, P206, DOI 10.1111/imr.12180; Araki Y, 2006, ONCOL REP, V16, P1357; Arsenescu V, 2011, DIGEST DIS SCI, V56, P2818, DOI 10.1007/s10620-011-1692-0; Berkowitz D, 2013, HUM IMMUNOL, V74, P1519, DOI 10.1016/j.humimm.2013.08.285; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Blain A, 2002, CLIN NUTR, V21, P51, DOI 10.1054/clnu.2001.0503; Burisch J, 2015, SCAND J GASTROENTERO, V50, P942, DOI 10.3109/00365521.2015.1014407; Chimen M, 2015, NAT MED, V21, P467, DOI 10.1038/nm.3842; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Cupi ML, 2014, J IMMUNOL, V192, P6083, DOI 10.4049/jimmunol.1302238; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fayad R, 2007, GASTROENTEROLOGY, V132, P601, DOI 10.1053/j.gastro.2006.11.026; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Harpsoe MC, 2014, INT J EPIDEMIOL, V43, P843, DOI 10.1093/ije/dyu045; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Hebbard L, 2014, BEST PRACT RES CL EN, V28, P59, DOI 10.1016/j.beem.2013.11.005; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kaur K, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0079-y; Kawashima R, 2011, GASTROENTEROLOGY, V141, P2119, DOI 10.1053/j.gastro.2011.08.040; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mann ER, 2014, WORLD J GASTROENTERO, V20, P9653, DOI 10.3748/wjg.v20.i29.9653; Mendall MA, 2011, DIGEST DIS SCI, V56, P837, DOI 10.1007/s10620-010-1541-6; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nigro E, 2013, INT J BIOCHEM CELL B, V45, P1145, DOI 10.1016/j.biocel.2013.03.003; Nishihara T, 2006, GASTROENTEROLOGY, V131, P853, DOI 10.1053/j.gastro.2006.06.015; Noronha AM, 2009, J LEUKOCYTE BIOL, V86, P1007, DOI 10.1189/jlb.0309203; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roberts-Thomson IC, 2011, EXPERT REV GASTROENT, V5, P703, DOI [10.1586/egh.11.74, 10.1586/EGH.11.74]; Rush JS, 2001, EUR J IMMUNOL, V31, P1150, DOI 10.1002/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V; Saxena A, 2013, INT J COLORECTAL DIS, V28, P1267, DOI 10.1007/s00384-013-1664-2; Saxena A, 2012, BBA-MOL BASIS DIS, V1822, P527, DOI 10.1016/j.bbadis.2011.12.006; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sideri A, 2015, AM J PHYSIOL-GASTR L, V308, pG591, DOI 10.1152/ajpgi.00269.2014; SNOOK JA, 1989, Q J MED, V72, P835; Song J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.220; Steed H, 2009, OBESITY FACTS, V2, P370, DOI 10.1159/000262276; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Yokota T, 2003, J IMMUNOL, V171, P5091, DOI 10.4049/jimmunol.171.10.5091	54	20	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6569	6582		10.1074/jbc.M115.712646	http://dx.doi.org/10.1074/jbc.M115.712646			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258220	hybrid, Green Published			2022-12-28	WOS:000399813400012
J	Pan, H; Finkel, T				Pan, Haihui; Finkel, Toren			Key proteins and pathways that regulate lifespan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMALL-MOLECULE ACTIVATORS; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; PROMOTE LONGEVITY; SOMATOTROPIC AXIS; AUTOPHAGY GENES; SIRT1; MICE; RAPAMYCIN; KINASE	Here, we review three sets of key proteins and their corresponding downstream pathways that have been linked to extending lifespan and promoting health span in a wide range of organisms. In particular, we review the biology of the sirtuin family of proteins, the insulin/insulin-like growth factor (IGF) signaling (IIS) pathway, and the mechanistic target of rapamycin (mTOR). Using insights derived from simple model organisms, mice, and humans we discuss how these proteins and pathways may potentially alter the rate of aging. We further describe how knowledge of these pathways may lead to the rational design of small molecules that modulate aging and hence alter the propensity for a host of age-related diseases.	[Pan, Haihui; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NIH, Bldg 10 CRC 5-3330,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov			National Institutes of Health Intramural Funds; Leducq Transatlantic Network Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012] Funding Source: NIH RePORTER	National Institutes of Health Intramural Funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Transatlantic Network Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Intramural Funds and a grant from the Leducq Transatlantic Network Consortium (to T.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Altintas O, 2016, BMB REP, V49, P81, DOI 10.5483/BMBRep.2016.49.2.261; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Apelo SIA, 2016, J GERONTOL A-BIOL, V71, P876, DOI 10.1093/gerona/glw064; Bartke A, 2003, NEUROENDOCRINOLOGY, V78, P210, DOI 10.1159/000073704; Bartke A, 2016, GROWTH HORM IGF RES, V27, P41, DOI 10.1016/j.ghir.2016.02.002; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351; Bitto A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025114; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; Conover CA, 2013, EXP GERONTOL, V48, P612, DOI 10.1016/j.exger.2012.06.017; Dang Weiwei, 2014, Drug Discov Today Technol, V12, pe9, DOI 10.1016/j.ddtec.2012.08.003; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; DORMAN JB, 1995, GENETICS, V141, P1399; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Garelick MG, 2013, CELL CYCLE, V12, P2493, DOI 10.4161/cc.25512; Gelino Sara, 2012, J Clin Exp Pathol, VSuppl 4; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; GOTTLIEB S, 1994, GENETICS, V137, P107; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Igarashi M, 2016, CELL, V166, P436, DOI 10.1016/j.cell.2016.05.044; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Mattison JA, 2014, CELL METAB, V20, P183, DOI 10.1016/j.cmet.2014.04.018; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Milman S, 2016, CELL METAB, V23, P980, DOI 10.1016/j.cmet.2016.05.014; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Newman JC, 2016, J GERONTOL A-BIOL, V71, P1424, DOI 10.1093/gerona/glw149; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Roichman A, 2017, J GERONTOL A-BIOL, V72, P603, DOI 10.1093/gerona/glw152; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Svensson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022640; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Tsai S, 2015, J CLIN INVEST, V125, P2952, DOI 10.1172/JCI77361; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	98	124	127	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6452	6460		10.1074/jbc.R116.771915	http://dx.doi.org/10.1074/jbc.R116.771915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28264931	Green Published, hybrid			2022-12-28	WOS:000399813400003
J	Yerabham, ASK; Mas, PJ; Decker, C; Soares, DC; Weiergraber, OH; Nagel-Steger, L; Willbold, D; Hart, DJ; Bradshaw, NJ; Korth, C				Yerabham, Antony S. K.; Mas, Philippe J.; Decker, Christina; Soares, Dinesh C.; Weiergraeber, Oliver H.; Nagel-Steger, Luitgard; Willbold, Dieter; Hart, Darren J.; Bradshaw, Nicholas J.; Korth, Carsten			A structural organization for the Disrupted in Schizophrenia 1 protein, identified by high-throughput screening, reveals distinctly folded regions, which are bisected by mental illness-related mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM SPECTRA; EVOLUTIONARY HISTORY; DISC1; DISEASE; DOMAIN; RISK; TRANSCRIPTION; HOMEOSTASIS; EXPRESSION	Disrupted in Schizophrenia 1 (DISC1) is a scaffolding protein of significant importance for neurodevelopment and a prominent candidate protein in the pathology of major mental illness. DISC1 modulates a number of critical neuronal signaling pathways through protein-protein interactions; however, the mechanism by which this occurs and how DISC1 causes mental illness is unclear, partly because knowledge of the structure of DISC1 is lacking. A lack of homology with known proteins has hindered attempts to define its domain composition. Here, we employed the high-throughput Expression of Soluble Proteins by Random Incremental Truncation (ESPRIT) technique to identify discretely folded regions of human DISC1 via solubility assessment of tens of thousands of fragments of recombinant DISC1. We identified four novel structured regions, named D, I, S, and C, at amino acids 257-383, 539-655, 635-738, and 691-836, respectively. One region (D) is located in a DISC1 section previously predicted to be unstructured. All regions encompass coiled-coil or alpha-helical structures, and three are involved in DISC1 oligomerization. Crucially, three of these domains would be lost or disrupted by a chromosomal translocation event after amino acid 597, which has been strongly linked to major mental illness. Furthermore, we observed that a known illness-related frameshift mutation after amino acid 807 causes the C region to form aberrantly multimeric and aggregated complexes with an unstable secondary structure. This newly revealed domain architecture of DISC1, therefore, provides a powerful framework for understanding the critical role of this protein in a variety of devastating mental illnesses.	[Yerabham, Antony S. K.; Bradshaw, Nicholas J.; Korth, Carsten] Heinrich Heine Univ, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Decker, Christina; Nagel-Steger, Luitgard; Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Mas, Philippe J.] Univ Grenoble Alpes, EMBL, CEA, ISBG CNRS, F-38042 Grenoble, France; [Soares, Dinesh C.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Weiergraeber, Oliver H.; Nagel-Steger, Luitgard; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Hart, Darren J.] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct IBS, F-38044 Grenoble, France	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); University of Edinburgh; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bradshaw, NJ (corresponding author), Univ Rijeka, Dept Biotechnol, Radmile Matejcic 2, Rijeka 51000, Croatia.; Korth, C (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Neuropathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	nicholas.bradshaw@hhu.de; ckorth@hhu.de	Weiergräber, Oliver H./G-8940-2013; Nagel-Steger, Luitgard/H-6415-2013; Bradshaw, Nicholas J./A-5625-2009; Willbold, Dieter/A-6280-2013; Soares, Dinesh/A-4425-2012; Hart, Darren/C-4858-2015	Weiergräber, Oliver H./0000-0002-2410-3691; Nagel-Steger, Luitgard/0000-0001-5232-2149; Bradshaw, Nicholas J./0000-0001-5581-8828; Willbold, Dieter/0000-0002-0065-7366; Yerabham, Antony Sravan Kumar/0000-0003-4194-8386; Soares, Dinesh/0000-0001-7557-0495; Mas, Philippe/0000-0002-8060-0289; Hart, Darren/0000-0002-3502-2002	French Infrastructure for Integrated Structural Biology [ANR-10-INSB-05-02]; Grenoble Alliance for Integrated Structural & Cell Biology within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	French Infrastructure for Integrated Structural Biology; Grenoble Alliance for Integrated Structural & Cell Biology within the Grenoble Partnership for Structural Biology (PSB)	The ESPRIT platform of the Grenoble Instruct Centre (ISBG: UMS 3518 CNRS-CEA-UJF-EMBL) receives financial support from the French Infrastructure for Integrated Structural Biology (ANR-10-INSB-05-02) and the Grenoble Alliance for Integrated Structural & Cell Biology (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Bord L, 2006, NEUROSCI RES, V56, P286, DOI 10.1016/j.neures.2006.07.010; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Durchschlag H., 1986, THERMODYNAMIC DATA B; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghirlando R, 2011, METHODS, V54, P145, DOI 10.1016/j.ymeth.2010.12.005; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Korth C, 2012, PRION, V6, P134, DOI 10.4161/pri.18989; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Narayanan S, 2011, J BIOL CHEM, V286, P44266, DOI 10.1074/jbc.M111.271593; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Puranik S, 2014, PLANT CELL, V26, P3603, DOI 10.1105/tpc.114.127910; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Sanchez-Pulido L, 2011, HUM MOL GENET, V20, pR175, DOI 10.1093/hmg/ddr374; Sawamura N, 2008, MOL PSYCHIATR, V13, P1138, DOI 10.1038/mp.2008.101; Shimizu S, 2008, BIOCHEM BIOPH RES CO, V377, P1051, DOI 10.1016/j.bbrc.2008.10.100; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sukackaite R, 2014, J BIOL CHEM, V289, P13903, DOI 10.1074/jbc.M114.557843; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taylor MS, 2003, GENOMICS, V81, P67, DOI 10.1016/S0888-7543(02)00026-5; Thomson PA, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.24; Trossbach SV, 2016, MOL PSYCHIATR, V21, P1561, DOI 10.1038/mp.2015.194; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yerabham ASK, 2013, BIOL CHEM, V394, P1425, DOI 10.1515/hsz-2013-0178; Yumerefendi H, 2010, J STRUCT BIOL, V172, P66, DOI 10.1016/j.jsb.2010.02.021	40	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6468	6477		10.1074/jbc.M116.773903	http://dx.doi.org/10.1074/jbc.M116.773903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	ES8NI	28249940	Green Published, hybrid			2022-12-28	WOS:000399813400005
J	Baytshtok, V; Chen, JJ; Glynn, SE; Nager, AR; Grant, RA; Baker, TA; Sauer, RT				Baytshtok, Vladimir; Chen, Jiejin; Glynn, Steven E.; Nager, Andrew R.; Grant, Robert A.; Baker, Tania A.; Sauer, Robert T.			Covalently linked HslU hexamers support a probabilistic mechanism that links ATP hydrolysis to protein unfolding and translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; ATPases associated with diverse cellular activities (AAA); crystal structure; protein engineering; protein turnover; AAA plus protease; mixed hexameric rings; protein unfolding; protein degradation; HslUV	ESCHERICHIA-COLI; DEPENDENT PROTEOLYSIS; I-DOMAIN; AAA; CLPXP; CRYSTAL; REVEAL; SUPERFAMILY; DEGRADATION; ACTIVATION	The HslUV proteolytic machine consists of HslV, a double-ring self-compartmentalized peptidase, and one or two AAA+ HslU ring hexamers that hydrolyze ATP to power the unfolding of protein substrates and their translocation into the proteolytic chamber of HslV. Here, we use genetic tethering and disulfide bonding strategies to construct HslU pseudohexamers containing mixtures of ATPase active and inactive subunits at defined positions in the hexameric ring. Genetic tethering impairs HslV binding and degradation, even for pseudohexamers with six active subunits, but disulfide-linked pseudohexamers do not have these defects, indicating that the peptide tether interferes with HslV interactions. Importantly, pseudohexamers containing different patterns of hydrolytically active and inactive subunits retain the ability to unfold protein substrates and/or collaborate with HslV in their degradation, supporting a model in which ATP hydrolysis and linked mechanical function in the HslU ring operate by a probabilistic mechanism.	[Baytshtok, Vladimir; Chen, Jiejin; Glynn, Steven E.; Nager, Andrew R.; Grant, Robert A.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chen, Jiejin] Takeda Pharmaceut, Cambridge, MA 02139 USA; [Glynn, Steven E.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Nager, Andrew R.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Glynn, Steven/0000-0001-6247-8913	National Institutes of Health [AI-16892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI-16892. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Baytshtok V, 2016, STRUCTURE, V24, P1766, DOI 10.1016/j.str.2016.08.012; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Stinson BM, 2015, NAT STRUCT MOL BIOL, V22, P411, DOI 10.1038/nsmb.3012; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Sundar S, 2012, PROTEIN SCI, V21, P188, DOI 10.1002/pro.2001; Sundar S, 2010, J MOL BIOL, V403, P420, DOI 10.1016/j.jmb.2010.09.008; Trame CB, 2001, ACTA CRYSTALLOGR D, V57, P1079, DOI 10.1107/S0907444901007673; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich J. A., 2008, THESIS; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696; Yoo SJ, 1998, J BIOL CHEM, V273, P22929, DOI 10.1074/jbc.273.36.22929	45	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5695	5704		10.1074/jbc.M116.768978	http://dx.doi.org/10.1074/jbc.M116.768978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223361	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000398813200008
J	Thangaraj, MP; Furber, KL; Gan, JK; Ji, SP; Sobchishin, L; Doucette, JR; Nazarali, AJ				Thangaraj, Merlin P.; Furber, Kendra L.; Gan, Jotham K.; Ji, Shaoping; Sobchishin, Larhonda; Doucette, J. Ronald; Nazarali, Adil J.			RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; BASIC-PROTEIN; NERVOUS-SYSTEM; MUTANT MICE; CELL-DIFFERENTIATION; PROTEOLIPID PROTEIN; GENE-EXPRESSION; PRECURSOR CELLS; CNS MYELIN; QKI	Myelination is controlled by timely expression of genes involved in the differentiation of oligodendrocyte precursor cells (OPCs) into myelinating oligodendrocytes (OLs). Sirtuin 2 (SIRT2), a NAD(+)-dependent deacetylase, plays a critical role in OL differentiation by promoting both arborization and downstream expression of myelin-specific genes. However, the mechanisms involved in regulating SIRT2 expression during OL development are largely unknown. The RNA-binding protein quaking (QKI) plays an important role in myelination by post-transcriptionally regulating the expression of several myelin specific genes. In quaking viable (qk(v)/qk(v)) mutant mice, SIRT2 protein is severely reduced; however, it is not known whether these genes interact to regulate OL differentiation. Here, we report for the first time that QKI directly binds to Sirt2 mRNA via a common quaking response element (QRE) located in the 3' untranslated region (UTR) to control SIRT2 expression in OL lineage cells. This interaction is associated with increased stability and longer half-lives of Sirt2.1 and Sirt2.2 transcripts leading to increased accumulation of Sirt2 transcripts. Consistent with this, overexpression of qkI promoted the expression of Sirt2 mRNA and protein. However, overexpression of the nuclear isoform qkI-5 promoted the expression of Sirt2mRNA, but not SIRT2 protein, and delayed OL differentiation. These results suggest that the balance in the subcellular distribution and temporal expression of QKI isoforms control the availability of Sirt2 mRNA for translation. Collectively, our study demonstrates that QKI directly plays a crucial role in the post-transcriptional regulation and expression of Sirt2 to facilitate OL differentiation.	[Thangaraj, Merlin P.; Furber, Kendra L.; Gan, Jotham K.; Ji, Shaoping; Sobchishin, Larhonda; Nazarali, Adil J.] Univ Saskatchewan, Coll Pharm & Nutr, Mol Cell Biol Lab, Saskatoon, SK S7N 5E5, Canada; [Doucette, J. Ronald] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; [Thangaraj, Merlin P.; Furber, Kendra L.; Gan, Jotham K.; Ji, Shaoping; Sobchishin, Larhonda; Doucette, J. Ronald; Nazarali, Adil J.] Univ Saskatchewan, Neurosci Res Cluster, Saskatoon, SK S7N 5E5, Canada; [Doucette, J. Ronald; Nazarali, Adil J.] City Hosp, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK S7K 0M7, Canada; [Ji, Shaoping] Henan Univ, Sch Med, Dept Biochem & Mol Biol, Kaifeng 475004, Peoples R China	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Henan University	Nazarali, AJ (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Mol Cell Biol Lab, Saskatoon, SK S7N 5E5, Canada.; Nazarali, AJ (corresponding author), Univ Saskatchewan, Neurosci Res Cluster, Saskatoon, SK S7N 5E5, Canada.; Nazarali, AJ (corresponding author), City Hosp, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK S7K 0M7, Canada.	aj.nazarali@usask.ca		Thangaraj, Merlin Premalatha/0000-0002-5407-0069	Canadian Institutes of Health Research (CIHR Institute of Aging); Saskatchewan Health Research Foundation (SHRF); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR Institute of Aging)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation (SHRF); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by an operating grant from the Canadian Institutes of Health Research (CIHR Institute of Aging), the Saskatchewan Health Research Foundation (SHRF) (to A.J.N. and J.R.D.) and the Natural Sciences and Engineering Research Council of Canada (NSERC) (to A.J.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Beuck C, 2012, J MOL BIOL, V423, P766, DOI 10.1016/j.jmb.2012.08.027; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Cox RD, 1999, GENOMICS, V57, P333, DOI 10.1006/geno.1999.5804; Doucette JR, 2010, CELL MOL NEUROBIOL, V30, P607, DOI 10.1007/s10571-009-9486-z; Doukhanine E, 2010, MOL BIOL CELL, V21, P3029, DOI 10.1091/mbc.E10-04-0305; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Emery B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020461; FOKSEANG J, 1994, J NEUROSCI RES, V37, P219, DOI 10.1002/jnr.490370208; FUJITA N, 1988, FEBS LETT, V232, P323, DOI 10.1016/0014-5793(88)80762-2; FUJITA N, 1990, J NEUROCHEM, V55, P1056, DOI 10.1111/j.1471-4159.1990.tb04596.x; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Kondo T, 1999, MAMM GENOME, V10, P662; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Li ZZ, 2000, J NEUROSCI, V20, P4944; LOUIS JC, 1992, GLIA, V6, P30, DOI 10.1002/glia.440060105; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Lu ZF, 2003, NUCLEIC ACIDS RES, V31, P4616, DOI 10.1093/nar/gkg635; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Niu JQ, 2012, J NEUROSCI METH, V209, P241, DOI 10.1016/j.jneumeth.2012.05.032; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; ROTH HJ, 1985, J NEUROCHEM, V45, P572, DOI 10.1111/j.1471-4159.1985.tb04025.x; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SORG BJA, 1986, J NEUROCHEM, V46, P379, DOI 10.1111/j.1471-4159.1986.tb12979.x; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Wang M, 2011, CELL MOL NEUROBIOL, V31, P875, DOI 10.1007/s10571-011-9685-2; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248	55	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5166	5182		10.1074/jbc.M117.775544	http://dx.doi.org/10.1074/jbc.M117.775544			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188285	hybrid, Green Published			2022-12-28	WOS:000397875500002
J	Lonhienne, T; Garcia, MD; Guddat, LW				Lonhienne, Thierry; Garcia, Mario D.; Guddat, Luke W.			The Role of a FAD Cofactor in the Regulation of Acetohydroxyacid Synthase by Redox Signaling Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETOLACTATE SYNTHASE; ACID SYNTHASE; PURIFICATION	Acetohydroxyacid synthase (AHAS) catalyzes the first step of branched-chain amino acid (BCAA) biosynthesis, a pathway essential to the lifecycle of plants and microorganisms. This enzyme is of high interest because its inhibition is at the base of the exceptional potency of herbicides and potentially a target for the discovery of new antimicrobial drugs. The enzyme has conserved attributes from its predicted ancestor, pyruvate oxidase, such as a ubiquinone-binding site and the requirement for FAD as cofactor. Here, we show that these requirements are linked to the regulation of AHAS, in relationship to its anabolic function. Using various soluble quinone derivatives (e.g. ubiquinones), we reveal a new path of down- regulation of AHAS activity involving inhibition by oxidized redox-signaling molecules. The inhibition process relies on two factors specific to AHAS: (i) the requirement of a reduced FAD cofactor for the enzyme to be active and (ii) a characteristic slow rate of FAD reduction by the pyruvate oxidase side reaction of the enzyme. The mechanism of inhibition involves the oxidation of the FAD cofactor, leading to a time-dependent inhibition of AHAS correlated with the slow process of FAD re-reduction. The existence and conservation of such a complex mechanism suggests that the redox level of the environment regulates the BCAA biosynthesis pathway. This mode of regulation appears to be the foundation of the inhibitory activity of many of the commercial herbicides that target AHAS.	[Lonhienne, Thierry; Garcia, Mario D.; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Lonhienne, T (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.; Guddat, LW (corresponding author), Univ Queensland, Dept Biosci, Sch Chem & Mol Biol, Bldg 76,Cooper Rd, St Lucia, Qld 4072, Australia.	t.lonhienne@uq.edu.au; luke.guddat@uq.edu.au	Guddat, Luke/AAI-2930-2021	Garcia, Mario/0000-0001-8378-7475	National Health and Medical Research Council [1008736]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by Grant 1008736 from the National Health and Medical Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hwang J, 2003, B KOREAN CHEM SOC, V24, P1856; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lonhienne T, 2016, ANGEW CHEM INT EDIT, V55, P4247, DOI 10.1002/anie.201511985; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pang SS, 1999, BIOCHEMISTRY-US, V38, P5222, DOI 10.1021/bi983013m; Pang SS, 2001, BIOCHEM J, V357, P749, DOI 10.1042/0264-6021:3570749; Pang SS, 2001, ACTA CRYSTALLOGR D, V57, P1321, DOI 10.1107/S0907444901011635; Schloss J. V., 1991, CHEM BIOCH FLAVOENZY, VIII, P531; SCHLOSS JV, 1985, BIOCHEMISTRY-US, V24, P4952, DOI 10.1021/bi00339a034; SCHLOSS JV, 1988, NATURE, V331, P360, DOI 10.1038/331360a0; SINGH BK, 1988, ANAL BIOCHEM, V171, P173, DOI 10.1016/0003-2697(88)90139-X; Tittmann K, 2004, BIOCHEMISTRY-US, V43, P8652, DOI 10.1021/bi049897t	16	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5101	5109		10.1074/jbc.M116.773242	http://dx.doi.org/10.1074/jbc.M116.773242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159840	Green Published, hybrid			2022-12-28	WOS:000397590400029
J	O'Hara, SP; Splinter, PL; Trussoni, CE; Pisarello, MJL; Loarca, L; Splinter, NS; Schutte, BF; LaRusso, NF				O'Hara, Steven P.; Splinter, Patrick L.; Trussoni, Christy E.; Pisarello, Maria J. Lorenzo; Loarca, Lorena; Splinter, Noah S.; Schutte, Bryce F.; LaRusso, Nicholas F.			ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence- associated Protein Cyclin-dependent Kinase Inhibitor 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SCLEROSING CHOLANGITIS; ONCOGENE-INDUCED SENESCENCE; BILIARY EPITHELIAL-CELLS; CELLULAR SENESCENCE; GENOME BROWSER; LIPOPOLYSACCHARIDE; INACTIVATION; EXPRESSION; UPDATE; CANCER	Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory cholangiopathy (disease of the bile ducts) of unknown pathogenesis. We reported that cholangiocyte senescence features prominently in PSC and that neuroblastoma RAS viral oncogene homolog (NRAS) is activated in PSC cholangiocytes. Additionally, persistent microbial insult (e.g. LPSs) induces cyclin-dependent kinase inhibitor 2A (CDKN2A/ p16(INK4a)) expression and senescence in cultured cholangiocytes in an NRAS-dependent manner. However, the molecular mechanisms involved in LPS-induced cholangiocyte senescence and NRAS-dependent regulation of CDKN2A remain unclear. Using our in vitro senescence model, we found that LPSinduced CDKN2A expression coincided with a 4.5-fold increase in ETS1 (ETS proto-oncogene 1) mRNA, suggesting that ETS1 is involved in regulating CDKN2A. This idea was confirmed by RNAi-mediated suppression or genetic deletion of ETS1, which blocked CDKN2A expression and reduced cholangiocyte senescence. Furthermore, site-directed mutagenesis of a predicted ETS-binding site within the CDKN2A promoter abolished luciferase reporter activity. Pharmacological inhibition of RAS/ MAPK reduced ETS1 and CDKN2A protein expression and CDKN2A promoter-driven luciferase activity by similar to 50%. In contrast, constitutively active NRAS expression induced ETS1 and CDKN2A protein expression, whereas ETS1 RNAi blocked this increase. Chromatin immunoprecipitation-PCR detected increased ETS1 and histone 3 lysine 4 trimethylation (H3K4Me3) at the CDKN2A promoter following LPS-induced senescence. Additionally, phospho-ETS1 expression was increased in cholangiocytes of human PSC livers and in the Abcb4 (Mdr2)(-/-) mouse model of PSC. These data pinpoint ETS1 and H3K4Me3 as key transcriptional regulators in NRAS-induced expression of CDKN2A, and this regulatory axis may therefore represent a potential therapeutic target for PSC treatment.	Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	LaRusso, NF (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	larusso.nicholas@mayo.edu		Trussoni, Christy/0000-0002-4247-076X; LORENZO PISARELLO, MARIA JOSE/0000-0001-6639-2965	National Institutes of Health [AI089713, DK057993]; Mayo Foundation, Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK057993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation, Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology; Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AI089713 (to S. P. O.), DK057993 (to N. F. L), the Mayo Foundation, Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567, and the Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment Fund in Primary Sclerosing Cholangitis. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahrendt SA, 1999, J SURG RES, V84, P88, DOI 10.1006/jsre.1999.5615; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bangarulingam SY, 2010, HEPATOLOGY, V51, P174, DOI 10.1002/hep.23277; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Burton DGA, 2009, AGE, V31, P1, DOI 10.1007/s11357-008-9075-y; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cho MC, 2008, BIOCHEM BIOPH RES CO, V377, P832, DOI 10.1016/j.bbrc.2008.10.053; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Esteller M, 2001, CANCER RES, V61, P3225; FARRANT JM, 1991, GASTROENTEROLOGY, V100, P1710, DOI 10.1016/0016-5085(91)90673-9; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hollenhorst Peter C, 2012, Small GTPases, V3, P154, DOI 10.4161/sgtp.19630; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Mao Zhiyong, 2012, Aging (Albany NY), V4, P431; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Plotnik JP, 2014, NUCLEIC ACIDS RES, V42, P11928, DOI 10.1093/nar/gku929; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Sasatomi K, 1998, J HEPATOL, V29, P409, DOI 10.1016/S0168-8278(98)80058-5; Shin J, 2013, CANC LETT, V1, P1; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; Tabibian James H, 2012, J Anal Oncol, V1, P50, DOI 10.6000/1927-7229.2012.01.01.7; Tabibian JH, 2013, EXPERT REV GASTROENT, V7, P103, DOI [10.1586/egh.12.80, 10.1586/EGH.12.80]; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Trussoni CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125793; Weismueller TJ, 2008, J HEPATOL, V48, pS38, DOI 10.1016/j.jhep.2008.01.020; Wu PK, 2015, FEBS J, V282, P1017, DOI 10.1111/febs.13197; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	45	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4833	4846		10.1074/jbc.M117.777409	http://dx.doi.org/10.1074/jbc.M117.777409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28184004	Green Published, hybrid			2022-12-28	WOS:000397590400008
J	Palma, A; Tinti, M; Paoluzi, S; Santonico, E; Brandt, BW; van Huijsduijnen, RH; Masch, A; Heringa, J; Schutkowski, M; Castagnoli, L; Cesareni, G				Palma, Anita; Tinti, Michele; Paoluzi, Serena; Santonico, Elena; Brandt, Bernd Willem; van Huijsduijnen, Rob Hooft; Masch, Antonia; Heringa, Jaap; Schutkowski, Mike; Castagnoli, Luisa; Cesareni, Gianni			Both Intrinsic Substrate Preference and Network Context Contribute to Substrate Selection of Classical Tyrosine Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; SEQUENCE ALIGNMENTS; TRAPPING MUTANTS; RPTP-ALPHA; SH2 DOMAIN; PTP-PEST; IN-VIVO; PROTEIN; SPECIFICITY; PHOSPHORYLATION	Reversible tyrosine phosphorylation is a widespread post-translational modification mechanism underlying cell physiology. Thus, understanding the mechanisms responsible for substrate selection by kinases and phosphatases is central to our ability to model signal transduction at a system level. Classical protein- tyrosine phosphatases can exhibit substrate specificity in vivo by combining intrinsic enzymatic specificity with the network of protein-protein interactions, which positions the enzymes in close proximity to their substrates. Here we use a high throughput approach, based on high density phosphopep-tide chips, to determine the in vitro substrate preference of 16 members of the protein-tyrosine phosphatase family. This approach helped identify one residue in the substrate binding pocket of the phosphatase domain that confers specificity for phosphopeptides in a specific sequence context. We also present a Bayesian model that combines intrinsic enzymatic specificity and interaction information in the context of the human protein interaction network to infer new phosphatase substrates at the proteome level.	[Palma, Anita; Tinti, Michele; Paoluzi, Serena; Santonico, Elena; Castagnoli, Luisa; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, Via Ric Scientifica, I-00133 Rome, Italy; [Masch, Antonia; Schutkowski, Mike] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Germany; [Brandt, Bernd Willem; Heringa, Jaap] Vrije Univ, Ctr Integrat Bioinformat, NL-1081 HV Amsterdam, Netherlands; [van Huijsduijnen, Rob Hooft] Merck Serono Int, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [van Huijsduijnen, Rob Hooft] Hooft Pharma Serv Sarl, Chemin Lechaire 27, CH-1233 Bernex, Switzerland	University of Rome Tor Vergata; Martin Luther University Halle Wittenberg; Vrije Universiteit Amsterdam; Merck KGaA; EMD Serono Inc.	Cesareni, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Scientifica, I-00133 Rome, Italy.	cesareni@uniroma2.it	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009; Santonico, Elena/ABB-8919-2020; Cesareni, Gianni/AAW-1382-2020; Palma, Anita/K-7656-2016	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Santonico, Elena/0000-0002-3897-8990; Brandt, Bernd/0000-0002-1155-1989; Palma, Anita/0000-0002-5971-3676; Tinti, Michele/0000-0002-0051-017X; Castagnoli, Luisa/0000-0001-5283-8671; Schutkowski, MIke/0000-0003-0919-7076	DEPTH project of the European Research Council [322749]; Italian Association for Cancer Research [14135]; Telethon Grant [GGP09243]	DEPTH project of the European Research Council; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon Grant(Fondazione Telethon)	This work was supported by the DEPTH project of the European Research Council under Grant Agreement 322749, by Italian Association for Cancer Research Grant IG 2013 N. 14135, and by Telethon Grant GGP09243 (to G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barker WC, 2001, NUCLEIC ACIDS RES, V29, P29, DOI 10.1093/nar/29.1.29; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Brandt BW, 2010, NUCLEIC ACIDS RES, V38, pW35, DOI 10.1093/nar/gkq415; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Carducci M, 2012, BIOTECHNOL ADV, V30, P4, DOI 10.1016/j.biotechadv.2011.06.012; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Critton DA, 2008, BIOCHEMISTRY-US, V47, P13336, DOI 10.1021/bi801724n; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Feenstra KA, 2007, NUCLEIC ACIDS RES, V35, pW495, DOI 10.1093/nar/gkm406; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fundel K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-372; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; He Z, 2013, P NATL ACAD SCI USA, V110, pE79, DOI 10.1073/pnas.1213000110; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kohn M, 2007, ANGEW CHEM INT EDIT, V46, P7700, DOI 10.1002/anie.200701601; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Liberti S, 2013, FEBS J, V280, P379, DOI 10.1111/j.1742-4658.2012.08712.x; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; RUZZENE M, 1993, EUR J BIOCHEM, V211, P289, DOI 10.1111/j.1432-1033.1993.tb19897.x; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Sun HY, 2009, CHEM COMMUN, P677, DOI 10.1039/b817853d; Taddei ML, 2000, BIOCHEM BIOPH RES CO, V270, P564, DOI 10.1006/bbrc.2000.2456; Thiele A, 2009, METHODS MOL BIOL, V570, P19, DOI 10.1007/978-1-60327-394-7_2; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Tomizaki K, 2010, FEBS J, V277, P1996, DOI 10.1111/j.1742-4658.2010.07626.x; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Wavreille AS, 2007, METHODS, V42, P207, DOI 10.1016/j.ymeth.2007.02.010; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Ye K, 2008, BIOINFORMATICS, V24, P18, DOI 10.1093/bioinformatics/btm537; Zhao BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134984	58	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4942	4952		10.1074/jbc.M116.757518	http://dx.doi.org/10.1074/jbc.M116.757518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159843	Green Published, hybrid			2022-12-28	WOS:000397590400016
J	Song, H; Lin, CW; Yao, E; Zhang, KA; Li, XL; Wu, QZ; Chuang, PT				Song, Hai; Lin, Chuwen; Yao, Erica; Zhang, Kuan; Li, Xiaoling; Wu, Qingzhe; Chuang, Pao-Tien			Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; gene knock-out; genomics; mouse genetics; tumor suppressor gene; CGRP; calcitonin; medullary thyroid carcinoma; parafollicular C cells	RET PROTOONCOGENE; TARGETED THERAPIES; MOLECULAR PATHOGENESIS; CANCER; INACTIVATION; MUTATIONS; RB; EXPRESSION; MANAGEMENT; PATHWAY	Among the four different types of thyroid cancer, treatment of medullary thyroid carcinoma poses a major challenge because of its propensity of early metastasis. To further investigate the molecular mechanisms of medullary thyroid carcinoma and discover candidates for targeted therapies, we developed a new mouse model of medullary thyroid carcinoma based on our CGRP(CreER) mouse line. This system enables gene manipulation in parafollicular C cells in the thyroid, the purported cells of origin of medullary thyroid carcinoma. Selective inactivation of tumor suppressors, such as p53, Rb, and Pten, in mature parafollicular C cells via an inducible Cre recombinase from CGRP(CreER) led to development of murine medullary thyroid carcinoma. Loss of Pten accelerated p53/Rb-induced medullary thyroid carcinoma, indicating interactions between pathways controlled by tumor suppressors. Moreover, labeling differentiated parafollicular C cells by CGRP(CreER) allows us to follow their fate during malignant transformation to medullary thyroid tumor. Our findings support a model in which mutational events in differentiated parafollicular C cells result in medullary thyroid carcinoma. Through expression analysis including RNA-Seq, we uncovered major signaling pathways and networks that are perturbed following the removal of tumor suppressors. Taken together, these studies not only increase our molecular understanding of medullary thyroid carcinoma but also offer new candidates for designing targeted therapies or other treatment modalities.	[Song, Hai; Li, Xiaoling; Wu, Qingzhe] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Song, Hai; Li, Xiaoling; Wu, Qingzhe] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Song, Hai; Lin, Chuwen; Yao, Erica; Zhang, Kuan; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S, San Francisco, CA 94158 USA	Zhejiang University; Zhejiang University; University of California System; University of California San Francisco	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S, San Francisco, CA 94158 USA.	pao-tien.chuang@ucsf.edu	Lin, Chuwen/I-3287-2018	Zhang, Kuan/0000-0002-9723-1328; Li, Xiaoling/0000-0002-1554-1569	National Natural Science Foundation of China [31471368]; Zhejiang Provincial Natural Science Foundation of China [LR16C120001]; National Institutes of Health [U01 HL111054, R01 HL115207]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111054, R01HL115207] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China Grant 31471368 and Zhejiang Provincial Natural Science Foundation of China Grant LR16C120001 (to H. S.) and National Institutes of Health Grants U01 HL111054 and R01 HL115207 (to P.-T.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akeno N, 2015, ONCOGENE, V34, P589, DOI 10.1038/onc.2013.589; Almeida MQ, 2012, CURR OPIN ONCOL, V24, P229, DOI 10.1097/CCO.0b013e328351c71a; Arciuch VGA, 2011, ONCOTARGET, V2, P1109, DOI 10.18632/oncotarget.380; Bikas A, 2016, EXPERT REV CLIN PHAR, V9, P1299, DOI 10.1080/17512433.2016.1204230; Cabanillas ME, 2016, LANCET, V388, P2783, DOI 10.1016/S0140-6736(16)30172-6; Cerrato A, 2009, J MOL ENDOCRINOL, V43, P143, DOI 10.1677/JME-09-0024; Champa D, 2015, HORM CANCER-US, V6, P37, DOI 10.1007/s12672-014-0208-8; Coxon AB, 1998, ONCOGENE, V17, P1625, DOI 10.1038/sj.onc.1202381; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Elisei R, 2007, J CLIN ENDOCR METAB, V92, P4725, DOI 10.1210/jc.2007-1005; Ernani V, 2016, CANCER TREAT REV, V50, P89, DOI 10.1016/j.ctrv.2016.09.006; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gujral TS, 2008, CANCER RES, V68, P1338, DOI 10.1158/0008-5472.CAN-07-6052; HARVEY M, 1995, CANCER RES, V55, P1146; Jaskula-Sztul R, 2011, J SURG RES, V171, P23, DOI 10.1016/j.jss.2011.03.035; Joyner AL, 2000, GENE TARGETING PRACT; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Krampitz GW, 2014, CANCER-AM CANCER SOC, V120, P1920, DOI 10.1002/cncr.28661; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Maliszewska A, 2013, AM J PATHOL, V182, P350, DOI 10.1016/j.ajpath.2012.10.025; Marino S, 2000, GENE DEV, V14, P994; Matias-Guiu X, 2014, ENDOCR PATHOL, V25, P21, DOI 10.1007/s12022-013-9287-2; Maxwell JE, 2014, CANCER-AM CANCER SOC, V120, P3287, DOI 10.1002/cncr.28858; Michiels FM, 1997, P NATL ACAD SCI USA, V94, P3330, DOI 10.1073/pnas.94.7.3330; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy A., 2003, MANIPULATING MOUSE E; Nikiforov YE, 2016, NAT REV ENDOCRINOL, V12, P67, DOI 10.1038/nrendo.2015.217; Nilsson M, 2016, EUR THYROID J, V5, P79, DOI 10.1159/000447333; Pozo K, 2016, TRENDS CANCER, V2, P606, DOI 10.1016/j.trecan.2016.09.001; Pozo K, 2013, CANCER CELL, V24, P499, DOI 10.1016/j.ccr.2013.08.027; Robbins HL, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00188; Romei C, 2016, NAT REV ENDOCRINOL, V12, P192, DOI 10.1038/nrendo.2016.11; Russo A, 2015, ONCOTARGET, V6, P26814, DOI 10.18632/oncotarget.4254; Sastre-Perona Ana, 2012, Front Endocrinol (Lausanne), V3, P31, DOI 10.3389/fendo.2012.00031; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spitzweg C, 2016, ENDOCR-RELAT CANCER, V23, pR287, DOI 10.1530/ERC-16-0104; Viola D, 2016, ENDOCR-RELAT CANCER, V23, pR185, DOI 10.1530/ERC-15-0555; Vitale G, 2017, ENDOCR-RELAT CANCER, V24, pR1, DOI 10.1530/ERC-16-0399; Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Yu XM, 2013, CANCER-AM CANCER SOC, V119, P774, DOI 10.1002/cncr.27742	45	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3888	3899		10.1074/jbc.M116.765727	http://dx.doi.org/10.1074/jbc.M116.765727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28119454	hybrid, Green Published			2022-12-28	WOS:000395542500029
J	Bruggisser, J; Kaser, S; Mani, J; Schneider, A				Bruggisser, Julia; Kaser, Sandro; Mani, Jan; Schneider, Andre			Biogenesis of a Mitochondrial Outer Membrane Protein in Trypanosoma brucei: TARGETING SIGNAL AND DEPENDENCE ON A UNIQUE BIOGENESIS FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						evolution; membrane biogenesis; mitochondrial transport; outer membrane; Trypanosoma brucei	BETA-BARREL PROTEINS; TOM COMPLEX; INTRACELLULAR MEMBRANES; PREPROTEIN TRANSLOCASE; ENDOPLASMIC-RETICULUM; ANCHORED PROTEINS; BACTERIAL ORIGIN; IMPORT PATHWAYS; MIM1; EVOLUTION	The mitochondrial outer membrane (OM) contains single and multiple membrane-spanning proteins that need to contain signals that ensure correct targeting and insertion into the OM. The biogenesis of such proteins has so far essentially only been studied in yeast and related organisms. Here we show that POMP10, an OM protein of the early diverging protozoan Trypanosoma brucei, is signal-anchored. Transgenic cells expressing variants of POMP10 fused to GFP demonstrate that the N-terminal membrane-spanning domain flanked by a few positively charged or neutral residues is both necessary and sufficient for mitochondrial targeting. Carbonate extraction experiments indicate that although the presence of neutral instead of positively charged residues did not interfere with POMP10 localization, it weakened its interaction with the OM. Expression of GFP-tagged POMP10 in inducible RNAi cell lines shows that its mitochondrial localization depends on pATOM36 but does not require Sam50 or ATOM40, the trypanosomal analogue of the Tom40 import pore. pATOM36 is a kinetoplastid-specific OM protein that has previously been implicated in the assembly of OM proteins and in mitochondrial DNA inheritance. In summary, our results show that although the features of the targeting signal in signal-anchored proteins are widely conserved, the protein machinery that mediates their biogenesis is not.	[Bruggisser, Julia; Kaser, Sandro; Mani, Jan; Schneider, Andre] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland	University of Bern	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@dcb.unibe.ch		Kaser, Sandro/0000-0002-2775-9469; Schneider, Andre/0000-0001-5421-0909	Swiss National Science Foundation [138355]; National Center of Competence in Research (NCCR) "RNA Disease"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) "RNA Disease"(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 138355 (to A. S.) and in part by the National Center of Competence in Research (NCCR) "RNA & Disease." The authors declare that they have no conflicts of interest with the contents of this article.	Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dimmer KS, 2012, J CELL SCI, V125, P3464, DOI 10.1242/jcs.103804; Dimmer KS, 2010, EUR J CELL BIOL, V89, P212, DOI 10.1016/j.ejcb.2009.11.002; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118; Hauser R, 1996, J CELL SCI, V109, P517; He D, 2014, CURR BIOL, V24, P465, DOI 10.1016/j.cub.2014.01.036; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Jores T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12036; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaser S, 2016, P NATL ACAD SCI USA, V113, pE4467, DOI 10.1073/pnas.1605497113; Lee J, 2011, PLANT CELL, V23, P1588, DOI 10.1105/tpc.110.082230; Lithgow T, 2010, PHILOS T R SOC B, V365, P799, DOI 10.1098/rstb.2009.0167; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Mani J, 2016, MOL BIOL EVOL, V33, P337, DOI 10.1093/molbev/msv219; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Pusnik M, 2012, MOL BIOL CELL, V23, P3420, DOI 10.1091/mbc.E12-02-0107; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15; Schmitt S, 2006, PROTEOMICS, V6, P72, DOI 10.1002/pmic.200402084; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schneider Andre, 2007, Methods Mol Biol, V372, P379, DOI 10.1007/978-1-59745-365-3_27; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Sharma S, 2010, MOL BIOCHEM PARASIT, V174, P89, DOI 10.1016/j.molbiopara.2010.07.003; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008; Suzuki H, 2002, J CELL SCI, V115, P1895; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; Vogtle FN, 2015, J CELL BIOL, V210, P951, DOI 10.1083/jcb.201506085; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740	52	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3400	3410		10.1074/jbc.M116.755983	http://dx.doi.org/10.1074/jbc.M116.755983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28100781	Green Published, hybrid			2022-12-28	WOS:000395538800029
J	Iskander, K; Li, J; Han, SH; Zheng, B; Jaiswal, AK				Iskander, Karim; Li, Jessica; Han, Shuhua; Zheng, Biao; Jaiswal, Anil K.			NQO1 and NQO2 regulation of humoral immunity and autoimmunity (vol 281, pg 30921, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														, Biao/0000-0002-0216-1022				Iskander K, 2017, J BIOL CHEM, V292, P2053, DOI 10.1074/jbc.A117.605809	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2053	2053		10.1074/jbc.A117.605809	http://dx.doi.org/10.1074/jbc.A117.605809			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159766	Green Published, hybrid			2022-12-28	WOS:000395515600048
J	Wen, J; Zeng, YW; Fang, ZQ; Gu, JJ; Ge, LX; Tang, F; Qu, ZP; Hu, J; Cui, YR; Zhang, KS; Wang, JB; Li, SG; Sun, Y; Jin, Y				Wen, Jing; Zeng, Yanwu; Fang, Zhuoqing; Gu, Junjie; Ge, Laixiang; Tang, Fan; Qu, Zepeng; Hu, Jing; Cui, Yaru; Zhang, Kushan; Wang, Junbang; Li, Siguang; Sun, Yi; Jin, Ying			Single-cell analysis reveals lineage segregation in early post-implantation mouse embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TRANSCRIPTION FACTOR; FATE DECISIONS; EXPRESSION ANALYSIS; PROGENITOR CELLS; BETA-CATENIN; PLURIPOTENCY; GASTRULATION; ENDODERM; AXIS	The mammalian post-implantation embryo has been extensively investigated at the tissue level. However, to unravel the molecular basis for the cell-fate plasticity and determination, it is essential to study the characteristics of individual cells. In particular, the individual definitive endoderm (DE) cells have not been characterized in vivo. Here, we report gene expression patterns in single cells freshly isolated from mouse embryos on days 5.5 and 6.5. Initial transcriptome data from 124 single cells yielded signature genes for the epiblast, visceral endoderm, and extra-embryonic ectoderm and revealed a unique distribution pattern of fibroblast growth factor (FGF) ligands and receptors. Further analysis indicated that early-stage epiblast cells do not segregate into lineages of the major germ layers. Instead, some cells began to diverge from epiblast cells, displaying molecular features of the premesendoderm by expressing higher levels of mesendoderm markers and lower levels of Sox3 transcripts. Analysis of single-cell high-throughput quantitative RT-PCR data from 441 cells identified a late stage of the day 6.5 embryo in which mesoderm and DE cells emerge, with many of them coexpressing Oct4 and Gata6. Analysis of single-cell RNA-sequence data from 112 cells of the late-stage day 6.5 embryos revealed differentially expressed signaling genes and networks of transcription factors that might underlie the segregation of the mesoderm and DE lineages. Moreover, we discovered a subpopulation of mesoderm cells that possess molecular features of the extraembryonic mesoderm. This study provides fundamental insight into the molecular basis for lineage segregation in post-implantation mouse embryos.	[Wen, Jing; Fang, Zhuoqing; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med,Shanghai Inst Biol Sci, Chinese Acad Sci,Key Lab Stem Cell Biol, CAS Ctr Excellence Mol Cell Sci,Inst Hlth Sci, Shanghai 200031, Peoples R China; [Zeng, Yanwu; Gu, Junjie; Ge, Laixiang; Tang, Fan; Qu, Zepeng; Hu, Jing; Jin, Ying] Shanghai Jiao Tong Univ, Dept Mol Dev Biol, Sch Med, Shanghai 200025, Peoples R China; [Cui, Yaru; Zhang, Kushan; Wang, Junbang; Li, Siguang; Sun, Yi] Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Jin, Y (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yjin@sibs.ac.cn	Qu, Zepeng/GYJ-3779-2022; Fang, Zhuoqing/AGF-7360-2022	Fang, Zhuoqing/0000-0002-7418-1313	Ministry of Science and Technology of China [2016YFA0100101, 2013CB966801, 2013CB967101]; Chinese Academy of Science [XDB19020103, XDA01010102]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0100101, 2013CB966801, and 2013CB967101 and Chinese Academy of Science Grants XDB19020103 and XDA01010102. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barnes RM, 2011, CIRC RES, V108, P940, DOI 10.1161/CIRCRESAHA.110.233171; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Fiorenzano A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12589; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Goncalves L, 2011, INT J DEV BIOL, V55, P281, DOI 10.1387/ijdb.103273lg; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Jin JZ, 2013, DEV BIOL, V381, P170, DOI 10.1016/j.ydbio.2013.05.029; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Kopper O, 2010, STEM CELLS, V28, P75, DOI 10.1002/stem.260; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lawson KA, 1999, INT J DEV BIOL, V43, P773; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Moody S. A., 2014, PRINCIPLES DEV GENET, P245; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nowotschin S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-15; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Posfai E, 2014, CURR TOP DEV BIOL, V107, P1, DOI 10.1016/B978-0-12-416022-4.00001-9; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Robertson EJ, 2003, PHILOS T R SOC B, V358, P1351, DOI 10.1098/rstb.2003.1332; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tsakiridis A, 2015, DEVELOPMENT, V142, P809, DOI 10.1242/dev.122093; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Wallingford MC, 2013, DEV DYNAM, V242, P1110, DOI 10.1002/dvdy.23991; Weidgang CE, 2013, STEM CELL REP, V1, P248, DOI 10.1016/j.stemcr.2013.08.002; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196; Zhou CL, 2016, CELL RES, V26, P171, DOI 10.1038/cr.2016.15; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	70	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9840	9854		10.1074/jbc.M117.780585	http://dx.doi.org/10.1074/jbc.M117.780585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28298438	hybrid, Green Published			2022-12-28	WOS:000403113000031
J	Rothert, M; Ronfeldt, D; Beitz, E				Rothert, Monja; Roenfeldt, Deike; Beitz, Eric			Electrostatic attraction of weak monoacid anions increases probability for protonation and passage through aquaporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL SOLUTE CHANNEL; WATER CHANNEL; MOLECULAR CHARACTERIZATION; GLYCEROL; CELLS; UREA; PERMEABILITY; TRANSPORTER; SELECTIVITY; EXPRESSION	A positive electrostatic field emanating from the center of the aquaporin (AQP) water and solute channel is responsible for the repulsion of cations. At the same time, however, a positive field will attract anions. In this regard, L-lactate/lactic acid permeability has been shown for various isoforms of the otherwise highly water and neutral substrate selective AQP family. The structural requirements rendering certain AQPs permeable for weak monoacids and the mechanism of conduction have remained unclear. Here, we show by profiling pH-dependent substrate permeability, measurements of media alkalization, and proton decoupling that AQP9 acts as a channel for the protonated, neutral monocarboxylic acid species. Intriguingly, the obtained permeability rates indicate an up to 10 times higher probability of passage via AQP9 than given by the fraction of the protonated acid substrate at a certain pH. We generated AQP9 point mutants showing that this effect is independent from properties of the channel interior but caused by the protein surface electrostatics. Monocarboxylic acid-conducting AQPs thus employ a mechanism similar to the family of formate-nitrite transporters for weak monoacids. On a more general basis, our data illustrate semiquantitatively the contribution of surface electrostatics to the interaction of charged molecule substrates or ligands with target proteins, such as channels, transporters, enzymes, or receptors.	[Rothert, Monja; Roenfeldt, Deike; Beitz, Eric] Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany; [Roenfeldt, Deike] Univ Hamburg, Dept Biochem & Mol Biol, D-20148 Hamburg, Germany	University of Kiel; University of Hamburg	Beitz, E (corresponding author), Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Henke and A. Fuchs for technical assistance, as well as M. Casal for providing the jen1 Delta ady2 Delta yeast strain. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (which is supported by NIGMS P41-GM103311).	Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bienert GP, 2013, BIOCHEM J, V454, P559, DOI 10.1042/BJ20130388; Calamita G, 2012, BIOL CELL, V104, P342, DOI 10.1111/boc.201100061; Choi WG, 2007, J BIOL CHEM, V282, P24209, DOI 10.1074/jbc.M700982200; Czodrowski P, 2006, PROTEINS, V65, P424, DOI 10.1002/prot.21110; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306; Faghiri Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010451; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gena P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078139; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Jelen S, 2012, AM J PHYSIOL-GASTR L, V303, pG1279, DOI 10.1152/ajpgi.00153.2012; Kirscht A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002411; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Liu K, 2005, P NATL ACAD SCI USA, V102, P2192, DOI 10.1073/pnas.0409232102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NARAYSZABO G, 1989, J MOL GRAPHICS, V7, P76, DOI 10.1016/S0263-7855(89)80003-7; Osaka H, 1998, J BIOL CHEM, V273, P12758, DOI 10.1074/jbc.273.21.12758; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; Rambow J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00199; Song J, 2012, BBA-BIOMEMBRANES, V1818, P1218, DOI 10.1016/j.bbamem.2012.01.025; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Viadiu H, 2007, J MOL BIOL, V367, P80, DOI 10.1016/j.jmb.2006.12.042; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wiechert M, 2017, EMBO J, V36, P949, DOI 10.15252/embj.201695776; Wree D, 2011, FEBS J, V278, P740, DOI 10.1111/j.1742-4658.2010.07993.x; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Wu BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7284; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134	44	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9358	9364		10.1074/jbc.M117.782516	http://dx.doi.org/10.1074/jbc.M117.782516			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28360107	Green Published, hybrid			2022-12-28	WOS:000402538900029
J	Yamaguchi, N; Nakayama, Y; Yamaguchi, N				Yamaguchi, Noritaka; Nakayama, Yuji; Yamaguchi, Naoto			Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; ACQUIRED-RESISTANCE; BINDING; INHIBITION; ACTIVATION; PHENOTYPE; ALPHA; RELB; GENE	The selective estrogen receptor (ER) modulator tamoxifen inhibits ER signaling in breast cancer cells, and it is used for the treatment of ER-positive breast cancer. However, this type of cancer often acquires resistance to tamoxifen, and a better understanding of the molecular mechanisms underlying tamoxifen resistance is required. In this study, we established tamoxifen-resistant (TAM-R) breast cancer cells by long-term tamoxifen treatment of ER-positive breast cancer MCF7 cells. In TAM-R cells, expression of not only ER alpha, a major form of ER in breast cancer, but also its transcriptional partner forkhead box protein A1 (FOXA1) was found to be reduced. In contrast, activation of the transcription factor nuclear factor-kappa B (NF-kappa B) and expression of its target IL6 were increased in these cells. Stable expression of FOXA1, but not ER alpha, reduced the expression of IL6 in the FOXA1- and ER alpha-negative breast cancer MDA-MB231 cells and TAM-R cells, without affecting the activation of the NF-kappa B signaling pathways. Conversely, FOXA1 knockdown induced IL6 expression in MCF7 cells. Chromatin immunoprecipitation assays revealed that FOXA1 bound to the promoter region of IL6 and repressed recruitment of the NF-kappa B complex to this region. TAM-R cells were found to have high mammosphere-forming activity, characteristics of cancer stem cells, and this activity was suppressed by NF-kappa B and IL6 signaling inhibitors. Taken together, these results suggest that FOXA1 suppresses expression of IL6 through inhibition of NF-kappa B recruitment to the IL6 promoter in an ER alpha-independent manner and that reduction in FOXA1 expression induces IL6 expression and contributes to cancer stem cell-like properties in TAM-R cells.	[Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba 2608675, Japan; [Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto 6078414, Japan	Chiba University; Kyoto Pharmaceutical University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	yamaguchinoritaka@chiba-u.jp		Nakayama, Yuji/0000-0001-7882-0066	Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University) [16K08227, 15K07922]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University) [16K08227, 15K07922]; Hamaguchi Foundation for the Advancement of Biochemistry; Japan Foundation for Applied Enzymology	Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Japan Foundation for Applied Enzymology	This work was supported in part by Grants-in-aid for Scientific Research C 16K08227 (to Noritaka Yamaguchi) and 15K07922 (to Naoto Yamaguchi), Scientific Research from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University), and grants from The Hamaguchi Foundation for the Advancement of Biochemistry (to Noritaka Yamaguchi) and the Japan Foundation for Applied Enzymology (to Naoto Yamaguchi). The authors declare that they have no conflicts of interest with the contents of this article.	Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cottu P, 2014, CLIN CANCER RES, V20, P4314, DOI 10.1158/1078-0432.CCR-13-3230; deGraffenried LA, 2004, ANN ONCOL, V15, P885, DOI 10.1093/annonc/mdh232; Ellis AJ, 2015, EXPERT OPIN DRUG SAF, V14, P921, DOI 10.1517/14740338.2015.1014799; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gu ZP, 2002, CANCER RES, V62, P3428; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McFarland BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078728; Nehra R, 2010, FASEB J, V24, P2040, DOI 10.1096/fj.09-138305; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Rondon-Lagos M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081357; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Yamaguchi N., 2016, J CELL BIOC IN PRESS; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064; Yamaguchi N, 2015, BIOCHEM J, V471, P67, DOI 10.1042/BJ20150372; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yde CW, 2012, BREAST CANCER RES TR, V135, P67, DOI 10.1007/s10549-012-2053-1; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012	36	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8136	8148		10.1074/jbc.M116.763276	http://dx.doi.org/10.1074/jbc.M116.763276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28270510	Green Published, hybrid			2022-12-28	WOS:000401788600002
J	Milstein, ML; Kimler, VA; Ghatak, C; Ladokhin, AS; Goldberg, AFX				Milstein, Michelle L.; Kimler, Victoria A.; Ghatak, Chiranjib; Ladokhin, Alexey S.; Goldberg, Andrew F. X.			An inducible amphipathic helix within the intrinsically disordered C terminus can participate in membrane curvature generation by peripherin-2/rds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENT; CGMP-GATED CHANNEL; ACID-RICH PROTEINS; DOMINANT RETINITIS-PIGMENTOSA; PHOTORECEPTOR DISK MEMBRANES; ENDOPLASMIC-RETICULUM; RETINAL DEGENERATION; UNILAMELLAR VESICLES; MOUSE MODELS; BETA-SUBUNIT	Peripherin-2/rds is required for biogenesis of vertebrate photoreceptor outer segment organelles. Its localization at the high-curvature rim domains of outer segment disk membranes suggests that it may act to shape these structures; however, the molecular function of this protein is not yet resolved. Here, we apply biochemical, biophysical, and imaging techniques to elucidate the role(s) played by the protein's intrinsically disordered C-terminal domain and an incipient amphipathic alpha-helix contained within it. We investigated a deletion mutant lacking only this alpha-helix in stable cell lines and Xenopus laevis photoreceptors. We also studied a soluble form of the full-length similar to 7-kDa cytoplasmic C terminus in cultured cells and purified from Escherichia coli. The alpha-helical motif was not required for protein biosynthesis, tetrameric subunit assembly, tetramer polymerization, localization at disk rims, interaction with GARP2, or the generation of membrane curvature. Interestingly, however, loss of the helical motif up-regulated membrane curvature generation in cellulo, introducing the possibility that it may regulate this activity in photoreceptors. Furthermore, the incipient alpha-helix (within the purified soluble C terminus) partitioned into membranes only when its acidic residues were neutralized by protonation. This suggests that within the context of full-length peripherin-2/rds, partitioning would most likely occur at a bilayer interfacial region, potentially adjacent to the protein's transmembrane domains. In sum, this study significantly strengthens the evidence that peripherin-2/rds functions directly to shape the high-curvature rim domains of the outer segment disk and suggests that the protein's C terminus may modulate membrane curvature-generating activity present in other protein domains.	[Milstein, Michelle L.; Kimler, Victoria A.; Goldberg, Andrew F. X.] Oakland Univ, Eye Res Inst, 417 Dodge Hall, Rochester, MI 48309 USA; [Ghatak, Chiranjib; Ladokhin, Alexey S.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA	Oakland University; University of Kansas; University of Kansas Medical Center	Goldberg, AFX (corresponding author), Oakland Univ, Eye Res Inst, 417 Dodge Hall, Rochester, MI 48309 USA.	goldberg@oakland.edu			National Institutes of Health [EY025291, EY013246]; Oakland University Research Excellence Fund; NATIONAL EYE INSTITUTE [R01EY013246, R01EY025291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oakland University Research Excellence Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole or in part by National Institutes of Health Grants EY025291(to A. F. X. G.) and EY013246 and by the Oakland University Research Excellence Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; ANDERSON RE, 1970, BIOCHEMISTRY-US, V9, P3624, DOI 10.1021/bi00820a019; Batra-Safferling R, 2006, J BIOL CHEM, V281, P1449, DOI 10.1074/jbc.M505012200; Boesze-Battaglia K, 2003, EXP EYE RES, V77, P505, DOI 10.1016/S0014-4835(03)00151-9; Boesze-Battaglia K, 2000, BBA-BIOMEMBRANES, V1463, P343, DOI 10.1016/S0005-2736(99)00226-6; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chen CH, 2002, BIOPHYS J, V83, P1403, DOI 10.1016/S0006-3495(02)73911-8; Chen ZM, 2016, J AM CHEM SOC, V138, P14616, DOI 10.1021/jacs.6b06820; Choi JY, 2015, GEN COMP ENDOCR, V222, P69, DOI 10.1016/j.ygcen.2015.07.006; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Edrington TC, 2007, BIOCHEMISTRY-US, V46, P3605, DOI 10.1021/bi061820c; FALK G, 1973, J CELL SCI, V13, P787; FALK G, 1969, J ULTRA MOL STRUCT R, V28, P41, DOI 10.1016/S0022-5320(69)90005-7; FLIESLER SJ, 1982, BIOCHIM BIOPHYS ACTA, V711, P138, DOI 10.1016/0005-2760(82)90020-0; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; Goldberg AFX, 2001, J BIOL CHEM, V276, P42700, DOI 10.1074/jbc.M107511200; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; Goldberg AFX, 2000, METHOD ENZYMOL, V316, P671; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; Goldberg AFX, 2007, INVEST OPHTH VIS SCI, V48, P2975, DOI 10.1167/iovs.07-0049; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; HOPE MJ, 1986, CHEM PHYS LIPIDS, V40, P89, DOI 10.1016/0009-3084(86)90065-4; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Kedzierski W, 2001, P NATL ACAD SCI USA, V98, P7718, DOI 10.1073/pnas.141124198; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kevany BM, 2013, J BIOL CHEM, V288, P36272, DOI 10.1074/jbc.M113.520700; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kyrychenko A, 2015, BIOPHYS J, V108, P791, DOI 10.1016/j.bpj.2015.01.002; Ladokhin AS, 2010, J MEMBRANE BIOL, V236, P247, DOI 10.1007/s00232-010-9291-0; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Molday RS, 2015, J CELL SCI, V128, P4039, DOI 10.1242/jcs.175687; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Posokhov YO, 2007, BIOPHYS J, V93, pL20, DOI 10.1529/biophysj.107.112375; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; Ritter LM, 2005, PROTEIN PEPTIDE LETT, V12, P677, DOI 10.2174/0929866054696217; Ritter LM, 2004, J BIOL CHEM, V279, P39958, DOI 10.1074/jbc.M403943200; Salinas RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054292; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Simunovic M, 2016, P NATL ACAD SCI USA, V113, P11226, DOI 10.1073/pnas.1606943113; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Stuck MW, 2015, J BIOL CHEM, V290, P27901, DOI 10.1074/jbc.M115.683698; Tam Beatrice M, 2013, Methods Mol Biol, V935, P113, DOI 10.1007/978-1-62703-080-9_8; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Teixeira VH, 2016, J CHEM THEORY COMPUT, V12, P930, DOI 10.1021/acs.jctc.5b01114; Tian G, 2014, J NEUROSCI, V34, P992, DOI 10.1523/JNEUROSCI.3437-13.2014; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; Vargas-Uribe M, 2015, J MEMBRANE BIOL, V248, P383, DOI 10.1007/s00232-014-9734-0; Vargas-Uribe M, 2013, BIOCHEMISTRY-US, V52, P7901, DOI 10.1021/bi400926k; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Wensel TG, 2016, PROG RETIN EYE RES, V55, P32, DOI 10.1016/j.preteyeres.2016.06.002; Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	70	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7850	7865		10.1074/jbc.M116.768143	http://dx.doi.org/10.1074/jbc.M116.768143			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325841	Green Published, hybrid			2022-12-28	WOS:000401154100015
J	Wang, PJ; Lin, ST; Liu, SH; Kuo, KT; Hsu, CH; Knepper, MA; Yu, MJ				Wang, Po-Jen; Lin, Shu-Ting; Liu, Shao-Hsuan; Kuo, Kuang-Ting; Hsu, Chun-Hua; Knepper, Mark A.; Yu, Ming-Jiun			Vasopressin-induced serine 269 phosphorylation reduces Sipa1l1 (signal-induced proliferation-associated 1 like 1)-mediated aquaporin-2 endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; WATER CHANNEL AQUAPORIN-2; EPITHELIAL-CELLS; PLASMA-MEMBRANE; PDZ-DOMAIN; MYOSIN-II; POSTTRANSLATIONAL MODIFICATION; PROTEIN INTERACTIONS; APICAL MEMBRANE; PRINCIPAL CELLS	The abundance of integral membrane proteins in the plasma membrane is determined by a dynamic balance between exocytosis and endocytosis, which can often be regulated by physiological stimuli. Here, we describe a mechanism that accounts for the ability of the peptide hormone vasopressin to regulate water excretion via a phosphorylation-dependent modulation of the PDZ domain-ligand interaction involving the water channel protein aquaporin-2. We discovered that the PDZ domain-containing protein Sipa1l1 (signal-induced proliferation-associated 1 like 1) binds to the cytoplasmic PDZ-ligand motif of aquaporin-2 and accelerates its endocytosis in the absence of vasopressin. Vasopressin-induced aquaporin-2 phosphorylation within the type I PDZ-ligand motif disrupted the interaction, in association with reduced aquaporin-2 endocytosis and prolonged plasma membrane aquaporin-2 retention. This phosphorylation-dependent alteration in the PDZ domain-ligand interaction was explained by 3D structural models, which showed a hormone-regulated mechanism that controls osmotic water transport and systemic water balance in mammals.	[Wang, Po-Jen; Lin, Shu-Ting; Liu, Shao-Hsuan; Kuo, Kuang-Ting; Yu, Ming-Jiun] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan; [Hsu, Chun-Hua] Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan; [Knepper, Mark A.] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Taiwan University; National Taiwan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yu, MJ (corresponding author), Rm 816,1 Sec 1 Jen Ai Rd, Taipei 10051, Taiwan.	mjyu@ntu.edu.tw	HSU, CHUN-HUA/W-4554-2019; wang, pojen/AAA-5587-2020; Knepper, Mark/AAF-8412-2020	HSU, CHUN-HUA/0000-0002-0008-7383; YU, MING-JIUN/0000-0003-0393-4696	Ministry of Science and Technology, Taiwan [MOST-104-2320-B-002-064-MY3]; National Institutes of Health, NHLBI Project [ZIA-HL001285, ZIA-HL006129]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006129, ZIAHL001285] Funding Source: NIH RePORTER	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Institutes of Health, NHLBI Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Ministry of Science and Technology, Taiwan Grant MOST-104-2320-B-002-064-MY3 (to M. J. Y.) and National Institutes of Health, NHLBI Project Grants ZIA-HL001285 and ZIA-HL006129 (to M. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Araki N, 2006, FRONT BIOSCI, V11, P1479, DOI 10.2741/1897; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Chou CL, 2008, AM J PHYSIOL-RENAL, V295, pF192, DOI 10.1152/ajprenal.00011.2008; Chou CL, 2004, J BIOL CHEM, V279, P49026, DOI 10.1074/jbc.M408565200; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Curran J, 2015, ANNU REV PHYSIOL, V77, P505, DOI 10.1146/annurev-physiol-021014-071838; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; DING G, 1991, AM J PHYSIOL, V260, pC9, DOI 10.1152/ajpcell.1991.260.1.C9; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Harris BZ, 2001, J CELL SCI, V114, P3219; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Katsura T, 1997, Am J Physiol, V272, pF817; Khositseth S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004036; Klussmann E, 2001, J BIOL CHEM, V276, P20451, DOI 10.1074/jbc.M010270200; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehmann GL, 2014, EXP EYE RES, V126, P5, DOI 10.1016/j.exer.2014.04.021; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, PFLUG ARCH EUR J PHY, V456, P737, DOI 10.1007/s00424-007-0404-2; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Riethmuller C, 2008, BIOPHYS J, V94, P671, DOI 10.1529/biophysj.107.104893; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; Yang CR, 2015, AM J PHYSIOL-CELL PH, V309, pC799, DOI 10.1152/ajpcell.00214.2015; Yang CR, 2015, AM J PHYSIOL-CELL PH, V309, pC785, DOI 10.1152/ajpcell.00213.2015; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Yui N, 2012, BIOL OPEN, V1, P101, DOI 10.1242/bio.2011042	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7984	7993		10.1074/jbc.M117.779611	http://dx.doi.org/10.1074/jbc.M117.779611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28336531	Green Published, hybrid			2022-12-28	WOS:000401154100024
J	Fong, KW; Au, FKC; Jia, Y; Yang, SZ; Zhou, LY; Qi, RZ				Fong, Ka-Wing; Au, Franco K. C.; Jia, Yue; Yang, Shaozhong; Zhou, Liying; Qi, Robert Z.			Microtubule plus-end tracking of end-binding protein 1 (EB1) is regulated by CDK5 regulatory subunit-associated protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cytoskeleton; microtubule; microtubule-associated protein (MAP); protein-protein interaction; CDK5RAP2; EB1; SXIP motif; microtubule plus end tracking protein ( plus TIPs)	TUBULIN RING COMPLEX; POLYPOSIS-COLI APC; CHROMOSOME INSTABILITY; STRUCTURAL BASIS; IN-VITRO; DYNAMICS; SPINDLE; MITOSIS; CELLS; POLYMERIZATION	Microtubules are polar cytoskeleton filaments that extend via growth at their plus ends. Microtubule plus-end-tracking proteins (+TIPs) accumulate at these growing plus ends to control microtubule dynamics and attachment. The +TIP end-binding protein 1 (EB1) and its homologs possess an autonomous plus-end-tracking mechanism and interact with other known +TIPs, which then recruit those +TIPs to the growing plus ends. A major +TIP class contains the SXIP (Ser-X-Ile-Pro, with X denoting any amino acid residue) motif, known to interact with EB1 and its homologs for plus-end tracking, but the role of SXIP in regulating EB1 activities is unclear. We show here that an interaction of EB1 with the SXIP-containing +TIP CDK5 regulatory subunit-associated protein 2 (CDK5RAP2) regulates several EB1 activities, including microtubule plus-end tracking, dynamics at microtubule plus ends, microtubule and /-tubulin binding, and microtubule polymerization. The SXIP motif fused with a dimerization domain from CDK5RAP2 significantly enhanced EB1 plus-end-tracking and microtubule-polymerizing and bundling activities, but the SXIP motif alone failed to do so. An SXIP-binding-deficient EB1 mutant displayed significantly lower microtubule plus-end tracking than the wild-type protein in transfected cells. These results suggest that EB1 cooperates with CDK5RAP2 and perhaps other SXIP-containing +TIPs in tracking growing microtubule tips. We also generated plus-end-tracking chimeras of CDK5RAP2 and the adenomatous polyposis coli protein (APC) and found that overexpression of the dimerization domains interfered with microtubule plus-end tracking of their respective SXIP-containing chimeras. Our results suggest that disruption of SXIP dimerization enables detailed investigations of microtubule plus-end-associated functions of individual SXIP-containing +TIPs.	[Qi, Robert Z.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Fong, Ka-Wing] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Northwestern University; Feinberg School of Medicine	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		YANG, Shaozhong/0000-0003-3429-8506; Au, Kin Chung Franco/0000-0002-0261-5354	Research Grants Council (General Research Fund and Theme-based Research Scheme) of Hong Kong; National Key Basic Research Program of China [2013CB530900]; University Grants Committee (Area of Excellence Scheme) of Hong Kong; Innovation and Technology Commission of Hong Kong [ITCPD/17-9)]; TUYF Charitable Trust	Research Grants Council (General Research Fund and Theme-based Research Scheme) of Hong Kong; National Key Basic Research Program of China(National Basic Research Program of China); University Grants Committee (Area of Excellence Scheme) of Hong Kong; Innovation and Technology Commission of Hong Kong; TUYF Charitable Trust	This work was supported by grants from the Research Grants Council (General Research Fund and Theme-based Research Scheme) of Hong Kong, the National Key Basic Research Program of China (2013CB530900), the University Grants Committee (Area of Excellence Scheme) of Hong Kong, the Innovation and Technology Commission (ITCPD/17-9) of Hong Kong, and the TUYF Charitable Trust. The authors declare that they have no conflicts of interest with contents of this article.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Alberico EO, 2013, CYTOSKELETON, V70, P317, DOI 10.1002/cm.21108; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Caldwell CM, 2009, ADV EXP MED BIOL, V656, P51, DOI 10.1007/978-1-4419-1145-2_5; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gireesh KK, 2014, BIOCHEMISTRY-US, V53, P5551, DOI 10.1021/bi5007942; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seetapun D, 2010, CURR BIOL, V20, P979, DOI 10.1016/j.cub.2010.04.040; Sen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074448; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; SU LK, 1993, CANCER RES, V53, P2728; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tortosa E, 2013, EMBO J, V32, P1293, DOI 10.1038/emboj.2013.76; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	46	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7675	7687		10.1074/jbc.M116.759746	http://dx.doi.org/10.1074/jbc.M116.759746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28320860	Green Published, hybrid			2022-12-28	WOS:000400761300033
J	Horsthemke, M; Bachg, AC; Groll, K; Moyzio, S; Muther, B; Hemkemeyer, SA; Wedlich-Soldner, R; Sixt, M; Tacke, S; Bahler, M; Hanley, PJ				Horsthemke, Markus; Bachg, Anne C.; Groll, Katharina; Moyzio, Sven; Muether, Barbara; Hemkemeyer, Sandra A.; Wedlich-Soeldner, Roland; Sixt, Michael; Tacke, Sebastian; Baehler, Martin; Hanley, Peter J.			Multiple roles of filopodial dynamics in particle capture and phagocytosis and phenotypes of Cdc42 and Myo10 deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-X; CELL-MIGRATION; F-ACTIN; MACROPHAGES; RECEPTOR; CYTOSKELETON; DECTIN-1; REORGANIZATION; ORGANIZATION; RECOGNITION	Macrophage filopodia, finger-like membrane protrusions, were first implicated in phagocytosis more than 100 years ago, but little is still known about the involvement of these actin-dependent structures in particle clearance. Using spinning disk confocal microscopy to image filopodial dynamics in mouse resident Lifeact-EGFP macrophages, we show that filopodia, or filopodia-like structures, support pathogen clearance by multiple means. Filopodia supported the phagocytic uptake of bacterial (Escherichia coli) particles by (i) capturing along the filopodial shaft and surfing toward the cell body, the most common mode of capture; (ii) capturing via the tip followed by retraction; (iii) combinations of surfing and retraction; or (iv) sweeping actions. In addition, filopodia supported the uptake of zymosan (Saccharomyces cerevisiae) particles by (i) providing fixation, (ii) capturing at the tip and filopodia-guided actin anterograde flow with phagocytic cup formation, and (iii) the rapid growth of new protrusions. To explore the role of filopodia-inducing Cdc42, we generated myeloid-restricted Cdc42 knock-out mice. Cdc42-deficient macrophages exhibited rapid phagocytic cup kinetics, but reduced particle clearance, which could be explained by the marked rounded-up morphology of these cells. Macrophages lacking Myo10, thought to act downstream of Cdc42, had normal morphology, motility, and phagocytic cup formation, but displayed markedly reduced filopodia formation. In conclusion, live-cell imaging revealed multiple mechanisms involving macrophage filopodia in particle capture and engulfment. Cdc42 is not critical for filopodia or phagocytic cup formation, but plays a key role in driving macrophage lamellipodial spreading.	[Horsthemke, Markus; Bachg, Anne C.; Groll, Katharina; Moyzio, Sven; Muether, Barbara; Hemkemeyer, Sandra A.; Baehler, Martin; Hanley, Peter J.] Westfal Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Wedlich-Soeldner, Roland] Westfal Wilhelms Univ Munster, Inst Zelldynam & Bildgebung, D-48149 Munster, Germany; [Sixt, Michael] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Tacke, Sebastian] Westfal Wilhelms Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany	University of Munster; University of Munster; Institute of Science & Technology - Austria; University of Munster	Hanley, PJ (corresponding author), Westfal Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	Hanley, Peter J/H-4915-2017	Tacke, Sebastian/0000-0002-4503-367X; Hemkemeyer, Sandra A./0000-0003-1854-9512; Sixt, Michael/0000-0002-6620-9179	Deutsche Forschungsgemeinschaft [HA 3271/4-1, EXC 1003]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA 3271/4-1 (to P. J. H.) and EXC 1003 (Cluster of Excellence 1003), Cells in Motion (CiM). The authors declare that they have no conflicts of interest with the contents of this article.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Chavrier P, 2002, NAT CELL BIOL, V4, pE169, DOI 10.1038/ncb0702-e169; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Faust N, 2000, BLOOD, V96, P719; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kohler F, 2015, BIOPHYS J, V108, P2114, DOI 10.1016/j.bpj.2015.02.029; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Metschnikoff E, 1902, IMMUNITAT BEI INFEKT; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884; Mohammadi S, 2013, J CELL BIOL, V200, P81, DOI 10.1083/jcb.201204090; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Plestant C, 2014, J CELL SCI, V127, P1660, DOI 10.1242/jcs.131284; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roeder A, 2004, MED MYCOL, V42, P485, DOI 10.1080/13693780400011112; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Schulte C, 2016, EUR J CELL BIOL, V95, P1, DOI 10.1016/j.ejcb.2015.10.002; SPEERT DP, 1985, J LEUKOCYTE BIOL, V38, P655, DOI 10.1002/jlb.38.5.655; Spiller S, 2007, J BIOL CHEM, V282, P13190, DOI 10.1074/jbc.M610340200; SUNG SSJ, 1983, J CELL BIOL, V96, P160, DOI 10.1083/jcb.96.1.160; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/nmeth.1841, 10.1038/NMETH.1841]; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; YOUNG VB, 1992, J CELL BIOL, V116, P197, DOI 10.1083/jcb.116.1.197	46	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7258	7273		10.1074/jbc.M116.766923	http://dx.doi.org/10.1074/jbc.M116.766923			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28289096	Green Published, hybrid			2022-12-28	WOS:000400478300035
J	Jo, I; Kim, D; Bang, YJ; Ahn, J; Choi, SH; Ha, NC				Jo, Inseong; Kim, Dukyun; Bang, Ye-Ji; Ahn, Jinsook; Choi, Sang Ho; Ha, Nam-Chul			The hydrogen peroxide hypersensitivity of OxyR2 in Vibrio vulnificus depends on conformational constraints	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; DISTINCT CHARACTERISTICS; 2-CYS PEROXIREDOXINS; REDOX SWITCH; EXPRESSION; REGULATOR; PROTEIN; SUITE	Most Gram-negative bacteria respond to excessive levels of H2O2 using the peroxide-sensing transcriptional regulator OxyR, which can induce the expression of antioxidant genes to restore normality. Vibrio vulnificus has two distinct OxyRs (OxyR1 and OxyR2), which are sensitive to different levels of H2O2 and induce expression of two different peroxidases, Prx1 and Prx2. Although OxyR1 has both high sequence similarity and H2O2 sensitivity comparable with that of other OxyR proteins, OxyR2 exhibits limited sequence similarity and is more sensitive to H2O2. To investigate the basis for this difference, we determined crystal structures and carried out biochemical analyses of OxyR2. The determined structure of OxyR2 revealed a flipped conformation of the peptide bond before Glu-204, a position occupied by glycine in other OxyR proteins. Activity assays showed that the sensitivity to H2O2 was reduced to the level of other OxyR proteins by the E204G mutation. We solved the structure of the OxyR2-E204G mutant with the same packing environment. The structure of the mutant revealed a dual conformation of the peptide bond before Gly-204, indicating the structural flexibility of the region. This structural duality extended to the backbone atoms of Gly-204 and the imidazole ring of His-205, which interact with H2O2 and invariant water molecules near the peroxidatic cysteine, respectively. Structural comparison suggests that Glu-204 in OxyR2 provides rigidity to the region that is important in H2O2 sensing, compared with the E204G structure or other OxyR proteins. Our findings provide a structural basis for the higher sensitivity of OxyR2 to H2O2 and also suggest a molecular mechanism for bacterial regulation of expression of antioxidant genes at divergent concentrations of cellular H2O2.	[Jo, Inseong; Kim, Dukyun; Bang, Ye-Ji; Ahn, Jinsook; Choi, Sang Ho; Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea; [Kim, Dukyun; Bang, Ye-Ji; Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea; [Bang, Ye-Ji] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Southwestern Medical Center Dallas	Choi, SH; Ha, NC (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea.	choish@snu.ac.kr; hanc210@snu.ac.kr	Jo, Inseong/AGY-9957-2022; Ahn, Jinsook/AAE-5827-2022	Ahn, Jinsook/0000-0002-4175-5181; Jo, Inseong/0000-0002-7964-4751; Bang, Ye-Ji/0000-0003-4009-0824; Choi, Sang Ho/0000-0003-3865-1039	R&D Convergence Center Support Program; Ministry of Agriculture, Food, and Rural Affairs Republic of Korea; Mid-career Researcher Program through the National Research Foundation [2015R1A2A1A13001654]; Ministry of Science, ICT, and Future Planning, Republic of Korea	R&D Convergence Center Support Program; Ministry of Agriculture, Food, and Rural Affairs Republic of Korea; Mid-career Researcher Program through the National Research Foundation; Ministry of Science, ICT, and Future Planning, Republic of Korea	This research was supported by the R&D Convergence Center Support Program (to S. H. C. and N.-C. H.), funded by Ministry of Agriculture, Food, and Rural Affairs Republic of Korea, and by Mid-career Researcher Program Grant 2015R1A2A1A13001654 (to S. H. C.) through the National Research Foundation, funded by the Ministry of Science, ICT, and Future Planning, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bang YJ, 2016, J BIOL CHEM, V291, P16038, DOI 10.1074/jbc.M115.710343; Bang YJ, 2012, J BIOL CHEM, V287, P42516, DOI 10.1074/jbc.M112.421214; Cha SS, 2012, ACTA CRYSTALLOGR D, V68, P1253, DOI 10.1107/S0907444912024420; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee MA, 2014, J MICROBIOL, V52, P1036, DOI 10.1007/s12275-014-4531-0; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Sainsbury S, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-10; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; STORZ G, 1992, J NUTR, V122, P627, DOI 10.1093/jn/122.suppl_3.627; Svintradze DV, 2013, ACTA CRYSTALLOGR D, V69, P2091, DOI 10.1107/S0907444913019471; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2016, MOL CELLS, V39, P26, DOI 10.14348/molcells.2016.2325; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	30	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7223	7232		10.1074/jbc.M116.743765	http://dx.doi.org/10.1074/jbc.M116.743765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28264933	Green Published, hybrid			2022-12-28	WOS:000400478300032
J	Iwahori, S; Umana, AC; VanDeusen, HR; Kalejta, RF				Iwahori, Satoko; Umana, Angie C.; VanDeusen, Halena R.; Kalejta, Robert F.			Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; CELLULAR-DNA-SYNTHESIS; PRB-FAMILY PROTEINS; TUMOR-SUPPRESSOR; FUNCTIONAL INTERACTION; GROWTH SUPPRESSION; GENE-PRODUCT; MOLECULAR-MECHANISMS; VIRUS ONCOPROTEINS; POCKET PROTEINS	The human cytomegalovirus (HCMV)-encoded viral cyclindependent kinase (v-CDK) UL97 phosphorylates the retinoblastoma (Rb) tumor suppressor. Here, we identify the other Rb family members p107 and p130 as novel targets of UL97. UL97 phosphorylates p107 and p130 thereby inhibiting their ability to represstheE2F-responsiveE2F1promoter. AswithRb, thisphosphorylation, and the rescue of E2F-responsive transcription, is dependent on the L1 LXCXE motif in UL97 and its interacting clefts on p107 and p130. Interestingly, UL97 does not induce the disruption of all p107-E2F or p130-E2F complexes, as it does to Rb-E2F complexes. UL97 strongly interacts with p107 but not Rb or p130. Thus the inhibitory mechanisms of UL97 for Rb family protein-mediated repression of E2F-responsive transcription appear to differ for each of the Rb family proteins. The immediate early 1 (IE1) protein ofHCMValso rescues p107-and p130-mediated repression of E2F-responsive gene expression, but it does not induce their phosphorylation and does not disrupt p107-E2F or p130-E2F complexes. The unique regulation of Rb family proteins byHCMVUL97 and IE1 attests to the importance of modulating Rb family protein function in HCMV-infected cells.	[Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA; [Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, 1525 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA.; Kalejta, RF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1525 Linden Dr, Madison, WI 53706 USA.	rfkalejta@wisc.edu	Iwahori, Satoko/L-1948-2019		National Institutes of Health [R01-AI080675, P01-CA022443, T32-GM08349, T32-CA009135]; Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program; NATIONAL CANCER INSTITUTE [P01CA022443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01-AI080675 (to R. F. K.) and P01-CA022443 (to Paul Lambert). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research.; Supported by University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program and by National Institutes of Health Training Grant T32-GM08349.; Supported by National Institutes of Health Training Grant T32-CA009135.	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Ashizawa S, 2001, J BIOL CHEM, V276, P11362, DOI 10.1074/jbc.M007992200; Baker GL, 2005, CELL CYCLE, V4, P330; Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12; BIGNON YJ, 1990, CELL GROWTH DIFFER, V1, P647; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Claudio PP, 2000, CANCER RES, V60, P372; Cobbs CS, 2002, CANCER RES, V62, P3347; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dong F, 1998, J BIOL CHEM, V273, P6190, DOI 10.1074/jbc.273.11.6190; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fortunato EA, 1997, J VIROL, V71, P8176, DOI 10.1128/JVI.71.11.8176-8185.1997; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gill RB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-9; Guiley KZ, 2015, GENE DEV, V29, P961, DOI 10.1101/gad.257568.114; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; He ZW, 1997, J VIROL, V71, P405, DOI 10.1128/JVI.71.1.405-411.1997; Helin K, 1997, P NATL ACAD SCI USA, V94, P6933, DOI 10.1073/pnas.94.13.6933; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Herbein G, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00230; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Iwahori S, 2007, J VIROL, V81, P9653, DOI 10.1128/JVI.00568-07; Iwahori S, 2015, J BIOL CHEM, V290, P19666, DOI 10.1074/jbc.M115.660043; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Johnson RA, 1999, J GEN VIROL, V80, P1293, DOI 10.1099/0022-1317-80-5-1293; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kuny CV, 2016, J VIROL, V90, P8634, DOI 10.1128/JVI.00731-16; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lacy S, 1997, ONCOGENE, V14, P2395, DOI 10.1038/sj.onc.1201085; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Liban TJ, 2016, J MOL BIOL, V428, P3960, DOI 10.1016/j.jmb.2016.08.017; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; MAYOL X, 1993, ONCOGENE, V8, P2561; Mcelroy AK, 2000, J VIROL, V74, P4192, DOI 10.1128/JVI.74.9.4192-4206.2000; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Oberstein A, 2015, PROTEOMICS, V15, P2006, DOI 10.1002/pmic.201400607; Paggi MG, 2001, CANCER RES, V61, P4651; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Penkert RR, 2012, FUTURE VIROL, V7, P855, DOI 10.2217/FVL.12.86; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Salvant BS, 1998, J VIROL, V72, P3729, DOI 10.1128/JVI.72.5.3729-3741.1998; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Taher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056795; Ueno T, 2006, ONCOGENE, V25, P4155, DOI 10.1038/sj.onc.1209445; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VanDeusen HR, 2015, J VIROL, V89, P11965, DOI 10.1128/JVI.01718-15; VanDeusen HR, 2015, J VIROL, V89, P5012, DOI 10.1128/JVI.00175-15; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHITE E, 1991, J VIROL, V65, P2968, DOI 10.1128/JVI.65.6.2968-2978.1991; Wiebusch L, 2001, EMBO J, V20, P1086, DOI 10.1093/emboj/20.5.1086; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	92	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6583	6599		10.1074/jbc.M116.773150	http://dx.doi.org/10.1074/jbc.M116.773150			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28289097	Green Published, hybrid			2022-12-28	WOS:000399813400013
J	McElroy, PB; Hari, AS; Day, BJ; Patel, M				McElroy, Pallavi B.; Hari, Ashwini Sri; Day, Brian J.; Patel, Manisha			Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol A NOVEL MECHANISM OF INHIBITING NEUROINFLAMMATION IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TEMPORAL-LOBE EPILEPSY; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; PROTEIN-KINASE; GLUTATHIONE SYNTHESIS; MULTIPLE-SCLEROSIS; CELL-DEATH; NEURODEGENERATIVE DISORDERS	Neuroinflammation and oxidative stress are hallmarks of various neurological diseases. However, whether and how the redox processes control neuroinflammation is incompletely understood. We hypothesized that increasing cellular glutathione (GSH) levels would inhibit neuroinflammation. A series of thiol compounds were identified to elevate cellular GSH levels by a novel approach (i.e. post-translational activation of glutamate cysteine ligase (GCL), the rate-limiting enzyme in GSH biosynthesis). These small thiol-containing compounds were examined for their ability to increase intracellular GSH levels in a murine microglial cell line (BV2), of which dimercaprol (2,3-dimercapto- 1-propanol (DMP)) was found to be the most effective compound. DMP increased GCL activity and decreased LPS-induced production of pro-inflammatory cytokines and inducible nitric-oxide synthase induction in BV2 cells in a concentration-dependent manner. The ability of DMP to elevate GSH levels and attenuate LPS-induced pro-inflammatory cytokine production was inhibited by buthionine sulfoximine, an inhibitor of GCL. DMP increased the expression of GCL holoenzyme without altering the expression of its subunits or Nrf2 target proteins (NQO1 and HO-1), suggesting a post-translational mechanism. DMP attenuated LPS-induced MAPK activation in BV2 cells, suggesting the MAPK pathway as the signaling mechanism underlying the effect of DMP. Finally, the ability of DMP to increase GSH via GCL activation was observed in mixed cerebrocortical cultures and N27 dopaminergic cells. Together, the data demonstrate a novel mechanism of GSH elevation by posttranslational activation of GCL. Post-translational activation of GCL offers a novel targeted approach to control inflammation in chronic neuronal disorders associated with impaired adaptive responses.	[McElroy, Pallavi B.; Hari, Ashwini Sri; Patel, Manisha] Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA; [Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Patel, M (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA.	Manisha.Patel@ucdenver.edu	HARI, ASHWINI SRI/AAH-8467-2019		National Institutes of Health [RO1NS039587, R01NS086423, RO1 NS45748]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039587, R01NS086423, R01NS045748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants RO1NS039587 (to M. P.), R01NS086423 (to M. P.), and RO1 NS45748 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6; Anderson MF, 2004, NEUROSCI LETT, V354, P163, DOI 10.1016/j.neulet.2003.09.067; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Backos DS, 2011, FREE RADICAL BIO MED, V50, P14, DOI 10.1016/j.freeradbiomed.2010.10.694; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Blum S, 1999, J NEUROSCI, V19, P3535; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Cantu D, 2011, J NEUROCHEM, V118, P79, DOI 10.1111/j.1471-4159.2011.07290.x; Carvalho AN, 2014, MULT SCLER J, V20, P1425, DOI 10.1177/1352458514533400; Cecchi C, 1999, NEUROSCI LETT, V275, P152, DOI 10.1016/S0304-3940(99)00751-X; Chen P, 2008, ACTA BIOCH BIOPH SIN, V40, P125, DOI 10.1111/j.1745-7270.2008.00386.x; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Chinta SJ, 2006, NEUROSCI LETT, V402, P137, DOI 10.1016/j.neulet.2006.03.056; Choi IY, 2011, MULT SCLER J, V17, P289, DOI 10.1177/1352458510384010; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Clarkson ED, 1998, P NATL ACAD SCI USA, V95, P1265, DOI 10.1073/pnas.95.3.1265; Diaz-Hernandez JI, 2005, J BIOL CHEM, V280, P38992, DOI 10.1074/jbc.M507065200; Drechsel DA, 2007, TOXICOL APPL PHARM, V220, P341, DOI 10.1016/j.taap.2007.02.002; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Gegg ME, 2002, ANAL BIOCHEM, V304, P26, DOI 10.1006/abio.2001.5607; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Haddad JJ, 2002, BIOCHEM PHARMACOL, V63, P305, DOI 10.1016/S0006-2952(01)00870-X; Haddad JJE, 2001, J PHARMACOL EXP THER, V296, P996; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kachadourian R, 2012, J MED CHEM, V55, P1382, DOI 10.1021/jm2016073; Kachadourian R, 2011, FREE RADICAL BIO MED, V51, P1146, DOI 10.1016/j.freeradbiomed.2011.05.041; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Koh K, 2011, J NEUROIMMUNOL, V233, P160, DOI 10.1016/j.jneuroim.2011.01.004; Krejsa CM, 2010, J BIOL CHEM, V285, P16116, DOI 10.1074/jbc.M110.116210; Lee IS, 2011, NEUROCHEM INT, V58, P153, DOI 10.1016/j.neuint.2010.11.008; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026; Limon-Pacheco JH, 2007, FREE RADICAL BIO MED, V43, P1335, DOI 10.1016/j.freeradbiomed.2007.06.028; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Mueller SG, 2001, NEUROLOGY, V57, P1422, DOI 10.1212/WNL.57.8.1422; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niso-Santano M, 2006, TOXICOL SCI, V92, P507, DOI 10.1093/toxsci/kfl013; Oh YT, 2010, NEUROSCI LETT, V474, P148, DOI 10.1016/j.neulet.2010.03.026; Palmeira CM, 1995, TOXICOL LETT, V81, P115, DOI 10.1016/0378-4274(95)03414-5; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Ramachandiran S, 2007, TOXICOL SCI, V95, P163, DOI 10.1093/toxsci/kfl125; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Ryan K, 2014, NEUROBIOL DIS, V64, P8, DOI 10.1016/j.nbd.2013.12.006; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Svensson C, 2010, BRAIN RES, V1322, P1, DOI 10.1016/j.brainres.2010.01.082; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vilensky JA, 2003, ANN EMERG MED, V41, P378, DOI 10.1067/mem.2003.72; Waldbaum S, 2010, J NEUROCHEM, V115, P1172, DOI 10.1111/j.1471-4159.2010.07013.x; YAN CYI, 1995, J BIOL CHEM, V270, P26827, DOI 10.1074/jbc.270.45.26827; Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4	85	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5532	5545		10.1074/jbc.M116.723700	http://dx.doi.org/10.1074/jbc.M116.723700			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202547	Green Published, hybrid			2022-12-28	WOS:000397875500032
J	Delorimier, E; Hinman, MN; Copperman, J; Datta, K; Guenza, M; Berglund, JA				delorimier, Elaine; Hinman, Melissa N.; Copperman, Jeremy; Datta, Kausiki; Guenza, Marina; Berglund, J. Andrew			Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTONIC-DYSTROPHY; MOLECULAR SIMULATION; BASE-PAIRS; RECOGNITION; PROTEINS; STABILIZATION; STABILITIES; MECHANISMS; PARAMETERS; MISMATCHES	Myotonic dystrophy type 2 is a genetic neuromuscular disease caused by the expression of expanded CCUG repeat RNAs from the non-coding region of the (C) under bar CHC-type zinc finger (n) under bar ucleic acid- (b) under bar inding (p) under bar rotein (CNBP) gene. These CCUG repeats bind and sequester a family of RNA-binding proteins known as Muscleblind-like 1, 2, and 3 (MBNL1, MBNL2, and MBNL3), and sequestration plays a significant role in pathogenicity. MBNL proteins are alternative splicing regulators that bind to the consensus RNA sequence YGCY (Y = pyrimidine). This consensus sequence is found in the toxic RNAs (CCUG repeats) and in cellular RNA substrates that MBNL proteins have been shown to bind. Replacing the uridine in CCUG repeats with pseudouridine (Psi) resulted in a modest reduction of MBNL1 binding. Interestingly, Psi modification of a minimally structured RNA containing YGCY motifs resulted in more robust inhibition of MBNL1 binding. The different levels of inhibition between CCUG repeat and minimally structured RNA binding appear to be due to the ability to modify both pyrimidines in the YGCY motif, which is not possible in the CCUG repeats. Molecular dynamic studies of unmodified and pseudouridylated minimally structured RNAs suggest that reducing the flexibility of the minimally structured RNA leads to reduced binding by MBNL1.	[delorimier, Elaine; Hinman, Melissa N.; Copperman, Jeremy; Guenza, Marina; Berglund, J. Andrew] Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene, OR 97403 USA; [Datta, Kausiki; Berglund, J. Andrew] Univ Florida, Coll Med, Ctr NeuroGenet, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Berglund, J. Andrew] Univ Florida, Ctr NeuroGenet, Dept Biochem & Mol Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA	University of Oregon; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Berglund, JA (corresponding author), Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene, OR 97403 USA.; Berglund, JA (corresponding author), Univ Florida, Coll Med, Ctr NeuroGenet, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.; Berglund, JA (corresponding author), Univ Florida, Ctr NeuroGenet, Dept Biochem & Mol Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA.	aberglund@ufl.edu	Guenza, Marina/H-6526-2017; Berglund, Andrew/AAS-1065-2021	Guenza, Marina/0000-0002-1151-4766; Hinman, Melissa/0000-0002-0743-646X	Muscular Dystrophy Association [294447]; National Institutes of Health [AR059833]; Myotonic Dystrophy/Wyck Foundation [Wyck-FF-2014-0013]; American Heart Association Pre-doctoral Fellowship [13PRE17350007]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059833] Funding Source: NIH RePORTER; Division Of Chemistry [1362500] Funding Source: National Science Foundation	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myotonic Dystrophy/Wyck Foundation; American Heart Association Pre-doctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Muscular Dystrophy Association Grant 294447 (to J.A.B.), National Institutes of Health Grant AR059833 (to J.A.B.), Myotonic Dystrophy/Wyck Foundation Grant Wyck-FF-2014-0013 (to M.N.H.), and American Heart Association Pre-doctoral Fellowship 13PRE17350007 (to E.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aduri R, 2007, J CHEM THEORY COMPUT, V3, P1464, DOI 10.1021/ct600329w; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Cass D, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-20; Charette M, 2000, IUBMB LIFE, V49, P341; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; deLorimier E, 2014, NUCLEIC ACIDS RES, V42, P12768, DOI 10.1093/nar/gku941; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Fu Y, 2012, CHEMBIOCHEM, V13, P112, DOI 10.1002/cbic.201100487; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hudson GA, 2013, RNA, V19, P1474, DOI 10.1261/rna.039610.113; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lietzke SE, 1996, STRUCTURE, V4, P917, DOI 10.1016/S0969-2126(96)00099-8; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; SANTALUCIA J, 1991, BIOCHEMISTRY-US, V30, P8242, DOI 10.1021/bi00247a021; Sheng J, 2013, NUCLEIC ACIDS RES, V41, P10476, DOI 10.1093/nar/gkt799; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; WU M, 1995, BIOCHEMISTRY-US, V34, P3204, DOI 10.1021/bi00010a009; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x	34	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4350	4357		10.1074/jbc.M116.770768	http://dx.doi.org/10.1074/jbc.M116.770768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130447	Green Published, hybrid			2022-12-28	WOS:000395837100031
J	Francis, JW; Newman, LE; Cunningham, LA; Kahn, RA				Francis, Joshua W.; Newman, Laura E.; Cunningham, Leslie A.; Kahn, Richard A.			A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and beta-Tubulin Is Required for Maintaining the Microtubule Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLDING COFACTOR-D; FISSION YEAST; ALPHA-TUBULIN; PROTEIN; COMPLEX; MUTATIONS; DYNAMICS; ENCEPHALOPATHY; MORPHOGENESIS; CYTOKINESIS	Microtubule dynamics involves the polymerization and de-polymerization of tubulin dimers and is an essential and highly regulated process required for cell viability, architecture, and division. The regulation of the microtubule network also depends on the maintenance of a pool of alpha beta-tubulin heterodimers. These dimers are the end result of complex folding and assembly events, requiring the TCP1 Ring Complex (TriC or CCT) chaperonin and five tubulin-specific chaperones, tubulin binding cofactors A-E (TBCA-TBCE). However, models of the actions of these chaperones are incomplete or inconsistent. We previously purified TBCD from bovine tissues and showed that it tightly binds the small GTPase ARL2 but appears to be inactive. Here, in an effort to identify the functional form of TBCD and using non-denaturing gels and immunoblotting, we analyzed lysates from a number of mouse tissues and cell lines to identify the quaternary state(s) of TBCD and ARL2. We found that both proteins co-migrated in native gels in a complex of similar to 200 kDa that also contained beta-tubulin. Using human embryonic kidney cells enabled the purification of the TBCD center dot ARL2 center dot beta-tubulin trimer found in cell and tissue lysates as well as two other novel TBCD complexes. Characterization of ARL2 point mutants that disrupt binding to TBCD suggested that the ARL2-TBCD interaction is critical for proper maintenance of microtubule densities in cells. We conclude that the TBCD center dot ARL2 center dot beta-tubulin trimer represents a functional complex whose activity is fundamental to microtubule dynamics.	[Francis, Joshua W.; Newman, Laura E.; Cunningham, Leslie A.; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601; Newman, Laura/0000-0001-5559-713X	National Institutes of Health [5R01GM090158, 1F31CA189672, 1F31GM111047]; American Heart Association Predoctoral Fellowship [14PRE18840040]; Emory University Integrated Cellular Imaging Microscopy Core; Proteomics Core of the Emory Neuroscience NINDS; National Institutes of Health Core Facilities Grant [P30NS055077]; Emory Integrated Genomics Core - Emory University School of Medicine; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CANCER INSTITUTE [F31CA189672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122568, R01GM090158, F31GM111047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Emory University Integrated Cellular Imaging Microscopy Core; Proteomics Core of the Emory Neuroscience NINDS; National Institutes of Health Core Facilities Grant; Emory Integrated Genomics Core - Emory University School of Medicine; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants 5R01GM090158 (to R.A.K.), 1F31CA189672 (to J.W.F.), and 1F31GM111047 (to L.E.N.) and American Heart Association Predoctoral Fellowship 14PRE18840040 (to L.E.N.). This research was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core and Proteomics Core of the Emory Neuroscience NINDS, National Institutes of Health Core Facilities Grant P30NS055077. This study was also supported in part by the Emory Integrated Genomics Core, which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award UL1TR000454. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bichet P, 2000, PROTEIN EXPRES PURIF, V19, P197, DOI 10.1006/prep.2000.1239; Chen K, 2016, J CELL BIOL, V212, P661, DOI 10.1083/jcb.201503047; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Edvardson S, 2016, HUM MOL GENET, V25, P4635, DOI 10.1093/hmg/ddw292; Fedyanina OS, 2006, CURR GENET, V50, P281, DOI 10.1007/s00294-006-0095-9; Flex E, 2016, AM J HUM GENET, V99, P962, DOI 10.1016/j.ajhg.2016.08.003; Francis Joshua W, 2016, Small GTPases, V7, P188; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Ikeda T, 2017, J HUM GENET, V62, P473, DOI 10.1038/jhg.2016.149; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; Fanarraga ML, 2010, METHOD CELL BIOL, V95, P59, DOI 10.1016/S0091-679X(10)95005-X; Fanarraga ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008846; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Miyake N, 2016, AM J HUM GENET, V99, P950, DOI 10.1016/j.ajhg.2016.08.005; Montecinos-Franjola F, 2016, J BIOL CHEM, V291, P9281, DOI 10.1074/jbc.M115.699728; Nithianantham S, 2015, ELIFE, V4, DOI 10.7554/eLife.08811; Okumura M, 2015, J NEUROSCI, V35, P1979, DOI 10.1523/JNEUROSCI.0973-14.2015; Pode-Shakked B, 2017, CLIN GENET, V91, P725, DOI 10.1111/cge.12914; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; Serna M, 2015, J CELL SCI, V128, P1824, DOI 10.1242/jcs.167387; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STEARNS T, 1990, GENETICS, V124, P251; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Zhang TL, 2009, STRUCTURE, V17, P602, DOI 10.1016/j.str.2009.01.014; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	39	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4336	4349		10.1074/jbc.M116.770909	http://dx.doi.org/10.1074/jbc.M116.770909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28126905	Green Published, hybrid			2022-12-28	WOS:000395837100030
J	Moss, B				Moss, Bernard			Investigating Viruses during the Transformation of Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; MESSENGER-RNA GUANYLYLTRANSFERASE; GENETICALLY-ENGINEERED POXVIRUSES; DOUBLE-STRANDED-RNA; VACCINIA VIRUS; METHYLATED NUCLEOTIDES; HEMOGLOBIN-SYNTHESIS; AMPHIBIAN METAMORPHOSIS; POLYMERASE ACTIVITY; LIVE VACCINES	This Reflections article describes my early work on viral enzymes and the discovery of mRNA capping, how my training in medicine and biochemistry merged as I evolved into a virologist, the development of viruses as vaccine vectors, and how scientific and technological developments during the 1970s and beyond set the stage for the interrogation of nearly every step in the reproductive cycle of vaccinia virus (VACV), a large DNA virus with about 200 genes. The reader may view this article as a work in progress, because I remain actively engaged in research at the National Institutes of Health (NIH) notwithstanding 50 memorable years there.	[Moss, Bernard] NIH, NIAID, Viral Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moss, B (corresponding author), NIH, NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	bmoss@niaid.nih.gov		Moss, Bernard/0000-0002-2154-8564	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001074, ZIAAI000307] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Two individuals stand out in my scientific development: Vernon Ingram and Norman Salzman. Both encouraged and supported me to become an independent investigator. Norman nominated me for tenure at NIH and promoted me to a Section Head. The NIH now honors Norman's memory by holding an annual virology symposium in his name. I thank Stuart Isaacs for comments on an early draft of the manuscript. Most importantly, I am grateful to my wife Toby and children Rob, Jennifer, and David for their patience and love when I neglected them for work. Preparation of this article was supported by the Division of Intramural Research, NIAID, National Institutes of Health.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; BARBOSA E, 1978, J BIOL CHEM, V253, P7692; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; BAROUDY BM, 1980, J BIOL CHEM, V255, P4372; BECKER Y, 1964, P NATL ACAD SCI USA, V51, P577, DOI 10.1073/pnas.51.4.577; Bisht H, 2009, J VIROL, V83, P9140, DOI 10.1128/JVI.00875-09; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BOTH GW, 1975, P NATL ACAD SCI USA, V72, P1189, DOI 10.1073/pnas.72.3.1189; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; BROYLES SS, 1988, J BIOL CHEM, V263, P10754; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Darnell JE, 2013, J BIOL CHEM, V288, P12957, DOI 10.1074/jbc.X113.471722; ENSINGER MJ, 1976, J BIOL CHEM, V251, P5283; FUERST TR, 1989, P NATL ACAD SCI USA, V86, P2549, DOI 10.1073/pnas.86.8.2549; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; Joklik WK, 2005, J BIOL CHEM, V280, P40385, DOI 10.1074/JBC.X500005200; KATES JR, 1967, P NATL ACAD SCI USA, V58, P134, DOI 10.1073/pnas.58.1.134; KEITH JM, 1982, BIOCHEMISTRY-US, V21, P327, DOI 10.1021/bi00531a020; KEITH JM, 1978, J BIOL CHEM, V253, P5033; KESSLER D, 1960, BIOCHIM BIOPHYS ACTA, V38, P549, DOI 10.1016/0006-3002(60)91290-7; KLEIMAN JH, 1975, J BIOL CHEM, V250, P2420; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; Liu RK, 2016, J VIROL, V90, P7864, DOI 10.1128/JVI.00869-16; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; MARTIN SA, 1975, J BIOL CHEM, V250, P9322; Maruri-Avidal L, 2013, J VIROL, V87, P12313, DOI 10.1128/JVI.02137-13; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MIURA KI, 1974, J MOL BIOL, V86, P31, DOI 10.1016/S0022-2836(74)80005-7; MOSS B, 1984, NATURE, V311, P67, DOI 10.1038/311067a0; MOSS B, 1976, J VIROL, V17, P385, DOI 10.1128/JVI.17.2.385-392.1976; MOSS B, 1969, NATURE, V224, P1280, DOI 10.1038/2241280a0; MOSS B, 1968, J VIROL, V2, P1016, DOI 10.1128/JVI.2.10.1016-1027.1968; MOSS B, 1977, J VIROL, V23, P234, DOI 10.1128/JVI.23.2.234-239.1977; MOSS B, 1973, NATURE-NEW BIOL, V245, P59, DOI 10.1038/newbio245059a0; MOSS B, 1968, J MOL BIOL, V32, P493, DOI 10.1016/0022-2836(68)90337-9; MOSS B, 1968, J MOL BIOL, V32, P481, DOI 10.1016/0022-2836(68)90336-7; MOSS B, 1977, CELL, V10, P113, DOI 10.1016/0092-8674(77)90145-3; MOSS B, 1965, P NATL ACAD SCI USA, V54, P967, DOI 10.1073/pnas.54.3.967; Moss B, 2013, FIELDS VIROLOGY, P2129; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199; Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; MUNYON W, 1967, P NATL ACAD SCI USA, V58, P2280, DOI 10.1073/pnas.58.6.2280; MUTHUKRISHNAN S, 1976, BIOCHEMISTRY-US, V15, P5761, DOI 10.1021/bi00671a012; ODA KI, 1967, J MOL BIOL, V27, P395, DOI 10.1016/0022-2836(67)90047-2; PANICALI D, 1983, P NATL ACAD SCI-BIOL, V80, P5364, DOI 10.1073/pnas.80.17.5364; PANICALI D, 1982, P NATL ACAD SCI-BIOL, V79, P4927, DOI 10.1073/pnas.79.16.4927; PAOLETTI E, 1974, J BIOL CHEM, V249, P3273; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Parrish S, 2007, J VIROL, V81, P12973, DOI 10.1128/JVI.01668-07; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; SALZMAN NP, 1964, J MOL BIOL, V8, P405, DOI 10.1016/S0022-2836(64)80204-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ LB, 1975, J BIOL CHEM, V250, P3221; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; SHATKIN AJ, 1974, P NATL ACAD SCI USA, V71, P3204, DOI 10.1073/pnas.71.8.3204; SHATKIN AJ, 1968, P NATL ACAD SCI USA, V61, P1462, DOI 10.1073/pnas.61.4.1462; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; SUBAKSHA.JH, 1969, NATURE, V222, P341, DOI 10.1038/222341a0; SUTTER G, 1994, J VIROL, V68, P4109, DOI 10.1128/JVI.68.7.4109-4116.1994; Thomas L, 1974, LIVES CELL NOTES BIO; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; VENKATESAN S, 1980, J BIOL CHEM, V255, P2829; VENKATESAN S, 1982, P NATL ACAD SCI-BIOL, V79, P340, DOI 10.1073/pnas.79.2.340; VENKATESAN S, 1981, CELL, V25, P805, DOI 10.1016/0092-8674(81)90188-4; Warren RD, 2012, J VIROL, V86, P9514, DOI 10.1128/JVI.06902-11; WEI CM, 1974, P NATL ACAD SCI USA, V71, P3014, DOI 10.1073/pnas.71.8.3014; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; WIKTOR TJ, 1984, P NATL ACAD SCI-BIOL, V81, P7194, DOI 10.1073/pnas.81.22.7194; WITTEK R, 1980, NATURE, V285, P21, DOI 10.1038/285021a0; WITTEK R, 1977, J VIROL, V23, P669, DOI 10.1128/JVI.23.3.669-678.1977; WITTEK R, 1980, CELL, V21, P487, DOI 10.1016/0092-8674(80)90485-7; Yang ZL, 2015, J VIROL, V89, P6874, DOI 10.1128/JVI.00528-15; ZHANG YF, 1991, P NATL ACAD SCI USA, V88, P1511, DOI 10.1073/pnas.88.4.1511	97	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3958	3969		10.1074/jbc.X117.778712	http://dx.doi.org/10.1074/jbc.X117.778712			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154190	hybrid, Green Published			2022-12-28	WOS:000395837100001
J	Gao, YS; Zhou, YL; Goldstein, JL; Brown, MS; Radhakrishnan, A				Gao, Yansong; Zhou, Yulian; Goldstein, Joseph L.; Brown, Michael S.; Radhakrishnan, Arun			Cholesterol-induced conformational changes in the sterol-sensing domain of the Scap protein suggest feedback mechanism to control cholesterol synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol regulation; cholesterol-binding protein; conformational change; membrane lipid; membrane protein	CLEAVAGE-ACTIVATING PROTEIN; HAMSTER OVARY CELLS; MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; REGULATED TRANSPORT; LOOP 1; BINDING; SREBPS; GOLGI; IDENTIFICATION	Scap is a polytopic protein of endoplasmic reticulum (ER) membranes that transports sterol regulatory element-binding proteins to the Golgi complex for proteolytic activation. Cholesterol accumulation in ER membranes prevents Scap transport and decreases cholesterol synthesis. Previously, we provided evidence that cholesterol inhibition is initiated when cholesterol binds to loop 1 of Scap, which projects into the ER lumen. Within cells, this binding causes loop 1 to dissociate from loop 7, another luminal Scap loop. However, we have been unable to demonstrate this dissociation when we added cholesterol to isolated complexes of loops 1 and 7. We therefore speculated that the dissociation requires a conformational change in the intervening polytopic sequence separating loops 1 and 7. Here we demonstrate such a change using a protease protection assay in sealed membrane vesicles. In the absence of cholesterol, trypsin or proteinase K cleaved cytosolic loop 4, generating a protected fragment that we visualized with a monoclonal antibody against loop 1. When cholesterol was added to these membranes, cleavage in loop 4 was abolished. Because loop 4 is part of the so-called sterol-sensing domain separating loops 1 and 7, these results support the hypothesis that cholesterol binding to loop 1 alters the conformation of the sterol-sensing domain. They also suggest that this conformational change helps transmit the cholesterol signal from loop 1 to loop 7, thereby allowing separation of the loops and facilitating the feedback inhibition of cholesterol synthesis. These insights suggest a new structural model for cholesterol-mediated regulation of Scap activity.	[Gao, Yansong; Zhou, Yulian; Goldstein, Joseph L.; Brown, Michael S.; Radhakrishnan, Arun] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Gao, Yansong] Cross Strait Tsinghua Res Inst, Biol & Med Res Ctr, Xiamen 361006, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL; Brown, MS; Radhakrishnan, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu; arun.radhakrishnan@utsouthwestern.edu	Radhakrishnan, Arun/R-8440-2019; Radhakrishnan, Arun/Q-7437-2019	Radhakrishnan, Arun/0000-0001-8972-7086; Radhakrishnan, Arun/0000-0002-7266-7336	National Institutes of Health [HL20948]; Robert A. Welch Foundation [I-1793]; American Heart Association [12SDG12040267]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL20948 (to J. L. G. and M. S. B.), Robert A. Welch Foundation Grant I-1793 (to A. R.), and American Heart Association Grant 12SDG12040267 (to A. R.).	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Zhang YX, 2016, J BIOL CHEM, V291, P12888, DOI 10.1074/jbc.M116.729798; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	23	23	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8729	8737		10.1074/jbc.M117.783894	http://dx.doi.org/10.1074/jbc.M117.783894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377508	hybrid, Green Published			2022-12-28	WOS:000402153900019
J	Filipowicz, W				Filipowicz, Witold			Traversing the RNA world	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; SMALL NUCLEOLAR RNA; DOUBLE-STRANDED-RNA; POLYPEPTIDE-CHAIN INITIATION; RIBOSE 1,2-CYCLIC PHOSPHATE; MIRNA-MEDIATED REPRESSION; EUKARYOTIC MESSENGER-RNAS; HELA-CELL EXTRACT; MOSAIC-VIRUS RNA; U-SNRNA GENES	An invitation to write a "Reflections" type of article creates a certain ambivalence: it is a great honor, but it also infers the end of your professional career. Before you vanish for good, your colleagues look forward to an interesting but entertaining account of the ups-and-downs of your past research and your views on science in general, peppered with indiscrete anecdotes about your former competitors and collaborators. What follows will disappoint those who await complaint and criticism, for example, about the difficulties of doing research in the 1960s and 1970s in Eastern Europe, or those seeking very personal revelations. My scientific life has in fact seen many happy coincidences, much good fortune, and several lucky escapes from situations that at the time were quite scary. I have also been fortunate with regard to competitors and collaborators, particularly because, whenever possible, I tried to "neutralize" my rivals by collaborating with them - to the benefit of all. I recommend this strategy to young researchers to dispel the nightmares that can occur when competing against powerful contenders. I have been blessed with the selection of my research topic: RNA biology. Over the last five decades, new and unexpected RNA-related phenomena emerged almost yearly. I experienced them very personally while studying transcription, translation, RNA splicing, ribosome biogenesis, and more recently, different classes of regulatory non-coding RNAs, including microRNAs. Some selected research and para-research stories, also covering many wonderful people I had a privilege to work with, are summarized below.	[Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, Maulberstr 66, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Filipowicz, W (corresponding author), Friedrich Miescher Inst Biomed Res, Maulberstr 66, CH-4058 Basel, Switzerland.	witold.filipowicz@fmi.ch						Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BESTER AJ, 1975, P NATL ACAD SCI USA, V72, P1523, DOI 10.1073/pnas.72.4.1523; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; CECH TR, 1983, CELL, V34, P713, DOI 10.1016/0092-8674(83)90527-5; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chekulaeva M, 2010, NUCLEIC ACIDS RES, V38, P6673, DOI 10.1093/nar/gkq501; CULVER GM, 1994, J BIOL CHEM, V269, P24928; Doyle M, 2012, ENZYMES, V32, P1, DOI 10.1016/B978-0-12-404741-9.00001-5; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Engl C, 2016, NUCLEIC ACIDS RES, V44, P9933, DOI 10.1093/nar/gkw628; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FILIPOWICZ W, 1976, P NATL ACAD SCI USA, V73, P1559, DOI 10.1073/pnas.73.5.1559; FILIPOWICZ W, 1979, P NATL ACAD SCI USA, V76, P3111, DOI 10.1073/pnas.76.7.3111; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1990, METHOD ENZYMOL, V181, P499; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; FILIPOWICZ W, 1972, FEBS LETT, V23, P249, DOI 10.1016/0014-5793(72)80353-3; FILIPOWICZ W, 1972, BIOCHEM BIOPH RES CO, V49, P1272, DOI 10.1016/0006-291X(72)90605-5; FILIPOWICZ W, 1975, P NATL ACAD SCI USA, V72, P3947, DOI 10.1073/pnas.72.10.3947; Filipowicz W, 1995, PREMRNA PROCESSING, V4, P65; Filipowicz Witold, 2016, Postepy Biochem, V62, P327; Filipowicz W, 2015, RNA, V21, P519, DOI 10.1261/rna.051219.115; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Genschik P, 1997, J BIOL CHEM, V272, P13211, DOI 10.1074/jbc.272.20.13211; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; GOODALL GJ, 1991, EMBO J, V10, P2635, DOI 10.1002/j.1460-2075.1991.tb07806.x; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; GROSS HJ, 1978, NATURE, V273, P203, DOI 10.1038/273203a0; GRUNBERGMANAGO M, 1956, BIOCHIM BIOPHYS ACTA, V20, P269, DOI 10.1016/0006-3002(56)90286-4; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hershko A, 2009, J BIOL CHEM, V284, P10291, DOI 10.1074/jbc.X800016200; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; KIKUCHI Y, 1982, NUCLEIC ACIDS RES, V10, P7521, DOI 10.1093/nar/10.23.7521; KISS T, 1991, CELL, V65, P517, DOI 10.1016/0092-8674(91)90469-F; Kiss T, 1996, MOL CELL BIOL, V16, P1391; KISS T, 1992, EMBO J, V11, P3737, DOI 10.1002/j.1460-2075.1992.tb05459.x; KISS T, 1993, EMBO J, V12, P2913, DOI 10.1002/j.1460-2075.1993.tb05953.x; KISS T, 1995, GENE DEV, V9, P1411, DOI 10.1101/gad.9.11.1411; KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; KOZAK M, 1978, CELL, V13, P201, DOI 10.1016/0092-8674(78)90150-2; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1979, NATURE, V280, P82, DOI 10.1038/280082a0; Krol J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8305; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lambermon MHL, 2002, MOL CELL BIOL, V22, P4346, DOI 10.1128/MCB.22.12.4346-4357.2002; LASKI FA, 1983, J BIOL CHEM, V258, P1974; LEEHUANG S, 1977, ARCH BIOCHEM BIOPHYS, V180, P276, DOI 10.1016/0003-9861(77)90039-X; LEVERETTE RD, 1992, CELL, V71, P1215, DOI 10.1016/S0092-8674(05)80069-8; LODISH HF, 1970, J MOL BIOL, V50, P689, DOI 10.1016/0022-2836(70)90093-8; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MURPHY S, 1989, TRENDS GENET, V5, P122, DOI 10.1016/0168-9525(89)90043-7; MUTHUKRISHNAN S, 1975, J BIOL CHEM, V250, P9336; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Ozgur S, 2015, CELL REP, V13, P703, DOI 10.1016/j.celrep.2015.09.033; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; ROTTMAN F, 1974, CELL, V3, P197, DOI 10.1016/0092-8674(74)90131-7; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; SHIMBA S, 1992, J BIOL CHEM, V267, P13772; Sonenberg N, 2012, SCIENCE, V337, P309, DOI 10.1126/science.1226820; Song YQ, 2015, NAT NEUROSCI, V18, P817, DOI 10.1038/nn.4019; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Temmel H, 2017, NUCLEIC ACIDS RES, V45, P4708, DOI 10.1093/nar/gkw1018; TYC K, 1983, EMBO J, V2, P605, DOI 10.1002/j.1460-2075.1983.tb01470.x; TYC K, 1987, J BIOL CHEM, V262, P12994; TYC K, 1984, EUR J BIOCHEM, V140, P503, DOI 10.1111/j.1432-1033.1984.tb08131.x; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; WAIBEL F, 1990, NATURE, V346, P199, DOI 10.1038/346199a0; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; WIEBAUER K, 1988, MOL CELL BIOL, V8, P2042, DOI 10.1128/MCB.8.5.2042; WODNARFILIPOWICZ A, 1975, ACTA BIOCHIM POL, V22, P11; WODNARFILIPOWICZ A, 1978, EUR J BIOCHEM, V92, P69, DOI 10.1111/j.1432-1033.1978.tb12724.x; ZANKOWALCZEWSKA M, 1977, NUCLEIC ACIDS RES, V4, P3065, DOI 10.1093/nar/4.9.3065; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	107	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8122	8135		10.1074/jbc.X117.789065	http://dx.doi.org/10.1074/jbc.X117.789065			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28381442	Green Published, hybrid			2022-12-28	WOS:000401788600001
J	Kawamata, T; Horie, T; Matsunami, M; Sasaki, M; Ohsumi, Y				Kawamata, Tomoko; Horie, Tetsuro; Matsunami, Miou; Sasaki, Michiko; Ohsumi, Yoshinori			Zinc starvation induces autophagy in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ALKALINE-PHOSPHATASE; KINASE; GENES; DEFICIENCY; INDUCTION; PATHWAY; COMPLEX; GROWTH	Zinc is an essential nutrient for all forms of life. Within cells, most zinc is bound to protein. Because zinc serves as a catalytic or structural cofactor for many proteins, cells must maintain zinc homeostasis under severely zinc-deficient conditions. In yeast, the transcription factor Zap1 controls the expression of genes required for uptake and mobilization of zinc, but to date the fate of existing zinc-binding proteins under zinc starvation remains poorly understood. Autophagy is an evolutionarily conserved cellular degradation/recycling process in which cytoplasmic proteins and organelles are sequestered for degradation in the vacuole/lysosome. In this study, we investigated how autophagy functions under zinc starvation. Zinc depletion induced non-selective autophagy, which is important for zinc-limited growth. Induction of autophagy by zinc starvation was not directly related to transcriptional activation of Zap1. Instead, TORC1 inactivation directed zinc starvation-induced autophagy. Abundant zinc proteins, such as Adh1, Fba1, and ribosomal protein Rpl37, were degraded in an autophagy-dependent manner. But the targets of autophagy were not restricted to zinc-binding proteins. When cellular zinc is severely depleted, this non-selective autophagy plays a role in releasing zinc from the degraded proteins and recycling zinc for other essential purposes.	[Kawamata, Tomoko; Horie, Tetsuro; Matsunami, Miou; Sasaki, Michiko; Ohsumi, Yoshinori] Tokyo Inst Technol, Inst Innovat Res, Res Unit Cell Biol, Yokohama, Kanagawa 2268503, Japan; [Horie, Tetsuro] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Res Ctr Odontol, Chiyoda Ku, Tokyo 1028159, Japan; [Kawamata, Tomoko] Japan Soc Promot Sci, Tokyo, Japan	Tokyo Institute of Technology; Nippon Dental University; Japan Society for the Promotion of Science	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Res Unit Cell Biol, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	, 堀江哲郎/AAV-2371-2020; Kawamata-HORIE, Tomoko/B-1699-2017; Ohsumi, Yoshinori/C-6449-2009	, 堀江哲郎/0000-0002-6713-6725; Kawamata-HORIE, Tomoko/0000-0002-3990-1194; Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science and Technology of Japan [23000015, 16H06375]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 23000015 (to Y. O.) and 16H06375 (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Horie T, 2017, J BIOL CHEM, V292, P8533, DOI 10.1074/jbc.M116.762963; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KANEKO Y, 1987, GENE, V58, P137; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3; Liuzzi JP, 2014, BIOMETALS, V27, P1087, DOI 10.1007/s10534-014-9773-0; Lynch CJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE25, DOI 10.1152/ajpendo.2001.281.1.E25; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Regalla LM, 2006, TOP CURR GENET, V14, P37; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Yamamoto H, 2016, DEV CELL, V38, P86, DOI 10.1016/j.devcel.2016.06.015; Zimbro M.J., 2009, DIFCO BBL MANUAL MAN	37	43	44	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8520	8530		10.1074/jbc.M116.762948	http://dx.doi.org/10.1074/jbc.M116.762948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28264932	Green Published, hybrid			2022-12-28	WOS:000401788600034
J	Zhao, HX; Han, ZJ; Liu, XY; Gu, JJ; Tang, F; Wei, G; Jin, Y				Zhao, Haixin; Han, Zhijun; Liu, Xinyuan; Gu, Junjie; Tang, Fan; Wei, Gang; Jin, Ying			The chromatin remodeler Chd4 maintains embryonic stem cell identity by controlling pluripotency- and differentiation-associated genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; NURD; COMPONENT; COMPLEX; NANOG; MBD3; ACTIVATION; ENZYMES; OCT3/4; STATE	The unique properties of embryonic stem cells (ESCs), including unlimited self-renewal and pluripotent differentiation potential, are sustained by integrated genetic and epigenetic networks composed of transcriptional factors and epigenetic modulators. However, the molecular mechanisms underlying the function of these regulators are not fully elucidated. Chromodomain helicase DNA-binding protein 4 (Chd4), an ATPase subunit of the nucleosome remodeling and deacetylase (NuRD) complex, is highly expressed in ESCs. However, its function in ESC regulation remains elusive. Here we report that Chd4 is required for the maintenance of ESC self-renewal. RNAi-mediated silencing of Chd4 disrupted self-renewal and up-regulated lineage commitment-associated genes under self-renewal culture conditions. During ESC differentiation in embryoid body formation, we observed significantly stronger induction of differentiation-associated genes in Chd4-deficient cells. The phenotype was different from that caused by the deletion of Mbd3, another subunit of the NuRD complex. Transcriptomic analyses revealed that Chd4 secured ESC identity by controlling the expression of subsets of pluripotency- and differentiation-associated genes. Importantly, Chd4 repressed the transcription of T box protein 3 (Tbx3), a transcription factor with important functions in ESC fate determination. Tbx3 knockdown partially rescued aberrant activation of differentiation-associated genes, especially of endoderm-associated genes, induced by Chd4 depletion. Moreover, we identified an interaction of Chd4 with the histone variant H2A. Z. This variant stabilized Chd4 by inhibiting Chd4 protein degradation through the ubiquitin-proteasome pathway. Collectively, this study identifies the Chd4-Tbx3 axis in controlling ESC fate and a role of H2A. Z in maintaining the stability of Chd4 proteins.	[Zhao, Haixin; Liu, Xinyuan; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci,Inst Hlth Sci,Shanghai Inst Biol, Key Lab Stem Cell Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Zhao, Haixin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Han, Zhijun; Wei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Gu, Junjie; Tang, Fan; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Shanghai Jiao Tong University	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci,Inst Hlth Sci,Shanghai Inst Biol, Key Lab Stem Cell Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022; WEI, GANG/AGL-1853-2022	WEI, GANG/0000-0001-5839-1276; Liu, Xinyuan/0000-0002-9754-0593	Ministry of Science and Technology of China [2016YFA0100101, 2013CB966801, 2013CB967101]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010102, XDB19020100]; National Natural Science Foundation [91419309, 91019023]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0100101, 2013CB966801, and 2013CB967101; Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA01010102 and XDB19020100; and National Natural Science Foundation Grants 91419309 and 91019023. The authors declare that they have no conflicts of interest with the contents of this article.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Fagnocchi L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11903; Gingold JA, 2014, MOL CELL, V56, P140, DOI 10.1016/j.molcel.2014.08.014; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lee DF, 2012, NAT PROTOC, V7, P729, DOI 10.1038/nprot.2012.018; Li YZ, 2013, GENOMICS, V102, P456, DOI 10.1016/j.ygeno.2013.09.004; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Low JKK, 2016, J BIOL CHEM, V291, P15853, DOI 10.1074/jbc.M115.707018; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Luo ZJ, 2015, MOL CELL, V57, P685, DOI 10.1016/j.molcel.2015.01.007; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Waghray A, 2015, STEM CELL REP, V5, P97, DOI 10.1016/j.stemcr.2015.05.009; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; Wang JX, 2015, STEM CELLS, V33, P2126, DOI 10.1002/stem.2011; Weidgang CE, 2013, STEM CELL REP, V1, P248, DOI 10.1016/j.stemcr.2013.08.002; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yang J, 2016, CELL REP, V15, P1809, DOI 10.1016/j.celrep.2016.04.058; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhang W, 2016, J MOL BIOL, V428, P2931, DOI 10.1016/j.jmb.2016.04.025; Zhao DY, 2014, BIOCHEM BIOPH RES CO, V444, P411, DOI 10.1016/j.bbrc.2014.01.093; Zhou Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.195; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684; Zhu LL, 2014, EMBO REP, V15, P1286, DOI 10.15252/embr.201438643	49	21	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8507	8519		10.1074/jbc.M116.770248	http://dx.doi.org/10.1074/jbc.M116.770248			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28298436	hybrid, Green Published			2022-12-28	WOS:000401788600033
J	Karlowicz, A; Wegrzyn, K; Gross, M; Kaczynska, D; Ropelewska, M; Siemiatkowska, M; Bujnicki, JM; Konieczny, I				Karlowicz, Anna; Wegrzyn, Katarzyna; Gross, Marta; Kaczynska, Dagmara; Ropelewska, Malgorzata; Siemiatkowska, Malgorzata; Bujnicki, Janusz M.; Konieczny, Igor			Defining the crucial domain and amino acid residues in bacterial Lon protease for DNA binding and processing of DNA-interacting substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; DNA-binding protein; Escherichia coli (E; coli); protein-DNA interaction; proteolysis	FOLD-RECOGNITION MODELS; ESCHERICHIA-COLI; MITOCHONDRIAL LON; ALLOSTERIC REGULATION; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; ATPASE ACTIVITY; PLASMID RK2; HOST-RANGE; REPLICATION	Lon protease previously has been shown to interact with DNA, but the role of this interaction for Lon proteolytic activity has not been characterized. In this study, we used truncated Escherichia coli Lon constructs, bioinformatics analysis, and site-directed mutagenesis to identify Lon domains and residues crucial for Lon binding with DNA and effects on Lon proteolytic activity. We found that deletion of Lon's ATPase domain abrogated interactions with DNA. Substitution of positively charged amino acids in this domain in full-length Lon with residues conferring a net negative charge disrupted binding of Lon to DNA. These changes also affected the degradation of nucleic acid-binding protein substrates of Lon, intracellular localization of Lon, and cell morphology. In vivo tests revealed that Lon-DNA interactions are essential for Lon activity in cell division control. In summary, we demonstrate that the ability of Lon to bind DNA is determined by its ATPase domain, that this binding is required for processing protein substrates in nucleoprotein complexes, and that Lon may help regulate DNA replication in response to growth conditions.	[Karlowicz, Anna; Wegrzyn, Katarzyna; Gross, Marta; Kaczynska, Dagmara; Ropelewska, Malgorzata; Konieczny, Igor] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Abrahama 58, PL-80307 Gdansk, Poland; [Siemiatkowska, Malgorzata; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Ksiecia Trojdena 4, PL-02109 Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Umultowska 89, PL-61614 Poznan, Poland	Fahrenheit Universities; University of Gdansk; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Konieczny, I (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Abrahama 58, PL-80307 Gdansk, Poland.	igor.konieczny@biotech.ug.edu.pl		Partyka, Malgorzata/0000-0002-4690-9223; Karlowicz, Anna/0000-0002-6940-8210; Konieczny, Igor/0000-0002-1588-5601; Wegrzyn, Katarzyna/0000-0002-3743-8597; Ropelewska, Malgorzata/0000-0003-0342-8320; Gross, Marta/0000-0001-5523-5702	Polish National Science Centre [2012/04/A/NZ1/00048]; Foundation for Polish Science - European Union [MPD/2010/5]; International Institute of Molecular and Cell Biology in Warsaw	Polish National Science Centre; Foundation for Polish Science - European Union(Foundation for Polish Science); International Institute of Molecular and Cell Biology in Warsaw	This work was supported in part by Polish National Science Centre Grant 2012/04/A/NZ1/00048. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Project MPD/2010/5 operated within the Foundation for Polish Science International Ph.D. Projects (MPD) Programme co-financed by the European Union European Regional Development Fund, Operational Program Innovative Economy 2007-2013.; Supported by statutory funds of the International Institute of Molecular and Cell Biology in Warsaw.	Arias-Palomo E, 2015, CELL, V162, P860, DOI 10.1016/j.cell.2015.07.037; Bissonnette SA, 2010, MOL MICROBIOL, V75, P1539, DOI 10.1111/j.1365-2958.2010.07070.x; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Cecarini V, 2016, CELL MOL LIFE SCI, V73, P3433, DOI 10.1007/s00018-016-2238-6; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; CHARETTE MF, 1984, J BACTERIOL, V158, P195, DOI 10.1128/JB.158.1.195-201.1984; CHUNG CH, 1982, P NATL ACAD SCI-BIOL, V79, P795, DOI 10.1073/pnas.79.3.795; Diago-Navarro E, 2013, PLASMID, V70, P78, DOI 10.1016/j.plasmid.2013.01.010; Doran KS, 1998, J BIOL CHEM, V273, P8447, DOI 10.1074/jbc.273.14.8447; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Duprey A, 2016, BBA-GENE REGUL MECH, V1859, P1470, DOI 10.1016/j.bbagrm.2016.08.001; Fu GK, 1997, J BIOL CHEM, V272, P534; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Gora KG, 2013, MOL MICROBIOL, V87, P1277, DOI 10.1111/mmi.12166; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur Eyal, 2013, Subcell Biochem, V66, P35, DOI 10.1007/978-94-007-5940-4_2; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; Kereiche S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33631; Kosinski J, 2005, PROTEINS, V61, P106, DOI 10.1002/prot.20726; Kosinski J, 2003, PROTEINS, V53, P369, DOI 10.1002/prot.10545; Kubik S, 2012, NUCLEIC ACIDS RES, V40, P1148, DOI 10.1093/nar/gkr813; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Lee AYL, 2014, ACTA CRYSTALLOGR D, V70, P218, DOI 10.1107/S139900471302631X; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Li M, 2010, ACTA CRYSTALLOGR D, V66, P865, DOI 10.1107/S0907444910019554; Lin CC, 2016, STRUCTURE, V24, P667, DOI 10.1016/j.str.2016.03.001; Lin YC, 2009, BIOCHEM BIOPH RES CO, V388, P62, DOI 10.1016/j.bbrc.2009.07.118; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7; Melnikov EE, 2008, ACTA BIOCHIM POL, V55, P281, DOI 10.18388/abp.2008_3075; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; Mukherjee S, 2015, P NATL ACAD SCI USA, V112, P250, DOI 10.1073/pnas.1417419112; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Nomura K, 2006, CELL MOL BIOL, V52, P22, DOI 10.1170/T723; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; Park SC, 2006, MOL CELLS, V21, P129; Pierechod M, 2009, PROTEIN SCI, V18, P637, DOI 10.1002/pro.68; Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Quiros PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018; Rudyak SG, 2000, PROTEIN SCI, V9, P1810, DOI 10.1110/ps.9.9.1810; Rudyak SG, 2001, BIOCHEMISTRY-US, V40, P9317, DOI 10.1021/bi0102508; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Shearstone JR, 1999, J BIOL CHEM, V274, P9937, DOI 10.1074/jbc.274.15.9937; Simmons LA, 2008, J BACTERIOL, V190, P6758, DOI 10.1128/JB.00590-08; Sonezaki S, 1995, APPL MICROBIOL BIOT, V44, P484; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; Su SC, 2016, STRUCTURE, V24, P676, DOI 10.1016/j.str.2016.03.003; TORRESCABASSA A, 1987, J BACTERIOL, V169, P4525, DOI 10.1128/jb.169.10.4525-4531.1987; Toukdarian AE, 1996, J BIOL CHEM, V271, P7072, DOI 10.1074/jbc.271.12.7072; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Vasilyeva OV, 2002, FEBS LETT, V526, P66, DOI 10.1016/S0014-5793(02)03117-4; Vieux EF, 2013, P NATL ACAD SCI USA, V110, pE2002, DOI 10.1073/pnas.1307066110; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Wawrzycka A, 2015, P NATL ACAD SCI USA, V112, pE4188, DOI 10.1073/pnas.1504926112; Wegrzyn K, 2014, NUCLEIC ACIDS RES, V42, P7807, DOI 10.1093/nar/gku453; Wegrzyn KE, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00039; WITKIN EM, 1947, GENETICS, V32, P221; Wohlever ML, 2014, MOL MICROBIOL, V91, P66, DOI 10.1111/mmi.12444; ZEHNBAUER BA, 1981, P NATL ACAD SCI-BIOL, V78, P2043, DOI 10.1073/pnas.78.4.2043; Zhang ET, 2015, P NATL ACAD SCI USA, V112, P14817, DOI 10.1073/pnas.1520104112; Zhong ZP, 2005, PLASMID, V54, P48, DOI 10.1016/j.plasmid.2004.11.001; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	73	14	14	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7507	7518		10.1074/jbc.M116.766709	http://dx.doi.org/10.1074/jbc.M116.766709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28292931	Green Published, hybrid			2022-12-28	WOS:000400761300019
J	Park, HB; Sampathkumar, P; Perez, CE; Lee, JH; Tran, J; Bonanno, JB; Hallem, EA; Almo, SC; Crawford, JM				Park, Hyun Bong; Sampathkumar, Parthasarathy; Perez, Corey E.; Lee, Joon Ha; Tran, Jeannie; Bonanno, Jeffrey B.; Hallem, Elissa A.; Almo, Steven C.; Crawford, Jason M.			Stilbene epoxidation and detoxification in a Photorhabdus luminescens-nematode symbiosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS EXPRESSION; JUVENILE-HORMONE; MODEL; XENORHABDUS; HOST; PATHOGENICITY; BIOSYNTHESIS; ASYMBIOTICA; MECHANISM; ECOLOGY	Members of the gammaproteobacterial Photorhabdus genus share mutualistic relationships with Heterorhabditis nematodes, and the pairs infect a wide swath of insect larvae. Photorhabdus species produce a family of stilbenes, with two major components being 3,5-dihydroxy-4-isopropyl-trans-stilbene (compound 1) and its stilbene epoxide (compound 2). This family of molecules harbors antimicrobial and immunosuppressive activities, and its pathway is responsible for producing a nematode "food signal" involved in nematode development. However, stilbene epoxidation biosynthesis and its biological roles remain unknown. Here, we identified an orphan protein (Plu2236) from Photorhabdus luminescens that catalyzes stilbene epoxidation. Structural, mutational, and biochemical analyses confirmed the enzyme adopts a fold common to FADdependent monooxygenases, contains a tightly bound FAD prosthetic group, and is required for the stereoselective epoxidation of compounds 1 and 2. The epoxidase gene was dispensable in a nematode-infective juvenile recovery assay, indicating the oxidized compound is not required for the food signal. The epoxide exhibited reduced cytotoxicity toward its producer, suggesting this may be a natural route for intracellular detoxification. In an insect infection model, we also observed two stilbene- derived metabolites that were dependent on the epoxidase. NMR, computational, and chemical degradation studies established their structures as new stilbene-L-proline conjugates, prolbenes A (compound 3) and B (compound 4). The prolbenes lacked immunosuppressive and antimicrobial activities compared with their stilbene substrates, suggesting a metabolite attenuation mechanism in the animal model. Collectively, our studies provide a structural view for stereoselective stilbene epoxidation and functionalization in an invertebrate animal infection model and provide new insights into stilbene cellular detoxification.	[Park, Hyun Bong; Perez, Corey E.; Crawford, Jason M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Park, Hyun Bong; Perez, Corey E.; Tran, Jeannie; Crawford, Jason M.] Yale Univ, Inst Chem Biol, West Haven, CT 06516 USA; [Sampathkumar, Parthasarathy; Bonanno, Jeffrey B.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Lee, Joon Ha; Hallem, Elissa A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Crawford, Jason M.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Sampathkumar, Parthasarathy] New York Struct Biol Ctr, New York, NY 10027 USA	Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles; Yale University	Crawford, JM (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	jason.crawford@yale.edu		Hallem, Elissa/0000-0003-0260-3174; Lee, Joon Ha/0000-0002-7254-829X	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886];  [U54 GM094662]; NATIONAL CANCER INSTITUTE [DP2CA186575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. David J. Clarke for providing P. luminescens hexA mutant strain. We thank the Yale Center for Research Computing for guidance and use of the research computing infrastructure. We also thank Dr. Joonseok Oh at Crawford laboratory for advice and comments regarding NMR computational chemistry. X-ray data presented in this publication was collected at the X29A beamline. We acknowledge the high-throughput X-ray crystallography team: M. Ahmed, N. Banu, R. Bhosle, S. Chamala, S. Chowdhury, A. Fiser, A. Gizzi, A. S. Glenn, J. Hammonds, B. Hillerich, K. Khafizov, J. Lafleur, J. D. Love, M. Stead, R. Seidel, and R. Toro. Use of the NSLS is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-98CH10886. The New York Structural Genomics Research Consortium was supported by U54 GM094662 to SCA.	AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; Bian XY, 2012, J NAT PROD, V75, P1652, DOI 10.1021/np300444e; Bode HB, 2015, ANGEW CHEM INT EDIT, V54, P10352, DOI 10.1002/anie.201502835; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brachmann AO, 2007, CHEMBIOCHEM, V8, P1721, DOI 10.1002/cbic.200700300; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Brachmann AO, 2012, J BIOTECHNOL, V157, P96, DOI 10.1016/j.jbiotec.2011.10.002; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Bruhn T, 2013, CHIRALITY, V25, P243, DOI 10.1002/chir.22138; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Clarke DJ, 2014, ADV APPL MICROBIOL, V88, P1, DOI 10.1016/B978-0-12-800260-5.00001-2; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Crawford JM, 2012, P NATL ACAD SCI USA, V109, P10821, DOI 10.1073/pnas.1201160109; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Dudnik A, 2013, MICROBIOL RES, V168, P73, DOI 10.1016/j.micres.2012.09.006; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu K, 2000, FEMS MICROBIOL LETT, V189, P219, DOI 10.1111/j.1574-6968.2000.tb09234.x; Hu KJ, 2006, BIOORGAN MED CHEM, V14, P4677, DOI 10.1016/j.bmc.2006.01.025; Hu KJ, 1997, J CHROMATOGR B, V703, P177, DOI 10.1016/S0378-4347(97)00398-8; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Kontnik R, 2010, ACS CHEM BIOL, V5, P659, DOI 10.1021/cb100117k; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nollmann FI, 2015, CHEMBIOCHEM, V16, P766, DOI 10.1002/cbic.201402650; Park HB, 2016, J ANTIBIOT, V69, P616, DOI 10.1038/ja.2016.79; Park HB, 2016, MOLECULES, V21, DOI 10.3390/molecules21070824; Park HB, 2015, J NAT PROD, V78, P1437, DOI 10.1021/np500974f; PAUL VJ, 1981, J CHEM ECOL, V7, P589, DOI 10.1007/BF00987707; RICHARDSON WH, 1988, APPL ENVIRON MICROB, V54, P1602, DOI 10.1128/AEM.54.6.1602-1605.1988; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smith SG, 2010, J AM CHEM SOC, V132, P12946, DOI 10.1021/ja105035r; Somvanshi VS, 2012, SCIENCE, V337, P88, DOI 10.1126/science.1216641; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Theodore CM, 2012, J NAT PROD, V75, P2007, DOI 10.1021/np300623x; Vivas EI, 2001, J BACTERIOL, V183, P4687, DOI 10.1128/JB.183.16.4687-4693.2001; Vizcaino MI, 2014, J IND MICROBIOL BIOT, V41, P285, DOI 10.1007/s10295-013-1356-5; Volkers G, 2011, FEBS LETT, V585, P1061, DOI 10.1016/j.febslet.2011.03.012; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	55	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6680	6694		10.1074/jbc.M116.762542	http://dx.doi.org/10.1074/jbc.M116.762542			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28246174	Green Published, hybrid			2022-12-28	WOS:000399813400020
J	Yiew, NKH; Chatterjee, TK; Tang, YL; Pellenberg, R; Stansfield, BK; Bagi, Z; Fulton, DJ; Stepp, DW; Chen, WQ; Patel, V; Kamath, VM; Litwin, SE; Hui, DY; Rudich, SM; Kim, HW; Weintraub, NL				Yiew, Nicole K. H.; Chatterjee, Tapan K.; Tang, Yao Liang; Pellenberg, Rod; Stansfield, Brian K.; Bagi, Zsolt; Fulton, David J.; Stepp, David W.; Chen, Weiqin; Patel, Vijay; Kamath, Vinayak M.; Litwin, Sheldon E.; Hui, David Y.; Rudich, Steven M.; Kim, Ha Won; Weintraub, Neal L.			A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE DYSFUNCTION; CATENIN SIGNALING PATHWAY; WNT/BETA-CATENIN; BETA-CATENIN; ADIPOGENIC DIFFERENTIATION; TRANSCRIPTION FACTORS; UP-REGULATION; STEM-CELLS; INFLAMMATION; MECHANISM	Impaired adipogenic differentiation during diet-induced obesity (DIO) promotes adipocyte hypertrophy and inflammation, thereby contributing to metabolic disease. Adenomatosis polyposis coli down-regulated 1 (APCDD1) has recently been identified as an inhibitor of Wnt signaling, a key regulator of adipogenic differentiation. Here we report a novel role for APCDD1 in adipogenic differentiation via repression of Wnt signaling and an epigenetic linkage between miR-130 and APCDD1 in DIO. APCDD1 expression was significantly up-regulated in mature adipocytes compared with undifferentiated preadipocytes in both human and mouse subcutaneous adipose tissues. siRNA-based silencing of APCDD1 in 3T3-L1 preadipocytes markedly increased the expression of Wnt signaling proteins (Wnt3a, Wnt5a, Wnt10b, LRP5, and beta-catenin) and inhibited the expression of adipocyte differentiation markers (CCAAT/enhancer-binding protein alpha (C/EBP alpha) and peroxisome proliferator-activated receptor gamma (PPAR gamma)) and lipid droplet accumulation, whereas adenovirus-mediated overexpression of APCDD1 enhanced adipogenic differentiation. Notably, DIO mice exhibited reduced APCDD1 expression and increased Wnt expression in both subcutaneous and visceral adipose tissues and impaired adipogenic differentiation in vitro. Mechanistically, we found that miR-130, whose expression is up-regulated in adipose tissues of DIO mice, could directly target the 3'-untranslated region of the APCDD1 gene. Furthermore, transfection of an miR-130 inhibitor in preadipocytes enhanced, whereas an miR-130 mimic blunted, adipogenic differentiation, suggesting that miR-130 contributes to impaired adipogenic differentiation during DIO by repressing APCDD1 expression. Finally, human subcutaneous adipose tissues isolated from obese individuals exhibited reduced expression of APCDD1, C/EBP alpha, and PPAR gamma compared with those from non-obese subjects. Taken together, these novel findings suggest that APCDD1 positively regulates adipogenic differentiation and that its down-regulation by miR-130 during DIO may contribute to impaired adipogenic differentiation and obesity-related metabolic disease.	[Yiew, Nicole K. H.; Fulton, David J.] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Chatterjee, Tapan K.; Tang, Yao Liang; Bagi, Zsolt; Kim, Ha Won; Weintraub, Neal L.] Augusta Univ, Med Coll Georgia, Dept Med, Div Cardiol, Augusta, GA 30912 USA; [Pellenberg, Rod; Stansfield, Brian K.] Augusta Univ, Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Stepp, David W.; Chen, Weiqin] Augusta Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA; [Patel, Vijay; Kamath, Vinayak M.] Augusta Univ, Med Coll Georgia, Dept Cardiothorac & Vasc Surg, Augusta, GA 30912 USA; [Yiew, Nicole K. H.; Chatterjee, Tapan K.; Tang, Yao Liang; Stansfield, Brian K.; Bagi, Zsolt; Fulton, David J.; Stepp, David W.; Kim, Ha Won; Weintraub, Neal L.] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Litwin, Sheldon E.] Med Univ South Carolina, Div Cardiol, Dept Med, Charleston, SC 29425 USA; [Hui, David Y.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45219 USA; [Rudich, Steven M.] Gift Life Michigan, Ann Arbor, MI 48108 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Medical University of South Carolina; University System of Ohio; University of Cincinnati	Kim, HW; Weintraub, NL (corresponding author), Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Dept Med,Div Cardiol, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	hkim3@augusta.edu; nweintraub@augusta.edu	Chen, Weiqin/I-9782-2019	Chen, Weiqin/0000-0002-3894-5953; Kim, Ha Won/0000-0001-6272-4248; Weintraub, Neal/0000-0002-5138-3705; Tang, Yaoliang/0000-0002-8372-1545; Stansfield, Brian/0000-0002-1105-8895; Bagi, Zsolt/0000-0001-8755-2980	National Institutes of Health [HL126949, HL112640, HL134354, AR070029]; Department of Defense [NF140031]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086555, R01HL124773, R01HL134354, R01HL126949, R01HL112640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants HL126949 and HL112640 (to N. L. W.) and HL134354 and AR070029 (to Y. L. T. and N. L. W.) and Department of Defense Grant NF140031 (to B. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aonuma H, 2012, CELL TISSUE RES, V350, P317, DOI 10.1007/s00441-012-1477-6; Catalan V, 2014, J CLIN ENDOCR METAB, V99, pE1407, DOI 10.1210/jc.2014-1191; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chatterjee TK, 2014, ADIPOCYTE, V3, P333, DOI 10.4161/adip.28814; Chatterjee TK, 2014, DIABETES, V63, P176, DOI 10.2337/db13-1148; Chatterjee TK, 2013, PHYSIOL GENOMICS, V45, P697, DOI 10.1152/physiolgenomics.00042.2013; Chatterjee TK, 2011, J BIOL CHEM, V286, P27836, DOI 10.1074/jbc.M111.262964; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Chen L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03819; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim C, 2013, FEBS LETT, V587, P3853, DOI 10.1016/j.febslet.2013.10.018; Kim JI, 2015, MOL CELL BIOL, V35, P1686, DOI 10.1128/MCB.01321-14; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lee HK, 2015, GLIA, V63, P1840, DOI 10.1002/glia.22848; Lee KT, 2006, GENOMICS, V87, P218, DOI 10.1016/j.ygeno.2005.09.002; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Neupane S, 2015, HISTOCHEM CELL BIOL, V144, P377, DOI 10.1007/s00418-015-1345-z; Qadir AS, 2013, EXP CELL RES, V319, P2125, DOI 10.1016/j.yexcr.2013.04.020; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Takahashi M, 2002, CANCER RES, V62, P5651; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Ullah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069754; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Viale-Bouroncle S, 2015, BIOCHEM BIOPH RES CO, V457, P314, DOI 10.1016/j.bbrc.2014.12.107; Villeneuve LM, 2011, CLIN EXP PHARMACOL P, V38, P401, DOI 10.1111/j.1440-1681.2011.05497.x; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600	48	16	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6312	6324		10.1074/jbc.M116.758078	http://dx.doi.org/10.1074/jbc.M116.758078			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28242765	Green Published, hybrid			2022-12-28	WOS:000399538700025
J	Belyaeva, OV; Adams, MK; Wu, LZ; Kedishvili, NY				Belyaeva, Olga V.; Adams, Mark K.; Wu, Lizhi; Kedishvili, Natalia Y.			The antagonistically bifunctional retinoid oxidoreductase complex is required for maintenance of all-trans-retinoic acid homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; homeostasis; reductase; retinoic acid; retinol; vitamin A	EMBRYONIC-DEVELOPMENT; DEHYDROGENASE 10; CELL-LINES; VITAMIN-A; DHRS3; METABOLISM; REDUCTASE; RDH10; BIOSYNTHESIS; ENZYME	All-trans-retinoic acid (RA), a bioactive derivative of vitamin A, exhibits diverse effects on gene transcription and non-genomic regulatory pathways. The steady-state levels of RA are therefore tightly controlled, but the mechanisms responsible for RA homeostasis are not fully understood. We report a molecular mechanism that allows cells to maintain a stable rate of RA biosynthesis by utilizing a biological circuit generated by a bifunctional retinoid oxidoreductive complex (ROC). We show that ROC is composed of at least two subunits of NAD(+)-dependent retinol dehydrogenase 10 (RDH10), which catalyzes the oxidation of retinol to retinaldehyde, and two subunits of NADPH-dependent dehydrogenase reductase 3 (DHRS3), which catalyzes the reduction of retinaldehyde back to retinol. RDH10 and DHRS3 also exist as homo-oligomers. When complexed, RDH10 and DHRS3 mutually activate and stabilize each other. These features of ROC ensure that the rate of RA biosynthesis in whole cells is largely independent of the concentration of the individual ROC components. ROC operates in various subcellular fractions including microsomes, mitochondria, and lipid droplets; however, lipid droplets display weaker mutual activation between RDH10 and DHRS3, suggesting reduced formation of ROC. Importantly, disruption of the ROC-generated circuit by a knockdown of DHRS3 results in an increased flux through the RA biosynthesis pathway and elevated RA levels despite the decrease in RDH10 protein destabilized by the absence of DHRS3, hence demonstrating a loss of control. Thus, the bifunctional nature of ROC provides the RA-based signaling system with robustness by safeguarding appropriate RA concentration despite naturally occurring fluctuations in RDH10 and DHRS3.	[Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, 720 20th St S,Kaul 440B, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, 720 20th St S,Kaul 440B, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, 720 20th St S,Kaul 440B, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891; Beliaeva, Olga/0000-0003-2512-925X	National Institutes of Health from the National Institute on Alcohol Abuse and Alcoholism [AA12153]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant AA12153 from the National Institute on Alcohol Abuse and Alcoholism. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams M. K., 2016, CHEM BIOL INTERACT; Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2012, J BIOL CHEM, V287, P9061, DOI 10.1074/jbc.M111.336727; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Bhatia C, 2015, CHEM-BIOL INTERACT, V234, P114, DOI 10.1016/j.cbi.2014.12.013; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Cerignoli F, 2002, CANCER RES, V62, P1196; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Lee SA, 2008, BBA-MOL BASIS DIS, V1782, P421, DOI 10.1016/j.bbadis.2008.03.004; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sandell LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030698; Venkatesan R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5805; Zolfaghari R, 2012, AM J PHYSIOL-GASTR L, V303, pG578, DOI 10.1152/ajpgi.00234.2012	27	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5884	5897		10.1074/jbc.M117.776914	http://dx.doi.org/10.1074/jbc.M117.776914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28232491	hybrid, Green Published			2022-12-28	WOS:000398813200023
J	Johnson, AN; Weil, PA				Johnson, Amanda N.; Weil, P. Anthony			Identification of a transcriptional activation domain in yeast repressor activator protein 1 (Rap1) using an altered DNA-binding specificity variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; protein engineering; Saccharomyces cerevisiae; transcription regulation; yeast; altered DNA binding specificity; transcription activation; transcription activator	RNA-POLYMERASE-II; HYDROPHOBIC AMINO-ACIDS; C-TERMINAL DOMAINS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ESCHERICHIA-COLI; BUDDING YEAST; IN-VIVO; REGULATORY MECHANISMS; HISTONE ACETYLATION	Repressor activator protein 1 (Rap1) performs multiple vital cellular functions in the budding yeast Saccharomyces cerevisiae. These include regulation of telomere length, transcriptional repression of both telomere-proximal genes and the silent mating type loci, and transcriptional activation of hundreds of mRNA-encoding genes, including the highly transcribed ribosomal protein- and glycolytic enzyme-encoding genes. Studies of the contributions of Rap1 to telomere length regulation and transcriptional repression have yielded significant mechanistic insights. However, the mechanism of Rap1 transcriptional activation remains poorly understood because Rap1 is encoded by a single copy essential gene and is involved in many disparate and essential cellular functions, preventing easy interpretation of attempts to directly dissect Rap1 structure-function relationships. Moreover, conflicting reports on the ability of Rap1-heterologous DNA-binding domain fusion proteins to serve as chimeric transcriptional activators challenge use of this approach to study Rap1. Described here is the development of an altered DNA-binding specificity variant of Rap1 (Rap1(AS)). We used Rap1(AS) to map and characterize a 41-amino acid activation domain (AD) within the Rap1 C terminus. We found that this AD is required for transcription of both chimeric reporter genes and authentic chromosomal Rap1 enhancer-containing target genes. Finally, as predicted for a bona fide AD, mutation of this newly identified AD reduced the efficiency of Rap1 binding to a known transcriptional coactivator TFIID-binding target, Taf5. In summary, we show here that Rap1 contains an AD required for Rap1-dependent gene transcription. The Rap1(AS) variant will likely also be useful for studies of the functions of Rap1 in other biological pathways.	[Johnson, Amanda N.; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu		Meyer Johnson, Amanda/0000-0001-7594-6747	National Institutes of Health [R01GM115892, T32DK007563]; National Institutes of Health Cancer Center Core Grant [5P30CA06848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM115892 (to P. A. W.) and National Institutes of Health Cancer Center Core Grant 5P30CA06848. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of National Institutes of Health Grant Training Grant T32DK007563 during the course of these studies.	An YF, 2005, APPL MICROBIOL BIOT, V68, P774, DOI 10.1007/s00253-005-1948-8; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Brachmann CB, 1998, YEAST, V14, P115; BRENNAN MB, 1980, J MOL BIOL, V136, P333, DOI 10.1016/0022-2836(80)90377-0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CHAMBERS A, 1989, MOL CELL BIOL, V9, P5516, DOI 10.1128/MCB.9.12.5516; Chambers A, 1995, CURR GENET, V29, P1, DOI 10.1007/BF00313187; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; CHOW J, 1994, MOL MICROBIOL, V11, P919, DOI 10.1111/j.1365-2958.1994.tb00371.x; Chu SW, 2012, GENOME RES, V22, P1889, DOI 10.1101/gr.139014.112; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Feeser EA, 2008, J MOL BIOL, V380, P520, DOI 10.1016/j.jmb.2008.04.078; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Graham IR, 1999, MOL CELL BIOL, V19, P7481; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Gregory BD, 2005, MOL MICROBIOL, V56, P1208, DOI 10.1111/j.1365-2958.2005.04624.x; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HENRY YAL, 1990, NUCLEIC ACIDS RES, V18, P2617, DOI 10.1093/nar/18.9.2617; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HUET J, 1985, EMBO J, V4, P3539, DOI 10.1002/j.1460-2075.1985.tb04114.x; Idrissi FZ, 1998, J MOL BIOL, V284, P925, DOI 10.1006/jmbi.1998.2215; Idrissi FZ, 2001, J BIOL CHEM, V276, P26090, DOI 10.1074/jbc.M101746200; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Irvin JD, 2006, J BIOL CHEM, V281, P6404, DOI 10.1074/jbc.M513776200; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kasahara K, 2008, NUCLEIC ACIDS RES, V36, P1343, DOI 10.1093/nar/gkm1068; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; KIM J, 1993, P NATL ACAD SCI USA, V90, P4513, DOI 10.1073/pnas.90.10.4513; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Knight B, 2014, GENE DEV, V28, P1695, DOI 10.1101/gad.244434.114; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Layer JH, 2013, J BIOL CHEM, V288, P23273, DOI 10.1074/jbc.M113.486829; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Ma DM, 1996, P NATL ACAD SCI USA, V93, P6583, DOI 10.1073/pnas.93.13.6583; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Matot B, 2012, NUCLEIC ACIDS RES, V40, P3197, DOI 10.1093/nar/gkr1166; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Miyake T, 2000, J BIOL CHEM, V275, P40169, DOI 10.1074/jbc.M007138200; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; MURTHY MSS, 1975, MUTAT RES, V27, P219, DOI 10.1016/0027-5107(75)90080-9; NIEUWINT RTM, 1989, CURR GENET, V15, P247, DOI 10.1007/BF00447039; Nilsson MTI, 2004, BIOCHEMISTRY-US, V43, P12038, DOI 10.1021/bi049122k; Ohtsuki K, 2010, NUCLEIC ACIDS RES, V38, P1805, DOI 10.1093/nar/gkp1172; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; PFAU J, 1994, BIOCHEMISTRY-US, V33, P11391, DOI 10.1021/bi00203a038; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ranish JA, 1996, CURR OPIN GENET DEV, V6, P151, DOI 10.1016/S0959-437X(96)80044-X; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Reja R, 2015, GENE DEV, V29, P1942, DOI 10.1101/gad.268896.115; Ren XD, 2011, MOL CELL, V42, P342, DOI 10.1016/j.molcel.2011.04.011; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; SCOTT EW, 1993, MOL CELL BIOL, V13, P543, DOI 10.1128/MCB.13.1.543; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Singh MV, 2004, MOL CELL BIOL, V24, P4929, DOI 10.1128/MCB.24.11.4929-4942.2004; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; Tomar RS, 2008, EMBO J, V27, P1575, DOI 10.1038/emboj.2008.93; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Uprety B, 2015, MOL CELL BIOL, V35, P2947, DOI 10.1128/MCB.01524-14; VIGNAIS ML, 1987, EMBO J, V6, P1451, DOI 10.1002/j.1460-2075.1987.tb02386.x; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Warfield L, 2014, P NATL ACAD SCI USA, V111, pE3506, DOI 10.1073/pnas.1412088111; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Yu LN, 2001, J BIOL CHEM, V276, P33257, DOI 10.1074/jbc.M104354200; Zhang W, 2011, BIOCHEM BIOPH RES CO, V404, P1055, DOI 10.1016/j.bbrc.2010.12.109; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05	130	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5705	5723		10.1074/jbc.M117.779181	http://dx.doi.org/10.1074/jbc.M117.779181			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196871	hybrid, Green Published			2022-12-28	WOS:000398813200009
J	Moody, LR; Barrett-Wilt, GA; Sussman, MR; Messing, A				Moody, Laura R.; Barrett-Wilt, Gregory A.; Sussman, Michael R.; Messing, Albee			Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of alexander disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glial cell; intermediate filament; mouse; protein turnover; Alexander disease; SILAC; SILAM; gfap; glial fibrillary acidic protein	ALPHA-B-CRYSTALLIN; CYTOSKELETAL PROTEINS; GFAP ACCUMULATION; ROSENTHAL FIBERS; STRESS-RESPONSE; CELL-CULTURE; ASTROCYTES; MUTATIONS; MICE; DEGRADATION	Mutations in the astrocyte-specific intermediate filament glial fibrillary acidic protein (GFAP) lead to the rare and fatal disorder, Alexander disease (AxD). A prominent feature of the disease is aberrant accumulation of GFAP. It has been proposed that this accumulation occurs because of an increase in gene transcription coupled with impaired proteasomal degradation, yet this hypothesis remains untested. We therefore sought to directly investigate GFAP turnover in a mouse model of AxD that is heterozygous for a disease-causing point mutation (Gfap(R236H/+)) (and thus expresses both wild-type and mutant protein). Stable isotope labeling by amino acids in cell culture, using primary cortical astrocytes, indicated that the in vitro half-lives of total GFAP in astrocytes from wild-type and mutant mice were similar at approximate to 3-4 days. Surprisingly, results obtained with stable isotope labeling of mammals revealed that, in vivo, the half-life of GFAP in mutant mice (15.4 +/- 0.5 days) was much shorter than that in wild-type mice (27.5 +/- 1.6 days). These unexpected in vivo data are most consistent with a model in which synthesis and degradation are both increased. Our work reveals that an AxD-causing mutation alters GFAP turnover kinetics in vivo and provides an essential foundation for future studies aimed at preventing or reducing the accumulation of GFAP. In particular, these data suggest that elimination of GFAP might be possible and occurs more quickly than previously surmised.	[Moody, Laura R.; Messing, Albee] Univ Wisconsin Madison, Waisman Ctr, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA; [Barrett-Wilt, Gregory A.; Sussman, Michael R.] Univ Wisconsin Madison, Ctr Biotechnol, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA; [Sussman, Michael R.] Univ Wisconsin Madison, Dept Biochem, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin Madison, Dept Comparat Biosci, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Messing, A (corresponding author), Univ Wisconsin Madison, Waisman Ctr, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA.	amessing@wisc.edu		Messing, Albee/0000-0001-6049-0521	Jelte Rijkaart Fund; National Institutes of Health [NS42803, HD076892, HD03352, HD090256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090256, P30HD003352, P01HD076892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER	Jelte Rijkaart Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Jelte Rijkaart Fund and by National Institutes of Health Grants NS42803, HD076892, HD03352, and HD090256. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Chen YS, 2011, EXP CELL RES, V317, P2252, DOI 10.1016/j.yexcr.2011.06.017; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Cho WS, 2010, HUM MOL GENET, V19, P3169, DOI 10.1093/hmg/ddq227; Cho WS, 2009, EXP CELL RES, V315, P1260, DOI 10.1016/j.yexcr.2008.12.012; Daniels CML, 2012, J NEUROSCI, V32, P10507, DOI 10.1523/JNEUROSCI.1494-12.2012; DEARMOND SJ, 1986, J NEUROCHEM, V47, P1749, DOI 10.1111/j.1471-4159.1986.tb13084.x; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Heaven MR, 2016, J PROTEOME RES, V15, P2265, DOI 10.1021/acs.jproteome.6b00316; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; INAGAKI M, 1994, BRAIN PATHOL, V4, P239, DOI 10.1111/j.1750-3639.1994.tb00839.x; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Perng MD, 1999, J CELL SCI, V112, P2099; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; RAJU TR, 1980, BRAIN RES, V200, P225, DOI 10.1016/0006-8993(80)91114-2; ROLLAND B, 1990, DEV BRAIN RES, V56, P144, DOI 10.1016/0165-3806(90)90175-X; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SMITH ME, 1984, NEUROCHEM RES, V9, P1493, DOI 10.1007/BF00964675; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Walker AK, 2014, J NEUROSCI, V34, P6448, DOI 10.1523/JNEUROSCI.0248-14.2014; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	51	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5814	5824		10.1074/jbc.M116.772020	http://dx.doi.org/10.1074/jbc.M116.772020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223355	Green Published, hybrid			2022-12-28	WOS:000398813200018
J	Sood, C; Marin, M; Chande, A; Pizzato, M; Melikyan, GB				Sood, Chetan; Marin, Mariana; Chande, Ajit; Pizzato, Massimo; Melikyan, Gregory B.			SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; host defense; membrane fusion; peptides; virus entry; Env inactivation; HIV neutralization; conformational changes; hemifusion; membrane-proximal extracellular domain	IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; MEDIATED MEMBRANE-FUSION; NEUTRALIZING ANTIBODIES; HEPTAD REPEAT; COILED-COIL; CELL-FUSION; NEF; GP41; INFECTIVITY	The host proteins, SERINC3 and SERINC5, have been recently shown to incorporate into HIV-1 particles and compromise their ability to fuse with target cells, an effect that is antagonized by the viral Nef protein. Envelope (Env) glycoproteins from different HIV-1 isolates exhibit a broad range of sensitivity to SERINC-mediated restriction, and the mechanism by which SERINCs interfere with HIV-1 fusion remains unclear. Here, we show that incorporation of SERINC5 into virions in the absence of Nef inhibits the formation of small fusion pores between viruses and cells. Strikingly, we found that SERINC5 promotes spontaneous functional inactivation of sensitive but not resistant Env glycoproteins. Although SERINC5-Env interaction was not detected by co-immunoprecipitation, incorporation of this protein enhanced the exposure of the conserved gp41 domains and sensitized the virus to neutralizing antibodies and gp41-derived inhibitory peptides. These results imply that SERINC5 restricts HIV-1 fusion at a step prior to small pore formation by selectively inactivating sensitive Env glycoproteins, likely through altering their conformation. The increased HIV-1 sensitivity to anti-gp41 antibodies and peptides suggests that SER5 also delays refolding of the remaining fusion-competent Env trimers.	[Sood, Chetan; Marin, Mariana; Melikyan, Gregory B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Chande, Ajit; Pizzato, Massimo] Univ Trento, Ctr Integrat Biol, I-38123 Trento, Italy	Emory University; University of Trento	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Pizzato, Massimo/AFL-0051-2022; Chande, Ajit/K-5031-2014	Pizzato, Massimo/0000-0002-9491-1483; Chande, Ajit/0000-0003-2210-5180	National Institutes of Health [R01 GM054787]; FP7 Marie Curie Career Integration Grant [322130]; Caritro "Ricerca Biomedica" [2013.0248]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7 Marie Curie Career Integration Grant; Caritro "Ricerca Biomedica"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM054787 (to G. B. M.), FP7 Marie Curie Career Integration Grant 322130, and Caritro "Ricerca Biomedica" Grant 2013.0248 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021339; Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Beitari S, 2017, J VIROL, V91, DOI 10.1128/JVI.02214-16; Brandenberg OF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004595; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Demirkhanyan L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003431; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gustchina E, 2005, J MED CHEM, V48, P3036, DOI 10.1021/jm049026h; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Jeetendra E, 2002, J VIROL, V76, P12300, DOI 10.1128/JVI.76.23.12300-12311.2002; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nelson JD, 2008, VIROLOGY, V377, P170, DOI 10.1016/j.virol.2008.04.005; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Peachman KK, 2010, VIROLOGY, V408, P213, DOI 10.1016/j.virol.2010.09.029; Pizzato M, 2008, J VIROL, V82, P10811, DOI 10.1128/JVI.01150-08; Rathinakumar R, 2012, J VIROL, V86, P1820, DOI 10.1128/JVI.05489-11; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Sood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148944; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Tobiume M, 2001, ARCH VIROL, V146, P1739, DOI 10.1007/s007050170060; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JQ, 2009, J VIROL METHODS, V161, P216, DOI 10.1016/j.jviromet.2009.06.017; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	64	79	82	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					6014	6026		10.1074/jbc.M117.777714	http://dx.doi.org/10.1074/jbc.M117.777714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28179429	Green Published, hybrid			2022-12-28	WOS:000398813200034
J	Schlame, M; Xu, Y; Ren, MD				Schlame, Michael; Xu, Yang; Ren, Mindong			The Basis for Acyl Specificity in the Tafazzin Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARTH-SYNDROME; LYSOPHOSPHOLIPID ACYLTRANSFERASES; BIOCHEMICAL THERMODYNAMICS; CARDIOLIPIN; TRANSACYLATION; METABOLISM; MECHANISM; MEMBRANE; KINETICS; P-31-NMR	Tafazzin is a mitochondrial enzyme that transfers fatty acids from phospholipids to lysophospholipids. Mutations in tafazzin cause abnormal molecular species of cardiolipin and the clinical phenotype of Barth syndrome. However, the mechanism by which tafazzin creates acyl specificity has been controversial. We have shown that the lipid phase state can produce acyl specificity in the tafazzin reaction, but others have reported that tafazzin itself carries enzymatic specificity. To resolve this issue, we replicated and expanded the controversial experiments, i.e. the transfer of different acyl groups from phosphatidylcholine to monolysocardiolipin by yeast tafazzin. Our data show that this reaction requires the presence of detergent and does not take place in liposomes but in mixed micelles. To separate thermodynamic (lipid-dependent) from kinetic (enzyme-dependent) parameters, we followed the accumulation of cardiolipin during the reaction from the initial state to the equilibrium state. The transacylation rates of different acyl groups varied over 2 orders of magnitude and correlated tightly with the concentration of cardiolipin in the equilibrium state (lipid-dependent parameter). In contrast, the rates by which different transacylations approached the equilibrium state were very similar (enzyme-dependent parameter). Furthermore, we found that tafazzin catalyzes the remodeling of cardiolipin by combinations of forward and reverse transacylations, essentially creating an equilibrium distribution of acyl groups. These data strongly support the idea that the acyl specificity of the tafazzin reaction results from the physical properties of lipids.	[Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Schlame, M (corresponding author), NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA.	michael.schlame@med.nyu.edu			National Institutes of Health [GM115593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM115593 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe M, 2016, J BIOL CHEM, V291, P15491, DOI 10.1074/jbc.M116.718510; Alberty RA, 2006, BIOPHYS CHEM, V124, P11, DOI 10.1016/j.bpc.2006.05.024; Alberty RA, 2011, BIOPHYS CHEM, V155, P89, DOI 10.1016/j.bpc.2011.03.007; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; CULLIS PR, 1980, BIOCHIM BIOPHYS ACTA, V600, P625, DOI 10.1016/0005-2736(80)90466-6; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V684, P47, DOI 10.1016/0005-2736(82)90047-5; DENNIS EA, 1974, ARCH BIOCHEM BIOPHYS, V165, P764, DOI 10.1016/0003-9861(74)90305-1; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Haldane JBS, 1930, ENZYMES, P74; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Neuwald AF, 1997, CURR BIOL, V7, pR465; Noor E, 2013, FEBS LETT, V587, P2772, DOI 10.1016/j.febslet.2013.07.028; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Tyurina YY, 2017, ACS CHEM BIOL, V12, P265, DOI 10.1021/acschembio.6b00995; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001	26	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5499	5506		10.1074/jbc.M116.769182	http://dx.doi.org/10.1074/jbc.M116.769182			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202545	hybrid, Green Published			2022-12-28	WOS:000397875500029
J	Nagalingam, RS; Sundaresan, NR; Noor, M; Gupta, MP; Solaro, RJ; Gupta, M				Nagalingam, Raghu S.; Sundaresan, Nagalingam R.; Noor, Mariam; Gupta, Mahesh P.; Solaro, R. John; Gupta, Madhu			RETRACTION: Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor beta(TGF beta 1)-dependent paracrine mechanism. (Retraction of Vol 289, Pg 27199, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Gupta, Madhu/E-7705-2019	Gupta, Madhu/0000-0002-8503-0609				NAGALINGAM RS, 2014, DEFICIENCY CARDIOMYO, V289, P27199	1	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5124	5124		10.1074/jbc.A114.580977	http://dx.doi.org/10.1074/jbc.A114.580977			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28341712	Green Published, hybrid			2022-12-28	WOS:000397590400032
J	Yang, Z; Li, J; Feng, GX; Gao, S; Wang, Y; Zhang, SQ; Liu, YX; Ye, LH; Li, YG; Zhang, XD				Yang, Zhe; Li, Jiong; Feng, Guoxing; Gao, Shan; Wang, Yuan; Zhang, Shuqin; Liu, Yunxia; Ye, Lihong; Li, Yueguo; Zhang, Xiaodong			MicroRNA-145 Modulates N-6-Methyladenosine Levels by Targeting the 3 '-Untranslated mRNA Region of the N-6-Methyladenosine Binding YTH Domain Family 2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); microRNA mechanism; mRNA decay; RNA methylation; RNA modification; N6-methyladenosine (m6A); YTH domain family 2 (YTHDF2); mRNA degradation; miR-145	BREAST-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; INHIBITS PROLIFERATION; HEPATOMA-CELLS; MIR-145; GROWTH; N6-METHYLADENOSINE; BIOGENESIS; M(6)A; METHYLATION	N-6-Methyladenosine (m(6)A) is a prevalent modification present in the mRNAs of higher eukaryotes. YTH domain family 2 (YTHDF2), an m(6)A reader protein, can recognize mRNA m(6)A sites to mediate mRNA degradation. However, the regulatory mechanism of YTHDF2 is poorly understood. To this end, we investigated the post-transcriptional regulation of YTHDF2. Bioinformatics analysis suggested that the microRNA miR-145 might target the 3-untranslated region (3-UTR) of YTHDF2 mRNA. The levels of miR-145 were negatively correlated with those of YTHDF2 mRNA in clinical hepatocellular carcinoma (HCC) tissues, and immunohistochemical staining revealed that YTHDF2 was closely associated with malignancy of HCC. Interestingly, miR-145 decreased the luciferase activities of 3-UTR of YTHDF2 mRNA. Mutation of predicted miR-145 binding sites in the 3-UTR of YTHDF2 mRNA abolished the miR-145-induced decrease in luciferase activity. Overexpression of miR-145 dose-dependently down-regulated YTHDF2 expression in HCC cells at the levels of both mRNA and protein. Conversely, inhibition of miR-145 resulted in the up-regulation of YTHDF2 in the cells. Dot blot analysis and immunofluorescence staining revealed that the overexpression of miR-145 strongly increased m(6)A levels relative to those in control HCC cells, and this increase could be blocked by YTHDF2 overexpression. Moreover, miR-145 inhibition strongly decreased m(6)A levels, which were rescued by treatment with a small interfering RNA-based YTHDF2 knockdown. Thus, we conclude that miR-145 modulates m(6)A levels by targeting the 3-UTR of YTHDF2 mRNA in HCC cells.	[Yang, Zhe; Li, Jiong; Feng, Guoxing; Gao, Shan; Wang, Yuan; Zhang, Shuqin; Liu, Yunxia; Zhang, Xiaodong] Nankai Univ, Dept Canc Res, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Li, Yueguo] Tianjin Med Univ, Dept Clin Lab, Natl Clin Res Ctr Canc, Canc Inst & Hosp,Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China	Nankai University; Nankai University; Tianjin Medical University	Zhang, XD (corresponding author), Nankai Univ, Dept Canc Res, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Li, YG (corresponding author), Tianjin Med Univ, Dept Clin Lab, Natl Clin Res Ctr Canc, Canc Inst & Hosp,Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China.	yli08@tmu.edu.cn; zhangxd@nankai.edu.cn	Feng, Guoxing/AAD-6163-2019; wangwangwang, yuanyaun/HHN-6432-2022; Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022		National Natural Scientific Foundation of China [81272218, 81372186, 31470756]; National Basic Research Program of China [2015CB553703]; Tianjin Natural Scientific Foundation [14JCZDJC32800]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Tianjin Natural Scientific Foundation	This work was supported by the National Natural Scientific Foundation of China (81272218, 81372186, 31470756), the National Basic Research Program of China (2015CB553703), and Tianjin Natural Scientific Foundation (14JCZDJC32800). The authors declare that they have no conflicts of interest with the contents of this article.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Haim MS, 2015, CELL RES, V25, P3, DOI 10.1038/cr.2014.162; Cardelli M, 2006, J GERONTOL A-BIOL, V61, P547, DOI 10.1093/gerona/61.6.547; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Chandola U, 2015, BRIEF FUNCT GENOMICS, V14, P169, DOI 10.1093/bfgp/elu039; Chen JP, 2015, J PHYSIOL BIOCHEM, V71, P405, DOI 10.1007/s13105-015-0420-1; Chiyomaru T, 2011, PROSTATE, V71, P1559, DOI 10.1002/pros.21372; Ding W, 2016, TUMOR BIOL, V37, P6255, DOI 10.1007/s13277-015-4462-3; Dong RF, 2014, ONCOTARGET, V5, P10816, DOI 10.18632/oncotarget.2522; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Dynoodt P, 2013, J INVEST DERMATOL, V133, P201, DOI 10.1038/jid.2012.266; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hastings MH, 2013, CELL, V155, P740, DOI 10.1016/j.cell.2013.10.028; Ji LY, 2013, PHARMAZIE, V68, P387, DOI 10.1691/ph.2013.2716; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Liu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9494; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Ozen M, 2015, CANCER INVEST, V33, P251, DOI 10.3109/07357907.2015.1025407; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Saletore Y, 2013, RNA BIOL, V10, P342, DOI 10.4161/rna.23812; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Todorova T, 2015, TRENDS MOL MED, V21, P373, DOI 10.1016/j.molmed.2015.03.002; Wang F, 2013, ONKOLOGIE, V36, P754, DOI 10.1159/000356978; Wang GH, 2015, DIGEST DIS SCI, V60, P3044, DOI 10.1007/s10620-015-3706-9; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang YS, 2014, J MOL CELL CARDIOL, V66, P94, DOI 10.1016/j.yjmcc.2013.08.007; Wang YL, 2014, BIOCHEM BIOPH RES CO, V446, P1255, DOI 10.1016/j.bbrc.2014.03.107; Wang ZG, 2012, BIOCHEM BIOPH RES CO, V427, P444, DOI 10.1016/j.bbrc.2012.06.123; Wu HJ, 2013, BIOCHEM BIOPH RES CO, V441, P693, DOI 10.1016/j.bbrc.2013.10.053; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; You XN, 2013, CARCINOGENESIS, V34, P1644, DOI 10.1093/carcin/bgt089; Zhang S, 2013, FEBS LETT, V587, P645, DOI 10.1016/j.febslet.2013.01.019; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	51	170	186	6	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3614	3623		10.1074/jbc.M116.749689	http://dx.doi.org/10.1074/jbc.M116.749689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28104805	Green Published, hybrid			2022-12-28	WOS:000395542500007
J	Yoo, SM; Latifkar, A; Cerione, RA; Antonyak, MA				Yoo, Sungsoo M.; Latifkar, Arash; Cerione, Richard A.; Antonyak, Marc A.			Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); Akt PKB; CDC42; mammalian target of rapamycin (mTOR); transformation; Cat-1; Git-1; p70S6 kinase; paxillin	ADAPTER PROTEIN; LUNG-CANCER; ADHESION; METASTASIS; MIGRATION; KINASE; FAMILY; ARF6; IDENTIFICATION; TRANSFORMATION	Cool-associated tyrosine-phosphorylated protein 1 (Cat-1) is a signaling scaffold as well as an ADP-ribosylation factor-GTPase-activating protein. Although best known for its role in cell migration, we recently showed that the ability of Cat-1 to bind paxillin, a major constituent of focal complexes, is also essential for the anchorage-independent growth of HeLa cervical carcinoma cells. Here we set out to learn more about the underlying mechanism by which Cat-paxillin interactions mediate this effect. We show that knocking down paxillin expression in HeLa cells promotes their ability to form colonies in soft agar, whereas ectopically expressing paxillin in these cells inhibits this transformed growth phenotype. Although knocking down Cat-1 prevents HeLa cells from forming colonies in soft agar, when paxillin is knocked down together with Cat-1, the cells are again able to undergo anchorage-independent growth. These results suggest that the requirement of Cat-1 for this hallmark of cellular transformation is coupled to its ability to bind paxillin and abrogate its actions as a negative regulator of anchorage-independent growth. We further show that knocking down Cat-1 expression in HeLa cells leads to a reduction in Akt activation, which can be reversed by knocking down paxillin. Moreover, expression of constitutively active forms of Akt1 and Akt2 restores the anchorage-independent growth capability of HeLa cells depleted of Cat-1 expression. Together, these findings highlight a novel mechanism whereby interactions between Cat-1 and its binding partner paxillin are necessary to ensure sufficient Akt activation so that cancer cells are able to grow under anchorage-independent conditions.	[Yoo, Sungsoo M.; Latifkar, Arash; Cerione, Richard A.; Antonyak, Marc A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Latifkar, Arash; Cerione, Richard A.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Yoo, Sungsoo M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Cornell University; Cornell University; Jefferson University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			National Institutes of Health [GM040654, GM047458, CA201402]; NATIONAL CANCER INSTITUTE [R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122575, R01GM040654, R01GM047458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM040654, GM047458, and CA201402 (to R. A. C.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azuma K, 2005, ONCOGENE, V24, P4754, DOI 10.1038/sj.onc.1208654; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Chang JS, 2015, ONCOTARGET, V6, P36278, DOI 10.18632/oncotarget.5531; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Salgia R, 1999, ONCOGENE, V18, P67, DOI 10.1038/sj.onc.1202273; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wade R, 2011, J BIOL CHEM, V286, P37932, DOI 10.1074/jbc.M111.294504; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Yoo SM, 2012, J BIOL CHEM, V287, P31462, DOI 10.1074/jbc.M112.353615; Yu JXA, 2010, CELL ADHES MIGR, V4, P342, DOI 10.4161/cam.4.3.11406; Zhao CJ, 2015, MED SCI MONITOR, V21, P1989, DOI 10.12659/MSM.893832; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	36	1	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3947	3957		10.1074/jbc.M116.769190	http://dx.doi.org/10.1074/jbc.M116.769190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100775	Green Published, hybrid			2022-12-28	WOS:000395542500035
J	Dalal, K; Roshan-Moniri, M; Sharma, A; Li, H; Ban, F; Hassona, MD; Hsing, M; Singh, K; LeBlanc, E; Dehm, S; Guns, EST; Cherkasov, A; Rennie, PS				Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hassona, Mohamed D.; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Dehm, Scott; Guns, Emma S. Tomlinson; Cherkasov, Artem; Rennie, Paul S.			Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer (vol 289, pg 26417, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Cherkasov, Artem/A-2134-2012					Dalal K, 2014, J BIOL CHEM, V289, P26417, DOI 10.1074/jbc.M114.553818	1	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4359	4359		10.1074/jbc.A117.553818	http://dx.doi.org/10.1074/jbc.A117.553818			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28283588	Green Published, hybrid			2022-12-28	WOS:000395837100033
J	Pan, XH; He, YJ; Lei, JP; Huang, XH; Zhao, YX				Pan, Xuehua; He, Yunjiao; Lei, Jinping; Huang, Xuhui; Zhao, Yanxiang			Crystallographic Snapshots of Class A beta-Lactamase Catalysis Reveal Structural Changes That Facilitate beta-Lactam Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAHIGH-RESOLUTION STRUCTURE; PENICILLIN-BINDING PROTEINS; TRANSITION-STATE ANALOG; STRUCTURE-BASED DESIGN; X-RAY CRYSTALLOGRAPHY; GENERAL BASE; MOLECULAR-GRAPHICS; ACTIVE-SITE; ACYL-ENZYME; 3 DECADES	beta-Lactamases confer resistance to beta-lactam-based antibiotics. There is great interest in understanding their mechanisms to enable the development of beta-lactamase-specific inhibitors. The mechanism of class A beta-lactamases has been studied extensively, revealing Lys-73 and Glu-166 as general bases that assist the catalytic residue Ser-70. However, the specific roles of these two residues within the catalytic cycle remain not fully understood. To help resolve this, we first identified an E166H mutant that is functional but is kinetically slow. We then carried out time-resolved crystallographic study of a full cycle of the catalytic reaction. We obtained structures that represent apo, ES*-acylation, and ES*-deacylation states and analyzed the conformational changes of His-166. The "in" conformation in the apo structure allows His-166 to form a hydrogen bond with Lys-73. The unexpected "flipped-out" conformation of His-166 in the ES*-acylation structure was further examined by molecular dynamics simulations, which suggested deprotonated Lys-73 serving as the general base for acylation. The "revert-in" conformation in the ES*-deacylation structure aligns His-166 toward the water molecule that hydrolyzes the acyl adduct. Finally, when the acyl adduct is fully hydrolyzed, His-166 rotates back to the "in" conformation of the apo-state, restoring the Lys-73/ His-166 interaction. Using His-166 as surrogate, our study identifies distinct conformational changes within the active site during catalysis. We suggest that the native Glu-166 executes similar changes in a less constricted way. Taken together, this structural series improves our understanding of beta-lactam hydrolysis in this important class of enzymes.	[Pan, Xuehua; He, Yunjiao; Zhao, Yanxiang] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Pan, Xuehua] Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen, Peoples R China; [Lei, Jinping; Huang, Xuhui] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Dept Chem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong University of Science & Technology	Zhao, YX (corresponding author), Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	yanxiang.zhao@polyu.edu.hk	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Zhao, Yanxiang/0000-0002-9408-9979	Research Grants Council GRF Grant [PolyU 5640/11M, PolyU 151043/14M]; Research Grants Council CRF Grant [C5030-14E, C6009-15G]; Research Grants Council AoE Grant [AoE/M-09/12]; Health and Medical Research Fund [14130502]; Research Committee of Hong Kong Polytechnic University	Research Grants Council GRF Grant; Research Grants Council CRF Grant; Research Grants Council AoE Grant; Health and Medical Research Fund; Research Committee of Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work was supported by Research Grants Council GRF Grants PolyU 5640/11M and PolyU 151043/14M, Research Grants Council CRF Grants C5030-14E and C6009-15G, Research Grants Council AoE Grant AoE/M-09/12, Health and Medical Research Fund Grant 14130502, and the Research Committee of Hong Kong Polytechnic University. The authors declare that they have no conflicts of interest with the contents of this article.	Adamski CJ, 2015, BIOCHEMISTRY-US, V54, P447, DOI 10.1021/bi501195g; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D. A., 2012, AMBER 12; Chan PH, 2008, J AM CHEM SOC, V130, P6351, DOI 10.1021/ja076111g; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; Chen CCH, 2001, BIOCHEMISTRY-US, V40, P2351, DOI 10.1021/bi002277h; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lei JP, 2015, J AM CHEM SOC, V137, P70, DOI 10.1021/ja5112964; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Ness S, 2000, BIOCHEMISTRY-US, V39, P5312, DOI 10.1021/bi992505b; Nichols DA, 2015, J AM CHEM SOC, V137, P8086, DOI 10.1021/jacs.5b00749; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; Pan XH, 2014, BIOCHEMISTRY-US, V53, P5414, DOI 10.1021/bi401609h; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Stojanoski V, 2015, J BIOL CHEM, V290, P10382, DOI 10.1074/jbc.M114.633438; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; Tomanicek SJ, 2010, J MOL BIOL, V396, P1070, DOI 10.1016/j.jmb.2009.12.036; Tremblay LV, 2010, BIOCHEMISTRY-US, V49, P9685, DOI 10.1021/bi1015088; Vandavasi VG, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01636-16, 10.1128/aac.01636-16]; Vandavasi VG, 2016, J MED CHEM, V59, P474, DOI 10.1021/acs.jmedchem.5b01215; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wong WT, 2011, J BIOL CHEM, V286, P31771, DOI 10.1074/jbc.M110.198895; Wong WT, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-15	45	19	19	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4022	4033		10.1074/jbc.M116.764340	http://dx.doi.org/10.1074/jbc.M116.764340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28100776	Green Published, hybrid			2022-12-28	WOS:000395837100006
J	Luo, MW; Li, D; Wang, ZM; Guo, W; Kang, L; Zhou, ST				Luo, Maowu; Li, Dong; Wang, Zhiming; Guo, Wei; Kang, Le; Zhou, Shutang			Juvenile hormone differentially regulates two Grp78 genes encoding protein chaperones required for insect fat body cell homeostasis and vitellogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; endoplasmic reticulum stress (ER stress); GRP78; homeostasis; juvenile hormone (JH); vitellogenesis	ENDOPLASMIC-RETICULUM STRESS; KRUPPEL-HOMOLOG 1; METHOPRENE-TOLERANT; LOCUSTA-MIGRATORIA; INDUCED APOPTOSIS; ER STRESS; SIGNALING PATHWAY; BINDING-PROTEIN; QUALITY-CONTROL; CANCER CELLS	Juvenile hormone (JH) has a well known role in stimulating insect vitellogenesis (i.e. yolk deposition) and oocyte maturation, but the molecular mechanisms of JH action in insect reproduction are unclear. The 78-kDa glucose-regulated protein (Grp78) is a heat shock protein 70-kDa family member and one of the most abundant chaperones in the endoplasmic reticulum (ER) where it helps fold newly synthesized peptides. Because of its prominent role in protein folding, and also ER stress, we hypothesized that Grp78 might be involved in fat body cell homeostasis and vitellogenesis and a regulatory target of JH. We report here that the migratory locust Locusta migratoria possesses two Grp78 genes that are differentially regulated by JH. We found that Grp78-1 is regulated by JH through Mcm4/7-dependent DNA replication and polyploidization, whereas Grp78-2 expression is directly activated by the JH-receptor complex comprising methoprene-tolerant and Taiman proteins. Interestingly, Grp78-2 expression in the fat body is about 10-fold higher than that of Grp78-1. Knockdown of either Grp78-1 or Grp78-2 significantly reduced levels of vitellogenin (Vg) protein, accompanied by retarded maturation of oocytes. Depletion of both Grp78-1 and Grp78-2 resulted in ER stress and apoptosis in the fat body and in severely defective Vg synthesis and oocyte maturation. These results indicate a crucial role of Grp78 in JH-dependent vitellogenesis and egg production. The presence and differential regulation of two Grp78 genes in L. migratoria likely help accelerate the production of this chaperone in the fat body to facilitate folding of massively synthesized Vg and other proteins.	[Luo, Maowu; Wang, Zhiming; Guo, Wei; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Li, Dong; Zhou, Shutang] Henan Univ, Inst Plant Stress Biol, Sch Life Sci, State Key Lab Cotton Biol, Kaifeng 475004, Henan, Peoples R China; [Luo, Maowu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Henan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kang, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.; Zhou, ST (corresponding author), Henan Univ, Inst Plant Stress Biol, Sch Life Sci, State Key Lab Cotton Biol, Kaifeng 475004, Henan, Peoples R China.	lkang@ioz.ac.cn; szhou@henu.edu.cn	Kang, Le/ABD-1116-2022	Kang, Le/0000-0003-4262-2329	National Natural Science Foundation of China [31630070, 31372258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31630070 and 31372258. The authors declare that they have no conflicts of interest with the contents of this article.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Belles X, 2005, REPRO BIOL, V12, P157; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Cruz J, 2003, INSECT BIOCHEM MOLEC, V33, P1219, DOI 10.1016/j.ibmb.2003.06.004; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; DALE JF, 1986, J INSECT PHYSIOL, V32, P763, DOI 10.1016/0022-1910(86)90079-X; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gao YY, 2010, J CLIN ENDOCR METAB, V95, pE319, DOI 10.1210/jc.2010-1043; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; GLINKA AV, 1995, INSECT BIOCHEM MOLEC, V25, P775, DOI 10.1016/0965-1748(94)00098-3; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; HUEBNER E, 1980, CAN J ZOOL, V58, P1617, DOI 10.1139/z80-222; Iwamune M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108997; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kaneda S, 2000, J BIOCHEM-TOKYO, V128, P529, DOI 10.1093/oxfordjournals.jbchem.a022783; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kusaczuk M, 2013, CURR PHARM DESIGN, V19, P2807, DOI 10.2174/1381612811319150016; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; NAIR KK, 1981, DEV BIOL, V81, P356, DOI 10.1016/0012-1606(81)90300-6; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; OISHI M, 1985, CAN J BIOCHEM CELL B, V63, P1064, DOI 10.1139/o85-132; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pfaffenbach KT, 2012, J CELL PHYSIOL, V227, P3803, DOI 10.1002/jcp.24090; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Raikhel A, 2005, COMPREHENSIVE MOL IN, V3, P433; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thon M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07096; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Ugrankar R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8102; Urena E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006020; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HX, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00377; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang ZM, 2017, INSECT BIOCHEM MOLEC, V82, P31, DOI 10.1016/j.ibmb.2017.01.009; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wu ZX, 2016, J BIOL CHEM, V291, P5418, DOI 10.1074/jbc.M115.698936; Wyatt G. R., 1996, ADV INSECT PHYSL, P213; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Zhang GJ, 2011, J INSECT PHYSIOL, V57, P1115, DOI 10.1016/j.jinsphys.2011.02.016; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	88	33	38	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8823	8834		10.1074/jbc.M117.780957	http://dx.doi.org/10.1074/jbc.M117.780957			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28356351	Green Published, hybrid			2022-12-28	WOS:000402153900027
J	Lin, S; Voyton, C; Morris, MT; Ackroyd, PC; Morris, JC; Christensen, KA				Lin, Sheng; Voyton, Charles; Morris, Meredith T.; Ackroyd, P. Christine; Morris, James C.; Christensen, Kenneth A.			pH regulation in glycosomes of procyclic form Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; BLOOD-STREAM; MOLECULAR CHARACTERIZATION; NUCLEAR TRANSPORT; ATP DEPLETION; METABOLISM; PEROXISOMES; PROTEIN; ACIDOCALCISOMES; DEHYDROGENASE	Here we report the use of a fluorescein-tagged peroxisomal targeting sequence peptide (F-PTS1, acetyl-C{K(FITC)} GGAKL) for investigating pH regulation of glycosomes in live procyclic form Trypanosoma brucei. When added to cells, this fluorescent peptide is internalized within vesicular structures, including glycosomes, and can be visualized after 30-60 min. Using F-PTS1 we are able to observe the pH conditions inside glycosomes in response to starvation conditions. Previous studies have shown that in the absence of glucose, the glycosome exhibits mild acidification from pH 7.4+/-0.2 to 6.8+/-0.2. Our results suggest that this response occurs under proline starvation as well. This pH regulation is found to be independent from cytosolic pH and requires a source of Na+ ions. Glycosomes were also observed to be more resistant to external pH changes than the cytosol; placement of cells in acidic buffers (pH 5) reduced the pH of the cytosol by 0.8+/-0.1 pH units, whereas glycosomalpHdecreases by 0.5+/-0.1 pH units. This observation suggests that regulation of glycosomal pH is different and independent from cytosolic pH regulation. Furthermore, pH regulation is likely to work by an active process, because cells depleted of ATP with 2-deoxyglucose and sodium azide were unable to properly regulate pH. Finally, inhibitor studies with bafilomycin and EIPA suggest that both V-ATPases and Na+/H+ exchangers are required for glycosomal pH regulation.	[Lin, Sheng; Voyton, Charles] Clemson Univ, Dept Chem, Clemson, SC 29634 USA; [Morris, Meredith T.; Morris, James C.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Voyton, Charles; Ackroyd, P. Christine; Christensen, Kenneth A.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Clemson University; Clemson University; Brigham Young University	Christensen, KA (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	kenc@chem.byu.edu	Christensen, Kenneth/S-1670-2019; Morris, James/L-7253-2019	Christensen, Kenneth/0000-0002-3736-5500; Morris, James/0000-0003-2515-5714	NIAID, National Institutes of Health [R21AI105656]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109094] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIAID, National Institutes of Health Grant R21AI105656 (to K. A. C). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; BARNARD JP, 1994, ARCH BIOCHEM BIOPHYS, V313, P77, DOI 10.1006/abbi.1994.1361; Ben Beard C., 2009, EMERG INFECT DIS, V15, P510, DOI 10.3201/eid1503.081597; Bhat R, 1996, J BIOL CHEM, V271, P32551, DOI 10.1074/jbc.271.51.32551; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Colasante Claudia, 2013, F1000Res, V2, P27, DOI 10.12688/f1000research.2-27.v1; Coley April F, 2011, Mol Biol Int, V2011, P123702, DOI 10.4061/2011/123702; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Dansen TB, 2000, NAT CELL BIOL, V2, P51, DOI 10.1038/71375; Dodson HC, 2011, J BIOL CHEM, V286, P33150, DOI 10.1074/jbc.M111.235705; DOUMA AC, 1990, YEAST, V6, P45, DOI 10.1002/yea.320060105; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; FraserLhostis C, 1997, BIOL CHEM, V378, P1039, DOI 10.1515/bchm.1997.378.9.1039; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KONDO T, 1979, J LAB CLIN MED, V94, P617; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lin S, 2013, BIOCHEMISTRY-US, V52, P3629, DOI 10.1021/bi400029m; Liniger M, 2003, INT J PARASITOL, V33, P1319, DOI 10.1016/S0020-7519(03)00182-6; Luo SH, 2006, J BIOL CHEM, V281, P21963, DOI 10.1074/jbc.M601057200; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; McMahon RJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE640, DOI 10.1152/ajpendo.1996.270.4.E640; Moyersoen J, 2004, FEMS MICROBIOL REV, V28, P603, DOI 10.1016/j.femsre.2004.06.004; Nolan DP, 2000, J BIOL CHEM, V275, P4072, DOI 10.1074/jbc.275.6.4072; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Sorensen M, 1999, MOL PHARMACOL, V55, P424; Stebeck CE, 1996, MOL BIOCHEM PARASIT, V76, P145, DOI 10.1016/0166-6851(95)02555-3; Stiles JK, 2003, ANN TROP MED PARASIT, V97, P351, DOI 10.1179/000349803235002362; ter Kuile BH, 2000, J BACTERIOL, V182, P3587, DOI 10.1128/JB.182.12.3587-3589.2000; Thomsson E, 2005, APPL ENVIRON MICROB, V71, P3007, DOI 10.1128/AEM.71.6.3007-3013.2005; Van Der Heyden N, 2000, MOL BIOCHEM PARASIT, V105, P237, DOI 10.1016/S0166-6851(99)00184-X; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Vercesi AE, 1996, BIOCHEM J, V315, P265, DOI 10.1042/bj3150265; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	43	3	3	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7795	7805		10.1074/jbc.M117.784173	http://dx.doi.org/10.1074/jbc.M117.784173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28348078	Green Published, hybrid			2022-12-28	WOS:000401154100010
J	Messenger, SW; Jones, EK; Holthaus, CL; Thomas, DDH; Cooley, MM; Byrne, JA; Mareninova, OA; Gukovskaya, AS; Groblewski, GE				Messenger, Scott W.; Jones, Elaina K.; Holthaus, Conner L.; Thomas, Diana D. H.; Cooley, Michelle M.; Byrne, Jennifer A.; Mareninova, Olga A.; Gukovskaya, Anna S.; Groblewski, Guy E.			Acute acinar pancreatitis blocks vesicle-associated membrane protein 8 (VAMP8)-dependent secretion, resulting in intracellular trypsin accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULE EXOCYTOSIS; ZYMOGEN ACTIVATION; CELLS; TRAFFICKING; PHOSPHORYLATION; IDENTIFICATION; MATURATION; AUTOPHAGY; PROTEASES; KINASE	Zymogen secretory granules in pancreatic acinar cells express two vesicle-associated membrane proteins (VAMP), VAMP2 and -8, each controlling 50% of stimulated secretion. Analysis of secretion kinetics identified a first phase (0-2 min) mediated by VAMP2 and second (2-10 min) and third phases (10-30 min) mediated by VAMP8. Induction of acinar pancreatitis by supramaximal cholecystokinin (CCK-8) stimulation inhibits VAMP8-mediated mid-and late-phase but not VAMP2-mediated early-phase secretion. Elevation of cAMP during supramaximal CCK-8 mitigates third-phase secretory inhibition and acinar damage caused by the accumulation of prematurely activated trypsin. VAMP8(-/-) acini are resistant to secretory inhibition by supramaximal CCK-8, and despite a 4.5-fold increase in total cellular trypsinogen levels, are fully protected from intracellular trypsin accumulation and acinar damage. VAMP8-mediated secretion is dependent on expression of the early endosomal proteins Rab5, D52, and EEA1. Supramaximal CCK-8 (60 min) caused a 60% reduction in the expression of D52 followed by Rab5 and EEA1 in isolated acini and in in vivo. The loss of D52 occurred as a consequence of its entry into autophagic vacuoles and was blocked by lysosomal cathepsin B and L inhibition. Accordingly, adenoviral overexpression of Rab5 or D52 enhanced secretion in response to supramaximal CCK-8 and prevented accumulation of activated trypsin. These data support that acute inhibition of VAMP8-mediated secretion during pancreatitis triggers intracellular trypsin accumulation and loss of the early endosomal compartment. Maintaining anterograde endosomal trafficking during pancreatitis maintains VAMP8-dependent secretion, thereby preventing accumulation of activated trypsin.	[Messenger, Scott W.; Jones, Elaina K.; Holthaus, Conner L.; Thomas, Diana D. H.; Cooley, Michelle M.; Groblewski, Guy E.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Byrne, Jennifer A.] Childrens Hosp, Childrens Canc Res Unit, Mol Oncol Lab, Westmead, NSW 2145, Australia; [Mareninova, Olga A.; Gukovskaya, Anna S.] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90073 USA; [Mareninova, Olga A.; Gukovskaya, Anna S.] Univ Calif Los Angeles, Los Angeles, CA 90073 USA	University of Wisconsin System; University of Wisconsin Madison; University of Sydney; University of California System; University of California Los Angeles	Groblewski, GE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	groby@nutrisci.wisc.edu		Gukovskaya, Anna/0000-0003-3737-5335; Jones, Elaina/0000-0002-0691-4933	National Institutes of Health [RO1DK07088, PO1DK098108, T32DK007665]; USDA/HATCH [WIS01583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665, P30DK041301, P01DK098108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/HATCH(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK07088 (to G. E. G.). This work was also supported by USDA/HATCH Grants WIS01583 (to G. E. G.) and National Institutes of Health Grants PO1DK098108 (to G. E. G. and A. S. G.) and T32DK007665 (to S. W. M and E. K. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dolai S, 2012, GASTROENTEROLOGY, V143, P832, DOI 10.1053/j.gastro.2012.06.011; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Groblewski GE, 1999, AM J PHYSIOL-GASTR L, V276, pG219, DOI 10.1152/ajpgi.1999.276.1.G219; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; He J, 2016, MOL BIOL CELL, V27, P572, DOI 10.1091/mbc.E15-05-0283; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; Kaspar KM, 2003, AM J PHYSIOL-GASTR L, V285, pG1300, DOI 10.1152/ajpgi.00534.2002; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Lerch MM, 2000, ADV EXP MED BIOL, V477, P403; Loo LS, 2009, EUR J IMMUNOL, V39, P3520, DOI 10.1002/eji.200939378; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; MACH L, 1994, J BIOL CHEM, V269, P13030; Mareninova OA, 2015, CELL MOL GASTROENTER, V1, P678, DOI 10.1016/j.jcmgh.2015.07.006; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Marshall MR, 2015, J CELL BIOL, V210, P135, DOI 10.1083/jcb.201411093; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Messenger SW, 2015, CELL MOL GASTROENTER, V1, P695, DOI 10.1016/j.jcmgh.2015.08.002; Messenger SW, 2014, J BIOL CHEM, V289, P28040, DOI 10.1074/jbc.M114.593913; Messenger SW, 2014, CELL CALCIUM, V55, P369, DOI 10.1016/j.ceca.2014.03.003; Messenger SW, 2013, AM J PHYSIOL-GASTR L, V305, pG439, DOI 10.1152/ajpgi.00143.2013; Otani T, 1998, AM J PHYSIOL-GASTR L, V275, pG999, DOI 10.1152/ajpgi.1998.275.5.G999; PADFIELD PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG647, DOI 10.1152/ajpgi.1995.269.5.G647; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Shah AU, 2008, AM J PHYSIOL-GASTR L, V294, pG1328, DOI 10.1152/ajpgi.00440.2007; Sphyris N, 2005, PANCREAS, V30, P148, DOI 10.1097/01.mpa.0000147086.15867.ab; Teng Q, 2005, GENE THER, V12, P108, DOI 10.1038/sj.gt.3302400; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Thomas DDH, 2001, J BIOL CHEM, V276, P28866, DOI 10.1074/jbc.M102214200; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200	40	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7828	7839		10.1074/jbc.M117.781815	http://dx.doi.org/10.1074/jbc.M117.781815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28242757	hybrid, Green Published			2022-12-28	WOS:000401154100013
J	Li, Z; Mukherjee, T; Bowler, K; Namdari, S; Snow, Z; Prestridge, S; Carlton, A; Bar-Peled, M				Li, Zi; Mukherjee, Thiya; Bowler, Kyle; Namdari, Sholeh; Snow, Zachary; Prestridge, Sarah; Carlton, Alexandra; Bar-Peled, Maor			A four-gene operon in Bacillus cereus produces two rare spore-decorating sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; carbohydrate biosynthesis; glycobiology; glycosylation; sporulation; BclA; cereose; cillose; germination; spores	ANTHRACIS EXOSPORIUM; SPIROTETRONATE ANTIBIOTICS; SURFACE GLYCOPROTEIN; STAINLESS-STEEL; MOLECULAR-BASIS; GENE-CLUSTER; BIOSYNTHESIS; BCLA; IDENTIFICATION; PROTEINS	Bacterial glycan structures on cell surfaces are critical for cell-cell recognition and adhesion and in host-pathogen interactions. Accordingly, unraveling the sugar composition of bacterial cell surfaces can shed light on bacterial growth and pathogenesis. Here, we found that two rare sugars with a 3-C-methyl-6-deoxyhexose structure were linked to spore glycans in Bacillus cereus ATCC 14579 and ATCC 10876. Moreover, we identified a four-gene operon in B. cereus ATCC 14579 that encodes proteins with the following sequential enzyme activities as determined by mass spectrometry and one- and two-dimensional NMR methods: CTP:glucose-1-phosphate cytidylyltransferase, CDP-Glc 4,6-dehydratase, NADH-dependent SAM:C-methyltransferase, and NADPH-dependent CDP-3-C-methyl-6-deoxyhexose 4-reductase. The last enzyme predominantly yielded CDP-3-C-methyl-6-deoxygulose (CDP-cereose) and likely generated a 4-epimer CDP-3-C-methyl-6-deoxyallose (CDP-cillose). Some members of the B. cereus sensu lato group produce CDP-3-C-methyl-6-deoxy sugars for the formation of cereose-containing glycans on spores, whereas others such as Bacillus anthracis do not. Gene knockouts of the Bacillus C-methyltransferase and the 4-reductase confirmed their involvement in the formation of cereose-containing glycan on B. cereus spores. We also found that cereose represented 0.2-1% spore dry weight. Moreover, mutants lacking cereose germinated faster than the wild type, yet the mutants exhibited no changes in sporulation or spore resistance to heat. The findings reported here may provide new insights into the roles of the uncommon 3-C-methyl-6-deoxy sugars in cell-surface recognition and host-pathogen interactions of the genus Bacillus.	[Li, Zi; Mukherjee, Thiya; Bowler, Kyle; Namdari, Sholeh; Snow, Zachary; Prestridge, Sarah; Carlton, Alexandra; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			BioEnergy Science Center, Biological and Environmental Research Program, U. S. Dept. of Energy Office of Science [DE-PS02-06ER64304]	BioEnergy Science Center, Biological and Environmental Research Program, U. S. Dept. of Energy Office of Science	This work was supported by Grant DE-PS02-06ER64304 from the BioEnergy Science Center, Biological and Environmental Research Program, U. S. Dept. of Energy Office of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Abhyankar W, 2013, J PROTEOME RES, V12, P4507, DOI 10.1021/pr4005629; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barlass PJ, 2002, MICROBIOL-SGM, V148, P2089, DOI 10.1099/00221287-148-7-2089; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bruender NA, 2010, BIOCHEMISTRY-US, V49, P5891, DOI 10.1021/bi100782b; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; Day CJ, 2015, P NATL ACAD SCI USA, V112, pE7266, DOI 10.1073/pnas.1421082112; Du YL, 2015, P NATL ACAD SCI USA, V112, P2717, DOI 10.1073/pnas.1419964112; Faille C, 2010, INT J FOOD MICROBIOL, V143, P125, DOI 10.1016/j.ijfoodmicro.2010.07.038; Fang J, 2008, J BACTERIOL, V190, P6014, DOI 10.1128/JB.00533-08; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Hornstra LM, 2006, APPL ENVIRON MICROB, V72, P3746, DOI 10.1128/AEM.72.5.3746-3749.2006; Hwang S, 2014, J BIOL CHEM, V289, P35620, DOI 10.1074/jbc.M114.614917; Jacques M, 1996, TRENDS MICROBIOL, V4, P408, DOI 10.1016/0966-842X(96)10054-8; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002; Lequette Y, 2011, BIOFOULING, V27, P751, DOI 10.1080/08927014.2011.599842; Lequette Y, 2011, APPL ENVIRON MICROB, V77, P4905, DOI 10.1128/AEM.02872-10; Li Z, 2016, J BIOL CHEM, V291, P19051, DOI 10.1074/jbc.M116.724708; Li Z, 2015, J BIOL CHEM, V290, P691, DOI 10.1074/jbc.M114.612747; Maes E, 2016, J BIOL CHEM, V291, P9666, DOI 10.1074/jbc.M116.718171; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; Thompson BM, 2007, J BACTERIOL, V189, P6704, DOI 10.1128/JB.00762-07; Thompson BM, 2011, MOL MICROBIOL, V79, P799, DOI 10.1111/j.1365-2958.2010.07488.x; THORSON JS, 1993, J AM CHEM SOC, V115, P5827, DOI 10.1021/ja00066a062; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854	38	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7636	7650		10.1074/jbc.M117.777417	http://dx.doi.org/10.1074/jbc.M117.777417			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28298443	hybrid, Green Published			2022-12-28	WOS:000400761300030
J	Adkins, NL; Swygert, SG; Kaur, P; Niu, HY; Grigoryev, SA; Sung, P; Wang, H; Peterson, CL				Adkins, Nicholas L.; Swygert, Sarah G.; Kaur, Parminder; Niu, Hengyao; Grigoryev, Sergei A.; Sung, Patrick; Wang, Hong; Peterson, Craig L.			Nucleosome-like, Single-stranded DNA (ssDNA)-Histone Octamer Complexes and the Implication for DNA Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; END-RESECTION; SEDIMENTATION-VELOCITY; RECOMBINANT HISTONES; DAMAGE RESPONSE; DISTINCT ROLES; CHROMATIN; RECRUITMENT; FUN30; PHOSPHORYLATION	Repair of DNA double strand breaks (DSBs) is key for maintenance of genome integrity. When DSBs are repaired by homologous recombination, DNA ends can undergo extensive processing, producing long stretches of single-stranded DNA (ssDNA). In vivo, DSB processing occurs in the context of chromatin, and studies indicate that histones may remain associated with processed DSBs. Here we demonstrate that histones are not evicted from ssDNA after in vitro chromatin resection. In addition, we reconstitute histone-ssDNA complexes (termed ssNucs) with ssDNA and recombinant histones and analyze these particles by a combination of native gel electrophoresis, sedimentation velocity, electron microscopy, and a recently developed electrostatic force microscopy technique, DREEM (dual-resonance frequency-enhanced electrostatic force microscopy). The reconstituted ssNucs are homogenous and relatively stable, and DREEM reveals ssDNA wrapping around histones. We also find that histone octamers are easily transferred in trans from ssNucs to either double-stranded DNA or ssDNA. Furthermore, the Fun30 remodeling enzyme, which has been implicated in DNA repair, binds ssNucs preferentially over nucleosomes, and ssNucs are effective at activating Fun30 ATPase activity. Our results indicate that ssNucs may be a hallmark of processes that generate ssDNA, and that posttranslational modification of ssNucs may generate novel signaling platforms involved in genome stability.	[Adkins, Nicholas L.; Swygert, Sarah G.; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kaur, Parminder; Wang, Hong] North Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Kaur, Parminder; Wang, Hong] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Peterson, CL (corresponding author), 373 Plantat St,Biotech 2,Ste 210, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu	Wang, Hong/F-3164-2014; Niu, Hengyao/AAE-9269-2020	Wang, Hong/0000-0003-0165-3559; kaur, Parminder/0000-0001-9183-4315	National Institutes of Health from the NIGMS from NIEHS [RO1 GM054096, RO1 GM107559, F32 GM096701, RO1 ES007061, P30 ES025128]; National Science Foundation [1516999]; Direct For Biological Sciences [1516999] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, P30ES025128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096701, R35GM122519, R01GM107559, R01GM054096] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS from NIEHS; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM054096 (to C. L. P.), RO1 GM107559 (to H. W.), and F32 GM096701 (to N. L. A.) from the NIGMS, RO1 ES007061 (to H. N. and P. S.) from NIEHS, Grant P30 ES025128 to the Center for Human Health and the Environment (CHHE), and National Science Foundation Grant 1516999 (to S. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Benarroch-Popivker D, 2016, MOL CELL, V61, P274, DOI 10.1016/j.molcel.2015.12.009; Bennett G, 2015, DNA REPAIR, V30, P38, DOI 10.1016/j.dnarep.2015.03.006; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; CAFFARELLI E, 1985, FEBS LETT, V181, P69, DOI 10.1016/0014-5793(85)81115-7; CAFFARELLI E, 1983, BIOCHIM BIOPHYS ACTA, V739, P235, DOI 10.1016/0167-4781(83)90034-9; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; Kaur P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20513; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; PALTER KB, 1979, CELL, V18, P451, DOI 10.1016/0092-8674(79)90064-3; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Swygert SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5751; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wang HD, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-10; Wu D, 2016, MOL CELL, V61, P315, DOI 10.1016/j.molcel.2015.12.012; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	37	25	25	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5271	5281		10.1074/jbc.M117.776369	http://dx.doi.org/10.1074/jbc.M117.776369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202543	Green Published, hybrid			2022-12-28	WOS:000397875500011
J	Jokela, T; Karna, R; Rauhala, L; Bart, G; Pasonen-Seppanen, S; Oikari, S; Tammi, MI; Tammi, RH				Jokela, Tiina; Karna, Riikka; Rauhala, Leena; Bart, Genevieve; Pasonen-Seppanen, Sanna; Oikari, Sanna; Tammi, Markku I.; Tammi, Raija H.			Human Keratinocytes Respond to Extracellular UTP by Induction of Hyaluronan Synthase 2 Expression and Increased Hyaluronan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HYALURONAN; ELEMENT-BINDING PROTEIN; PURINERGIC RECEPTORS; EPIDERMAL-KERATINOCYTES; P2Y(14) RECEPTOR; O-GLCNACYLATION; DOWN-REGULATION; CELL-MIGRATION; RETINOIC ACID; ATP	The release of nucleotides into extracellular space is triggered by insults like wounding and ultraviolet radiation, resulting in stimulatory or inhibitory signals via plasma membrane nucleotide receptors. As similar insults are known to activate hyaluronan synthesis we explored the possibility that extracellular UTP or its breakdown products UDP and UMP act as mediators for hyaluronan synthase (HAS) activation in human epidermal keratinocytes. UTP increased hyaluronan both in the pericellular matrix and in the culture medium of HaCaT cells. 10-100 mu M UTP strongly up-regulated HAS2 expression, although the other hyaluronan synthases (HAS1, HAS3) and hyaluronidases (HYAL1, HYAL2) were not affected. The HAS2 response was rapid and transient, with the maximum stimulation at 1.5 h. UDP exerted a similar effect, but higher concentrations were required for the response, and UMP showed no stimulation at all. Specific siRNAs against the UTP receptor P2Y(2),and inhibitors of UDP receptors P2Y(6) and P2Y(14), indicated that the response to UTP was mediated mainly through P2Y(2) and to a lesser extent via UDP receptors. UTP increased the phosphorylation of p38, ERK, CREB, and Ser-727 of STAT3 and induced nuclear translocation of pCaMKII. Inhibitors of PKC, p38, ERK, CaMKII, STAT3, and CREB partially blocked the activation of HAS2 expression, confirming the involvement of these pathways in the UTP-induced HAS2 response. The present data reveal a selective up-regulation of HAS2 expression by extracellular UTP, which is likely to contribute to the previously reported rapid activation of hyaluronan metabolism in response to tissue trauma or ultraviolet radiation.	[Jokela, Tiina; Karna, Riikka; Rauhala, Leena; Bart, Genevieve; Pasonen-Seppanen, Sanna; Oikari, Sanna; Tammi, Markku I.; Tammi, Raija H.] Univ Eastern Finland, Inst Biomed, Kuopio 70211, Finland	University of Eastern Finland	Tammi, RH (corresponding author), Univ Eastern Finland, Inst Biomed, Kuopio 70211, Finland.	tammi@uef.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021	Jokela, Tiina/0000-0002-7521-3866; Bart, Genevieve/0000-0001-9809-150X	Sigrid Juselius Foundation; Kuopio University Hospital; University of Eastern Finland/Cancer Center of Eastern Finland; Cancer Foundation of Northern Savo	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio University Hospital; University of Eastern Finland/Cancer Center of Eastern Finland; Cancer Foundation of Northern Savo	This work was supported by grants from the Sigrid Juselius Foundation (to R. H. T., M. I. T., and S. P. S.), the Special Government Funding of Kuopio University Hospital (to M. I. T.), The Spearhead Funds of the University of Eastern Finland/Cancer Center of Eastern Finland (to M. I. T. and R. H. T.), and the Cancer Foundation of Northern Savo (to L. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Boarder MR, 1998, TRENDS PHARMACOL SCI, V19, P99, DOI 10.1016/S0165-6147(98)01170-5; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Burrell HE, 2005, J BIOL CHEM, V280, P29667, DOI 10.1074/jbc.M505381200; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Cheng SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054125; Deen AJ, 2016, CELL MOL LIFE SCI, V73, P3183, DOI 10.1007/s00018-016-2158-5; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Faure E, 2012, J CELL SCI, V125, P4264, DOI 10.1242/jcs.097600; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Fricks IP, 2009, J PHARMACOL EXP THER, V330, P162, DOI 10.1124/jpet.109.150730; Gendaszewska-Darmach E, 2011, PURINERG SIGNAL, V7, P193, DOI 10.1007/s11302-011-9233-z; Giltaire S, 2011, J CELL PHYSIOL, V226, P1651, DOI 10.1002/jcp.22496; Glaser T, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-12; Grandoch M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0340-6; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Grimm I, 2009, J CELL SCI, V122, P2524, DOI 10.1242/jcs.044891; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Ho CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057666; Holzer AM, 2004, J CUTAN MED SURG, V8, P90, DOI 10.1177/120347540400800203; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang QS, 1998, J CELL BIOL, V143, P645, DOI 10.1083/jcb.143.3.645; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2014, J BIOL CHEM, V289, P18569, DOI 10.1074/jbc.M114.551804; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kobayashi D, 2006, J PHARMACOL SCI, V102, P368, DOI 10.1254/jphs.FP0060669; KOPF GS, 1991, METHOD ENZYMOL, V195, P257; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lamarca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098998; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Lee JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122628; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Li W, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0046-3; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9; Murakami S, 2001, INT IMMUNOL, V13, P1533, DOI 10.1093/intimm/13.12.1533; Nagakura C, 2014, TOXICOLOGY, V322, P61, DOI 10.1016/j.tox.2014.03.010; Oikari S, 2016, GLYCOBIOLOGY, V26, P710, DOI 10.1093/glycob/cww019; Oikari S, 2014, J CHROMATOGR A, V1323, P82, DOI 10.1016/j.chroma.2013.11.004; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pastore S, 2007, J INVEST DERMATOL, V127, P660, DOI 10.1038/sj.jid.5700591; Pauloin T, 2009, MOL VIS, V15, P577; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; RCore Team R, 2015, R LANG ENV STAT COMP; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Rooney P, 2015, ACTA BIOMATER, V19, P66, DOI 10.1016/j.actbio.2015.02.030; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Seo M, 2010, BIOCHEM BIOPH RES CO, V393, P190, DOI 10.1016/j.bbrc.2010.01.085; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takabe P, 2015, EXP CELL RES, V337, P1, DOI 10.1016/j.yexcr.2015.07.026; Takai E, 2011, RADIAT RES, V175, P358, DOI 10.1667/RR2375.1; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vistejnova L, 2014, CYTOKINE, V70, P97, DOI 10.1016/j.cyto.2014.07.006; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Wang Y, 2014, J BIOL CHEM, V289, P32253, DOI 10.1074/jbc.M114.578377; Wang ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010095; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wood MW, 2011, INFECT IMMUN, V79, P708, DOI 10.1128/IAI.01102-10; Ye J, 2012, EYE, V26, P1012, DOI 10.1038/eye.2012.89; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	98	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4861	4872		10.1074/jbc.M116.760322	http://dx.doi.org/10.1074/jbc.M116.760322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28188289	Green Published, hybrid			2022-12-28	WOS:000397590400010
J	Schmidt, EA; Fee, BE; Henry, SC; Nichols, AG; Shinohara, ML; Rathmell, JC; Maclver, NJ; Coers, J; Ilkayeva, OR; Koves, TR; Taylor, GA				Schmidt, Elyse A.; Fee, Brian E.; Henry, Stanley C.; Nichols, Amanda G.; Shinohara, Mari L.; Rathmell, Jeffrey C.; Maclver, Nancie J.; Coers, Jorn; Ilkayeva, Olga R.; Koves, Timothy R.; Taylor, Gregory A.			Metabolic Alterations Contribute to Enhanced Inflammatory Cytokine Production in Irgm1-deficient Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-AUTONOMOUS IMMUNITY; MITOCHONDRIAL DYNAMICS; ENDOPLASMIC-RETICULUM; RESISTANCE GTPASES; INDUCIBLE GTPASES; IRG PROTEINS; AUTOPHAGY; IMMUNOMETABOLISM; ACTIVATION; SUSCEPTIBILITY	The immunity-related GTPases (IRGs) are a family of proteins that are induced by interferon (IFN)-gamma and play pivotal roles in immune and inflammatory responses. IRGs ostensibly function as dynamin-like proteins that bind to intracellular membranes and promote remodeling and trafficking of those membranes. Prior studies have shown that loss of Irgm1 in mice leads to increased lethality to bacterial infections as well as enhanced inflammation to non-infectious stimuli; however, the mechanisms underlying these phenotypes are unclear. In the studies reported here, we found that uninfected Irgm1-deficient mice displayed high levels of serum cytokines typifying profound autoinflammation. Similar increases in cytokine production were also seen in cultured, IFN-gamma-primed macrophages that lacked Irgm1. A series of metabolic studies indicated that the enhanced cytokine production was associated with marked metabolic changes in the Irgm1-deficient macrophages, including increased glycolysis and an accumulation of long chain acylcarnitines. Cells were exposed to the glycolytic inhibitor, 2-deoxyglucose, or fatty acid synthase inhibitors to perturb the metabolic alterations, which resulted in dampening of the excessive cytokine production. These results suggest that Irgm1 deficiency drives metabolic dysfunction in macrophages in a manner that is cell-autonomous and independent of infectious triggers. This may be a significant contributor to excessive inflammation seen in Irgm1-deficient mice in different contexts.	[Schmidt, Elyse A.; Shinohara, Mari L.; Coers, Jorn; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Nichols, Amanda G.; Maclver, Nancie J.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Endocrinol & Diabet, Durham, NC 27710 USA; [Shinohara, Mari L.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Ilkayeva, Olga R.; Koves, Timothy R.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Koves, Timothy R.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Koves, Timothy R.; Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Fee, Brian E.; Henry, Stanley C.; Taylor, Gregory A.] Durham Vet Affairs Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Durham, NC 27705 USA; [Rathmell, Jeffrey C.] Vanderbilt Univ, Vanderbilt Ctr Immunobiol, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; Vanderbilt University	Taylor, GA (corresponding author), 508 Fulton St,Rm N3008, Durham, NC 27705 USA.	gregory.taylor@duke.edu	Koves, Tim/I-4806-2012	Koves, Tim/0000-0001-8763-5866; MacIver, Nancie/0000-0003-3676-9391; Shinohara, Mari/0000-0002-6808-9844; Coers, Jorn/0000-0001-8707-4608	NIAID, National Institutes of Health [UC6-AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088100, R01AI057831, UC6AI058607, R01AI103197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106090] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002369] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs. Tso-Pang Yao, Patrick Seed, and David Pickup for many helpful conversations regarding this work. Cytokine profiling was performed under the management of Dr. Heather E. Lynch and the direction of Dr. Gregory D. Sempowski in the Immunology Unit of the Duke Regional Biocontainment Laboratory, which received partial support for construction from NIAID, National Institutes of Health, Grant UC6-AI058607.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; [Anonymous], 2014, THESIS; Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096; Bafica A, 2007, J IMMUNOL, V179, P5514, DOI 10.4049/jimmunol.179.8.5514; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; DOUGAN G, 1988, J INFECT DIS, V158, P1329, DOI 10.1093/infdis/158.6.1329; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Freitag J, 2016, IMMUNOL CELL BIOL, V94, P925, DOI 10.1038/icb.2016.77; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422; Guerra C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028378; Hahn WS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1033, DOI 10.1152/ajpendo.00422.2013; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963; Henry SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095021; Henry SC, 2010, J LEUKOCYTE BIOL, V87, P333, DOI 10.1189/jlb.0509299; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Infantino V, 2014, BBA-GENE REGUL MECH, V1839, P1217, DOI 10.1016/j.bbagrm.2014.07.013; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091522; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Lin YC, 2016, J HEPATOL, V65, P1209, DOI 10.1016/j.jhep.2016.06.029; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Maric-Biresev J, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0255-4; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Namgaladze D, 2014, DIABETOLOGIA, V57, P1067, DOI 10.1007/s00125-014-3173-4; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Park J, 2013, J NEUROCHEM, V127, P221, DOI 10.1111/jnc.12361; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Perkins DJ, 2016, J INTERF CYTOK RES, V36, P454, DOI 10.1089/jir.2016.0003; Petkova DS, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00426; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qi XF, 2011, J CELL PHYSIOL, V226, P58, DOI 10.1002/jcp.22303; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rathmell JC, 2012, IMMUNOL REV, V249, P5, DOI 10.1111/j.1600-065X.2012.01158.x; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Saiga H, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/347594; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schertzer JD, 2014, IMMUNOL CELL BIOL, V92, P303, DOI 10.1038/icb.2014.12; Schwartz YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P246, DOI 10.1134/S0006297912030030; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Springer HM, 2013, J IMMUNOL, V191, P1765, DOI 10.4049/jimmunol.1300641; Steinberg GR, 2014, IMMUNOL CELL BIOL, V92, P340, DOI 10.1038/icb.2014.11; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Van den Bossche J, 2015, JOVE-J VIS EXP, DOI 10.3791/53424; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang Y, 2014, J ATHEROSCLER THROMB, V21, P381, DOI 10.5551/jat.23929; Wei WC, 2015, J LEUKOCYTE BIOL, V97, P1071, DOI 10.1189/jlb.2A0414-206RR; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Xia FC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01867; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	94	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4651	4662		10.1074/jbc.M116.770735	http://dx.doi.org/10.1074/jbc.M116.770735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154172	Green Published, hybrid			2022-12-28	WOS:000397585100022
J	Jung, HJ; Byun, HO; Jee, BA; Min, S; Jeoun, UW; Lee, YK; Seo, Y; Woo, HG; Yoon, G				Jung, Hyun-Jung; Byun, Hae-Ok; Jee, Byul A.; Min, Seongki; Jeoun, Un-woo; Lee, Young-Kyoung; Seo, Yonghak; Woo, Hyun Goo; Yoon, Gyesoon			The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular senescence; DNA methylation; gene expression; gene regulation; microarray	DNA METHYLATION; GENE-EXPRESSION; CANCER; STABILITY; UHRF1; PHOSPHORYLATION; OVEREXPRESSION; MAINTENANCE; MECHANISM; CARCINOMA	As senescence develops, cells sequentially acquire diverse senescent phenotypes along with simultaneous multistage gene reprogramming. It remains unclear what acts as the key regulator of the collective changes in gene expression at initiation of senescent reprogramming. Here we analyzed time series gene expression profiles obtained in two different senescence models in human diploid fibroblasts: replicative senescence and H2O2-induced senescence. Our results demonstrate that suppression of DNA methyltransferase 1 (DNMT1)-mediated DNA methylation activity was an initial event prior to the display of senescent phenotypes. We identified seven DNMT1-interacting proteins, ubiquitin-like with PHD and ring finger domains 1 (UHRF1), EZH2, CHEK1, SUV39H1, CBX5, PARP1, and HELLS (also known as LSH (lymphoid-specific helicase) 1), as being commonly down-regulated at the same time point as DNMT1 in both senescence models. Knockdown experiments revealed that, among the DNMT1-interacting proteins, only UHRF1 knockdown suppressed DNMT1 transcription. However, UHRF1 overexpression alone did not induce DNMT1 expression, indicating that UHRF1 was essential but not sufficient for DNMT1 transcription. Although UHRF1 knockdown effectively induced senescence, this was significantly attenuated by DNMT1 overexpression, clearly implicating the UHRF1/DNMT1 axis in senescence. Bioinformatics analysis further identified WNT5A as a downstream effector of UHRF1/DNMT1-mediated senescence. Senescence-associated hypomethylation was found at base pairs -1569 to -1363 from the transcription start site of the WNT5A gene in senescent human diploid fibroblasts. As expected, WNT5A overexpression induced senescent phenotypes. Overall, our results indicate that decreased UHRF1 expression is a key initial event in the suppression of DNMT1-mediated DNA methylation and in the consequent induction of senescence via increasing WNT5A expression.	[Jung, Hyun-Jung; Byun, Hae-Ok; Min, Seongki; Jeoun, Un-woo; Lee, Young-Kyoung; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Biochem & Mol Biol, Suwon 16499, South Korea; [Jee, Byul A.; Woo, Hyun Goo] Ajou Univ, Grad Sch, Dept Physiol, Suwon 16499, South Korea; [Jung, Hyun-Jung; Jee, Byul A.; Min, Seongki; Jeoun, Un-woo; Lee, Young-Kyoung; Woo, Hyun Goo; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 16499, South Korea; [Seo, Yonghak] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	Ajou University; Ajou University; Ajou University; University of Massachusetts System; University of Massachusetts Worcester	Woo, HG (corresponding author), Ajou Univ, Sch Med, Dept Physiol, Suwon 443721, South Korea.; Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 443721, South Korea.	hg@ajou.ac.kr; ypeace@ajou.ac.kr	Woo, Hyun Goo | 우현구/I-8954-2019; Woo, Hyun Goo/AEJ-7372-2022	Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Woo, Hyun Goo/0000-0002-0916-893X	National Research Foundation of Korea [2012R1A5A2048183, 2015R1A2A1A10055038]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2012R1A5A2048183 and 2015R1A2A1A10055038. The authors declare that they have no conflicts of interest with the contents of this article. The raw data from the microarray experiments are available in the GEO database (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE80322.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Bitler BG, 2011, CANCER RES, V71, P6184, DOI 10.1158/0008-5472.CAN-11-1341; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Iannetti A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004642; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Ma J, 2015, BIOCHEM BIOPH RES CO, V464, P147, DOI 10.1016/j.bbrc.2015.06.104; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Piskunova Tatiana S, 2008, Curr Gerontol Geriatr Res, P754190, DOI 10.1155/2008/754190; Poehlmann A, 2011, J CELL MOL MED, V15, P1528, DOI 10.1111/j.1582-4934.2010.01143.x; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sidler C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00411; So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503; Sugiyama Y, 2010, BIOCHEM J, V427, P489, DOI 10.1042/BJ20091856; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WILSON VL, 1983, SCIENCE, V220, P1054; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	39	23	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3729	3739		10.1074/jbc.M116.750539	http://dx.doi.org/10.1074/jbc.M116.750539			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100769	hybrid, Green Published			2022-12-28	WOS:000395542500016
J	Li, WM; Chan, CM; Miller, AL; Lee, CH				Li, Wai Ming; Chan, Ching-Man; Miller, Andrew L.; Lee, Chow H.			Dual Functional Roles of Molecular Beacon as a MicroRNA Detector and Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene silencing; in vivo imaging; microRNA (miRNA); microscopy; zebrafish; anti-miR; miR-430; molecular beacon	IMAGING-SYSTEM; RNA DECAY; ZEBRAFISH; EXPRESSION; FATE; MIR-430; CELLS; HYBRIDIZATION; ORGANIZATION	MicroRNAs are essential in many cellular processes. The ability to detect microRNAs is important for understanding its function and biogenesis. This study is aimed at using a molecular beacon to detect miR-430 in developing zebrafish embryos as a proof of principle. miR-430 is crucial for the clearance of maternal mRNA during maternal zygotic transition in embryonic development. Despite its known function, the temporal and spatial expression of miR-430 remains unclear. We used various imaging techniques, including laser scanning confocal microscopy, spinning disk, and lightsheet microscopy, to study the localization of miR-430 and any developmental defects possibly caused by the molecular beacon. Our results show that miR-430 is expressed early in development and is localized in distinct cytoplasmic granules where its target mRNA can be detected. We also show that the designed molecular beacon can inhibit the function of miR-430 and cause developmental defect in the brain, notochord, heart, and kidney, depending on the delivery site within the embryo, suggesting that miR-430 plays a diverse role in embryonic morphogenesis. When compared with morpholino, molecular beacon is 2 orders of magnitude more potent in inhibiting miR-430. Thus, our results reveal that in addition to being used as a valuable tool for the detection of microRNAs in vivo, molecular beacons can also be employed to inhibit microRNAs in a specific manner.	[Li, Wai Ming; Lee, Chow H.] Univ Northern British Columbia, Chem Program, 3333 Univ Way, Prince George, BC V2N 4Z9, Canada; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Key State Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	University of Northern British Columbia; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Lee, CH (corresponding author), Univ Northern British Columbia, Chem Program, 3333 Univ Way, Prince George, BC V2N 4Z9, Canada.	chow.lee@unbc.ca			Natural Sciences & Engineering Research Council Discovery Grant [227158]; Hong Kong Research Grant Council (RGC) General Research Fund Awards [662113, 16101714, 16100115]; Hong Kong Innovation and Technology Commission Grant [ITCPD/17-9]	Natural Sciences & Engineering Research Council Discovery Grant; Hong Kong Research Grant Council (RGC) General Research Fund Awards; Hong Kong Innovation and Technology Commission Grant	This work was supported by Natural Sciences & Engineering Research Council Discovery Grant 227158 (to C. H. L.), Hong Kong Research Grant Council (RGC) General Research Fund Awards 662113, 16101714, and 16100115, and Hong Kong Innovation and Technology Commission Grant ITCPD/17-9 (to A. L. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Arribas-Layton M, 2013, BBA-GENE REGUL MECH, V1829, P580, DOI 10.1016/j.bbagrm.2012.12.006; Baker MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1016; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bratu DP, 2011, METHODS MOL BIOL, V714, P141, DOI 10.1007/978-1-61779-005-8_9; Cheng CJ, 2013, CURR MED CHEM, V20, P3582; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Choi Y.J., 2014, ARCH PHARM RES, V2014, P1, DOI DOI 10.1016/j.jaccpubpol.2014.06.001; Dhanasiri AKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065028; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hernandez R, 2013, CURR MED CHEM, V20, P3594; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kang WJ, 2011, BIOMATERIALS, V32, P1915, DOI 10.1016/j.biomaterials.2010.11.007; Kato Y, 2010, J BIOCHEM, V147, P63, DOI 10.1093/jb/mvp144; Kato Y, 2009, INT J BIOCHEM CELL B, V41, P2225, DOI 10.1016/j.biocel.2009.04.018; Khudayberdiev SA, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00043; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Ko HY, 2015, CHEM COMMUN, V51, P2159, DOI 10.1039/c4cc08898k; Ko HY, 2009, NAT PROTOC, V4, P1663, DOI 10.1038/nprot.2009.119; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee C. H., 2013, J MOL IMAGING DYNAM, V2, P113; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Salmanidis M, 2014, INT J BIOCHEM CELL B, V54, P304, DOI 10.1016/j.biocel.2014.03.010; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Urbanek MO, 2015, INT J MOL SCI, V16, P13259, DOI 10.3390/ijms160613259; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WOO K, 1995, CURR OPIN GENET DEV, V5, P439, DOI 10.1016/0959-437X(95)90046-J; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhao ZX, 2001, DEV BIOL, V229, P215, DOI 10.1006/dbio.2000.9982	48	9	10	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3568	3580		10.1074/jbc.M116.765776	http://dx.doi.org/10.1074/jbc.M116.765776			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100783	Green Published, hybrid			2022-12-28	WOS:000395542500003
J	San Martin, A; Arce-Molina, R; Galaz, A; Perez-Guerra, G; Barros, LF				San Martin, Alejandro; Arce-Molina, Robinson; Galaz, Alex; Perez-Guerra, Gustavo; Felipe Barros, L.			Nanomolar nitric oxide concentrations quickly and reversibly modulate astrocytic energy metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL RESPIRATION; BLOOD-VESSELS; BRAIN MICROVESSELS; NEURONAL-ACTIVITY; D-SERINE; LACTATE; INHIBITION; CELLS; EXPRESSION	Nitric oxide (NO) is an intercellular messenger involved in multiple bodily functions. Prolonged NO exposure irreversibly inhibits respiration by covalent modification of mitochondrial cytochrome oxidase, a phenomenon of pathological relevance. However, the speed and potency of NO's metabolic effects at physiological concentrations are incompletely characterized. To this end, we set out to investigate the metabolic effects of NO in cultured astrocytes from mice by taking advantage of the high spatiotemporal resolution afforded by genetically encoded Frster resonance energy transfer (FRET) nanosensors. NO exposure resulted in immediate and reversible intracellular glucose depletion and lactate accumulation. Consistent with cytochrome oxidase involvement, the glycolytic effect was enhanced at a low oxygen level and became irreversible at a high NO concentration or after prolonged exposure. Measurements of both glycolytic rate and mitochondrial pyruvate consumption revealed significant effects even at nanomolar NO concentrations. We conclude that NO can modulate astrocytic energy metabolism in the short term, reversibly, and at concentrations known to be released by endothelial cells under physiological conditions. These findings suggest that NO modulates the size of the astrocytic lactate reservoir involved in neuronal fueling and signaling.	[San Martin, Alejandro; Arce-Molina, Robinson; Galaz, Alex; Perez-Guerra, Gustavo; Felipe Barros, L.] Ctr Estudios Cient, Valdivia 5110466, Chile; [San Martin, Alejandro; Arce-Molina, Robinson; Perez-Guerra, Gustavo] Univ Austral Chile, Valdivia 5110566, Chile	Universidad Austral de Chile	San Martin, A; Barros, LF (corresponding author), Ctr Estudios Cient, Arturo Prat 514, Valdivia 5110466, Chile.	aalejo@cecs.cl; fbarros@cecs.cl		San Martin, Alejandro/0000-0002-5608-5117	Chilean Government through the Centers of Excellence Base Financing Program of Conicyt	Chilean Government through the Centers of Excellence Base Financing Program of Conicyt	We thank Karin Alegria for expert assistance with cell culture and Planta Valdivia of Arauco S.A., particularly Manager Sergio Carreno Moscoso and Production sub-manager Manuel Gonzalez Saldivia, for kindly lending the oxygen electrode. We also thank Karen Everett for critical reading of the manuscript. The Centro de Estudios Cientificos is funded by the Chilean Government through the Centers of Excellence Base Financing Program of Conicyt.	Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Andrews AM, 2010, NITRIC OXIDE-BIOL CH, V23, P335, DOI 10.1016/j.niox.2010.08.003; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Barros LF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00027; Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Blackshaw S, 2003, NEUROSCIENCE, V119, P979, DOI 10.1016/S0306-4522(03)00217-3; Bohlen HG, 2013, MICROCIRCULATION, V20, P30, DOI 10.1111/micc.12003; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brix B, 2012, J NEUROSCI, V32, P9727, DOI 10.1523/JNEUROSCI.0879-12.2012; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Chen KJ, 2008, ANTIOXID REDOX SIGN, V10, P1185, DOI 10.1089/ars.2007.1959; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Derouiche A, 2015, NEUROCHEM RES, V40, P2402, DOI 10.1007/s11064-015-1563-8; Devor A, 2011, J NEUROSCI, V31, P13676, DOI 10.1523/JNEUROSCI.1968-11.2011; Barros LF, 2014, NEUROMETHODS, V90, P145, DOI 10.1007/978-1-4939-1059-5_6; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garthwaite J, 2016, J PHYSIOL-LONDON, V594, P9, DOI 10.1113/JP270297; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Jackson JG, 2015, J NEUROSCI, V35, P15199, DOI 10.1523/JNEUROSCI.2049-15.2015; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Kasparov S, 2016, CELL METAB, V23, P1, DOI 10.1016/j.cmet.2015.11.001; Koivisto A, 1997, FEBS LETT, V417, P75, DOI 10.1016/S0014-5793(97)01258-1; LeMaistre JL, 2012, J CEREBR BLOOD F MET, V32, P537, DOI 10.1038/jcbfm.2011.161; Lerchundi R, 2015, P NATL ACAD SCI USA, V112, P11090, DOI 10.1073/pnas.1508259112; Loaiza A, 2003, J NEUROSCI, V23, P7337; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Mamczur P, 2015, GLIA, V63, P328, DOI 10.1002/glia.22753; Marcillac F, 2011, GLIA, V59, P1987, DOI 10.1002/glia.21240; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Moller M, 2005, J BIOL CHEM, V280, P8850, DOI 10.1074/jbc.M413699200; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rodriguez-Juarez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033; ROSENBERG JC, 1966, CLIN CHEM, V12, P299; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; San Martin A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011004; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Stanarius A, 1997, ACTA HISTOCHEM, V99, P411, DOI 10.1016/S0065-1281(97)80034-7; Stobart JLL, 2013, P NATL ACAD SCI USA, V110, P3149, DOI 10.1073/pnas.1215929110; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Yamakawa H, 2003, J CEREBR BLOOD F MET, V23, P371, DOI 10.1097/01.WCB.0000047369.05600.03; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	65	27	27	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9432	9438		10.1074/jbc.M117.777243	http://dx.doi.org/10.1074/jbc.M117.777243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28341740	Green Published, hybrid			2022-12-28	WOS:000402538900036
J	Ito, T; Murai, M; Ninokura, S; Kitazumi, Y; Mezic, KG; Cress, BF; Koffas, MAG; Morgan, JE; Barquera, B; Miyoshi, H				Ito, Takeshi; Murai, Masatoshi; Ninokura, Satoshi; Kitazumi, Yuki; Mezic, Katherine G.; Cress, Brady F.; Koffas, Mattheos A. G.; Morgan, Joel E.; Barquera, Blanca; Miyoshi, Hideto			Identification of the binding sites for ubiquinone and inhibitors in the Na+-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae by photoaffinity labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; QUINONE OXIDOREDUCTASE; NADHQUINONE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; BC(1) COMPLEX; NQRC SUBUNITS; ALGINOLYTICUS; REDUCTASE; KORORMICIN; DEHYDROGENASE	The Na+-pumping NADH-quinone oxidoreductase (Na+-NQR) is the first enzyme of the respiratory chain and the main ion transporter in many marine and pathogenic bacteria, including Vibrio cholerae. The V. cholerae Na+-NQR has been extensively studied, but its binding sites for ubiquinone and inhibitors remain controversial. Here, using a photoreactive ubiquinone PUQ-3 as well as two aurachin-type inhibitors [I-125] PAD-1 and [I-125] PAD-2 and photoaffinity labeling experiments on the isolated enzyme, we demonstrate that the ubiquinone ring binds to the NqrA subunit in the regions Leu-32Met- 39 and Phe-131-Lys-138, encompassing the rear wall of a predicted ubiquinone-binding cavity. The quinolone ring and alkyl side chain of aurachin bound to the NqrB subunit in the regions Arg-43-Lys-54 and Trp-23-Gly-89, respectively. These results indicate that the binding sites for ubiquinone and aurachin- type inhibitors are in close proximity but do not overlap one another. Unexpectedly, although the inhibitory effects of PAD-1 and PAD-2 were almost completely abolished by certain mutations in NqrB (i. e. G140A and E144C), the binding reactivities of [I-125] PAD-1 and [I-125] PAD-2 to the mutated enzymes were unchanged compared with those of the wild-type enzyme. We also found that photoaffinity labeling by [I-125] PAD-1 and [I-125] PAD-2, rather than being competitively suppressed in the presence of other inhibitors, is enhanced undersomeexperimental conditions. To explain these apparently paradoxical results, we propose models for the catalytic reaction of Na+-NQR and its interactions with inhibitors on the basis of the biochemical and biophysical results reported here and in previous work.	[Ito, Takeshi; Murai, Masatoshi; Ninokura, Satoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Mezic, Katherine G.; Koffas, Mattheos A. G.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Cress, Brady F.; Koffas, Mattheos A. G.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Mezic, Katherine G.; Cress, Brady F.; Koffas, Mattheos A. G.; Morgan, Joel E.; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Kyoto University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp	Cress, Brady F/G-9823-2011	Cress, Brady F/0000-0002-2948-2846; Miyoshi, Hideto/0000-0002-1792-554X; Koffas, Mattheos/0000-0002-1405-0565; Murai, Masatoshi/0000-0001-6601-2854; Ito, Takeshi/0000-0001-7739-8705	Japan Society for the Promotion of Science [26292060, 15K07411, 16J02535]; Grants-in-Aid for Scientific Research [15K07411, 16J02535] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 26292060 (to H. M.), 15K07411 (to M. M.), and 16J02535 (to T. I.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Casutt MS, 2012, BBA-BIOENERGETICS, V1817, P1817, DOI 10.1016/j.bbabio.2012.02.012; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Murai M, 2017, BIOCHEMISTRY-US, V56, P570, DOI 10.1021/acs.biochem.6b01011; Murai M, 2014, BIOCHEMISTRY-US, V53, P3995, DOI 10.1021/bi500347s; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Omori A, 2002, ELECTROPHORESIS, V23, P4167, DOI 10.1002/elps.200290034; Sakamoto K, 2002, J PESTIC SCI, V27, P147; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; Tebben J, 2014, MAR DRUGS, V12, P2802, DOI 10.3390/md12052802; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Yoshikawa K, 1997, J ANTIBIOT, V50, P949, DOI 10.7164/antibiotics.50.949; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	35	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7727	7742		10.1074/jbc.M117.781393	http://dx.doi.org/10.1074/jbc.M117.781393			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28298441	Green Published, hybrid			2022-12-28	WOS:000401154100003
J	Matteo, DA; Grunseth, AJ; Gonzalez, ER; Anselmo, SL; Kennedy, MA; Moman, P; Scott, DA; Hoang, A; Sohl, CD				Matteo, Diego Avellaneda; Grunseth, Adam J.; Gonzalez, Eric R.; Anselmo, Stacy L.; Kennedy, Madison A.; Moman, Precious; Scott, David A.; Hoang, An; Sohl, Christal D.			Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT IDH; ONCOMETABOLITE 2-HYDROXYGLUTARATE; CANCER; D-2-HYDROXYGLUTARATE; SUFFICIENT; LEUKEMIA; GLIOMAS; (R)-2-HYDROXYGLUTARATE; FREQUENCY; CELLS	Isocitrate dehydrogenase 1 (IDH1) catalyzes the reversible NADP(+) -dependent conversion of isocitrate (ICT) to alpha-ketoglutarate (alpha KG) in the cytosol and peroxisomes. Mutations in IDH1 have been implicated in >80% of lower grade gliomas and secondary glioblastomas and primarily affect residue 132, which helps coordinate substrate binding. However, other mutations found in the active site have also been identified in tumors. IDH1 mutations typically result in a loss of catalytic activity, but many also can catalyze a new reaction, the NADPH-dependent reduction of alpha KG to D-2-hydroxyglutarate (D2HG). D2HG is a proposed oncometabolite that can competitively inhibit alpha KG-dependent enzymes. Some kinetic parameters have been reported for several IDH1 mutations, and there is evidence that mutant IDH1 enzymes vary widely in their ability to produce D2HG. We report that most IDH1 mutations identified in tumors are severely deficient in catalyzing the normal oxidation reaction, but that D2HG production efficiency varies among mutant enzymes up to similar to 640-fold. Common IDH1 mutations have moderate catalytic efficiencies for D2HG production, whereas rarer mutations exhibit either very low or very high efficiencies. We then designed a series of experimental IDH1 mutants to understand the features that support D2HG production. We show that this new catalytic activity observed in tumors is supported by mutations at residue 132 that have a smaller van der Waals volume and are more hydrophobic. We report that one mutation can support both the normal and neomorphic reactions. These studies illuminate catalytic features of mutations found in the majority of patients with lower grade gliomas.	[Matteo, Diego Avellaneda; Grunseth, Adam J.; Gonzalez, Eric R.; Anselmo, Stacy L.; Kennedy, Madison A.; Moman, Precious; Hoang, An; Sohl, Christal D.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA; [Scott, David A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA	California State University System; San Diego State University; Sanford Burnham Prebys Medical Discovery Institute	Sohl, CD (corresponding author), CSL 328,MC1030,5500 Campanile Dr, San Diego, CA 92182 USA.	csohl@mail.sdsu.edu		Scott, David/0000-0002-8668-2449	National Institute of Health [K99 CA187594, R00 CA187594, 5T34 GM008303, P30 CA030199]; Summer Undergraduate Research Program Grant from San Diego State University; San Diego State University startup funds; NATIONAL CANCER INSTITUTE [R00CA187594, K99CA187594, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008303] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Undergraduate Research Program Grant from San Diego State University; San Diego State University startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants K99 CA187594 (to C. D. S.), R00 CA187594 (to C. D. S.), 5T34 GM008303 (to E. R. G. and M. A. K.), and P30 CA030199 (to D. A. S.), a Summer Undergraduate Research Program Grant from San Diego State University (to M. A. K.), and San Diego State University startup funds (to C. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2016, ANN ONCOL, V27, P599, DOI 10.1093/annonc/mdw013; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DiNardo CD, 2013, BLOOD, V121, P4917, DOI 10.1182/blood-2013-03-493197; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Grassian AR, 2014, CURR OPIN GASTROEN, V30, P295, DOI 10.1097/MOG.0000000000000050; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Halamkova L, 2012, TALANTA, V100, P7, DOI 10.1016/j.talanta.2012.08.022; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Hirata M, 2015, P NATL ACAD SCI USA, V112, P2829, DOI 10.1073/pnas.1424400112; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Koszarska M, 2013, LEUKEMIA LYMPHOMA, V54, P1028, DOI 10.3109/10428194.2012.736981; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Liu AZ, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00016; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Ma SH, 2015, ONCOTARGET, V6, P8606, DOI 10.18632/oncotarget.3330; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Oizel K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.13; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Pusch S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-19; RACKER E, 1972, AM SCI, V60, P56; Ratnikov B, 2015, ONCOTARGET, V6, P7379, DOI 10.18632/oncotarget.3132; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schrodinger L, 2010, PYMOL MOL GRAPH SYST; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; WARBURG O, 1956, Oncologia, V9, P75; Warburg O., 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; Ward PS, 2012, ONCOGENE, V31, P2491, DOI 10.1038/onc.2011.416; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Zhang CZ, 2013, NEURO-ONCOLOGY, V15, P1114, DOI 10.1093/neuonc/not087; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	54	27	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7971	7983		10.1074/jbc.M117.776179	http://dx.doi.org/10.1074/jbc.M117.776179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28330869	Green Published, hybrid			2022-12-28	WOS:000401154100023
J	Rigoldi, F; Metrangolo, P; Redaelli, A; Gautieri, A				Rigoldi, Federica; Metrangolo, Pierangelo; Redaelli, Alberto; Gautieri, Alfonso			Nanostructure and stability of calcitonin amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; amyloid; molecular dynamics; protein misfolding; protein-protein interaction	MOLECULAR-DYNAMICS SIMULATION; SOLID-STATE NMR; FIBRIL FORMATION; PEPTIDE NANOTUBES; C-13 NMR; OLIGOMERIZATION; SPECTROSCOPY; RESIDUES; SEQUENCE; PARALLEL	Calcitonin is a 32-amino acid thyroid hormone that can form amyloid fibrils. The structural basis of the fibril formation and stabilization is still debated and poorly understood. The reason is that NMR data strongly suggest antiparallel -sheet calcitonin assembly, whereas modeling studies on the short DFNKF peptide (corresponding to the sequence from Asp(15) to Phe(19) of human calcitonin and reported as the minimal amyloidogenic module) show that it assembles with parallel -sheets. In this work, we first predict the structure of human calcitonin through two complementary molecular dynamics (MD) methods, finding that human calcitonin forms an -helix. We use extensive MD simulations to compare previously proposed calcitonin fibril structures. We find that two conformations, the parallel arrangement and one of the possible antiparallel structures (with Asp(15) and Phe(19) aligned), are highly stable and ordered. Nonetheless, fibrils with parallel molecules show bulky loops formed by residues 1 to 7 located on the same side, which could limit or prevent the formation of larger amyloids. We investigate fibrils formed by the DFNKF peptide by simulating different arrangements of this amyloidogenic core sequence. We show that DFNKF fibrils are highly stable when assembled in parallel -sheets, whereas they quickly unfold in antiparallel conformation. Our results indicate that the DFNKF peptide represents only partially the full-length calcitonin behavior. Contrary to the full-length polypeptide, in fact, the DFNKF sequence is not stable in antiparallel conformation, suggesting that the residue flanking the amyloidogenic peptide contributes to the stabilization of the experimentally observed antiparallel -sheet packing.	[Rigoldi, Federica; Redaelli, Alberto; Gautieri, Alfonso] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy; [Metrangolo, Pierangelo] Politecn Milan, Dipartimento Chim Mat & Ingn Chim Giulio Natta, Via L Mancinelli 7, I-20131 Milan, Italy; [Metrangolo, Pierangelo] VTT Tecn Res Ctr Finland, Biologinkuja 7, Espoo 02150, Finland	Polytechnic University of Milan; Polytechnic University of Milan	Gautieri, A (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	alfonso.gautieri@polimi.it	redaelli, alberto/K-3137-2018	redaelli, alberto/0000-0002-9020-2188; METRANGOLO, PIERANGELO/0000-0002-7945-099X	Fondazione Cariplo [2013-0766, 2016-0481]; European Research Council (ERC) [FOLDHALO 307108]	Fondazione Cariplo(Fondazione Cariplo); European Research Council (ERC)(European Research Council (ERC))	This work was supported by Fondazione Cariplo Grants 2013-0766 and 2016-0481. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Research Council (ERC) starting grant FOLDHALO 307108.	Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Andreotti G, 2011, J BIOL CHEM, V286, P2707, DOI 10.1074/jbc.M110.182014; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; Bertolani A., 2016, CHEMISTRY, V23, P2051; Bertolani A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8574; Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w; Du AW, 2014, BIOMACROMOLECULES, V15, P1097, DOI 10.1021/bm500169p; Fichman G, 2014, NANOMATERIALS-BASEL, V4, P726, DOI 10.3390/nano4030726; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gautieri A, 2014, MATRIX BIOL, V34, P89, DOI 10.1016/j.matbio.2013.09.004; Gautieri A, 2010, J MOL MODEL, V16, P1845, DOI 10.1007/s00894-010-0687-7; Guo CA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13556; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Haspel N, 2005, J MOL BIOL, V345, P1213, DOI 10.1016/j.jmb.2004.11.002; Hauser CAE, 2014, CHEM SOC REV, V43, P5326, DOI 10.1039/c4cs00082j; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh-Watanabe H, 2013, PHYS CHEM CHEM PHYS, V15, P8890, DOI 10.1039/c3cp44544e; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamihira M, 2003, J BIOL CHEM, V278, P2859, DOI 10.1074/jbc.M205285200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Nair AK, 2014, BIOMACROMOLECULES, V15, P2494, DOI 10.1021/bm5003416; Naito A, 2004, MAGN RESON CHEM, V42, P247, DOI 10.1002/mrc.1323; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Reches M, 2005, ISR J CHEM, V45, P363, DOI 10.1560/5MC0-V3DX-KE0B-YF3J; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Tsai HH, 2004, BIOPHYS J, V87, P146, DOI 10.1529/biophysj.104.040352; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367	38	14	14	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7348	7357		10.1074/jbc.M116.770271	http://dx.doi.org/10.1074/jbc.M116.770271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28283568	hybrid, Green Published			2022-12-28	WOS:000400761300007
J	Christensen, EM; Patel, SM; Korasick, DA; Campbell, AC; Krause, KL; Becker, DF; Tanner, JJ				Christensen, Emily M.; Patel, Sagar M.; Korasick, David A.; Campbell, Ashley C.; Krause, Kurt L.; Becker, Donald F.; Tanner, John J.			Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-10-FORMYLTETRAHYDROFOLATE SYNTHETASE; CRYSTAL-STRUCTURES; ELECTRON-DENSITY; PROTEIN CRYSTALLOGRAPHY; GENERAL ACID; TIME PASSES; DEHYDROGENASE; FEATURES; METABOLISM; RESOLUTION	Pyrroline-5-carboxylate reductase (PYCR) is the final enzyme in proline biosynthesis, catalyzing the NAD(P)H-dependent reduction of Delta(1)-pyrroline-5-carboxylate (P5C) to proline. Mutations in the PYCR1 gene alter mitochondrial function and cause the connective tissue disorder cutis laxa. Furthermore, PYCR1 is overexpressed in multiple cancers, and the PYCR1 knock-out suppresses tumorigenic growth, suggesting that PYCR1 is a potential cancer target. However, inhibitor development has been stymied by limited mechanistic details for the enzyme, particularly in light of a previous crystallographic study that placed the cofactor-binding site in the C-terminal domain rather than the anticipated Rossmann fold of the N-terminal domain. To fill this gap, we report crystallographic, sedimentation-velocity, and kinetics data for human PYCR1. Structures of binary complexes of PYCR1 with NADPH or proline determined at 1.9 angstrom resolution provide insight into cofactor and substrate recognition. We see NADPH bound to the Rossmann fold, over 25 angstrom from the previously proposed site. The 1.85 angstrom resolution structure of a ternary complex containing NADPH and a P5C/proline analog provides a model of the Michaelis complex formed during hydride transfer. Sedimentation velocity shows that PYCR1 forms a concentration-dependent decamer in solution, consistent with the pentamer-of-dimers assembly seen crystallographically. Kinetic and mutational analysis confirmed several features seen in the crystal structure, including the importance of a hydrogen bond between Thr-238 and the substrate as well as limited cofactor discrimination.	[Christensen, Emily M.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Korasick, David A.; Campbell, Ashley C.; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Krause, Kurt L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Patel, Sagar M.; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Patel, Sagar M.; Becker, Donald F.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Otago; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	tannerjj@missouri.edu	Patel, Sagar M./ABI-1741-2020	Patel, Sagar M./0000-0002-1700-3350; Tanner, John/0000-0001-8314-113X; Korasick, David/0000-0002-6337-2085	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065546] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jay Nix for help with X-ray diffraction data collection at beamline 4.2.2 of the Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; ADAMS MJ, 1970, NATURE, V227, P1098, DOI 10.1038/2271098a0; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Branden C., 1991, INTRO PORTEIN STRUCT, pChapter 10; BUEHNER M, 1974, J MOL BIOL, V90, P25, DOI 10.1016/0022-2836(74)90254-X; Celeste L, 2013, PROTEIN SCI, V22, P675, DOI 10.1002/pro.2251; Celeste LR, 2012, PROTEIN SCI, V21, P219, DOI 10.1002/pro.2005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Deller MC, 2015, J COMPUT AID MOL DES, V29, P817, DOI 10.1007/s10822-015-9833-8; Edwards MA, 2017, ENVIRON ENG SCI, V34, P51, DOI 10.1089/ees.2016.0223; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franklin MC, 2015, PROTEINS, V83, P2124, DOI 10.1002/prot.24841; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keenholtz RA, 2013, J BIOL CHEM, V288, P29206, DOI 10.1074/jbc.M113.508028; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu D, 2000, BIOCHEMISTRY-US, V39, P11955, DOI 10.1021/bi000790p; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng ZH, 2006, J MOL BIOL, V359, P1364, DOI 10.1016/j.jmb.2006.04.053; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Muller YA, 2013, ACTA CRYSTALLOGR F, V69, P1071, DOI 10.1107/S1744309113014383; Nakayama T, 2015, AM J HUM GENET, V96, P709, DOI 10.1016/j.ajhg.2015.03.003; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Nocek B, 2005, J MOL BIOL, V354, P91, DOI 10.1016/j.jmb.2005.08.036; Ou RY, 2016, TUMOR BIOL, V37, P6485, DOI 10.1007/s13277-015-3927-8; Pemberton TA, 2012, ACTA CRYSTALLOGR D, V68, P1010, DOI 10.1107/S0907444912019580; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; Pozharski E, 2013, ACTA CRYSTALLOGR D, V69, P150, DOI 10.1107/S0907444912044423; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Ruszkowski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00869; Sang P, 2017, J BIOMOL STRUCT DYN, V35, P2441, DOI 10.1080/07391102.2016.1222967; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Singh RK, 2011, J BIOL CHEM, V286, P43144, DOI 10.1074/jbc.M111.292474; Stec B, 2013, PROTEIN SCI, V22, P671, DOI 10.1002/pro.2252; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Touw WG, 2016, J MOL BIOL, V428, P1375, DOI 10.1016/j.jmb.2016.02.002; Weichenberger CX, 2013, ACTA CRYSTALLOGR F, V69, P195, DOI 10.1107/S1744309112044387; Weiss MS, 2016, HUM MOL GENET, V25, P4717, DOI 10.1093/hmg/ddw298; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; Wlodawer A, 2013, FEBS J, V280, P5705, DOI 10.1111/febs.12495; Zeng TY, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0870-5	53	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7233	7243		10.1074/jbc.M117.780288	http://dx.doi.org/10.1074/jbc.M117.780288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28258219	hybrid, Green Published			2022-12-28	WOS:000400478300033
J	Lee, H; Smith, SB; Yoon, Y				Lee, Hakjoo; Smith, Sylvia B.; Yoon, Yisang			The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT OPTIC ATROPHY; M-AAA PROTEASE; INNER-MEMBRANE-FUSION; PROTEOLYTIC CLEAVAGE; OXIDATIVE-PHOSPHORYLATION; INTERMEMBRANE SPACE; CELL-PROLIFERATION; MAMMALIAN-CELLS; OMA1 PROTEASE; FISSION	The protein optic atrophy 1 (OPA1) is a dynamin-related protein associated with the inner mitochondrial membrane and functions in mitochondrial inner membrane fusion and cristae maintenance. Inner membrane-anchored long OPA1 (L-OPA1) undergoes proteolytic cleavage resulting in short OPA1 (S-OPA1). It is often thought that S-OPA1 is a functionally insignificant proteolytic product of L-OPA1 because the accumulation of S-OPA1 due to L-OPA1 cleavage is observed in mitochondrial fragmentation and dysfunction. However, cells contain a mixture of both L-and S-OPA1 in normal conditions, suggesting the functional significance of maintaining both OPA1 forms, but the differential roles of L-and S-OPA1 in mitochondrial fusion and energetics are ill-defined. Here, we examined mitochondrial fusion and energetic activities in cells possessing L-OPA1 alone, S-OPA1 alone, or both L-and S-OPA1. Using a mitochondrial fusion assay, we established that L-OPA1 confers fusion competence, whereas S-OPA1 does not. Remarkably, we found that S-OPA1 alone without L-OPA1 can maintain oxidative phosphorylation function as judged by growth in oxidative phosphorylation-requiring media, respiration measurements, and levels of the respiratory complexes. Most strikingly, S-OPA1 alone maintained normal mitochondrial cristae structure, which has been commonly assumed to be the function of OPA1 oligomers containing both L-and S-OPA1. Furthermore, we found that the GTPase activity of OPA1 is critical for maintaining cristae tightness and thus energetic competency. Our results demonstrate that, contrary to conventional notion, S-OPA1 is fully competent for maintaining mitochondrial energetics and cristae structure.	[Lee, Hakjoo; Yoon, Yisang] Augusta Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA; [Smith, Sylvia B.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Yoon, Y (corresponding author), Augusta Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	yyoon@augusta.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	American Heart Association [16GRNT31170032]; National Institutes of Health [R01 EY012830]; NATIONAL EYE INSTITUTE [R01EY012830] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by American Heart Association Grant 16GRNT31170032 (to Y. Y.) and National Institutes of Health Grant R01 EY012830 (to S. B. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Barrera M, 2016, FEBS LETT, V590, P3309, DOI 10.1002/1873-3468.12384; Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Bohovych I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13989; Cabodevilla AG, 2013, J BIOL CHEM, V288, P27777, DOI 10.1074/jbc.M113.466656; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Desmurs M, 2015, MOL CELL BIOL, V35, P1139, DOI 10.1128/MCB.01047-14; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; MacVicar TDB, 2014, J CELL SCI, V127, P2313, DOI 10.1242/jcs.144337; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wang L, 2015, CARDIOVASC RES, V106, P272, DOI 10.1093/cvr/cvv005; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Yoon Yisang, 2005, Sci STKE, V2005, ppe18, DOI 10.1126/stke.2802005pe18; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933	76	103	112	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7115	7130		10.1074/jbc.M116.762567	http://dx.doi.org/10.1074/jbc.M116.762567			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298442	Green Published, hybrid			2022-12-28	WOS:000400478300022
J	Nikonorova, IA; Al-Baghdadi, RJT; Mirek, ET; Wang, YP; Goudie, MP; Wetstein, BB; Dixon, JL; Hine, C; Mitchell, JR; Adams, CM; Wek, RC; Anthony, TG				Nikonorova, Inna A.; Al-Baghdadi, Rana J. T.; Mirek, Emily T.; Wang, Yongping; Goudie, Michael P.; Wetstein, Berish B.; Dixon, Joseph L.; Hine, Christopher; Mitchell, James R.; Adams, Christopher M.; Wek, Ronald C.; Anthony, Tracy G.			Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DEPRIVATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED GENE-EXPRESSION; PEGYLATED ARGINASE I; LEUCINE DEPRIVATION; PROTEIN-SYNTHESIS; HYDROGEN-SULFIDE; GCN2; TRANSLATION; INSULIN	Obesity increases risk for liver toxicity by the anti-leukemic agent asparaginase, but the mechanism is unknown. Asparaginase activates the integrated stress response (ISR) via sensing amino acid depletion by the eukaryotic initiation factor 2 (eIF2) kinase GCN2. The goal of this work was to discern the impact of obesity, alone versus alongside genetic disruption of the ISR, on mechanisms of liver protection during chronic asparaginase exposure in mice. Following diet-induced obesity, biochemical analysis of livers revealed that asparaginase provoked hepatic steatosis that coincided with activation of another eIF2 kinase PKR-like endoplasmic reticulum kinase (PERK), a major ISR transducer to ER stress. Genetic loss of Gcn2 intensified hepatic PERK activation to asparaginase, yet surprisingly, mRNA levels of key ISR gene targets such as Atf5 and Trib3 failed to increase. Instead, mechanistic target of rapamycin complex 1 (mTORC1) signal transduction was unleashed, and this coincided with liver dysfunction reflected by a failure to maintain hydrogen sulfide production or apolipoprotein B100 (ApoB100) expression. In contrast, obese mice lacking hepatic activating transcription factor 4 (Atf4) showed an exaggerated ISR and greater loss of endogenous hydrogen sulfide but normal inhibition of mTORC1 and maintenance of ApoB100 during asparaginase exposure. In both genetic mouse models, expression and phosphorylation of Sestrin2, an ATF4 gene target, was increased by asparaginase, suggesting mTORC1 inhibition during asparagi-nase exposure is not driven via eIF2-ATF4-Sestrin2. In conclusion, obesity promotes a maladaptive ISR during asparaginase exposure. GCN2 functions to repress mTORC1 activity and maintain ApoB100 protein levels independently of Atf4 expression, whereas hydrogen sulfide production is promoted via GCN2-ATF4 pathway.	[Nikonorova, Inna A.; Mirek, Emily T.; Wang, Yongping; Goudie, Michael P.; Wetstein, Berish B.; Dixon, Joseph L.; Anthony, Tracy G.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Al-Baghdadi, Rana J. T.; Anthony, Tracy G.] Rutgers State Univ, Endocrinol & Anim Biosci Grad Program, New Brunswick, NJ 08901 USA; [Dixon, Joseph L.; Anthony, Tracy G.] New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Hine, Christopher; Mitchell, James R.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Adams, Christopher M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Al-Baghdadi, Rana J. T.] Univ Al Qadisiyah, Coll Vet Med, Dept Physiol & Pharmacol, Al Diwaniyah, Iraq	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Harvard University; Harvard T.H. Chan School of Public Health; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; University of Al-Qadisiyah	Anthony, TG (corresponding author), 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tracy.anthony@rutgers.edu	Anthony, Tracy/K-7951-2017; Al-Baghdadi, Rana Jaber Tarish/R-8270-2017	Anthony, Tracy/0000-0002-8586-5884; Al-Baghdadi, Rana Jaber Tarish/0000-0003-1111-6896; Wek, Ronald/0000-0002-2087-5504; Mirek, Emily/0000-0002-9683-8216; Nikonorova, Inna/0000-0001-8498-848X; Adams, Christopher/0000-0002-5795-7212; Hine, Christopher/0000-0003-1926-7939	National Institutes of Health [RO1HD070487, K99AG050777, AR059115]; Veterans Affairs [BX00976, RX001477]; IRACDA New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health [K12GM093854]; Higher Committee for Education Development in Iraq (HCED) fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG050777, R00AG050777] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976, I01RX001477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); IRACDA New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health; Higher Committee for Education Development in Iraq (HCED) fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HD070487 (to T. G. A.), K99AG050777 (to C. H.), and AR059115 (to C. M. A.) and Veterans Affairs Grants BX00976 and RX001477 (to C. M. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by IRACDA New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant K12GM093854.; Supported via The Higher Committee for Education Development in Iraq (HCED) fellowship. Present address: Dept. of Physiology and Pharmacology, College of Veterinary Medicine, University of Al-Qadisiyah, Iraq.	Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Averous J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27698; Ben Tanfous M, 2015, CLIN CANCER RES, V21, P329, DOI 10.1158/1078-0432.CCR-14-0508; Bodmer M, 2006, DIGESTION, V74, P28, DOI 10.1159/000095827; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Erazo T, 2016, CLIN CANCER RES, V22, P2508, DOI 10.1158/1078-0432.CCR-15-1808; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kimball SR, 2016, CELL SIGNAL, V28, P896, DOI 10.1016/j.cellsig.2016.03.008; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mani S, 2014, NITRIC OXIDE-BIOL CH, V41, P62, DOI 10.1016/j.niox.2014.02.006; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Morrow K, 2013, LEUKEMIA, V27, P569, DOI 10.1038/leu.2012.247; Ni Y, 2008, CANCER LETT, V261, P1, DOI 10.1016/j.canlet.2007.11.038; Orgel E, 2014, J CLIN ONCOL, V32, P1331, DOI 10.1200/JCO.2013.52.6962; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patil MD, 2016, ONCOGENE, V35, P4957, DOI 10.1038/onc.2016.37; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Phillipson-Weiner L, 2016, AM J PHYSIOL-GASTR L, V310, pG1061, DOI 10.1152/ajpgi.00052.2016; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rousseau J, 2011, BLOOD, V118, P5883, DOI 10.1182/blood-2011-05-355560; Sahoo S, 2003, SEMIN LIVER DIS, V23, P295; Salazar M, 2015, CELL DEATH DIFFER, V22, P131, DOI 10.1038/cdd.2014.133; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Sikalidis AK, 2011, AMINO ACIDS, V41, P159, DOI 10.1007/s00726-010-0571-x; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; Wilson GJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE283, DOI 10.1152/ajpendo.00361.2014; Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yau T, 2013, INVEST NEW DRUG, V31, P99, DOI 10.1007/s10637-012-9807-9; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	51	17	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6786	6798		10.1074/jbc.M116.768408	http://dx.doi.org/10.1074/jbc.M116.768408			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28242759	Green Published, hybrid			2022-12-28	WOS:000399813400029
J	Ruetz, M; Kumutima, J; Lewis, BE; Filipovic, MR; Lehnert, N; Stemmler, TL; Banerjee, R				Ruetz, Markus; Kumutima, Jacques; Lewis, Brianne E.; Filipovic, Milos R.; Lehnert, Nicolai; Stemmler, Timothy L.; Banerjee, Ruma			A distal ligand mutes the interaction of hydrogen sulfide with human neuroglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC-RESONANCE SPECTROSCOPY; CYSTATHIONINE BETA-SYNTHASE; BINDING-PROPERTIES; OXIDATIVE STRESS; MOUSE NEUROGLOBIN; FLASH-PHOTOLYSIS; GLOBIN FAMILY; RAMAN-SPECTRA; CYTOCHROME-C; ACTIVE-SITE	Hydrogen sulfide is a critical signaling molecule, but high concentrations cause cellular toxicity. A four-enzyme pathway in the mitochondrion detoxifies H2S by converting it to thiosulfate and sulfate. Recent studies have shown that globins like hemoglobin and myoglobin can also oxidize H2S to thiosulfate and hydropolysulfides. Neuroglobin, a globin enriched in the brain, was reported to bind H2S tightly and was postulated to play a role in modulating neuronal sensitivity to H2S in conditions such as stroke. However, the H2S reactivity of the coordinately saturated heme in neuroglobin is expected a priori to be substantially lower than that of the 5-coordinate hemes present in myoglobin and hemoglobin. To resolve this discrepancy, we explored the role of the distal histidine residue in muting the reactivity of human neuroglobin toward H2S. Ferric neuroglobin is slowly reduced by H2S and catalyzes its inefficient oxidative conversion to thiosulfate. Mutation of the distal His64 residue to alanine promotes rapid binding of H2S and its efficient conversion to oxidized products. X-ray absorption, EPR, and resonance Raman spectroscopy highlight the chemically different reaction options influenced by the distal histidine ligand. This study provides mechanistic insights into how the distal heme ligand in neuroglobin caps its reactivity toward H2S and identifies by cryo-mass spectrometry a range of sulfide oxidation products with 2-6 catenated sulfur atoms with or without oxygen insertion, which accumulate in the absence of the His(64) ligand.	[Ruetz, Markus; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kumutima, Jacques; Lehnert, Nicolai] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Kumutima, Jacques; Lehnert, Nicolai] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Lewis, Brianne E.; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Filipovic, Milos R.] Univ Bordeaux, IBGC, UMR 5090, F-33077 Bordeaux, France; [Filipovic, Milos R.] CNRS, Inst Biochem & Cellular Genet, UMR 5095, F-33077 Bordeaux, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Lewis, Brianne/AAU-5344-2021	Stemmler, Timothy/0000-0002-6298-088X; Lewis, Brianne/0000-0003-1584-6407	Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	XAS studies were performed at the Stanford Synchrotron Radiation Lightsource, which is a national user facility operated by Stanford University on behalf of the Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, Biomedical Technology Program.	Abe K, 1996, J NEUROSCI, V16, P1066; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; Brittain T, 2008, IUBMB LIFE, V60, P135, DOI 10.1002/iub.16; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CHOI S, 1982, J AM CHEM SOC, V104, P4337, DOI 10.1021/ja00380a005; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cotelesage JJH, 2012, J INORG BIOCHEM, V115, P127, DOI 10.1016/j.jinorgbio.2012.06.019; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Das TN, 1999, J PHYS CHEM A, V103, P5221, DOI 10.1021/jp9907544; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Du WH, 2003, J AM CHEM SOC, V125, P8080, DOI 10.1021/ja034584r; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Fabrizius A, 2016, NEUROSCIENCE, V337, P339, DOI 10.1016/j.neuroscience.2016.07.042; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Giordano D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044508; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; JANZ GJ, 1976, INORG CHEM, V15, P1759, DOI 10.1021/ic50162a004; JEYARAJAH S, 1994, J BIOL CHEM, V269, P31047; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; MORIKIS D, 1990, J BIOL CHEM, V265, P12143; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; Paulat F, 2006, INORG CHEM, V45, P2835, DOI 10.1021/ic0510866; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Pesce A, 2004, IUBMB LIFE, V56, P657, DOI 10.1080/15216540500078830; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Smith AT, 2015, CHEM REV, V115, P2532, DOI 10.1021/cr500056m; SPIRO TG, 1974, J AM CHEM SOC, V96, P338, DOI 10.1021/ja00809a004; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Tejero J, 2015, BIOCHEMISTRY-US, V54, P722, DOI 10.1021/bi501196k; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Uno T, 2004, J BIOL CHEM, V279, P5886, DOI 10.1074/jbc.M311748200; van Doorslaer S, 2004, IUBMB LIFE, V56, P665, DOI 10.1080/15216540500037877; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	63	31	33	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6512	6528		10.1074/jbc.M116.770370	http://dx.doi.org/10.1074/jbc.M116.770370			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28246171	Green Published, hybrid			2022-12-28	WOS:000399813400008
J	Li, W; Li, H; Zhang, LY; Hu, M; Li, F; Deng, JQ; An, MX; Wu, SQ; Ma, R; Lu, JC; Zhou, YF				Li, Wei; Li, Hua; Zhang, Liyuan; Hu, Min; Li, Fang; Deng, Jieqiong; An, Mingxing; Wu, Siqi; Ma, Rui; Lu, Jiachun; Zhou, Yifeng			Long non-coding RNA LINC00672 contributes to p53 protein-mediated gene suppression and promotes endometrial cancer chemosensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; heterogeneous nuclear ribonucleoprotein (hnRNP); long noncoding RNA (long ncRNA; lncRNA); p53; paclitaxel (taxol); Lasp1; endometrial cancer	INFLUENCES ZYXIN LOCALIZATION; SQUAMOUS-CELL CARCINOMA; SH3 DOMAIN PROTEIN-1; BREAST-CANCER; ESOPHAGEAL ADENOCARCINOMA; EXPRESSION; PROLIFERATION; MIGRATION; LIM; CHROMATIN	Thousands of long intergenic non-protein coding RNAs (lincRNAs) have been identified in mammals in genome-wide sequencing studies. Some of these RNAs have been consistently conserved during the evolution of species and could presumably function in important biologic processes. Therefore, we measured the levels of 26 highly conserved lincRNAs in a total of 176 pairs of endometrial carcinoma (EC) and surrounding non-tumor tissues of two distinct Chinese populations. Here, we report that a lincRNA, LINC00672, which possesses an ultra-conserved region, is aberrantly down-regulated during the development of EC. Nevertheless, LINC00672 is a p53-targeting lincRNA acting along with heterogeneous nuclear ribonucleoproteins as a suppressive cofactor, which locally reinforces p53-mediated suppression of LASP1, an evolutionarily conserved neighboring gene of LINC00672 and putatively associated with increased tumor aggressiveness, during anti-tumor processes. LINC00672 overexpression could lower the levels of LASP1 and slow the development of malignant phenotypes of EC both in vitro and in vivo. Moreover, LINC00672 significantly increased the 50% inhibitory concentration of paclitaxel in EC cells and increased the sensitivity of xenograft mice to paclitaxel. These findings indicate that LINC00672 can influence LASP1 expression as a locus-restricted cofactor for p53-mediated gene suppression, thus impacting EC malignancies and chemosensitivity to paclitaxel.	[Li, Wei; Li, Fang; Deng, Jieqiong; An, Mingxing; Wu, Siqi; Ma, Rui; Zhou, Yifeng] Soochow Univ, Coll Med, Dept Genet, Suzhou 215123, Peoples R China; [Li, Hua] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100191, Peoples R China; [Zhang, Liyuan] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, San Xiang Rd 1055, Suzhou 215004, Peoples R China; [Hu, Min] Soochow Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, San Xiang Rd 1055, Suzhou 215004, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou 510182, Guangdong, Peoples R China	Soochow University - China; Peking University; Soochow University - China; Soochow University - China; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhou, YF (corresponding author), Soochow Univ, Coll Med, Suzhou 215123, Peoples R China.	zhouyifeng@suda.edu.cn	李, 巍/L-7829-2019; Wu, Siqi/GVT-6711-2022; Li, Wei/H-8477-2018	Wu, Siqi/0000-0002-5051-2923; Zhang, Liyuan/0000-0002-7469-1743	National Scientific Foundation of China [81472630]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Special Program of Clinical Medical Science [BL2014040]; Science Foundation for Distinguished Young Scholars in Jiangsu [BK20160008]; National Key R&D Program of China [2016YFC1302100]; Suzhou Science and Technology Development Program [SZS201509]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Special Program of Clinical Medical Science; Science Foundation for Distinguished Young Scholars in Jiangsu(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Key R&D Program of China; Suzhou Science and Technology Development Program	This work was supported by National Scientific Foundation of China Grant 81472630, by Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Special Program of Clinical Medical Science Grant BL2014040, Science Foundation for Distinguished Young Scholars in Jiangsu Grant BK20160008, National Key R&D Program of China Grant 2016YFC1302100, and Suzhou Science and Technology Development Program Grant SZS201509. The authors declare that they have no conflicts of interest with the contents of this article.	Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hailer A, 2014, ONCOTARGET, V5, P4144, DOI 10.18632/oncotarget.1928; He B, 2013, ONCOL REP, V29, P1115, DOI 10.3892/or.2012.2199; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kumar PP, 2014, ELIFE, V3, DOI 10.7554/eLife.02805; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Montesano R, 1996, INT J CANCER, V69, P225, DOI 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Orth MF, 2015, ONCOTARGET, V6, P26, DOI 10.18632/oncotarget.3083; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Tang RX, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-163; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wang B, 2009, J HEPATOL, V50, P528, DOI 10.1016/j.jhep.2008.10.025; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wei CC, 2006, J BIOL CHEM, V281, P25344, DOI 10.1074/jbc.M601945200; Wu WJ, 2013, GASTROENTEROLOGY, V144, P956, DOI 10.1053/j.gastro.2013.01.019; Yang X, 2014, GUT, V63, P881, DOI 10.1136/gutjnl-2013-305266; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zhao TS, 2015, CANCER RES, V75, P111, DOI 10.1158/0008-5472.CAN-14-2040; Zhou J, 2011, J SURG ONCOL, V104, P278, DOI 10.1002/jso.21941	53	45	45	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5801	5813		10.1074/jbc.M116.758508	http://dx.doi.org/10.1074/jbc.M116.758508			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28232485	Green Published, hybrid			2022-12-28	WOS:000398813200017
J	Alonge, KM; Meares, GP; Hillgartner, FB				Alonge, Kimberly M.; Meares, Gordon P.; Hillgartner, F. Bradley			Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; LIPID-METABOLISM; RAT HEPATOCYTES; PPAR-ALPHA; X RECEPTOR; HEPATIC GLUCONEOGENESIS; AKT ACTIVATION; BILE-ACIDS; FGF21	Previous studies have shown that glucagon cooperatively interacts with insulin to stimulate hepatic FGF21 gene expression. Here we investigated the mechanism by which glucagon and insulin increased FGF21 gene transcription in primary hepatocyte cultures. Transfection analyses demonstrated that glucagon plus insulin induction of FGF21 transcription was conferred by two activating transcription factor 4 (ATF4) binding sites in the FGF21 gene. Glucagon plus insulin stimulated a 5-fold increase in ATF4 protein abundance, and knockdown of ATF4 expression suppressed the ability of glucagon plus insulin to increase FGF21 expression. In hepatocytes incubated in the presence of insulin, treatment with a PKA-selective agonist mimicked the ability of glucagon to stimulate ATF4 and FGF21 expression. Inhibition of PKA, PI3K, Akt, and mammalian target of rapamycin complex 1 (mTORC1) suppressed the ability of glucagon plus insulin to stimulate ATF4 and FGF21 expression. Additional analyses demonstrated that chenodeoxycholic acid (CDCA) induced a 6-fold increase in ATF4 expression and that knockdown of ATF4 expression suppressed the ability of CDCA to increase FGF21 gene expression. CDCA increased the phosphorylation of eIF2 alpha, and inhibition of eIF2 alpha signaling activity suppressed CDCA regulation of ATF4 and FGF21 expression. These results demonstrate that glucagon plus insulin increases FGF21 transcription by stimulating ATF4 expression and that activation of cAMP/PKA and PI3K/Akt/mTORC1 mediates the effect of glucagon plus insulin on ATF4 expression. These results also demonstrate that CDCA regulation of FGF21 transcription is mediated at least partially by an eIF2 alpha-dependent increase in ATF4 expression.	[Alonge, Kimberly M.; Hillgartner, F. Bradley] West Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA; [Meares, Gordon P.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Hillgartner, FB (corresponding author), West Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155; Alonge, Kimberly/0000-0002-2171-1640	American Heart Association [17GRNT33210002]; American Diabetes Association Basic Science Award [1-12-BS-75]; West Virginia University Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association Basic Science Award(American Diabetes Association); West Virginia University Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant-in-aid 17GRNT33210002 (to F.B.H.), American Diabetes Association Basic Science Award 1-12-BS-75 (to F.B.H.), and a West Virginia University Foundation distinguished doctoral scholarship (to K.M.A.). The authors declare that they have no conflicts of interest with the contents of this article.	Almahariq M, 2014, TRENDS ENDOCRIN MET, V25, P60, DOI 10.1016/j.tem.2013.10.004; Anand P, 2005, J BIOL CHEM, V280, P16427, DOI 10.1074/jbc.M410576200; Arisawa S, 2009, BIOCHEM PHARMACOL, V77, P858, DOI 10.1016/j.bcp.2008.11.012; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BEEBE SJ, 1988, METHOD ENZYMOL, V159, P118; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; BUCHER NLR, 1975, P NATL ACAD SCI USA, V72, P1157, DOI 10.1073/pnas.72.3.1157; Cai K, 2013, BIOCHEM J, V454, P267, DOI 10.1042/BJ20130609; Carey M.F., 2009, COLD SPRING HARB PRO, V2009; Chan CP, 2013, BBA-MOL CELL RES, V1833, P2165, DOI 10.1016/j.bbamcr.2013.05.002; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cyphert HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094996; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; De Sousa-Coelho AL, 2013, J LIPID RES, V54, P1786, DOI 10.1194/jlr.M033415; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Furusawa Y, 2014, GENES CELLS, V19, P864, DOI 10.1111/gtc.12186; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kelly P, 2010, J BIOL CHEM, V285, P15777, DOI 10.1074/jbc.M109.069112; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007; Kimura M, 1997, EUR J PHARMACOL, V327, P87, DOI 10.1016/S0014-2999(97)89682-3; Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Stabile LP, 1998, J LIPID RES, V39, P1951; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tsai BP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140180; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	62	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5239	5252		10.1074/jbc.M116.762922	http://dx.doi.org/10.1074/jbc.M116.762922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188284	Green Published, hybrid			2022-12-28	WOS:000397875500008
J	Hayashi, M; Suzuki, R; Colleoni, C; Ball, SG; Fujita, N; Suzuki, E				Hayashi, Mari; Suzuki, Ryuichiro; Colleoni, Christophe; Ball, Steven G.; Fujita, Naoko; Suzuki, Eiji			Bound Substrate in the Structure of Cyanobacterial Branching Enzyme Supports a New Mechanistic Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; CRYSTAL-STRUCTURE; AMYLOPECTIN BIOSYNTHESIS; MOLECULAR-REPLACEMENT; GLYCOGEN-METABOLISM; STARCH STRUCTURE; I BEI; COMPLEX; BINDING; CYANOTHECE	Branching enzyme (BE) catalyzes the formation of alpha-1,6-glucosidic linkages in amylopectin and glycogen. The reaction products are variable, depending on the organism sources, and the mechanistic basis for these different outcomes is unclear. Although most cyanobacteria have only one BE isoform belonging to glycoside hydrolase family 13, Cyanothece sp. ATCC 51142 has three isoforms (BE1, BE2, and BE3) with distinct enzymatic properties, suggesting that investigations of these enzymes might provide unique insights into this system. Here, we report the crystal structure of ligand-free wild-type BE1 (residues 5-759 of 1-773) at 1.85 angstrom resolution. The enzyme consists of four domains, including domain N, carbohydrate- binding module family 48 (CBM48), domain A containing the catalytic site, and domain C. The central domain A displays a (beta/alpha)(8)-barrel fold, whereas the other domains adopt beta-sandwich folds. Domain N was found in a new location at the back of the protein, forming hydrogen bonds and hydrophobic interactions with CBM48 and domain A. Site-directed mutational analysis identified a mutant (W610N) that bound maltoheptaose with sufficient affinity to enable structure determination at 2.30 angstrom resolution. In this structure, maltoheptaose was bound in the active site cleft, allowing us to assign subsites -7 to -1. Moreover, seven oligosaccharide-binding sites were identified on the protein surface, and we postulated that two of these in domain A served as the entrance and exit of the donor/acceptor glucan chains, respectively. Based on these structures, we propose a substrate binding model explaining the mechanism of glycosylation/deglycosylation reactions catalyzed by BE.	[Hayashi, Mari; Suzuki, Ryuichiro; Fujita, Naoko; Suzuki, Eiji] Akita Prefectural Univ, Fac Bioresource Sci, Dept Biol Prod, Akita 0100195, Japan; [Colleoni, Christophe; Ball, Steven G.] Univ Sci & Technol Lille, CNRS, Unite Mixte Rech 8576, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Akita Prefectural University; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Suzuki, R; Suzuki, E (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Dept Biol Prod, Akita 0100195, Japan.	ryuichi@akita-pu.ac.jp; esuzuki@akita-pu.ac.jp	Colleoni, Christophe/AAP-2411-2021	Ball, Steven/0000-0003-1629-1650	Shimadzu Science Foundation [120003]; JSPS KAKENHI [15K18685, 16K07467]; Grants-in-Aid for Scientific Research [16K07467] Funding Source: KAKEN	Shimadzu Science Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Shimadzu Science Foundation Grant 120003 (to R. S.) and JSPS KAKENHI Grants 15K18685 (to R. S.) and 16K07467 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaen K, 2012, BIOCHEM BIOPH RES CO, V424, P508, DOI 10.1016/j.bbrc.2012.06.145; Cockburn D, 2015, INT J BIOL MACROMOL, V75, P338, DOI 10.1016/j.ijbiomac.2015.01.054; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280; Devillers CH, 2003, ARCH BIOCHEM BIOPHYS, V418, P34, DOI 10.1016/S0003-9861(03)00341-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng L, 2016, ACTA CRYSTALLOGR D, V72, P641, DOI 10.1107/S2059798316003272; Feng L, 2015, BIOCHEMISTRY-US, V54, P6207, DOI 10.1021/acs.biochem.5b00228; Froese DS, 2015, HUM MOL GENET, V24, P5667, DOI 10.1093/hmg/ddv280; Fujita N., 2014, AGRIBIOSCI MONOGR, V4, P1, DOI [10.5047/agbm.2014.00401.0001, DOI 10.5047/AGBM.2014.00401.0001]; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; Hayashi M, 2015, ACTA CRYSTALLOGR F, V71, P1109, DOI 10.1107/S2053230X1501198X; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Janecek S, 2002, BIOLOGIA, V57, P29; Jo HJ, 2015, FEBS LETT, V589, P1089, DOI 10.1016/j.febslet.2015.03.011; Li C, 2016, PLANTA, V243, P13, DOI 10.1007/s00425-015-2421-2; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2005, PLANT CELL PHYSIOL, V46, P539, DOI 10.1093/pcp/pci045; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Pfister B, 2016, CELL MOL LIFE SCI, V73, P2781, DOI 10.1007/s00018-016-2250-x; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Robert X, 2005, J BIOL CHEM, V280, P32968, DOI 10.1074/jbc.M505515200; Sawada T, 2014, ARCH BIOCHEM BIOPHYS, V562, P9, DOI 10.1016/j.abb.2014.07.032; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Suzuki E., 2013, J APPL GLYOSCI, V60, P21, DOI 10.5458/jag.jag.JAG-2012_016; Suzuki E, 2016, CELL MOL LIFE SCI, V73, P2643, DOI 10.1007/s00018-016-2243-9; Suzuki E, 2013, PLANT CELL PHYSIOL, V54, P465, DOI 10.1093/pcp/pcs190; Suzuki R, 2015, BBA-PROTEINS PROTEOM, V1854, P476, DOI 10.1016/j.bbapap.2015.02.012; Svensson B., 2015, J APPL GLYCOSCI, V62, P87, DOI DOI 10.5458/JAG.JAG.JAG-2015_006; Tetlow IJ, 2014, IUBMB LIFE, V66, P546, DOI 10.1002/iub.1297; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Welkie DG, 2016, J BACTERIOL, V198, P701, DOI 10.1128/JB.00830-15; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x	45	24	25	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5465	5475		10.1074/jbc.M116.755629	http://dx.doi.org/10.1074/jbc.M116.755629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193843	Green Published, hybrid			2022-12-28	WOS:000397875500026
J	Pero, R; Palmieri, D; Angrisano, T; Valentino, T; Federico, A; Franco, R; Lembo, F; Klein-Szanto, AJ; Del Vecchio, L; Montanaro, D; Keller, S; Arra, C; Papadopoulou, V; Wagner, SD; Croce, CM; Fusco, A; Chiariotti, L; Fedele, M				Pero, Raffaela; Palmieri, Dario; Angrisano, Tiziana; Valentino, Teresa; Federico, Antonella; Franco, Renato; Lembo, Francesca; Klein-Szanto, Andres J.; Del Vecchio, Luigi; Montanaro, Donatella; Keller, Simona; Arra, Claudio; Papadopoulou, Vasiliki; Wagner, Simon D.; Croce, Carlo M.; Fusco, Alfredo; Chiariotti, Lorenzo; Fedele, Monica			RETRACTION: POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. (Retraction of Vol 287, Pg 18308, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Angrisano, Tiziana/AAC-5353-2022; Young, Richard A/F-6495-2012; Chiariotti, Lorenzo/AAC-5262-2022	Young, Richard A/0000-0001-8855-8647; 				Pero R, 2012, J BIOL CHEM, V287, P18308, DOI 10.1074/jbc.M112.346270	1	0	0	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5609	5609		10.1074/jbc.A117.346270	http://dx.doi.org/10.1074/jbc.A117.346270			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28363935	hybrid, Green Published			2022-12-28	WOS:000397875500039
J	Remesh, SG; Andreatta, M; Ying, G; Kaever, T; Nielsen, M; McMurtrey, C; Hildebrand, W; Peters, B; Zajonc, DM				Remesh, Soumya G.; Andreatta, Massimo; Ying, Ge; Kaever, Thomas; Nielsen, Morten; McMurtrey, Curtis; Hildebrand, William; Peters, Bjoern; Zajonc, Dirk M.			Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01 BREAKING CONFINEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; T-CELLS; INTERFERON-GAMMA; PARASITE BURDEN; TAP TRANSPORT; MOLECULES; RECEPTOR; EPITOPES; MICE; ENCEPHALITIS	Peptide antigen presentation by major histocompatibility complex (MHC) class I proteins initiates CD8(+) T cell-mediated immunity against pathogens and cancers. MHCI molecules typically bind peptides with 9 amino acids in length with both ends tucked inside the major A and F binding pockets. It has been known for a while that longer peptides can also bind by either bulging out of the groove in the middle of the peptide or by binding in a zigzag fashion inside the groove. In a recent study, we identified an alternative binding conformation of naturally occurring peptides from Toxoplasma gondii bound by HLA-A*02:01. These peptides were extended at the C terminus (P Omega) and contained charged amino acids not more than 3 residues after the anchor amino acid at P Omega, which enabled them to open the F pocket and expose their C-terminal extension into the solvent. Here, we show that the mechanism of F pocket opening is dictated by the charge of the first charged amino acid found within the extension. Although positively charged amino acids result in the Tyr-84 swing, amino acids that are negatively charged induce a not previously described Lys-146 lift. Furthermore, we demonstrate that the peptides with alternative binding modes have properties that fit very poorly to the conventional MHC class I pathway and suggest they are presented via alternative means, potentially including cross-presentation via the MHC class II pathway.	[Remesh, Soumya G.; Ying, Ge; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA; [Andreatta, Massimo; Kaever, Thomas; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Andreatta, Massimo; Nielsen, Morten] Univ Nacl San Martin, Inst Invest Biotecnol, RA-1650 San Martin, Argentina; [Nielsen, Morten] Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [McMurtrey, Curtis; Hildebrand, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [McMurtrey, Curtis; Hildebrand, William] Pure MHC LLC, San Antonio, TX 78229 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Technical University of Denmark; University of Oklahoma System; University of Oklahoma Health Sciences Center; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org	Nielsen, Morten/AAL-8700-2020; Remesh, Soumya G/I-3558-2019; Andreatta, Massimo/AAA-4061-2020	Nielsen, Morten/0000-0001-7885-4311; Andreatta, Massimo/0000-0002-8036-2647	National Institutes of Health [AI128609, AI062629]; Immune Epitope Database National Institutes of Health [HHSN272201200010C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629, R21AI128609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immune Epitope Database National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI128609 (to D.M.Z.) and AI062629 (subcontract to W.H.) and Immune Epitope Database National Institutes of Health Contract HHSN272201200010C (to B.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Blanchard N, 2010, TRENDS IMMUNOL, V31, P414, DOI 10.1016/j.it.2010.08.004; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cong H, 2012, HUM IMMUNOL, V73, P1, DOI 10.1016/j.humimm.2011.10.006; Cong H, 2011, VACCINE, V29, P754, DOI 10.1016/j.vaccine.2010.11.015; DECKERTSCHLUTER M, 1994, INFECT IMMUN, V62, P221; Denkers EY, 1999, MICROBES INFECT, V1, P699, DOI 10.1016/S1286-4579(99)80071-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grover HS, 2012, INFECT IMMUN, V80, P3279, DOI 10.1128/IAI.00425-12; HAKIM FT, 1991, J IMMUNOL, V147, P2310; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; ISRAELSKI DM, 1993, CLIN INFECT DIS, V17, pS423, DOI 10.1093/clinids/17.Supplement_2.S423; Leroux LP, 2015, INT J PARASITOL, V45, P319, DOI 10.1016/j.ijpara.2015.01.003; Luder CGK, 2001, INT J PARASITOL, V31, P1355, DOI 10.1016/S0020-7519(01)00260-0; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMurtrey C, 2016, ELIFE, V5, DOI 10.7554/eLife.12556; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Webster JP., 2010, PARASITES VECT, V3, P112, DOI [10.1186/1756-3305-3-112, DOI 10.1186/1756-3305-3-112]	36	36	37	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5262	5270		10.1074/jbc.M117.776542	http://dx.doi.org/10.1074/jbc.M117.776542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28179428	Green Published, hybrid			2022-12-28	WOS:000397875500010
J	Scott, EE				Scott, Emily E.			omega-versus (omega-1)-hydroxylation: Cytochrome P450 4B1 sterics make the call	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CYP4B1; CANCER; ACTIVATION; HUMANS; P450	Many family 4 cytochrome P450s play key roles in fatty acid hydroxylation at the terminal, or omega, carbon, but the mechanistic basis for this energetically disfavored regiostereochemistry has been less clear. A co-crystal structure of the rabbit family 4 enzyme CYP4B1 with its substrate octane reveals that the propensity for omega-hydroxylation is orchestrated by active-site sterics, partially mediated by an unusual heme-polypeptide ester bond.	[Scott, Emily E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	scottee@umich.edu			National Institutes of Health [R37GM076343]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health R37GM076343. To whom correspondence should be addressed: Dept. of Medicinal Chemistry, Pharmacology, and Biophysics, University of Michigan, 428 Church St., Ann Arbor, MI 48109. E-mail: scottee@umich.edu.	Akhtar M Kalim, 2015, Metab Eng Commun, V2, P1, DOI 10.1016/j.meteno.2014.11.001; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Cheesman MJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P17, DOI 10.1016/S0003-9861(03)00278-9; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; Imaoka S, 2000, BIOCHEM BIOPH RES CO, V277, P776, DOI 10.1006/bbrc.2000.3740; Lonsdale TH, 2015, CHEM COMMUN, V51, P16173, DOI 10.1039/c5cc06078h; Parkinson OT, 2013, TOXICOL SCI, V134, P243, DOI 10.1093/toxsci/kft123; Rainov NG, 1998, HUM GENE THER, V9, P1261, DOI 10.1089/hum.1998.9.9-1261; ROWINSKY EK, 1993, CANCER RES, V53, P1794	9	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5622	5623		10.1074/jbc.H117.775494	http://dx.doi.org/10.1074/jbc.H117.775494			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28363936	Green Published, hybrid			2022-12-28	WOS:000397875500041
J	Thai, V; Dephoure, N; Weiss, A; Ferguson, J; Leitao, R; Gygi, SP; Kellogg, DR				Thai, Vu; Dephoure, Noah; Weiss, Amit; Ferguson, Jacqueline; Leitao, Ricardo; Gygi, Steven P.; Kellogg, Douglas R.			Protein Kinase C Controls Binding of Igo/ENSA Proteins to Protein Phosphatase 2A in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SIZE CONTROL; SACCHAROMYCES-CEREVISIAE; SITE LOCALIZATION; MITOTIC ENTRY; GROWTH; MITOSIS; SECRETION; DIVISION; CYCLE; PHOSPHORYLATION	Protein phosphatase 2A (PP2A) plays important roles in controlling mitosis in all eukaryotic cells. The form of PP2A that controls mitosis is associated with a conserved regulatory subunit that is called B55 in vertebrates and Cdc55 in budding yeast. The activity of this form of PP2A can be inhibited by binding of conserved Igo/ ENSA proteins. Although the mechanisms that activate Igo/ ENSA to bind and inhibit PP2A are well understood, little is known about how Igo/ Ensa are inactivated. Here, we have analyzed regulation of Igo/ ENSA in the context of a checkpoint pathway that links mitotic entry to membrane growth in budding yeast. Protein kinase C (Pkc1) relays signals in the pathway by activating PP2A(Cdc55). We discovered that constitutively active Pkc1 can drive cells through a mitotic checkpoint arrest, which suggests that Pkc1-dependent activation of PP2A(Cdc55) plays a critical role in checkpoint signaling. We therefore used mass spectrometry to determine how Pkc1 modifies the PP2A(Cdc55) complex. This revealed that Pkc1 induces changes in the phosphorylation of multiple subunits of the complex, as well as dissociation of Igo/ ENSA. Pkc1 directly phosphorylates Cdc55 and Igo/ ENSA, and phosphorylation site mapping and mutagenesis indicate that phosphorylation of Cdc55 contributes to Igo/ ENSA dissociation. Association of Igo2 with PP2A(Cdc55) is regulated during the cell cycle, yet mutation of Pkc1-dependent phosphorylation sites on Cdc55 and Igo2 did not cause defects in mitotic progression. Together, the data suggest that Pkc1 controls PP2A(Cdc55) by multiple overlapping mechanisms.	[Thai, Vu; Weiss, Amit; Ferguson, Jacqueline; Leitao, Ricardo; Kellogg, Douglas R.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Dephoure, Noah] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California Santa Cruz; Cornell University; Harvard University; Harvard Medical School	Kellogg, DR (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	dkellogg@ucsc.edu	Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657	University of California Cancer Research; National Institutes of Health [GM069602]; National Institutes of Health Postdoctoral Fellowship Grant [F32GM087103-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069602] Funding Source: NIH RePORTER	University of California Cancer Research(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of California Cancer Research Coordinating Committee and National Institutes of Health Grant GM069602. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Postdoctoral Fellowship Grant F32GM087103-02.	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Anastasia SD, 2012, J CELL BIOL, V197, P89, DOI 10.1083/jcb.201108108; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; Andrews PD, 2000, J CELL SCI, V113, P2685; Artiles K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000727; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bontron S, 2013, CELL REP, V3, P16, DOI 10.1016/j.celrep.2012.11.025; Chica N, 2016, CURR BIOL, V26, P319, DOI 10.1016/j.cub.2015.12.035; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Harvey SL, 2011, MOL BIOL CELL, V22, P3595, DOI 10.1091/mbc.E11-04-0340; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Juanes MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003575; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Nanduri J, 2001, MOL CELL, V8, P281, DOI 10.1016/S1097-2765(01)00312-4; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wicky S, 2011, MOL BIOL CELL, V22, P20, DOI 10.1091/mbc.E10-06-0487; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yasutis K, 2010, MOL BIOL CELL, V21, P4373, DOI 10.1091/mbc.E10-04-0326; Zimmerman ZA, 2001, MOL BIOL CELL, V12, P201, DOI 10.1091/mbc.12.1.201	50	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4925	4941		10.1074/jbc.M116.753004	http://dx.doi.org/10.1074/jbc.M116.753004			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28100785	hybrid, Green Published			2022-12-28	WOS:000397590400015
J	Korshavn, KJ; Satriano, C; Lin, YX; Zhang, RC; Dulchavsky, M; Bhunia, A; Ivanova, MI; Lee, YH; La Rosa, C; Lim, MH; Ramamoorthy, A				Korshavn, Kyle J.; Satriano, Cristina; Lin, Yuxi; Zhang, Rongchun; Dulchavsky, Mark; Bhunia, Anirban; Ivanova, Magdalena I.; Lee, Young-Ho; La Rosa, Carmelo; Lim, Mi Hee; Ramamoorthy, Ayyalusamy			Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid- beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; ALPHA-SYNUCLEIN; MEMBRANE FRAGMENTATION; PHOSPHOLIPID-BILAYERS; PROTEIN AGGREGATION; OXIDATIVE STRESS; FIBRILS; BINDING; STATE	The aggregation of amyloid-beta (A beta) on lipid bilayers has been implicated as Amechanism by which A beta exerts its toxicity in Alzheimer's disease (AD). Lipid bilayer thinning has been observed during both oxidative stress and protein aggregation in AD, but whether these pathological modifications of the bilayer correlate withA beta misfolding is unclear. Here, we studied peptide-lipid interactions in synthetic bilayers of the shortchain lipid dilauroyl phosphatidylcholine (DLPC) as Asimplified model for diseased bilayers to determine their impact on A beta aggregate, protofibril, and fibril formation. A beta aggregation and fibril formation in membranes composed of dioleoyl phosphatidylcholine (DOPC) or 1-palmitoyl-2-oleoyl phosphatidylcholine mimicking normal bilayers served as controls. Differences in aggregate formation and stability were monitored by a combination of thioflavin-T fluorescence, circular dichroism, atomic force microscopy, transmission electron microscopy, and NMR. Despite the ability of all three lipid bilayers to catalyze aggregation, DLPC accelerates aggregation at much lower concentrations and prevents the fibrillation of A beta at low micromolar concentrations. DLPC stabilized globular, membrane-associated oligomers, which could disrupt the bilayer integrity. DLPC bilayers also remodeled preformed amyloid fibrils into Apseudo-unfolded, molten globule state, which resembled on-pathway, protofibrillar aggregates. Whereas the stabilized, membrane-associated oligomers were found to be nontoxic, the remodeled species displayed toxicity similar to that of conventionally prepared aggregates. These results provide mechanistic insights into the roles that pathologically thin bilayers may play in A beta aggregation on neuronal bilayers, and pathological lipid oxidation may contribute to A beta misfolding.	[Korshavn, Kyle J.; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Korshavn, Kyle J.; Zhang, Rongchun; Ivanova, Magdalena I.; Ramamoorthy, Ayyalusamy] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Dulchavsky, Mark; Ivanova, Magdalena I.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Satriano, Cristina; La Rosa, Carmelo] Univ Catania, Dept Chem Sci, I-95124 Catania, Italy; [Lin, Yuxi; Lee, Young-Ho] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; [Bhunia, Anirban] Bose Inst, Dept Biophys, Kolkata 700009, W Bengal, India; [Lim, Mi Hee] Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan 44919, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Catania; Osaka University; Department of Science & Technology (India); Bose Institute; Ulsan National Institute of Science & Technology (UNIST)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Ramamoorthy, A (corresponding author), Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Cristina, Satriano/A-3976-2012; Zhang, Rongchun/A-5656-2015; Lim, Mi Hee/D-1913-2018; La Rosa, Carmelo/A-2631-2012	Cristina, Satriano/0000-0001-5348-5863; Zhang, Rongchun/0000-0002-2480-2652; La Rosa, Carmelo/0000-0002-7123-5347; Korshavn, Kyle/0000-0003-2623-1838; Bhunia, Anirban/0000-0002-8752-2842; Dulchavsky, Mark/0000-0002-5253-8924	National Institutes of Health [AG048934]; Protein Folding Initiative at the University of Michigan; National Research Foundation of Korea (NRF) - Korean Government [NRF-2014S1A2A2028270]; University of Catania Grant FIR; NATIONAL INSTITUTE ON AGING [R01AG048934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding Initiative at the University of Michigan; National Research Foundation of Korea (NRF) - Korean Government; University of Catania Grant FIR; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant AG048934 (to A. R.), the Protein Folding Initiative at the University of Michigan (to M. H. L., M. I. I., and A. R.), National Research Foundation of Korea (NRF) Grant NRF-2014S1A2A2028270 funded by the Korean Government (to M. H. L. and A. R.), and University of Catania Grant FIR 2014 (to C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahsan N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09862; Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Arce FT, 2011, SOFT MATTER, V7, P5267, DOI 10.1039/c1sm05162h; Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Batzli KM, 2015, MAT SCI ENG C-MATER, V48, P359, DOI 10.1016/j.msec.2014.09.015; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Beranova L, 2010, LANGMUIR, V26, P6140, DOI 10.1021/la100657a; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bradley-Whitman MA, 2015, ARCH TOXICOL, V89, P1035, DOI 10.1007/s00204-015-1517-6; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Buboltz JT, 2005, LANGMUIR, V21, P6296, DOI 10.1021/la047086k; Canale C, 2013, BIOPHYS CHEM, V182, P23, DOI 10.1016/j.bpc.2013.07.010; Cao P, 2012, BIOCHEMISTRY-US, V51, P2670, DOI 10.1021/bi2015162; Chiurchiu V, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7909380; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Connelly L, 2012, BIOCHEMISTRY-US, V51, P3031, DOI 10.1021/bi300257e; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elkins MR, 2016, J AM CHEM SOC, V138, P9840, DOI 10.1021/jacs.6b03715; FATTAL DR, 1993, BIOPHYS J, V65, P1795, DOI 10.1016/S0006-3495(93)81249-9; Fleming PJ, 2012, BBA-BIOMEMBRANES, V1818, P126, DOI 10.1016/j.bbamem.2011.07.016; Galvagnion C, 2016, P NATL ACAD SCI USA, V113, P7065, DOI 10.1073/pnas.1601899113; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ikenoue T, 2014, ANGEW CHEM INT EDIT, V53, P7799, DOI 10.1002/anie.201403815; Jang H, 2014, CHEM SOC REV, V43, P6750, DOI 10.1039/c3cs60459d; Jang H, 2013, J PHYS CHEM B, V117, P11518, DOI 10.1021/jp405389n; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Korshavn KJ, 2016, CHEM COMMUN, V52, P882, DOI 10.1039/c5cc08634e; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; Kumar S, 2013, CHEM COMMUN, V49, P4749, DOI 10.1039/c3cc41452c; La Rosa C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4948323; LAROSA C, 1995, J PHYS CHEM-US, V99, P14864, DOI 10.1021/j100040a041; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Lee CC, 2012, BIOPHYS J, V102, P1059, DOI 10.1016/j.bpj.2012.01.039; Lockhart C, 2014, BBA-BIOMEMBRANES, V1838, P2678, DOI 10.1016/j.bbamem.2014.07.010; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Manetto GD, 2005, J THERM ANAL CALORIM, V80, P263, DOI 10.1007/s10973-005-0646-1; Marsh D., 1990, CRC HDB LIPID BILAYE, P816; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Nakazawa Y, 2009, CHEM PHYS LIPIDS, V158, P54, DOI 10.1016/j.chemphyslip.2008.12.001; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Nichols MR, 2015, BIOCHEMISTRY-US, V54, P2193, DOI 10.1021/bi500957g; Noda S, 2016, BIOCHEMISTRY-US, V55, P3937, DOI 10.1021/acs.biochem.6b00231; Nystrom S, 2012, J BIOL CHEM, V287, P25975, DOI 10.1074/jbc.M112.372136; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Pithadia AS, 2016, CHEM COMMUN, V52, P942, DOI 10.1039/c5cc07792c; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Rankenberg JM, 2012, BIOCHEMISTRY-US, V51, P3554, DOI 10.1021/bi300281k; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Satriano C, 2017, COLLOID SURFACE B, V149, P48, DOI 10.1016/j.colsurfb.2016.10.004; Satriano C, 2012, PHYS CHEM CHEM PHYS, V14, P16695, DOI 10.1039/c2cp43254d; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Scalisi S, 2010, CHEMBIOCHEM, V11, P1856, DOI 10.1002/cbic.201000090; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Sciacca MFM, 2016, BIOPHYS J, V111, P140, DOI 10.1016/j.bpj.2016.05.050; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; So M, 2015, LANGMUIR, V31, P9973, DOI 10.1021/acs.langmuir.5b02186; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stefanovic AND, 2015, BIOCHEMISTRY-US, V54, P3142, DOI 10.1021/bi501369k; Suzuki Y, 2012, BIOCHEMISTRY-US, V51, P8154, DOI 10.1021/bi3012548; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Terakawa MS, 2015, J BIOL CHEM, V290, P815, DOI 10.1074/jbc.M114.592527; Tofoleanu F, 2012, J MOL BIOL, V421, P572, DOI 10.1016/j.jmb.2011.12.063; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Wong AG, 2016, BIOCHEMISTRY-US, V55, P510, DOI 10.1021/acs.biochem.5b01107; Yates EA, 2014, BIOCHEMISTRY-US, V53, P7038, DOI 10.1021/bi500792f; Yates EA, 2013, J MOL BIOL, V425, P1915, DOI 10.1016/j.jmb.2013.03.022; Yi XY, 2015, BIOCHEMISTRY-US, V54, P6323, DOI 10.1021/acs.biochem.5b00719; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	80	102	101	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4638	4650		10.1074/jbc.M116.764092	http://dx.doi.org/10.1074/jbc.M116.764092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154182	Green Published, hybrid			2022-12-28	WOS:000397585100021
J	Guerra, D; Chapiro, SM; Pratelli, R; Yu, S; Jia, WT; Leary, J; Pilot, G; Callis, J				Guerra, Damian; Chapiro, Sonia M.; Pratelli, Rejane; Yu, Shi; Jia, Weitao; Leary, Julie; Pilot, Guillaume; Callis, Judy			Control of Amino Acid Homeostasis by a Ubiquitin Ligase-Coactivator Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; E3 ubiquitin ligase; protein degradation; ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); glutamine dumper; Loss of GDU1 2; amino acid resistance	ENDOPLASMIC-RETICULUM; GLUTAMINE; SYSTEM; DOMAIN; MONOUBIQUITINATION; TRANSFORMATION; DEGRADATION; INHIBITORS; TRANSPORT; BINDING	Intercellular amino acid transport is essential for the growth of all multicellular organisms, and its dysregulation is implicated in developmental disorders. By an unknown mechanism, amino acid efflux is stimulated in plants by overexpression of a membrane-localized protein (GLUTAMINE DUMPER 1 (GDU1)) that requires a ubiquitin ligase (LOSS OF GDU 2 (LOG2). Here we further explore the physiological consequences of the interaction between these two proteins. LOG2 ubiquitin ligase activity is necessary for GDU1-dependent tolerance to exogenous amino acids, and LOG2 self-ubiquitination was markedly stimulated by the GDU1 cytosolic domain, suggesting that GDU1 functions as an adaptor or coactivator of amino acid exporter(s). However, other consequences more typical of a ligase-substrate relationship are observed: disruption of the LOG2 gene increased the in vivo half-life of GDU1, mass spectrometry confirmed that LOG2 ubiquitinates GDU1 at cytosolic lysines, and GDU1 protein levels decreased upon co-expression with active, but not enzymatically inactive LOG2. Altogether these data indicate LOG2 negatively regulates GDU1 protein accumulation by a mechanism dependent upon cytosolic GDU1 lysines. Although GDU1-lysine substituted protein exhibited diminished in vivo ubiquitination, overexpression of GDU1 lysine mutants still conferred amino acid tolerance in a LOG2-dependent manner, consistent with GDU1 being both a substrate and facilitator of LOG2 function. From these data, we offer a model in which GDU1 activates LOG2 to stimulate amino acid export, a process that could be negatively regulated by GDU1 ubiquitination and LOG2 self-ubiquitination.	[Guerra, Damian; Chapiro, Sonia M.; Jia, Weitao; Leary, Julie; Callis, Judy] Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA; [Pratelli, Rejane; Yu, Shi; Pilot, Guillaume] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Guerra, Damian] Univ Colorado, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Chapiro, Sonia M.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Chapiro, Sonia M.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Yu, Shi] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Jia, Weitao] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA	University of California System; University of California Davis; Virginia Polytechnic Institute & State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Scripps Research Institute; Roche Holding; Genentech	Callis, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA.	jcallis@ucdavis.edu	Yu, Shi/R-2287-2018	Callis, Judy/0000-0002-0622-078X; Pilot, Guillaume/0000-0001-7520-1059; Guerra, Damian/0000-0002-6621-4656; Yu, Shi/0000-0003-0735-9713	National Science Foundation [MCB-0929100, IOS-1557760, MCB-1052048]; National Institutes of Health [GM0007377l, 1S10RR023558-01]; Hatch Program of the National Institute of Food and Agriculture [VA-135908, CA-D-MCB-5554-H]; Virginia Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Program of the National Institute of Food and Agriculture; Virginia Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (MCB-0929100 and IOS-1557760 (to J. C.) and MCB-1052048 (to G. P.)). This work was also supported, in whole or in part, by the National Institutes of Health (Predoctoral Training Grant fellowship GM0007377l to J. Trimmer (principal investigator) (to D. G.). and Grant 1S10RR023558-01 (to J. L.)), the Hatch Program of the National Institute of Food and Agriculture (VA-135908 (to G. P.) and CA-D-MCB-5554-H (to J. C.)), and the Virginia Agricultural Experiment Station (to G. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; BONNER CA, 1992, PHYSIOL PLANTARUM, V84, P319; Bourgeois-Daigneault MC, 2012, J IMMUNOL, V188, P4959, DOI 10.4049/jimmunol.1102708; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chen X, 2011, VET PATHOL, V48, P245, DOI 10.1177/0300985810385154; Chen YT, 2013, PLANT J, V75, P965, DOI 10.1111/tpj.12259; Chhangani D, 2014, BBA-MOL BASIS DIS, V1842, P1472, DOI 10.1016/j.bbadis.2014.04.014; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Guerra DD, 2013, FEBS LETT, V587, P3400, DOI 10.1016/j.febslet.2013.08.045; Guerra DD, 2012, PLANT PHYSIOL, V160, P56, DOI 10.1104/pp.112.199869; HANSEN SH, 1995, J BIOL CHEM, V270, P28425; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hommema E., 2013, 1602635 THERM FISH S; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; Hsia MM, 2010, J BIOL CHEM, V285, P37070, DOI 10.1074/jbc.M110.168021; Ihara Yasuo, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006361; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Loebke C, 2007, PROTEOMICS, V7, P558, DOI 10.1002/pmic.200600757; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mimnaugh Edward G., 2005, V301, P223; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; NORRIS SR, 1993, PLANT MOL BIOL, V21, P895, DOI 10.1007/BF00027120; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Pratelli R, 2006, FEBS LETT, V580, P6961, DOI 10.1016/j.febslet.2006.11.064; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Pratelli R, 2012, PLANT PHYSIOL, V158, P1628, DOI 10.1104/pp.111.191965; Pratelli R, 2007, PLANT SIGNAL BEHAV, V2, P182, DOI 10.4161/psb.2.3.3972; Pratelli R, 2010, PLANT PHYSIOL, V152, P762, DOI 10.1104/pp.109.151746; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Uhrig RG, 2008, J BIOL CHEM, V283, P29650, DOI 10.1074/jbc.M806102200; Upadhyay A, 2016, MOL NEUROBIOL, V53, P4484, DOI 10.1007/s12035-015-9379-8; Verdaguer B, 1998, PLANT MOL BIOL, V37, P1055, DOI 10.1023/A:1006004819398; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; WOO JT, 1992, J ANTIBIOT, V45, P1108, DOI 10.7164/antibiotics.45.1108; Yu S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00593; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153	54	6	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3827	3840		10.1074/jbc.M116.766469	http://dx.doi.org/10.1074/jbc.M116.766469			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100770	Green Published, hybrid			2022-12-28	WOS:000395542500024
J	Mergner, J; Kuster, B; Schwechheimer, C				Mergner, Julia; Kuster, Bernhard; Schwechheimer, Claus			DENEDDYLASE1 Protein Counters Automodification of Neddylating Enzymes to Maintain NEDD8 Protein Homeostasis in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Arabidopsis thaliana; deubiquitylation (deubiquitination); ubiquitin; ubiquitin-dependent protease; ubiquitylation (ubiquitination)	COP9 SIGNALOSOME; UBIQUITIN-LIGASE; DEUBIQUITINATING ENZYME; AUXIN RESPONSE; IN-VIVO; CULLIN; CONJUGATION; YEAST; SCF; SYSTEM	In eukaryotes, the conjugation of the ubiquitin-like protein NEDD8 onto protein targets is an important post-translational modification. The best understood neddylation targets are the cullins, scaffold subunits of E3 ubiquitin ligases, where neddylation as well as deneddylation, facilitated by the protease activity of the CSN (COP9 signalosome), are required to control ubiquitin ligase assembly, function, and ultimately substrate degradation. Little is known about the role of other deneddylating enzymes besides CSN and the role of neddylation and deneddylation of their substrates. We previously characterized Arabidopsis thaliana mutants with defects in the conserved NEDD8-specific protease DEN1 (DENEDDYLASE1). These mutants display only subtle growth phenotypes despite the strong accumulation of a broad range of neddylated proteins. Specifically, we identified AXR1 (AUXIN-RESISTANT1), a subunit of the heterodimeric NAE (E1 NEDD8-ACTIVATING ENZYME), as highly neddylated in den1 mutants. Here, we examined the mechanism and consequences of AXR1 neddylation in more detail. We find that AXR1 as well as other neddylation enzymes are autoneddylated at multiple lysines. NAE autoneddylation can be linked to reduced NCE (E2 NEDD8-CONJUGATING ENZYME) NEDD8 thioester levels, either by critically reducing the pool of free NEDD8 or by reducing NAE activity. In planta, increasing NEDD8 gene dosage is sufficient to suppress den1 mutant phenotypes. We therefore suggest that DEN1 serves to recover diverted NEDD8 moieties from autoneddylated NAE subunits, and possibly also other neddylated proteins, to maintain NEDD8 pathway activity toward other NEDD8-dependent processes such as cullin E3 ligase regulation.	[Mergner, Julia; Schwechheimer, Claus] Tech Univ Munich, Chair Plant Syst Biol, Emil Ramann Str 8, D-85354 Freising Weihenstephan, Germany; [Mergner, Julia; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich	Schwechheimer, C (corresponding author), Tech Univ Munich, Chair Plant Syst Biol, Emil Ramann Str 8, D-85354 Freising Weihenstephan, Germany.	claus.schwechheimer@wzw.tum.de	; Kuster, Bernhard/Q-6031-2016; Schwechheimer, Claus/Q-7907-2016	Mergner, Julia/0000-0002-4332-1280; Kuster, Bernhard/0000-0002-9094-1677; Schwechheimer, Claus/0000-0003-0269-2330	Deutsche Forschungsgemeinschaft as part of the Schwerpunktprogramm SPP1365 [SCHW751/11-1]; Deutsche Forschungsgemeinschaft as part of Sonderforschungsbereich Grant [924]; COST ACTION in the European Union [BM1307 PROTEOSTASIS]	Deutsche Forschungsgemeinschaft as part of the Schwerpunktprogramm SPP1365(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft as part of Sonderforschungsbereich Grant(German Research Foundation (DFG)); COST ACTION in the European Union	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHW751/11-1 (to C. S.) as part of the Schwerpunktprogramm SPP1365 "Ubiquitin Family Proteins" and as part of Sonderforschungsbereich Grant 924 (to C. S. and B. K.). This work was also supported by the COST ACTION BM1307 PROTEOSTASIS in the European Union Framework Programme Horizon 2020. The authors declare that they have no conflicts of interest with the contents of this article.	ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Banka PA, 2015, J MOL BIOL, V427, P2290, DOI 10.1016/j.jmb.2015.04.011; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bostick M, 2004, PLANT CELL, V16, P2418, DOI 10.1105/tpc.104.024943; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Christmann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003275; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Dharmasiri N, 2007, PLANT J, V52, P114, DOI 10.1111/j.1365-313X.2007.03211.x; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hotton SK, 2011, PLANT MOL BIOL, V75, P515, DOI 10.1007/s11103-011-9750-8; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Truong K, 2012, J BIOL CHEM, V287, P42611, DOI 10.1074/jbc.M112.420877; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lu XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12580; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Mergner J, 2015, PLANT CELL, V27, P741, DOI 10.1105/tpc.114.135996; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2002, PLANT CELL, V14, P2553, DOI 10.1105/tpc.003434; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vierstra RD, 2012, PLANT PHYSIOL, V160, P2, DOI 10.1104/pp.112.200667; Vogl AM, 2015, NAT NEUROSCI, V18, P239, DOI 10.1038/nn.3912; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhou LH, 2005, BIOCHEM J, V389, P307, DOI 10.1042/BJ20041991	58	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3854	3865		10.1074/jbc.M116.767103	http://dx.doi.org/10.1074/jbc.M116.767103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096463	Green Published, hybrid			2022-12-28	WOS:000395542500026
J	Kassas, N; Tanguy, E; Thahouly, T; Fouillen, L; Heintz, D; Chasserot-Golaz, S; Bader, MF; Grant, NJ; Vitale, N				Kassas, Nawal; Tanguy, Emeline; Thahouly, Tamou; Fouillen, Laetitia; Heintz, Dimitri; Chasserot-Golaz, Sylvette; Bader, Marie-France; Grant, Nancy J.; Vitale, Nicolas			Comparative Characterization of Phosphatidic Acid Sensors and Their Localization during Frustrated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSYLATION FACTOR DOMAIN; CAMP-SPECIFIC PHOSPHODIESTERASE; GTPASE-ACTIVATING DOMAIN; PHOSPHOLIPASE-D; MEMBRANE CURVATURE; MEDIATED PHAGOCYTOSIS; PLASMA-MEMBRANE; LIPID PACKING; BINDING; MACROPHAGES	Phosphatidic acid (PA) is the simplest phospholipid naturally existing in living organisms, but it constitutes only a minor fraction of total cell lipids. PA has attracted considerable attention because it is a phospholipid precursor, a lipid second messenger, and a modulator of membrane shape, and it has thus been proposed to play key cellular functions. The dynamics of PA in cells and in subcellular compartments, however, remains an open question. The recent generation of fluorescent probes for PA, by fusing GFP to PA-binding domains, has provided direct evidence for PA dynamics in different intracellular compartments. Here, three PA sensors were characterized in vitro, and their preferences for different PA species in particular lipidic environments were compared. In addition, the localization of PA in macrophages during frustrated phagocytosis was examined using these PA sensors and was combined with a lipidomic analysis of PA in intracellular compartments. The results indicate that the PA sensors display some preferences for specific PA species, depending on the lipid environment, and the localization study in macrophages revealed the complexity of intracellular PA dynamics.	[Kassas, Nawal; Tanguy, Emeline; Thahouly, Tamou; Chasserot-Golaz, Sylvette; Bader, Marie-France; Grant, Nancy J.; Vitale, Nicolas] CNRS, Inst Neurosci Cellulaires & Integrat INCI, 5 Rue Blaise Pascal, F-67084 Strasbourg, France; [Kassas, Nawal; Tanguy, Emeline; Thahouly, Tamou; Chasserot-Golaz, Sylvette; Bader, Marie-France; Grant, Nancy J.; Vitale, Nicolas] Univ Strasbourg, 5 Rue Blaise Pascal, F-67084 Strasbourg, France; [Fouillen, Laetitia] Univ Bordeaux, UMR 5200 CNRS, Lab Biogenese Membranaire, Plateforme Metabolome, F-33883 Villenave Dornon, France; [Heintz, Dimitri] CNRS, Inst Biol Mol Plantes, UPR 2357, Plateforme Metabolom, 28 Rue Goethe, F-67083 Strasbourg, France; [Heintz, Dimitri] Univ Strasbourg, Inst Botan, 28 Rue Goethe, F-67083 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vitale, N (corresponding author), CNRS, Inst Neurosci Cellulaires & Integrat INCI, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	vitalen@unistra.fr	Chasserot-Golaz, Sylvette/K-7625-2017; Bader, Marie-France/O-2098-2016; Vitale, Nicolas/G-5967-2014; FOUILLEN, Laetitia/AAV-9710-2020	Vitale, Nicolas/0000-0002-4752-4907; FOUILLEN, Laetitia/0000-0002-1204-9296; THAHOULY, Tamou/0000-0001-5980-6859; Chasserot-Golaz, Sylvette/0000-0002-7437-2558	Agence National pour la Recherche [MetaboHUB-ANR-11-INBS-0010]	Agence National pour la Recherche(French National Research Agency (ANR))	We thank Valerie Demais for scanning electron microscopy experiments and the microscopy facilities of Plateforme Imagerie In Vitro; Dr. Miles Houslay (King's College, London) for the original GFP-PDE4A1-PABD construct; Dr. S. Friant (CNRS and Universite de Strasbourg, France) for yeast DNA; Dr. Bernard Lorber (CNRS and Universite de Strasbourg, France) for help with the dynamic light scattering experiments; and Dr. Bruno Antonny for stimulating discussion (Institut de Pharmacologie Moleculaire et Cellulaire, Nice, France). The Metabolome Facility of Bordeaux was supported by Grant MetaboHUB-ANR-11-INBS-0010 from Agence National pour la Recherche.	Ali WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055325; Ammar Mohamed Raafet, 2013, Front Endocrinol (Lausanne), V4, P125, DOI 10.3389/fendo.2013.00125; Ammar MR, 2014, BIOCHIMIE, V107, P51, DOI 10.1016/j.biochi.2014.07.026; Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; BAINTON DF, 1989, AM J PATHOL, V134, P15; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; Comoglio Y, 2014, P NATL ACAD SCI USA, V111, P13547, DOI 10.1073/pnas.1407160111; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Corrotte M, 2010, J IMMUNOL, V185, P2942, DOI 10.4049/jimmunol.0903138; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Dalton KA, 1998, BIOCHEM J, V329, P637; Fan Z, 2003, AM J PHYSIOL-CELL PH, V284, pC94, DOI 10.1152/ajpcell.00255.2002; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Hofbauer HF, 2014, DEV CELL, V29, P729, DOI 10.1016/j.devcel.2014.04.025; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Huston E, 2006, J CELL SCI, V119, P3799, DOI 10.1242/jcs.03106; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Liu Y, 2013, ADV EXP MED BIOL, V991, P159, DOI 10.1007/978-94-007-6331-9_9; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Potocky M, 2014, NEW PHYTOL, V203, P483, DOI 10.1111/nph.12814; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Putta P, 2016, BBA-BIOMEMBRANES, V1858, P2709, DOI 10.1016/j.bbamem.2016.07.014; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; Vitale N, 2000, J BIOL CHEM, V275, P21331, DOI 10.1074/jbc.M909642199; Vitale N, 1996, P NATL ACAD SCI USA, V93, P1941, DOI 10.1073/pnas.93.5.1941; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wang WJ, 2012, J PHYS CHEM B, V116, P7213, DOI 10.1021/jp303840a; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013	50	55	56	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4266	4279		10.1074/jbc.M116.742346	http://dx.doi.org/10.1074/jbc.M116.742346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28115519	Green Published, hybrid			2022-12-28	WOS:000395837100024
J	Goloviznina, NA; Verghese, SC; Yoon, YM; Taratula, O; Marks, DL; Kurre, P				Goloviznina, Natalya A.; Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Taratula, Oleh; Marks, Daniel L.; Kurre, Peter			Mesenchymal stromal cell-derived extracellular vesicles promote myeloid-biased multipotent hematopoietic progenitor expansion via Toll-like receptor engagement (vol 291, pg 24607, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIGMS NIH HHS [T32 GM113846] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA184324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM113846] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Goloviznina NA, 2016, J BIOL CHEM, V291, P24607, DOI 10.1074/jbc.M116.745653	1	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3541	3541		10.1074/jbc.A116.745653	http://dx.doi.org/10.1074/jbc.A116.745653			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28235900	hybrid, Green Published			2022-12-28	WOS:000395538800041
J	Gillard, BK; Bassett, GR; Gotto, AM; Rosales, C; Pownall, HJ				Gillard, Baiba K.; Bassett, G. Randall; Gotto, Antonio M., Jr.; Rosales, Corina; Pownall, Henry J.			Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; cholesterol; high-density lipoprotein (HDL); lipid; scavenger receptor; apolipoprotein AII; reverse cholesterol transport; scavenger receptor B1; selective lipid uptake	SERUM OPACITY FACTOR; PHOSPHOLIPID TRANSFER PROTEIN; SELECTIVE LIPID UPTAKE; SR-BI; A-I; DEFICIENT MICE; MECHANISM; CELLS; ATHEROSCLEROSIS; EXPRESSION	Reverse cholesterol transport (transfer of macrophage-cholesterol in the subendothelial space of the arterial wall to the liver) is terminated by selective high density lipoprotein (HDL)-cholesteryl ester (CE) uptake, mediated by scavenger receptor class B, type 1 (SR-B1). We tested the validity of two models for this process: "gobbling," i.e. one-step transfer of all HDL-CE to the cell and "nibbling," multiple successive cycles of SR-B1-HDL association during which a few CEs transfer to the cell. Concurrently, we compared cellular uptake of apoAI with that of apoAII, which is more lipophilic than apoAI, using HDL-[H-3]CE labeled with [I-125]apoAI or [I-125]apoAII. The studies were conducted in CHO-K1 and CHO-ldlA7 cells (LDLR-/-) with (CHO-SR-B1) and without SR-B1 overexpression and in human Huh7 hepatocytes. Relative to CE, both apoAI and apoAII were excluded from uptake by all cells. However, apoAII was more highly excluded from uptake (2-4x) than apoAI. To distinguish gobbling versus nibbling mechanisms, media from incubations of HDL with CHO-SR-B1 cells were analyzed by non-denaturing PAGE, size-exclusion chromatography, and the distribution of apoAI, apoAII, cholesterol, and phospholipid among HDL species as a function of incubation time. HDL size gradually decreased, i.e. nibbling, with the concurrent release of lipid-free apoAI; apoAII was retained in an HDL remnant. Our data support an SR-B1 nibbling mechanism that is similar to that of streptococcal serum opacity factor, which also selectively removes CE and releases apoAI, leaving an apoAII-rich remnant.	[Gillard, Baiba K.; Gotto, Antonio M., Jr.; Rosales, Corina; Pownall, Henry J.] Houston Methodist Res Inst, 6670 Bertner Ave,Rm. R11-218, Houston, TX 77030 USA; [Gillard, Baiba K.; Gotto, Antonio M., Jr.; Rosales, Corina; Pownall, Henry J.] Weill Cornell Med, New York, NY 10065 USA; [Bassett, G. Randall] Baylor Coll Med, Houston, TX 77030 USA; [Bassett, G. Randall] Medtron Aort Therapies, 3576 Unocal Pl, Santa Rosa, CA 95403 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Baylor College of Medicine	Gillard, BK (corresponding author), Houston Methodist Res Inst, 6670 Bertner Ave,Rm. R11-218, Houston, TX 77030 USA.; Gillard, BK (corresponding author), Weill Cornell Med, New York, NY 10065 USA.	bgillard@houstonmethodist.org; g.randy.bassett@medtronic.com		Pownall, Henry/0000-0001-8412-506X; Gillard, Baiba/0000-0002-2527-5102	National Institutes of Health [HL-56865, HL-129767]; Bass Foundation; Houston Methodist Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056865, R01HL129767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bass Foundation; Houston Methodist Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL-56865 (to H. J. P.) and HL-129767 (to H. J. P. and C. R.). This work was also supported by the Bass Foundation (to A. M. G.) and Houston Methodist Foundation funding from Charif Souki, Patrick Studdert, and the Jerold B. Katz family. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; BISGAIER CL, 1991, J LIPID RES, V32, P21; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CHEUNG MC, 1977, J CLIN INVEST, V60, P43, DOI 10.1172/JCI108767; Connelly MA, 2003, TRENDS ENDOCRIN MET, V14, P467, DOI 10.1016/j.tem.2003.10.002; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; de Beer MC, 2005, J LIPID RES, V46, P2143, DOI 10.1194/jlr.M500068-JLR200; EDELSTEIN C, 1982, J BIOL CHEM, V257, P7189; Eyvazian VA, 2017, CARDIOL REV, V25, P43, DOI 10.1097/CRD.0000000000000137; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gillard BK, 2013, ARTERIOSCL THROM VAS, V33, P1714, DOI 10.1161/ATVBAHA.113.301538; Gillard BK, 2010, BIOCHEMISTRY-US, V49, P9866, DOI 10.1021/bi101412m; Gillard BK, 2009, BBA-MOL CELL BIOL L, V1791, P1125, DOI 10.1016/j.bbalip.2009.07.004; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; HAMILTON JA, 1982, J BIOL CHEM, V257, P7318; Han M, 2009, BIOCHEMISTRY-US, V48, P1481, DOI 10.1021/bi802287q; Handa D, 2015, BIOCHEMISTRY-US, V54, P1123, DOI 10.1021/bi501345j; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Havel RJ, 1980, METABOLIC CONTROL DI, P393; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; KUNITAKE ST, 1982, J LIPID RES, V23, P936; Levinson SS, 2015, CLIN CHIM ACTA, V439, P154, DOI 10.1016/j.cca.2014.10.018; LI WH, 1988, J LIPID RES, V29, P245; Liang HQ, 1996, J LIPID RES, V37, P1962; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Pownall HJ, 2007, BIOCHEMISTRY-US, V46, P7449, DOI 10.1021/bi700496w; Pownall HJ, 2016, TRENDS ENDOCRIN MET, V27, P44, DOI 10.1016/j.tem.2015.11.004; POWNALL HJ, 1981, BIOCHEMISTRY-US, V20, P6630, DOI 10.1021/bi00526a017; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rao R, 1997, BIOCHEMISTRY-US, V36, P3645, DOI 10.1021/bi962776b; Rodriguez PJ, 2016, BIOCHEMISTRY-US, V55, P5845, DOI 10.1021/acs.biochem.6b00946; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rosales C, 2011, ARTERIOSCL THROM VAS, V31, P1834, DOI 10.1161/ATVBAHA.111.224360; Schwartz CC, 2004, J LIPID RES, V45, P1594, DOI 10.1194/jlr.M300511-JLR200; Settasatian N, 2001, J BIOL CHEM, V276, P26898, DOI 10.1074/jbc.M010708200; SILVER ET, 1990, J BIOL CHEM, V265, P22487; Thuahnai ST, 2001, J BIOL CHEM, V276, P43801, DOI 10.1074/jbc.M106695200; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Webb NR, 2004, J LIPID RES, V45, P1666, DOI 10.1194/jlr.M400026-JLR200; Webb NR, 2002, J LIPID RES, V43, P1890, DOI 10.1194/jlr.M200173-JLR200; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	52	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8864	8873		10.1074/jbc.M117.781963	http://dx.doi.org/10.1074/jbc.M117.781963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373285	Green Published, hybrid			2022-12-28	WOS:000402153900040
J	Hirata, Y; Takahashi, M; Kudoh, Y; Kano, K; Kawana, H; Makide, K; Shinoda, Y; Yabuki, Y; Fukunaga, K; Aoki, J; Noguchi, T; Matsuzawa, A				Hirata, Yusuke; Takahashi, Miki; Kudoh, Yuki; Kano, Kuniyuki; Kawana, Hiroki; Makide, Kumiko; Shinoda, Yasuharu; Yabuki, Yasushi; Fukunaga, Kohji; Aoki, Junken; Noguchi, Takuya; Matsuzawa, Atsushi			trans-Fatty acids promote proinflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DIETARY FATS; ATHEROSCLEROSIS; INFLAMMATION; ACTIVATION; RECEPTOR; DISEASE; BRAIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION	Food-borne trans-fatty acids (TFAs) are mainly produced as byproducts during food manufacture. Recent epidemiological studies have revealed that TFA consumption is a major risk factor for various disorders, including atherosclerosis. However, the underlying mechanisms in this disease etiology are largely unknown. Here we have shown that TFAs potentiate activation of apoptosis signal-regulating kinase 1 (ASK1) induced by extracellular ATP, a damage-associated molecular pattern leaked from injured cells. Major food-associated TFAs such as elaidic acid (EA), linoelaidic acid, and trans-vaccenic acid, but not their corresponding cis isomers, dramatically enhanced extracellular ATP-induced apoptosis, accompanied by elevated activation of the ASK1-p38 pathway in a macrophage-like cell line, RAW264.7. Moreover, knocking out the ASK1-encoding gene abolished EA-mediated enhancement of apoptosis. We have reported previously that extracellular ATP induces apoptosis through the ASK1-p38 pathway activated by reactive oxygen species generated downstream of the P2X purinoceptor 7 (P2X(7)). However, here we show that EA did not increase ATP-induced reactive oxygen species generation but, rather, augmented the effects of calcium/calmodulin-dependentkinase II-dependent ASK1 activation. These results demonstrate that TFAs promote extracellular ATP-induced apoptosis by targeting ASK1 and indicate novel TFA-associated pathways leading to inflammatory signal transduction and cell death that underlie the pathogenesis and progression of TFA-induced atherosclerosis. Our study thus provides insight into the pathogenic mechanisms of and proposes potential therapeutic targets for these TFA-related disorders.	[Hirata, Yusuke; Takahashi, Miki; Kudoh, Yuki; Noguchi, Takuya; Matsuzawa, Atsushi] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Kano, Kuniyuki; Kawana, Hiroki; Makide, Kumiko; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Shinoda, Yasuharu; Yabuki, Yasushi; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Kano, Kuniyuki; Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1000004, Japan	Tohoku University; Tohoku University; Tohoku University	Noguchi, T; Matsuzawa, A (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	noguchi@m.tohoku.ac.jp; matsushi@m.tohoku.ac.jp	Fukunaga, Kohji/AAI-8811-2021; Yabuki, Yasushi/AAF-7931-2021; Shinoda, Yasuharu/AAE-6135-2019; Matsuzawa, Atsushi/GLU-1387-2022; Hirata, Yusuke/T-9580-2019; Noguchi, Takuya/T-6767-2019	Shinoda, Yasuharu/0000-0001-9910-048X; Hirata, Yusuke/0000-0002-1428-2075; Noguchi, Takuya/0000-0001-6187-6645; Kano, Kuniyuki/0000-0002-4539-5750; Matsuzawa, Atsushi/0000-0001-8303-3905; Fukunaga, Kohji/0000-0001-8526-2824	Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan; KAKENHI from the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [16H05219] Funding Source: KAKEN	Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan; KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan, KAKENHI from the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Bassett CMC, 2009, METABOLISM, V58, P1802, DOI 10.1016/j.metabol.2009.06.010; CENEDELL.RJ, 1971, LIPIDS, V6, P475, DOI 10.1007/BF02531232; Chung MY, 2015, J MED FOOD, V18, P648, DOI 10.1089/jmf.2014.0048; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Dorfman SE, 2009, OBESITY, V17, P1200, DOI 10.1038/oby.2008.662; Druart C, 2013, BRIT J NUTR, V110, P998, DOI 10.1017/S0007114513000123; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Ferrari D, 2015, TRENDS MOL MED, V21, P184, DOI 10.1016/j.molmed.2014.12.008; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; Gebauer SK, 2007, LIPIDS, V42, P787, DOI 10.1007/s11745-007-3095-8; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Han SN, 2002, J LIPID RES, V43, P445; Hayakawa R, 2012, P JPN ACAD B-PHYS, V88, P434, DOI 10.2183/pjab.88.434; Hussein O, 2007, WORLD J GASTROENTERO, V13, P361, DOI 10.3748/wjg.v13.i3.361; Ibrahim A, 2005, METABOLISM, V54, P240, DOI 10.1016/j.metabol.2004.08.019; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Jimenez-Gomez Yolanda, 2009, Atherosclerosis, V204, pe70, DOI 10.1016/j.atherosclerosis.2008.09.011; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; Liu WH, 2010, J AGR FOOD CHEM, V58, P10247, DOI 10.1021/jf102379n; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Machado RM, 2012, ATHEROSCLEROSIS, V224, P66, DOI 10.1016/j.atherosclerosis.2012.06.059; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mattiazzi A, 2015, AM J PHYSIOL-HEART C, V308, pH1177, DOI 10.1152/ajpheart.00007.2015; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Mori K, 2015, CIRC J, V79, P2017, DOI 10.1253/circj.CJ-14-0750; Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085; Morris MC, 2004, NEUROLOGY, V62, P1573, DOI 10.1212/01.WNL.0000123250.82849.B6; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Ouellet V, 2008, J NUTR, V138, P2386, DOI 10.3945/jn.108.092346; Peng K, 2015, INT J MOL MED, V35, P1179, DOI 10.3892/ijmm.2015.2129; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Shioda N, 2015, J BIOL CHEM, V290, P21663, DOI 10.1074/jbc.M115.664920; Siddiqui RA, 2009, BRIT J NUTR, V102, P1811, DOI 10.1017/S0007114509992030; Strack S, 1997, J NEUROCHEM, V68, P2119; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Teixeira AM, 2012, BEHAV BRAIN RES, V226, P504, DOI 10.1016/j.bbr.2011.10.005; Tewari M, 2015, AGEING RES REV, V24, P328, DOI 10.1016/j.arr.2015.10.001; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199	58	30	34	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8174	8185		10.1074/jbc.M116.771519	http://dx.doi.org/10.1074/jbc.M116.771519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360100	Green Published, hybrid			2022-12-28	WOS:000401788600005
J	Fujiki, K; Inamura, H; Miyayama, T; Matsuoka, M				Fujiki, Kota; Inamura, Hisako; Miyayama, Takamitsu; Matsuoka, Masato			Involvement of Notch1 signaling in malignant progression of A549 cells subjected to prolonged cadmium exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE; BREAST-CANCER; PROLIFERATION; RECEPTOR; ACTIVATION; EXPRESSION; APOPTOSIS; INSIGHTS; PATHWAYS	Cadmium exposure is known to increase lung cancer risk, but the underlying molecular mechanisms in cadmium-stimulated progression of malignancy are unclear. Here, we examined the effects of prolonged cadmium exposure on the malignant progression of A549 human lung adenocarcinoma cells and the roles of Notch1, hypoxia-inducible factor 1 alpha (HIF-1 alpha), and insulin-like growth factor 1 receptor (IGF-1R)/Akt/extracellular signal-regulated kinase (ERK)/p70 S6 kinase 1 (S6K1) signaling pathways. Exposing A549 cells to 10 or 20 mu M cadmium chloride (CdCl2) for 9-15 weeks induced a high proliferative potential, the epithelial-mesenchymal transition (EMT), stress fiber formation, high cell motility, and resistance to antitumor drugs. Of note, the CdCl2 exposure increased the levels of the Notch1 intracellular domain and of the downstream Notch1 target genes Snail and Slug. Strikingly, siRNA-mediated Notch1 silencing partially suppressed the CdCl2-induced EMT, stress fiber formation, high cell motility, and antitumor drug resistance. In addition, we found that prolonged CdCl2 exposure induced reduction of E-cadherin in BEAS-2B human bronchial epithelial cells and antitumor drug resistance in H1975 human tumor-derived non-small-cell lung cancer cells depending on Notch1 signaling. Moreover, Notch1, HIF-1 alpha, and IGF-1R/Akt/ERK/S6K1 activated each other to induce EMT in the CdCl2-exposed A549 cells. These results suggest that Notch1, along with HIF-1 alpha and IGF-1R/Akt/ERK/S6K1 signaling pathways, promotes malignant progression stimulated by prolonged cadmium exposure in this lung adenocarcinoma model.	[Fujiki, Kota; Inamura, Hisako; Miyayama, Takamitsu; Matsuoka, Masato] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 1, Tokyo 1628666, Japan	Tokyo Women's Medical University	Fujiki, K (corresponding author), Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 1, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	bunnsidairoku@gmail.com	Miyayama, Takamitsu/N-6175-2017		Japan Society for the Promotion of Science KAKENHI [15K18910, 26460175]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26460175] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 15K18910 and 26460175 and a grant-in-aid for medicine from the Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Beveridge R, 2010, AM J IND MED, V53, P476, DOI 10.1002/ajim.20801; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Ding XB, 2011, INT J BIOL SCI, V7, P269, DOI 10.7150/ijbs.7.269; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Filosto S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023240; Fujiki K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.339; Gao XH, 2015, ENVIRON HEALTH PERSP, V123, P331, DOI 10.1289/ehp.1408234; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Hales EC, 2014, CELL SIGNAL, V26, P149, DOI 10.1016/j.cellsig.2013.09.021; HERNANDEZSANCHEZ C, 1995, J BIOL CHEM, V270, P29176, DOI 10.1074/jbc.270.49.29176; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; IARC, 2012, IARC MONOGR EVAL CAR, V100C, P121; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Kim TH, 2014, J PHARMACOL EXP THER, V349, P268, DOI 10.1124/jpet.113.207563; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liu JT, 2014, BIOCHEM BIOPH RES CO, V444, P670, DOI 10.1016/j.bbrc.2014.01.164; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; National Toxicology Program (NTP), 2014, 13 NTP DEP HLTH HUM, P1; Person RJ, 2013, TOXICOL APPL PHARM, V273, P281, DOI 10.1016/j.taap.2013.06.013; Satarug S, 2006, TOHOKU J EXP MED, V208, P179, DOI 10.1620/tjem.208.179; Schwanbeck R, 2011, EUR J CELL BIOL, V90, P572, DOI 10.1016/j.ejcb.2010.10.004; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Sriuranpong V, 2001, CANCER RES, V61, P3200; Surolia R, 2015, AM J PHYSIOL-LUNG C, V309, pL280, DOI 10.1152/ajplung.00097.2015; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Villa JC, 2014, CELL REP, V8, P1077, DOI 10.1016/j.celrep.2014.07.028; Wael H, 2014, LUNG CANCER, V85, P131, DOI 10.1016/j.lungcan.2014.05.001; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033853; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P119; World Health Organization (WHO), 2008, WHO GUID DRINK WAT Q, V1, P317; Wu WD, 2015, ENVIRON HEALTH PERSP, V123, P231, DOI 10.1289/ehp.1307379; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Yuan X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0087-z; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437	49	31	31	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7942	7953		10.1074/jbc.M116.759134	http://dx.doi.org/10.1074/jbc.M116.759134			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302721	Green Published, hybrid			2022-12-28	WOS:000401154100021
J	Kotenko, SV; Durbin, JE				Kotenko, Sergei V.; Durbin, Joan E.			Contribution of type III interferons to antiviral immunity: location, location, location	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						antiviral agent; interferon; mucosal immunology; viral immunology; virology	IFN-LAMBDA RECEPTOR; HEPATITIS-C; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; STIMULATED GENES; VIRUS-REPLICATION; EPITHELIAL-CELLS; EXPRESSION; ALPHA; INFECTION	Type I interferons (IFN-/) and the more recently identified type III IFNs (IFN-) function as the first line of defense against virus infection and regulate the development of both innate and adaptive immune responses. Type III IFNs were originally identified as a novel ligand-receptor system acting in parallel with type I IFNs, but subsequent studies have provided increasing evidence for distinct roles for each IFN family. In addition to their compartmentalized antiviral actions, these two systems appear to have multiple levels of cross-regulation and act coordinately to achieve effective antimicrobial protection with minimal collateral damage to the host.	[Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Durbin, Joan E.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA; [Kotenko, Sergei V.; Durbin, Joan E.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Kotenko, Sergei V.; Durbin, Joan E.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Univ Hosp Canc Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kotenko, SV (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.; Durbin, JE (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA.; Kotenko, SV; Durbin, JE (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA.; Kotenko, SV; Durbin, JE (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Univ Hosp Canc Ctr, Newark, NJ 07103 USA.	kotenkse@njms.rutgers.edu; durbinje@njms.rutgers.edu			National Institutes of Health [RO1 AI057468, AI104669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104669, R01AI057468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants RO1 AI057468 (to S.V.K.) and AI104669 (to S.V.K. and J.E.D.). S.V.K. is an inventor of patents and patent applications related to IFN-lambda s, which have been licensed for commercial development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3; Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; Amanzada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084026; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Boudinot P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110298; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; de Groen RA, 2015, EUR J IMMUNOL, V45, P250, DOI 10.1002/eji.201444903; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2003, BIOCHEM J, V370, P391, DOI 10.1042/BJ20021935; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Friborg J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121734; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Heim MH, 2016, J HEPATOL, V65, pS22, DOI 10.1016/j.jhep.2016.07.037; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Kelly A, 2016, J INTERF CYTOK RES, V36, P671, DOI 10.1089/jir.2015.0169; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Klinkhammer J, 2015, CYTOKINE, V76, P74, DOI 10.1016/j.cyto.2015.08.082; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 1996, J BIOL CHEM, V271, P17174, DOI 10.1074/jbc.271.29.17174; Kotenko SV, 2004, INT IMMUNOPHARMACOL, V4, P593, DOI 10.1016/j.intimp.2004.01.003; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krause CD, 2015, CYTOKINE, V76, P480, DOI 10.1016/j.cyto.2015.07.019; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lasfar A, 2016, ONCOTARGET, V7, P49259, DOI 10.18632/oncotarget.10272; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lee HC, 2014, J BIOL CHEM, V289, P5310, DOI 10.1074/jbc.M113.536102; Lee SJ, 2012, INT J MOL MED, V30, P945, DOI 10.3892/ijmm.2012.1064; Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Mahlakoiv T, 2012, J GEN VIROL, V93, P2601, DOI 10.1099/vir.0.046284-0; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Megjugorac NJ, 2010, BLOOD, V115, P4185, DOI 10.1182/blood-2009-09-246157; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Misumi I, 2014, J IMMUNOL, V192, P3596, DOI 10.4049/jimmunol.1301705; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morrison MH, 2014, HUM IMMUNOL, V75, P996, DOI 10.1016/j.humimm.2014.06.016; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059611; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Paquin A, 2016, J INTERF CYTOK RES, V36, P30, DOI 10.1089/jir.2015.0096; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Rauch I, 2015, MOL CELL BIOL, V35, P2332, DOI 10.1128/MCB.01498-14; Sang YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29072; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Swamy M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8090; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389	101	62	64	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7295	7303		10.1074/jbc.R117.777102	http://dx.doi.org/10.1074/jbc.R117.777102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28289095	Green Published, hybrid			2022-12-28	WOS:000400761300002
J	Richards, R; Dempski, RE				Richards, Ryan; Dempski, Robert E.			Adjacent channelrhodopsin-2 residues within transmembranes 2 and 7 regulate cation selectivity and distribution of the two open states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydomonas; electrophysiology; gating; ion channel; optogenetics; Chlamydomonas reinhardtii	MOLECULAR-DYNAMICS SIMULATIONS; EMPIRICAL FORCE-FIELD; ION CONDUCTANCE; ALPHA-HELICES; THREONINE RESIDUES; PROTON AFFINITY; EXCITABLE CELLS; OPTICAL CONTROL; NUCLEIC-ACIDS; SCHIFF-BASE	Channelrhodopsin-2 (ChR2) is a light-activated channel that can conduct cations of multiple valencies down the electrochemical gradient. Under continuous light exposure, ChR2 transitions from a high-conducting open state (O1) to a low-conducting open state (O2) with differing ion selectivity. The molecular basis for the O1 O2 transition and how ChR2 modulates selectivity between states is currently unresolved. To this end, we used steered molecular dynamics, electrophysiology, and kinetic modeling to identify residues that contribute to gating and selectivity in discrete open states. Analysis of steered molecular dynamics experiments identified three transmembrane residues (Val-86, Lys-93, and Asn-258) that form a putative barrier to ion translocation. Kinetic modeling of photocurrents generated from ChR2 proteins with conservative mutations at these positions demonstrated that these residues contribute to cation selectivity (Val-86 and Asn-258), the transition between the two open states (Val-86), open channel stability, and the hydrogen-bonding network (K93I and K93N). These results suggest that this approach can be used to identify residues that contribute to the open-state transitions and the discrete ion selectivity within these states. With the rise of ChR2 use in optogenetics, it will be critical to identify residues that contribute to O1 or O2 selectivity and gating to minimize undesirable effects.	[Richards, Ryan; Dempski, Robert E.] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Dempski, RE (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	rdempski@wpi.edu			WPI; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation [1053575]	WPI; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation(National Science Foundation (NSF))	This work was supported by WPI and the Extreme Science and Engineering Discovery Environment (XSEDE) and by National Science Foundation Grant 1053575. The authors declare that they have no conflicts of interest with the contents of this article.	Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cui YB, 2011, BIOCHEM BIOPH RES CO, V412, P654, DOI 10.1016/j.bbrc.2011.08.019; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Gaiko O, 2013, BIOPHYS J, V104, P1230, DOI 10.1016/j.bpj.2013.02.013; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Isralewitz B, 1997, BIOPHYS J, V73, P2972, DOI 10.1016/S0006-3495(97)78326-7; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kruger J, 2011, CONCURR COMP-PRACT E, V23, P279, DOI 10.1002/cpe.1666; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lorenz-Fonfria VA, 2015, P NATL ACAD SCI USA, V112, pE5796, DOI 10.1073/pnas.1511462112; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MARTI T, 1991, J BIOL CHEM, V266, P6919; Nack M, 2012, FEBS LETT, V586, P1344, DOI 10.1016/j.febslet.2012.03.047; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; NINA M, 1995, BIOPHYS J, V68, P25, DOI 10.1016/S0006-3495(95)80184-0; Peralavarez-Marin A, 2004, J BIOL CHEM, V279, P16403, DOI 10.1074/jbc.M313988200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Richards R, 2015, SPRINGER SER BIOPHYS, V18, P361, DOI 10.1007/978-3-319-20149-8_15; Richards R, 2015, BIOCHEMISTRY-US, V54, P5665, DOI 10.1021/acs.biochem.5b00738; Richards R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050018; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Sattig T, 2013, ANGEW CHEM INT EDIT, V52, P9705, DOI 10.1002/anie.201301698; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stefanescu RA, 2013, B MATH BIOL, V75, P2208, DOI 10.1007/s11538-013-9888-4; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; Takemoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131094; Talathi SS, 2011, J COMPUT NEUROSCI, V31, P87, DOI 10.1007/s10827-010-0296-6; Volz P, 2016, J BIOL CHEM, V291, P17382, DOI 10.1074/jbc.M115.711200; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Williams JC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003220; Yu J, 2006, STRUCTURE, V14, P1411, DOI 10.1016/j.str.2006.07.006; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	65	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7314	7326		10.1074/jbc.M116.770321	http://dx.doi.org/10.1074/jbc.M116.770321			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302720	Green Published, hybrid			2022-12-28	WOS:000400761300004
J	Chen, JL; De Raeymaecker, J; Hovgaard, JB; Smaardijk, S; Vandecaetsbeek, I; Wuytack, F; Moller, JV; Eggermont, J; De Maeyer, M; Christensen, SB; Vangheluwe, P				Chen, Jialin; De Raeymaecker, Joren; Hovgaard, Jannik Brondsted; Smaardijk, Susanne; Vandecaetsbeek, Ilse; Wuytack, Frank; Moller, Jesper Vuust; Eggermont, Jan; De Maeyer, Marc; Christensen, Soren Brogger; Vangheluwe, Peter			Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM CA2+ ATPASE; HAILEY-HAILEY-DISEASE; AMINO-ACID 256; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CALCIUM-PUMP; BINDING-SITE; CRYSTAL-STRUCTURES; CA2+-ATPASE SPCA1; GENETIC ALGORITHM	The Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a) is implicated in breast cancer and Hailey-Hailey disease. Here, we purified recombinant human SPCA1a from Saccharomyces cerevisiae and measured Ca2+-dependent ATPase activity following reconstitution in proteoliposomes. The purified SPCA1a displays a higher apparent Ca2+ affinity and a lower maximal turnover rate than the purified sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1a). The lipids cholesteryl hemisuccinate, linoleamide/oleamide, and phosphatidylethanolamine inhibit and phosphatidic acid and sphingomyelin enhance SPCA1a activity. Moreover, SPCA1a is blocked by micromolar concentrations of the commonly used SERCA1a inhibitors thapsigargin (Tg), cyclopiazonic acid, and 2,5-di-tert-butylhydroquinone. Because tissue-specific targeting of SERCA2b by Tg analogues is considered for prostate cancer therapy, the inhibition of SPCA1a by Tg might represent an off-target risk. We assessed the structure-activity relationship (SAR) of Tg for SPCA1a by in silico modeling, site-directed mutagenesis, and measuring the potency of a series of Tg analogues. These indicate that Tg and the analogues are bound via the Tg scaffold but with lower affinity to the same homologous cavity as on the membrane surface of SERCA1a. The lower Tg affinity may depend on a more flexible binding cavity in SPCA1a, with low contributions of the Tg O-3, O-8, and O-10 chains to the binding energy. Conversely, the protein interaction of the Tg O-2 side chain with SPCA1a appears comparable with that of SERCA1a. These differences define a SAR of Tg for SPCA1a distinct from that of SERCA1a, indicating that Tg analogues with a higher specificity for SPCA1a can probably be developed.	[Chen, Jialin; Smaardijk, Susanne; Vandecaetsbeek, Ilse; Wuytack, Frank; Eggermont, Jan; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, ON1 Campus Gasthuisberg,Herestr 49,Box 802, B-3000 Leuven, Belgium; [De Raeymaecker, Joren; De Maeyer, Marc] Katholieke Univ Leuven, Dept Chem, Biochem Mol & Struct Biol Sect, B-3000 Leuven, Belgium; [Hovgaard, Jannik Brondsted; Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Moller, Jesper Vuust] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark	KU Leuven; KU Leuven; University of Copenhagen; Aarhus University	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, ON1 Campus Gasthuisberg,Herestr 49,Box 802, B-3000 Leuven, Belgium.	peter.vangheluwe@kuleuven.be	Christensen, Søren Brøgger/H-4526-2019; Vangheluwe, Peter/P-5476-2017	Christensen, Søren Brøgger/0000-0002-5773-6874; Vangheluwe, Peter/0000-0002-7822-2944; Eggermont, Jan/0000-0002-8497-1159	Flanders Research Foundation FWO [G044212N, G0B1115N]; Inter-University Attraction Poles Program [P7/13]; Danish Council for Strategic Research	Flanders Research Foundation FWO(FWO); Inter-University Attraction Poles Program(Belgian Federal Science Policy Office); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by Flanders Research Foundation FWO Grants G044212N and G0B1115N, the Inter-University Attraction Poles Program P7/13, and by the Danish Council for Strategic Research. The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSEN A, 1994, ACTA CHEM SCAND, V48, P340, DOI 10.3891/acta.chem.scand.48-0340; [Anonymous], 2014, MOL OP ENV MOE VERS; Autzen HE, 2015, MOL MEMBR BIOL, V32, P75, DOI 10.3109/09687688.2015.1073382; Baron S, 2010, BBA-BIOMEMBRANES, V1798, P1512, DOI 10.1016/j.bbamem.2010.03.023; Baron S, 2009, BBA-MOL CELL RES, V1793, P1041, DOI 10.1016/j.bbamcr.2008.11.005; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Benaim G, 2016, BIOCHEM BIOPH RES CO, V473, P572, DOI 10.1016/j.bbrc.2016.03.123; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Buettner S, 2013, CELL DEATH DIFFER, V20, P465, DOI 10.1038/cdd.2012.142; BURGE SM, 1992, BRIT J DERMATOL, V126, P275, DOI 10.1111/j.1365-2133.1992.tb00658.x; CHRISTENSEN SB, 1993, FEBS LETT, V335, P345, DOI 10.1016/0014-5793(93)80416-R; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Denmeade S.R., 2012, SCI TRANSL MED, V4, P140, DOI DOI 10.2174/1871520610909030276; Dode L, 2006, J BIOL CHEM, V281, P3182, DOI 10.1074/jbc.M511547200; Dode L, 2005, J BIOL CHEM, V280, P39124, DOI 10.1074/jbc.M506181200; Dubois C, 2013, FEBS J, V280, P5430, DOI 10.1111/febs.12475; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Fairclough RJ, 2003, J BIOL CHEM, V278, P24721, DOI 10.1074/jbc.M300509200; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Holemans Tine, 2014, Cold Spring Harb Protoc, V2014, P876, DOI 10.1101/pdb.prot076893; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KADOWAKI H, 1994, J LIPID RES, V35, P1956; Kaneko M, 2014, NAT GENET, V46, P144, DOI 10.1038/ng.2850; Lai P, 2012, BIOCHEM BIOPH RES CO, V424, P616, DOI 10.1016/j.bbrc.2012.07.004; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; Law BYK, 2010, MOL CANCER THER, V9, P718, DOI 10.1158/1535-7163.MCT-09-0700; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Micaroni M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.147; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Missiaen L, 2002, J BIOL CHEM, V277, P6898, DOI 10.1074/jbc.M110939200; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Doan NTQ, 2015, CURR PHARM DESIGN, V21, P5501, DOI 10.2174/1381612821666151002112824; Doan NTQ, 2015, STEROIDS, V97, P2, DOI 10.1016/j.steroids.2014.07.009; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PlengeTellechea F, 1997, J BIOL CHEM, V272, P2794, DOI 10.1074/jbc.272.5.2794; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; SIMMONDS AC, 1982, BIOCHIM BIOPHYS ACTA, V693, P398, DOI 10.1016/0005-2736(82)90447-3; Skytte DM, 2010, BIOORGAN MED CHEM, V18, P5634, DOI 10.1016/j.bmc.2010.06.032; Smaardijk S., 2016, TISSUE CELL, V2016, pS0040; SMITT UW, 1991, PLANTA MED, V57, P196, DOI 10.1055/s-2006-960067; Sohoel H, 2005, J MED CHEM, V48, P7005, DOI 10.1021/jm058036v; Sorin A, 1997, J BIOL CHEM, V272, P9895; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vandecaetsbeek I, 2011, BBA-MOL CELL RES, V1813, P1118, DOI 10.1016/j.bbamcr.2010.12.020; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Wootton LL, 2006, J BIOL CHEM, V281, P6970, DOI 10.1074/jbc.M510978200; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yamamoto S, 2016, BIOCHEM BIOPH RES CO, V477, P266, DOI 10.1016/j.bbrc.2016.06.055; Young HS, 1997, BIOPHYS J, V72, P2545, DOI 10.1016/S0006-3495(97)78898-2; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542; Yu MH, 1999, ARCH BIOCHEM BIOPHYS, V362, P225, DOI 10.1006/abbi.1998.1049	76	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6938	6951		10.1074/jbc.M117.778431	http://dx.doi.org/10.1074/jbc.M117.778431			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28264934	hybrid, Green Published			2022-12-28	WOS:000400478300007
J	Horakova, E; Changmai, P; Vancova, M; Sobotka, R; Van den Abbeele, J; Vanhollebeke, B; Lukes, J				Horakova, Eva; Changmai, Piya; Vancova, Marie; Sobotka, Roman; Van den Abbeele, Jan; Vanhollebeke, Benoit; Lukes, Julius			The Trypanosoma brucei TbHrg protein is a heme transporter involved in the regulation of stage-specific morphological transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-CYCLE STAGES; SURFACE GLYCOPROTEIN; WIDE ANALYSIS; TSETSE-FLY; DIFFERENTIATION; PATHWAY; QUANTIFICATION; MITOCHONDRION; BIOSYNTHESIS; TRAFFICKING	The human parasite Trypanosoma brucei does not synthesize heme de novo and instead relies entirely on heme supplied by its vertebrate host or its insect vector, the tsetse fly. In the host bloodstream T. brucei scavenges heme via haptoglobin-hemoglobin (HpHb) receptor-mediated endocytosis occurring in the flagellar pocket. However, in the procyclic developmental stage, in which T. brucei is confined to the tsetse fly midgut, this receptor is apparently not expressed, suggesting that T. brucei takes up heme by a different, unknown route. To define this alternative route, we functionally characterized heme transporter TbHrg in the procyclic stage. RNAi-induced down-regulation of TbHrg in heme-limited culture conditions resulted in slower proliferation, decreased cellular heme, and marked changes in cellular morphology so that the cells resemble mesocyclic trypomastigotes. Nevertheless, the TbHrg KO developed normally in the tsetse flies at rates comparable with wild-type cells. T. brucei cells overexpressing TbHrg displayed up-regulation of the early procyclin GPEET and down-regulation of the late procyclin EP1, two proteins coating the T. brucei surface in the procyclic stage. Light microscopy of immunostained TbHrg indicated localization to the flagellar membrane, and scanning electron microscopy revealed more intense TbHrg accumulation toward the flagellar pocket. Based on these findings, we postulate that T. brucei senses heme levels via the flagellar TbHrg protein. Heme deprivation in the tsetse fly anterior midgut might represent an environmental stimulus involved in the transformation of this important human parasite, possibly through metabolic remodeling.	[Horakova, Eva; Changmai, Piya; Vancova, Marie; Lukes, Julius] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice 37005, Budweis, Czech Republic; [Vancova, Marie; Sobotka, Roman; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic; [Sobotka, Roman] Czech Acad Sci, Inst Microbiol, Trebon 37981, Czech Republic; [Van den Abbeele, Jan] Inst Trop Med, Unit Vet Protozool, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Vanhollebeke, Benoit] Univ Libre Bruxelles, Inst Biol & Med Mol, B-6041 Gosselies, Belgium; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Changmai, Piya] Univ Ostrava, Fac Sci, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Institute of Tropical Medicine (ITM); Universite Libre de Bruxelles; Canadian Institute for Advanced Research (CIFAR); University of Ostrava	Lukes, J (corresponding author), Inst Parasitol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	jula@paru.cas.cz	Changmai, Piya/AAA-8208-2019; Sobotka, Roman/J-3077-2014; Horakova, Eva/G-9322-2014; Vancova, Marie/G-8347-2014; Horáková, Eva/AAD-9124-2021; Lukes, Julius/H-6760-2012	Sobotka, Roman/0000-0001-5909-3879; Vancova, Marie/0000-0003-0678-8268; Horáková, Eva/0000-0002-3730-8979; Lukes, Julius/0000-0002-0578-6618; Van Den Abbeele, Jan/0000-0002-4533-4480; Vanhollebeke, Benoit/0000-0002-0353-365X; Changmai, Piya/0000-0003-3307-0585	Czech Grant Agency [16-18699S]; Interuniversity Attraction Poles Programme, Belgian Science Policy	Czech Grant Agency(Grant Agency of the Czech Republic); Interuniversity Attraction Poles Programme, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Czech Grant Agency (16-18699S; to J. L.) and by the Interuniversity Attraction Poles Programme, Belgian Science Policy (to J. V. D. A. and B. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Cabello-Donayre M, 2016, MOL MICROBIOL, V101, P895, DOI 10.1111/mmi.13430; Campos-Salinas J, 2011, MOL MICROBIOL, V79, P1430, DOI 10.1111/j.1365-2958.2010.07531.x; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Changmai P, 2013, MOL MICROBIOL, V89, P135, DOI 10.1111/mmi.12264; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Ciccarelli A, 2007, PARASITOLOGY, V134, P959, DOI 10.1017/S0031182007002399; da Silva Augusto L., 2015, PLOS PATHOG, V11; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Dyer NA, 2013, TRENDS PARASITOL, V29, P188, DOI 10.1016/j.pt.2013.02.003; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; FERGUSON MAJ, 1988, PARASITE IMMUNOL, V10, P465, DOI 10.1111/j.1365-3024.1988.tb00236.x; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; HOUSEMAN JG, 1980, CAN J ZOOL, V58, P79, DOI 10.1139/z80-011; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Knusel S, 2013, MOL BIOCHEM PARASIT, V191, P66, DOI 10.1016/j.molbiopara.2013.09.004; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Lehane MJ., 2005, BIOL BLOODS INS 2 ED, DOI 10.1017/CBO9780511610493; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Merli ML, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004359; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Ooi Cher-Pheng, 2013, Front Cell Infect Microbiol, V3, P71, DOI 10.3389/fcimb.2013.00071; Pal JK, 2001, J BIOSCIENCE, V26, P225, DOI 10.1007/BF02703646; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Renberg RL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003804; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Sunter JD, 2015, J CELL SCI, V128, P3117, DOI 10.1242/jcs.171645; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Tripodi Karina E J, 2011, Enzyme Res, V2011, P873230, DOI 10.4061/2011/873230; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2010, EUKARYOT CELL, V9, P1272, DOI 10.1128/EC.00076-10; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wassell J, 2000, Clin Lab, V46, P547; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785	58	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6998	7010		10.1074/jbc.M116.762997	http://dx.doi.org/10.1074/jbc.M116.762997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28232490	Green Published, hybrid			2022-12-28	WOS:000400478300012
J	Tikhanovich, I; Zhao, J; Olson, J; Adams, A; Taylor, R; Bridges, B; Marshall, L; Roberts, B; Weinman, SA				Tikhanovich, Irina; Zhao, Jie; Olson, Jody; Adams, Abby; Taylor, Ryan; Bridges, Brian; Marshall, Laurie; Roberts, Benjamin; Weinman, Steven A.			Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor gamma-dependent macrophage differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; GENE-EXPRESSION; ALTERNATIVE ACTIVATION; C-MYC; METHYLATION; SEPSIS; PRMT1; MONOCYTES; TISSUE; CARM1	Arginine methylation is a common posttranslational modification that has been shown to regulate both gene expression and extranuclear signaling events. We recently reported defects in protein arginine methyltransferase 1 (PRMT1) activity and arginine methylation in the livers of cirrhosis patients with a history of recurrent infections. To examine the role of PRMT1 in innate immune responses in vivo, we created a cell type-specific knockout mouse model. We showed that myeloid-specific PRMT1 knock-out mice demonstrate higher proinflammatory cytokine production and a lower survival rate after cecal ligation and puncture. We found that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPAR gamma)-dependent M2 macrophage differentiation. PPAR gamma is one of the key transcription factors regulating macrophage polarization toward a more anti-inflammatory and pro-resolving phenotype. We found that PRMT1 knock-out macrophages failed to up-regulate PPAR gamma expression in response to IL4 treatment resulting in 4-fold lower PPAR gamma expression in knock-out cells than in wild-type cells. Detailed study of the mechanism revealed that PRMT1 regulates PPAR gamma gene expression through histone H4R3me2a methylation at the PPAR gamma promoter. Supplementing with PPAR gamma agonists rosiglitazone and GW1929 was sufficient to restore M2 differentiation in vivo and in vitro and abrogated the difference in survival between wild-type and PRMT1 knock-out mice. Taken together these data suggest that PRMT1-dependent regulation of macrophage PPAR gamma expression contributes to the infection susceptibility in PRMT1 knock-out mice.	[Tikhanovich, Irina; Zhao, Jie; Olson, Jody; Adams, Abby; Taylor, Ryan; Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA; [Bridges, Brian; Marshall, Laurie; Roberts, Benjamin; Weinman, Steven A.] Univ Kansas, Med Ctr, Liver Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Weinman, SA (corresponding author), Mailstop 1018, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Tikhanovich, Irina/GOK-0267-2022		National Institute on Alcoholism and Alcohol Abuse [AA012863]; COBRE Pilot Grant [NCRR/NIH P20 RR021940]; Pinnacle Research Award from AASLD; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); COBRE Pilot Grant; Pinnacle Research Award from AASLD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute on Alcoholism and Alcohol Abuse Grant AA012863, COBRE Pilot Grant NCRR/NIH P20 RR021940, and the 2016 Pinnacle Research Award from AASLD. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Antoniades CG, 2005, J HEPATOL, V42, P163, DOI 10.1016/j.jhep.2004.12.005; Aprelikova O, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0205-6; BAKER CC, 1983, SURGERY, V94, P331; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bernsmeier C, 2015, GASTROENTEROLOGY, V148, P603, DOI 10.1053/j.gastro.2014.11.045; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chittka A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013807; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Croasdell A, 2015, PPAR RES, V2015, DOI 10.1155/2015/549691; Davies John Q, 2005, Methods Mol Biol, V290, P91; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Jung UJ, 2012, ARTERIOSCL THROM VAS, V32, P2929, DOI 10.1161/ATVBAHA.112.300188; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Reddy A. T., 2016, PPAR RES, V2016; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Schleicher U, 2016, CELL REP, V15, P1062, DOI 10.1016/j.celrep.2016.04.001; Steiner JL, 2015, SHOCK, V43, P344, DOI 10.1097/SHK.0000000000000304; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tikhanovich I, 2015, HEPATOLOGY, V62, p846A; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Zingarelli B, 2005, SHOCK, V23, P393, DOI 10.1097/01.shk.0000160521.91363.88	43	45	48	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6882	6894		10.1074/jbc.M117.778761	http://dx.doi.org/10.1074/jbc.M117.778761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28330868	Green Published, hybrid			2022-12-28	WOS:000400478300003
J	Desrochers, G; Cappadocia, L; Lussier-Price, M; Ton, AT; Ayoubi, R; Serohijos, A; Omichinski, JG; Angers, A				Desrochers, Guillaume; Cappadocia, Laurent; Lussier-Price, Mathieu; Ton, Anh-Tien; Ayoubi, Riham; Serohijos, Adrian; Omichinski, James G.; Angers, Annie			Molecular basis of interactions between SH3 domain-containing proteins and the proline-rich region of the ubiquitin ligase Itch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING; PEPTIDE; RECOGNITION; ENDOPHILIN; SPECIFICITY; COMPLEXES; DIAGRAMS; AFFINITY; MOTIFS	The ligase Itch plays major roles in signaling pathways by inducing ubiquitylation-dependent degradation of several substrates. Substrate recognition and binding are critical for the regulation of this reaction. Like closely related ligases, Itch can interact with proteins containing a PPXY motif via its WW domains. In addition to these WW domains, Itch possesses a proline-rich region (PRR) that has been shown to interact with several Src homology 3 (SH3) domain-containing proteins. We have previously established that despite the apparent surface uniformity and conserved fold of SH3 domains, they display different binding mechanisms and affinities for their interaction with the PRR of Itch. Here, we attempt to determine the molecular bases underlying the wide range of binding properties of the Itch PRR. Using pulldown assays combined with mass spectrometry analysis, we show that the Itch PRR preferentially forms complexes with endophilins, amphyphisins, and pacsins but can also target a variety of other SH3 domain-containing proteins. In addition, we map the binding sites of these proteins using a combination of PRR sub-sequences and mutants. We find that different SH3 domains target distinct proline-rich sequences overlapping significantly. We also structurally analyze these protein complexes using crystallography and molecular modeling. These structures depict the position of Itch PRR engaged in a 1: 2 protein complex with beta-PIX and a 1:1 complex with the other SH3 domain-containing proteins. Taken together, these results reveal the binding preferences of the Itch PRR toward its most common SH3 domain-containing partners and demonstrate that the PRR region is sufficient for binding.	[Desrochers, Guillaume; Ayoubi, Riham; Angers, Annie] Univ Montreal, Dept Biol Sci, Montreal, PQ H3C 3J7, Canada; [Cappadocia, Laurent; Lussier-Price, Mathieu; Ton, Anh-Tien; Serohijos, Adrian; Omichinski, James G.] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Angers, A (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ H3C 3J7, Canada.	annie.angers@umontreal.ca	Angers, Annie/P-1217-2018	Angers, Annie/0000-0003-0131-256X; Cappadocia, Laurent/0000-0001-7348-1982; Serohijos, Adrian/0000-0001-8369-982X	Natural Sciences and Engineering Research Council of Canada (NSERC) [288238]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 288238 (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Baumann C, 2010, FEBS J, V277, P2803, DOI 10.1111/j.1742-4658.2010.07698.x; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Blott EJ, 2001, J CELL SCI, V114, P2405; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Desrochers G., 2013, ADV MED BIOL, V62, P177; Desrochers G, 2015, BIOCHEMISTRY-US, V54, P7345, DOI 10.1021/acs.biochem.5b01131; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fenyo D, 2010, METHODS MOL BIOL, V673, P189, DOI 10.1007/978-1-60761-842-3_11; Gay DL, 2008, IMMUNOL RES, V42, P51, DOI 10.1007/s12026-008-8034-0; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoelz A, 2006, J MOL BIOL, V358, P509, DOI 10.1016/j.jmb.2006.02.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janz JM, 2007, J BIOL CHEM, V282, P28893, DOI 10.1074/jbc.M702678200; Jozic D, 2005, NAT STRUCT MOL BIOL, V12, P972, DOI 10.1038/nsmb1000; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelil A, 2016, P NATL ACAD SCI USA, V113, pE3862, DOI 10.1073/pnas.1518469113; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Martin-Garcia JM, 2012, ACTA CRYSTALLOGR D, V68, P1030, DOI 10.1107/S0907444912019798; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wuertenberger S, 2015, FEBS LETT, V589, P1156, DOI 10.1016/j.febslet.2015.03.014; Zucconi A, 2001, J MOL BIOL, V307, P1329, DOI 10.1006/jmbi.2001.4572	46	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6325	6338		10.1074/jbc.M116.754440	http://dx.doi.org/10.1074/jbc.M116.754440			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28235806	hybrid, Green Published			2022-12-28	WOS:000399538700026
J	Wen, Y; Liao, G; Pritchard, T; Zhao, TT; Connelly, JP; Pruett-Miller, SM; Blanc, V; Davidson, NO; Madison, BB				Wen, Yahong; Liao, Grace; Pritchard, Thomas; Zhao, Ting-Ting; Connelly, Jon P.; Pruett-Miller, Shondra M.; Blanc, Valerie; Davidson, Nicholas O.; Madison, Blair B.			A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE-INDUCED MUTATIONS; HUMAN GENOME; HUMAN-CELLS; PIGGYBAC TRANSPOSASE; MOUSE GENOME; CRISPR-CAS9; GENES; ENRICHMENT; SYSTEMS; CAS9	The discovery and application of CRISPR/Cas9 technology for genome editing has greatly accelerated targeted mutagenesis in a variety of organisms. CRISPR/Cas9-mediated site-specific cleavage is typically exploited for the generation of insertions or deletions (indels) after aberrant dsDNA repair via the endogenous non-homology end-joining (NHEJ) pathway or, alternatively, for enhancing homology-directed repair to facilitate the generation of a specific mutation (or "knock-in"). However, there is a need for efficient cellular assays that can measure Cas9/guide RNA activity. Reliable methods for enriching and identifying desired mutants are also lacking. Here we describe a method using the Piggybac transposon for stable genomic integration of an H2B-GFP reporter or a hygromycin resistance gene for assaying Cas9 target cleavage and homology-directed repair. The H2B-GFP fusion protein provides increased stability and an obvious pattern of nuclear localization. This method, called SRIRACCHA (i.e. a (s) under bar table, but (r) under bar eversible, (i) under bar ntegrated (r) under bar eporter for (a) under bar ssaying (C) under bar RISPR/(c) under bar as-stimulated (H) under bar DR (a) under bar ctivity), enables the enrichment of mutants via selection of GFP-positive or hygromycin-resistant mammalian cells (immortalized or non-immortalized) as a surrogate for the modification of the endogenous target site. Currently available hyperactive Piggybac transposase mutants allow both delivery and removal of the surrogate reporters, with minimal risk of generating undesirable mutations. This assay permits rapid screening for efficient guide RNAs and the accelerated identification of mutant clones and is applicable to many cell types. We foresee the utility of this approach in contexts in which the maintenance of genomic integrity is essential, for example, when engineering cells for therapeutic purposes.	[Wen, Yahong; Liao, Grace; Pritchard, Thomas; Blanc, Valerie; Davidson, Nicholas O.; Madison, Blair B.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Connelly, Jon P.; Pruett-Miller, Shondra M.] Washington Univ, Dept Genet, GEiC, St Louis, MO 63110 USA; [Zhao, Ting-Ting] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); China Medical University	Madison, BB (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gastroenterol, 923 CSRB NTA,660 S Euclid Blvd, St Louis, MO 63110 USA.	bmadison@wustl.edu	Pruett-Miller, Shondra M./M-9414-2018	Pruett-Miller, Shondra M./0000-0002-3793-585X	National Institutes of Health [K01 DK093885, R03 DK108764, P30 DK052574]; Cancer Research Foundation Young Investigator Award; Siteman Investment Program at the Siteman Cancer Center; Digestive Disease Research Core Center (ARAC and Murine Cores); NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180, R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, R03DK108764, P30DK052574, K01DK093885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Foundation Young Investigator Award; Siteman Investment Program at the Siteman Cancer Center; Digestive Disease Research Core Center (ARAC and Murine Cores); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants K01 DK093885, R03 DK108764, and P30 DK052574 Pilot (to B. B. M.) and HL-38180, DK-56260, and DK-52574 (to N. O. D.). This work was also supported by a Cancer Research Foundation Young Investigator Award and the Siteman Investment Program at the Siteman Cancer Center (to B. B. M.) and by the Digestive Disease Research Core Center (ARAC and Murine Cores) (to N. O. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; He ZY, 2016, J BIOTECHNOL, V221, P49, DOI 10.1016/j.jbiotec.2016.01.009; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Madison BB, 2013, GENE DEV, V27, P2233, DOI 10.1101/gad.224659.113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; Rulten SL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600209; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Schwank G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076871; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang YM, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5564, 10.1038/ncomms6110]; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	61	8	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6148	6162		10.1074/jbc.M117.777722	http://dx.doi.org/10.1074/jbc.M117.777722			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28228480	Green Published, hybrid			2022-12-28	WOS:000399538700012
J	Pomowski, A; Uson, I; Nowakowska, Z; Veillard, F; Sztukowska, MN; Guevara, T; Goulas, T; Mizgalska, D; Nowak, M; Potempa, B; Huntington, JA; Potempa, J; Gomis-Ruth, FX				Pomowski, Anja; Uson, Isabel; Nowakowska, Zuzanna; Veillard, Florian; Sztukowska, Maryta N.; Guevara, Tibisay; Goulas, Theodoros; Mizgalska, Danuta; Nowak, Magdalena; Potempa, Barbara; Huntington, James A.; Potempa, Jan; Gomis-Rueth, F. Xavier			Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from Porphyromonas gingivalis, a causative agent of gum disease from the human oral microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; protein crystallization; protein degradation; protein domain; protein structure; proteinase; X-ray crystal structure; host-microbiome interaction; oral microbiota; zymogenic latency	IX SECRETION SYSTEM; STRUCTURE VALIDATION; GLIDING MOTILITY; BACTERIAL; PROTEINS; RGPB; ACTIVATION; REFINEMENT; MOLPROBITY; COMPONENT	Skewing of the human oral microbiome causes dysbiosis and preponderance of bacteria such as Porphyromonas gingivalis, the main etiological agent of periodontitis. P. gingivalis secretes proteolytic gingipains (Kgp and RgpA/B) as zymogens inhibited by a pro-domain that is removed during extracellular activation. Unraveling the molecular mechanism of Kgp zymogenicity is essential to design inhibitors blocking its activity. Here, we found that the isolated 209-residue Kgp pro-domain is a boomerang-shaped all- protein similar to the RgpB pro-domain. Using composite structural information of Kgp and RgpB, we derived a plausible homology model and mechanism of Kgp-regulating zymogenicity. Accordingly, the pro-domain would laterally attach to the catalytic moiety in Kgp and block the active site through an exposed inhibitory loop. This loop features a lysine (Lys(129)) likely occupying the S-1 specificity pocket and exerting latency. Lys(129) mutation to glutamate or arginine led to misfolded protein that was degraded in vivo. Mutation to alanine gave milder effects but still strongly diminished proteolytic activity, without affecting the subcellular location of the enzyme. Accordingly, the interactions of Lys(129) within the S-1 pocket are also essential for correct folding. Uniquely for gingipains, the isolated Kgp pro-domain dimerized through an interface, which partially overlapped with that between the catalytic moiety and the pro-domain within the zymogen, i.e. both complexes are mutually exclusive. Thus, pro-domain dimerization, together with partial rearrangement of the active site upon activation, explains the lack of inhibition of the pro-domain in trans. Our results reveal that the specific latency mechanism of Kgp differs from those of Rgps.	[Pomowski, Anja; Huntington, James A.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Uson, Isabel; Guevara, Tibisay; Goulas, Theodoros; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, Barcelona 08010, Catalonia, Spain; [Uson, Isabel; Guevara, Tibisay; Goulas, Theodoros; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Crystallog Methods Lab,Struct Biol Unit, Barcelona 08010, Catalonia, Spain; [Uson, Isabel] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain; [Nowakowska, Zuzanna; Mizgalska, Danuta; Nowak, Magdalena; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Veillard, Florian; Sztukowska, Maryta N.; Potempa, Barbara; Potempa, Jan] Univ Louisville, Dept Oral Immunol & Infect Dis, Sch Dent, Louisville, KY 40202 USA; [Veillard, Florian] CNRS, Inst Biol Mol & Cellulaire, URP9022, Strasbourg, France	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Jagiellonian University; University of Louisville; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Crystallog Methods Lab,Struct Biol Unit, Barcelona 08010, Catalonia, Spain.; Potempa, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland.; Potempa, J (corresponding author), Univ Louisville, Dept Oral Immunol & Infect Dis, Sch Dent, Louisville, KY 40202 USA.	jan.potempa@louisville.edu; fxgr@ibmb.csic.es	Potempa, Jan/AAA-6850-2021; Goulas, Theodoros/H-1951-2015; Nowak, Magdalena/HGB-7801-2022	Goulas, Theodoros/0000-0002-6938-5493; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Potempa, Jan/0000-0002-3600-7461; Nowakowska, Zuzanna/0000-0003-2848-7538; Veillard, Florian/0000-0003-1248-2396	"TRIGGER" from the Seventh Framework Programme [FP7-HEALTH-2012-306029-2]; Spanish Ministerio de Economia y Competitividad [BFU2015-64487R, MDM-2014-0435, BIO2013-49320-EXP, BIO2015-64216-P, BIO2013-49604-EXP]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014SGR9]; Polish Ministerstwo Nauki i Szkolnictwa Wyzszego [0218/DIA/2012/41]; Diamond Light Source; Ministry of Science and Higher Education; ICREA Funding Source: Custom	"TRIGGER" from the Seventh Framework Programme; Spanish Ministerio de Economia y Competitividad(Spanish Government); Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); Polish Ministerstwo Nauki i Szkolnictwa Wyzszego; Diamond Light Source; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); ICREA(ICREA)	This work was supported in part by Grant FP7-HEALTH-2012-306029-2 "TRIGGER" from the Seventh Framework Programme; Grants BFU2015-64487R, MDM-2014-0435, BIO2013-49320-EXP, BIO2015-64216-P, and BIO2013-49604-EXP from the Spanish Ministerio de Economia y Competitividad; Grant 2014SGR9 from the Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya; and Diamentowy Grant 0218/DIA/2012/41 from the Polish Ministerstwo Nauki i Szkolnictwa Wyzszego. The Structural Biology Unit of Molecular Biology Institute of Barcelona (IBMB) is a "Maria de Maeztu" Unit of Excellence from the Spanish Ministry of Economy, Innovation and Competitiveness. Funding for travelling and synchrotron data collection was provided in part by Diamond Light Source. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education. The authors declare that they have no conflicts of interest with the contents of this article.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BICKEL M, 1985, J DENT RES, V64, P1218, DOI 10.1177/00220345850640100801; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Diego I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23123; de Diego I, 2014, J BIOL CHEM, V289, P32291, DOI 10.1074/jbc.M114.602052; de Diego I, 2013, J BIOL CHEM, V288, P14287, DOI 10.1074/jbc.M112.444927; De La Fuente C, 2013, ARCHAEOMETRY, V55, DOI 10.1111/j.1475-4754.2012.00707.x; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubin G, 2013, CURR PHARM DESIGN, V19, P1090, DOI 10.2174/13816128130611; Eloe-Fadrosh EA, 2013, ANNU REV MED, V64, P145, DOI 10.1146/annurev-med-010312-133513; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Guentsch A, 2011, J PERIODONTOL, V82, P1051, DOI 10.1902/jop.2011.100565; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; HOLZER H, 1980, ANNU REV BIOCHEM, V49, P63, DOI 10.1146/annurev.bi.49.070180.000431; How KY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00053; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kataoka S, 2014, FASEB J, V28, P3564, DOI 10.1096/fj.14-252130; Khan AR, 1998, PROTEIN SCI, V7, P815; Kharade SS, 2015, J BACTERIOL, V197, P147, DOI 10.1128/JB.02085-14; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lasica AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37708; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Maixner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099994; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Mittl PRE, 2006, CURR OPIN STRUC BIOL, V16, P769, DOI 10.1016/j.sbi.2006.10.014; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pathirana RD, 2007, INFECT IMMUN, V75, P1436, DOI 10.1128/IAI.01627-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pike RN, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2337, DOI 10.1016/B978-0-12-382219-2.00521-4; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Potempa Jan, 2005, V12, P132, DOI 10.1159/000081693; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Sheldrick G. M., 2011, INT TABLES CRYSTALLO, P413; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Subramanian S, 2015, CELL, V161, P36, DOI 10.1016/j.cell.2015.03.013; Tang YQ, 2011, ADV EXP MED BIOL, V712, P15, DOI 10.1007/978-1-4419-8414-2_2; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Veillard F, 2013, BBA-GEN SUBJECTS, V1830, P4218, DOI 10.1016/j.bbagen.2013.04.005; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x	64	7	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5724	5735		10.1074/jbc.M117.776724	http://dx.doi.org/10.1074/jbc.M117.776724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196869	Green Published, hybrid			2022-12-28	WOS:000398813200010
J	Qi, J; Lee, HJ; Saquet, A; Cheng, XN; Shao, M; Zheng, JJ; Shi, DL				Qi, Jing; Lee, Ho-Jin; Saquet, Audrey; Cheng, Xiao-Ning; Shao, Ming; Zheng, Jie J.; Shi, De-Li			Autoinhibition of Dishevelled protein regulated by its extreme C terminus plays a distinct role in Wnt/-catenin and Wnt/planar cell polarity (PCP) signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PDZ domain; signal transduction; structural biology; Wnt pathway; Wnt signaling	CONVERGENT EXTENSION MOVEMENTS; DEP DOMAIN; SUBCELLULAR-LOCALIZATION; VERTEBRATE EMBRYOS; PLANAR POLARITY; CORECEPTOR LRP6; XENOPUS-LAEVIS; AXIS FORMATION; BETA-CATENIN; PHOSPHORYLATION	Dishevelled (Dvl) is a key intracellular signaling molecule that mediates the activation of divergent Wnt pathways. It contains three highly conserved domains known as DIX, PDZ, and DEP, the functions of which have been well characterized in -catenin-dependent canonical and -catenin-independent noncanonical Wnt signaling. The C-terminal region is also highly conserved from invertebrates to vertebrates. However, its function in regulating the activation of different Wnt signals remains unclear. We reported previously that Dvl conformational change triggered by the highly conserved PDZ-binding C terminus is important for the pathway specificity. Here we provide further evidence demonstrating that binding of the C terminus to the PDZ domain results in Dvl autoinhibition in the Wnt signaling pathways. Therefore, the forced binding of the C terminus to the PDZ domain reduces the activity of Dvl in noncanonical Wnt signaling, whereas obstruction of this interaction releases Dvl autoinhibition, impairs its functional interaction with LRP6 in canonical Wnt signaling, and increases its specificity in noncanonical Wnt signaling, which is closely correlated with an enhanced Dvl membrane localization. Our findings highlight the importance of the C terminus in keeping Dvl in an appropriate autoinhibited state, accessible for regulation by other partners to switch pathway specificity. Particularly, the C-terminally tagged Dvl fusion proteins that have been widely used to study the function and cellular localization of Dvl may not truly represent the wild-type Dvl because those proteins cannot be autoinhibited.	[Qi, Jing; Cheng, Xiao-Ning; Shao, Ming; Shi, De-Li] Shandong Univ, Sch Life Sci, 27 Shanda Nan Rd, Jinan 250100, Peoples R China; [Lee, Ho-Jin; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zheng, Jie J.] Univ Calif Los Angeles, Dept Ophthalmol, Stein Eye Inst, David Geffen Sch Med, 100 Stein Plaza, Los Angeles, CA 90095 USA; [Zheng, Jie J.] Univ Calif Los Angeles, Inst Mol Biol, 100 Stein Plaza, Los Angeles, CA 90095 USA; [Qi, Jing] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Jinan 250100, Peoples R China; [Saquet, Audrey; Shi, De-Li] Univ Paris 06, Sorbonne Univ,UPMC, CNRS,UMR7622, IBPS,Dev Biol Lab, F-75005 Paris, France	Shandong University; St Jude Children's Research Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Shandong Academy of Agricultural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Zheng, JJ (corresponding author), Univ Calif Los Angeles, Dept Ophthalmol, Stein Eye Inst, David Geffen Sch Med, 100 Stein Plaza, Los Angeles, CA 90095 USA.; Shi, DL (corresponding author), IBPS Dev Biol Lab, 9 Quai St Bernard, F-75005 Paris, France.	jzheng@jsei.ucla.edu; de-li.shi@upmc.fr	xiaoning, cheng/AAD-5771-2019; Shi, De-Li/AAG-1807-2021; Lee, Ho-Jin/N-1973-2015; Shao, Ming/AAZ-8099-2021; Lee, Ho-Jin/O-9944-2014	Lee, Ho-Jin/0000-0002-3251-4984; Zheng, Jie/0000-0001-6524-6800	Shandong University from the National Natural Science Foundation of China [31271556, 31471360, 31671509]; Shandong University from the Department of Science and Technology of Shandong Province [2015GSF118158]; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC Paris); National Institutes of Health [GM100909]; Research to Prevent Blindness; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100909, R01GM061739] Funding Source: NIH RePORTER	Shandong University from the National Natural Science Foundation of China; Shandong University from the Department of Science and Technology of Shandong Province; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC Paris); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Shandong University, Grants 31271556, 31471360, and 31671509 from the National Natural Science Foundation of China, Grant 2015GSF118158 from the Department of Science and Technology of Shandong Province, and by the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC Paris). This work was also supported by National Institutes of Health Grant GM100909 and by Research to Prevent Blindness (to J. J. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cao JM, 2012, MECH DEVELOP, V129, P263, DOI 10.1016/j.mod.2012.07.001; Cao JM, 2014, J GENET GENOMICS, V41, P417, DOI 10.1016/j.jgg.2014.06.008; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Carreira-Barbosa F, 2009, DEVELOPMENT, V136, P383, DOI 10.1242/dev.026542; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; He X, 2006, DEVELOPMENT, V133, P2597, DOI 10.1242/dev.02452; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee H. J., 2015, ELIFE, V4; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li HY, 2013, DEVELOPMENT, V140, P4903, DOI 10.1242/dev.098319; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma Li, 2010, J Mol Signal, V5, P19, DOI 10.1186/1750-2187-5-19; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Mlodzik M, 2016, CURR TOP DEV BIOL, V117, P75, DOI 10.1016/bs.ctdb.2015.11.027; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Shao M, 2009, DEVELOPMENT, V136, P2121, DOI 10.1242/dev.032649; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Singh J, 2012, WIRES DEV BIOL, V1, P479, DOI 10.1002/wdev.32; Singh J, 2010, GENE DEV, V24, P2157, DOI 10.1101/gad.1961010; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang HY, 2012, ACTA PHYSIOL, V204, P65, DOI 10.1111/j.1748-1716.2011.02291.x; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Weitzel HE, 2004, DEVELOPMENT, V131, P2947, DOI 10.1242/dev.01152; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	61	15	16	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5898	5908		10.1074/jbc.M116.772509	http://dx.doi.org/10.1074/jbc.M116.772509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223363	Green Published, hybrid			2022-12-28	WOS:000398813200024
J	Chu, Q; Sun, YN; Cui, JX; Xu, TJ				Chu, Qing; Sun, Yuena; Cui, Junxia; Xu, Tianjun			Inducible microRNA-214 contributes to the suppression of NF-kappa B-mediated inflammatory response via targeting myd88 gene in fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; MIIUY CROAKER; NEGATIVE REGULATION; SIGNALING PATHWAY; INNATE IMMUNITY; TLR; EXPRESSION; IKK; ACTIVATION	Upon recognition of bacterial pathogens by pattern recognition receptors, cells are activated to produce pro-inflammatory cytokines and type I IFN by multiple signaling pathways. Every step of the process must be precisely regulated to prevent dysregulation. MicroRNAs (miRNAs) have been shown to be important regulators with profound effects on inflammatory response. Nevertheless, the miRNA-mediated regulatory mechanism remains unclear in fish species. Here, we addressed the role of miiuy croaker miR-214 in the bacteria triggered inflammatory response. miR-214 could significantly be up-regulated by Vibro harveyi and LPS stimulation. Up-regulating miR-214 subsequently inhibits the production of inflammatory cytokines by targeting myd88 to avoid excessive inflammation. Moreover, the negative regulatory mechanism of miR-214 has been demonstrated to be via the myd88-mediated NF-kappa B pathway. This is the first to focus on miR-214 acting as the negative regulator involved in the bacteria-triggered inflammatory response and thus may provide knowledge on the host-cell regulator responses to microbial infection.	[Chu, Qing; Sun, Yuena; Cui, Junxia; Xu, Tianjun] Zhejiang Ocean Univ, Lab Fish Biogenet & Immune Evolut, Coll Marine Sci, Zhoushan 316022, Peoples R China	Zhejiang Ocean University	Xu, TJ (corresponding author), Zhejiang Ocean Univ, Lab Fish Biogenet & Immune Evolut, Coll Marine Sci, Zhoushan 316022, Peoples R China.	tianjunxu@163.com	Xia, Cui/AAA-2699-2022		National Natural Science Foundation of China [31370049, 31672682]; Natural Science Foundation of Zhejiang Province [LR14C040001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grants 31370049 and 31672682 and Natural Science Foundation of Zhejiang Province Grant LR14C040001. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Che RB, 2014, FISH SHELLFISH IMMUN, V41, P163, DOI 10.1016/j.fsi.2014.08.025; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chu Q, 2017, DEV COMP IMMUNOL, V67, P117, DOI 10.1016/j.dci.2016.11.004; Chu Q, 2015, FISH SHELLFISH IMMUN, V47, P168, DOI 10.1016/j.fsi.2015.08.032; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo HY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-77; He XB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945169; Heikham R, 2010, J BIOSCIENCES, V35, P105, DOI 10.1007/s12038-010-0013-7; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Koziczak-Holbro M, 2008, EUR J IMMUNOL, V38, P788, DOI 10.1002/eji.200737886; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lang CH, 2003, SHOCK, V19, P538, DOI 10.1097/01.shk.0000055237.25446.80; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Liu YH, 2010, J IMMUNOL, V185, P3391, DOI 10.4049/jimmunol.0903147; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rebl A, 2011, DEV COMP IMMUNOL, V35, P81, DOI 10.1016/j.dci.2010.08.012; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21902	43	56	59	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5282	5290		10.1074/jbc.M117.777078	http://dx.doi.org/10.1074/jbc.M117.777078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28235799	Green Published, hybrid			2022-12-28	WOS:000397875500012
J	Han, YB; Chen, LQ; Li, Z; Tan, YM; Feng, Y; Yang, GY				Han, Yun-Bin; Chen, Liu-Qing; Li, Zhuo; Tan, Yu-Meng; Feng, Yan; Yang, Guang-Yu			Structural Insights into the Broad Substrate Specificity of a Novel Endoglycoceramidase I Belonging to a New Subfamily of GH5 Glycosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CERAMIDE-GLYCANASE; CRYPTOCOCCUS-NEOFORMANS; CRYSTAL-STRUCTURE; PROTEIN; GLYCOSPHINGOLIPIDS; PURIFICATION; OLIGOSACCHARIDE; XYLOGLUCAN; VALIDATION	Endoglycoceramidases (EGCases) specifically hydrolyze the glycosidic linkage between the oligosaccharide and the ceramide moieties of various glycosphingolipids, and they have received substantial attention in the emerging field of glycosphingolipidology. However, the mechanism regulating the strict substrate specificity of these GH5 glycosidases has not been identified. In this study, we report a novel EGCase I from Rhodococcus equi 103S (103S_ EGCase I) with remarkably broad substrate specificity. Based on phylogenetic analyses, the enzyme may represent a new subfamily of GH5 glycosidases. The X-ray crystal structures of 103S_ EGCase I alone and in complex with its substrates monosialodihexosylganglioside (GM3) and monosialotetrahexosylganglioside (GM1) enabled us to identify several structural features that may account for its broad specificity. Compared with EGCase II from Rhodococcus sp. M-777 (M777_ EGCase II), which possesses strict substrate specificity, 103S_ EGCase I possesses a longer alpha 7-helix and a shorter loop 4, which forms a larger substrate-binding pocket that could accommodate more extended oligosaccharides. In addition, loop 2 and loop 8 of the enzyme adopt a more open conformation, which also enlarges the oligosaccharide-binding cavity. Based on this knowledge, a rationally designed experiment was performed to examine the substrate specificity of EGCase II. The truncation of loop 4 in M777_ EGCase II increased its activity toward GM1 (163%). Remarkably, the S63G mutant of M777_ EGCase II showed a broader substrate spectra and significantly increased activity toward bulky substrates (up to > 1370-fold for fucosyl-GM1). Collectively, the results presented here reveal the exquisite substrate recognitionmechanismofEGCasesandprovideanopportunityfor further engineering of these enzymes.	[Han, Yun-Bin; Chen, Liu-Qing; Li, Zhuo; Tan, Yu-Meng; Feng, Yan; Yang, Guang-Yu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Han, Yun-Bin] ShanghaiTech Univ, Shanghai Inst Adv Immunol Studies, Shanghai 200031, Peoples R China; [Yang, Guang-Yu] East China Univ Sci & Technol, Shanghai Collaborat Innovat Ctr Biomfg, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; ShanghaiTech University; East China University of Science & Technology	Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yanggy@sjtu.edu.cn		Chen, Liuqing/0000-0002-2104-3697	National Basic Research Program of China [2012CB721003]; Natural Science Foundation of China [31470788, 11371142]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2012CB721003) and Natural Science Foundation of China Grants 31470788 and 11371142. The authors declare that they have no conflicts of interest with the contents of this article.	ASHIDA H, 1992, EUR J BIOCHEM, V205, P729, DOI 10.1111/j.1432-1033.1992.tb16836.x; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BASU SS, 1994, ANAL BIOCHEM, V222, P270, DOI 10.1006/abio.1994.1484; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Caines MEC, 2007, J BIOL CHEM, V282, P14300, DOI 10.1074/jbc.M611455200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2011, J BIOL CHEM, V286, P22510, DOI 10.1074/jbc.M110.217315; D'Arcy A, 2014, ACTA CRYSTALLOGR F, V70, P1117, DOI 10.1107/S2053230X14015507; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujitani N, 2011, J BIOL CHEM, V286, P41669, DOI 10.1074/jbc.M111.301796; Furukawa J, 2015, J LIPID RES, V56, P2399, DOI 10.1194/jlr.D062083; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horibata Y, 2004, J BIOL CHEM, V279, P33379, DOI 10.1074/jbc.M401460200; Horibata Y, 2000, J BIOL CHEM, V275, P31297, DOI 10.1074/jbc.M003575200; Ishibashi Y, 2007, J BIOL CHEM, V282, P11386, DOI 10.1074/jbc.M608445200; Ishibashi Y, 2012, J LIPID RES, V53, P2242, DOI 10.1194/jlr.D028951; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; ITO M, 1986, J BIOL CHEM, V261, P14278; ITO M, 1989, J BIOL CHEM, V264, P9510; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; LI SC, 1986, BIOCHEM BIOPH RES CO, V141, P346, DOI 10.1016/S0006-291X(86)80375-8; LI YT, 1987, BIOCHEM BIOPH RES CO, V149, P167, DOI 10.1016/0006-291X(87)91619-6; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Watanabe T, 2015, J BIOL CHEM, V290, P1005, DOI 10.1074/jbc.M114.616300; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	43	36	38	2	41	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4789	4800		10.1074/jbc.M116.763821	http://dx.doi.org/10.1074/jbc.M116.763821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28179425	hybrid, Green Published			2022-12-28	WOS:000397590400004
J	Nagalingam, RS; Sundaresan, NR; Gupta, MP; Geenen, DL; Solaro, RJ; Gupta, M				Nagalingam, Raghu S.; Sundaresan, Nagalingam R.; Gupta, Mahesh P.; Geenen, David L.; Solaro, R. John; Gupta, Madhu			RETRACTION: A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. (Retraction of Vol 288, Pg 11216, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Gupta, Madhu/E-7705-2019	Gupta, Madhu/0000-0002-8503-0609				NAGALINGAM RS, 2013, CARDIAC ENRICHED MIC, V288, P11216	1	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5123	5123		10.1074/jbc.A112.442384	http://dx.doi.org/10.1074/jbc.A112.442384			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28341711	Green Published, hybrid			2022-12-28	WOS:000397590400031
J	Aykul, S; Parenti, A; Chu, KY; Reske, J; Floer, M; Ralston, A; Martinez-Hackert, E				Aykul, Senem; Parenti, Anthony; Chu, Kit Yee; Reske, Jake; Floer, Monique; Ralston, Amy; Martinez-Hackert, Erik			Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; REPULSIVE GUIDANCE MOLECULE; LEFT-RIGHT AXIS; EGF-CFC FAMILY; TGF-BETA; VERTEBRATE DEVELOPMENT; SIGNALING PATHWAY; COLORECTAL-CANCER; VISCERAL ENDODERM; MOUSE EMBRYO	Transforming growth factor beta (TGF-beta) pathways are key determinants of cell fate in animals. Their basic mechanism of action is simple. However, to produce cell-specific responses, TGF-beta pathways are heavily regulated by secondary factors, such as membrane-associated EGF-CFC family proteins. Cellular activities of EGF-CFC proteins have been described, but their molecular functions, including how the mammalian homologs Cripto-1 and Cryptic recognize and regulate TGF-beta family ligands, are less clear. Here we use purified human Cripto-1 and mouse Cryptic produced in mammalian cells to show that these two EGF-CFC homologs have distinct, highly specific ligand binding activities. Cripto-1 interacts with BMP-4 in addition to its known partner Nodal, whereas Cryptic interacts only with Activin B. These interactions depend on the integrity of the protein, as truncated or deglycosylated Cripto-1 lacked BMP-4 binding activity. Significantly, Cripto-1 and Cryptic blocked binding of their cognate ligands to type I and type II TGF-beta receptors, indicating that Cripto-1 and Cryptic contact ligands at their receptor interaction surfaces and, thus, that they could inhibit their ligands. Indeed, soluble Cripto-1 and Cryptic inhibited ligand signaling in various cell-based assays, including SMAD-mediated luciferase reporter gene expression, and differentiation of a multipotent stem cell line. But in agreement with previous work, the membrane bound form of Cripto-1 potentiated signaling, revealing a critical role of membrane association for its established cellular activity. Thus, our studies provide new insights into the mechanism of ligand recognition by this enigmatic family of membrane-anchored TGF-beta family signaling regulators and link membrane association with their signal potentiating activities.	[Aykul, Senem; Parenti, Anthony; Chu, Kit Yee; Reske, Jake; Floer, Monique; Ralston, Amy; Martinez-Hackert, Erik] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Martinez-Hackert, E (corresponding author), Rm 509,603 Wilson Rd, E Lansing, MI 48824 USA.	emh@msu.edu		Martinez-Hackert, Erik/0000-0002-6182-7023; AYKUL, SENEM/0000-0001-7250-2913; Ralston, Amy/0000-0003-3755-8262	Michigan State University; Clinical and Translational Sciences Institute; National Institutes of Health [R41 AR068804, R43 CA203180, R01 GM104009]; NATIONAL CANCER INSTITUTE [R43CA203180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104009] Funding Source: NIH RePORTER	Michigan State University; Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Michigan State University, the Clinical and Translational Sciences Institute, and National Institutes of Health Grants R41 AR068804, R43 CA203180, and R01 GM104009 (to A. R.). S. A., E. M. H., and Michigan State University have filed a patent application on the use of Cripto-1/Cryptic as inhibitors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Artus J, 2012, DEV BIOL, V361, P245, DOI 10.1016/j.ydbio.2011.10.015; Aykul S, 2016, ANAL BIOCHEM, V508, P97, DOI 10.1016/j.ab.2016.06.025; Aykul S, 2016, J BIOL CHEM, V291, P10792, DOI 10.1074/jbc.M115.713487; Aykul S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114954; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bianco C, 2003, CANCER RES, V63, P1192; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blanchet MH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1165027; Calvanese L, 2010, BIOPOLYMERS, V93, P1011, DOI 10.1002/bip.21517; Calvanese L, 2009, J PEPT SCI, V15, P175, DOI 10.1002/psc.1091; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Francescangeli F, 2015, CELL DEATH DIFFER, V22, P1700, DOI 10.1038/cdd.2015.19; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gjidoda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093971; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Liguori GL, 2008, DEV BIOL, V315, P280, DOI 10.1016/j.ydbio.2007.12.027; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Miyoshi N, 2010, INT J ONCOL, V36, P563, DOI 10.3892/ijo_00000530; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; Nagaoka T, 2013, CELL SIGNAL, V25, P178, DOI 10.1016/j.cellsig.2012.09.024; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; Parenti A, 2016, STEM CELL REP, V6, P447, DOI 10.1016/j.stemcr.2016.02.003; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 1997, DEVELOPMENT, V124, P429; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Watanabe K, 2007, J BIOL CHEM, V282, P35772, DOI 10.1074/jbc.M707351200; Watanabe K, 2007, J BIOL CHEM, V282, P31643, DOI 10.1074/jbc.M702713200; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Xu CH, 1999, DEVELOPMENT, V126, P483; Xu CH, 2014, TUMOR BIOL, V35, P8673, DOI 10.1007/s13277-014-2039-1; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	67	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	10					4138	4151		10.1074/jbc.M116.747501	http://dx.doi.org/10.1074/jbc.M116.747501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ4GV	28126904	hybrid, Green Published			2022-12-28	WOS:000404672500002
J	Bu, PL; Le, Y; Zhang, Y; Zhang, YC; Cheng, XG				Bu, Pengli; Le, Yuan; Zhang, Yue; Zhang, Youcai; Cheng, Xingguo			Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B; COTRANSPORTING POLYPEPTIDE; GENE-EXPRESSION; D VIRUSES; LIVER; PROLACTIN; ABSORPTION; ENTRY; RATS; NTCP	Sodium-taurocholate co-transporting polypeptide (Ntcp/NTCP) is the major uptake transporter of bile salts in mouse and human livers. In certain diseases, including endotoxemia, cholestasis, diabetes, and hepatocarcinoma, Ntcp/NTCP expression is markedly reduced, which interferes with enterohepatic circulation of bile salts, impairing the absorption of lipophilic compounds. Therefore, normal Ntcp/NTCP expression in the liver is physiologically important. Berberine is an herbal medicine used historically to improve liver function and has recently been shown to repress STAT signaling. However, berberine effects on Ntcp/NTCP expression are unknown, prompting use to investigate this possible connection. Our results showed that berberine dose-dependently increased Ntcp expression in male mouse liver and decreased taurocholic acid levels in serum but increased them in the liver. In mouse and human hepatoma cells, berberine induced Ntcp/NTCP mRNA and protein expression and increased cellular uptake of [3H] taurocholate. Mechanistically, berberine decreased nuclear protein levels of phospho-JAK2 and phospho-STAT5, thus disrupting the JAK2-STAT5 signaling. Moreover, berberine stimulated luciferase reporter expression from the mouse Ntcp promoter when one putative STAT5 response element (RE) (-1137 bp) was deleted and from the human NTCP promoter when three putative STAT5REs (-2898, -2164, and -691 bp) were deleted. Chromatin immunoprecipitation demonstrated that berberine decreased binding of phospho-STAT5 protein to the -2164 and -691 bp STAT5REs in the human NTCP promoter. In summary, berberine-disrupted STAT5 signaling promoted mouse and human Ntcp/NTCP expression, resulting in enhanced bile acid uptake. Therefore, berberine may be a therapeutic candidate compound for maintaining bile acid homeostasis.	[Bu, Pengli; Le, Yuan; Zhang, Yue; Cheng, Xingguo] St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA; [Bu, Pengli] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA; [Zhang, Yue] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China	Saint John's University; Saint John's University; Tianjin University	Cheng, XG (corresponding author), St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA.	chengx@stjohns.edu	Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; Zhang, Yue/0000-0002-1161-0141	St. John's University	St. John's University	This work is supported in part by internal research funds including the new faculty start fund and a seed grant (to X. C.) from St. John's University. The authors declare that they have no conflicts of interest with the contents of this article.	Abd El-Wahab Abeer E, 2013, BMC Complement Altern Med, V13, P218, DOI 10.1186/1472-6882-13-218; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; Bollard J, 2017, GUT, V66, P1286, DOI 10.1136/gutjnl-2016-312268; Cao JS, 2001, ENDOCRINOLOGY, V142, P4212, DOI 10.1210/en.142.10.4212; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; GANGULY T, 1993, J PHARMACOL EXP THER, V267, P82; Ganguly TC, 1997, J CLIN INVEST, V99, P2906, DOI 10.1172/JCI119485; GANGULY TC, 1994, BIOCHEM J, V303, P33, DOI 10.1042/bj3030033; Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029; Gartung C, 1996, GASTROENTEROLOGY, V110, P199, DOI 10.1053/gast.1996.v110.pm8536857; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; HAGENBUCH B, 1990, J BIOL CHEM, V265, P5357; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Jaffe CA, 1998, J CLIN INVEST, V102, P153, DOI 10.1172/JCI2908; Kang J, 2016, ONCOTARGET; Kim BH, 2011, BRIT J PHARMACOL, V164, P106, DOI 10.1111/j.1476-5381.2011.01353.x; Kumar A, 2015, EUR J PHARMACOL, V761, P288, DOI 10.1016/j.ejphar.2015.05.068; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Li YH, 2016, PHARMACOL RES, V110, P227, DOI 10.1016/j.phrs.2016.02.010; Liu J, 2014, TOXICOL SCI, V141, P538, DOI 10.1093/toxsci/kfu151; Liu XF, 2016, BIOMED PHARMACOTHER, V79, P222, DOI 10.1016/j.biopha.2016.02.015; LIU Y, 1995, AM J PHYSIOL-GASTR L, V268, pG11, DOI 10.1152/ajpgi.1995.268.1.G11; Newall CA., 1996, HERBAL MED GUIDE HLT; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Pan GY, 2002, PHARMACOL TOXICOL, V91, P193, DOI 10.1034/j.1600-0773.2002.t01-1-910403.x; Simon FR, 2004, AM J PHYSIOL-GASTR L, V287, pG782, DOI 10.1152/ajpgi.00379.2003; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; You GF, 2004, CURR DRUG METAB, V5, P55, DOI 10.2174/1389200043489207; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; Zhu T, 2015, AM J CHINESE MED, V43, P1487, DOI 10.1142/S0192415X15500846; Zollner G, 2005, LIVER INT, V25, P367, DOI 10.1111/j.1478-3231.2005.01033.x	42	10	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4602	4613		10.1074/jbc.M116.757567	http://dx.doi.org/10.1074/jbc.M116.757567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154180	Green Published, hybrid			2022-12-28	WOS:000397585100018
J	Chen, RY; Zhang, Q; Duan, XY; York, P; Chen, GD; Yin, PC; Zhu, HJ; Xu, MC; Chen, PL; Wu, QH; Li, DL; Samarut, J; Xu, GL; Zhang, PM; Cao, XH; Li, JW; Wong, JM				Chen, Ruoyu; Zhang, Qiao; Duan, Xiaoya; York, Philippe; Chen, Guo-Dong; Yin, Pengcheng; Zhu, Haijun; Xu, Meichen; Chen, Peilin; Wu, Qihan; Li, Dali; Samarut, Jacques; Xu, Guoliang; Zhang, Pumin; Cao, Xiaohua; Li, Jiwen; Wong, Jiemin			The 5-Hydroxymethylcytosine (5hmC) Reader UHRF2 Is Required for Normal Levels of 5hmC in Mouse Adult Brain and Spatial Learning and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLUCOSAMINE TRANSFERASE OGT; EMBRYONIC STEM-CELLS; DNA METHYLATION; BASE-RESOLUTION; MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; DNMT1; CHROMATIN; 5-CARBOXYLCYTOSINE	UHRF2 has been implicated as a novel regulator for both DNA methylation (5mC) and hydroxymethylation (5hmC), but its physiological function and role in DNA methylation/ hydroxymethylation are unknown. Here we show that in mice, UHRF2 is more abundantly expressed in the brain and a few other tissues. Uhrf2 knock-out mice are viable and fertile and exhibit no gross defect. Although there is no significant change of DNA methylation, the Uhrf2 null mice exhibit a reduction of 5hmC in the brain, including the cortex and hippocampus. Furthermore, the Uhrf2 null mice exhibit a partial impairment in spatial memory acquisition and retention. Consistent with the phenotype, gene expression profiling uncovers a role for UHRF2 in regulating neuron-related gene expression. Finally, we provide evidence that UHRF2 binds 5hmC in cells but does not appear to affect the TET1 enzymatic activity. Together, our study supports UHRF2 as a bona fide 5hmC reader and further demonstrates a role for 5hmC in neuronal function.	[Chen, Ruoyu; Zhang, Qiao; Duan, Xiaoya; Zhu, Haijun; Chen, Peilin; Wu, Qihan; Li, Dali; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Inst Biomed Sci & Sch Life Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [York, Philippe; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chen, Guo-Dong] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yin, Pengcheng; Xu, Meichen; Cao, Xiaohua] China Normal Univ, Shanghai Key Lab Brain Funct Genom, Key Lab Brain Funct Genom, Minist Educ, Shanghai 200062, Peoples R China; [Samarut, Jacques] Univ Lyon 1, CNRS, UMR5242, Inst Genom Fonctionnelle Lyon, F-69007 Lyon, France; [Wong, Jiemin] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China	East China Normal University; Baylor College of Medicine; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; East China Normal University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Sun Yat Sen University	Li, JW; Wong, JM (corresponding author), East China Normal Univ, Inst Biomed Sci & Sch Life Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn	Samarut, Jacques/AAD-2587-2019	Wong, Jiemin/0000-0002-5311-842X	National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507002-002]; Ministry of Science and Technology of China [2015CB910402, 2015CB856200]; National Natural Science Foundation of China [91419303, 91219202, 31525013]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070214] Funding Source: NIH RePORTER	National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China Grant 2014ZX09507002-002, Ministry of Science and Technology of China Grant 2015CB910402, National Natural Science Foundation of China Grant 91419303, and Science and Technology Commission of Shanghai Municipality Grants 14XD1401700 and 11DZ2260300 (to J. W.) and National Natural Science Foundation of China Grants 91219202 and 31525013 and Ministry of Science and Technology of China Grant 2015CB856200 (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jia YH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.7; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Walker DL, 2008, LEARN MEMORY, V15, P67, DOI 10.1101/lm.798908; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	39	28	28	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4533	4543		10.1074/jbc.M116.754580	http://dx.doi.org/10.1074/jbc.M116.754580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28115522	hybrid, Green Published			2022-12-28	WOS:000397585100012
J	Wall, AA; Luo, L; Hung, Y; Tong, SJ; Condon, ND; Blumenthal, A; Sweet, MJ; Stow, JL				Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Blumenthal, Antje; Sweet, Matthew J.; Stow, Jennifer L.			Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase gamma Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED MACROPHAGES; GROWTH-FACTOR; PI3K-GAMMA; MTOR; PI3K; INFLAMMATION; DISCOVERY; RUFFLES; PATHWAY; BINDING	LPS-mediated activation of Toll-like receptor 4 (TLR4) in macrophages results in the coordinated release of proinflammatory cytokines, followed by regulatory mediators, to ensure that this potentially destructive pathway is tightly regulated. We showed previously that Rab8a recruits PI3K gamma for Akt-dependent signaling during TLR4 activation to limit the production of the proinflammatory cytokines IL-6 and IL-12p40 while enhancing the release of the regulatory/ anti-inflammatory cytokine IL-10. Here we broaden the array of immune receptors controlled by Rab8a-PI3K gamma and further define the Rab-mediated membrane domains required for signaling. With CRISPR/Cas9mediated gene editing to stably knock out and recover Rab8a in macrophage cell lines, we match Akt signaling profiles with cytokine outputs, confirming that Rab8a is a novel regulator of the Akt/mammalian target of rapamycin (mTOR) pathway downstream of multiple TLRs. Upondeveloping a Rab8a activation assay, weshow that TLR3 and 9 agonists also activate Rab8a. Live-cell imaging reveals that Rab8a is first recruited to the plasma membrane and dorsal ruffles, but it is retained during collapse of ruffles to form macropinosomes enriched for phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5) P3) and phosphatidylinositol 3,4-bisphosphate (PI(3,4) P-2), suggesting that the macropinosome is the location where Rab8a is active. We pinpoint macropinosomes as the sites for Rab8-mediated biasing of inflammatory signaling responses via inducible production of anti-inflammatory cytokines. Thus, Rab8a and PI3K gamma are positioned in multiple TLR pathways, and this signalingaxismayserveasapharmacologicallytractabletargetduring infection and inflammation.	[Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB, Brisbane, Qld 4072, Australia; [Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia; [Blumenthal, Antje] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia	University of Queensland; University of Queensland; University of Queensland	Stow, JL (corresponding author), Univ Queensland, IMB, Brisbane, Qld 4072, Australia.; Stow, JL (corresponding author), Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia.	j.stow@imb.uq.edu.au	Tong, Samuel/GPX-6390-2022; Sweet, Matthew J/F-2229-2011; Blumenthal, Antje/A-3608-2011; Wall, Adam/C-5985-2017; Luo, Lin/B-7845-2016; Stow, Jennifer/I-4723-2013	Tong, Samuel/0000-0002-4950-3544; Sweet, Matthew J/0000-0002-0406-8139; Blumenthal, Antje/0000-0003-3673-7015; Wall, Adam/0000-0001-8301-2899; Luo, Lin/0000-0001-5556-7096; Stow, Jennifer/0000-0002-5409-9101; Hung, Yu/0000-0003-1461-5287	National Health and Medical Research Council of Australia [APP1003021, APP1098710, APP1107914]; Australian Infectious Diseases Research Centre	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Infectious Diseases Research Centre	This work was supported by the National Health and Medical Research Council of Australia (Fellowship APP1003021 to J. L. S., Grant APP1098710 to J. L. S. and A. B., and Senior Research Fellowship APP1107914 to M. J. S.) and was supported by the Australian Infectious Diseases Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ariffin JK, 2016, ANTIMICROB AGENTS CH, V60, P1521, DOI 10.1128/AAC.01876-15; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Evans CA, 2016, ACS MED CHEM LETT, V7, P862, DOI 10.1021/acsmedchemlett.6b00238; Hagemann Nina, 2012, Small GTPases, V3, P107, DOI 10.4161/sgtp.19380; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HUME DA, 1982, ADV EXP MED BIOL, V155, P261; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Luo L, 2016, J BIOL CHEM, V291, P9411, DOI 10.1074/jbc.M115.703108; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Welliver TP, 2012, BIOL OPEN, V1, P754, DOI 10.1242/bio.20121784; Yeo JC, 2015, MOL BIOL CELL, V26, P952, DOI 10.1091/mbc.E14-10-1457; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207	38	38	38	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4411	4422		10.1074/jbc.M116.766337	http://dx.doi.org/10.1074/jbc.M116.766337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28130450	Green Published, hybrid			2022-12-28	WOS:000397585100003
J	Yin, YT; de Waal, PW; He, YZ; Zhao, LH; Yang, DH; Cai, XQ; Jiang, Y; Melcher, K; Wang, MW; Xu, HE				Yin, Yanting; de Waal, Parker W.; He, Yuanzheng; Zhao, Li-Hua; Yang, Dehua; Cai, Xiaoqing; Jiang, Yi; Melcher, Karsten; Wang, Ming-Wei; Xu, H. Eric			Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; CROSS-LINKING STRATEGY; GLUCAGON RECEPTOR; METAPHYSEAL CHONDRODYSPLASIA; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-BINDING; IONIC LOCK; PEPTIDE	The glucagon receptor (GCGR) belongs to the secretin-like (class B) family of G protein-coupled receptors (GPCRs) and is activated by the peptide hormone glucagon. The structures of an activated class B GPCR have remained unsolved, preventing a mechanistic understanding of how these receptors are activated. Using a combination of structural modeling and mutagenesis studies, we present here two modes of ligand-independent activation of GCGR. First, we identified a GCGR-specific hydrophobic lock comprising Met-338 and Phe-345 within the IC3 loop and transmembrane helix 6 (TM6) and found that this lock stabilizes the TM6 helix in the inactive conformation. Disruption of this hydrophobic lock led to constitutive G protein and arrestin signaling. Second, we discovered a polar core comprising conserved residues in TM2, TM3, TM6, and TM7, and mutations that disrupt this polar core led to constitutive GCGR activity. On the basis of these results, we propose a mechanistic model of GCGR activation in which TM6 is held in an inactive conformation by the conserved polar core and the hydrophobic lock. Mutations that disrupt these inhibitory elements allow TM6 to swing outward to adopt an active TM6 conformation similar to that of the canonical beta(2)-adrenergic receptor complexed with G protein and to that of rhodopsin complexed with arrestin. Importantly, mutations in the corresponding polar core of several other members of class B GPCRs, including PTH1R, PAC1R, VIP1R, and CRFR1, also induce constitutive G protein signaling, suggesting that the rearrangement of the polar core is a conserved mechanism for class B GPCR activation.	[Yin, Yanting; Zhao, Li-Hua; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Van Andel Res Inst, Shanghai Inst Mat Med VARI SIMM Ctr,Shanghai Inst, Ctr Struct & Funct Drug Targets,CAS Key Lab Recep, Shanghai 201203, Peoples R China; [Yin, Yanting; de Waal, Parker W.; He, Yuanzheng; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Yin, Yanting; de Waal, Parker W.; He, Yuanzheng; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Biol & Biochem, Grand Rapids, MI 49503 USA; [Yin, Yanting; Xu, H. Eric] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yang, Dehua; Cai, Xiaoqing; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Yang, Dehua; Cai, Xiaoqing; Wang, Ming-Wei] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Van Andel Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University	Wang, MW (corresponding author), Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Xu, HE (corresponding author), Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA.	mwwang@simm.ac.cn; Eric.Xu@vai.org	Yang, Dehua/M-5789-2019; Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; Yang, Dehua/S-6156-2017; de Waal, Parker/M-1138-2017	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; de Waal, Parker/0000-0001-6922-9768; Yin, Yanting/0000-0001-9310-1094; He, Yuanzheng/0000-0001-9131-140X	National Natural Science Foundation of China [31300245]; Jay and Betty Van Andel Foundation, Ministry of Science and Technology of China [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); National Institutes of Health [DK071662, GM102545, GM104212]; Outstanding Young Scientist Foundation of CAS; Youth Innovation Promotion Association of CAS; Shanghai Science and Technology Development Fund [15DZ2291600, 14431901200]; National Natural Science Foundation [81373463]; CAS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545, R01GM104212] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jay and Betty Van Andel Foundation, Ministry of Science and Technology of China; Amway (China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Outstanding Young Scientist Foundation of CAS; Youth Innovation Promotion Association of CAS; Shanghai Science and Technology Development Fund; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant 31300245 (to L. H. Z.) and in part by the Jay and Betty Van Andel Foundation, Ministry of Science and Technology of China Grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001; Amway (China); National Institutes of Health Grants DK071662 (to H. E. X.) and GM102545 and GM104212 (to K. M.); the Outstanding Young Scientist Foundation of CAS; the Youth Innovation Promotion Association of CAS; Shanghai Science and Technology Development Fund Grants 15DZ2291600 and 14431901200 (to M. W. W.); National Natural Science Foundation Grant 81373463 (to D. Y.); and the CAS-Novo Nordisk Research Fund (to D. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hennen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26236; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Mukund S, 2013, J BIOL CHEM, V288, P36168, DOI 10.1074/jbc.M113.496984; Nampoothiri S, 2016, J CLIN ENDOCR METAB, V101, P4283, DOI 10.1210/jc.2016-2054; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Pabreja K, 2014, BRIT J PHARMACOL, V171, P1114, DOI 10.1111/bph.12313; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; REN Q, 1993, J BIOL CHEM, V268, P16483; Schipani E, 1997, MOL ENDOCRINOL, V11, P851, DOI 10.1210/me.11.7.851; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siu FY, 2010, STRUCTURE, V18, P1067, DOI 10.1016/j.str.2010.08.004; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Ward SDC, 2006, BIOCHEMISTRY-US, V45, P676, DOI 10.1021/bi051503q; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42; Zhao LH, 2016, J BIOL CHEM, V291, P15119, DOI 10.1074/jbc.M116.726620	38	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9865	9881		10.1074/jbc.M117.782987	http://dx.doi.org/10.1074/jbc.M117.782987			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28356352	hybrid, Green Published			2022-12-28	WOS:000403580600002
J	Chen, L; Bi, DL; Lu, ZH; McClafferty, H; Shipston, MJ				Chen, Lie; Bi, Danlei; Lu, Zen Huat; McClafferty, Heather; Shipston, Michael J.			Distinct domains of the beta 1-subunit cytosolic N terminus control surface expression and functional properties of large-conductance calcium-activated potassium (BK) channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; electrophysiology; membrane trafficking; membrane transport; potassium channel	CA2+-ACTIVATED K+ CHANNEL; BETA-SUBUNIT; STRUCTURE PREDICTION; SWISS-MODEL; WEB SERVER; VOLTAGE; ALPHA; MODULATION; TRAFFICKING; PALMITOYLATION	The properties and function of large-conductance calcium- and voltage-activated potassium (BK) channels are modified by the tissue-specific expression of regulatory beta 1-subunits. Although the short cytosolic N-terminal domain of the beta 1-subunit is important for controlling both BK channel trafficking and function, whether the same, or different, regions of the N terminus control these distinct processes remains unknown. Here we demonstrate that the first six N-terminal residues including Lys-3, Lys-4, and Leu-5 are critical for controlling functional regulation, but not trafficking, of BK channels. This membrane-distal region has features of an amphipathic helix that is predicted to control the orientation of the first transmembrane-spanning domain (TM1) of the beta 1-subunit. In contrast, a membrane-proximal leucine residue (Leu-17) controls trafficking without affecting functional coupling, an effect that is in part dependent on controlling efficient endoplasmic reticulum exit of the pore-forming alpha-subunit. Thus cell surface trafficking and functional coupling with BK channels are controlled by distinct domains of the beta 1-subunit N terminus.	[Chen, Lie; Bi, Danlei; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Chen, Lie; Lu, Zen Huat] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link, BE-1410 Gadong, Brunei; [Bi, Danlei] Univ Sci & Technol China, Sch Life Sci, Neurodegenerat Dis Res Ctr, Hefei 230026, Peoples R China; [Lu, Zen Huat] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH25 9RG, Midlothian, Scotland	University of Edinburgh; University Brunei Darussalam; Chinese Academy of Sciences; University of Science & Technology of China, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Michael/C-7309-2013	Shipston, Michael/0000-0001-7544-582X; Lu, Zen H./0000-0002-9408-0579; Chen, Lie/0000-0001-9764-4299	Wellcome Trust; Diabetes UK; Medical Research Council	Wellcome Trust(Wellcome Trust); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a in part by grants from the Wellcome Trust, Diabetes UK, and Medical Research Council (to M. J. S.).	Castillo JP, 2016, P NATL ACAD SCI USA, V113, pE3231, DOI 10.1073/pnas.1606381113; Castillo K, 2015, P NATL ACAD SCI USA, V112, P4809, DOI 10.1073/pnas.1504378112; Chen L, 2013, J BIOL CHEM, V288, P13136, DOI 10.1074/jbc.M113.461830; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Foss SM, 2013, J NEUROSCI, V33, P10647, DOI 10.1523/JNEUROSCI.5662-12.2013; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Ge LS, 2014, INT IMMUNOPHARMACOL, V22, P427, DOI 10.1016/j.intimp.2014.06.040; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Jeffries O, 2012, J BIOL CHEM, V287, P1468, DOI 10.1074/jbc.M111.224840; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kuntamallappanavar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109306; Latorre R, 2017, PHYSIOL REV, V97, P39, DOI 10.1152/physrev.00001.2016; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu GX, 2015, J GEN PHYSIOL, V145, P185, DOI 10.1085/jgp.201411337; Liu HW, 2014, J BIOL CHEM, V289, P16914, DOI 10.1074/jbc.M114.557991; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; Steinle M, 2011, RADIOTHER ONCOL, V101, P122, DOI 10.1016/j.radonc.2011.05.069; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Torres YP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00383; Wang B, 2006, J GEN PHYSIOL, V128, P731, DOI 10.1085/jgp.200609596; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhang JY, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00401; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	40	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8694	8704		10.1074/jbc.M116.769505	http://dx.doi.org/10.1074/jbc.M116.769505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373283	hybrid, Green Published			2022-12-28	WOS:000402153900016
J	Echelman, DJ; Lee, AQ; Fernandez, JM				Echelman, Daniel J.; Lee, Alex Q.; Fernandez, Julio M.			Mechanical forces regulate the reactivity of a thioester bond in a bacterial adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; atomic force microscopy (AFM); bacterial adhesion; Gram-positive bacteria; single-molecule biophysics; pilus mechanics; thioester bond	COMPLEMENT COMPONENT C3; INTERNAL THIOESTER; SINGLE PROTEIN; KINETICS; TITIN; ELASTICITY; INSIGHTS; PILUS	Bacteria must withstand large mechanical shear forces when adhering to and colonizing hosts. Recent structural studies on a class of Gram-positive bacterial adhesins have revealed an intramolecular Cys-Gln thioester bond that can react with surface-associated ligands to covalently anchor to host surfaces. Two other examples of such internal thioester bonds occur in certain anti-proteases and in the immune complement system, both of which react with the ligand only after the thioester bond is exposed by a proteolytic cleavage. We hypothesized that mechanical forces in bacterial adhesion could regulate thioester reactivity to ligand analogously to such proteolytic gating. Studying the pilus tip adhesin Spy0125 of Streptococcus pyogenes, we developed a single molecule assay to unambiguously resolve the state of the thioester bond. We found that when Spy0125 was in a folded state, its thioester bond could be cleaved with the small-molecule nucleophiles methylamine and histamine, but when Spy0125 was mechanically unfolded and subjected to forces of 50-350 piconewtons, thioester cleavage was no longer observed. For folded Spy0125 without mechanical force exposure, thioester cleavage was in equilibrium with spontaneous thioester reformation, which occurred with a half-life of several minutes. Functionally, this equilibrium reactivity allows thioester-containing adhesins to sample potential substrates without irreversible cleavage and inactivation. We propose that such reversible thioester reactivity would circumvent potential soluble inhibitors, such as histamine released at sites of inflammation, and allow the bacterial adhesin to selectively associate with surface-bound ligands.	[Echelman, Daniel J.; Lee, Alex Q.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, 550 West 120th St, New York, NY 10027 USA	Columbia University	Echelman, DJ (corresponding author), Columbia Univ, Dept Biol Sci, 550 West 120th St, New York, NY 10027 USA.	dje2122@columbia.edu		Lee, Alex/0000-0002-9615-8894	National Institutes of Health [GM116122, HL061228]; National Institutes of Health Medical Scientist Training Program Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Medical Scientist Training Program Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM116122 and HL061228 (to J. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a National Institutes of Health Medical Scientist Training Program Grant to Columbia University.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Baker EN, 2015, BIOCHEM SOC T, V43, P787, DOI 10.1042/BST20150066; Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Ding AM, 2010, APPL ENVIRON MICROB, V76, P1294, DOI 10.1128/AEM.02083-09; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Echelman DJ, 2016, P NATL ACAD SCI USA, V113, P2490, DOI 10.1073/pnas.1522946113; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Garcia-Ferrer I, 2015, P NATL ACAD SCI USA, V112, P8290, DOI 10.1073/pnas.1506538112; George NPE, 2006, ARTERIOSCL THROM VAS, V26, P2394, DOI 10.1161/01.ATV.0000237606.90523.94; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kahn TB, 2015, J BIOL CHEM, V290, P14518, DOI 10.1074/jbc.M115.646000; KHAN SA, 1986, BIOCHEMISTRY-US, V25, P5165, DOI 10.1021/bi00366a027; Law SKA, 1997, PROTEIN SCI, V6, P263; Linke-Winnebeck C, 2014, J BIOL CHEM, V289, P177, DOI 10.1074/jbc.M113.523761; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mitchell SC, 2001, CLIN CHIM ACTA, V312, P107, DOI 10.1016/S0009-8981(01)00608-8; Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884; Nilsson B, 2012, IMMUNOBIOLOGY, V217, P1106, DOI 10.1016/j.imbio.2012.07.008; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; PANGBURN MK, 1992, J BIOL CHEM, V267, P8584; Peng Q, 2009, J AM CHEM SOC, V131, P14050, DOI 10.1021/ja903589t; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Prussin Calman, 2003, Journal of Allergy and Clinical Immunology, V111, pS486; Reardon-Robinson ME, 2016, J BACTERIOL, V198, P746, DOI 10.1128/JB.00769-15; Rivas-Pardo JA, 2016, CELL REP, V14, P1339, DOI 10.1016/j.celrep.2016.01.025; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schwartz DJ, 2013, P NATL ACAD SCI USA, V110, P15530, DOI 10.1073/pnas.1315203110; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wong SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5917	43	24	24	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8988	8997		10.1074/jbc.M117.777466	http://dx.doi.org/10.1074/jbc.M117.777466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28348083	hybrid, Green Published			2022-12-28	WOS:000402153900049
J	Ithychanda, SS; Dou, K; Robertson, SP; Qin, J				Ithychanda, Sujay S.; Dou, Kevin; Robertson, Stephen P.; Qin, Jun			Structural and thermodynamic basis of a frontometaphyseal dysplasia mutation in filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOTYPIC DIVERSITY; MOLECULAR-BASIS; LIGAND-BINDING; PHOSPHORYLATION; PROTEIN; FLNA; FLUORESCENCE; MECHANISM; TRANSITIONS; COMPETITION	Filamin-mediated linkages between transmembrane receptors (TR) and the actin cytoskeleton are crucial for regulating many cytoskeleton-dependent cellular processes such as cell shape change and migration. A major TR binding site in the immunoglobulin repeat 21 (Ig21) of filamin is masked by the adjacent repeat Ig20, resulting in autoinhibition. The TR binding to this site triggers the relief of Ig20 and protein kinase A (PKA)-mediated phosphorylation of Ser-2152, thereby dynamically regulating the TR-actin linkages. A P2204L mutation in Ig20 reportedly cause frontometaphyseal dysplasia, a skeletal disorder with unknown pathogenesis. We show here that the P2204L mutation impairs a hydrophobic core of Ig20, generating a conformationally fluctuating molten globule-like state. Consequently, unlike in WT filamin, where PKA-mediated Ser-2152 phosphorylation is ligand-dependent, the P2204L mutant is readily accessible to PKA, promoting ligand-independent phosphorylation on Ser-2152. Strong TR peptide ligands from platelet GP1b alpha and G-protein-coupled receptor MAS effectively bound Ig21 by displacing Ig20 from autoinhibited WT filamin, but surprisingly, the capacity of these ligands to bind the P2204L mutant was much reduced despite the mutation-induced destabilization of the Ig20 structure that supposedly weakens the autoinhibition. Thermodynamic analysis indicated that compared with WT filamin, the conformationally fluctuating state of the Ig20 mutant makes Ig21 enthalpically favorable to bind ligand but with substantial entropic penalty, resulting in total higher free energy and reduced ligand affinity. Overall, our results reveal an unusual structural and thermodynamic basis for the P2204L-induced dysfunction of filamin and frontometaphyseal dysplasia disease.	[Ithychanda, Sujay S.; Dou, Kevin; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dunedin 9016, New Zealand	Cleveland Clinic Foundation; University of Otago	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, NB2-88,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org		Robertson, Stephen/0000-0002-5181-7809; Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	NIH [1S10RR031537-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Peptides were synthesized by the Molecular Biotechnology Core at the Lerner Research Institute (Cleveland Clinic, Cleveland, OH). We acknowledge Dr. Smarajit Bandyopadhyay and Weizhen Shen for excellent peptide preparations. We thank Dr. Belinda Willard of the Proteomics and Metabolomics laboratory for help with mass spectrometry (NIH shared instrument Grant 1S10RR031537-01). We also sincerely thank David Schumick from the Center for Medical Art and Photography at the Cleveland Clinic (Cleveland, OH) for help with graphic illustrations. We thank Dr. Mohammed Mahfuzul Haque and Yue Dai of the Department of Pathobiology for help with use of the fluorimeter.	Bertola D, 2015, AM J MED GENET A, V167, P1161, DOI 10.1002/ajmg.a.36981; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Henkels KM, 2015, FASEB J, V29, P1299, DOI 10.1096/fj.14-260992; Ithychanda SS, 2015, J BIOL CHEM, V290, P8527, DOI 10.1074/jbc.M114.633446; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jay D, 2004, MOL CELL BIOCHEM, V260, P49, DOI 10.1023/B:MCBI.0000026052.76418.55; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim KH, 2016, J MOL RECOGNIT, V29, P446, DOI 10.1002/jmr.2543; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Li LZ, 2015, ONCOTARGET, V6, P12009, DOI 10.18632/oncotarget.3617; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; Mezawa M, 2016, FASEB J, V30, P3613, DOI 10.1096/fj.201600354RR; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Robertson SP, 2006, AM J MED GENET A, V140A, P1726, DOI 10.1002/ajmg.a.31322; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Seppala J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136969; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Tirupula KC, 2015, BIOCHEMISTRY-US, V54, P6673, DOI 10.1021/acs.biochem.5b00975; Travis MA, 2004, FEBS LETT, V569, P185, DOI 10.1016/j.febslet.2004.04.099; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; van Kogelenberg M, 2015, J MOL MED, V93, P773, DOI 10.1007/s00109-015-1261-7; WALLACH D, 1978, J BIOL CHEM, V253, P4739; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhang J. Q., 2013, ADV MATER SCI ENG, V2013, P2, DOI DOI 10.1371/J0URNAL.P0NE.0057251; Zhang JP, 2012, J NEUROSCI, V32, P12619, DOI 10.1523/JNEUROSCI.1063-12.2012; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	41	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8390	8400		10.1074/jbc.M117.776740	http://dx.doi.org/10.1074/jbc.M117.776740			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348077	Green Published, hybrid			2022-12-28	WOS:000401788600023
J	Hoffer, ED; Miles, SJ; Dunham, CM				Hoffer, Eric D.; Miles, Stacey J.; Dunham, Christine M.			The structure and function of Mycobacterium tuberculosis MazF-mt6 toxin provide insights into conserved features of MazF endonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; BACTERIAL PERSISTENCE; ANTITOXIN SYSTEMS; CLEAVAGE; PROTEIN; ENDORIBONUCLEASE; RECOGNITION; TRANSLATION; COMPLEX	Toxin-antitoxin systems are ubiquitous in prokaryotic and archaeal genomes and regulate growth in response to stress. Escherichia coli contains at least 36 putative toxin-antitoxin gene pairs, and some pathogens such as Mycobacterium tuberculosis have over 90 toxin-antitoxin operons. E. coli MazF cleaves free mRNA after encountering stress, and nine M. tuberculosis MazF family members cleave mRNA, tRNA, or rRNA. Moreover, M. tuberculosis MazF-mt6 cleaves 23S rRNA Helix 70 to inhibit protein synthesis. The overall tertiary folds of these MazFs are predicted to be similar, and therefore, it is unclear how they recognize structurally distinct RNAs. Here we report the 2.7-angstrom X-ray crystal structure of MazF-mt6. MazF-mt6 adopts a PemK-like fold but lacks an elongated beta 1-beta 2 linker, a region that typically acts as a gate to direct RNA or antitoxin binding. In the absence of an elongated beta 1-beta 2 linker, MazF-mt6 is unable to transition between open and closed states, suggesting that the regulation of RNA or antitoxin selection may be distinct from other canonical MazFs. Additionally, a shortened beta 1-beta 2 linker allows for the formation of a deep, solvent- accessible, active-site pocket, which may allow recognition of specific, structured RNAs like Helix 70. Structure-based mutagenesis and bacterial growth assays demonstrate that MazF-mt6 residues Asp-10, Arg-13, and Thr-36 are critical for RNase activity and likely catalyze the proton-relay mechanism for RNA cleavage. These results provide further critical insights into how MazF secondary structural elements adapt to recognize diverse RNA substrates.	[Hoffer, Eric D.] Emory Univ, Sch Med, Grad Div Biol & Biomed Sci, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA; [Hoffer, Eric D.; Miles, Stacey J.; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA	Emory University; Emory University	Dunham, CM (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu		Hoffer, Eric/0000-0002-2273-6743	National Institute of General Medical Sciences; National Institutes of Health [P41 GM103403]; Southeast Regional Collaborative Access Team beamline; National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation [S10 RR029205]; United States DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southeast Regional Collaborative Access Team beamline; National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation; United States DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dunham laboratory members Drs. T. Maehigashi, J. Meisner, and M. A. Schureck for helpful discussions throughout the project; Dr. M. Witek for providing purified E. coli 50S; and Dr. G. L. Conn for critical reading of the manuscript. We thank Dr. Woychik for reagents and Woychik laboratory member Dr. J. M. Schifano for technical guidance. This work is based upon research conducted at the Northeastern Collaborative Access Team beamline, which is funded by the National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403, and at the Southeast Regional Collaborative Access Team beamline. The Pilatus 6M detector on the 24-ID-C beamline is funded by a National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation Grant S10 RR029205. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bertini I, 2009, J AM CHEM SOC, V131, P5134, DOI 10.1021/ja8080764; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2004, ACTA CRYSTALLOGR D, V60, P1132, DOI 10.1107/S0907444904007814; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; Han JS, 2010, BIOCHEM BIOPH RES CO, V400, P293, DOI 10.1016/j.bbrc.2010.08.023; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Lobato-Marquez D, 2016, FEMS MICROBIOL REV, V40, P592, DOI 10.1093/femsre/fuw022; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schifano JM, 2016, NUCLEIC ACIDS RES, V44, P1256, DOI 10.1093/nar/gkv1370; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Witek MA, 2016, NUCLEIC ACIDS RES, V44, P342, DOI 10.1093/nar/gkv1306; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zorzini V, 2016, J BIOL CHEM, V291, P10950, DOI 10.1074/jbc.M116.715912; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	46	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7718	7726		10.1074/jbc.M117.779306	http://dx.doi.org/10.1074/jbc.M117.779306			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28298445	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000401154100002
J	Seydlova, G; Beranova, J; Bibova, I; Dienstbier, A; Drzmisek, J; Masin, J; Fiser, R; Konopasek, I; Vecerek, B				Seydlova, Gabriela; Beranova, Jana; Bibova, Ilona; Dienstbier, Ana; Drzmisek, Jakub; Masin, Jiri; Fiser, Radovan; Konopasek, Ivo; Vecerek, Branislav			The extent of the temperature-induced membrane remodeling in two closely related Bordetella species reflects their adaptation to diverse environmental niches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS ADENYLATE-CYCLASE; VIRULENCE FACTORS; PHYSICAL-PROPERTIES; FATTY-ACIDS; LIPIDS; EXPRESSION; FLUIDITY; PROTEIN; PHOSPHATIDYLCHOLINES; BRONCHISEPTICA	Changes in environmental temperature represent one of the major stresses faced by microorganisms as they affect the function of the cytoplasmic membrane. In this study, we have analyzed the thermal adaptation in two closely related respiratory pathogens Bordetella pertussis and Bordetella bronchiseptica. Although B. pertussis represents a pathogen strictly adapted to the human body temperature, B. bronchiseptica causes infection in a broad range of animals and survives also outside of the host. We applied GC-MS to determine the fatty acids of both Bordetella species grown at different temperatures and analyzed the membrane fluidity by fluorescence anisotropy measurement. In parallel, we also monitored the effect of growth temperature changes on the expression and production of several virulence factors. In response to low temperatures, B. pertussis adapted its fatty acid composition and membrane fluidity to a considerably lesser extent when compared with B. bronchiseptica. Remarkably, B. pertussis maintained the production of virulence factors at 24 degrees C, whereas B. bronchiseptica cells resumed the production only upon temperature upshift to 37 degrees C. This growth temperature-associated differential modulation of virulence factor production was linked to the phosphorylation state of transcriptional regulator BvgA. The observed differences in low-temperature adaptation between B. pertussis and B. bronchiseptica may result from selective adaptation of B. pertussis to the human host. We propose that the reduced plasticity of the B. pertussis membranes ensures sustained production of virulence factors at suboptimal temperatures and may play an important role in the transmission of the disease.	[Seydlova, Gabriela; Beranova, Jana; Fiser, Radovan; Konopasek, Ivo] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Vinicna 5, Prague 12843, Czech Republic; [Bibova, Ilona; Dienstbier, Ana; Drzmisek, Jakub; Vecerek, Branislav] Acad Sci Czech Republ, Inst Microbiol Vvi, Lab Posttranscript Control Gene Express, Videnska 1083, Prague 14220, Czech Republic; [Masin, Jiri] Acad Sci Czech Republ, Inst Microbiol Vvi, Lab Mol Biol Bacterial Pathogens, Videnska 1083, Prague 14220, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vecerek, B (corresponding author), AS CR, Inst Microbiol Vvi, Videnska 1083, Prague 14220, Czech Republic.	vecerek@biomed.cas.cz	Konopásek, Ivo/AAE-9034-2021; Vecerek, Branislav/H-2545-2014; Fiser, Radovan/E-4908-2012; Seydlová, Gabriela/H-2050-2014; Masin, Jiri/H-3125-2014; Držmíšek, Jakub/S-5903-2017	Konopásek, Ivo/0000-0002-6824-5974; Vecerek, Branislav/0000-0001-9520-6324; Fiser, Radovan/0000-0003-4516-0086; Seydlová, Gabriela/0000-0001-8424-9249; Držmíšek, Jakub/0000-0002-8585-3189; Masin, Jiri/0000-0001-6258-4599; Bibova, Ilona/0000-0002-0839-8434	Czech Science Foundation [16-34825L, 16-05919S, 13-18051P]; Czech Health Research Council [16-30782A]; Research concept of the Institute of Microbiology v.v.i. [RVO61388971]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; European Regional Development Fund Project "BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" [CZ.1.05/1.1.00/02.0109]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Health Research Council; Research concept of the Institute of Microbiology v.v.i.; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund Project "BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University"	This work was supported by Czech Science Foundation Grants 16-34825L (to B. V.), 16-05919S (to J. M.), and 13-18051P (to G. S.); Czech Health Research Council Grant 16-30782A (to B. V.); Research concept of the Institute of Microbiology v.v.i., RVO61388971; Ministry of Education, Youth and Sports of the Czech Republic Projects CZ.1.07/2.3.00/20.0055 (to B. V. and I. B.) and CZ.1.07/2.3.00/30.0003 (to B. V.); and European Regional Development Fund Project "BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" CZ.1.05/1.1.00/02.0109 (to B. V., A. D., and I. B.). The authors declare that they have no conflicts of interest with the contents of this article.	ADLER M, 1988, BIOPHYS J, V53, P989, DOI 10.1016/S0006-3495(88)83179-5; ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671; BALDASSARE JJ, 1976, BIOCHEMISTRY-US, V15, P2986, DOI 10.1021/bi00659a008; Bart MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01301-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bibova I, 2013, INFECT IMMUN, V81, P4081, DOI 10.1128/IAI.00345-13; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; CRONAN JE, 1973, J BIOL CHEM, V248, P1188; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; DEMENDOZA D, 1983, J BIOL CHEM, V258, P2098; deTejada GM, 1996, MOL MICROBIOL, V22, P895, DOI 10.1046/j.1365-2958.1996.01538.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dupre E, 2015, J BIOL CHEM, V290, P26473, DOI 10.1074/jbc.A115.655720; Dupre E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004700; FRIEDMAN RL, 1987, INFECT IMMUN, V55, P135, DOI 10.1128/IAI.55.1.135-140.1987; FULCO AJ, 1974, ANNU REV BIOCHEM, V43, P215, DOI 10.1146/annurev.bi.43.070174.001243; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASS RL, 1970, ANAL BIOCHEM, V37, P219, DOI 10.1016/0003-2697(70)90286-1; Hamidou Soumana Illiassou, 2017, Front Microbiol, V8, P28, DOI 10.3389/fmicb.2017.00028; JUNGKIND DL, 1974, BIOCHIM BIOPHYS ACTA, V337, P298, DOI 10.1016/0005-2760(74)90211-2; KAWAI Y, 1982, J BACTERIOL, V151, P996, DOI 10.1128/JB.151.2.996-1005.1982; LACEY B. W., 1960, JOUR HYG, V58, P57; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lakowicz JR, 1999, ANAL BIOCHEM, V267, P397, DOI 10.1006/abio.1998.3029; LAKOWICZ JR, 1979, BIOCHEMISTRY-US, V18, P508, DOI 10.1021/bi00570a021; Lam O, 2014, VIRULENCE, V5, P852, DOI 10.4161/21505594.2014.970949; Locht C, 1999, Int Microbiol, V2, P137; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MANETTI R, 1994, GENE, V150, P123, DOI 10.1016/0378-1119(94)90870-2; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MCGARRITY JT, 1981, BIOCHIM BIOPHYS ACTA, V640, P544, DOI 10.1016/0005-2736(81)90478-8; MELTON AR, 1989, J BACTERIOL, V171, P6206, DOI 10.1128/jb.171.11.6206-6212.1989; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; MOSS J, 1983, J BIOL CHEM, V258, P1879; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PORTER JF, 1991, APPL ENVIRON MICROB, V57, P1202, DOI 10.1128/AEM.57.4.1202-1206.1991; PRUGNOLA A, 1995, MICROBIOL-UK, V141, P2529, DOI 10.1099/13500872-141-10-2529; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUSSELL NJ, 1983, BIOCHEM SOC T, V11, P333, DOI 10.1042/bst0110333; Schneider B, 2000, INFECT IMMUN, V68, P7039, DOI 10.1128/IAI.68.12.7039-7048.2000; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; SILVIUS JR, 1979, CHEM PHYS LIPIDS, V25, P125, DOI 10.1016/0009-3084(79)90062-8; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984	58	8	8	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8048	8058		10.1074/jbc.M117.781559	http://dx.doi.org/10.1074/jbc.M117.781559			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28348085	Green Published, hybrid			2022-12-28	WOS:000401154100029
J	de Weerd, NA; Matthews, AY; Pattie, PR; Bourke, NM; Lim, SS; Vivian, JP; Rossjohn, J; Hertzog, PJ				de Weerd, Nicole A.; Matthews, Antony Y.; Pattie, Phillip R.; Bourke, Nollaig M.; Lim, San S.; Vivian, Julian P.; Rossjohn, Jamie; Hertzog, Paul J.			A hot spot on interferon alpha/beta receptor subunit 1 (IFNAR1) underpins its interaction with interferon-beta and dictates signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; mutagenesis; receptor; signal transduction; structure-function	I-INTERFERON; INFECTION; CELLS; MICE; ACTIVATION; EXPRESSION; RESPONSES; BLOCKADE; PROTEINS; IMMUNITY	The interaction of IFN- with its receptor IFNAR1 (interferon / receptor subunit 1) is vital for host-protective anti-viral and anti-proliferative responses, but signaling via this interaction can be detrimental if dysregulated. Whereas it is established that IFNAR1 is an essential component of the IFNAR signaling complex, the key residues underpinning the IFN--IFNAR1 interaction are unknown. Guided by the crystal structure of the IFN--IFNAR1 complex, we used truncation variants and site-directed mutagenesis to investigate domains and residues enabling complexation of IFN- to IFNAR1. We have identified an interface on IFNAR1-subdomain-3 that is differentially utilized by IFN- and IFN- for signal transduction. We used surface plasmon resonance and cell-based assays to investigate this important IFN- binding interface that is centered on IFNAR1 residues Tyr(240) and Tyr(274) binding the C and N termini of the B and C helices of IFN-, respectively. Using IFNAR1 and IFN- variants, we show that this interface contributes significantly to the affinity of IFN- for IFNAR1, its ability to activate STAT1, the expression of interferon stimulated genes, and ultimately to the anti-viral and anti-proliferative properties of IFN-. These results identify a key interface created by IFNAR1 residues Tyr(240) and Tyr(274) interacting with IFN- residues Phe(63), Leu(64), Glu(77), Thr(78), Val(81), and Arg(82) that underlie IFN--IFNAR1-mediated signaling and biological processes.	[de Weerd, Nicole A.; Matthews, Antony Y.; Pattie, Phillip R.; Bourke, Nollaig M.; Lim, San S.; Hertzog, Paul J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia; [de Weerd, Nicole A.; Matthews, Antony Y.; Bourke, Nollaig M.; Lim, San S.; Hertzog, Paul J.] Monash Univ, Monash Hlth, Sch Clin Sci, Dept Mol & Translat Sci, 27-31 Wright St, Clayton, Vic 3168, Australia; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Hudson Institute of Medical Research; Monash University; Monash University; Monash University; Monash University; Cardiff University	de Weerd, NA; Hertzog, PJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	nicole.deweerd@hudson.org.au; paul.hertzog@hudson.org.au	Bourke, Nollaig/AAE-7279-2019; Rossjohn, Jamie/F-9032-2013; de Weerd, Nicole/X-5886-2019; Bourke, Nollaig M/A-9840-2017; Hertzog, Paul/I-7053-2013	Bourke, Nollaig/0000-0003-4313-6859; Rossjohn, Jamie/0000-0002-2020-7522; de Weerd, Nicole/0000-0002-7985-189X; Bourke, Nollaig M/0000-0003-4313-6859; Hertzog, Paul/0000-0002-1373-8472; Vivian, Julian/0000-0002-9400-4437	National Health and Medical Research Council (NHMRC) [APP1070782]; NHMRC [APP1126524, APP1117527]; Victorian Government's Operational Infrastructure Support Program; Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Research Council (ARC)(Australian Research Council)	Supported by a National Health and Medical Research Council (NHMRC) New Investigator grant (2014-2016, APP1070782) and NHMRC Project Grant APP1126524 and the Victorian Government's Operational Infrastructure Support Program.; Supported by an Australian Research Council (ARC) Laureate Fellowship.; Supported by NHMRC SPRF (Senior Principal Research Fellow) Fellowship APP1117527 and Project Grant APP1126524 and the Victorian Government's Operational Infrastructure Support Program.	Annibali V, 2015, CYTOKINE GROWTH F R, V26, P221, DOI 10.1016/j.cytogfr.2014.10.010; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Dejager L, 2014, J INFECT DIS, V209, P960, DOI 10.1093/infdis/jit600; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaitin DA, 2007, J INTERF CYTOK RES, V27, P653, DOI 10.1089/jir.2006.0162; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Lebrun C, 2011, Int MS J, V17, P88; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lehmann MH, 2016, J LEUKOCYTE BIOL, V99, P1057, DOI 10.1189/jlb.4MA0815-376RR; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Lin S., 2014, PETROLEUM PROJECT CO, V2, P1, DOI DOI 10.1186/S12929-014-0099-6; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Mahieu T, 2007, INFECT IMMUN, V75, P22, DOI 10.1128/IAI.00829-06; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Sharma N, 2016, J BIOL CHEM, V291, P3371, DOI 10.1074/jbc.M115.686071; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Stifter SA, 2014, PROTEIN EXPRES PURIF, V94, P7, DOI 10.1016/j.pep.2013.10.019; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483	37	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7554	7565		10.1074/jbc.M116.773788	http://dx.doi.org/10.1074/jbc.M116.773788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28289093	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000400761300023
J	Mugabo, Y; Zhao, S; Lamontagne, J; Al-Mass, A; Peyot, ML; Corkey, BE; Joly, E; Madiraju, SRM; Prentki, M				Mugabo, Yves; Zhao, Shangang; Lamontagne, Julien; Al-Mass, Anfal; Peyot, Marie-Line; Corkey, Barbara E.; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc			Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; insulin secretion; lipid metabolism; metabolomics; mitochondrial metabolism; glucodetoxification; pancreatic cells	STIMULATED INSULIN-SECRETION; BETA-CELL; MALONYL-COA; ISLET CELLS; REGULATED ANAPLEROSIS; OBESE MICE; ACID CYCLE; RESISTANCE; ACCUMULATION; CHOLESTEROL	Glucose metabolism promotes insulin secretion in -cells via metabolic coupling factors that are incompletely defined. Moreover, chronically elevated glucose causes -cell dysfunction, but little is known about how cells handle excess fuels to avoid toxicity. Here we sought to determine which among the candidate pathways and coupling factors best correlates with glucose-stimulated insulin secretion (GSIS), define the fate of glucose in the -cell, and identify pathways possibly involved in excess-fuel detoxification. We exposed isolated rat islets for 1 h to increasing glucose concentrations and measured various pathways and metabolites. Glucose oxidation, oxygen consumption, and ATP production correlated well with GSIS and saturated at 16 mm glucose. However, glucose utilization, glycerol release, triglyceride and glycogen contents, free fatty acid (FFA) content and release, and cholesterol and cholesterol esters increased linearly up to 25 mm glucose. Besides being oxidized, glucose was mainly metabolized via glycerol production and release and lipid synthesis (particularly FFA, triglycerides, and cholesterol), whereas glycogen production was comparatively low. Using targeted metabolomics in INS-1(832/13) cells, we found that several metabolites correlated well with GSIS, in particular some Krebs cycle intermediates, malonyl-CoA, and lower ADP levels. Glucose dose-dependently increased the dihydroxyacetone phosphate/glycerol 3-phosphate ratio in INS-1(832/13) cells, indicating a more oxidized state of NAD in the cytosol upon glucose stimulation. Overall, the data support a role for accelerated oxidative mitochondrial metabolism, anaplerosis, and malonyl-CoA/lipid signaling in -cell metabolic signaling and suggest that a decrease in ADP levels is important in GSIS. The results also suggest that excess-fuel detoxification pathways in -cells possibly comprise glycerol and FFA formation and release extracellularly and the diversion of glucose carbons to triglycerides and cholesterol esters.	[Mugabo, Yves; Zhao, Shangang; Lamontagne, Julien; Al-Mass, Anfal; Peyot, Marie-Line; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ H2X 0A9, Canada; [Mugabo, Yves; Zhao, Shangang; Lamontagne, Julien; Al-Mass, Anfal; Peyot, Marie-Line; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Al-Mass, Anfal] McGill Univ, Dept Med, Montreal, PQ H3A 1B1, Canada; [Zhao, Shangang; Al-Mass, Anfal] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Mugabo, Yves; Prentki, Marc] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Mugabo, Yves; Prentki, Marc] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Mugabo, Yves; Prentki, Marc] Univ Montreal, Fac Med, Dept Mol Med, Montreal, PQ H3C 3J7, Canada; [Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Zhao, Shangang] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Prentki, M (corresponding author), CRCHUM, Montreal Diabet Res Ctr, 900 St Denis,Viger Tower,Rm R08-412, Montreal, PQ H2X 0A9, Canada.	marc.prentki@umontreal.ca	ZHao, Shangang/H-5730-2019	Zhao, Shangang/0000-0002-9209-8206	Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante; department of Nutrition of Universite de Montreal; Diabete Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); department of Nutrition of Universite de Montreal; Diabete Quebec	This work was supported in part by grants from the Canadian Institutes of Health Research (to M. P. and S. R. M. M.) and fellowships from Fonds de Recherche du Quebec-Sante, the department of Nutrition of Universite de Montreal, and Diabete Quebec (to Y. M.). The authors declare that they have no conflicts of interest with the contents of this article.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Brereton MF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13496; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Ferdaoussi M, 2017, TRENDS CELL BIOL, V27, P163, DOI 10.1016/j.tcb.2016.10.003; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Gehrmann W, 2010, DIABETES OBES METAB, V12, P149, DOI 10.1111/j.1463-1326.2010.01265.x; Gooding JR, 2016, ARCH BIOCHEM BIOPHYS, V589, P120, DOI 10.1016/j.abb.2015.06.013; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang M, 2012, ISLETS, V4, P210, DOI 10.4161/isl.20141; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Krebs M, 2004, CURR MED CHEM, V11, P901, DOI 10.2174/0929867043455620; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314; Llanos P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129238; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maechler P, 2010, ADV EXP MED BIOL, V654, P193, DOI 10.1007/978-90-481-3271-3_9; Martins EF, 2004, DIABETES METAB, V30, P21, DOI 10.1016/S1262-3636(07)70085-X; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694; Nolan CJ, 2013, LANCET DIABETES ENDO, V1, P9, DOI 10.1016/S2213-8587(13)70027-5; Pearson GL, 2016, MOL METAB, V5, P404, DOI 10.1016/j.molmet.2016.04.003; Pepin E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153017; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Proks P, 2010, J GEN PHYSIOL, V136, P389, DOI 10.1085/jgp.201010475; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Rancoule C, 2013, DIABETOLOGIA, V56, P1394, DOI 10.1007/s00125-013-2891-3; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Sandberg MB, 2005, MOL CELL ENDOCRINOL, V240, P94, DOI 10.1016/j.mce.2005.05.005; Sarre A, 2012, FREE RADICAL BIO MED, V52, P142, DOI 10.1016/j.freeradbiomed.2011.10.437; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Xue JH, 2010, CARDIOVASC RES, V86, P141, DOI 10.1093/cvr/cvp388; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9; Zhao S, 2015, MOL METAB, V4, P940, DOI 10.1016/j.molmet.2015.09.012; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; Zhou YP, 1996, METABOLISM, V45, P981, DOI 10.1016/S0026-0495(96)90267-X	93	34	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7407	7422		10.1074/jbc.M116.763060	http://dx.doi.org/10.1074/jbc.M116.763060			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28280244	Green Published, hybrid			2022-12-28	WOS:000400761300012
J	Weems, JC; Slaughter, BD; Unruh, JR; Boeing, S; Hall, SM; McLaird, MB; Yasukawa, T; Aso, T; Svejstrup, JQ; Conaway, JW; Conaway, RC				Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Boeing, Stefan; Hall, Shawn M.; McLaird, Merry B.; Yasukawa, Takashi; Aso, Teijiro; Svejstrup, Jesper Q.; Conaway, Joan W.; Conaway, Ronald C.			Cockayne syndrome B protein regulates recruitment of the Elongin A ubiquitin ligase to sites of DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR-SIII; NUCLEOTIDE EXCISION-REPAIR; MAMMALIAN ELONGIN; CUL5-RBX2 MODULES; COUPLED REPAIR; CSB PROTEIN; ELONGATION; ACTIVATION; POLYUBIQUITYLATION	Elongin A performs dual functions as the transcriptionally active subunit of RNA polymerase II (Pol II) elongation factor Elongin and as the substrate recognition subunit of a Cullin-RING E3 ubiquitin ligase that ubiquitylates Pol II in response to DNA damage. Assembly of the ElonginAubiquitin ligase and its recruitment to sites ofDNAdamage is a tightly regulated process induced by DNA-damaging agents and alpha-amanitin, a drug that induces Pol II stalling. In this study, we demonstrate (i) that Elongin A and the ubiquitin ligase subunit CUL5 associate in cells with the Cockayne syndrome B (CSB) protein and (ii) that this interaction is also inducedbyDNA-damagingagentsand alpha-amanitin. Inaddition, we presentevidencethattheCSBproteinpromotesstablerecruitment of the ElonginAubiquitin ligase to sites ofDNAdamage. Our findings are consistent with the model that the Elongin A ubiquitin ligase and theCSBprotein function together in acommonpathway in response to Pol II stalling and DNA damage.	[Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Hall, Shawn M.; McLaird, Merry B.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA; [Boeing, Stefan; Svejstrup, Jesper Q.] Clare Hall Labs, Francis Crick Inst, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nanko Ku, Oko Cho, Kochi 7838505, Japan	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Kochi University	Conaway, JW; Conaway, RC (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org		Svejstrup, Jesper/0000-0003-4964-6147; Unruh, Jay/0000-0003-3077-4990; Conaway, Joan/0000-0002-2786-0663	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; Francis Crick Institute from Cancer Research UK [FC001166]; UK Medical Research Council [FC001166]; Wellcome Trust [FC001166]; European Research Council [693327, 268797]; Cancer Research UK [11567] Funding Source: researchfish; The Francis Crick Institute [10168, 10166, 10490, 10002] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K08177] Funding Source: KAKEN	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation. This work was also supported by the Francis Crick Institute (which receives its core funding from Cancer Research UK (FC001166), the UK Medical Research Council (FC001166), and the Wellcome Trust (FC001166)) and by grants from the European Research Council, Agreements 693327 (TRANSDAM) and 268797 (TRANSINTEG). The authors declare that they have no conflicts of interest with the contents of this article.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Batenburg NL, 2015, EMBO J, V34, P1399, DOI 10.15252/embj.201490041; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Iyama T, 2016, J MOL BIOL, V428, P62, DOI 10.1016/j.jmb.2015.11.020; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Menoni H, 2012, J CELL BIOL, V199, P1037, DOI 10.1083/jcb.201205149; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249	44	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6431	6437		10.1074/jbc.C117.777946	http://dx.doi.org/10.1074/jbc.C117.777946			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28292928	Green Published, hybrid			2022-12-28	WOS:000399813400001
J	Fabre, L; Bao, H; Innes, J; Duong, F; Rouiller, I				Fabre, Lucien; Bao, Huan; Innes, James; Duong, Franck; Rouiller, Isabelle			Negative Stain Single-particle EM of the Maltose Transporter in Nanodiscs Reveals Asymmetric Closure of MalK(2) and Catalytic Roles of ATP, MalE, and Maltose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; ABC TRANSPORTER; ELECTRON-MICROSCOPY; SUBUNIT INTERACTIONS; FACING CONFORMATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; HYDROLYSIS; DIMER	The Escherichia coli MalE-MalFGK(2) complex is one of the best characterized members of the large and ubiquitous family of ATP-binding cassette (ABC) transporters. It is composed of a membrane-spanning heterodimer, MalF-MalG; a homodimeric ATPase, MalK(2); and a periplasmic maltose receptor, MalE. Opening and closure of MalK(2) is coupled to conformational changes in MalF-MalG and the alternate exposition of the substrate-binding site to either side of the membrane. To further define this alternate access mechanism and the impact of ATP, MalE, and maltose on the conformation of the transporter during the transport cycle, we have reconstituted MalFGK(2) in nanodiscs and analyzed its conformations under 10 different biochemical conditions using negative stain single-particle EM. EM map results (at 15-25 angstrom resolution) indicate that binding of ATP to MalK(2) promotes an asymmetric, semi-closed conformation in accordance with the low ATPase activity of MalFGK(2). In the presence of MalE, the MalK dimer becomes fully closed, gaining the ability to hydrolyze ATP. In the presence of ADP or maltose, MalE.MalFGK(2) remains essentially in a semi-closed symmetric conformation, indicating that release of these ligands is required for the return to the initial state. Taken together, this structural information provides a rationale for the stimulation of MalK ATPase activity by MalE as well as by maltose.	[Fabre, Lucien; Innes, James; Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Grp Rech Axe Struct Prot, Grp Etud Prot Membranaires, 3640 Univ St, Montreal, PQ H3A 2B2, Canada; [Bao, Huan; Duong, Franck] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	McGill University; University of British Columbia	Duong, F (corresponding author), Life Sci Ctr, Off 5407,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.; Rouiller, I (corresponding author), Rm 115,Strathcona Anat & Dent Bldg,3640 Univ St, Montreal, PQ H3A 2B2, Canada.	fduong@mail.ubc.ca; isabelle.rouiller@mcgill.ca	Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	rouiller, isabelle/0000-0002-1288-8575; Bao, Huan/0000-0002-4301-4627; Duong Van Hoa, Franck/0000-0001-7328-6124	Canadian Institutes of Health Research [86693MOP, 74525MOP]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04798]; Bourse de Prestige from the Groupe d'Etude des Proteines Membranaires (Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada Create Training Program in Bionanomachines	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bourse de Prestige from the Groupe d'Etude des Proteines Membranaires (Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada Create Training Program in Bionanomachines	This work was supported by Canadian Institutes of Health Research Grants 86693MOP (to I. R.) and 74525MOP (to F. D.), the Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04798 (to I. R.), a Bourse de Prestige from the Groupe d'Etude des Proteines Membranaires (which is supported by the Fonds de la Recherche en Sante du Quebec) (to L. F.), and a summer fellowship from the Natural Sciences and Engineering Research Council of Canada Create Training Program in Bionanomachines (to J. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez FJD, 2015, MOL MICROBIOL, V98, P878, DOI 10.1111/mmi.13165; Bao H, 2015, J BIOL CHEM, V290, P25452, DOI 10.1074/jbc.M115.671826; Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2013, J BIOL CHEM, V288, P23666, DOI 10.1074/jbc.M113.489567; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, JOVE-J VIS EXP, DOI 10.3791/3910; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hsu WL, 2016, J PHYS CHEM B, V120, P11102, DOI 10.1021/acs.jpcb.6b07332; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuler Mary A, 2013, Methods Mol Biol, V974, P415, DOI 10.1007/978-1-62703-275-9_18; Seyffer F, 2015, BBA-GEN SUBJECTS, V1850, P449, DOI 10.1016/j.bbagen.2014.05.022; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139	35	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5457	5464		10.1074/jbc.M116.757898	http://dx.doi.org/10.1074/jbc.M116.757898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188291	hybrid, Green Published			2022-12-28	WOS:000397875500025
J	Miyata, N; Tang, ZY; Conti, MA; Johnson, ME; Douglas, CJ; Hasson, SA; Damoiseaux, R; Chang, CEA; Koehler, CM				Miyata, Non; Tang, Zhiye; Conti, Michael A.; Johnson, Meghan E.; Douglas, Colin J.; Hasson, Samuel A.; Damoiseaux, Robert; Chang, Chia-en A.; Koehler, Carla M.			Adaptation of a Genetic Screen Reveals an Inhibitor for Mitochondrial Protein Import Component Tim44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; C-TERMINAL DOMAIN; INNER MEMBRANE; PRESEQUENCE TRANSLOCASE; INTERMEMBRANE SPACE; MULTIENZYME NANOSTRUCTURES; SUPEROXIDE-PRODUCTION; YEAST MITOCHONDRIA; TIM23 COMPLEX; MATRIX HSP70	Diverse protein import pathways into mitochondria use translocons on the outer membrane (TOM) and inner membrane (TIM). We adapted a genetic screen, based on Ura3 mis-targeting from mitochondria to the cytosol, to identify small molecules that attenuated protein import. Small molecule mitochondrial import blockers of the Carla Koehler laboratory (MB)-10 inhibited import of substrates that require the TIM23 translocon. Mutational analysis coupled with molecular docking and molecular dynamics modeling revealed that MB-10 binds to a specific pocket in the C-terminal domain of Tim44 of the protein-associated motor (PAM) complex. This region was proposed to anchor Tim44 to the membrane, but biochemical studies with MB-10 show that this region is required for binding to the translocating precursor and binding to mtHsp70 in low ATP conditions. This study also supports a direct role for the PAM complex in the import of substrates that are laterally sorted to the inner membrane, as well as the mitochondrial matrix. Thus, MB-10 is the first small molecule modulator to attenuate PAM complex activity, likely through binding to the C-terminal region of Tim44.	[Miyata, Non; Conti, Michael A.; Johnson, Meghan E.; Douglas, Colin J.; Hasson, Samuel A.; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Box 95156, Los Angeles, CA 90095 USA; [Damoiseaux, Robert] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Koehler, Carla M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Koehler, Carla M.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Tang, Zhiye] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Riverside	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 95156, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu	Damoiseaux, Robert/F-1086-2011; Damoiseaux, Robert/S-6712-2019	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; Koehler, Carla/0000-0001-8685-2412; Tang, Zhiye/0000-0002-5092-1575; Hasson, Samuel/0000-0003-2258-0678	National Institutes of Health [GM073981, GM61721]; California Institute of Regenerative Medicine [RS1-00313, RB1-01397]; National Science Foundation [MCB-0919586]; U.S. Public Health Service NRSA [GM07185, GM08496]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM109045, T32GM007185, T32GM008496, R01GM073981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); U.S. Public Health Service NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM073981 and GM61721 (to C. M. K.), California Institute of Regenerative Medicine Grants RS1-00313 and RB1-01397 (to C. M. K.), National Science Foundation Grant MCB-0919586 (to C. A. C.), and U.S. Public Health Service NRSA Grants GM07185 (to M. E. J., M. A. C., and C. J. D.) and GM08496 (to S. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai R, 2010, J COMPUT AID MOL DES, V24, P819, DOI 10.1007/s10822-010-9376-y; Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Banerjee R, 2015, ELIFE, V4, DOI 10.7554/eLife.11897; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonora E, 2006, BRIT J CANCER, V95, P1529, DOI 10.1038/sj.bjc.6603455; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang CE, 2003, J COMPUT CHEM, V24, P1987, DOI 10.1002/jcc.10325; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; DePaul AJ, 2010, NUCLEIC ACIDS RES, V38, P4856, DOI 10.1093/nar/gkq134; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Handa N, 2007, ACTA CRYSTALLOGR D, V63, P1225, DOI 10.1107/S0907444907051463; Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; HWANG ST, 1991, J BIOL CHEM, V266, P21083; Josyula R, 2006, J MOL BIOL, V359, P798, DOI 10.1016/j.jmb.2006.04.020; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Matsuoka T, 2005, DIABETES, V54, P2882, DOI 10.2337/diabetes.54.10.2882; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Milisav I, 2001, J BIOL CHEM, V276, P25856, DOI 10.1074/jbc.M102132200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Popov-Celeketic D, 2011, EMBO REP, V12, P542, DOI 10.1038/embor.2011.72; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Roberts CC, 2016, J PHYS CHEM B, V120, P8518, DOI 10.1021/acs.jpcb.6b02236; Roberts CC, 2015, J CHEM THEORY COMPUT, V11, P286, DOI 10.1021/ct5007482; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; Ungermann C, 1996, EMBO J, V15, P735, DOI 10.1002/j.1460-2075.1996.tb00409.x; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119; Wada J, 1998, P NATL ACAD SCI USA, V95, P144, DOI 10.1073/pnas.95.1.144; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148	56	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5429	5442		10.1074/jbc.M116.770131	http://dx.doi.org/10.1074/jbc.M116.770131			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28167535	Green Published, hybrid			2022-12-28	WOS:000397875500023
J	Nakano, M; Fukami, T; Gotoh, S; Nakajima, M				Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki			A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED FOLATE CARRIER; INOSINE RNA; MAMMALIAN-CELLS; ADENOSINE DEAMINASES; THYMIDYLATE SYNTHASE; ADAR DEAMINASES; L5178Y CELLS; 2 FORMS; EXPRESSION; METHOTREXATE	Dihydrofolate reductase (DHFR) plays a key role in folate metabolism and is a target molecule of methotrexate. An increase in the cellular expression level of DHFR is one of the mechanisms of tumor resistance to methotrexate. The pres-ent study investigated the possibility that adenosine-to-inosine RNA editing, which causes nucleotide conversion by adenosine deaminase acting on RNA (ADAR) enzymes, might modulate DHFR expression. In human breast adenocarcinoma-derived MCF-7 cells, 26 RNA editing sites were identified in the 3 ' -UTR of DHFR. Knockdown of ADAR1 decreased the RNA editing levels of DHFR and resulted in a decrease in the DHFR mRNA and protein levels, indicating that ADAR1 up-regulates DHFR expression. Using a computational analysis, miR-25-3p and miR-125a-3p were predicted to bind to the non-edited 3 ' -UTR of DHFR but not to the edited sequence. The decrease in DHFR expression by the knockdown of ADAR1 was restored by transfection of antisense oligonucleotides for these miRNAs, suggesting that RNA editing mediated up-regulation of DHFR requires the function of these miRNAs. Interestingly, we observed that the knockdown of ADAR1 decreased cell viability and increased the sensitivity of MCF-7 cells to methotrexate. ADAR1 expression levels and the RNA editing levels in the 3 ' -UTR of DHFR in breast cancer tissues were higher than those in adjacent normal tissues. Collectively, the present study dem-onstrated that ADAR1 positively regulates the expression of DHFR by editing the miR-25-3p and miR-125a-3p binding sites in the 3 ' -UTR of DHFR, enhancing cellular proliferation and resistance to methotrexate.	[Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Nakajima, M (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan.	nmiki@p.kanazawa-u.ac.jp		Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [15H04663]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant- in-Aid for Scientific Research ( B) from Japan Society for the Promotion of Science number 15H04663. The authors declare that they have no conflicts of interest with contents of this article.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; ALBRECHT AM, 1972, CANCER RES, V32, P1539; ALT FW, 1978, J BIOL CHEM, V253, P1357; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Banerjee D, 2002, BBA-MOL BASIS DIS, V1587, P164, DOI 10.1016/S0925-4439(02)00079-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 1997, RNA, V3, P947; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; DOLNICK BJ, 1979, J CELL BIOL, V83, P394, DOI 10.1083/jcb.83.2.394; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Fix Lindsey N., 2010, Cancer Genomics & Proteomics, V7, P261; Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gerber A, 1997, RNA, V3, P453; GOLDIE JH, 1980, EUR J CANCER, V16, P1539, DOI 10.1016/0014-2964(80)90026-2; He H, 2015, GENET MOL RES, V14, P17927, DOI 10.4238/2015.December.22.17; HILL BT, 1979, CANCER RES, V39, P2440; JACKSON RC, 1976, CANCER RES, V36, P1991; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kobayashi H, 1998, CANCER LETT, V124, P135, DOI 10.1016/S0304-3835(97)00464-3; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Liu H, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-44; Llado V, 2009, P NATL ACAD SCI USA, V106, P13754, DOI 10.1073/pnas.0907300106; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; McEntee G, 2011, P NATL ACAD SCI USA, V108, P15157, DOI 10.1073/pnas.1103605108; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; MOSCOW JA, 1995, CANCER RES, V55, P3790; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Nazki FH, 2014, GENE, V533, P11, DOI 10.1016/j.gene.2013.09.063; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Salonga D, 2000, CLIN CANCER RES, V6, P1322; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tariq A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00099; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Wu XJ, 2015, GENE, V557, P195, DOI 10.1016/j.gene.2014.12.030; Xu X, 2016, BIOCHEM BIOPH RES CO, V479, P893, DOI 10.1016/j.bbrc.2016.09.087; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoon SA, 2010, CANCER RES TREAT, V42, P163, DOI 10.4143/crt.2010.42.3.163	66	55	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4873	4884		10.1074/jbc.M117.775684	http://dx.doi.org/10.1074/jbc.M117.775684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28188287	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000397590400011
J	Baba, SA; Vishwakarma, RA; Ashraf, N				Baba, Shoib Ahmad; Vishwakarma, Ram A.; Ashraf, Nasheeman			Functional Characterization of CsBGlu12, a beta-Glucosidase from Crocus sativus, Provides Insights into Its Role in Abiotic Stress through Accumulation of Antioxidant Flavonols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SCAVENGING ACTIVITY; CELL-SUSPENSION CULTURES; MANIHOT-ESCULENTA CRANTZ; MOLECULAR CHARACTERIZATION; ALKALOID BIOSYNTHESIS; DROUGHT TOLERANCE; ACTIVE-SITE; ARABIDOPSIS; EXPRESSION; GLUCOSYLTRANSFERASE	Glycosylation and deglycosylation are impressive mechanisms that allow plants to regulate the biological activity of an array of secondary metabolites. Although glycosylation improves solubility and renders the metabolites suitable for transport and sequestration, deglycosylation activates them to carry out biological functions. Herein, we report the functional characterization of CsBGlu12, a beta-glucosidase from Crocus sativus. CsBGlu12 has a characteristic glucoside hydrolase 1 family (alpha/beta) 8 triose-phosphate isomerase (TIM) barrel structure with a highly conserved active site. In vitro enzyme activity revealed that CsBGlu12 catalyzes the hydrolysis of flavonol beta-glucosides and cello-oligosaccharides. Site-directed mutagenesis of any of the two conserved catalytic glutamic acid residues (Glu(200) and Glu(414)) of the active site completely abolishes the beta-glucosidase activity. Transcript analysis revealed that Csbglu12 is highly induced in response to UV-B, dehydration, NaCl, methyl jasmonate, and abscisic acid treatments indicating its possible role in plant stress response. Transient overexpression of CsBGlu12 leads to the accumulation of antioxidant flavonols in Nicotiana benthamiana and confers tolerance to abiotic stresses. Antioxidant assays indicated that accumulation of flavonols alleviated the accretion of reactive oxygen species during abiotic stress conditions. beta-Glucosidases are known to play a role in abiotic stresses, particularly dehydration through abscisic acid; however, their role through accumulation of reactive oxygen species (ROS) scavenging flavonols has not been established. Furthermore, only one beta-glucosidase 12 homolog has been characterized so far. Therefore, this work presents an important report on characterization of CsBGlu12 and its role in abiotic stress through ROS scavenging.	[Baba, Shoib Ahmad; Ashraf, Nasheeman] Indian Inst Integrat Med, CSIR, Plant Biotechnol Div, Srinagar 190005, Jammu & Kashmir, India; [Baba, Shoib Ahmad; Ashraf, Nasheeman] Indian Inst Integrat Med, CSIR, Acad Sci & Innovat Res, Canal Rd, Jammu 180001, India; [Vishwakarma, Ram A.] Indian Inst Integrat Med, CSIR, Div Med Chem, Canal Rd, Jammu 180001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Ashraf, N (corresponding author), Indian Inst Integrat Med, Srinagar 190005, Jammu & Kashmir, India.	nashraf@iiim.ac.in	Baba, Shoib/AAA-5264-2022	Baba, Shoib Ahmad/0000-0002-4106-994X	Grant SIMPLE Council of Scientific and Industrial Research and MLP [BSC-0109]; Indian Institute of Integrative Medicine [MLP 3012]	Grant SIMPLE Council of Scientific and Industrial Research and MLP; Indian Institute of Integrative Medicine	This work was supported by Grant SIMPLE (BSC-0109) from the Council of Scientific and Industrial Research and MLP 3012 from Indian Institute of Integrative Medicine. This paper has institutional manuscript number IIIM/1993/2017. The authors declare that they have no conflicts of interest with the contents of this article.	Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Ashraf N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0423-7; Baba SA, 2015, J PLANT PHYSIOL, V189, P114, DOI 10.1016/j.jplph.2015.11.001; Baba SA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1894-5; Baba SA, 2015, S AFR J BOT, V99, P80, DOI 10.1016/j.sajb.2015.03.194; Barleben L, 2007, PLANT CELL, V19, P2886, DOI 10.1105/tpc.106.045682; Cairns JRK, 2015, PLANT SCI, V241, P246, DOI 10.1016/j.plantsci.2015.10.014; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Davies GJ, 2002, BIOCHEM SOC T, V30, P291, DOI 10.1042/BST0300291; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Djilianov D, 2011, PLANT BIOLOGY, V13, P767, DOI 10.1111/j.1438-8677.2010.00436.x; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; GRAHAM TL, 1990, MOL PLANT MICROBE IN, V3, P157, DOI 10.1094/MPMI-3-157; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; HEMSCHEIDT T, 1980, FEBS LETT, V110, P187, DOI 10.1016/0014-5793(80)80069-X; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Jones PR, 2000, RECENT ADV PHYTOCHEM, V34, P191, DOI 10.1016/S0079-9920(00)80008-8; Keresztessy Z, 2001, BIOCHEM J, V353, P199, DOI 10.1042/0264-6021:3530199; KERESZTESSY Z, 1994, ARCH BIOCHEM BIOPHYS, V315, P323, DOI 10.1006/abbi.1994.1507; KLECZKOWSKI K, 1995, CRIT REV PLANT SCI, V14, P283, DOI 10.1080/07352689509382361; Koudounas K, 2015, J EXP BOT, V66, P2093, DOI 10.1093/jxb/erv002; Le Roy J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00735; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; MACKENBROCK U, 1991, Z NATURFORSCH C, V46, P43; Middleton E, 1994, IMPACT PLANT FLAVONO, P619; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nakabayashi R, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29518; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Nakajima J, 2004, J BIOMED BIOTECHNOL, P241, DOI 10.1155/S1110724304404045; NISIUS A, 1988, PLANTA, V173, P474, DOI 10.1007/BF00958960; Nomura T, 2008, J BIOL CHEM, V283, P34650, DOI 10.1074/jbc.M806953200; Opassiri R, 2010, PLANT SCI, V179, P273, DOI 10.1016/j.plantsci.2010.05.013; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roepke J, 2015, PHYTOCHEMISTRY, V109, P14, DOI 10.1016/j.phytochem.2014.10.028; Roepke J, 2013, CHEMBIOCHEM, V14, P2418, DOI 10.1002/cbic.201300474; Rouyi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096712; Moraga AR, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-109; Rubio-Moraga A, 2010, PHYTOCHEMISTRY, V71, P1506, DOI 10.1016/j.phytochem.2010.05.026; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Samappito S, 2002, PLANTA, V216, P64, DOI 10.1007/s00425-002-0872-8; Sansenya S, 2011, ARCH BIOCHEM BIOPHYS, V510, P62, DOI 10.1016/j.abb.2011.04.005; Scarpeci TE, 2008, PLANT GROWTH REGUL, V54, P133, DOI 10.1007/s10725-007-9236-5; SCHUBEL H, 1986, HELV CHIM ACTA, V69, P538, DOI 10.1002/hlca.19860690303; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tohge T, 2005, BIOTECHNOL LETT, V27, P297, DOI 10.1007/s10529-005-0683-7; Trapero A, 2012, PLANT PHYSIOL, V159, P1335, DOI 10.1104/pp.112.198069; Tringali C, 2003, BIOACTIVE COMPOUNDS; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Yoo D, 2013, PLANT SCI, V208, P10, DOI 10.1016/j.plantsci.2013.03.006	65	29	30	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4700	4713		10.1074/jbc.M116.762161	http://dx.doi.org/10.1074/jbc.M116.762161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154174	Green Published, hybrid			2022-12-28	WOS:000397585100026
J	Paumann-Page, M; Katz, RS; Bellei, M; Schwartz, I; Edenhofer, E; Sevcnikar, B; Soudi, M; Hofbauer, S; Battistuzzi, G; Furtmuller, PG; Obinger, C				Paumann-Page, Martina; Katz, Romy-Sophie; Bellei, Marzia; Schwartz, Irene; Edenhofer, Eva; Sevcnikar, Benjamin; Soudi, Monika; Hofbauer, Stefan; Battistuzzi, Gianantonio; Furtmueller, Paul G.; Obinger, Christian			Pre-steady-state Kinetics Reveal the Substrate Specificity and Mechanism of Halide Oxidation of Truncated Human Peroxidasin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT HEME-BINDING; HUMAN MYELOPEROXIDASE; COLLAGEN-IV; COMPOUND-I; REDOX THERMODYNAMICS; MAMMALIAN PEROXIDASES; BACTERIAL PEROXIDASE; PROSTHETIC GROUP; PROTEIN BONDS; HIGH-SPIN	Human peroxidasin 1 is a homotrimeric multidomain peroxidase that is secreted to the extracellular matrix. The heme enzyme was shown to release hypobromous acid that mediates the formation of specific covalent sulfilimine bonds to reinforce collagen IV in basement membranes. Maturation by proteolytic cleavage is known to activate the enzyme. Here, we present the first multimixing stopped-flow study on a fully functional truncated variant of human peroxidasin 1 comprising four immunoglobulin-like domains and the catalytically active peroxidase domain. The kinetic data unravel the so far unknown substrate specificity and mechanism of halide oxidation of human peroxidasin 1. The heme enzyme is shown to follow the halogenation cycle that is induced by the rapid H2O2-mediated oxidation of the ferric enzyme to the redox intermediate compound I. We demonstrate that chloride cannot act as a two-electron donor of compound I, whereas thiocyanate, iodide, and bromide efficiently restore the ferric resting state. We present all relevant apparent bimolecular rate constants, the spectral signatures of the redox intermediates, and the standard reduction potential of the Fe(III)/Fe(II) couple, and we demonstrate that the prosthetic heme group is post-translationally modified and cross-linked with the protein. These structural features provide the basis of human peroxidasin 1 to act as an effective generator of hypobromous acid, which mediates the formation of covalent cross-links in collagen IV.	[Paumann-Page, Martina; Katz, Romy-Sophie; Schwartz, Irene; Edenhofer, Eva; Sevcnikar, Benjamin; Soudi, Monika; Hofbauer, Stefan; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy; [Bellei, Marzia; Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, I-41125 Modena, Italy	University of Natural Resources & Life Sciences, Vienna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Furtmuller, PG; Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.	paul.furtmueller@boku.ac.at; christian.obinger@boku.ac.at	Obinger, Christian/AAV-3173-2021; Battistuzzi, Gianantonio/L-7183-2015; Furtmüller, Paul G./Y-5819-2018; Hofbauer, Stefan/I-3889-2014	Battistuzzi, Gianantonio/0000-0003-4716-5745; Furtmüller, Paul G./0000-0002-1199-2469; Hofbauer, Stefan/0000-0003-3375-7715; Obinger, Christian/0000-0002-7133-3430	Austrian Science Fund [P25538]; Biomolecular Technology of Proteins (BioToP) [FWF W1224]	Austrian Science Fund(Austrian Science Fund (FWF)); Biomolecular Technology of Proteins (BioToP)	This work was supported by Austrian Science Fund Project P25538 and Doctoral Program Biomolecular Technology of Proteins (BioToP) FWF W1224. The authors declare that they have no conflicts of interest with the contents of this article.	ASMUSSEN I, 1979, Clinical Cardiology, V2, P246; Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Battistuzzi G, 2002, J AM CHEM SOC, V124, P26, DOI 10.1021/ja017188m; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Colon S, 2016, J BIOL CHEM, V291, P24009, DOI 10.1074/jbc.M116.745935; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Ero-Tolliver IA, 2015, J BIOL CHEM, V290, P21741, DOI 10.1074/jbc.M115.673996; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Hawkins CL, 2009, FREE RADICAL RES, V43, P1147, DOI 10.3109/10715760903214462; Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; Singh PK, 2017, BBA-PROTEINS PROTEOM, V1865, P329, DOI 10.1016/j.bbapap.2016.12.006; Soudi M, 2015, J BIOL CHEM, V290, P10876, DOI 10.1074/jbc.M114.632273; Soudi M, 2012, CHEM BIODIVERS, V9, P1776, DOI 10.1002/cbdv.201100438; Tsuge K, 2000, J HEALTH SCI, V46, P343; VANLEEUWEN FXR, 1987, CRIT REV TOXICOL, V18, P189, DOI 10.3109/10408448709089861; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157	38	28	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4583	4592		10.1074/jbc.M117.775213	http://dx.doi.org/10.1074/jbc.M117.775213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154175	Green Published, hybrid			2022-12-28	WOS:000397585100016
J	Su, WP; Foster, SC; Xing, RB; Feistel, K; Olsen, RHJ; Acevedo, SF; Raber, J; Sherman, LS				Su, Weiping; Foster, Scott C.; Xing, Rubing; Feistel, Kerstin; Olsen, Reid H. J.; Acevedo, Summer F.; Raber, Jacob; Sherman, Larry S.			CD44 Transmembrane Receptor and Hyaluronan Regulate Adult Hippocampal Neural Stem Cell Quiescence and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE PROGENITOR MATURATION; DENTATE GYRUS; EXTRACELLULAR-MATRIX; GRANULE CELLS; STATUS EPILEPTICUS; STEM/PROGENITOR CELLS; SYNAPTIC PLASTICITY; IN-VITRO; NEUROGENESIS; BRAIN	Adult neurogenesis in the hippocampal subgranular zone (SGZ) is involved in learning and memory throughout life but declines with aging. Mice lacking the CD44 transmembrane receptor for the glycosaminoglycan hyaluronan (HA) demonstrate a number of neurological disturbances including hippocampal memory deficits, implicating CD44 in the processes underlying hippocampal memory encoding, storage, or retrieval. Here, we found that HA and CD44 play important roles in regulating adult neurogenesis, and we provide evidence that HA contributes to age-related reductions in neural stem cell (NSC) expansion and differentiation in the hippocampus. CD44-expressing NSCs isolated from the mouse SGZ are selfrenewing and capable of differentiating into neurons, astrocytes, and oligodendrocytes. Mice lacking CD44 demonstrate increases in NSC proliferation in the SGZ. This increased proliferation is also observed in NSCs grown in vitro, suggesting that CD44 functions to regulate NSC proliferation in a cell-autonomous manner. HA is synthesized by NSCs and increases in the SGZ with aging. TreatingwildtypebutnotCD44-null NSCs with HAinhibits NSC proliferation. HAdigestion in wild type NSC cultures or in the SGZinducesincreased NSC proliferation, andCD44-nullaswellas HA-disrupted wild type NSCs demonstrate delayed neuronal differentiation. HA therefore signals through CD44 to regulate NSC quiescence and differentiation, and HA accumulation in the SGZ may contribute to reductions in neurogenesis that are linked to age-related decline in spatial memory.	[Su, Weiping; Foster, Scott C.; Xing, Rubing; Feistel, Kerstin; Raber, Jacob; Sherman, Larry S.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, 505 NW 185th Ave, Beaverton, OR 97006 USA; [Feistel, Kerstin] Univ Hohenheim, Inst Zool, Garbenstr 30, D-70593 Stuttgart, Germany; [Olsen, Reid H. J.; Acevedo, Summer F.; Raber, Jacob] Oregon Hlth & Sci Univ, Sch Med, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol & Radiat Med, Portland, OR 97239 USA; [Sherman, Larry S.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon National Primate Research Center; University Hohenheim; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Sherman, LS (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	shermanl@ohsu.edu	su, wei/GZM-3986-2022	Feistel, Kerstin/0000-0003-3397-8972	National Institutes of Health [RR00163, P30-NS061800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS056234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Steven Matsumoto for helpful comments. The Oregon National Primate Research Center was supported by Core Grant RR00163 from the National Institutes of Health. The imaging core at the Oregon National Primate Research Center was supported by Grant P30-NS061800 from the National Institutes of Health.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Arranz AM, 2014, J NEUROSCI, V34, P6164, DOI 10.1523/JNEUROSCI.3458-13.2014; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Barzilay R, 2016, J MOL NEUROSCI, V60, P548, DOI 10.1007/s12031-016-0835-3; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bausch SB, 2006, NEUROSCIENCE, V143, P339, DOI 10.1016/j.neuroscience.2006.07.037; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Cargill R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.006; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; FUXE K, 1994, NEUROSCI LETT, V169, P25, DOI 10.1016/0304-3940(94)90348-4; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; JENKINS HG, 1988, J NEUROCHEM, V51, P1634, DOI 10.1111/j.1471-4159.1988.tb01134.x; JENKINS HG, 1988, J NEUROCHEM, V51, P1641, DOI 10.1111/j.1471-4159.1988.tb01135.x; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jiruska P, 2013, NEUROBIOL DIS, V54, P492, DOI 10.1016/j.nbd.2013.02.001; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lauren HB, 2013, BRAIN RES, V1516, P33, DOI 10.1016/j.brainres.2013.04.028; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; McRae PA, 2012, EUR J NEUROSCI, V36, P3471, DOI 10.1111/j.1460-9568.2012.08268.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x; Pan Y. W., 2012, PLOS ONE, V7; Pan YW, 2013, NEUROBIOL LEARN MEM, V105, P81, DOI 10.1016/j.nlm.2013.07.011; Parent JM, 2007, PROG BRAIN RES, V163, P529, DOI 10.1016/S0079-6123(07)63028-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165; Raber J, 2014, BEHAV BRAIN RES, V275, P146, DOI 10.1016/j.bbr.2014.09.010; Roszkowska M, 2016, MOL BIOL CELL, V27, P4055, DOI 10.1091/mbc.E16-06-0423; Rotheneichner P, 2013, EPILEPSIA, V54, P40, DOI 10.1111/epi.12274; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Steindler DA, 2012, METHODS MOL BIOL, V814, P9, DOI 10.1007/978-1-61779-452-0_2; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Su WP, 2004, GLIA, V45, P297, DOI 10.1002/glia.10340; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; SUZUKI K, 1965, J NEUROPATH EXP NEUR, V24, P211, DOI 10.1097/00005072-196504000-00004; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	61	44	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4434	4445		10.1074/jbc.M116.774109	http://dx.doi.org/10.1074/jbc.M116.774109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154169	Green Published, hybrid			2022-12-28	WOS:000397585100005
J	Barison, MJ; Rapado, LN; Merino, EF; Pral, EMF; Mantilla, BS; Marchese, L; Nowicki, C; Silber, AM; Cassera, MB				Barison, Maria Julia; Rapado, Ludmila Nakamura; Merino, Emilio F.; Furusho Pral, Elizabeth Mieko; Mantilla, Brian Suarez; Marchese, Leticia; Nowicki, Cristina; Silber, Ariel Mariano; Cassera, Maria Belen			Metabolomic profiling reveals a finely tuned, starvation-induced metabolic switch in Trypanosoma cruzi epimastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell growth; cell metabolism; energy metabolism; metabolomics; Trypanosoma cruzi; Chagas disease; epimastigotes; oxidative imbalance	AEROBIC GLUCOSE FERMENTATION; L-PROLINE; FUNCTIONAL-CHARACTERIZATION; ACTIVE-TRANSPORT; ATP PRODUCTION; ACID; DIFFERENTIATION; BIOSYNTHESIS; GROWTH; MS/MS	Trypanosoma cruzi, the etiological agent of Chagas disease, is a protozoan parasite with a complex life cycle involving a triatomine insect and mammals. Throughout its life cycle, the T. cruzi parasite faces several alternating events of cell division and cell differentiation in which exponential and stationary growth phases play key biological roles. It is well accepted that arrest of the cell division in the epimastigote stage, both in the midgut of the triatomine insect and in vitro, is required for metacyclogenesis, and it has been previously shown that the parasites change the expression profile of several proteins when entering this quiescent stage. However, little is known about the metabolic changes that epimastigotes undergo before they develop into the metacyclic trypomastigote stage. We applied targeted metabolomics to measure the metabolic intermediates in the most relevant pathways for energy metabolism and oxidative imbalance in exponentially growing and stationary growth-arrested epimastigote parasites. We show for the first time that T. cruzi epimastigotes transitioning from the exponential to the stationary phase exhibit a finely tuned adaptive metabolic mechanism that enables switching from glucose to amino acid consumption, which is more abundant in the stationary phase. This metabolic plasticity appears to be crucial for survival of the T. cruzi parasite in the myriad different environmental conditions to which it is exposed during its life cycle.	[Barison, Maria Julia; Rapado, Ludmila Nakamura; Furusho Pral, Elizabeth Mieko; Mantilla, Brian Suarez; Marchese, Leticia; Silber, Ariel Mariano] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Biochem Tryps LaBTryps, BR-05508000 Sao Paulo, Brazil; [Merino, Emilio F.; Cassera, Maria Belen] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Merino, Emilio F.; Cassera, Maria Belen] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA; [Nowicki, Cristina] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol IQUIFIB, CONICET, RA-1113 Buenos Aires, DF, Argentina	Universidade de Sao Paulo; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Silber, AM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.; Cassera, MB (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, CTEGD, Athens, GA 30602 USA.	asilber@usp.br; maria.cassera@uga.edu	BARISON, MARIA JULIA/ABF-8078-2020; Silber, Ariel/O-6951-2015	BARISON, MARIA JULIA/0000-0003-1774-2281; Suarez Mantilla, Brian/0000-0001-7839-1222; Silber, Ariel/0000-0003-4528-4732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/18970-6, 2016/06034-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2013/18970-6, 308351/2013-4]; National Institutes of Health [AI108819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108819] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2013/18970-6 and 2016/06034-2 (to A. M. S.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 2013/18970-6 and 308351/2013-4 (to A. M. S.). Metabolomics analysis was supported by National Institutes of Health Grant AI108819 (to M. B. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADROHER FJ, 1987, J PARASITOL, V73, P438, DOI 10.2307/3282112; Antunes LCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077283; Armenta JM, 2010, ANAL CHEM, V82, P548, DOI 10.1021/ac901790q; Barison MJ, 2016, J BIOENERG BIOMEMBR, V48, P437, DOI 10.1007/s10863-016-9665-9; BARRETT FM, 1975, COMP BIOCHEM PHYS B, V52, P427; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENER Z, 1965, J PARASITOL, V51, P922, DOI 10.2307/3275869; BRENER Z, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P171; Carrillo C, 1999, FEBS LETT, V454, P192, DOI 10.1016/S0014-5793(99)00804-2; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Cazzulo Juan Jose, 1992, V18, P235; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Dias Fde A., 2015, PLOS NEGLECT TROP D, V9; ENGEL JC, 1987, MOL BIOCHEM PARASIT, V26, P1, DOI 10.1016/0166-6851(87)90123-X; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Goldenberg S, 2011, ADV PARASIT, V75, P285, DOI 10.1016/B978-0-12-385863-4.00013-7; Gonzalez NS, 2001, FEBS LETT, V508, P323, DOI 10.1016/S0014-5793(01)03091-5; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Henriques C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0950-y; Hernandez R, 2012, PARASITOL RES, V111, P509, DOI 10.1007/s00436-012-2974-y; HUNTER KJ, 1994, EUR J BIOCHEM, V226, P1019, DOI 10.1111/j.1432-1033.1994.t01-1-01019.x; Li QL, 2014, J LIPID RES, V55, P592, DOI 10.1194/jlr.D045112; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Manchola NC, 2016, J EUKARYOT MICROBIOL, V63, P299, DOI 10.1111/jeu.12278; MANCILLA R, 1967, EXP PARASITOL, V21, P154, DOI 10.1016/0014-4894(67)90077-X; Mantilla BS, 2015, J BIOL CHEM, V290, P7767, DOI 10.1074/jbc.M114.574525; Marciano D, 2012, MOL BIOCHEM PARASIT, V185, P114, DOI [10.1016/j.molbiopara.2012.07.009, 10.10]; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Maugeri DA, 2011, ESSAYS BIOCHEM, V51, P15, DOI [10.1042/BSE0510015, 10.1042/bse0510015]; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Nogueira NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116712; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Paes LS, 2011, CURR PHARM DESIGN, V17, P2074, DOI 10.2174/138161211796904786; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Shaw AK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00051-16; Silber AM, 2006, INT J PARASITOL, V36, P157, DOI 10.1016/j.ijpara.2005.10.006; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	47	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8964	8977		10.1074/jbc.M117.778522	http://dx.doi.org/10.1074/jbc.M117.778522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28356355	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000402153900047
J	Geng, YY; Ferreira, JJ; Dzikunu, V; Butler, A; Lybaert, P; Yuan, P; Magleby, KL; Salkoff, L; Santi, CM				Geng, Yanyan; Ferreira, Juan J.; Dzikunu, Victor; Butler, Alice; Lybaert, Pascale; Yuan, Peng; Magleby, Karl L.; Salkoff, Lawrence; Santi, Celia M.			A genetic variant of the sperm-specific SLO3 K+ channel has altered pH and Ca2+ sensitivities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fertilization; patch clamp; potassium channel; reproduction; sperm; spermatozoa; calcium sensitivity; genetic variant; human SLO3; pH sensitivity	ACTIVATED POTASSIUM CHANNELS; INTRACELLULAR PH; CALCIUM SENSITIVITY; POSITIVE SELECTION; RAPID EVOLUTION; BK CHANNEL; DOMAIN; SPERMATOZOA; PROTEINS; CURRENTS	To fertilize an oocyte, sperm must first undergo capacitation in which the sperm plasma membrane becomes hyperpolarized via activation of potassium (K+) channels and resultant K+ efflux. Sperm-specific SLO3 K+ channels are responsible for these membrane potential changes critical for fertilization in mouse sperm, and they are only sensitive to pH(i). However, in human sperm, the major K+ conductance is both Ca2+- and pH(i)-sensitive. It has been debated whether Ca2+-sensitive SLO1 channels substitute for human SLO3 (hSLO3) in human sperm or whether human SLO3 channels have acquired Ca2+ sensitivity. Here we show that hSLO3 is rapidly evolving and reveal a natural structural variant with enhanced apparent Ca2+ and pH sensitivities. This variant allele (C382R) alters an amino acid side chain at a principal interface between the intramembrane-gated pore and the cytoplasmic gating ring of the channel. Because the gating ring contains sensors to intracellular factors such as pH and Ca2+, the effectiveness of transduction between the gating ring and the pore domain appears to be enhanced. Our results suggest that sperm-specific genes can evolve rapidly and that natural genetic variation may have led to a SLO3 variant that differs from wild type in both pH and intracellular Ca2+ sensitivities. Whether this physiological variation confers differences in fertility among males remains to be established.	[Ferreira, Juan J.; Lybaert, Pascale; Santi, Celia M.] Washington Univ, Sch Med, Dept Obstet & Gynecol, BJC Inst Hlth Bldg,425 South Euclid, St Louis, MO 63110 USA; [Dzikunu, Victor; Butler, Alice; Salkoff, Lawrence] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Salkoff, Lawrence] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yuan, Peng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Geng, Yanyan; Magleby, Karl L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Miami	Santi, CM (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, BJC Inst Hlth Bldg,425 South Euclid, St Louis, MO 63110 USA.	santic@wustl.edu	Ferreira, Juan/GNW-6445-2022	Bouca-Machado, Raquel/0000-0003-3756-2763; Ferreira, Juan/0000-0001-8175-9067	National Institute of Health [R01 HD069631, R21 NS 088611, R21 MH107955, R01 GM114694]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088611] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants R01 HD069631 (to C. M. S.), R21 NS 088611 and R21 MH107955 (to L. S.), and R01 GM114694 (to K. L. M. and L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brenker C, 2014, ELIFE, V3, DOI 10.7554/eLife.01438; Brewis IA, 2000, J ANDROL, V21, P238; Budelli G, 2013, P NATL ACAD SCI USA, V110, P16657, DOI 10.1073/pnas.1313433110; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Cross NL, 1997, BIOL REPROD, V56, P1169, DOI 10.1095/biolreprod56.5.1169; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; Hou SW, 2009, CHANNELS, V3, P249; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Leonetti MD, 2012, P NATL ACAD SCI USA, V109, P19274, DOI 10.1073/pnas.1215078109; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; Mannowetz N, 2013, ELIFE, V2, DOI 10.7554/eLife.01009; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Podlaha O, 2005, MOL BIOL EVOL, V22, P1845, DOI 10.1093/molbev/msi178; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Santi CM, 2009, J BIOL CHEM, V284, P21589, DOI 10.1074/jbc.M109.015040; SASAKI S, 1992, BIOCHIM BIOPHYS ACTA, V1137, P45, DOI 10.1016/0167-4889(92)90098-V; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Turner LM, 2008, GENETICS, V179, P2075, DOI 10.1534/genetics.107.085902; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2010, J GEN PHYSIOL, V136, P189, DOI 10.1085/jgp.200910374; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zhang X, 2006, J GEN PHYSIOL, V128, P301, DOI 10.1085/jgp.200609551	40	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8978	8987		10.1074/jbc.M117.776013	http://dx.doi.org/10.1074/jbc.M117.776013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377504	Green Published, hybrid			2022-12-28	WOS:000402153900048
J	Wei, P; Sun, FD; Zuo, LM; Qu, J; Chen, P; Xu, LD; Luo, SZ				Wei, Peng; Sun, Fu-de; Zuo, Li-min; Qu, Jing; Chen, Peng; Xu, Li-da; Luo, Shi-Zhong			Critical residues and motifs for homodimerization of the first transmembrane domain of the plasma membrane glycoprotein CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); molecular dynamics; protein conformation; protein motif; protein self-assembly; CD36; TOXCAT; homodimerization; packing switch	MOLECULAR-DYNAMICS SIMULATIONS; FATTY-ACID UPTAKE; RECEPTOR CLASS-B; DIMERIZATION MOTIF; FORCE-FIELD; HELIX ASSOCIATION; POLAR RESIDUES; GXXXG MOTIF; FLUORESCENCE; PROTEINS	The plasma transmembrane (TM) glycoprotein CD36 is critically involved in many essential signaling processes, especially the binding/uptake of long-chain fatty acids and oxidized low-density lipoproteins. The association of CD36 potentially activates cytosolic protein tyrosine kinases that are thought to associate with the C-terminal cytoplasmic tail of CD36. To understand the mechanisms by which CD36 mediates ligand binding and signal transduction, we have characterized the homo-oligomeric interaction of CD36 TM domains in membrane environments and with molecular dynamics (MD) simulations. Analysis of pyrene- and coumarin-labeled TM1 peptides in SDS by FRET confirmed the homodimerization of the CD36 TM1 peptide. Homodimerization assays of CD36 TM domains with the TOXCAT technique showed that its first TM (TM1) domain, but not the second TM (TM2) domain, could homodimerize in a cell membrane. Small-residue, site-specific mutation scanning revealed that the CD36 TM1 dimerization is mediated by the conserved small residues Gly(12), Gly(16), Ala(20), and Gly(23). Furthermore, molecular dynamics (MD) simulation studies demonstrated that CD36 TM1 exhibited a switching dimerization with two right-handed packing modes driven by the (12)GXXXGXXXA(20) and (20)AXXG(23) motifs, and the mutational effect of G16I and G23I revealed these representative conformations of CD36 TM1. This packing switch pattern of CD36 TM1 homodimer was further examined and confirmed by FRET analysis of monobromobimane (mBBr)-labeled CD36 TM1 peptides. Overall, this work provides a structural basis for understanding the role of TM association in regulating signal transduction via CD36.	[Wei, Peng; Sun, Fu-de; Qu, Jing; Chen, Peng; Xu, Li-da; Luo, Shi-Zhong] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China; [Wei, Peng] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing 100029, Peoples R China; [Zuo, Li-min] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China	Beijing University of Chemical Technology; Beijing University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS	Luo, SZ (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China.	luosz@mail.buct.edu.cn	xu, li/GNH-3667-2022		National Basic Research Program of China [2013CB910700]; National Natural Science Foundation of China [21372026, 61304147, 21672019]; BUCT Fund [XK1701]; NSFC-Guangdong Joint Fund	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BUCT Fund; NSFC-Guangdong Joint Fund	This work was supported by National Basic Research Program of China Grant 2013CB910700; National Natural Science Foundation of China Grants 21372026, 61304147, and 21672019; BUCT Fund for Disciplines Construction Project XK1701; and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase).	Baaden M, 2013, CURR OPIN STRUC BIOL, V23, P878, DOI 10.1016/j.sbi.2013.09.004; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Brosig B, 1998, PROTEIN SCI, V7, P1052; Brunette AMJ, 2014, BIOCHEMISTRY-US, V53, P6290, DOI 10.1021/bi500493r; Cai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036785; Chen YL, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa9623; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Eslami H, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3474951; Eyre NS, 2007, J LIPID RES, V48, P528, DOI 10.1194/jlr.M600255-JLR200; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; Goyal T, 2012, CURR ATHEROSCLER REP, V14, P150, DOI 10.1007/s11883-012-0228-1; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jay AG, 2018, PROSTAG LEUKOTR ESS, V138, P64, DOI 10.1016/j.plefa.2016.05.005; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kim I, 2014, P NATL ACAD SCI USA, V111, P2128, DOI 10.1073/pnas.1324014111; Knoblich K, 2015, CELL REP, V11, P1184, DOI 10.1016/j.celrep.2015.04.045; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Luiken JJFP, 2016, BBA-MOL BASIS DIS, V1862, P2253, DOI 10.1016/j.bbadis.2016.09.004; Magnetto S, 1998, CELL BIOCHEM FUNCT, V16, P211, DOI 10.1002/(SICI)1099-0844(199809)16:3<211::AID-CBF788>3.3.CO;2-Q; Magwenzi S, 2015, BLOOD, V125, P2693, DOI 10.1182/blood-2014-05-574491; Makarewicz T, 2013, J CHEM INF MODEL, V53, P1229, DOI 10.1021/ci400071x; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2010, PHYS CHEM CHEM PHYS, V12, P2254, DOI 10.1039/b915293h; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; Negami T, 2014, J COMPUT CHEM, V35, P1835, DOI 10.1002/jcc.23693; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Patel JV, 2015, WORLD J DIABETES, V6, P983, DOI 10.4239/wjd.v6.i7.983; PEARCE SFA, 1995, J BIOL CHEM, V270, P2981, DOI 10.1074/jbc.270.7.2981; Rios FJ, 2013, MEDIAT INFLAMM, V2013, P8, DOI DOI 10.1155/2013/198193; Rotem E, 2016, BIOCHEMISTRY-US, V55, P1049, DOI 10.1021/acs.biochem.5b01307; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sal-Man N, 2005, J BIOL CHEM, V280, P27449, DOI 10.1074/jbc.M503095200; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Skjold-Jorgensen J, 2015, BIOCHEMISTRY-US, V54, P4186, DOI 10.1021/acs.biochem.5b00328; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Sun FD, 2015, J PHYS CHEM B, V119, P7816, DOI 10.1021/acs.jpcb.5b01116; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Thorne RF, 1997, BIOCHEM BIOPH RES CO, V240, P812, DOI 10.1006/bbrc.1997.7755; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Oort MM, 2014, ARCH PHYSIOL BIOCHEM, V120, P40, DOI 10.3109/13813455.2013.876049; Wang DD, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027994; Wei P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105560; Wei P, 2013, BIOPHYS J, V104, P1435, DOI 10.1016/j.bpj.2013.01.054; Wei P, 2011, PROTEIN SCI, V20, P1814, DOI 10.1002/pro.713; Winger M, 2009, PHYS CHEM CHEM PHYS, V11, P1934, DOI 10.1039/b818713d; Yang XP, 2013, J LIPID RES, V54, P2450, DOI 10.1194/jlr.M038877; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]	65	6	8	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8683	8693		10.1074/jbc.M117.779595	http://dx.doi.org/10.1074/jbc.M117.779595			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28336533	hybrid, Green Published			2022-12-28	WOS:000402153900015
J	Zhao, XH; Rodriguez, R; Silberman, RE; Ahearn, JM; Saidha, S; Cummins, KC; Eisenberg, E; Greene, LE				Zhao, Xiaohong; Rodriguez, Ramon; Silberman, Rebecca E.; Ahearn, Joseph M.; Saidha, Sheela; Cummins, Kaelyn C.; Eisenberg, Evan; Greene, Lois E.			Heat shock protein 104 (Hsp104)-mediated curing of [PSI+] yeast prions depends on both [PSI+] conformation and the properties of the Hsp104 homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; molecular chaperone; prion; protein folding; yeast; Hsp104	SACCHAROMYCES-CEREVISIAE PSI+; N-TERMINAL DOMAIN; GUANIDINE-HYDROCHLORIDE; MOLECULAR CHAPERONE; PROPAGATION; OVEREXPRESSION; THERMOTOLERANCE; DISAGGREGATION; SUPPORT; PSI(+)	Prions arise from proteins that have two possible conformations: properly folded and non-infectious or misfolded and infectious. The [PSI+] yeast prion, which is the misfolded and self-propagating form of the translation termination factor eRF3 (Sup35), can be cured of its infectious conformation by overexpression of Hsp104, which helps dissolve the prion seeds. This dissolution depends on the trimming activity of Hsp104, which reduces the size of the prion seeds without increasing their number. To further understand the relationship between trimming and curing, trimming was followed by measuring the loss of GFP-labeled Sup35 foci from both strong and weak [PSI+] variants; the former variant has more seeds and less soluble Sup35 than the latter. Overexpression of Saccharomyces cerevisiae Hsp104 (Sc-Hsp104) trimmed the weak [PSI+] variants much faster than the strong variants and cured the weak variants an order of magnitude faster than the strong variants. Overexpression of the fungal Hsp104 homologs from Schizosaccharomyces pombe (Sp-Hsp104) or Candida albicans (Ca-Hsp104) also trimmed and cured the weak variants, but interestingly, it neither trimmed nor cured the strong variants. These results show that, because Sc-Hsp104 has greater trimming activity than either Ca-Hsp104 or Sp-Hsp104, it cures both the weak and strong variants, whereas Ca-Hsp104 and Sp-Hsp104 only cure the weak variants. Therefore, curing by Hsp104 overexpression depends on both the trimming ability of the fungal Hsp104 homolog and the strength of the [PSI+] variant: the greater the trimming activity of the Hsp104 homolog and the weaker the variant, the greater the curing.	[Zhao, Xiaohong; Rodriguez, Ramon; Silberman, Rebecca E.; Ahearn, Joseph M.; Saidha, Sheela; Cummins, Kaelyn C.; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, 50 South Dr,Rm 2537,MSC 8017, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 South Dr,Rm 2537,MSC 8017, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; Derkatch IL, 1996, GENETICS, V144, P1375; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Frederick KK, 2014, CHEM BIOL, V21, P295, DOI 10.1016/j.chembiol.2013.12.013; Gorkovskiy A, 2014, P NATL ACAD SCI USA, V111, pE4615, DOI 10.1073/pnas.1417974111; Greene LE, 2009, PROTEIN PEPTIDE LETT, V16, P635, DOI 10.2174/092986609788490221; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jordan B E, 1996, Methods Mol Biol, V53, P193; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Ness F, 2017, MOL MICROBIOL, V104, P125, DOI 10.1111/mmi.13617; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Park YN, 2014, EUKARYOT CELL, V13, P635, DOI 10.1128/EC.00300-13; Park YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037692; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Reidy M, 2013, EUKARYOT CELL, V12, P739, DOI 10.1128/EC.00301-12; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Senechal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006939; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wickner RB, 2012, METHODS MOL BIOL, V849, P321, DOI 10.1007/978-1-61779-551-0_22; Wong SH, 2015, J BIOL CHEM, V290, P25062, DOI 10.1074/jbc.M115.676379; Wu YX, 2006, METHODS, V39, P43, DOI 10.1016/j.ymeth.2006.04.004; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	50	23	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8630	8641		10.1074/jbc.M116.770719	http://dx.doi.org/10.1074/jbc.M116.770719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373280	Green Published, hybrid			2022-12-28	WOS:000402153900011
J	Norris, NC; Joseph, S; Aditya, S; Karunasekara, Y; Board, PG; Dulhunty, AF; Oakley, AJ; Casarotto, MG				Norris, Nicole C.; Joseph, Soumya; Aditya, Shouvik; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Oakley, Aaron J.; Casarotto, Marco G.			Structural and biophysical analyses of the skeletal dihydropyridine receptor beta subunit beta(1a) reveal critical roles of domain interactions for stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CA2+ CHANNELS; RYANODINE RECEPTOR; MUSCLE; PROTEINS; COMPLEX	Excitation-contraction (EC) coupling in skeletal muscle requires a physical interaction between the voltage-gated calcium channel dihydropyridine receptor (DHPR) and the ryanodine receptor Ca2+ release channel. Although the exact molecular mechanism that initiates skeletal EC coupling is unresolved, it is clear that both the alpha(1) and beta subunits ofDHPR are essential for this process. Here, we employed a series of techniques, including size-exclusion chromatography-multi-angle light scattering, differential scanning fluorimetry, and isothermal calorimetry, to characterize various biophysical properties of the skeletal DHPR beta subunit beta(1a). Removal of the intrinsically disordered N and C termini and the hook region of beta(1a) prevented oligomerization, allowing for its structural determination by X-ray crystallography. The structure had a topology similar to that of previously determined beta isoforms, which consist of SH3 and guanylate kinase domains. However, transition melting temperatures derived from the differential scanning fluorimetry experiments indicated a significant difference in stability of similar to 2-3 degrees C between the beta(1a) and beta(2a) constructs, and the addition of the DHPR alpha(1s) I-II loop (alpha -interaction domain) peptide stabilized both beta isoforms by similar to 6-8 degrees C. Similar to other beta isoforms, beta(1a) bound with nanomolar affinity to the alpha-interaction domain, but binding affinities were influenced by amino acid substitutions in the adjacent SH3 domain. These results suggest that intramolecular interactions between the SH3 and guanylate kinase domains play a role in the stability of beta(1a) while also providing a conduit for allosteric signaling events.	[Norris, Nicole C.; Joseph, Soumya; Aditya, Shouvik; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] Univ Wollongong, Dept Chem, Wollongong, NSW 2522, Australia	Australian National University; John Curtin School of Medical Research; University of Wollongong	Casarotto, MG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Marco.Casarotto@anu.edu.au	Dulhunty, Angela/AAO-5421-2020; Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X; Dulhunty, Angela/0000-0001-9493-4944; Casarotto, Marco/0000-0002-0571-7671; Joseph, Soumya/0000-0002-0487-1378	Australian National Health; Medical Research Council [APP1020589, APP1002589]	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by grants from Australian National Health and Medical Research Council Grants APP1020589 and APP1002589 (to A.F.D., P.G.B., A.J.O., and M.G.C.) The authors declare that they have no conflicts of interest with the contents of this article.	Bonita R., 2006, BASIC EPIDEMIOLOGY, P73; Campiglio M, 2013, J CELL SCI, V126, P2092, DOI 10.1242/jcs.jcs124537; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Coronado R, 2004, BIOL RES, V37, P565; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eltit JM, 2014, J BIOL CHEM, V289, P36116, DOI 10.1074/jbc.M114.615526; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Karunasekara Y, 2012, FASEB J, V26, P5049, DOI 10.1096/fj.12-211334; Lao QZ, 2010, FASEB J, V24, P5013, DOI 10.1096/fj.10-165381; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Opatowsky Y., 2004, NEURON; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Ristic M, 2015, ACTA CRYSTALLOGR F, V71, P1359, DOI 10.1107/S2053230X15012662; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236	30	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8401	8411		10.1074/jbc.M116.763896	http://dx.doi.org/10.1074/jbc.M116.763896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28351836	hybrid, Green Published			2022-12-28	WOS:000401788600024
J	Bourens, M; Barrientos, A				Bourens, Myriam; Barrientos, Antoni			Human mitochondrial cytochrome c oxidase assembly factor COX18 acts transiently as a membrane insertase within the subunit 2 maturation module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SCO1; GENE; BIOGENESIS; MUTATIONS; COA6; DEFICIENCY; PROTEIN; EXPORT; TAIL; TRANSLATION	Defects in mitochondrial cytochrome c oxidase or respiratory chain complex IV (CIV) assembly are a frequent cause of human mitochondrial disorders. Specifically, mutations in four conserved assembly factors impinging the biogenesis of the mitochondrion-encoded catalytic core subunit 2 (COX2) result in myopathies. These factors afford stability of newly synthesized COX2(the dystonia-ataxia syndrome protein COX20), a protein with two transmembrane domains, and maturation of its copper center, Cu-A (cardiomyopathy proteins SCO1, SCO2, and COA6). COX18 is an additional COX2 assembly factor that belongs to the Oxa1 family of membrane protein insertases. Here, we used a gene-editing approach to generate a human COX18 knock-out HEK293T cell line that displays isolated complete CIV deficiency. We demonstrate that COX20 stabilizes COX2 during insertion of its N-proximal transmembrane domain, and subsequently, COX18 transiently interacts with COX2 to promote translocation across the inner membrane of the COX2 C-tail that contains the apo-CuA site. The release of COX18 from this complex coincides with the binding of the SCO1-SCO2-COA6 copper metallation module to COX2-COX20 to finalize COX2 biogenesis. Therefore, COX18 is a new candidate when screening for mitochondrial disorders associated with isolated CIV deficiency.	[Bourens, Myriam; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA	University of Miami; University of Miami	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA.; Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Neurol Res Bldg NRB 3 103,1600 NW 10th Ave, Miami, FL 33136 USA.	abarrientos@med.miami.edu			NIGMS; National Institutes of Health [GM071775, GM105781, GM112179, R35GM118141]; Muscular Dystrophy Association Grant [381828]; American Heart Association fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118141, R01GM112179, R01GM071775, R01GM105781] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Grant(Muscular Dystrophy Association); American Heart Association fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM071775, GM105781, GM112179, and R35GM118141 (to A. B.), Muscular Dystrophy Association Grant 381828 (to A. B.), and an American Heart Association fellowship (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bourens M, 2017, EMBO REP, V18, P477, DOI 10.15252/embr.201643103; Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Fiumera HL, 2007, MOL CELL BIOL, V27, P4664, DOI 10.1128/MCB.01955-06; Fontanesi F., 2013, MITOCHONDRIAL DISORD, P239; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Gaisne M, 2006, FEMS YEAST RES, V6, P869, DOI 10.1111/j.1567-1364.2006.00083.x; Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069; Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Morgada MN, 2015, P NATL ACAD SCI USA, V112, P11771, DOI 10.1073/pnas.1505056112; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012; Papadopoulou LC, 1999, NAT GENET, V23, P333; POUTRE CG, 1987, GENETICS, V115, P637; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; Valnot I, 2000, AM J HUM GENET, V67, P1104; van Bloois E, 2007, FEBS J, V274, P5704, DOI 10.1111/j.1742-4658.2007.06094.x; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200	39	38	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7774	7783		10.1074/jbc.M117.778514	http://dx.doi.org/10.1074/jbc.M117.778514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28330871	Green Published, hybrid			2022-12-28	WOS:000401154100008
J	Dokanehiifard, S; Yasari, A; Najafi, H; Jafarzadeh, M; Nikkhah, M; Mowla, SJ; Soltani, BM				Dokanehiifard, Sadat; Yasari, Atena; Najafi, Hadi; Jafarzadeh, Meisam; Nikkhah, Maryam; Mowla, Seyed Javad; Soltani, Bahram M.			A novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						annexin; biomarker; cancer; cell cycle; colorectal cancer; TrkC-miR2; Survival; Wnt signaling; Colorectal cancer; Biomarker	COLON-CANCER; NEUROTROPHIN RECEPTORS; TUMOR-SUPPRESSOR; CELL-SURVIVAL; BETA-CATENIN; IDENTIFICATION; PROGRESSION; METASTASIS; ACTIVATION; BIOMARKERS	Tropomyosin receptor kinase C (TrkC) is involved in cell survival, apoptosis, differentiation, and tumorigenesis. TrkC diverse functions might be attributed to the hypothetical non-coding RNAs embedded within the gene. Using bioinformatics approaches, a novel microRNA named TrkC-miR2 was predicted within the TrkC gene capable of regulating the Wnt pathway. For experimental verification of this microRNA, the predicted TrkC-premir2 sequence was overexpressed in SW480 cells, which led to the detection of two mature TrkC-miR2 isomiRs, and their endogenous forms were detected in human cell lines as well. Later, an independent promoter was deduced for TrkC-miR2 after the treatment of HCT116 cells with 5-azacytidine, which resulted in differential expression of TrkC-miR2 and TrkC host gene. RT-quantitative PCR and luciferase assays indicated that the APC2 gene is targeted by TrkC-miR2, and Wnt signaling is up-regulated. Also, Wnt inhibition by using small molecules along with TrkC-miR2 overexpression and TOP/FOP flash assays confirmed the positive effect of TrkC-miR2 on the Wnt pathway. Consistently, TrkC-miR2 overexpression promoted SW480 cell survival, which was detected by flow cytometry, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays, and crystal violate analysis. RT-qPCR analysis revealed that TrkC-miR2 is significantly up-regulated (approximate to 70 times) in colorectal tumor tissues compared with their normal pairs. Moreover, the TrkC-miR2 expression level discriminated grades of tumor malignancies, which was consistent with its endogenous levels in HCT116, HT29, and SW480 colorectal cancer cell lines. Finally, an opposite expression pattern was observed for TrkC-miR2 and the APC2 gene in colorectal cancer specimens. In conclusion, here we introduce TrkC-miR2 as a novel regulator of Wnt signaling, which might be a candidate oncogenic colorectal cancer biomarker.	[Dokanehiifard, Sadat; Yasari, Atena; Najafi, Hadi; Jafarzadeh, Meisam; Mowla, Seyed Javad; Soltani, Bahram M.] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran 11114115, Iran; [Nikkhah, Maryam] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran 11114115, Iran	Tarbiat Modares University; Tarbiat Modares University	Soltani, BM (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran 11114115, Iran.	soltanib@modares.ac.ir	Jafarzadeh, Meisam/AAT-9666-2020; Soltani, Bahram/ABH-2649-2021; Dokaneheifard, Sadat/AAE-2871-2020	Soltani, Bahram/0000-0003-2468-901X; Yasari, Atena/0000-0003-1785-0039; Najafi, Hadi/0000-0002-1885-6689; Mowla, Seyed Javad/0000-0002-3300-6332	Tarbiat Modares University; Iran National Science Foundation [91001522]	Tarbiat Modares University; Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by financial aid from Tarbiat Modares University and Iran National Science Foundation Grant 91001522. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cammarata PR, 2015, MOL VIS, V21, P1024; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Demilly A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2915; Dokanehiifard S, 2015, CELL MOL LIFE SCI, V72, P2613, DOI 10.1007/s00018-015-1868-4; Genevois AL, 2013, P NATL ACAD SCI USA, V110, P3017, DOI 10.1073/pnas.1212333110; Gomes Clarissa P. C., 2013, Frontiers in Genetics, V4, P81, DOI 10.3389/fgene.2013.00081; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Hartwell L, 2006, NAT BIOTECHNOL, V24, P905, DOI 10.1038/nbt0806-905; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kalkman HO, 2009, PHARMACOL THERAPEUT, V121, P115, DOI 10.1016/j.pharmthera.2008.11.002; KONDOH N, 1992, CANCER RES, V52, P791; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar S, 1998, J NEUROSCI RES, V54, P754, DOI 10.1002/(SICI)1097-4547(19981215)54:6<754::AID-JNR3>3.0.CO;2-K; Kunttas-Tatli E, 2012, GENETICS, V190, P1059, DOI 10.1534/genetics.111.133280; Li BS, 2013, PLANT MOL BIOL, V81, P525, DOI 10.1007/s11103-013-0010-y; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027496; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003552; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; McGregor LM, 1999, P NATL ACAD SCI USA, V96, P4540, DOI 10.1073/pnas.96.8.4540; McInroy L, 2011, EXP CELL RES, V317, P2468, DOI 10.1016/j.yexcr.2011.07.013; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Parsi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035561; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	53	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7566	7577		10.1074/jbc.M116.760710	http://dx.doi.org/10.1074/jbc.M116.760710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28100780	Green Published, hybrid			2022-12-28	WOS:000400761300024
J	Mookerjee, SA; Gerencser, AA; Nicholls, DG; Brand, MD				Mookerjee, Shona A.; Gerencser, Akos A.; Nicholls, David G.; Brand, Martin D.			Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPARE RESPIRATORY CAPACITY; AEROBIC GLYCOLYSIS; ADENOSINE-TRIPHOSPHATE; MITOCHONDRIAL; INHIBITION; METABOLISM; STRESS; DEMAND; SODIUM; INDEX	Partitioning of ATP generation between glycolysis and oxidative phosphorylation is central to cellular bioenergetics but cumbersome to measure. We describe here how rates of ATP generation by each pathway can be calculated from simultaneous measurements of extracellular acidification and oxygen consumption. We update theoretical maximum ATP yields by mitochondria and cells catabolizing different substrates. Mitochondrial P/O ratios (mol of ATP generated per mol of [O] consumed) are 2.73 for oxidation of pyruvate plus malate and 1.64 for oxidation of succinate. Complete oxidation of glucose by cells yields up to 33.45 ATP/glucose with a maximum P/O of 2.79. We introduce novel indices to quantify bioenergetic phenotypes. The glycolytic index reports the proportion of ATP production from glycolysis and identifies cells as primarily glycolytic (glycolytic index > 50%) or primarily oxidative. The Warburg effect is a chronic increase in glycolytic index, quantified by the Warburg index. Additional indices quantify the acute flexibility of ATP supply. The Crabtree index and Pasteur index quantify the responses of oxidative and glycolytic ATP production to alterations in glycolysis and oxidative reactions, respectively; the supply flexibility index quantifies overall flexibility of ATP supply; and the bioenergetic capacity quantifies the maximum rate of total ATP production. We illustrate the determination of these indices using C2C12 myoblasts. Measurement of ATP use revealed no significant preference for glycolytic or oxidative ATP by specific ATP consumers. Overall, we demonstrate how extracellular fluxes quantitatively reflect intracellular ATP turnover and cellular bioenergetics. We provide a simple spreadsheet to calculate glycolytic and oxidative ATP production rates from raw extracellular acidification and respiration data.	[Mookerjee, Shona A.; Brand, Martin D.] Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA; [Mookerjee, Shona A.; Gerencser, Akos A.; Nicholls, David G.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Touro University California; Buck Institute for Research on Aging	Mookerjee, SA (corresponding author), Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA.; Mookerjee, SA (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	shona.mookerjee@tu.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153				Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Arora R, 2015, ONCOTARGET, V6, P662, DOI 10.18632/oncotarget.2689; Barnett JA, 2005, YEAST, V22, P835, DOI 10.1002/yea.1249; BEUTLER E, 1978, P NATL ACAD SCI USA, V75, P2825, DOI 10.1073/pnas.75.6.2825; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 1996, J THEOR BIOL, V182, P351, DOI 10.1006/jtbi.1996.0174; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; BRAND MD, 1984, BIOCHEM J, V224, P1027, DOI 10.1042/bj2241027; BUTTGEREIT F, 1992, BIOSCIENCE REP, V12, P381, DOI 10.1007/BF01121501; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Chacko BK, 2016, REDOX BIOL, V8, P43, DOI 10.1016/j.redox.2015.12.008; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; FELBER SM, 1983, BIOCHEM J, V210, P893, DOI 10.1042/bj2100893; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; IBSEN KH, 1961, CANCER RES, V21, P829; James AD, 2015, J BIOL CHEM, V290, P24760, DOI 10.1074/jbc.M115.668707; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Mangnall David, 1993, Biochemical Society Transactions, V21, p438S; MERCER RW, 1981, J GEN PHYSIOL, V78, P547, DOI 10.1085/jgp.78.5.547; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Mouradian M, 2015, MOL CARCINOGEN, V54, P810, DOI 10.1002/mc.22151; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nicholls D. G., 2010, JOVE-J VIS EXP, DOI 10.3791/2511; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NICHOLLS DG, 1979, BIOCHIM BIOPHYS ACTA, V549, P1, DOI 10.1016/0304-4173(79)90016-8; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; STICKLAND LH, 1956, BIOCHEM J, V64, P503, DOI 10.1042/bj0640503; THOMPSON J, 1984, J BACTERIOL, V158, P791, DOI 10.1128/JB.158.3.791-800.1984; Tourmente M, 2015, J BIOL CHEM, V290, P20613, DOI 10.1074/jbc.M115.664813; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vayalil PK, 2015, ONCOTARGET, V6, P43065, DOI 10.18632/oncotarget.5487; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007	44	183	185	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7189	7207		10.1074/jbc.M116.774471	http://dx.doi.org/10.1074/jbc.M116.774471			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28270511	hybrid, Green Published			2022-12-28	WOS:000400478300030
J	Zufferey, M; Montandon, C; Douet, V; Demarsy, E; Agne, B; Baginsky, S; Kessler, F				Zufferey, Monica; Montandon, Cyrille; Douet, Veronique; Demarsy, Emilie; Agne, Birgit; Baginsky, Sacha; Kessler, Felix			The novel chloroplast outer membrane kinase KOC1 is a required component of the plastid protein import machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; PREPROTEIN RECEPTOR; ARABIDOPSIS CHLOROPLASTS; DISTINCT PATHWAYS; GTP-BINDING; IN-VIVO; TOC159; BIOGENESIS; TRANSLOCATION; COMPLEX	The biogenesis and maintenance of cell organelles such as mitochondria and chloroplasts require the import of many proteins from the cytosol, a process that is controlled by phosphorylation. In the case of chloroplasts, the import of hundreds of different proteins depends on translocons at the outer and inner chloroplast membrane (TOC and TIC, respectively) complexes. The essential protein TOC159 functions thereby as an import receptor. It has an N-terminal acidic (A-) domain that extends into the cytosol, controls receptor specificity, and is highly phosphorylated in vivo. However, kinases that phosphorylate the TOC159 A-domain to enable protein import have remained elusive. Here, using co-purification with TOC159 from Arabidopsis, we discovered a novel component of the chloroplast import machinery, the regulatory kinase at the outer chloroplast membrane 1 (KOC1). We found that KOC1 is an integral membrane protein facing the cytosol and stably associates with TOC. Moreover, KOC1 phosphorylated the A-domain of TOC159 in vitro, and in mutant koc1 chloroplasts, preprotein import efficiency was diminished. koc1 Arabidopsis seedlings had reduced survival rates after transfer from the dark to the light in which protein import into plastids is required to rapidly complete chloroplast biogenesis. In summary, our data indicate that KOC1 is a functional component of the TOC machinery that phosphorylates import receptors, supports preprotein import, and contributes to efficient chloroplast biogenesis.	[Zufferey, Monica; Douet, Veronique; Kessler, Felix] Univ Neuchatel, Lab Plant Physiol, CH-2000 Neuchatel, Switzerland; [Montandon, Cyrille] Cornell Univ, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Demarsy, Emilie] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Agne, Birgit; Baginsky, Sacha] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Saale, Germany	University of Neuchatel; Cornell University; University of Geneva; Martin Luther University Halle Wittenberg	Kessler, F (corresponding author), Univ Neuchatel, Lab Plant Physiol, CH-2000 Neuchatel, Switzerland.	felix.kessler@unine.ch	Kessler, Felix Henrique/AAO-1722-2020	Kessler, Felix/0000-0001-6409-5043; Baginsky, Sacha/0000-0002-5440-3898	University of Neuchatel; Swiss National Science Foundation [31003A_156998, IZEBZ0_143169]	University of Neuchatel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	lThis work was supported by the University of Neuchatel and Swiss National Science Foundation Grants 31003A_156998 and IZEBZ0_143169. The authors declare that they have no conflicts of interest with the contents of this article.	Agne B, 2010, PLANT PHYSIOL, V153, P1016, DOI 10.1104/pp.110.158048; Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andres C, 2010, BBA-MOL CELL RES, V1803, P715, DOI 10.1016/j.bbamcr.2010.03.004; Aronsson H, 2006, FEBS LETT, V580, P649, DOI 10.1016/j.febslet.2005.12.055; Aronsson H, 2010, PLANT J, V63, P297, DOI 10.1111/j.1365-313X.2010.04242.x; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Demarsy E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00483; Dhanoa PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010098; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Flores-Perez U, 2013, BBA-MOL CELL RES, V1833, P332, DOI 10.1016/j.bbamcr.2012.03.019; Fulgosi H, 2002, J BIOL CHEM, V277, P8934, DOI 10.1074/jbc.M110679200; Gerbeth C, 2013, CELL METAB, V18, P578, DOI 10.1016/j.cmet.2013.09.006; Helm S, 2014, J PROTEOMICS, V98, P79, DOI 10.1016/j.jprot.2013.12.007; Hiltbrunner A, 2001, BIOCHEM CELL BIOL, V79, P629, DOI 10.1139/bcb-79-5-629; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Inoue H, 2010, PLANT CELL, V22, P1947, DOI 10.1105/tpc.110.074328; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kessler F, 2004, TRENDS CELL BIOL, V14, P334, DOI 10.1016/j.tcb.2004.05.004; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kessler F, 2012, SCIENCE, V338, P622, DOI 10.1126/science.1230658; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kim DH, 2013, TRAFFIC, V14, P613, DOI 10.1111/tra.12043; Kohler D, 2015, PLANT PHYSIOL, V167, P972, DOI 10.1104/pp.114.255562; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Lee KH, 2003, J BIOL CHEM, V278, P36794, DOI 10.1074/jbc.M304457200; Ling QH, 2015, CURR BIOL, V25, P2527, DOI 10.1016/j.cub.2015.08.015; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; Nakai M, 2015, BBA-BIOENERGETICS, V1847, P957, DOI 10.1016/j.bbabio.2015.02.011; Paila YD, 2016, ELIFE, V5, DOI 10.7554/eLife.12631; Paila YD, 2015, J MOL BIOL, V427, P1038, DOI 10.1016/j.jmb.2014.08.016; Richardson LGL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00269; Richardson LGL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-35; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Schnell DJ, 1997, TRENDS CELL BIOL, V7, P303, DOI 10.1016/S0962-8924(97)01111-2; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smith Matthew D, 2003, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1116s17; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Sveshnikova N, 2000, P NATL ACAD SCI USA, V97, P4973, DOI 10.1073/pnas.080491597; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	56	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6952	6964		10.1074/jbc.M117.776468	http://dx.doi.org/10.1074/jbc.M117.776468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283569	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000400478300008
J	Kang, JY; Chadchankar, J; Vien, TN; Mighdoll, MI; Hyde, TM; Mather, RJ; Deeb, TZ; Pangalos, MN; Brandon, NJ; Dunlop, J; Moss, SJ				Kang, Ji-Yong; Chadchankar, Jayashree; Vien, Thuy N.; Mighdoll, Michelle I.; Hyde, Thomas M.; Mather, Robert J.; Deeb, Tarek Z.; Pangalos, Menelas N.; Brandon, Nicholas J.; Dunlop, John; Moss, Stephen J.			Deficits in the activity of presynaptic gamma-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMORTEM HUMAN BRAIN; GABA(B) RECEPTOR; MOUSE MODEL; METABOTROPIC GLUTAMATE; SUSHI DOMAINS; KNOCKOUT MICE; PROTEIN; EXPRESSION; FMR1; GENE	The behavioral and anatomical deficits seen in fragile X syndrome (FXS) are widely believed to result from imbalances in the relative strengths of excitatory and inhibitory neurotransmission. Although modified neuronal excitability is thought to be of significance, the contribution that alterations in GABAergic inhibition play in the pathophysiology of FXS are ill defined. Slow sustained neuronal inhibition is mediated by alpha-aminobutyric acid type B (GABAB) receptors, which are heterodimeric G-protein-coupled receptors constructed from R1a and R2 or R1b and R2 subunits. Via the activation of Gi/o, they limit cAMP accumulation, diminish neurotransmitter release, and induce neuronal hyperpolarization. Here we reveal that selective deficits in R1a subunit expression are seen in Fmr1 knock-out mice (KO) mice, a widely used animal model of FXS, but the levels of the respective mRNAs were unaffected. Similar trends of R1a expression were seen in a subset of FXS patients. GABAB receptors (GABA(B)Rs) exert powerful pre-and postsynaptic inhibitory effects on neurotransmission. R1a-containing GABA(B)Rs are believed to mediate presynaptic inhibition in principal neurons. In accordance with this result, deficits in the ability of GABA(B)Rs to suppress glutamate release were seen in Fmr1-KO mice. In contrast, the ability of GABA(B)Rs to suppress GABA release and induce postsynaptic hyperpolarization was unaffected. Significantly, this deficit contributes to the pathophysiology of FXS as the GABA(B)R agonist (R)baclofen rescued the imbalances between excitatory and inhibitory neurotransmission evident in Fmr1-KO mice. Col-lectively, our results provided evidence that selective deficits in the activity of presynaptic GABA(B)Rs contribute to the pathophysiology of FXS.	[Kang, Ji-Yong; Chadchankar, Jayashree; Vien, Thuy N.; Mather, Robert J.; Deeb, Tarek Z.; Brandon, Nicholas J.; Dunlop, John; Moss, Stephen J.] Tufts Univ, Sch Med, AstraZeneca Tufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Mighdoll, Michelle I.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Mather, Robert J.; Brandon, Nicholas J.; Dunlop, John; Moss, Stephen J.] AstraZeneca, Neurosci Innovat Med & Early Dev, Waltham, MA 02451 USA; [Pangalos, Menelas N.] AstraZeneca, Innovat Med & Early Dev, Melbourn Sci Pk,Cambridge Rd, Royston SG8 6EE, Herts, England; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Tufts University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; AstraZeneca; AstraZeneca; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu		Brandon, Nicholas/0000-0002-3917-0096	National Institutes of Health NINDS [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIMH [MH097446]; United States Department of Defense [AR140209]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087662, R01NS056359, R21NS080064, R01NS051195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037170] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health NINDS Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 and NIMH Grant MH097446 and United States Department of Defense Grant AR140209 (to S. J. M.). S. J. M. serves as a consultant for AstraZeneca and SAGE Therapeutics, relationships that are regulated by Tufts University and do not impact this study. At the time this work was conducted, R. J. M., M. N. P., N. J. B., and J. D. were full-time employees and shareholders in AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bakker CE, 2003, CYTOGENET GENOME RES, V100, P111, DOI 10.1159/000072845; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Benke Dietmar, 2015, Adv Pharmacol, V73, P41, DOI 10.1016/bs.apha.2014.11.002; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Cea-Del Rio CA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00245; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Chiurazzi P, 2003, CURR OPIN PEDIATR, V15, P559, DOI 10.1097/00008480-200312000-00003; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cullen PK, 2014, LEARN MEMORY, V21, P180, DOI 10.1101/lm.032961.113; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; D'Hulst C, 2009, BRAIN RES, V1253, P176, DOI 10.1016/j.brainres.2008.11.075; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Erickson CA, 2014, J AUTISM DEV DISORD, V44, P958, DOI 10.1007/s10803-013-1963-z; Gao XP, 2011, J PHYSIOL-LONDON, V589, P1991, DOI 10.1113/jphysiol.2010.198945; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Hannan S, 2016, CELL REP, V16, P1962, DOI 10.1016/j.celrep.2016.07.021; Hannan S, 2012, P NATL ACAD SCI USA, V109, P12171, DOI 10.1073/pnas.1201660109; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jacob TC, 2012, P NATL ACAD SCI USA, V109, P18595, DOI 10.1073/pnas.1204994109; Jacobson LH, 2006, J NEUROSCI, V26, P8800, DOI 10.1523/JNEUROSCI.2076-06.2006; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kasten CR, 2015, NEUROSCI BIOBEHAV R, V57, P70, DOI 10.1016/j.neubiorev.2015.08.007; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kooy RF, 2003, TRENDS GENET, V19, P148; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; Kunii Y, 2014, MOL PSYCHIATR, V19, P192, DOI 10.1038/mp.2012.174; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Maurin T, 2014, NEUROSCI BIOBEHAV R, V46, P242, DOI 10.1016/j.neubiorev.2014.01.006; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pacey LKK, 2011, J PHARMACOL EXP THER, V338, P897, DOI 10.1124/jpet.111.183327; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Pasciuto E, 2014, CELL, V158, P1446, DOI 10.1016/j.cell.2014.08.035; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rotschafer SE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00019; Schaefer TL, 2015, APPL CLIN GENET, V8, P75, DOI 10.2147/TACG.S35673; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Skov J, 2011, CELL MOL NEUROBIOL, V31, P587, DOI 10.1007/s10571-011-9652-y; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Zhang Wen-liang, 2007, Proceedings of the CSEE, V27, P1	60	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6621	6632		10.1074/jbc.M116.772541	http://dx.doi.org/10.1074/jbc.M116.772541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28213518	Green Published, hybrid			2022-12-28	WOS:000399813400015
J	Landeta, C; Meehan, BM; McPartland, L; Ingendahl, L; Hatahet, F; Tran, NQ; Boyd, D; Beckwith, J				Landeta, Cristina; Meehan, Brian M.; McPartland, Laura; Ingendahl, Linda; Hatahet, Feras; Tran, Ngoc Q.; Boyd, Dana; Beckwith, Jon			Inhibition of virulence-promoting disulfide bond formation enzyme DsbB is blocked by mutating residues in two distinct regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNATURE-TAGGED MUTAGENESIS; BARREL ASSEMBLY MACHINE; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12; FORMATION IN-VIVO; RESPIRATORY-CHAIN; FORMATION PATHWAY; IDENTIFICATION; COMPLEX; SYSTEM	Disulfide bonds contribute to protein stability, activity, and folding in a variety of proteins, including many involved in bacterial virulence such as toxins, adhesins, flagella, and pili, among others. Therefore, inhibitors of disulfide bond formation enzymes could have profound effects on pathogen virulence. In the Escherichia coli disulfide bond formation pathway, the periplasmic protein DsbA introduces disulfide bonds into substrates, and then the cytoplasmic membrane protein DsbB reoxidizes DsbA's cysteines regenerating its activity. Thus, DsbB generates a protein disulfide bond de novo by transferring electrons to the quinone pool. Wepreviously identified an effective pyridazinone-related inhibitor of DsbB enzymes from several Gram-negative bacteria. To map the protein residues that are important for the interaction with this inhibitor, we randomly mutagenized by error-prone PCR the E. coli dsbB gene and selected dsbB mutants that confer resistance to this drug using two approaches. We characterized in vivo and in vitro some of these mutants that map to two areas in the structure of DsbB, one located between the two first transmembrane segments where the quinone ring binds and the other located in the second periplasmic loop of DsbB, which interacts with DsbA. In addition, we show that a mutant version of a protein involved in lipopolysaccharide assembly, lptD4213, is synthetically lethal with the deletion of dsbB as well as with DsbB inhibitors. This finding suggests that drugs decreasing LptD assembly may be synthetically lethal with inhibitors of the Dsb pathway, potentiating the antibiotic effects.	[Landeta, Cristina; Meehan, Brian M.; McPartland, Laura; Ingendahl, Linda; Hatahet, Feras; Tran, Ngoc Q.; Boyd, Dana; Beckwith, Jon] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	Jon_Beckwith@hms.harvard.edu	Landeta, Cristina/AAQ-4320-2020	Landeta, Cristina/0000-0003-4065-9646	National Institutes of Health Grant from NIGMS [GMO41883]; Blavatnik Biomedical Accelerator at Harvard University; F. Hoffmann-La Roche Ltd.; F. Hoffmann-La Roche Inc.; Consejo Nacional de Ciencia y Tecnologia (CONACYT); Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Blavatnik Biomedical Accelerator at Harvard University; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); F. Hoffmann-La Roche Inc.(Hoffmann-La Roche); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GMO41883 from NIGMS (to J. B. and D. B.), by the Blavatnik Biomedical Accelerator at Harvard University (to J. B.), and by an industry research agreement with F. Hoffmann-La Roche Ltd. and F. Hoffmann-La Roche Inc. (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Consejo Nacional de Ciencia y Tecnologia (CONACYT) postdoctoral fellowship.; Supported by a Ruth L. Kirschstein National Research Service Award.	Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; GIGOT D, 1980, J BACTERIOL, V143, P914, DOI 10.1128/JB.143.2.914-920.1980; Gonzalez MD, 2001, FEMS MICROBIOL LETT, V198, P125, DOI 10.1111/j.1574-6968.2001.tb10630.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Himpsl SD, 2008, J MED MICROBIOL, V57, P1068, DOI 10.1099/jmm.0.2008/002071-0; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Landeta C, 2015, NAT CHEM BIOL, V11, P292, DOI [10.1038/NCHEMBIO.1752, 10.1038/nchembio.1752]; Lasica AM, 2010, J APPL GENET, V51, P383, DOI 10.1007/BF03208868; Lee J, 2016, P NATL ACAD SCI USA, V113, P8717, DOI 10.1073/pnas.1604100113; Meehan BM, 2017, MOL MICROBIOL, V103, P413, DOI 10.1111/mmi.13565; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NEWTON NA, 1971, BIOCHIM BIOPHYS ACTA, V244, P155, DOI 10.1016/0304-4165(71)90132-2; Regeimbal J, 2003, P NATL ACAD SCI USA, V100, P13779, DOI 10.1073/pnas.1935988100; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Rosadini CV, 2008, INFECT IMMUN, V76, P1498, DOI 10.1128/IAI.01378-07; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; SAMPSON BA, 1989, GENETICS, V122, P491; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Straskova A, 2009, J PROTEOME RES, V8, P5336, DOI 10.1021/pr900570b; Tellez R, 2012, J BACTERIOL, V194, P317, DOI 10.1128/JB.06192-11; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Wang XY, 2011, ANTIOXID REDOX SIGN, V14, P1413, DOI 10.1089/ars.2010.3558; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	45	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6529	6541		10.1074/jbc.M116.770891	http://dx.doi.org/10.1074/jbc.M116.770891			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28232484	Green Published, hybrid			2022-12-28	WOS:000399813400009
J	Fujiki, R; Hijikata, A; Shirai, T; Okada, S; Kobayashi, M; Ohara, O				Fujiki, Ryoji; Hijikata, Atsushi; Shirai, Tsuyoshi; Okada, Satoshi; Kobayashi, Masao; Ohara, Osamu			Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INBORN-ERRORS; ACTIVATION	Gain-of-function (GOF) mutations in the STAT1 gene are critical for the onset of chronic mucocutaneous candidiasis (CMC) disease. However, the molecular basis for the gain of STAT1 function remains largely unclear. Here, we investigated the structural features of STAT1 GOF residues to better understand the impact of these pathogenic mutations. We constructed STAT1 alanine mutants of the alpha 3 helix residues of the coiled-coil domain, which are frequently found in CMC pathogenic mutations, and measured their transcriptional activities. Most of the identified GOF residues were located inside the coiled-coil domain stem structure or at the protein surface of the anti-parallel dimer interface. Unlike those, Arg-274 was adjacent to the DNA-binding domain. In addition, Arg-274 was found to functionally interact with Gln-441 in the DNA-binding domain. Because Gln-441 is located at the anti-parallel dimer contact site, Gln-441 reorientation by Arg-274 mutation probably impedes formation of the dimer. Further, the statistical analysis of RNA-seq data with STAT1-deficient epithelial cells and primary T cells from a CMC patient revealed that the R274Q mutation affected gene expression levels of 66 and 76 non-overlapping RefSeq genes, respectively. Because their transcription levels were only slightly modulated by wild-type STAT1, we concluded that the R274Q mutation increased transcriptional activity but did not change dramatically the repertoire of STAT1 targets. Hence, we provide a novel mechanism of STAT1 GOF triggered by a CMC pathogenic mutation.	[Fujiki, Ryoji; Ohara, Osamu] Kazusa DNA Res Inst, Dev Technol Dept, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Hijikata, Atsushi; Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, 1266 Tamura, Nagahama, Shiga 5260829, Japan; [Okada, Satoshi; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan	Kazusa DNA Research Institute; Hiroshima University	Fujiki, R (corresponding author), Kazusa DNA Res Inst, Dev Technol Dept, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan.	fujiki@kazusa.or.jp	Okada, Satoshi/B-8901-2011; Ohara, Osamu/G-5448-2015	Okada, Satoshi/0000-0002-4622-5657; Ohara, Osamu/0000-0002-3328-9571; Hijikata, Atsushi/0000-0003-4297-8368	Platform for Drug Design, Informatics, and Structural Lifescience (PDIS); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [15K00411] Funding Source: KAKEN	Platform for Drug Design, Informatics, and Structural Lifescience (PDIS); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Platform for Drug Design, Informatics, and Structural Lifescience (PDIS) and by the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Bonjardim CA, 1998, BRAZ J MED BIOL RES, V31, P1389, DOI 10.1590/S0100-879X1998001100004; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hoey T, 1998, CURR OPIN GENET DEV, V8, P582, DOI 10.1016/S0959-437X(98)80015-4; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Liu LD, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-2; Mao X, 2005, ACTA CRYSTALLOGR F, V61, P666, DOI 10.1107/S1744309105017392; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	21	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6240	6254		10.1074/jbc.M116.753848	http://dx.doi.org/10.1074/jbc.M116.753848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258222	Green Published, hybrid			2022-12-28	WOS:000399538700019
J	Moutkine, I; Quentin, E; Guiard, BP; Maroteaux, L; Doly, S				Moutkine, Imane; Quentin, Emily; Guiard, Bruno P.; Maroteaux, Luc; Doly, Stephane			Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIAL PREFRONTAL CORTEX; DORSAL RAPHE NUCLEUS; G-PROTEIN; RAT-BRAIN; NOREPINEPHRINE NEURONS; FUNCTIONAL SELECTIVITY; DEPENDENT MECHANISM; FIRING ACTIVITY; MESSENGER-RNAS; 5-HYDROXYTRYPTAMINE	The serotonin receptor subtypes 2 comprise 5-HT2A,5-HT2B, and 5-HT2C, which are G alpha(q)-coupled receptors and display distinct pharmacological properties. Although co-expressed in some brain regions and involved in various neurological disorders, their functional interactions have not yet been studied. We report that 5-HT2 receptors can form homo-and heterodimers when expressed alone or co-expressed in transfected cells. Co-immunoprecipitation and bioluminescence resonance energy transfer studies confirmed that 5-HT2C receptors interact with either 5-HT2A or 5-HT2B receptors. Although heterodimerization with 5-HT2C receptors does not alter 5-HT2C G alpha(q)-dependent inositol phosphate signaling, 5-HT2A or 5-HT2B receptor-mediated signaling was totally blunted. This feature can be explained by a dominance of 5-HT2C on 5-HT2A and 5-HT2B receptor binding; in 5-HT2C-containing heterodimers, ligands bind and activate the 5-HT2C protomer exclusively. This dominant effect on the associated protomer was also observed in neurons, supporting the physiological relevance of 5-HT2 receptor heterodimerization in vivo. Accordingly, exogenous expression of an inactive form of the 5-HT2C receptor in the locus ceruleus is associated with decreased 5-HT2A-dependent noradrenergic transmission. These data demonstrate that 5-HT2 receptors can form functionally asymmetric heterodimers in vitro and in vivo that must be considered when analyzing the physiological or pathophysiological roles of serotonin in tissues where 5-HT2 receptors are co-expressed.	[Moutkine, Imane; Quentin, Emily; Maroteaux, Luc] INSERM, UMR S839, F-75005 Paris, France; [Moutkine, Imane; Quentin, Emily; Maroteaux, Luc] Univ Paris 06, F-75005 Paris, France; [Moutkine, Imane; Quentin, Emily; Maroteaux, Luc] Inst Fer Moulin, F-75005 Paris, France; [Doly, Stephane] Inst Cochin, CNRS UMR8104, INSERM U1016, F-75014 Paris, France; [Doly, Stephane] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Doly, Stephane] Univ Clermont Auvergne, INSERM, NEURO DOL, F-63000 Clermont Ferrand, France; [Guiard, Bruno P.] Univ Paul Sabatier, Res Ctr Anim Cognit, Ctr Integrat Biol, CNRS UMR5169, 118 Route Narbonne, F-31062 Toulouse 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Maroteaux, L (corresponding author), INSERM, UMR S839, F-75005 Paris, France.; Maroteaux, L (corresponding author), Univ Paris 06, F-75005 Paris, France.; Maroteaux, L (corresponding author), Inst Fer Moulin, F-75005 Paris, France.; Doly, S (corresponding author), Univ Clermont Auvergne, INSERM, NEURO DOL, F-63000 Clermont Ferrand, France.	Luc.maroteaux@upmc.fr; stephane.doly@inserm.fr	Guiard, Bruno/A-3955-2016; Maroteaux, Luc/H-4585-2019; Core, Vector/CAF-4832-2022; doly, stephane/Y-2318-2019	Maroteaux, Luc/0000-0002-9499-8603; doly, stephane/0000-0002-3517-8605	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Universite Paris Descartes; Fondation de France; Fondation pour la Recherche Medicale "Equipe" [FRM DEQ2014039529]; French Ministry of Research [ANR-12-BSV1-0015-01]; Investissements d'Avenir Programme [ANR-11-IDEX-0004-02]; French state funds; ANR within the Investissements d'Avenir programme [ANR-11-IDEX-0004-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Universite Paris Descartes; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale "Equipe"(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Investissements d'Avenir Programme(French National Research Agency (ANR)); French state funds; ANR within the Investissements d'Avenir programme(French National Research Agency (ANR))	This work was supported by funds from the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, the Universite Paris Descartes, grants from the Fondation de France, Fondation pour la Recherche Medicale "Equipe FRM DEQ2014039529," and the French Ministry of Research (Agence Nationale pour la Recherche Grant ANR-12-BSV1-0015-01 and the Investissements d'Avenir Programme Grant ANR-11-IDEX-0004-02). The L.M. team is part of the Ecole des Neurosciences de Paris Ile-de-France network and the Bio-Psy Labex, and as such this work was supported by French state funds managed by the ANR within the Investissements d'Avenir programme under Reference ANR-11-IDEX-0004-02. The authors declare that they have no conflicts of interest with the contents of this article.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; AGHAJANIAN GK, 1982, J HISTOCHEM CYTOCHEM, V30, P813, DOI 10.1177/30.8.6749973; Albizu L, 2011, NEUROPHARMACOLOGY, V61, P770, DOI 10.1016/j.neuropharm.2011.05.023; Anastasio NC, 2015, ACS CHEM NEUROSCI, V6, P1248, DOI 10.1021/acschemneuro.5b00094; Banas SM, 2011, NEUROPSYCHOPHARMACOL, V36, P423, DOI 10.1038/npp.2010.173; Beique JC, 2004, J PHYSIOL-LONDON, V556, P739, DOI 10.1113/jphysiol.2003.051284; Beique JC, 2004, J NEUROSCI, V24, P4807, DOI 10.1523/JNEUROSCI.5113-03.2004; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn LM, 2010, CRIT REV BIOCHEM MOL, V45, P555, DOI 10.3109/10409238.2010.516741; Bombardi C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00068; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Boothman LJ, 2005, NEUROREPORT, V16, P891, DOI 10.1097/00001756-200506210-00004; Bortolozzi A, 2003, NEUROPSYCHOPHARMACOL, V28, P421, DOI 10.1038/sj.npp.1300061; Brea J, 2009, MOL PHARMACOL, V75, P1380, DOI 10.1124/mol.108.054395; Bubar MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020508; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Carr DB, 2002, J NEUROSCI, V22, P6846; Cornea-Hebert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P; Cussac D, 2012, CELL SIGNAL, V24, P1648, DOI 10.1016/j.cellsig.2012.04.010; Deraet M, 2005, MOL PHARMACOL, V67, P983, DOI 10.1124/mol.104.008268; Diaz SL, 2012, MOL PSYCHIATR, V17, P154, DOI 10.1038/mp.2011.159; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Doly S, 2004, J COMP NEUROL, V472, P496, DOI 10.1002/cne.20082; Du YZ, 2006, GENE, V382, P39, DOI 10.1016/j.gene.2006.06.007; Esposito E, 2006, CURR DRUG TARGETS, V7, P177, DOI 10.2174/138945006775515455; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2013, EXP BRAIN RES, V230, P375, DOI 10.1007/s00221-013-3622-1; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Janoshazi A, 2007, MOL PHARMACOL, V71, P1463, DOI 10.1124/mol.106.032656; Jastrzebska B, 2013, AMINO ACIDS, V45, P1303, DOI 10.1007/s00726-013-1593-y; Kamal M, 2015, J BIOL CHEM, V290, P11537, DOI 10.1074/jbc.M114.559542; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Lukasiewicz S, 2007, PHARMACOL REP, V59, P379; Maeshima T, 1998, NEUROSCI LETT, V252, P72, DOI 10.1016/S0304-3940(98)00546-1; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Moreno JL, 2012, J BIOL CHEM, V287, P44301, DOI 10.1074/jbc.M112.413161; Nocjar C, 2015, NEUROSCIENCE, V297, P22, DOI 10.1016/j.neuroscience.2015.03.050; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Quesseveur G, 2013, EXP BRAIN RES, V226, P285, DOI 10.1007/s00221-013-3434-3; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Roth BL, 2011, NEUROPHARMACOLOGY, V61, P348, DOI 10.1016/j.neuropharm.2011.01.012; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Siddiquee K, 2013, BRIT J PHARMACOL, V168, P1104, DOI 10.1111/j.1476-5381.2012.02192.x; Smith C, 2011, MOL PHARMACOL, V79, P318, DOI 10.1124/mol.110.069278; Szabo ST, 2002, J PHARMACOL EXP THER, V302, P983, DOI 10.1124/jpet.102.033282; Szabo ST, 2001, BRAIN RES, V922, P9, DOI 10.1016/S0006-8993(01)03121-3; Vinals X, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002194; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Ward RP, 1996, J COMP NEUROL, V370, P405, DOI 10.1002/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304; Xie XD, 1999, FEBS LETT, V456, P63, DOI 10.1016/S0014-5793(99)00918-7; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	67	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6352	6368		10.1074/jbc.M117.779041	http://dx.doi.org/10.1074/jbc.M117.779041			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258217	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000399538700028
J	Zinn, S; Sisignano, M; Kern, K; Pierre, S; Tunaru, S; Jordan, H; Suo, J; Treutlein, EM; Angioni, C; Ferreiros, N; Leffler, A; DeBruin, N; Offermanns, S; Geisslinger, G; Scholich, K				Zinn, Sebastian; Sisignano, Marco; Kern, Katharina; Pierre, Sandra; Tunaru, Sorin; Jordan, Holger; Suo, Jing; Treutlein, Elsa-Marie; Angioni, Carlo; Ferreiros, Nerea; Leffler, Andreas; DeBruin, Natasja; Offermanns, Stefan; Geisslinger, Gerd; Scholich, Klaus			The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; B-4 RECEPTOR; NOCICEPTIVE NEURONS; SYNAPTIC PLASTICITY; OPPOSING ROLES; CHANNEL TRPV1; ION-CHANNEL; IN-VITRO; PAIN; INFLAMMATION	Sensitization of the heat-activated ion channel transient receptor potential vanilloid 1 (TRPV1) through lipids is a fundamental mechanism during inflammation-induced peripheral sensitization. Leukotriene B4 is a proinflammatory lipid mediator whose role in peripheral nociceptive sensitization is not well understood to date. Two major G-protein-coupled receptors for leukotriene B4 have been identified: the high-affinity receptor BLT1 and the low-affinity receptor BLT2. Transcriptional screening for the expression G-protein-coupled receptors in murine dorsal root ganglia showed that both receptors were among the highest expressed in dorsal root ganglia. Calcium imaging revealed a sensitization of TRPV1-mediated calcium increases in a relative narrow concentration range for leukotriene B4 (100-200 nM). Selective antagonists and neurons from knock-out mice demonstrated a BLT1-dependent sensitization of TRPV1-mediated calcium increases. Accordingly, leukotriene B4-induced thermal hyperalgesia was mediated through BLT1 and TRPV1 as shown using the respective knock-out mice. Importantly, higher leukotriene B4 concentrations (> 0.5 mu M) and BLT2 agonists abolished sensitization of the TRPV1-mediated calcium increases. Also, BLT2 activation inhibited protein kinase C-and protein kinase A-mediated sensitization processes through the phosphatase calcineurin. Consequently, a selective BLT2-receptor agonist increased thermal and mechanical withdrawal thresholds during zymosan-induced inflammation. In accordance with these data, immunohisto-chemical analysis showed that both leukotriene B4 receptors were expressed in peripheral sensory neurons. Thus, the data show that the two leukotriene B4 receptors have opposing roles in the sensitization of peripheral sensory neurons forming a self-restricting system.	[Zinn, Sebastian; Sisignano, Marco; Kern, Katharina; Pierre, Sandra; Suo, Jing; Treutlein, Elsa-Marie; Angioni, Carlo; Ferreiros, Nerea; Geisslinger, Gerd; Scholich, Klaus] Klinikum Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Inst Klin Pharmakol, D-60590 Frankfurt, Germany; [Tunaru, Sorin; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Jordan, Holger; DeBruin, Natasja] Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol, D-60590 Frankfurt, Germany; [Leffler, Andreas] Hannover Med Sch, Dept Anaesthesiol & Crit Care Med, D-30625 Hannover, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; Fraunhofer Gesellschaft; Hannover Medical School	Scholich, K (corresponding author), Klinikum Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Inst Klin Pharmakol, D-60590 Frankfurt, Germany.	scholich@em.uni-frankfurt.de	Tunaru, Sorin/G-8516-2011; de Bruin, Natasja/D-8063-2014; Offermanns, Stefan/L-3313-2017	Tunaru, Sorin/0000-0002-6005-1737; de Bruin, Natasja/0000-0002-2456-2783; Sisignano, Marco/0000-0002-7581-0951; Offermanns, Stefan/0000-0001-8676-6805	Deutsche Forschungsgemeinschaft Grants [SFB1039-TP04, SFB1039-TP08, SFB1039-TP09, SFB1039-Z01, SCHO817]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius-Foundation as part of the Else Kroner graduate school; Else Kroner-Fresenius-Foundation Research Training Group Translational Research Innovation-Pharma	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius-Foundation as part of the Else Kroner graduate school; Else Kroner-Fresenius-Foundation Research Training Group Translational Research Innovation-Pharma	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB1039-TP04, SFB1039-TP08, SFB1039-TP09, SFB1039-Z01, and SCHO817. This research work was also supported by the research funding program Landes-Offensive zur Entwicklung Wissenschaftlich- okonomischer Exzellenz of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP, by funds from the Else Kroner-Fresenius-Foundation as part of the Else Kroner graduate school (to E.-M.T.), and by the Else Kroner-Fresenius-Foundation Research Training Group Translational Research Innovation-Pharma (to S.Z. and K.K.). The authors declare.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Asahara M, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0010-9; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Casarotto PC, 2012, NEUROPSYCHOPHARMACOL, V37, P478, DOI 10.1038/npp.2011.207; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Gibbs ME, 2005, NEUROSCIENCE, V131, P567, DOI 10.1016/j.neuroscience.2004.11.033; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Holland S, 2011, J BIOL CHEM, V286, P3671, DOI 10.1074/jbc.M110.154765; Horn T, 2015, PROG LIPID RES, V57, P13, DOI 10.1016/j.plipres.2014.11.001; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Kawahara H, 2011, BRIT J PHARMACOL, V163, P1214, DOI 10.1111/j.1476-5381.2010.01157.x; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Lizanecz E, 2006, MOL PHARMACOL, V69, P1015, DOI 10.1124/mol.105.015644; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; MARTIN HA, 1988, J NEUROPHYSIOL, V60, P438, DOI 10.1152/jn.1988.60.2.438; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; Matsunaga Y, 2013, FASEB J, V27, P3306, DOI 10.1096/fj.12-217000; Meller S T, 1997, Eur J Pain, V1, P43, DOI 10.1016/S1090-3801(97)90052-5; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Puchalowicz K, 2014, INT J MOL SCI, V15, P23672, DOI 10.3390/ijms151223672; SCHAIBLE HG, 1983, J NEUROPHYSIOL, V49, P1118, DOI 10.1152/jn.1983.49.5.1118; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Sisignano M, 2014, PROG LIPID RES, V53, P93, DOI 10.1016/j.plipres.2013.11.002; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suo J, 2014, J LEUKOCYTE BIOL, V96, P133, DOI 10.1189/jlb.3A1213-628R; Viguier F, 2013, EUR J PHARMACOL, V716, P8, DOI 10.1016/j.ejphar.2013.01.074; Wang SP, 2015, J CLIN INVEST, V125, P3077, DOI 10.1172/JCI81067; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yamamoto Y, 1999, NEUROSCIENCE, V91, P59, DOI 10.1016/S0306-4522(98)00611-3; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	52	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6123	6134		10.1074/jbc.M116.769125	http://dx.doi.org/10.1074/jbc.M116.769125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28242764	Green Published, hybrid			2022-12-28	WOS:000399538700010
J	Wang, B; Wang, YJ; Frabutt, DA; Zhang, XH; Yao, XY; Hu, D; Zhang, Z; Liu, CN; Zheng, SM; Xiang, SH; Zheng, YH				Wang, Bin; Wang, Yujie; Frabutt, Dylan A.; Zhang, Xihe; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Liu, Chaonan; Zheng, Shimin; Xiang, Shi-Hua; Zheng, Yong-Hui			Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; Ebola virus; glycoprotein; glycosylation; virus entry; calnexin	SIMIAN IMMUNODEFICIENCY VIRUS; PROTEIN-DEGRADATION PATHWAY; ENDOPLASMIC-RETICULUM; VIRION GLYCOPROTEINS; LINKED GLYCANS; ANTIBODY; IDENTIFICATION; TRANSMISSION; INFECTIVITY; CEM.NKR	The Ebola virus (EBOV) trimeric envelope glycoprotein (GP) precursors are cleaved into the receptor-binding GP(1) and the fusion-mediating GP(2) subunits and incorporated into virions to initiate infection. GP(1) and GP(2) form heterodimers that have 15 or two N-glycosylation sites (NGSs), respectively. Here we investigated the mechanism of how N-glycosylation contributes to GP expression, maturation, and function. As reported before, we found that, although GP(1) NGSs are not critical, the two GP(2) NGSs, Asn(563) and Asn(618), are essential for GP function. Further analysis uncovered that Asn(563) and Asn(618) regulate GP processing, demannosylation, oligomerization, and conformation. Consequently, these two NGSs are required for GP incorporation into EBOV-like particles and HIV type 1 (HIV-1) pseudovirions and determine viral transduction efficiency. Using CRISPR/Cas9 technology, we knocked out the two classical endoplasmic reticulum chaperones calnexin (CNX) and/or calreticulin (CRT) and found that both CNX and CRT increase GP expression. Nevertheless, NGSs are not required for the GP interaction with CNX or CRT. Together, we conclude that, although Asn(563) and Asn(618) are not required for EBOV GP expression, they synergistically regulate its maturation, which determines its functionality.	[Wang, Bin; Wang, Yujie; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Zheng, Yong-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, CAAS Michigan State Univ Joint Lab Innate Immun, State Key Lab Vet Biotechnol, Harbin 150059, Peoples R China; [Liu, Chaonan; Zheng, Shimin] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China; [Xiang, Shi-Hua] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Xiang, Shi-Hua] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, 2215 BPS,567 Wilson Rd, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 BPS,567 Wilson Rd, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385; Frabutt, Dylan/0000-0002-8693-6656; Zhang, Xihe/0000-0002-4857-9774	National Natural Science Foundation of China [31502089]; Harbin Veterinary Research Institute Grant [SKLVBP2015012]; NIAID, National Institutes of Health [AI120189, AI106477, AI122863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122863, R01AI120189, R21AI106477] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Veterinary Research Institute Grant; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Natural Science Foundation of China Grant 31502089 and Harbin Veterinary Research Institute Grant SKLVBP2015012. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIAID, National Institutes of Health Grants AI120189, AI106477, and AI122863. To whom correspondence should be addressed: Dept. of Microbiology and Molecular Genetics, Michigan State University, 2215 BPS, 567 Wilson Rd., East Lansing, MI 48824. Tel.: 517-884-5314; Fax: 517-353-8957; E-mail: zhengyo@msu.edu.	Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gaskill PJ, 2008, J VIROL, V82, P1615, DOI 10.1128/JVI.01757-07; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Karsten CB, 2015, J VIROL, V89, P11727, DOI 10.1128/JVI.01358-15; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lennemann NJ, 2015, J INFECT DIS, V212, pS204, DOI 10.1093/infdis/jiv201; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Mohan GS, 2015, J VIROL, V89, P1205, DOI 10.1128/JVI.01810-14; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shen RZ, 2014, J VIROL, V88, P14258, DOI 10.1128/JVI.02164-14; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Vygen S, 2016, AM J TROP MED HYG, V95, P897, DOI 10.4269/ajtmh.16-0295; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wojczyk BS, 2005, GLYCOBIOLOGY, V15, P655, DOI 10.1093/glycob/cwi046; Wojczyk BS, 1998, GLYCOBIOLOGY, V8, P121, DOI 10.1093/glycob/8.2.121; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zhou T, 2015, J BIOL CHEM, V290, P22184, DOI 10.1074/jbc.M115.675207; Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13; Zhou T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-93; Zhou T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-31	37	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5860	5870		10.1074/jbc.M116.768168	http://dx.doi.org/10.1074/jbc.M116.768168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196864	hybrid, Green Published			2022-12-28	WOS:000398813200021
J	Qin, L; GuimaraES, DSPSF; Melesse, M; Hall, MC				Qin, Liang; GuimaraES, Dimitrius Santiago P. S. F.; Melesse, Michael; Hall, Mark C.			Substrate recognition by the Cdh1 destruction box receptor is a general requirement for APC/C-Cdh1-mediated proteolysis (vol 291, pg 15564, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Melesse, Michael/AAA-9425-2019					Qin L, 2016, J BIOL CHEM, V291, P15564, DOI 10.1074/jbc.M116.731190	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5125	5127		10.1074/jbc.A116.731190	http://dx.doi.org/10.1074/jbc.A116.731190			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28341713	Green Published, hybrid			2022-12-28	WOS:000397590400033
J	Safar, F; Hurdiss, E; Erotocritou, M; Greiner, T; Lape, R; Irvine, MW; Fang, GY; Jane, D; Yu, RL; Damgen, MA; Biggin, PC; Sivilotti, LG				Safar, Fatemah; Hurdiss, Elliot; Erotocritou, Marios; Greiner, Timo; Lape, Remigijus; Irvine, Mark W.; Fang, Guangyu; Jane, David; Yu, Rilei; Damgen, Marc A.; Biggin, Philip C.; Sivilotti, Lucia G.			The Startle Disease Mutation E103K Impairs Activation of Human Homomeric alpha 1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; SINGLE-CHANNEL; INTERMEDIATE STATES; FORCE-FIELD; MECHANISM; VALIDATION; DOMAIN; RECOGNITION; PRINCIPLES; MODEL	Glycine receptors (GlyR) belong to the pentameric ligandgated ion channel (pLGIC) superfamily and mediate fast inhibitory transmission in the vertebrate CNS. Disruption of glycinergic transmission by inherited mutations produces startle disease in man. Many startle mutations are in GlyRs and provide useful clues to the function of the channel domains. E103K is one of few startle mutations found in the extracellular agonist binding site of the channel, in loop A of the principal side of the subunit interface. Homology modeling shows that the side chain of Glu-103 is close to that of Arg-131, in loop E of the complementary side of the binding site, and may form a salt bridge at the back of the binding site, constraining its size. We investigated this hypothesis in recombinant human alpha 1 GlyR by site directed mutagenesis and functional measurements of agonist efficacy and potency by whole cell patch clamp and single channel recording. Despite its position near the binding site, E103K causes hyperekplexia by impairing the efficacy of glycine, its ability to gate the channel once bound, which is very high in wild type GlyR. Mutating Glu-103 and Arg-131 caused various degrees of loss-of-function in the action of glycine, whereas mutations in Arg-131 enhanced the efficacy of the slightly bigger partial agonist sarcosine (N-methylglycine). The effects of the single charge-swapping mutations of these two residues were largely rescued in the double mutant, supporting the possibility that they interact via a salt bridge that normally constrains the efficacy of larger agonist molecules.	[Safar, Fatemah; Hurdiss, Elliot; Erotocritou, Marios; Greiner, Timo; Lape, Remigijus; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England; [Yu, Rilei; Damgen, Marc A.; Biggin, Philip C.] Univ Oxford, Dept Biochem Struct Bioinformat & Computat Bioche, South Parks Rd, Oxford OX1 3QU, England; [Irvine, Mark W.; Fang, Guangyu; Jane, David] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Yu, Rilei] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Peoples R China	University of London; University College London; University of Oxford; University of Bristol; Ocean University of China	Sivilotti, LG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	l.sivilotti@ucl.ac.uk	Greiner, Timo/Y-1900-2019; Lape, Remigijus/C-6175-2008; Erotocritou, Marios/HHN-1342-2022; Yu, Rilei/G-2353-2014	Greiner, Timo/0000-0002-0909-570X; Lape, Remigijus/0000-0002-6604-0828; Yu, Rilei/0000-0001-6625-2014; Biggin, Philip/0000-0001-5100-8836; Irvine, Mark/0000-0001-9321-1867	Medical Research Council [MR/J007110/1]; Kuwaiti state scholarship; UCL Impact studentship; Oxford Wolfson Marriott Biochemistry Graduate Scholarship; Studienstiftung des deutschen Volkes; MRC [MR/J007110/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kuwaiti state scholarship; UCL Impact studentship; Oxford Wolfson Marriott Biochemistry Graduate Scholarship; Studienstiftung des deutschen Volkes; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council Project Grant MR/J007110/1 ( to L. G. S. and P. C. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Kuwaiti state scholarship.; Supported by a UCL Impact studentship (to L. G. S.).; Supported by an Oxford Wolfson Marriott Biochemistry Graduate Scholarship and the Studienstiftung des deutschen Volkes.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Beato M, 2008, J NEUROSCI, V28, P7412, DOI 10.1523/JNEUROSCI.0581-08.2008; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berendsen H.J.C., 2007, SIMULATING PHYS WORL; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Jong DH, 2016, COMPUT PHYS COMMUN, V199, P1, DOI 10.1016/j.cpc.2015.09.014; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jambeck JPM, 2013, J CHEM THEORY COMPUT, V9, P774, DOI 10.1021/ct300777p; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lynagh T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00160; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmieden V, 1999, MOL PHARMACOL, V56, P464, DOI 10.1124/mol.56.3.464; Schrodinger LLC, 2013, MAESTR VERS 9 5; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sivilotti L, 2016, J GEN PHYSIOL, V148, P79, DOI 10.1085/jgp.201611649; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wilkins ME, 2016, J PHYSIOL-LONDON, V594, P3589, DOI 10.1113/JP272122; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f; Zhang HX, 2009, NEUROPHARMACOLOGY, V57, P551, DOI 10.1016/j.neuropharm.2009.07.019; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	58	6	6	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5031	5042		10.1074/jbc.M116.767616	http://dx.doi.org/10.1074/jbc.M116.767616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28174298	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000397590400024
J	Vadvalkar, SS; Matsuzaki, S; Eyster, CA; Giorgione, JR; Bockus, LB; Kinter, CS; Kinter, M; Humphries, KM				Vadvalkar, Shraddha S.; Matsuzaki, Satoshi; Eyster, Craig A.; Giorgione, Jennifer R.; Bockus, Lee B.; Kinter, Caroline S.; Kinter, Michael; Humphries, Kenneth M.			Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; PROTEIN ACETYLATION; DEHYDROGENASE; SIRT3; PHOSPHORYLATION; DEACETYLATES; SPECIFICITY; DYSFUNCTION; MECHANISMS; STARVATION	Alterations in mitochondrial function contribute to diabetic cardiomyopathy. We have previously shown that heart mitochondrial proteins are hyperacetylated in OVE26 mice, a transgenic model of type 1 diabetes. However, the universality of this modification and its functional consequences are not well established. In this study, we demonstrate that Akita type 1 diabetic mice exhibit hyperacetylation. Functionally, isolated Akita heart mitochondria have significantly impaired maximal (state 3) respiration with physiological pyruvate (0.1mM) but not with 1.0mM pyruvate. In contrast, pyruvate dehydrogenase activity is significantly decreased regardless of the pyruvate concentration. We found that there is a 70% decrease in the rate of pyruvate transport in Akita heart mitochondria but no decrease in the mitochondrial pyruvate carriers 1 and 2 (MPC1 and MPC2). The potential role of hyperacetylation in mediating this impaired pyruvate uptake was examined. The treatment of control mitochondria with the acetylating agent acetic anhydride inhibits pyruvate uptake and pyruvate- supported respiration in a similar manner to the pyruvate transport inhibitor alpha- cyano4- hydroxycinnamate. A mass spectrometry selective reactive monitoring assay was developed and used to determine that acetylation of lysines 19 and 26 of MPC2 is enhanced in Akita heart mitochondria. Expression of a double acetylation mimic of MPC2(K19Q/ K26Q) in H9c2 cells was sufficient to decrease the maximal cellular oxygen consumption rate. This study supports the conclusion that deficient pyruvate transport activity, mediated in part by acetylation of MPC2, is a contributor to metabolic inflexibility in the diabetic heart.	[Kinter, Caroline S.; Kinter, Michael; Humphries, Kenneth M.] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA; [Bockus, Lee B.; Humphries, Kenneth M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Humphries, KM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kenneth-humphries@omrf.org		Humphries, Kenneth/0000-0002-6167-3175; Kinter, Michael/0000-0001-7409-8918	Oklahoma City Veterans Affairs Medical Center; Development of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	Oklahoma City Veterans Affairs Medical Center; Development of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Q-Exactive Plus system used in this study was purchased by the Oklahoma City Veterans Affairs Medical Center with a grant from the Development of Veterans Affairs to Dr. Arlan Richardson.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; BUECHLER JA, 1989, BIOCHEMISTRY-US, V28, P3018, DOI 10.1021/bi00433a042; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Fernandes J, 2015, BIOCHEMISTRY-US, V54, P4008, DOI 10.1021/acs.biochem.5b00375; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fukushima A, 2016, BBA-MOL CELL BIOL L, V1861, P1525, DOI 10.1016/j.bbalip.2016.03.020; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kuznetsov AV, 2015, BBA-MOL CELL RES, V1853, P276, DOI 10.1016/j.bbamcr.2014.11.015; Liang L, 2015, BIOCHEM BIOPH RES CO, V468, P807, DOI 10.1016/j.bbrc.2015.11.036; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Schell JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-6; Schummer CM, 2008, AM J PHYSIOL-ENDOC M, V294, pE88, DOI 10.1152/ajpendo.00178.2007; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; Vanderperre B, 2015, CURR OPIN CELL BIOL, V33, P35, DOI 10.1016/j.ceb.2014.10.008; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Willard BB, 2003, ANAL CHEM, V75, P2370, DOI 10.1021/ac034033j; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Xu Y, 2014, NATURE, V515, P448, DOI 10.1038/nature13670	36	31	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4423	4433		10.1074/jbc.M116.753509	http://dx.doi.org/10.1074/jbc.M116.753509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154187	Green Published, hybrid			2022-12-28	WOS:000397585100004
J	Yu, JY; Liang, C; Liu, SL				Yu, Jingyou; Liang, Chen; Liu, Shan-Lu			Interferon-inducible LY6E Protein Promotes HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC SHARED ANTIGEN-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; STEM-CELL ANTIGEN-2; DEAMINASE ADAR1; IFITM PROTEINS; T-LYMPHOCYTES; LOCUS-E; VIRUS; TYPE-1; GENE	LY6E is a glycosylphosphatidylinositol-anchored, IFN-inducible protein that regulates T lymphocytes proliferation, differentiation, and development. Single-nucleotide polymorphism rs2572886 in the LY6 family protein locus has been shown to associate with accelerated progression to AIDS. In this study, we show that LY6E promotes HIV, type 1 (HIV-1) infection by enhancing viral entry and gene expression. Knockdown of LY6E in human peripheral blood mononuclear, SupT1, and THP-1 cells diminishes HIV-1 replication. Virion-cell and cell-cell fusion experiments revealed that LY6E promotes membrane fusion of the viral entry step. Interestingly, we find that LTR-driven HIV-1 gene expression is also enhanced by LY6E, suggesting additional roles of LY6E in HIV-1 replication. HIV-1 infection induces LY6E expression in human peripheral blood mononuclear cells, concomitant with increased production of type I IFN and some classical IFN-stimulated genes. Altogether, our results demonstrate that IFN-inducible LY6E promotes HIV-1 entry and replication and highlight a positive regulatory role of IFN-induced proteins in HIV-1 infection. Our work emphasizes the complexity of IFN-mediated signaling in HIV-host interaction and AIDS pathogenesis.	[Yu, Jingyou; Liu, Shan-Lu] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Liu, Shan-Lu] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Yu, Jingyou] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Liang, Chen] Lady Davis Inst, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lady Davis Institute; McGill University; McGill University	Liu, SL (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Ctr Microbial Interface Biol, Dept Vet Biosci, Columbus, OH 43210 USA.	liu.6244@osu.edu	Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817	National Institutes of Health [R01 AI112381, R21 AI109464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109464, R01AI112381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI112381 and R21 AI109464 (to S.L.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Classon B J, 1998, Dev Immunol, V6, P149, DOI 10.1155/1998/53157; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Feng XB, 2015, CLIN RHEUMATOL, V34, P71, DOI 10.1007/s10067-014-2799-4; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; FREED EO, 1994, NATURE, V369, P107, DOI 10.1038/369107b0; GODFREY DI, 1992, J IMMUNOL, V148, P2006; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; KOSUGI A, 1994, INT IMMUNOL, V6, P1967, DOI 10.1093/intimm/6.12.1967; Kosugi A, 1998, J BIOL CHEM, V273, P12301, DOI 10.1074/jbc.273.20.12301; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li QX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004999; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; MACNEIL I, 1993, J IMMUNOL, V151, P6913; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; SAITOH SI, 1995, J IMMUNOL, V155, P5574; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; Stier MT, 2012, MAMM GENOME, V23, P250, DOI 10.1007/s00335-011-9368-9; SU B, 1991, J CELL BIOL, V112, P377, DOI 10.1083/jcb.112.3.377; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wetzel MA, 2002, VIROLOGY, V292, P6, DOI 10.1006/viro.2001.1249; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06; Xu X, 2014, J IMMUNOL, V193, P4125, DOI 10.4049/jimmunol.1401249; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111	46	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4674	4685		10.1074/jbc.M116.755819	http://dx.doi.org/10.1074/jbc.M116.755819			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28130445	Green Published, hybrid			2022-12-28	WOS:000397585100024
J	Kern, C; Erdem, FA; El-Kasaby, A; Sandtner, W; Freissmuth, M; Sucic, S				Kern, Carina; Erdem, Fatma Asli; El-Kasaby, Ali; Sandtner, Walter; Freissmuth, Michael; Sucic, Sonja			The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurotransmitter release; neurotransmitter transport; patch clamp; serotonin; serotonin transporter	OSMOREGULATED BETAINE TRANSPORTER; DOPAMINE TRANSPORTER; AMPHETAMINE ACTION; C-TERMINUS; BINDING; PHOSPHORYLATION; INHIBITION; DYNAMICS; IBOGAINE; STATE	The serotonin transporter (SERT) and other monoamine transporters operate in either a forward transport mode where the transporter undergoes a full transport cycle or an exchange mode where the transporter seesaws through half-cycles. Amphetamines trigger the exchange mode, leading to substrate efflux. This efflux was proposed to rely on the N terminus, which was suggested to adopt different conformations in the inward facing, outward facing and amphetamine-bound states. This prediction was verified by tryptic digestion of SERT-expressing membranes: in the absence of Na+, the N terminus was rapidly digested. Amphetamine conferred protection against cleavage, suggesting a relay between the conformational states of the hydrophobic core and the N terminus. We searched for a candidate segment that supported the conformational switch by serial truncation removing 22 (N22), 32 (N32), or 42 (N42) N-terminal residues. This did not affect surface expression, inhibitor binding, and substrate influx. However, amphetamine-induced efflux by SERT-N32 or SERT-N42 (but not by SERT-N22) was markedly diminished. We examined the individual steps in the transport cycle by recording transporter-associated currents: the recovery rate of capacitive peak, but not of steady state, currents was significantly lower for SERT-N32 than that of wild type SERT and SERT-N22. Thus, the exchange mode of SERT-N32 was selectively impaired. Our observations show that the N terminus affords the switch between transport modes. The findings are consistent with a model where the N terminus acts as a lever to support amphetamine-induced efflux by SERT.	[Kern, Carina; Erdem, Fatma Asli; El-Kasaby, Ali; Sandtner, Walter; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Sucic, S (corresponding author), Inst Pharmacol, Dept Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	sonja.sucic@meduniwien.ac.at		Freissmuth, Michael/0000-0001-9398-1765; Erdem, Fatma A./0000-0003-1381-5009; Sucic, Sonja/0000-0001-5136-8022	Austrian Science Fund/FWF [P27518-B27, P28090, F3510]	Austrian Science Fund/FWF(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund/FWF Project P27518-B27 (to S. S.), Project P28090 (to W. S.), and Project Program Grant SFB35 (F3510 to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Guler G, 2016, J BIOL CHEM, V291, P4295, DOI 10.1074/jbc.M114.621979; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hasenhuetl PS, 2016, J BIOL CHEM, V291, P25864, DOI 10.1074/jbc.M116.753319; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Khelashvili G, 2016, J BIOL CHEM, V291, P19786, DOI 10.1074/jbc.M116.731455; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Montgomery TR, 2014, J NEUROSCI, V34, P6344, DOI 10.1523/JNEUROSCI.2991-13.2014; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Steinkellner T, 2015, J NEUROSCI, V35, P8258, DOI 10.1523/JNEUROSCI.4034-14.2015; Steinkellner T, 2014, NEUROPSYCHOPHARMACOL, V39, P2681, DOI 10.1038/npp.2014.124; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sweeney CG, 2017, J BIOL CHEM, V292, P1302, DOI 10.1074/jbc.M116.762872; Yuan LX, 2013, PLANT CELL, V25, P974, DOI 10.1105/tpc.112.108027; Zestos AG, 2016, ACS CHEM NEUROSCI, V7, P757, DOI 10.1021/acschemneuro.6b00028	37	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3603	3613		10.1074/jbc.M116.771360	http://dx.doi.org/10.1074/jbc.M116.771360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28104804	Green Published, hybrid			2022-12-28	WOS:000395542500006
J	Sergin, I; Jong, YJI; Harmon, SK; Kumar, V; O'Malley, KL				Sergin, Ismail; Jong, Yuh-Jiin I.; Harmon, Steven K.; Kumar, Vikas; O'Malley, Karen L.			Sequences within the C Terminus of the Metabotropic Glutamate Receptor 5 (mGluR5) Are Responsible for Inner Nuclear Membrane Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; chromatin; G-protein-coupled receptor (GPCR); glutamate; metabotropic glutamate receptor (mGluR); nuclear membrane; nuclear transport	PROTEIN-COUPLED RECEPTORS; SUBCELLULAR-LOCALIZATION; INTRACELLULAR MGLUR5; STRIATAL NEURONS; CELL-NUCLEUS; LAMIN-B; TRAFFICKING; BINDING; TRANSPORT; CA2+	Traditionally, G-protein-coupled receptors (GPCR) are thought to be located on the cell surface where they transmit extracellular signals to the cytoplasm. However, recent studies indicate that some GPCRs are also localized to various subcellular compartments such as the nucleus where they appear required for various biological functions. For example, the metabotropic glutamate receptor 5 (mGluR5) is concentrated at the inner nuclear membrane (INM) where it mediates Ca2+ changes in the nucleoplasm by coupling with G(q/11). Here, we identified a region within the C-terminal domain (amino acids 852-876) that is necessary and sufficient for INM localization of the receptor. Because these sequences do not correspond to known nuclear localization signal motifs, they represent a new motif for INM trafficking. mGluR5 is also trafficked to the plasma membrane where it undergoes re-cycling/degradation in a separate receptor pool, one that does not interact with the nuclear mGluR5 pool. Finally, our data suggest that once at the INM, mGluR5 is stably retained via interactions with chromatin. Thus, mGluR5 is perfectly positioned to regulate nucleoplasmic Ca(2+)in situ.	[Sergin, Ismail; Jong, Yuh-Jiin I.; Harmon, Steven K.; Kumar, Vikas; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), 660 S Euclid Ave,Campus Box 8108, St Louis, MO 63110 USA.	omalleyk@wustl.edu			Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; NINDS, National Institutes of Health [NS086741]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH109019, R01MH057817, R21MH069646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086741, R21NS081454, R21NS102783] Funding Source: NIH RePORTER	Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. M. Nathanson (Yale University) for IP<INF>3</INF> sponge constructs. Microscopes and software were provided in part through the use of Washington University Center for Cellular Imaging (WUCCI) supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505), and the NINDS, National Institutes of Health (NS086741).	ABE T, 1992, J BIOL CHEM, V267, P13361; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Benyair R, 2015, SEMIN CELL DEV BIOL, V41, P99, DOI 10.1016/j.semcdb.2014.11.006; Bhave G, 2003, J BIOL CHEM, V278, P30294, DOI 10.1074/jbc.M303258200; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Branco AF, 2015, J CARDIOVASC PHARM, V65, P101, DOI 10.1097/FJC.0000000000000196; Calebiro D, 2015, METHODS MOL BIOL, V1234, P197, DOI 10.1007/978-1-4939-1755-6_16; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Campden R, 2015, J CARDIOVASC PHARM, V65, P110, DOI 10.1097/FJC.0000000000000198; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Goodchild RE, 2015, J CELL SCI, V128, P2854, DOI 10.1242/jcs.167452; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; HOLZENBURG A, 1992, BIOCHEM SOC T, V20, P591, DOI 10.1042/bst0200591; Hubert GW, 2001, J NEUROSCI, V21, P1838, DOI 10.1523/JNEUROSCI.21-06-01838.2001; Hurt CM, 2013, METHOD ENZYMOL, V521, P171, DOI 10.1016/B978-0-12-391862-8.00009-0; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2014, MOL PHARMACOL, V86, P774, DOI 10.1124/mol.114.094763; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Joyal JS, 2014, NAT MED, V20, P1165, DOI 10.1038/nm.3669; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Katta SS, 2014, TRENDS CELL BIOL, V24, P221, DOI 10.1016/j.tcb.2013.10.006; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Ko SJ, 2012, J NEUROSCI, V32, P16391, DOI 10.1523/JNEUROSCI.1964-12.2012; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Kumar V, 2012, J BIOL CHEM, V287, P5412, DOI 10.1074/jbc.M111.301366; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Lester HA, 2012, BIOL PSYCHIAT, V72, P907, DOI 10.1016/j.biopsych.2012.05.020; Lopez-Bendito G, 2002, CEREB CORTEX, V12, P625, DOI 10.1093/cercor/12.6.625; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mao LM, 2008, NEUROPHARMACOLOGY, V55, P403, DOI 10.1016/j.neuropharm.2008.05.034; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Meads MB, 2004, J BIOL CHEM, V279, P51793, DOI 10.1074/jbc.M407382200; Morinelli TA, 2007, AM J PHYSIOL-CELL PH, V292, pC1398, DOI 10.1152/ajpcell.00337.2006; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Purgert CA, 2014, J NEUROSCI, V34, P4589, DOI 10.1523/JNEUROSCI.3451-13.2014; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shirvani Hamasseh, 2012, Subcell Biochem, V63, P97, DOI 10.1007/978-94-007-4765-4_6; Snapp E.L., 2003, CURR PROTOC CELL BIO; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Vincent K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10604; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wright CD, 2012, CELL SIGNAL, V24, P794, DOI 10.1016/j.cellsig.2011.11.014; YE Q, 1994, J BIOL CHEM, V269, P11306; Zuleger N, 2012, CELL MOL LIFE SCI, V69, P2205, DOI 10.1007/s00018-012-0929-1; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	77	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3637	3655		10.1074/jbc.M116.757724	http://dx.doi.org/10.1074/jbc.M116.757724			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096465	hybrid, Green Published			2022-12-28	WOS:000395542500009
J	Yang, XR; Liu, XR; Musser, DM; Moustafa, IM; Arnold, JJ; Cameron, CE; Boehr, DD				Yang, Xiaorong; Liu, Xinran; Musser, Derek M.; Moustafa, Ibrahim M.; Arnold, Jamie J.; Cameron, Craig E.; Boehr, David D.			Triphosphate Reorientation of the Incoming Nucleotide as a Fidelity Checkpoint in Viral RNA-dependent RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; nuclear magnetic resonance (NMR); plus-stranded RNA virus; poliovirus; protein dynamic; RNA polymerase; RNA virus; polymerase fidelity	NUCLEAR-MAGNETIC-RESONANCE; STATE KINETIC-ANALYSIS; DNA-POLYMERASE; STRUCTURAL BASIS; ESCHERICHIA-COLI; BINDING POCKET; LARGE FRAGMENT; RIBONUCLEOTIDE INCORPORATION; CRYSTAL-STRUCTURES; METAL-IONS	The nucleotide incorporation fidelity of the viral RNA-dependent RNA polymerase (RdRp) is important for maintaining functional genetic information but, at the same time, is also important for generating sufficient genetic diversity to escape the bottlenecks of the host's antiviral response. We have previously shown that the structural dynamics of the motif D loop are closely related to nucleotide discrimination. Previous studies have also suggested that there is a reorientation of the triphosphate of the incoming nucleotide, which is essential before nucleophilic attack from the primer RNA 3-hydroxyl. Here, we have used P-31 NMR with poliovirus RdRp to show that the binding environment of the triphosphate is different when correct versus incorrect nucleotide binds. We also show that amino acid substitutions at residues known to interact with the triphosphate can alter the binding orientation/environment of the nucleotide, sometimes lead to protein conformational changes, and lead to substantial changes in RdRp fidelity. The analyses of other fidelity variants also show that changes in the triphosphate binding environment are not always accompanied by changes in the structural dynamics of the motif D loop or other regions known to be important for RdRp fidelity, including motif B. Altogether, our studies suggest that the conformational changes in motifs B and D, and the nucleoside triphosphate reorientation represent separable, tunable fidelity checkpoints.	[Yang, Xiaorong; Liu, Xinran; Musser, Derek M.; Boehr, David D.] Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA 16802 USA; [Moustafa, Ibrahim M.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA 16802 USA.	ddb12@psu.edu	Liu, Xinran/GON-4955-2022	Liu, Xinran/0000-0002-3732-6632	National Institutes of Health [AI104878, AI45818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104878, R01AI045818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI104878 (to D. D. B.) and AI45818 (to C. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold JJ, 2006, ANAL BIOCHEM, V350, P214, DOI 10.1016/j.ab.2005.11.001; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; BOCK JL, 1980, J INORG BIOCHEM, V12, P119, DOI 10.1016/S0162-0134(00)80123-3; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; COHN M, 1962, J BIOL CHEM, V237, P176; Curti E, 2013, J VIROL, V87, P199, DOI 10.1128/JVI.06968-11; FERRIN LJ, 1986, BIOCHEMISTRY-US, V25, P5131, DOI 10.1021/bi00366a023; FERRIN LJ, 1985, BIOCHEMISTRY-US, V24, P6904, DOI 10.1021/bi00345a024; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Furukawa A, 2016, PROG NUCL MAG RES SP, V96, P47, DOI 10.1016/j.pnmrs.2016.02.002; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; GUPTA RK, 1977, J BIOL CHEM, V252, P5967; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P7256, DOI 10.1021/bi960537i; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liu XR, 2015, VIRUSES-BASEL, V7, P5571, DOI 10.3390/v7102894; Liu XR, 2013, J BIOL CHEM, V288, P32753, DOI 10.1074/jbc.M113.484428; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; McDonald S, 2016, J BIOL CHEM, V291, P13999, DOI 10.1074/jbc.M116.726596; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; Moustafa IM, 2014, J BIOL CHEM, V289, P36229, DOI 10.1074/jbc.M114.616193; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; NOMOTO A, 1982, P NATL ACAD SCI-BIOL, V79, P5793, DOI 10.1073/pnas.79.19.5793; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; RAO BDN, 1978, J BIOL CHEM, V253, P8056; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113; SLOAN DL, 1975, J BIOL CHEM, V250, P8913; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Trakselis MA, 2014, NUCLEIC ACIDS MOL BI, V30, P1, DOI 10.1007/978-3-642-39796-7_1; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Wang WN, 2012, J BIOL CHEM, V287, P28215, DOI 10.1074/jbc.M112.366609; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	64	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3810	3826		10.1074/jbc.M116.750638	http://dx.doi.org/10.1074/jbc.M116.750638			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100782	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000395542500023
J	Bonvin, P; Gueneau, F; Buatois, V; Charreton-Galby, M; Lasch, S; Messmer, M; Christen, U; Luster, AD; Johnson, Z; Ferlin, W; Kosco-Vilbois, M; Proudfoot, A; Fischer, N				Bonvin, Pauline; Gueneau, Franck; Buatois, Vanessa; Charreton-Galby, Maud; Lasch, Stanley; Messmer, Marie; Christen, Urs; Luster, Andrew D.; Johnson, Zoe; Ferlin, Walter; Kosco-Vilbois, Marie; Proudfoot, Amanda; Fischer, Nicolas			Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODY; CARLUMAB CNTO 888; HEPARAN-SULFATE; LIGAND 2; OLIGOMERIZATION; INTERLEUKIN-8; TRAFFICKING; EXPRESSION; RECEPTORS; INDUCTION	To improve our understanding of properties that confer successful inhibition of chemokines in vivo, we analyzed antimurine CXCL10 monoclonal antibodies (mAb) having different characteristics. 1B6 displayed potent inhibition of cell recruitment in vitro with an IC50 of 0.5 nM but demonstrated little efficacy in various animal models of human disease. On the contrary, 1P11 showed efficacy in several models of inflammation yet was less potent at inhibiting chemotaxis in vitro with an IC50 of 21 nM. Furthermore, we observed that 1B6 displayed a rapid dosedependent clearance (t1/ 2 1060 h) in contrast to 1F11, which presented a dose-proportional pharmacokinetic profile and a half-life of 12 days. Moreover, 1B6 recognized glycosaminoglycan (GAG)bound CXCL10, resulting in target-mediated clearance, which was corroborated using CXCL10-deficient mice. In contrast to 1B6, 1F11 inhibited the interaction of CXCL10 with GAGs, did not recognize GAG-bound CXCL10, and did not display target-mediated drug disposition. Confirming previous animal studies, 1B6 was poor at reversing glycemia in a model of type 1 diabetes, whereas 1F11 induced early and prolonged control of diabetes. Furthermore, when using 1A4, a subsequently generated anti-mCXCL10 mAb that shares the property with 1F11 of being unable to recognize CXCL10 immobilized on GAG, we observed a similar superior control of diabetes as compared with 1B6. We therefore concluded that targeting chemokines with antibodies such as 1B6 that recognize the more abundant GAG-bound form of the chemokine may not be the optimal strategy to achieve disease control.	[Bonvin, Pauline; Gueneau, Franck; Buatois, Vanessa; Charreton-Galby, Maud; Johnson, Zoe; Ferlin, Walter; Kosco-Vilbois, Marie; Proudfoot, Amanda; Fischer, Nicolas] Novimmune SA, Chemin Aulx 14, CH-1228 Geneva, Switzerland; [Lasch, Stanley; Messmer, Marie; Christen, Urs] ZAFES Goethe Univ Hosp Frankfurt, Pharmazentrum Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Luster, Andrew D.] Massachusetts Gen Hosp, Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA	NovImmune SA; Harvard University; Harvard Medical School; Massachusetts General Hospital	Fischer, N (corresponding author), Novimmune SA, Chemin Aulx 14, CH-1228 Geneva, Switzerland.	nfischer@novimmune.com	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912; Johnson, Zoe/0000-0002-4120-2579; Christen, Urs/0000-0003-4165-7976	European Union [HEALTH-F4-2011-281608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	European Union(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This was supported by Grant HEALTH-F4-2011-281608 (TIMER) from the European Union Seventh Framework Programme (FP7-2007-2013). P. B., F. G., V. B., M. C.-G., Z. J., W. F., M. K.-V., A. P., and N. F. are current or former employees of Novimmune SA.	[Anonymous], 2012, Drug Discov Today Technol, V9, pe227, DOI 10.1016/j.ddtec.2012.05.003; Bonvin P, 2015, MABS-AUSTIN, V7, P294, DOI 10.1080/19420862.2015.1006993; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Comerford I, 2014, BRIT J HAEMATOL, V164, P329, DOI 10.1111/bjh.12616; de Graaf Katrien L., 2012, Current Immunology Reviews, V8, P141; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Fetterly GJ, 2013, J CLIN PHARMACOL, V53, P1020, DOI 10.1002/jcph.140; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hillyer P, 2005, IMMUNOL CELL BIOL, V83, P375, DOI 10.1111/j.1440-1711.2005.01345.x; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Johnson Zoe, 2012, Current Immunology Reviews, V8, P181; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Koelink PJ, 2012, PHARMACOL THERAPEUT, V133, P1, DOI 10.1016/j.pharmthera.2011.06.008; Lasch S, 2015, DIABETES, V64, P4198, DOI 10.2337/db15-0479; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Mayer L, 2014, GUT, V63, P442, DOI 10.1136/gutjnl-2012-303424; Mordelet E, 2007, ENDOTHELIUM-J ENDOTH, V14, P7, DOI 10.1080/10623320601177312; Mukaida N, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/170381; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Proudfoot AEI, 2000, METH MOL B, V138, P75; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salib R., 2003, Journal of Allergy and Clinical Immunology, V111, pS347, DOI 10.1016/S0091-6749(03)81276-9; Sandhu SK, 2013, CANCER CHEMOTH PHARM, V71, P1041, DOI 10.1007/s00280-013-2099-8; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Solari R, 2015, EUR J PHARMACOL, V746, P363, DOI 10.1016/j.ejphar.2014.06.060; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Sweeney EA, 2001, ANN NY ACAD SCI, V938, P48; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wang X, 2013, PROG MOL BIOL TRANSL, V117, P531, DOI 10.1016/B978-0-12-386931-9.00020-9; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Yellin M, 2008, GASTROENTEROLOGY, V134, pA493; Yellin M, 2012, ARTHRITIS RHEUM-US, V64, P1730, DOI 10.1002/art.34330; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zhang Z, 2002, J IMMUNOL, V168, P3205, DOI 10.4049/jimmunol.168.7.3205; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	51	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4185	4197		10.1074/jbc.M116.745877	http://dx.doi.org/10.1074/jbc.M116.745877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154179	hybrid, Green Published			2022-12-28	WOS:000395837100017
J	Tsirkone, VG; Blokken, J; De Wit, F; Breemans, J; De Houwer, S; Debyser, Z; Christ, F; Strelkov, SV				Tsirkone, Vicky G.; Blokken, Jolien; De Wit, Flore; Breemans, Jolien; De Houwer, Stephanie; Debyser, Zeger; Christ, Frauke; Strelkov, Sergei V.			N-terminal half of transportin SR2 interacts with HIV integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NUCLEAR IMPORT; STRUCTURAL BASIS; MACROMOLECULAR STRUCTURES; REVERSE TRANSCRIPTION; NONDIVIDING CELLS; CRYSTAL-STRUCTURE; PROTEIN; DNA; INFECTION	The karyopherin transportin SR2 (TRN-SR2, TNPO3) is responsible for shuttling specific cargoes such as serine/arginine-rich splicing factors from the cytoplasm to the nucleus. This protein plays a key role in HIV infection by facilitating the nuclear import of the pre-integration complex (PIC) that contains the viral DNA as well as several cellular and HIV proteins, including the integrase. The process of nuclear import is considered to be the bottleneck of the viral replication cycle and therefore represents a promising target for anti-HIV drug design. Previous studies have demonstrated that the direct interaction between TRN-SR2 and HIV integrase predominantly involves the catalytic core domain (CCD) and the C-terminal domain (CTD) of the integrase. We aimed at providing a detailed molecular view of this interaction through a biochemical characterization of the respective protein complex. Size-exclusion chromatography was used to characterize the interaction of TRN-SR2 with a truncated variant of the HIV-1 integrase, including both the CCD and CTD. These experiments indicate that one TRN-SR2 molecule can specifically bind one CCD-CTD dimer. Next, the regions of the solenoid-like TRN-SR2 molecule that are involved in the interaction with integrase were identified using AlphaScreen binding assays, revealing that the integrase interacts with the N-terminal half of TRN-SR2 principally through the HEAT repeats 4, 10, and 11. Combining these results with small-angle X-ray scattering data for the complex of TRN-SR2 with truncated integrase, we propose a molecular model of the complex. We speculate that nuclear import of the PIC may proceed concurrently with the normal nuclear transport.	[Tsirkone, Vicky G.; Breemans, Jolien; Strelkov, Sergei V.] Katholieke Univ Leuven, Lab Biocrystallog, B-3000 Leuven, Belgium; [Blokken, Jolien; De Wit, Flore; De Houwer, Stephanie; Debyser, Zeger; Christ, Frauke] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium	KU Leuven; KU Leuven	Strelkov, SV (corresponding author), Herestr 49 Bus 822, B-3000 Leuven, Belgium.	sergei.strelkov@kuleuven.be	Blokken, Jolien/H-7626-2018; Christ, Frauke/H-7513-2018; debyser, zeger/H-1310-2013	Blokken, Jolien/0000-0002-8152-824X; debyser, zeger/0000-0002-3982-1565; Christ, Frauke/0000-0001-9580-3874	Belgian IAP BelVir; Seventh Framework Programme of the EC [6131]	Belgian IAP BelVir; Seventh Framework Programme of the EC	We thank Dr. Stephen D. Weeks for guidance on cloning and protein expression as well as for help with SAXS data collection and Dr. Alexander V. Shkumatov for valuable advice on SAXS data collection and processing. An expression plasmid for human CDC-like kinase 1 was a kind gift of Prof. Peter Cherepanov. Research at the Laboratory of Molecular Virology and Gene Therapy was also funded by Belgian IAP BelVir. Support from the Seventh Framework Programme of the EC under the BioStruct-X initiative (Project Number 6131) toward the synchrotron SAXS measurements is acknowledged.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; De Houwer S, 2014, J BIOL CHEM, V289, P25351, DOI 10.1074/jbc.M113.533281; De Houwer S, 2012, J BIOL CHEM, V287, P34059, DOI 10.1074/jbc.M112.387944; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Graewert MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10734; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Jayappa Kallesh Danappa, 2012, Int J Biochem Mol Biol, V3, P70; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Luban J, 2008, CURR BIOL, V18, pR710, DOI 10.1016/j.cub.2008.07.037; Lusic M, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2017.22; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Matreyek KA, 2013, VIRUSES-BASEL, V5, P2483, DOI 10.3390/v5102483; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Taltynov O, 2013, J BIOL CHEM, V288, P25603, DOI 10.1074/jbc.M113.484345; Taltynov Oliver, 2012, Mol Biol Int, V2012, P863405, DOI 10.1155/2012/863405; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Tsirkone VG, 2014, ACTA CRYSTALLOGR F, V70, P723, DOI 10.1107/S2053230X14009492; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	72	10	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9699	9710		10.1074/jbc.M117.777029	http://dx.doi.org/10.1074/jbc.M117.777029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28356354	Green Published, hybrid			2022-12-28	WOS:000403113000020
J	Batiuk, MY; de Vin, F; Duque, SI; Li, C; Saito, T; Saido, T; Fiers, M; Belgard, TG; Holt, MG				Batiuk, Mykhailo Y.; de Vin, Filip; Duque, Sandra I.; Li, Chen; Saito, Takashi; Saido, Takaomi; Fiers, Mark; Belgard, T. Grant; Holt, Matthew G.			An immunoaffinity-based method for isolating ultrapure adult astrocytes based on ATP1B2 targeting by the ACSA-2 antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; cell surface protein; membrane protein; neuroscience; plasma membrane; flow cytometry; immunoblotting; immunohistochemistry; immunoisolation; single-cell RNA-seq	ADHESION MOLECULE; GLUTAMATE TRANSPORTERS; FUNCTIONAL-CHARACTERIZATION; GLIA AMOG; IN-VIVO; CELLS; BRAIN; PROTEINS; NEURONS; TRANSCRIPTOME	Astrocytes are a major cell type in the mammalian CNS. Astrocytes are now known to play a number of essential roles in processes including synapse formation and function, as well as blood-brain barrier formation and control of cerebral blood flow. However, our understanding of the molecular mechanisms underlying astrocyte development and function is still rudimentary. This lack of knowledge is at least partly due to the lack of tools currently available for astrocyte biology. ACSA-2 is a commercially available antibody originally developed for the isolation of astrocytes from young postnatal mouse brain, using magnetic cell-sorting methods, but its utility in isolating cells from adult tissue has not yet been published. Using a modified protocol, we now show that this tool can also be used to isolate ultrapure astrocytes from the adult brain. Furthermore, using a variety of techniques (including single-cell sequencing, overexpression and knockdown assays, immunoblotting, and immunohistochemistry), we identify the ACSA-2 epitope for the first time as ATP1B2 and characterize its distribution in the CNS. Finally, we show that ATP1B2 is stably expressed in multiple models of CNS injury and disease. Hence, we show that the ACSA-2 antibody possesses the potential to be an extremely valuable tool for astrocyte research, allowing the purification and characterization of astrocytes (potentially including injury and disease models) without the need for any specialized and expensive equipment. In fact, our results suggest that ACSA-2 should be a first-choice method for astrocyte isolation and characterization.	[Batiuk, Mykhailo Y.; de Vin, Filip; Duque, Sandra I.; Li, Chen; Holt, Matthew G.] Katholieke Univ Leuven, Lab Glia Biol, VIB KU Leuven Ctr Brain & Dis Res, Herestr 49, B-3000 Leuven, Belgium; [Batiuk, Mykhailo Y.; de Vin, Filip; Duque, Sandra I.; Li, Chen; Holt, Matthew G.] Katholieke Univ Leuven, Lab Glia Biol, KU Leuven Dept Neurosci, Herestr 49, B-3000 Leuven, Belgium; [Fiers, Mark] Katholieke Univ Leuven, VIB KU Leuven Ctr Brain & Dis Res, Herestr 49, B-3000 Leuven, Belgium; [Saito, Takashi; Saido, Takaomi] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510106, Japan; [Belgard, T. Grant] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, South Parks Rd, Oxford OX1 3PT, England; [Belgard, T. Grant] Verge Genom, 42A Dore St,Ste 201, San Francisco, CA 94103 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; RIKEN; University of Oxford	Holt, MG (corresponding author), VIB KU Leuven Ctr Brain & Dis Res, KU Leuven Dept Neurosci, Lab Glia Biol, Herestr 49, B-3000 Leuven, Belgium.	Matthew.Holt@kuleuven.vib.be	Sado, Takaomi/AAN-2759-2021; Fiers, Mark WEJ/E-6755-2010; Saido, Takaomi C/N-5472-2015; Batiuk, Mykhailo Y./AAY-7125-2021; please delete, please delete/AAY-7192-2021; Holt, Matthew/AAJ-1813-2020; Saito, Takashi/G-2563-2015	Sado, Takaomi/0000-0003-1970-6903; Fiers, Mark WEJ/0000-0001-5694-2409; Saido, Takaomi C/0000-0003-1970-6903; Batiuk, Mykhailo Y./0000-0001-6681-4048; Holt, Matthew/0000-0002-8958-4027; Saito, Takashi/0000-0002-9659-9251; Belgard, Tildon/0000-0002-6962-7894	European Research Council (ERC) [AstroFunc: 281961]; Inframouse (VIB-KU Leuven), through a Hercules type 3 grant [ZW09-03]	European Research Council (ERC)(European Research Council (ERC)); Inframouse (VIB-KU Leuven), through a Hercules type 3 grant	The Leica SP8 confocal microscope used in this study was provided by Inframouse (VIB-KU Leuven), through a Hercules type 3 grant (ZW09-03). We thank Dr. Enrico Radaelli for help with dissections of brains and Dr. Carlos Dotti for advice and critical reading of the manuscript. M. G. H. thanks Dr. Ben Barres for generous support, advice, and the gift of several reagents during the early phase of this work. M. G. H. and F. d. V. also acknowledge Ian Hutchinson, Bruce Anstey, and John McGuinness. Artwork for Fig. 1 was made by David Pennington (Pennington Art).	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; GLOOR S, 1992, GENE, V120, P307, DOI 10.1016/0378-1119(92)90111-2; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Grosche A, 2016, MOL CELL PROTEOMICS, V15, P462, DOI 10.1074/mcp.M115.052183; HAAS RJ, 1970, J ANAT, V107, P421; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; He P, 2015, GLYCOBIOLOGY, V25, P836, DOI 10.1093/glycob/cwv024; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holt M, 2008, CURR BIOL, V18, P715, DOI 10.1016/j.cub.2008.04.069; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jungblut M, 2012, GLIA, V60, P894, DOI 10.1002/glia.22322; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kantzer C. G., 2015, THESIS; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Nolte C, 2001, GLIA, V33, P72; PAGLIUSI SR, 1990, EUR J NEUROSCI, V2, P471, DOI 10.1111/j.1460-9568.1990.tb00438.x; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schubert V, 2011, GLIA, V59, P1472, DOI 10.1002/glia.21190; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; Slezak M, 2013, GLIA, V61, P623, DOI 10.1002/glia.22460; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Voutsinos-Porche B, 2003, CEREB CORTEX, V13, P1110, DOI 10.1093/cercor/13.10.1110; White JK, 2004, BIOCHEM J, V382, P811, DOI 10.1042/BJ20040808; Wilhelm A, 2004, NEUROSCI RES, V48, P249, DOI 10.1016/j.neures.2003.11.002; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	54	44	44	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8874	8891		10.1074/jbc.M116.765313	http://dx.doi.org/10.1074/jbc.M116.765313			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373281	Green Published, hybrid			2022-12-28	WOS:000402153900041
J	Juhasz, A; Markel, S; Gaur, S; Liu, H; Lu, JM; Jiang, GJ; Wu, XW; Antony, S; Wu, YZ; Melillo, G; Meitzler, JL; Haines, DC; Butcher, D; Roy, K; Doroshow, JH				Juhasz, Agnes; Markel, Susan; Gaur, Shikha; Liu, Han; Lu, Jiamo; Jiang, Guojian; Wu, Xiwei; Antony, Smitha; Wu, Yongzhong; Melillo, Giovanni; Meitzler, Jennifer L.; Haines, Diana C.; Butcher, Donna; Roy, Krishnendu; Doroshow, James H.			NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FLAVIN DEHYDROGENASE INHIBITORS; ELEMENT-BINDING PROTEIN; GROWTH-FACTOR; HYDROGEN-PEROXIDE; EPITHELIAL-CELLS; REDOX REGULATION; GENE-EXPRESSION; KINASE-ACTIVATION; CYCLE PROGRESSION	Reactive oxygen species (ROS) play a critical role in cell signaling and proliferation. NADPH oxidase 1 (NOX1), a membrane-bound flavin dehydrogenase that generates O-2((center dot) over bar), is highly expressed in colon cancer. To investigate the role that NOX1 plays in colon cancer growth, we used shRNA to decrease NOX1 expression stably in HT-29 human colon cancer cells. The 80-90% decrease in NOX1 expression achieved by RNAi produced a significant decline in ROS production and a G(1)/S block that translated into a 2-3-fold increase in tumor cell doubling time without increased apoptosis. The block at the G(1)/S checkpoint was associated with a significant decrease in cyclin D-1 expression and profound inhibition of mitogen-activated protein kinase (MAPK) signaling. Decreased steady-state MAPK phosphorylation occurred concomitant with a significant increase in protein phosphatase activity for two colon cancer cell lines in which NOX1 expression was knocked down by RNAi. Diminished NOX1 expression also contributed to decreased growth, blood vessel density, and VEGF and hypoxia-inducible factor 1 alpha (HIF-1 alpha) expression in HT-29 xenografts initiated from NOX1 knockdown cells. Microarray analysis, supplemented by real-time PCR and Western blotting, revealed that the expression of critical regulators of cell proliferation and angiogenesis, including c-MYC, c-MYB, and VEGF, were down-regulated in association with a decline in hypoxic HIF-1 alpha protein expression downstream of silenced NOX1 in both colon cancer cell lines and xenografts. These studies suggest a role for NOX1 in maintaining the proliferative phenotype of some colon cancers and the potential of NOX1 as a therapeutic target in this disease.	[Juhasz, Agnes; Lu, Jiamo; Jiang, Guojian; Antony, Smitha; Wu, Yongzhong; Meitzler, Jennifer L.; Doroshow, James H.] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Han; Roy, Krishnendu; Doroshow, James H.] NCI, Div Canc Treatment & Diag, NIH, Bldg 31,Rm 3A44,31 Ctr Dr, Bethesda, MD 20892 USA; [Markel, Susan; Gaur, Shikha] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Comprehens Canc Ctr, Bioinformat Grp, Duarte, CA 91010 USA; [Melillo, Giovanni] NCI Frederick, Dev Therapeut Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Haines, Diana C.; Butcher, Donna] NCI, Pathol Histotechnol Lab, Leidos Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Doroshow, JH (corresponding author), NCI, Div Canc Treatment & Diag, NIH, Bldg 31,Rm 3A44,31 Ctr Dr, Bethesda, MD 20892 USA.	doroshoj@mail.NIH.gov		Meitzler, Jennifer/0000-0001-9798-2124	NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010677] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by federal funds from the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn JH, 2008, MOL CELL BIOCHEM, V317, P121, DOI 10.1007/s11010-008-9839-9; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arnold RS, 2007, AM J PATHOL, V171, P2021, DOI 10.2353/ajpath.2007.061144; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Castanotto D, 2002, RNA, V8, P1454, DOI 10.1017/S1355838202021362; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Doroshow JH, 2013, FREE RADICAL BIO MED, V57, P162, DOI 10.1016/j.freeradbiomed.2013.01.002; Doroshow JH, 2012, BIOCHEM PHARMACOL, V83, P1195, DOI 10.1016/j.bcp.2012.01.022; Doroshow JH, 2006, JNCI-J NATL CANCER I, V98, P223, DOI 10.1093/jnci/djj065; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Esworthy RS, 2014, FREE RADICAL BIO MED, V68, P315, DOI 10.1016/j.freeradbiomed.2013.12.018; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2006, CARDIOVASC RES, V71, P289, DOI 10.1016/j.cardiores.2006.05.004; Honore S, 2003, EXP CELL RES, V285, P59, DOI 10.1016/S0014-4827(02)00038-1; Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Kietzmann T, 2005, SEMIN CELL DEV BIOL, V16, P474, DOI 10.1016/j.semcdb.2005.03.010; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Knowles HJ, 2003, CANCER RES, V63, P1764; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Li BH, 2008, BIOCHEM BIOPH RES CO, V369, P554, DOI 10.1016/j.bbrc.2008.02.052; MacFie TS, 2014, INFLAMM BOWEL DIS, V20, P514, DOI 10.1097/01.MIB.0000442012.45038.0e; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Menon SG, 2003, CANCER RES, V63, P2109; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Mouzaoui S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/312484; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Nisimoto Y, 2008, BIOCHEM J, V415, P57, DOI 10.1042/BJ20080300; Okada F, 2006, AM J PATHOL, V169, P294, DOI 10.2353/ajpath.2006.060073; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; Qiu J, 2008, LAB INVEST, V88, P910, DOI 10.1038/labinvest.2008.66; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roy K, 2015, CLIN SCI, V128, P863, DOI 10.1042/CS20140542; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; See V, 2001, J BIOL CHEM, V276, P35049, DOI 10.1074/jbc.M104988200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sharma P, 2008, IMMUNITY, V29, P551, DOI 10.1016/j.immuni.2008.07.019; SOARES FA, 1994, LAB INVEST, V71, P480; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Teshima S, 2000, AM J PHYSIOL-GASTR L, V279, pG1169, DOI 10.1152/ajpgi.2000.279.6.G1169; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610; Wolf C, 2001, FEBS LETT, V488, P154, DOI 10.1016/S0014-5793(00)02403-0; Wu YZ, 2016, ONCOTARGET, V7, P68412, DOI 10.18632/oncotarget.12032; Wu YZ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191031; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	75	55	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7866	7887		10.1074/jbc.M116.768283	http://dx.doi.org/10.1074/jbc.M116.768283			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28330872	Green Published, hybrid			2022-12-28	WOS:000401154100016
J	Yoshida, K; Tsunoda, SP; Brown, LS; Kandori, H				Yoshida, Kazuho; Tsunoda, Satoshi P.; Brown, Leonid S.; Kandori, Hideki			A unique choanoflagellate enzyme rhodopsin exhibits light-dependent cyclic nucleotide phosphodiesterase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; cyclic nucleotide; enzyme mechanism; membrane enzyme; optogenetics; phosphodiesterases; photoreceptor; rhodopsin	SENSORY-RHODOPSIN; PHARAONIS PHOBORHODOPSIN; GUANYLYL-CYCLASE; ADENYLYL-CYCLASE; OPTICAL CONTROL; CELLULAR CAMP; HAMP DOMAIN; MANIPULATION; MECHANISM; SIGNAL	Photoactivated adenylyl cyclase (PAC) and guanylyl cyclase rhodopsin increase the concentrations of intracellular cyclic nucleotides upon illumination, serving as promising second-generation tools in optogenetics. To broaden the arsenal of such tools, it is desirable to have light-activatable enzymes that can decrease cyclic nucleotide concentrations in cells. Here, we report on an unusual microbial rhodopsin that may be able to meet the demand. It is found in the choanoflagellate Salpingoeca rosetta and contains a C-terminal cyclic nucleotide phosphodiesterase (PDE) domain. We examined the enzymatic activity of the protein (named Rh-PDE) both in HEK293 membranes and whole cells. Although Rh-PDE was constitutively active in the dark, illumination increased its hydrolytic activity 1.4-fold toward cGMP and 1.6-fold toward cAMP, as measured in isolated crude membranes. Purified full-length Rh-PDE displayed maximal light absorption at 492 nm and formed the M intermediate with the deprotonated Schiff base upon illumination. The M state decayed to the parent spectral state in 7 s, producing long-lasting activation of the enzyme domain with increased activity. We discuss a possible mechanism of the Rh-PDE activation by light. Furthermore, Rh-PDE decreased cAMP concentration in HEK293 cells in a light-dependent manner and could do so repeatedly without losing activity. Thus, Rh-PDE may hold promise as a potential optogenetic tool for light control of intracellular cyclic nucleotides (e.g. to study cyclic nucleotide-associated signal transduction cascades).	[Yoshida, Kazuho; Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsunoda, Satoshi P.] JST PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Brown, Leonid S.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada	Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); University of Guelph	Tsunoda, SP; Kandori, H (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan.	tsunoda.satoshi@nitech.ac.jp; kandori@nitech.ac.jp	Brown, Leonid/X-7445-2019; Brown, Leonid/A-1050-2008; Tsunoda, Satoshi/AAN-7023-2021	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317; Tsunoda, Satoshi/0000-0003-3636-1521	Japanese Ministry of Education, Culture, Sports, Science, and Technology [25104009, 15H02391]; PRESTO, Japan Science and Technology Agency [JPMJPR1688]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2013-250202]; Grants-in-Aid for Scientific Research [15J06657] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, 25104009 and 15H02391 (to H. K.), by PRESTO, Japan Science and Technology Agency Grant JPMJPR1688 (to S. P. T.), and by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN-2013-250202 (to L. S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Costa WS, 2014, METHODS MOL BIOL, V1148, P161, DOI 10.1007/978-1-4939-0470-9_11; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dugue GP, 2012, PROG BRAIN RES, V196, P1, DOI 10.1016/B978-0-444-59426-6.00001-X; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Katayama K, 2012, BIOCHEMISTRY-US, V51, P1126, DOI 10.1021/bi201676y; Katayama K, 2010, ANGEW CHEM INT EDIT, V49, P891, DOI 10.1002/anie.200903837; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Miesenbock G, 2011, ANNU REV CELL DEV BI, V27, P731, DOI 10.1146/annurev-cellbio-100109-104051; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; SCHARF B, 1992, EUR J BIOCHEM, V206, P359, DOI 10.1111/j.1432-1033.1992.tb16935.x; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shichida Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P70, DOI 10.1562/2006-03-22-IR-854; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	46	54	54	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7531	7541		10.1074/jbc.M117.775569	http://dx.doi.org/10.1074/jbc.M117.775569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302718	Green Published, hybrid			2022-12-28	WOS:000400761300021
J	Gorelik, A; Liu, FY; Illes, K; Nagar, B				Gorelik, Alexei; Liu, Fangyu; Illes, Katalin; Nagar, Bhushan			Crystal structure of the human alkaline sphingomyelinase provides insights into substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-SALTS; IDENTIFICATION; BINDING; LIPASE; ENZYME; PHOSPHATIDYLCHOLINE; PURIFICATION; HYDROLYSIS; ACTIVATION; AUTOTAXIN	Absorption of dietary sphingomyelin (SM) requires its initial degradation into ceramide, a process catalyzed by the intestinal enzyme alkaline sphingomyelinase (alk-SMase, NPP7, ENPP7). alk-SMase belongs to the nucleotide pyrophosphatase/phosphodiesterase (NPP) family, the members of which hydrolyze nucleoside phosphates, phospholipids, and other related molecules. NPP7 is the only paralog that can cleave SM, and its activity requires the presence of bile salts, a class of physiological anionic detergents. To elucidate the mechanism of substrate recognition, we determined the crystal structure of human alk-SMase in complex with phosphocholine, a reaction product. Although the overall fold and catalytic center are conserved relative to other NPPs, alk-SMase recognizes the choline moiety of its substrates via an NPP7-specific aromatic box composed of tyrosine residues. Mutational analysis and enzymatic activity assays identified features on the surface of the protein-a cationic patch and a unique hydrophobic loop-that are essential for accessing SM in bile salt micelles. These results shed new light on substrate specificity determinants within the NPP enzyme family.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Nagar, B (corresponding author), Rm 464,3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca		Gorelik, Alexei/0000-0001-6236-4633	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology; CREATE Training Program in Bionanomachines (Natural Sciences and Engineering Research Council of Canada); Canada Research Chair; Canadian Institutes of Health Research Operating Grant [MOP-133535]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR)); CREATE Training Program in Bionanomachines (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research (to the Canadian Light Source). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology and the CREATE Training Program in Bionanomachines (Natural Sciences and Engineering Research Council of Canada).; Supported by a Canada Research Chair and Canadian Institutes of Health Research Operating Grant MOP-133535. To whom correspondence should be addressed: Rm. 464, 3649 Promenade Sir-William-Osler, Montreal, PQ H3G 0B1, Canada. Tel.: 514-398-7272; Fax: 514-398-3387; E-mail: bhushan.nagar@mcgill.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Airola MV, 2015, STRUCTURE, V23, P1482, DOI 10.1016/j.str.2015.06.013; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Albright RA, 2014, J BIOL CHEM, V289, P3294, DOI 10.1074/jbc.M113.505867; CAREY MC, 1972, ARCH INTERN MED, V130, P506, DOI 10.1001/archinte.130.4.506; Chen Y, 2015, MOL CANCER THER, V14, P259, DOI 10.1158/1535-7163.MCT-14-0468-T; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Duan JX, 2010, BIOCHEMISTRY-US, V49, P9096, DOI 10.1021/bi101069u; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2003, J LIPID RES, V44, P1241, DOI 10.1194/jlr.M300037-JLR200; Duan RD, 1997, HEPATOLOGY, V26, P823, DOI 10.1053/jhep.1997.v26.pm0009328299; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freie AB, 2006, J BIOL CHEM, V281, P7793, DOI 10.1074/jbc.M512984200; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Hertervig E, 1999, BRIT J CANCER, V81, P232, DOI 10.1038/sj.bjc.6690682; Jansen S, 2012, STRUCTURE, V20, P1948, DOI 10.1016/j.str.2012.09.001; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Keune WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11248; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Liu JJ, 2000, J NUTR BIOCHEM, V11, P192, DOI 10.1016/S0955-2863(00)00064-4; Maldonado-Valderrama J, 2011, ADV COLLOID INTERFAC, V165, P36, DOI 10.1016/j.cis.2010.12.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morita J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20995; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nyberg L, 1996, BBA-LIPID LIPID MET, V1300, P42, DOI 10.1016/0005-2760(95)00245-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrill AL, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-65; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsai SH, 2015, IMMUNITY, V42, P279, DOI 10.1016/j.immuni.2015.01.015; Wang XQ, 1997, STRUCTURE, V5, P1209, DOI 10.1016/S0969-2126(97)00271-2; Wu J, 2006, BIOCHEM J, V394, P299, DOI 10.1042/BJ20051121; Wu J, 2005, BIOCHEM J, V386, P153, DOI 10.1042/BJ20041455; Wu J, 2004, AM J PHYSIOL-GASTR L, V287, pG967, DOI 10.1152/ajpgi.00190.2004; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	39	23	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7087	7094		10.1074/jbc.M116.769273	http://dx.doi.org/10.1074/jbc.M116.769273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28292932	Green Published, hybrid			2022-12-28	WOS:000400478300019
J	Maki, K; Shibata, T; Kawabata, SI				Maki, Kouki; Shibata, Toshio; Kawabata, Shun-Ichiro			Transglutaminase-catalyzed incorporation of polyamines masks the DNA-binding region of the transcription factor Relish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; TISSUE TRANSGLUTAMINASE; NUCLEAR-LOCALIZATION; NEGATIVE REGULATION; PROTEINS DORSAL; GUT-MICROBIOTA; DROSOPHILA; GENE; CELLS; HOMEOSTASIS	In Drosophila, the final immune deficiency (IMD) pathway-dependent signal is transmitted through proteolytic conversion of the nuclear factor-kappa B (NF-kappa B)-like transcription factor Relish to the active N-terminal fragment Relish-N. Relish-N is then translocated from the cytosol into the nucleus for the expression of IMD- controlled genes. We previously demonstrated that transglutaminase (TG) suppresses the IMD pathway by polymerizing Relish-N to inhibit its nuclear translocation. Conversely, we also demonstrated that orally ingested synthetic amines, such as monodansylcadaverine (DCA) and biotin-labeled pentylamine, are TG-dependently incorporated into Relish-N, causing the nuclear translocation of modified Relish-N in gut epithelial cells. It remains unclear, however, whether polyamine- containing Relish-N retains transcriptional activity. Here, we used mass spectrometry analysis of a recombinant Relish- N modified with DCA by TG activity after proteolytic digestion and show that the DCA-modified Gln residues are located in the DNA-binding region of Relish-N. TG-catalyzed DCA incorporation inhibited binding of Relish-N to the Rel-responsive element in the NF-kappa B-binding DNA sequence. Subcellular fractionation of TG-expressing Drosophila S2 cells indicated that TG was localized in both the cytosol and nucleus. Of note, natural polyamines, including spermidine and spermine, competitively inhibited TG-dependent DCA incorporation into Relish- N. Moreover, in vivo experiments demonstrated that Relish-N was modified by spermine and that this modification reduced transcription of IMD pathway-controlled cecropin A1 and diptericin genes. These findings suggest that intracellular TG regulates Relish-N-mediated transcriptional activity by incorporating polyamines into Relish- N and via protein-protein cross-linking.	[Maki, Kouki; Kawabata, Shun-Ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8190395, Japan; [Shibata, Toshio; Kawabata, Shun-Ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan	Kyushu University; Kyushu University; Kyushu University	Kawabata, SI (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	skawascb@kyudai.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund Grant [26701];  [15H04353];  [26860333];  [16J02938]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund Grant; ; ; 	This work was supported in part by Grants-in-aid for Scientific Research (B) 15H04353 (to S.K.), for Young Scientists (B) 26860333 (toT.S.), and for Japan Society for the Promotion of Science Fellows 16J02938 (to K.M.) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund Grant 26701 (Tenure track type; to T.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Aparicio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062052; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Dickneite G, 2015, THROMB HAEMOSTASIS, V113, P686, DOI 10.1160/TH14-07-0625; Djouhri-Bouktab Lamia, 2014, Anti-Infective Agents, V12, P95; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; FOLK JE, 1980, J BIOL CHEM, V255, P3695; Gao JH, 2013, J PHYSIOL PHARMACOL, V64, P681; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Kawabata S., 2015, TRANSGLUTAMINASES MU, P117; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116; Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kuraishi T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00375; Lee KZ, 2011, EMBO J, V30, P988, DOI 10.1038/emboj.2011.47; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Lindgren M, 2008, J INSECT PHYSIOL, V54, P586, DOI 10.1016/j.jinsphys.2007.12.008; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Park SS, 2006, J BIOL CHEM, V281, P34965, DOI 10.1074/jbc.M604150200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peng XJ, 1999, FEBS LETT, V446, P35, DOI 10.1016/S0014-5793(99)00018-6; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Piredda L, 1999, FASEB J, V13, P355, DOI 10.1096/fasebj.13.2.355; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekihara S, 2016, J BIOL CHEM, V291, P25077, DOI 10.1074/jbc.M116.761791; Shibata T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005244; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Shrestha R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.339; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takeuchi Y, 1998, Z NATURFORSCH C, V53, P352; Tatsukawa H., 2009, GASTROENTEROLOGY, V136; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	53	10	12	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6369	6380		10.1074/jbc.M117.779579	http://dx.doi.org/10.1074/jbc.M117.779579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258224	Green Published, hybrid			2022-12-28	WOS:000399538700029
J	Minami, A; Meguro, Y; Ishibashi, S; Ishii, A; Shiratori, M; Sai, S; Horii, Y; Shimizu, H; Fukumoto, H; Shimba, S; Taguchi, R; Takahashi, T; Otsubo, T; Ikeda, K; Suzuki, T				Minami, Akira; Meguro, Yuko; Ishibashi, Sayaka; Ishii, Ami; Shiratori, Mako; Sai, Saki; Horii, Yuuki; Shimizu, Hirotaka; Fukumoto, Hokuto; Shimba, Sumika; Taguchi, Risa; Takahashi, Tadanobu; Otsubo, Tadamune; Ikeda, Kiyoshi; Suzuki, Takashi			Rapid regulation of sialidase activity in response to neural activity and sialic acid removal during memory processing in rat hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hippocampus; imaging; rat; sialic acid; sialidase	CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; POLYSIALIC ACID; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; PSA-NCAM; BRAIN; EXPRESSION; NEU4; GANGLIOSIDE	Sialidase cleaves sialic acids on the extracellular cell surface as well as inside the cell and is necessary for normal long-term potentiation (LTP) at mossy fiber-CA3 pyramidal cell synapses and for hippocampus-dependent spatial memory. Here, we investigated in detail the role of sialidase in memory processing. Sialidase activity measured with 4-methylumbelliferyl--d-N-acetylneuraminic acid (4MU-Neu5Ac) or 5-bromo-4-chloroindol-3-yl--d-N-acetylneuraminic acid (X-Neu5Ac) and Fast Red Violet LB was increased by high-K+-induced membrane depolarization. Sialidase activity was also increased by chemical LTP induction with forskolin and activation of BDNF signaling, non-NMDA receptors, or NMDA receptors. The increase in sialidase activity with neural excitation appears to be caused not by secreted sialidase or by an increase in sialidase expression but by a change in the subcellular localization of sialidase. Astrocytes as well as neurons are also involved in the neural activity-dependent increase in sialidase activity. Sialidase activity visualized with a benzothiazolylphenol-based sialic acid derivative (BTP3-Neu5Ac), a highly sensitive histochemical imaging probe for sialidase activity, at the CA3 stratum lucidum of rat acute hippocampal slices was immediately increased in response to LTP-inducible high-frequency stimulation on a time scale of seconds. To obtain direct evidence for sialic acid removal on the extracellular cell surface during neural excitation, the extracellular free sialic acid level in the hippocampus was monitored using in vivo microdialysis. The free sialic acid level was increased by high-K+-induced membrane depolarization. Desialylation also occurred during hippocampus-dependent memory formation in a contextual fear-conditioning paradigm. Our results show that neural activity-dependent desialylation by sialidase may be involved in hippocampal memory processing.	[Minami, Akira; Meguro, Yuko; Ishibashi, Sayaka; Ishii, Ami; Shiratori, Mako; Sai, Saki; Horii, Yuuki; Shimizu, Hirotaka; Fukumoto, Hokuto; Shimba, Sumika; Taguchi, Risa; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp			KAKENHI [24790080, 16K08277]; Hokuto Foundation for Bioscience; Futaba Electronics Memorial Foundation; Takahashi Industrial and Economic Research Foundation; Grants-in-Aid for Scientific Research [15K08037] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Futaba Electronics Memorial Foundation; Takahashi Industrial and Economic Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Young Scientists (B) KAKENHI 24790080 and for Scientific Research (C) KAKENHI 16K08277, the Hokuto Foundation for Bioscience, Futaba Electronics Memorial Foundation, and the Takahashi Industrial and Economic Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ando S, 1998, ANN NY ACAD SCI, V845, P232, DOI 10.1111/j.1749-6632.1998.tb09676.x; Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Boyzo A, 2003, BRAIN RES, V964, P211, DOI 10.1016/S0006-8993(02)03985-9; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; Fujii S, 2002, GLYCOBIOLOGY, V12, P339, DOI 10.1093/glycob/12.5.339; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hoffman KB, 1997, BRAIN RES, V753, P309, DOI 10.1016/S0006-8993(96)01468-0; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jung WR, 2008, NEUROSCI LETT, V439, P220, DOI 10.1016/j.neulet.2008.05.020; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kato K, 2008, NEUROSCI LETT, V441, P286, DOI 10.1016/j.neulet.2008.06.058; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Minami A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165257; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, P80; Prendergast J, 2014, J NEUROSCI, V34, P13246, DOI 10.1523/JNEUROSCI.1149-14.2014; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Shiozaki K, 2014, FISH PHYSIOL BIOCHEM, V40, P1461, DOI 10.1007/s10695-014-9940-9; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Takeda A, 2006, J NEUROCHEM, V99, P670, DOI 10.1111/j.1471-4159.2006.04092.x; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x	48	23	23	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5645	5654		10.1074/jbc.M116.764357	http://dx.doi.org/10.1074/jbc.M116.764357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213516	Green Published, hybrid			2022-12-28	WOS:000398813200003
J	Aramsangtienchai, P; Spiegelman, NA; Cao, J; Lin, HN				Aramsangtienchai, Pornpun; Spiegelman, Nicole A.; Cao, Ji; Lin, Hening			S-Palmitoylation of Junctional Adhesion Molecule C Regulates Its Tight Junction Localization and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAM FAMILY; IDENTIFICATION; METASTASIS; MECHANISM; POLARITY; CANCER; ALPHA; PALMITOYLTRANSFERASES; PROTEINS	Junctional adhesion molecule C (JAM-C) is an immunoglobulin superfamily protein expressed in epithelial cells, endothelial cells, and leukocytes. JAM-C has been implicated in leukocyte transendothelial migration, angiogenesis, cell adhesion, cell polarity, spermatogenesis, and metastasis. Here, we show that JAM-C undergoes S-palmitoylation on two juxtamembrane cysteine residues, Cys-264 and Cys-265. We have identified DHHC7 as a JAM-C palmitoylating enzyme by screening all known palmitoyltransferases (DHHCs). Ectopic expression of DHHC7, but not a DHHC7 catalytic mutant, enhances JAM-C S-palmitoylation. Moreover, DHHC7 knockdown decreases the S-palmitoylation level of JAM-C. Palmitoylation of JAM-C promotes its localization to tight junctions and inhibits transwell migration of A549 lung cancer cells. These results suggest that S-palmitoylation of JAM-C can be potentially targeted to control cancer metastasis.	[Aramsangtienchai, Pornpun; Spiegelman, Nicole A.; Cao, Ji; Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Howard Hughes Medical Institute	Lin, HN (corresponding author), Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	hl379@cornell.edu		Spiegelman, Nicole/0000-0001-8981-8375; Lin, Hening/0000-0002-0255-2701	National Institutes of Health [1S10RR025502]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The imaging data were enabled by the Cornell University Biotechnology Resource Center with National Institutes of Health Grant 1S10RR025502 funding for the Zeiss LSM 710 confocal microscope.	Akawi NA, 2013, HUM MUTAT, V34, P498, DOI 10.1002/humu.22263; Arcangeli ML, 2012, FEBS LETT, V586, P4046, DOI 10.1016/j.febslet.2012.10.005; Babina IS, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3614; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Chen BE, 2016, NAT CHEM BIOL, V12, P686, DOI 10.1038/nchembio.2119; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fuse C, 2007, J BIOL CHEM, V282, P8276, DOI 10.1074/jbc.M608836200; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Guo JS, 2014, ANN NEUROL, V75, P255, DOI 10.1002/ana.24086; Hao SN, 2014, TUMOR BIOL, V35, P5675, DOI 10.1007/s13277-014-1751-1; Iwamoto M, 2001, BBA-BIOMEMBRANES, V1514, P152, DOI 10.1016/S0005-2736(01)00380-7; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keiper T, 2005, HISTOL HISTOPATHOL, V20, P197, DOI 10.14670/HH-20.197; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Leinster DA, 2013, FASEB J, V27, P4244, DOI 10.1096/fj.13-230441; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Lu DM, 2012, J BIOL CHEM, V287, P21856, DOI 10.1074/jbc.M112.348094; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rossin A, 2015, CELL DEATH DIFFER, V22, P643, DOI 10.1038/cdd.2014.153; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Tenan M, 2010, GLIA, V58, P524, DOI 10.1002/glia.20941; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yount Jacob S, 2011, Curr Protoc Chem Biol, V3, P65	38	22	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5325	5334		10.1074/jbc.M116.730523	http://dx.doi.org/10.1074/jbc.M116.730523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196865	Green Published, hybrid			2022-12-28	WOS:000397875500015
J	Chen, ZY; Wang, XH; Yang, F; Hu, QQ; Tong, HC; Dong, XZ				Chen, Zhaoyuan; Wang, Xinhui; Yang, Fan; Hu, Qingqing; Tong, Huichun; Dong, Xiuzhu			Molecular Insights into Hydrogen Peroxide-sensing Mechanism of the Metalloregulator MntR in Controlling Bacterial Resistance to Oxidative Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-MUTANS; MANGANESE HOMEOSTASIS; BACILLUS-SUBTILIS; INTERSPECIES COMPETITION; SUPEROXIDE-DISMUTASE; LACTIC-ACID; SP-NOV.; VIRULENCE; OLIGOFERMENTANS; PNEUMONIAE	Manganese contributes to anti-oxidative stress particularly in catalase-devoid bacteria, and DtxR family metalloregulators, through sensing cellular Mn2+ content, regulate its homeostasis. Here, we show that metalloregulator MntR (So-MntR) functions dually as Mn2+ and H2O2 sensors in mediating H2O2 resistance by an oral streptococcus. H2O2 disrupted So-MntR binding to Mn2+ transporter mntABC promoter and induced disulfide-linked dimerization of the protein. Mass spectrometry identified Cys-11/Cys-156 and Cys-11/Cys-11 disulfide- linked peptides in H2O2-treated So-MntR. Site mutagenesis of Cys-11 and Cys-156 and particularly Cys-11 abolished H2O2-induced disulfide- linked dimers and weakened H2O2 damage on So-MntR binding, indicating that H2O2 inactivates So-MntR via disulfide- linked dimerization. So-MntR C123S mutant was extremely sensitive to H2O2 oxidization in dimerization/ oligomerization, probably because the mutagenesis caused a conformational change that facilitates Cys-11/Cys-156 disulfide linkage. Intermolecular Cys-11/Cys-11 disulfide was detected in C123S/C156S double mutant. Redox Western blot detected So-MntR oligomers in air-exposed cells but remarkably decreased upon H2O2 pulsing, suggesting a proteolysis of the disulfide-linked So-MntR oligomers. Remarkably, elevated C11S and C156S but much lower C123S proteins were detected in H2O2-pulsed cells, confirming Cys-11 and Cys-156 contributed to H2O2-induced oligomerization and degradation. Accordingly, in the C11S and C156S mutants, expression of mntABC and cellular Mn2+ decreased, but H2O2 susceptibility increased. In the C123S mutant, increased mntABC expression, cellular Mn2+ content, and manganese-mediated H2O2 survival were determined. Given the wide distribution of Cys-11 in streptococcal DtxR-like metalloregulators, the disclosed redox regulatory function and mechanism of So-MntR can be employed by the DtxR family proteins in bacterial resistance to oxidative stress.	[Chen, Zhaoyuan; Wang, Xinhui; Hu, Qingqing; Tong, Huichun; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Chen, Zhaoyuan; Wang, Xinhui; Hu, Qingqing; Tong, Huichun; Dong, Xiuzhu] Univ Chinese Acad Sci, Sch Life Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yang, Fan] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Tong, HC; Dong, XZ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China.; Tong, HC; Dong, XZ (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China.	tonghuichun@im.ac.cn; dongxz@im.ac.cn	Dong, Xiuzhu/EBF-2196-2022	Dong, Xiuzhu/0000-0002-6926-5459	National Natural Science Foundation of China [31370098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31370098. The authors declare that they have no conflicts of interest with the contents of this article.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Bates CS, 2005, INFECT IMMUN, V73, P5743, DOI 10.1128/IAI.73.9.5743-5753.2005; BOYD J, 1990, P NATL ACAD SCI USA, V87, P5968, DOI 10.1073/pnas.87.15.5968; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Dong XZ, 2000, INT J SYST EVOL MICR, V50, P119, DOI 10.1099/00207713-50-1-119; Eijkelkamp BA, 2015, BIOMETALS, V28, P491, DOI 10.1007/s10534-015-9826-z; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Goldstein S, 1999, ACCOUNTS CHEM RES, V32, P547, DOI 10.1021/ar9800789; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Haswell JR, 2013, J BACTERIOL, V195, P126, DOI 10.1128/JB.01648-12; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Huang XJ, 2017, MOL MICROBIOL, V103, P253, DOI 10.1111/mmi.13554; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Jin D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-141; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Juttukonda LJ, 2015, MOL MICROBIOL, V97, P216, DOI 10.1111/mmi.13034; Kafle P, 2016, J BIOL CHEM, V291, P11776, DOI 10.1074/jbc.M116.719351; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; Liu L, 2012, APPL ENVIRON MICROB, V78, P2120, DOI 10.1128/AEM.07539-11; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Liu Z., 2016, ENV HLTH PREVENT MED, V1, P1; Martin JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004977; McGuire AM, 2013, BIOCHEMISTRY-US, V52, P701, DOI 10.1021/bi301550t; Merchant AT, 2014, MOL ORAL MICROBIOL, V29, P1, DOI 10.1111/omi.12039; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Rolerson E, 2006, J BACTERIOL, V188, P5033, DOI 10.1128/JB.00155-06; Spatafora G, 2015, J BACTERIOL, V197, P3601, DOI 10.1128/JB.00612-15; STADTMAN ER, 1990, P NATL ACAD SCI USA, V87, P384, DOI 10.1073/pnas.87.1.384; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Tong H., 2013, GENOME ANNOUNC, V1; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2008, J BACTERIOL, V190, P4716, DOI 10.1128/JB.00363-08; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tong HC, 2006, FEMS MICROBIOL LETT, V264, P213, DOI 10.1111/j.1574-6968.2006.00453.x; Turner AG, 2015, MBIO, V6, DOI 10.1128/mBio.00278-15; Wang XH, 2014, APPL ENVIRON MICROB, V80, P2351, DOI 10.1128/AEM.00064-14; Watts RJ, 2005, J ENVIRON ENG-ASCE, V131, P158, DOI 10.1061/(ASCE)0733-9372(2005)131:1(158); Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	55	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5519	5531		10.1074/jbc.M116.764126	http://dx.doi.org/10.1074/jbc.M116.764126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28223356	Green Published, hybrid			2022-12-28	WOS:000397875500031
J	Pimviriyakul, P; Thotsaporn, K; Sucharitakul, J; Chaiyen, P				Pimviriyakul, Panu; Thotsaporn, Kittisak; Sucharitakul, Jeerus; Chaiyen, Pimchai			Kinetic Mechanism of the Dechlorinating Flavin-dependent Monooxygenase HadA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLIC ACID OXYGENASE; SEQUENCE SIMILARITY NETWORKS; BURKHOLDERIA-CEPACIA AC1100; COUPLED ELECTRON-TRANSFER; ACINETOBACTER-BAUMANNII; REDUCED FLAVIN; 2,4,6-TRICHLOROPHENOL DEGRADATION; PENTACHLOROPHENOL HYDROXYLASE; CHLOROPHENOL 4-MONOOXYGENASE	The accumulation of chlorophenols (CPs) in the environment, due to their wide use as agrochemicals, has become a serious environmental problem. These organic halides can be degraded by aerobic microorganisms, where the initial steps of various biodegradation pathways include an oxidative dechlorinating process in which chloride is replaced by a hydroxyl substituent. Harnessing these dechlorinating processes could provide an opportunity for environmental remediation, but detailed catalytic mechanisms for these enzymes are not yet known. To close this gap, we now report transient kinetics and product analysis of the dechlorinating flavin-dependent monooxygenase, HadA, from the aerobic organism Ralstonia pickettii DTP0602, identifying several mechanistic properties that differ from other enzymes in the same class. We first overexpressed and purified HadA to homogeneity. Analyses of the products from single and multiple turnover reactions demonstrated thatHadAprefers 4-CP and 2-CP over CPs with multiple substituents. Stopped-flow and rapid-quench flow experiments of HadA with 4-CP show the involvement of specific intermediates (C4a-hydroperoxy-FAD and C4a-hydroxy-FAD) in the reaction, define rate constants and the order of substrate binding, and demonstrate that the hydroxylation step occurs prior to chloride elimination. The data also identify the non-productive and productive paths of the HadA reactions and demonstrate that product formation is the rate-limiting step. This is the first elucidation of the kinetic mechanism of a two-component flavin-dependent monooxygenase that can catalyze oxidative dechlorination of various CPs, and as such it will serve as the basis for future investigation of enzyme variants that will be useful for applications in detoxifying chemicals hazardous to human health.	[Pimviriyakul, Panu; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok 10400, Thailand; [Pimviriyakul, Panu; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot & Enzyme Technol, Fac Sci, Bangkok 10400, Thailand; [Thotsaporn, Kittisak; Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10300, Thailand	Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Fac Sci, Bangkok 10400, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Ctr Excellence Prot & Enzyme Technol, Fac Sci, Bangkok 10400, Thailand.	pimchai.cha@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Pimviriyakul, Panu/0000-0002-0410-0610	The Thailand Research Fund [RTA5980001]; Mahidol University; Development and Promotion of Science and Technology Talents Project (DPST) Scholarship	The Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Development and Promotion of Science and Technology Talents Project (DPST) Scholarship	This work was supported by The Thailand Research Fund through Grant RTA5980001, a grant from Mahidol University (to P. C.), and a Development and Promotion of Science and Technology Talents Project (DPST) Scholarship (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Agency for Toxic Substances and Disease Registry, 2015, PRIOR LIST HAZ SUBST; Agency for Toxic Substances and Disease Registry, 1999, TOX PROF CHLOR; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Arora PK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-31; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bobyk KD, 2015, BIOCHEMISTRY-US, V54, P4487, DOI 10.1021/acs.biochem.5b00410; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Dadson OA, 2013, TOXICOLOGY, V306, P35, DOI 10.1016/j.tox.2013.01.023; DANGANAN CE, 1994, APPL ENVIRON MICROB, V60, P4100, DOI 10.1128/AEM.60.11.4100-4106.1994; Dhammaraj T, 2016, ACS CHEM BIOL, V11, P2889, DOI 10.1021/acschembio.6b00402; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; FRANCISCO WA, 1993, J BIOL CHEM, V268, P24734; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Hatta T, 2012, BIOSCI BIOTECH BIOCH, V76, P892, DOI 10.1271/bbb.110843; Hayes RP, 2012, INT J MOL SCI, V13, P9769, DOI 10.3390/ijms13089769; Hlouchova K, 2012, BIOCHEMISTRY-US, V51, P3848, DOI 10.1021/bi300261p; Hu JM, 2015, J BIOL CHEM, V290, P590, DOI 10.1074/jbc.M114.605964; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Igbinosa EO, 2013, SCI WORLD J, DOI [10.1155/2013/460215, 10.1155/2013/798096]; Kitagawa W, 2004, J BACTERIOL, V186, P4894, DOI 10.1128/JB.186.15.4894-4902.2004; KIYOHARA H, 1992, APPL ENVIRON MICROB, V58, P1276, DOI 10.1128/AEM.58.4.1276-1283.1992; Kovacic P, 2014, J APPL TOXICOL, V34, P810, DOI 10.1002/jat.2980; Li YW, 2015, RSC ADV, V5, P13871, DOI 10.1039/c4ra16165c; Louie TM, 2002, J BACTERIOL, V184, P3492, DOI 10.1128/JB.184.13.3492-3500.2002; Luanloet T, 2015, FEBS J, V282, P3107, DOI 10.1111/febs.13220; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; Matus V, 2003, APPL ENVIRON MICROB, V69, P7108, DOI 10.1128/AEM.69.12.7108-7115.2003; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; Olaniran AO, 2011, CHEMOSPHERE, V83, P1297, DOI 10.1016/j.chemosphere.2011.04.009; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Phongsak T, 2012, J BIOL CHEM, V287, P26213, DOI 10.1074/jbc.M112.354472; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Rudolph J, 2014, BIOCHEMISTRY-US, V53, P6539, DOI 10.1021/bi5010427; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Sucharitakul J, 2013, J BIOL CHEM, V288, P35210, DOI 10.1074/jbc.M113.515205; Takeo M, 2003, J BIOSCI BIOENG, V95, P139, DOI 10.1016/S1389-1723(03)80119-6; Takeo M, 2008, J BACTERIOL, V190, P7367, DOI 10.1128/JB.00742-08; TAKIZAWA N, 1995, J FERMENT BIOENG, V80, P318, DOI 10.1016/0922-338X(95)94198-Z; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2016, ADV BIOCHEM ENG BIOT, V154, P47, DOI 10.1007/10_2014_281; Tinikul R, 2013, BIOCHEMISTRY-US, V52, P6834, DOI 10.1021/bi4006545; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; USEPA, 2014, PRIOR POLL LIST; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Warner JR, 2007, BIOCHEMISTRY-US, V46, P13211, DOI 10.1021/bi701069n; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; Xun LY, 2004, J BIOL CHEM, V279, P6696, DOI 10.1074/jbc.M312072200; XUN LY, 1992, J BACTERIOL, V174, P5745, DOI 10.1128/JB.174.17.5745-5747.1992; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhan X, 2008, BIOCHEMISTRY-US, V47, P2221, DOI 10.1021/bi701853w	64	33	33	5	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4818	4832		10.1074/jbc.M116.774448	http://dx.doi.org/10.1074/jbc.M116.774448			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159841	Green Published, hybrid			2022-12-28	WOS:000397590400007
J	Yin, GW; Kistler, S; George, SD; Kuhlmann, N; Garvey, L; Huynh, M; Bagni, RK; Lammers, M; Der, CJ; Campbell, SL				Yin, Guowei; Kistler, Samantha; George, Samuel D.; Kuhlmann, Nora; Garvey, Leslie; Minh Huynh; Bagni, Rachel K.; Lammers, Michael; Der, Channing J.; Campbell, Sharon L.			A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; NUCLEAR-MAGNETIC-RESONANCE; RAS ACTIVATOR SON; K-RAS; BINDING PROTEINS; STRUCTURAL BASIS; H-RAS; ACETYLATION; EFFECTORS; DYNAMICS	The KRAS GTPase plays a critical role in the control of cellular growth. The activity of KRAS is regulated by guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and also post-translational modification. Lysine 104 in KRAScan be modified by ubiquitylation and acetylation, but the role of this residue in intrinsic KRAS function has not been well characterized. We find that lysine 104 is important for GEF recognition, because mutations at this position impaired GEF-mediated nucleotide exchange. Because the KRAS K104Q mutant has recently been employed as an acetylation mimetic, we conducted a series of studies to evaluate its in vitro and cellbased properties. Herein, we found that KRAS K104Q exhibited defects in both GEF-mediated exchange and GAP-mediated GTP hydrolysis, consistent with NMR-detected structural perturbations in localized regions of KRAS important for recognition of these regulatory proteins. Despite the partial defect in both GEF and GAP regulation, KRAS K104Q did not alter steady-state GTP-bound levels or the ability of the oncogenic KRAS G12V mutant to cause morphologic transformation of NIH 3T3 mouse fibroblasts and of WT KRAS to rescue the growth defect of mouse embryonic fibroblasts deficient in all Ras genes. We conclude that the KRAS K104Q mutant retains bothWTand mutant KRAS function, probably due to offsetting defects in recognition of factors that up-regulate (GEF) and down-regulate (GAP) RAS activity.	[Yin, Guowei; Kistler, Samantha; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Eshelman Sch Pharm, Chapel Hill, NC 27699 USA; [Kistler, Samantha] Univ N Carolina, Dept Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27699 USA; [George, Samuel D.; Minh Huynh; Der, Channing J.; Campbell, Sharon L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27699 USA; [George, Samuel D.; Der, Channing J.; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27699 USA; [Kuhlmann, Nora; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kuhlmann, Nora; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Garvey, Leslie; Bagni, Rachel K.] Frederick Natl Lab Canc Res, Canc Res Technol Program, NCI RAS Initiat, Frederick, MD 21702 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cologne; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Campbell, SL (corresponding author), 120 Mason Farm Rd,CB 7260,3093 Genet Med, Chapel Hill, NC 27599 USA.	campbesl@med.unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022; Lammers, Michael/AAX-1164-2020	campbell, sharon/0000-0003-0311-409X; Yin, Guowei/0000-0003-2669-7160; Der, Channing/0000-0002-7751-2747; Lammers, Michael/0000-0003-4168-4640	National Institutes of Health [R01-GM106227, PO1-CA5104986, P01-CA5104986, R01-CA042978, U01-CA199235]; Deutsche Forschungsgemeinschaft (DFG) [LA2984/3-1]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA042978, U01CA199235, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106227, T32GM008570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM106227 and PO1-CA5104986 (to S.L.C.) and P01-CA5104986, R01-CA042978, and U01-CA199235 (to C.J.D.) and Heisenberg Program of the Deutsche Forschungsgemeinschaft (DFG) Grant LA2984/3-1 (to M.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Fujimoto H, 2012, J COMPUT CHEM, V33, P239, DOI 10.1002/jcc.21956; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Knyphausen P, 2016, BIOL CHEM, V397, P1071, DOI 10.1515/hsz-2016-0118; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Long D, 2013, ANGEW CHEM INT EDIT, V52, P10771, DOI 10.1002/anie.201305434; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Terada T, 1999, J MOL BIOL, V286, P219, DOI 10.1006/jmbi.1998.2472; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T	42	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4446	4456		10.1074/jbc.M116.762435	http://dx.doi.org/10.1074/jbc.M116.762435			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154176	Green Published, hybrid			2022-12-28	WOS:000397585100006
J	Heider, MR; Burkhart, BW; Santangelo, TJ; Gardner, AF				Heider, Margaret R.; Burkhart, Brett W.; Santangelo, Thomas J.; Gardner, Andrew F.			Defining the RNaseH2 enzyme-initiated ribonucleotide excision repair pathway in Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; DNA damage; DNA repair; DNA replication; DNA synthesis; enzyme kinetics; pre-steady-state kinetics; RNaseH2; ribonucleotide excision repair	AICARDI-GOUTIERES-SYNDROME; D DNA-POLYMERASE; THERMOCOCCUS-KODAKARENSIS; CRYSTAL-STRUCTURES; GENOME INTEGRITY; 2-HYDROXYL GROUP; REPLICATION; H2; TRIPHOSPHATES; KODAKARAENSIS	Incorporation of ribonucleotides during DNA replication has severe consequences for genome stability. Although eukaryotes possess a number of redundancies for initiating and completing repair of misincorporated ribonucleotides, archaea such as Thermococcus rely only upon RNaseH2 to initiate the pathway. Because Thermococcus DNA polymerases incorporate as many as 1,000 ribonucleotides per genome, RNaseH2 must be efficient at recognizing and nicking at embedded ribonucleotides to ensure genome integrity. Here, we show that ribonucleotides are incorporated by the hyperthermophilic archaeon Thermococcus kodakarensis both in vitro and in vivo and a robust ribonucleotide excision repair pathway is critical to keeping incorporation levels low in wild-type cells. Using pre-steady-state and steady-state kinetics experiments, we also show that archaeal RNaseH2 rapidly cleaves at embedded ribonucleotides (200-450 s(-1)), but exhibits an approximate to 1,000-fold slower turnover rate (0.06-0.17 s(-1)), suggesting a potential role for RNaseH2 in protecting or marking nicked sites for further processing. We found that following RNaseH2 cleavage, the combined activities of polymerase B (PolB), flap endonuclease (Fen1), and DNA ligase are required to complete ribonucleotide processing. PolB formed a ribonucleotide-containing flap by strand displacement synthesis that was cleaved by Fen1, and DNA ligase sealed the nick for complete repair. Our study reveals conservation of the overall mechanism of ribonucleotide excision repair across domains of life. The lack of redundancies in ribonucleotide repair in archaea perhaps suggests a more ancestral form of ribonucleotide excision repair compared with the eukaryotic pathway.	[Heider, Margaret R.; Gardner, Andrew F.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Burkhart, Brett W.; Santangelo, Thomas J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80521 USA	New England Biolabs; Colorado State University	Gardner, AF (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	gardner@neb.com	Santangelo, Tom/L-8206-2019	Santangelo, Tom/0000-0003-4559-3244	New England Biolabs, Inc.	New England Biolabs, Inc.	This work was supported by New England Biolabs, Inc. The authors declare that they have no conflicts of interest with the contents of this article.	BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Cerritelli SM, 2016, TRENDS BIOCHEM SCI, V41, P434, DOI 10.1016/j.tibs.2016.02.005; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Clausen A. R., 2015, DNA REPLICATION METH, P123; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Cubonova L, 2013, J BACTERIOL, V195, P2322, DOI 10.1128/JB.02037-12; EDER PS, 1991, J BIOL CHEM, V266, P6472; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Greenough L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv899; Greenough L, 2015, J BIOL CHEM, V290, P12514, DOI 10.1074/jbc.M115.638130; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Hileman TH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00195; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; KONG HM, 1993, J BIOL CHEM, V268, P1965; Ladner JE, 2011, P NATL ACAD SCI USA, V108, P2711, DOI 10.1073/pnas.1019179108; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sarmiento F, 2013, P NATL ACAD SCI USA, V110, P4726, DOI 10.1073/pnas.1220225110; Schermerhorn KM, 2015, J BIOL CHEM, V290, P21800, DOI 10.1074/jbc.M115.662841; Spaans SK, 2015, EXTREMOPHILES, V19, P741, DOI 10.1007/s00792-015-0750-5; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaisman A, 2014, MUTAT RES-FUND MOL M, V761, P21, DOI 10.1016/j.mrfmmm.2014.01.005; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110	46	20	20	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8835	8845		10.1074/jbc.M117.783472	http://dx.doi.org/10.1074/jbc.M117.783472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373277	Green Published, hybrid			2022-12-28	WOS:000402153900028
J	Mitchell, RK; Nguyen-Tu, MS; Chabosseau, P; Callingham, RM; Pullen, TJ; Cheung, R; Leclerc, I; Hodson, DJ; Rutter, GA				Mitchell, Ryan K.; Nguyen-Tu, Marie-Sophie; Chabosseau, Pauline; Callingham, Rebecca M.; Pullen, Timothy J.; Cheung, Rebecca; Leclerc, Isabelle; Hodson, David J.; Rutter, Guy A.			The transcription factor Pax6 is required for pancreatic beta cell identity, glucose-regulated ATP synthesis, and Ca2+ dynamics in adult mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; diabetes; gene expression; imaging; islet; insulin	INSULIN-SECRETION; ALPHA-CELLS; EARLY-ONSET; ISLET; EXPRESSION; GENES; REVEALS; DIFFERENTIATION; INACTIVATION; SLC30A8/ZNT8	Heterozygous mutations in the human paired box gene PAX6 lead to impaired glucose tolerance. Although embryonic deletion of the Pax6 gene in mice leads to loss of most pancreatic islet cell types, the functional consequences of Pax6 loss in adults are poorly defined. Here we developed a mouse line in which Pax6 was selectively inactivated in beta cells by crossing animals with floxed Pax6 alleles to mice expressing the inducible Pdx1CreERT transgene. Pax6 deficiency, achieved by tamoxifen injection, caused progressive hyperglycemia. Although beta cell mass was preserved 8 days post-injection, total insulin content and insulin:chromogranin A immunoreactivity were reduced by similar to 60%, and glucose-stimulated insulin secretion was eliminated. RNA sequencing and quantitative real-time PCR analyses revealed that, although the expression of key beta cell genes, including Ins2, Slc30a8, MafA, Slc2a2, G6pc2, and Glp1r, was reduced after Pax6 deletion, that of several genes that are usually selectively repressed (disallowed) in beta cells, including Slc16a1, was increased. Assessed in intact islets, glucose-induced ATP:ADP increases were significantly reduced (p < 0.05) in Pax6KO versus control beta cells, and the former displayed attenuated increases in cytosolic Ca2+. Unexpectedly, glucose-induced increases in intercellular connectivity were enhanced after Pax6 deletion, consistent with increases in the expression of the glucose sensor glucokinase, but decreases in that of two transcription factors usually expressed in fully differentiated -cells, Pdx1 and Nkx6.1, were observed in islet hub cells. These results indicate that Pax6 is required for the functional identity of adult beta cells. Furthermore, deficiencies in beta cell glucose sensing are likely to contribute to defective insulin secretion in human carriers of PAX6 mutations.	[Mitchell, Ryan K.; Nguyen-Tu, Marie-Sophie; Chabosseau, Pauline; Callingham, Rebecca M.; Pullen, Timothy J.; Cheung, Rebecca; Leclerc, Isabelle; Hodson, David J.; Rutter, Guy A.] Imperial Coll London, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, Du Can Rd, London W12 0NN, England; [Hodson, David J.] Univ Birmingham, Inst Metab & Syst Res, Edgbaston B15 2TT, England; [Hodson, David J.] Univ Birmingham, Ctr Membrane Prot & Receptors, Edgbaston B15 2TT, England; [Hodson, David J.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TH, W Midlands, England	Imperial College London; University of Birmingham; University of Birmingham	Hodson, DJ; Rutter, GA (corresponding author), Imperial Coll London, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, Du Can Rd, London W12 0NN, England.; Hodson, DJ (corresponding author), Univ Birmingham, Inst Metab & Syst Res, Edgbaston B15 2TT, England.; Hodson, DJ (corresponding author), Univ Birmingham, Ctr Membrane Prot & Receptors, Edgbaston B15 2TT, England.; Hodson, DJ (corresponding author), Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TH, W Midlands, England.	d.hodson@imperial.ac.uk; g.rutter@imperial.ac.uk	Pullen, Timothy/H-2143-2011	Pullen, Timothy/0000-0002-6853-5701; Leclerc, Isabelle/0000-0003-0044-7921; Hodson, David/0000-0002-8641-8568; Rutter, Guy/0000-0001-6360-0343	Wellcome Trust [WT098424AIA]; Diabetes UK [BDA 11/0004210]; MRC (UK) [GO401641, MR/J0003042/1]; Royal Society Research Merit Award; Diabetes UK R.D. Lawrence [12/0004431]; EFSD/Novo Nordisk Rising Star; ERC starting grant (OptoBETA) [715884]; MRC [MR/N00275X/1]; Imperial Confidence in Concept grants; Birmingham fellowships; MRC [MR/K001981/1] Funding Source: UKRI; Medical Research Council [MR/K001981/1, MR/N00275X/1] Funding Source: researchfish; European Foundation for the Study of Diabetes [RS FS 2015_3] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Research Merit Award; Diabetes UK R.D. Lawrence(Diabetes UK); EFSD/Novo Nordisk Rising Star; ERC starting grant (OptoBETA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial Confidence in Concept grants; Birmingham fellowships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); European Foundation for the Study of Diabetes	This work was supported by grants to G. A. R. from the Wellcome Trust (Senior Investigator Award WT098424AIA), Diabetes UK (Project BDA 11/0004210), the MRC (UK, Project GO401641; Programme MR/J0003042/1), and by a Royal Society Research Merit Award. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Diabetes UK R.D. Lawrence (12/0004431), EFSD/Novo Nordisk Rising Star and Birmingham fellowships, a Wellcome Trust institutional support award, an ERC starting grant (OptoBETA, 715884), MRC Project Grant MR/N00275X/1), and Imperial Confidence in Concept grants.	Adriaenssens AE, 2016, DIABETOLOGIA, V59, P2156, DOI 10.1007/s00125-016-4033-1; Ahlqvist E, 2012, DIABETOLOGIA, V55, P94, DOI 10.1007/s00125-011-2300-8; Ahmad Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144597; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Brun PJ, 2015, FASEB J, V29, P671, DOI 10.1096/fj.14-256743; Carrat GR, 2017, AM J HUM GENET, V100, P238, DOI 10.1016/j.ajhg.2017.01.011; Chen YY, 2014, DIABETES-METAB RES, V30, P467, DOI 10.1002/dmrr.2572; DEFTOS LJ, 1991, ENDOCR REV, V12, P181, DOI 10.1210/edrv-12-2-181; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; ELAYAT AA, 1995, J ANAT, V186, P629; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gutierrez GD, 2017, J CLIN INVEST, V127, P244, DOI 10.1172/JCI88017; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Hodson DJ, 2014, MOL ENDOCRINOL, V28, P860, DOI 10.1210/me.2014-1038; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Katsuta H, 2012, ENDOCRINOLOGY, V153, P5180, DOI 10.1210/en.2012-1257; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Lee HJ, 2013, SEMIN OPHTHALMOL, V28, P306, DOI 10.3109/08820538.2013.825293; Li J, 2015, FASEB J, V29, P3379, DOI 10.1096/fj.14-265918; Loder Merewyn K, 2013, Methods Mol Biol, V950, P13, DOI 10.1007/978-1-62703-137-0_2; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martinez-Sanchez A, 2015, MOL ENDOCRINOL, V29, P1067, DOI 10.1210/me.2015; MEDA P, 1984, Q J EXP PHYSIOL CMS, V69, P719; Mitchell RK, 2016, MOL ENDOCRINOL, V30, P77, DOI 10.1210/me.2015-1227; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Oropeza D, 2015, DIABETES, V64, P3798, DOI 10.2337/db15-0272; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Piccand J, 2014, CELL REP, V9, P2219, DOI 10.1016/j.celrep.2014.11.033; Pullen TJ, 2013, DIABETES OBES METAB, V15, P503, DOI 10.1111/dom.12029; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Soedling H, 2015, MOL METAB, V4, P619, DOI 10.1016/j.molmet.2015.06.007; Solomou A, 2015, J BIOL CHEM, V290, P21432, DOI 10.1074/jbc.M115.645291; Sun G, 2011, DIS MODEL MECH, V4, P193, DOI 10.1242/dmm.006833; Swisa A, 2017, J CLIN INVEST, V127, P230, DOI 10.1172/JCI88015; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137	67	34	35	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8892	8906		10.1074/jbc.M117.784629	http://dx.doi.org/10.1074/jbc.M117.784629			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377501	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000402153900042
J	Ahmed, S; Shrivastava, T; Kumar, N; Ozorowski, G; Ward, AB; Chakrabarti, BK				Ahmed, Shubbir; Shrivastava, Tripti; Kumar, Naresh; Ozorowski, Gabriel; Ward, Andrew B.; Chakrabarti, Bimal K.			Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; ENV TRIMERS; DEPENDENT EPITOPE; DESIGN; VACCINE; GP120; RECOGNITION; STRATEGIES	Designing an effective HIV-1 envelope glycoprotein (Env) immunogen for elicitation of broadly neutralizing antibodies (bNAbs) is a challenging task because of the high sequence diversity, heavy glycosylation, and inherent meta-stability of Env. Based on the antigenic profile of recently isolated bNAbs, the rational approach to immunogen design is to make a stable version of the Env trimer, which mimics the native trimeric Env present on the viral surface. The SOSIP. 664 form of a clade A Env, BG505, yields a homogeneous and well ordered prefusion trimeric form, which maintains structural integrity and desired antigenicity. Following the same approach, we attempted to stabilize a naturally occurring efficiently cleaved clade C Env, namely 4-2.J41, isolated from an Indian patient. Although the SOSIP form of 4-2.J41 failed to produce reasonably well ordered trimers, the 4-2.J41. SOSIP. 664 Env could be stabilized in a native-like trimeric form by swapping a domain from BG505 Env to 4-2.J41 Env. Using various biochemical and biophysical means we confirmed that this engineered Env is cleaved, trimeric, and it retains its native-like quaternary conformation exposing mostly broadly neutralizing epitopes. Moreover, introduction of a disulfide bond in the bridging sheet region further stabilized the closed conformation of the Env. Thus, our 4-2.J41. SOSIP. 664 Env adds to the increasing pool of potential immunogens for a HIV-1 vaccine, particularly for clade C, which is the most prevalent in India and many other countries. Besides, the approach used to stabilize the 4-2.J41 Env may be used successfully with Envs from other HIV-1 strains as well. Additionally, a soluble native trimeric form of an efficiently cleaved membrane-bound Env, 4-2.J41, may be beneficial for immunization studies using various prime-boost strategies.	[Ahmed, Shubbir; Shrivastava, Tripti; Kumar, Naresh; Chakrabarti, Bimal K.] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, HIV Vaccine Translat Res Lab, Faridabad 121001, Haryana, India; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, Dept Integrat Struct & Computat Biol,Ctr HIV AIDS, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Chakrabarti, Bimal K.] Int AIDS Vaccine Initiat, New York, NY 10004 USA	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative	Ahmed, S; Chakrabarti, BK (corresponding author), NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, HIV Vaccine Translat Res Lab, Faridabad 121001, Haryana, India.	sahmed@thsti.res.in; bchakrabarti@iavi.org	Ahmed, Shubbir/AAC-4289-2019; Ward, Andrew B/F-9203-2014; Ozorowski, Gabriel/HCH-0634-2022; Ward, Andrew/ABD-7728-2021	Ahmed, Shubbir/0000-0003-1655-6735; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation CAVD Grants [OPP1115782, OPP1084519]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation CAVD Grants	The work at IAVI was made possible by generous support from many donors including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid; the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. The electron microscopy studies were supported by the International AIDS Vaccine Initiative, and Bill and Melinda Gates Foundation CAVD Grants OPP1115782 and OPP1084519. We thank the Neutralizing Antibody Consortium and the NIH AIDS Research and Reference Reagent Program for providing monoclonal antibodies and sCD4. We also thank Dr. Jayanta Bhattacharya, Dr. Supratik Das, and Dr. Rajesh Kumar for helpful discussions.	Benjelloun F, 2012, J VIROL, V86, P13152, DOI 10.1128/JVI.01110-12; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Boliar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122443; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Center RJ, 2004, J VIROL, V78, P2265, DOI 10.1128/JVI.78.5.2265-2276.2004; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dey AK, 2007, VIROLOGY, V360, P199, DOI 10.1016/j.virol.2006.09.046; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mann JK, 2015, VIROL J, V12, DOI 10.1186/s12985-014-0221-0; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	39	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8236	8243		10.1074/jbc.M117.776419	http://dx.doi.org/10.1074/jbc.M117.776419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28283570	hybrid, Green Published			2022-12-28	WOS:000401788600010
J	Colomb, F; Wang, WK; Simpson, D; Zafar, M; Beynon, R; Rhodes, JM; Yu, LG				Colomb, Florent; Wang, Weikun; Simpson, Deborah; Zafar, Mudaser; Beynon, Robert; Rhodes, Jonathan M.; Yu, Lu-Gang			Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CIRCULATING GALECTIN-3; ADHESION MOLECULE; CANCER-PATIENTS; TUMOR; MELANOMA; ANGIOGENESIS; PROGRESSION; RECEPTOR; INTERLEUKIN-6	The galactoside-binding protein galectin-3 is increasingly recognized as an important player in cancer development, progression, and metastasis via its interactions with various galactoside- terminated glycans. We have shown previously that circulating galectin-3, which is increased up to 30-fold in cancer patients, promotes blood-borne metastasis in an animal cancer model. This effect is partly attributable to the interaction of galectin-3 with unknown receptor(s) on vascular endothelial cells and causes endothelial secretion of several metastasis-promoting cytokines. Here we sought to identify the galectin-3binding molecule(s) on the endothelial cell surface responsible for the galectin-3-mediated cytokine secretion. Using two different galectin-3 affinity purification processes, we extracted four cell membrane glycoproteins, CD146/melanoma cell adhesion molecule (MCAM)/MUC18, CD31/platelet endothelial cell adhesion molecule-1 (PECAM-1), CD144/VE-cadherin, and CD106/Endoglin, from vascular endothelial cells. CD146 was the major galectin-3-binding ligand and strongly co-localized with galectin-3 on endothelial cell surfaces treated with exogenous galectin-3. Moreover, galectin-3 bound to N-linked glycans on CD146 and induced CD146 dimerization and subsequent activation of AKT signaling. siRNA-mediatedsuppressionof CD146 expression completely abolished the galectin-3-induced secretion of IL-6 and G-CSF cytokines from the endothelial cells. Thus, CD146/MCAM is the functional galectin-3-binding ligand on endothelial cell surfaces responsible for galectin-3induced secretion of metastasis-promoting cytokines. We conclude that CD146/MCAM interactions with circulating galectin- 3 may have an important influence on cancer progression and metastasis.	[Colomb, Florent; Wang, Weikun; Zafar, Mudaser; Rhodes, Jonathan M.; Yu, Lu-Gang] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Liverpool L69 3GE, Merseyside, England; [Simpson, Deborah; Beynon, Robert] Univ Liverpool, Inst Integrat Biol, Ctr Proteome Res, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Yu, LG (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Liverpool L69 3GE, Merseyside, England.	lgyu@liv.ac.uk	Beynon, Robert/K-1408-2014	Beynon, Robert/0000-0003-0857-495X; Zafar, Mudaser/0000-0001-5424-6514	North West Cancer Research Fund [CR975]	North West Cancer Research Fund	This work was supported by North West Cancer Research Fund Grant CR975. The authors declare that they have no conflicts of interest with the contents of this article.	Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Bu PC, 2007, BBA-MOL CELL RES, V1773, P513, DOI 10.1016/j.bbamcr.2007.01.009; Chen C, 2013, CLIN CANCER RES, V19, P1693, DOI 10.1158/1078-0432.CCR-12-2940; Duckworth CA, 2015, ONCOTARGET, V6, P23671, DOI 10.18632/oncotarget.4409; Erdbruegger U, 2010, CURR STEM CELL RES T, V5, P294, DOI 10.2174/157488810793351721; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Jiang GQ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0313-3; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jouve N, 2015, INT J CANCER, V137, P50, DOI 10.1002/ijc.29370; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Kitazume S, 2014, GLYCOBIOLOGY, V24, P1260, DOI 10.1093/glycob/cwu094; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nodomi S, 2016, ONCOGENE, V35, P5317, DOI 10.1038/onc.2016.72; Pop VV, 2017, IMMUNOL LETT, V181, P45, DOI 10.1016/j.imlet.2016.11.010; Ruma IMW, 2016, CLIN EXP METASTAS, V33, P609, DOI 10.1007/s10585-016-9801-2; Sakaki M, 2008, J MED INVESTIG, V55, P127, DOI 10.2152/jmi.55.127; Saussez S, 2008, THYROID, V18, P705, DOI 10.1089/thy.2007.0361; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; SERS C, 1994, CANCER RES, V54, P5689; SHIH IM, 1994, CANCER RES, V54, P2514; Sindrewicz P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00079; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Tu T, 2015, CELL RES, V25, P275, DOI 10.1038/cr.2015.15; Ulmansky R, 2015, J IMMUNOL, V194, P5103, DOI 10.4049/jimmunol.1500023; Undi RB, 2016, CYTOKINE, V83, P245, DOI 10.1016/j.cyto.2016.05.007; Vereecken P, 2006, CLIN EXP DERMATOL, V31, P105, DOI 10.1111/j.1365-2230.2005.01992.x; Wang J, 2015, ONCOGENE, V34, P5781, DOI 10.1038/onc.2015.36; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	36	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8381	8389		10.1074/jbc.M117.783431	http://dx.doi.org/10.1074/jbc.M117.783431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28364041	hybrid, Green Published			2022-12-28	WOS:000401788600022
J	Dong, XD; Guan, JH; Zheng, CF; Zheng, XF				Dong, Xiaodong; Guan, Junhong; Zheng, Chunfu; Zheng, Xiaofeng			The herpes simplex virus 1 UL36USP deubiquitinase suppresses DNA repair in host cells via deubiquitination of proliferating cell nuclear antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TEGUMENT PROTEIN; POLYMERASE-ETA; MONOUBIQUITINATED PCNA; DAMAGE; REPLICATION; PATHWAY; TYPE-1; DOMAIN; VP1/2; UBIQUITINATION	Herpes simplex virus 1 (HSV-1) infection manipulates distinct host DNA-damage responses to facilitate virus proliferation, but the molecular mechanisms remain to be elucidated. One possible HSV-1 target might be DNA damage-tolerance mechanisms, such as the translesion synthesis (TLS) pathway. In TLS, proliferating cell nuclear antigen (PCNA) is monoubiquitinated in response to DNA damage-caused replication fork stalling. Ubiquitinated PCNA then facilitates the error-prone DNA polymerase eta (pol eta)-mediated TLS, allowing the fork to bypass damaged sites. Because of the involvement of PCNA ubiquitination in DNA-damage repair, we hypothesized that the function of PCNA might be altered by HSV-1. Here we show that PCNA is a substrate of the HSV-1 deubiquitinase UL36USP, which has previously been shown to be involved mainly in virus uptake and maturation. In HSV-1-infected cells, viral infection-associated UL36USP consistently reduced PCNA ubiquitination. The deubiquitination of PCNA inhibited the formation of pol eta foci and also increased cell sensitivity to DNA-damage agents. Moreover, the catalytically inactive mutant UL36C40A failed to deubiquitinate PCNA. Of note, the levels of virus marker genes increased strikingly in cells infected with wild-type HSV-1, but only moderately in UL36C40A mutant virus-infected cells, indicating that the UL36USP deubiquitinating activity supports HSV-1 virus replication during infection. These findings suggest a role of UL36USP in the DNA damage-response pathway.	[Dong, Xiaodong; Guan, Junhong; Zheng, Xiaofeng] Peking Univ, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Dong, Xiaodong; Guan, Junhong; Zheng, Xiaofeng] Peking Univ, Dept Biochem & Mol Biol, Sch Life Sci, Beijing 100871, Peoples R China; [Zheng, Chunfu] Soochow Univ, Inst Biol & Med Sci, Suzhou 215123, Peoples R China; [Zheng, Chunfu] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada	Peking University; Peking University; Soochow University - China; University of Calgary	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	zheng, Chunfu/F-2404-2012; 关, 俊宏/AAG-1046-2021; Guan, Junhong/HIK-0559-2022	zheng, Chunfu/0000-0002-8797-1322; 关, 俊宏/0000-0003-4900-0610; 	National Science Foundation of China [31470754, 31670786]; National Key Research and Development Program of China [2016YFC1302401]; Doctoral Fund of Ministry of Education of China [20130001130003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Science Foundation of China Grants 31470754 and 31670786, the National Key Research and Development Program of China Grant 2016YFC1302401, and Doctoral Fund of Ministry of Education of China Grant 20130001130003. The authors declare that they have no conflicts of interest with the contents of this article.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Bolstad M, 2011, J VIROL, V85, P8738, DOI 10.1128/JVI.00798-11; Bucks MA, 2007, VIROLOGY, V361, P316, DOI 10.1016/j.virol.2006.11.031; Cardone G, 2012, J VIROL, V86, P4058, DOI 10.1128/JVI.00012-12; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; GIBSON W, 1972, J VIROL, V10, P1044, DOI 10.1128/JVI.10.5.1044-1052.1972; Han JH, 2014, J CELL BIOL, V205, P811, DOI 10.1083/jcb.201311007; Haracska L, 2005, MOL CELL BIOL, V25, P1183, DOI 10.1128/MCB.25.3.1183-1190.2005; Hedglin M, 2016, ELIFE, V5, DOI 10.7554/eLife.19788; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hu B, 2014, NUCLEIC ACIDS RES, V42, P5582, DOI 10.1093/nar/gku230; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karttunen H, 2014, MOL CELL, V55, P111, DOI 10.1016/j.molcel.2014.05.020; Kashiwaba S, 2015, CELL REP, V13, P2072, DOI 10.1016/j.celrep.2015.11.014; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kim ET, 2009, J VIROL, V83, P12046, DOI 10.1128/JVI.00411-09; Kumar R, 2014, J VIROL, V88, P6411, DOI 10.1128/JVI.00536-14; Lee JIH, 2006, J VIROL, V80, P12086, DOI 10.1128/JVI.01184-06; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Newcomb WW, 2010, J VIROL, V84, P9408, DOI 10.1128/JVI.00361-10; Park JM, 2014, MOL CELL, V54, P626, DOI 10.1016/j.molcel.2014.03.031; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sanders I, 2015, J NEUROVIROL, V21, P358, DOI 10.1007/s13365-015-0321-7; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Shanda SK, 2008, J VIROL, V82, P7388, DOI 10.1128/JVI.00225-08; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Wang S, 2013, J VIROL, V87, P11851, DOI 10.1128/JVI.01211-13; Weitzman MD, 2014, CELL HOST MICROBE, V15, P283, DOI 10.1016/j.chom.2014.02.010; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Whitehurst CB, 2012, J VIROL, V86, P8097, DOI 10.1128/JVI.00588-12; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009; Zeman MK, 2014, J CELL BIOL, V206, P183, DOI 10.1083/jcb.201311063; Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999	47	8	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8472	8483		10.1074/jbc.M117.778076	http://dx.doi.org/10.1074/jbc.M117.778076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348081	Green Published, hybrid			2022-12-28	WOS:000401788600030
J	Wang, S; Wang, S; Asgar, J; Joseph, J; Ro, JY; Wei, F; Campbell, JN; Chung, MK				Wang, Sheng; Wang, Sen; Asgar, Jamila; Joseph, John; Ro, Jin Y.; Wei, Feng; Campbell, James N.; Chung, Man-Kyo			Ca2+ and calpain mediate capsaicin-induced ablation of axonal terminals expressing transient receptor potential vanilloid 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PRIMARY AFFERENT NEURONS; ROOT GANGLION NEURONS; NEUROPATHIC PAIN; PLASMA-MEMBRANE; ION-CHANNEL; DEGENERATION; INJURY; TRPV1; DEATH	Capsaicin is an ingredient in spicy peppers that produces burning pain by activating transient receptor potential vanilloid 1 (TRPV1), a Ca2+-permeable ion channel in nociceptors. Capsaicin has also been used as an analgesic, and its topical administration is approved for the treatment of certain pain conditions. The mechanisms underlying capsaicin-induced analgesia likely involve reversible ablation of nociceptor terminals. However, the mechanisms underlying these effects are not well understood. To visualize TRPV1-lineage axons, a genetically engineered mouse model was used in which a fluorophore is expressed under the TRPV1 promoter. Using a combination of these TRPV1-lineage reporter mice and primary afferent cultures, we monitored capsaicin-induced effects on afferent terminals in real time. We found that Ca2+ influx through TRPV1 is necessary for capsaicin-induced ablation of nociceptive terminals. Although capsaicin-induced mitochondrial Ca2+ uptake was TRPV1-dependent, dissipation of the mitochondrial membrane potential, inhibition of the mitochondrial transition permeability pore, and scavengers of reactive oxygen species did not attenuate capsaicin-induced ablation. In contrast, MDL28170, an inhibitor of the Ca2+-dependent protease calpain, diminished ablation. Furthermore, overexpression of calpastatin, an endogenous inhibitor of calpain, or knockdown of calpain 2 also decreased ablation. Quantitative assessment of TRPV1-lineage afferents in the epidermis of the hind paws of the reporter mice showed that EGTA and MDL28170 diminished capsaicin-induced ablation. Moreover, MDL28170 prevented capsaicin-induced thermal hypoalgesia. These results suggest that TRPV1/Ca2+/calpain-dependent signaling plays a dominant role in capsaicin-induced ablation of nociceptive terminals and further our understanding of the molecular mechanisms underlying the effects of capsaicin on nociceptors.	[Wang, Sheng; Wang, Sen; Asgar, Jamila; Joseph, John; Ro, Jin Y.; Wei, Feng; Chung, Man-Kyo] Univ Maryland, Sch Dent, Ctr Adv Chron Pain Res, Dept Neural & Pain Sci,Program Neurosci, Baltimore, MD 21201 USA; [Campbell, James N.] Centrexion, Baltimore, MD 21202 USA	University System of Maryland; University of Maryland Baltimore	Chung, MK (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, 650 W Baltimore St,8 South, Baltimore, MD 21201 USA.	mchung@umaryland.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148	National Institutes of Health [R01 DE023846]; Maryland Industrial Partnership [5403]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Industrial Partnership; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health Grant R01 DE023846 (to M. K. C.) and Maryland Industrial Partnership Grant 5403 (to M. K. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Borbiro I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005667; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Campbell CM, 2016, PAIN, V157, P1297, DOI 10.1097/j.pain.0000000000000544; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; CHARD PS, 1995, NEUROSCIENCE, V65, P1099, DOI 10.1016/0306-4522(94)00548-J; Chiang H, 2015, ACTA NEUROPATHOL, V129, P81, DOI 10.1007/s00401-014-1354-3; Chung MK, 2012, J DENT RES, V91, P777, DOI 10.1177/0022034512450298; Chung MK, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040066; Chung MK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916668526; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Dedov VN, 2001, NEUROSCIENCE, V103, P219, DOI 10.1016/S0306-4522(00)00540-6; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Iadarola Michael J, 2013, Open Pain J, V6, P95; Jackson JG, 2006, J NEUROPHYSIOL, V96, P1093, DOI 10.1152/jn.00283.2006; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd; Kunz S, 2004, PAIN, V110, P409, DOI 10.1016/j.pain.2004.04.031; Liu L, 2001, J NEUROPHYSIOL, V85, P745, DOI 10.1152/jn.2001.85.2.745; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; Ma XL, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0019-0; Malmberg AB, 2004, PAIN, V111, P360, DOI 10.1016/j.pain.2004.07.017; Mou J, 2013, PAIN, V154, P1632, DOI 10.1016/j.pain.2013.04.044; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neubert JK, 2003, PAIN, V104, P219, DOI 10.1016/S0304-3959(03)00009-5; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Premkumar L. S., 2015, OPEN PAIN J, V8, P1; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Shin CY, 2003, MOL CELL NEUROSCI, V24, P57, DOI 10.1016/S1044-7431(03)00121-0; Shutov LP, 2013, J PHYSIOL-LONDON, V591, P2443, DOI 10.1113/jphysiol.2012.249219; Simone DA, 1998, J NEUROSCI, V18, P8947; Stantcheva KK, 2016, EMBO REP, V17, P585, DOI 10.15252/embr.201540983; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Szallasi A, 1999, PHARMACOL REV, V51, P159; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Tsantoulas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080722; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Wang S., 2015, COMPUT MATH METHOD M, V2015, P1, DOI DOI 10.1016/J.EC0C0M.2015.04.004; Wang S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-22; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wu JH, 2014, BIOCHEM J, V464, P13, DOI 10.1042/BJ20140931; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034; Zang Y, 2015, BRAIN BEHAV IMMUN, V44, P37, DOI 10.1016/j.bbi.2014.08.003; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	57	21	21	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8291	8303		10.1074/jbc.M117.778290	http://dx.doi.org/10.1074/jbc.M117.778290			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360106	hybrid, Green Published			2022-12-28	WOS:000401788600015
J	Desai, TM; Marin, M; Mason, C; Melikyan, GB				Desai, Tanay M.; Marin, Mariana; Mason, Caleb; Melikyan, Gregory B.			pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; INDUCED MEMBRANE-FUSION; HIV-1 VIRION FUSION; PORE FORMATION; LEUKOSIS-VIRUS; ENVELOPE GLYCOPROTEIN; DENGUE VIRUS; HOST FACTORS; FLUORESCENT PROTEINS; 6-HELIX BUNDLE	Enveloped viruses infect host cells by fusing their membranes with those of the host cell, a process mediated by viral glycoproteins upon binding to cognate host receptors or entering into acidic intracellular compartments. Whereas the effect of receptor density on viral infection has been well studied, the role of cell type-specific factors/processes, such as pH regulation, has not been characterized in sufficient detail. Here, we examined the effects of cell-extrinsic factors (buffer environment) and cell-intrinsic factors (interferon-inducible transmembrane proteins, IFITMs), on the pH regulation in early endosomes and on the efficiency of acid-dependent fusion of the avian sarcoma and leukosis virus (ASLV), with endosomes. First, we found that a modest elevation of external pH can raise the pH in early endosomes in a cell type-dependent manner and thereby delay the acid-induced fusion of endocytosed ASLV. Second, we observed a cell type-dependent delay between the low pH-dependent and temperature-dependent steps of viral fusion, consistent with the delayed enlargement of the fusion pore. Third, ectopic expression of IFITMs, known to potently block influenza virus fusion with late compartments, was found to only partially inhibit ASLV fusion with early endosomes. Interestingly, IFITM expression promoted virus uptake and the acidification of endosomal compartments, resulting in an accelerated fusion rate when driven by the glycosylphosphatidylinositol-anchored, but not by the transmembrane isoform of the ASLV receptor. Collectively, these results highlight the role of cell-extrinsic and cell-intrinsic factors in regulating the efficiency and kinetics of virus entry and fusion with target cells.	[Desai, Tanay M.; Marin, Mariana; Mason, Caleb; Melikyan, Gregory B.] Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30032 USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA 30322 USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30032 USA.	gmeliki@emory.edu			National Institutes of Health [R01 AI053668]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI053668 (to G. B. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Barnard RJO, 2004, J VIROL, V78, P10433, DOI 10.1128/JVI.78.19.10433-10441.2004; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Delos SE, 2010, J VIROL, V84, P5687, DOI 10.1128/JVI.02583-09; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Dube M, 2016, J VIROL, V90, P6303, DOI 10.1128/JVI.00634-16; Elleder D, 2004, J VIROL, V78, P13489, DOI 10.1128/JVI.78.24.13489-13500.2004; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gallo SA, 2004, BIOCHEMISTRY-US, V43, P8230, DOI 10.1021/bi049957v; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; KIELIAN MC, 1986, EMBO J, V5, P3103, DOI 10.1002/j.1460-2075.1986.tb04616.x; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lee ASY, 2014, J VIROL, V88, P8355, DOI 10.1128/JVI.00642-14; Leikina E, 2002, EMBO J, V21, P5701, DOI 10.1093/emboj/cdf559; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Markosyan RM, 2004, BIOPHYS J, V87, P3291, DOI 10.1529/biophysj.104.047696; Markosyan RM, 2001, BIOPHYS J, V80, P812, DOI 10.1016/S0006-3495(01)76060-2; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Netter RC, 2004, J VIROL, V78, P13430, DOI 10.1128/JVI.78.24.13430-13439.2004; Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Padilla-Parra S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-47; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; PAK CC, 1994, J GEN VIROL, V75, P395, DOI 10.1099/0022-1317-75-2-395; Pasqual G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002232; Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Pirooz SD, 2014, P NATL ACAD SCI USA, V111, P2716, DOI 10.1073/pnas.1320629111; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; Stauffer S, 2014, J VIROL, V88, P13029, DOI 10.1128/JVI.01430-14; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	65	15	15	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7817	7827		10.1074/jbc.M117.783878	http://dx.doi.org/10.1074/jbc.M117.783878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28341742	hybrid, Green Published			2022-12-28	WOS:000401154100012
J	Ferreira, NS; Engelsby, H; Neess, D; Kelly, SL; Volpert, G; Merrill, AH; Futerman, AH; Faergeman, NJ				Ferreira, Natalia Santos; Engelsby, Hanne; Neess, Ditte; Kelly, Samuel L.; Volpert, Giora; Merrill, Alfred H.; Futerman, Anthony H.; Faergeman, Nils J.			Regulation of very-long acyl chain ceramide synthesis by acyl-CoA-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; ceramide synthase; fatty acid metabolism; lipid binding protein; sphingolipid; ACBP; Acyl-CoA	SPHINGOLIPID METABOLISM; ENDOPLASMIC-RETICULUM; LIGAND-BINDING; SYNTHASES; COENZYME; SPECIFICITY; RESIDUES; ESTERS; MICE	Ceramide and more complex sphingolipids constitute a diverse group of lipids that serve important roles as structural entities of biological membranes and as regulators of cellular growth, differentiation, and development. Thus, ceramides are vital players in numerous diseases including metabolic and cardiovascular diseases, as well as neurological disorders. Here we show that acyl-coenzyme A-binding protein (ACBP) potently facilitates very-long acyl chain ceramide synthesis. ACBP increases the activity of ceramide synthase 2 (CerS2) by more than 2-fold and CerS3 activity by 7-fold. ACBP binds very-long-chain acyl-CoA esters, which is required for its ability to stimulate CerS activity. We also show that high-speed liver cytosol from wild-type mice activates CerS3 activity, whereas cytosol from ACBP knock-out mice does not. Consistently, CerS2 and CerS3 activities are significantly reduced in the testes of ACBP(-/-) mice, concomitant with a significant reduction in long- and very-long-chain ceramide levels. Importantly, we show that ACBP interacts with CerS2 and CerS3. Our data uncover a novel mode of regulation of very-long acyl chain ceramide synthesis by ACBP, which we anticipate is of crucial importance in understanding the regulation of ceramide metabolism in pathogenesis.	[Ferreira, Natalia Santos; Volpert, Giora; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Engelsby, Hanne; Neess, Ditte; Faergeman, Nils J.] Univ Southern Denmark, Dept Biochem & Mol Biol, Villum Ctr Bioanalyt Sci, Campusvej 55, DK-5230 Odense M, Denmark; [Kelly, Samuel L.; Merrill, Alfred H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel L.; Merrill, Alfred H.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Futerman, Anthony H.] Weizmann Inst Sci, Biochem, Rehovot, Israel	Weizmann Institute of Science; University of Southern Denmark; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Weizmann Institute of Science	Faergeman, NJ (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Villum Ctr Bioanalyt Sci, Campusvej 55, DK-5230 Odense M, Denmark.	nils.f@bmb.sdu.dk		Futerman, Anthony/0000-0003-0013-0115; Faergeman, Nils/0000-0002-9281-5287	Israel Science Foundation [0888/11]; Danish Council for Independent Research-Natural Science Grant [23459]; Novo Nordisk Foundation; Lundbeck Foundation [R126-2012-12264] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0001867, NNF14OC0012021] Funding Source: researchfish; Villum Fonden [00007292] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Danish Council for Independent Research-Natural Science Grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	This work was supported by Israel Science Foundation Grants 0888/11, by Danish Council for Independent Research-Natural Science Grant 23459, and by the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Astudillo L, 2015, J INHERIT METAB DIS, V38, P65, DOI 10.1007/s10545-014-9736-1; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Eckl KM, 2013, J INVEST DERMATOL, V133, P2202, DOI 10.1038/jid.2013.153; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Fulceri R, 1997, BIOCHEM J, V325, P423, DOI 10.1042/bj3250423; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Hutzler JM, 2001, DRUG METAB DISPOS, V29, P1029; Inouye K, 2000, BBA-PROTEIN STRUCT M, V1481, P265, DOI 10.1016/S0167-4838(00)00135-7; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Kragelund BB, 1999, BIOCHEMISTRY-US, V38, P2386, DOI 10.1021/bi982427c; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001; Neess D, 2013, CELL REP, V5, P1403, DOI 10.1016/j.celrep.2013.11.010; Neess D, 2011, J BIOL CHEM, V286, P3460, DOI 10.1074/jbc.M110.161109; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Radner FPW, 2011, DERM-ENDOCRINOL, V3, P77, DOI 10.4161/derm.3.2.15472; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rolf B, 1995, BBA-LIPID LIPID MET, V1259, P245, DOI 10.1016/0005-2760(95)00170-0; Sassa T, 2016, J BIOL CHEM, V291, P7477, DOI 10.1074/jbc.M115.695858; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sullards MC, 2011, BBA-MOL CELL BIOL L, V1811, P838, DOI 10.1016/j.bbalip.2011.06.027; Thymiakou E, 2011, JOVE-J VIS EXP, DOI 10.3791/2631; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Wadum MCT, 2002, BIOCHEM J, V365, P165, DOI 10.1042/BJ20011727; Wegner MS, 2014, BIOCHEM PHARMACOL, V92, P577, DOI 10.1016/j.bcp.2014.10.007; Wronowska W, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0176-9; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239	48	25	25	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7588	7597		10.1074/jbc.M117.785345	http://dx.doi.org/10.1074/jbc.M117.785345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28320857	Green Published, hybrid			2022-12-28	WOS:000400761300026
J	Jaremko, WJ; Huang, Z; Wen, W; Wu, A; Karl, N; Niu, L				Jaremko, William J.; Huang, Zhen; Wen, Wei; Wu, Andrew; Karl, Nicholas; Niu, Li			Identification and characterization of RNA aptamers: A long aptamer blocks the AMPA receptor and a short aptamer blocks both AMPA and kainate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); central nervous system (CNS); glutamate receptor; inhibitor; RNA; kainate receptor; RNA aptamers; SELEX	SELECTIVE GLUTAMATE RECEPTORS; ANTERIOR CINGULATE CORTEX; SUBUNIT MESSENGER-RNAS; METHYL-D-ASPARTATE; CAT SPINAL-CORD; RAT-BRAIN; CHANNEL PROPERTIES; ACID RECEPTORS; BINDING-SITES; DENTATE GYRUS	AMPA and kainate receptors, along with NMDA receptors, represent different subtypes of glutamate ion channels. AMPA and kainate receptors share a high degree of sequence and structural similarities, and excessive activity of these receptors has been implicated in neurological diseases such as epilepsy. Therefore, blocking detrimental activity of both receptor types could be therapeutically beneficial. Here, we report the use of an in vitro evolution approach involving systematic evolution of ligands by exponential enrichment with a single AMPA receptor target (i.e. GluA1/2R) to isolate RNA aptamers that can potentially inhibit both AMPA and kainate receptors. A full-length or 101-nucleotide (nt) aptamer selectively inhibited GluA1/2R with a K-I of approximate to 5 m, along with GluA1 and GluA2 AMPA receptor subunits. Of note, its shorter version (55 nt) inhibited both AMPA and kainate receptors. In particular, this shorter aptamer blocked equally potently the activity of both the GluK1 and GluK2 kainate receptors. Using homologous binding and whole-cell recording assays, we found that an RNA aptamer most likely binds to the receptor's regulatory site and inhibits it noncompetitively. Our results suggest the potential of using a single receptor target to develop RNA aptamers with dual activity for effectively blocking both AMPA and kainate receptors.	SUNY Albany, Dept Chem, Albany, NY 12222 USA; SUNY Albany, Ctr Neurosci Res, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Niu, L (corresponding author), SUNY Albany, LSRB 1060, Albany, NY 12222 USA.	lniu@albany.edu		Wen, Wei/0000-0003-1422-856X	National Institutes of Health NINDS [R01 NS060812]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060812] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grant R01 NS060812 and the Muscular Dystrophy Association (to L. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beneyto M, 2004, J COMP NEUROL, V468, P530, DOI 10.1002/cne.10981; Bliss TVP, 2016, NAT REV NEUROSCI, V17, P485, DOI 10.1038/nrn.2016.68; Borbely S, 2015, NEUROTOX RES, V27, P441, DOI 10.1007/s12640-014-9515-7; Bortolotto ZA, 2003, PHILOS T ROY SOC B, V358, P657, DOI 10.1098/rstb.2002.1216; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Calias P, 2014, PHARMACOL THERAPEUT, V144, P114, DOI 10.1016/j.pharmthera.2014.05.009; Clements JD, 1998, J NEUROSCI, V18, P119; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Crepel V, 2015, CURR OPIN PHARMACOL, V20, P83, DOI 10.1016/j.coph.2014.11.012; DAVIES J, 1985, BRAIN RES, V327, P113, DOI 10.1016/0006-8993(85)91505-7; DAVIES J, 1983, EXP BRAIN RES, V49, P280; Dev KK, 1996, J NEUROCHEM, V67, P2609; Dingledine R, 1999, PHARMACOL REV, V51, P7; Domingues A, 2006, ANN NY ACAD SCI, V1074, P458, DOI 10.1196/annals.1369.046; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Hagihara H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00100; Huang Z, 2007, BIOCHEMISTRY-US, V46, P12648, DOI 10.1021/bi701036p; Huang Z, 2013, ANAL BIOCHEM, V435, P35, DOI 10.1016/j.ab.2012.12.011; Huang Z, 2010, BIOCHEMISTRY-US, V49, P5790, DOI 10.1021/bi100690k; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Koike M, 2000, J NEUROSCI, V20, P2166; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; MARTIN LJ, 1993, J NEUROSCI, V13, P782; McConnell EM, 2014, NUCLEIC ACID THER, V24, P388, DOI 10.1089/nat.2014.0492; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Nussinov R, 2012, CURR PHARM DESIGN, V18, P1311; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Park JS, 2011, J BIOL CHEM, V286, P15608, DOI 10.1074/jbc.M111.229559; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Pinheiro PS, 2013, CEREB CORTEX, V23, P323, DOI 10.1093/cercor/bhs022; Porter RHP, 1997, BRAIN RES, V751, P217, DOI 10.1016/S0006-8993(96)01404-7; RAIGORODSKY G, 1990, EUR J PHARMACOL, V182, P37, DOI 10.1016/0014-2999(90)90491-N; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Ritz M, 2008, BIOCHEMISTRY-US, V47, P1061, DOI 10.1021/bi700782x; Ritz M, 2011, ACS CHEM NEUROSCI, V2, P506, DOI 10.1021/cn200033j; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Schiffer HH, 2000, J NEUROSCI, V20, P9025; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; ShimizuSasamata M, 1996, J PHARMACOL EXP THER, V276, P84; Solyom S, 2002, CURR PHARM DESIGN, V8, P913, DOI 10.2174/1381612024607081; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SPREAFICO R, 1994, DEV BRAIN RES, V82, P231, DOI 10.1016/0165-3806(94)90166-X; Sullenger BA, 2016, SCIENCE, V352, P1417, DOI 10.1126/science.aad8709; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Swanson GT, 2009, NEUROPSYCHOPHARMACOL, V34, P249, DOI 10.1038/npp.2008.158; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Zundert B, 2017, NEUROSCI LETT, V636, P1, DOI 10.1016/j.neulet.2016.10.014; Wallace Mark S, 2006, Expert Rev Neurother, V6, P1423, DOI 10.1586/14737175.6.10.1423; Watanabe-Iida I, 2016, J NEUROCHEM, V136, P295, DOI 10.1111/jnc.13384; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wilding TJ, 1996, MOL PHARMACOL, V49, P540; WISDEN W, 1993, J NEUROSCI, V13, P3582; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; ZHOU N, 1993, NEUROPHARMACOLOGY, V32, P767, DOI 10.1016/0028-3908(93)90185-6; Zhu SJ, 2017, NEUROPHARMACOLOGY, V112, P11, DOI 10.1016/j.neuropharm.2016.08.034	67	8	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7338	7347		10.1074/jbc.M116.774752	http://dx.doi.org/10.1074/jbc.M116.774752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28325839	Green Published, hybrid			2022-12-28	WOS:000400761300006
J	Zuo, RJ; Liu, XH; Wang, WS; Li, WJ; Ying, H; Sun, K				Zuo, Rujuan; Liu, Xiaohui; Wang, Wangsheng; Li, Wenjiao; Ying, Hao; Sun, Kang			A repressive role of enhancer of zeste homolog 2 in 11 beta-hydroxysteroid dehydrogenase type 2 expression in the human placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2F transcription factor; glucocorticoid; histone methylation; histone modification; placenta; trophoblast; 11-hydroxysteroid dehydrogenase 2; EZH2; fetal development	11-BETA-HSD2 EXPRESSION; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; METHYLATION; TROPHOBLAST; INHIBITION; EZH2; GLUCOCORTICOIDS; ACETYLATION	The expression of 11-hydroxysteroid dehydrogenase type 2 (11-HSD2), which acts as a placental glucocorticoid barrier, is silenced in cytotrophoblasts but substantially up-regulated during syncytialization. However, the repressive mechanism of 11-HSD2 expression before syncytialization and how this repression is lifted during syncytialization remain mostly unresolved. Here we found that enhancer of zeste homolog 2 (EZH2) accounts for the silence of 11-HSD2 expression via trimethylation of histone H3 lysine 27 at the promoter of the 11-HSD2 gene. Further studies revealed that, upon syncytialization, human chorionic gonadotropin reduced the phosphorylation of retinoblastoma protein (pRB) via activation of the cAMP/PKA pathway, which sequesters E2F transcription factor 1 (E2F1), the transcription factor for EZH2 expression. As a result of inactivation of the pRB-E2F1-EZH2 pathway, the repressive marker trimethylation of histone H3 lysine 27 at the 11-HSD2 promoter is removed, which leads to the robust expression of 11-HSD2 during syncytialization.	[Zuo, Rujuan; Wang, Wangsheng; Li, Wenjiao; Sun, Kang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China; [Zuo, Rujuan; Wang, Wangsheng; Li, Wenjiao; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China; [Liu, Xiaohui; Ying, Hao] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai 200135, Peoples R China	Shanghai Jiao Tong University; Tongji University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China.; Sun, K (corresponding author), Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China.	sungangrenji@hotmail.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Zuo, Rujuan/0000-0003-3060-2179	National Natural Science Foundation of China [31671566, 81330018, 81601286]; National Key Basic Research Program of China [2014CB943302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31671566, 81330018, and 81601286 and National Key Basic Research Program of China Grant 2014CB943302. The authors declare that they have no conflicts of interest with the contents of this article.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Conradt E, 2013, EPIGENETICS-US, V8, P1321, DOI 10.4161/epi.26634; Costa MA, 2016, MOL CELL ENDOCRINOL, V420, P180, DOI 10.1016/j.mce.2015.11.010; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fogarty NME, 2015, PLACENTA, V36, P796, DOI 10.1016/j.placenta.2015.05.006; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gundisch S, 2012, ANTICANCER RES, V32, P4251; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Hunkapiller J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002576; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; Jensen Pena Catherine, 2012, PLoS One, V7, pe39791, DOI 10.1371/journal.pone.0039791; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Li JN, 2011, J CLIN ENDOCR METAB, V96, pE899, DOI 10.1210/jc.2010-2852; Li JN, 2013, J CLIN ENDOCR METAB, V98, pE1189, DOI 10.1210/jc.2012-4291; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Naderi S, 2005, MOL BIOL CELL, V16, P1527, DOI 10.1091/mbc.E04-06-0501; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Ni XT, 2009, PLACENTA, V30, P1023, DOI 10.1016/j.placenta.2009.10.005; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Rugg-Gunn PJ, 2012, REPROD BIOMED ONLINE, V25, P21, DOI 10.1016/j.rbmo.2012.01.012; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Sun K, 1997, J CLIN ENDOCR METAB, V82, P300, DOI 10.1210/jc.82.1.300; Togher KL, 2014, EPIGENETICS-US, V9, P816, DOI 10.4161/epi.28703; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; Ward AC, 1996, BIOCHEM BIOPH RES CO, V224, P10, DOI 10.1006/bbrc.1996.0976; Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003; Williamson EA, 1997, LEUKEMIA, V11, P73, DOI 10.1038/sj.leu.2400551; Zhang N, 2015, J CLIN ENDOCR METAB, V100, pE542, DOI 10.1210/jc.2014-4376; Zhao Y, 2014, EUR J HUM GENET, V22, P734, DOI 10.1038/ejhg.2013.226; Zuo RJ, 2015, J BIOL CHEM, V290, P21280, DOI 10.1074/jbc.M115.656629	39	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7578	7587		10.1074/jbc.M116.765800	http://dx.doi.org/10.1074/jbc.M116.765800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302719	hybrid, Green Published			2022-12-28	WOS:000400761300025
J	Guha, M; Saare, M; Maslovskaja, J; Kisand, K; Liiv, I; Haljasorg, U; Tasa, T; Metspalu, A; Milani, L; Peterson, P				Guha, Mithu; Saare, Mario; Maslovskaja, Julia; Kisand, Kai; Liiv, Ingrid; Haljasorg, Uku; Tasa, Tonis; Metspalu, Andres; Milani, Lili; Peterson, Part			DNA breaks and chromatin structural changes enhance the transcription of autoimmune regulator target genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; SELF-ANTIGEN EXPRESSION; RNA-POLYMERASE-II; TOPOISOMERASE-II; P-TEFB; IMMUNOLOGICAL-TOLERANCE; IMMUNE TOLERANCE; HISTONE H3K4; AIRE; PROTEIN	The autoimmune regulator (AIRE) protein is the key factor in thymic negative selection of autoreactive T cells by promoting the ectopic expression of tissue-specific genes in the thymic medullary epithelium. Mutations in AIRE cause a monogenic autoimmune disease called autoimmune polyendocrinopathycandidiasis- ectodermal dystrophy. AIRE has been shown to promote DNA breaks via its interaction with topoisomerase 2 (TOP2). In this study, we investigated topoisomerase-induced DNA breaks and chromatin structural alterations in conjunction with AIRE-dependent gene expression. Using RNA sequencing, we found that inhibition of TOP2 religation activity by etoposide in AIRE-expressing cells had a synergistic effect on genes with low expression levels. AIRE-mediated transcription was not only enhanced by TOP2 inhibition but also by the TOP1 inhibitor camptothecin. The transcriptional activation was associated with structural rearrangements in chromatin, notably the accumulation of gamma H2AX and the exchange of histone H1 with HMGB1 at AIRE target gene promoters. In addition, we found the transcriptional up-regulation to co-occur with the chromatin structural changes within the genomic cluster of carcinoembryonic antigen-like cellular adhesion molecule genes. Overall, our results suggest that the presence of AIRE can trigger molecular events leading to an altered chromatin landscape and the enhanced transcription of low-expressed genes.	[Guha, Mithu; Saare, Mario; Maslovskaja, Julia; Kisand, Kai; Liiv, Ingrid; Haljasorg, Uku; Peterson, Part] Univ Tartu, Inst Biomed & Translat Med, Mol Pathol, EE-50411 Tartu, Estonia; [Tasa, Tonis] Univ Tartu, Inst Comp Sci, EE-50411 Tartu, Estonia; [Metspalu, Andres; Milani, Lili] Univ Tartu, Estonian Genome Ctr, EE-50411 Tartu, Estonia; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50411 Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu; University of Tartu	Peterson, P (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Mol Pathol, EE-50411 Tartu, Estonia.	part.peterson@ut.ee	Saare, Mario/F-1986-2011; Kisand, Kai/J-3483-2015; Haljasorg, Uku/Q-6147-2017; Milani, Lili/N-1097-2019; Peterson, Pärt/A-5788-2009	Saare, Mario/0000-0003-3372-7700; Kisand, Kai/0000-0002-5426-4648; Haljasorg, Uku/0000-0002-1541-6020; Milani, Lili/0000-0002-5323-3102; Peterson, Pärt/0000-0001-6755-791X; Tasa, Tonis/0000-0001-7754-6413	Estonian Research Council [IUT2-2]; European Union through the European Regional Development Fund [2014-2020.4.01.15-0012]; Estonian Research Council Mobilitas Grant [MJD164]; ERA-Net. Rus project EGIDA	Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund(European Commission); Estonian Research Council Mobilitas Grant(Estonian Research Council); ERA-Net. Rus project EGIDA	This work was supported by the Estonian Research Council funding IUT2-2, by the European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012), by Estonian Research Council Mobilitas Grant MJD164, and ERA-Net. Rus project EGIDA. The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2016, IMMUNOL REV, V271, P127, DOI 10.1111/imr.12419; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Cloosen S, 2007, CANCER RES, V67, P3919, DOI 10.1158/0008-5472.CAN-06-2112; Dahl JA, 2007, FRONT BIOSCI-LANDMRK, V12, P4925, DOI 10.2741/2438; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Favorov A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002529; Ferguson BJ, 2008, J BIOL CHEM, V283, P1723, DOI 10.1074/jbc.M707211200; Gaetani M, 2012, NUCLEIC ACIDS RES, V40, P11756, DOI 10.1093/nar/gks933; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kisand K, 2015, J CLIN IMMUNOL, V35, P463, DOI 10.1007/s10875-015-0176-y; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Liiv I, 2012, BIOCHEM BIOPH RES CO, V423, P32, DOI 10.1016/j.bbrc.2012.05.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Mondal N, 2003, NUCLEIC ACIDS RES, V31, P5016, DOI 10.1093/nar/gkg705; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Oti M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2516-6; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Pignatelli M, 2009, BIOINFORMATICS, V25, P1552, DOI 10.1093/bioinformatics/btp248; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Ragab A, 2003, NUCLEIC ACIDS RES, V31, P7083, DOI 10.1093/nar/gkg923; Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; St-Pierre C, 2015, J IMMUNOL, V195, P498, DOI 10.4049/jimmunol.1500558; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11; Zumer K, 2011, NUCLEIC ACIDS RES, V39, P7908, DOI 10.1093/nar/gkr527	61	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6542	6554		10.1074/jbc.M116.764704	http://dx.doi.org/10.1074/jbc.M116.764704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28242760	Green Published, hybrid			2022-12-28	WOS:000399813400010
J	Guan, L; He, P; Yang, F; Zhang, Y; Hu, YF; Ding, J; Hua, Y; Zhang, Y; Ye, Q; Hu, JZ; Wang, T; Jin, CW; Kong, DC				Guan, Ling; He, Peng; Yang, Fang; Zhang, Yuan; Hu, Yunfei; Ding, Jienv; Hua, Yu; Zhang, Yi; Ye, Qiong; Hu, Jiazhi; Wang, Tao; Jin, Changwen; Kong, Daochun			Sap1 is a replication-initiation factor essential for the assembly of pre-replicative complex in the fission yeast Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; ORC-BINDING; PROTEIN; P65(CDC18); CONSISTS; DOMAINS; SYSTEM; SITES	A central step in the initiation of chromosomal DNA replication in eukaryotes is the assembly of pre-replicative complex (pre-RC) at late M and early G(1) phase of the cell cycles. Since 1973, four proteins or protein complexes, including cell division control protein 6 (Cdc6)/Cdc18, minichromosome maintenance protein complex, origin recognition complex (ORC), and Cdt1, are known components of the pre-RC. Previously, we reported that a non-ORC protein binds to the essential element Delta 9 of the Schizosaccharomyces pombe DNA-replication origin ARS3001. In this study, we identified that the non-ORC protein is Sap1. Like ORC, Sap1 binds to DNA origins during cell growth cycles. But unlike ORC, which binds to asymmetric AT-rich sequences through its nine AT-hook motifs, Sap1 preferentially binds to a DNA sequence of 5'-(A/T)(n)(C/G)(A/T)(9-10)(G/C)(A/T)(n)-3' (n >= 1). We also found that Sap1 and ORC physically interact. We further demonstrated that Sap1 is required for the assembly of the pre-RC because of its essential role in recruiting Cdc18 to DNA origins. Thus, we conclude that Sap1 is a replication-initiation factor that directly participates in the assembly of the pre-RC. DNA-replication origins in fission yeast are defined by possessing two essential elements with one bound by ORC and the other by Sap1.	[Guan, Ling; He, Peng; Yang, Fang; Zhang, Yuan; Hua, Yu; Ye, Qiong; Hu, Jiazhi; Kong, Daochun] Peking Univ, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Yunfei; Ding, Jienv; Zhang, Yi; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Wang, Tao] South Univ Sci & Technol China, Dept Biol, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University; Southern University of Science & Technology	Kong, DC (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.; Wang, T (corresponding author), South Univ Sci & Technol China, Dept Biol, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China.	wangtao@sustc.edu.cn; changwen@pku.edu.cn; kongdc@pku.edu.cn	Zhang, Yi/J-7181-2019	Zhang, Yi/0000-0001-8170-9983; Hu, Jiazhi/0000-0002-6345-0039	National Natural Science Foundation of China [30770441, 31170739, 31230021, 31300600]; Ministry of Science and Technology of China [2006CB910300, 2010CB912201, 2013CB911000, 2013CB911500]; 985 Program; National Key Laboratory of Protein and Plant Gene Research; Peking-Tsinghua Center for Life Sciences; Shenzhen Science and technology Innovation (SZSTI) [JCYJ20160331115853521, GGJS20130329180714793]; National Key Research and Development Plan [2016YFA0501201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 985 Program; National Key Laboratory of Protein and Plant Gene Research; Peking-Tsinghua Center for Life Sciences; Shenzhen Science and technology Innovation (SZSTI); National Key Research and Development Plan	This work was supported by grants from the National Natural Science Foundation of China (30770441, 31170739, and 31230021 to D. K.; 31300600 to T. W.) and from the Ministry of Science and Technology of China (2006CB910300, 2010CB912201, and 2013CB911000 to D. K.; 2013CB911500 to T. W.). This work was also supported by the '985 Program,' the National Key Laboratory of Protein and Plant Gene Research and Peking-Tsinghua Center for Life Sciences (to D. K.) and grants from Shenzhen Science and technology Innovation (SZSTI) JCYJ20160331115853521 and GGJS20130329180714793 to T. W. All NMR experiments were performed at the Beijing NMR Center and the NMR facility of National Center for Protein Sciences at Peking University and supported by Grant 2016YFA0501201 from the National Key Research and Development Plan (to C. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARCANGIOLI B, 1994, MOL CELL BIOL, V14, P2058, DOI 10.1128/MCB.14.3.2058; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Bada M, 2000, J MOL BIOL, V300, P563, DOI 10.1006/jmbi.2000.3854; Baum B, 1998, EMBO J, V17, P5689, DOI 10.1093/emboj/17.19.5689; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; HARTWELL LH, 1973, GENETICS, V74, P267; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HUIBREGTSE J M, 1991, P550; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2012, J BIOL CHEM, V287, P23819, DOI 10.1074/jbc.M112.371492; KEARSEY S, 1983, EMBO J, V2, P1571, DOI 10.1002/j.1460-2075.1983.tb01626.x; Kim SM, 1998, MOL CELL BIOL, V18, P7294, DOI 10.1128/MCB.18.12.7294; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Kong DC, 2002, EMBO J, V21, P5567, DOI 10.1093/emboj/cdf546; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Kuszewski J, 2001, J AM CHEM SOC, V123, P3903, DOI 10.1021/ja010033u; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; MAINE GT, 1984, GENETICS, V106, P365; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Takahashi T, 2001, GENES CELLS, V6, P837, DOI 10.1046/j.1365-2443.2001.00468.x; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287	47	3	3	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6056	6075		10.1074/jbc.M116.767806	http://dx.doi.org/10.1074/jbc.M116.767806			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223353	Green Published, hybrid			2022-12-28	WOS:000399538700004
J	Kalantari, P; Harandi, OF; Agarwal, S; Rus, F; Kurt-Jones, EA; Fitzgerald, KA; Caffrey, DR; Golenbock, DT				Kalantari, Parisa; Harandi, Omid F.; Agarwal, Sarika; Rus, Florentina; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Caffrey, Daniel R.; Golenbock, Douglas T.			miR-718 represses proinflammatory cytokine production through targeting phosphatase and tensin homolog (PTEN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; bacterial pathogenesis; lipopolysaccharide (LPS); microRNA (miRNA); phosphatase and tensin homolog (PTEN); Toll-like receptor 4 (TLR4); miR-718	TUMOR-SUPPRESSOR GENE; MICE LACKING; EXPRESSION; RECEPTOR; LIPOPOLYSACCHARIDE; IDENTIFICATION; MICRORNAS; SEPSIS; KINASE; BRAIN	Bacterial sepsis involves a complex interaction between the host immune response and bacterial LPS. LPS binds Toll-like receptor (TLR) 4, which leads to the release of proinflammatory cytokines that are essential for a potent innate immune response against pathogens. The innate immune system is tightly regulated, as excessive inflammation can lead to organ failure and death. MicroRNAs have recently emerged as important regulators of the innate immune system. Here we determined the function of miR-718, which is conserved across mammals and overlaps with the 5 UTR of the interleukin 1 receptor-associated kinase (IRAK1) gene. As IRAK1 is a key component of innate immune signaling pathways that are downstream of most TLRs, we hypothesized that miR-718 helps regulate the innate immune response. Activation of TLR4, but not TLR3, induced the expression of miR-718 in macrophages. miR-718 expression was also induced in the spleens of mice upon LPS injection. miR-718 modulates PI3K/Akt signaling by directly down-regulating phosphatase and tensin homolog (PTEN), thereby promoting phosphorylation of Akt, which leads to a decrease in proinflammatory cytokine production. Phosphorylated Akt induces let-7e expression, which, in turn, down-regulates TLR4 and further diminishes TLR4-mediated proinflammatory signals. Decreased miR-718 expression is associated with bacterial burden during Neisseria gonorrhoeae infection and alters the infection dynamics of N. gonorrhoeae in vitro. Furthermore, miR-718 regulates the induction of LPS tolerance in macrophages. We propose a role for miR-718 in controlling TLR4 signaling and inflammatory cytokine signaling through a negative feedback regulation loop involving down-regulation of TLR4, IRAK1, and NF-B.	[Kalantari, Parisa; Agarwal, Sarika; Rus, Florentina; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Caffrey, Daniel R.; Golenbock, Douglas T.] Univ Massachusetts, Div Infect Dis & Immunol, Sch Med, Worcester, MA 01605 USA; [Harandi, Omid F.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Harandi, Omid F.] Rubius Therapeut, 325 Vassar St,Suite 1A, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kalantari, P (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, 150 Harrison Ave, Boston, MA 02111 USA.	Parisa.Kalantari@tufts.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [R37GM54060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37GM54060. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jeffrey PL, 2000, MOL CELL NEUROSCI, V16, P185, DOI 10.1006/mcne.2000.0866; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawagoe T., 2008, NAT IMMUNOL; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee ES, 2004, J IMMUNOL, V173, P6864, DOI 10.4049/jimmunol.173.11.6864; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Montaner S, 2007, CELL CYCLE, V6, P438, DOI 10.4161/cc.6.4.3843; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suffredini AF, 1999, J CLIN IMMUNOL, V19, P203, DOI 10.1023/A:1020563913045; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Thomas JA, 1999, J IMMUNOL, V163, P978; Wan XL, 2003, ONCOGENE, V22, P8205, DOI 10.1038/sj.onc.1206878; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	47	30	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5634	5644		10.1074/jbc.M116.749325	http://dx.doi.org/10.1074/jbc.M116.749325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28209713	Green Published, hybrid			2022-12-28	WOS:000398813200002
J	Burr, R; Stewart, EV; Espenshade, PJ				Burr, Risa; Stewart, Emerson V.; Espenshade, Peter J.			Coordinate Regulation of Yeast Sterol Regulatory Element-binding Protein (SREBP) and Mga2 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DSC E3 LIGASE; UNSATURATED FATTY-ACIDS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; ANTIBIOTIC CERULENIN; GENE-EXPRESSION; SYNTHASE PROMOTER; CLEAVAGE; REQUIRES; ACTIVATION	The Mga2 and Sre1 transcription factors regulate oxygen-responsive lipid homeostasis in the fission yeast Schizosaccharomyces pombe in a manner analogous to the mammalian sterol regulatory element-binding protein (SREBP)-1 and SREBP-2 transcription factors. Mga2 and SREBP-1 regulate triacylglycerol and glycerophospholipid synthesis, whereas Sre1 and SREBP-2 regulate sterol synthesis. In mammals, a shared activation mechanism allows for coordinate regulation of SREBP-1 and SREBP-2. In contrast, distinct pathways activate fission yeast Mga2 and Sre1. Therefore, it is unclear whether and how these two related pathways are coordinated to maintain lipid balance in fission yeast. Previously, we showed that Sre1 cleavage is defective in the absence of mga2. Here, we report that this defect is due to deficient unsaturated fatty acid synthesis, resulting in aberrant membrane transport. This defect is recapitulated by treatment with the fatty acid synthase inhibitor cerulenin and is rescued by addition of exogenous unsaturated fatty acids. Furthermore, sterol synthesis inhibition blocks Mga2 pathway activation. Together, these data demonstrate that Sre1 and Mga2 are each regulated by the lipid product of the other transcription factor pathway, providing a source of coordination for these two branches of lipid synthesis.	[Burr, Risa; Stewart, Emerson V.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Burr, Risa/AGK-7711-2022	Burr, Risa/0000-0001-6851-2932; Espenshade, Peter/0000-0002-6433-0178	National Institutes of Health [HL077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL077588 (to P. J. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AWAYA J, 1975, BIOCHIM BIOPHYS ACTA, V409, P267, DOI 10.1016/0005-2760(75)90022-3; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Burr R, 2016, J BIOL CHEM, V291, P12171, DOI 10.1074/jbc.M116.723650; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Jiang YD, 2002, EUKARYOT CELL, V1, P481, DOI 10.1128/EC.1.3.481-490.2002; Kandasamy P, 2004, J BIOL CHEM, V279, P36586, DOI 10.1074/jbc.M401557200; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lloyd SJA, 2013, J BIOL CHEM, V288, P21043, DOI 10.1074/jbc.M113.468215; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Los D A, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.62.pe1; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magdeleine M, 2016, ELIFE, V5, DOI 10.7554/eLife.16988; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Matynia A, 2002, J CELL SCI, V115, P421; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Melser S, 2011, PLANT CELL REP, V30, P177, DOI 10.1007/s00299-010-0954-1; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Raychaudhuri S, 2015, J BIOL CHEM, V290, P14430, DOI 10.1074/jbc.M114.630863; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Zhang SR, 1999, GENETICS, V151, P473	44	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5311	5324		10.1074/jbc.M117.778209	http://dx.doi.org/10.1074/jbc.M117.778209			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202541	Green Published, hybrid			2022-12-28	WOS:000397875500014
J	Liu, BC; Hu, JZ; Wang, JN; Kong, DC				Liu, Bochao; Hu, Jiazhi; Wang, Jingna; Kong, Daochun			Direct Visualization of RNA-DNA Primer Removal from Okazaki Fragments Provides Support for Flap Cleavage and Exonucleolytic Pathways in Eukaryotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; YEAST; EXCISION; PROTEIN; FEN-1; EXONUCLEASE; MATURATION; INTERACTS	During DNA replication in eukaryotic cells, short single stranded DNA segments known as Okazaki fragments are first synthesized on the lagging strand. The Okazaki fragments originate from similar to 35-nucleotide-long RNA-DNA primers. After Okazaki fragment synthesis, these primers must be removed to allow fragment joining into a continuous lagging strand. To date, the models of enzymatic machinery that removes the RNADNA primers have come almost exclusively from biochemical reconstitution studies and some genetic interaction assays, and there is little direct evidence to confirm these models. One obstacle to elucidating Okazaki fragment processing has been the lack of methods that can directly examine primer removal in vivo. In this study, we developed an electron microscopy assay that can visualize nucleotide flap structures on DNA replication forks in fission yeast (Schizosaccharomyces pombe). With this assay, we first demonstrated the generation of flap structures during Okazaki fragment processing in vivo. The mean and median lengths of the flaps in wild-type cells were similar to 51 and similar to 41 nucleotides, respectively. We also used yeast mutants to investigate the impact of deleting key DNA replication nucleases on these flap structures. Our results provided direct in vivo evidence for a previously proposed flap cleavage pathway and the critical function of Dna2 and Fen1 in cleaving these flaps. In addition, we found evidence for another previously proposed exonucleolytic pathway involving RNA-DNA primer digestion by exonucleases RNase H2and Exo1. Taken together, our observations suggest a dual mechanism for Okazaki fragment maturation in lagging strand synthesis and establish	[Liu, Bochao; Hu, Jiazhi; Wang, Jingna; Kong, Daochun] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Kong, DC (corresponding author), Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	kongdc@pku.edu.cn		Hu, Jiazhi/0000-0002-6345-0039	National Natural Science Foundation of China [31230021, 31400674]; Ministry of Science and Technology of China [2013CB911000]; Peking-Tsinghua Center for Life Sciences; School of Life Sciences; National Key Laboratory of Protein and Plant Gene Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Peking-Tsinghua Center for Life Sciences; School of Life Sciences; National Key Laboratory of Protein and Plant Gene Research	This work was supported by National Natural Science Foundation of China Grants 31230021 (to D.K.) and 31400674 (to J.W.), Ministry of Science and Technology of China Grant 2013CB911000 (to D.K.), and Peking-Tsinghua Center for Life Sciences, School of Life Sciences, and the National Key Laboratory of Protein and Plant Gene Research (to D.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BUSEN W, 1977, EUR J BIOCHEM, V74, P203, DOI 10.1111/j.1432-1033.1977.tb11382.x; BUSEN W, 1975, EUR J BIOCHEM, V52, P179, DOI 10.1111/j.1432-1033.1975.tb03985.x; ENGLER MJ, 1983, J BIOL CHEM, V258, P1197; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Levikova M, 2015, NUCLEIC ACIDS RES, V43, P7888, DOI 10.1093/nar/gkv710; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu SF, 2015, TECTONICS, V34, P413, DOI 10.1002/2014TC003784; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Qiu JZ, 1999, J BIOL CHEM, V274, P17893, DOI 10.1074/jbc.274.25.17893; Qiu JZ, 2004, J BIOL CHEM, V279, P24394, DOI 10.1074/jbc.M401464200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SAKABE K, 1966, BIOCHIM BIOPHYS ACTA, V129, P651, DOI 10.1016/0005-2787(66)90088-8; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; WAGA S, 1994, J BIOL CHEM, V269, P10923; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	53	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4777	4788		10.1074/jbc.M116.758599	http://dx.doi.org/10.1074/jbc.M116.758599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159842	Green Published, hybrid			2022-12-28	WOS:000397590400003
J	Abe, S; Nagai, T; Masukawa, M; Okumoto, K; Homma, Y; Fujiki, Y; Mizuno, K				Abe, Shoko; Nagai, Tomoaki; Masukawa, Moe; Okumoto, Kanji; Homma, Yuta; Fujiki, Yukio; Mizuno, Kensaku			Localization of Protein Kinase NDR2 to Peroxisomes and Its Role in Ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARY CELL MUTANT; TARGETING SIGNAL; BIOGENESIS; CILIA; TRIPEPTIDE; COMPLEX; RABIN8; PEX5P; IDENTIFICATION; TRAFFICKING	Nuclear Dbf2-related (NDR) kinases, comprising NDR1 and NDR2, are serine/threonine kinases that play crucial roles in the control of cell proliferation, apoptosis, and morphogenesis. We recently showed that NDR2, but not NDR1, is involved in primary cilium formation; however, the mechanism underlying their functional difference in ciliogenesis is unknown. To address this issue, we examined their subcellular localization. Despite their close sequence similarity, NDR2 exhibited punctate localization in the cytoplasm, whereas NDR1 was diffusely distributed within the cell. Notably, NDR2 puncta mostly co-localized with the peroxisome marker proteins, catalase and CFPSKL (cyan fluorescent protein carrying the C-terminal typical peroxisome-targeting signal type-1 (PTS1) sequence, Ser-LysLeu). NDR2 contains the PTS1-like sequence, Gly-Lys-Leu, at the C-terminal end, whereas the C-terminal end ofNDR1is AlaLys. An NDR2 mutant lacking the C-terminal Leu, NDR2(Delta L), exhibited almost diffuse distribution in cells. Additionally, NDR2, but neither NDR1 nor NDR2(Delta L), bound to the PTS1 receptor Pex5p. Together, these findings indicate that NDR2 localizes to the peroxisome by using the C-terminal GKL sequence. Intriguingly, topology analysis of NDR2 suggests that NDR2 is exposed to the cytosolic surface of the peroxisome. The expression of wild-type NDR2, but not NDR2(Delta L), recovered the suppressive effect of NDR2 knockdown on ciliogenesis. Furthermore, knockdown of peroxisome biogenesis factor genes (PEX1 or PEX3) partially suppressed ciliogenesis. These results suggest that the peroxisomal localization of NDR2 is implicated in its function to promote primary cilium formation.	[Abe, Shoko; Nagai, Tomoaki; Masukawa, Moe; Homma, Yuta; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Okumoto, Kanji] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Fujiki, Yukio] Kyushu Univ, Med Inst Bioregulat, Maidashi, Fukuoka 8128582, Japan	Tohoku University; Kyushu University; Kyushu University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Nagai, Tomoaki/N-8924-2017; Homma, Yuta/T-3089-2018; Homma, Yuta/O-1029-2019	Nagai, Tomoaki/0000-0002-9577-9314; Homma, Yuta/0000-0002-3676-6089; Homma, Yuta/0000-0002-3676-6089	Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants for Scientific Research [15H04347, 15H01197, 24247038, 26116007]; Grants-in-Aid for Scientific Research [15K14511, 26440032] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants for Scientific Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants for Scientific Research 15H04347 and 15H01197 (to K. M.) and 24247038 and 26116007 (to Y. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Berta AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024074; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Emoto K, 2011, J BIOCHEM, V150, P133, DOI 10.1093/jb/mvr080; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Hettema EH, 2014, CURR OPIN CELL BIOL, V29, P25, DOI 10.1016/j.ceb.2014.02.002; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lazarow PB, 2011, CURR OPIN MICROBIOL, V14, P458, DOI 10.1016/j.mib.2011.07.009; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Mast FD, 2015, CURR OPIN CELL BIOL, V35, P131, DOI 10.1016/j.ceb.2015.05.002; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MIURA S, 1992, J BIOL CHEM, V267, P14405; Mohan KVK, 2002, J VIROL, V76, P2543, DOI 10.1128/JVI.76.5.2543-2547.2002; Nagai T, 2014, J BIOCHEM, V155, P137, DOI 10.1093/jb/mvu001; Oda T, 2014, GENES CELLS, V19, P927, DOI 10.1111/gtc.12191; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Zaki MS, 2016, HUM MUTAT, V37, P170, DOI 10.1002/humu.22934; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054	47	8	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4089	4098		10.1074/jbc.M117.775916	http://dx.doi.org/10.1074/jbc.M117.775916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28122914	Green Published, hybrid			2022-12-28	WOS:000395837100012
J	Maruoka, M; Kedashiro, S; Ueda, Y; Mizutani, K; Takai, Y				Maruoka, Masahiro; Kedashiro, Shin; Ueda, Yuki; Mizutani, Kiyohito; Takai, Yoshimi			Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; GROWTH-FACTOR RECEPTORS; CELL-CELL JUNCTIONS; MOVING NIH3T3 CELLS; INTEGRIN ALPHA(6)BETA(4); ACTIVATION LOOP; BREAST-CANCER; PROTEIN; CYTOKINE; ADHESION	Cell-surface cytokine receptors are regulated by their cis-interacting stimulatory and inhibitory co-receptors. We previously showed that the Ig-like cell-adhesion molecule nectin-4 cis-interacts with the prolactin receptor through the extracellular region and stimulates prolactin-induced prolactin receptor activation and signaling, resulting in alveolar development in the mouse mammary gland. However, it remains unknown how this interaction stimulates these effects. We show here that the cis-interaction of the extracellular region of nectin-4 with the prolactin receptor was not sufficient for eliciting these effects and that the cytoplasmic region of nectin-4 was also required for this interaction. The cytoplasmic region of nectin-4 directly interacted with suppressor of cytokine signaling 1 (SOCS1), but not SOCS3, JAK2, or STAT5a, and inhibited the interaction of SOCS1 with JAK2, eventually resulting in the increased phosphorylation of STAT5a. The juxtamembrane region of nectin-4 interacted with the Src homology 2 domain of SOCS1. Both the interaction of nectin-4 with the extracellular region of the prolactin receptor and the interaction of SOCS1 with the cytoplasmic region of nectin-4 were required for the stimulatory effect of nectin-4 on the prolactin-induced prolactin receptor activation. The third Ig-like domain of nectin-4 and the second fibronectin type III domain of the prolactin receptor were involved in this cis-interaction, and both the extracellular and transmembrane regions of nectin-4 and the prolactin receptor were required for this direct interaction. These results indicate that nectin-4 serves as a stimulatory co-receptor for the prolactin receptor by regulating the feedback inhibition of SOCS1 in the JAK2-STAT5a signaling pathway.	[Maruoka, Masahiro; Kedashiro, Shin; Ueda, Yuki; Mizutani, Kiyohito; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Maruoka, Masahiro] RIKEN Compass Hlth Life Res Complex Program, Hlth Metr Dev Team, Chuo Ku, 6-7-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Takai, Yoshimi] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan	Kobe University; RIKEN; RIKEN	Mizutani, K; Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.; Takai, Y (corresponding author), RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	mizutani@med.kobe-u.ac.jp; ytakai@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019	Maruoka, Masahiro/0000-0003-4625-8544	Japan Society for the Promotion of Science [26251013, 26860190, 16K19035]; Ministry of Education, Culture, Sports, Science, and Technology [26114007]; P-CREATE from the Japan Agency for Medical Research and Development (AMED); Japan Foundation for Applied Enzymology; Research Complex Promotion Program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [26114007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); P-CREATE from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Foundation for Applied Enzymology; Research Complex Promotion Program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 26251013 (to Y. T.), 26860190 (to K. M.), and 16K19035 (to M. M.) from the Japan Society for the Promotion of Science; Grant-in-Aid for Scientific Research on Innovative Areas 26114007 (to Y. T.) from the Ministry of Education, Culture, Sports, Science, and Technology; P-CREATE from the Japan Agency for Medical Research and Development (AMED) (to Y. T.); and the Japan Foundation for Applied Enzymology (to Y. T.). This work was also supported in part by the Research Complex Promotion Program of the Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Bernard V, 2015, NAT REV ENDOCRINOL, V11, P265, DOI 10.1038/nrendo.2015.36; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Bojesen KB, 2012, J BIOL CHEM, V287, P37420, DOI 10.1074/jbc.M112.345215; Chen CY, 2003, GENE CHROMOSOME CANC, V37, P300, DOI 10.1002/gcc.10222; Das D, 2015, CANCER CHEMOTH PHARM, V76, P471, DOI 10.1007/s00280-015-2794-8; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Ishiuchi T, 2012, GENES CELLS, V17, P387, DOI 10.1111/j.1365-2443.2012.01593.x; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kawano S, 2010, GENES CELLS, V15, P995, DOI 10.1111/j.1365-2443.2010.01438.x; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Kitayama M, 2016, J BIOL CHEM, V291, P5817, DOI 10.1074/jbc.M115.685917; Komazaki T, 2004, JPN J CLIN ONCOL, V34, P191, DOI 10.1093/jjco/hyh035; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Mandai K, 2015, CURR TOP DEV BIOL, V112, P197, DOI 10.1016/bs.ctdb.2014.11.019; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Minami A, 2010, GENES CELLS, V15, P1123, DOI 10.1111/j.1365-2443.2010.01450.x; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Mizutani K, 2011, J BIOL CHEM, V286, P36667, DOI 10.1074/jbc.M110.200535; Msaouel P, 2013, EXPERT OPIN BIOL TH, V13, P483, DOI 10.1517/14712598.2013.749851; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sugiyama H, 2013, GENES CELLS, V18, P519, DOI 10.1111/gtc.12056; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tomic S, 1999, MOL CELL ENDOCRINOL, V158, P45, DOI 10.1016/S0303-7207(99)00180-X; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yamada A, 2013, MOL CELL NEUROSCI, V56, P234, DOI 10.1016/j.mcn.2013.06.003; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309	56	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6895	6909		10.1074/jbc.M116.769091	http://dx.doi.org/10.1074/jbc.M116.769091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28258213	hybrid, Green Published			2022-12-28	WOS:000400478300004
J	Jeong, J; VanHouten, JN; Kim, W; Dann, P; Sullivan, C; Choi, J; Sneddon, WB; Friedman, PA; Wysolmerski, JJ				Jeong, Jaekwang; VanHouten, Joshua N.; Kim, Wonnam; Dann, Pamela; Sullivan, Catherine; Choi, Jungmin; Sneddon, W. Bruce; Friedman, Peter A.; Wysolmerski, John J.			The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; MAMMARY EPITHELIAL-CELLS; CALCIUM-TRANSPORT; SIGNAL-TRANSDUCTION; GLAND INVOLUTION; LIPID RAFTS; RECEPTOR; EXPRESSION; LOCALIZATION; ASSOCIATION	Weexamined whether the scaffolding protein sodium-hydrogen exchanger regulatory factor 1 (NHERF1) interacts with the calcium pump PMCA2 and the tyrosine kinase receptor ErbB2/ HER2 in normal mammary epithelial cells and breast cancer cells. NHERF1 interacts with the PDZ-binding motif in PMCA2 in both normal and malignant breast cells. NHERF1 expression is increased in HER2-positive breast cancers and correlates with HER2-positive status in human ductal carcinoma in situ (DCIS) lesions and invasive breast cancers as well as with increased mortality in patients. NHERF1 is part of a multiprotein complex that includes PMCA2, HSP90, and HER2 within specific actinrich and lipid raft-rich membrane signaling domains. Knocking down NHERF1 reduces PMCA2 and HER2 expression, inhibits HER2 signaling, dissociates HER2 from HSP90, and causes the internalization, ubiquitination, and degradation of HER2. These results demonstrate that NHERF1 acts with PMCA2 to regulate HER2 signaling and membrane retention in breast cancers.	[Jeong, Jaekwang; VanHouten, Joshua N.; Kim, Wonnam; Dann, Pamela; Wysolmerski, John J.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Sullivan, Catherine] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Choi, Jungmin] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Sneddon, W. Bruce; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA	Yale University; Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wysolmerski, JJ (corresponding author), Yale Sch Med, TAC S123a,Box 208020, New Haven, CT 06520 USA.	john.wysolmerski@yale.edu		Choi, Jungmin/0000-0002-8614-0973	National Institutes of Health Grants [CA153702, HD076248, DK105811]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076248] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA153702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA153702 and HD076248 (to J. J. W.) and DK105811 (to P. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso MA, 2001, J CELL SCI, V114, P3957; Antalffy G, 2011, BIOCHEM BIOPH RES CO, V410, P322, DOI 10.1016/j.bbrc.2011.05.147; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bellizzi A, 2010, BREAST CARE, V5, P86, DOI 10.1159/000298962; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; CARRAWAY CAC, 1993, J BIOL CHEM, V268, P5582; Chan MM, 2005, CARCINOGENESIS, V26, P1343, DOI 10.1093/carcin/bgi100; Cheng S, 2013, FEBS LETT, V587, P3289, DOI 10.1016/j.febslet.2013.08.026; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; Du GF, 2016, ONCOTARGET, V7, P29440, DOI 10.18632/oncotarget.8751; Du GF, 2016, ANTICANCER RES, V36, P1165; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Georgescu MM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1992; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ivanova JL, 2012, BIOCHIMIE, V94, P1833, DOI 10.1016/j.biochi.2012.04.011; Jeong J, 2016, P NATL ACAD SCI USA, V113, pE282, DOI 10.1073/pnas.1516138113; Karn T, 2011, BREAST CANCER RES TR, V130, P409, DOI 10.1007/s10549-010-1333-x; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; MORI S, 1987, VIRCHOWS ARCH B, V54, P8, DOI 10.1007/BF02899192; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; Paradiso A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.439; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2013, J PHARM PHARM SCI, V16, P190, DOI 10.18433/J3Z011; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; VanHouten J, 2010, P NATL ACAD SCI USA, V107, P11405, DOI 10.1073/pnas.0911186107; VanHouten JN, 2007, J MAMMARY GLAND BIOL, V12, P223, DOI 10.1007/s10911-007-9057-1; VanHouten JN, 2007, ENDOCRINOLOGY, V148, P5943, DOI 10.1210/en.2007-0850; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; Zagouri F, 2013, BREAST, V22, P569, DOI 10.1016/j.breast.2013.06.003	52	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6555	6568		10.1074/jbc.M116.770883	http://dx.doi.org/10.1074/jbc.M116.770883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28235801	Green Published, hybrid			2022-12-28	WOS:000399813400011
J	Choo, M; Tan, HL; Ding, V; Castangia, R; Belgacem, O; Liau, B; Hartley-Tassell, L; Haslam, SM; Dell, A; Choo, A				Choo, Matthew; Tan, Heng Liang; Ding, Vanessa; Castangia, Roberto; Belgacem, Omar; Liau, Brian; Hartley-Tassell, Lauren; Haslam, Stuart M.; Dell, Anne; Choo, Andre			Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; LEWIS Y ANTIGEN; EPITHELIAL OVARIAN; ESCHERICHIA-FREUNDII; BIOSYNTHETIC-PATHWAY; CYTOTOXIC ANTIBODY; MASS-SPECTROMETRY; GLYCOMIC ANALYSIS; DNA METHYLATION; GENE-EXPRESSION	Cancer-specific glycans of ovarian cancer are promising epitopes for targeting with monoclonal antibodies (mAb). Despite their potential, structural characterization of these glycan epitopes remains a significant challenge in mAb preclinical development. Our group generated the monoclonal antibody mAb-A4 against human embryonic stem cells (hESC), which also bound specifically to N-glycans present on 11 of 19 ovarian cancer (OC) and 8 of 14 breast cancer cell lines tested. Normal cell lines and tissue were unstained by mAb-A4. To characterize the N-linked glycan epitopes on OC cell lines targeted by mAb-A4, we used glycosidases, glycan microarray, siRNA, and advanced high sensitivity matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). The mAb-A4 epitopes were found to be Fuc alpha 1-2Gal beta 1-3GlcNAc beta (H type 1) and Gal beta 1-3GlcNAc beta (type 1 LacNAc). These structures were found to be present on multiple proteins from hESC and OC. Importantly, endo-beta-galactosidase coupled with MALDI-MS allowed these two epitopes, for the first time, to be directly identified on the polylactosamines of N-glycans of SKOV3, IGROV1, OV90, and OVCA433. Furthermore, siRNA knockdown of B3GALT5 expression in SKOV3 demonstrated that mAb-A4 binding was dependent on B3GALT5, providing orthogonal evidence of the epitopes' structures. The recognition of oncofetal H type 1 and type 1 LacNAc on OC by mAb-A4 is a novel and promising way to target OC and supports the theory that cancer can acquire stem-like phenotypes. We propose that the orthogonal framework used in this work could be the basis for advancing anti-glycan mAb characterization.	[Choo, Matthew; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Choo, Matthew; Tan, Heng Liang; Ding, Vanessa; Liau, Brian; Choo, Andre] Bioproc Technol Inst, Singapore 138668, Singapore; [Hartley-Tassell, Lauren] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia; [Castangia, Roberto; Belgacem, Omar] Shimadzu, Manchester M17 1GP, Lancs, England	Imperial College London; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Griffith University	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, Fac Nat Sci, South Kensington Campus, London SW7 2AZ, England.; Choo, A (corresponding author), Bioproc Technol Inst, Stem Cell Grp 1, 20 Biopolis Way 06-01, Singapore 138668, Singapore.	a.dell@imperial.ac.uk; andre_choo@bti.a-star.edu.sg		Dell, Anne/0000-0003-1380-2347; Choo, Andre/0000-0001-9648-0755; Choo, Matthew Sern Farh/0000-0002-1376-3352; Liau, Brian/0000-0002-8233-771X	Strategic Positioning Fund ("GlycoSing") from the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore [SPF2013/001]; A*STAR's Joint Council Visiting Investigator Programme ("HighGlycoART"); A*STAR-Imperial College London Partnership; Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish; BBSRC [BB/K016164/1] Funding Source: UKRI	Strategic Positioning Fund ("GlycoSing") from the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore; A*STAR's Joint Council Visiting Investigator Programme ("HighGlycoART"); A*STAR-Imperial College London Partnership; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Strategic Positioning Fund SPF2013/001 ("GlycoSing") from the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore, the A*STAR's Joint Council Visiting Investigator Programme ("HighGlycoART"), and the A*STAR-Imperial College London Partnership. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Abbott KL, 2010, PROTEOMICS, V10, P470, DOI 10.1002/pmic.200900537; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Chua JX, 2015, CLIN CANCER RES, V21, P2963, DOI 10.1158/1078-0432.CCR-14-3030; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Coberly SK, 2009, ARCH PATHOL LAB MED, V133, P1403, DOI 10.1043/1543-2165-133.9.1403; Coward JIG, 2015, INT J WOMENS HEALTH, V7, P189, DOI 10.2147/IJWH.S52379; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; DELL A, 1994, METHOD ENZYMOL, V230, P108; DELL A, 1988, BIOMED ENVIRON MASS, V16, P19, DOI 10.1002/bms.1200160104; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Escrevente C, 2006, INT J ONCOL, V29, P557; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; Gao C, 2014, J BIOL CHEM, V289, P16462, DOI 10.1074/jbc.M114.558932; Gao LL, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-15; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Haslam SM, 2006, CURR OPIN STRUC BIOL, V16, P584, DOI 10.1016/j.sbi.2006.08.006; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Kemp Z, 2013, INT J WOMENS HEALTH, V5, P45, DOI 10.2147/IJWH.S30231; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Lee J, 2012, J CHROMATOGR A, V1270, P162, DOI 10.1016/j.chroma.2012.10.062; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Loo D, 2007, MOL CANCER THER, V6, P856, DOI 10.1158/1535-7163.MCT-06-0581; Lucena MC, 2016, J BIOL CHEM, V291, P12917, DOI 10.1074/jbc.M116.729236; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; National Cancer Institute, 2015, OV EP FALL TUB PRIM; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; Nonaka M, 2014, J BIOL CHEM, V289, P16478, DOI 10.1074/jbc.M114.559047; O'Cearbhaill R. E., 2014, ANN ONCOL, V25, piv311; Ojima T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14988; Pochechueva T, 2012, METABOLITES, V2, P913, DOI 10.3390/metabo2040913; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricardo S, 2015, MOL ONCOL, V9, P503, DOI 10.1016/j.molonc.2014.10.005; Ruhaak LR, 2013, MOL CELL PROTEOMICS, V12, P846, DOI 10.1074/mcp.R112.026799; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; SCUDDER P, 1984, J BIOL CHEM, V259, P6586; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Shoreibah MG, 2011, STEM CELLS DEV, V20, P515, DOI 10.1089/scd.2010.0172; Spina E, 2004, RAPID COMMUN MASS SP, V18, P392, DOI 10.1002/rcm.1350; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P425; Suzuki N, 2004, GYNECOL ONCOL, V95, P290, DOI 10.1016/j.ygyno.2004.06.024; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Trinchera Marco, 2014, Biology (Basel), V3, P484, DOI 10.3390/biology3030484; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Waespy M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004120; Wang YF, 2011, INT J MOL SCI, V12, P3409, DOI 10.3390/ijms12063409; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Zulueta A., 2014, THESIS	68	12	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6163	6176		10.1074/jbc.M116.768887	http://dx.doi.org/10.1074/jbc.M116.768887			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28167527	Green Published, hybrid			2022-12-28	WOS:000399538700013
J	South, K; Freitas, MO; Lane, DA				South, Kieron; Freitas, Marta O.; Lane, David A.			A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von willebrand factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS13; allosteric regulation; hemostasis; protein conformation; von Willebrand factor	THROMBOTIC THROMBOCYTOPENIC PURPURA; PLATELET GLYCOPROTEIN-IB; FACTOR A2 DOMAIN; VONWILLEBRAND-FACTOR; ISCHEMIC-STROKE; SCISSILE BOND; MYOCARDIAL-INFARCTION; VICINAL CYSTEINES; BINDING-SITES; HUMAN-PLASMA	Blood loss is prevented by the multidomain glycoprotein von Willebrand factor (VWF), which binds exposed collagen at damaged vessels and captures platelets. VWF is regulated by the metalloprotease ADAMTS13, which in turn is conformationally activated by VWF. To delineate the structural requirements for VWF-mediated conformational activation of ADAMTS13, we performed binding and functional studies with a panel of truncated ADAMTS13 variants. We demonstrate that both the isolated CUB1 and CUB2 domains in ADAMTS13 bind to the spacer domain exosite of a truncated ADAMTS13 variant, MDTCS (K-D of 135 +/- 1 0.1 nm and 86.9 +/- 9.0 nm, respectively). However, only the CUB1 domain inhibited proteolytic activity of MDTCS. Moreover, ADAMTS13CUB2, unlike ADAMTS13CUB1-2, exhibited activity similar to wild-type ADAMTS13 and could be activated by VWF D4-CK. The CUB2 domain is, therefore, not essential for maintaining the inactive conformation of ADAMTS13. Both CUB domains could bind to the VWF D4-CK domain fragment (K-D of 53.7 +/- 2.1 nm and 84.3 +/- 2.0 nm, respectively). However, deletion of both CUB domains did not prevent VWF D4-CK binding, suggesting that competition for CUB-domain binding to the spacer domain is not the dominant mechanism behind the conformational activation. ADAMTS13TSP8-CUB2 could no longer bind to VWF D4-CK, and deletion of TSP8 abrogated ADAMTS13 conformational activation. These findings support an ADAMTS13 activation model in which VWF D4-CK engages the TSP8-CUB2 domains, inducing the conformational change that disrupts the CUB1-spacer domain interaction and thereby activates ADAMTS13.	[South, Kieron; Freitas, Marta O.; Lane, David A.] Imperial Coll London, Ctr Haematol, London W12 0NN, England	Imperial College London	South, K; Lane, DA (corresponding author), Imperial Coll London, Hammersmith Hosp, Commonwealth Bldg 5S5,Du Cane Rd, London W12 0NN, England.	ksouth@imperial.ac.uk; d.lane@imperial.ac.uk	; Freitas, Marta/J-8699-2013	Lane, David/0000-0003-4283-3695; South, Kieron/0000-0002-9141-3438; Freitas, Marta/0000-0001-5779-2289	British Heart Foundation [PG/14/87/31181, PG/12/55/29740]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/14/87/31181 (to D. A. L. and K. S.) and PG/12/55/29740 (to D. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Chion CKNK, 2007, BLOOD, V109, P1998, DOI 10.1182/blood-2006-07-038166; Crawley JTB, 2008, J THROMB HAEMOST, V6, P583, DOI 10.1111/j.1538-7836.2008.02902.x; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; de Groot R, 2015, BLOOD, V125, P1968, DOI 10.1182/blood-2014-08-594556; de Groot R, 2010, BLOOD, V116, P3064, DOI 10.1182/blood-2009-12-258780; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Deforche L, 2015, J THROMB HAEMOST, V13, P2063, DOI 10.1111/jth.13149; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; HOYER LW, 1980, BLOOD, V55, P1056; Jian C, 2012, BLOOD, V119, P3836, DOI 10.1182/blood-2011-12-399501; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; Lynch CJ, 2016, BLOOD, V127, P1711, DOI 10.1182/blood-2015-09-672014; Lynch CJ, 2014, BLOOD, V123, P2585, DOI 10.1182/blood-2013-11-538173; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; Matsushita T, 2000, J BIOL CHEM, V275, P11044, DOI 10.1074/jbc.275.15.11044; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; MOHRI H, 1989, J BIOL CHEM, V264, P17361; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Qizilbash N, 1997, NEUROLOGY, V49, P1552, DOI 10.1212/WNL.49.6.1552; ROTH GJ, 1986, BIOCHEMISTRY-US, V25, P8357, DOI 10.1021/bi00374a004; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; South K, 2016, J THROMB HAEMOST, V14, P2011, DOI 10.1111/jth.13445; South K, 2014, P NATL ACAD SCI USA, V111, P18578, DOI 10.1073/pnas.1411979112; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	40	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5760	5769		10.1074/jbc.M117.776732	http://dx.doi.org/10.1074/jbc.M117.776732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28209710	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000398813200014
J	Devost, D; Sleno, R; Petrin, D; Zhang, A; Shinjo, Y; Okde, R; Aoki, J; Inoue, A; Hebert, TE				Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Zhang, Alice; Shinjo, Yuji; Okde, Rakan; Aoki, Junken; Inoue, Asuka; Hebert, Terence E.			Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AT(1) RECEPTOR; BIOSENSORS REVEAL; FUNCTIONAL SELECTIVITY; SIGNALING PATHWAYS; ACTIVATION; GPCRS; DETERMINANTS; MODULATION; MECHANISMS; COMPLEX	Here, we report the design and use of G protein-coupled receptor-based biosensors to monitor ligand-mediated conformational changes in receptors in intact cells. These biosensors use bioluminescence resonance energy transfer with Renilla luciferase (RlucII) as an energy donor, placed at the distal end of the receptor C-tail, and the small fluorescent molecule FlAsH as an energy acceptor, its binding site inserted at different positions throughout the intracellular loops and C-terminal tail of the angiotensin II type I receptor. We verified that the modifications did not compromise receptor localization or function before proceeding further. Our biosensors were able to capture effects of both canonical and biased ligands, even to the extent of discriminating between different biased ligands. Using a combination of G protein inhibitors and HEK 293 cell lines that were CRISPR/Cas9-engineered to delete G alpha(q), G alpha(11), G alpha(12), and G alpha(13) or beta-arrestins, we showed that G alpha(q) and G alpha(11) are required for functional responses in conformational sensors in ICL3 but not ICL2. Loss of beta-arrestin did not alter biased ligand effects on ICL2P2. We also demonstrate that such biosensors are portable between different cell types and yield context-dependent read-outs of G protein-coupled receptor conformation. Our study provides mechanistic insights into signaling events that depend on either G proteins or beta-arrestin.	[Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Zhang, Alice; Okde, Rakan; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada; [Shinjo, Yuji; Aoki, Junken; Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chiyoda Ku, Tokyo 1000004, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	McGill University; Tohoku University; Japan Science & Technology Agency (JST)	Hebert, TE (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca			Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research (CIHR) [MOP-130309]; PRESTO, JST; AMED-CREST; McGill-CIHR Drug Development Training Program	Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); PRESTO, JST(Japan Science & Technology Agency (JST)); AMED-CREST; McGill-CIHR Drug Development Training Program(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Consortium Quebecois sur la Decouverte du Medicament and Canadian Institutes of Health Research (CIHR) Grant MOP-130309 (to T. E. H.) as well as grants from PRESTO, JST (to A. I.) and AMED-CREST (to J. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the McGill-CIHR Drug Development Training Program.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Casiraghi M, 2016, J AM CHEM SOC, V138, P11170, DOI 10.1021/jacs.6b04432; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Devost D, 2016, METHOD CELL BIOL, V132, P319, DOI 10.1016/bs.mcb.2015.11.010; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Domazet I, 2015, MOL PHARMACOL, V87, P982, DOI 10.1124/mol.114.097337; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Hao Y, 2016, BIOINFORMATICS, V32, P3435, DOI 10.1093/bioinformatics/btw510; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kahsai AW, 2016, NAT CHEM BIOL, V12, P709, DOI 10.1038/nchembio.2126; Kenakin T, 2015, MOL PHARMACOL, V88, P1055, DOI 10.1124/mol.115.099770; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Maier-Peuschel M, 2010, J BIOL CHEM, V285, P8793, DOI 10.1074/jbc.M109.098517; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Namkung Y, 2016, METHODS, V92, P5, DOI 10.1016/j.ymeth.2015.04.010; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebois RV, 2012, CELL SIGNAL, V24, P2051, DOI 10.1016/j.cellsig.2012.06.011; Robertson DN, 2016, METHODS, V92, P19, DOI 10.1016/j.ymeth.2015.07.011; Ronan T, 2016, J BIOL CHEM, V291, P5528, DOI 10.1074/jbc.M115.710087; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sleno R, 2016, METHODS, V92, P11, DOI 10.1016/j.ymeth.2015.05.003; Spille JH, 2011, BIOPHYS J, V100, P1139, DOI 10.1016/j.bpj.2010.08.080; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Stumpf AD, 2016, BRIT J PHARMACOL, V173, P255, DOI 10.1111/bph.13382; Svensson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038517; Tian H, 2017, CHEM REV, V117, P186, DOI 10.1021/acs.chemrev.6b00084; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	50	53	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5443	5456		10.1074/jbc.M116.763854	http://dx.doi.org/10.1074/jbc.M116.763854			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213525	Green Published, hybrid			2022-12-28	WOS:000397875500024
J	Schumacher, MA; Huang, KH; Zeng, WJ; Janakiraman, A				Schumacher, Maria A.; Huang, Kuo-Hsiang; Zeng, Wenjie; Janakiraman, Anuradha			Structure of the Z Ring-associated Protein, ZapD, Bound to the C-terminal Domain of the Tubulin-like Protein, FtsZ, Suggests Mechanism of Z Ring Stabilization through FtsZ Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; cytokinesis; electron microscopy (EM); protein-protein interaction; X-ray crystallography; FtsZ; ZapD	CELL-DIVISION; BACTERIAL CYTOKINESIS; CYTOSKELETAL PROTEIN; CRYSTAL-STRUCTURE; GTP-BINDING; SUPERRESOLUTION; REVEAL; ZIPA; SITE; IDENTIFICATION	Cell division in most bacteria is mediated by the tubulin-like FtsZ protein, which polymerizes in a GTP-dependent manner to form the cytokinetic Z ring. A diverse repertoire of FtsZ-binding proteins affects FtsZ localization and polymerization to ensure correct Z ring formation. Many of these proteins bind the C-terminal domain (CTD) of FtsZ, which serves as a hub for FtsZ regulation. FtsZ ring-associated proteins, ZapA-D (Zaps), are important FtsZ regulatory proteins that stabilize FtsZ assembly and enhance Z ring formation by increasing lateral assembly of FtsZ protofilaments, which then form the Z ring. There are no structures of a Zap protein bound to FtsZ; therefore, how these proteins affect FtsZ polymerization has been unclear. Recent data showed ZapD binds specifically to the FtsZ CTD. Thus, to obtain insight into the ZapD-CTD interaction and how it may mediate FtsZ protofilament assembly, we determined the Escherichia coli ZapD-FtsZ CTD structure to 2.67 resolution. The structure shows that the CTD docks within a hydrophobic cleft in the ZapD helical domain and adopts an unusual structure composed of two turns of helix separated by a proline kink. FtsZ CTD residue Phe-377 inserts into the ZapD pocket, anchoring the CTD in place and permitting hydrophobic contacts between FtsZ residues Ile-374, Pro-375, and Leu-378 with ZapD residues Leu-74, Trp-77, Leu-91, and Leu-174. The structural findings were supported by mutagenesis coupled with biochemical and in vivo studies. The combined data suggest that ZapD acts as a molecular cross-linking reagent between FtsZ protofilaments to enhance FtsZ assembly.	[Schumacher, Maria A.; Zeng, Wenjie] Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,DUMC Box 3711, Durham, NC 27710 USA; [Huang, Kuo-Hsiang; Janakiraman, Anuradha] CUNY City Coll, Dept Biol, 160 Convent Ave,MR526, New York, NY 10031 USA; [Huang, Kuo-Hsiang; Janakiraman, Anuradha] CUNY City Coll, Grad Ctr, New York, NY 10016 USA	Duke University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY)	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,DUMC Box 3711, Durham, NC 27710 USA.; Janakiraman, A (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave,MR526, New York, NY 10031 USA.	maria.schumacher@duke.edu; anuj@ccny.cuny.edu			NIGMS; National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; Sandler Foundation [MR-15-328599]; Direct For Biological Sciences [1615858] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115563] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); Sandler Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Advanced Light Source beamlines 8.3.1 and 5.0.2 for data collection. The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231. Beamline 8.3.1 at the Advanced Light Source is operated by the University of California Office of the President, Multicampus Research Programs and Initiatives Grant MR-15-328599 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. We also thank Aaron Mychack for help in plasmid construction.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arjes HA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0544-z; Bhattacharya A, 2015, INT J BIOL MACROMOL, V81, P435, DOI 10.1016/j.ijbiomac.2015.08.030; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Choi H, 2016, MOL CELLS, V39, P814, DOI 10.14348/molcells.2016.0202; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DeLano W.L, PYMOL MOL GRAPHICS S; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Huang KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153337; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Jennings PC, 2011, MICRON, V42, P336, DOI 10.1016/j.micron.2010.09.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Ortiz C, 2015, FEBS LETT, V589, P3822, DOI 10.1016/j.febslet.2015.11.030; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Roach EJ, 2016, J BACTERIOL, V198, P1683, DOI 10.1128/JB.00969-15; Roach EJ, 2014, J BIOL CHEM, V289, P23276, DOI 10.1074/jbc.M114.561928; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Rowlett VW, 2014, BIOPHYS J, V107, pL17, DOI 10.1016/j.bpj.2014.08.024; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P4988, DOI 10.1073/pnas.1602327113; Schumacher MA, 2016, J BIOL CHEM, V291, P2485, DOI 10.1074/jbc.M115.697037; Soderstrom B, 2017, CURR GENET, V63, P161, DOI 10.1007/s00294-016-0630-2; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003	51	17	17	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3740	3750		10.1074/jbc.M116.773192	http://dx.doi.org/10.1074/jbc.M116.773192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100778	Green Published, hybrid			2022-12-28	WOS:000395542500017
J	Kumazoe, M; Nakamura, Y; Yamashita, M; Suzuki, T; Takamatsu, K; Huang, Y; Bae, J; Yamashita, S; Murata, M; Yamada, S; Shinoda, Y; Yamaguchi, W; Toyoda, Y; Tachibana, H				Kumazoe, Motofumi; Nakamura, Yuki; Yamashita, Mai; Suzuki, Takashi; Takamatsu, Kanako; Huang, Yuhui; Bae, Jaehoon; Yamashita, Shuya; Murata, Motoki; Yamada, Shuhei; Shinoda, Yuki; Yamaguchi, Wataru; Toyoda, Yui; Tachibana, Hirofumi			Green Tea Polyphenol Epigallocatechin-3-gallate Suppresses Toll-like Receptor 4 Expression via Up-regulation of E3 Ubiquitin-protein Ligase RNF216	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							67-KDA LAMININ RECEPTOR; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE ACCUMULATION; COMMON POLYMORPHISM; METABOLIC SYNDROME; RAT-LIVER; INFLAMMATION; OBESITY	Toll-like receptor 4 (TLR4) plays an essential role in innate immunity through inflammatory cytokine induction. Recent studies demonstrated that the abnormal activation of TLR4 has a pivotal role in obesity-induced inflammation, which is associated with several diseases, including hyperinsulinemia, hypertriglyceridemia, and cardiovascular disease. Here we demonstrate that (-)-epigallocatechin-3-O-gallate, a natural agonist of the 67-kDa laminin receptor (67LR), suppressed TLR4 expression through E3 ubiquitin-protein ring finger protein 216 (RNF216) up-regulation. Our data indicate cyclic GMP mediates 67LR agonist-dependent RNF216 up-regulation. Moreover, we show that the highly absorbent 67LR agonist (-)-epigallocatechin- 3-O-(3-O-methyl)-gallate (EGCG3"Me) significantly attenuated TLR4 expression in the adipose tissue. EGCG3"Me completely inhibited the high-fat/high-sucrose (HF/HS)-induced up-regulation of tumor necrosis factor alpha in adipose tissue and serum monocyte chemoattractant protein-1 increase. Furthermore, this agonist intake prevented HF/HS-induced hyperinsulinemia and hypertriglyceridemia. Taken together, 67LR presents an attractive target for the relief of obesity-induced inflammation.	[Kumazoe, Motofumi; Nakamura, Yuki; Yamashita, Mai; Suzuki, Takashi; Takamatsu, Kanako; Huang, Yuhui; Bae, Jaehoon; Yamashita, Shuya; Murata, Motoki; Yamada, Shuhei; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Shinoda, Yuki; Yamaguchi, Wataru; Toyoda, Yui] Asahi Soft Drinks Co Ltd, Prod Res Dev Lab, Ibaraki 3020106, Japan	Kyushu University; Asahi Group Holdings Ltd.	Tachibana, H (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [22228002, 15H02448]; JSPS KAKENHI Grant [15K18821]	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 22228002 and 15H02448 (to H. T.), Grant-in-Aid for JSPS Fellows (to M. K.) (postdoctoral researcher (PD)), and JSPS KAKENHI Grant 15K18821. The authors declare that they have no conflicts of interest with the contents of this article.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Boden G, 2013, OBESITY, V21, P1208, DOI 10.1002/oby.20134; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Byun EB, 2012, BIOCHEM BIOPH RES CO, V426, P480, DOI 10.1016/j.bbrc.2012.08.096; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Fernandez ML, 2008, J AM COLL NUTR, V27, P1, DOI 10.1080/07315724.2008.10719668; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; Hotston M, 2008, ASIAN J ANDROL, V10, P905, DOI 10.1111/j.1745-7262.2008.00380.x; Iida Y, 2014, MOL MED REP, V10, P1383, DOI 10.3892/mmr.2014.2389; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Jovinge S, 1998, METABOLISM, V47, P113, DOI 10.1016/S0026-0495(98)90203-7; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim HS, 2004, ANTICANCER RES, V24, P747; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10130; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kumazoe M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09474; Kumazoe M, 2013, FEBS LETT, V587, P3052, DOI 10.1016/j.febslet.2013.07.041; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Lai HL, 2007, PEDIATR NEPHROL, V22, P1751, DOI 10.1007/s00467-007-0533-z; Li JL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-161; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Maeda-Yamamoto M, 2007, CYTOTECHNOLOGY, V55, P135, DOI 10.1007/s10616-007-9112-1; Medina EA, 2002, METABOLISM, V51, P1104, DOI 10.1053/meta.2002.34699; Merial C, 2000, AM J PHYSIOL-CELL PH, V279, pC1100, DOI 10.1152/ajpcell.2000.279.4.C1100; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Subramanian S, 2009, CURR OPIN LIPIDOL, V20, P39, DOI 10.1097/MOL.0b013e32831bef8b; Suzuki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02749; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	50	40	43	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4077	4088		10.1074/jbc.M116.755959	http://dx.doi.org/10.1074/jbc.M116.755959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154178	hybrid, Green Published			2022-12-28	WOS:000395837100011
J	Li, Z; Kitanishi, K; Twahir, UT; Cracan, V; Chapman, D; Warncke, K; Banerjee, R				Li, Zhu; Kitanishi, Kenichi; Twahir, Umar T.; Cracan, Valentin; Chapman, Derrell; Warncke, Kurt; Banerjee, Ruma			Cofactor Editing by the G-protein Metallochaperone Domain Regulates the Radical B-12 Enzyme IcmF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRINOID-ADENOSYLTRANSFERASE PDUO; METHYLMALONYL-COA MUTASE; COENZYME B-12; SALMONELLA-ENTERICA; SUBSTRATE-SPECIFICITY; LACTOBACILLUS-REUTERI; COMPLEMENTATION GROUP; MECHANISM; ATP; MEAB	IcmF is a 5 '-deoxyadenosylcobalamin (AdoCbl)-dependent enzyme that catalyzes the carbon skeleton rearrangement of isobutyryl-CoA to butyryl-CoA. It is a bifunctional protein resulting from the fusion of a G-protein chaperone with GTPase activity and the cofactor-and substrate-binding mutase domains with isomerase activity. IcmF is prone to inactivation during catalytic turnover, thus setting up its dependence on a cofactor repair system. Herein, we demonstrate that the GTPase activity of IcmF powers the ejection of the inactive cob(II) alamin cofactor and requires the presence of an acceptor protein, adenosyltransferase, for receiving it. Adenosyltransferase in turn converts cob(II) alamin to AdoCbl in the presence of ATP and a reductant. The repaired cofactor is then reloaded onto IcmF in a GTPase-gated step. The mechanistic details of cofactor loading and offloading from the AdoCbl-dependent IcmF are distinct from those of the better characterized and homologous methylmalonyl-CoA mutase/ G-protein chaperone system.	[Li, Zhu; Kitanishi, Kenichi; Cracan, Valentin; Chapman, Derrell; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Twahir, Umar T.; Warncke, Kurt] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Kitanishi, Kenichi] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Cracan, Valentin] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	University of Michigan System; University of Michigan; Emory University; Ibaraki University; Harvard University; Massachusetts General Hospital	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kitanishi, Kenichi/I-3323-2014	Kitanishi, Kenichi/0000-0002-2110-8104; Cracan, Valentin/0000-0002-3280-0593; Li, Zhu/0000-0003-1536-9401	National Institutes of Health Grant [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK45776. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bauer CB, 2001, BIOCHEMISTRY-US, V40, P361, DOI 10.1021/bi002145o; Brunold TC, 2009, COORDIN CHEM REV, V253, P779, DOI 10.1016/j.ccr.2008.09.013; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Dong SL, 1999, J AM CHEM SOC, V121, P7063, DOI 10.1021/ja982753f; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jost M, 2015, J BIOL CHEM, V290, P26882, DOI 10.1074/jbc.M115.676890; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Kitanishi K, 2015, J BIOL CHEM, V290, P20466, DOI 10.1074/jbc.M115.646299; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Liptak MD, 2009, J PHYS CHEM B, V113, P5245, DOI 10.1021/jp810136d; Lofgren M, 2013, J BIOL CHEM, V288, P30980, DOI 10.1074/jbc.M113.499970; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Lofgren M, 2011, BIOCHEMISTRY-US, V50, P5790, DOI 10.1021/bi2006306; Mera PE, 2007, BIOCHEMISTRY-US, V46, P13829, DOI 10.1021/bi701622j; Mera PE, 2009, BIOCHEMISTRY-US, V48, P3138, DOI 10.1021/bi9000134; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; Pallares IG, 2016, J AM CHEM SOC, V138, P3694, DOI 10.1021/jacs.5b11708; Park K, 2008, BIOCHEMISTRY-US, V47, P9007, DOI 10.1021/bi800419e; Park K, 2015, ANGEW CHEM INT EDIT, V54, P7158, DOI 10.1002/anie.201501930; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; St Maurice M, 2008, BIOCHEMISTRY-US, V47, P5755, DOI 10.1021/bi800132d; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WOLFLE K, 1986, EUR J BIOCHEM, V156, P545, DOI 10.1111/j.1432-1033.1986.tb09614.x; Yamanishi M, 2005, J AM CHEM SOC, V127, P526, DOI 10.1021/ja044365l	41	4	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3977	3987		10.1074/jbc.M117.775957	http://dx.doi.org/10.1074/jbc.M117.775957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130442	Green Published, hybrid			2022-12-28	WOS:000395837100003
J	Nguyen, TB; Jayaraman, P; Bergseng, E; Madhusudhan, MS; Kim, CY; Sollid, LM				Thanh-Binh Nguyen; Jayaraman, Priya; Bergseng, Elin; Madhusudhan, M. S.; Kim, Chu-Young; Sollid, Ludvig M.			Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-II; CELIAC-DISEASE; HLA-DM; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; BINDING MOTIF; MOLECULES; PROTEIN; CLIP; DQ	Human leukocyte antigen (HLA)-DQ2.5 (DQA1* 05/ DQB1* 02) is a class-II major histocompatibility complex protein associated with both type 1 diabetes and celiac disease. One unusual feature of DQ2.5 is its high class-II-associated invariant chain peptide (CLIP) content. Moreover, HLA-DQ2.5 preferentially binds the non-canonical CLIP2 over the canonical CLIP1. To better understand the structural basis of HLA-DQ2.5 ' s unusual CLIP association characteristics, better insight into the HLADQ2.5.CLIP complex structures is required. To this end, we determined the X-ray crystal structure of the HLA-DQ2.5.CLIP1 and HLA-DQ2.5.CLIP2 complexes at 2.73 and 2.20 angstrom, respectively. We found that HLA-DQ2.5 has an unusually large P4 pocket and a positively charged peptide-binding groove that together promote preferential binding of CLIP2 over CLIP1. An alpha 9-alpha 22-alpha 24-alpha 31-beta 86-beta 90 hydrogen bond network located at the bottom of the peptide-binding groove, spanning from the P1 to P4 pockets, renders the residues in this region relatively immobile. This hydrogen bond network, along with a deletion mutation at alpha 53, may lead to HLA-DM insensitivity in HLA-DQ2.5. A molecular dynamics simulation experiment reported here and recent biochemical studies by others support this hypothesis. The diminished HLA-DM sensitivity is the likely reason for the CLIP-rich phenotype of HLA-DQ2.5.	[Kim, Chu-Young] Univ Texas El Paso, Dept Chem, 1852 Hawthorne St, El Paso, TX 79968 USA; [Kim, Chu-Young] Univ Texas El Paso, Sch Pharm, El Paso, TX 79968 USA; [Kim, Chu-Young] Natl Univ Singapore, Life Sci Inst, Synthet Biol Clin & Technol Innovat, Singapore 117456, Singapore; [Thanh-Binh Nguyen; Jayaraman, Priya] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Thanh-Binh Nguyen] Bioinformat Inst, Singapore 138671, Singapore; [Madhusudhan, M. S.] Indian Inst Sci Educ & Res, Pune 411008, Maharashtra, India; [Bergseng, Elin; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Bergseng, Elin; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Bergseng, Elin; Sollid, Ludvig M.] Oslo Univ Hosp, N-0372 Oslo, Norway	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Indian Institute of Science Education & Research (IISER) Pune; University of Oslo; University of Oslo; University of Oslo	Kim, CY (corresponding author), Univ Texas El Paso, Dept Chem, 1852 Hawthorne St, El Paso, TX 79968 USA.; Sollid, LM (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Ctr Immune Regulat, N-0372 Oslo, Norway.; Sollid, LM (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Dept Immunol, N-0372 Oslo, Norway.	ckim7@utep.edu; l.m.sollid@medisin.uio.no	Kim, Chu-Young/D-8849-2012	Kim, Chu-Young/0000-0003-3744-7802; Nguyen, Thanh Binh/0000-0002-4150-5991	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; United States Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data collection was performed at the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, which is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). We thank Dr. I. I. Mathews at SSRL for assistance with X-ray data collection and processing and Dr. Chandra Verma at the Bioinformatics Institute for discussion on molecular dynamics simulation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Bergseng E, 2005, J BIOL CHEM, V280, P21791, DOI 10.1074/jbc.M501558200; Bergseng E, 2015, IMMUNOGENETICS, V67, P73, DOI 10.1007/s00251-014-0819-9; Busch R, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.9; Camacho CJ, 1999, BIOPHYS J, V76, P1166, DOI 10.1016/S0006-3495(99)77281-4; Case DA, 2012, AMBER 12; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chu XK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002608; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Drozdov-Tikhomirov LN, 2001, J BIOMOL STRUCT DYN, V19, P279, DOI 10.1080/07391102.2001.10506738; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALK K, 1994, IMMUNOGENETICS, V39, P230; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kumar V, 2011, INT J PHARMACEUT, V421, P82, DOI 10.1016/j.ijpharm.2011.09.017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YC, 2009, CHEM BIOL DRUG DES, V74, P611, DOI 10.1111/j.1747-0285.2009.00896.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogata K, 2002, PROTEIN ENG, V15, P697, DOI 10.1093/protein/15.8.697; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Schlundt A, 2012, J MOL BIOL, V423, P294, DOI 10.1016/j.jmb.2012.07.008; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Tinto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138324; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; Uchikoga N, 2005, PROTEIN SCI, V14, P74, DOI 10.1110/ps.04984505; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132; VIKEN HD, 1995, HUM IMMUNOL, V42, P319, DOI 10.1016/0198-8859(94)00110-C; Volz T, 2004, HUM IMMUNOL, V65, P594, DOI 10.1016/j.humimm.2004.02.027; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiesner M, 2008, IMMUNOGENETICS, V60, P551, DOI 10.1007/s00251-008-0310-6; Yin LS, 2014, J BIOL CHEM, V289, P23449, DOI 10.1074/jbc.M114.585539; Zhou ZM, 2016, EUR J IMMUNOL, V46, P834, DOI 10.1002/eji.201545942; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	61	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9218	9228		10.1074/jbc.M117.785139	http://dx.doi.org/10.1074/jbc.M117.785139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28364043	Green Published, hybrid			2022-12-28	WOS:000402538900017
J	Grishkovskaya, I; Paumann-Page, M; Tscheliessnig, R; Stampler, J; Hofbauer, S; Soudi, M; Sevcnikar, B; Oostenbrink, C; Furtmuller, PG; Djinovic-Carugo, K; Nauseef, WM; Obinger, C				Grishkovskaya, Irina; Paumann-Page, Martina; Tscheliessnig, Rupert; Stampler, Johanna; Hofbauer, Stefan; Soudi, Monika; Sevcnikar, Benjamin; Oostenbrink, Chris; Furtmueller, Paul G.; Djinovic-Carugo, Kristina; Nauseef, William M.; Obinger, Christian			Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID LYSOSOMAL-ENZYME; HUMAN MYELOPEROXIDASE; MACROMOLECULAR STRUCTURES; REDOX THERMODYNAMICS; CELL-LINE; HEME; BIOSYNTHESIS; HL-60; PROTEIN; IMPACT	Myeloperoxidase (MPO) is synthesized by neutrophil and monocyte precursor cells and contributes to host defense by mediating microbial killing. Although several steps in MPO biosynthesis and processing have been elucidated, many questions remained, such as the structure-function relationship of monomeric unprocessed proMPO versus the mature dimeric MPO and the functional role of the propeptide. Here we have presented the first and high resolution (at 1.25 angstrom) crystal structure of proMPO and its solution structure obtained by small-angle X-ray scattering. Promyeloperoxidase hosts five occupied glycosylation sites and six intrachain cystine bridges with Cys-158 of the very flexible N-terminal propeptide being covalently linked to Cys-319 and thereby hindering homodimerization. Furthermore, the structure revealed (i) the binding site of proMPO-processing proconvertase, (ii) the structural motif for subsequent cleavage to the heavy and light chains of mature MPO protomers, and (iii) three covalent bonds between heme and the protein. Studies of the mutants C158A, C319A, and C158A/C319A demonstrated significant differences from the wild-type protein, including diminished enzymatic activity and prevention of export to the Golgi due to prolonged association with the chaperone calnexin. These structural and functional findings provide novel insights into MPO biosynthesis and processing.	[Grishkovskaya, Irina; Hofbauer, Stefan; Djinovic-Carugo, Kristina] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria; [Paumann-Page, Martina; Stampler, Johanna; Soudi, Monika; Sevcnikar, Benjamin; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria; [Tscheliessnig, Rupert] ACIB, Muthgasse 11, A-1190 Vienna, Austria; [Oostenbrink, Chris] BOKU Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, Dept Mat Sci & Proc Engn, A-1190 Vienna, Austria; [Nauseef, William M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Nauseef, William M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Med, Iowa City, IA 52242 USA; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Vecna Pot 113, Ljubljana 1000, Slovenia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna; University of Iowa; University of Iowa; University of Ljubljana	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.; Nauseef, WM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA.; Nauseef, WM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Med, Iowa City, IA 52242 USA.	william-nauseef@uiowa.edu; christian.obinger@boku.ac.at	Obinger, Christian/AAV-3173-2021; Oostenbrink, Chris/S-8002-2019; Furtmüller, Paul G./Y-5819-2018; Djinovic-Carugo, Kristina/AAW-1167-2021; Hofbauer, Stefan/I-3889-2014	Oostenbrink, Chris/0000-0002-4232-2556; Furtmüller, Paul G./0000-0002-1199-2469; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Hofbauer, Stefan/0000-0003-3375-7715; Obinger, Christian/0000-0002-7133-3430; Nauseef, William/0000-0003-4032-757X; Grishkovskaya, Irina/0000-0003-0164-9373	Federal Ministry of Economy, Family, and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116546, P01AI044642] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	Federal Ministry of Economy, Family, and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The Austrian Centre of Industrial Biotechnology was supported by the Federal Ministry of Economy, Family, and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation, and Technology (BMVIT), the Styrian Business Promotion Agency (SFG), and the Standortagentur Tirol and ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency (FFG). The Nauseef laboratory had the use of facilities at the Iowa City Dept. of Veterans Affairs Medical Center, Iowa City, IA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKIN DT, 1986, J BIOL CHEM, V261, P8370; Andersson E, 1998, J BIOL CHEM, V273, P4747, DOI 10.1074/jbc.273.8.4747; ANDREWS PC, 1984, ARCH BIOCHEM BIOPHYS, V228, P439, DOI 10.1016/0003-9861(84)90008-0; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Brogioni S, 2006, J RAMAN SPECTROSC, V37, P263, DOI 10.1002/jrs.1442; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; CASTANEDA VL, 1992, EXP HEMATOL, V20, P916; Chemical Computing Group, 2016, MOE MOL OP ENV 2013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; de Montellano PRO, 2016, RSC METALLOBIO SER, V4, P3; DeLano W.L, PYMOL MOL GRAPHICS S; DeLeo FR, 1998, J CLIN INVEST, V101, P2900, DOI 10.1172/JCI2649; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; HASILIK A, 1984, EMBO J, V3, P2671, DOI 10.1002/j.1460-2075.1984.tb02192.x; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hofbauer S, 2016, BIOCHEMISTRY-US, V55, P5398, DOI 10.1021/acs.biochem.6b00701; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kettle AJ, 2016, RSC METALLOBIO SER, V4, P272; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; NAUSEEF WM, 1988, EUR J HAEMATOL, V40, P97; NAUSEEF WM, 1983, J CLIN INVEST, V71, P1297, DOI 10.1172/JCI110880; Nauseef WM, 1996, J BIOL CHEM, V271, P9546, DOI 10.1074/jbc.271.16.9546; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NAUSEEF WM, 1986, BLOOD, V68, P442; NAUSEEF WM, 1987, BLOOD, V70, P1143; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nauseef WM, 1998, J BIOL CHEM, V273, P7107, DOI 10.1074/jbc.273.12.7107; OLSSON I, 1984, BIOCHEM J, V223, P911, DOI 10.1042/bj2230911; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PINNIX IB, 1994, ARCH BIOCHEM BIOPHYS, V312, P447, DOI 10.1006/abbi.1994.1331; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; TAYLOR KL, 1990, BIOCHEMISTRY-US, V29, P1533, DOI 10.1021/bi00458a026; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YAMADA M, 1990, BIOCHEM BIOPH RES CO, V166, P852, DOI 10.1016/0006-291X(90)90888-T; YAMADA M, 1982, J BIOL CHEM, V257, P5980; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157	62	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8244	8261		10.1074/jbc.M117.775031	http://dx.doi.org/10.1074/jbc.M117.775031			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348079	Green Published, hybrid			2022-12-28	WOS:000401788600011
J	Liu, M; Yuan, C; Jensen, JK; Zhao, BY; Jiang, YB; Jiang, LG; Huang, MD				Liu, Min; Yuan, Cai; Jensen, Jan K.; Zhao, Baoyu; Jiang, Yunbin; Jiang, Longguang; Huang, Mingdong			The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; PHYSIOLOGICAL INHIBITOR; SERINE PROTEINASE; KUNITZ DOMAINS; TYPE-1; MATRIPTASE; PURIFICATION; RECEPTOR; DYNAMICS	Hepatocyte growth factor activator inhibitor 1 (HAI-1) is a membrane-bound multidomain protein essential to the integrity of the basement membrane during placental development and is also important in maintaining postnatal homeostasis in many tissues. HAI-1 is a Kunitz-type serine protease inhibitor, and soluble fragments of HAI-1 with variable lengths have been identified in vivo. The full-length extracellular portion of HAI-1 (sHAI-1) shows weaker inhibitory activity toward target proteases than the smaller fragments, suggesting auto-inhibition of HAI-1. However, this possible regulatory mechanism has not yet been evaluated. Here, we solved the crystal structure of sHAI-1 and determined the solution structure by small-angle X-ray scattering. These structural analyses revealed that, despite the presence of long linkers, sHAI-1 exists in a compact conformation in which sHAI-1 active sites in Kunitz domain 1 are sterically blocked by neighboring structural elements. Wealso found that in the presence of target proteases, sHAI-1 adopts an extended conformation that disables the auto-inhibition effect. Our results also reveal the roles of non-inhibitory domains of this multidomain protein and explain the low activity of the full-length protein. The structural insights gained here improve our understanding of the regulation of HAI-1 inhibitory activities and point to new approaches for better controlling these activities.	[Liu, Min; Zhao, Baoyu; Jiang, Yunbin; Jiang, Longguang; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Liu, Min; Jiang, Yunbin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yuan, Cai] Fuzhou Univ, Coll Biosci & Biotechnol, Fuzhou 350108, Fujian, Peoples R China; [Yuan, Cai] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Jiang, Longguang; Huang, Mingdong] Fuzhou Univ, Coll Chem, Fuzhou 350108, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fuzhou University; Aarhus University; Fuzhou University	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.; Yuan, C (corresponding author), Fuzhou Univ, Coll Biosci & Biotechnol, Fuzhou 350108, Fujian, Peoples R China.; Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China.	cyuan@fzu.edu.cn; mhuang@fjirsm.ac.cn	Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141; Jiang, Longguang/0000-0002-4734-3778	National Natural Science Foundation of China [31170707, 31570745, 31370737, 31400637, 31670739, U1405229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 31170707, 31570745, 31370737, 31400637, 31670739, and U1405229 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bhaskara RM, 2013, J BIOMOL STRUCT DYN, V31, P1467, DOI 10.1080/07391102.2012.743438; Clayton D, 2000, FEBS LETT, V479, P118, DOI 10.1016/S0014-5793(00)01842-1; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Hong ZB, 2015, BIOCHEM J, V466, P299, DOI 10.1042/BJ20141236; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi M, 2015, AM J PATHOL, V185, P1610, DOI 10.1016/j.ajpath.2015.02.009; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Koivuniemi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056117; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kojima K, 2009, J BIOCHEM, V145, P783, DOI 10.1093/jb/mvp036; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Liu HG, 2012, J STRUCT BIOL, V180, P226, DOI 10.1016/j.jsb.2012.05.011; Liu M, 2017, ACTA CRYSTALLOGR F, V73, P45, DOI 10.1107/S2053230X16020082; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Nakamura K, 2009, ANN ONCOL, V20, P63, DOI 10.1093/annonc/mdn556; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Roy A, 2016, J CHEM THEORY COMPUT, V12, P274, DOI 10.1021/acs.jctc.5b00796; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Skou S, 2014, NAT PROTOC, V9, P1727, DOI 10.1038/nprot.2014.116; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Vadivel K, 2014, J BIOL CHEM, V289, P31647, DOI 10.1074/jbc.M114.569665; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen B, 2013, J THEOR COMPUT CHEM, V12, DOI 10.1142/S0219633613410083; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; Zhao B., 2013, ADV MATER SCI ENG, V2013, P1, DOI DOI 10.1155/2013/390285; Zheng QL, 2014, MOL MED REP, V10, P2779, DOI 10.3892/mmr.2014.2628	56	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8412	8423		10.1074/jbc.M117.779256	http://dx.doi.org/10.1074/jbc.M117.779256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348076	Green Published, hybrid			2022-12-28	WOS:000401788600025
J	Calinescu, O; Dwivedi, M; Patino-Ruiz, M; Padan, E; Fendler, K				Calinescu, Octavian; Dwivedi, Manish; Patino-Ruiz, Miyer; Padan, Etana; Fendler, Klaus			Lysine 300 is essential for stability but not for electrogenic transport of the Escherichia coli NhaA Na+/H+ antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; MODEL-STRUCTURE; PH REGULATION; MEMBRANE; EXCHANGER; MECHANISM; HOMEOSTASIS; MUTATIONS	Na+/H+ antiporters are located in the cytoplasmic and intracellular membranes and play crucial roles in regulating intracellular pH, Na+, and volume. The NhaA antiporter of Escherichia coli is the best studied member of the Na+/H+ exchanger family and a model system for all related Na+/H+ exchangers, including eukaryotic representatives. Several amino acid residues are important for the transport activity of NhaA, including Lys-300, a residue that has recently been proposed to carry one of the two H+ ions that NhaA exchanges for one Na+ ion during one transport cycle. Here, we sought to characterize the effects of mutating Lys-300 of NhaA to amino acid residues containing side chains of different polarity and length (i.e. Ala, Arg, Cys, His, Glu, and Leu) on transporter stability and function. Salt resistance assays, acridine-orange fluorescence dequenching, solid supported membrane-based electrophysiology, and differential scanning fluorometry were used to characterize Na+ and H+ transport, charge translocation, and thermal stability of the different variants. These studies revealed that NhaA could still perform electrogenic Na+/H+ exchange even in the absence of a protonatable residue at the Lys-300 position. However, all mutants displayed lower thermal stability and reduced ion transport activity compared with the wild-type enzyme, indicating the critical importance of Lys-300 for optimal NhaA structural stability and function. On the basis of these experimental data, we propose a tentative mechanism integrating the functional and structural role of Lys-300.	[Calinescu, Octavian; Patino-Ruiz, Miyer; Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Calinescu, Octavian] Carol Davila Univ Med & Pharm, Bucharest 050474, Romania; [Dwivedi, Manish; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Carol Davila University of Medicine & Pharmacy; Hebrew University of Jerusalem	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biol Chem, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de	DWIVEDI, MANISH/AAI-8940-2021; Calinescu, Octavian/P-4278-2014	DWIVEDI, MANISH/0000-0001-5217-9039; Calinescu, Octavian/0000-0001-8003-0442; Patino-Ruiz, Miyer Fabian/0000-0003-0607-4281	DIP (Deutsche Forschungsgemeinschaft, German-Israeli Project Cooperation) [LA3655/1-1]; Israel Science Foundation (ISF) [284/12, 939/14]; PBC, Council for Higher Education; Hebrew University Program for Fellowships; Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI [PN-II-RU-TE-2014-4-0604]	DIP (Deutsche Forschungsgemeinschaft, German-Israeli Project Cooperation); Israel Science Foundation (ISF)(Israel Science Foundation); PBC, Council for Higher Education; Hebrew University Program for Fellowships; Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI	This work was supported by the DIP (Deutsche Forschungsgemeinschaft, German-Israeli Project Cooperation # LA3655/1-1; to M.P.-R., E.P., and K. F.), the Israel Science Foundation (ISF, Grants 284/12 and 939/14; to E. P), and the PBC, Council for Higher Education and the Hebrew University Program for Fellowships for Outstanding Postdoctoral Fellows from China and India (2015) (to M. D.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI, project PN-II-RU-TE-2014-4-0604.	Calinescu O, 2016, J BIOL CHEM, V291, P26786, DOI 10.1074/jbc.M116.761080; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Calinescu O, 2014, J BIOL CHEM, V289, P13168, DOI 10.1074/jbc.M113.542993; Deisl C, 2013, P NATL ACAD SCI USA, V110, P10004, DOI 10.1073/pnas.1220009110; Dwivedi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23339; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Inoue S, 2001, J BIOCHEM, V129, P569, DOI 10.1093/oxfordjournals.jbchem.a002892; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kohlstaedt M, 2015, ACTA CRYSTALLOGR D, V71, P1112, DOI 10.1107/S1399004715004058; Kondapalli KC, 2012, J BIOL CHEM, V287, P36239, DOI 10.1074/jbc.M112.403550; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Kuwabara N, 2006, BIOCHEMISTRY-US, V45, P14834, DOI 10.1021/bi061048d; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee C, 2014, J GEN PHYSIOL, V144, P529, DOI 10.1085/jgp.201411219; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Lescat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108738; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Minato Y, 2013, INFECT IMMUN, V81, P3163, DOI 10.1128/IAI.00071-13; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2016, METAL IONS LIFE SCI, V16, P391, DOI 10.1007/978-3-319-21756-7_12; Padan E, 2015, ISR J CHEM, V55, P1233, DOI 10.1002/ijch.201500044; Padan E, 2014, BBA-BIOENERGETICS, V1837, P1047, DOI 10.1016/j.bbabio.2013.12.007; Paulino C, 2014, ELIFE, V3, DOI 10.7554/eLife.03583; PINNER E, 1993, J BIOL CHEM, V268, P1729; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Weichel M, 2008, BIOPROCESS INT, P42; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Wohlert D, 2014, ELIFE, V3, DOI 10.7554/eLife.03579; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	51	22	22	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7932	7941		10.1074/jbc.M117.778175	http://dx.doi.org/10.1074/jbc.M117.778175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28330875	Green Published, hybrid			2022-12-28	WOS:000401154100020
J	Lyu, L; Wang, BL; Xiong, CY; Zhang, XT; Zhang, XY; Zhang, JJ				Lyu, Lin; Wang, Baolu; Xiong, Chaoyang; Zhang, Xiaotian; Zhang, Xiaoyan; Zhang, Junjie			Selective export of autotaxin from the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY SECRETORY PATHWAY; LYSOPHOSPHOLIPASE-D; PI3K/AKT/MTOR PATHWAY; ANCHORED PROTEINS; CELL-MIGRATION; P24 PROTEINS; CANCER; LPA; ER; EXPRESSION	Autotaxin (ATX) or ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) is a secretory glycoprotein and functions as the key enzyme for lysophosphatidic acid generation. The mechanism of ATX protein trafficking is largely unknown. Here, we demonstrated that p23, a member of the p24 protein family, was the protein-sorting receptor required for endoplasmic reticulum (ER) export of ATX. A di-phenylalanine (Phe-838/Phe-839) motif in the human ATX C-terminal region was identified as a transport signal essential for the ATX-p23 interaction. Knockdown of individual Sec24 isoforms by siRNA revealed that ER export of ATX was impaired only if Sec24C was down-regulated. These results suggest that ATX is selectively exported from the ER through a p23, Sec24C-dependent pathway. In addition, it was found that AKT signaling played a role in ATX secretion regulation to facilitate ATX ER export by enhancing the nuclear factor of activated T cell-mediated p23 expression. Furthermore, the di-hydrophobic amino acid motifs (FY) also existed in the C-terminal regions of human ENPP1 and ENPP3. Such a p23, Sec24C-dependent selective ER export mechanism is conserved among these ENPP family members.	[Lyu, Lin; Wang, Baolu; Xiong, Chaoyang; Zhang, Xiaotian; Zhang, Xiaoyan; Zhang, Junjie] Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Inst Cell Biol, Beijing 100875, Peoples R China; [Wang, Baolu] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Xian 710062, Shanxi, Peoples R China; [Xiong, Chaoyang] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Beijing Normal University; Shaanxi Normal University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, JJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Inst Cell Biol, Beijing 100875, Peoples R China.	jjzhang@bnu.edu.cn		Zhang, Junjie/0000-0001-8809-1485	National Natural Science Foundation of China [31470765, 31500619]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 31470765 and 31500619 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Contreras I, 2004, PLANT CELL PHYSIOL, V45, P1779, DOI 10.1093/pcp/pch200; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Im DS, 2010, ACTA PHARMACOL SIN, V31, P1213, DOI 10.1038/aps.2010.135; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Jansen S, 2007, J BIOL CHEM, V282, P11084, DOI 10.1074/jbc.M611503200; Jansen S, 2009, J BIOL CHEM, V284, P14296, DOI 10.1074/jbc.M900790200; Kim MS, 2014, J BIOL CHEM, V289, P31349, DOI 10.1074/jbc.M114.587188; Kinoshita T, 2013, BBA-MOL CELL RES, V1833, P2473, DOI 10.1016/j.bbamcr.2013.01.027; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Li X, 2015, BIOCHEM BIOPH RES CO, V463, P483, DOI 10.1016/j.bbrc.2015.04.151; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Liu SC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-21; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Nishimasu H, 2012, TRENDS PHARMACOL SCI, V33, P138, DOI 10.1016/j.tips.2011.12.004; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nufer O, 2002, J CELL SCI, V115, P619; Pradere JP, 2007, BBA-MOL CELL BIOL L, V1771, P93, DOI 10.1016/j.bbalip.2006.11.010; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tabchy A, 2011, NAT STRUCT MOL BIOL, V18, P117, DOI 10.1038/nsmb0211-117; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; Wu Guangyu, 2012, Subcell Biochem, V63, P83, DOI 10.1007/978-94-007-4765-4_5; Wu T, 2014, FASEB J, V28, P861, DOI 10.1096/fj.13-232868; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009; Zaslavsky A, 2006, BBA-MOL CELL BIOL L, V1761, P1200, DOI 10.1016/j.bbalip.2006.08.011	48	11	11	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7011	7022		10.1074/jbc.M116.774356	http://dx.doi.org/10.1074/jbc.M116.774356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298439	Green Published, hybrid			2022-12-28	WOS:000400478300013
J	Shukla, S; Abel, B; Chufan, EE; Ambudkar, SV				Shukla, Suneet; Abel, Biebele; Chufan, Eduardo E.; Ambudkar, Suresh V.			Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG TRANSPORTER; ATP-BINDING; ELECTRON-MICROSCOPY; CATALYTIC CYCLE; DRUG-BINDING; RESISTANCE; ABCB1; INHIBITION; MECHANISM	P-glycoprotein (P-gp) is a multidrug transporter that uses energy from ATP hydrolysis to export many structurally dissimilar hydrophobic and amphipathic compounds, including anticancer drugs from cells. Several structural studies on purified P-gp have been reported, but only limited and sometimes conflicting information is available on ligand interactions with the isolated transporter in a dodecyl-maltoside detergent environment. In this report we compared the biochemical properties of P-gp in native membranes, detergent micelles, and when reconstituted in artificial membranes. We found that the modulators zosuquidar, tariquidar, and elacridar stimulated the ATPase activity of purified human or mouse P-gp in a detergent micelle environment. In contrast, these drugs inhibited ATPase activity in native membranes or in proteoliposomes, with IC50 values in the 10-40 nM range. Similarly, a 30-150-fold decrease in the apparent affinity for verapamil and cyclic peptide inhibitor QZ59-SSS was observed in detergent micelles compared with native or artificial membranes. Together, these findings demonstrate that the high-affinity site is inaccessible because of either a conformational change or binding of detergent at the binding site in a detergent micelle environment. The ligands bind to a low-affinity site, resulting in altered modulation of P-gp ATPase activity. We, therefore, recommend studying structural and functional aspects of ligand interactions with purified P-gp and other ATP-binding cassette transporters that transport amphipathic or hydrophobic substrates in a detergent-free native or artificial membrane environment.	[Shukla, Suneet; Abel, Biebele; Chufan, Eduardo E.; Ambudkar, Suresh V.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, 37 Convent Dr,Rm 2120, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Lab Cell Biol, Ctr Canc Res, NIH, 37 Convent Dr,Rm 2120, Bethesda, MD 20892 USA.	ambudkar@helix.nih.gov	Ambudkar, Suresh V/L-1317-2016		Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Beck A, 2013, BIOCHEMISTRY-US, V52, P3297, DOI 10.1021/bi400203d; Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Chufan EE, 2016, BIOCHEM PHARMACOL, V101, P40, DOI 10.1016/j.bcp.2015.12.007; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; Denisov IG, 2016, NAT STRUCT MOL BIOL, V23, P481, DOI 10.1038/nsmb.3195; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kapoor K., 2013, MOL MECH TUMOR CELL, P1; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2016, BIOCHEM BIOPH RES CO, V472, P379, DOI 10.1016/j.bbrc.2016.02.124; Loo TW, 2015, J BIOL CHEM, V290, P29389, DOI 10.1074/jbc.M115.695171; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Maki N, 2003, J BIOL CHEM, V278, P18132, DOI 10.1074/jbc.M210413200; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Orlowski S, 1998, Cancer Biochem Biophys, V16, P85; Pluchino KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136396; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rybczynska M, 2001, BRIT J CANCER, V84, P1405, DOI 10.1054/bjoc.2001.1776; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Singh S, 2014, CHEMBIOCHEM, V15, P157, DOI 10.1002/cbic.201300565; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Zoghbi ME, 2016, J BIOL CHEM, V291, P4453, DOI 10.1074/jbc.M115.698498	43	32	32	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7066	7076		10.1074/jbc.M116.771634	http://dx.doi.org/10.1074/jbc.M116.771634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283574	Green Published, hybrid			2022-12-28	WOS:000400478300017
J	Xu, J; McPherson, PS				Xu, Jie; McPherson, Peter S.			Regulation of DENND3, the exchange factor for the small GTPase Rab12 through an intramolecular interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXANUCLEOTIDE REPEAT; STRUCTURAL BASIS; N-WASP; PHOSPHORYLATION; C9ORF72; AUTOINHIBITION; ACTIVATION; AUTOPHAGY; PROTEIN; DOMAIN	The Rab family of small GTPases functions in multiple aspects of cellular membrane trafficking. Proteins bearing a differentially expressed in normal and neoplastic cells (DENN) domain have emerged as the largest family of Rab-activating guanine nucleotide exchange factors (GEFs). Rab12 functions in the initiation of starvation-induced autophagy, and our previous work revealed that its activator, DENN domain-containing protein 3 (DENND3), is phosphorylated and activated upon starvation. However, how the GEF activity of DENND3 toward Rab12 is regulated at the molecular level is still not understood. Here, we combine size-exclusion chromatography, Forster resonance energy transfer, pulldown, and in vitro GEF assays to demonstrate that regulation of GEF activity is achieved through an intramolecular interaction that is controlled by a key residue in DENND3, tyrosine 940. Our study sheds light on the regulation of Rab12 activation and lays the groundwork for characterizing the regulation of other DENN domain-containing proteins.	[Xu, Jie; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada	McGill University	Xu, J; McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	jie.xu3@mail.mcgill.ca; peter.mcpherson@mcgill.ca			Canadian Institutes of Health Research [MOP-62684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-62684 (to P. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Amick J, 2016, MOL BIOL CELL, V27, P3040, DOI 10.1091/mbc.E16-01-0003; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Fisslthaler B, 2008, CIRC RES, V102, P1520, DOI 10.1161/CIRCRESAHA.108.172072; Han CS, 2016, AM J HUM GENET, V99, P1359, DOI 10.1016/j.ajhg.2016.10.006; He XJ, 2013, STRUCTURE, V21, P355, DOI 10.1016/j.str.2013.01.001; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu J, 2015, CELL CYCLE, V14, P2717, DOI 10.1080/15384101.2015.1071136; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang Z, 2014, ELIFE, V3, DOI 10.7554/eLife.02687; Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7274	7282		10.1074/jbc.M116.772434	http://dx.doi.org/10.1074/jbc.M116.772434			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28249939	Green Published, hybrid			2022-12-28	WOS:000400478300036
J	Appleby, TC; Greenstein, AE; Hung, M; Liclican, A; Velasquez, M; Villasenor, AG; Wang, R; Wong, MH; Liu, XH; Papalia, GA; Schultz, BE; Sakowicz, R; Smith, V; Kwon, HJ				Appleby, Todd C.; Greenstein, Andrew E.; Hung, Magdeleine; Liclican, Albert; Velasquez, Maile; Villasenor, Armando G.; Wang, Ruth; Wong, Melanie H.; Liu, Xiaohong; Papalia, Giuseppe A.; Schultz, Brian E.; Sakowicz, Roman; Smith, Victoria; Kwon, Hyock Joo			Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE-9 MMP-9; 92-KDA GELATINASE; MOLECULAR-BIOLOGY; BINDING DOMAIN; CANCER; ACTIVATION; STROMELYSIN; EXPRESSION; PRECURSOR	Matrix metalloproteinase 9 (MMP9) is a member of a large family of proteases that are secreted as inactive zymogens. It is a key regulator of the extracellular matrix, involved in the degradation of various extracellular matrix proteins. MMP9 plays a pathological role in a variety of inflammatory and oncology disorders and has long been considered an attractive therapeutic target. GS-5745, a potent, highly selective humanized monoclonal antibody inhibitor of MMP9, has shown promise in treating ulcerative colitis and gastric cancer. Here we describe the crystal structure of GS-5745.MMP9 complex and biochemical studies to elucidate the mechanism of inhibition of MMP9 by GS-5745. GS-5745 binds MMP9 distal to the active site, near the junction between the prodomain and catalytic domain, and inhibits MMP9 by two mechanisms. Binding to pro-MMP9 prevents MMP9 activation, whereas binding to active MMP9 allosterically inhibits activity.	[Appleby, Todd C.; Greenstein, Andrew E.; Hung, Magdeleine; Liclican, Albert; Velasquez, Maile; Villasenor, Armando G.; Wang, Ruth; Wong, Melanie H.; Liu, Xiaohong; Papalia, Giuseppe A.; Schultz, Brian E.; Sakowicz, Roman; Smith, Victoria; Kwon, Hyock Joo] Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	Kwon, HJ (corresponding author), Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.	HyockJoo.Kwon@gilead.com		Greenstein, Andrew/0000-0002-1470-1970	Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	This work was funded by Gilead Sciences, Inc. All authors are employees of Gilead Sciences, Inc.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bendell JC, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4030; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Duncan ME, 1998, EUR J BIOCHEM, V258, P37, DOI 10.1046/j.1432-1327.1998.2580037.x; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fisher KE, 2002, BIOCHEMISTRY-US, V41, P8289, DOI 10.1021/bi012076t; GalleaRobache S, 1997, CYTOKINE, V9, P340, DOI 10.1006/cyto.1996.0174; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Lakatos G, 2012, PATHOL ONCOL RES, V18, P85, DOI 10.1007/s12253-011-9420-9; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MULLBERG J, 1995, J IMMUNOL, V155, P5198; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Sheu BC, 2001, CANCER RES, V61, P237; Sparano JA, 2004, J CLIN ONCOL, V22, P4683, DOI 10.1200/JCO.2004.08.054; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren Jennifer, 2011, World J Biol Chem, V2, P14, DOI 10.4331/wjbc.v2.i1.14	32	53	56	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6810	6820		10.1074/jbc.M116.760579	http://dx.doi.org/10.1074/jbc.M116.760579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28235803	Green Published, hybrid			2022-12-28	WOS:000399813400031
J	Pressey, JC; Mahadevan, V; Khademullah, CS; Dargaei, Z; Chevrier, J; Ye, WQ; Huang, M; Chauhan, AK; Meas, SJ; Uvarov, P; Airaksinen, MS; Woodin, MA				Pressey, Jessica C.; Mahadevan, Vivek; Khademullah, C. Sahara; Dargaei, Zahra; Chevrier, Jonah; Ye, Wenqing; Huang, Michelle; Chauhan, Alamjeet K.; Meas, Steven J.; Uvarov, Pavel; Airaksinen, Matti S.; Woodin, Melanie A.			A kainate receptor subunit promotes the recycling of the neuron-specific K+-Cl- co-transporter KCC2 in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE RECEPTORS; GABAERGIC INHIBITION; CHLORIDE HOMEOSTASIS; SURFACE STABILITY; RAT HIPPOCAMPUS; PHOSPHORYLATION; TRAFFICKING; EXPRESSION; ENDOCYTOSIS; SUMOYLATION	Synaptic inhibition depends on a transmembrane gradient of chloride, which is set by the neuron-specific K+-Cl- co-transporter KCC2. Reduced KCC2 levels in the neuronal membrane contribute to the generation of epilepsy, neuropathic pain, and autism spectrum disorders; thus, it is important to characterize the mechanisms regulating KCC2 expression. In the present study, we determined the role of KCC2-protein interactions in regulating total and surface membrane KCC2 expression. Using quantitative immunofluorescence in cultured mouse hippocampal neurons, we discovered that the kainate receptor subunit GluK2 and the auxiliary subunit Neto2 significantly increase the total KCC2 abundance in neurons but that GluK2 exclusively increases the abundance of KCC2 in the surface membrane. Using a live cell imaging assay, we further determined that KCC2 recycling primarily occurs within 1-2 h and that GluK2 produces an similar to 40% increase in the amount of KCC2 recycled to the membrane during this time period. This GluK2-mediated increase in surface recycling translated to a significant increase in KCC2 expression in the surface membrane. Moreover, we found that KCC2 recycling is enhanced by protein kinase C-mediated phosphorylation of the GluK2 C-terminal residues Ser-846 and Ser-868. Lastly, using gramicidin-perforated patch clamp recordings, we found that the GluK2-mediated increase in KCC2 recycling to the surface membrane translates to a hyperpolarization of the reversal potential for GABA(E-GABA). In conclusion, our results have revealed a mechanism by which kainate receptors regulate KCC2 expression in the hippocampus.	[Pressey, Jessica C.; Mahadevan, Vivek; Khademullah, C. Sahara; Dargaei, Zahra; Chevrier, Jonah; Ye, Wenqing; Huang, Michelle; Chauhan, Alamjeet K.; Meas, Steven J.; Woodin, Melanie A.] Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada; [Uvarov, Pavel; Airaksinen, Matti S.] Univ Helsinki, Dept Anat, Helsinki 00014, Finland; [Pressey, Jessica C.] INSERM, F-75011 Paris, France; [Mahadevan, Vivek] NICHD, NIH, Bethesda, MD 20892 USA	University of Toronto; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Woodin, MA (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	m.woodin@utoronto.ca	Mahadevan, Vivek/O-4114-2018; Uvarov, Pavel/AGR-2614-2022; Woodin, Melanie/A-2761-2008	Mahadevan, Vivek/0000-0002-0805-827X; Uvarov, Pavel/0000-0001-8439-6150; Khademullah, C. Sahara/0000-0003-3887-8946; Ye, Wenqing/0000-0002-0342-041X; Airaksinen, Matti/0000-0002-7199-4984; Meas, Steven/0000-0001-8651-2047; Woodin, Melanie/0000-0003-2984-8630; Dargaei, Zahra/0000-0003-2243-2034	Canadian Institute of Health Research Operating Grant; Canadian Institute of Health Research Scholarship from the Sleep and Biological Rhythms Training Program; Natural Sciences and Engineering Research Council of Canada Scholarship	Canadian Institute of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research Scholarship from the Sleep and Biological Rhythms Training Program(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Canadian Institute of Health Research Operating Grant (to M. A. W.), a Natural Sciences and Engineering Research Council of Canada Scholarship (to J. C. P.), and a Canadian Institute of Health Research Scholarship from the Sleep and Biological Rhythms Training Program (to V. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Acton BA, 2012, J NEUROSCI, V32, P8746, DOI 10.1523/JNEUROSCI.6089-11.2012; Arancibia-Carcamo I.L., 2006, FRON NEUROS, P91; BAHN S, 1994, J NEUROSCI, V14, P5525; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Caster Amanda H, 2012, Cell Logist, V2, P176; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chamma I, 2013, J NEUROSCI, V33, P15488, DOI 10.1523/JNEUROSCI.5889-12.2013; Chevy Q, 2015, J NEUROSCI, V35, P15772, DOI 10.1523/JNEUROSCI.1735-15.2015; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Fisher MT, 2014, NEUROSCIENCE, V278, P70, DOI 10.1016/j.neuroscience.2014.08.009; Gauvain G, 2011, P NATL ACAD SCI USA, V108, P15474, DOI 10.1073/pnas.1107893108; Gonzalez-Gonzalez IM, 2013, TRAFFIC, V14, P810, DOI 10.1111/tra.12071; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Hanack C, 2015, CELL, V160, P759, DOI 10.1016/j.cell.2015.01.022; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ivakine EA, 2013, P NATL ACAD SCI USA, V110, P3561, DOI 10.1073/pnas.1212907110; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Mahadevan V, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00368; Mahadevan V, 2014, CELL REP, V7, P1762, DOI 10.1016/j.celrep.2014.05.022; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Pahl S, 2014, MEMBRANES, V4, P565, DOI 10.3390/membranes4030565; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Puskarjov M, 2014, EMBO REP, V15, P723, DOI 10.1002/embr.201438749; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Rodriguez-Moreno A, 2007, TRENDS NEUROSCI, V30, P630, DOI 10.1016/j.tins.2007.10.001; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rojas A, 2013, MOL PHARMACOL, V83, P746, DOI 10.1124/mol.112.083352; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Tang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051433; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tao R, 2012, J NEUROSCI, V32, P5216, DOI 10.1523/JNEUROSCI.4626-11.2012; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Vesikansa A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00310; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	51	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6190	6201		10.1074/jbc.M116.767236	http://dx.doi.org/10.1074/jbc.M116.767236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28235805	hybrid, Green Published			2022-12-28	WOS:000399538700015
J	Wang, XXX; Levi, J; Luo, YH; Myakala, K; Herman-Edelstein, M; Qiu, LR; Wang, D; Peng, YQ; Grenz, A; Lucia, S; Dobrinskikh, E; D'Agati, VD; Koepsell, H; Kopp, JB; Rosenberg, AZ; Levi, M				Wang, Xiaoxin X.; Levi, Jonathan; Luo, Yuhuan; Myakala, Komuraiah; Herman-Edelstein, Michal; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; D'Agati, Vivette D.; Koepsell, Hermann; Kopp, Jeffrey B.; Rosenberg, Avi Z.; Levi, Moshe			SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL LIPID-METABOLISM; GLUCOSE COTRANSPORTER 2; CHRONIC KIDNEY-DISEASE; GLOMERULAR HYPERFILTRATION; OXIDATIVE STRESS; RECEPTOR ACTIVATION; SIGNALING PATHWAYS; INHIBITORS; HYPERGLYCEMIA; EMPAGLIFLOZIN	There is very limited human renal sodium gradient-dependent glucose transporter protein (SGLT2) mRNA and protein expression data reported in the literature. The first aim of this study was to determine SGLT2 mRNA and protein levels in human and animal models of diabetic nephropathy. We have found that the expression of SGLT2 mRNA and protein is increased in renal biopsies from human subjects with diabetic nephropathy. This is in contrast to db-db mice that had no changes in renal SGLT2 protein expression. Furthermore, the effect of SGLT2 inhibition on renal lipid content and inflammation is not known. The second aim of this study was to determine the potential mechanisms of beneficial effects of SGLT2 inhibition in the progression of diabetic renal disease. We treated db/db mice with a selective SGLT2 inhibitor JNJ 39933673. We found that SGLT2 inhibition caused marked decreases in systolic blood pressure, kidney weight/body weight ratio, urinary albumin, and urinary thiobarbituric acid-reacting substances. SGLT2 inhibition prevented renal lipid accumulation via inhibition of carbohydrate-responsive element-binding protein-beta, pyruvate kinase L, SCD-1, and DGAT1, key transcriptional factors and enzymes that mediate fatty acid and triglyceride synthesis. SGLT2 inhibition also prevented inflammation via inhibition of CD68 macrophage accumulation and expression of p65, TLR4, MCP-1, and osteopontin. These effects were associated with reduced mesangial expansion, accumulation of the extracellular matrix proteins fibronectin and type IV collagen, and loss of podocyte markers WT1 and synaptopodin, as deter-mined by immunofluorescence microscopy. In summary, our study showed that SGLT2 inhibition modulates renal lipid metabolism and inflammation and prevents the development of nephropathy in db/db mice.	[Wang, Xiaoxin X.; Luo, Yuhuan; Myakala, Komuraiah; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80220 USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Myakala, Komuraiah; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO 80220 USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Myakala, Komuraiah; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80220 USA; [Wang, Xiaoxin X.; Levi, Moshe] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [Levi, Jonathan; Kopp, Jeffrey B.] NIDDK, NIH, Bethesda, MD 20892 USA; [Herman-Edelstein, Michal] Tel Aviv Univ, Rabin Med Ctr, Dept Hypertens & Nephrol, Felsenstein Med Res Ctr,Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [D'Agati, Vivette D.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10027 USA; [Koepsell, Hermann] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Rosenberg, Avi Z.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Columbia University; University of Wurzburg; Johns Hopkins University	Levi, M (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, 12700 East 19th Ave,Res 2,Rm 7002,Box C281, Aurora, CO 80045 USA.	moshe.levi@ucdenver.edu	Komuraiah, Myakala/AAQ-9961-2021; Wang, Dong/A-6518-2018; Kopp, Jeffrey B/O-2681-2015; qiu, liru/AAA-4648-2022	Komuraiah, Myakala/0000-0003-3233-047X; Kopp, Jeffrey B/0000-0001-9052-186X; qiu, liru/0000-0002-1583-7183; Rosenberg, Avi/0000-0003-2356-950X	NIDDK Intramural Research Program, NIDDK, National Institutes of Health; Medical School grant by Janssen Research AMP; Development, LLC, Raritan, NJ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098336] Funding Source: NIH RePORTER	NIDDK Intramural Research Program, NIDDK, National Institutes of Health; Medical School grant by Janssen Research AMP; Development, LLC, Raritan, NJ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIDDK Intramural Research Program, NIDDK, National Institutes of Health (to J. L., J. B. K., and A. Z. R.). This work was funded in part by a Medical School grant provided by Janssen Research & Development, LLC, Raritan, NJ (to M. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; BANK N, 1990, J CLIN INVEST, V86, P309, DOI 10.1172/JCI114700; Barnett AH, 2014, LANCET DIABETES ENDO, V2, P369, DOI 10.1016/S2213-8587(13)70208-0; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brosius FC, 2014, ADV CHRONIC KIDNEY D, V21, P304, DOI 10.1053/j.ackd.2014.03.011; Caldas YA, 2011, KIDNEY INT, V80, P535, DOI 10.1038/ki.2011.159; Cardenas A, 2013, LAB INVEST, V93, P135, DOI 10.1038/labinvest.2012.143; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; De Nicola L, 2014, AM J KIDNEY DIS, V64, P16, DOI 10.1053/j.ajkd.2014.02.010; FARBER SJ, 1951, J CLIN INVEST, V30, P125, DOI 10.1172/JCI102424; Faulhaber-Walter R, 2008, J AM SOC NEPHROL, V19, P722, DOI 10.1681/ASN.2007060721; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Ferrannini E, 2013, DIABETES CARE, V36, P1260, DOI 10.2337/dc12-1503; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Gallo LA, 2015, DIABETES VASC DIS RE, V12, P78, DOI 10.1177/1479164114561992; Gembardt F, 2014, AM J PHYSIOL-RENAL, V307, pF317, DOI 10.1152/ajprenal.00145.2014; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Giral H, 2012, J BIOL CHEM, V287, P35047, DOI 10.1074/jbc.M112.392415; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Guebre-Egziabher F, 2013, BIOCHIMIE, V95, P1971, DOI 10.1016/j.biochi.2013.07.017; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Hunley Tracy E, 2010, Curr Opin Nephrol Hypertens, V19, P227, DOI 10.1097/MNH.0b013e3283374c09; Ishibashi Y, 2016, HORM METAB RES, V48, P191, DOI 10.1055/s-0035-1555791; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Komala MG, 2013, CURR OPIN NEPHROL HY, V22, P113, DOI 10.1097/MNH.0b013e32835a17ae; Maeda S, 2013, DIABETES-METAB RES, V29, P406, DOI 10.1002/dmrr.2407; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; Mende CW, 2017, CURR MED RES OPIN, V33, P541, DOI 10.1080/03007995.2016.1271779; Mudaliar S, 2015, DIABETES CARE, V38, P2344, DOI 10.2337/dc15-0642; Novikov A, 2016, CURR OPIN NEPHROL HY, V25, P50, DOI 10.1097/MNH.0000000000000187; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Persson P, 2010, ACTA PHYSIOL, V200, P3, DOI 10.1111/j.1748-1716.2010.02147.x; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Roa H, 2009, FEBS LETT, V583, P3192, DOI 10.1016/j.febslet.2009.09.003; Rosolowsky ET, 2011, J AM SOC NEPHROL, V22, P545, DOI 10.1681/ASN.2010040354; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Schnermann J, 2015, ANNU REV PHYSIOL, V77, P301, DOI 10.1146/annurev-physiol-021014-071829; Skrtic M, 2015, CURR OPIN NEPHROL HY, V24, P96, DOI 10.1097/MNH.0000000000000084; Stanton RC, 2014, CIRCULATION, V129, P542, DOI 10.1161/CIRCULATIONAHA.113.007071; Tak E, 2014, J AM SOC NEPHROL, V25, P547, DOI 10.1681/ASN.2012101014; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Thomas MC, 2014, THER ADV ENDOCRINOL, V5, DOI 10.1177/2042018814544153; Thomson SC, 2012, AM J PHYSIOL-REG I, V302, pR75, DOI 10.1152/ajpregu.00357.2011; Tsimihodimos V, 2017, CURR VASC PHARMACOL, V15, P96, DOI 10.2174/1570161114666161007163426; Vallianou NG, 2017, DIABETES METAB SYND, V11, P311, DOI 10.1016/j.dsx.2016.12.003; Vallon V, 2017, DIABETOLOGIA, V60, P215, DOI 10.1007/s00125-016-4157-3; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7; Wang XXX, 2016, J AM SOC NEPHROL, V27, P1362, DOI 10.1681/ASN.2014121271; Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Zhu YQ, 2007, SEMIN NEPHROL, V27, P153, DOI 10.1016/j.semnephrol.2007.01.008	73	173	177	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5335	5348		10.1074/jbc.M117.779520	http://dx.doi.org/10.1074/jbc.M117.779520			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196866	hybrid, Green Published			2022-12-28	WOS:000397875500016
J	Xu, DQ; Zhou, JL; Lou, XD; He, JH; Ran, TT; Wang, WW				Xu, Dongqing; Zhou, Jiale; Lou, Xiangdi; He, Jianhua; Ran, Tingting; Wang, Weiwu			Myroilysin Is a New Bacterial Member of the M12A Family of Metzincin Metallopeptidases and Is Activated by a Cysteine Switch Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOCELLULAR PROTEASE; ALKALINE PROTEASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; STRUCTURAL BASIS; ASTACIN; CRYSTALLIZATION; SUPERFAMILY; SERRALYSINS; VALIDATION	Proteases play important roles in all living organisms and also have important industrial applications. Family M12A metalloproteases, mainly found throughout the animal kingdom, belong to the metzincin protease family and are synthesized as inactive precursors. So far, only flavastacin and myroilysin, isolated from bacteria, were reported to be M12A proteases, whereas the classification of myroilysin is still unclear due to the lack of structural information. Here, we report the crystal structures of pro-myroilysin from bacterium Myroides sp. cslb8. The catalytic zinc ion of pro-myroilysin, at the bottom of a deep active site, is coordinated by three histidine residues in the conserved motif HEXXHXXGXXH; the cysteine residue in the propeptide coordinates the catalytic zinc ion and inhibits myroilysin activity. Structure comparisons revealed that myroilysin shares high similarity with the members of the M12A, M10A, and M10B families of metalloproteases. However, a unique "cap" structure tops the active site cleft in the structure of pro-myroilysin, and this "cap" structure does not exist in the above structure-reported subfamilies. Further structure-based sequence analysis revealed that myroilysin appears to belong to the M12A family, but pro-myroilysin uses a "cysteine switch" activation mechanism with a unique segment, including the conserved cysteine residue, whereas other reported M12A family proteases use an "aspartate switch" activation mechanism. Thus, our results suggest that myroilysin is a new bacterial member of the M12A family with an exceptional cysteine switch activation mechanism. Our results shed new light on the classification of the M12A family and may suggest a divergent evolution of the M12 family.	[Xu, Dongqing; Zhou, Jiale; Lou, Xiangdi; Ran, Tingting; Wang, Weiwu] Nanjing Agr Univ, Key Lab Agr & Environm Microbiol, Minist Agr, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Ran, TT; Wang, WW (corresponding author), Nanjing Agr Univ, Key Lab Agr & Environm Microbiol, Minist Agr, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.	rantt@njau.edu.cn; wwwang@njau.edu.cn	wang, weiwu/AAD-1490-2022	Xu, Dongqing/0000-0002-8388-2330; , weiwu/0000-0001-6922-9207; , Tingting/0000-0002-5541-3553	National Natural Science Foundation of China [31400055, 31170686, 31100028]; Natural Science Foundation of Jiangsu Province [BK20140690]; Youth Science and Technology Innovation Fund from Nanjing Agricultural University [KJ2013027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Youth Science and Technology Innovation Fund from Nanjing Agricultural University	This work was supported by National Natural Science Foundation of China Grants 31400055, 31170686, and 31100028; Natural Science Foundation of Jiangsu Province Grant BK20140690; and Youth Science and Technology Innovation Fund from Nanjing Agricultural University Grant KJ2013027. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEHLE W, 1993, J BIOTECHNOL, V28, P31, DOI 10.1016/0168-1656(93)90123-5; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XL, 2009, APPL ENVIRON MICROB, V75, P1838, DOI 10.1128/AEM.02285-08; Cheng SW, 1995, BIOSCI BIOTECH BIOCH, V59, P2239, DOI 10.1271/bbb.59.2239; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLEMING AB, 1995, APPL ENVIRON MICROB, V61, P3775, DOI 10.1128/AEM.61.11.3775-3780.1995; FRANKENA J, 1986, APPL MICROBIOL BIOT, V24, P106, DOI 10.1007/BF00938779; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Guevara T, 2013, ACTA CRYSTALLOGR F, V69, P472, DOI 10.1107/S1744309113007392; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Ichida JM, 2001, J MICROBIOL METH, V47, P199, DOI 10.1016/S0167-7012(01)00302-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu LH, 2009, VET PARASITOL, V164, P173, DOI 10.1016/j.vetpar.2009.05.016; Lopez-Pelegrin M, 2015, J BIOL CHEM, V290, P4728, DOI 10.1074/jbc.M114.605956; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Maeda H, 1996, MICROBIOL IMMUNOL, V40, P685, DOI 10.1111/j.1348-0421.1996.tb01129.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; NISHINA Y, 1992, INFECT IMMUN, V60, P2128, DOI 10.1128/IAI.60.5.2128-2132.1992; Okada A, 2010, J MOL BIOL, V402, P865, DOI 10.1016/j.jmb.2010.08.023; Okujo N, 1996, MICROBIOL IMMUNOL, V40, P595, DOI 10.1111/j.1348-0421.1996.tb01114.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PLUMMER TH, 1995, J BIOL CHEM, V270, P13192, DOI 10.1074/jbc.270.22.13192; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; REINHOLD BB, 1995, J BIOL CHEM, V270, P13197, DOI 10.1074/jbc.270.22.13197; REYSSET G, 1972, BIOCHEM BIOPH RES CO, V49, P328, DOI 10.1016/0006-291X(72)90414-7; Rosenthal C, 2006, ACTA CRYSTALLOGR F, V62, P1286, DOI 10.1107/S174430910605041X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASTRY KJ, 1983, J BACTERIOL, V153, P511, DOI 10.1128/JB.153.1.511-519.1983; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; TARENTINO AL, 1995, ARCH BIOCHEM BIOPHYS, V319, P281, DOI 10.1006/abbi.1995.1293; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Wu DX, 2016, ACTA CRYSTALLOGR F, V72, P10, DOI 10.1107/S2053230X15023092; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Yiallouros I, 2002, J MOL BIOL, V324, P237, DOI 10.1016/S0022-2836(02)01102-6; ZHU WS, 1990, DIAGN MICR INFEC DIS, V13, P491, DOI 10.1016/0732-8893(90)90081-6	61	6	7	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5195	5206		10.1074/jbc.M116.758110	http://dx.doi.org/10.1074/jbc.M116.758110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188295	Green Published, hybrid			2022-12-28	WOS:000397875500004
J	Pandey, KK; Bera, S; Shi, K; Aihara, H; Grandgenett, DP				Pandey, Krishan K.; Bera, Sibes; Shi, Ke; Aihara, Hideki; Grandgenett, Duane P.			A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DNA ENDS; AVIAN RETROVIRUS INTEGRASE; HIV-1 INTEGRASE; SYNAPTIC COMPLEX; CRYSTAL-STRUCTURE; BINDING PROTEIN; DOMAIN; ENDONUCLEASE; PHOSPHORYLATION; ORGANIZATION	The retrovirus integrase (IN) inserts the viral cDNA into the host DNA genome. Atomic structures of five different retrovirus INs complexed with their respective viral DNA or branched viral/target DNA substrates have indicated these intasomes are composed of IN subunits ranging from tetramers, to octamers, or to hexadecamers. IN precursors are monomers, dimers, or tetramers in solution. But how intasome assembly is controlled remains unclear. Therefore, we sought to unravel the functional mechanisms in different intasomes. We produced kinetically stabilized Rous sarcoma virus (RSV) intasomes with human immunodeficiency virus type 1 strand transfer inhibitors that interact simultaneously with IN and viral DNA within intasomes. We examined the ability of RSV IN dimers to assemble two viral DNA molecules into intasomes containing IN tetramers in contrast to one possessing IN octamers. We observed that the last 18 residues of the C terminus ("tail" region) of IN (residues 1-286) determined whether an IN tetramer or octamer assembled with viral DNA. A series of truncations of the tail region indicated that these 18 residues are critical for the assembly of an intasome containing IN octamers but not for an intasome containing IN tetramers. The C-terminally truncated IN (residues 1-269) produced an intasome that contained tetramers but failed to produce an intasome with octamers. Both intasomes have similar catalytic activities. The results suggest a high degree of plasticity for functional multimerization and reveal a critical role of the C-terminal tail region of IN in higher order oligomerization of intasomes, potentially informing future strategies to prevent retroviral integration.	[Pandey, Krishan K.; Bera, Sibes; Grandgenett, Duane P.] St Louis Univ, Inst Mol Virol, Dept Microbiol & Immunol, 1100 S Grand Blvd, St Louis, MO 63104 USA; [Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities	Grandgenett, DP (corresponding author), St Louis Univ, Inst Mol Virol, Dept Microbiol & Immunol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	grandgdp@slu.edu		, Ke/0000-0003-4175-3714; Pandey, Krishan/0000-0002-3973-9844	National Institutes of Health [AI127196, GM118047]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109770, R35GM118047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI127196 (to D. P. G.) and GM118047 (to H. A.) and by Saint Louis University (to D. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALEXANDER F, 1987, J VIROL, V61, P534, DOI 10.1128/JVI.61.2.534-542.1987; Andrake MD, 2015, ANNU REV VIROL, V2, P241, DOI 10.1146/annurev-virology-100114-055043; [Anonymous], 2013, MOL OP ENV MOE; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Chen HM, 1999, J BIOL CHEM, V274, P17358, DOI 10.1074/jbc.274.24.17358; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; GRANDGENETT D, 1985, J BIOL CHEM, V260, P8243; GRANDGENETT DP, 1978, VIROLOGY, V89, P119, DOI 10.1016/0042-6822(78)90046-6; Grandgenett Duane P, 2015, World J Biol Chem, V6, P83, DOI 10.4331/wjbc.v6.i3.83; Grobler JA, 2009, ANTIVIR THER, V14, pA27; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; HIPPENMEYER PJ, 1984, VIROLOGY, V137, P358, DOI 10.1016/0042-6822(84)90228-9; HORTON R, 1988, J VIROL, V62, P2067, DOI 10.1128/JVI.62.6.2067-2075.1988; HORTON R, 1991, J VIROL, V65, P1141, DOI 10.1128/JVI.65.3.1141-1148.1991; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KATZ RA, 1988, J VIROL, V62, P2686, DOI 10.1128/JVI.62.8.2686-2695.1988; KATZ RA, 1988, J VIROL, V62, P528, DOI 10.1128/JVI.62.2.528-533.1988; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Lesbats P, 2016, CHEM REV, V116, P12730, DOI 10.1021/acs.chemrev.6b00125; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; MUMM SR, 1991, J VIROL, V65, P1160, DOI 10.1128/JVI.65.3.1160-1167.1991; MUMM SR, 1992, J VIROL, V66, P1995, DOI 10.1128/JVI.66.4.1995-1999.1992; Pandey KK, 2014, J BIOL CHEM, V289, P19648, DOI 10.1074/jbc.M114.573311; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Pandey KK, 2010, BIOCHEMISTRY-US, V49, P8376, DOI 10.1021/bi100514s; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Pommier Y, 2015, BIOORG MED CHEM LETT, V25, P3961, DOI 10.1016/j.bmcl.2015.07.032; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; Skalka AM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0005-2014; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora A, 2001, J VIROL, V75, P3556, DOI 10.1128/JVI.75.8.3556-3567.2001; Wei SQ, 1998, P NATL ACAD SCI USA, V95, P10535, DOI 10.1073/pnas.95.18.10535; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166	57	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5018	5030		10.1074/jbc.M116.773382	http://dx.doi.org/10.1074/jbc.M116.773382			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28184005	Green Published, hybrid			2022-12-28	WOS:000397590400023
J	Pires, VMR; Pereira, PMM; Bras, JLA; Correia, M; Cardoso, V; Bule, P; Alves, VD; Najmudin, S; Venditto, I; Ferreira, LMA; Romao, MJ; Carvalho, AL; Fontes, CMGA; Prazeres, DM				Pires, Virgnia M. R.; Pereira, Pedro M. M.; Bras, Joana L. A.; Correia, Marcia; Cardoso, Vania; Bule, Pedro; Alves, Victor D.; Najmudin, Shabir; Venditto, Immacolata; Ferreira, Luis M. A.; Romao, Maria Joao; Carvalho, Ana Luisa; Fontes, Carlos M. G. A.; Prazeres, Duarte Miguel			Stability and Ligand Promiscuity of Type A Carbohydrate-binding Modules Are Illustrated by the Structure of Spirochaeta thermophila StCBM64C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING; CLOSTRIDIUM-THERMOCELLUM; DOMAIN; FAMILY; RECOGNITION; DISPLAY; HYDROLYSIS; ANTIBODIES; DISTINCT; SYSTEM	Deconstruction of cellulose, the most abundant plant cell wall polysaccharide, requires the cooperative activity of a large repertoire of microbial enzymes. Modular cellulases contain noncatalytic type A carbohydrate-binding modules (CBMs) that specifically bind to the crystalline regions of cellulose, thus promoting enzyme efficacy through proximity and targeting effects. Although type A CBMs play a critical role in cellulose recycling, their mechanism of action remains poorly understood. Here we produced a library of recombinant CBMs representative of the known diversity of typeAmodules. The binding properties of 40 CBMs, in fusion with an N-terminal GFP domain, revealed that type A CBMs possess the ability to recognize different crystalline forms of cellulose and chitin over a wide range of temperatures, pH levels, and ionic strengths. ASpirochaeta thermophila CBM64, in particular, displayed plasticity in its capacity to bind both crystalline and soluble carbohydrates under a wide range of extreme conditions. The structure of S. thermophila StCBM64C revealed an untwisted, flat, carbohydrate-binding interface comprising the side chains of four tryptophan residues in a coplanar linear arrangement. Significantly, two highly conserved asparagine side chains, each one located between two tryptophan residues, are critical to insoluble and soluble glucan recognition but not to bind xyloglucan. Thus, CBM64 compact structure and its extended and versatile ligand interacting platform illustrate how type A CBMs target their appended plant cell wall-degrading enzymes to a diversity of recalcitrant carbohydrates under a wide range of environmental conditions.	[Pires, Virgnia M. R.; Bras, Joana L. A.; Cardoso, Vania; Bule, Pedro; Alves, Victor D.; Najmudin, Shabir; Venditto, Immacolata; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] Univ Lisbon, CIISA, Fac Med Vet, Polo Univ Ajuda, P-1300477 Lisbon, Portugal; [Pereira, Pedro M. M.; Prazeres, Duarte Miguel] Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, Dept Bioengn, P-1049001 Lisbon, Portugal; [Bras, Joana L. A.; Cardoso, Vania; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] NZYTech Genes Enzymes, P-1649038 Lisbon, Portugal; [Correia, Marcia; Romao, Maria Joao; Carvalho, Ana Luisa] Univ Nova Lisboa, Dept Quim, UCIBIO REQUIMTE, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade Nova de Lisboa	Fontes, CMGA (corresponding author), Univ Lisbon, CIISA, Fac Med Vet, Polo Univ Ajuda, P-1300477 Lisbon, Portugal.; Prazeres, DM (corresponding author), Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, Dept Bioengn, P-1049001 Lisbon, Portugal.; Fontes, CMGA (corresponding author), NZYTech Genes Enzymes, P-1649038 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt; miguelprazeres@tecnico.ulisboa.pt	Pires, Virginia/J-4799-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017; Prazeres, Duarte Miguel F/E-2526-2011; Romao, Maria J/A-4115-2013; Bule, Pedro/W-6838-2019; Carvalho, Ana Luísa/G-5638-2011; Correia, Márcia/D-2077-2013	Pires, Virginia/0000-0003-1307-3797; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Prazeres, Duarte Miguel F/0000-0002-6928-692X; Romao, Maria J/0000-0002-3004-0543; Bule, Pedro/0000-0003-2531-9926; Carvalho, Ana Luísa/0000-0002-3824-0240; Correia, Márcia/0000-0003-0636-8095; Cardoso, Vania/0000-0001-8389-7543; Alves, Victor Diogo/0000-0002-8430-4380; Bras, Joana/0000-0002-1141-5530; VENDITTO, IMMACOLATA/0000-0003-0392-2871; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454	Qren [30270]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/5947/2014, IF/01621/2013, RECI/BBB-BEP/0124/2012, PEst-C/EQB/LA0006/2013, UID/Multi/04378/2013]; Institute for Bio engineering and Biosciences through FCT-Portuguese Foundation for Science and Technology [UID/BIO/04565/2013]; Programa Operacional Regional de Lisboa [007317];  [SFRH/BPD/64917/2009];  [SFRH/BD/86821/2012];  [SFRH/BDE/101026/2014]	Qren; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Institute for Bio engineering and Biosciences through FCT-Portuguese Foundation for Science and Technology; Programa Operacional Regional de Lisboa; ; ; 	This work was supported by Qren, Grant 30270, and by Fundacao para a Ciencia e Tecnologia through projects PTDC/BIA-MIC/5947/2014, IF/01621/2013, RECI/BBB-BEP/0124/2012, PEst-C/EQB/LA0006/2013, and UID/Multi/04378/2013. This work was also supported by Fellowships IF/01621/2013 (to V. M. R. P.), SFRH/BPD/64917/2009 (to M. C.), SFRH/BD/86821/2012 (to P. B.), and SFRH/BDE/101026/2014 (to V. C.) and by Institute for Bio engineering and Biosciences through FCT-Portuguese Foundation for Science and Technology Grant UID/BIO/04565/2013 and by Programa Operacional Regional de Lisboa 2020 Project 007317. C. M. G. A. F. is financial beneficiary of the company that sells the cloning kits used in this study.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelov A, 2011, APPL ENVIRON MICROB, V77, P5483, DOI 10.1128/AEM.00523-11; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2005, BIOCHEM J, V385, P479, DOI 10.1042/BJ20041473; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao Y, 2007, J CHROMATOGR A, V1149, P228, DOI 10.1016/j.chroma.2007.03.032; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; GILBERT HJ, 1990, MOL MICROBIOL, V4, P759, DOI 10.1111/j.1365-2958.1990.tb00646.x; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Hernandez-Gomez MC, 2015, FEBS LETT, V589, P2297, DOI 10.1016/j.febslet.2015.07.009; Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAMED R, 1980, J BACTERIOL, V144, P569, DOI 10.1128/JB.144.2.569-578.1980; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luis AS, 2013, J BIOL CHEM, V288, P4799, DOI 10.1074/jbc.M112.432781; Ofir K, 2005, PROTEOMICS, V5, P1806, DOI 10.1002/pmic.200401078; Oliveira C, 2015, BIOTECHNOL ADV, V33, P358, DOI 10.1016/j.biotechadv.2015.02.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Rosa AMM, 2014, ANAL CHEM, V86, P4340, DOI 10.1021/ac5001288; Saez NJ, 2014, METHODS MOL BIOL, V1091, P33, DOI 10.1007/978-1-62703-691-7_3; Schiefner A, 2016, PROTEINS, V84, P855, DOI 10.1002/prot.25010; Sequeira AF, 2016, MOL BIOTECHNOL, V58, P573, DOI 10.1007/s12033-016-9957-7; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tolba M, 2010, APPL ENVIRON MICROB, V76, P528, DOI 10.1128/AEM.02294-09; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Wang AJA, 2002, APPL ENVIRON MICROB, V68, P1684, DOI 10.1128/AEM.68.4.1684-1689.2002; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011	42	15	15	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4847	4860		10.1074/jbc.M116.767541	http://dx.doi.org/10.1074/jbc.M116.767541			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28179427	Green Published, hybrid			2022-12-28	WOS:000397590400009
J	Sacoman, JL; Dagda, RY; Burnham-Marusich, AR; Dagda, RK; Berninsone, PM				Sacoman, Juliana L.; Dagda, Raul Y.; Burnham-Marusich, Amanda R.; Dagda, Ruben K.; Berninsone, Patricia M.			Mitochondrial O-GlcNAc Transferase (mOGT) Regulates Mitochondrial Structure, Function, and Survival in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; PROTEIN PHOSPHATASE 2A; N-ACETYLGLUCOSAMINE; CARDIAC MYOCYTES; GLOBAL IDENTIFICATION; INSULIN-RESISTANCE; STATISTICAL-MODEL; ALZHEIMER-DISEASE; CROSS-TALK; GLCNACYLATION	O-Linked N-acetylglucosamine transferase (OGT) catalyzes O-GlcNAcylation of target proteins and regulates numerous biological processes. OGT is encoded by a single gene that yields nucleocytosolic and mitochondrial isoforms. To date, the role of the mitochondrial isoform of OGT (mOGT) remains largely unknown. Using high throughput proteomics, we identified 84 candidate mitochondrial glycoproteins, of which 44 are novel. Notably, two of the candidate glycoproteins identified (cytochrome oxidase 2 (COX2) and NADH: ubiquinone oxidoreductase core subunit 4 (MT-ND4)) are encoded by mitochondrial DNA. Using siRNA in HeLa cells, we found that reducing endogenous mOGT expression leads to alterations in mitochondrial structure and function, including Drp1-dependent mitochondrial fragmentation, reduction in mitochondrial membrane potential, and a significant loss of mitochondrial content in the absence of mitochondrial ROS. These defects are associated with a compensatory increase in oxidative phosphorylation per mitochondrion. mOGT is also critical for cell survival; siRNA-mediated knockdown of endogenous mOGT protected cells against toxicity mediated by rotenone, a complex I inhibitor. Conversely, reduced expression of both nucleocytoplasmic (ncOGT) and mitochondrial (mOGT) OGT isoforms is associated with increased mitochondrial respiration and elevated glycolysis, suggesting that ncOGT is a negative regulator of cellular bioenergetics. Last, we determined thatmOGTis probably involved in the glycosylation of a restricted set of mitochondrial targets. Weidentified four proteins implicated in mitochondrial biogenesis and metabolism regulation as candidate substrates of mOGT, includ-ing leucine-rich PPR-containing protein and mitochondrial aconitate hydratase. Our findings suggest that mOGT is catalytically active in vivo and supports mitochondrial structure, health, and survival, whereas ncOGT predominantly regulates cellular bioenergetics.	[Sacoman, Juliana L.; Berninsone, Patricia M.] Univ Nevada, Dept Biol, 1664 N Virginia St, Reno, NV 89557 USA; [Dagda, Raul Y.; Dagda, Ruben K.] Univ Nevada, Reno Sch Med, Dept Pharmacol, 1664 N Virginia St, Reno, NV 89557 USA; [Burnham-Marusich, Amanda R.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Sacoman, Juliana L.] Univ Nevada, Dept Biochem & Mol Biol, 1664 N Virginia St, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Berninsone, PM (corresponding author), Univ Nevada, Dept Biol, 1664 N Virginia St, Reno, NV 89557 USA.; Dagda, RK (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, 1664 N Virginia St, Reno, NV 89557 USA.	rdagda@medicine.nevada.edu; berninsone@unr.edu		Burnham-Marusich, Amanda/0000-0003-2320-2222	National Institutes of Health [P20 GM103554, R21 AG047623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG047623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by National Institutes of Health Grants P20 GM103554 (a COBRE grant in " Cell Biology of Signaling Across Membranes") and R21 AG047623 (Role of Protein Glycosylation on Mitochondrial Function). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Burnham-Marusich AR, 2014, ELECTROPHORESIS, V35, P2621, DOI 10.1002/elps.201400241; Burnham-Marusich AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049020; Burnham-Marusich AR, 2012, MITOCHONDRION, V12, P423, DOI 10.1016/j.mito.2012.04.004; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chu CH, 2007, PROTEIN EXPRES PURIF, V53, P421, DOI 10.1016/j.pep.2007.01.012; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Gusdon AM, 2011, ANTIOXID REDOX SIGN, V14, P1979, DOI 10.1089/ars.2010.3763; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2014, J BIOL CHEM, V289, P34422, DOI 10.1074/jbc.R114.609776; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Holzinger A, 2001, HUM MOL GENET, V10, P1299, DOI 10.1093/hmg/10.12.1299; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lozano L, 2014, EXP GERONTOL, V58, P198, DOI 10.1016/j.exger.2014.08.008; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mitchell T, 2013, BIOCHEM SOC T, V41, P127, DOI 10.1042/BST20120231; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pace C, 2016, TOXICOL IN VITRO, V35, P188, DOI 10.1016/j.tiv.2016.06.006; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suchorolski MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056884; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	57	51	53	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4499	4518		10.1074/jbc.M116.726752	http://dx.doi.org/10.1074/jbc.M116.726752			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28100784	hybrid, Green Published			2022-12-28	WOS:000397585100010
J	Juang, C; Chen, BH; Bru, JL; Nguyen, K; Huynh, E; Momen, M; Kim, J; Aswad, DW				Juang, Charity; Chen, Baihe; Bru, Jean-Louis; Nguyen, Katherine; Huynh, Eric; Momen, Mahsa; Kim, Jeungjin; Aswad, Dana W.			Polymorphic Variants of Human Protein l-Isoaspartyl Methyltransferase Affect Catalytic Activity, Aggregation, and Thermal Stability: IMPLICATIONS FOR THE ETIOLOGY OF NEUROLOGICAL DISORDERS AND COGNITIVE AGING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epilepsy; genetic polymorphism; neurological disease; protein aggregation; protein methylation; protein stability; recombinant protein expression; S-adenosylmethionine (SAM)	AGE-DAMAGED PROTEINS; CARBOXYL METHYLTRANSFERASE; O-METHYLTRANSFERASE; BOVINE BRAIN; RAT-BRAIN; REPAIR; MICE; PEPTIDES; CARBOXYMETHYLASE; ACCUMULATION	Protein l-isoaspartyl methyltransferase (PIMT/PCMT1), a product of the human pcmt1 gene, catalyzes repair of abnormal l-isoaspartyl linkages in age-damaged proteins. Pcmt1 knock-out mice exhibit a profound neuropathology and die 30-60 days postnatal from an epileptic seizure. Here we express 15 reported variants of human PIMT and characterize them with regard to their enzymatic activity, thermal stability, and propensity to aggregation. One mutation, R36C, renders PIMT completely inactive, whereas two others, A7P and I58V, exhibit activity that is 80-100% higher than wild type. G175R is highly prone to aggregation and has greatly reduced activity. R17S and R17H show markedly enhanced sensitivity to thermal denaturation. Based on previous studies of moderate PIMT variation in humans and mice, we predict that heterozygosity for R36C, G175R, R17S, and R17H will prove detrimental to cognitive function and successful aging, whereas homozygosity (if it ever occurs) will lead to severe neurological problems in the young.	[Juang, Charity; Chen, Baihe; Bru, Jean-Louis; Nguyen, Katherine; Huynh, Eric; Momen, Mahsa; Kim, Jeungjin; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	dwaswad@uci.edu		Aswad, Dana/0000-0001-5098-3461; Bru, Jean-Louis/0000-0001-8797-6652	Faculty Research and Travel Committee in the School of Biological Sciences of the University of California Irvine; Summer Undergraduate Research Opportunity Award	Faculty Research and Travel Committee in the School of Biological Sciences of the University of California Irvine; Summer Undergraduate Research Opportunity Award	This work was supported by private donations to the Department of Molecular Biology at the University of California Irvine; by funds from the Faculty Research and Travel Committee in the School of Biological Sciences of the University of California Irvine; and by a Summer Undergraduate Research Opportunity Award (to J.-L.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; ASWAD DW, 1983, J NEUROCHEM, V40, P1718, DOI 10.1111/j.1471-4159.1983.tb08147.x; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; DAVID CL, 1995, PROTEIN EXPRES PURIF, V6, P312, DOI 10.1006/prep.1995.1041; David CL, 1997, ARCH BIOCHEM BIOPHYS, V346, P277, DOI 10.1006/abbi.1997.0303; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Dimitrijevic A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100622; Farrar CE, 2004, THESIS; Franco RS, 2012, TRANSFUS MED HEMOTH, V39, P302, DOI 10.1159/000342232; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1991, NEUROBIOL AGING, V12, P19, DOI 10.1016/0197-4580(91)90034-H; JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MIZOBUCHI M, 1994, J NEUROCHEM, V62, P322; Qin ZX, 2015, NEUROBIOL AGING, V36, P1029, DOI 10.1016/j.neurobiolaging.2014.10.036; Qin ZX, 2014, INVEST OPHTH VIS SCI, V55, P1572, DOI 10.1167/iovs.13-13668; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	31	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3656	3665		10.1074/jbc.M116.765222	http://dx.doi.org/10.1074/jbc.M116.765222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100787	Green Published, hybrid			2022-12-28	WOS:000395542500010
J	Huang, Q; Merriman, CF; Zhang, H; Fu, D				Huang, Qiong; Merriman, Chengfeng; Zhang, Hao; Fu, Dax			Coupling of Insulin Secretion and Display of a Granule-resident Zinc Transporter ZnT8 on the Surface of Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; GLUCOSE-HOMEOSTASIS; EXPRESSION; AUTOANTIGEN	The islet-specific zinc transporter ZnT8 mediates zinc enrichment in the insulin secretory granules of the pancreatic beta cell. This granular zinc transporter is also a major self-antigen found in type 1 diabetes patients. It is not clear whether ZnT8 can be displayed on the cell surface and how insulin secretion may regulate the level of ZnT8 exposure to extracellular immune surveillance. Here we report specific antibody binding to the extracellular surface of rat insulinoma INS-1E cells that stably expressed a tagged human zinc transporter ZnT8. Flow cytometry analysis after fluorescent antibody labeling revealed strong correlations among the levels of ZnT8 expression, its display on the cell surface, and glucose-stimulated insulin secretion (GSIS). Glucose stimulation increased the surface display of endogenous ZnT8 from a basal level to 32.5% of the housekeeping Na+/K+ ATPase on the cell surface, thereby providing direct evidence for a GSIS-dependent surface exposure of the ZnT8 self-antigen. Moreover, the variation in tagged-ZnT8 expression and surface labeling enabled sorting of heterogeneous beta cells to subpopulations that exhibited marked differences in GSIS with parallel changes in endogenous ZnT8 expression. The abundant surface display of endogenous ZnT8 and its coupling to GSIS demonstrated the potential of ZnT8 as a surface bio-marker for tracking and isolating functional beta cells in mixed cell populations.	[Huang, Qiong; Merriman, Chengfeng; Zhang, Hao; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	Huang, Qiong/HGC-7895-2022	Huang, Qiong/0000-0002-0570-5961; Fu, Dax/0000-0002-2663-1316	National Institutes of Health shared instrumentation Grant [S10OD016374, S10OD016315, S10RR13777001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374, S10OD016315] Funding Source: NIH RePORTER	National Institutes of Health shared instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Zeiss confocal microscope was funded through National Institutes of Health shared instrumentation Grant S10OD016374. The MoFlo XDP cell sorter was funded through National Institutes of Health Grants S10OD016315 and S10RR13777001.	Arvan P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007658; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; El Muayed M, 2010, J ENDOCRINOL, V206, P159, DOI 10.1677/JOE-09-0420; Enee E, 2012, DIABETES, V61, P1779, DOI 10.2337/db12-0071; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005679; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hamel Y, 2016, J AUTOIMMUN, V73, P54, DOI 10.1016/j.jaut.2016.06.003; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mariot P, 1998, DIABETES, V47, P365, DOI 10.2337/diabetes.47.3.365; Mauvals F.X., 2016, F1000RES, DOI 10.12688/f1000research.7411.1; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Petersen AB, 2011, APMIS, V119, P93, DOI 10.1111/j.1600-0463.2010.02698.x; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Tamaki M, 2009, ISLETS, V1, P124, DOI 10.4161/isl.1.2.9433; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; Vo YP, 2004, BIOCHEM BIOPH RES CO, V324, P1004, DOI 10.1016/j.bbrc.2004.09.147; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Yu C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9083103	38	24	25	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4034	4043		10.1074/jbc.M116.772152	http://dx.doi.org/10.1074/jbc.M116.772152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130446	hybrid, Green Published			2022-12-28	WOS:000395837100007
J	Yogalingam, G; Lee, AR; Mackenzie, DS; Maures, TJ; Rafalko, A; Prill, H; Berguig, GY; Hague, C; Christianson, T; Bell, SM; LeBowitz, JH				Yogalingam, Gouri; Lee, Amanda R.; Mackenzie, Donald S.; Maures, Travis J.; Rafalko, Agnes; Prill, Heather; Berguig, Geoffrey Y.; Hague, Chuck; Christianson, Terri; Bell, Sean M.; LeBowitz, Jonathan H.			Cellular Uptake and Delivery of Myeloperoxidase to Lysosomes Promote Lipofuscin Degradation and Lysosomal Stress in Retinal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECOGNITION; MACULAR DEGENERATION; PIGMENT EPITHELIUM; A2E; PRECURSOR; PATHOGENESIS; FIBROBLASTS; DISEASE; BINDING; MODEL	Neutrophil myeloperoxidase (MPO) catalyzes the H2O2-dependent oxidation of chloride anion to generate hypochlorous acid, a potent antimicrobial agent. Besides its well defined role in innate immunity, aberrant degranulation of neutrophils in several inflammatory diseases leads to redistribution of MPO to the extracellular space, where it can mediate tissue damage by promoting the oxidation of several additional substrates. Here, we demonstrate that mannose 6-phosphate receptor-mediated cellular uptake and delivery of MPO to lysosomes of retinal pigmented epithelial (RPE) cells acts to clear this harmful enzyme from the extracellular space, with lysosomal-delivered MPO exhibiting a half-life of 10 h. Lysosomal-targeted MPO exerts both cell-protective and cytotoxic functions. From a therapeutic standpoint, MPO catalyzes the in vitro degradation of N-retinylidene-N-retinylethanolamine, a toxic form of retinal lipofuscin that accumulates in RPE lysosomes and drives the pathogenesis of Stargardt macular degeneration. Furthermore, chronic cellular uptake and accumulation of MPO in lysosomes coincides with N-retinylidene-N-retinylethanolamine elimination in a cell-based model of macular degeneration. However, lysosomal-delivered MPO also disrupts lysosomal acidification in RPE cells, which coincides with nuclear translocation of the lysosomal stress-sensing transcription factor EB and, eventually, cell death. Based on these findings we predict that under periods of acute exposure, cellular uptake and lysosomal degradation of MPO mediates elimination of this harmful enzyme, whereas chronic exposure results in progressive accumulation of MPO in lysosomes. Lysosomal-accumulated MPO can be both cell-protective, by promoting the degradation of toxic retinal lipofuscin deposits, and cytotoxic, by triggering lysosomal stress and cell death.	[Lee, Amanda R.; Mackenzie, Donald S.; Maures, Travis J.; Rafalko, Agnes; Prill, Heather; Berguig, Geoffrey Y.; Hague, Chuck; Christianson, Terri; Bell, Sean M.; LeBowitz, Jonathan H.] BioMarin Pharmaceut Inc, Dept Res, San Rafael, CA 94901 USA	BioMarin Pharmaceutical Inc.	Yogalingam, G (corresponding author), BioMarin Pharmaceut Inc, Res Dept, Cell & Mol Biol Grp, 790 Lindaro St, San Rafael, CA 94901 USA.	gyogalingam@bmrn.com						Arafat SN, 2014, OPHTHALMOLOGY, V121, P79, DOI 10.1016/j.ophtha.2013.06.049; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Cardone M., 2008, PATHOGENETICS, V1, P6; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; HASILIK A, 1984, EMBO J, V3, P2671, DOI 10.1002/j.1460-2075.1984.tb02192.x; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LEMANSKY P, 1985, J BIOL CHEM, V260, P9023; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; OWADA M, 1982, BIOCHEM BIOPH RES CO, V105, P814, DOI 10.1016/0006-291X(82)91042-7; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Ray RS, 2016, NEUROSCI BIOBEHAV R, V68, P611, DOI 10.1016/j.neubiorev.2016.06.031; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Soubhye J, 2016, CURR MED CHEM, V23, P3975, DOI 10.2174/0929867323666160607111806; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Sparrow JR, 2010, METHODS MOL BIOL, V652, P315, DOI 10.1007/978-1-60327-325-1_18; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Winkler BS, 1999, MOL VIS, V5; Wu YL, 2011, J AM CHEM SOC, V133, P849, DOI 10.1021/ja107195u; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164	30	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4255	4265		10.1074/jbc.M116.739441	http://dx.doi.org/10.1074/jbc.M116.739441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28115520	Green Published, hybrid			2022-12-28	WOS:000395837100023
J	Guan, CC; Li, J; Sun, DP; Liu, YF; Liang, HH				Guan, Chengcheng; Li, Jun; Sun, Dapeng; Liu, Yingfang; Liang, Huanhuan			The structure and polymerase-recognition mechanism of the crucial adaptor protein AND-1 in the human replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; LINKS DNA-REPLICATION; S-PHASE CHECKPOINT; BINDING PROTEIN; CTF4; COMPLEX; ESTABLISHMENT; PROGRESSION; HELICASE; ALPHA	DNA replication in eukaryotic cells is performed by a multiprotein complex called the replisome, which consists of helicases, polymerases, and adaptor molecules. Human (a) under bar cidic (n) under bar ucleoplasmic (D) under bar NA-binding protein 1 (AND-1), also known as WD repeat and high mobility group (HMG)-box DNA-binding protein 1 (WDHD1), is an adaptor molecule crucial for DNA replication. Although structural information for the AND-1 yeast ortholog is available, the mechanistic details for how human AND-1 protein anchors the lagging-strand DNA polymerase alpha (pol alpha) to the DNA helicase complex ((C) under bar dc45-(M) over bar CM2-7-(G) under bar INS, CMG) await elucidation. Here, we report the structures of the N-terminal WD40 and SepB domains of human AND-1, as well as a biochemical analysis of the C-terminal HMG domain. We show that AND-1 exists as a homotrimer mediated by the SepB domain. Mutant study results suggested that a positively charged groove within the SepB domain provides binding sites for pol alpha. Different from its ortholog protein in budding yeast, human AND-1 is recruited to the CMG complex, mediated by unknown participants other than Go Ichi Ni San. In addition, we show that AND-1 binds to DNA in vitro, using its C-terminal HMG domain. In conclusion, our findings provide important insights into the mechanistic details of human AND-1 function, advancing our understanding of replisome formation during eukaryotic replication.	[Guan, Chengcheng; Li, Jun; Sun, Dapeng; Liu, Yingfang; Liang, Huanhuan] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Guan, Chengcheng; Li, Jun] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YF; Liang, HH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	liuyingfang@ibp.ac.cn; hhliang@moon.ibp.ac.cn		sun, dapeng/0000-0003-0220-8844	NSFC Foundation [31530015]; CAS [XDB08000000]; Frontier Sciences Project [CAS QYZDY-SSW-SMC018]	NSFC Foundation(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Frontier Sciences Project	This work was supported by NSFC Foundation Grant 31530015, Strategic Priority Research Program CAS Grant XDB08000000, and Frontier Sciences Project Grant CAS QYZDY-SSW-SMC018. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Chen Z, 2016, MOL CELL PROTEOMICS, V15, P1299, DOI [10.1074/mcp.M115.056093, 10.1074/mcp.M115.056093 ]; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gosnell JA, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-13; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hao J, 2015, EMBO J, V34, P2096, DOI 10.15252/embj.201488016; Hsieh CL, 2011, NUCLEIC ACIDS RES, V39, P4048, DOI 10.1093/nar/gkq1338; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jaramillo-Lambert A, 2013, J BIOL CHEM, V288, P1480, DOI 10.1074/jbc.M112.429266; Kang YH, 2013, P NATL ACAD SCI USA, V110, P19760, DOI 10.1073/pnas.1320202110; Kohler A, 1997, J CELL SCI, V110, P1051; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Li YC, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-1; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; O'Donnell M., 2013, COLD SPRING HARB PER; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Villa F, 2016, MOL CELL, V63, P385, DOI 10.1016/j.molcel.2016.06.009; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	54	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9627	9636		10.1074/jbc.M116.758524	http://dx.doi.org/10.1074/jbc.M116.758524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28381552	Green Published, hybrid			2022-12-28	WOS:000403113000014
J	Dhavale, DD; Tsai, C; Bagchi, DP; Engel, LA; Sarezky, J; Kotzbauer, PT				Dhavale, Dhruva D.; Tsai, Christina; Bagchi, Devika P.; Engel, Laura A.; Sarezky, Jonathan; Kotzbauer, Paul T.			A sensitive assay reveals structural requirements for alpha-synuclein fibril growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; SPORADIC PARKINSONS-DISEASE; LEWY BODY DEMENTIA; IN-VITRO; E46K MUTATION; AGGREGATION; MUTANT; STRAINS; BINDING; OLIGOMERIZATION	The accumulation of alpha-synuclein (alpha-syn) fibrils in neuronal inclusions is the defining pathological process in Parkinson's disease (PD). A pathogenic role for alpha-syn fibril accumulation is supported by the identification of dominantly inherited alpha-syn (SNCA) gene mutations in rare cases of familial PD. Fibril formation involves a spontaneous nucleation event in which soluble alpha-syn monomers associate to form seeds, followed by fibril growth during which monomeric alpha-syn molecules sequentially associate with existing seeds. To better investigate this process, we developed sensitive assays that use the fluorescein arsenical dye FlAsH (fluorescein arsenical hairpin binder) to detect soluble oligomers and mature fibrils formed from recombinant alpha-syn protein containing an N-terminal bicysteine tag (C2--alpha-syn). Using seed growth by monomer association (SeGMA) assays to measure fibril growth over 3 h in the presence of C2-alpha-syn monomer, we observed that some familial PD-associated alpha-syn mutations (i.e. H50Q and A53T) greatly increased growth rates, whereas others (E46K, A30P, and G51D) decreased growth rates. Experiments with wild-type seeds extended by mutant monomer and vice versa revealed that single-amino acid differences between seed and monomer proteins consistently decreased growth rates. These results demonstrate that alpha-syn monomer association during fibril growth is a highly ordered process that can be disrupted by misalignment of individual amino acids and that only a subset of familial-PD mutations causes fibril accumulation through increased fibril growth rates. The SeGMA assays reported herein can be utilized to further elucidate structural requirements of alpha-syn fibril growth and to identify growth inhibitors as a potential therapeutic approach in PD.	[Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Kotzbauer, PT (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	kotzbauerp@wustl.edu	Dhavale, Dhruva/AAI-3934-2021	Dhavale, Dhruva/0000-0002-0096-1085	Hope Center Alafi Neuroimaging Laboratory; NIH Shared Instrumentation Grant [S10 RR024733]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097799, K08NS048924] Funding Source: NIH RePORTER	Hope Center Alafi Neuroimaging Laboratory; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The atomic force microscope used in the study was supported by the Hope Center Alafi Neuroimaging Laboratory and NIH Shared Instrumentation Grant S10 RR024733.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bagchi DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055031; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Chu WH, 2015, J MED CHEM, V58, P6002, DOI 10.1021/acs.jmedchem.5b00571; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Goodman JL, 2009, CHEMBIOCHEM, V10, P1644, DOI 10.1002/cbic.200900207; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Kamiyoshihara T, 2007, BIOCHEM BIOPH RES CO, V355, P398, DOI 10.1016/j.bbrc.2007.01.162; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lemkau LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049750; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Mahul-Mellier AL, 2015, CELL DEATH DIFFER, V22, P2107, DOI 10.1038/cdd.2015.79; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mbefo MK, 2015, J BIOL CHEM, V290, P9412, DOI 10.1074/jbc.M114.610774; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Narkiewicz J, 2014, PRION, V8, P19, DOI 10.4161/pri.28125; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Ono K, 2011, NEUROBIOL DIS, V43, P715, DOI 10.1016/j.nbd.2011.05.025; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Recasens A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00159; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; Sato H, 2015, MOL NEUROBIOL, V52, P226, DOI 10.1007/s12035-014-8858-7; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Sidhu A, 2016, ACS CHEM NEUROSCI, V7, P719, DOI 10.1021/acschemneuro.5b00322; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tashiro M, 2008, BIOCHEM BIOPH RES CO, V369, P910, DOI 10.1016/j.bbrc.2008.02.127; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	71	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9034	9050		10.1074/jbc.M116.767053	http://dx.doi.org/10.1074/jbc.M116.767053			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28373279	Green Published, hybrid			2022-12-28	WOS:000402538900004
J	Hirano, M; Takada, Y; Wong, CF; Yamaguchi, K; Kotani, H; Kurokawa, T; Mori, MX; Snutch, TP; Ronjat, M; De Waard, M; Mori, Y				Hirano, Mitsuru; Takada, Yoshinori; Wong, Chee Fah; Yamaguchi, Kazuma; Kotani, Hiroshi; Kurokawa, Tatsuki; Mori, Masayuki X.; Snutch, Terrance P.; Ronjat, Michel; De Waard, Michel; Mori, Yasuo			C-terminal splice variants of P/Q-type Ca2+ channel Ca(V)2.1 alpha(1) subunits are differentially regulated by Rab3-interacting molecule proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; NEURONAL CALCIUM-CHANNELS; PRESYNAPTIC ACTIVE ZONES; N-TYPE; DEPENDENT INACTIVATION; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; TRANSMITTER RELEASE; STATE INACTIVATION; PURKINJE-CELLS	Voltage-dependent Ca2+ channels (VDCCs) mediate neurotransmitter release controlled by presynaptic proteins such as the scaffolding proteins Rab3-interacting molecules (RIMs). RIMs confer sustained activity and anchoring of synaptic vesicles to the VDCCs. Multiple sites on the VDCC alpha(1) and beta subunits have been reported to mediate the RIMs-VDCC interaction, but their significance is unclear. Because alternative splicing of exons 44 and 47 in the P/Q-type VDCC alpha(1) subunit Ca(V)2.1 gene generates major variants of the Ca(V)2.1 C-terminal region, known for associating with presynaptic proteins, we focused here on the protein regions encoded by these two exons. Co-immunoprecipitation experiments indicated that the C-terminal domain (CTD) encoded by Ca(V)2.1 exons 40-47 interacts with the alpha-RIMs, RIM1 alpha and RIM2 alpha, and this interaction was abolished by alternative splicing that deletes the protein regions encoded by exons 44 and 47. Electrophysiological characterization of VDCC currents revealed that the suppressive effect of RIM2 alpha on voltage-dependent inactivation (VDI) was stronger than that of RIM1 alpha for the Ca(V)2.1 variant containing the region encoded by exons 44 and 47. Importantly, in the CaV2.1 variant in which exons 44 and 47 were deleted, strong RIM2 alpha-mediated VDI suppression was attenuated to a level comparable with that of RIM1 alpha-mediated VDI suppression, which was unaffected by the exclusion of exons 44 and 47. Studies of deletion mutants of the exon 47 region identified 17 amino acid residues on the C-terminal side of a polyglutamine stretch as being essential for the potentiated VDI suppression characteristic of RIM2 alpha. These results suggest that the interactions of the Ca(V)2.1 CTD with RIMs enable Ca(V)2.1 proteins to distinguish alpha-RIM isoforms in VDI suppression of P/Q-type VDCC currents.	[Hirano, Mitsuru; Takada, Yoshinori; Wong, Chee Fah; Yamaguchi, Kazuma; Kotani, Hiroshi; Kurokawa, Tatsuki; Mori, Masayuki X.; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan; [Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Studies, Kyoto 6158510, Japan; [Wong, Chee Fah] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Biol, Tanjung Malim 35900, Perak, Malaysia; [Snutch, Terrance P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Snutch, Terrance P.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z4, Canada; [Ronjat, Michel; De Waard, Michel] Univ Nantes, LabEx Ion Channels Sci & Therapeut, CNRS UMR6291, INSERM UMR1087,Inst Thorax, F-44000 Nantes, France	Kyoto University; Kyoto University; Universiti Pendidikan Sultan Idris; University of British Columbia; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Lab Mol Biol, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Mori, Masayuki/AAI-6992-2020; Snutch, Terrance P/L-3464-2019; De Waard, Michel/G-7406-2014	Snutch, Terrance P/0000-0001-5182-1296; De Waard, Michel/0000-0002-2782-9615; Wong, Chee Fah/0000-0003-1114-7000; Ronjat, Michel/0000-0002-9728-6425	Japan Society for the Promotion of Science [16H05140]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research (B) 16H05140 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann F, 2015, EMBO REP, V16, P923, DOI 10.15252/embr.201540434; Adams PJ, 2009, CHANNELS, V3, P110, DOI 10.4161/chan.3.2.7932; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; Bachnoff N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01620; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; Chen HY, 2007, AM J PHYSIOL-CELL PH, V292, pC1078, DOI 10.1152/ajpcell.00353.2006; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; Gandini MA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187757; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giunti P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00036; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; GUTNICK MJ, 1989, J PHYSIOL-LONDON, V412, P197, DOI 10.1113/jphysiol.1989.sp017611; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Hu QP, 2005, GENES CELLS, V10, P87, DOI 10.1111/j.1365-2443.2005.00820.x; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kanumilli S, 2006, PHYSIOL GENOMICS, V24, P86, DOI 10.1152/physiolgenomics.00149.2005; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kulik A, 2004, EUR J NEUROSCI, V19, P2169, DOI 10.1111/j.0953-816X.2004.03319.x; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Ludwig A, 1997, J NEUROSCI, V17, P1339; Matsuyama Z, 1997, HUM MOL GENET, V6, P1283, DOI 10.1093/hmg/6.8.1283; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Miki Takafumi, 2007, Channels (Austin), V1, P144; Miki T, 2013, J NEUROSCI, V33, P18755, DOI 10.1523/JNEUROSCI.3161-13.2013; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Nakao A, 2015, PFLUG ARCH EUR J PHY, V467, P737, DOI 10.1007/s00424-014-1555-6; Nishimune H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038029; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; RANDALL A, 1995, J NEUROSCI, V15, P2995; Ricoy UM, 2014, J NEUROPHYSIOL, V111, P2404, DOI 10.1152/jn.00335.2013; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Soong TW, 2002, J NEUROSCI, V22, P10142; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Takada Y, 2015, CELL CALCIUM, V58, P296, DOI 10.1016/j.ceca.2015.06.007; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Tsunemi T, 2002, J BIOL CHEM, V277, P7214, DOI 10.1074/jbc.M108222200; Tsunemi T, 2008, NEUROSCI LETT, V447, P78, DOI 10.1016/j.neulet.2008.09.065; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Wong FK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00071; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	91	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9365	9381		10.1074/jbc.M117.778829	http://dx.doi.org/10.1074/jbc.M117.778829			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28377503	Green Published, hybrid			2022-12-28	WOS:000402538900030
J	Samuchiwal, SK; Balestrieri, B; Raff, H; Boyce, JA				Samuchiwal, Sachin K.; Balestrieri, Barbara; Raff, Hannah; Boyce, Joshua A.			Endogenous prostaglandin E-2 amplifies IL-33 production by macrophages through an E prostanoid (EP)(2)/EP4-cAMP-EPAC-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE LYMPHOID-CELLS; INDUCED COX-2 EXPRESSION; NF-KAPPA-B; LUNG INFLAMMATION; ADAPTIVE IMMUNITY; PGE(2); EP4; INTERLEUKIN-33; ACTIVATION; RECEPTORS	When activated through toll-like receptors (TLRs), macrophages generate IL-33, an IL-1 family member that induces innate immune responses through ST2 signaling. LPS, a TLR4 ligand, induces macrophages to generate prostaglandin E-2 (PGE(2)) through inducible COX-2 and microsomal PGE(2) synthase 1 (mPGES-1) (1). We demonstrate that IL-33 production by bone marrow-derived murine macrophages (bmMFs) requires the generation of endogenous PGE(2) and the intrinsic expression of EP2 receptors to amplify NF-kappa B-dependent, LPS-induced IL-33 expression via exchange protein activated by cAMP (EPAC). Compared with WT cells, bmMFs lacking either mPGES-1 or EP2 receptors displayed reduced LPS-induced IL-33 levels. A selective EP2 agonist and, to a lesser extent, EP4 receptor agonist potentiated LPS-induced IL-33 generation from both mPGES-1-null and WT bmMFs, whereas EP1 and EP3 receptor agonists were inactive. The effects of PGE(2) depended on cAMP, were mimicked by an EPAC-selective agonist, and were attenuated by EPAC-selective antagonism and knockdown. LPS-induced p38 MAPK and NF-kappa B activations were necessary for both IL-33 production and PGE(2) generation, and exogenous PGE(2) partly reversed the suppression of IL-33 production caused by p38 MAPK and NF-kappa B inhibition. Mice lacking mPGES-1 showed lower IL-33 levels and attenuated lung inflammation in response to repetitive Alternaria inhalation challenges. Cumulatively, our data demonstrate that endogenous PGE(2), EP2 receptors, and EPAC are prerequisites for maximal LPS-induced IL-33 expression and that exogenous PGE(2) can amplify IL-33 production via EP2 and EP4 receptors. The ubiquitous induction of mPGES-1-dependent PGE(2) may be crucial for innate immune system activation during various IL-33 driven pathologic disorders.	[Samuchiwal, Sachin K.; Balestrieri, Barbara; Raff, Hannah; Boyce, Joshua A.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; [Samuchiwal, Sachin K.; Balestrieri, Barbara; Boyce, Joshua A.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Boyce, JA (corresponding author), Brigham & Womens Hosp, Smith Bldg,Rm 638,1 Jimmy Fund Way, Boston, MA 02115 USA.	jboyce@rics.bwh.harvard.edu	Balestrieri, Barbara/Y-2547-2018; Samuchiwal, Sachin/AAL-2904-2021	Balestrieri, Barbara/0000-0002-0323-3278; SAMUCHIWAL, SACHIN/0000-0001-6232-5650	National Institutes of Health [AI078908, AI095219, AT002782, AI082369, HL111113, HL117945]; Vinik family; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111113, R01HL136209, R01HL117945, R01HL113071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082369, U19AI095219, R37AI052353, R01AI078908, R21AI115137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vinik family; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI078908, AI095219, AT002782, AI082369, HL111113, and HL117945 and by the Vinik family. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson EL, 2016, ALLERGY, V71, P977, DOI 10.1111/all.12861; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Duan YZ, 2014, BMB REP, V47, P45, DOI 10.5483/BMBRep.2014.47.1.089; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hardman C, 2016, CURR OPIN IMMUNOL, V42, P16, DOI 10.1016/j.coi.2016.05.004; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Lander F., 2010, PADIATR PRAX, V75, P233, DOI DOI 10.1055/S; Li WF, 2014, INT IMMUNOPHARMACOL, V22, P311, DOI 10.1016/j.intimp.2014.07.017; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Lund Sean, 2013, Current Immunology Reviews, V9, P214; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; Nabe T, 2015, EUR J PHARMACOL, V757, P34, DOI 10.1016/j.ejphar.2015.03.015; Nakatsuji M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005542; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Sato S, 2016, MICROBIOL IMMUNOL, V60, P382, DOI 10.1111/1348-0421.12381; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schwartz C, 2016, EUR J IMMUNOL, V46, P1091, DOI 10.1002/eji.201545780; Shi QH, 2014, INT IMMUNOPHARMACOL, V20, P298, DOI 10.1016/j.intimp.2014.04.004; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Woo Yeonduk, 2014, Immune Netw, V14, P171, DOI 10.4110/in.2014.14.4.171; Yariagawa Y, 2011, IMMUNOL LETT, V141, P55, DOI 10.1016/j.imlet.2011.07.005; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195	32	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8195	8206		10.1074/jbc.M116.769422	http://dx.doi.org/10.1074/jbc.M116.769422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28341741	Green Published, hybrid			2022-12-28	WOS:000401788600007
J	Kerkour, A; Marquevielle, J; Ivashchenko, S; Yatsunyk, LA; Mergny, JL; Salgado, GF				Kerkour, Abdelaziz; Marquevielle, Julien; Ivashchenko, Stefaniia; Yatsunyk, Liliya A.; Mergny, Jean-Louis; Salgado, Gilmar F.			High-resolution three-dimensional NMR structure of the KRAS proto-oncogene promoter reveals key features of a G-quadruplex involved in transcriptional regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR G-QUADRUPLEX; TELOMERIC G-QUADRUPLEX; ONCOGENIC KRAS; DNA-REPLICATION; LIGAND-BINDING; CANCER CELLS; RAS; REGION; PROPELLER; PROTEIN	Non-canonical base pairing within guanine-rich DNA and RNAsequences can produce G-quartets, whose stacking leads to the formation of a G-quadruplex (G4). G4s can coexist with canonical duplex DNA in the human genome and have been suggested to suppress gene transcription, and much attention has therefore focused on studying G4s in promotor regions of disease-related genes. For example, the human KRAS proto-oncogene contains a nuclease-hypersensitive element located upstream of the major transcription start site. The KRAS nuclease-hypersensitive element (NHE) region contains a G-rich element (22RT; 5'-AGGGCGGTGTGGGAATAGG-GAA-3') and encompasses a Myc-associated zinc finger-binding site that regulates KRAS transcription. The NEH region therefore has been proposed as a target for new drugs that control KRAS transcription, which requires detailed knowledge of the NHE structure. In this study, we report a high-resolution NMR structure of the G-rich element within the KRAS NHE. We found that the G-rich element forms a parallel structure with three G-quartets connected by a four-nucleotide loop and two short one-nucleotide double-chain reversal loops. In addition, a thymine bulge is found between G8 and G9. The loops of different lengths and the presence of a bulge between the G-quartets are structural elements that potentially can be targeted by small chemical ligands that would further stabilize the structure and interfere or block transcriptional regulators such as Myc-associated zinc finger from accessing their binding sites on the KRAS promoter. In conclusion, our work suggests a possible new route for the development of anticancer agents that could suppress KRAS expression.	[Kerkour, Abdelaziz; Marquevielle, Julien; Ivashchenko, Stefaniia; Yatsunyk, Liliya A.; Mergny, Jean-Louis; Salgado, Gilmar F.] Univ Bordeaux, CNRS,ARNA Lab, INSERM,European Inst Chem & Biol, U1212,UMR 5320, 2 Rue Robert Escarpit, F-33000 Pessac, France; [Yatsunyk, Liliya A.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Swarthmore College	Salgado, GF (corresponding author), Univ Bordeaux, CNRS,ARNA Lab, INSERM,European Inst Chem & Biol, U1212,UMR 5320, 2 Rue Robert Escarpit, F-33000 Pessac, France.	g.salgado@iecb.u-bordeaux.fr	Mergny, Jean-Louis/E-2860-2013; Salgado, Gilmar/M-5476-2019; SALGADO, Gilmar/AAQ-8734-2020	Mergny, Jean-Louis/0000-0003-3043-8401; Salgado, Gilmar/0000-0002-0296-5979; Ivashchenko, Stefaniia/0000-0002-2302-115X; MARQUEVIELLE, Julien/0000-0001-8155-5195	TGIR-RMNTHC [Fr3050 CNRS]	TGIR-RMNTHC	This work benefited from the facilities and expertise of UMS3033/US001. Financial support from the TGIR-RMNTHC Fr3050 CNRS for conducting the research is gratefully acknowledged. We thank B. Vialet for synthesis of isotopically labeled oligonucleotides and the Olifans team for useful discussions.	Ali A, 2015, J PHYS CHEM B, V119, P5, DOI 10.1021/jp505792z; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Andreyev HJN, 2001, GUT, V48, P230, DOI 10.1136/gut.48.2.230; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Boncina M, 2015, NUCLEIC ACIDS RES, V43, P10376, DOI 10.1093/nar/gkv1167; Brito H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126891; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carvalho J, 2017, BIOCHIMIE, V135, P186, DOI 10.1016/j.biochi.2017.02.005; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2016, BBA-GENE REGUL MECH, V1859, P663, DOI 10.1016/j.bbagrm.2016.02.002; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Cogoi S, 2009, J MED CHEM, V52, P564, DOI 10.1021/jm800874t; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cromm PM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11300; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; David AP, 2016, NUCLEIC ACIDS RES, V44, P4163, DOI 10.1093/nar/gkw011; De Nicola B, 2016, NUCLEIC ACIDS RES, V44, P6442, DOI 10.1093/nar/gkw432; Dent P, 2013, CANCER BIOL THER, V14, P877, DOI 10.4161/cbt.26176; Di Leva FS, 2014, NUCLEIC ACIDS RES, V42, P5447, DOI 10.1093/nar/gku247; Du Z, 2007, BIOCHEM BIOPH RES CO, V354, P1067, DOI 10.1016/j.bbrc.2007.01.093; Duchler M, 2012, J DRUG TARGET, V20, P389, DOI 10.3109/1061186X.2012.669384; Ebrahimi M, 2015, J BIOMOL STRUCT DYN, V33, P2316, DOI 10.1080/07391102.2014.1003195; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Groves P, 2010, CHEM-EUR J, V16, P6451, DOI [10.1002/them.200901248, 10.1002/chem.200901248]; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Gupta P, 2015, BIOORG MED CHEM LETT, V25, P4757, DOI 10.1016/j.bmcl.2015.07.075; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JORDANO J, 1986, NUCLEIC ACIDS RES, V14, P7361, DOI 10.1093/nar/14.18.7361; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kerkour A, 2017, BBA-GEN SUBJECTS, V1861, P1293, DOI 10.1016/j.bbagen.2016.12.016; Krens LL, 2010, DRUG DISCOV TODAY, V15, P502, DOI 10.1016/j.drudis.2010.05.012; Laguerre A, 2014, J AM CHEM SOC, V136, P12406, DOI 10.1021/ja506331x; Lavrado J, 2015, CHEMMEDCHEM, V10, P836, DOI 10.1002/cmdc.201500067; Lavrado J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09696; Leshchiner ES, 2015, P NATL ACAD SCI USA, V112, P1761, DOI 10.1073/pnas.1413185112; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Madireddy A, 2016, NUCLEIC ACIDS RES, V44, P3675, DOI 10.1093/nar/gkw038; Mancini J, 2016, BIOCHIMIE, V121, P287, DOI 10.1016/j.biochi.2015.12.015; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; McCormick F, 2016, J MOL MED, V94, P253, DOI 10.1007/s00109-016-1382-7; Merle P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16255; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Nicoludis JM, 2012, NUCLEIC ACIDS RES, V40, P5432, DOI 10.1093/nar/gks152; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Paramasivam M, 2011, CHEM COMMUN, V47, P4965, DOI 10.1039/c1cc10269a; Paramasivam M, 2009, NUCLEIC ACIDS RES, V37, P2841, DOI 10.1093/nar/gkp138; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Podbevsek P, 2016, NUCLEIC ACIDS RES, V44, P917, DOI 10.1093/nar/gkv1359; Qin XY, 2014, CHEMMEDCHEM, V9, P1665, DOI 10.1002/cmdc.201402060; RAMSAY GD, 1994, METHOD ENZYMOL, V240, P615; Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Shin YJ, 2015, ONCOGENE, V34, P1292, DOI 10.1038/onc.2014.65; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; Stanton A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3183-3; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tomar JS, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2723-0; Valton AL, 2016, TRENDS GENET, V32, P697, DOI 10.1016/j.tig.2016.09.004; Wang JH, 2012, AM J PATHOL, V180, P82, DOI 10.1016/j.ajpath.2011.09.036; Wong A, 2005, J AM CHEM SOC, V127, P6990, DOI 10.1021/ja042794d; Wong HM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/564946; Xodo Luigi, 2008, Nucleic Acids Symp Ser (Oxf), P159, DOI 10.1093/nass/nrn081; Yan J, 2016, MOL CARCINOGEN, V55, P897, DOI 10.1002/mc.22330; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhou JK, 2015, PHYS CHEM CHEM PHYS, V17, P12857, DOI 10.1039/c5cp00378d; Zhu ZH, 2014, PHARMACOGENOMICS, V15, P1507, DOI [10.2217/PGS.14.108, 10.2217/pgs.14.108]; Zimmer J, 2016, MOL CELL, V61, P449, DOI 10.1016/j.molcel.2015.12.004	86	47	47	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8082	8091		10.1074/jbc.M117.781906	http://dx.doi.org/10.1074/jbc.M117.781906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28330874	hybrid, Green Published			2022-12-28	WOS:000401154100032
J	Phan, K; Ng, CA; David, E; Shishmarev, D; Kuchel, PW; Vandenberg, JI; Perry, MD				Phan, Kevin; Ng, Chai Ann; David, Erikka; Shishmarev, Dmitry; Kuchel, Philip W.; Vandenberg, Jamie I.; Perry, Matthew D.			The S1 helix critically regulates the finely tuned gating of Kv11.1 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; cardiovascular disease; channel activation; electrophysiology; hERG; ion channel; mutagenesis in vitro; nuclear magnetic resonance (NMR); oocyte; potassium channel	LONG-QT-SYNDROME; HERG K+ CHANNELS; CRYOELECTRON MICROSCOPY STRUCTURE; VOLTAGE-SENSING DOMAIN; SWISS-MODEL WORKSPACE; POTASSIUM CHANNEL; ION-CHANNEL; CARDIAC-ARRHYTHMIA; TRAFFICKING DEFECT; STRUCTURAL BASIS	Congenital mutations in the cardiac Kv11.1 channel can cause long QT syndrome type 2 (LQTS2), a heart rhythm disorder associated with sudden cardiac death. Mutations act either by reducing protein expression at the membrane and/or by perturbing the intricate gating properties of Kv11.1 channels. A number of clinical LQTS2-associated mutations have been reported in the first transmembrane segment (S1) of Kv11.1 channels, but the role of this region of the channel is largely unexplored. In part, this is due to problems defining the extent of the S1 helix, as a consequence of its low sequence homology with other Kv family members. Here, we used NMR spectroscopy and electrophysiological characterization to show that the S1 of Kv11.1 channels extends seven helical turns, from Pro-405 to Phe-431, and is flanked by unstructured loops. Functional analysis suggests that pre-S1 loop residues His-402 and Tyr-403 play an important role in regulating the kinetics and voltage dependence of channel activation and deactivation. Multiple residues within the S1 helix also play an important role in fine-tuning the voltage dependence of activation, regulating slow deactivation, and modulating C-type inactivation of Kv11.1 channels. Analyses of LQTS2-associated mutations in the pre-S1 loop or S1 helix of Kv11.1 channels demonstrate perturbations to both protein expression and most gating transitions. Thus, S1 region mutations would reduce both the action potential repolarizing current passed by Kv11.1 channels in cardiac myocytes, as well as the current passed in response to premature depolarizations that normally helps protect against the formation of ectopic beats.	[Phan, Kevin; Ng, Chai Ann; David, Erikka; Vandenberg, Jamie I.; Perry, Matthew D.] Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW 2010, Australia; [Phan, Kevin; Ng, Chai Ann; Vandenberg, Jamie I.; Perry, Matthew D.] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Shishmarev, Dmitry; Kuchel, Philip W.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Sydney	Perry, MD (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	m.perry@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013; Shishmarev, Dmitry/A-6468-2018	Vandenberg, Jamie I/0000-0002-3859-3716; Shishmarev, Dmitry/0000-0002-0724-0002; Kuchel, Philip/0000-0003-4100-7332; Ng, Chai Ann/0000-0002-3120-5450	Australian Research Council Discovery Grant [DP150101929]; National Health and Medical Research Council [App1074386]; National Health and Medical Research Council Fellowship [App1116948]	Australian Research Council Discovery Grant(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in whole or part by Australian Research Council Discovery Grant DP150101929, National Health and Medical Research Council Program Grant App1074386, and National Health and Medical Research Council Fellowship App1116948 (to J. I. V). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Anderson CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6535; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balijepalli SY, 2012, CIRCULATION, V126, P2809, DOI 10.1161/CIRCULATIONAHA.112.118018; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; Bocksteins E, 2011, EUR BIOPHYS J BIOPHY, V40, P783, DOI 10.1007/s00249-011-0694-3; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cheng YM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00083; Colenso CK, 2013, J CHEM INF MODEL, V53, P1358, DOI 10.1021/ci4000739; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Dhillon MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04201; Es-Salah-Lamoureux Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010876; Garcia-Elias A, 2015, STRUCTURE, V23, P1404, DOI 10.1016/j.str.2015.05.018; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gong QM, 2007, CIRCULATION, V116, P17, DOI 10.1161/CIRCULATIONAHA.107.708818; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Haitin Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001935; Hite RK, 2017, NATURE, V541, P52, DOI 10.1038/nature20775; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Kanters JK, 2015, SCAND J CLIN LAB INV, V75, P699, DOI 10.3109/00365513.2015.1091090; Ke Y, 2013, BIOCHEM J, V454, P69, DOI 10.1042/BJ20130328; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lacroix JJ, 2012, J GEN PHYSIOL, V140, P635, DOI 10.1085/jgp.201210827; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Liu QN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123951; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Ng CA, 2014, J BIOL CHEM, V289, P25822, DOI 10.1074/jbc.M114.558379; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Perry MD, 2016, J PHYSIOL-LONDON, V594, P4031, DOI 10.1113/JP271805; Perry MD, 2013, J BIOL CHEM, V288, P11482, DOI 10.1074/jbc.M113.461442; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Piper DR, 2008, CELL PHYSIOL BIOCHEM, V21, P37, DOI 10.1159/000113745; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Shimizu W, 2009, J AM COLL CARDIOL, V54, P2052, DOI 10.1016/j.jacc.2009.08.028; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Tao X, 2017, NATURE, V541, P46, DOI 10.1038/nature20608; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhang T, 2010, HUM MUTAT, V31, pE1801, DOI 10.1002/humu.21341; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	71	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7688	7705		10.1074/jbc.M117.779298	http://dx.doi.org/10.1074/jbc.M117.779298			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28280240	hybrid, Green Published			2022-12-28	WOS:000400761300034
J	Jiang, JY; Creasy, KT; Purnell, J; Peterson, ML; Spear, BT				Jiang, Jieyun; Creasy, Kate Townsend; Purnell, Justin; Peterson, Martha L.; Spear, Brett T.			Zhx2 (zinc fingers and homeoboxes 2) regulates major urinary protein gene expression in the mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FETOPROTEIN SYNTHESIS; INTIMA-MEDIA THICKNESS; AGGRESSIVE-BEHAVIOR; MICE; FAMILY; ASSOCIATION; BALB/CJ; IDENTIFICATION; REPRESSION; MEMBER	The mouse major urinary proteins (Mups) are encoded by a large family of highly related genes clustered on chromosome 4. Mups, synthesized primarily and abundantly in the liver and secreted through the kidneys, exhibit male-biased expression. Mups bind a variety of volatile ligands; these ligands, and Mup proteins themselves, influence numerous behavioral traits. Although urinary Mup protein levels vary between inbred mouse strains, this difference is most pronounced in BALB/cJ mice, which have dramatically low urinary Mup levels; this BALB/cJ trait had been mapped to a locus on chromosome 15. We previously identified Zhx2 (zinc fingers and homeoboxes 2) as a regulator of numerous liver-enriched genes. Zhx2 is located on chromosome 15, and a natural hypomorphic mutation in the BALB/cJ Zhx2 allele dramatically reduces Zhx2 expression. Based on these data, we hypothesized that reduced Zhx2 levels are responsible for lower Mup expression in BALB/cJ mice. Using both transgenic and knock-out mice along with in vitro assays, our data show that Zhx2 binds Mup promoters and is required for high levels of Mup expression in the adult liver. In contrast to previously identified Zhx2 targets that appear to be repressed by Zhx2, Mup genes are positively regulated by Zhx2. These data identify Zhx2 as a novel regulator of Mup expression and indicate that Zhx2 activates as well as represses expression of target genes.	[Jiang, Jieyun; Purnell, Justin; Peterson, Martha L.; Spear, Brett T.] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, 800 Rose St, Lexington, KY 40536 USA; [Creasy, Kate Townsend; Spear, Brett T.] Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Peterson, Martha L.; Spear, Brett T.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Creasy, Kate Townsend] Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,Rm 282T, San Francisco, CA 94158 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of California System; University of California San Francisco	Jiang, JY; Spear, BT (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, 800 Rose St, Lexington, KY 40536 USA.	jieyun.jiang2@uky.edu; bspear@uky.edu	Creasy, Kate Townsend/GMW-8097-2022	Creasy, Kate Townsend/0000-0003-1870-4586; Peterson, Martha/0000-0002-7214-421X	Public Health Service [R01DK074816, P20RR021954, T32DK007778]; National Science Foundation [MCB-1158234]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074816, T32DK007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Public Health Service Grants R01DK074816 (to B. T. S.), P20RR021954 (to B. T. S.), and T32DK007778 (to K. T. C.) and National Science Foundation Grant MCB-1158234 (to M. L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	ABELEV GI, 1963, TRANSPLANTATION, V1, P174, DOI 10.1097/00007890-196301020-00004; BELAYEW A, 1982, MOL CELL BIOL, V2, P1427, DOI 10.1128/MCB.2.11.1427; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; BISHOP JO, 1982, EMBO J, V1, P615, DOI 10.1002/j.1460-2075.1982.tb01217.x; BLANKENHORN EP, 1988, GENETICS, V119, P687; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; CIARANELLO RD, 1974, P NATL ACAD SCI USA, V71, P3006, DOI 10.1073/pnas.71.8.3006; CIARANELLO RD, 1974, J BIOL CHEM, V249, P4528; Creasy Kate Townsend, 2016, Gene Expression, V17, P7, DOI 10.3727/105221616X691712; Dow HC, 2011, GENES BRAIN BEHAV, V10, P57, DOI 10.1111/j.1601-183X.2010.00640.x; DRAGANI TA, 1989, MOL CARCINOGEN, V2, P355, DOI 10.1002/mc.2940020610; DUNCAN R, 1988, MOL CELL BIOL, V8, P2705, DOI 10.1128/MCB.8.7.2705; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Gargalovic PS, 2010, CIRC-CARDIOVASC GENE, V3, P60, DOI 10.1161/CIRCGENETICS.109.902320; Gomez-Baena G, 2014, BIOCHEM SOC T, V42, P886, DOI 10.1042/BST20140083; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Kaur AW, 2014, CELL, V157, P676, DOI 10.1016/j.cell.2014.02.025; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; Kawata H, 2003, GENE, V323, P133, DOI 10.1016/j.gene.2003.09.013; KNOPF JL, 1983, MOL CELL BIOL, V3, P2232, DOI 10.1128/MCB.3.12.2232; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Li CW, 2015, GENE, V562, P226, DOI 10.1016/j.gene.2015.02.078; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Morford LA, 2007, HEPATOLOGY, V46, P1541, DOI 10.1002/hep.21825; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; OLSSON M, 1977, J EXP MED, V145, P819, DOI 10.1084/jem.145.4.819; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; Perincheri S, 2005, P NATL ACAD SCI USA, V102, P396, DOI 10.1073/pnas.0408555102; Perincheri S, 2008, MAMM GENOME, V19, P26, DOI 10.1007/s00335-007-9077-6; Peyton DK, 2000, GENOMICS, V63, P173, DOI 10.1006/geno.1999.6073; SHAW PH, 1983, CELL, V32, P755, DOI 10.1016/0092-8674(83)90061-2; Shen H, 2008, J CELL MOL MED, V12, P2772, DOI 10.1111/j.1582-4934.2008.00233.x; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; SZOKA PR, 1978, GENETICS, V90, P597; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Yamada K, 2003, BIOCHEM J, V373, P167, DOI 10.1042/BJ20021866; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	46	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6765	6774		10.1074/jbc.M116.768275	http://dx.doi.org/10.1074/jbc.M116.768275			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258223	Green Published, hybrid			2022-12-28	WOS:000399813400027
J	Li, A; Ziehr, JL; Johnson, KA				Li, An; Ziehr, Jessica L.; Johnson, Kenneth A.			A new general method for simultaneous fitting of temperature and concentration dependence of reaction rates yields kinetic and thermodynamic parameters for HIV reverse transcriptase specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL RESISTANCE; DNA-POLYMERASE; MECHANISM; AZT; DISCRIMINATION; POLYMERIZATION; INTERMEDIATE; SELECTIVITY; ZIDOVUDINE; MUTATIONS	Recent studies have demonstrated the dominant role of induced fit in enzyme specificity of HIV reverse transcriptase and many other enzymes. However, relevant thermodynamic parameters are lacking, and equilibrium thermodynamic methods are of no avail because the key parameters can only be determined by kinetic measurement. By modifying KinTek Explorer software, we present a new general method for globally fitting data collected over a range of substrate concentrations and temperatures and apply it to HIV reverse transcriptase. Fluorescence stopped-flow methods were used to record the kinetics of enzyme conformational changes that monitor nucleotide binding and incorporation. The nucleotide concentration dependence was measured at temperatures ranging from 5 to 37 degrees C, and the raw data were fit globally to derive a single set of rate constants at 37 degrees C and a set of activation enthalpy terms to account for the kinetics at all other temperatures. This comprehensive analysis afforded thermodynamic parameters for nucleotide binding (K-d, Delta G, Delta H, and Delta S at 37 degrees C) and kinetic parameters for enzyme conformational changes and chemistry (rate constants and activation enthalpy). Comparisons between wildtype enzyme and a mutant resistant to nucleoside analogs used to treat HIV infections reveal that the ground state binding is weaker and the activation enthalpy for the conformational change step is significantly larger for the mutant. Further studies to explore the structural underpinnings of the observed thermodynamics and kinetics of the conformational change step may help to design better analogs to treat HIV infections and other diseases. Our new method is generally applicable to enzyme and chemical kinetics.	[Li, An; Ziehr, Jessica L.; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Mol Biosci Dept, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), 2500 Speedway,MBB3 122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			Welch Foundation [F-1604]; National Institutes of Health [R01 GM084741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084741] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant F-1604 and National Institutes of Health Grant R01 GM084741. K. A. J. is the President of KinTek Corp., which provided the AutoSF-120 stopped flow instrument and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bec G, 2013, J AM CHEM SOC, V135, P9743, DOI 10.1021/ja4018418; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Das K, 2016, ACS CHEM BIOL, V11, P3226, DOI 10.1021/acschembio.6b00798; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Kirmizialtin S, 2015, J PHYS CHEM B, V119, P11513, DOI 10.1021/acs.jpcb.5b05467; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Prasad BR, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1288-6; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shafer RW, 2008, AIDS REV, V10, P67; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Zhu W, 2016, BIOCHEMISTRY-US, V55, P2163, DOI 10.1021/acs.biochem.6b00043	28	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6695	6702		10.1074/jbc.M116.760827	http://dx.doi.org/10.1074/jbc.M116.760827			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28255091	Green Published, hybrid			2022-12-28	WOS:000399813400021
J	Boulton, S; Akimoto, M; Akbarizadeh, S; Melacini, G				Boulton, Stephen; Akimoto, Madoka; Akbarizadeh, Sam; Melacini, Giuseppe			Free energy landscape remodeling of the cardiac pacemaker channel explains the molecular basis of familial sinus bradycardia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; DRIVEN PROTEIN ALLOSTERY; HCN ION CHANNELS; CONFORMATIONAL DYNAMICS; STRUCTURAL BASIS; LIGAND-BINDING; COVARIANCE ANALYSIS; CAMP SENSITIVITY; KINASE-A; DOMAIN	The hyperpolarization-activated and cyclic nucleotide-modulated ion channel (HCN) drives the pacemaker activity in the heart, and its malfunction can result in heart disorders. One such disorder, familial sinus bradycardia, is caused by the S672R mutation in HCN, whose electrophysiological phenotypes include a negative shift in the channel activation voltage and an accelerated HCN deactivation. The outcomes of these changes are abnormally low resting heart rates. However, the molecular mechanism underlying these electrophysiological changes is currently not fully understood. Crystallographic investigations indicate that the S672R mutation causes limited changes in the structure of the HCN intracellular gating tetramer, but its effects on protein dynamics are unknown. Here, we utilize comparative S672R versus WT NMR analyses to show that the S672R mutation results in extensive perturbations of the dynamics in both apo- and holo-forms of the HCN4 isoform, reflecting how S672R remodels the free energy landscape for the modulation of HCN4 by cAMP, i.e. the primary cyclic nucleotide modulator of HCN channels. We show that the S672R mutation results in a constitutive shift of the dynamic auto-inhibitory equilibrium toward inactive states of HCN4 and broadens the free-energy well of the apo-form, enhancing the millisecond to microsecond dynamics of the holo-form at sites critical for gating cAMP binding. These S672R-induced variations in dynamics provide a molecular basis for the electrophysiological phenotypes of this mutation and demonstrate that the pathogenic effects of the S672R mutation can be rationalized primarily in terms of modulations of protein dynamics.	[Boulton, Stephen; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Akimoto, Madoka; Akbarizadeh, Sam; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada.; Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Boulton, Stephen/AAM-3440-2021	Boulton, Stephen/0000-0002-2521-2240	Canadian Institutes of Health Research [MOP-68897]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04514]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Grant MOP-68897 (to G.M.) and Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04514 (to G.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Baruscotti M, 2017, EUR HEART J, V38, P280, DOI 10.1093/eurheartj/ehv582; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Boulton S, 2016, CHEM REV, V116, P6267, DOI 10.1021/acs.chemrev.5b00718; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Boulton S, 2014, BIOCHEM SOC T, V42, P302, DOI 10.1042/BST20130282; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Cembran A, 2014, PHYS CHEM CHEM PHYS, V16, P6508, DOI 10.1039/c4cp00110a; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFrancesco D, 2013, J PHYSIOL-LONDON, V591, P4117, DOI 10.1113/jphysiol.2013.253765; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Goddard T. D., 2008, SPARKY3; Greenwood AI, 2011, J BIOMOL NMR, V51, P21, DOI 10.1007/s10858-011-9538-9; Guo C, 2016, P NATL ACAD SCI USA, V113, pE6776, DOI 10.1073/pnas.1610142113; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Guo JJ, 2015, BIOPHYS J, V108, P2771, DOI 10.1016/j.bpj.2015.04.035; Kim J, 2015, P NATL ACAD SCI USA, V112, P3716, DOI 10.1073/pnas.1502299112; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Loh AP, 1999, BIOCHEMISTRY-US, V38, P12547, DOI 10.1021/bi9913707; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ma BY, 2016, NAT CHEM BIOL, V12, P890, DOI 10.1038/nchembio.2212; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Moleschi KJ, 2015, J AM CHEM SOC, V137, P10777, DOI 10.1021/jacs.5b06557; Ng LCT, 2016, STRUCTURE, V24, P1629, DOI 10.1016/j.str.2016.06.024; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Omidvar R, 2016, BBA-PROTEINS PROTEOM, V1864, P1739, DOI 10.1016/j.bbapap.2016.08.017; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Schweizer PA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P542, DOI 10.1161/CIRCEP.110.949768; Seifert R, 2016, STRUCTURE, V24, P1627, DOI 10.1016/j.str.2016.09.002; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE6939, DOI 10.1073/pnas.1611418113; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; VanSchouwen B, 2016, J PHYS CHEM B, V120, P10936, DOI 10.1021/acs.jpcb.6b07735; VanSchouwen B, 2015, J BIOL CHEM, V290, P28631, DOI 10.1074/jbc.M115.685305; VanSchouwen B, 2015, J BIOL CHEM, V290, P17642, DOI 10.1074/jbc.M115.651877; Verkerk AO, 2014, EUROPACE, V16, P384, DOI 10.1093/europace/eut348; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; Wicks NL, 2011, P NATL ACAD SCI USA, V108, P609, DOI 10.1073/pnas.1012750108; Xu XP, 2012, STRUCTURE, V20, P2116, DOI 10.1016/j.str.2012.09.017; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	56	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6414	6428		10.1074/jbc.M116.773697	http://dx.doi.org/10.1074/jbc.M116.773697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28174302	Green Published, hybrid			2022-12-28	WOS:000399538700033
J	Golubev, A; Hanson, AD; Gladyshev, VN				Golubev, Alexey; Hanson, Andrew D.; Gladyshev, Vadim N.			Non-enzymatic molecular damage as a prototypic driver of aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							METABOLITE DAMAGE; OXIDATIVE STRESS; REPAIR; MECHANISMS; ENZYMES; BIOLOGY; ACCUMULATION; NEUROMELANIN; CHEMISTRY; SYSTEMS	The chemical potentialities of metabolites far exceed metabolic requirements. The required potentialities are realized mostly through enzymatic catalysis. The rest are realized spontaneously through organic reactions that (i) occur wherever appropriate reactants come together, (ii) are so typical that many have proper names (e.g. Michael addition, Amadori rearrangement, and Pictet-Spengler reaction), and (iii) often have damaging consequences. There are many more causes of nonenzymatic damage to metabolites than reactive oxygen species and free radical processes (the "usual suspects"). Endogenous damage accumulation in non-renewable macromolecules and spontaneously polymerized material is sufficient to account for aging and differentiates aging from wear-and-tear of inanimate objects by deriving it from metabolism, the essential attribute of life.	[Golubev, Alexey] St Petersburg State Univ, Dept Biochem, St Petersburg 199034, Russia; [Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Gladyshev, Vadim N.] Harvard Med Sch, Div Genet, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA	Saint Petersburg State University; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Golubev, A (corresponding author), St Petersburg State Univ, Dept Biochem, St Petersburg 199034, Russia.; Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	aeeouelxglbv@gmail.com; adha@ufl.edu; vgladyshev@rics.bwh.harvard.edu		Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health Grants [AG021518, AG047745, GM0625204, GM061603]; National Science Foundation (NSF) Award [MCB 1611711]; Div Of Molecular and Cellular Bioscience [1611711] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603, R37GM065204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG047745, R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Award(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG021518, AG047745, GM0625204, and GM061603 (to V. N. G.) and by National Science Foundation (NSF) Award MCB 1611711 (to A. D. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avanesov AS, 2014, ELIFE, V3, DOI 10.7554/eLife.02077; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Barea F, 2008, MUTAT RES-FUND MOL M, V642, P43, DOI 10.1016/j.mrfmmm.2008.04.003; Bisaglia M, 2014, AGEING RES REV, V13, P107, DOI 10.1016/j.arr.2013.12.009; BJORKSTEN J, 1990, EXP GERONTOL, V25, P91, DOI 10.1016/0531-5565(90)90039-5; Bohler A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004941; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Cheung CYM, 2013, PLANT J, V75, P1050, DOI 10.1111/tpj.12252; Clewett DV, 2016, NEUROBIOL AGING, V37, P117, DOI 10.1016/j.neurobiolaging.2015.09.019; Copes N, 2015, EXP GERONTOL, V72, P67, DOI 10.1016/j.exger.2015.09.013; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Deng Y, 2012, CURR GERIATR REP, V1, P59, DOI 10.1007/s13670-012-0012-7; DILMAN VM, 1986, INT REV NEUROBIOL, V28, P89, DOI 10.1016/S0074-7742(08)60107-5; ElAyaan U, 1997, J CHEM SOC DALTON, P2813, DOI 10.1039/a701054k; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Frelin O, 2015, BIOCHEM J, V466, P137, DOI 10.1042/BJ20141237; Gebauer J, 2016, CELL SYST, V2, P312, DOI 10.1016/j.cels.2016.04.017; Gladyshev VN, 2016, AGING CELL, V15, P594, DOI 10.1111/acel.12480; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Golubev A, 2009, J THEOR BIOL, V258, P1, DOI 10.1016/j.jtbi.2009.01.009; Golubev AG, 1996, BIOCHEMISTRY-MOSCOW+, V61, P1443; Gorissea L, 2016, P NATL ACAD SCI USA, V113, P1191, DOI 10.1073/pnas.1517096113; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hanson AD, 2016, ANNU REV PLANT BIOL, V67, P131, DOI 10.1146/annurev-arplant-043015-111648; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Herraiz T, 2014, BIOCHEM BIOPH RES CO, V451, P42, DOI 10.1016/j.bbrc.2014.07.047; Hipkiss AR, 2016, MATURITAS, V93, P28, DOI 10.1016/j.maturitas.2016.06.002; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; HORNSBY PJ, 1989, FREE RADICAL BIO MED, V6, P103, DOI 10.1016/0891-5849(89)90163-9; Jameson GNL, 2004, ORG BIOMOL CHEM, V2, P777, DOI 10.1039/b316294j; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kaya A, 2015, AGING CELL, V14, P366, DOI 10.1111/acel.12290; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Lade SJ, 2015, J THEOR BIOL, V378, P47, DOI 10.1016/j.jtbi.2015.04.022; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Laye MJ, 2015, AGING CELL, V14, P797, DOI 10.1111/acel.12358; Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014; Lerma-Ortiz C, 2016, BIOCHEM SOC T, V44, P961, DOI 10.1042/BST20160073; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Liu X, 2016, INVEST OPHTH VIS SCI, V57, P1017, DOI 10.1167/iovs.15-18429; Lo MJ, 2000, J INVEST MED, V48, P335; Lyons TJ, 1997, DIABETES REV, V5, P365; Ma SM, 2015, CELL METAB, V22, P332, DOI 10.1016/j.cmet.2015.07.005; McMurry J., 2015, ORGANIC CHEM BIOL AP; Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT PHYSIOL, V165, P52, DOI 10.1104/pp.114.236539; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Piedrafita G, 2015, BIOMOLECULES, V5, P2101, DOI 10.3390/biom5032101; QUINN PG, 1985, J BIOL CHEM, V260, P2092; Rabbani N, 2016, CLIN SCI, V130, P1677, DOI 10.1042/CS20160025; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Schaible R, 2015, P NATL ACAD SCI USA, V112, P15701, DOI 10.1073/pnas.1521002112; Schneider M, 2004, CHEM RES TOXICOL, V17, P1385, DOI 10.1021/tx049929d; Seaver SMD, 2012, J EXP BOT, V63, P2247, DOI 10.1093/jxb/err371; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Semchyshyn HM, 2014, SCI WORLD J, DOI 10.1155/2014/417842; Shen XM, 1997, BIOORG CHEM, V25, P130, DOI 10.1006/bioo.1997.1061; Simic Z, 2015, CHEMBIOCHEM, V16, P2337, DOI 10.1002/cbic.201500364; Solis-Calero C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/319505; Stingele J, 2015, NAT REV MOL CELL BIO, V16, P455, DOI 10.1038/nrm4015; Stockigt J, 2011, ANGEW CHEM INT EDIT, V50, P8538, DOI 10.1002/anie.201008071; Stroikin Y, 2005, BIOGERONTOLOGY, V6, P39, DOI 10.1007/s10522-004-7382-y; Tasset I, 2016, FEBS J, V283, P2403, DOI 10.1111/febs.13677; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Van Schaftingen E, 2012, AMINO ACIDS, V42, P1143, DOI 10.1007/s00726-010-0780-3; Vanhooren V, 2015, MECH AGEING DEV, V151, P71, DOI 10.1016/j.mad.2015.03.009; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wakamatsu K, 2015, J NEUROCHEM, V135, P768, DOI 10.1111/jnc.13237; Wang AD, 2012, GENETICS, V192, P361, DOI 10.1534/genetics.112.143321; Weber AL, 2004, ORIGINS LIFE EVOL B, V34, P473, DOI 10.1023/B:ORIG.0000043128.30559.fe; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wishart DS, 2016, METABOLITES, V6, DOI 10.3390/metabo6010010; Wolfe AJ, 2016, CURR GENET, V62, P335, DOI 10.1007/s00294-015-0552-4; Yin DZ, 2005, EXP GERONTOL, V40, P455, DOI 10.1016/j.exger.2005.03.012; Zaidi SK, 2012, OPEN LONGEVITY SCI, V6, P1, DOI [10.2174/1876326X01206010001, DOI 10.2174/1876326X01206010001]; Zucca FA, 2014, NEUROTOX RES, V25, P13, DOI 10.1007/s12640-013-9435-y	92	39	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6029	6038		10.1074/jbc.R116.751164	http://dx.doi.org/10.1074/jbc.R116.751164			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28264930	Green Published, hybrid			2022-12-28	WOS:000399538700001
J	Hohl, M; Stintzi, A; Schaller, A				Hohl, Mathias; Stintzi, Annick; Schaller, Andreas			A novel subtilase inhibitor in plants shows structural and functional similarities to protease propeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PROTEINASE-B; C-TERMINAL REGION; INTRAMOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; PLEUROTUS-OSTREATUS; PROTEOLYTIC-ENZYMES; PRO-SEQUENCE; SUBTILISIN-E; ACTIVATION; MECHANISMS	The propeptides of subtilisin-like serine proteinases (subtilases, SBTs) serve dual functions as intramolecular chaperones that are required for enzyme folding and as inhibitors of the mature proteases. SBT propeptides are homologous to the I9 family of protease inhibitors that have only been described in fungi. Here we report the identification and characterization of subtilisin propeptide-like inhibitor 1 (SPI-1) from Arabidopsis thaliana. Sequence similarity and the shared beta-alpha-beta-beta-alpha-beta core structure identified SPI-1 as a member of the I9 inhibitor family and as the first independent I9 inhibitor in higher eukaryotes. SPI-1 was characterized as a high-affinity, tight-binding inhibitor of Arabidopsis subtilase SBT4.13 with K-d and K-i values in the picomolar range. SPI-1 acted as a stable inhibitor of SBT4.13 over the physiologically relevant range of pH, and its inhibitory profile included many other SBTs from plants but not bovine chymotrypsin or bacterial subtilisin A. Upon binding to SBT4.13, the C-terminal extension of SPI-1 was proteolytically cleaved. The last four amino acids at the newly formed C terminus of SPI-1 matched both the cleavage specificity of SBT4.13 and the consensus sequence of Arabidopsis SBTs at the junction of the propeptide with the catalytic domain. The data suggest that the C terminus of SPI-1 acts as a competitive inhibitor of target proteases as it remains bound to the active site in a product-like manner. SPI-1 thus resembles SBT propeptides with respect to its mode of protease inhibition. However, in contrast to SBT propeptides, SPI-1 could not substitute as a folding assistant for SBT4.13.	[Hohl, Mathias; Stintzi, Annick; Schaller, Andreas] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany	University Hohenheim	Schaller, A (corresponding author), Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany.	andreas.schaller@uni-hohenheim.de	Schaller, Andreas/AAC-1940-2020	Schaller, Andreas/0000-0001-6872-9576; Hohl, Mathias/0000-0003-3676-6705				Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Birk Y., 2003, PLANT PROTEASE INHIB, P5; Bleckmann A, 2016, METHODS, V98, P66, DOI 10.1016/j.ymeth.2015.10.019; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; DOHMAE N, 1995, ARCH BIOCHEM BIOPHYS, V316, P498, DOI 10.1006/abbi.1995.1066; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Santamara ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-812; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Farmer Edward E., 1992, Trends in Cell Biology, V2, P236, DOI 10.1016/0962-8924(92)90311-A; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GRECO WR, 1979, J BIOL CHEM, V254, P2104; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Khan AR, 1998, PROTEIN SCI, V7, P815; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Kojima S, 2005, FEBS LETT, V579, P4430, DOI 10.1016/j.febslet.2005.06.083; Kojima S, 2001, BIOCHEM BIOPH RES CO, V281, P1271, DOI 10.1006/bbrc.2001.4515; Kojima S, 1999, J MOL BIOL, V286, P775, DOI 10.1006/jmbi.1998.2498; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Layton CJ, 2011, PROTEIN SCI, V20, P1439, DOI 10.1002/pro.674; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; MAIER K, 1979, J BIOL CHEM, V254, P8491; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meyer M, 2016, J BIOL CHEM, V291, P19449, DOI 10.1074/jbc.M116.744151; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sasakawa H, 2002, J MOL BIOL, V317, P159, DOI 10.1006/jmbi.2002.5412; Schaller A, 2012, PHYSIOL PLANTARUM, V145, P52, DOI 10.1111/j.1399-3054.2011.01529.x; Schardon K, 2016, SCIENCE, V354, P1594, DOI 10.1126/science.aai8550; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; SHINDE U, 1994, J BIOCHEM, V115, P629, DOI 10.1093/oxfordjournals.jbchem.a124386; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; Sotokawauchi A, 2017, J BIOCHEM, V161, P45, DOI 10.1093/jb/mvw053; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Williams J W, 1979, Methods Enzymol, V63, P437; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	65	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6389	6401		10.1074/jbc.M117.775445	http://dx.doi.org/10.1074/jbc.M117.775445			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223360	Green Published, hybrid			2022-12-28	WOS:000399538700031
J	Jin, X; Yang, C; Fan, P; Xiao, J; Zhang, WL; Zhan, SD; Liu, T; Wang, DJ; Wu, HS				Jin, Xin; Yang, Chong; Fan, Ping; Xiao, Jun; Zhang, Wanli; Zhan, Sudong; Liu, Tao; Wang, Dejie; Wu, Heshui			CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; PHOSPHORYLATION-DEPENDENT DEGRADATION; ZESTE HOMOLOG 2; TUMOR-SUPPRESSOR; E-CADHERIN; BREAST-CANCER; CYCLIN-E; C-MYC; FBW7; DIFFERENTIATION	Pancreatic cancer is one of the most lethal cancer types. Enhancer of zeste homolog 2 (EZH2) is an oncogenic protein over-expressed in pancreatic cancer, and EZH2 could be a potential therapeutic target for the treatment of pancreatic cancer. Although significant progress has been made toward understanding the function and deregulation of EZH2 in cancer cells, the posttranslational regulation of EZH2 in cancer cells is still unclear. F-box and WD repeat domain-containing 7 (FBW7) acts as a tumor suppressor by targeting multiple oncoprotein substrates for ubiquitination and degradation. Here we demonstrate that EZH2 is a bona fide substrate of FBW7 in pancreatic cancer cells. We provide evidence that the activated CDK5 kinase is involved in the EZH2 phosphorylation that is required for FBW7-mediated degradation. We further show that FBW7 suppresses EZH2 activity and inhibits tumor migration and invasion via degradation of EZH2 in pancreatic cancer cells. Furthermore, immunohistochemistry analysis revealed that expression of EZH2 protein negatively correlates with FBW7 protein levels in a cohort of human pancreatic cancer specimens. Collectively, our findings demonstrate that FBW7 is a novel E3 ligase of EZH2 that regulates the EZH2 protein level in pancreatic cancer and represents a viable strategy for effective treatment of pancreatic cancer.	[Jin, Xin; Fan, Ping; Xiao, Jun; Zhang, Wanli; Zhan, Sudong; Liu, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Digest Surg Oncol, Wuhan 430022, Hubei, Peoples R China; [Wu, Heshui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pancreat Surg, Wuhan 430022, Hubei, Peoples R China; [Yang, Chong] Hosp Univ Elect Sci & Technol China, Organ Transplantat Ctr, Chengdu 610072, Sichuan, Peoples R China; [Yang, Chong] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China; [Wang, Dejie] Nanchang Univ, Affiliated Hosp 1, Jiangxi Inst Gastroenterol & Hepatol, Dept Gastroenterol, Nanchang 330006, Jiangxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; Nanchang University	Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pancreat Surg, Wuhan 430022, Hubei, Peoples R China.; Wang, DJ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Jiangxi Inst Gastroenterol & Hepatol, Dept Gastroenterol, Nanchang 330006, Jiangxi, Peoples R China.	wdj5257@sina.com; heshuiwu@163.com	jin, xin/ABC-4632-2020; Wang, Dejie/AAJ-9461-2020	Jin, Xin/0000-0001-6461-6005; Yang, Chong/0000-0002-0060-706X	National Natural Science Foundation of China [31560320]; Natural Science Foundation of Jiangxi Province [20142BAB215049]; Scientific Research Training Program for Young Talents of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Scientific Research Training Program for Young Talents of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	This work was supported in part by grants from the National Natural Science Foundation of China (31560320 to D. W.), the Natural Science Foundation of Jiangxi Province (20142BAB215049 to D. W.), and the Scientific Research Training Program for Young Talents of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2014, LANCET ONCOL, V15, P241; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chen YC, 2010, CANCER LETT, V297, P109, DOI 10.1016/j.canlet.2010.05.003; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Han T, 2016, ONCOTARGET, V7, P11194, DOI 10.18632/oncotarget.7156; Ji SR, 2015, CELL RES, V25, P561, DOI 10.1038/cr.2015.30; Jin X., 2016, ONCOL RES IN PRESS; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Ko HW, 2016, ONCOTARGET, V7, P57131, DOI 10.18632/oncotarget.11008; Koo J, 2015, J BIOL CHEM, V290, P14120, DOI 10.1074/jbc.M114.633057; Kumar Y, 2015, J BIOL CHEM, V290, P30975, DOI 10.1074/jbc.M115.669531; Li XM, 2016, ONCOTARGET, V7, P33440, DOI [10.18632/oncotarget.7961, 10.18632/oncotarget.6497]; Liu L, 2016, BJU INT, V117, P351, DOI 10.1111/bju.12702; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Maskey D, 2015, EMBO J, V34, P2424, DOI 10.15252/embj.201490831; Nakajima T, 2015, J BIOL CHEM, V290, P10368, DOI 10.1074/jbc.M114.613018; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Reijm EA, 2014, ANN ONCOL, V25, P2185, DOI 10.1093/annonc/mdu391; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang D., 2015, ACM T INFORM SYST SE, V1, P1; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253	35	68	68	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6269	6280		10.1074/jbc.M116.764407	http://dx.doi.org/10.1074/jbc.M116.764407			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28242758	Green Published, hybrid			2022-12-28	WOS:000399538700021
J	Lanfranco, MF; Garate, F; Engdahl, AJ; Maillard, RA				Lanfranco, Maria Fe; Garate, Fernanda; Engdahl, Ashton J.; Maillard, Rodrigo A.			Asymmetric configurations in a reengineered homodimer reveal multiple subunit communication pathways in protein allostery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RECEPTOR PROTEIN; CYCLIC-NUCLEOTIDE BINDING; GENE ACTIVATOR PROTEIN; SINGLE-SITE MUTATIONS; ESCHERICHIA-COLI; DNA RECOGNITION; DESIGN; ENSEMBLES; SWITCHES; MUTANT	Many allosteric proteins form homo-oligomeric complexes to regulate a biological function. In homo-oligomers, subunits establish communication pathways that are modulated by external stimuli like ligand binding. A challenge for dissecting the communication mechanisms in homo-oligomers is identifying intermediate liganded states, which are typically transiently populated. However, their identities provide the most mechanistic information on how ligand-induced signals propagate from bound to empty subunits. Here, we dissected the directionality and magnitude of subunit communication in a reengineered single-chain version of the homodimeric transcription factor cAMP receptor protein. By combining wild-type and mutant subunits in various asymmetric configurations, we revealed a linear relationship between the magnitude of cooperative effects and the number of mutant subunits. We found that a single mutation is sufficient to change the global allosteric behavior of the dimer even when one subunit was wild type. Dimers harboring two mutations with opposite cooperative effects had different allosteric properties depending on the arrangement of the mutations. When the two mutations were placed in the same subunit, the resulting cooperativity was neutral. In contrast, when placed in different subunits, the observed cooperativity was dominated by the mutation with strongest effects over cAMP affinity relative to wild type. These results highlight the distinct roles of intrasubunit interactions and intersubunit communication in allostery. Finally, dimers bound to either one or two cAMP molecules had similar DNA affinities, indicating that both asymmetric and symmetric liganded states activate DNA interactions. These studies have revealed the multiple communication pathways that homo-oligomers employ to transduce signals.	[Lanfranco, Maria Fe; Garate, Fernanda; Engdahl, Ashton J.; Maillard, Rodrigo A.] Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA	Georgetown University	Maillard, RA (corresponding author), Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA.	rodrigo.maillard@georgetown.edu			startup funds from Georgetown University	startup funds from Georgetown University	This work was supported with startup funds from Georgetown University. The authors declare that they have no conflicts of interest with the contents of this article.	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Choi JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7968; Dai JY, 2004, BIOCHEMISTRY-US, V43, P8901, DOI 10.1021/bi0499359; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GORSHKOVA I, 1995, J BIOL CHEM, V270, P21679, DOI 10.1074/jbc.270.37.21679; Ha JH, 2012, CHEM-EUR J, V18, P7984, DOI 10.1002/chem.201200348; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Li JQ, 2011, BIOPHYS CHEM, V159, P210, DOI 10.1016/j.bpc.2011.06.015; Li PTX, 2002, J BIOL CHEM, V277, P11838, DOI 10.1074/jbc.M110860200; Lin SH, 2002, BIOCHEMISTRY-US, V41, P14935, DOI 10.1021/bi026756n; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Lin SH, 2002, BIOCHEMISTRY-US, V41, P2946, DOI 10.1021/bi0119215; Makhlynets OV, 2015, BIOCHEMISTRY-US, V54, P1444, DOI 10.1021/bi5015248; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; REZNIKOFF WS, 1992, J BACTERIOL, V174, P655, DOI 10.1128/jb.174.3.655-658.1992; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Yu SN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404806	32	6	6	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6086	6093		10.1074/jbc.M117.776047	http://dx.doi.org/10.1074/jbc.M117.776047			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28188293	Green Published, hybrid			2022-12-28	WOS:000399538700006
J	Schonauer, S; Koorschen, HG; Penno, A; Rennhack, A; Breiden, B; Sandhoff, K; Gutbrod, K; Dormann, P; Raju, DN; Haberkant, P; Gerl, MJ; Brugger, B; Zigdon, H; Vardi, A; Futerman, AH; Thiele, C; Wachten, D				Schonauer, Sophie; Koerschen, Heinz G.; Penno, Anke; Rennhack, Andreas; Breiden, Bernadette; Sandhoff, Konrad; Gutbrod, Katharina; Dormann, Peter; Raju, Diana N.; Haberkant, Per; Gerl, Mathias J.; Bruegger, Britta; Zigdon, Hila; Vardi, Ayelet; Futerman, Anthony H.; Thiele, Christoph; Wachten, Dagmar			Identification of a feedback loop involving beta-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSYLCERAMIDE ACCUMULATION; MULTIPLE-SCLEROSIS; FINGOLIMOD FTY720; B EPOXIDE; GLUCOSYLSPHINGOSINE; DEFICIENCY; MODEL; MICE; MUTATION; TYPE-3	The lysosomal acid beta-glucosidase GBA1 and the non-lysosomal beta-glucosidase GBA2 degrade glucosylceramide (GlcCer) to glucose and ceramide in different cellular compartments. Loss of GBA2 activity and the resulting accumulation of GlcCer results in male infertility, whereas mutations in the GBA1 gene and loss of GBA1 activity cause the lipid-storage disorder Gaucher disease. However, the role of GBA2 in Gaucher disease pathology and its relationship to GBA1 is not well understood. Here, we report a GBA1-dependent down-regulation of GBA2 activity in patients with Gaucher disease. Using an experimental approach combining cell biology, biochemistry, and mass spectrometry, we show that sphingosine, the cytotoxic metabolite accumulating in Gaucher cells through the action of GBA2, directly binds to GBA2 and inhibits its activity. We propose a negative feedback loop, in which sphingosine inhibits GBA2 activity in Gaucher cells, preventing further sphingosine accumulation and, thereby, cytotoxicity. Our findings add a new chapter to the understanding of the complex molecular mechanism underlying Gaucher disease and the regulation of beta-glucosidase activity in general.	[Schonauer, Sophie; Raju, Diana N.; Wachten, Dagmar] Ctr Adv European Studies & Res Caesar, Minerva Max Planck Res Grp, Mol Physiol, D-53175 Bonn, Germany; [Koerschen, Heinz G.; Rennhack, Andreas] Ctr Adv European Studies & Res Caesar, Dept Mol Sensory Syst, D-53175 Bonn, Germany; [Thiele, Christoph] Univ Bonn, Dept Cell Biol Lipids, LIMES Inst, Bonn, Germany; [Breiden, Bernadette; Sandhoff, Konrad] Univ Bonn, LIMES Inst, Kekule Inst, D-53115 Bonn, Germany; [Gutbrod, Katharina; Dormann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53115 Bonn, Germany; [Haberkant, Per] EMBL Heidelberg, Prote Core Facil, D-69117 Heidelberg, Germany; [Gerl, Mathias J.; Bruegger, Britta] Heidelberg Univ, Biochem Zentrum BZH, D-69120 Heidelberg, Germany; [Zigdon, Hila; Vardi, Ayelet; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Wachten, Dagmar] Univ Bonn, Inst Innate Immun, Univ Hosp, D-53127 Bonn, Germany; [Gerl, Mathias J.] Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany; [Futerman, Anthony H.] Weizmann Inst Sci, Biochem, Rehovot, Israel	Center of Advanced European Studies & Research (CAESAR); Center of Advanced European Studies & Research (CAESAR); University of Bonn; University of Bonn; University of Bonn; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Weizmann Institute of Science; University of Bonn; Weizmann Institute of Science	Wachten, D (corresponding author), Ctr Adv European Studies & Res Caesar, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	dagmar.wachten@caesar.de	Breiden, Bernadette/S-3005-2019; Breiden, Bernadette/F-2422-2014	Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109; Haberkant, Per/0000-0002-5608-9062; Futerman, Anthony/0000-0003-0013-0115; Gerl, Mathias/0000-0002-8074-7221	Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft [SFB645, TRR83]; Excellence Cluster ImmunoSensation, Bonn	Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation, Bonn	The work was supported in part by a grant from the Fritz Thyssen Foundation and by the Deutsche Forschungsgemeinschaft Grants SFB645 (to D. W., C. T., and P. D.) and TRR83 (to C. T., B. B., and K. S.), and a grant from the Excellence Cluster ImmunoSensation, Bonn (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Burke DG, 2013, J INHERIT METAB DIS, V36, P869, DOI 10.1007/s10545-012-9561-3; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Contreras FX, 2006, BIOPHYS J, V90, P4085, DOI 10.1529/biophysj.105.076471; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; ERICKSON JS, 1973, J LIPID RES, V14, P133; Farfel-Becker T, 2011, DIS MODEL MECH, V4, P746, DOI 10.1242/dmm.008185; Ferraz MJ, 2016, MOL GENET METAB, V117, P186, DOI 10.1016/j.ymgme.2015.12.006; Filocamo M, 2014, OPEN J BIORESOURCES, V1, pe2, DOI [DOI 10.5334/0JB.AB, 10.5334/ojb.ab, DOI 10.5334/OJB.AB]; Fuller M, 2008, MOL GENET METAB, V93, P437, DOI 10.1016/j.ymgme.2007.11.011; Futerman A.H., 2006, GAUCHER DIS; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; LEGLER G, 1988, ARCH BIOCHEM BIOPHYS, V260, P437, DOI 10.1016/0003-9861(88)90467-5; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; Mistry PK, 2014, P NATL ACAD SCI USA, V111, P4934, DOI 10.1073/pnas.1400768111; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Pastores GM, 1997, BAILLIERE CLIN HAEM, V10, P739, DOI 10.1016/S0950-3536(97)80037-6; Raju D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005063; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; SARMIENTOS F, 1986, EUR J BIOCHEM, V160, P527, DOI 10.1111/j.1432-1033.1986.tb10071.x; Sasaki H, 2009, BIOPHYS J, V96, P2727, DOI 10.1016/j.bpj.2008.12.3926; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Vardi A, 2016, J PATHOL, V239, P496, DOI 10.1002/path.4751; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	37	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6177	6189		10.1074/jbc.M116.762831	http://dx.doi.org/10.1074/jbc.M116.762831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258214	hybrid, Green Published			2022-12-28	WOS:000399538700014
J	Binsker, U; Kohler, TP; Krauel, K; Kohler, S; Habermeyer, J; Schwertz, H; Hammerschmidt, S				Binsker, Ulrike; Kohler, Thomas P.; Krauel, Krystin; Kohler, Sylvia; Habermeyer, Johanna; Schwertz, Hansjoerg; Hammerschmidt, Sven			Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; bacterial pathogenesis; extracellular matrix protein; surface plasmon resonance (SPR); thrombospondin; Hic; Streptococcus pneumoniae; human serum; pneumococcal surface protein C	STREPTOCOCCUS-PNEUMONIAE; FACTOR-H; SECRETE THROMBOSPONDIN; EPITHELIAL-CELLS; BINDING PROTEIN; SURFACE PROTEIN; PHASE VARIATION; PSPC; ADHERENCE; MATRIX	Streptococcus pneumoniae serotype 3 strains emerge frequently within clinical isolates of invasive diseases. Bacterial invasion into deeper tissues is associated with colonization and immune evasion mechanisms. Thus, pneumococci express a versatile repertoire of surface proteins sequestering and interacting specifically with components of the human extracellular matrix and serum. Hic, a PspC-like pneumococcal surface protein, possesses vitronectin and factor H binding activity. Here, we show that heterologously expressed Hic domains interact, similar to the classical PspC molecule, with human matricellular thrombospondin-1 (hTSP-1). Binding studies with isolated human thrombospondin-1 and various Hic domains suggest that the interaction between hTSP-1 and Hic differs from binding to vitronectin and factor H. Binding of Hic to hTSP-1 is inhibited by heparin and chondroitin sulfate A, indicating binding to the N-terminal globular domain or type I repeats of hTSP-1. Competitive inhibition experiments with other pneumococcal hTSP-1 adhesins demonstrated that PspC and PspC-like Hic recognize similar domains, whereas PavB and Hic can bind simultaneously to hTSP-1. In conclusion, Hic binds specifically hTSP-1; however, truncation in the N-terminal part of Hic decreases the binding activity, suggesting that the full length of the -helical regions of Hic is required for an optimal interaction.	[Binsker, Ulrike; Kohler, Thomas P.; Kohler, Sylvia; Habermeyer, Johanna; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany; [Krauel, Krystin; Schwertz, Hansjoerg] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17489 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School	Kohler, TP (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany.	kohlert@uni-greifswald.de	Habermeyer, Johanna/ABG-1984-2020; Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Krauel, Krystin/0000-0002-2030-1332	Deutsche Forschungsgemeinschaft [SFB TRR 34, HA 3125/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants from Deutsche Forschungsgemeinschaft Grant SFB TRR 34, Project C10 (to S. H.) and Deutsche Forschungsgemeinschaft Grant HA 3125/4-2. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Binsker U, 2015, J BIOL CHEM, V290, P14542, DOI 10.1074/jbc.M114.623876; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carron JA, 1996, BBA-GEN SUBJECTS, V1289, P305, DOI 10.1016/0304-4165(95)00095-X; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hayashi Masao, 1994, Journal of Tissue Culture Methods, V16, P193, DOI 10.1007/BF01540649; HOSTETTER MK, 1986, J INFECT DIS, V153, P682, DOI 10.1093/infdis/153.4.682; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; JAFFE EA, 1985, BLOOD, V65, P79; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kohler S, 2015, THROMB HAEMOSTASIS, V113, P125, DOI 10.1160/TH14-06-0561; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; LAWLER J, 1993, J MOL EVOL, V36, P509, DOI 10.1007/BF00556355; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Li-Korotky HS, 2010, MICROB PATHOGENESIS, V49, P204, DOI 10.1016/j.micpath.2010.05.014; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; MAJACK RA, 1985, J CELL BIOL, V101, P1059, DOI 10.1083/jcb.101.3.1059; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; REED MJ, 1995, AM J PATHOL, V147, P1068; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; SAGLIO SD, 1982, BLOOD, V59, P162; Sanchez CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026587; Selva L, 2012, EUR J CLIN MICROBIOL, V31, P1487, DOI 10.1007/s10096-011-1468-7; Starlinger P, 2010, J THROMB HAEMOST, V8, P1809, DOI 10.1111/j.1538-7836.2010.03908.x; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Vaziri-Sani F, 2005, J THROMB HAEMOST, V3, P154, DOI 10.1111/j.1538-7836.2004.01010.x; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597	50	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5770	5783		10.1074/jbc.M116.760504	http://dx.doi.org/10.1074/jbc.M116.760504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28209711	Green Published, hybrid			2022-12-28	WOS:000398813200015
J	Cao, SY; Liu, WB; Tan, YF; Yang, HY; Zhang, TT; Wang, T; Wang, XY; Song, YJ; Yang, RF; Du, ZM				Cao, Shi-Yang; Liu, Wan-Bin; Tan, Ya-Fang; Yang, Hui-Ying; Zhang, Ting-Ting; Wang, Tong; Wang, Xiao-Yi; Song, Ya-Jun; Yang, Rui-Fu; Du, Zong-Min			An Interaction between the Inner Rod Protein YscI and the Needle Protein YscF Is Required to Assemble the Needle Structure of the Yersinia Type Three Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION; SUBSTRATE-SPECIFICITY; EUKARYOTIC CELLS; MOLECULAR RULER; INJECTISOME; LENGTH; ENTEROCOLITICA; COMPLEX; PESTIS; POLYMERIZATION	The type III secretion system is a highly conserved virulence mechanism that is widely distributed in Gram-negative bacteria. It has a syringe-like structure composed of a multi-ring basal body that spans the bacterial envelope and a projecting needle that delivers virulence effectors into host cells. Here, we showed that the Yersinia inner rod protein YscI directly interacts with the needle protein YscF inside the bacterial cells and that this interaction depends on amino acid residues 83-102 in the carboxyl terminus of YscI. Alanine substitution of Trp-85 or Ser-86 abrogated the binding of YscI to YscF as well as needle assembly and the secretion of effectors (Yops) and the needle tip protein LcrV. However, yscI null mutants that were trans-complemented with YscI mutants that bind YscF still assembled the needle and secreted Yops, demonstrating that a direct interaction between YscF and YscI is critical for these processes. Consistently, YscI mutants that did not bind YscF resulted in greatly decreased HeLa cell cytotoxicity. Together, these results show that YscI participates in needle assembly by directly interacting with YscF.	[Cao, Shi-Yang; Liu, Wan-Bin; Tan, Ya-Fang; Yang, Hui-Ying; Zhang, Ting-Ting; Wang, Tong; Wang, Xiao-Yi; Song, Ya-Jun; Yang, Rui-Fu; Du, Zong-Min] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, RF; Du, ZM (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	ruifuyang@gmail.com; zmduams@163.com	Song, Yajun/F-3714-2011; Song, Yajun/GQQ-0476-2022	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747	National Basic Research Program of China (973 program) [2013CB910804, 2012CB518704]; National Natural Science Foundation of China [31470242, 81501716]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 program) Grants 2013CB910804 and 2012CB518704 and National Natural Science Foundation of China Grants 31470242 and 81501716. The authors declare that they have no conflicts of interest with the contents of this article.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blaylock B, 2010, MOL MICROBIOL, V75, P221, DOI 10.1111/j.1365-2958.2009.06988.x; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Diepold A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002039; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Du ZM, 2009, INT J MED MICROBIOL, V299, P355, DOI 10.1016/j.ijmm.2008.10.003; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Hamad MA, 2007, ADV EXP MED BIOL, V603, P225; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Lefebre MD, 2014, P NATL ACAD SCI USA, V111, P817, DOI 10.1073/pnas.1319698111; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Monlezun L, 2015, MOL MICROBIOL, V96, P419, DOI 10.1111/mmi.12947; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wagner S, 2009, MOL MICROBIOL, V71, P692, DOI 10.1111/j.1365-2958.2008.06556.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054121; Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005; Zhou DS, 2004, VACCINE, V22, P3367, DOI 10.1016/j.vaccine.2004.02.035; Zilkenat S, 2016, MOL CELL PROTEOMICS, V15, P1598, DOI 10.1074/mcp.M115.056598	38	13	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5488	5498		10.1074/jbc.M116.743591	http://dx.doi.org/10.1074/jbc.M116.743591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196868	hybrid, Green Published			2022-12-28	WOS:000397875500028
J	Dayan, O; Nagarajan, A; Shah, R; Ben-Yona, A; Forrest, LR; Kanner, BI				Dayan, Oshrat; Nagarajan, Anu; Shah, Raven; Ben-Yona, Assaf; Forrest, Lucy R.; Kanner, Baruch I.			An Extra Amino Acid Residue in Transmembrane Domain 10 of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1 Is Required for Efficient Ion-coupled Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OOCYTE-MEMBRANE-PATCHES; CL-COTRANSPORT FUNCTION; X-RAY STRUCTURES; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GLYCINE TRANSPORTERS; SECONDARY STRUCTURE; PROTEIN STRUCTURES; XENOPUS OOCYTES	The GABA transporter GAT-1 mediates electrogenic transport of its substrate together with sodium and chloride. It is a member of the neurotransmitter: sodium: symporters, which are crucial for synaptic transmission. Compared with all other neurotransmitter: sodium: symporters, GAT-1 and other members of the GABA transporter subfamily all contain an extra amino acid residue at or near a conserved glycine in transmembrane segment 10. Therefore, we studied the functional impact of deletion and replacement mutants of Gly-457 and its two adjacent residues in GAT-1. The glycine replacement mutants were devoid of transport activity, but remarkably the deletion mutant was active, as were mutants obtained by deleting positions on either side of Gly-457. However, the inward rectification of GABA-induced transport currents by all three deletion mutants was diminished, and the charge-to-flux ratio was increased by more than 2.5-fold, both of which indicate substantial uncoupled transport. These observations suggest that the deletions render the transporters less tightly packed. Consistent with this interpretation, the inactive G457A mutant was partially rescued by removing the adjacent serine residue. Moreover, the activity of several gating mutants was also partially rescued upon deletion of Gly-457. Structural modeling showed that the stretch surrounding Gly-457 is likely to form a pi-helix. Our data indicate that the "extra" residue in transmembrane domain 10 of the GABA transporter GAT-1 provides extra bulk, probably in the form of a pi-helix, which is required for stringent gating and tight coupling of ion and substrate fluxes in the GABA transporter family.	[Dayan, Oshrat; Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel; [Nagarajan, Anu; Shah, Raven; Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Rm 3D991,35 Convent Dr MSC3761, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.; Forrest, LR (corresponding author), NINDS, Computat Struct Biol Sect, NIH, Rm 3D991,35 Convent Dr MSC3761, Bethesda, MD 20892 USA.	lucy.forrest@nih.gov; baruch.kanner@mail.huji.ac.il	Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985	Israel Science Foundation [531/15]; Rosetrees Trust; Division of Intramural Research of the National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003139] Funding Source: NIH RePORTER; Rosetrees Trust [M18-F1] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Division of Intramural Research of the National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rosetrees Trust(Rosetrees Trust)	This work was supported in part by Grant 531/15 from the Israel Science Foundation (to B. I. K.), a grant from the Rosetrees Trust (to B. I. K.), and a grant from the Division of Intramural Research of the National Institutes of Health, NINDS (to L. R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ben-Yona A, 2013, J BIOL CHEM, V288, P4549, DOI 10.1074/jbc.M112.430215; Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Cartailler JP, 2004, STRUCTURE, V12, P133, DOI 10.1016/j.str.2003.12.001; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Konagurthu AS, 2012, BIOINFORMATICS, V28, pI97, DOI 10.1093/bioinformatics/bts223; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; Olivella M, 2013, BIOINFORMATICS, V29, P1589, DOI 10.1093/bioinformatics/btt249; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Ray A, 2010, BIOINFORMATICS, V26, P3067, DOI 10.1093/bioinformatics/btq581; Riek RP, 2001, J MOL BIOL, V306, P349, DOI 10.1006/jmbi.2000.4402; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sonders MS, 1997, J NEUROSCI, V17, P960; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weaver TM, 2000, PROTEIN SCI, V9, P201; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Willford SL, 2015, J MEMBRANE BIOL, V248, P795, DOI 10.1007/s00232-015-9797-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	53	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5418	5428		10.1074/jbc.M117.775189	http://dx.doi.org/10.1074/jbc.M117.775189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213519	hybrid, Green Published			2022-12-28	WOS:000397875500022
J	Ueki, K; Fruman, DA; Yballe, CM; Fasshauer, M; Klein, J; Asano, T; Cantley, LC; Kahn, CR				Ueki, Kohjiro; Fruman, David A.; Yballe, Claudine M.; Fasshauer, Mathias; Klein, Johannes; Asano, Tomoichiro; Cantley, Lewis C.; Kahn, C. Ronald			Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. (vol 278, 48453, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228				Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200	1	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5608	5608		10.1074/jbc.A117.305602	http://dx.doi.org/10.1074/jbc.A117.305602			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28363934	Green Published, hybrid			2022-12-28	WOS:000397875500038
J	Hoffman, H; Rice, C; Skordalakes, E				Hoffman, Hunter; Rice, Cory; Skordalakes, Emmanuel			Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA RECOGNITION; BINDING; TERT; TETRAHYMENA; TEMPLATE; ENZYME; GENE	Naturally occurring mutations in the ribonucleoprotein reverse transcriptase, telomerase, are associated with the bone marrow failure syndromes dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis. However, the mechanism by which these mutations impact telomerase function remains unknown. Here we present the structure of the human telomerase C-terminal extension (or thumb domain) determined by the method of single-wavelength anomalous diffraction to 2.31 angstrom resolution. We also used direct telomerase activity and nucleic acid binding assays to explain how naturally occurring mutations within this portion of telomerase contribute to human disease. The single mutations localize within three highly conserved regions of the telomerase thumb domain referred to as motifs E-I (thumb loop and helix), E-II, and E-III (the FVYL pocket, comprising the hydrophobic residues Phe-1012, Val-1025, Tyr-1089, and Leu-1092). Biochemical data show that the mutations associated with dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis disrupt the binding between the protein subunit reverse transcriptase of the telomerase and its nucleic acid substrates leading to loss of telomerase activity and processivity. Collectively our data show that although these mutations do not alter the overall stability or expression of telomerase reverse transcriptase, these rare genetic disorders are associated with an impaired telomerase holoenzyme that is unable to correctly assemble with its nucleic acid substrates, leading to incomplete telomere extension and telomere attrition, which are hallmarks of these diseases.	[Hoffman, Hunter; Rice, Cory; Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA; [Rice, Cory; Skordalakes, Emmanuel] Univ Penn, Perelman Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine	Skordalakes, E (corresponding author), Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA.; Skordalakes, E (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA.	skorda@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833; Rice, Cory/0000-0003-2270-030X	National Institutes of Health [R01CA201312]; Wistar Cancer Center [P30 CA10815]; NATIONAL CANCER INSTITUTE [R01CA201312, T32CA009171, P30CA010815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA201312 and Wistar Cancer Center Support Grant P30 CA10815. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Bryan C, 2015, STRUCTURE, V23, P1934, DOI 10.1016/j.str.2015.08.006; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cohen SB, 2008, NAT METHODS, V5, P355, DOI 10.1038/NMETH.F.209; Cristofari G, 2007, NAT METHODS, V4, P851, DOI 10.1038/NMETH1099; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dokal I, 1996, BRIT J HAEMATOL, V92, P775, DOI 10.1046/j.1365-2141.1996.355881.x; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Harkisheimer M, 2013, STRUCTURE, V21, P1870, DOI 10.1016/j.str.2013.08.013; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Huard S, 2003, NUCLEIC ACIDS RES, V31, P4059, DOI 10.1093/nar/gkg437; Jansson LI, 2015, NAT STRUCT MOL BIOL, V22, P883, DOI 10.1038/nsmb.3101; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Mason M, 2011, CURR OPIN STRUC BIOL, V21, P92, DOI 10.1016/j.sbi.2010.11.005; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Palmer H.M., 2000, J ANTIMICROB CHEMOTH, V45, P413, DOI [10.1093/jac/45.3.413, DOI 10.1093/JAC/45.3.413]; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Tomlinson CG, 2016, BIOCHIMIE, V128, P114, DOI 10.1016/j.biochi.2016.07.010; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Wang F, 2011, METHODS MOL BIOL, V735, P173, DOI 10.1007/978-1-61779-092-8_17; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	40	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4593	4601		10.1074/jbc.M116.771204	http://dx.doi.org/10.1074/jbc.M116.771204			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154186	hybrid, Green Published			2022-12-28	WOS:000397585100017
J	Xu, F; Dong, F; Wang, P; Cao, HY; Li, CY; Li, PY; Pang, XH; Zhang, YZ; Chen, XL				Xu, Fei; Dong, Fang; Wang, Peng; Cao, Hai-Yan; Li, Chun-Yang; Li, Ping-Yi; Pang, Xiu-Hua; Zhang, Yu-Zhong; Chen, Xiu-Lan			Novel Molecular Insights into the Catalytic Mechanism of Marine Bacterial Alginate Lyase AlyGC from Polysaccharide Lyase Family 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PECTATE LYASE; PSEUDOMONAS-AERUGINOSA; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; MAJOR SOURCES; URONIC-ACID; EVOLUTION; OLIGOSACCHARIDES; ADAPTATION	Alginate lyases that degrade alginate via a beta-elimination reaction fall into seven polysaccharide lyase (PL) families. Although the structures and catalytic mechanisms of alginate lyases in the other PL families have been clarified, those in family PL6 have yet to be revealed. Here, the crystal structure of AlyGC, a PL6 alginate lyase from marine bacterium Glaciecola chathamensis S18K6(T), was solved, and its catalytic mechanism was illustrated. AlyGC is a homodimeric enzyme and adopts a structure distinct from other alginate lyases. Each monomer contains a catalytic N-terminal domain and a functionally unknown C-terminal domain. A combined structural and mutational analysis using the structures of AlyGC and of an inactive mutant R241A in complex with an alginate tetrasaccharide indicates that conformational changes occur in AlyGC when a substrate is bound and that the two active centers in AlyGC may not bind substrates simultaneously. The C-terminal domain is shown to be essential for the dimerization and the catalytic activity of AlyGC. Residues Tyr(130), Arg(187), His(242), Arg(265), and Tyr(304) in the active center are also important for the activity of AlyGC. In catalysis, Lys(220) and Arg(241) function as the Bronsted base and acid, respectively, and a Ca2+ in the active center neutralizes the negative charge of the C5 carboxyl group of the substrate. Finally, based on our data, we propose a metal ion assisted catalytic mechanism of AlyGC for alginate cleavage with a state change mode, which provides a better understanding for polysaccharide lyases and alginate degradation.	[Xu, Fei; Dong, Fang; Wang, Peng; Cao, Hai-Yan; Li, Chun-Yang; Li, Ping-Yi; Pang, Xiu-Hua; Zhang, Yu-Zhong; Chen, Xiu-Lan] Shandong Univ, Inst Marine Sci & Technol, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Yu-Zhong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266000, Peoples R China	Shandong University; Qingdao National Laboratory for Marine Science & Technology	Chen, XL (corresponding author), Shandong Univ, Inst Marine Sci & Technol, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	cxl0423@sdu.edu.cn	WANG, Peng/GSN-5263-2022; xu, fei/AAU-4859-2020	Zhang, Yu-Zhong/0000-0002-2017-1005; Li, Chun-Yang/0000-0002-1151-4897	National Science Foundation of China [31290230, 31290231, 41676180, 31670038]; Program of Shandong for Taishan Scholars Grant [TS20090803]; National Postdoctoral Program for Innovative Talents Grant [BX201600095]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shandong for Taishan Scholars Grant; National Postdoctoral Program for Innovative Talents Grant	This work was supported by National Science Foundation of China Grants 31290230, 31290231, 41676180, and 31670038, Program of Shandong for Taishan Scholars Grant TS20090803, and National Postdoctoral Program for Innovative Talents Grant BX201600095. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alahuhta M, 2011, ACTA CRYSTALLOGR F, V67, P1498, DOI 10.1107/S1744309111038449; BROWN BJ, 1991, CARBOHYD RES, V211, P91, DOI 10.1016/0008-6215(91)84148-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dong S, 2014, J BIOL CHEM, V289, P29558, DOI 10.1074/jbc.M114.584573; DOUBET RS, 1984, APPL ENVIRON MICROB, V47, P699, DOI 10.1128/AEM.47.4.699-703.1984; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Ducruix A., 1999, CRYSTALLIZATION NUCL, P391; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertesvag H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00523; Hatch RA, 1998, ANTIMICROB AGENTS CH, V42, P974, DOI 10.1128/AAC.42.4.974; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Islan GA, 2013, MACROMOL BIOSCI, V13, P1238, DOI 10.1002/mabi.201300134; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Li LY, 2011, CARBOHYD RES, V346, P794, DOI 10.1016/j.carres.2011.01.023; Li SY, 2016, J BIOCHEM, V159, P77, DOI 10.1093/jb/mvv076; MAKI H, 1993, J GEN MICROBIOL, V139, P987, DOI 10.1099/00221287-139-5-987; Matsuyama H, 2006, INT J SYST EVOL MICR, V56, P2883, DOI 10.1099/ijs.0.64413-0; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; NAKADA HI, 1967, J BIOL CHEM, V242, P845; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; PREISS J, 1962, J BIOL CHEM, V237, P309; Qin QL, 2014, ENVIRON MICROBIOL, V16, P1642, DOI 10.1111/1462-2920.12318; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smidsrod O., 1996, CARBOHYDR EUR, V14, P6; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Thompson JE, 2010, J BIOL CHEM, V285, P23963, DOI 10.1074/jbc.M110.127571; Wang P, 2015, MOL MICROBIOL, V98, P289, DOI 10.1111/mmi.13119; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Zhu BW, 2015, BIOENGINEERED, V6, P125, DOI 10.1080/21655979.2015.1030543	47	63	66	8	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4457	4468		10.1074/jbc.M116.766030	http://dx.doi.org/10.1074/jbc.M116.766030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154171	hybrid, Green Published			2022-12-28	WOS:000397585100007
J	Gao, CJ; Guo, HT; Wei, JP; Mi, ZY; Wai, P; Kuo, PC				Gao, Chengjiang; Guo, Hongtao; Wei, Junping; Mi, Zhiyong; Wai, Philip; Kuo, Paul C.			S-Nitrosylation of heterogeneous nuclear ribonucleoprotein A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages (vol 279, pg 11236, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Gao, Chengjiang/0000-0002-9365-4497				Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3542	3542		10.1074/jbc.A117.313385	http://dx.doi.org/10.1074/jbc.A117.313385			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28235901	hybrid, Green Published			2022-12-28	WOS:000395538800042
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			RETRACTION: Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 center dot Rbx1 complex to degrade nuclear Nrf2 (Retraction of Vol 284, Pg 13856, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200	1	0	0	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2049	2049		10.1074/jbc.A117.808084	http://dx.doi.org/10.1074/jbc.A117.808084			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159762	Green Published, hybrid			2022-12-28	WOS:000395515600044
J	Cha, BY; Yang, JB; Singh, V; Zachos, NC; Sarker, RI; Chen, TE; Chakraborty, M; Tse, CM; Donowitz, M				Cha, Boyoung; Yang, Jianbo; Singh, Varsha; Zachos, Nicholas C.; Sarker, Rafiquel I.; Chen, Tian-e; Chakraborty, Molee; Tse, Chung-Ming; Donowitz, Mark			PDZ domain-dependent regulation of NHE3 protein by both internal Class II and C-terminal Class I PDZ-binding motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; BRUSH-BORDER; INHIBITION; MEMBRANE; KINASE; NHERF2; TRAFFICKING; BASAL; STIMULATION; SPECIFICITY	NHE3 directly binds Na+/H+ exchanger regulatory factor (NHERF) family scaffolding proteins that are required for many aspects of NHE3 regulation. The NHERFs bind both to an internal region (amino acids 586-660) of the NHE3 C terminus and to the NHE3 C-terminal four amino acids. The internal NHERF-binding region contains both putative Class I (-(592)SAV-) and Class II (-(CLDM)-C-595-) PDZ-binding motifs (PBMs). Point mutagenesis showed that only the Class II motif contributes to NHERF binding. In this study, the roles in regulation of NHE3 activity of these two PBMs were investigated, revealing the following findings. 1) Interaction occurred between these binding sites because mutation of either removed nearly all NHERF binding. 2) Mutations in either significantly reduced basal NHE3 activity. Total and percent plasma membrane (PM) NHE3 protein expression was reduced in the C-terminal but not in the internal PBD mutation. 3) cGMP- and Ca2+-mediated inhibition of NHE3 was impaired in both the internal and the C-terminal PBM mutations. 4) There was a significant reduction in half-life of the PM pool of NHE3 in only the internal PBM mutation but no change in total NHE3 half-life in either. 5) There were some differences in NHE3-associating proteins in the two PBM mutations. In conclusion, NHE3 binds to NHERF proteins via both an internal Class II PBM and C-terminal Class I PBM, which interact. The former determines NHE3 stability in the PM, and the latter determines total expression and percent PM expression.	Johns Hopkins Univ, Sch Med, Gastroenterol Div, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Gastroenterol Div, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022; yang, jian/HIK-0188-2022		NIDDK; National Institutes of Health [R01-DK26523, R01-DK61765, P01-DK072084, P30-DK89502]; The Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061765, R01DK026523, P01DK072084, P30DK089502] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants R01-DK26523, R01-DK61765, P01-DK072084, and P30-DK89502; The Hopkins Digestive Diseases Basic and Translational Research Core Center; and The Hopkins Center for Epithelial Disorders. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Boisguerin P, 2004, CHEM BIOL, V11, P449, DOI 10.1016/j.chembiol.2004.03.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Cha BY, 2014, AM J PHYSIOL-CELL PH, V307, pC55, DOI 10.1152/ajpcell.00045.2014; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chen T, 2015, J BIOL CHEM, V290, P1952, DOI 10.1074/jbc.M114.590174; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Singh V, 2015, MOL BIOL CELL, V26, P2030, DOI 10.1091/mbc.E14-12-1597; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SRINIVASAN R, 1995, PROTEINS, V22, P81, DOI 10.1002/prot.340220202; Srinivasan R, 2002, PROTEINS, V47, P489, DOI 10.1002/prot.10103; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Vaccaro P, 2002, FEBS LETT, V512, P345, DOI 10.1016/S0014-5793(02)02220-2; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zencir S, 2013, BIOCHEM BIOPH RES CO, V432, P10, DOI 10.1016/j.bbrc.2013.01.098; Zhu XJ, 2011, J BIOL CHEM, V286, P34486, DOI 10.1074/jbc.M111.230219; Zizak M, 2012, J BIOL CHEM, V287, P13442, DOI 10.1074/jbc.M111.307256	42	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8279	8290		10.1074/jbc.M116.774489	http://dx.doi.org/10.1074/jbc.M116.774489			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28283572	Green Published, hybrid			2022-12-28	WOS:000401788600014
J	Hariri, BM; McMahon, DB; Chen, B; Freund, JR; Mansfield, CJ; Doghramji, LJ; Adappa, ND; Palmer, JN; Kennedy, DW; Reed, DR; Jiang, PH; Lee, RJ				Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Freund, Jenna R.; Mansfield, Corrine J.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Reed, Danielle R.; Jiang, Peihua; Lee, Robert J.			Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BITTER TASTE RECEPTORS; CILIARY-BEAT FREQUENCY; SEROUS ACINAR-CELLS; NONPOLYPOID CHRONIC RHINOSINUSITIS; CA2+-STIMULATED FLUID SECRETION; NASAL MUCOCILIARY CLEARANCE; NITRIC-OXIDE PRODUCTION; MUCIN GENE-EXPRESSION; NF-KAPPA-B	Chronic rhinosinusitis has a significant impact on patient quality of life, creates billions of dollars of annual healthcare costs, and accounts for similar to 20% of adult antibiotic prescriptions in the United States. Because of the rise of resistant microorganisms, there is a critical need to better understand how to stimulate and/or enhance innate immune responses as a therapeutic modality to treat respiratory infections. We recently identified bitter taste receptors (taste family type 2 receptors, or T2Rs) as important regulators of sinonasal immune responses and potentially important therapeutic targets. Here, we examined the immunomodulatory potential of flavones, a class of flavonoids previously demonstrated to have antibacterial and anti-inflammatory effects. Some flavones are also T2R agonists. We found that several flavones inhibit Muc5AC and inducible NOS up-regulation as well as cytokine release in primary and cultured airway cells in response to several inflammatory stimuli. This occurs at least partly through inhibition of protein kinase C and receptor tyrosine kinase activity. We also demonstrate that sinonasal ciliated epithelial cells express T2R14, which closely co-localizes (< 7 nm) with the T2R38 isoform. Heterologously expressed T2R14 responds to multiple flavones. These flavones also activate T2R14-driven calcium signals in primary cells that activate nitric oxide production to increase ciliary beating and mucociliary clearance. TAS2R38 polymorphisms encode functional (PAV: proline, alanine, and valine at positions 49, 262, and 296, respectively) or nonfunctional (AVI: alanine, valine, isoleucine at positions 49, 262, and 296, respectively) T2R38. Our data demonstrate that T2R14 in sinonasal cilia is a potential therapeutic target for upper respiratory infections and that flavones may have clinical potential as topical therapeutics, particularly in T2R38 AVI/AVI individuals.	[Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Freund, Jenna R.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mansfield, Corrine J.; Reed, Danielle R.; Jiang, Peihua] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Monell Chemical Senses Center	Lee, RJ (corresponding author), Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 5th Floor Ste A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@mail.med.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	National Institutes of Health Grants [P30DC011735, S10OD018125]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC011735, R03DC013862] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018125] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Gruenert (University of California at San Francisco) for 16HBE14o - cells and M. Victoria (University of Pennsylvania) for excellent technical assistance. Genotyping of patient samples was supported by National Institutes of Health Grants P30DC011735 and S10OD018125 (to D. R. R.).	Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P783, DOI 10.1002/alr.21803; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P25, DOI 10.1002/alr.21666; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adappa ND, 2013, INT FORUM ALLERGY RH, V3, P184, DOI 10.1002/alr.21140; Agullo G, 1997, BIOCHEM PHARMACOL, V53, P1649, DOI 10.1016/S0006-2952(97)82453-7; Aksoy E, 2004, INT J BIOCHEM CELL B, V36, P183, DOI 10.1016/S1357-2725(03)00210-3; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Atsuta S, 1998, ANN OTO RHINOL LARYN, V107, P47, DOI 10.1177/000348949810700109; Babu KS, 2006, BIOORG MED CHEM LETT, V16, P221, DOI 10.1016/j.bmcl.2005.09.009; Bachmanov AA, 2014, CURR PHARM DESIGN, V20, P2669, DOI 10.2174/13816128113199990566; Bhattacharyya N, 2008, ANN OTO RHINOL LARYN, V117, P448, DOI 10.1177/000348940811700608; Bhattacharyya N, 2012, OTOLARYNG HEAD NECK, V146, P307, DOI 10.1177/0194599811426089; Braverman I, 1998, J OTOLARYNGOL, V27, P145; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Campa D, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-88; Caramori G, 2009, HISTOPATHOLOGY, V55, P321, DOI 10.1111/j.1365-2559.2009.03377.x; Chen B, 2006, AM J RHINOL, V20, P325, DOI 10.2500/ajr.2006.20.2870; Cherry Donald K, 2002, Adv Data, P1; Cohen NA, 2006, ANN OTO RHINOL LARYN, V115, P20; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cruickshank SF, 2003, BRIT J PHARMACOL, V140, P1442, DOI 10.1038/sj.bjp.0705571; CUSHMAN M, 1991, J MED CHEM, V34, P798, DOI 10.1021/jm00106a047; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Dao TT, 2003, ARCH PHARM RES, V26, P581, DOI 10.1007/BF02976703; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Dzaman Karolina, 2016, Otolaryngol Pol, V70, P13, DOI 10.5604/00306657.1209438; Eynott PR, 2003, J PHARMACOL EXP THER, V304, P22, DOI 10.1124/jpet.102.040295; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; Fischer A, 2002, PULM PHARMACOL THER, V15, P73, DOI 10.1006/pupt.2001.0332; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Gallegos LL, 2011, METHODS MOL BIOL, V756, P295, DOI 10.1007/978-1-61779-160-4_17; Gallo S, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0321-3; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; GEAHLEN RL, 1989, J NAT PROD, V52, P982, DOI 10.1021/np50065a011; Godoy JM, 2011, OTOLARYNG HEAD NECK, V145, P673, DOI 10.1177/0194599811407279; Grecco HE, 2011, CHEMPHYSCHEM, V12, P484, DOI 10.1002/cphc.201000795; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudis DA, 2010, OTOLARYNG CLIN N AM, V43, P461, DOI 10.1016/j.otc.2010.02.007; Guo SW, 2001, ANN HUM BIOL, V28, P111; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P319, DOI 10.2500/ajra.2016.30.4360; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; HAWS C, 1992, AM J PHYSIOL, V263, pL692, DOI 10.1152/ajplung.1992.263.6.L692; Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P467, DOI 10.2500/ajra.2013.27.3960; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Kim JO, 2012, PHYTOTHER RES, V26, P1784, DOI 10.1002/ptr.4650; Kim KC, 2014, INT J MOL MED, V34, P592, DOI 10.3892/ijmm.2014.1804; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Kuhn C, 2013, METHOD CELL BIOL, V117, P229, DOI 10.1016/B978-0-12-408143-7.00013-X; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Kuroda Y., 2016, SCI REP, V80, P2014; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Lee RJ, 2008, J GEN PHYSIOL, V132, P161, DOI 10.1085/jgp.200810017; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2016, SCI AM, V314, P38; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, J MOL MED, V92, P1235, DOI 10.1007/s00109-014-1222-6; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412817; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Li F, 2013, MOL HUM REPROD, V19, P349, DOI 10.1093/molehr/gat009; Lipchock SV, 2013, AM J CLIN NUTR, V98, P1136, DOI 10.3945/ajcn.113.066688; Liu IX, 2001, J PHARM PHARMACOL, V53, P129, DOI 10.1211/0022357011775118; Ll Li, 2008, Shengli Xuebao, V60, P743; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Ly Nghi, 2002, Adv Data, P1; Ma LL, 2016, BIOMED PHARMACOTHER, V81, P491, DOI 10.1016/j.biopha.2016.04.006; MAJIMA Y, 1986, CLIN OTOLARYNGOL, V11, P55, DOI 10.1111/j.1365-2273.1986.tb00108.x; Manes RP, 2012, FACIAL PLAST SURG CL, V20, P87, DOI 10.1016/j.fsc.2011.10.010; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Marcinkiewicz J, 1997, IMMUNOPHARMACOLOGY, V37, P35, DOI 10.1016/S0162-3109(96)00168-3; Marcinkiewicz J, 2013, POL ARCH MED WEWN, V123, P309, DOI 10.20452/pamw.1780; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Martinez-Anton A, 2006, CLIN EXP ALLERGY, V36, P448, DOI 10.1111/j.1365-2222.2006.02451.x; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mfuna Endam L, 2014, INT FORUM ALLERGY RH, V4, P200, DOI 10.1002/alr.21275; Mughal EU, 2006, BIOORGAN MED CHEM, V14, P4704, DOI 10.1016/j.bmc.2006.03.031; Nanua S, 2006, AM J RESP CELL MOL, V35, P602, DOI 10.1165/rcmb.2006-0149OC; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Navarro-Gonzalez JF, 2011, CONTRIB NEPHROL, V170, P113, DOI 10.1159/000325646; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; Pan MH, 2002, CARCINOGENESIS, V23, P1677, DOI 10.1093/carcin/23.10.1677; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Roland WSU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118200; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Rom DI, 2017, RHINOLOGY, V55, P90, DOI [10.4193/Rhino16.181, 10.4193/Rhin16.181]; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sato M, 1996, J ETHNOPHARMACOL, V54, P171, DOI 10.1016/S0378-8741(96)01464-X; Sato Y, 2004, INT J ANTIMICROB AG, V24, P226, DOI 10.1016/j.ijantimicag.2004.02.028; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seleem D, 2017, ARCH ORAL BIOL, V76, P76, DOI 10.1016/j.archoralbio.2016.08.030; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Settipane RA, 2013, AM J RHINOL ALLERGY, V27, pS11, DOI 10.2500/ajra.2013.27.3925; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shin HD, 2012, TUBERC RESPIR DIS, V73, P204, DOI 10.4046/trd.2012.73.4.204; Sikder MA, 2014, TUBERC RESPIR DIS, V76, P120, DOI 10.4046/trd.2014.76.3.120; Sikder MA, 2014, PHYTOTHER RES, V28, P62, DOI 10.1002/ptr.4954; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Song JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-28; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Suh YA, 2015, INT J ONCOL, V46, P1405, DOI 10.3892/ijo.2014.2808; Vaiyapuri S, 2013, ARTERIOSCL THROM VAS, V33, P2740, DOI 10.1161/ATVBAHA.113.301988; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Woo KJ, 2005, FEBS LETT, V579, P705, DOI 10.1016/j.febslet.2004.12.048; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Yang H, 2014, ONCOTARGET, V5, P8188, DOI 10.18632/oncotarget.2340; Yao J, 2014, IMMUNOLOGY, V143, P241, DOI 10.1111/imm.12305; Yeh CH, 2014, ENVIRON TOXICOL, V29, P1162, DOI 10.1002/tox.21847; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4; Zhang SY, 2011, AM J RHINOL ALLERGY, V25, P307, DOI 10.2500/ajra.2011.25.3643; Zhang XW, 2011, PHARM BIOL, V49, P256, DOI 10.3109/13880209.2010.501803; Zhang Y, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/173748; Zhao KQ, 2012, FASEB J, V26, P3178, DOI 10.1096/fj.11-202184	140	63	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8484	8497		10.1074/jbc.M116.771949	http://dx.doi.org/10.1074/jbc.M116.771949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28373278	Green Published, hybrid			2022-12-28	WOS:000401788600031
J	Taschner, M; Mourao, A; Awasthi, M; Basquin, J; Lorentzen, E				Taschner, Michael; Mourao, Andre; Awasthi, Mayanka; Basquin, Jerome; Lorentzen, Esben			Structural basis of outer dynein arm intraflagellar transport by the transport adaptor protein ODA16 and the intraflagellar transport protein IFT46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; crystal structure; dynein; intracellular trafficking; primary cilium; IFT; cilium; flagellum; intraflagellar transport; outer dynein arms	B CORE COMPLEX; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; TUBULIN TRANSPORT; CRYSTAL-STRUCTURE; ARCHITECTURE; CILIUM; PURIFICATION; RESOLUTION; MOTILITY	Motile cilia are found on unicellular organisms such as the green alga Chlamydomonas reinhardtii, on sperm cells, and on cells that line the trachea and fallopian tubes in mammals. The motility of cilia relies on a number of large protein complexes including the force-generating outer dynein arms (ODAs). The transport of ODAs into cilia has been previously shown to require the transport adaptor ODA16, as well as the intraflagellar transport (IFT) protein IFT46, but the molecular mechanism by which ODAs are recognized and transported into motile cilia is still unclear. Here, we determined the high-resolution crystal structure of C. reinhardtii ODA16 (CrODA16) and mapped the binding to IFT46 and ODAs. The CrODA16 structure revealed a small 80-residue N-terminal domain and a C-terminal 8-bladed -propeller domain that are both required for the association with the N-terminal 147 residues of IFT46. The dissociation constant of the IFT46-ODA16 complex was 200 nm, demonstrating that CrODA16 associates with the IFT complex with an affinity comparable with that of the individual IFT subunits. Furthermore, we show, using ODAs extracted from the axonemes of C. reinhardtii, that the C-terminal -propeller but not the N-terminal domain of CrODA16 is required for the interaction with ODAs. These data allowed us to present an architectural model for ODA16-mediated IFT of ODAs.	[Taschner, Michael; Lorentzen, Esben] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Mourao, Andre] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Awasthi, Mayanka] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Basquin, Jerome] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Aarhus University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland College Park; Max Planck Society	Lorentzen, E (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	el@mbg.au.dk	AWASTHI, MAYANKA/J-1219-2019; Lorentzen, Esben/AAX-8077-2020	AWASTHI, MAYANKA/0000-0002-4395-0589; Taschner, Michael/0000-0002-8881-3705; Lorentzen, Esben/0000-0001-6493-7220	Novo Nordisk Foundation [NNF15OC0014164]; European Research Council [310343]; Novo Nordisk Fonden [NNF15OC0016050] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Novo Nordisk Foundation Grant NNF15OC0014164 and European Research Council Grant 310343. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Bhogaraju S, 2014, BIOESSAYS, V36, P463, DOI 10.1002/bies.201400007; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Bieniossek C., 2008, CURR PROTOC PROTEIN; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Brennich ME, 2017, JOVE-J VIS EXP, DOI 10.3791/54861; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Dobell C., 1932, A LEEUWENHOEK HIS LI; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2014, ELIFE, V3, DOI 10.7554/eLife.01566; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Jiang X, 2017, J CELL SCI, V130, P879, DOI 10.1242/jcs.199117; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; King SM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028100; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kubo T, 2016, J CELL SCI, V129, P2106, DOI 10.1242/jcs.187120; Lechtreck KF, 2015, TRENDS BIOCHEM SCI, V40, P765, DOI 10.1016/j.tibs.2015.09.003; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Moon TM, 2013, J MOL BIOL, V425, P1245, DOI 10.1016/j.jmb.2013.01.031; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Taschner M, 2016, METHODS MOL BIOL, V1454, P69, DOI 10.1007/978-1-4939-3789-9_5; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD	65	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7462	7473		10.1074/jbc.M117.780155	http://dx.doi.org/10.1074/jbc.M117.780155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28298440	Green Published, hybrid			2022-12-28	WOS:000400761300016
J	Yamamoto, H; Tobisawa, Y; Inubushi, T; Irie, F; Ohyama, C; Yamaguchi, Y				Yamamoto, Hayato; Tobisawa, Yuki; Inubushi, Toshihiro; Irie, Fumitoshi; Ohyama, Chikara; Yamaguchi, Yu			A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface; glycosaminoglycan; hyaluronan; hyaluronidase; membrane function; CEMIP; KIAA1199; TMEM2	JAAGSIEKTE SHEEP RETROVIRUS; SYNDROMIC HEARING-LOSS; PECTATE LYASE-C; ERWINIA-CHRYSANTHEMI; 3-DIMENSIONAL STRUCTURE; CUSHION DEVELOPMENT; GENE; EXPRESSION; CANCER; KIAA1199	Hyaluronan (HA) is an extremely large polysaccharide (glycosaminoglycan) involved in many cellular functions. HA catabolism is thought to involve the initial cleavage of extracellular high-molecular-weight (HMW) HA into intermediate-size HA by an extracellular or cell-surface hyaluronidase, internalization of intermediate-size HA, and complete degradation into monosaccharides in lysosomes. Despite considerable research, the identity of the hyaluronidase responsible for the initial HA cleavage in the extracellular space remains elusive. HYAL1 and HYAL2 have properties more consistent with lysosomal hyaluronidases, whereas CEMIP/KIAA1199, a recently identified HA-binding molecule that has HA-degrading activity, requires the participation of the clathrin-coated pit pathway of live cells for HA degradation. Here we show that transmembrane protein 2 (TMEM2), a mammalian homolog of a protein playing a role in zebrafish endocardial cushion development, is a cell-surface hyaluronidase. Live immunostaining and surface biotinylation assays confirmed that mouse TMEM2 is expressed on the cell surface in a type II transmembrane topology. TMEM2 degraded HMW-HA into approximate to 5-kDa fragments but did not cleave chondroitin sulfate or dermatan sulfate, indicating its specificity to HA. The hyaluronidase activity of TMEM2 was Ca2+-dependent; the enzyme's pH optimum is around 6-7, and unlike CEMIP/KIAA1199, TMEM2 does not require the participation of live cells for its hyaluronidase activity. Moreover, TMEM2-expressing cells could eliminate HA immobilized on a glass surface in a contact-dependent manner. Together, these data suggest that TMEM2 is the long-sought-after hyaluronidase that cleaves extracellular HMW-HA into intermediate-size fragments before internalization and degradation in the lysosome.	[Yamamoto, Hayato; Tobisawa, Yuki; Inubushi, Toshihiro; Irie, Fumitoshi; Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA; [Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan	Sanford Burnham Prebys Medical Discovery Institute; Hirosaki University	Yamaguchi, Y (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA.	yyamaguchi@sbpdiscovery.org	Tobisawa, Yuki/G-3802-2014	Tobisawa, Yuki/0000-0001-8026-9541	National Institutes of Health [R01 AR062692]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grant R01 AR062692. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; AFIFY AM, 1993, ARCH BIOCHEM BIOPHYS, V305, P434, DOI 10.1006/abbi.1993.1443; Beech DJ, 2002, J SURG RES, V103, P203, DOI 10.1006/jsre.2002.6351; Bouga H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-499; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chanmee T, 2016, CANCER LETT, V375, P20, DOI 10.1016/j.canlet.2016.02.031; Cherr GN, 2001, MATRIX BIOL, V20, P515, DOI 10.1016/S0945-053X(01)00171-8; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Evensen NA, 2013, JNCI-J NATL CANCER I, V105, P1402, DOI 10.1093/jnci/djt224; Fink SP, 2015, ONCOTARGET, V6, P30500, DOI 10.18632/oncotarget.5921; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Godin DA, 2000, ARCH OTOLARYNGOL, V126, P402, DOI 10.1001/archotol.126.3.402; Guo JH, 2006, FEBS LETT, V580, P581, DOI 10.1016/j.febslet.2005.12.076; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123; Hida D, 2015, MATRIX BIOL, V48, P42, DOI 10.1016/j.matbio.2015.04.002; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; LIETZKE SE, 1994, PLANT PHYSIOL, V106, P849, DOI 10.1104/pp.106.3.849; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Miller AD, 2006, OSTEOARTHR CARTILAGE, V14, P1315, DOI 10.1016/j.joca.2006.08.004; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Totong R, 2011, DEVELOPMENT, V138, P4199, DOI 10.1242/dev.064261; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; Vigdorovich V, 2005, J VIROL, V79, P79, DOI 10.1128/JVI.79.1.79-86.2005; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Wrzesinski T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1530-4; YODER MD, 1995, PLANT PHYSIOL, V107, P349, DOI 10.1104/pp.107.2.349; Yoshida H, 2014, FEBS LETT, V588, P111, DOI 10.1016/j.febslet.2013.11.017; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	44	87	90	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7304	7313		10.1074/jbc.M116.770149	http://dx.doi.org/10.1074/jbc.M116.770149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28246172	Green Published, hybrid			2022-12-28	WOS:000400761300003
J	Kulawik, A; Engesser, R; Ehlting, C; Raue, A; Albrecht, U; Hahn, B; Lehmann, WD; Gaestel, M; Klingmuller, U; Haussinger, D; Timmer, J; Bode, JG				Kulawik, Andreas; Engesser, Raphael; Ehlting, Christian; Raue, Andreas; Albrecht, Ute; Hahn, Bettina; Lehmann, Wolf-Dieter; Gaestel, Matthias; Klingmueller, Ursula; Haeussinger, Dieter; Timmer, Jens; Bode, Johannes G.			IL-1 beta-induced and p38(MAPK)-dependent activation of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) in hepatocytes: Signal transduction with robust and concentration-independent signal amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CELLS; PRO-INFLAMMATORY CYTOKINES; NF-KAPPA-B; TISSUE DISPERSION; GENE-EXPRESSION; IN-VITRO; SYSTEMS; MECHANISMS; PATHWAY; MODELS	The IL-1 beta-induced activation of the p38(MAPK)/MAPK-activated protein kinase 2 (MK2) pathway in hepatocytes is important for control of the acute phase response and regulation of liver regeneration. Many aspects of the regulatory relevance of this pathway have been investigated in immune cells in the context of inflammation. However, very little is known about concentration-dependent activation kinetics and signal propagation in hepatocytes and the role of MK2. We established a mathematical model for IL-1 beta-induced activation of the p38(MAPK)/MK2 pathway in hepatocytes that was calibrated to quantitative data on time-and IL-1 beta concentration-dependent phosphorylation of p38(MAPK) and MK2 in primary mouse hepatocytes. This analysis showed that, in hepatocytes, signal transduction from IL-1 beta via p38MAPK to MK2 is characterized by strong signal amplification. Quantification of p38MAPK and MK2 revealed that, in hepatocytes, at maximum, 11.3% of p38MAPK molecules and 36.5% of MK2 molecules are activated in response to IL-1 beta. The mathematical model was experimentally validated by employing phosphatase inhibitors and the p38MAPK inhibitor SB203580. Model simulations predicted an IC50 of 1-1.2 mu M for SB203580 in hepatocytes. In silico analyses and experimental validation demonstrated that the kinase activity of p38(MAPK) determines signal amplitude, whereas phosphatase activity affects both signal amplitude and duration. p38(MAPK) and MK2 concentrations and responsiveness toward IL-1 beta were quantitatively compared between hepatocytes and macrophages. In macrophages, the absolute p38(MAPK) and MK2 concentration was significantly higher. Finally, in line with experimental observations, the mathematical model predicted a significantly higher half-maximal effective concentration for IL-1 beta-induced pathway activation in macrophages compared with hepatocytes, underscoring the importance of cell type-specific differences in pathway regulation.	[Kulawik, Andreas; Ehlting, Christian; Albrecht, Ute; Haeussinger, Dieter; Bode, Johannes G.] Heinrich Heine Univ, Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany; [Engesser, Raphael; Raue, Andreas; Timmer, Jens] Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany; [Klingmueller, Ursula] German Canc Res Ctr, Div Syst Biol Signal Transduct, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Physiol Chem, D-30625 Hannover, Germany; [Engesser, Raphael; Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Schanzlestr 18, D-79104 Freiburg, Germany	Heinrich Heine University Dusseldorf; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School; University of Freiburg	Bode, JG (corresponding author), Heinrich Heine Univ, Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	Johannes.Bode@med.uni-duesseldorf.de	Ehlting, Christian/AAI-3791-2020; Klingmüller, Ursula/G-8477-2013; Gaestel, Matthias/A-6560-2013	Ehlting, Christian/0000-0003-0103-1856; Klingmüller, Ursula/0000-0001-9845-3099; Gaestel, Matthias/0000-0002-4944-4652	Virtual Liver Network - German Federal Ministry of Education and Research (BmBF); collaborative research center - Deutsche Forschungsgemeinschaft	Virtual Liver Network - German Federal Ministry of Education and Research (BmBF)(Federal Ministry of Education & Research (BMBF)); collaborative research center - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was mainly supported by the Virtual Liver Network funded by the German Federal Ministry of Education and Research (BmBF) and in part by the collaborative research center SFB 974 funded by the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht U, 2007, CELL SIGNAL, V19, P1866, DOI 10.1016/j.cellsig.2007.04.007; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bode JG, 2001, BIOL CHEM, V382, P1447, DOI 10.1515/BC.2001.178; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Ehlting C, 2016, J HEPATOL, V64, P380, DOI 10.1016/j.jhep.2015.08.012; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Espelin CW, 2010, MOL BIOSYST, V6, P1956, DOI 10.1039/c002848g; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Frantz S, 2002, NAT REV DRUG DISCOV, V1, P253, DOI 10.1038/nrd785; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Grubelnik V, 2009, BIOPHYS CHEM, V143, P132, DOI 10.1016/j.bpc.2009.04.009; Hahn B, 2013, J PROTEOME RES, V12, P637, DOI 10.1021/pr3007232; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Hendriks BS, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-23; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Ligeti E, 2012, ACTA PHYSIOL, V204, P469, DOI 10.1111/j.1748-1716.2012.02414.x; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Mavropoulos A, 2013, AUTOIMMUN REV, V12, P580, DOI 10.1016/j.autrev.2012.10.019; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074335; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; SEGLEN PO, 1973, EXP CELL RES, V76, P25, DOI 10.1016/0014-4827(73)90414-X; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6291	6302		10.1074/jbc.M117.775023	http://dx.doi.org/10.1074/jbc.M117.775023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223354	hybrid, Green Published			2022-12-28	WOS:000399538700023
J	Lim, CS; Alkon, DL; Stephenson, FA				Lim, Chol Seung; Alkon, Daniel L.; Stephenson, F. Anne			Inhibition of coactivator-associated arginine methyltransferase 1 modulates dendritic arborization and spine maturation of cultured hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; MEMORY; PKC; METHYLATION; STABILITY; PHOSPHORYLATION	An improved understanding of the molecular mechanisms in synapse formation provides insight into both learning and memory and the etiology of neurodegenerative disorders. Coactivator-associated arginine methyltransferase 1 (CARM1) is a protein methyltransferase that negatively regulates synaptic gene expression and inhibits neuronal differentiation. Despite its regulatory function in neurons, little is known about the CARM1 cellular location and its role in dendritic maturation and synapse formation. Here, we examined the effects of CARM1 inhibition on dendritic spine and synapse morphology in the rat hippocampus. CARM1 was localized in hippocampal post-synapses, with immunocytochemistry and electron microscopy revealing co-localization of CARM1 with post-synaptic density (PSD)-95 protein, a post-synaptic marker. Specific siRNA-mediated suppression of CARM1 expression resulted in precocious dendritic maturation, with increased spine width and density at sites along dendrites and induction of mushroom-type spines. These changes were accompanied by a striking increase in the cluster size and number of key synaptic proteins, including N-methyl-D-aspartate receptor subunit 2B (NR2B) and PSD-95. Similarly, pharmacological inhibition of CARM1 activity with the CARM1-specific inhibitor AMI-1 significantly increased spine width and mushroom-type spines and also increased the cluster size and number of NR2B and cluster size of PSD-95. These results suggest that CARM1 is a postsynaptic protein that plays roles in dendritic maturation and synaptic formation and that spatiotemporal regulation of CARM1 activity modulates neuronal connectivity and improves synaptic dysfunction.	[Lim, Chol Seung; Alkon, Daniel L.; Stephenson, F. Anne] West Virginia Univ, Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA	West Virginia University	Lim, CS (corresponding author), West Virginia Univ, Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA.	clim@hsc.wvu.edu						Amtul Z, 2015, REV NEUROSCIENCE, V26, P253, DOI 10.1515/revneuro-2014-0075; Basso M, 2015, EXP NEUROL, V271, P77, DOI 10.1016/j.expneurol.2015.05.003; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Colombrita C, 2013, MOL CELL NEUROSCI, V56, P447, DOI 10.1016/j.mcn.2013.02.003; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Feng Q, 2009, J BIOL CHEM, V284, P36167, DOI 10.1074/jbc.M109.065524; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; McBride AE, 2006, ENZYMES, V24, P51, DOI 10.1016/S1874-6047(06)80005-3; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Nagura H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-43; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Pontrello Crystal G, 2009, Open Neurosci J, V3, P67; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sun MK, 2010, PHARMACOL THERAPEUT, V127, P66, DOI 10.1016/j.pharmthera.2010.03.001; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Wondolowski J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00223; Woolfrey KM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3025948; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhu JW, 2016, NAT REV NEUROSCI, V17, P209, DOI 10.1038/nrn.2016.18	51	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6402	6413		10.1074/jbc.M117.775619	http://dx.doi.org/10.1074/jbc.M117.775619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28264928	hybrid, Green Published			2022-12-28	WOS:000399538700032
J	Stalnecker, CA; Erickson, JW; Cerione, RA				Stalnecker, Clint A.; Erickson, Jon W.; Cerione, Richard A.			Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; RAT-LIVER GLUTAMINASE; PHOSPHATE ACTIVATION; BPTES INHIBITION; CELL BIOLOGY; METABOLISM; CANCER; MECHANISM; GROWTH; GLUTAMINOLYSIS	The first step in glutamine catabolism is catalysis by the mitochondrial enzyme glutaminase, with a specific isoform, glutaminase C (GAC), being highly expressed in cancer cells. GAC activation requires the formation of homotetramers, promoted by anionic allosteric activators such as inorganic phosphate. This leads to the proper orientation of a flexible loop proximal to the dimer-dimer interface that is essential for catalysis (i.e. the "activation loop"). A major class of allosteric inhibitors of GAC, with the prototype being bis-2-(5-phenylacetamido-1,2,4-thiadiazol- 2-yl) ethyl sulfide (BPTES) and the related molecule CB-839, binds to the activation loop and induces the formation of an inactive tetramer (two inhibitors bound per active tetramer). Here we describe a direct readout for monitoring the dynamics of the activation loop of GAC in response to these allosteric inhibitors, as well as allosteric activators, through the substitution of phenylalanine at position 327 with tryptophan (F327W). The tryptophan fluorescence of the GAC(F327W) mutant undergoes a marked quenching upon the binding of BPTES or CB-839, yielding titration profiles that make it possible to measure the binding affinities of these inhibitors for the enzyme. Allosteric activators like phosphate induce the opposite effect (i.e. fluorescence enhancement). These results describe direct readouts for the binding of the BPTES class of allosteric inhibitors as well as for inorganic phosphate and related activators of GAC, which should facilitate screening for additional modulators of this important metabolic enzyme.	[Stalnecker, Clint A.; Erickson, Jon W.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Stalnecker, Clint A.] Albright Coll, Dept Chem & Biochem, Reading, PA 19612 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.; Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Stalnecker, Clint/0000-0002-0570-4416	NIGMS; National Institutes of Health Grants [R01 GM040654, R01 GM047458]; NCI; National Institutes of Health National Research Service Award Predoctoral Fellowship [F31 CA180650]; NATIONAL CANCER INSTITUTE [R01CA201402, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R35GM122575, R01GM040654] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01 GM040654 and R01 GM047458 (to R.A.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NCI, National Institutes of Health National Research Service Award Predoctoral Fellowship F31 CA180650. Present address: Dept. of Chemistry and Biochemistry, Albright College, Reading, PA 19612.	Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V174, P82, DOI 10.1016/0003-9861(76)90326-X; DARMAUN D, 1986, AM J PHYSIOL, V251, pE117, DOI 10.1152/ajpendo.1986.251.1.E117; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hartwick EW, 2012, J ENZYM INHIB MED CH, V27, P861, DOI 10.3109/14756366.2011.622272; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; HUANG YZ, 1976, ENZYME, V21, P408; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Krall AS, 2015, NAT CELL BIOL, V17, P1515, DOI 10.1038/ncb3278; Laake JH, 1999, NEUROSCIENCE, V88, P1137, DOI 10.1016/S0306-4522(98)00298-X; Li YX, 2016, J BIOL CHEM, V291, P20900, DOI 10.1074/jbc.M116.720268; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Lukey MJ, 2013, FUTURE MED CHEM, V5, P1685, DOI 10.4155/fmc.13.130; Matre P, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.3763.3763; McDermott LA, 2016, BIOORGAN MED CHEM, V24, P1819, DOI 10.1016/j.bmc.2016.03.009; McDonald CJ, 2015, NEUROCHEM INT, V88, P10, DOI 10.1016/j.neuint.2014.12.003; MCGIVAN J, 1985, EUR J BIOCHEM, V148, P323, DOI 10.1111/j.1432-1033.1985.tb08842.x; Moller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074783; Newcomb R.W., 2002, U.S. Pat., Patent No. 6451828; PATEL M, 1984, BIOCHEM J, V220, P583, DOI 10.1042/bj2200583; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Shukla K, 2012, J MED CHEM, V55, P10551, DOI 10.1021/jm301191p; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Thomas AG, 2014, BIOCHEM BIOPH RES CO, V443, P32, DOI 10.1016/j.bbrc.2013.11.043; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zimmermann SC, 2016, ACS MED CHEM LETT, V7, P520, DOI 10.1021/acsmedchemlett.6b00060	39	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6095	6107		10.1074/jbc.M116.758219	http://dx.doi.org/10.1074/jbc.M116.758219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28196863	Green Published, hybrid			2022-12-28	WOS:000399538700008
J	Wijesinghe, KJ; Urata, S; Bhattarai, N; Kooijman, EE; Gerstman, BS; Chapagain, PP; Li, S; Stahelin, RV				Wijesinghe, Kaveesha J.; Urata, Sarah; Bhattarai, Nisha; Kooijman, Edgar E.; Gerstman, Bernard S.; Chapagain, Prem P.; Li, Sheng; Stahelin, Robert V.			Detection of lipid-induced structural changes of the Marburg virus matrix protein VP40 using hydrogen/deuterium exchange-mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBOLA-VIRUS; PLASMA-MEMBRANE; PHOSPHOLIPASE A(2); VIRAL-EGRESS; MOLECULAR-DYNAMICS; BINDING; DOMAIN; OLIGOMERIZATION; ENVELOPE; THERAPEUTICS	Marburg virus (MARV) is a lipid-enveloped virus from the Filoviridae family containing a negative sense RNA genome. One of the seven MARV genes encodes the matrix protein VP40, which forms a matrix layer beneath the plasma membrane inner leaflet to facilitate budding from the host cell. MARV VP40 (mVP40) has been shown to be a dimeric peripheral protein with a broad and flat basic surface that can associate with anionic phospholipids such as phosphatidylserine. Although a number of mVP40 cationic residues have been shown to facilitate binding to membranes containing anionic lipids, much less is known on how mVP40 assembles to form the matrix layer following membrane binding. Here we have used hydrogen/deuterium exchange (HDX) mass spectrometry to determine the solvent accessibility of mVP40 residues in the absence and presence of phosphatidylserine and phosphatidylinositol 4,5-bisphosphate. HDX analysis demonstrates that two basic loops in the mVP40 C-terminal domain make important contributions to anionic membrane binding and also reveals a potential oligomerization interface in the C-terminal domain as well as a conserved oligomerization interface in the mVP40 N-terminal domain. Lipid binding assays confirm the role of the two basic patches elucidated with HD/X measurements, whereas molecular dynamics simulations and membrane insertion measurements complement these studies to demonstrate that mVP40 does not appreciably insert into the hydrocarbon region of anionic membranes in contrast to the matrix protein from Ebola virus. Taken together, we propose a model by which association of the mVP40 dimer with the anionic plasma membrane facilitates assembly of mVP40 oligomers.	[Wijesinghe, Kaveesha J.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Wijesinghe, Kaveesha J.; Stahelin, Robert V.] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Urata, Sarah; Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bhattarai, Nisha; Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Kooijman, Edgar E.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA	University of Notre Dame; University of Notre Dame; University of California System; University of California San Diego; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Indiana University System; Indiana University South Bend	Li, S (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,0652, La Jolla, CA 92093 USA.; Stahelin, RV (corresponding author), Indiana Univ Sch Med, 1234 Notre Dame Ave, South Bend, IN 46617 USA.	s4li@ucsd.edu; rstaheli@iu.edu	Stahelin, Robert/L-3567-2019; Wijesinghe, Kaveesha/AAF-5610-2020	Stahelin, Robert/0000-0001-5443-7863; Chapagain, Prem/0000-0002-0999-4975	National Institutes of Health Grants [AI081077, 1U19AI117905, R01GM020501, R01AI101436]; CBBI fellowship - National Institutes of Health Grant [T32GM075762]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117905, R01AI081077, R01AI101436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBBI fellowship - National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI081077 (to R. V. S.), 1U19AI117905, R01GM020501, and R01AI101436 (to S. L.), and a CBBI fellowship funded by National Institutes of Health Grant T32GM075762 (to K. J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Dolnik O, 2010, J VIROL, V84, P7847, DOI 10.1128/JVI.00476-10; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia RA, 2004, ASSAY DRUG DEV TECHN, V2, P81, DOI 10.1089/154065804322966342; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Kolesnikova L, 2012, CELL MICROBIOL, V14, P182, DOI 10.1111/j.1462-5822.2011.01709.x; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mendoza EJ, 2016, TRENDS MOL MED, V22, P164, DOI 10.1016/j.molmed.2015.12.005; Miles P, 2015, SOFT MATTER, V11, P7722, DOI 10.1039/c5sm01695a; Natesan M, 2016, CLIN VACCINE IMMUNOL, V23, P717, DOI 10.1128/CVI.00107-16; Oda S, 2016, J VIROL, V90, P1839, DOI 10.1128/JVI.01597-15; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rathnayake SS, 2014, BBA-BIOMEMBRANES, V1838, P482, DOI 10.1016/j.bbamem.2013.09.020; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Timmins J, 2001, VIROLOGY, V283, P1, DOI 10.1006/viro.2001.0860; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wei H, 2014, DRUG DISCOV TODAY, V19, P95, DOI 10.1016/j.drudis.2013.07.019; Wijesinghe KJ, 2016, J VIROL, V90, P3074, DOI 10.1128/JVI.02607-15; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	42	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6108	6122		10.1074/jbc.M116.758300	http://dx.doi.org/10.1074/jbc.M116.758300			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28167534	hybrid, Green Published			2022-12-28	WOS:000399538700009
J	Dauner, K; Eid, W; Raghupathy, R; Presley, JF; Zha, XH				Dauner, Kristin; Eid, Walaa; Raghupathy, Riya; Presley, John F.; Zha, Xiaohui			mTOR complex 1 activity is required to maintain the canonical endocytic recycling pathway against lysosomal delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; endocytosis; endosomal sorting complexes required for transport (ESCRT); lysosome; membrane recycling; mTOR complex (mTORC); receptor recycling; transferrin; Hrs	MEMBRANE; AUTOPHAGY; TRANSPORT; METABOLISM; CELLS	The plasma membrane of mammalian cells undergoes constitutive endocytosis, endocytic sorting, and recycling, which delivers nutrients to the lysosomes. The receptors, along with membrane lipids, are normally returned to the plasma membrane to sustain this action. It is not known, however, whether this process is influenced by metabolic conditions. Here we report that endocytic recycling requires active mechanistic target of rapamycin (aka mammalian target of rapamycin) (mTORC1), a master metabolic sensor. Upon mTORC1 inactivation, either by starvation or by inhibitor, recycling receptors and plasma membrane lipids, such as transferrin receptors and sphingomyelin, are delivered to the lysosomes. This lysosomal targeting is independent of canonical autophagy: both WT and Atg5(-/-) mouse embryonic fibroblasts responded similarly. Furthermore, we identify hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), an endosomal sorting complexes required for transport (ESCORT-0) component, as a downstream target of mTORC1. Hrs requires mTORC1 activity to maintain its protein expression level. Silencing Hrs without decreasing mTORC1 activity is sufficient to target transferrin and sphingomyelin to the lysosomes. It is thus evident that the canonical recycling pathway is under the regulation of mTORC1 and likely most predominant in proliferating cells where mTORC1 is highly active.	[Dauner, Kristin; Raghupathy, Riya; Zha, Xiaohui] Univ Ottawa, Chron Dis Program, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Eid, Walaa; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada; [Presley, John F.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McGill University	Zha, XH (corresponding author), Ottawa Hosp, Res Inst, Chron Dis Program, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	xzha@ohri.ca			Canadian Institutes of Health Research [MOP-130453]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-130453. The authors declare that they have no conflicts of interest with the contents of this article.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Dobzinski N, 2015, CELL REP, V12, P1876, DOI 10.1016/j.celrep.2015.08.026; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Giordano F, 2011, P NATL ACAD SCI USA, V108, P11906, DOI 10.1073/pnas.1103381108; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim J, 2011, CELL CYCLE, V10, P1337, DOI 10.4161/cc.10.9.15291; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mueller M, 2015, ELIFE, V4, DOI 10.7554/eLife.07736; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RUTLEDGE EA, 1991, J BIOL CHEM, V266, P21125; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	24	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5737	5747		10.1074/jbc.M116.771451	http://dx.doi.org/10.1074/jbc.M116.771451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196862	Green Published, hybrid			2022-12-28	WOS:000398813200012
J	Oakley, RH; Busillo, JM; Cidlowski, JA				Oakley, Robert H.; Busillo, John M.; Cidlowski, John A.			Cross-talk between the glucocorticoid receptor and MyoD family inhibitor domain-containing protein provides a new mechanism for generating tissue-specific responses to glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; gene regulation; glucocorticoid; glucocorticoid receptor; phosphorylation; MyoD family inhibitor domain-containing protein	GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; NUCLEAR-LOCALIZATION; PHOSPHORYLATION; INTERACT; MATURATION; DISEASE; CELLS; SEQUESTRATION; RESISTANCE	Glucocorticoids are primary stress hormones that regulate many physiological processes, and synthetic derivatives of these molecules are widely used in the clinic. The molecular factors that govern tissue specificity of glucocorticoids, however, are poorly understood. The actions of glucocorticoids are mediated by the glucocorticoid receptor (GR). To discover new proteins that interact with GR and modulate its function, we performed a yeast two-hybrid assay. The MyoD family inhibitor domain-containing protein (MDFIC) was identified as a binding partner for GR. MDFIC associated with GR in the cytoplasm of cells, and treatment with glucocorticoids resulted in the dissociation of the GR-MDFIC complex. To investigate the function of the GR-MDFIC interaction, we performed a genome-wide microarray in intact and MDFIC-deficient A549 cells that were treated with glucocorticoids. A large cohort of genes was differentially regulated by GR depending on the presence or absence of MDFIC. These gene changes were strongly associated with inflammation, and glucocorticoid regulation of the inflammatory response was altered in MDFIC-deficient cells. At a molecular level, the interaction of MDFIC with GR altered the phosphorylation status of the receptor. We demonstrate in COS-1 cells that changes in receptor phosphorylation underlie the ability of MDFIC to regulate the transcriptional activity of GR. Finally, we show that GR directly represses the MDFIC gene, revealing a negative feedback loop by which glucocorticoids limit MDFIC activity. These findings identify a new binding partner for cytoplasmic GR that modulates the receptor transcriptome and contributes to the tissue-specific actions of glucocorticoids.	[Oakley, Robert H.; Busillo, John M.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, NIH, Dept Hlth & Human Serv, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	Intramural Research Program of the NIEHS, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090079, ZIAES090057, ZICES102445] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; GOROVITS R, 1994, P NATL ACAD SCI USA, V91, P4786, DOI 10.1073/pnas.91.11.4786; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Gu L, 2009, IMMUNOL LETT, V123, P179, DOI 10.1016/j.imlet.2009.03.010; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Kusano S, 2015, VIROLOGY, V486, P219, DOI 10.1016/j.virol.2015.09.020; Kusano S, 2010, BIOCHEM BIOPH RES CO, V396, P608, DOI 10.1016/j.bbrc.2010.04.111; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Lamberts SWJ, 1996, STEROIDS, V61, P157, DOI 10.1016/0039-128X(96)00005-0; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; LIGGINS GC, 1976, AM J OBSTET GYNECOL, V126, P931, DOI 10.1016/0002-9378(76)90680-3; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Miracle X, 2008, J PERINAT MED, V36, P191, DOI 10.1515/JPM.2008.032; NATHANIELSZ PW, 1978, Q J EXP PHYSIOL CMS, V63, P211, DOI 10.1113/expphysiol.1978.sp002436; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Peffer ME, 2014, MOL CELL BIOL, V34, P2611, DOI 10.1128/MCB.01121-13; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ren RQ, 2012, ENDOCRINOLOGY, V153, P5346, DOI 10.1210/en.2012-1563; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Scoltock AB, 2007, CELL DEATH DIFFER, V14, P840, DOI 10.1038/sj.cdd.4402071; Snider L, 2005, MOL CELL BIOL, V25, P5061, DOI 10.1128/MCB.25.12.5061-5072.2005; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; te Pas MFW, 2000, MOL BIOL REP, V27, P87, DOI 10.1023/A:1007120921064; Thebault S, 2001, CURR PROTEIN PEPT SC, V2, P155, DOI 10.2174/1389203013381143; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003; Zhou J, 2008, MOL ENDOCRINOL, V22, P1521, DOI 10.1210/me.2007-0273	54	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5825	5844		10.1074/jbc.M116.758888	http://dx.doi.org/10.1074/jbc.M116.758888			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223352	hybrid, Green Published			2022-12-28	WOS:000398813200019
J	Pozo, FM; Tang, JS; Bonk, KW; Keri, RA; Yao, XS; Zhang, YW				Pozo, Franklin Mayca; Tang, Jinshan; Bonk, Kristen W.; Keri, Ruth A.; Yao, Xinsheng; Zhang, Youwei			Regulatory cross-talk determines the cellular levels of 53BP1 protein, a critical factor in DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; checkpoint control; DNA damage; DNA damage response; DNA repair; degradation	DOUBLE-STRAND BREAKS; CHECKPOINT KINASE 1; 5' END RESECTION; A-TYPE LAMINS; HOMOLOGOUS RECOMBINATION; BRCA1 DEFICIENCY; PATHWAY CHOICE; CATHEPSIN-L; DSB REPAIR; DAMAGE	DNA double strand breaks (DSBs) severely disrupt DNA integrity. 53BP1 plays critical roles in determining DSB repair. Whereas the recruitment of 53BP1 to the DSB site is key for its function, recent evidence suggests that 53BP1's abundance also plays an important role in DSB repair because recruitment to damage sites will be influenced by protein availability. Initial evidence has pointed to three proteins, the ubiquitin-conjugating enzyme UbcH7, the cysteine protease cathepsin L (CTSL), and the nuclear structure protein lamin A/C, that may impact 53BP1 levels, but the roles of each protein and any interplay between them were unclear. Here we report that UbcH7-dependent degradation plays a major role in controlling 53BP1 levels both under normal growth conditions and during DNA damage. CTSL influenced 53BP1 degradation during DNA damage while having little effect under normal growth conditions. Interestingly, both the protein and the mRNA levels of CTSL were reduced in UbcH7-depleted cells. Lamin A/C interacted with 53BP1 under normal conditions. DNA damage disrupted the lamin A/C-53BP1 interaction, which preceded the degradation of 53BP1 in soluble, but not chromatin-enriched, cellular fractions. Inhibition of 53BP1 degradation by a proteasome inhibitor or by UbcH7 depletion restored the 53BP1-lamin A/C interaction. Depletion of lamin A/C, but not CTSL, caused a similar enhancement in cell sensitivity to DNA damage as UbcH7 depletion. These data suggest that multiple pathways collectively fine-tune the cellular levels of 53BP1 protein to ensure proper DSB repair and cell survival.	[Pozo, Franklin Mayca; Tang, Jinshan; Bonk, Kristen W.; Keri, Ruth A.; Zhang, Youwei] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Tang, Jinshan; Yao, Xinsheng] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China	Case Western Reserve University; Jinan University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2109 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [CA163214]; Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]; Case Cancer Center [CA043703, CA126710]; American Cancer Society [ACS RSG-15-042 DMC]; United States Department of Defense [W81XWH-14-1-0354]; National 111 Project of China [B13038]; NATIONAL CANCER INSTITUTE [R01CA163214, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Case Cancer Center; American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense); National 111 Project of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA163214 (NCI; to Y. Z.), the Clinical and Translational Science Collaborative of Cleveland Grant UL1TR000439 (National Center for National Center for Translational Sciences (NCATS) (to Y. Z.), Case Cancer Center P30 Grant CA043703 (to Y. Z.), and Grant CA126710 (NCI; to R. A. K.). This work was also supported by American Cancer Society Grant ACS RSG-15-042 DMC (to Y. Z.) and United States Department of Defense Grant W81XWH-14-1-0354) (to R. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National 111 Project of China (B13038).	Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burden RE, 2012, BIOCHIMIE, V94, P487, DOI 10.1016/j.biochi.2011.08.017; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gibbs-Seymour I, 2015, AGING CELL, V14, P162, DOI 10.1111/acel.12258; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Goodarzi AA, 2013, ADV GENET, V82, P1, DOI 10.1016/B978-0-12-407676-1.00001-9; Grotsky DA, 2013, J CELL BIOL, V200, P187, DOI 10.1083/jcb.201204053; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Han XZ, 2014, P NATL ACAD SCI USA, V111, P17456, DOI 10.1073/pnas.1408538111; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Jacot W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-523; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jullien D, 2002, J CELL SCI, V115, P71; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Neboori HJR, 2012, INT J RADIAT ONCOL, V83, pE677, DOI 10.1016/j.ijrobp.2012.01.089; Pennington KP, 2013, GYNECOL ONCOL, V128, P493, DOI 10.1016/j.ygyno.2012.12.007; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zhang HX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10201; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Zong DL, 2015, NUCLEIC ACIDS RES, V43, P4950, DOI 10.1093/nar/gkv336	43	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5992	6003		10.1074/jbc.M116.760645	http://dx.doi.org/10.1074/jbc.M116.760645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28255090	Green Published, hybrid			2022-12-28	WOS:000398813200032
J	Yang, X; Yang, SQ; Wang, C; Kuang, SH				Yang, Xin; Yang, Shiqi; Wang, Chao; Kuang, Shihuan			The hypoxia-inducible factors HIF1 and HIF2 are dispensable for embryonic muscle development but essential for postnatal muscle regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; hypoxia; hypoxia-inducible factor (HIF); muscle regeneration; Notch pathway	CELL SELF-RENEWAL; SATELLITE CELLS; STEM-CELLS; PROGENITOR CELLS; NOTCH; HIF-1-ALPHA; ACTIVATION; MYOGENESIS; DIFFERENTIATION; EXPRESSION	Muscle satellite cells are myogenic stem cells whose quiescence, activation, self-renewal, and differentiation are influenced by oxygen supply, an environmental regulator of stem cell activity. Accordingly, stem cell-specific oxygen signaling pathways precisely control the balance between muscle growth and regeneration in response to oxygen fluctuations, and hypoxia-inducible factors (HIFs) are central mediators of these cellular responses. However, the in vivo roles of HIFs in quiescent satellite cells and activated satellite cells (myoblasts) are poorly understood. Using transgenic mouse models for cell-specific HIF expression, we show here that HIF1 and HIF2 are preferentially expressed in pre- and post-differentiation myoblasts, respectively. Interestingly, double knockouts of HIF1 and HIF2 (HIF1/2 dKO) generated with the MyoD(Cre) system in embryonic myoblasts resulted in apparently normal muscle development and growth. However, HIF1/2 dKO produced with the tamoxifen-inducible, satellite cell-specific Pax7(CreER) system in postnatal satellite cells delayed injury-induced muscle repair due to a reduced number of myoblasts during regeneration. Analysis of satellite cell dynamics on myofibers confirmed that HIF1/2 dKO myoblasts exhibit reduced self-renewal but more pronounced differentiation under hypoxic conditions. Mechanistically, the HIF1/2 dKO blunted hypoxia-induced activation of Notch signaling, a key determinant of satellite cell self-renewal. We conclude that HIF1 and HIF2 are dispensable for muscle stem cell function under normoxia but are required for maintaining satellite cell self-renewal in hypoxic environments. Our insights into a critical mechanism in satellite cell homeostasis during muscle regeneration could help inform research efforts to treat muscle diseases or improve muscle function.	[Yang, Xin; Yang, Shiqi; Wang, Chao; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.; Kuang, SH (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Kuang, Shihuan/0000-0001-9180-3180	Muscular Dystrophy Association [294644]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a research grant (#294644) from the Muscular Dystrophy Association (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Drevytska T, 2012, Pathophysiology, V19, P205, DOI 10.1016/j.pathophys.2012.06.002; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; KATZ B, 1961, J PHYSIOL-LONDON, V155, P399, DOI 10.1113/jphysiol.1961.sp006636; Kim H, 2015, CYTOTHERAPY, V17, P579, DOI 10.1016/j.jcyt.2014.12.003; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Krinner A, 2009, CELL PROLIFERAT, V42, P471, DOI 10.1111/j.1365-2184.2009.00621.x; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li QF, 2005, ACTA BIOCH BIOPH SIN, V37, P665, DOI 10.1111/j.1745-7270.2005.00095.x; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Lunde IG, 2011, J PHYSIOL-LONDON, V589, P1443, DOI 10.1113/jphysiol.2010.202762; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; Merrick MA, 2002, J ATHL TRAINING, V37, P209; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ono Y, 2006, J CELL BIOCHEM, V98, P642, DOI 10.1002/jcb.20804; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sakagami H, 2014, AM J PHYSIOL-ENDOC M, V306, pE1065, DOI 10.1152/ajpendo.00597.2012; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Villa JC, 2014, CELL REP, V8, P1077, DOI 10.1016/j.celrep.2014.07.028; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	51	36	38	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5981	5991		10.1074/jbc.M116.756312	http://dx.doi.org/10.1074/jbc.M116.756312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28232488	Green Published, hybrid			2022-12-28	WOS:000398813200031
J	Zhao, P; Liu, Q; Miller, WA; Goss, DJ				Zhao, Pei; Liu, Qiao; Miller, W. Allen; Goss, Dixie J.			Eukaryotic translation initiation factor 4G (eIF4G) coordinates interactions with eIF4A, eIF4B, and eIF4E in binding and translation of the barley yellow dwarf virus 3 cap-independent translation element (BTE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein synthesis; RNA virus; RNA-protein interaction; translation initiation factor; translation regulation	RNA HELICASE ACTIVITY; STIMULATED ATPASE ACTIVITY; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; PLANT-VIRUSES; POLY(A); REGION; DOMAIN; EFFICIENCY; ENHANCERS	Barley yellow dwarf virus RNA, lacking a 5 cap and a 3 poly(A) tail, contains a cap-independent translation element (BTE) in the 3-untranslated region that interacts with host translation initiation factor eIF4G. To determine how eIF4G recruits the mRNA, three eIF4G deletion mutants were constructed: (i) eIF4G601-1196, containing amino acids 601-1196, including the putative BTE-binding region, and binding domains for eIF4E, eIF4A, and eIF4B; (ii) eIF4G601-1488, which contains an additional C-terminal eIF4A-binding domain; and (iii) eIF4G742-1196, which lacks the eIF4E-binding site. eIF4G601-1196 binds BTE tightly and supports efficient translation. The helicase complex, consisting of eIF4A, eIF4B, and ATP, stimulated BTE binding with eIF4G601-1196 but not eIF4G601-1488, suggesting that the eIF4A binding domains may serve a regulatory role, with the C-terminal binding site having negative effects. eIF4E binding to eIF4G601-1196 induced a conformational change, significantly increasing the binding affinity to BTE. A comparison of the binding of eIF4G deletion mutants with BTEs containing mutations showed a general correlation between binding affinity and ability to facilitate translation. In summary, these results reveal a new role for the helicase complex in 3 cap-independent translation element-mediated translation and show that the functional core domain of eIF4G plus an adjacent probable RNA-binding domain mediate translation initiation.	[Zhao, Pei; Liu, Qiao; Goss, Dixie J.] CUNY, Grad Ctr, Biochem Grad Program, New York, NY 10065 USA; [Zhao, Pei; Liu, Qiao; Goss, Dixie J.] CUNY, Grad Ctr, Chem Grad Program, New York, NY 10065 USA; [Zhao, Pei; Liu, Qiao; Goss, Dixie J.] CUNY, Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA; [Miller, W. Allen] Iowa State Univ, Plant Pathol & Microbiol Dept, Ames, IA 50011 USA; [Miller, W. Allen] Iowa State Univ, Biochem Biophys & Mol Biol Dept, Ames, IA 50011 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); Iowa State University; Iowa State University	Goss, DJ (corresponding author), CUNY, Hunter Coll, Dept Chem, New York, NY 10065 USA.; Goss, DJ (corresponding author), CUNY, Grad Ctr, New York, NY 10065 USA.	dgoss@hunter.cuny.edu			National Institutes of Health [R01GM067104]; National Science Foundation [NSF MCB 1513737]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM067104 (to W. A. M., subward to D. J. G.) and National Science Foundation Grant NSF MCB 1513737 (to D. J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee B, 2014, J BIOL CHEM, V289, P4286, DOI 10.1074/jbc.M113.530329; Bi XP, 2000, J BIOL CHEM, V275, P17740, DOI 10.1074/jbc.M909464199; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; De Gregorio E, 1998, RNA, V4, P828, DOI 10.1017/S1355838298980372; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Guo L, 2000, RNA, V6, P1808, DOI 10.1017/S1355838200001539; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Khan MA, 2008, BBA-GENE REGUL MECH, V1779, P622, DOI 10.1016/j.bbagrm.2008.07.004; Koev G, 2000, J VIROL, V74, P5988, DOI 10.1128/JVI.74.13.5988-5996.2000; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Kraft JJ, 2013, NUCLEIC ACIDS RES, V41, P3398, DOI 10.1093/nar/gkt026; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Mizumoto H, 2003, J VIROL, V77, P12113, DOI 10.1128/JVI.77.22.12113-12121.2003; MUNROE D, 1990, GENE, V91, P151, DOI 10.1016/0378-1119(90)90082-3; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Nicholson BL, 2011, CURR OPIN VIROL, V1, P373, DOI 10.1016/j.coviro.2011.10.002; Pestova TV, 2006, NAT CHEM BIOL, V2, P176, DOI 10.1038/nchembio0406-176; Pestova TV, 2006, NAT STRUCT MOL BIOL, V13, P98, DOI 10.1038/nsmb0206-98; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rakotondrafara AM, 2006, RNA, V12, P1893, DOI 10.1261/rna.115606; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sharma Sohani Das, 2015, J Biol Chem, V290, P11268, DOI 10.1074/jbc.M115.645002; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yumak H, 2010, BBA-GENE REGUL MECH, V1799, P653, DOI 10.1016/j.bbagrm.2010.08.003	46	25	25	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5921	5931		10.1074/jbc.M116.764902	http://dx.doi.org/10.1074/jbc.M116.764902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28242763	hybrid, Green Published			2022-12-28	WOS:000398813200026
J	Fraile, JM; Manchado, E; Lujambio, A; Quesada, V; Campos-Iglesias, D; Webb, TR; Lowe, SW; Lopez-Otin, C; Freije, JMP				Fraile, Julia M.; Manchado, Eusebio; Lujambio, Amaia; Quesada, Victor; Campos-Iglesias, Diana; Webb, Thomas R.; Lowe, Scott W.; Lopez-Otin, Carlos; Freije, Jose M. P.			USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC LETHAL INTERACTIONS; UBIQUITIN-SPECIFIC PROTEASES; PRE-MESSENGER-RNA; THERAPEUTIC TARGET; MEK INHIBITION; RAS ONCOGENE; LUNG-CANCER; ADDICTION; CELLS; SPLICEOSOME	KRAS is the most frequently mutated oncogene in human cancer, but its therapeutic targeting remains challenging. Here, we report a synthetic lethal screen with a library of deubiquitinases and identify USP39, which encodes an essential splicing factor, as a critical gene for the viability of KRAS-dependent cells. We show that splicing fidelity inhibitors decrease preferentially the proliferation rate of KRAS-active cells. Moreover, depletion of DHX38, encoding an USP39-interacting splicing factor, also reduces the viability of these cells. In agreement with these results, USP39 depletion caused a significant reduction in pre-mRNA splicing efficiency, as demonstrated through RNAseq experiments. Furthermore, we show that USP39 is up-regulated in lung and colon carcinomas and its expression correlates with KRAS levels and poor clinical outcome. Accordingly, our work provides critical information for the development of splicing-directed antitumor treatments and supports the potential of USP39-targeting strategies as the basis of new anticancer therapies.	[Fraile, Julia M.; Quesada, Victor; Campos-Iglesias, Diana; Lopez-Otin, Carlos; Freije, Jose M. P.] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Fraile, Julia M.; Quesada, Victor; Lopez-Otin, Carlos; Freije, Jose M. P.] Ctr Invest Biomed Red Canc, Madrid, Spain; [Manchado, Eusebio; Lujambio, Amaia; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Webb, Thomas R.] SRI Int, Div Biosci, Menlo Pk, CA 94025 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Memorial Sloan Kettering Cancer Center; SRI International	Freije, JMP (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	jmpf@uniovi.es	López-Otín, Carlos/AAB-2106-2020; Quesada, Víctor/B-6557-2014; Freije, José M.P./A-6535-2008	López-Otín, Carlos/0000-0001-6964-1904; Quesada, Víctor/0000-0002-8398-3457; Freije, José M.P./0000-0002-4688-8266; Lujambio, Amaia/0000-0002-2798-1481; Campos-Iglesias, Diana/0000-0002-7679-229X	Principado de Asturias, Spain; National Institutes of Health Grant [CA140474]; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; Ministerio de Economia y Competitividad; Instituto de Salud Carlos III (CIBERONC, Plan Feder); Fundacion EDP; NATIONAL CANCER INSTITUTE [R01CA140474] Funding Source: NIH RePORTER	Principado de Asturias, Spain; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III (CIBERONC, Plan Feder); Fundacion EDP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBERONC, Plan Feder), Fundacion EDP, and Principado de Asturias, Spain. The discovery and synthesis of sudemycin D1 and D6 were supported in part by National Institutes of Health Grant CA140474, the American Lebanese Syrian Associated Charities (ALSAC), and St. Jude Children's Research Hospital. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Costa-Cabral S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149099; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fraile JM, 2016, ONCOTARGET, V7, P74427, DOI 10.18632/oncotarget.12769; Fraile JM, 2013, ONCOTARGET, V4, P1919, DOI 10.18632/oncotarget.1303; Freije JMP, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00025; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hadjivassiliou H, 2014, RNA, V20, P656, DOI 10.1261/rna.042838.113; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/nchembio.1455, 10.1038/NCHEMBIO.1455]; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Pal A, 2014, CANCER RES, V74, P4955, DOI 10.1158/0008-5472.CAN-14-1211; Pan J, 2015, ONCOGENE, V34, P3957, DOI 10.1038/onc.2014.327; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Pringle LM, 2012, ONCOGENE, V31, P3525, DOI 10.1038/onc.2011.520; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; 杨晓杰, 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P109	63	27	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	10					4164	4175		10.1074/jbc.M116.762757	http://dx.doi.org/10.1074/jbc.M116.762757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ4GV	28154181	Green Published, hybrid			2022-12-28	WOS:000404672500003
J	Cheng, XY; Yamauchi, J; Lee, S; Zhang, T; Gong, ZW; Muzumdar, R; Qu, S; Dong, HH				Cheng, Xiaoyun; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Gong, Zhenwei; Muzumdar, Radhika; Qu, Shen; Dong, H. Henry			APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; lipid metabolism; liver; obesity; triglyceride; Apolipoprotein C3; Hypertriglyceridemia; Nonalcoholic fatty liver disease; Steatosis; Triglyceride metabolism	APOLIPOPROTEIN-C-III; LOW-DENSITY LIPOPROTEINS; TRIGLYCERIDE-RICH LIPOPROTEINS; INSULIN-RESISTANCE; TRANSGENIC MICE; LIPASE ACTIVITY; LIPID PROFILE; PNPLA3 I148M; GENE; PLASMA	Nonalcoholic fatty liver disease (NAFLD), characterized by excessive fat accumulation in liver, is prevalent in obesity. Genetic factors that link obesity to NAFLD remain obscure. Apolipoprotein C3 (APOC3) is a lipid-binding protein with a pivotal role in triglyceride metabolism. Humans with APOC3 gain-of-function mutations and mice with APOC3 overproduction are associated with hypertriglyceridemia. Nonetheless, it remains controversial whether APOC3 is culpable for diet-induced NAFLD. To address this fundamental issue, we fed APOC3-transgenic and wild-type littermates a high fructose diet or high fat diet, followed by determination of the effect of APOC3 on hepatic lipid metabolism and inflammation and the progression of NAFLD. To gain mechanistic insight into NAFLD, we determined the impact of APOC3 on hepatic triglyceride synthesis and secretion versus fatty acid oxidation. APOC3-transgenic mice were hypertriglyceridemic, culminating in marked elevation of triglycerides, cholesterols, and non-esterified fatty acids in plasma. Despite the prevailing hypertriglyceridemia, APOC3-transgenic mice, relative to wild-type littermates, had similar weight gain and hepatic lipid content without alterations in hepatic expression of key genes involved in triglyceride synthesis and secretion and fatty acid oxidation. APOC3-transgenic and wild-type mice had similar Kupffer cell content without alterations in hepatic expression of pro- and anti-inflammatory cytokines. APOC3 neither exacerbated diet-induced adiposity nor aggravated the degree of steatosis in high fructose or high fat-fed APOC3-transgenic mice. These effects ensued independently of weight gain even after 10-month high fat feeding. We concluded that APOC3, whose dysregulation is liable for hypertriglyceridemia, is not a predisposing factor for linking overnutrition to NAFLD in obesity.	[Cheng, Xiaoyun; Qu, Shen] Tongji Univ, Sch Med, Dept Endocrinol & Metab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Cheng, Xiaoyun; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Gong, Zhenwei; Muzumdar, Radhika; Dong, H. Henry] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh UPMC, Dept Pediat,Div Endocrinol & Diabet, Pittsburgh, PA 15224 USA	Tongji University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Qu, S (corresponding author), Tongji Univ, Sch Med, Dept Endocrinol & Metab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China.; Dong, HH (corresponding author), Childrens Hosp Pittsburgh UPMC, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	qushencn@hotmail.com; dongh@pitt.edu	Cheng, Xiaoyun/HDM-5535-2022	Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK098437]; Fundamental Research Funds for the Central Universities and National Science Foundation, China [81570782]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities and National Science Foundation, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grant R01 DK098437. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Fundamental Research Funds for the Central Universities and National Science Foundation Grant 81570782, China.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010; Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54; CHEN M, 1994, J LIPID RES, V35, P1918; Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Duivenvoorden I, 2005, DIABETES, V54, P664, DOI 10.2337/diabetes.54.3.664; Dunn Winston, 2008, Curr Gastroenterol Rep, V10, P67, DOI 10.1007/s11894-008-0011-1; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Gaudet D, 2014, NEW ENGL J MED, V371, P2200, DOI 10.1056/NEJMoa1400284; Gerritsen G, 2005, J LIPID RES, V46, P1466, DOI 10.1194/jlr.M400479-JLR200; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Gordts PLSM, 2016, J CLIN INVEST, V126, P2855, DOI 10.1172/JCI86610; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P2753, DOI 10.1161/01.ATV.17.11.2753; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Jong MC, 2001, J LIPID RES, V42, P1578; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Khetarpal SA, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0609-y; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lerret SM, 2008, GASTROENTEROL NURS, V31, P115, DOI 10.1097/01.SGA.0000316530.31366.6e; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu YZ, 2016, J BIOL CHEM, V291, P14695, DOI 10.1074/jbc.M115.707885; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MCCONATHY WJ, 1992, J LIPID RES, V33, P995; Niu TH, 2014, WORLD J GASTROENTERO, V20, P3655, DOI 10.3748/wjg.v20.i13.3655; Nobili V, 2009, WORLD J GASTROENTERO, V15, P6017, DOI 10.3748/wjg.15.6017; Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001; Nugent C, 2007, NAT CLIN PRACT GASTR, V4, P432, DOI 10.1038/ncpgasthep0879; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Qu S, 2007, J LIPID RES, V48, P1476, DOI 10.1194/jlr.M600498-JLR200; Qu S, 2007, AM J PHYSIOL-ENDOC M, V292, pE421, DOI 10.1152/ajpendo.00157.2006; QUARFORDT SH, 1982, J BIOL CHEM, V257, P4642; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sentinelli F, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-93; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Talmud PJ, 1997, CURR OPIN LIPIDOL, V8, P154, DOI 10.1097/00041433-199706000-00005; Taskinen MR, 2011, ARTERIOSCL THROM VAS, V31, P2144, DOI 10.1161/ATVBAHA.111.224808; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Valenti L, 2011, J HEPATOL, V55, P1409, DOI 10.1016/j.jhep.2011.03.035; Verrijken A, 2013, OBESITY, V21, P2138, DOI 10.1002/oby.20366; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Waterworth DM, 2000, J LIPID RES, V41, P1103; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yao Zemin, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P133; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053; Zhang HY, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.23100; Zhang LH, 2008, METABOLISM, V57, P1115, DOI 10.1016/j.metabol.2008.03.017; Zhang T, 2016, ENDOCRINOLOGY, V157, P1055, DOI 10.1210/en.2015-1852	66	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3692	3705		10.1074/jbc.M116.765917	http://dx.doi.org/10.1074/jbc.M116.765917			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28115523	Green Published, hybrid			2022-12-28	WOS:000395542500013
J	Shi, SY; Luk, CT; Schroer, SA; Kim, MJ; Dodington, DW; Sivasubramaniyam, T; Lin, LR; Cai, EP; Lu, SY; Wagner, KU; Bazinet, RP; Woo, M				Shi, Sally Yu; Luk, Cynthia T.; Schroer, Stephanie A.; Kim, Min Jeong; Dodington, David W.; Sivasubramaniyam, Tharini; Lin, Lauren; Cai, Erica P.; Lu, Shun-Yan; Wagner, Kay-Uwe; Bazinet, Richard P.; Woo, Minna			Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; cell proliferation; hepatocellular carcinoma; inflammation; Janus kinase (JAK); mouse; diethylnitrosamine; non-alcoholic fatty liver disease	FATTY LIVER-DISEASE; NF-KAPPA-B; NONALCOHOLIC STEATOHEPATITIS; CHEMICAL HEPATOCARCINOGENESIS; CANCER DEVELOPMENT; HEPATIC STEATOSIS; MOUSE MODELS; INFLAMMATION; EXPRESSION; ACTIVATION	Hepatocellular carcinoma is an end-stage complication of non-alcoholic fatty liver disease (NAFLD). Inflammation plays a critical role in the progression of non-alcoholic fatty liver disease and the development of hepatocellular carcinoma. However, whether steatosis per se promotes liver cancer, and the molecular mechanisms that control the progression in this disease spectrum remain largely elusive. The Janus kinase signal transducers and activators of transcription (JAK-STAT) pathway mediates signal transduction by numerous cytokines that regulate inflammation and may contribute to hepatocarcinogenesis. Mice with hepatocyte-specific deletion of JAK2 (L-JAK2 KO) develop extensive fatty liver spontaneously. We show here that this simple steatosis was insufficient to drive carcinogenesis. In fact, L-JAK2 KO mice were markedly protected from chemically induced tumor formation. Using the methionine choline-deficient dietary model to induce steatohepatitis, we found that steatohepatitis development was completely arrested in L-JAK2 KO mice despite the presence of steatosis, suggesting that JAK2 is the critical factor required for inflammatory progression in the liver. In line with this, L-JAK2 KO mice exhibited attenuated inflammation after chemical carcinogen challenge. This was associated with increased hepatocyte apoptosis without elevated compensatory proliferation, thus thwarting expansion of transformed hepatocytes. Taken together, our findings identify an indispensable role of JAK2 in hepatocarcinogenesis through regulating critical inflammatory pathways. Targeting the JAK-STAT pathway may provide a novel therapeutic option for the treatment of hepatocellular carcinoma.	[Shi, Sally Yu; Luk, Cynthia T.; Schroer, Stephanie A.; Kim, Min Jeong; Dodington, David W.; Sivasubramaniyam, Tharini; Cai, Erica P.; Lu, Shun-Yan; Woo, Minna] Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada; [Shi, Sally Yu; Luk, Cynthia T.; Sivasubramaniyam, Tharini; Cai, Erica P.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Kim, Min Jeong] Sungkyunkwan Univ, Inst Med Res, Kangbuk Samsung Hosp, Sch Med, Seoul 03181, South Korea; [Lin, Lauren; Bazinet, Richard P.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Woo, Minna] Univ Toronto, Div Endocrinol, Dept Med, Toronto Gen Hosp,Univ Hlth Network, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Sungkyunkwan University (SKKU); University of Toronto; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Woo, M (corresponding author), Toronto Gen Hosp, Res Inst, MaRS Ctr TMDT, 101 Coll St,Rm 10-363, Toronto, ON M5G 1L7, Canada.	mwoo@uhnresearch.ca	Dodington, David W/GNM-6943-2022; Cai, Erica/ABE-4408-2020	Shi, Sally Yu/0000-0002-5528-3824; Wagner, Kay-Uwe/0000-0002-5081-0226; Dodington, David/0000-0003-3575-3259; Cai, Erica/0000-0003-2386-5747	Canadian Institute of Health Research (CIHR) [MOP-142193]; Canadian Cancer Society Innovation Grant; Canadian Diabetes Association (CDA); CIHR Doctoral Research Award; CDA Doctoral Student Research Award; Canadian Liver Foundation Graduate Studentship; Eliot Phillipson Clinician Scientist Training Program; CDA Postdoctoral Fellowship; Banting and Best Diabetes Centre Postdoctoral Fellowship; Canada Research Chair in Signal Transduction in Diabetes Pathogenesis	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Innovation Grant; Canadian Diabetes Association (CDA); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); CDA Doctoral Student Research Award; Canadian Liver Foundation Graduate Studentship; Eliot Phillipson Clinician Scientist Training Program; CDA Postdoctoral Fellowship; Banting and Best Diabetes Centre Postdoctoral Fellowship; Canada Research Chair in Signal Transduction in Diabetes Pathogenesis	This work was supported by Canadian Institute of Health Research (CIHR) Operating Grant MOP-142193, a Canadian Cancer Society Innovation Grant, and by a Canadian Diabetes Association (CDA) grant-in-aid (to M. W.), The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a CIHR Doctoral Research Award, a CDA Doctoral Student Research Award, and a Canadian Liver Foundation Graduate Studentship.; Supported by the Eliot Phillipson Clinician Scientist Training Program, a CDA Postdoctoral Fellowship, and a Banting and Best Diabetes Centre Postdoctoral Fellowship.; Supported by the Canada Research Chair in Signal Transduction in Diabetes Pathogenesis. To whom correspondence should be addressed: Toronto General Hospital Research Institute, 101 College St., MaRS Centre/TMDT, Rm. 10-363, Toronto, Ontario, Canada M5G 1L7. Tel.: 416-581-7531; Fax: 416-581-7880; E-mail: mwoo@uhnresearch.ca.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Chen CT, 2011, J NEUROCHEM, V116, P363, DOI 10.1111/j.1471-4159.2010.07116.x; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ellouk-Achard S, 1998, J HEPATOL, V29, P807, DOI 10.1016/S0168-8278(98)80263-8; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Freitas MCS, 2010, LIVER TRANSPLANT, V16, P600, DOI 10.1002/lt.22036; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gao DQ, 2004, AM J PHYSIOL-GASTR L, V287, pG1070, DOI 10.1152/ajpgi.00228.2004; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Joung YH, 2014, INT J ONCOL, V44, P883, DOI 10.3892/ijo.2014.2250; Judd LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095993; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Klein S, 2017, GUT, V66, P145, DOI 10.1136/gutjnl-2015-309600; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee JH, 2013, CLIN CANCER RES, V19, P6777, DOI 10.1158/1078-0432.CCR-13-1110; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Shi SY, 2012, J BIOL CHEM, V287, P10277, DOI 10.1074/jbc.M111.317453; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Upegui-Gonzalez LC, 1998, ADV EXP MED BIOL, V451, P35; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wang LY, 2014, NAT MED, V20, P488, DOI 10.1038/nm.3527; Weltman MD, 1996, GASTROENTEROLOGY, V111, P1645, DOI 10.1016/S0016-5085(96)70028-8; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu JH, 2012, HEPATOLOGY, V56, P2375, DOI 10.1002/hep.25900	47	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3789	3799		10.1074/jbc.M116.752519	http://dx.doi.org/10.1074/jbc.M116.752519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100771	Green Published, hybrid			2022-12-28	WOS:000395542500021
J	Bolten, M; Vahlensieck, C; Lipp, C; Leibundgut, M; Ban, N; Weber-Ban, E				Bolten, Marcel; Vahlensieck, Christian; Lipp, Colette; Leibundgut, Marc; Ban, Nenad; Weber-Ban, Eilika			Depupylase Dop Requires Inorganic Phosphate in the Active Site for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ENZYME; PUP; SYNTHETASE; PATHWAY; COMPLEX	Analogous to eukaryotic ubiquitination, proteins in actino-bacteria can be post-translationally modified in a process referred to as pupylation, the covalent attachment of prokaryotic ubiquitin-like protein Pup to lysine side chains of the target protein via an isopeptide bond. As in eukaryotes, an opposing activity counteracts the modification by specific cleavage of the isopeptide bond formed with Pup. However, the enzymes involved in pupylation and depupylation have evolved independently of ubiquitination and are related to the family of ATP-binding and hydrolyzing carboxylate-amine ligases of the glutamine synthetase type. Furthermore, the Pup ligase PafA and the depupylase Dop share close structural and sequence homology and have a common evolutionary history despite catalyzing opposing reactions. Here, we investigate the role played by the nucleotide in the active site of the depupylase Dop using a combination of biochemical experiments and X-ray crystallographic studies. We show that, although Dop does not turn over ATP stoichiometrically with substrate, the active site nucleotide species in Dop is ADP and inorganic phosphate rather than ATP, and that non-hydrolyzable analogs of ATP cannot support the enzymatic reaction. This finding suggests that the catalytic mechanism is more similar to the mechanism of the ligase PafA than previously thought and likely involves the transient formation of a phosphorylated Pup-intermediate. Evidence is presented for a mechanism where the inorganic phosphate acts as the nucleophilic species in amide bond cleavage and implications for Dop function are discussed.	[Bolten, Marcel; Vahlensieck, Christian; Lipp, Colette; Leibundgut, Marc; Ban, Nenad; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Bolten, Marcel/0000-0002-3808-2481; Vahlensieck, Christian/0000-0002-7716-6469; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland) [X06SA]	Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland)	We thank B. Blattmann and C. Stutz-Ducommun for support with initial screening and acknowledge the staff of X06SA at the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland) for support with data collection.	Abbott JJ, 2001, J BIOL CHEM, V276, P42099, DOI 10.1074/jbc.M104672200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Barandun J, 2013, J AM CHEM SOC, V135, P6794, DOI 10.1021/ja4024012; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Biterova EI, 2010, J BIOL CHEM, V285, P14459, DOI 10.1074/jbc.M110.104802; Burns KE, 2012, J BIOL CHEM, V287, P37522, DOI 10.1074/jbc.M112.384784; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Bystrom CE, 1997, BIOORG MED CHEM LETT, V7, P2613, DOI 10.1016/S0960-894X(97)10051-8; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chen B, 2009, FEBS J, V276, P807, DOI 10.1111/j.1742-4658.2008.06825.x; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Hecht N, 2015, ANAL BIOCHEM, V485, P97, DOI 10.1016/j.ab.2015.06.019; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; Lazar I., 2010, GELANALYZER 2010A; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ozcelik D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2009; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rasband W, 1997, IMAGEJ VERSION 1 48; Samanovic Marie I, 2013, Subcell Biochem, V66, P267, DOI 10.1007/978-94-007-5940-4_10; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522	38	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4044	4053		10.1074/jbc.M116.755645	http://dx.doi.org/10.1074/jbc.M116.755645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28119453	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000395837100008
J	Wang, Y; Huang, XZ; He, LJ; Pu, WJ; Li, Y; Liu, QZ; Li, Y; Zhang, LB; Yu, W; Zhao, H; Zhou, YQ; Zhou, B				Wang, Yue; Huang, XiuZhen; He, Lingjuan; Pu, Wenjuan; Li, Yan; Liu, Qiaozhen; Li, Yi; Zhang, Libo; Yu, Wei; Zhao, Huan; Zhou, Yingqun; Zhou, Bin			Genetic tracing of hepatocytes in liver homeostasis, injury, and regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR CELLS; MOUSE-LIVER; PERIPORTAL HEPATOCYTES; MATURE HEPATOCYTES; STEM-CELLS; RISE; DIFFERENTIATION; CHOLANGIOCYTES; CONTRIBUTES; RATHER	The liver possesses a remarkable capacity to regenerate after damage. There is a heated debate on the origin of new hepatocytes after injuries in adult liver. Hepatic stem/progenitor cells have been proposed to produce functional hepatocytes after injury. Recent studies have argued against this model and suggested that pre-existing hepatocytes, rather than stem cells, contribute new hepatocytes. This hepatocyte-to-hepatocyte model is mainly based on labeling of hepatocytes with Cre-recombinase delivered by the adeno-associated virus. However, the impact of virus infection on cell fate determination, consistency of infection efficiency, and duration of Cre-virus in hepatocytes remain confounding factors that interfere with the data interpretation. Here, we generated a new genetic tool Alb-DreER to label almost all hepatocytes (>99.5%) and track their contribution to different cell lineages in the liver. By pulse-and-chase strategy, we found that pre-existing hepatocytes labeled by Alb-DreER contribute to almost all hepatocytes during normal homeostasis and after liver injury. Virtually all hepatocytes in the injured liver are descendants of pre-existing hepatocytes through self-expansion. We concluded that stem cell differentiation is unlikely to be responsible for the generation of a substantial number of new hepatocytes in adult liver. Our study also provides a new mouse tool for more precise in vivo genetic study of hepatocytes in the field.	[Wang, Yue; Huang, XiuZhen; He, Lingjuan; Pu, Wenjuan; Li, Yan; Liu, Qiaozhen; Li, Yi; Zhang, Libo; Yu, Wei; Zhao, Huan; Zhou, Bin] Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,Chinese Acad Sci, Shanghai 200031, Peoples R China; [Wang, Yue; Huang, XiuZhen; He, Lingjuan; Pu, Wenjuan; Li, Yan; Liu, Qiaozhen; Li, Yi; Zhang, Libo; Yu, Wei; Zhao, Huan; Zhou, Bin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [Zhou, Yingqun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, 301 Yanchang Rd, Shanghai 200072, Peoples R China; [Zhou, Bin] Jinan Univ, Inst Aging & Regenerat Med, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Guangdong, Peoples R China; [Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tongji University; Jinan University; ShanghaiTech University	Zhou, YQ (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, 301 Yanchang Rd, Shanghai 200072, Peoples R China.; Zhou, B (corresponding author), 320 Yueyang Rd,Life Sci Res Bld A-2112, Shanghai 200031, Peoples R China.	yqzh02@163.com; zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	National Science Foundation of China [91639302, 31625019, 91339104, 31271552, 31222038, 31571503, 31501172, 31601168, 81300340]; Ministry of Science and Technology [2013CB945302, 2016YFC1300600]; Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB19000000]; Youth Innovation Promotion Association of CAS [2015218]; Key Project of Frontier Sciences of CAS [QYZDB-SSW-SMC003]; International Cooperation Fund of CAS, Shanghai Zhangjiang Stem Cell Research Project [ZJ2014-ZD002]; Shanghai Science and Technology Commission [14JC1407400, 16DZ2280800]; Shanghai Yangfan Project [15YF1414000]; Rising Star Program [15QA1404300]; China Postdoctoral Science Foundation [2015M581669, 2016T90387, 2016LH0042]; President Fund of Shanghai Institutes for Biological Sciences (SIBS); AstraZeneca and SanofiSIBS Fellowship	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); Youth Innovation Promotion Association of CAS; Key Project of Frontier Sciences of CAS; International Cooperation Fund of CAS, Shanghai Zhangjiang Stem Cell Research Project; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Yangfan Project; Rising Star Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); President Fund of Shanghai Institutes for Biological Sciences (SIBS); AstraZeneca and SanofiSIBS Fellowship	This work was supported by the National Science Foundation of China (91639302, 31625019, 91339104, 31271552, 31222038, 31571503, 31501172, 31601168, and 81300340), Ministry of Science and Technology (2013CB945302 and 2016YFC1300600), Strategic Priority Research Program of the Chinese Academy of Sciences (CAS, XDB19000000), Youth Innovation Promotion Association of CAS (2015218), Key Project of Frontier Sciences of CAS (QYZDB-SSW-SMC003), International Cooperation Fund of CAS, Shanghai Zhangjiang Stem Cell Research Project (ZJ2014-ZD002), Shanghai Science and Technology Commission (14JC1407400 and 16DZ2280800), Shanghai Yangfan Project (15YF1414000) and Rising Star Program (15QA1404300), China Postdoctoral Science Foundation (2015M581669, 2016T90387, and 2016LH0042), President Fund of Shanghai Institutes for Biological Sciences (SIBS), and an AstraZeneca and SanofiSIBS Fellowship. The authors declare that they have no conflicts of interest with the contents of this article.	Addis RC, 2013, NAT MED, V19, P829, DOI 10.1038/nm.3225; Arroyo V, 2014, J HEPATOL, V61, P396, DOI 10.1016/j.jhep.2014.04.012; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; He LJ, 2016, CARDIOVASC RES, V109, P419, DOI 10.1093/cvr/cvw005; Heinrich C, 2015, NAT CELL BIOL, V17, P204, DOI 10.1038/ncb3108; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Kubota H, 2000, P NATL ACAD SCI USA, V97, P12132, DOI 10.1073/pnas.97.22.12132; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Overturf K, 1997, AM J PATHOL, V151, P1273; Pu WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13369; Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhang H, 2016, NAT GENET, V48, P537, DOI 10.1038/ng.3536; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202	34	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8594	8604		10.1074/jbc.M117.782029	http://dx.doi.org/10.1074/jbc.M117.782029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377509	hybrid, Green Published			2022-12-28	WOS:000402153900008
J	Azouaoui, H; Montigny, C; Dieudonne, T; Champeil, P; Jacquot, A; Vazquez-Ibar, JL; Le Marechal, P; Ulstrup, J; Ash, MR; Lyons, JA; Nissen, P; Lenoir, G				Azouaoui, Hassina; Montigny, Cedric; Dieudonne, Thibaud; Champeil, Philippe; Jacquot, Aurore; Vazquez-Ibar, Jose Luis; Le Marechal, Pierre; Ulstrup, Jakob; Ash, Miriam-Rose; Lyons, Joseph A.; Nissen, Poul; Lenoir, Guillaume			High phosphatidylinositol 4-phosphate (PI4P)-dependent ATPase activity for the Drs2p-Cdc50p flippase after removal of its N- and C-terminal extensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; MEMBRANE CALCIUM-PUMP; AMINOPHOSPHOLIPID TRANSPORT; PHOSPHOLIPID FLIPPASE; TRANSLOCASE ACTIVITY; BETA-SUBUNIT; GOLGI; PROTEIN; YEAST	P4-ATPases, also known as phospholipid flippases, are responsible for creating and maintaining transbilayer lipid asymmetry in eukaryotic cell membranes. Here, we use limited proteolysis to investigate the role of theNand C termini in ATP hydrolysis and auto-inhibition of the yeast flippase Drs2p-Cdc50p. We show that limited proteolysis of the detergent-solubilized and purified yeast flippase may result in more than 1 order of magnitude increase of its ATPase activity, which remains dependent on phosphatidylinositol 4-phosphate (PI4P), a regulator of this lipid flippase, and specific to a phosphatidyl-serine substrate. Using thrombin as the protease, Cdc50p remains intact and in complex with Drs2p, which is cleaved at two positions, namely after Arg(104) and after Arg(1290), resulting in a homogeneous sample lacking 104 and 65 residues from its N and C termini, respectively. Removal of the 1291-1302-amino acid region of the C-terminal extension is critical for relieving the auto-inhibition of full-length Drs2p, whereas the 1-104 N-terminal residues have an additional but more modest significance for activity. The present results therefore reveal that trimming off appropriate regions of the terminal extensions of Drs2p can greatly increase its ATPase activity in the presence of PI4P and demonstrate that relief of such auto-inhibition remains compatible with subsequent regulation by PI4P. These experiments suggest that activation of the Drs2p-Cdc50p flippase follows a multistep mechanism, with preliminary release of a number of constraints, possibly through the binding of regulatory proteins in the trans-Golgi network, followed by full activation by PI4P.	[Azouaoui, Hassina; Montigny, Cedric; Dieudonne, Thibaud; Champeil, Philippe; Jacquot, Aurore; Vazquez-Ibar, Jose Luis; Lenoir, Guillaume] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France; [Le Marechal, Pierre] Univ Paris Saclay, Univ Paris Sud, CNRS, NeuroPSI,UMR 9197, Batiment 430, F-91405 Orsay, France; [Ulstrup, Jakob; Ash, Miriam-Rose; Lyons, Joseph A.; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, DANDRITE, Nord EMBL Partnership Mol Med, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Ulstrup, Jakob; Ash, Miriam-Rose; Lyons, Joseph A.; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, Dept Mol Biol & Genet, PUMPkin, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond	Lenoir, G (corresponding author), CEA Saclay, Inst Integrat Biol Cell, Batiment 528,PC 103, F-91191 Gif Sur Yvette, France.	guillaume.lenoir@i2bc.paris-saclay.fr	Lyons, Joseph/AAA-2528-2020; Lenoir, Guillaume/I-4002-2019; Vazquez-Ibar, Jose-Luis/AAD-8827-2021; MONTIGNY, Cédric/AAH-4216-2021	Lenoir, Guillaume/0000-0002-8759-5179; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; Dieudonne, Thibaud/0000-0001-6988-4121; Lyons, Joseph/0000-0003-0218-4862; Nissen, Poul/0000-0003-0948-6628	CNRS; Agence Nationale de la Recherche (ANR) [ANR-14-CE09-0022]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05]; Lundbeck Foundation [R171-2014-663]; Lundbeck Foundation [R155-2015-2666, R209-2015-2704] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the CNRS, by Agence Nationale de la Recherche (ANR) Grant ANR-14-CE09-0022 (to G. L.) (AsymLip), by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05, and by Postdoctoral Fellowship R171-2014-663 from the Lundbeck Foundation (to J. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Azouaoui H, 2016, METHODS MOL BIOL, V1377, P37, DOI 10.1007/978-1-4939-3179-8_6; Azouaoui H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112176; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; FADOK VA, 1992, J IMMUNOL, V148, P2207; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Montigny C, 2014, J BIOL CHEM, V289, P33850, DOI 10.1074/jbc.M114.590307; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619	47	17	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7954	7970		10.1074/jbc.M116.751487	http://dx.doi.org/10.1074/jbc.M116.751487			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302728	Green Published, hybrid			2022-12-28	WOS:000401154100022
J	Sato, Y; Katoh, Y; Matsumoto, M; Sato, M; Ebina, M; Itoh-Nakadai, A; Funayama, R; Nakayama, K; Unno, M; Igarashi, K				Sato, Yoshihiro; Katoh, Yasutake; Matsumoto, Mitsuyo; Sato, Masaki; Ebina, Masayuki; Itoh-Nakadai, Ari; Funayama, Ryo; Nakayama, Keiko; Unno, Michiaki; Igarashi, Kazuhiko			Regulatory signatures of liver regeneration distilled by integrative analysis of mRNA, histone methylation, and proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE GENE LISTS; METHIONINE ADENOSYLTRANSFERASE; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; IDENTIFICATION; HEPATECTOMY; EXPRESSION; FOXM1; EMBOLIZATION	The capacity of the liver to regenerate is likely to be encoded as a plasticity of molecular networks within the liver. By applying a combination of comprehensive analyses of the epigenome, transcriptome, and proteome, we herein depict the molecular landscape of liver regeneration. We demonstrated that histone H3 Lys-4 was trimethylated at the promoter regions of many loci, among which only a fraction, including cell-cycle-related genes, were transcriptionally up-regulated. A cistrome analysis guided by the histone methylation patterns and the transcriptome identified FOXM1 as the key transcription factor promoting liver regeneration, which was confirmed in vitro using a hepatocarcinoma cell line. The promoter regions of cell-cycle-related genes and Foxm1 acquired higher levels of trimethylated histone H3 Lys-4, suggesting that epigenetic regulations of these key regulatory genes define quiescence and regeneration of the liver cells. A quantitative proteome analysis of the regenerating liver revealed that conditional protein degradation also mediated regeneration-specific protein expression. These sets of informational resources should be useful for further investigations of liver regeneration.	[Sato, Yoshihiro; Katoh, Yasutake; Matsumoto, Mitsuyo; Sato, Masaki; Ebina, Masayuki; Itoh-Nakadai, Ari; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Sato, Yoshihiro; Sato, Masaki; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Katoh, Yasutake; Funayama, Ryo; Nakayama, Keiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Dept Cell Proliferat, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Ebina, Masayuki; Igarashi, Kazuhiko] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Matsumoto, Mitsuyo/AAC-3065-2019; Unno, Michiaki/A-8633-2010; Unno, Michiaki/AAX-5246-2020	Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416; Igarashi, Kazuhiko/0000-0002-2470-2475; Sato, Yoshihiro/0000-0003-3722-6815	Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; AMED-CREST from the Japan Agency for Medical Research and Development;  [15H02506];  [25670156];  [24390066];  [23116003]; Grants-in-Aid for Scientific Research [15H02506] Funding Source: KAKEN	Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid 15H02506, 25670156, 24390066, and 23116003 and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan and AMED-CREST from the Japan Agency for Medical Research and Development. Additional initiative supports were from the Uehara Foundation, Takeda Foundation, and Astellas Foundation for Research on Metabolic Disorders. Restoration of the laboratory from the damage due to the 2011 Tohoku earthquake was provided in part by the Astellas Foundation for Research on Metabolic Disorders, the Banyu Foundation, the Naito Foundation, A. Miyazaki, and A. Iida. The authors declare that they have no conflicts of interest with the contents of this article.	Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen H, 2014, BBA-GENE REGUL MECH, V1839, P415, DOI 10.1016/j.bbagrm.2014.03.010; Chen T, 2014, CANCER GENE THER, V21, P133, DOI 10.1038/cgt.2014.8; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Chen XG, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-59; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Gehart H, 2015, TRENDS GENET, V31, P344, DOI 10.1016/j.tig.2015.04.005; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JS, 2014, EPIGENETICS-US, V9, P1521, DOI 10.4161/15592294.2014.983371; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Jin S, 2013, WORLD J GASTROENTERO, V19, P7983, DOI 10.3748/wjg.v19.i44.7983; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kera Y, 2013, J BIOL CHEM, V288, P13592, DOI 10.1074/jbc.M112.429738; Kowalik MA, 2011, HEPATOLOGY, V53, P2086, DOI 10.1002/hep.24289; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuttippurathu L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2492-x; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Low TY, 2013, CELL REP, V5, P1469, DOI 10.1016/j.celrep.2013.10.041; MAKUUCHI M, 1990, SURGERY, V107, P521; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Mencalha AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048160; Muller GA, 2014, NUCLEIC ACIDS RES, V42, P10331, DOI 10.1093/nar/gku696; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Obata F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9332; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shirasaki K, 2014, HEPATOLOGY, V59, P2371, DOI 10.1002/hep.27020; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Sun HC, 2011, ONCOL REP, V25, P1533, DOI 10.3892/or.2011.1230; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tashiro S, 2009, J HEPATO-BILIARY-PAN, V16, P292, DOI 10.1007/s00534-009-0058-x; van Lienden KP, 2013, CARDIOVASC INTER RAD, V36, P25, DOI 10.1007/s00270-012-0440-y; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200	49	12	12	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8019	8037		10.1074/jbc.M116.774547	http://dx.doi.org/10.1074/jbc.M116.774547			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302717	hybrid, Green Published			2022-12-28	WOS:000401154100027
J	Go, SJ; Go, S; Veillon, L; Ciampa, MG; Mauri, L; Sato, C; Kitajima, K; Prinetti, A; Sonnino, S; Inokuchi, J				Go, Shinji; Go, Shiori; Veillon, Lucas; Ciampa, Maria Grazia; Mauri, Laura; Sato, Chihiro; Kitajima, Ken; Prinetti, Alessandro; Sonnino, Sandro; Inokuchi, Jin-ichi			Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; CERAMIDE SYNTHASES; ACETYLNEURAMINIC ACID; POLYSIALIC ACID; NEU3 SIALIDASE; CELL; FUSION; CHOLESTEROL; ACTIVATION	Gangliosides (sialic acid-containing glycosphingolipids) help regulate many important biological processes, including cell proliferation, signal transduction, and differentiation, via formation of functional microdomains in plasma membranes. The structural diversity of gangliosides arises from both the ceramide moiety and glycan portion. Recently, differing molecular species of a given ganglioside are suggested to have distinct biological properties and regulate specific and distinct biological events. Elucidation of the function of each molecular species is important and will provide new insights into ganglioside biology. Gangliosides are also suggested to be involved in skeletal muscle differentiation; however, the differential roles of ganglioside molecular species remain unclear. Here we describe striking changes in quantity and quality of gangliosides (particularly GM3) during differentiation of mouse C2C12 myoblast cells and key roles played by distinct GM3 molecular species at each step of the process.	[Go, Shinji; Go, Shiori; Veillon, Lucas; Inokuchi, Jin-ichi] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Go, Shiori; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Ciampa, Maria Grazia; Mauri, Laura; Prinetti, Alessandro; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, I-20090 Segrate, Italy	Tohoku Medical & Pharmaceutical University; Nagoya University; University of Milan	Inokuchi, J (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jin@tohoku-mpu.ac.jp	Naganawa, Shinji/I-1572-2012; Prinetti, Alessandro/R-4206-2017; Inokuchi, Jin-ichi/AAW-9964-2020; SATO, Chihiro/B-7396-2014; Sonnino, Sandro/R-4154-2017; mauri, laura/GPS-4868-2022; MAURI, LAURA/H-5076-2017	Naganawa, Shinji/0000-0002-0214-613X; Prinetti, Alessandro/0000-0003-0252-2593; Inokuchi, Jin-ichi/0000-0002-0703-5746; Sonnino, Sandro/0000-0001-8180-5908; MAURI, LAURA/0000-0002-4194-4804	MEXT, Japan [23110002]; MEXT	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research (B) (to J.-i.I.) and for Scientific Research on Innovative Areas (23110002, Deciphering sugar chain-based signals regulating integrative neuronal functions) from MEXT, Japan and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; ANDO S, 1978, ANAL BIOCHEM, V89, P437, DOI 10.1016/0003-2697(78)90373-1; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Charrin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2675; Chisada S, 2009, J BIOL CHEM, V284, P30534, DOI 10.1074/jbc.M109.016188; CORNELL RB, 1980, J CELL BIOL, V86, P820, DOI 10.1083/jcb.86.3.820; Go S, 2007, BIOCHEM BIOPH RES CO, V357, P537, DOI 10.1016/j.bbrc.2007.03.181; Hayashi N, 2013, CANCER SCI, V104, P43, DOI 10.1111/cas.12027; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Inokuchi J, 2014, GLYCOCONJUGATE J, V31, P193, DOI 10.1007/s10719-013-9516-4; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Jennemann R, 2013, PROG LIPID RES, V52, P231, DOI 10.1016/j.plipres.2013.02.001; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin PT, 2013, GLYCOBIOLOGY, V23, P833, DOI 10.1093/glycob/cwt020; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Mukai A, 2008, EXP CELL RES, V314, P387, DOI 10.1016/j.yexcr.2007.10.006; Mukai A, 2009, EXP CELL RES, V315, P3052, DOI 10.1016/j.yexcr.2009.07.010; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Naito-Matsui Y, 2014, J BIOL CHEM, V289, P1564, DOI 10.1074/jbc.M113.523753; Ong E, 2002, J BIOL CHEM, V277, P18182, DOI 10.1074/jbc.M201312200; OZAWA H, 1992, ARCH BIOCHEM BIOPHYS, V294, P427, DOI 10.1016/0003-9861(92)90707-4; PALESTINI P, 1995, BBA-BIOMEMBRANES, V1235, P221, DOI 10.1016/0005-2736(95)80008-4; Papini N, 2012, J CELL BIOCHEM, V113, P2967, DOI 10.1002/jcb.24174; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033; Scaringi R, 2013, J BIOL CHEM, V288, P3153, DOI 10.1074/jbc.M112.404327; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Schwarzmann G, 2001, SEMIN CELL DEV BIOL, V12, P163, DOI 10.1006/scdb.2000.0233; SEKIYA T, 1984, CELL STRUCT FUNCT, V9, P143, DOI 10.1247/csf.9.143; Singhal N, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0028-0; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Valiente O, 2001, J LIPID RES, V42, P1318; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Veillon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129645; Casadesus AV, 2013, GLYCOCONJUGATE J, V30, P687, DOI 10.1007/s10719-013-9473-y; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; YU RK, 1972, J LIPID RES, V13, P680	52	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7040	7051		10.1074/jbc.M116.771253	http://dx.doi.org/10.1074/jbc.M116.771253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28275055	Green Published, hybrid			2022-12-28	WOS:000400478300015
J	Jansen, S; Melkova, K; Trosanova, Z; Hanakova, K; Zachrdla, M; Novacek, J; Zupa, E; Zdrahal, Z; Hritz, J; Zidek, L				Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Hanakova, Katerina; Zachrdla, Milan; Novacek, Jiri; Zupa, Erikz; Zdrahal, Zbynek; Hritz, Jozef; Zidek, Lukas			Quantitative mapping of microtubule-associated protein 2c (MAP2c) phosphorylation and regulatory protein 14-3-3 zeta-binding sites reveals key differences between MAP2c and its homolog Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; PAIRED HELICAL FILAMENTS; TUBULIN POLYMERIZATION; MULTIDIMENSIONAL NMR; NEURONAL DEVELOPMENT; DISORDERED PROTEINS; SYNAPTIC PLASTICITY; BETA-STRUCTURE; KINASE-A; BINDING	Microtubule-associated protein 2c (MAP2c) is involved in neuronal development and is less characterized than its homolog Tau, which has various roles in neurodegeneration. Using NMR methods providing single-residue resolution and quantitative comparison, we investigated molecular interactions important for the regulatory roles of MAP2c in microtubule dynamics. We found that MAP2c and Tau significantly differ in the position and kinetics of sites that are phosphorylated by cAMP-dependent protein kinase (PKA), even in highly homologous regions. Wedetermined the binding sites of unphosphorylated and phosphorylated MAP2c responsible for interactions with the regulatory protein 14-3-3 zeta. Differences in phosphorylation and in charge distribution between MAP2c and Tau suggested that both MAP2c and Tau respond to the same signal (phosphorylation by PKA) but have different downstream effects, indicating a signaling branch point for controlling microtubule stability. Although the interactions of phosphorylated Tau with 14-3-3 zeta are supposed to be a major factor in microtubule destabilization, the binding of 14-3-3 zeta to MAP2c enhanced by PKA-mediated phosphorylation is likely to influence microtubule-MAP2c binding much less, in agreement with the results of our tubulin co-sedimentation measurements. The specific location of the major MAP2c phosphorylation site in a region homologous to the muscarinic receptor-binding site of Tau suggests that MAP2c also may regulate processes other than microtubule dynamics.	[Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Zachrdla, Milan; Zupa, Erikz; Hritz, Jozef; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic; [Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Hanakova, Katerina; Zachrdla, Milan; Novacek, Jiri; Zupa, Erikz; Hritz, Jozef; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Hritz, J; Zidek, L (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic.; Hritz, J (corresponding author), Masaryk Univ, Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic.	jozef.hritz@ceitec.muni.cz; lzidek@chemi.muni.cz	Zidek, Lukas/D-7112-2012; Zidek, Lukas/AAB-6109-2020; Novacek, Jiri/AAQ-4739-2021; Hritz, Jozef/J-6887-2015; Jansen, Severine/Q-6364-2019; Zdrahal, Zbynek/D-9491-2012; Novacek, Jiri/D-8551-2012	Zidek, Lukas/0000-0002-8013-0336; Zidek, Lukas/0000-0002-8013-0336; Novacek, Jiri/0000-0003-4013-3898; Hritz, Jozef/0000-0002-4512-9241; Novacek, Jiri/0000-0003-4013-3898; Zdrahal, Zbynek/0000-0003-3044-5548; Hanakova, Katerina/0000-0001-9575-8866; Trosanova, Zuzana/0000-0002-0247-4168	Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR) [LM2015043]	Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR)	CIISB research infrastructure project LM2015043, funded by Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR), is gratefully acknowledged for partial financial support of the measurements at the Josef Dadok National NMR Centre, Biomolecular Interactions and Crystallization and Proteomics Core Facilities, Central European Institute of Technology (CEITEC), Masaryk University. We thank Tanvir Shaikh for language corrections and Arnost Mladek and Irmgard Fischer for technical help.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; AINSZTEIN AM, 1994, J BIOL CHEM, V269, P28465; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6; AVILA J, 1994, INT J DEV BIOL, V38, P13; Bermel W, 2009, J AM CHEM SOC, V131, P15339, DOI 10.1021/ja9058525; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; Busceti CL, 2015, PHARMACOL RES, V99, P258, DOI 10.1016/j.phrs.2015.06.017; Dehmelt L, 2005, GENOME BIOL, V6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elie A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09964; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gardiner J, 2011, SYNAPSE, V65, P249, DOI 10.1002/syn.20841; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; Hritz J, 2014, BIOPHYS J, V107, P2185, DOI 10.1016/j.bpj.2014.08.039; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kazimierczuk K, 2008, J MAGN RESON, V192, P123, DOI 10.1016/j.jmr.2008.02.003; Kazimierczuk K, 2009, J MAGN RESON, V197, P219, DOI 10.1016/j.jmr.2009.01.003; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim HA, 1997, J NEUROSCI RES, V49, P236; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lousa P, 2017, BIOPHYS CHEM, V223, P25, DOI 10.1016/j.bpc.2017.01.003; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mohan R, 2015, IUBMB LIFE, V67, P395, DOI 10.1002/iub.1384; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ovsepian SV, 2016, NEUROSCIENTIST, V22, P238, DOI 10.1177/1073858415588264; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Sluchanko NN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1528, DOI 10.1134/S0006297910130031; Sluchanko NN, 2011, J ALZHEIMERS DIS, V27, P467, DOI 10.3233/JAD-2011-110692; Sluchanko NN, 2009, FEBS LETT, V583, P2739, DOI 10.1016/j.febslet.2009.07.043; Sluchanko NN, 2009, BIOCHEM BIOPH RES CO, V379, P990, DOI 10.1016/j.bbrc.2008.12.164; Stanek J, 2010, J BIOMOL NMR, V47, P65, DOI 10.1007/s10858-010-9411-2; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; VIERECK C, 1989, J NEUROSCI, V9, P3547; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang HB, 2012, REV NEUROSCIENCE, V23, P67, DOI 10.1515/revneuro-2011-0063; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xie C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089796; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; YAMAUCHI T, 1983, BIOCHEM BIOPH RES CO, V110, P287, DOI 10.1016/0006-291X(83)91293-7; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x	76	13	13	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6715	6727		10.1074/jbc.M116.771097	http://dx.doi.org/10.1074/jbc.M116.771097			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258221	hybrid, Green Published			2022-12-28	WOS:000399813400023
J	Kamariah, N; Eisenhaber, B; Eisenhaber, F; Gruber, G				Kamariah, Neelagandan; Eisenhaber, Birgit; Eisenhaber, Frank; Gruber, Gerhard			Essential role of the flexible linker on the conformational equilibrium of bacterial peroxiredoxin reductase for effective regeneration of peroxiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL-HYDROPEROXIDE REDUCTASE; SMALL-ANGLE SCATTERING; XYLANUS NADH OXIDASE; ESCHERICHIA-COLI; ALKYLHYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; BIOLOGICAL MACROMOLECULES; THIOREDOXIN REDUCTASE; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER	Reactive oxygen species (ROS) can damage DNA, proteins, and lipids, so cells have antioxidant systems that regulate ROS. In many bacteria, a dedicated peroxiredoxin reductase, alkyl hydroperoxide reductase subunit F (AhpF), catalyzes the rapid reduction of the redox-active disulfide center of the antioxidant protein peroxiredoxin (AhpC) to detoxifyROSsuch as hydrogen peroxide, organic hydroperoxide, and peroxynitrite. AhpF is a flexible multidomain protein that enables a series of electron transfers among the redox centers by accepting reducing equivalents from NADH. A flexible linker connecting the N-terminal domain (NTD) and C-terminal domain (CTD) of AhpF suggests that the enzyme adopts a large-scale domain motion that alternates between the closed and open states to shuttle electrons from the CTD via the NTD to AhpC. Here, we conducted comprehensive mutational, biochemical, and biophysical analyses to gain insights into the role of the flexible linker and the residues critical for the domain motions of Escherichia coli AhpF (EcAhpF) during electron transfer. Small-angle X-ray scattering studies of linker mutants revealed that a group of charged residues, 200EKR202, is crucial for the swiveling motion of the NTD. Moreover, NADH binding significantly affected EcAhpF flexibility and the movement of the NTD relative to the CTD. The mutants also exhibited a decrease in H2O2 reduction by the AhpF-AhpC ensemble. We propose that a concerted movement involving the NTD, C-terminal NADH, and FAD domains, and the flexible linker between them is essential for optimal intradomain cross-talk and for efficient electron transfer to the redox partner AhpC required for peroxidation.	[Kamariah, Neelagandan; Eisenhaber, Birgit; Eisenhaber, Frank; Gruber, Gerhard] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Eisenhaber, Frank] Nanyang Technol Univ, Sch Comp Engn, Singapore 637553, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg			NTU-fund (Nanyang Technological University) [M4080811.080]; Genome Informatics Grant [IAF311010]	NTU-fund (Nanyang Technological University)(Nanyang Technological University); Genome Informatics Grant	This work was supported in part by NTU-fund (Nanyang Technological University) Grant M4080811.080 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Genome Informatics Grant IAF311010.	Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dip PV, 2014, BBA-BIOENERGETICS, V1837, P1932, DOI 10.1016/j.bbabio.2014.08.007; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Dreiss CA, 2006, J APPL CRYSTALLOGR, V39, P32, DOI 10.1107/S0021889805033091; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Kamariah N, 2016, SCI REP-UK, V6, DOI 10.1038/srep37610; Kamariah N, 2016, J STRUCT BIOL, V193, P13, DOI 10.1016/j.jsb.2015.11.004; Kamariah N, 2015, BBA-BIOENERGETICS, V1847, P1139, DOI 10.1016/j.bbabio.2015.06.011; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leys D, 2004, CURR OPIN STRUC BIOL, V14, P642, DOI 10.1016/j.sbi.2004.10.002; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Nartey W, 2015, FEBS J, V282, P4620, DOI 10.1111/febs.13522; Niimura Y, 1996, J BIOL CHEM, V271, P30459, DOI 10.1074/jbc.271.48.30459; NIIMURA Y, 1995, J BIOL CHEM, V270, P25645, DOI 10.1074/jbc.270.43.25645; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wood ZA, 2001, BIOCHEMISTRY-US, V40, P3900, DOI 10.1021/bi002765p	44	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6667	6679		10.1074/jbc.M117.775858	http://dx.doi.org/10.1074/jbc.M117.775858			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28270505	hybrid, Green Published			2022-12-28	WOS:000399813400019
J	Liu, XL; Xia, YJ; Tang, JX; Ma, L; Li, CC; Ma, PC; Mao, BY				Liu, Xiaoliang; Xia, Yingjie; Tang, Jixin; Ma, Li; Li, Chaocui; Ma, Pengcheng; Mao, Bingyu			Dual roles of Akirin2 protein during Xenopus neural development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; chromatin remodeling; embryo; neurodevelopment; Xenopus	CELL-CYCLE; PLURIPOTENT CELLS; NERVOUS-SYSTEM; STEM-CELLS; CHROMATIN; GEMININ; DIFFERENTIATION; EXPRESSION; GENES; SOX2	To ensure correct spatial and temporal patterning, embryos must maintain pluripotent cell populations and control when cells undergo commitment. The newly identified nucleoprotein Akirin has been shown to modulate the innate immune response through epigenetic regulation and to play important roles in other physiological processes, but its role in neural development remains unknown. Here we show that Akirin2 is required for neural development in Xenopus and that knockdown of Akirin2 expands the expression of the neural progenitor marker Sox2 and inhibits expression of the differentiated neuronal marker N-tubulin. Akirin2 acts antagonistically to Geminin, thus regulating Sox2 expression, and maintains the neural precursor state by participating in the Brg1/Brm-associated factor (BAF) complex mediated by BAF53a. Additionally, Akirin2 also modulates N-tubulin expression by acting upstream of neuronal differentiation 1 (NeuroD) and in parallel with neurogenin-related 1 (Ngnr1) during terminal neuronal differentiation. Thus, our results reveal a novel model in which Akirin2 precisely coordinates and temporally controls Xenopus neural development.	[Liu, Xiaoliang; Xia, Yingjie; Tang, Jixin; Ma, Li; Li, Chaocui; Ma, Pengcheng; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, 32 Jiaochang East Rd, Kunming 650223, Peoples R China; [Liu, Xiaoliang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650223, Peoples R China; [Xia, Yingjie] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Tang, Jixin] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Ma, Li] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University System of Maryland; University of Maryland College Park	Ma, PC; Mao, BY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, 32 Jiaochang East Rd, Kunming 650223, Peoples R China.	kunmapch@mail.kiz.ac.cn; mao@mail.kiz.ac.cn		Mao, Bingyu/0000-0002-7993-3158; Ma, Pengcheng/0000-0002-1067-8021	National Natural Science Foundation of China [31171404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31171404 (to B.Y.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aigner S, 2005, DEV CELL, V9, P171, DOI 10.1016/j.devcel.2005.07.005; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bally-Cuif L, 2003, CURR OPIN NEUROBIOL, V13, P16, DOI 10.1016/S0959-4388(03)00015-1; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Bosch PJ, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0076-8; Chen XL, 2012, ANIM BIOTECHNOL, V23, P124, DOI 10.1080/10495398.2011.652326; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Farah MH, 2000, DEVELOPMENT, V127, P693; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hou FJ, 2013, DEV COMP IMMUNOL, V41, P703, DOI 10.1016/j.dci.2013.08.005; Kishi M, 2000, DEVELOPMENT, V127, P791; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroll KL, 2007, FRONT BIOSCI, V12, P1395, DOI 10.2741/2156; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Liu N, 2016, DEV COMP IMMUNOL, V55, P80, DOI 10.1016/j.dci.2015.10.015; Liu TX, 2015, DEV COMP IMMUNOL, V52, P17, DOI 10.1016/j.dci.2015.04.010; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; Ma PC, 2013, DEV GENES EVOL, V223, P253, DOI 10.1007/s00427-013-0437-9; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Macqueen DJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-34; Mathis L, 2002, TRENDS GENET, V18, P627, DOI 10.1016/S0168-9525(02)02806-8; Narayanan R, 2014, CELL TISSUE RES, V356, P575, DOI 10.1007/s00441-013-1791-7; Neilson KM, 2012, DEV BIOL, V365, P363, DOI 10.1016/j.ydbio.2012.03.004; Nowak Scott J, 2012, Bioarchitecture, V2, P209, DOI 10.4161/bioa.22907; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Salerno MS, 2009, EXP CELL RES, V315, P2012, DOI 10.1016/j.yexcr.2009.04.014; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Tartey S, 2015, BIOMOLECULES, V5, P1618, DOI 10.3390/biom5031618; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yan J, 2013, FISH SHELLFISH IMMUN, V35, P564, DOI 10.1016/j.fsi.2013.05.020; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Yellajoshyula D, 2012, MOL CELL BIOL, V32, P4549, DOI 10.1128/MCB.00737-12; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006	47	13	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5676	5684		10.1074/jbc.M117.777110	http://dx.doi.org/10.1074/jbc.M117.777110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28193841	Green Published, hybrid			2022-12-28	WOS:000398813200006
J	Hsia, HC; Hutti, JE; Baldwin, AS				Hsia, Hung-Ching; Hutti, Jessica E.; Baldwin, Albert S.			Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-RELATED KINASES; CYCLIC GMP-AMP; INNATE IMMUNITY; NEGATIVE REGULATOR; ANTIVIRAL RESPONSE; ANTITUMOR IMMUNITY; INTRACELLULAR DNA; PATHWAY; RECOGNITION; INTERFERON	Cytosolic DNA can elicit beneficial as well as undesirable immune responses. For example, viral or microbial DNA triggers cell-intrinsic immune responses to defend against infections, whereas aberrant cytosolic accumulation of self-DNA results in pathological conditions, such as autoimmunity. Given the importance of these DNA-provoked responses, a better understanding of their molecular mechanisms is needed. Cytosolic DNA engages stimulator of interferon genes (STING) to activate TANK-binding kinase 1 (TBK1), which subsequently phosphorylates the transcription factor interferon regulatory factor 3 (IRF3) to promote interferon expression. Recent studies have reported that additional transcription factors, including nuclear factor kappa B (NF-kappa B) and signal transducer and activator of transcription 6 (STAT6), are also activated by cytosolic DNA, suggesting that cytosolic DNA-induced gene expression is orchestrated by multiple factors. Here we show that cytosolic DNA activates STAT3, another member of the STAT family, via an autocrine mechanism involving interferon beta (IFN beta) and IL-6. Additionally, we observed a novel cytosolic DNA-induced phosphorylation at serine 754 in the transactivation domain of STAT3. Upon cytosolic DNA stimulation, Ser(754) is directly phosphorylated by TBK1 in a STING-dependent manner. Moreover, Ser(754) phosphorylation inhibits cytosolic DNA-induced STAT3 transcriptional activity and selectively reduces STAT3 target genes that are up-regulated in response to cytosolic DNA. Taken together, our results suggest that cytosolic DNA-induced STAT3 activation via IFN beta and IL-6 is restrained by Ser(754) phosphorylation of STAT3. Our findings reveal a new signaling axis downstream of the cytosolic DNA pathway and suggest potential interactions between innate immune responses and STAT3-driven oncogenic pathways.	[Hsia, Hung-Ching; Baldwin, Albert S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Hsia, Hung-Ching; Hutti, Jessica E.; Baldwin, Albert S.] Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA; [Hutti, Jessica E.] AbbVie Inc, 1 N Waukegan Rd, Abbott Pk, IL 60064 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; AbbVie	Baldwin, AS (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA.	albert_baldwin@med.unc.edu			National Institutes of Health (NIH) [AI35098, R35CA197684]; NATIONAL CANCER INSTITUTE [R35CA197684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098, R01AI035098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants AI35098 and R35CA197684 (to A. S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hutti JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041494; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Lawrence CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165005; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Marinis JM, 2012, MOL CELL BIOL, V32, P2479, DOI 10.1128/MCB.00106-12; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083639; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang T, 2012, BIOORG MED CHEM LETT, V22, P2063, DOI 10.1016/j.bmcl.2012.01.018; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	56	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5405	5417		10.1074/jbc.M116.771964	http://dx.doi.org/10.1074/jbc.M116.771964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188292	hybrid, Green Published			2022-12-28	WOS:000397875500021
J	Demberg, LM; Winkler, J; Wilde, C; Simon, KU; Schon, J; Rothemund, S; Schoneberg, T; Promel, S; Liebscher, I				Demberg, Lilian M.; Winkler, Jana; Wilde, Caroline; Simon, Kay-Uwe; Schoen, Julia; Rothemund, Sven; Schoeneberg, Torsten; Proemel, Simone; Liebscher, Ines			Activation of Adhesion G Protein-coupled Receptors AGONIST SPECIFICITY OF STACHEL SEQUENCE-DERIVED PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERED AGONIST; PROTEOLYTIC SITE; CLEAVAGE; GPR126; DOMAIN; MOTIF; GPCR; MECHANISMS	Members of the adhesion G protein-coupled receptor (aGPCR) family carry an agonistic sequence within their large ectodomains. Peptides derived from this region, called the Stachel sequence, can activate the respective receptor. As the conserved core region of the Stachel sequence is highly similar between aGPCRs, the agonist specificity of Stachel sequencederived peptides was tested between family members using cell culture-based second messenger assays. Stachel peptides derived from aGPCRs of subfamily VI (GPR110/ADGRF1, GPR116/ADGRF5) and subfamily VIII (GPR64/ADGRG2, GPR126/ADGRG6) are able to activate more than one member of the respective subfamily supporting their evolutionary relationship and defining them as pharmacological receptor subtypes. Extended functional analyses of the Stachel sequences and derived peptides revealed agonist promiscuity, not only within, but also between aGPCR subfamilies. For example, the Stachelderived peptide of GPR110 (subfamily VI) can activate GPR64 and GPR126 (both subfamily VIII). Our results indicate that key residues in the Stachel sequence are very similar between aGPCRs allowing for agonist promiscuity of several Stachel-derived peptides. Therefore, aGPCRs appear to be pharmacologically more closely related than previously thought. Our findings have direct implications for many aGPCR studies, as potential functional overlap has to be considered for in vitro and in vivo studies. However, it also offers the possibility of a broader use of more potent peptides when the original Stachel sequence is less effective.	[Demberg, Lilian M.; Winkler, Jana; Wilde, Caroline; Simon, Kay-Uwe; Schoen, Julia; Schoeneberg, Torsten; Proemel, Simone; Liebscher, Ines] Univ Leipzig, Fac Med, Mol Biochem, Rudolf Schonheimer Inst Biochem, D-04103 Leipzig, Germany; [Rothemund, Sven] Univ Leipzig, Fac Med, Core Unit Peptide Technol, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Promel, S; Liebscher, I (corresponding author), Univ Leipzig, Fac Med, Mol Biochem, Rudolf Schonheimer Inst Biochem, D-04103 Leipzig, Germany.	simone.proemel@medizin.uni-leipzig.de; ines.liebscher@medizin.uni-leipzig.de	Liebscher, Ines/AAX-7478-2020	Liebscher, Ines/0000-0003-4480-8987; Promel, Simone/0000-0001-7800-7323; Wilde, Caroline/0000-0003-4548-1760	Deutsche Forschungsgemeinschaft [FOR2149]; BMBF (IFB AdipositasDiseases Leipzig) [ADI-K767]; European Social Fund; Free State of Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (IFB AdipositasDiseases Leipzig)(Federal Ministry of Education & Research (BMBF)); European Social Fund(European Social Fund (ESF)); Free State of Saxony	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR2149, BMBF (IFB AdipositasDiseases Leipzig) Grant ADI-K767, the European Social Fund, and the Free State of Saxony. The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Coster M, 2012, FASEB J, V26, P3273, DOI 10.1096/fj.12-203737; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liebscher I, 2016, HANDB EXP PHARMACOL, V234, P111, DOI 10.1007/978-3-319-41523-9_6; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liebscher I, 2013, BIOL CHEM, V394, P937, DOI 10.1515/hsz-2013-0109; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Muller A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005624; Okayama H., 1992, BIOTECHNOLOGY, V24, P270; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Promel S, 2012, DEV DYNAM, V241, P1591, DOI 10.1002/dvdy.23841; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220	32	59	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4383	4394		10.1074/jbc.M116.763656	http://dx.doi.org/10.1074/jbc.M116.763656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154189	hybrid, Green Published			2022-12-28	WOS:000397585100001
J	Nagao, H; Nishizawa, H; Bamba, T; Nakayama, Y; Isozumi, N; Nagamori, S; Kanai, Y; Tanaka, Y; Kita, S; Fukuda, S; Funahashi, T; Maeda, N; Fukusaki, E; Shimomura, I				Nagao, Hirofumi; Nishizawa, Hitoshi; Bamba, Takeshi; Nakayama, Yasumune; Isozumi, Noriyoshi; Nagamori, Shushi; Kanai, Yoshikatsu; Tanaka, Yoshimitsu; Kita, Shunbun; Fukuda, Shiro; Funahashi, Tohru; Maeda, Norikazu; Fukusaki, Eiichiro; Shimomura, Iichiro			Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose Tissue IN VIVO METABOLIC TURNOVER ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ASPARTATE TRANSPORTER; ADIPONECTIN LEVELS; VISCERAL FAT; RAT-BRAIN; EXPRESSION; PLASMA; CELLS; CLONING; MICE	Obesity is closely associated with various metabolic disorders. However, little is known about abnormalities in the metabolic change of obese adipose tissue. Here we use static metabolic analysis and in vivo metabolic turnover analysis to assess metabolic dynamics in obese mice. The static metabolic analyses showed that glutamate and constitutive metabolites of the TCA cycle were increased in the white adipose tissue (WAT) of ob/ob and diet-induced obesity mice but not in the liver or skeletal muscle of these obese mice. Moreover, in vivo metabolic turnover analyses demonstrated that these glucose-derived metabolites were dynamically and specifically produced in obese WAT compared with lean WAT. Glutamate rise in obese WAT was associated with down-regulation of glutamate aspartate transporter (GLAST), a major glutamate transporter for adipocytes, and low uptake of glutamate into adipose tissue. In adipocytes, glutamate treatment reduced adiponectin secretion and insulin-mediated glucose uptake and phosphorylation of Akt. These data suggest that a high intra-adipocyte glutamate level potentially relates to adipocyte dysfunction in obesity. This study provides novel insights into metabolic dysfunction in obesity through comprehensive application of in vivo metabolic turnover analysis in two obese animal models.	[Tanaka, Yoshimitsu; Kita, Shunbun; Fukuda, Shiro; Funahashi, Tohru; Maeda, Norikazu; Shimomura, Iichiro] Osaka Univ, Grad Sch Engn, Dept Metab Med, 2-2-B5, Suita, Osaka 5650871, Japan; [Isozumi, Noriyoshi; Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Engn, Dept Biosyst Pharmacol, Suita, Osaka 5650871, Japan; [Kita, Shunbun; Funahashi, Tohru; Maeda, Norikazu] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan; [Bamba, Takeshi; Nakayama, Yasumune; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Med, Dept Biotechnol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Nishizawa, H (corresponding author), Osaka Univ, Grad Sch Engn, Dept Metab Med, 2-2-B5, Suita, Osaka 5650871, Japan.	hitoshin1127@endmet.med.osaka-u.ac.jp	Nagamori, Shushi/P-4530-2018; Nakayama, Yasumune/H-2982-2019	Nagamori, Shushi/0000-0003-0203-2754; Nakayama, Yasumune/0000-0002-6810-4354	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25136714, 26293221, 15K09412]; Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST); Kowa Co. Ltd.	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Kowa Co. Ltd.	This work was supported in part by Grant-in-Aid for Scientific Research (C) 15K09412 (to H.Nishizawa), Grant-in-Aid for Scientific Research (B) 26293221 (to T.F.), Grant-in-Aid for Scientific Research Innovative Areas " HD Physiology" 25136714 (to S.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST) (to E.F and I.S.). S.K., T.F., and N. M. are members of the Department of Metabolism and Atherosclerosis, a sponsored course endowed by Kowa Co. Ltd. The company has a scientific officer who oversees the program.	Abrahamsen B, 2013, J NEUROSCI, V33, P1068, DOI 10.1523/JNEUROSCI.3396-12.2013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; CONRADT M, 1995, EUR J BIOCHEM, V229, P682, DOI 10.1111/j.1432-1033.1995.tb20514.x; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FREDERICH RC, 1992, HYPERTENSION, V19, P339, DOI 10.1161/01.HYP.19.4.339; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Harada K, 2006, BIOTECHNOL PROGR, V22, P1003, DOI 10.1021/bp060139z; Hashim Z, 2014, J CHROMATOGR B, V966, P83, DOI 10.1016/j.jchromb.2014.05.041; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kitata RB, 2015, J PROTEOME RES, V14, P3658, DOI 10.1021/acs.jproteome.5b00477; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mittelman SD, 2002, DIABETES, V51, P755, DOI 10.2337/diabetes.51.3.755; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nakagawa Y, 2011, J ATHEROSCLER THROMB, V18, P240, DOI 10.5551/jat.6593; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Nakayama Y, 2014, J BIOSCI BIOENG, V118, P350, DOI 10.1016/j.jbiosc.2014.02.014; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SCHULTE S, 1995, EUR J BIOCHEM, V233, P947, DOI 10.1111/j.1432-1033.1995.947_3.x; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Shimizu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11617; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; SMITH U, 1979, EUR J CLIN INVEST, V9, P327, DOI 10.1111/j.1365-2362.1979.tb00892.x; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsushima Y, 2013, J BIOL CHEM, V288, P27138, DOI 10.1074/jbc.M113.485094; Uetsuka S, 2015, EUR J NEUROSCI, V42, P1984, DOI 10.1111/ejn.12973; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Varma V, 2015, METABOLOMICS, V11, P529, DOI 10.1007/s11306-014-0716-0; Yamakado M, 2012, CLIN OBES, V2, P29, DOI 10.1111/j.1758-8111.2012.00039.x; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014	54	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4469	4483		10.1074/jbc.M116.770172	http://dx.doi.org/10.1074/jbc.M116.770172			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28119455	Green Published, hybrid			2022-12-28	WOS:000397585100008
J	Nakajima, H; Itakura, M; Kubo, T; Kaneshige, A; Harada, N; Izawa, T; Azuma, YT; Kuwamura, M; Yamaji, R; Takeuchi, T				Nakajima, Hidemitsu; Itakura, Masanori; Kubo, Takeya; Kaneshige, Akihiro; Harada, Naoki; Izawa, Takeshi; Azuma, Yasu-Taka; Kuwamura, Mitsuru; Yamaji, Ryouichi; Takeuchi, Tadayoshi			Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Aggregation Causes Mitochondrial Dysfunction during Oxidative Stress-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; ENDOPLASMIC-RETICULUM STRESS; ACTIVE-SITE CYSTEINE; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; APOPTOSIS; ACTIVATION	Glycolytic glyceraldehyde-3-phosphatedehydrogenase(GAPDH) is a multifunctional protein that also mediates cell death under oxidative stress. Wereported previously that the active-site cysteine (Cys-152) of GAPDH plays an essential role in oxidative stress-induced aggregation of GAPDH associated with cell death, and a C152A-GAPDH mutant rescues nitric oxide (NO)induced cell death by interfering with the aggregation of wild type (WT)-GAPDH. However, the detailed mechanism underlying GAPDH aggregate-induced cell death remains elusive. Here we report that NO-induced GAPDH aggregation specifically causes mitochondrial dysfunction. First, we observed a correlation between NO-induced GAPDH aggregation and mitochondrial dysfunction, when GAPDH aggregation occurred at mitochondria in SH-SY5Y cells. In isolated mitochondria, aggregates of WT-GAPDH directly induced mitochondrial swelling and depolarization, whereas mixtures containing aggregates ofC152AGAPDH reduced mitochondrial dysfunction. Additionally, treatment with cyclosporin A improved WT-GAPDH aggregate-induced swelling and depolarization. In doxycycline-inducible SH-SY5Y cells, overexpression of WT-GAPDH augmented NO-induced mitochondrial dysfunction and increased mitochondrial GAPDH aggregation, whereas induced overexpression of C152A-GAPDH significantly suppressed mitochondrial impairment. Further, NO-induced cytochrome c release into the cytosol and nuclear translocation of apoptosis-inducing factor from mitochondria were both augmented in cells overexpressing WT-GAPDH but ameliorated in C152A-GAPDHoverexpressing cells. Interestingly, GAPDH aggregates induced necrotic cell death via a permeability transition pore (PTP) opening. The expression of either WT-or C152A-GAPDH did not affect other cell death pathways associated with protein aggregation, such as proteasome inhibition, gene expression induced by endoplasmic reticulum stress, or autophagy. Collectively, these results suggest that NO-induced GAPDH aggregation specifically induces mitochondrial dysfunction via PTP opening, leading to cell death.	[Nakajima, Hidemitsu; Itakura, Masanori; Kubo, Takeya; Kaneshige, Akihiro; Azuma, Yasu-Taka; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Osaka 5988531, Japan; [Harada, Naoki; Yamaji, Ryouichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Osaka 5988531, Japan; [Izawa, Takeshi; Kuwamura, Mitsuru] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pathol, Osaka 5988531, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Nakajima, H (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Osaka 5988531, Japan.	hnakajima@vet.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X; Nakajima, Hidemitsu/0000-0002-0441-1929; Izawa, Takeshi/0000-0003-3236-6050; Azuma, Yasu-Taka/0000-0002-3515-171X	JSPS KAKENHI [15J05838]; Japan Society for the Promotion of Science [AS232Z02185G, AS242Z02311Q];  [22580339];  [25450428];  [16H05029]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; 	This work was supported in part by Grants-in-aid 22580339, 25450428, and 16H05029 (to H.N.), JSPS KAKENHI Grant 15J05838 (to M. I.) from the Japan Society for the Promotion of Science, and Grants-in-aid AS232Z02185G and AS242Z02311Q for Exploratory Research in A-STEP. The authors declare that they have no conflicts of interest with the contents of this article.	Abbasabadi AO, 2013, INT J BIOL MACROMOL, V61, P212, DOI 10.1016/j.ijbiomac.2013.07.007; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bobba A, 2002, FEBS LETT, V515, P8, DOI 10.1016/S0014-5793(02)02231-7; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; Glockzin S, 1999, J BIOL CHEM, V274, P19581, DOI 10.1074/jbc.274.28.19581; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Itakura M, 2015, J BIOL CHEM, V290, P26072, DOI 10.1074/jbc.M115.669291; Itakura M, 2015, BIOCHEM BIOPH RES CO, V467, P373, DOI 10.1016/j.bbrc.2015.09.150; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Kohr MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111448; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kubo T, 2016, NITRIC OXIDE-BIOL CH, V53, P13, DOI 10.1016/j.niox.2015.12.005; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Lazarev VF, 2015, FEBS LETT, V589, P581, DOI 10.1016/j.febslet.2015.01.018; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; LETKO G, 1973, ACTA BIOL MED GER, V30, P365; Liu L, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-014-0345-y; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2015, J BIOL CHEM, V290, P14493, DOI 10.1074/jbc.M114.635607; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Xu K, 2009, ATHEROSCLEROSIS, V207, P123, DOI 10.1016/j.atherosclerosis.2009.04.019; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	63	38	38	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4727	4742		10.1074/jbc.M116.759084	http://dx.doi.org/10.1074/jbc.M116.759084			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28167533	Green Published, hybrid			2022-12-28	WOS:000397585100028
J	Reppschlager, K; Gosselin, J; Dangelmaier, CA; Thomas, DH; Carpino, N; McKenzie, SE; Kunapuli, SP; Tsygankov, AY				Reppschlager, Kevin; Gosselin, Jeanne; Dangelmaier, Carol A.; Thomas, Dafydd H.; Carpino, Nick; McKenzie, Steven E.; Kunapuli, Satya P.; Tsygankov, Alexander Y.			TULA-2 protein phosphatase suppresses activation of Syk through the GPVI platelet receptor for collagen by dephosphorylating Tyr(P)(346), a regulatory site of Syk (vol 291, pg 22427,2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														McKenzie, Steven/0000-0003-2654-8560				Reppschlager K, 2016, J BIOL CHEM, V291, P22427, DOI 10.1074/jbc.M116.743732	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4360	4360		10.1074/jbc.A116.743732	http://dx.doi.org/10.1074/jbc.A116.743732			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28283589	Green Published, hybrid			2022-12-28	WOS:000395837100034
J	Niture, SK; Jain, AK; Shelton, PM; Jaiswal, AK				Niture, Suryakant K.; Jain, Abhinav K.; Shelton, Phillip M.; Jaiswal, Anil K.			RETRACTION: Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression (Retraction of Vol 286, Pg 28821, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042	1	3	3	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2048	2048		10.1074/jbc.A117.255042	http://dx.doi.org/10.1074/jbc.A117.255042			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159761	hybrid, Green Published			2022-12-28	WOS:000395515600043
J	Ludtmann, MHR; Arber, C; Bartolome, F; de Vicente, M; Preza, E; Carro, E; Houlden, H; Gandhi, S; Wray, S; Abramov, AY				Ludtmann, Marthe H. R.; Arber, Charles; Bartolome, Fernando; de Vicente, Macarena; Preza, Elisavet; Carro, Eva; Houlden, Henry; Gandhi, Sonia; Wray, Selina; Abramov, Andrey Y.			Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); ATP; induced pluripotent stem cell (iPS cell) (iPSC); mitochondria; ANT; VCP	ADENINE-NUCLEOTIDE TRANSLOCASE; PLURIPOTENT STEM-CELLS; ATP LEVELS; MICE; BIOENERGETICS; PROGENITORS; MECHANISM; SYNTHASE; NETWORKS; DISEASE	Mutations in the gene encoding valosin-containing protein (VCP) lead to multisystem proteinopathies including frontotemporal dementia. We have previously shown that patient-derived VCP mutant fibroblasts exhibit lower mitochondrial membrane potential, uncoupled respiration, and reduced ATP levels. This study addresses the underlying basis for mitochondrial uncoupling using VCP knockdown neuroblastoma cell lines, induced pluripotent stem cells (iPSCs), and iPSC-derived cortical neurons from patients with pathogenic mutations in VCP. Using fluorescent live cell imaging and respiration analysis we demonstrate a VCP mutation/knockdown-induced dysregulation in the adenine nucleotide translocase, which results in a slower rate of ADP or ATP translocation across the mitochondrial membranes. This deregulation can explain the mitochondrial uncoupling and lower ATP levels in VCP mutation-bearing neurons via reduced ADP availability for ATP synthesis. This study provides evidence for a role of adenine nucleotide translocase in the mechanism underlying altered mitochondrial function in VCP-related degeneration, and this new insight may inform efforts to better understand and manage neurodegenerative disease and other proteinopathies.	[Ludtmann, Marthe H. R.; Arber, Charles; Preza, Elisavet; Wray, Selina; Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Bartolome, Fernando; de Vicente, Macarena; Carro, Eva] Hosp 12 Octubre I 12, Neurodegenerat Disorders Grp, Res Inst, Madrid 28041, Spain; [Houlden, Henry] Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Gandhi, Sonia] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Bartolome, Fernando; de Vicente, Macarena; Carro, Eva] Biomed Res Networking Ctr Neurodegenerat Dis CIBE, Madrid 28041, Spain	University of London; University College London; Hospital Universitario 12 de Octubre; University of London; University College London; University of London; University College London	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Bartolome, Fernando/D-4618-2011; Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; Carro, Eva/D-6240-2018; Houlden, Henry J/C-1532-2008; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Wray, Selina/C-3682-2009; Ludtmann, Marthe/A-1446-2013; Arber, Charles/L-9989-2015	Bartolome, Fernando/0000-0001-9322-8933; Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Carro, Eva/0000-0002-6504-4579; Houlden, Henry J/0000-0002-2866-7777; Wray, Selina/0000-0003-3062-7050; Ludtmann, Marthe/0000-0003-1051-6425; Arber, Charles/0000-0002-9743-8134; PREZA, ELISAVET/0000-0003-4082-4621	National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); Wellcome Trust grant; NIHR Queen Square Dementia Biomedical Research Unit UCL/UCLH; MRC [MR/M02492X/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL5-Gandhi] Funding Source: researchfish; Medical Research Council [MR/M02492X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; Wellcome Trust [100172/Z/12/Z] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish	National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); Wellcome Trust grant(Wellcome Trust); NIHR Queen Square Dementia Biomedical Research Unit UCL/UCLH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Muscular Dystrophy UK	This work was supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), a Wellcome Trust grant, and the NIHR Queen Square Dementia Biomedical Research Unit UCL/UCLH. The authors declare that they have no conflicts of interest with the contents of this article.	Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Angelova PR, 2016, J CELL SCI, V129, P1792, DOI 10.1242/jcs.180737; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Bobba A, 2013, BBA-BIOENERGETICS, V1827, P848, DOI 10.1016/j.bbabio.2013.04.001; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Edri R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7500; Ganote CE, 2003, J MOL CELL CARDIOL, V35, P749, DOI 10.1016/S0022-2828(03)00114-7; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Johnson AE, 2015, ELIFE, V4, DOI 10.7554/eLife.07366; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Nalbandian A, 2015, MITOCHONDRION, V22, P1, DOI 10.1016/j.mito.2015.02.004; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Papkovskaia TD, 2012, HUM MOL GENET, V21, P4201, DOI 10.1093/hmg/dds244; Plun-Favreau H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.77; Schirris TJJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14533; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; WEINBACH EC, 1963, P NATL ACAD SCI USA, V50, P561, DOI 10.1073/pnas.50.3.561; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043099; Yin HZ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.115; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	34	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8907	8917		10.1074/jbc.M116.762898	http://dx.doi.org/10.1074/jbc.M116.762898			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28360103	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000402153900043
J	Guntupalli, S; Jang, SE; Zhu, TY; Huganir, RL; Widagdo, J; Anggono, V				Guntupalli, Sumasri; Jang, Se Eun; Zhu, Tianyi; Huganir, Richard L.; Widagdo, Jocelyn; Anggono, Victor			GluA1 subunit ubiquitination mediates amyloid-beta-induced loss of surface alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT UBIQUITINATION; ALZHEIMERS-DISEASE; REGULATORY PHOSPHORYLATION; TRAFFICKING; SITES; GLUR1; ENDOCYTOSIS; OLIGOMERS; REQUIRE	The accumulation of soluble amyloid-beta (A beta) peptides produces profound neuronal changes in the brain during the pathogenesis of Alzheimer's disease. Excessive levels of A beta disrupt excitatory synaptic transmission by promoting the removal of synaptic AMPA receptors (AMPARs), dendritic spine loss, and synaptic depression. Recently, activity-dependent ubiquitination of the GluA1 subunit has been shown to regulate the intracellular sorting of AMPARs toward late endosomes for degradation. However, whether this ubiquitin signaling pathway mediates A beta-induced loss of surface AMPARs is unknown. In this study, we demonstrate that acute exposure of cultured neurons to soluble A beta oligomers induces AMPAR ubiquitination concomitant with the removal of AMPARs from the plasma membrane. Importantly, expression of the GluA1 ubiquitin-deficient mutants inhibited the adverse effects of A beta on the surface expression of AMPARs in neurons. Furthermore, we revealed the cross-talk between GluA1 ubiquitination and phosphorylation, in particular phosphorylation at Ser-845, which is crucial for AMPAR recycling and is known to be dephosphorylated in the presence of A beta. Our data showed that the GluA1 ubiquitin-deficient mutant enhances GluA1 phosphorylation on Ser-845. Conversely, the GluA1 S845D phosphomimetic mutant reduced binding with Nedd4-1 and hence the ubiquitination of AMPARs. Importantly, the GluA1 S845D mutant also prevented A beta-induced removal of surface AMPARs. Taken together, these findings provide the first demonstration of the dynamic cross-modulation of GluA1 ubiquitination and phosphorylation, a process that is perturbed by A beta, in regulating the membrane sorting decision that ultimately determines the number of AMPARs on the cell surface.	[Guntupalli, Sumasri; Jang, Se Eun; Zhu, Tianyi; Widagdo, Jocelyn; Anggono, Victor] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld 4072, Australia; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA	University of Queensland; Johns Hopkins University; Johns Hopkins University	Anggono, V (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld 4072, Australia.	v.anggono@uq.edu.au	Anggono, Victor/J-2750-2013; Widagdo, Jocelyn/J-6316-2013	Anggono, Victor/0000-0002-4062-4884; Widagdo, Jocelyn/0000-0001-9667-9203	John T. Reid Charitable Trusts; Alzheimer's Australia Dementia Research Foundation [DGP14-57]; Australian National Health and Medical Research Council [GNT1083209, GNT1099114, 477108]; Clem Jones Centre for Ageing Dementia Research; National Institutes of Health [P50AG005146]; Millipore Corporation; University of Queensland International Scholarships; Australian Research Council Discovery Early Career Researcher Award [DE170100112]; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	John T. Reid Charitable Trusts; Alzheimer's Australia Dementia Research Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Clem Jones Centre for Ageing Dementia Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore Corporation; University of Queensland International Scholarships; Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the John T. Reid Charitable Trusts, Alzheimer's Australia Dementia Research Foundation Grant DGP14-57, Australian National Health and Medical Research Council Grants GNT1083209 and GNT1099114, and the Clem Jones Centre for Ageing Dementia Research (to V. A.) and by National Institutes of Health Grant P50AG005146 (to R. L. H.). Under a licensing agreement between Millipore Corporation and The Johns Hopkins University, R. L. H. is entitled to a share of royalties received by the University on sales of products described in this article. R. L. H. is a paid consultant to Millipore Corporation. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict-of-interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipients of University of Queensland International Scholarships.; Supported by Australian Research Council Discovery Early Career Researcher Award Fellowship DE170100112.; Supported by Australian National Health and Medical Research Council Fellowship 477108.	Alfonso S, 2014, EUR J NEUROSCI, V39, P1225, DOI 10.1111/ejn.12499; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anggono V, 2013, P NATL ACAD SCI USA, V110, P13976, DOI 10.1073/pnas.1312467110; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Anggono V, 2011, J NEUROSCI, V31, P2188, DOI 10.1523/JNEUROSCI.5633-10.2011; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; DEWAR D, 1991, BRAIN RES, V553, P58, DOI 10.1016/0006-8993(91)90230-S; Diering GH, 2016, P NATL ACAD SCI USA, V113, pE4920, DOI 10.1073/pnas.1610631113; Dong ZF, 2015, J CLIN INVEST, V125, P234, DOI 10.1172/JCI77888; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Goo MS, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00060; Guntupalli S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3204519; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Liu SJ, 2010, J ALZHEIMERS DIS, V21, P655, DOI 10.3233/JAD-2010-091654; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rodrigues EM, 2016, J NEUROSCI, V36, P1590, DOI 10.1523/JNEUROSCI.2964-15.2016; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Widagdo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31070; Widagdo J, 2015, ONCOTARGET, V6, P15718, DOI 10.18632/oncotarget.4645; Widagdo J, 2015, CELL REP, V10, P783, DOI 10.1016/j.celrep.2015.01.015; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	39	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8186	8194		10.1074/jbc.M116.774554	http://dx.doi.org/10.1074/jbc.M116.774554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28377502	Green Published, hybrid			2022-12-28	WOS:000401788600006
J	Mercado-Matos, J; Clark, JL; Piper, AJ; Janusis, J; Shaw, LM				Mercado-Matos, Jose; Clark, Jennifer L.; Piper, Andrew J.; Janusis, Jenny; Shaw, Leslie M.			Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR METASTASIS; PHOSPHATIDYLINOSITOL 3-KINASE; CANCER CELLS; INSULIN-RECEPTOR-SUBSTRATE-1 IRS-1; AEROBIC GLYCOLYSIS; EXPRESSION; ACTIVATION; APOPTOSIS; TAXOL; PHOSPHORYLATION	The insulin receptor substrate (IRS) proteins serve as essential signaling intermediates for the activation of PI3K by both the insulin-like growth factor 1 receptor (IGF-1R) and its close family member, the insulin receptor (IR). Although IRS-1 and IRS-2 share significant homology, they regulate distinct cellular responses downstream of these receptors and play divergent roles in breast cancer. To investigate the mechanism by which signaling through IRS-1 and IRS-2 results in differential outcomes, we assessed the involvement of the microtubule cytoskeleton in IRS-dependent signaling. Treatment with drugs that either stabilize or disrupt microtubules reveal that an intact microtubule cytoskeleton contributes to IRS-2- but not IRS-1-mediated activation of AKT by IGF-1. Proximal IGF-1R signaling events, including IRS tyrosine phosphorylation and recruitment of PI3K, are not inhibited by microtubule disruption, indicating that IRS-2 requires the microtubule cytoskeleton at the level of downstream effector activation. IRS-2 colocalization with tubulin is enhanced upon Taxol-mediated microtubule stabilization, which, together with the signaling data, suggests that the microtubule cytoskeleton may facilitate access of IRS-2 to downstream effectors such as AKT. Of clinical relevance is that our data reveal that expression of IRS-2 sensitizes breast carcinoma cells to apoptosis in response to treatment with microtubule-disrupting drugs, identifying IRS-2 as a potential biomarker for the response of breast cancer patients to Vinca alkaloid drug treatment.	[Mercado-Matos, Jose; Clark, Jennifer L.; Piper, Andrew J.; Janusis, Jenny; Shaw, Leslie M.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, 364 Plantat St,LRB 409, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Shaw, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, 364 Plantat St,LRB 409, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu		Clark, Jennifer/0000-0001-9114-4285; Piper-Vallillo, Andrew J./0000-0003-0742-0350	National Institutes of Health [CA142782]; National Institutes of Health F31 Predoctoral Fellowship [CA180706]; Department of Defense Breast Cancer Predoctoral Fellowship [W81XWH-10-1-0038]; NATIONAL CANCER INSTITUTE [F31CA180706, R01CA142782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Predoctoral Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA142782 (to L. M. S.), National Institutes of Health F31 Predoctoral Fellowship CA180706 (to J. M. M.), and Department of Defense Breast Cancer Predoctoral Fellowship W81XWH-10-1-0038 (to J. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aapro M, 2012, CANCER TREAT REV, V38, P120, DOI 10.1016/j.ctrv.2011.05.005; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Clark JL, 2011, BREAST CANCER RES TR, V130, P759, DOI 10.1007/s10549-011-1353-1; De Bruyne E, 2010, BLOOD, V115, P2430, DOI 10.1182/blood-2009-07-232801; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gagnon V, 2008, APOPTOSIS, V13, P259, DOI 10.1007/s10495-007-0165-6; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; HADARI YR, 1992, J BIOL CHEM, V267, P17483; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jackson JG, 1999, GROWTH HORM IGF RES, V9, P280, DOI 10.1054/ghir.1999.0113; Koda M, 2005, J CLIN PATHOL, V58, P645, DOI 10.1136/jcp.2004.022590; Landis J, 2014, J BIOL CHEM, V289, P18603, DOI 10.1074/jbc.M114.564070; Linseman DA, 2002, J NEUROSCI, V22, P9287; Liu LZ, 2013, MOL CELL ENDOCRINOL, V365, P64, DOI 10.1016/j.mce.2012.09.005; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Migliaccio I, 2010, BREAST CANCER RES TR, V123, P651, DOI 10.1007/s10549-009-0632-6; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Myers MG, 1996, MOL CELL BIOL, V16, P4147; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Page C, 2000, ANTICANCER RES, V20, P407; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Rohatgi RA, 2015, ONCOGENE, V34, P5352, DOI 10.1038/onc.2014.454; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Sisci D, 2007, J CLIN PATHOL, V60, P633, DOI 10.1136/jcp.2006.039107; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thomas EC, 2006, INT J BIOCHEM CELL B, V38, P1686, DOI 10.1016/j.biocel.2006.03.009; TISHLER RB, 1995, CANCER RES, V55, P6021; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Valverde AM, 2004, HEPATOLOGY, V40, P1285, DOI 10.1002/hep.20485; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Yang SX, 2010, J CLIN ONCOL, V28, P2974, DOI 10.1200/JCO.2009.26.1602	40	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7806	7816		10.1074/jbc.M117.785832	http://dx.doi.org/10.1074/jbc.M117.785832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28320862	hybrid, Green Published			2022-12-28	WOS:000401154100011
J	Reitberger, S; Haimerl, P; Aschenbrenner, I; Bieren, JEV; Feige, MJ				Reitberger, Susanne; Haimerl, Pascal; Aschenbrenner, Isabel; Bieren, Julia Esser-von; Feige, Matthias J.			Assembly-induced folding regulates interleukin 12 biogenesis and secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL STIMULATORY FACTOR; LYMPHOCYTE MATURATION FACTOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; HETERODIMERIC CYTOKINE; IL-12 FAMILY; P40 SUBUNIT; T-CELLS; HEAVY-CHAIN; P35 SUBUNIT	Members of the IL-12 family perform essential functions in immunoregulation by connecting innate and adaptive immunity and are emerging therapeutic targets. They are unique among other interleukins in forming heterodimers that arise from extensive subunit sharing within the family, leading to the production of at least four functionally distinct heterodimers from only five subunits. This raises important questions about how the assembly of IL-12 family members is regulated and controlled in the cell. Here, using cell-biological approaches, we have dissected basic principles that underlie the biogenesis of the founding member of the family, IL-12. Within the native IL-12 heterodimer, composed of IL-12 alpha and IL-12 alpha, IL-12 alpha possesses three intramolecular and one intermolecular disulfide bridges. We show that, in isolation, IL-12 alpha fails to form its native structure but, instead, misfolds, forming incorrect disulfide bonds. Co-expression of its beta subunit inhibits misfolding and thus allows secretion of biologically active heterodimeric IL-12. On the basis of these findings, we identified the disulfide bonds in IL-12 alpha that are critical for assembly-induced secretion and biological activity of IL-12 versus misfolding and degradation of IL-12 alpha. Surprisingly, two of the three disulfide bridges in IL-12 alpha are dispensable for IL-12 secretion, stability, and biological activity. Extending our findings, we show that misfolding also occurs for IL-23 alpha, another IL-12 family protein. Our results indicate that assembly-induced folding is key in IL-12 family biogenesis and secretion. The identification of essential disulfide bonds that underlie this process lays the basis for a simplified yet functional IL-12 cytokine.	[Reitberger, Susanne; Aschenbrenner, Isabel; Feige, Matthias J.] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, D-85748 Garching, Germany; [Reitberger, Susanne; Aschenbrenner, Isabel; Feige, Matthias J.] Tech Univ Munich, Inst Adv Study, Lichtenbergstr 2a, D-85748 Garching, Germany; [Haimerl, Pascal; Bieren, Julia Esser-von] Tech Univ Munich, Ctr Allergy & Environm, D-80802 Munich, Germany; [Haimerl, Pascal; Bieren, Julia Esser-von] Helmholtz Zentrum Munchen, D-80802 Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Feige, MJ (corresponding author), Tech Univ Munich, Inst Adv Study, Lichtenbergstr 2a, D-85748 Garching, Germany.; Feige, MJ (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 2a, D-85748 Garching, Germany.	matthias.feige@tum.de		Feige, Matthias/0000-0001-5435-4312; Esser-von Bieren, Julia/0000-0003-1898-9382	CIPSM; Fonds der Chemischen Industrie; Daimler and Benz Foundation; Else Kroner-Fresenius Foundation [2015_A195]; Marie Curie COFUND Program; Technical University of Munich Institute for Advanced Study - German Excellence Initiative; European Union Seventh Framework Program [291763]	CIPSM; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Daimler and Benz Foundation; Else Kroner-Fresenius Foundation; Marie Curie COFUND Program; Technical University of Munich Institute for Advanced Study - German Excellence Initiative; European Union Seventh Framework Program(European Commission)	This work was supported by CIPSM, the Fonds der Chemischen Industrie, and the Daimler and Benz Foundation and was performed in the framework of SFB 1035 (German Research Foundation DFG, Sonderforschungsbereich 1035, Project B11). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Else Kroner-Fresenius Foundation Grant 2015_A195.r A Rudolf Mossbauer Tenure Track Professor supported by the Marie Curie COFUND Program and the Technical University of Munich Institute for Advanced Study, funded by the German Excellence Initiative and the European Union Seventh Framework Program under Grant Agreement 291763. To whom correspondence should be addressed: Dept. of Chemistry and Institute for Advanced Study, Technical University of Munich, Lichtenberg-str. 2a, 85748 Garching, Germany. Tel.: 49-89-289-10595; Fax: 49-89-289-10698; E-mail: matthias.feige@tum.de.	Abdi K, 2014, J IMMUNOL, V192, P6028, DOI 10.4049/jimmunol.1400159; Aparicio-Siegmund S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107990; Braakman I, 2001, CURR PROTOC PROTEIN, P1411; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Carra G, 2000, J IMMUNOL, V164, P4752, DOI 10.4049/jimmunol.164.9.4752; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Dixon KO, 2015, EUR J IMMUNOL, V45, P1736, DOI 10.1002/eji.201445217; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Fayadat L, 2003, MOL BIOL CELL, V14, P1268, DOI 10.1091/mbc.E02-06-0363; Feige MJ, 2015, J BIOL CHEM, V290, P26821, DOI 10.1074/jbc.M115.689471; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; GEISLER C, 1989, J IMMUNOL, V143, P4069; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Hasegawa H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00479; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Hernandez-Alcoceba R, 2016, IMMUNOTHERAPY-UK, V8, P179, DOI 10.2217/imt.15.109; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; LING P, 1995, J IMMUNOL, V154, P116; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; Muller R, 2013, P NATL ACAD SCI USA, V110, P10183, DOI 10.1073/pnas.1300547110; Murphy FJ, 2000, J IMMUNOL, V164, P839, DOI 10.4049/jimmunol.164.2.839; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; WOLF SF, 1991, J IMMUNOL, V146, P3074; Yeku OO, 2016, BIOCHEM SOC T, V44, P412, DOI 10.1042/BST20150291; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Zheng, 2015, F1000 RES, V4	56	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8073	8081		10.1074/jbc.M117.782284	http://dx.doi.org/10.1074/jbc.M117.782284			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28325840	hybrid, Green Published			2022-12-28	WOS:000401154100031
J	Chanda, D; Oligschlaeger, Y; Geraets, I; Liu, YL; Zhu, XQ; Li, JY; Nabben, M; Coumans, W; Luiken, JJFP; Glatz, JFC; Neumann, D				Chanda, Dipanjan; Oligschlaeger, Yvonne; Geraets, Ilvy; Liu, Yilin; Zhu, Xiaoqing; Li, Jieyi; Nabben, Miranda; Coumans, Will; Luiken, Joost J. F. P.; Glatz, Jan F. C.; Neumann, Dietbert			2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DIABETIC CARDIOMYOPATHY; ENDOCANNABINOID SYSTEM; RECEPTOR; HEART; METABOLISM; DISEASE; HEALTH; CANNABINOIDS; EXPRESSION	Several studies have linked impaired glucose uptake and insulin resistance (IR) to functional impairment of the heart. Recently, endocannabinoids have been implicated in cardiovascular disease. However, the mechanisms involving endocannabinoid signaling, glucose uptake, and IR in cardiomyocytes are understudied. Here we report that the endocannabinoid 2-arachidonoylglycerol (2-AG), via stimulation of cannabinoid type 1 (CB1) receptor and Ca2+/calmodulin-dependent protein kinase beta, activates AMP-activated kinase (AMPK), leading to increased glucose uptake. Interestingly, we have observed that the mRNA expression of CB1 and CB2 receptors was decreased in diabetic mice, indicating reduced endocannabinoid signaling in the diabetic heart. We further establish that TNF alpha-induces IR in cardiomyocytes. Treatment with 2-AG suppresses TNF alpha-induced proinflammatory markers and improves IR and glucose uptake. Conversely, pharmacological inhibition or knockdown of AMPK attenuates the anti-inflammatory effect and reversal of IR elicited by 2-AG. Additionally, in human embryonic stem cell-derived cardiomyocytes challenged with TNF alpha or FFA, we demonstrate that 2-AG improves insulin sensitivity and glucose uptake. In conclusion, 2-AG abates inflammatory responses, increases glucose uptake, and overcomes IR in an AMPK-dependent manner in cardiomyocytes.	[Chanda, Dipanjan; Oligschlaeger, Yvonne; Geraets, Ilvy; Liu, Yilin; Zhu, Xiaoqing; Li, Jieyi; Nabben, Miranda; Coumans, Will; Luiken, Joost J. F. P.; Glatz, Jan F. C.; Neumann, Dietbert] Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands	Maastricht University	Chanda, D (corresponding author), Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands.	d.chanda@maastrichtuniversity.nl	Geraets, Ilvy/HII-4771-2022; Chanda, Dipanjan/AAU-3996-2021	Chanda, Dipanjan/0000-0003-0685-187X; Nabben, Miranda/0000-0002-5691-1634; Neumann, Dietbert/0000-0002-4316-684X	Marie Curie fellowship [PIIF-GA-2012-332230]; VENI Innovational Research Grant from The Netherlands Organization for Scientific Research (NWO) [916.14.050]; NWO VIDI [864.10.007]	Marie Curie fellowship(European Commission); VENI Innovational Research Grant from The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO VIDI(Netherlands Organization for Scientific Research (NWO))	Recipient of a Marie Curie fellowship (Grant PIIF-GA-2012-332230). To whom correspondence should be addressed. Tel.: 31-43-388-1979; Fax: 31-43-388-4574; E-mail: d.chanda@maastrichtuniversity.nl.; Recipient of a VENI Innovational Research Grant 916.14.050 from The Netherlands Organization for Scientific Research (NWO).; Supported by NWO VIDI Grant 864.10.007.	Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Dirkx E, 2014, J MOL CELL CARDIOL, V76, P208, DOI 10.1016/j.yjmcc.2014.08.017; Dirkx E, 2011, PROSTAG LEUKOTR ESS, V85, P219, DOI 10.1016/j.plefa.2011.04.018; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Hiley CR, 2009, J CARDIOVASC PHARM, V53, P267, DOI 10.1097/FJC.0b013e318192671d; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Irwin N, 2008, EUR J PHARMACOL, V581, P226, DOI 10.1016/j.ejphar.2007.12.003; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Luiken JJFP, 1997, J LIPID RES, V38, P745; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Montecucco F, 2012, TRENDS PHARMACOL SCI, V33, P331, DOI 10.1016/j.tips.2012.03.002; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Szmitko PE, 2008, ATHEROSCLEROSIS, V199, P248, DOI 10.1016/j.atherosclerosis.2008.03.011; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505	31	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7105	7114		10.1074/jbc.M116.767384	http://dx.doi.org/10.1074/jbc.M116.767384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28320859	Green Published, hybrid			2022-12-28	WOS:000400478300021
J	Robinson, PJ; Pringle, MA; Woolhead, CA; Bulleid, NJ				Robinson, Philip J.; Pringle, Marie Anne; Woolhead, Cheryl A.; Bulleid, Neil J.			Folding of a single domain protein entering the endoplasmic reticulum precedes disulfide formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PROTEINS; BOND FORMATION; IN-VITRO; ISOMERASE; MEMBRANE; RIBOSOME; TRANSLOCATION; CELLS; BETA(2)-MICROGLOBULIN; COMPLEX	The relationship between protein synthesis, folding, and disulfide formation within the endoplasmic reticulum (ER) is poorly understood. Previous studies have suggested that preexisting disulfide links are absolutely required to allow protein folding and, conversely, that protein folding occurs prior to disulfide formation. To address the question of what happens first within the ER, that is, protein folding or disulfide formation, we studied folding events at the early stages of polypeptide chain translocation into the mammalian ER using stalled translation intermediates. Our results demonstrate that polypeptide folding can occur without complete domain translocation. Protein disulfide isomerase (PDI) interacts with these early intermediates, but disulfide formation does not occur unless the entire sequence of the protein domain is translocated. This is the first evidence that folding of the polypeptide chain precedes disulfide formation within a cellular context and highlights key differences between protein folding in the ER and refolding of purified proteins.	[Robinson, Philip J.; Pringle, Marie Anne; Woolhead, Cheryl A.; Bulleid, Neil J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Bulleid, NJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Robinson, Philip/0000-0003-2576-5010; Bulleid, Neil/0000-0002-9839-5279; PRINGLE, MARIE ANNE/0000-0002-1358-4610	Wellcome Trust [103720]; BBSRC [BB/M017656/1, BB/D00764X/1, BB/L00593X/1, BB/P017665/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Wellcome Trust Grant 103720. The authors declare that they have no conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Ellgaard L, 2004, BIOCHEM SOC T, V32, P663, DOI 10.1042/BST0320663; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Frisch C, 1996, FOLD DES, V1, P431, DOI 10.1016/S1359-0278(96)00059-4; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Irvine AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082511; ISENMAN DE, 1975, P NATL ACAD SCI USA, V72, P548, DOI 10.1073/pnas.72.2.548; Jackson SE, 2013, TOP CURR CHEM, V328, P1, DOI 10.1007/128_2011_171; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; KADERBHAI MA, 1985, EUR J BIOCHEM, V153, P167, DOI 10.1111/j.1432-1033.1985.tb09283.x; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; KLAPPA P, 1995, EUR J BIOCHEM, V232, P755, DOI 10.1111/j.1432-1033.1995.tb20870.x; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer S, 2016, BBA-GEN SUBJECTS, V1860, P2122, DOI 10.1016/j.bbagen.2016.06.024; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; RUDIKOFF S, 1986, P NATL ACAD SCI USA, V83, P7875, DOI 10.1073/pnas.83.20.7875; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	39	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6978	6986		10.1074/jbc.M117.780742	http://dx.doi.org/10.1074/jbc.M117.780742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298446	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000400478300010
J	Chakraborty, S; Ain, R				Chakraborty, Shreeta; Ain, Rupasri			Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RECEPTOR TYROSINE KINASES; BLOOD-VESSEL FORMATION; GROWTH-FACTOR; IN-VIVO; TRANSCRIPTIONAL REGULATION; INTERACTING PROTEIN-2; INDUCED ANGIOGENESIS; VEGF RECEPTORS; BREAST-CANCER	Endothelial nitric-oxide synthase (eNOS) and its bioactive product, nitric oxide (NO), mediate many endothelial cell functions, including angiogenesis and vascular permeability. For example, vascular endothelial growth factor (VEGF)-mediated angiogenesis is inhibited upon reduction ofNObioactivity both in vitro and in vivo. Moreover, genetic disruption or pharmacological inhibition of eNOS attenuates angiogenesis during tissue repair, resulting in delayed wound closure. These observations emphasize that eNOS-derived NO can promote angiogenesis. Intriguingly, eNOS activity is regulated by nitric-oxide synthase trafficking inducer (NOSTRIN), which sequesters eNOS, thereby attenuating NO production. This has prompted significant interest in NOSTRIN's function in endothelial cells. We show here that NOSTRIN affects the functional transcriptome of endothelial cells by down-regulating several genes important for invasion and angiogenesis. Interestingly, the effects of NOSTRIN on endothelial gene expression were independent of eNOS activity. NOSTRIN also affected the expression of secreted cytokines involved in inflammatory responses, and ectopic NOSTRIN overexpression functionally restricted endothelial cell proliferation, invasion, adhesion, and VEGF-induced capillary tube formation. Furthermore, NOSTRIN interacted directly withTNFreceptor-associated factor 6 (TRAF6), leading to the suppression of NF kappa B activity and inhibition of AKT activation via phosphorylation. Interestingly, TNF-alpha-induced NF kappa B pathway activation was reversed by NOSTRIN. Wefound that the SH3 domain of NOSTRIN is involved in the NOSTRINTRAF6 interaction and is required for NOSTRIN-induced down-regulation of endothelial cell proteins. These results have broad biological implications, as aberrantNOSTRINexpression leading to deactivation of the NF kappa B pathway, in turn triggering an anti-angiogenic cascade, might inhibit tumorigenesis and cancer progression.	[Chakraborty, Shreeta; Ain, Rupasri] Indian Inst Chem Biol, CSIR, Div Cell Biol & Physiol, 4,Raja SC Mullick Rd, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ain, R (corresponding author), Indian Inst Chem Biol, CSIR, Div Cell Biol & Physiol, 4,Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	rupasri@iicb.res.in	Ain, Rupasri/HHS-4162-2022; Ain, Rupasri/H-5419-2012		Department of Biotechnology, India [BT/PR9113/MED/97/134/2013]; Indian Council of Medical Research [2012-0524]; Department of Science and Technology, Council of Scientific and Industrial Research, India [SB/SO/AS-114/2012, BSC 0101, BSC 0206]; University Grant Commission, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology, Council of Scientific and Industrial Research, India; University Grant Commission, India(University Grants Commission, India)	This work was supported by Grant BT/PR9113/MED/97/134/2013 from the Department of Biotechnology, India; Grant 2012-0524 from the Indian Council of Medical Research; and Grant SB/SO/AS-114/2012 from the Department of Science and Technology, Council of Scientific and Industrial Research, India, in the form of network Projects BSC 0101 and BSC 0206. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a predoctoral fellowship from the University Grant Commission, India.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ain R, 2004, P NATL ACAD SCI USA, V101, P16543, DOI 10.1073/pnas.0406185101; Arbiser JL, 2000, AM J PATHOL, V156, P1469, DOI 10.1016/S0002-9440(10)65015-8; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bae SH, 2014, BIOCHEM BIOPH RES CO, V443, P924, DOI 10.1016/j.bbrc.2013.12.066; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Bhaskar V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-61; Bonavida B., 2010, NITRIC OXIDE NO CANC, P458; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Bruneau S, 2012, BIOCHEM BIOPH RES CO, V419, P66, DOI 10.1016/j.bbrc.2012.01.128; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chakraborty S, 2016, TRENDS EXPT BIOL, P1; Chikaraishi Y, 2009, CURR NEUROVASC RES, V6, P140, DOI 10.2174/156720209788970072; Choi YJ, 2005, BIOCHEM BIOPH RES CO, V326, P594, DOI 10.1016/j.bbrc.2004.11.079; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eroglu A, 2007, MED ONCOL, V24, P169, DOI 10.1007/BF02698036; Fong TAT, 1999, CANCER RES, V59, P99; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gooz P, 2009, BIOCHEM BIOPH RES CO, V380, P33, DOI 10.1016/j.bbrc.2009.01.013; Haider S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0105-3; Hasenstein JR, 2012, NEOPLASIA, V14, P131, DOI 10.1593/neo.111770; HILDENBRAND R, 1995, PATHOL RES PRACT, V191, P403, DOI 10.1016/S0344-0338(11)80726-0; Icking A, 2006, FEBS LETT, V580, P223, DOI 10.1016/j.febslet.2005.11.078; Icking A, 2005, J CELL SCI, V118, P5059, DOI 10.1242/jcs.02620; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kaneko T, 2003, CANCER SCI, V94, P43, DOI 10.1111/j.1349-7006.2003.tb01350.x; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kim HW, 2005, BIOCHEM BIOPH RES CO, V337, P75, DOI 10.1016/j.bbrc.2005.08.262; Kirsch T, 2013, HYPERTENSION, V62, P726, DOI 10.1161/HYPERTENSIONAHA.113.01882; Kovacevic I, 2012, EMBO J, V31, P3309, DOI 10.1038/emboj.2012.176; Kruzliak P, 2013, ANGIOGENESIS, V16, P289, DOI 10.1007/s10456-012-9327-4; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Li XD, 2012, MICROVASC RES, V84, P44, DOI 10.1016/j.mvr.2012.04.002; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; McCormick ME, 2011, ARTERIOSCL THROM VAS, V31, P643, DOI 10.1161/ATVBAHA.110.216200; Mezyk-Kopec R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132661; Millauer B, 1996, CANCER RES, V56, P1615; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Mookerjee RP, 2007, GASTROENTEROLOGY, V132, P2533, DOI 10.1053/j.gastro.2006.12.035; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mukhopadhyay S, 2007, AM J PHYSIOL-HEART C, V292, pH1373, DOI 10.1152/ajpheart.00990.2006; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nakabayashi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-453; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Ozes ON, 1999, NATURE, V401, P82; Robinson SD, 2009, J BIOL CHEM, V284, P33966, DOI 10.1074/jbc.M109.030700; Rocha-Zavaleta L, 2004, CELL SIGNAL, V16, P1239, DOI 10.1016/j.cellsig.2004.03.011; Rossoni LV, 2011, CLIN SCI, V121, P449, DOI 10.1042/CS20110259; Saha S, 2015, MOL CELL ENDOCRINOL, V414, P186, DOI 10.1016/j.mce.2015.07.030; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schilling K, 2006, MOL BIOL CELL, V17, P3870, DOI 10.1091/mbc.E05-08-0709; Shaheen RM, 1999, CANCER RES, V59, P5412; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Taylor KL, 2006, J INTERF CYTOK RES, V26, P353, DOI 10.1089/jir.2006.26.353; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Wang J, 2016, CLIN CANCER RES, V22, P5992, DOI 10.1158/1078-0432.CCR-16-0511; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; Wiesenthal A, 2009, TRAFFIC, V10, P26, DOI 10.1111/j.1600-0854.2008.00850.x; Xiang W, 2005, INT J GYNECOL OBSTET, V89, P103, DOI 10.1016/j.ijgo.2004.12.041; Xiang Wen-pei, 2011, Zhonghua Nan Ke Xue, V17, P38; Xiang Wenpei, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P356; Xiang WP, 2009, J HUAZHONG U SCI-MED, V29, P243, DOI 10.1007/s11596-009-0222-1; Xu XY, 2013, J HUAZHONG U SCI-MED, V33, P272, DOI 10.1007/s11596-013-1110-2; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Yoo SY, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/127170; Yoon K, 2008, CELL DEATH DIFFER, V15, P730, DOI 10.1038/sj.cdd.4402304; Zimmermann K, 2002, P NATL ACAD SCI USA, V99, P17167, DOI 10.1073/pnas.252345399; Zobel T, 2015, J CELL SCI, V128, P1453, DOI 10.1242/jcs.170944	81	24	24	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6600	6620		10.1074/jbc.M116.742627	http://dx.doi.org/10.1074/jbc.M116.742627			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28235804	Green Published, hybrid			2022-12-28	WOS:000399813400014
J	Dib, K; Tikhonova, IG; Ivetic, A; Schu, P				Dib, Karim; Tikhonova, Irina G.; Ivetic, Aleksandar; Schu, Peter			The cytoplasmic tail of L-selectin interacts with the adaptor-protein complex AP-1 subunit mu 1A via a novel basic binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; LEUKOCYTE ADHESION; SORTING SIGNALS; COATED VESICLES; RECEPTOR; DOMAIN; PHOSPHORYLATION; SURFACE; MICE; INTERNALIZATION	L-selectin regulates leukocyte adhesion and rolling along the endothelium. Proteins binding to the cytoplasmic tail of L-selectin regulate L-selectin functions. We used L-selectin cytoplasmic tail peptide pulldown assays combined with high sensitivity liquid chromatography/mass spectrometry to identify novel L-selectin tail-binding proteins. Incubation of the L-selectin tail with cell extracts from phorbol 12-myristate 13-acetatestimulated Raw 264.7 macrophages resulted in the binding of mu 1A of the clathrin-coated vesicle AP-1 complex. Furthermore, full-length GST-mu 1A and the GST-mu 1A C-terminal domain, but not the GST-mu 1A N-terminal domain, bind to L-selectin tail peptide, and the intracellular pool of L-selectin colocalizes with AP-1 at the trans-Golgi network. We identified a novel basic protein motif consisting of a cluster of three dibasic residues (356RR357, 359KK360, and 362KK363) in the membrane-proximal domain of the L-selectin tail as well as a doublet of aspartic acid residues (369DD370) in the membrane-distal end of the L-selectin tail involved in mu 1A binding. Stimulation of Raw 264.7 macrophages with PMA augmented the amount of mu 1A associated with anti-L-selectin immunoprecipitates. However, fulllength GST-mu 1A did not bind to the phospho-L-selectin tail or phospho-mimetic S364D L-selectin tail. Accordingly, we propose that phosphorylation of mu 1A is required for interaction with the L-selectin tail and that L-selectin tail phosphorylation may regulate this interaction in vivo. Molecular docking of the L-selectin tail to mu 1A was used to identify the mu 1A surface domain binding the L-selectin tail and to explain how phosphorylation of the L-selectin tail abrogates mu 1A interaction. Our findings indicate that L-selectin is transported constitutively by the AP-1 complex, leading to the formation of a trans-Golgi network reserve pool and that phosphorylation of the L-selectin tail blocks AP-1-dependent retrograde transport of L-selectin.	[Dib, Karim] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Dib, Karim] Queens Univ Belfast, Ctr Med Expt, Belfast BT9 7BL, Antrim, North Ireland; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Ivetic, Aleksandar] Kings Coll London, Fac Life Sci & Med, BHF Ctr Res Excellence, Cardiovasc Div, London SE5 9NU, England; [Schu, Peter] Georg August Univ Gottingen, Dept Cellular Biochem, Univ Med Ctr Gottingen, D-37073 Gottingen, Germany	Max Planck Society; Queens University Belfast; Queens University Belfast; University of London; King's College London; University of Gottingen	Dib, K (corresponding author), Queens Univ Belfast, Ctr Med Expt, Ctr Med Biol, Fl 3,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	k.dib@qub.ac.uk		Ivetic, Aleksandar/0000-0001-9844-6518; Dib, Karim/0000-0002-1777-1915	European Commission [326812]; Deutsche Forschungsgemeinschaft (DFG) [Schu802/2-4]; British Heart Foundation (BHF)	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); British Heart Foundation (BHF)(British Heart Foundation)	This work was supported by the 7th Framework Programme for Research of the European Commission through the award of an individual Intra-European Marie Curie Fellowship (to K. D.) (project 326812). This work was also supported by Deutsche Forschungsgemeinschaft (DFG) Grant Schu802/2-4 (to P. S) and grants from the British Heart Foundation (BHF) (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Baltes J, 2014, J CELL SCI, V127, P3477, DOI 10.1242/jcs.146886; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng W, 2013, J MOL BIOL, V425, P3549, DOI 10.1016/j.jmb.2013.06.008; Deng W, 2011, J MOL BIOL, V411, P220, DOI 10.1016/j.jmb.2011.05.041; Foote C, 2006, J CELL BIOL, V173, P615, DOI 10.1083/jcb.200510161; Ghoorah AW, 2013, PROTEINS, V81, P2150, DOI 10.1002/prot.24433; Ghosh P, 2003, J CELL BIOL, V160, P699, DOI 10.1083/jcb.200211080; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; Haribabu B, 1997, J BIOL CHEM, V272, P13961, DOI 10.1074/jbc.272.21.13961; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Marschner S, 1999, P NATL ACAD SCI USA, V96, P9763, DOI 10.1073/pnas.96.17.9763; Medigeshi GR, 2008, TRAFFIC, V9, P121, DOI 10.1111/j.1600-0854.2007.00672.x; Melcrova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38035; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Radhakrishnan K, 2013, J CELL SCI, V126, P1155, DOI 10.1242/jcs.116079; Regal L, 2014, NEUROLOGY, V82, P1254, DOI 10.1212/WNL.0000000000000295; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rzeniewicz K, 2015, P NATL ACAD SCI USA, V112, pE1461, DOI 10.1073/pnas.1417100112; Schrodinger LLC, 2011, PRIM VERS 3 0; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Xu T, 2008, J LEUKOCYTE BIOL, V84, P1192, DOI 10.1189/jlb.0208084; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022560; Yoneyama Y, 2013, MOL CELL BIOL, V33, P1991, DOI 10.1128/MCB.01394-12; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	44	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6703	6714		10.1074/jbc.M116.768598	http://dx.doi.org/10.1074/jbc.M116.768598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28235798	Green Published, hybrid			2022-12-28	WOS:000399813400022
J	Zhang, AL; Peng, B; Huang, P; Chen, JJ; Gong, ZH				Zhang, Aili; Peng, Bo; Huang, Ping; Chen, Junjie; Gong, Zihua			The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5' END RESECTION; HOMOLOGOUS RECOMBINATION; 53BP1; BREAKS; RIF1; PATHWAY; BINDING; CELLS	The 53BP1-dependent end-joining pathway plays a critical role in double strand break repair and is uniquely responsible for cellular sensitivity to poly(ADP-ribose) polymerase inhibitors (PARPi) in BRCA1-deficient cancers. We and others have investigated the downstream effectors of 53BP1, including replication timing regulatory factor 1 (RIF1) and Pax transactivation domain-interacting protein (PTIP), in the past few years to elucidate how loss of the 53BP1-dependent repair pathway results in PARPi resistance in BRCA1 patients. However, questions regarding the upstream regulation of the 53BP1 pathway remain unanswered. In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1. 53BP1 and TIRR form a stable complex, which is required for their expression. Moreover, the 53BP1-TIRR complex dissociates afterDNAdamage, and this dissociation may be ataxia telangiectasia mutated-dependent. Similar to 53BP1, loss of TIRR restores PARPi resistance in BRCA1-deficient cells. Collectively, our data identified a novel 53BP1-TIRR complex in DNA damage response. TIRR may play both positive and negative roles in 53BP1 regulation. On the one hand, it stabilizes 53BP1 and thus positively regulates 53BP1. On the other hand, its association with 53BP1 prevents 53BP1 localization to sites of DNA damage, and thus TIRR is also an inhibitor of 53BP1.	[Zhang, Aili; Peng, Bo; Huang, Ping; Gong, Zihua] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center	Gong, ZH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.; Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org; gongz@ccf.org		Chen, Junjie/0000-0002-1493-2189	National Institutes of Health [CA089239, CA092312, CA100109]; Ovarian Cancer Research Fund Alliance [373376]; National Institutes of Health Grant from NCI [CA192052]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA092312, R21CA192052, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund Alliance; National Institutes of Health Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.), an Ovarian Cancer Research Fund Alliance Grant 373376 (to Z. G.), and National Institutes of Health Grant CA192052 from NCI (to Z. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	22	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6461	6467		10.1074/jbc.M117.777474	http://dx.doi.org/10.1074/jbc.M117.777474			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28213517	hybrid, Green Published			2022-12-28	WOS:000399813400004
J	Liu, YL; Qin, S; Lei, M; Tempel, W; Zhang, YZ; Loppnau, P; Li, YJ; Min, JR				Liu, Yanli; Qin, Su; Lei, Ming; Tempel, Wolfram; Zhang, Yuzhe; Loppnau, Peter; Li, Yanjun; Min, Jinrong			Peptide recognition by heterochromatin protein 1 (HP1) chromoshadow domains revisited: Plasticity in the pseudosymmetric histone binding site of human HP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; chromatin structure; heterochromatin; histone; peptide interaction	X-RAY-DIFFRACTION; LYSINE 9; H3; FAMILY; ELECTROSTATICS; LOCALIZATION; METHYLATION; VALIDATION; MECHANISMS; HP1-ALPHA	Heterochromatin protein 1 (HP1), a highly conserved non-histone chromosomal protein in eukaryotes, plays important roles in the regulation of gene transcription. Each of the three human homologs of HP1 includes a chromoshadow domain (CSD). The CSD interacts with various proteins bearing the PXVXL motif but also with a region of histone H3 that bears the similar PXXVXL motif. The latter interaction has not yet been resolved in atomic detail. Here we demonstrate that the CSDs of all three human HP1 homologs have comparable affinities to the PXXVXL motif of histone H3. The HP1 C-terminal extension enhances the affinity, as does the increasing length of the H3 peptide. The crystal structure of the human HP1 CSD (CSD) in complex with an H3 peptide suggests that recognition of H3 by CSD to some extent resembles CSD-PXVXL interaction. Nevertheless, the prolyl residue of the PXXVXL motif appears to play a role distinct from that of Pro in the known HP1 CSD-PXVXL complexes. We consequently generalize the historical CSD-PXVXL interaction model and expand the search scope for additional CSD binding partners.	[Liu, Yanli; Qin, Su; Lei, Ming; Tempel, Wolfram; Zhang, Yuzhe; Loppnau, Peter; Li, Yanjun; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	jr.min@utoronto.ca	QIN, SU/H-8735-2015; zhang, yuzhe/ABC-8021-2021; Qin, Su/Y-3750-2019; Liu, Yanli/AAA-3283-2019; Min, Jinrong/G-3449-2011	Qin, Su/0000-0001-9437-6292; Liu, Yanli/0000-0003-0197-7617; Min, Jinrong/0000-0001-5210-3130	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank Masoud Vedadi and Irene Chau for the generous gift of nucleosome. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Chandra T, 2013, NUCLEUS-PHILA, V4, P23, DOI 10.4161/nucl.23189; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Jang SM, 2014, EMBO REP, V15, P686, DOI 10.15252/embr.201338356; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; KELLUM R, 1995, J CELL SCI, V108, P1419; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Richart AN, 2012, J BIOL CHEM, V287, P18730, DOI 10.1074/jbc.M111.337204; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Smart O., 2014, GRADE VERSION 12 9; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Stephens GE, 2005, BIOCHEMISTRY-US, V44, P13394, DOI 10.1021/bi051006+; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; WILL H, 1980, EXP CELL RES, V125, P401, DOI 10.1016/0014-4827(80)90134-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	59	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5655	5664		10.1074/jbc.M116.768374	http://dx.doi.org/10.1074/jbc.M116.768374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223359	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000398813200004
J	Wang, JJ; Luo, JS; Aryal, DK; Wetsel, WC; Nass, R; Benovic, JL				Wang, Jianjun; Luo, Jiansong; Aryal, Dipendra K.; Wetsel, William C.; Nass, Richard; Benovic, Jeffrey L.			G protein-coupled receptor kinase-2 (GRK-2) regulates serotonin metabolism through the monoamine oxidase AMX-2 in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); protein kinase; serotonin; signal transduction; 5-hydroxyindole acetic acid; egg laying; monoamine oxidase	BIPOLAR DISORDER; GENE; TRAFFICKING; G-ALPHA(O); PROMOTER; PATHWAY	G protein-coupled receptors (GPCRs) regulate many animal behaviors. GPCR signaling is mediated by agonist-promoted interactions of GPCRs with heterotrimeric G proteins, GPCR kinases (GRKs), and arrestins. To further elucidate the role of GRKs in regulating GPCR-mediated behaviors, we utilized the genetic model system Caenorhabditis elegans. Our studies demonstrate that grk-2 loss-of-function strains are egg laying-defective and contain low levels of serotonin (5-HT) and high levels of the 5-HT metabolite 5-hydroxyindole acetic acid (5-HIAA). The egg laying defect could be rescued by the expression of wild type but not by catalytically inactive grk-2 or by the selective expression of grk-2 in hermaphrodite-specific neurons. The addition of 5-HT or inhibition of 5-HT metabolism also rescued the egg laying defect. Furthermore, we demonstrate that AMX-2 is the primary monoamine oxidase that metabolizes 5-HT in C. elegans, and we also found that grk-2 loss-of-function strains have abnormally high levels of AMX-2 compared with wild-type nematodes. Interestingly, GRK-2 was also found to interact with and promote the phosphorylation of AMX-2. Additional studies reveal that 5-HIAA functions to inhibit egg laying in a manner dependent on the 5-HT receptor SER-1 and the G protein GOA-1. These results demonstrate that GRK-2 modulates 5-HT metabolism by regulating AMX-2 function and that 5-HIAA may function in the SER-1 signaling pathway.	[Wang, Jianjun; Luo, Jiansong; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Aryal, Dipendra K.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Nass, Richard] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Jefferson University; Duke University; Duke University; Duke University; Duke University; Indiana University System; Indiana University Bloomington	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu			North Carolina Biotechnology Center; Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Michael Koelle for providing the cell type-specific promoter constructs; Dr. Anne Hart for providing the grk-2(rt97) strain; Drs. Janet Duerr, Denise Ferkey, Bryan Roth, and Konstantin Komolov for helpful comments; the Sidney Kimmel Cancer Center Bioimaging Facility for technical advice and support; and the Caenorhabditis Genetics Center for providing multiple C. elegans strains. The neurochemistry experiments were conducted with equipment purchased with a grant from the North Carolina Biotechnology Center.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Barrett TB, 2003, MOL PSYCHIATR, V8, P546, DOI 10.1038/sj.mp.4001268; Bastiani CA, 2003, GENETICS, V165, P1805; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Carnell L, 2005, J NEUROSCI, V25, P10671, DOI 10.1523/JNEUROSCI.3399-05.2005; Carre-Pierrat Maite, 2006, Invertebrate Neuroscience, V6, P189, DOI 10.1007/s10158-006-0033-z; Chase Daniel L, 2007, WormBook, P1; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Duerr Janet S, 2006, WormBook, P1; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; Ezak MJ, 2010, GENETICS, V185, P233, DOI 10.1534/genetics.110.115188; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Garcia-Sevilla JA, 1999, J NEUROCHEM, V72, P282, DOI 10.1046/j.1471-4159.1999.0720282.x; Grange-Midroit M, 2003, MOL BRAIN RES, V111, P31, DOI 10.1016/S0169-328X(02)00667-8; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Matuzany-Ruban A, 2010, INT J NEUROPSYCHOPH, V13, P83, DOI 10.1017/S1461145709000364; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Murphy DL, 1998, J NEURAL TRANSM-SUPP, P39; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; Rebrin I, 2001, J BIOL CHEM, V276, P29499, DOI 10.1074/jbc.M100431200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Schafer WF, 2006, ANNU REV GENET, V40, P487, DOI 10.1146/annurev.genet.40.110405.090527; Schmid T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005236; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; So CH, 2013, MOL BIOL CELL, V24, P2795, DOI 10.1091/mbc.E13-01-0013; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Taneja M, 2011, BEHAV BRAIN RES, V221, P25, DOI 10.1016/j.bbr.2011.02.018; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; TRENT C, 1983, GENETICS, V104, P619; Wani KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037831; Wood JF, 2012, J BIOL CHEM, V287, P12634, DOI 10.1074/jbc.M111.336818; Zhou XJ, 2008, BIOL PSYCHIAT, V64, P104, DOI 10.1016/j.biopsych.2007.12.017	46	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5943	5956		10.1074/jbc.M116.760850	http://dx.doi.org/10.1074/jbc.M116.760850			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213524	Green Published, hybrid			2022-12-28	WOS:000398813200028
J	Hao, JL; Lou, Q; Wei, QQ; Mei, SQ; Li, L; Wu, GY; Mi, QS; Mei, CL; Dong, Z				Hao, Jielu; Lou, Qiang; Wei, Qingqing; Mei, Shuqin; Li, Lin; Wu, Guangyu; Mi, Qing-Sheng; Mei, Changlin; Dong, Zheng			MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACUTE KIDNEY INJURY; TRANSCRIPTION FACTORS; CELL APOPTOSIS; P53; DISEASES; MECHANISMS; TARGETS; CANCER; ROLES	Nephrotoxicity is a major adverse effect of cisplatin-mediated chemotherapy in cancer patients. The pathogenesis of cisplatininduced nephrotoxicity remains largely unclear, making it difficult to design effective renoprotective approaches. Here, we have examined the role of microRNAs (miRNAs) in cisplatininduced nephrotoxicity. We show that cisplatin nephrotoxicity was not affected by overall depletion of both beneficial and detrimental miRNAs from kidney proximal tubular cells in mice in which the miRNA-generating enzyme Dicer had been conditionally knocked out. To identify miRNAs involved in cisplatin nephrotoxicity, we used microarray analysis to profile miRNA expression and identified 47 up-regulated microRNAs and 20 down-regulated microRNAs in kidney cortical tissues. One upregulated miRNA was miR-375, whose expression was also induced in cisplatin-treated renal tubular cells. Interestingly, inhibition of miR-375 decreased cisplatin-induced apoptosis, suggesting that miR-375 is a cell-damaging or pro-apoptotic agent. Blockade of P53 or NF-kappa B attenuated cisplatin-induced miR-375 expression, supporting a role of P53 and NF-kappa B in miR-375 induction. We also identified hepatocyte nuclear factor 1 homeobox B(HNF-1 beta) as a key downstream target of miR-375. Of note, we further demonstrated that HNF-1 beta protected renal cells against cisplatin-induced apoptosis. Together, these results suggest that upon cisplatin exposure, P53 and NF-kappa B collaboratively induce miR-375 expression, which, in turn, represses HNF-1 beta activity, resulting in renal tubular cell apoptosis and nephrotoxicity.	[Hao, Jielu; Mei, Shuqin; Li, Lin; Mei, Changlin] Second Mil Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai 200003, Peoples R China; [Lou, Qiang] Henan Univ, Sch Med, Antibody Drug Engn Lab Henan Prov, Kaifeng 475004, Henan, Peoples R China; [Hao, Jielu; Lou, Qiang; Wei, Qingqing; Mei, Shuqin; Li, Lin; Dong, Zheng] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Wu, Guangyu] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30912 USA; [Mi, Qing-Sheng] Henry Ford Hlth Syst, Dept Dermatol & Internal Med, Detroit, MI 48202 USA; [Dong, Zheng] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China	Naval Medical University; Henan University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Henry Ford Health System; Henry Ford Hospital; Central South University	Mei, CL (corresponding author), 415 Fengyang Rd, Shanghai, Peoples R China.; Dong, Z (corresponding author), 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	chlmei1954@126.com; zdong@augusta.edu		Hao, Jielu/0000-0002-0760-745X	National Natural Science Foundation of China [81430017, 31371172]; Major Fundamental Research Program of Shanghai Committee of Science and Technology [12DJ1400300]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period Grant [2011BAI10B07]; American Heart Association [12SDG8270002]; National Institutes of Health [5R01DK058831, 2R01DK087843]; Department of Veterans Administration [5I01BX000319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087843, R01DK058831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118915] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000319] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Fundamental Research Program of Shanghai Committee of Science and Technology; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period Grant; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Natural Science Foundation of China Grants 81430017 and 31371172, Major Fundamental Research Program of Shanghai Committee of Science and Technology Grant 12DJ1400300, the Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period Grant 2011BAI10B07, American Heart Association Grant 12SDG8270002, National Institutes of Health Grants 5R01DK058831 and 2R01DK087843, and Department of Veterans Administration Grant 5I01BX000319. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badal SS, 2015, PEDIATR NEPHROL, V30, P727, DOI 10.1007/s00467-014-2867-7; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chen JZ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.39; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Clissold RL, 2015, NAT REV NEPHROL, V11, P102, DOI 10.1038/nrneph.2014.232; Deng QP, 2014, J MOL CELL BIOL, V6, P198, DOI 10.1093/jmcb/mju017; Faguer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063585; Finkel M., 2014, PEDIAT NEPHROLOGY, V29, P2421; Gong ZJ, 2016, TUMOR BIOL, V37, P3683, DOI 10.1007/s13277-015-4156-x; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kanki M, 2014, TOXICOLOGY, V324, P158, DOI 10.1016/j.tox.2014.05.004; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Launay-Vacher V, 2008, CANCER CHEMOTH PHARM, V61, P903, DOI 10.1007/s00280-008-0711-0; Li JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16422; Limaye PB, 2008, LAB INVEST, V88, P865, DOI 10.1038/labinvest.2008.56; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Naylor RW, 2014, PEDIATR NEPHROL, V29, P659, DOI 10.1007/s00467-013-2662-x; Ozkok A, 2016, TOXICOL LETT, V240, P105, DOI 10.1016/j.toxlet.2015.10.028; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pavkovic M, 2016, TOXICOL SCI, V152, P205, DOI 10.1093/toxsci/kfw077; Pavkovic M, 2014, TOXICOLOGY, V324, P147, DOI 10.1016/j.tox.2014.05.005; Pellegrini KL, 2014, TOXICOL SCI, V141, P484, DOI 10.1093/toxsci/kfu143; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Shang YL, 2016, ONCOTARGET, V7, P538, DOI 10.18632/oncotarget.6374; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wei QQ, 2016, J AM SOC NEPHROL, V27, P2784, DOI 10.1681/ASN.2015080870; Wei QQ, 2013, IUBMB LIFE, V65, P602, DOI 10.1002/iub.1174; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Yang T, 2016, THERANOSTICS, V6, P142, DOI 10.7150/thno.13130; Yuan Y, 2015, ADV EXP MED BIOL, V887, P157, DOI 10.1007/978-3-319-22380-3_9; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902	47	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4571	4582		10.1074/jbc.M116.754929	http://dx.doi.org/10.1074/jbc.M116.754929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28119452	hybrid, Green Published			2022-12-28	WOS:000397585100015
J	Shukla, P; Mansoori, MN; Kakaji, M; Shukla, M; Gupta, SK; Singh, D				Shukla, Priyanka; Mansoori, Mohd Nizam; Kakaji, Manisha; Shukla, Manoj; Gupta, Sushil Kumar; Singh, Divya			Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; T-CELLS; OSTEOCLAST DIFFERENTIATION; TR1 CELLS; B-CELLS; INFLAMMATION; OSTEOBLAST; TH17; PROLIFERATION; ACTIVATION	A growing understanding of the bone remodeling process suggests that inflammation significantly contributes to the pathogenesis of osteoporosis. T cells and various cytokines contribute majorly to the estrogen deficiency-induced bone loss. Recent studies have identified the IL-12 cytokine family as consisting of pro-inflammatory IL-12 and IL-23 and the anti-inflammatory IL-27 and IL-35 cytokines. IL-27 exerts protective effects in autoimmune diseases like experimental autoimmune encephalomyelitis; however, its role in the pathogenesis of osteoporosisremains to be determined. In this report, we study the effect of IL-27 supplementation on ovariectomized estrogen-deficient mice on various immune and skeletal parameters. IL-27 treatment in ovariectomized mice suppressed Th17 cell differentiation by inhibiting transcription factor ROR gamma t. Supplementation of IL-27 activates Egr-2 to induce IL-10 producing Tr1 cells. IL-27 treatment prevented the loss of trabecular micro-architecture and preserved corticalboneparameters. IL-27 also in hibite do steoblastapoptosis through increased Egr-2 expression, which induces antiapoptotic factors like MCL-1. IL-27 suppressed osteoclastogenesis in an Egr-2-dependentmannerthat up-regulates Id2, the repressor of the receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Additionally, these results were corroborated in female osteoporotic subjects where we found decreased serum IL-27 levels along with reduced Egr-2 expression. Our study forms a strong basis for using humanized IL-27 toward the treatment of post-menopausal osteoporosis.	[Shukla, Priyanka; Mansoori, Mohd Nizam; Singh, Divya] Cent Drug Res Inst, CSIR, Div Endocrinol, BS 10-1,Sect 10, Lucknow 226031, Cdri, India; [Shukla, Priyanka; Mansoori, Mohd Nizam; Singh, Divya] Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, BS 10-1,Sect 10, Lucknow 226031, Cdri, India; [Kakaji, Manisha; Shukla, Manoj; Gupta, Sushil Kumar] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Pgi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Sanjay Gandhi Postgraduate Institute of Medical Sciences	Singh, D (corresponding author), Cent Drug Res Inst, CSIR, Div Endocrinol, BS 10-1,Sect 10, Lucknow 226031, Cdri, India.; Singh, D (corresponding author), Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, BS 10-1,Sect 10, Lucknow 226031, Cdri, India.	divya_singh@cdri.res.in			Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI) [BSC0201]; Department of Biotechnology, India [102/IFD/SAN/3486/2014-15]; CDRI [9424]; Council of Scientific and Industrial Research; University Grant Commission	Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI); Department of Biotechnology, India(Department of Biotechnology (DBT) India); CDRI; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India)	This work was supported in part by Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI) Grant BSC0201, Department of Biotechnology, India, Grants 102/IFD/SAN/3486/2014-15 (dated Nov. 25, 2014), CDRI Communication no. 9424, and the Council of Scientific and Industrial Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of support from University Grant Commission for fellowship.; Recipient of support from Council of Scientific and Industrial Research for fellowship.	Adamopoulos IE, 2013, CYTOKINE GROWTH F R, V24, P115, DOI 10.1016/j.cytogfr.2012.10.001; Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jin JO, 2013, J AUTOIMMUN, V40, P28, DOI 10.1016/j.jaut.2012.07.009; Kalliolias GD, 2010, ARTHRITIS RHEUM-US, V62, P402, DOI 10.1002/art.27200; Kamiya S, 2007, J BONE MINER METAB, V25, P277, DOI 10.1007/s00774-007-0766-8; Kim HJ, 2012, BONE, V51, P643, DOI 10.1016/j.bone.2012.07.015; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; Liu H, 2011, J INTERF CYTOK RES, V31, P459, DOI 10.1089/jir.2010.0115; Mansoori MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep33680; Moon SJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.89; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Okamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7329; Park JS, 2012, IMMUNOLOGY, V137, P326, DOI 10.1111/j.1365-2567.2012.03622.x; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tyagi AM, 2012, OSTEOPOROSIS INT, V23, P1151, DOI 10.1007/s00198-011-1650-x; Tyagi AM, 2014, J BONE MINER RES, V29, P1981, DOI 10.1002/jbmr.2228; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Tyagi AM, 2010, MOL CELL ENDOCRINOL, V325, P101, DOI 10.1016/j.mce.2010.05.016; Vasanthakumar A, 2013, EUR J IMMUNOL, V43, P882, DOI 10.1002/eji.201343479; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550	37	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4686	4699		10.1074/jbc.M116.764779	http://dx.doi.org/10.1074/jbc.M116.764779			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28130449	Green Published, hybrid			2022-12-28	WOS:000397585100025
J	Lee, H; Min, K; Yi, JS; Shi, H; Chang, W; Jackson, L; Bennett, AM				Lee, Hojin; Min, Kisuk; Yi, Jae-Sung; Shi, Hao; Chang, Woochul; Jackson, Leandra; Bennett, Anton M.			A Phosphoproteomic Screen Identifies a Guanine Nucleotide Exchange Factor for Rab3A Protein as a Mitogen-activated Protein (MAP) Kinase Phosphatase-5-regulated MAP Kinase Target in Interleukin 6 (IL-6) Secretion and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; dual specificity phosphoprotein phosphatase; mitogen-activated protein kinase (MAPK); myogenesis; phosphoproteomics; skeletal muscle	SKELETAL-MUSCLE; IMMUNOAFFINITY ENRICHMENT; MUSCULAR-DYSTROPHY; MOLECULAR-CLONING; LC-MS/MS; PATHWAY; CANCER; CELLS; REGENERATION; SPECIFICITY	The mitogen-activated protein kinases (MAPKs) have been shown to regulate skeletal muscle function. Previously, we showed that MAPK phosphatase-5 (MKP-5) negatively regulates myogenesis and regeneration of skeletal muscle through inhibition of p38 MAPK and c-Jun N-terminal kinase (JNK). However, the identity and contribution of MKP-5-regulated MAPK targets in the control of skeletal muscle function and regenerative myogenesis have not been established. To identify MKP-5-regulated MAPK substrates in skeletal muscle, we performed a global differential phospho-MAPK substrate screen in regenerating skeletal muscles of wild type and MKP-5-deficient mice. We discovered a novel MKP-5-regulated MAPK substrate called guanine nucleotide exchange factor for Rab3A (GRAB) that was hyperphosphorylated on a phospho-MAPK motif in skeletal muscle of MKP-5-deficient mice. GRAB was found to be phosphorylated by JNK on serine 169. Myoblasts overexpressing a phosphorylation-defective mutant of GRAB containing a mutation at Ser-169 to Ala-169 (GRAB-S169A) inhibited the ability of C2C12 myoblasts to differentiate. We found that GRAB phosphorylation at Ser-169 was required for the secretion of the promyogenic cytokine interleukin 6 (IL-6). Consistent with this observation, MKP-5-deficient mice exhibited increased circulating IL-6 expression as compared with wild type mice. Collectively, these data demonstrate a novel mechanism whereby MKP-5-mediated regulation of JNK negatively regulates phosphorylation of GRAB, which subsequently controls secretion of IL-6. These data support the notion that MKP-5 serves as a negative regulator of MAPK-dependent signaling of critical skeletal muscle signaling pathways.	[Lee, Hojin; Min, Kisuk; Yi, Jae-Sung; Bennett, Anton M.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Bennett, Anton M.] Yale Univ, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Shi, Hao] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24060 USA; [Chang, Woochul] Pusan Natl Univ, Dept Biol Educ, Coll Educ, Busan 609735, South Korea; [Jackson, Leandra] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA	Yale University; Yale University; Virginia Polytechnic Institute & State University; Pusan National University; University of California System; University of California Irvine	Bennett, AM (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B226D,333 Cedar St, New Haven, CT 06520 USA.	anton.bennett@yale.edu		Chang, Woochul/0000-0001-7367-2586; Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [R01 GM099801, RO1 AR066601]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grants R01 GM099801 and RO1 AR066601.	Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Cazares VA, 2014, TRAFFIC, V15, P997, DOI 10.1111/tra.12182; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gu HB, 2016, MOL CELL PROTEOMICS, V15, P692, DOI 10.1074/mcp.O115.052266; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Lee H, 2013, MOL CELL BIOL, V33, P1430, DOI 10.1128/MCB.01708-12; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shi H. P., 2015, ELECT J DIFFERENTIAL, V2015, P1, DOI DOI 10.1089/CELL.2015.0039; Shi H, 2013, J CLIN INVEST, V123, P2064, DOI 10.1172/JCI64375; Shi H, 2010, FASEB J, V24, P2985, DOI 10.1096/fj.09-150045; Sim JCH, 2015, INTRACTABLE RARE DIS, V4, P17, DOI 10.5582/irdr.2014.01021; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; TAKAI T, 1994, NUCLEIC ACIDS RES, V22, P5576, DOI 10.1093/nar/22.25.5576; TANG PM, 1991, J BIOL CHEM, V266, P15782; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	34	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3581	3590		10.1074/jbc.M116.769208	http://dx.doi.org/10.1074/jbc.M116.769208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096466	Green Published, hybrid			2022-12-28	WOS:000395542500004
J	Kasturirangan, S; Rainey, GJ; Xu, L; Wang, X; Portnoff, A; Chen, T; Fazenbaker, C; Zhong, H; Bee, J; Zeng, Z; Jenne, C; Wu, H; Gao, C				Kasturirangan, Srinath; Rainey, G. Jonah; Xu, Linda; Wang, Xinwei; Portnoff, Alyse; Chen, Tracy; Fazenbaker, Christine; Zhong, Helen; Bee, Jared; Zeng, Zhutian; Jenne, Craig; Wu, Herren; Gao, Changshou			Targeted Fc gamma Receptor (Fc gamma R)-mediated Clearance by a Biparatopic Bispecific Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGG IMMUNE-COMPLEXES; IN-VIVO; MONOCLONAL-ANTIBODY; NONOVERLAPPING EPITOPES; MEDIATED ENDOCYTOSIS; ENDOTHELIAL-CELLS; RAT-LIVER; HALF-LIFE; BINDING; PHAGOCYTOSIS	Soluble ligands have commonly been targeted by antibody therapeutics for cancers and other diseases. Although monoclonal antibodies targeting such ligands can block their interactions with their cognate receptors, they can also significantly increase the half-life of their ligands by FcRn-mediated antibody recycling, thereby evading ligand renal clearance and requiring increasingly high antibody doses to neutralize the increasing pool of target. To overcome this issue, we generated a bispecific/biparatopic antibody (BiSAb) that targets two different epitopes on IL-6 to block IL-6-mediated signaling. The BiSAb formed large immune complexes with IL-6 that can bind Fc gamma receptors on phagocytic cells and are rapidly internalized. In addition, rapid clearance of the BiSAb . IL-6 complex was observed in mice while the parental antibodies prolonged the serum half-life of IL-6. Intravital imaging of the liver in mice confirmed that the rapid clearance of these large immune complexes was associated with Fc gamma receptor-dependent binding to Kupffer cells in the liver. The approach described here provides a general strategy for therapeutic antibodies with the ability to not only neutralize but also actively drive clearance of their soluble antigens.	[Kasturirangan, Srinath; Rainey, G. Jonah; Xu, Linda; Wang, Xinwei; Portnoff, Alyse; Wu, Herren; Gao, Changshou] Medimmune LLC, Dept Antibody Discovery & Prot Engn, 1 Medimmune Way, Gaithersburg, MD 20878 USA; [Chen, Tracy; Fazenbaker, Christine; Zhong, Helen] Medimmune LLC, Dept Oncol, Gaithersburg, MD 20878 USA; [Bee, Jared] Medimmune LLC, Dept Analyt Biotechnol, Gaithersburg, MD 20878 USA; [Zeng, Zhutian; Jenne, Craig] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; University of Calgary	Gao, C (corresponding author), Medimmune LLC, Dept Antibody Discovery & Prot Engn, 1 Medimmune Way, Gaithersburg, MD 20878 USA.		Jenne, Craig/HCH-3413-2022	Bee, Jared/0000-0002-4391-0560				AREND WP, 1979, J IMMUNOL, V123, P447; BENACERRAF B, 1959, J IMMUNOL, V82, P131; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V86, P328; Bonvin P, 2015, MABS-AUSTIN, V7, P294, DOI 10.1080/19420862.2015.1006993; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Chen WZ, 2012, MOL CANCER THER, V11, P1400, DOI 10.1158/1535-7163.MCT-12-0172; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; CORNACOFF JB, 1984, CLIN IMMUNOL IMMUNOP, V30, P255, DOI 10.1016/0090-1229(84)90060-6; Datta-Mannan A, 2016, MABS-AUSTIN, V8, P969, DOI 10.1080/19420862.2016.1178435; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Ding CH, 2009, EXPERT OPIN INV DRUG, V18, P1457, DOI 10.1517/13543780903203789; Eggleton P., 2015, ELS, P1, DOI [10.1002/9780470015902.a0001118.pub2, DOI 10.1002/9780470015902.A0001118.PUB2]; Eggleton P., 1999, NATURE ENCY LIFE SCI; Feng Y, 2014, EXP MOL PATHOL, V97, P359, DOI 10.1016/j.yexmp.2014.09.007; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; Igawa T, 2014, BBA-PROTEINS PROTEOM, V1844, P1943, DOI 10.1016/j.bbapap.2014.08.003; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Iwayanagi Y, 2015, J IMMUNOL, V195, P3198, DOI 10.4049/jimmunol.1401470; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; KURLANDER RJ, 1984, J IMMUNOL, V133, P855; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laue T.M., 1992, COMPUTER AIDED INTER; LIU MY, 1992, EXP HEMATOL, V20, P974; Lovdal T, 2000, J CELL SCI, V113, P3255; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; MANNIK M, 1980, J INVEST DERMATOL, V74, P333, DOI 10.1111/1523-1747.ep12543582; MANNIK M, 1971, J EXP MED, V133, P713, DOI 10.1084/jem.133.4.713; MCCLUSKEY RT, 1978, HUM PATHOL, V9, P71, DOI 10.1016/S0046-8177(78)80009-4; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; MIHARA M, 1991, IMMUNOLOGY, V74, P55; Mihara M, 2005, EXPERT OPIN BIOL TH, V5, P683, DOI 10.1517/14712598.5.5.683; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Pandey M, 2014, FUTURE ONCOL, V10, P609, DOI [10.2217/FON.13.197, 10.2217/fon.13.197]; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rehlaender BN, 2001, PHARMACEUT RES, V18, P745, DOI 10.1023/A:1011072009408; Rojko JL, 2014, TOXICOL PATHOL, V42, P725, DOI 10.1177/0192623314526475; Rossi JF, 2010, BRIT J CANCER, V103, P1154, DOI 10.1038/sj.bjc.6605872; Santora LC, 2001, ANAL BIOCHEM, V299, P119, DOI 10.1006/abio.2001.5380; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SKOGH T, 1985, IMMUNOLOGY, V55, P585; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Ward ES, 2015, MOL IMMUNOL, V67, P131, DOI 10.1016/j.molimm.2015.02.007; WAXMAN FJ, 1984, J CLIN INVEST, V74, P1329, DOI 10.1172/JCI111543; Wener M., 2007, SYSTEMIC LUPUS ERYTH, P214; Whyte J, 2000, LETT APPL MICROBIOL, V30, P90, DOI 10.1046/j.1472-765x.2000.00701.x; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	62	21	22	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4361	4370		10.1074/jbc.M116.770628	http://dx.doi.org/10.1074/jbc.M116.770628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28100773	Green Published, hybrid			2022-12-28	WOS:000395837100035
J	Paczkowski, JE; Mukherjee, S; McCready, AR; Cong, JP; Aquino, CJ; Kim, H; Henke, BR; Smith, CD; Bassler, BL				Paczkowski, Jon E.; Mukherjee, Sampriti; McCready, Amelia R.; Cong, Jian-Ping; Aquino, Christopher J.; Kim, Hahn; Henke, Brad R.; Smith, Chari D.; Bassler, Bonnie L.			Flavonoids Suppress Pseudomonas aeruginosa Virulence through Allosteric Inhibition of Quorum-sensing Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; HALOGENATED FURANONES; GENE-EXPRESSION; PROTEIN; SIGNAL; LASR; NODULATION; BINDING; RESISTANCE; REGULATOR	Quorum sensing is a process of cell-cell communication that bacteria use to regulate collective behaviors. Quorum sensing depends on the production, detection, and group-wide response to extracellular signal molecules called auto inducers. In many bacterial species, quorum sensing controls virulence factor production. Thus, disrupting quorum sensing is considered a promising strategy to combat bacterial pathogenicity. Several members of a family of naturally produced plant metabolites called flavonoids inhibit Pseudomonas aeruginosa biofilm formation by an unknown mechanism. Here, we explore this family of molecules further, and we demonstrate that flavonoids specifically inhibit quorum sensing via antagonism of the autoinducer-binding receptors, LasR and RhlR. Structure-activity relationship analyses demonstrate that the presence of two hydroxyl moieties in the flavone A-ring backbone are essential for potent inhibition of LasR/RhlR. Biochemical analyses reveal that the flavonoids function non-competitively to prevent LasR/RhlR DNA binding. Administration of the flavonoids to P. aeruginosa alters transcription of quorum sensing-controlled target promoters and suppresses virulence factor production, confirming their potential as anti-infectives that do not function by traditional bacteriocidal or bacteriostatic mechanisms.	[Paczkowski, Jon E.; Mukherjee, Sampriti; McCready, Amelia R.; Cong, Jian-Ping; Smith, Chari D.; Bassler, Bonnie L.] Princeton Univ, Small Mol Screening Ctr, Dept Mol Biol, Princeton, NJ 08544 USA; [Kim, Hahn] Princeton Univ, Small Mol Screening Ctr, Dept Chem, Princeton, NJ 08544 USA; [Aquino, Christopher J.] CJA MedChem, Hillsborough, NC 27278 USA; [Henke, Brad R.] LLC, Opti Mol Consulting, Cary, NC 27513 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Princeton University; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Labs 329, Princeton, NJ 08544 USA.	bbassler@princeton.edu		McCready, Amelia/0000-0001-6176-4432; Mukherjee, Sampriti/0000-0002-5509-8776; Bassler, Bonnie/0000-0002-0043-746X	Howard Hughes Medical Institute; National Institutes of Health Grant [2R37GM065859]; National Science Foundation Grant [MCB-0948112]; Jane Coffin Childs Memorial Fund; Life Science Research Foundation Postdoctoral Fellowship through the Gordon and Betty Moore Foundation [GBMF2550.06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM065859, R37GM065859] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0948112] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; Life Science Research Foundation Postdoctoral Fellowship through the Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health Grant 2R37GM065859, National Science Foundation Grant MCB-0948112 (to B.L.B.), a Jane Coffin Childs Memorial Fund for Biomedical Research Postdoctoral Fellowship (to J.E.P.), and a Life Science Research Foundation Postdoctoral Fellowship through the Gordon and Betty Moore Foundation through Grant GBMF2550.06 (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Begum AA, 2001, J EXP BOT, V52, P1537, DOI 10.1093/jexbot/52.360.1537; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bodini SF, 2009, LETT APPL MICROBIOL, V49, P551, DOI 10.1111/j.1472-765X.2009.02704.x; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dholvitayakhun A, 2012, NAT PROD RES, V26, P356, DOI 10.1080/14786419.2010.545777; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Kiratisin P, 2002, J BACTERIOL, V184, P4912, DOI 10.1128/JB.184.17.4912-4919.2002; Koch B, 2005, MICROBIOL-SGM, V151, P3589, DOI 10.1099/mic.0.27954-0; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; Manefield M, 2002, MICROBIOL-SGM, V148, P1119, DOI 10.1099/00221287-148-4-1119; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; Muh U, 2006, P NATL ACAD SCI USA, V103, P16948, DOI 10.1073/pnas.0608348103; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Nazzaro F, 2013, INT J MOL SCI, V14, P12607, DOI 10.3390/ijms140612607; Ng WL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002767; Novak K, 2002, J EXP BOT, V53, P1735, DOI 10.1093/jxb/erf016; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Ouyang J, 2016, J APPL MICROBIOL, V120, P966, DOI 10.1111/jam.13073; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Pinto UM, 2009, MOL MICROBIOL, V73, P32, DOI 10.1111/j.1365-2958.2009.06730.x; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Raj U, 2017, J BIOMOL STRUCT DYN, V35, P2351, DOI 10.1080/07391102.2016.1217276; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Rosier A, 2016, PLANT MOL BIOL, V90, P537, DOI 10.1007/s11103-016-0433-3; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sato Y, 2004, ANTIMICROB AGENTS CH, V48, P1357, DOI 10.1128/AAC.48.4.1357-1360.2004; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; Seyedi SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24027; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Swem LR, 2008, CELL, V134, P461, DOI 10.1016/j.cell.2008.06.023; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Tsitsanou KE, 2013, FOOD CHEM TOXICOL, V61, P14, DOI 10.1016/j.fct.2012.12.030; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vasavi HS, 2014, MICROBIOL IMMUNOL, V58, P286, DOI 10.1111/1348-0421.12150; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welsh MA, 2016, CELL CHEM BIOL, V23, P361, DOI 10.1016/j.chembiol.2016.01.006; Welsh MA, 2015, J AM CHEM SOC, V137, P1510, DOI 10.1021/ja5110798; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Zakhari JS, 2011, J AM CHEM SOC, V133, P3840, DOI 10.1021/ja111138y; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833; Zhu J, 1998, J BACTERIOL, V180, P5398, DOI 10.1128/JB.180.20.5398-5405.1998; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507; Zou YZ, 2009, CHEM BIOL, V16, P961, DOI 10.1016/j.chembiol.2009.09.001	59	117	125	4	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4064	4076		10.1074/jbc.M116.770552	http://dx.doi.org/10.1074/jbc.M116.770552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28119451	Green Published, hybrid			2022-12-28	WOS:000395837100010
J	Srikumar, A; Krishna, PS; Sivaramakrishna, D; Kopfmann, S; Hess, WR; Swamy, MJ; Lin-Chao, S; Prakash, JSS				Srikumar, Afshan; Krishna, Pilla Sankara; Sivaramakrishna, Dokku; Kopfmann, Stefan; Hess, Wolfgang R.; Swamy, Musti J.; Lin-Chao, Sue; Prakash, Jogadhenu S. S.			The Ssl2245-Sll1130 Toxin-Antitoxin System Mediates Heat-induced Programmed Cell Death in Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MARINE CYANOBACTERIUM; BIOFILM FORMATION; MOLTEN GLOBULE; PLASMID; GENES; MAINTENANCE; MECHANISMS; REGULATOR; BINDING	Twoputative heat-responsive genes, ssl2245 and sll1130, constitute an operon that also has characteristics of a toxin-antitoxin system, thus joining several enigmatic features. Closely related orthologs of Ssl2245 and Sll1130 exist in widely different bacteria, which thrive under environments with large fluctuations in temperature and salinity, among which some are thermo-epilithic biofilm-forming cyanobacteria. Transcriptome analyses revealed that the clustered regularly interspaced short palindromic repeats (CRISPR) genes as well as several hypothetical genes were commonly up-regulated in Delta ssl2245 and Delta sll1130 mutants. Genes coding for heat shock proteins and pilins were also induced in Delta sll1130. We observed that the majority of cells in a Delta sll1130 mutant strain remained unicellular and viable after prolonged incubation at high temperature (50 degrees C). In contrast, the wild type formed large cell clumps of dead and live cells, indicating the attempt to form biofilms under harsh conditions. Furthermore, we observed that Sll1130 is a heat-stable ribonuclease whose activity was inhibited by Ssl2245 at optimal temperatures but not at high temperatures. In addition, we demonstrated that Ssl2245 is physically associated with Sll1130 by electrostatic interactions, thereby inhibiting its activity at optimal growth temperature. This association is lost upon exposure to heat, leaving Sll1130 to exhibit its ribonuclease activity. Thus, the activation of Sll1130 leads to the degradation of cellular RNA and thereby heat-induced programmed cell death that in turn supports the formation of a more resistant biofilm for the surviving cells. Wesuggest to designate Ssl2245 and Sll1130 as MazE and MazF, respectively.	[Srikumar, Afshan; Krishna, Pilla Sankara; Prakash, Jogadhenu S. S.] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India; [Sivaramakrishna, Dokku; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Kopfmann, Stefan; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Genet & Expt Bioinformat, D-79104 Freiburg, Germany; [Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Krishna, Pilla Sankara] Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, S-75236 Uppsala, Sweden	University of Hyderabad; University of Hyderabad; University of Freiburg; Academia Sinica - Taiwan; Uppsala University	Prakash, JSS (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India.	syamsunderp@yahoo.com	Lin-Chao, Sue/AAZ-8246-2021; Lin-Chao, Sue/AGI-2030-2022; Swamy, Musti/B-9418-2009	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304; Swamy, Musti/0000-0002-3108-3633; Dokku, Sivaramakrishna/0000-0002-1256-8096; Hess, Wolfgang/0000-0002-5340-3423	University Grants Commission (India)	University Grants Commission (India)(University Grants Commission, India)	We acknowledge the Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology program of the School of Life Sciences, University of Hyderabad for providing genomics facility. We acknowledge Taiwan International Graduate Program, Academia Sinica, Taiwan for the summer internship to A. S. The MicroCal VP-ITC and VP-DSC equipment used in this study were obtained from the funds made available to the University of Hyderabad through the Universities with Potential for Excellence program of the University Grants Commission (India). We acknowledge the University Grants Commission (India) for support through the Centre for Advanced Studies program to the School of Chemistry.	Allocati N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.570; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bar-Zeev E, 2013, ISME J, V7, P2340, DOI 10.1038/ismej.2013.121; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Chan WT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00009; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; de Laureto PP, 2002, PROTEINS, V49, P385, DOI 10.1002/prot.10234; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kavitha M, 2010, BIOCHIMIE, V92, P58, DOI 10.1016/j.biochi.2009.09.009; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Klemencic M, 2016, CURR GENET, V62, P669, DOI 10.1007/s00294-016-0582-6; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kopfmann S, 2013, J BIOL CHEM, V288, P7399, DOI 10.1074/jbc.M112.434100; Krishna PS, 2013, BIOCHEM J, V449, P751, DOI 10.1042/BJ20120928; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Narahari A, 2011, J PHYS CHEM B, V115, P4110, DOI 10.1021/jp110468n; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pandey V., 2013, INT J CURR MICROBIOL, V2, P519; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Sabart M, 2013, ENV MICROBIOL REP, V5, P747, DOI 10.1111/1758-2229.12077; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Soo VWC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03186; Spungin D, 2016, BIOGEOSCIENCES, V13, P4187, DOI 10.5194/bg-13-4187-2016; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Tanouchi Y, 2013, TRENDS MICROBIOL, V21, P265, DOI 10.1016/j.tim.2013.04.001; Tseng YT, 2015, J BIOL CHEM, V290, P29953, DOI 10.1074/jbc.M115.691881; WALSBY AE, 1983, PROC R SOC SER B-BIO, V217, P417, DOI 10.1098/rspb.1983.0019; Wen YR, 2014, PATHOG DIS, V70, P240, DOI 10.1111/2049-632X.12145; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	53	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4222	4234		10.1074/jbc.M116.748178	http://dx.doi.org/10.1074/jbc.M116.748178			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28104802	Green Published, hybrid			2022-12-28	WOS:000395837100020
J	Jain, AK; Jaiswal, AK				Jain, Abhinav K.; Jaiswal, Anil K.			Phosphorylation of tyrosine 568 controls nuclear export of Nrf2 (vol 281, pg 12132, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200	1	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2051	2051		10.1074/jbc.A117.511198	http://dx.doi.org/10.1074/jbc.A117.511198			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28159764	hybrid, Green Published			2022-12-28	WOS:000395515600046
J	Singh, A; Xu, YJ				Singh, Amanpreet; Xu, Yong-jie			Heme deficiency sensitizes yeast cells to oxidative stress induced by hydroxyurea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION CHECKPOINT; RIBONUCLEOTIDE REDUCTASE; FISSION YEAST; IN-VIVO; COPROPORPHYRINOGEN OXIDASE; HEREDITARY COPROPORPHYRIA; OXYGEN; ACTIVATION; BIOSYNTHESIS; EXPRESSION	Hydroxyurea (HU) has a long history of clinical and scientific use as an antiviral, antibacterial, and antitumor agent. It inhibits ribonucleotide reductase and reversibly arrests cells in S phase. However, high concentrations or prolonged treatment with low doses of HU can cause cell lethality. Although the cytotoxicity of HU may significantly contribute to its therapeutic effects, the underlying mechanisms remain poorly understood. We have previously shown that HU can induce cytokinesis arrest in the erg11-1 mutant of fission yeast, which has a partial defect in the biosynthesis of fungal membrane sterol ergosterol. Here, we report the identification of a new mutant in heme biosynthesis, hem13-1, that is hypersensitive to HU. We found that the HU hypersensitivity of the hem13-1 mutant is caused by oxidative stress and not by replication stress or a defect in cellular response to replication stress. The mutation is hypomorphic and causes heme deficiency, which likely sensitizes the cells to the HU-induced oxidative stress. Because the heme biosynthesis pathway is highly conserved in eukaryotes, this finding, as we show in our separate report, may help to expand the therapeutic spectrum of HU to additional pathological conditions.	[Singh, Amanpreet; Xu, Yong-jie] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Singh, Amanpreet] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA	University System of Ohio; Wright State University Dayton; State University of New York (SUNY) System; Wadsworth Center	Xu, YJ (corresponding author), Wright State Univ, Boonshoft Sch Med, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu			National Institutes of Health [RO1 GM110132]; Wright State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wright State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM110132 and the start-up fund provided by Wright State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; Bandhu A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004136; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; BRODIE MJ, 1977, Q J MED, V46, P229; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; CHOY BK, 1988, CANCER RES, V48, P2029; Culotta VC, 2000, CURR TOP CELL REGUL, V36, P117; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Di YJ, 2012, EMBO J, V31, P563, DOI 10.1038/emboj.2011.438; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; ELDER GH, 1978, BIOCHEM J, V169, P215, DOI 10.1042/bj1690215; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Harris P, 1996, MOL GEN GENET, V252, P284; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Huang ZW, 2011, EUKARYOT CELL, V10, P1536, DOI 10.1128/EC.05170-11; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Juul T, 2010, J BIOL CHEM, V285, P21411, DOI 10.1074/jbc.M110.103564; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kluza K, 2005, EUR J PHARMACOL, V525, P32, DOI 10.1016/j.ejphar.2005.09.050; KRAKOFF IH, 1968, CANCER RES, V28, P1559; Lamoril J, 1998, BLOOD, V91, P1453, DOI 10.1182/blood.V91.4.1453; LARSEN IK, 1982, EUR J BIOCHEM, V125, P75; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Marchetti MA, 2006, J CELL SCI, V119, P124, DOI 10.1242/jcs.02703; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakayashiki T, 2013, J BACTERIOL, V195, P1226, DOI 10.1128/JB.02145-12; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; Philpott CC, 2012, NUTR HEALTH SER, P653, DOI 10.1007/978-1-60327-485-2_30; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Schmitt C, 2005, HUM MOL GENET, V14, P3089, DOI 10.1093/hmg/ddi342; Scozzafava A, 2003, BIOORGAN MED CHEM, V11, P2241, DOI 10.1016/S0968-0896(03)00112-3; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Singh A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7110099; Sneeden JL, 2004, J BIOL CHEM, V279, P40723, DOI 10.1074/jbc.M402699200; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Spivak JL, 2011, EXPERT REV ANTICANC, V11, P403, DOI [10.1586/ERA.11.10, 10.1586/era.11.10]; Stevens MR, 1999, J BIOL REG HOMEOS AG, V13, P172; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tang HL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09015; TSUCHIYA M, 1994, METHOD ENZYMOL, V233, P128; TURI TG, 1992, J BIOL CHEM, V267, P2046; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Xu YJ, 2016, GENETICS, V204, P959, DOI 10.1534/genetics.116.191536; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Yue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092936; Yue M, 2011, J BIOL CHEM, V286, P22864, DOI 10.1074/jbc.M111.236687; ZAGOREC M, 1986, J BIOL CHEM, V261, P2506; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	59	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9088	9103		10.1074/jbc.M117.781211	http://dx.doi.org/10.1074/jbc.M117.781211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28377506	Green Published, hybrid			2022-12-28	WOS:000402538900008
J	Carvalho, LAC; Truzzi, DR; Fallani, TS; Alves, SV; Toledo, JC; Augusto, O; Netto, LES; Meotti, FC				Carvalho, Larissa A. C.; Truzzi, Daniela R.; Fallani, Thamiris S.; Alves, Simone V.; Toledo, Jose Carlos; Augusto, Ohara; Netto, Luis E. S.; Meotti, Flavia C.			Urate hydroperoxide oxidizes human peroxiredoxin 1 and peroxiredoxin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; inflammation; oxidation-reduction (redox); peroxiredoxin; uric acid; urate hydroperoxide	CYSTEINE SULFINIC ACID; URIC-ACID; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; ANTIOXIDANT DEFENSE; OXIDASE ACTIVITY; RATE-CONSTANTS; REDUCTION	Urate hydroperoxide is a product of the oxidation of uric acid by inflammatory heme peroxidases. The formation of urate hydroperoxide might be a key event in vascular inflammation, where there is large amount of uric acid and inflammatory peroxidases. Urate hydroperoxide oxidizes glutathione and sulfur-containing amino acids and is expected to react fast toward reactive thiols from peroxiredoxins (Prxs). The kinetics for the oxidation of the cytosolic 2-Cys Prx1 and Prx2 revealed that urate hydroperoxide oxidizes these enzymes at rates comparable with hydrogen peroxide. The second-order rate constants of these reactions were 4.9 x 10(5) and 2.3 x 10(6) m(-1) s(-1) for Prx1 and Prx2, respectively. Kinetic and simulation data suggest that the oxidation of Prx2 by urate hydroperoxide occurs by a three-step mechanism, where the peroxide reversibly associates with the enzyme; then it oxidizes the peroxidatic cysteine, and finally, the rate-limiting disulfide bond is formed. Of relevance, the disulfide bond formation was much slower in Prx2 (k(3) = 0.31 s(-1)) than Prx1 (k(3) = 14.9 s(-1)). In addition, Prx2 was more sensitive than Prx1 to hyperoxidation caused by both urate hydroperoxide and hydrogen peroxide. Urate hydroperoxide oxidized Prx2 from intact erythrocytes to the same extent as hydrogen peroxide. Therefore, Prx1 and Prx2 are likely targets of urate hydroperoxide in cells. Oxidation of Prxs by urate hydroperoxide might affect cell function and be partially responsible for the pro-oxidant and pro-inflammatory effects of uric acid.	[Carvalho, Larissa A. C.; Truzzi, Daniela R.; Fallani, Thamiris S.; Augusto, Ohara; Meotti, Flavia C.] Univ Sao Paulo, Dept Bioquim, Inst Quim IQUSP, BR-05508000 Sao Paulo, SP, Brazil; [Alves, Simone V.; Netto, Luis E. S.] Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias IB USP, BR-05508000 Sao Paulo, SP, Brazil; [Toledo, Jose Carlos] Univ Sao Paulo, Dept Quim, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Meotti, FC (corresponding author), Univ Sao Paulo, Inst Quim IQUSP, Ave Prof Lineu Prestes 748,Bloco 10,Sala 1001, BR-05508000 Sao Paulo, SP, Brazil.	flaviam@iq.usp.br	Netto, Luis/A-3783-2008; Augusto, Ohara/D-3839-2012; Truzzi, Daniela R/B-2540-2014; Meotti, Flavia/AAS-8804-2021; Toledo, Jose C/J-4360-2015; Meotti, Flavia/H-1621-2015	Netto, Luis/0000-0002-4250-9177; Augusto, Ohara/0000-0002-7220-4286; Truzzi, Daniela R/0000-0003-4421-9621; Meotti, Flavia/0000-0002-7217-3352; Toledo Junior, Jose Carlos/0000-0003-0818-0846; Anastacio da Costa Carvalho, Larissa/0000-0001-5720-5910	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; CEPID Redoxoma [2013/07937-8]; Conselho Nacional de Pesquisa Tecnologica (CNPq) [472105/2012-4];  [2011/18106-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CEPID Redoxoma; Conselho Nacional de Pesquisa Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, CEPID Redoxoma 2013/07937-8, Young Researcher 2011/18106-4, and Conselho Nacional de Pesquisa Tecnologica (CNPq) 472105/2012-4.; Recipients of scholarship support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Alderman MH, 2007, CIRCULATION, V116, P880, DOI 10.1161/CIRCULATIONAHA.107.728600; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARUOMA OI, 1989, FEBS LETT, V244, P76, DOI 10.1016/0014-5793(89)81166-4; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Domazou AS, 2012, FREE RADICAL BIO MED, V52, P1929, DOI 10.1016/j.freeradbiomed.2012.02.045; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Filipe P, 2002, EUR J BIOCHEM, V269, P5474, DOI 10.1046/j.1432-1033.2002.03245.x; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Johnson RJ, 2004, NEW ENGL J MED, V350, P1071, DOI 10.1056/NEJMp048015; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; KITTRIDGE KJ, 1984, FEBS LETT, V170, P162, DOI 10.1016/0014-5793(84)81391-5; Klebanoff S. J, 1991, PEROXIDASES CHEM BIO, V1, P1; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lotufo PA, 2016, ANGIOLOGY, V67, P180, DOI 10.1177/0003319715585037; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Madrigal-Matute J, 2015, FREE RADICAL BIO MED, V86, P352, DOI 10.1016/j.freeradbiomed.2015.06.001; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Mullen L, 2015, MOL MED, V21, DOI 10.2119/molmed.2015.00033; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Patricio ES, 2015, CHEM RES TOXICOL, V28, P1556, DOI 10.1021/acs.chemrestox.5b00132; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2016, J BIOL CHEM, V291, P3053, DOI 10.1074/jbc.M115.692798; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Seidel A, 2014, J BIOL CHEM, V289, P21937, DOI 10.1074/jbc.M113.544957; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Tairum CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33133; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Winterbourn CC, 2016, MOL CELLS, V39, P26, DOI 10.14348/molcells.2016.2325; Winterbourn CC, 2015, NAT CHEM BIOL, V11, P5, DOI 10.1038/nchembio.1722; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; WOODWARD JJ, 1994, NEUROPHARMACOLOGY, V33, P635, DOI 10.1016/0028-3908(94)90168-6	68	32	33	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8705	8715		10.1074/jbc.M116.767657	http://dx.doi.org/10.1074/jbc.M116.767657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28348082	hybrid, Green Published			2022-12-28	WOS:000402153900017
J	Song, R; Fullerton, DA; Ao, LH; Zhao, KS; Meng, XZ				Song, Rui; Fullerton, David A.; Ao, Lihua; Zhao, Ke-seng; Meng, Xianzhong			An epigenetic regulatory loop controls pro-osteogenic activation by TGF-beta 1 or bone morphogenetic protein 2 in human aortic valve interstitial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcification; gene regulation; growth factor; microRNA (miRNA); signaling; aortic valve	OSTEOBLAST DIFFERENTIATION; CALCIFICATION; EXPRESSION; MICRORNAS; RUNX2; OSTERIX; PROGRESSION; MECHANISMS; DISEASE; FAMILY	Calcific aortic valve disease (CAVD) is common in the elderly population, but pharmacological interventions for managing valvular calcification are unavailable. Transforming growth factor beta 1 (TGF-beta 1) and bone morphogenetic protein 2 (BMP-2) induce pro-osteogenic activation of human aortic valve interstitial cells (AVICs) that play an important role in valvular calcification. However, the molecular mechanism underlying pro-osteogenic activation in AVICs is incompletely understood. Here, we investigated an epigenetic regulatory mechanism in human AVIC pro-osteogenic activation induced by TGF-beta 1 and BMP-2. Microarray and real-time PCR analyses revealed that microRNA (miR)-486 up-regulation and miR-204 down-regulation were characteristic changes in TGF-beta 1- and BMP-2-stimulated normal AVICs and in AVICs from calcified valves. Both TGF-beta 1 and BMP-2 down-regulated miR-204 through Smad pathways. Interestingly, an miR-486 antagomir diminished the effect of TGF-beta 1 and BMP-2 on miR-204 levels and calcium deposit formation. Furthermore, the miR-486 antagomir increased the expression of Smurf2, a Smad inhibitor, in the presence or absence of TGF-beta 1 or BMP-2 stimulation, whereas a miR-486 mimic reduced Smurf2 expression. Smurf2 knockdown augmented TGF-beta 1- or BMP-2-induced miR-204 down-regulation and resulted in increased expression of the osteoblastic biomarkers Osx and Runx2. In summary, we found that TGF-beta 1 and BMP-2 up-regulate miR-486 and down-regulate miR-204 in human AVICs to promote pro-osteogenic activity and that miR-486 inhibits Smurf2 expression to augment the miR-204 down-regulation. We conclude that the miR-486-Smurf2-Smad loop plays an important role in regulating AVIC pro-osteogenic activation in response to TGF-beta 1 or BMP-2. Targeting this regulatory loop may have therapeutic potential for suppressing aortic valve calcification.	[Song, Rui; Fullerton, David A.; Ao, Lihua; Meng, Xianzhong] Univ Colorado Denver, Dept Surg, Aurora, CO 80045 USA; [Zhao, Ke-seng] Southern Med Univ, Dept Pathophysiol, Guangdong Key Lab Shock & Microcirculat Res, Guangzhou 510515, Guangdong, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Medical University - China	Meng, XZ (corresponding author), Box C-320,12700 E 19th Ave, Aurora, CO 80045 USA.	Xianzhong.meng@ucdenver.edu		SONG, RUI/0000-0002-5485-3741	National Institutes of Health NHLBI [HL106582, HL121776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106582, R01HL121776] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health NHLBI Grants HL106582 and HL121776.	Alexopoulos A, 2010, INT J CARDIOL, V139, P142, DOI 10.1016/j.ijcard.2008.10.014; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benton JA, 2008, J HEART VALVE DIS, V17, P689; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Cowan CM, 2012, BIOCHEM BIOPH RES CO, V422, P351, DOI 10.1016/j.bbrc.2012.04.077; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Du YY, 2011, CIRC RES, V108, P917, DOI 10.1161/CIRCRESAHA.110.234328; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; Messika-Zeitoun D, 2007, ARTERIOSCL THROM VAS, V27, P642, DOI 10.1161/01.ATV.0000255952.47980.c2; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Nigam V, 2010, J HEART VALVE DIS, V19, P459; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song R, 2015, J MOL MED, V93, P403, DOI 10.1007/s00109-014-1229-z; Song R, 2012, ARTERIOSCL THROM VAS, V32, P2711, DOI 10.1161/ATVBAHA.112.300116; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang YJ, 2015, J CARDIOVASC PHARM, V66, P63, DOI 10.1097/FJC.0000000000000244; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Yanagawa B, 2012, J THORAC CARDIOV SUR, V144, P256, DOI 10.1016/j.jtcvs.2011.10.097; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052; Zeng QC, 2012, CIRCULATION, V126, pS222, DOI 10.1161/CIRCULATIONAHA.111.083675; Zhang M, 2014, J THORAC CARDIOV SUR, V147, P1073, DOI 10.1016/j.jtcvs.2013.05.011; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	41	31	35	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8657	8666		10.1074/jbc.M117.783308	http://dx.doi.org/10.1074/jbc.M117.783308			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377507	Green Published, hybrid			2022-12-28	WOS:000402153900013
J	Andersen, KR				Andersen, Kasper Rojkjaer			Insights into Rad3 kinase recruitment from the crystal structure of the DNA damage checkpoint protein Rad26	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYO-EM STRUCTURE; BIOLOGICAL MACROMOLECULES; RESOLUTION STRUCTURE; SOLUTION SCATTERING; CATALYTIC SUBUNIT; ANALYSIS REVEALS; ATR-ATRIP; BINDING; TOPBP1; DOMAIN	Metabolic products and environmental factors constantly damage DNA. To protect against these insults and maintain genome integrity, cells have evolved mechanisms to repair DNA lesions. One such mechanism involves Rad3, a master kinase coordinating the DNA damage response. Rad26 is a functional subunit of the Rad3-Rad26 complex and is responsible for bringing the kinase to sites of DNA damage. Here, I present the crystal structure of Rad26 and identify the elements important for recruiting Rad3. The structure suggests that Rad26 is a dimer with a conserved interface in the N-terminal part of the protein. Biochemical data showed that Rad26 uses its C-terminal domain and the flanking kinase- docking motif to bind specific HEAT repeats in Rad3. Analysis of the reconstituted Rad3-Rad26 heterotetrameric complex with electron microscopy enabled me to propose a structural model for its quaternary structure. In conclusion, these results suggest that Rad26 exists as a dimer and provide crucial insight into how Rad3 is recruited and incorporated into the Rad3-Rad26 DNA repair complex.	[Andersen, Kasper Rojkjaer] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark	Aarhus University	Andersen, KR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	kra@mbg.au.dk		Andersen, Kasper Rojkjaer/0000-0002-4415-8067	Danish Diabetes Academy; Novo Nordisk Foundation; Sapere Aude grant from the Danish Council for Independent Research; Lundbeck Foundation; Lundbeck Foundation [R194-2015-1555] Funding Source: researchfish	Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sapere Aude grant from the Danish Council for Independent Research; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Diabetes Academy, which is supported by the Novo Nordisk Foundation, and by the Sapere Aude grant from the Danish Council for Independent Research, and a grant from the Lundbeck Foundation. The author declares that he has no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Baretic D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11016; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Gaubitz C, 2012, STRUCTURE, V20, P1993, DOI 10.1016/j.str.2012.11.006; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Itakura E, 2005, MOL BIOL CELL, V16, P5551, DOI 10.1091/mbc.E05-05-0427; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Sawicka M, 2016, J BIOL CHEM, V291, P13436, DOI 10.1074/jbc.M115.708263; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8149	8157		10.1074/jbc.M117.780189	http://dx.doi.org/10.1074/jbc.M117.780189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28314775	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000401788600003
J	Reyes-Reveles, J; Dhingra, A; Alexander, D; Bragin, A; Philp, NJ; Boesze-Battaglia, K				Reyes-Reveles, Juan; Dhingra, Anuradha; Alexander, Desiree; Bragin, Alvina; Philp, Nancy J.; Boesze-Battaglia, Kathleen			Phagocytosis-dependent ketogenesis in retinal pigment epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-OXIDATION; 3-HYDROXYACYL-COA DEHYDROGENASE-DEFICIENCY; OUTER SEGMENT MEMBRANES; PHOTORECEPTOR CELLS; FATTY-ACIDS; DOCOSAHEXAENOIC ACID; ARACHIDONIC ACIDS; RPE CELLS; ROD; METABOLISM	Daily, the retinal pigment epithelium (RPE) ingests a bolus of lipid and protein in the form of phagocytized photoreceptor outer segments (OS). The RPE, like the liver, expresses enzymes required for fatty acid oxidation and ketogenesis. This suggests that these pathways play a role in the disposal of lipids from ingested OS, as well as providing a mechanism for recycling metabolic intermediates back to the outer retina. In this study, we examined whether OS phagocytosis was linked to ketogenesis. We found increased levels of beta-hydroxybutyrate (beta-HB) in the apical medium following ingestion of OS by human fetal RPE and ARPE19 cells cultured on Transwell inserts. No increase in ketogenesis was observed following ingestion of oxidized OS or latex beads. Our studies further defined the connection between OS phagocytosis and ketogenesis in wild-type mice and mice with defects in phagosome maturation using a mouse RPE explant model. In explant studies, the levels of beta-HB released were temporally correlated with OS phagocytic burst after light onset. In the Mreg(-/-) mouse where phagosome maturation is delayed, there was a temporal shift in the release of beta-HB. An even more pronounced shift in maximal beta-HB production was observed in the Abca4(-/-) RPE, in which loss of the ATP-binding cassette A4 transporter results in defective phagosome processing and accumulation of lipid debris. These studies suggest that FAO and ketogenesis are key to supporting the metabolism of the RPE and preventing the accumulation of lipids that lead to oxidative stress and mitochondrial dysfunction.	[Reyes-Reveles, Juan; Dhingra, Anuradha; Alexander, Desiree; Bragin, Alvina; Boesze-Battaglia, Kathleen] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19146 USA	University of Pennsylvania; Jefferson University	Boesze-Battaglia, K (corresponding author), Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA.; Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19146 USA.	nancy.philp@jefferson.edu; battagli@upenn.edu		Philp, Nancy/0000-0001-7028-0448	National Institutes of Health [EY010420, EY 012042, EY026525]; NATIONAL EYE INSTITUTE [R29EY010420, R56EY012042, R01EY012042, R01EY010420, P30EY001583, R01EY026525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole or in part by National Institutes of Health Grants EY010420 (to K. B.-B.), EY 012042 (to N. J. P.), and EY026525 (to K. B.-B. and N. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Bazan N G, 1989, Prog Clin Biol Res, V312, P95; BAZAN NG, 1994, J OCUL PHARMACOL, V10, P591, DOI 10.1089/jop.1994.10.591; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1992, BIOCHIM BIOPHYS ACTA, V1111, P256, DOI 10.1016/0005-2736(92)90318-G; Burke JM, 2005, MOL INTERV, V5, P241, DOI 10.1124/mi.5.4.7; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; CHEN HM, 1993, J LIPID RES, V34, P1943; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; De Rosa MC, 2015, J CELL PHYSIOL, V230, P2059, DOI 10.1002/jcp.24932; DETURCO EBR, 1990, J NEUROSCI RES, V27, P522, DOI 10.1002/jnr.490270413; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Frost LS, 2015, MOL NEUROBIOL, V52, P1135, DOI 10.1007/s12035-014-8920-5; Frost LS, 2013, VISUAL NEUROSCI, V30, P55, DOI 10.1017/S0952523813000096; GORDON WC, 1992, CURR EYE RES, V11, P73, DOI 10.3109/02713689209069169; Handa JT, 2017, BBA-MOL CELL BIOL L, V1862, P430, DOI 10.1016/j.bbalip.2016.07.013; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Jiang M, 2015, J CELL BIOL, V210, P595, DOI 10.1083/jcb.201410112; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1976, EXP EYE RES, V23, P277, DOI 10.1016/0014-4835(76)90209-8; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Nelson CP, 2015, ARTERIOSCL THROM VAS, V35, P1456, DOI 10.1161/ATVBAHA.114.304925; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Polinati PP, 2015, INVEST OPHTH VIS SCI, V56, P3371, DOI 10.1167/iovs.14-14007; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Shenker BJ, 2015, INFECT IMMUN, V83, P1487, DOI 10.1128/IAI.03132-14; SINGH I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P44, DOI 10.1016/0005-2760(93)90174-8; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; VANKUIJK FJGM, 1987, FREE RADICAL BIO MED, V3, P349, DOI 10.1016/S0891-5849(87)80046-1; Volland S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125631; Wang W, 2016, CELL REP, V15, P372, DOI 10.1016/j.celrep.2016.03.022; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wihlmark U, 1996, APMIS, V104, P272, DOI 10.1111/j.1699-0463.1996.tb00717.x; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	48	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8038	8047		10.1074/jbc.M116.770784	http://dx.doi.org/10.1074/jbc.M116.770784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302729	Green Published, hybrid			2022-12-28	WOS:000401154100028
J	Li, Z; Du, L; Zhang, W; Zhang, XW; Jiang, YY; Liu, K; Men, P; Xu, HF; Fortman, JL; Sherman, DH; Yu, B; Gao, S; Li, SY				Li, Zhong; Du, Lei; Zhang, Wei; Zhang, Xingwang; Jiang, Yuanyuan; Liu, Kun; Men, Ping; Xu, Huifang; Fortman, Jeffrey L.; Sherman, David H.; Yu, Bing; Gao, Song; Li, Shengying			Complete elucidation of the late steps of bafilomycin biosynthesis in Streptomyces lohii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-SYNTHETASE; GENE-CLUSTER; MACROLIDE ANTIBIOTICS; SP CS; ACID; A(1); INHIBITORS; MICROORGANISMS; FERMENTATION; PURIFICATION	Bafilomycins are an important subgroup of polyketides with diverse biological activities and possible applications as specific inhibitors of vacuolar H+-ATPase. However, the general toxicity and structural complexity of bafilomycins present formidable challenges to drug design via chemical modification, prompting interests in improving bafilomycin activities via biosynthetic approaches. Two bafilomycin biosynthetic gene clusters have been identified, but their post-polyketide synthase (PKS) tailoring steps for structural diversification and bioactivity improvement remain largely unknown. In this study, the post-PKS tailoring pathway from bafilomycin A(1) (1)-> C-1 (2)-> B-1 (3) in the marine microorganism Streptomyces lohii was elucidated for the first time by in vivo gene inactivation and in vitro biochemical characterization. We found that fumarate is first adenylated by a novel fumarate adenylyltransferase Orf3. Then, the fumaryl transferase Orf2 is responsible for transferring the fumarate moiety from fumaryl-AMP to the 21-hydroxyl group of 1 to generate 2. Last, the ATP-dependent amide synthetase BafY catalyzes the condensation of 2 and 2-amino-3-hydroxycyclopent-2-enone (C5N) produced by the 5-aminolevulinic acid synthase BafZ and the acyl-CoA ligase BafX, giving rise to the final product 3. The elucidation of fumarate incorporation mechanism represents the first paradigm for biosynthesis of natural products containing the fumarate moiety. Moreover, the bafilomycin post-PKS tailoring pathway features an interesting cross-talk between primary and secondary metabolisms for natural product biosynthesis. Taken together, this work provides significant insights into bafilomycin biosynthesis to inform future pharmacological development of these compounds.	[Li, Zhong; Du, Lei; Zhang, Wei; Zhang, Xingwang; Jiang, Yuanyuan; Liu, Kun; Men, Ping; Xu, Huifang; Li, Shengying] Chinese Acad Sci, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China; [Li, Zhong; Du, Lei; Zhang, Wei; Zhang, Xingwang; Jiang, Yuanyuan; Liu, Kun; Men, Ping; Xu, Huifang; Li, Shengying] Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Li, Zhong; Du, Lei; Jiang, Yuanyuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Fortman, Jeffrey L.; Sherman, David H.] Univ Michigan, Life Sci Inst, Dept Med Chem, Ann Arbor, MI 48109 USA; [Fortman, Jeffrey L.; Sherman, David H.] Univ Michigan, Life Sci Inst, Dept Chem, Ann Arbor, MI 48109 USA; [Fortman, Jeffrey L.; Sherman, David H.] Univ Michigan, Life Sci Inst, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Yu, Bing; Gao, Song] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State Key Lab Oncology South China; Sun Yat Sen University	Li, SY (corresponding author), Chinese Acad Sci, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China.; Li, SY (corresponding author), Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China.	lishengying@qibebt.ac.cn	jiang, anyi/GPT-0379-2022	Gao, Song/0000-0001-7427-6681; Zhang, Wei/0000-0001-9459-680X	National Natural Science Foundation of China [NSFC 21472204]; Shandong Provincial Natural Science Foundation [JQ201407]; Primary Research & Development Plan of Shandong Province [2016GSF121001]; Applied Basic Research Program of Qingdao [15-9-1-93-jch]; China Postdoctoral Science Foundation [2016M590669]; Youth Innovation Promotion Association of CAS [2015166]; National Institutes of Health [R35GM118101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118101] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Primary Research & Development Plan of Shandong Province; Applied Basic Research Program of Qingdao; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Promotion Association of CAS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant NSFC 21472204, Shandong Provincial Natural Science Foundation Grant JQ201407, Primary Research & Development Plan of Shandong Province Grant 2016GSF121001, Applied Basic Research Program of Qingdao Grant 15-9-1-93-jch, China Postdoctoral Science Foundation Grant 2016M590669, and the Youth Innovation Promotion Association of CAS Grant 2015166. This work was also supported by National Institutes of Health Grant R35GM118101 (to D. H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bera AK, 2010, ACTA CRYSTALLOGR D, V66, P664, DOI 10.1107/S0907444910008425; BEWLEY CA, 1994, J AM CHEM SOC, V116, P7631, DOI 10.1021/ja00096a020; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Carr G, 2010, J NAT PROD, V73, P422, DOI 10.1021/np900632r; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Dai WM, 2005, CURR MED CHEM, V12, P1947, DOI 10.2174/0929867054546591; Drose S, 1997, J EXP BIOL, V200, P1; Elix JA, 1999, AUST J CHEM, V52, P713, DOI 10.1071/CH99056; FISHER SH, 1989, J BACTERIOL, V171, P2378, DOI 10.1128/jb.171.5.2378-2383.1989; Fremlin L, 2011, ORG BIOMOL CHEM, V9, P1201, DOI 10.1039/c0ob00654h; Gagliardi S, 1998, J MED CHEM, V41, P1883, DOI 10.1021/jm9707838; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; GOETZ MA, 1985, J ANTIBIOT, V38, P161, DOI 10.7164/antibiotics.38.161; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HUANG L, 1984, J ANTIBIOT, V37, P970, DOI 10.7164/antibiotics.37.970; Hwang JY, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-24; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KINASHI H, 1984, J ANTIBIOT, V37, P1333, DOI 10.7164/antibiotics.37.1333; Kleinbeck F, 2009, ANGEW CHEM INT EDIT, V48, P578, DOI 10.1002/anie.200804645; KOWALSKY A, 1956, J BIOL CHEM, V219, P719; KRETSCHMER A, 1985, AGR BIOL CHEM TOKYO, V49, P2509, DOI 10.1080/00021369.1985.10867119; KRISHNASWAMY PR, 1962, J BIOL CHEM, V237, P2932; Li JA, 2010, J ANTIBIOT, V63, P595, DOI 10.1038/ja.2010.95; Li PW, 2015, APPL MICROBIOL BIOT, V99, P1923, DOI 10.1007/s00253-014-6369-0; Lu CH, 2004, J ANTIBIOT, V57, P597, DOI 10.7164/antibiotics.57.597; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McQuade TJ, 2009, ANAL BIOCHEM, V386, P244, DOI 10.1016/j.ab.2008.12.014; Moon SS, 2003, J ANTIBIOT, V56, P856, DOI 10.7164/antibiotics.56.856; Nara A, 2017, J ANTIBIOT, V70, P616, DOI 10.1038/ja.2017.33; Ostash B, 2013, MOL MICROBIOL, V90, P1324, DOI 10.1111/mmi.12437; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rui Z, 2010, J BIOL CHEM, V285, P24915, DOI 10.1074/jbc.M110.128850; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; Scheidt KA, 2002, J AM CHEM SOC, V124, P6981, DOI 10.1021/ja017885e; Suzuki H, 2007, J ANTIBIOT, V60, P380, DOI 10.1038/ja.2007.52; Toshima K, 1997, J ORG CHEM, V62, P3271, DOI 10.1021/jo970314d; TOYOTA M, 1990, PHYTOCHEMISTRY, V29, P1485, DOI 10.1016/0031-9422(90)80106-Q; UYEDA M, 1995, J ANTIBIOT, V48, P1234, DOI 10.7164/antibiotics.48.1234; Wang P, 2015, TETRAHEDRON, V71, P5362, DOI 10.1016/j.tet.2015.05.112; WERNER G, 1984, J ANTIBIOT, V37, P110, DOI 10.7164/antibiotics.37.110; WERNER G, 1983, TETRAHEDRON LETT, V24, P5193, DOI 10.1016/S0040-4039(00)88394-X; WILTON JH, 1985, J ANTIBIOT, V38, P1449, DOI 10.7164/antibiotics.38.1449; WRAY LV, 1988, GENE, V71, P247, DOI 10.1016/0378-1119(88)90041-8; Wu CS, 2016, ACS CHEM BIOL, V11, P478, DOI 10.1021/acschembio.5b00801; Yu ZG, 2011, J ANTIBIOT, V64, P159, DOI 10.1038/ja.2010.147; Zhang DJ, 2011, J ANTIBIOT, V64, P391, DOI 10.1038/ja.2011.12; Zhang W, 2013, CHEMBIOCHEM, V14, P301, DOI 10.1002/cbic.201200743; Zhang WJ, 2010, J AM CHEM SOC, V132, P6402, DOI 10.1021/ja1002845; Zhao F, 2016, FITOTERAPIA, V109, P113, DOI 10.1016/j.fitote.2015.12.015; Zhuang YB, 2011, ORG LETT, V13, P1130, DOI 10.1021/ol103164n	51	12	15	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7095	7104		10.1074/jbc.M116.751255	http://dx.doi.org/10.1074/jbc.M116.751255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28292933	Green Published, hybrid			2022-12-28	WOS:000400478300020
J	Newton, R; Shah, S; Altonsy, MO; Gerber, AN				Newton, Robert; Shah, Suharsh; Altonsy, Mohammed O.; Gerber, Antony N.			Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; DUAL-SPECIFICITY PHOSPHATASE-1; EPITHELIAL-CELLS; GENE-EXPRESSION; MESSENGER-RNA; TRISTETRAPROLIN EXPRESSION; IFN-GAMMA; TRANSCRIPTIONAL REGULATION	Inflammatory signals induce feedback and feedforward systems that provide temporal control. Although glucocorticoids can repress inflammatory gene expression, glucocorticoid receptor recruitment increases expression of negative feedback and feedforward regulators, including the phosphatase, DUSP1, the ubiquitin-modifying enzyme, TNFAIP3, or the mRNA-destabilizing protein, ZFP36. Moreover, glucocorticoid receptor cooperativity with factors, including nuclear factor-kappa B (NF-kappa B), may enhance regulator expression to promote repression. Conversely, MAPKs, which are inhibited by glucocorticoids, provide feedforward control to limit expression of the transcription factor IRF1, and the chemokine, CXCL10. We propose that modulation of feedback and feedforward control can determine repression or resistance of inflammatory gene expression toglucocorticoid.	[Newton, Robert; Altonsy, Mohammed O.] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB T2N 4Z6, Canada; [Shah, Suharsh] Univ Calgary, Dept Oncol, Arnie Charbonneau Canc Inst, Calgary, AB T2N 4Z6, Canada; [Altonsy, Mohammed O.] Sohag Univ, Fac Sci, Sohag 82524, Egypt; [Gerber, Antony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Sohag University; National Jewish Health	Newton, R (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB T2N 4Z6, Canada.	rnewton@ucalgary.ca	Newton, Robert/C-6814-2012	Newton, Robert/0000-0002-4919-8498; Altonsy, Mohammed Omar/0000-0002-9086-5934	Canadian Institutes of Health Research operating grant [MOP 125918]; Alberta Innovates Health Solutions; NHLBI, National Institutes of Health [R01 HL-109557]; AstraZeneca; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER	Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research operating grant (MOP 125918) (to R. N.), Alberta Innovates Health Solutions Senior Scholar salary support (to R. N.), and NHLBI, National Institutes of Health Grant R01 HL-109557 (to A. N. G.). R. N. receives research funding from AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; AbuSara N, 2015, CANCER LETT, V357, P575, DOI 10.1016/j.canlet.2014.12.017; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; Ammit AJ, 2013, CURR OPIN PHARMACOL, V13, P370, DOI 10.1016/j.coph.2013.02.001; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Bhandare R, 2010, AM J RESP CELL MOL, V42, P9, DOI 10.1165/rcmb.2009-0239RC; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bladh LG, 2009, BBA-MOL CELL RES, V1793, P439, DOI 10.1016/j.bbamcr.2008.11.013; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2016, BIOCHEM SOC T, V44, P1321, DOI 10.1042/BST20160166; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Hua GQ, 2016, P NATL ACAD SCI USA, V113, pE626, DOI 10.1073/pnas.1522821113; Hua GQ, 2016, P NATL ACAD SCI USA, V113, pE635, DOI 10.1073/pnas.1522826113; Hubbard LLN, 2010, INFECT DIS REP, V2, P22, DOI 10.4081/idr.2010.e9; Hudson WH, 2013, NAT STRUCT MOL BIOL, V20, P53, DOI 10.1038/nsmb.2456; Huotari N, 2012, APMIS, V120, P988, DOI 10.1111/j.1600-0463.2012.02927.x; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Jalonen U, 2005, BIOCHEM PHARMACOL, V69, P733, DOI 10.1016/j.bcp.2004.11.027; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; Jubb AW, 2016, J IMMUNOL, V196, P813, DOI 10.4049/jimmunol.1502009; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Keenan CR, 2012, DRUG DISCOV TODAY, V17, P1031, DOI 10.1016/j.drudis.2012.05.011; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langlais D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000224; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; Leigh R, 2015, PHARMACOL THERAPEUT, V148, P185, DOI 10.1016/j.pharmthera.2014.12.005; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Mylona A, 2016, SCIENCE, V354, P233, DOI 10.1126/science.aad1872; Nair S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003999; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Prabhala P, 2016, J CELL PHYSIOL, V231, P2153, DOI 10.1002/jcp.25327; Prabhala P, 2015, AM J PHYSIOL-LUNG C, V308, pL973, DOI 10.1152/ajplung.00219.2014; Rahman MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10063; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Remoli AL, 2016, MBIO, V7, DOI 10.1128/mBio.01528-16; Ross EA, 2015, J IMMUNOL, V195, P265, DOI 10.4049/jimmunol.1402826; Sasse SK, 2016, AM J PHYSIOL-LUNG C, V311, pL421, DOI 10.1152/ajplung.00179.2016; Sasse SK, 2015, PHARMACOL THERAPEUT, V145, P85, DOI 10.1016/j.pharmthera.2014.08.004; Sauty A, 1999, J IMMUNOL, V162, P3549; Shah S, 2016, J BIOL CHEM, V291, P21802, DOI 10.1074/jbc.M116.728964; Shah S, 2016, J BIOL CHEM, V291, P110, DOI 10.1074/jbc.M115.697599; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Smallie T, 2015, J IMMUNOL, V195, P277, DOI 10.4049/jimmunol.1402830; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Soye KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022323; Sukkar MB, 2004, AM J PHYSIOL-LUNG C, V287, pL1230, DOI 10.1152/ajplung.00014.2004; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tokunaga F, 2013, J BIOCHEM, V154, P313, DOI 10.1093/jb/mvt079; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zaheer RS, 2010, AM J RESP CELL MOL, V43, P413, DOI 10.1165/rcmb.2009-0203OC; Zaheer RS, 2009, J IMMUNOL, V182, P4854, DOI 10.4049/jimmunol.0802401; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	99	46	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7163	7172		10.1074/jbc.R117.777318	http://dx.doi.org/10.1074/jbc.R117.777318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283576	Green Published, hybrid			2022-12-28	WOS:000400478300028
J	Garlich, J; Strecker, V; Wittig, I; Stuart, RA				Garlich, Joshua; Strecker, Valentina; Wittig, Ilka; Stuart, Rosemary A.			Mutational Analysis of the QRRQ Motif in the Yeast Hig1 Type 2 Protein Rcf1 Reveals a Regulatory Role for the Cytochrome c Oxidase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; SUPERCOMPLEX ORGANIZATION; MITOCHONDRIAL PROTEIN; CARDIOLIPIN; IDENTIFICATION; COMPONENTS; INSIGHT; GLUCOSE; HIGD1A	The yeast Rcf1 protein is a member of the conserved family of proteins termed the hypoxia-induced gene (domain) 1 (Hig1 or HIGD1) family. Rcf1 interacts with components of the mitochondrial oxidative phosphorylation system, in particular the cytochrome bc(1) (complex III)-cytochrome c oxidase (complex IV) supercomplex (termed III-IV) and the ADP/ATP carrier proteins. Rcf1 plays a role in the assembly and modulation of the activity of complex IV; however, the molecular basis for how Rcf1 influences the activity of complex IV is currently unknown. Hig1 type 2 isoforms, which include the Rcf1 protein, are characterized in part by the presence of a conserved motif, (Q/I) X-3(R/H) XRX(3)Q, termed here the QRRQ motif. We show that mutation of conserved residues within the Rcf1 QRRQ motif alters the interactions between Rcf1 and partner proteins and results in the destabilization of complex IV and alteration of its enzymatic properties. Our findings indicate that Rcf1 does not serve as a stoichiometric component, i.e. as a subunit of complex IV, to support its activity. Rather, we propose that Rcf1 serves to dynamically interact with complex IV during its assembly process and, in doing so, regulates a late maturation step of complex IV. We speculate that the Rcf1/Hig1 proteins play a role in the incorporation and/or remodeling of lipids, in particular cardiolipin, into complex IV and. possibly, other mitochondrial proteins such as ADP/ATP carrier proteins.	[Garlich, Joshua; Stuart, Rosemary A.] Marquette Univ, Dept Biol Sci, 530 N 15th St, Milwaukee, WI 53233 USA; [Strecker, Valentina; Wittig, Ilka] Goethe Univ, Funct Prote, SFB Core Unit 815, D-60590 Frankfurt, Germany	Marquette University; Goethe University Frankfurt	Stuart, RA (corresponding author), Marquette Univ, Dept Biol Sci, 530 N 15th St, Milwaukee, WI 53233 USA.	rosemary.stuart@marquette.edu			National Science Foundation [MCB1157722]; National Institutes of Health [R15-GM101594, R15GM117551]; Cluster of Excellence "Macromolecular Complexes" at the Goethe University Frankfurt (DFG) [EXC 115, SFB815]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM117551, R15GM101594] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cluster of Excellence "Macromolecular Complexes" at the Goethe University Frankfurt (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB1157722 and National Institutes of Health Grants R15-GM101594 and R15GM117551 (to R.A.S.), an Arthur J. Schmitt graduate fellowship award (to J.G.), and by Cluster of Excellence "Macromolecular Complexes" at the Goethe University Frankfurt (DFG Project EXC 115) and SFB815 Project Z1 (to I.W.).The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameri K, 2015, CELL REP, V10, P891, DOI 10.1016/j.celrep.2015.01.020; Ameri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062758; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ogunjimi EO, 2000, J BIOENERG BIOMEMBR, V32, P617, DOI 10.1023/A:1005678729157; Pebay-Peyroula E, 2004, CURR OPIN STRUC BIOL, V14, P420, DOI 10.1016/j.sbi.2004.06.009; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	41	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5216	5226		10.1074/jbc.M116.758045	http://dx.doi.org/10.1074/jbc.M116.758045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28167530	hybrid, Green Published			2022-12-28	WOS:000397875500006
J	Jadhav, S; Russo, S; Cowart, LA; Greenberg, ML				Jadhav, Shyamalagauri; Russo, Sarah; Cowart, L. Ashley; Greenberg, Miriam L.			Inositol Depletion Induced by Acute Treatment of the Bipolar Disorder Drug Valproate Increases Levels of Phytosphingosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SPHINGOLIPID HOMEOSTASIS; PROTEIN; BIOSYNTHESIS; YEAST; GENES; ORM2; PHOSPHORYLATION; MODULATION; LITHIUM	Bipolar disorder (BD) is a severe psychiatric illness affecting similar to 1% of the world population. Valproate (VPA) and lithium, widely used for the treatment of BD, are not universally effec-tive. These drugs have been shown to cause inositol depletion, but translating this observation to a specific therapeutic mech-anism has been difficult, hampering the development of more effective therapies. We have shown previously in yeast that chronic VPA treatment induces the unfolded protein response due to increasing ceramide levels. To gain insight into the mechanisms activated during acute VPA treatment, we performed a genome-wide expression study in yeast treated with VPA for 30 min. We observed increased mRNA and protein levels of RSB1, which encodes an exporter of long chain bases dihydrosphingosine (DHS) and phytosphingosine (PHS), and further saw that VPA increased sensitivity of an rsb1 Delta mutant to PHS, suggesting that VPA increases long chain base levels. Consistent with this, PHS levels were elevated in wild type and, to a greater extent, in rsb1 Delta cells. Expression of ORM genes (negative regulators of PHS synthesis) and of fatty acid elongase genes FEN1 and SUR4 were decreased, and expression of YOR1 (exporter of PHS-1P) and DPL1 (lyase that degrades DHS-1P and PHS-1P) was increased. These effects were more pronounced in medium lacking inositol, and were mirrored by inositol starvation of an ino1 Delta mutant. These findings provide a metabolic explanation as to how VPA-mediated inositol depletion causes increased synthesis of PHS and further support the therapeutic relevance of inositol depletion as a bipolar disorder treatment.	[Jadhav, Shyamalagauri; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Russo, Sarah; Cowart, L. Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Russo, Sarah; Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Jadhav, Shyamalagauri] NIDDK, NIH, Bethesda, MD 20892 USA	Wayne State University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu		Jadhav, Shyamalagauri/0000-0003-4302-6713	National Institutes of Health [DK081367]; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081367 (to M. L. G.), and support from the Graduate School of Wayne State University (to S. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jadhav S, 2016, J BIOL CHEM, V291, P22253, DOI 10.1074/jbc.M116.752634; Johnson SS, 2010, J BIOL CHEM, V285, P35792, DOI 10.1074/jbc.M110.162883; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Panwar SL, 2006, J BIOL CHEM, V281, P6376, DOI 10.1074/jbc.M512115200; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Ye CQ, 2015, J NEUROCHEM, V133, P273, DOI 10.1111/jnc.12978	25	2	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4953	4959		10.1074/jbc.M117.775460	http://dx.doi.org/10.1074/jbc.M117.775460			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28100786	hybrid, Green Published			2022-12-28	WOS:000397590400017
J	Jones, AJY; Blaza, JN; Varghese, F; Hirst, J				Jones, Andrew J. Y.; Blaza, James N.; Varghese, Febin; Hirst, Judy			Respiratory Complex I in Bos taurus and Paracoccus denitrificans Pumps Four Protons across the Membrane for Every NADH Oxidized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; CRYSTAL-STRUCTURE; ATP SYNTHASE; STOICHIOMETRY; INHIBITORS; REDUCTION; MECHANISM; SUBUNITS; GENES	Respiratory complex I couples electron transfer between NADH and ubiquinone to proton translocation across an ener-gy-transducing membrane to support the proton-motive force that drives ATP synthesis. The proton-pumping stoichiometry of complex I (i. e. the number of protons pumped for each two electrons transferred) underpins all mechanistic proposals. However, it remains controversial and has not been determined for any of the bacterial enzymes that are exploited as model systems for the mammalian enzyme. Here, we describe a simple method for determining the proton-pumping stoichiometry of complex I in inverted membrane vesicles under steady-state ADP-phosphorylating conditions. Our method exploits the rate of ATP synthesis, driven by oxidation of NADH or succinate with different sections of the respiratory chain engaged in catalysis as a proxy for the rate of proton translocation and determines the stoichiometry of complex I by reference to the known stoichiometries of complexes III and IV. Using vesicles prepared from mammalian mitochondria (from Bos taurus) and from the bacterium Paracoccus denitrificans, we show that four protons are pumped for every two electrons transferred in both cases. By confirming the four-proton stoichiometry for mammalian complex I and, for the first time, demonstrating the same value for a bacterial complex, we establish the utility of P. denitrificans complex I as a model system for the mammalian enzyme. P. denitrificans is the first system described in which mutagenesis in any complex I core subunit may be combined with quantitative proton-pumping measurements for mechanistic studies.	[Jones, Andrew J. Y.; Blaza, James N.; Varghese, Febin; Hirst, Judy] MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England		Hirst, J (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797; Blaza, Jamie/0000-0001-5420-2116; Varghese, Febin/0000-0003-4457-7736	Medical Research Council [U105663141]; MRC [MC_U105663141] Funding Source: UKRI; Medical Research Council [1095779, MC_U105663141, 1236985] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grant U105663141 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ABELE U, 1995, PROTEIN SCI, V4, P1262, DOI 10.1002/pro.5560040702; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Biason JV, 2011, J MOL BIOL, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Bogachev AV, 1996, J BACTERIOL, V178, P6233, DOI 10.1128/jb.178.21.6233-6237.1996; BURSTEIN C, 1979, EUR J BIOCHEM, V94, P387, DOI 10.1111/j.1432-1033.1979.tb12905.x; Castro PJ, 2016, BBA-BIOENERGETICS, V1857, P928, DOI 10.1016/j.bbabio.2015.12.008; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Devin A, 1997, BBA-BIOENERGETICS, V1319, P293, DOI 10.1016/S0005-2728(96)00172-7; Dimroth P, 2000, J EXP BIOL, V203, P51; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; Ferguson SJ, 2010, P NATL ACAD SCI USA, V107, P16755, DOI 10.1073/pnas.1012260107; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; JOHN P, 1970, BIOCHIM BIOPHYS ACTA, V216, P342, DOI 10.1016/0005-2728(70)90225-2; Jones AJY, 2013, ANAL BIOCHEM, V442, P19, DOI 10.1016/j.ab.2013.07.018; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Klingenberg M., 2008, ENERGY TRANSFORMATIO, P105; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; LINNANE AW, 1958, BIOCHIM BIOPHYS ACTA, V29, P630, DOI 10.1016/0006-3002(58)90021-0; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; NICHOLLS DG, 2013, BIOENERGETICS; Otten MF, 2001, EUR J BIOCHEM, V268, P2486, DOI 10.1046/j.1432-1327.2001.02131.x; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Ripple MO, 2013, J BIOL CHEM, V288, P5374, DOI 10.1074/jbc.M112.438945; Roberts PG, 2012, J BIOL CHEM, V287, P34743, DOI 10.1074/jbc.M112.384560; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6948, DOI 10.1128/jb.173.21.6948-6961.1991; Vignais PM, 2005, BIOCHEM SOC T, V33, P28, DOI 10.1042/BST0330028; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; WISKICH JT, 1977, ANNU REV PLANT PHYS, V28, P45, DOI 10.1146/annurev.pp.28.060177.000401; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430; Zharova TV, 1997, BBA-BIOENERGETICS, V1320, P256, DOI 10.1016/S0005-2728(97)00029-7; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	54	44	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4987	4995		10.1074/jbc.M116.771899	http://dx.doi.org/10.1074/jbc.M116.771899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28174301	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000397590400020
J	Wang, YD; Wang, Y; Ma, LL; Nie, M; Ju, JY; Liu, M; Deng, YX; Yao, B; Gui, T; Li, XY; Guo, C; Ma, C; Tan, RX; Zhao, Q				Wang, Yadong; Wang, Ying; Ma, Lingling; Nie, Min; Ju, Junyi; Liu, Ming; Deng, Yexuan; Yao, Bing; Gui, Tao; Li, Xinyu; Guo, Chan; Ma, Chi; Tan, Renxiang; Zhao, Quan			Heterochromatin Protein 1 gamma Is a Novel Epigenetic Repressor of Human Embryonic epsilon-Globin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FETAL; DNA METHYLATION; GAMMA-GLOBIN; HEMOGLOBIN; TRIMETHYLATION; MECHANISMS; INTEGRITY; DISEASE; MOUSE; CELLS	Production of hemoglobin during development is tightly regulated. For example, expression from the human beta-globin gene locus, comprising beta, delta, epsilon, and gamma globin genes, switches from beta-globin to epsilon-globin during embryonic development and then from beta-globin to beta-globin after birth. Expression of human beta-globin in mice has been shown to ameliorate anemia caused by beta-globin mutations, including those causing beta-thalassemia and sickle cell disease, raising the prospect that reactivation of beta-globin expression could be used in managing these conditions in humans. Although the human globin genes are known to be regulated by a variety of multiprotein complexes containing enzymes that catalyze epigenetic modifications, the exact mechanisms controlling beta-globin gene silencing remain elusive. Here we found that the heterochromatin protein HP1 gamma, a multifunctional chromatin-and DNA-binding protein with roles in transcriptional activation and elongation, represses epsilon-globin expression by interacting with a histone-modifying enzyme, lysine methyltransferase SUV4-20h2. Silencing of HP1 gamma expression markedly decreased repressive histone marks and the multimethylation of histone H3 lysine 9 and H4 lysine 20, leading to a significant decrease in DNA methylation at the proximal promoter of the epsilon-globin gene and greatly increased epsilon-globin expression. In addition, using chromatin immunoprecipitation, we showed that SUV4-20h2 facilitates the deposition of HP1 gamma on the epsilon-globin-proximal promoter. Thus, these data indicate that HP1 gamma is a novel epigenetic repressor of epsilon-globin gene expression and provide a potential strategy for targeted therapies for beta-thalassemia and sickle cell disease.	[Wang, Yadong; Wang, Ying; Ma, Lingling; Nie, Min; Ju, Junyi; Liu, Ming; Deng, Yexuan; Yao, Bing; Gui, Tao; Li, Xinyu; Guo, Chan; Ma, Chi; Tan, Renxiang; Zhao, Quan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University	Zhao, Q (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	qzhao@nju.edu.cn	Zhao, Quan/E-9147-2011; Xinyu, Li/AAG-1655-2021	Zhao, Quan/0000-0002-8533-1938; Xinyu, Li/0000-0003-3694-4188; ju, junyi/0000-0002-9141-2363	National Natural Science Foundation of China (NFSC) [31470750, 31270811, 81421091, 2015M571736, 2016M590442]	National Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants NSFC 31470750 and 31270811 (to Q. Z.), 81421091 (to R. T.), 2015M571736 (to J. J.), and 2016M590442 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bian CJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05606; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Cui SY, 2015, BLOOD, V125, P1477, DOI 10.1182/blood-2014-10-605022; Fathallah H, 2008, BLOOD CELL MOL DIS, V40, P166, DOI 10.1016/j.bcmd.2007.08.001; Ginder GD, 2015, TRANSL RES, V165, P115, DOI 10.1016/j.trsl.2014.05.002; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hahn M, 2013, GENE DEV, V27, P859, DOI 10.1101/gad.210377.112; He ZN, 2002, P NATL ACAD SCI USA, V99, P10635, DOI 10.1073/pnas.162269099; Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014; Lavelle D, 2006, BLOOD CELL MOL DIS, V36, P269, DOI 10.1016/j.bcmd.2006.01.004; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Miyagi S, 2014, STEM CELL REP, V2, P145, DOI 10.1016/j.stemcr.2013.12.008; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Russell JE, 1998, BLOOD, V92, P3057, DOI 10.1182/blood.V92.9.3057.421k57_3057_3063; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; STAMATOYANNOPOULOS JA, 1992, ANNU REV MED, V43, P497; Suzuki M, 2014, MOL CELL BIOL, V34, P3560, DOI 10.1128/MCB.00714-14; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Wang YY, 2016, 2016 INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY, ENVIRONMENT AND INFORMATION ENGINEERING (SEEIE 2016), P4; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xu Z, 2012, HAEMATOL-HEMATOL J, V97, P1632, DOI 10.3324/haematol.2012.061937; Zhao QL, 2009, CPGPS 2009: GLOBAL NAVIGATION SATELLITE SYSTEM: TECHNOLOGY INNOVATION AND APPLICATION, PROCEEDINGS, P5	30	3	3	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4811	4817		10.1074/jbc.M116.768515	http://dx.doi.org/10.1074/jbc.M116.768515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28154185	Green Published, hybrid			2022-12-28	WOS:000397590400006
J	Ohoka, N; Okuhira, K; Ito, M; Nagai, K; Shibata, N; Hattori, T; Ujikawa, O; Shimokawa, K; Sano, O; Koyama, R; Fujita, H; Teratani, M; Matsumoto, H; Imaeda, Y; Nara, H; Cho, N; Naito, M				Ohoka, Nobumichi; Okuhira, Keiichiro; Ito, Masahiro; Nagai, Katsunori; Shibata, Norihito; Hattori, Takayuki; Ujikawa, Osamu; Shimokawa, Kenichiro; Sano, Osamu; Koyama, Ryokichi; Fujita, Hisashi; Teratani, Mika; Matsumoto, Hirokazu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko			In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; SMALL-MOLECULE PROTACS; CELL-DEATH; UBIQUITIN LIGASE; IAP PROTEINS; DEGRADATION; CANCER; TARGET; CIAP1; ESTROGEN	Many diseases, especially cancers, result from aberrant or overexpression of pathogenic proteins. Specific inhibitors against these proteins have shown remarkable therapeutic effects, but these are limited mainly to enzymes. An alternative approach that may have utility in drug development relies on selective degradation of pathogenic proteins via small chimeric molecules linking an E3 ubiquitin ligase to the targeted protein for proteasomal degradation. To this end, we recently developed a protein knockdown system based on hybrid small molecule SNIPERs (Specific and Nongenetic IAP-dependent Protein Erasers) that recruit inhibitor of the apoptosis protein (IAP) ubiquitin ligases to specifically degrade targeted proteins. Here, we extend our previous study to show a proof of concept of the SNIPER technology in vivo. By incorporating a high affinity IAP ligand, we developed a novel SNIPER against estrogen receptor alpha(ER alpha), SNIPER(ER)-87, that has a potent protein knockdown activity. The SNIPER(ER) reduced ER alpha levels in tumor xenografts and suppressed the growth of ER alpha-positive breast tumors in mice. Mechanistically, it preferentially recruits X-linked IAP (XIAP) rather than cellular IAP1, to degrade ER alpha via the ubiquitin-proteasome pathway. With this IAP ligand, potent SNIPERs against other pathogenic proteins, BCR-ABL, bromodo-main- containing protein 4 (BRD4), and phosphodiesterase-4 (PDE4) could also be developed. These results indicate that forced ubiquitylation by SNIPERs is a useful method to achieve efficient protein knockdown with potential therapeutic activities and could also be applied to study the role of ubiquitylation in many cellular processes.	[Ohoka, Nobumichi; Okuhira, Keiichiro; Shibata, Norihito; Hattori, Takayuki; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan; [Ito, Masahiro; Nagai, Katsunori; Ujikawa, Osamu; Shimokawa, Kenichiro; Nara, Hiroshi; Cho, Nobuo] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Med Chem Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Sano, Osamu; Koyama, Ryokichi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Fujita, Hisashi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Teratani, Mika; Matsumoto, Hirokazu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Technol Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Imaeda, Yasuhiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Okuhira, Keiichiro] Univ Tokushima, Grad Sch, Inst Biomed Sci, 1-78-1 Shomachi, Tokushima 7708505, Japan	National Institute of Health Sciences - Japan; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Tokushima University	Naito, M (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	miki-naito@nihs.go.jp		SHIBATA, NORIHITO/0000-0001-5792-8510; Shimokawa, Kenichiro/0000-0003-1982-0407; , Hiroshi/0000-0001-6770-2750	Japan Society for the Promotion of Science KAKENHI [26860049, 16H05090, 16K15121]; Japan Agency for Medical Research and Development [15ak0101029h1402, 16ak0101029j1403, 16cm0106124j0001]; Ministry of Health and Labor Welfare, Japan; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health and Labor Welfare, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 26860049 (to N. O.) and 16H05090 and 16K15121 (to M. N.), Japan Agency for Medical Research and Development Grants 15ak0101029h1402 and 16ak0101029j1403 (to M. N.) and 16cm0106124j0001 (to N. O.), the Ministry of Health and Labor Welfare, Japan (to M. N.), and Takeda Science Foundation (to N. O.). M. I., K. N., O. U., K. S., O. S., R. K., H. F., M. T., H. M., Y. I., H. N., and N. C. are employees of Takeda Pharmaceutical Co., Ltd. The authors filed a patent for the novel compounds described in this paper.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Demizu Y, 2012, BIOORG MED CHEM LETT, V22, P1793, DOI 10.1016/j.bmcl.2011.11.086; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Honsho M, 2016, BBA-MOL CELL RES, V1863, P984, DOI 10.1016/j.bbamcr.2015.09.032; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Itoh Y, 2010, J AM CHEM SOC, V132, P5820, DOI 10.1021/ja100691p; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mansoori B, 2014, ADV PHARM BULL, V4, P313, DOI 10.5681/apb.2014.046; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Ohoka N, 2016, CURR CANCER DRUG TAR, V16, P136, DOI 10.2174/1568009616666151112122502; Okuhira K, 2013, CANCER SCI, V104, P1492, DOI 10.1111/cas.12272; Okuhira K, 2011, FEBS LETT, V585, P1147, DOI 10.1016/j.febslet.2011.03.019; Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007; Pedersen J, 2014, TRENDS MOL MED, V20, P652, DOI 10.1016/j.molmed.2014.09.006; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sekine K, 2008, J BIOL CHEM, V283, P8961, DOI 10.1074/jbc.M709525200; Shibata N, 2015, J BIOL CHEM, V290, P28428, DOI 10.1074/jbc.M115.670901; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	40	140	155	3	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4556	4570		10.1074/jbc.M116.768853	http://dx.doi.org/10.1074/jbc.M116.768853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154167	Green Published, hybrid			2022-12-28	WOS:000397585100014
J	Yang, L; Scarlata, S				Yang, Lu; Scarlata, Suzanne			Super-resolution Visualization of Caveola Deformation in Response to Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; fluorescence; G protein; membrane structure; osmotic swelling	FLUORESCENCE CORRELATION SPECTROSCOPY; PROTEIN-COUPLED RECEPTORS; LIPID RAFTS; RYANODINE RECEPTORS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; HEK293 CELLS; CARDIOMYOCYTES; TRAFFICKING; G(S)	Caveolae are protein-dense plasma membrane domains structurally composed of caveolin-1 or -3 along with other proteins. Our previous studies have shown that caveolae enhance calcium signals generated through the G(q)/phospholipase C signaling pathway and that subjecting cells to hypo-osmotic stress reverses this enhancement. In this study, we have used super-resolution fluorescence microscopy supplemented by fluorescence correlation studies to determine the structural factors that underlie this behavior. We find similar and significant population of G(q) and one of its receptors, bradykinin type 2 receptor (B2R), as well as a significant population of G(i) and its coupled 2-adrenergic receptor (AR), are localized to caveola domains. Although mild osmotic stress deforms caveolae and alters interactions between the caveolae and these proteins, the general structure and the localization of caveola components remain largely unchanged. This deformation eliminates the ability of caveolae to stabilize calcium signals mediated through G(q)-B2R, but does not affect cAMP signals mediated through G(i) and AR. Structurally, we find that mild osmotic stress corresponding roughly to a pressure of 3.82 newtons/m(2) increases the domain diameter by approximate to 30% and increases the fluorescence intensity in the center of the domain mouth suggesting a flattening of the invagination. Approximate calculations show that caveolae in muscle tissue have the strength to handle the stress of muscle movement.	[Yang, Lu; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			National Institutes of Health [1S10OD016405-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116178] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Christian Soeller for advice on handling the super-resolution data, Dr. Yuanjian Guo for help with some of the experimental methods, and Dr. Urszula Golebiewska for reading the manuscript. The purchase of the Nikon SIM (or STORM) was supported, in part, by National Institutes of Health Grant 1S10OD016405-01.	Abulrob A, 2008, J MICROSC-OXFORD, V232, P225, DOI 10.1111/j.1365-2818.2008.02093.x; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Calizo RC, 2013, ANAL BIOCHEM, V440, P40, DOI 10.1016/j.ab.2013.04.033; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Gabor K, 2011, BIOPHYS J, V100, P21; Golias Ch, 2007, Hippokratia, V11, P124; Guo YJ, 2015, J BIOL CHEM, V290, P16698, DOI 10.1074/jbc.M115.655126; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Jayasinghe ID, 2012, BIOPHYS J, V102, pL9, DOI 10.1016/j.bpj.2012.01.034; Lamb ME, 2002, BIOCHEMISTRY-US, V41, P14340, DOI 10.1021/bi020231d; Lamb ME, 2001, BIOCHEM J, V355, P741, DOI 10.1042/bj3550741; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Murthy KS, 2000, J BIOL CHEM, V275, P30211, DOI 10.1074/jbc.M002194200; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; OHYASHIKI T, 1985, J BIOL CHEM, V260, P6857; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Philip Finly, 2006, Sci STKE, V2006, ppl5, DOI 10.1126/stke.3502006pl5; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Wong J, 2013, BIOPHYS J, V104, pL22, DOI 10.1016/j.bpj.2013.02.059	32	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3779	3788		10.1074/jbc.M116.768499	http://dx.doi.org/10.1074/jbc.M116.768499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096469	Green Published, hybrid			2022-12-28	WOS:000395542500020
J	Murakami, A; Matsuda, M; Harada, Y; Hirata, M				Murakami, Ayako; Matsuda, Miho; Harada, Yui; Hirata, Masato			Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; INS(1,4,5)P-3 BINDING-PROTEIN; ORTHODONTIC TOOTH MOVEMENT; NECROSIS-FACTOR RECEPTOR; GENE-EXPRESSION; EXPERIMENTAL-MODEL; GABA(A) RECEPTORS; NFATC1; CELLS; MICE	Phospholipase C-related, but catalytically inactive protein (PRIP) was previously identified as a novel inositol 1,4,5-trisphosphate-binding protein with a domain organization similar to that of phospholipase C-delta but lacking phospholipase activity. We recently showed that PRIP gene knock-out (KO) in mice increases bone formation and concomitantly decreases bone resorption, resulting in increased bone mineral density and trabecular bone volume. However, the role of PRIP in osteoclastogenesis has not yet been fully elucidated. Here, we investigated the effects of PRIP on bone remodeling by investigating dynamic tooth movement in mice fitted with orthodontic devices. Morphological analysis indicated that the extent of tooth movement was smaller in the PRIP-KO mice than in wild-type mice. Histological analysis revealed fewer osteoclasts on the bone-resorption side in maxillary bones of PRIP-KO mice, and osteoclast formation assays and flow cytometry indicated lower osteoclast differentiation in bone marrow cells isolated from these mice. The expression of genes implicated in bone resorption was lower in differentiated PRIP-KO cells, and genes involved in osteoclast differentiation, such as the transcription factor NFATc1, exhibited lower expression in immature PRIP-KO cells initiated by M-CSF. Moreover, calcineurin expression and activity were also lower in the PRIP-KO cells. The PRIP-KO cells also displayed fewer M-CSF-induced changes in intracellular Ca2+ and exhibited reduced nuclear localization of NFATc1. Up-regulation of intracellular Ca2+ restored osteoclastogenesis of the PRIP-KO cells. These results indicate that PRIP deficiency impairs osteoclast differentiation, particularly at the early stages, and that PRIP stimulates osteoclast differentiation through calcium-calcineurin-NFATc1 signaling via regulating intracellular Ca2+.	[Murakami, Ayako; Matsuda, Miho; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Harada, Yui] Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Fukuoka 8128582, Japan; [Hirata, Masato] Fukuoka Dent Coll, Fukuoka 8140175, Japan	Kyushu University; Kyushu University; Fukuoka Dental College (FDC)	Matsuda, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	natural@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24229009, 24592804]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research (KAKENHI nos. 24229009 (to M. H.) and 24592804 (to M. M.)) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andrade I, 2007, J DENT RES, V86, P1089, DOI 10.1177/154405910708601113; Andrade I, 2009, J DENT RES, V88, P1037, DOI 10.1177/0022034509346230; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crotti T. N., 2008, J CELL; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Inaba T, 1996, MOL CELL BIOL, V16, P2264; Inoue M, 1998, MOL ENDOCRINOL, V12, P1955, DOI 10.1210/me.12.12.1955; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kotani M, 2015, J CELL BIOCHEM, V116, P2814, DOI 10.1002/jcb.25228; Long Courtney L, 2012, Bonekey Rep, V1; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pavlin D, 2000, ORTHODONTICALLY STRE, V3, P55; Ren YJ, 2007, J PERIODONTOL, V78, P453, DOI 10.1902/jop.2007.060261; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; SHINAR DM, 1993, J BONE MINER RES, V8, P403; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Soysa Niroshani Surangika, 2012, J Med Dent Sci, V59, P65; STOREY E, 1973, AM J ORTHOD DENTOFAC, V63, P292, DOI 10.1016/0002-9416(73)90353-9; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugiyama Goro, 2013, Advances in Biological Regulation, V53, P331, DOI 10.1016/j.jbior.2013.07.001; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Toyoda H, 2015, PFLUG ARCH EUR J PHY, V467, P267, DOI 10.1007/s00424-014-1511-5; Tsutsumi K, 2011, J BIOL CHEM, V286, P31032, DOI 10.1074/jbc.M111.235903; Verna C, 2004, EUR J ORTHODONT, V26, P459, DOI 10.1093/ejo/26.5.459; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimatsu M, 2006, J BONE MINER METAB, V24, P20, DOI 10.1007/s00774-005-0641-4; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Zhu HJ, 1996, J CELL BIOCHEM, V61, P420; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	60	20	23	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7994	8006		10.1074/jbc.M117.784777	http://dx.doi.org/10.1074/jbc.M117.784777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28341745	Green Published, hybrid			2022-12-28	WOS:000401154100025
